Citrus Sinensis ID: 016152
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 394 | 2.2.26 [Sep-21-2011] | |||||||
| P18160 | 2410 | Dual specificity protein | yes | no | 0.581 | 0.095 | 0.412 | 1e-39 | |
| Q5GIG6 | 834 | Serine/threonine-protein | yes | no | 0.824 | 0.389 | 0.340 | 6e-38 | |
| Q59H18 | 835 | Serine/threonine-protein | no | no | 0.824 | 0.389 | 0.337 | 8e-38 | |
| Q7TQP6 | 835 | Serine/threonine-protein | yes | no | 0.824 | 0.389 | 0.337 | 9e-38 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.606 | 0.185 | 0.385 | 4e-37 | |
| Q54R58 | 918 | Probable tyrosine-protein | no | no | 0.558 | 0.239 | 0.412 | 4e-36 | |
| Q54N73 | 691 | Seven transmembrane domai | no | no | 0.545 | 0.311 | 0.402 | 3e-35 | |
| Q66L42 | 940 | Mitogen-activated protein | no | no | 0.545 | 0.228 | 0.387 | 1e-34 | |
| Q54IP4 | 653 | Dual specificity protein | no | no | 0.573 | 0.346 | 0.377 | 1e-34 | |
| Q3U1V8 | 1077 | Mitogen-activated protein | no | no | 0.550 | 0.201 | 0.384 | 3e-34 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 164 bits (415), Expect = 1e-39, Method: Composition-based stats.
Identities = 104/252 (41%), Positives = 145/252 (57%), Gaps = 23/252 (9%)
Query: 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
+ ++EID +EL+F + IGKG FGE+ + YWR T VAIK I + + F++EV
Sbjct: 2105 RSEYEIDFNELEFGQT--IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEV 2162
Query: 207 NLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKEKGAL---SPSTAVNFA 261
+L KLRHPN+VQFLGA T ++TE++ GG L ++L + L +P + A
Sbjct: 2163 GILSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLA 2222
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLL----------VNSSAD-HLKVGDFGLSKLIK 310
LDIA+GM YLH I+HRDL RN+LL V+S D K+ DFGLS+L
Sbjct: 2223 LDIAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKM 2282
Query: 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
Q S +MT G YMAPEVFK +K DV+S+ M+L+E+L + P + +P +
Sbjct: 2283 EQAS----QMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLFELLTSDEPQQDMKPMK 2338
Query: 371 AAKYVA-EGHRP 381
A A E +RP
Sbjct: 2339 MAHLAAYESYRP 2350
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2 |
| >sp|Q5GIG6|TNI3K_MOUSE Serine/threonine-protein kinase TNNI3K OS=Mus musculus GN=Tnni3k PE=2 SV=4 | Back alignment and function description |
|---|
Score = 158 bits (400), Expect = 6e-38, Method: Compositional matrix adjust.
Identities = 126/370 (34%), Positives = 183/370 (49%), Gaps = 45/370 (12%)
Query: 50 VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN--AQDRWKNTPLAD 107
V+ LL+++ ++ R D T LH A HG I + + L++ GAD+N A D +++ D
Sbjct: 321 VKFLLDQNAVNINHRGRDGHTGLHSACYHGHIRLVQFLLDNGADMNLVACDPSRSSGEKD 380
Query: 108 AEGA------KKFNMMELLNAHGGL--------SYGQNGSHFEPKPVPPPL-------PN 146
+ K + + L H Y Q G VP PL
Sbjct: 381 EQTCLMWAYEKGHDAIVTLLKHYKRPQDELPCNEYSQPGGDGSYVSVPSPLGKIKSMTKE 440
Query: 147 KCD-----------WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD 195
K D + + SE++F IIG GSFG++ K R VAIKR +
Sbjct: 441 KADVLLLRAELPSRFHLQLSEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCS 498
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-KPLMLITEYLRGGDLHKYLKE-KGALS 253
+ + F EV++L +L HP +VQF+GA + ++T+Y+ GG L L E K L
Sbjct: 499 KSDVDMFCREVSILCQLNHPCVVQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILD 558
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
+ + A+D+A+GM YLH+ IIHRDL N+LL H V DFG S+ ++
Sbjct: 559 LQSKLIIAVDVAKGMEYLHSLTQPIIHRDLNSHNILLYEDG--HAVVADFGESRFLQ--- 613
Query: 314 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372
S D MT + G+ R+MAPEVF +Y K DVFS+A+ L+E+L GE P A+ +P AA
Sbjct: 614 SLDEDNMTKQPGNLRWMAPEVFTQCTRYTIKADVFSYALCLWELLTGEIPFAHLKPAAAA 673
Query: 373 KYVAEGH-RP 381
+A H RP
Sbjct: 674 ADMAYHHIRP 683
|
May play a role in cardiac physiology. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q59H18|TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3 | Back alignment and function description |
|---|
Score = 158 bits (399), Expect = 8e-38, Method: Compositional matrix adjust.
Identities = 125/370 (33%), Positives = 184/370 (49%), Gaps = 45/370 (12%)
Query: 50 VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN--AQDRWKNTPLAD 107
V+ LL+++ ++ + D T LH A HG I + + L++ GAD+N A D +++ D
Sbjct: 322 VKFLLDQNVININHQGRDGHTGLHSACYHGHIRLVQFLLDNGADMNLVACDPSRSSGEKD 381
Query: 108 AEGA------KKFNMMELLNAHGGL--------SYGQNGSHFEPKPVPPPL-------PN 146
+ K + + L H Y Q G VP PL
Sbjct: 382 EQTCLMWAYEKGHDAIVTLLKHYKRPQDELPCNEYSQPGGDGSYVSVPSPLGKIKSMTKE 441
Query: 147 KCD-----------WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD 195
K D + + SE++F IIG GSFG++ K R VAIKR +
Sbjct: 442 KADILLLRAGLPSHFHLQLSEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCS 499
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGA-VTERKPLMLITEYLRGGDLHKYLKE-KGALS 253
+ + F EV++L +L HP ++QF+GA + + ++T+Y+ GG L L E K L
Sbjct: 500 KSDVDMFCREVSILCQLNHPCVIQFVGACLNDPSQFAIVTQYISGGSLFSLLHEQKRILD 559
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
+ + A+D+A+GM YLHN IIHRDL N+LL H V DFG S+ ++
Sbjct: 560 LQSKLIIAVDVAKGMEYLHNLTQPIIHRDLNSHNILLYEDG--HAVVADFGESRFLQ--- 614
Query: 314 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372
S D MT + G+ R+MAPEVF +Y K DVFS+A+ L+E+L GE P A+ +P AA
Sbjct: 615 SLDEDNMTKQPGNLRWMAPEVFTQCTRYTIKADVFSYALCLWEILTGEIPFAHLKPAAAA 674
Query: 373 KYVAEGH-RP 381
+A H RP
Sbjct: 675 ADMAYHHIRP 684
|
May play a role in cardiac physiology. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7TQP6|TNI3K_RAT Serine/threonine-protein kinase TNNI3K OS=Rattus norvegicus GN=Tnni3k PE=2 SV=3 | Back alignment and function description |
|---|
Score = 157 bits (398), Expect = 9e-38, Method: Compositional matrix adjust.
Identities = 125/370 (33%), Positives = 183/370 (49%), Gaps = 45/370 (12%)
Query: 50 VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN--AQDRWKNTPLAD 107
V+ LL+++ ++ R D T LH A HG I + + L++ GAD+N A D +++ D
Sbjct: 322 VKFLLDQNAVNINHRGRDGHTGLHSACYHGHIRLVQFLLDNGADMNLVACDPSRSSGEKD 381
Query: 108 AEGA------KKFNMMELLNAHGGL--------SYGQNGSHFEPKPVPPPL-------PN 146
+ K + + L H Y Q G VP PL
Sbjct: 382 EQTCLMWAYEKGHDAIVTLLKHYKRPQEELPCNEYSQPGGDGSYVSVPSPLGKIKSMTKE 441
Query: 147 KCD-----------WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD 195
K D + + SE++F IIG GSFG++ K R VAIKR +
Sbjct: 442 KADVLLLRAELPSRFHLQLSEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCS 499
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-KPLMLITEYLRGGDLHKYLKE-KGALS 253
+ + F EV++L +L HP +VQF+GA + ++T+Y+ GG L L E K L
Sbjct: 500 KSDVDMFCREVSILCQLNHPCVVQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILD 559
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
+ + A+D+A+GM YLH+ IIHRDL N+LL H V DFG S+ ++
Sbjct: 560 LQSKLIIAVDVAKGMEYLHSLTQPIIHRDLNSHNILLYEDG--HAVVADFGESRFLQ--- 614
Query: 314 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372
S D MT + G+ R+MAPEVF +Y K DVFS+++ L+E+L GE P A+ +P AA
Sbjct: 615 SLDEDNMTKQPGNLRWMAPEVFTQCTRYTIKADVFSYSLCLWELLTGEIPFAHLKPAAAA 674
Query: 373 KYVAEGH-RP 381
+A H RP
Sbjct: 675 ADMAYHHIRP 684
|
May play a role in cardiac physiology. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (393), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 99/257 (38%), Positives = 139/257 (54%), Gaps = 18/257 (7%)
Query: 130 QNGSHFEPKPVPPP----LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAI 185
QN H P P P + +WE+ SE+ A IG+G +G++ + WRGT VA+
Sbjct: 820 QNKDHQFPVPTIPAKIIEVEKPFEWEVPLSEIAIG--ARIGRGGYGQVFRGSWRGTEVAV 877
Query: 186 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL-HK 244
K + + +L I D R EV+LL KLRHPNIV F+GA TE ++TEYL G L +
Sbjct: 878 KMLFNDNVNLKL-ISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANI 936
Query: 245 YLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
L E + + D ARGM YLH+ +IIHRDLK N+L+ +S +KV DFG
Sbjct: 937 LLDESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSW--QVKVADFG 994
Query: 305 LSKLIKVQNSHDVYK-MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
L+ + SH K M G TG ++APEV Y +K DV+S+A++L+E+L P
Sbjct: 995 LATV----KSHTFAKTMCGTTG---WVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPY 1047
Query: 364 ANYEPYEAAKYVAEGHR 380
A + + + G R
Sbjct: 1048 AGKNTMQVVRSIDRGER 1064
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54R58|YTYK2_DICDI Probable tyrosine-protein kinase DDB_G0283397 OS=Dictyostelium discoideum GN=DDB_G0283397 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (384), Expect = 4e-36, Method: Compositional matrix adjust.
Identities = 96/233 (41%), Positives = 129/233 (55%), Gaps = 13/233 (5%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224
IG+G FG++ KA WRG VA+K+I D + F EV+++ KL HP V F+GA
Sbjct: 183 IGQGFFGKVYKARWRGKSVALKKITLIKFRDLTETEIFDKEVSIMSKLCHPTCVMFIGAC 242
Query: 225 TERKP---LMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHN--EPNV 277
+ P +I EY+ GG L + L EK + L PS ++ A DIA GM YLH +
Sbjct: 243 SLDGPSNDRSIIMEYMEGGSLRRLLDEKSSYHLPPSLQLSIARDIAEGMNYLHTNFKEGP 302
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
I+HRDL N+LL NSS K+ DFGLSK +K + +MT GS +MAPE FK
Sbjct: 303 IVHRDLTSSNILL-NSSYTVAKINDFGLSKEMKPGPT----EMTAAMGSLAWMAPECFKA 357
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390
Y +KVDV+SFA+IL+E++ P EP A ++A GF P
Sbjct: 358 ENYTEKVDVYSFAIILWEIVTCRDPYNGMEPLRLA-FLASVEDYRLPLNGFPP 409
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54N73|7TMK1_DICDI Seven transmembrane domain-containing tyrosine-protein kinase 1 OS=Dictyostelium discoideum GN=7tmk1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 149 bits (376), Expect = 3e-35, Method: Compositional matrix adjust.
Identities = 93/231 (40%), Positives = 130/231 (56%), Gaps = 16/231 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIK---RILPSLSDDRLVIQDFRHEVNLLVKLRH 214
+F +IG+G FGE+ KA W+G VA+K R +D F EV +L LRH
Sbjct: 362 EFKFGQVIGEGYFGEVRKAVWKGAVVAVKILHRNSFRNTDGNKEENVFLKEVAILSILRH 421
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGAL---SPSTAVNFALDIARGMAYL 271
PN++QFLG +E ++TEY+ GG L + L ++ L +P A N A+ IARGM YL
Sbjct: 422 PNVLQFLGVCSETNLNGIVTEYMGGGSLDRLLTDRYFLIKQNPILAWNMAISIARGMFYL 481
Query: 272 HN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
H+ +PN I+HRDL +N+LL + S KV DFGLSK ++MT G Y
Sbjct: 482 HDWKPNPILHRDLSTKNILL-DESLTIAKVADFGLSK-------EQGFEMTSTVGHLCYQ 533
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHR 380
APEVF Y K DV+SF ++++ ++ GE P N +P + A A E +R
Sbjct: 534 APEVFIGELYTPKADVYSFGLLVWCIITGEQPNQNLQPLKMAHLAAYENYR 584
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q66L42|M3K10_MOUSE Mitogen-activated protein kinase kinase kinase 10 OS=Mus musculus GN=Map3k10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 147 bits (371), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 91/235 (38%), Positives = 128/235 (54%), Gaps = 20/235 (8%)
Query: 154 PSELDFSS---SAIIGKGSFGEILKAYWRGTPVAIK--RILPSLSDDRLVIQDFRHEVNL 208
P E+ F IIG G FG++ +A WRG VA+K R+ P D + + R E L
Sbjct: 90 PQEIPFHELQLEEIIGVGGFGKVYRAVWRGEEVAVKAARLDPE-RDPAVTAEQVRQEARL 148
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
L+HPNI+ GA L L+ EY RGG L + L + + P VN+A+ +ARGM
Sbjct: 149 FGALQHPNIIALRGACLSPPNLCLVMEYARGGALSRVLAGR-RVPPHVLVNWAVQVARGM 207
Query: 269 AYLHNE-PNVIIHRDLKPRNVLLVNSSADH------LKVGDFGLSKLIKVQNSHDVYKMT 321
YLHN+ P IIHRDLK N+L++ + +H LK+ DFGL++ H KM+
Sbjct: 208 NYLHNDAPVPIIHRDLKSINILILEAIENHNLADTVLKITDFGLAR-----EWHKTTKMS 262
Query: 322 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376
G+Y +MAPEV + + K DV+SF ++L+E+L GE P + A VA
Sbjct: 263 A-AGTYAWMAPEVIRLSLFSKSSDVWSFGVLLWELLTGEVPYREIDALAVAYGVA 316
|
Activates the JUN N-terminal pathway. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 147 bits (371), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 91/241 (37%), Positives = 144/241 (59%), Gaps = 15/241 (6%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
WEID +E+ ++ A +G G+FG + K RG VAIK++ ++ ++ + +F+ EV+L+
Sbjct: 165 WEIDRNEISYNREAKLGSGAFGSVYKGIVRGKEVAIKKLTQTVFEEN-TMNEFKKEVSLM 223
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR--- 266
KLR+P+++ F+GA T + L ++TE + G +H L+ K S A+ IAR
Sbjct: 224 AKLRNPHLLLFMGACTAPEDLSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIARDTV 283
Query: 267 -GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
GM +LH + I+H DLKP N+L+ + +KV DFGLSK +K +S D K+ G+ G
Sbjct: 284 LGMTWLH--ASNILHLDLKPANLLVDQNWV--VKVADFGLSKYMK-PDSKD--KLLGQAG 336
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP---LANYEPYEAAKYVAEGHRPF 382
S YMAPE+ ++ YD KVDVFSF+++L+E+L + P L + P V + +RP
Sbjct: 337 SPLYMAPEMLVNQPYDGKVDVFSFSILLWELLTKQEPYNKLYSSYPQLVEGVVNKKNRPI 396
Query: 383 F 383
Sbjct: 397 I 397
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus GN=Map3k9 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 146 bits (368), Expect = 3e-34, Method: Compositional matrix adjust.
Identities = 90/234 (38%), Positives = 128/234 (54%), Gaps = 17/234 (7%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-RLVIQDFRHEVNLL 209
EID +EL IIG G FG++ +A+W G VA+K +D I++ R E L
Sbjct: 131 EIDFAELTLEE--IIGIGGFGKVYRAFWAGDEVAVKAARHDPDEDISQTIENVRQEAKLF 188
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
L+HPNI+ G + L L+ E+ RGG L++ L K + P VN+A+ IARGM
Sbjct: 189 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 247
Query: 270 YLHNEPNV-IIHRDLKPRNVLLVNS------SADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
YLH+E V IIHRDLK N+L++ S LK+ DFGL++ H KM+
Sbjct: 248 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSA 302
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376
G+Y +MAPEV + + K DV+S+ ++L+E+L GE P + A VA
Sbjct: 303 -AGTYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA 355
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 394 | ||||||
| 255562954 | 431 | protein kinase, putative [Ricinus commun | 0.989 | 0.904 | 0.913 | 0.0 | |
| 225462932 | 435 | PREDICTED: dual specificity protein kina | 1.0 | 0.905 | 0.878 | 0.0 | |
| 449434754 | 446 | PREDICTED: dual specificity protein kina | 0.989 | 0.874 | 0.886 | 0.0 | |
| 449478377 | 446 | PREDICTED: LOW QUALITY PROTEIN: dual spe | 0.989 | 0.874 | 0.884 | 0.0 | |
| 356521649 | 421 | PREDICTED: dual specificity protein kina | 0.941 | 0.881 | 0.878 | 0.0 | |
| 224101399 | 440 | predicted protein [Populus trichocarpa] | 0.946 | 0.847 | 0.917 | 0.0 | |
| 15223025 | 438 | VH1-interacting kinase [Arabidopsis thal | 1.0 | 0.899 | 0.858 | 0.0 | |
| 116643246 | 449 | flag-tagged protein kinase domain of put | 1.0 | 0.877 | 0.858 | 0.0 | |
| 18700097 | 438 | At1g14000/F7A19_9 [Arabidopsis thaliana] | 1.0 | 0.899 | 0.858 | 0.0 | |
| 297844308 | 438 | kinase family protein [Arabidopsis lyrat | 1.0 | 0.899 | 0.856 | 0.0 |
| >gi|255562954|ref|XP_002522482.1| protein kinase, putative [Ricinus communis] gi|223538367|gb|EEF39974.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 718 bits (1854), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/394 (91%), Positives = 376/394 (95%), Gaps = 4/394 (1%)
Query: 1 MSSGNSSPGDSTTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL 60
MSSG SS G +G S+DKQKEKARVSRTS+ILWHAHQNDAAAVRKLLEED+SL
Sbjct: 1 MSSGTSSAGGE----RGPPPPSSDKQKEKARVSRTSMILWHAHQNDAAAVRKLLEEDRSL 56
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V ARDYD+RTPLHVASLHGWIDVAKCLIE+GADVNAQDRWKNTPLADAEGAKK NM+ELL
Sbjct: 57 VRARDYDSRTPLHVASLHGWIDVAKCLIEFGADVNAQDRWKNTPLADAEGAKKHNMIELL 116
Query: 121 NAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG 180
++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+SAIIGKGSFGEILKAYWRG
Sbjct: 117 KSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSAIIGKGSFGEILKAYWRG 176
Query: 181 TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240
TPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE+KPLMLITEYLRGG
Sbjct: 177 TPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTEKKPLMLITEYLRGG 236
Query: 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300
DLH+YLKEKGALSPSTA+NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS+ADHLKV
Sbjct: 237 DLHQYLKEKGALSPSTAINFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSNADHLKV 296
Query: 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE 360
GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE
Sbjct: 297 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE 356
Query: 361 PPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
PPLANYEPYEAAK+VAEGHRP F AKGFT ELRE
Sbjct: 357 PPLANYEPYEAAKFVAEGHRPTFHAKGFTIELRE 390
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225462932|ref|XP_002266329.1| PREDICTED: dual specificity protein kinase pyk1 isoform 1 [Vitis vinifera] gi|296087790|emb|CBI35046.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1825), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/394 (87%), Positives = 372/394 (94%)
Query: 1 MSSGNSSPGDSTTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL 60
MS + + G ++ G ++DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL
Sbjct: 1 MSCRDDNSGGHSSTSAAGKDKASDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL 60
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
VHARDYD+RTPLHVASLHGWIDVAKCLIE+GADVNAQDRWKNTPLADAEGAKK +M+ELL
Sbjct: 61 VHARDYDSRTPLHVASLHGWIDVAKCLIEFGADVNAQDRWKNTPLADAEGAKKHSMIELL 120
Query: 121 NAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG 180
++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+S+IIGKGSFGEILKA WRG
Sbjct: 121 KSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSSIIGKGSFGEILKACWRG 180
Query: 181 TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240
TPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT++KPLMLITEYLRGG
Sbjct: 181 TPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTDKKPLMLITEYLRGG 240
Query: 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300
DLH+YLKEKG+LSPSTA+ FA+DIARGMAYLHNEPNVIIHRDLKPRNVLLVN+ ADHLKV
Sbjct: 241 DLHQYLKEKGSLSPSTAITFAMDIARGMAYLHNEPNVIIHRDLKPRNVLLVNTGADHLKV 300
Query: 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE 360
GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG+
Sbjct: 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGD 360
Query: 361 PPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
PPL+NYEPYEAAKYVAEG RP FRAKG+ EL+E
Sbjct: 361 PPLSNYEPYEAAKYVAEGQRPMFRAKGYITELKE 394
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434754|ref|XP_004135161.1| PREDICTED: dual specificity protein kinase splA-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 703 bits (1814), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/398 (88%), Positives = 376/398 (94%), Gaps = 8/398 (2%)
Query: 3 SGNSSPGDSTTPCKGG------ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE 56
+G+ SPG +T +G + +S +KQKEKARVSRTSLILWHAHQND +AVRKLLEE
Sbjct: 10 AGSPSPG--STGGRGNISSSSASGTSKEKQKEKARVSRTSLILWHAHQNDPSAVRKLLEE 67
Query: 57 DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNM 116
DQSLVHARDYD+RTPLHVASLHGWIDVAKCLIE+GADVNAQDRWKNTPLADAEGAKK M
Sbjct: 68 DQSLVHARDYDSRTPLHVASLHGWIDVAKCLIEHGADVNAQDRWKNTPLADAEGAKKHGM 127
Query: 117 MELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKA 176
+ELL ++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+SAIIGKGSFGEILKA
Sbjct: 128 IELLKSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSAIIGKGSFGEILKA 187
Query: 177 YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236
YWRGTPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE+KPLMLITEY
Sbjct: 188 YWRGTPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTEKKPLMLITEY 247
Query: 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
LRGGDLH+YLK+KG+LSP+TA+NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS AD
Sbjct: 248 LRGGDLHQYLKDKGSLSPATAINFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSGAD 307
Query: 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM
Sbjct: 308 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 367
Query: 357 LEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
LEG+PPLANYEPYEAAKYVAEGHRP FRAKG+ P LRE
Sbjct: 368 LEGDPPLANYEPYEAAKYVAEGHRPMFRAKGYLPVLRE 405
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449478377|ref|XP_004155301.1| PREDICTED: LOW QUALITY PROTEIN: dual specificity protein kinase splA-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 700 bits (1807), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/398 (88%), Positives = 375/398 (94%), Gaps = 8/398 (2%)
Query: 3 SGNSSPGDSTTPCKGG------ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE 56
+G+ SPG +T +G + +S +KQKEKARVSRTSLILWHAHQND +AVRKLLEE
Sbjct: 10 AGSPSPG--STGGRGNISSSSASGTSKEKQKEKARVSRTSLILWHAHQNDPSAVRKLLEE 67
Query: 57 DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNM 116
DQSLVHARDYD+RTPLHVASLHGWIDVAKCLIE+GADVNAQDRWKNTPLADAEGAKK M
Sbjct: 68 DQSLVHARDYDSRTPLHVASLHGWIDVAKCLIEHGADVNAQDRWKNTPLADAEGAKKHGM 127
Query: 117 MELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKA 176
+ELL ++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+SAIIGKGSFGEILKA
Sbjct: 128 IELLKSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSAIIGKGSFGEILKA 187
Query: 177 YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236
YWRGTPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE+KPLMLITEY
Sbjct: 188 YWRGTPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTEKKPLMLITEY 247
Query: 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
LRGGDLH+YLK+KG+LSP+TA+NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS AD
Sbjct: 248 LRGGDLHQYLKDKGSLSPATAINFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSGAD 307
Query: 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVD FSFAMILYEM
Sbjct: 308 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDXFSFAMILYEM 367
Query: 357 LEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
LEG+PPLANYEPYEAAKYVAEGHRP FRAKG+ P LRE
Sbjct: 368 LEGDPPLANYEPYEAAKYVAEGHRPMFRAKGYLPVLRE 405
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521649|ref|XP_003529466.1| PREDICTED: dual specificity protein kinase pyk1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 694 bits (1792), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 326/371 (87%), Positives = 353/371 (95%)
Query: 24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDV 83
+K+KEK RVSRTSLILWHAHQNDA +VRKLL+ED SLV ARDYDNRTPLHVASLHGWIDV
Sbjct: 10 EKEKEKQRVSRTSLILWHAHQNDAGSVRKLLQEDPSLVKARDYDNRTPLHVASLHGWIDV 69
Query: 84 AKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPP 143
A CLIE+GADVNAQDRWKNTPLADAEGAKK N++ELL +HGGLS+GQNGSHFEPKPV PP
Sbjct: 70 ATCLIEFGADVNAQDRWKNTPLADAEGAKKSNVIELLQSHGGLSFGQNGSHFEPKPVAPP 129
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFR 203
LPNKCDWE++P+ELDFS+S IGKGSFGEILKA+WRGTPVA+KRILPSLS+DRLVIQDFR
Sbjct: 130 LPNKCDWEVEPTELDFSNSVRIGKGSFGEILKAHWRGTPVAVKRILPSLSEDRLVIQDFR 189
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
HEVNLLVKLRHPNIVQFLGAVT RKPLMLITEYLRGGDLH+YLKEKGALSP+TA+NF++D
Sbjct: 190 HEVNLLVKLRHPNIVQFLGAVTARKPLMLITEYLRGGDLHQYLKEKGALSPATAINFSMD 249
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
I RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI VQ+SHDVYKMTGE
Sbjct: 250 IVRGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLITVQSSHDVYKMTGE 309
Query: 324 TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383
TGSYRYMAPEVFKHR+YDKKVDV+SFAMILYEMLEGEPP A+ EPYE AKY AEGHRP F
Sbjct: 310 TGSYRYMAPEVFKHRRYDKKVDVYSFAMILYEMLEGEPPFASREPYEGAKYAAEGHRPHF 369
Query: 384 RAKGFTPELRE 394
RAKG+TPEL+E
Sbjct: 370 RAKGYTPELQE 380
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224101399|ref|XP_002312262.1| predicted protein [Populus trichocarpa] gi|222852082|gb|EEE89629.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1781), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/374 (91%), Positives = 359/374 (95%), Gaps = 1/374 (0%)
Query: 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWI 81
+A KQKEKARVSRTSLILWHAHQNDAAAVRKLLEED SLV ARDYD RTPLHVASLHGWI
Sbjct: 26 TAGKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDPSLVSARDYDKRTPLHVASLHGWI 85
Query: 82 DVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVP 141
DVAKCLIE+GADVNAQDRWKNTPLADAEGAKK +M+ELL ++GGLSYGQNGSHFEPKPVP
Sbjct: 86 DVAKCLIEFGADVNAQDRWKNTPLADAEGAKKHSMIELLKSYGGLSYGQNGSHFEPKPVP 145
Query: 142 PPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD 201
PP PNKCDWEI+PSELDFS+S IIGKGSFGEILKA WRGTPVA+KRILPSLSDDRLVIQD
Sbjct: 146 PPQPNKCDWEIEPSELDFSNSNIIGKGSFGEILKASWRGTPVAVKRILPSLSDDRLVIQD 205
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLH+YLKEKGALSPSTA+NFA
Sbjct: 206 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHQYLKEKGALSPSTAINFA 265
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
LDIARGMA LHNEPNVI+HRDLKPRNVLLVNS+ADHLKVGDFGLSKLIKVQNSHDVYKMT
Sbjct: 266 LDIARGMACLHNEPNVIVHRDLKPRNVLLVNSNADHLKVGDFGLSKLIKVQNSHDVYKMT 325
Query: 322 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP +N+EPYEAAKYVAEGHRP
Sbjct: 326 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPFSNFEPYEAAKYVAEGHRP 385
Query: 382 FFRAKGFTP-ELRE 394
FR+KGF ELRE
Sbjct: 386 TFRSKGFNVFELRE 399
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15223025|ref|NP_172853.1| VH1-interacting kinase [Arabidopsis thaliana] gi|5080776|gb|AAD39286.1|AC007576_9 Similar to protein kinases [Arabidopsis thaliana] gi|111074450|gb|ABH04598.1| At1g14000 [Arabidopsis thaliana] gi|332190976|gb|AEE29097.1| VH1-interacting kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1780), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/397 (85%), Positives = 369/397 (92%), Gaps = 3/397 (0%)
Query: 1 MSSGNSSPGDSTTPCKGGAT---SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 57
MSS + + GD G + S DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED
Sbjct: 1 MSSDSPAAGDGGEQAAAGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60
Query: 58 QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
+LVHARDYD RTPLHVASLHGWIDV KCL+E+GADVNAQDRWKNTPLADAEGA+K M+
Sbjct: 61 PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120
Query: 118 ELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY 177
ELL +HGGLSYGQNGSHFEPKPVPPP+P KCDWEI+P+ELDFS++A+IGKGSFGEI+KAY
Sbjct: 121 ELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAY 180
Query: 178 WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237
WRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITEYL
Sbjct: 181 WRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYL 240
Query: 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
RGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSADH
Sbjct: 241 RGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADH 300
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR+YDKKVDVFSFAMILYEML
Sbjct: 301 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRRYDKKVDVFSFAMILYEML 360
Query: 358 EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
EGEPP AN+EPYEAAK+V++GHRP FR+KG TP+LRE
Sbjct: 361 EGEPPFANHEPYEAAKHVSDGHRPTFRSKGCTPDLRE 397
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116643246|gb|ABK06431.1| flag-tagged protein kinase domain of putative mitogen-activated protein kinase kinase kinase [synthetic construct] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1780), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/397 (85%), Positives = 369/397 (92%), Gaps = 3/397 (0%)
Query: 1 MSSGNSSPGDSTTPCKGGAT---SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 57
MSS + + GD G + S DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED
Sbjct: 1 MSSDSPAAGDGGEQAAAGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60
Query: 58 QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
+LVHARDYD RTPLHVASLHGWIDV KCL+E+GADVNAQDRWKNTPLADAEGA+K M+
Sbjct: 61 PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120
Query: 118 ELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY 177
ELL +HGGLSYGQNGSHFEPKPVPPP+P KCDWEI+P+ELDFS++A+IGKGSFGEI+KAY
Sbjct: 121 ELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAY 180
Query: 178 WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237
WRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITEYL
Sbjct: 181 WRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYL 240
Query: 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
RGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSADH
Sbjct: 241 RGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADH 300
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR+YDKKVDVFSFAMILYEML
Sbjct: 301 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRRYDKKVDVFSFAMILYEML 360
Query: 358 EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
EGEPP AN+EPYEAAK+V++GHRP FR+KG TP+LRE
Sbjct: 361 EGEPPFANHEPYEAAKHVSDGHRPTFRSKGCTPDLRE 397
|
Source: synthetic construct Species: synthetic construct Genus: N/A Family: N/A Order: N/A Class: N/A Phylum: N/A Superkingdom: |
| >gi|18700097|gb|AAL77660.1| At1g14000/F7A19_9 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1777), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/397 (85%), Positives = 369/397 (92%), Gaps = 3/397 (0%)
Query: 1 MSSGNSSPGDSTTPCKGGAT---SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 57
MSS + + GD G + S DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED
Sbjct: 1 MSSDSPAAGDGGEQAAVGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60
Query: 58 QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
+LVHARDYD RTPLHVASLHGWIDV KCL+E+GADVNAQDRWKNTPLADAEGA+K M+
Sbjct: 61 PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120
Query: 118 ELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY 177
ELL +HGGLSYGQNGSHFEPKPVPPP+P KCDWEI+P+ELDFS++A+IGKGSFGEI+KAY
Sbjct: 121 ELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAY 180
Query: 178 WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237
WRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITEYL
Sbjct: 181 WRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYL 240
Query: 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
RGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSADH
Sbjct: 241 RGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADH 300
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR+YDKKVDVFSFAMILYEML
Sbjct: 301 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRRYDKKVDVFSFAMILYEML 360
Query: 358 EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
EGEPP AN+EPYEAAK+V++GHRP FR+KG TP+LRE
Sbjct: 361 EGEPPFANHEPYEAAKHVSDGHRPTFRSKGCTPDLRE 397
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297844308|ref|XP_002890035.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297335877|gb|EFH66294.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 688 bits (1776), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/397 (85%), Positives = 369/397 (92%), Gaps = 3/397 (0%)
Query: 1 MSSGNSSPGDSTTPCKGGAT---SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 57
MSS + + GD G + S DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED
Sbjct: 1 MSSDSPASGDGGEQAAAGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60
Query: 58 QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
+LVHARDYD RTPLHVASLHGWIDV KCL+E+GADVNAQDRWKNTPLADAEGA+K M+
Sbjct: 61 PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120
Query: 118 ELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY 177
ELL +HGGLSYGQNGSHFEPKPVPPP+P KCDWEI+P+ELDFS++A+IGKGSFGEI+KAY
Sbjct: 121 ELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAY 180
Query: 178 WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237
WRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITEYL
Sbjct: 181 WRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYL 240
Query: 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
RGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSADH
Sbjct: 241 RGGDLHQYLKEKGGLTPATAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADH 300
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF+HR+YDKKVDVFSFAMILYEML
Sbjct: 301 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFRHRRYDKKVDVFSFAMILYEML 360
Query: 358 EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
EGEPP AN+EPYEAAK+V++GHRP FR+KG TP+LRE
Sbjct: 361 EGEPPFANHEPYEAAKHVSDGHRPTFRSKGCTPDLRE 397
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 394 | ||||||
| TAIR|locus:2014849 | 438 | VIK "VH1-interacting kinase" [ | 1.0 | 0.899 | 0.838 | 1.3e-180 | |
| TAIR|locus:2098999 | 471 | AT3G58760 [Arabidopsis thalian | 0.857 | 0.717 | 0.451 | 1e-68 | |
| TAIR|locus:2117129 | 459 | AT4G18950 [Arabidopsis thalian | 0.840 | 0.721 | 0.448 | 1e-68 | |
| TAIR|locus:2045258 | 476 | AT2G31800 [Arabidopsis thalian | 0.885 | 0.733 | 0.392 | 2.2e-59 | |
| TAIR|locus:2044034 | 479 | AT2G43850 [Arabidopsis thalian | 0.885 | 0.728 | 0.386 | 1.5e-58 | |
| TAIR|locus:2080517 | 477 | AT3G59830 [Arabidopsis thalian | 0.885 | 0.731 | 0.395 | 2.3e-55 | |
| UNIPROTKB|F1P6V7 | 835 | TNNI3K "Uncharacterized protei | 0.558 | 0.263 | 0.411 | 1.1e-42 | |
| UNIPROTKB|A0JNG5 | 835 | TNNI3K "TNNI3 interacting kina | 0.558 | 0.263 | 0.411 | 1.1e-42 | |
| UNIPROTKB|F1P4W8 | 935 | TNNI3K "Uncharacterized protei | 0.558 | 0.235 | 0.406 | 2e-42 | |
| UNIPROTKB|Q59H18 | 835 | TNNI3K "Serine/threonine-prote | 0.558 | 0.263 | 0.406 | 3.1e-42 |
| TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1753 (622.1 bits), Expect = 1.3e-180, P = 1.3e-180
Identities = 333/397 (83%), Positives = 360/397 (90%)
Query: 1 MSSGNSSPGDSTTPCKGGAT---SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 57
MSS + + GD G + S DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED
Sbjct: 1 MSSDSPAAGDGGEQAAAGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60
Query: 58 QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
+LVHARDYD RTPLHVASLHGWIDV KCL+E+GADVNAQDRWKNTPLADAEGA+K M+
Sbjct: 61 PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120
Query: 118 ELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY 177
ELL +HGGLSYGQNGSHFE KCDWEI+P+ELDFS++A+IGKGSFGEI+KAY
Sbjct: 121 ELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAY 180
Query: 178 WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237
WRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITEYL
Sbjct: 181 WRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYL 240
Query: 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
RGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSADH
Sbjct: 241 RGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADH 300
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR+YDKKVDVFSFAMILYEML
Sbjct: 301 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRRYDKKVDVFSFAMILYEML 360
Query: 358 EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
EGEPP AN+EPYEAAK+V++GHRP FR+KG TP+LRE
Sbjct: 361 EGEPPFANHEPYEAAKHVSDGHRPTFRSKGCTPDLRE 397
|
|
| TAIR|locus:2098999 AT3G58760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 697 (250.4 bits), Expect = 1.0e-68, P = 1.0e-68
Identities = 160/354 (45%), Positives = 214/354 (60%)
Query: 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
T +++ A++ D + K+L+ + V RD D RT LHVA+ G DV + L+ GA V
Sbjct: 50 TIRLMYLANEGDIDGINKMLDSGTN-VDYRDIDARTALHVAACQGRTDVVELLLSRGAKV 108
Query: 95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDP 154
+ +DRW +TPLADA K ++++LL HG ++EI P
Sbjct: 109 DTKDRWGSTPLADAVYYKNHDVIKLLEKHGA-------KPTIAPMHVLTDKEVPEYEIHP 161
Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
+ELDFS+S I KG+F KA WRG VA+K + D + FR E+ LL K+RH
Sbjct: 162 TELDFSNSVKISKGTFN---KASWRGIDVAVKTFGEEMFTDEDKVNAFRDELALLQKIRH 218
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH-N 273
PN+VQFLGAVT+ P+M++TEYL GDL +YL KG L P+ AV FAL+IARGM YLH +
Sbjct: 219 PNVVQFLGAVTQSTPMMIVTEYLPKGDLRQYLDRKGPLMPAHAVKFALEIARGMNYLHEH 278
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS--HDVYKMTGETGSYRYMA 331
+P IIH DL+P N+L +S HLKV DFG+SKL+ V+ + D +T S+RYMA
Sbjct: 279 KPEAIIHCDLEPPNILRDDSG--HLKVADFGVSKLLVVKKTVKKDRPVVTCLDSSWRYMA 336
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 385
PEV+++ +YD KVDVFSFA+IL EM+EG P E E K E RP F A
Sbjct: 337 PEVYRNEEYDTKVDVFSFALILQEMIEGCEPFHEIEDREVPKAYIEDERPPFNA 390
|
|
| TAIR|locus:2117129 AT4G18950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 697 (250.4 bits), Expect = 1.0e-68, P = 1.0e-68
Identities = 157/350 (44%), Positives = 221/350 (63%)
Query: 38 ILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97
+++ A++ D +++L++ + RD D+RT LHVA+ G DV + L++ A+V+ +
Sbjct: 47 LMYLANEGDIEGIKELIDSGID-ANYRDIDDRTALHVAACQGLKDVVELLLDRKAEVDPK 105
Query: 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDPSEL 157
DRW +TP ADA K +++++L HG + H + ++EI+PSEL
Sbjct: 106 DRWGSTPFADAIFYKNIDVIKILEIHGA-KHPMAPMHVKTAREVP------EYEINPSEL 158
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPS-LSDDRLVIQDFRHEVNLLVKLRHPN 216
DF+ S I KG++ A WRG VA+K++ LSDD V + F E+ LL +LRHPN
Sbjct: 159 DFTQSKEITKGTY---CMAMWRGIQVAVKKLDDEVLSDDDQV-RKFHDELALLQRLRHPN 214
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EP 275
IVQFLGAVT+ P+M++TEYL GDL + LK KG L P+TAV +ALDIARGM+YLH +
Sbjct: 215 IVQFLGAVTQSNPMMIVTEYLPRGDLRELLKRKGQLKPATAVRYALDIARGMSYLHEIKG 274
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
+ IIHRDL+P N+L +S HLKV DFG+SKL+ V+ T + S RY+APEVF
Sbjct: 275 DPIIHRDLEPSNILRDDSG--HLKVADFGVSKLVTVKEDKP---FTCQDISCRYIAPEVF 329
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 385
+YD K DVFSFA+I+ EM+EG P A E EA++ A HRP F+A
Sbjct: 330 TSEEYDTKADVFSFALIVQEMIEGRMPFAEKEDSEASEAYAGKHRPLFKA 379
|
|
| TAIR|locus:2045258 AT2G31800 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 609 (219.4 bits), Expect = 2.2e-59, P = 2.2e-59
Identities = 144/367 (39%), Positives = 210/367 (57%)
Query: 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
T +L+ A + D V+ LL+E V++ D D RT LH+A+ G +DV K L+ A++
Sbjct: 76 TMQLLFVACRGDVEGVQDLLDEGID-VNSIDLDGRTALHIAACEGHVDVVKLLLTRKANI 134
Query: 95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDP 154
+A+DRW +T ADA+ ++ +L A G + ++E++P
Sbjct: 135 DARDRWGSTAAADAKYYGNMDVFNILKARGA----KVPKTKRTPMVVANPREVPEYELNP 190
Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
EL + I KG + ++ K W GT V++K + L D I F+HE+ L K+RH
Sbjct: 191 QELQVRKADGISKGIY-QVAK--WNGTKVSVKILDKDLYKDSDTINAFKHELTLFEKVRH 247
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN- 273
PN+VQF+GAVT+ P+M+++EY GDL YL++KG LSP+ + FALDIARGM YLH
Sbjct: 248 PNVVQFVGAVTQNVPMMIVSEYHPKGDLGSYLQKKGRLSPAKVLRFALDIARGMNYLHEC 307
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG---ETGSYRYM 330
+P +IH DLKP+N++L S HLKV FGL K+ + G + +Y M
Sbjct: 308 KPEPVIHCDLKPKNIML--DSGGHLKVAGFGLISFAKLSSDKSKILNHGAHIDPSNY-CM 364
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRPFFRAKGFT 389
APEV+K +D+ VD +SF ++LYEM+EG P P EA K + EG RP F+AK +
Sbjct: 365 APEVYKDEIFDRSVDSYSFGVVLYEMIEGVQPFHPKPPEEAVKLMCLEGRRPSFKAKSKS 424
Query: 390 -P-ELRE 394
P E+RE
Sbjct: 425 CPQEMRE 431
|
|
| TAIR|locus:2044034 AT2G43850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 601 (216.6 bits), Expect = 1.5e-58, P = 1.5e-58
Identities = 142/367 (38%), Positives = 213/367 (58%)
Query: 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
T +L+ A + D + +LL+E V++ D D RT LH+A+ G + V K L+ A++
Sbjct: 79 TMQLLFMASKGDVRGIEELLDEGID-VNSIDLDGRTALHIAACEGHLGVVKALLSRRANI 137
Query: 95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDP 154
+A+DRW +T ADA+ ++ LL A G + + ++E++P
Sbjct: 138 DARDRWGSTAAADAKYYGNLDVYNLLKARGA----KVPKTRKTPMTVSNPREVPEYELNP 193
Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
E+ S I KG++ ++ K W GT V++K + D I FRHE+ LL K+RH
Sbjct: 194 LEVQVRKSDGISKGAY-QVAK--WNGTRVSVKILDKDSYSDPERINAFRHELTLLEKVRH 250
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN- 273
PN++QF+GAVT+ P+M++ EY GDL YL++KG LSPS A+ FALDIARGM YLH
Sbjct: 251 PNVIQFVGAVTQNIPMMIVVEYNPKGDLSVYLQKKGRLSPSKALRFALDIARGMNYLHEC 310
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV-QNSHDV--YKMTGETGSYRYM 330
+P+ IIH DLKP+N+LL LK+ FG+ +L K+ Q+ V +K + +Y Y+
Sbjct: 311 KPDPIIHCDLKPKNILL--DRGGQLKISGFGMIRLSKISQDKAKVANHKAHIDLSNY-YI 367
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRPFFRAKG-- 387
APEV+K +D +VD SF +ILYE+ EG P P E A+ + EG RP F+ K
Sbjct: 368 APEVYKDEIFDLRVDAHSFGVILYEITEGVPVFHPRPPEEVARMMCLEGKRPVFKTKSRS 427
Query: 388 FTPELRE 394
+ P+++E
Sbjct: 428 YPPDIKE 434
|
|
| TAIR|locus:2080517 AT3G59830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 571 (206.1 bits), Expect = 2.3e-55, P = 2.3e-55
Identities = 145/367 (39%), Positives = 204/367 (55%)
Query: 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
T +L+ A + D V +LL E V++ D D RT LH+AS G DV K L+ A++
Sbjct: 77 TMQLLFMASKGDVNGVEELLNEGID-VNSIDLDGRTALHIASCEGHYDVVKVLLSRRANI 135
Query: 95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDP 154
+A+DRW +T DA+ + LL A G + + ++E++P
Sbjct: 136 DARDRWGSTAAVDAKYYGNVEVYNLLKARGAKAPKTR----KTPMTVGNPKEVPEYELNP 191
Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLR 213
EL I KG++ ++ K W GT V++K S SD V F +E+ LL K R
Sbjct: 192 LELQVRKVDGISKGTY-QVAK--WNGTRVSVKIFDKDSYSDPERV-NAFTNELTLLAKAR 247
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
HPNIVQF+GAVT+ P+M++ E GDL YL++KG LSPS A+ FALDIARGM YLH
Sbjct: 248 HPNIVQFVGAVTQNLPMMIVVECNPKGDLSVYLQKKGRLSPSKALRFALDIARGMNYLHE 307
Query: 274 -EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV-QNSHDVYKMTGETG-SYRYM 330
+P+ IIH +L P+N+LL LK+ FGL KL K+ ++S V + S Y+
Sbjct: 308 CKPDPIIHCELMPKNILL--DRGGQLKISGFGLIKLSKIGEDSAKVVNHEAQIDKSNYYI 365
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRPFFR--AKG 387
APE++K +DK+ DV SF +ILYE+ EG P E A+ + EG RP R +K
Sbjct: 366 APEIYKDEVFDKRADVHSFGVILYELTEGVSLFHPKPPEEVAESICIEGKRPTIRTKSKS 425
Query: 388 FTPELRE 394
+ PEL+E
Sbjct: 426 YPPELKE 432
|
|
| UNIPROTKB|F1P6V7 TNNI3K "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 389 (142.0 bits), Expect = 1.1e-42, Sum P(2) = 1.1e-42
Identities = 95/231 (41%), Positives = 133/231 (57%)
Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
SE++F IIG GSFG++ K R VAIKR + + + F EV++L +L H
Sbjct: 461 SEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMFCREVSILCRLNH 518
Query: 215 PNIVQFLGA-VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLH 272
P I+QF+GA + + ++T+Y+ GG L L E K L + + A+D+A+GM YLH
Sbjct: 519 PCIIQFVGACLNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLIIAVDVAKGMEYLH 578
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
N IIHRDL N+LL H V DFG S+ ++ S D MT + G+ R+MAP
Sbjct: 579 NLTQPIIHRDLNSHNILLCEDG--HAVVADFGESRFLQ---SLDEDNMTKQPGNLRWMAP 633
Query: 333 EVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RP 381
EVF +Y K DVFS+A+ L+E+L GE P A+ +P AA +A H RP
Sbjct: 634 EVFTQCTRYTIKADVFSYALCLWELLTGEIPFAHLKPAAAAADMAYHHLRP 684
|
|
| UNIPROTKB|A0JNG5 TNNI3K "TNNI3 interacting kinase" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 389 (142.0 bits), Expect = 1.1e-42, Sum P(2) = 1.1e-42
Identities = 95/231 (41%), Positives = 133/231 (57%)
Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
SE++F IIG GSFG++ K R VAIKR + + + F EV++L +L H
Sbjct: 461 SEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMFCREVSILCRLNH 518
Query: 215 PNIVQFLGA-VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLH 272
P I+QF+GA + + ++T+Y+ GG L L E K L + + A+D+A+GM YLH
Sbjct: 519 PCIIQFVGACLNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLIIAVDVAKGMEYLH 578
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
N IIHRDL N+LL H V DFG S+ ++ S D MT + G+ R+MAP
Sbjct: 579 NLTQPIIHRDLNSHNILLYEDG--HAVVADFGESRFLQ---SLDEDNMTKQPGNLRWMAP 633
Query: 333 EVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RP 381
EVF +Y K DVFS+A+ L+E+L GE P A+ +P AA +A H RP
Sbjct: 634 EVFTQCTRYTIKADVFSYALCLWELLTGEIPFAHLKPAAAAADMAYHHIRP 684
|
|
| UNIPROTKB|F1P4W8 TNNI3K "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 388 (141.6 bits), Expect = 2.0e-42, Sum P(2) = 2.0e-42
Identities = 94/231 (40%), Positives = 133/231 (57%)
Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
SE++F IIG GSFG++ K R VAIKR + + + F EV++L +L H
Sbjct: 560 SEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMFCREVSILCRLNH 617
Query: 215 PNIVQFLGA-VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLH 272
P ++QF+GA + + ++T+Y+ GG L L E K L + + A+D+A+GM YLH
Sbjct: 618 PCVIQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRTLDLQSKLIIAVDVAKGMEYLH 677
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
N IIHRDL N+LL H V DFG S+ ++ S D MT + G+ R+MAP
Sbjct: 678 NLTQPIIHRDLNSHNILLYEDG--HAVVADFGESRFLQ---SLDEDNMTKQPGNLRWMAP 732
Query: 333 EVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RP 381
EVF +Y K DVFS+A+ L+E+L GE P A+ +P AA +A H RP
Sbjct: 733 EVFTQCTRYTIKADVFSYALCLWELLTGEIPFAHLKPAAAAADMAYHHIRP 783
|
|
| UNIPROTKB|Q59H18 TNNI3K "Serine/threonine-protein kinase TNNI3K" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 386 (140.9 bits), Expect = 3.1e-42, Sum P(2) = 3.1e-42
Identities = 94/231 (40%), Positives = 133/231 (57%)
Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
SE++F IIG GSFG++ K R VAIKR + + + F EV++L +L H
Sbjct: 461 SEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMFCREVSILCQLNH 518
Query: 215 PNIVQFLGA-VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLH 272
P ++QF+GA + + ++T+Y+ GG L L E K L + + A+D+A+GM YLH
Sbjct: 519 PCVIQFVGACLNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLIIAVDVAKGMEYLH 578
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
N IIHRDL N+LL H V DFG S+ ++ S D MT + G+ R+MAP
Sbjct: 579 NLTQPIIHRDLNSHNILLYEDG--HAVVADFGESRFLQ---SLDEDNMTKQPGNLRWMAP 633
Query: 333 EVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RP 381
EVF +Y K DVFS+A+ L+E+L GE P A+ +P AA +A H RP
Sbjct: 634 EVFTQCTRYTIKADVFSYALCLWEILTGEIPFAHLKPAAAAADMAYHHIRP 684
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00005943001 | SubName- Full=Chromosome undetermined scaffold_161, whole genome shotgun sequence; (435 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 394 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-75 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-74 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-70 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-68 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-66 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-66 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-63 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-49 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-46 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-43 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-43 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-42 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-42 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-42 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-40 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-40 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-39 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-38 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-38 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-38 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-37 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-37 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-37 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-37 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-37 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-36 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-36 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-35 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-35 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-34 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-34 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-33 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-33 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-33 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-32 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-32 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-32 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-32 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-32 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-31 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-31 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-31 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-31 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-30 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-30 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-30 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-30 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-29 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-29 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-29 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-29 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-29 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-29 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-29 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-29 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-29 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-29 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-28 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-28 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-28 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-28 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-27 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-27 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-27 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-27 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-27 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-27 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-27 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-27 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-26 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-26 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-26 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-26 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-26 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-26 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-26 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-26 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-25 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-25 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-25 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-25 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-25 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-25 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-24 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-24 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-24 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-24 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-24 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-24 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-24 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-24 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-24 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-24 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-23 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-23 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-23 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-23 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-23 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-23 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-23 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-23 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-23 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-23 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-22 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-22 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-22 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-22 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-22 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-22 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-22 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-21 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-21 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-21 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-21 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-21 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-21 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-20 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-20 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-20 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-20 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-20 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-20 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-20 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-19 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-19 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-19 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-18 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-18 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-18 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-17 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-17 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-17 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-16 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-15 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 2e-15 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 2e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-15 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-14 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 8e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-12 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-11 | |
| PTZ00322 | 664 | PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct | 1e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-11 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-09 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 7e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-08 | |
| pfam00023 | 33 | pfam00023, Ank, Ankyrin repeat | 2e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-08 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-07 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-06 | |
| pfam13606 | 30 | pfam13606, Ank_3, Ankyrin repeat | 5e-06 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 7e-06 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 9e-06 | |
| pfam13857 | 56 | pfam13857, Ank_5, Ankyrin repeats (many copies) | 9e-06 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 2e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 5e-05 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 5e-05 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 9e-05 | |
| smart00248 | 30 | smart00248, ANK, ankyrin repeats | 2e-04 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-04 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 3e-04 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 4e-04 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 5e-04 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 7e-04 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 0.001 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.002 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 0.002 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 0.004 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 232 bits (595), Expect = 7e-75
Identities = 85/226 (37%), Positives = 126/226 (55%), Gaps = 17/226 (7%)
Query: 164 IIGKGSFGEILKAYWRGTP------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G+G+FGE+ K +G VA+K + S+ I++F E ++ KL HPN+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNV 63
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPN 276
V+ LG TE +PL ++ EY+ GGDL YL++ + LS S ++FAL IARGM YL ++
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN- 122
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
IHRDL RN L+ +K+ DFGLS+ + D Y+ G R+MAPE K
Sbjct: 123 -FIHRDLAARNCLV--GENLVVKISDFGLSRDLY---DDDYYRKRGGKLPIRWMAPESLK 176
Query: 337 HRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381
K+ K DV+SF ++L+E+ GE P E +Y+ G+R
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRL 222
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 231 bits (591), Expect = 3e-74
Identities = 88/227 (38%), Positives = 128/227 (56%), Gaps = 18/227 (7%)
Query: 164 IIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G+G+FGE+ K +G VA+K + S+ I++F E ++ KL HPNI
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNI 63
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEP 275
V+ LG TE +PLM++ EY+ GGDL YL++ LS S ++FAL IARGM YL ++
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
IHRDL RN L+ +K+ DFGLS+ + D YK+ G R+MAPE
Sbjct: 124 --FIHRDLAARNCLV--GENLVVKISDFGLSRDLY---DDDYYKVKGGKLPIRWMAPESL 176
Query: 336 KHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381
K K+ K DV+SF ++L+E+ GE P E +Y+ +G+R
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRL 223
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 5e-70
Identities = 80/226 (35%), Positives = 127/226 (56%), Gaps = 18/226 (7%)
Query: 165 IGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+G+G+FGE+ K +G T VA+K + S++ ++F E +++ KL HPNIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKLSHPNIV 64
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNV 277
+ LG T+ +PL ++TEY+ GGDL +L++ G L+ + AL IA+GM YL ++
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN-- 122
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-GSYRYMAPEVFK 336
+HRDL RN L+ + +K+ DFGLS+ I D Y+ G ++MAPE K
Sbjct: 123 FVHRDLAARNCLV--TENLVVKISDFGLSRDIY---EDDYYRKRGGGKLPIKWMAPESLK 177
Query: 337 HRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381
K+ K DV+SF ++L+E+ GE P E + + +G+R
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRL 223
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 6e-68
Identities = 83/235 (35%), Positives = 123/235 (52%), Gaps = 15/235 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+G+GSFG++ A + T VAIK I + + E+ +L KL+HPNIV+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVI--KKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ L L+ EY GGDL LK++G LS A + I + YLH+ I+HR
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHS--KGIVHR 121
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
DLKP N+LL H+K+ DFGL++ + K+T G+ YMAPEV + Y
Sbjct: 122 DLKPENILLDEDG--HVKLADFGLARQL-----DPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 342 KKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPF-FRAKGFTPELRE 394
K VD++S +ILYE+L G+PP + + E K + + PF +PE ++
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD 229
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 4e-66
Identities = 81/234 (34%), Positives = 124/234 (52%), Gaps = 25/234 (10%)
Query: 164 IIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+G+G+FGE+ K +G T VA+K + S++ +DF E ++ KL HPN+V
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVV 59
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKE---------KGALSPSTAVNFALDIARGMA 269
+ LG TE +PL L+ EY+ GGDL YL++ K LS ++FA+ IA+GM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY-R 328
YL ++ +HRDL RN L+ +K+ DFGLS+ + D Y+ R
Sbjct: 120 YLASKK--FVHRDLAARNCLV--GEDLVVKISDFGLSRDV---YDDDYYRKKTGGKLPIR 172
Query: 329 YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381
+MAPE K + K DV+SF ++L+E+ G P E +Y+ +G+R
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL 226
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 5e-66
Identities = 84/205 (40%), Positives = 114/205 (55%), Gaps = 12/205 (5%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+G GSFG + KA +GT VA+K + + R E+ +L +L HPNIV+ +
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPNIVRLI 64
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
A ++ L L+ EY GGDL YL G LS A AL I RG+ YLH+ IIHR
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG--IIHR 122
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 340
DLKP N+LL + +K+ DFGL+K + +S +T G+ YMAPEV Y
Sbjct: 123 DLKPENILLDEN--GVVKIADFGLAKKLLKSSSS----LTTFVGTPWYMAPEVLLGGNGY 176
Query: 341 DKKVDVFSFAMILYEMLEGEPPLAN 365
KVDV+S +ILYE+L G+PP +
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSG 201
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 2e-63
Identities = 76/196 (38%), Positives = 105/196 (53%), Gaps = 13/196 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G FG + A + G VAIK I S L ++ E+ +L KL HPNIV+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKLNHPNIVKLYG 58
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ L L+ EY GG L LKE LS + L I G+ YLH+ IIHR
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHR 116
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KY 340
DLKP N+LL + + +K+ DFGLSKL+ + D + G+ YMAPEV + Y
Sbjct: 117 DLKPENILLDSDN-GKVKLADFGLSKLL----TSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 341 DKKVDVFSFAMILYEM 356
+K D++S +ILYE+
Sbjct: 172 SEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 4e-49
Identities = 67/229 (29%), Positives = 113/229 (49%), Gaps = 18/229 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
+++ ++G+GSFG + A + T +A+K + D ++ E+ +L L+HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHP 59
Query: 216 NIVQFLGAVTERKPLML--ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
NIV++ G+ + + L EY+ GG L LK+ G L + I G+AYLH+
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET---GSYRYM 330
N I+HRD+K N+L+ S +K+ DFG +K + D+ G G+ +M
Sbjct: 120 --NGIVHRDIKGANILV--DSDGVVKLADFGCAKRL-----GDIETGEGTGSVRGTPYWM 170
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEG 378
APEV + +Y + D++S + EM G+PP + P A +
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 3e-47
Identities = 84/234 (35%), Positives = 126/234 (53%), Gaps = 20/234 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
W I+ EL ++ IGKG FG+++ +RG VA+K L DD Q F E +++
Sbjct: 1 WAINSKELKLGAT--IGKGEFGDVMLGDYRGQKVAVK----CLKDDSTAAQAFLAEASVM 54
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARG 267
LRHPN+VQ LG V + PL ++TEY+ G L YL+ +G ++ + + FALD+ G
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
M YL E +HRDL RNVL+ S KV DFGL+K + D K+
Sbjct: 115 MEYL--EEKNFVHRDLAARNVLV--SEDLVAKVSDFGLAK--EASQGQDSGKL-----PV 163
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
++ APE + +K+ K DV+SF ++L+E+ G P + +V +G+R
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR 217
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 4e-46
Identities = 78/235 (33%), Positives = 124/235 (52%), Gaps = 18/235 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IGKG FGE+ KA + G VAIK I L S +I E+ +L K +HPNIV++
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN----EIQILKKCKHPNIVKYY 63
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF-ALDIARGMAYLHNEPNVIIH 280
G+ ++ L ++ E+ GG L LK + + + ++ +G+ YLH+ N IIH
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS--NGIIH 121
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RD+K N+LL S +K+ DFGLS ++ ++ M G + +MAPEV + Y
Sbjct: 122 RDIKAANILL-TSDG-EVKLIDFGLSA--QLSDTKARNTMVG---TPYWMAPEVINGKPY 174
Query: 341 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRE 394
D K D++S + E+ EG+PP + P +A +A P R + ++ E ++
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKD 229
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 6e-45
Identities = 83/235 (35%), Positives = 122/235 (51%), Gaps = 17/235 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNL 208
WE E F+ +G G FGE+ + W+ VAIK + SDD L QDF+ EV
Sbjct: 1 WERPREE--FTLERKLGSGYFGEVWEGLWKNRVRVAIKILK---SDDLLKQQDFQKEVQA 55
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
L +LRH +++ + +P+ +ITE + G L +L+ E L ++ ++ A +A
Sbjct: 56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAE 115
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
GMAYL E IHRDL RN+L+ KV DFGL++LIK DVY + +
Sbjct: 116 GMAYL--EEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIK----EDVYLSSDKKIP 167
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
Y++ APE H + K DV+SF ++LYEM G+ P +E + G+R
Sbjct: 168 YKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR 222
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 1e-43
Identities = 65/207 (31%), Positives = 118/207 (57%), Gaps = 21/207 (10%)
Query: 165 IGKGSFGEILKAYWR----GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
IGKGSFG++ R G +K I L ++S+ +D +EV +L KL HPNI++
Sbjct: 8 IGKGSFGKVYLV--RRKSDGKLYVLKEIDLSNMSEK--EREDALNEVKILKKLNHPNIIK 63
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGA----LSPSTAVNFALDIARGMAYLHNEP 275
+ + E+ L ++ EY GGDL + +K++ +++ + + + YLH+
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-- 121
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
I+HRD+KP+N+ L +S +K+GDFG+SK+ + ++ D+ K G+ Y++PE+
Sbjct: 122 RKILHRDIKPQNIFL--TSNGLVKLGDFGISKV--LSSTVDLAKTV--VGTPYYLSPELC 175
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPP 362
+++ Y+ K D++S +LYE+ + P
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 9e-43
Identities = 85/235 (36%), Positives = 123/235 (52%), Gaps = 22/235 (9%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
I PSEL IG G FG + YW VAIK I + +DF E +++
Sbjct: 1 IHPSELTLVQE--IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMM 54
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMA 269
KL HP +VQ G TER P+ L+ E++ G L YL+ ++G S T + LD+ GMA
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA 114
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS--- 326
YL E + +IHRDL RN L+ + +KV DFG+++ + D Y T TG+
Sbjct: 115 YL--ESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFV----LDDQY--TSSTGTKFP 164
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
++ +PEVF KY K DV+SF ++++E+ EG+ P N E + + G R
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR 219
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 2e-42
Identities = 85/234 (36%), Positives = 127/234 (54%), Gaps = 20/234 (8%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVNLL 209
I+PSEL F +G G FG + WR VAIK I ++S++ DF E ++
Sbjct: 1 INPSELTFMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-----DFIEEAKVM 53
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGM 268
+KL HP +VQ G T++KPL ++TE++ G L YL+++ G LS ++ D+ GM
Sbjct: 54 MKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGM 113
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTGETGSY 327
YL E N IHRDL RN L+ SS +KV DFG+++ + D Y +G
Sbjct: 114 EYL--ERNSFIHRDLAARNCLV--SSTGVVKVSDFGMTRYV----LDDEYTSSSGAKFPV 165
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
++ PEVF KY K DV+SF ++++E+ EG+ P YE + ++ G R
Sbjct: 166 KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR 219
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-42
Identities = 86/236 (36%), Positives = 129/236 (54%), Gaps = 24/236 (10%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVNLL 209
IDPSEL F +G G FG + WRG VAIK I ++S+D DF E ++
Sbjct: 1 IDPSELTFLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-----DFIEEAKVM 53
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
+KL HPN+VQ G T+++P+ ++TEY+ G L YL+E KG L ++ D+ M
Sbjct: 54 MKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAM 113
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS-- 326
YL E N IHRDL RN L+ + +KV DFGL++ + D Y T G+
Sbjct: 114 EYL--ESNGFIHRDLAARNCLV--GEDNVVKVSDFGLARYV----LDDQY--TSSQGTKF 163
Query: 327 -YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
++ PEVF + ++ K DV+SF ++++E+ EG+ P + E + V+ G+R
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR 219
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-42
Identities = 71/212 (33%), Positives = 114/212 (53%), Gaps = 9/212 (4%)
Query: 164 IIGKGSFGEILKAYW--RGTPVAIKRI--LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
++G+G+FG + Y G +A+K++ P + + + E+ LL L+H IVQ
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ G + + + L + EY+ GG + LK GAL+ + + I G+ YLH+ N+I+
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS--NMIV 126
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
HRD+K N+L SA ++K+GDFG SK ++ S M TG+ +M+PEV
Sbjct: 127 HRDIKGANIL--RDSAGNVKLGDFGASKRLQTICSSGTG-MKSVTGTPYWMSPEVISGEG 183
Query: 340 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
Y +K DV+S + EML +PP A +E A
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-40
Identities = 88/239 (36%), Positives = 126/239 (52%), Gaps = 23/239 (9%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-----PVAIKRILPSLSD-DRLVIQDFRHE 205
IDPS + +IG G FGE+ + + VAIK + SD RL DF E
Sbjct: 1 IDPS--YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL---DFLTE 55
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDI 264
+++ + HPNI++ G VT+ +P+M+ITEY+ G L K+L+E G + V I
Sbjct: 56 ASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGI 115
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTG 322
A GM YL V HRDL RN+ LVNS +L KV DFGLS+ + ++S Y G
Sbjct: 116 ASGMKYLSEMNYV--HRDLAARNI-LVNS---NLVCKVSDFGLSRRL--EDSEATYTTKG 167
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE-MLEGEPPLANYEPYEAAKYVAEGHR 380
R+ APE +RK+ DV+SF ++++E M GE P + + K V +G+R
Sbjct: 168 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 8e-40
Identities = 75/215 (34%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
WEI L +G G FGE+ W G T VA+K + P + F E +
Sbjct: 1 WEIPRESLKLERK--LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQI 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
+ KLRH +VQ +E +P+ ++TEY+ G L +LK E L V+ A IA
Sbjct: 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTGET 324
GMAYL E IHRDL RN+L+ ++L K+ DFGL++LI+ D Y T
Sbjct: 115 GMAYL--ESRNYIHRDLAARNILV----GENLVCKIADFGLARLIED----DEY--TARE 162
Query: 325 GS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
G+ ++ APE + ++ K DV+SF ++L E+
Sbjct: 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-39
Identities = 74/201 (36%), Positives = 111/201 (55%), Gaps = 12/201 (5%)
Query: 165 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+GKGSFG++L + T A+K + R ++ E N+L ++ HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
A + L L+ EY GG+L +L ++G S A +A +I + YLH+ II+RD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRD 118
Query: 283 LKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
LKP N+LL AD H+K+ DFGL+K + S + + G+ Y+APEV + Y
Sbjct: 119 LKPENILL---DADGHIKLTDFGLAK----ELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171
Query: 342 KKVDVFSFAMILYEMLEGEPP 362
K VD +S ++LYEML G+PP
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 144 bits (362), Expect = 3e-39
Identities = 73/207 (35%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP-NIVQFLGA 223
+G+GSFGE+ A VA+K + L ++ F E+ +L L HP NIV+
Sbjct: 8 LGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ L L+ EY+ GG L LK+ KG LS S A+ I + YLH IIH
Sbjct: 67 FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--SKGIIH 124
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIK--VQNSHDVYKMTGETGSYRYMAPEVFKH- 337
RD+KP N+LL + +K+ DFGL+KL+ S + G+ YMAPEV
Sbjct: 125 RDIKPENILL-DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 338 --RKYDKKVDVFSFAMILYEMLEGEPP 362
D++S + LYE+L G PP
Sbjct: 184 SLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 4e-39
Identities = 75/246 (30%), Positives = 124/246 (50%), Gaps = 17/246 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP EL + + IG+G+ GE+ KA R T VAIK++ + L+I E+ ++
Sbjct: 16 DPREL-YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMK 70
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMA 269
+HPNIV + + L ++ EY+ GG L + + ++ ++ +G+
Sbjct: 71 DCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLE 130
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 329
YLH+ +IHRD+K N+LL S +K+ DFG + Q + + K G+ +
Sbjct: 131 YLHS--QNVIHRDIKSDNILL--SKDGSVKLADFGFA----AQLTKEKSKRNSVVGTPYW 182
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRPFFRAKGF 388
MAPEV K + Y KVD++S ++ EM EGEPP P A + +G P + +
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW 242
Query: 389 TPELRE 394
+PE ++
Sbjct: 243 SPEFKD 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-38
Identities = 72/209 (34%), Positives = 108/209 (51%), Gaps = 22/209 (10%)
Query: 165 IGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRL--VIQDFRHEVNLLVKLRHPNI 217
+G GSFG + + W + PVA+K L D+L ++ DF E ++ L H N+
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVK----CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEP 275
++ G V PLM++TE G L L++ G ST ++A+ IA GM YL ++
Sbjct: 59 IRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEV 334
IHRDL RN+LL +S D +K+GDFGL + + + D Y M + + APE
Sbjct: 118 --FIHRDLAARNILL--ASDDKVKIGDFGLMRALP--QNEDHYVMEEHLKVPFAWCAPES 171
Query: 335 FKHRKYDKKVDVFSFAMILYEMLE-GEPP 362
+ R + DV+ F + L+EM GE P
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 6e-38
Identities = 72/225 (32%), Positives = 112/225 (49%), Gaps = 20/225 (8%)
Query: 165 IGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQ--DFRHEVNLLVKLRHPNI 217
+G G+FG ++K + VA+K +L + + +F E +++ +L HP I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVK----TLKQEHIAAGKKEFLREASVMAQLDHPCI 58
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
V+ +G V + +PLML+ E G L KYLK++ + S A +A GMAYL E
Sbjct: 59 VRLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL--ESKH 115
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM-TGETGSYRYMAPEVFK 336
+HRDL RNVLLVN K+ DFG+S+ + + D Y+ T ++ APE
Sbjct: 116 FVHRDLAARNVLLVNR--HQAKISDFGMSRALGAGS--DYYRATTAGRWPLKWYAPECIN 171
Query: 337 HRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
+ K+ K DV+S+ + L+E G P + E + G R
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER 216
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 8e-38
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 14/212 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKR--ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G GSFG + + G A+K + + ++ E+ LL KL+HPNIVQ+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
LG E L + E + GG L K LK+ G+ + I G+ YLH+ +H
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD--RNTVH 125
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-K 339
RD+K N+L+ + +K+ DFG++K + + +K GS +MAPEV +
Sbjct: 126 RDIKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFK-----GSPYWMAPEVIAQQGG 178
Query: 340 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
Y D++S + EM G+PP + E A
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAA 210
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 9e-38
Identities = 71/204 (34%), Positives = 113/204 (55%), Gaps = 18/204 (8%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+G+G++G + KA + G VA+K+I ++ + R E++LL +L+HPNIV+ L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPNIVKLL 64
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ + L L+ EY DL KYL ++ G LSP+ + + RG+AY H+ + I+H
Sbjct: 65 DVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS--HRILH 121
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKH 337
RDLKP+N+L+ + LK+ DFGL++ + T E T YR APE+
Sbjct: 122 RDLKPQNILI--NRDGVLKLADFGLARAF----GIPLRTYTHEVVTLWYR--APEILLGS 173
Query: 338 RKYDKKVDVFSFAMILYEMLEGEP 361
+ Y VD++S I EM+ G+P
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 76/207 (36%), Positives = 110/207 (53%), Gaps = 15/207 (7%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IGKGSFGE+ KA + T VAIK I L D+ I+D + E+ L + R P I ++
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE---IEDIQQEIQFLSQCRSPYITKYY 65
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
G+ + L +I EY GG LK G L + ++ G+ YLH E IHR
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEGK--IHR 122
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+K N+LL + D +K+ DFG+S Q + + K G+ +MAPEV K YD
Sbjct: 123 DIKAANILL-SEEGD-VKLADFGVSG----QLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEP 368
+K D++S + E+ +GEPPL++ P
Sbjct: 177 EKADIWSLGITAIELAKGEPPLSDLHP 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 6e-37
Identities = 71/239 (29%), Positives = 115/239 (48%), Gaps = 42/239 (17%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ---DFRH-----------EVNLL 209
IGKGSFG + K ++R SD ++++ D+ + EVN+L
Sbjct: 7 TIGKGSFGTVRK---------VRRK----SDGKILVWKEIDYGNMTEKEKQQLVSEVNIL 53
Query: 210 VKLRHPNIVQFLGAVTER--KPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALD 263
+L+HPNIV++ + +R + L ++ EY GGDL K KE+ +
Sbjct: 54 RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113
Query: 264 IARGMAYLHNEP---NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
+ + HN N ++HRDLKP N+ L + +++K+GDFGL+K++ HD
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFL--DANNNVKLGDFGLAKIL----GHDSSFA 167
Query: 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 379
G+ YM+PE H YD+K D++S ++YE+ PP + A + EG
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 6e-37
Identities = 80/236 (33%), Positives = 124/236 (52%), Gaps = 19/236 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
WEID + + +G G FGE+ + W TPVA+K + P D +DF E +
Sbjct: 1 WEIDRTSIQLLRK--LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQI 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
+ KLRHP ++Q T +P+ ++TE ++ G L +YL+ AL ++ A +A
Sbjct: 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS 114
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM-TGETG 325
GMAYL E IHRDL RNVL+ ++ KV DFGL+++IK D+Y+ G
Sbjct: 115 GMAYL--EAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIK----EDIYEAREGAKF 166
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
++ APE + ++ K DV+SF ++L E++ G P E + V +G+R
Sbjct: 167 PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR 222
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 7e-37
Identities = 68/235 (28%), Positives = 113/235 (48%), Gaps = 17/235 (7%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
E + ++G G+FG + K W PVAIK + ++ E
Sbjct: 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAY 61
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIAR 266
++ + HP++V+ LG + + LIT+ + G L Y++ K + +N+ + IA+
Sbjct: 62 VMASVDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
GM+YL E ++HRDL RNVL+ + H+K+ DFGL+KL+ V Y G
Sbjct: 121 GMSYL--EEKRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLDVDEKE--YHAEGGKVP 174
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
++MA E HR Y K DV+S+ + ++E++ G P E + +G R
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 7e-37
Identities = 73/204 (35%), Positives = 107/204 (52%), Gaps = 10/204 (4%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
I KG++G + A + T AIK I + + + E ++L + + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ +K L L+ EYL GGDL L+ G+L A + +I + YLH+ N IIHRD
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHS--NGIIHRD 118
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSYRYMAPEVFKHR 338
LKP N+L+ S HLK+ DFGLSK+ V+ ++ E G+ Y+APEV +
Sbjct: 119 LKPDNILI--DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 339 KYDKKVDVFSFAMILYEMLEGEPP 362
+ K VD +S ILYE L G PP
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 9e-37
Identities = 85/237 (35%), Positives = 128/237 (54%), Gaps = 16/237 (6%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHE 205
EI PS + + +IG G FGE+ + + VAIK + P ++ + QDF E
Sbjct: 1 EIHPSHI--TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSE 56
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDI 264
+++ + H NI++ G VT+ KP M+ITEY+ G L KYL++ G S V I
Sbjct: 57 ASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGI 116
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
A GM YL + V HRDL RN+ LVNS+ + KV DFGLS++++ + Y +G
Sbjct: 117 AAGMKYLSDMNYV--HRDLAARNI-LVNSNLE-CKVSDFGLSRVLE-DDPEGTYTTSGGK 171
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYE-MLEGEPPLANYEPYEAAKYVAEGHR 380
R+ APE +RK+ DV+SF ++++E M GE P + +E K + +G R
Sbjct: 172 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 74/237 (31%), Positives = 122/237 (51%), Gaps = 20/237 (8%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+IG+G+FG + K G VAIK+I ++ E++LL L+HPNIV+++
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLE-KIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
G++ L +I EY G L + +K+ G S + + +G+AYLH + +IHR
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHR 123
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLS-KLIKV-QNSHDVYKMTGETGSYRYMAPEVFKHRK 339
D+K N+L + +K+ DFG++ KL V ++ V G+ +MAPEV +
Sbjct: 124 DIKAANILT--TKDGVVKLADFGVATKLNDVSKDDASV------VGTPYWMAPEVIEMSG 175
Query: 340 YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY--VAEGHRPFFRAKGFTPELRE 394
D++S + E+L G PP + P AA + V + H P +G +PEL++
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPM-AALFRIVQDDHPPL--PEGISPELKD 229
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 8e-36
Identities = 85/236 (36%), Positives = 124/236 (52%), Gaps = 24/236 (10%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVNLL 209
IDP +L F +G G FG + WRG VAIK I S+S+D +F E ++
Sbjct: 1 IDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVM 53
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGM 268
+KL H +VQ G T+++P+ ++TEY+ G L YL+E G PS + D+ GM
Sbjct: 54 MKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGM 113
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS-- 326
AYL E IHRDL RN LV+ +KV DFGLS+ + D Y T GS
Sbjct: 114 AYL--ESKQFIHRDLAARNC-LVDDQGC-VKVSDFGLSRYV----LDDEY--TSSVGSKF 163
Query: 327 -YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
R+ PEV + K+ K DV++F ++++E+ G+ P + E + V++G R
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 73/249 (29%), Positives = 124/249 (49%), Gaps = 32/249 (12%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS-DDRLVIQD 201
WE+ ++ +G+GSFG + + +G T VAIK + + S +R+ +
Sbjct: 1 WELPREKITLIRE--LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI---E 55
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK--------GALS 253
F +E +++ + ++V+ LG V+ +P +++ E + GDL YL+ + G
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 254 PST--AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
P+ + A +IA GMAYL +HRDL RN ++ + +K+GDFG+++ I
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMV--AEDLTVKIGDFGMTRDI-- 169
Query: 312 QNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 369
D Y+ G+ R+MAPE K + K DV+SF ++L+EM E P
Sbjct: 170 -YETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE 228
Query: 370 EAAKYVAEG 378
E K+V +G
Sbjct: 229 EVLKFVIDG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-35
Identities = 67/221 (30%), Positives = 115/221 (52%), Gaps = 15/221 (6%)
Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
IGKG+FG++ K + T VA+K +L D + + F E +L + HPNIV+ +G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD--LKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 224 VTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+++P+ ++ E + GG L +L K+K L+ + +LD A GM YL E IHRD
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESKNCIHRD 118
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS--YRYMAPEVFKHRKY 340
L RN L+ + LK+ DFG+S+ + +Y ++ ++ APE + +Y
Sbjct: 119 LAARNCLV--GENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 341 DKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
+ DV+S+ ++L+E G+ P + + + G+R
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR 213
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 9e-35
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+IGKG+FG++ R T A+K + ++ +++ +E +L +L HP +V
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ + + + L+ + L GGDL +L +K S + +I + YLH+ IIHR
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS--KGIIHR 124
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+KP N+LL H+ + DF ++ + T +G+ YMAPEV + Y
Sbjct: 125 DIKPDNILLDEQG--HVHITDFNIATKV-----TPDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 342 KKVDVFSFAMILYEMLEGEPP 362
VD +S + YE L G+ P
Sbjct: 178 VAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 69/214 (32%), Positives = 109/214 (50%), Gaps = 20/214 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+G+G FG++ + G VA+K + S + DF E+ +L L H NIV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQ--HRSDFEREIEILRTLDHENIV 69
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEP 275
++ G + + L LI EYL G L YL+ + ++ + F+ I +GM YL ++
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
IHRDL RN+L+ S D +K+ DFGL+K++ + K GE+ + Y APE
Sbjct: 130 --YIHRDLAARNILV--ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 336 KHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEP 368
+ K+ DV+SF + LYE+ G+P + P
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDP---SQSP 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 79/235 (33%), Positives = 124/235 (52%), Gaps = 22/235 (9%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
W ++ EL + IGKG FG+++ +RG VA+K I + Q F E +++
Sbjct: 1 WALNMKELKLLQT--IGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVM 53
Query: 210 VKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIAR 266
+LRH N+VQ LG + E K L ++TEY+ G L YL+ +G L + F+LD+
Sbjct: 54 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
M YL E N +HRDL RNVL+ S + KV DFGL+K + ++ D K+
Sbjct: 114 AMEYL--EANNFVHRDLAARNVLV--SEDNVAKVSDFGLTK--EASSTQDTGKL-----P 162
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
++ APE + +K+ K DV+SF ++L+E+ G P + V +G++
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK 217
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 79/221 (35%), Positives = 122/221 (55%), Gaps = 14/221 (6%)
Query: 164 IIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
++GKG+FGE+ K + TPVA+K L + L I+ F E +L + HPNIV+ +G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE-LKIK-FLSEARILKQYDHPNIVKLIG 59
Query: 223 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
T+R+P+ ++ E + GGD +L K+K L V FALD A GMAYL E IHR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL--ESKNCIHR 117
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG-ETGSYRYMAPEVFKHRKY 340
DL RN L+ ++ LK+ DFG+S+ Q +Y +G + ++ APE + +Y
Sbjct: 118 DLAARNCLVGENNV--LKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 341 DKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
+ DV+S+ ++L+E G P +A + V +G+R
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR 212
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 5e-33
Identities = 69/215 (32%), Positives = 117/215 (54%), Gaps = 25/215 (11%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
WE++ +++ +G G +GE+ + W+ VA+K +L +D + +++F E
Sbjct: 1 WEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVK----TLKEDTMEVEEFLKEAA 54
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIA 265
++ +++HPN+VQ LG T P +ITE++ G+L YL+E + ++ + A I+
Sbjct: 55 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGET 324
M YL E IHRDL RN L+ +HL KV DFGLS+L+ D Y T
Sbjct: 115 SAMEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT----GDTY--TAHA 163
Query: 325 GS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
G+ ++ APE + K+ K DV++F ++L+E+
Sbjct: 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 9e-33
Identities = 73/218 (33%), Positives = 114/218 (52%), Gaps = 37/218 (16%)
Query: 165 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G+G+FG++ K G T VAIK + + V Q+FR E L+ L+HPNI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMSDLQHPNI 70
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYL----------------KEKGALSPSTAVNFA 261
V LG T+ +P ++ EYL GDLH++L K +L S ++ A
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYK 319
+ IA GM YL + + +HRDL RN L+ + L K+ DFGLS+ I S D Y+
Sbjct: 131 IQIAAGMEYLSS--HHFVHRDLAARNCLV----GEGLTVKISDFGLSRDIY---SADYYR 181
Query: 320 MTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
+ ++ R+M PE + K+ + D++SF ++L+E+
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-32
Identities = 80/236 (33%), Positives = 122/236 (51%), Gaps = 16/236 (6%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEV 206
ID S + +IG G FGE+ R PVAIK + ++ + +DF E
Sbjct: 1 IDASCIKIEK--VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEA 56
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIA 265
+++ + HPNI+ G VT+ KP+M++TEY+ G L +L K G + V IA
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIA 116
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
GM YL + V HRDL RN+ LVNS+ KV DFGLS++++ + Y G
Sbjct: 117 SGMKYLSDMGYV--HRDLAARNI-LVNSNL-VCKVSDFGLSRVLE-DDPEAAYTTRGGKI 171
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
R+ APE +RK+ DV+S+ ++++E++ GE P + K + EG+R
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR 227
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 16/219 (7%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
E F +G+GS+G + KA + G VAIK ++P D +Q+ E+++L +
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIK-VVPVEED----LQEIIKEISILKQCD 56
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLH 272
P IV++ G+ + L ++ EY G + +K + L +G+ YLH
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
+ N IHRD+K N+LL + K+ DFG+S Q + + K G+ +MAP
Sbjct: 117 S--NKKIHRDIKAGNILL--NEEGQAKLADFGVSG----QLTDTMAKRNTVIGTPFWMAP 168
Query: 333 EVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
EV + Y+ K D++S + EM EG+PP ++ P A
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 73/238 (30%), Positives = 125/238 (52%), Gaps = 19/238 (7%)
Query: 164 IIGKGSFGEILKAYW--RGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRH---PNI 217
+IG+G++G + + G VA+K I L + DD + D + EV LL +LR PNI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD---VSDIQREVALLSQLRQSQPPNI 64
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
++ G+ + L +I EY GG + + L + G ++ ++ + Y+H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVG-- 121
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
+IHRD+K N+L+ N+ ++K+ DFG++ L+ QNS K + G+ +MAPEV
Sbjct: 122 VIHRDIKAANILVTNTG--NVKLCDFGVAALL-NQNSS---KRSTFVGTPYWMAPEVITE 175
Query: 338 -RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
+ YD K D++S + +YEM G PP ++ + + A + + P G++ LRE
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE 233
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 67/225 (29%), Positives = 113/225 (50%), Gaps = 15/225 (6%)
Query: 165 IGKGSFGEILKAYW--RGTPVAIK--RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
IG G+FG++ A G +A+K RI + D I++ E+ +L L+HPN+V++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDN---DPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
G R+ + + EY GG L + L+ L + L + G+AYLH+ + I+H
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS--HGIVH 122
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RD+KP N+ L ++ +K+GDFG + +K + ++ G+ YMAPEV K
Sbjct: 123 RDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 341 DKK---VDVFSFAMILYEMLEGEPPLANYEPYEAAKY-VAEGHRP 381
D++S ++ EM G+ P + + + V GH+P
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 80/233 (34%), Positives = 120/233 (51%), Gaps = 18/233 (7%)
Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDD-----RLVIQDFRHEVNLLVKLRH 214
A+IG GSFG + G +A+K++ LPS+S R ++ E+ LL +L+H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
NIVQ+LG+ + L + EY+ GG + L GA + NF I +G+ YLHN
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE----TGSYRYM 330
IIHRD+K N+L+ N +K+ DFG+SK K++ + K G GS +M
Sbjct: 126 G--IIHRDIKGANILVDNKGG--IKISDFGISK--KLEANSLSTKTNGARPSLQGSVFWM 179
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383
APEV K Y +K D++S ++ EML G+ P + +A + E P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 74/201 (36%), Positives = 110/201 (54%), Gaps = 18/201 (8%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G G+FG + A G VAIK+I+ S L + +R E+ LL LRH NI+
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76
Query: 223 A-VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
++ + + +TE L G DLH+ L + L F I RG+ Y+H+ ++HR
Sbjct: 77 IFISPLEDIYFVTE-LLGTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAG--VVHR 132
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 340
DLKP N +L+N + D LK+ DFGL++ +Q+ MTG + Y APE+ +KY
Sbjct: 133 DLKPSN-ILINENCD-LKICDFGLAR---IQDPQ----MTGYVSTRYYRAPEIMLTWQKY 183
Query: 341 DKKVDVFSFAMILYEMLEGEP 361
D +VD++S I EMLEG+P
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 14/235 (5%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+GS G + K + T A+K+I + D + E+ L P +V+ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
A + + ++ EY+ GG L LK+ G + A I +G+ YLH + + IIHRD
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH-IIHRD 125
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK 342
+KP N+L+ +S +K+ DFG+SK++ + T G+ YM+PE + Y
Sbjct: 126 IKPSNLLI--NSKGEVKIADFGISKVL---ENTLDQCNTFV-GTVTYMSPERIQGESYSY 179
Query: 343 KVDVFSFAMILYEMLEGEPPLA---NYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
D++S + L E G+ P +E + + +G P A+ F+PE R+
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-32
Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G+ G + KA R T VA+K++ + + Q R E+ L +HP +V+ L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLD 66
Query: 223 AVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+L+ EY+ DL + L+ E+ L + ++ + +G+AY+H N I+HR
Sbjct: 67 VFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA--NGIMHR 123
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 340
DLKP N+L+ S+ LK+ DFGL+ ++ + + + + + Y APE+ + RKY
Sbjct: 124 DLKPANLLI--SADGVLKIADFGLA---RLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 341 DKKVDVFSFAMILYEMLEGEP 361
D VD+++ I E+L G P
Sbjct: 179 DPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 9e-32
Identities = 72/216 (33%), Positives = 108/216 (50%), Gaps = 26/216 (12%)
Query: 164 IIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
+G+G FGE+ A +G T V +K + + D + +FR E+++ KL H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA--------LSPSTAVNFALDIARG 267
+V+ LG E +P +I EY GDL ++L+ K LS V IA G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
M +L N +HRDL RN L+ SS +KV LSK V NS + YK+
Sbjct: 130 MDHLSN--ARFVHRDLAARNCLV--SSQREVKVSLLSLSK--DVYNS-EYYKLRNALIPL 182
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPP 362
R++APE + + K DV+SF ++++E+ +GE P
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-31
Identities = 79/254 (31%), Positives = 128/254 (50%), Gaps = 35/254 (13%)
Query: 165 IGKGSFGEILKAYWR-GTP------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G+G+FG++ P VA+K + + S+D +DF E LL +H NI
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND--ARKDFEREAELLTNFQHENI 70
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLK--------------EKGALSPSTAVNFALD 263
V+F G TE P +++ EY+ GDL+K+L+ G L+ S + A+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTG 322
IA GM YL ++ V HRDL RN L+ D + K+GDFG+S+ + + D Y++ G
Sbjct: 131 IASGMVYLASQHFV--HRDLATRNCLV---GYDLVVKIGDFGMSRDVY---TTDYYRVGG 182
Query: 323 ETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
T R+M PE +RK+ + DV+SF ++L+E+ G+ P E + + +G R
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG-R 241
Query: 381 PFFRAKGFTPELRE 394
R + E+ +
Sbjct: 242 LLQRPRTCPSEVYD 255
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G++G + KA + G VAIK+I + + R E+ LL +L HPNI++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ L L+ E++ DL+K +K++ L S ++ + +G+A+ H+ + I+HR
Sbjct: 66 VFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS--HGILHR 122
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 340
DLKP N+L+ ++ LK+ DFGL++ T + Y APE+ + Y
Sbjct: 123 DLKPENLLI--NTEGVLKLADFGLARSFGSPVRP----YTHYVVTRWYRAPELLLGDKGY 176
Query: 341 DKKVDVFSFAMILYEMLEGEP 361
VD++S I E+L P
Sbjct: 177 STPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 72/222 (32%), Positives = 115/222 (51%), Gaps = 16/222 (7%)
Query: 165 IGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G+FGE+ R TPVA+K +L D + F E +L + HPNIV+ +G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD--LKAKFLQEARILKQYSHPNIVRLIG 60
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
T+++P+ ++ E ++GGD +L+ +G L + + A GM YL E IHR
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL--ESKHCIHR 118
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG--ETGSYRYMAPEVFKHRK 339
DL RN L+ + LK+ DFG+S+ + VY TG + ++ APE + +
Sbjct: 119 DLAARNCLVTEKNV--LKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 340 YDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
Y + DV+SF ++L+E G P AN + + + +G R
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR 214
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 18/215 (8%)
Query: 163 AIIGKGSFGEILKA--YWRGTPVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G G+F +A GT +A+K++ + S+ V++ R E+ L+ +L HP+I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
++ LGA E L E++ GG + L + GA + +N+ + RG++YLH N
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE--NQ 123
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE-----TGSYRYMAP 332
IIHRD+K N LL++S+ L++ DFG + + + + GE G+ +MAP
Sbjct: 124 IIHRDVKGAN-LLIDSTGQRLRIADFGAAARLAAKGTG-----AGEFQGQLLGTIAFMAP 177
Query: 333 EVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367
EV + +Y + DV+S ++ EM +PP +
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 9e-31
Identities = 79/224 (35%), Positives = 121/224 (54%), Gaps = 21/224 (9%)
Query: 164 IIGKGSFGEILKAYW--RGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
++G+G+FGE+ Y G +A+K++ P + + E+ LL LRH IVQ
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 220 FLGAVT--ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
+ G + E K L + EY+ GG + LK GAL+ + + I +G++YLH+ N+
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS--NM 126
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE-----TGSYRYMAP 332
I+HRD+K N+L SA ++K+GDFG SK I+ + M+G TG+ +M+P
Sbjct: 127 IVHRDIKGANIL--RDSAGNVKLGDFGASKRIQT-----IC-MSGTGIKSVTGTPYWMSP 178
Query: 333 EVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376
EV Y +K DV+S A + EML +PP A YE A +A
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 69/223 (30%), Positives = 114/223 (51%), Gaps = 29/223 (13%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLV----IQDFRHEVNLLVK 211
DF +G GSFG ++ +G+ A+K LS ++V ++ +E +L
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKI----LSKAKIVKLKQVEHVLNEKRILQS 57
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
+RHP +V G+ + L L+ EY+ GG+L +L++ G A +A + + YL
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSY 327
H+ I++RDLKP N+LL S ++K+ DFG +K +K G T G+
Sbjct: 118 HS--LDIVYRDLKPENLLL--DSDGYIKITDFGFAKRVK-----------GRTYTLCGTP 162
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
Y+APE+ + Y K VD ++ +++YEML G PP + P +
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH-----EVNLLV 210
DF IIG+GSF ++ A + AIK + D R +I++ + E +L
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-----DKRQLIKEKKVKYVKIEKEVLT 56
Query: 211 KL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
+L HP I++ + + L + EY G+L +Y+++ G+L +A +I +
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK------------VQNSHDV 317
YLH+ IIHRDLKP N+LL H+K+ DFG +K++ +
Sbjct: 117 YLHS--KGIIHRDLKPENILL--DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 318 YKMTGETGSY----RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
K S+ Y++PE+ + K D+++ I+Y+ML G+PP
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 17/213 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G++G++ KA G VAIK I DD +IQ E+++L + RHPNIV + G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ---QEISMLKECRHPNIVAYFG 67
Query: 223 AVTERKPLMLITEYLRGGDLHK-YLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ R L ++ EY GG L Y +G LS + +G+AYLH IHR
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE--TGKIHR 125
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF---KHR 338
D+K N+LL + +K+ DFG+S + + + K G+ +MAPEV +
Sbjct: 126 DIKGANILL--TEDGDVKLADFGVSAQL----TATIAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
YD K D+++ + E+ E +PP+ + P A
Sbjct: 180 GYDGKCDIWALGITAIELAELQPPMFDLHPMRA 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 76/215 (35%), Positives = 112/215 (52%), Gaps = 25/215 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR---GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLR 213
DF +GKGS+G + K R A+K + L S+S +D +E+ +L +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKER--EDAVNEIRILASVN 57
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL---KEKGALSPSTAV-NFALDIARGMA 269
HPNI+ + A + L ++ EY GDL K + K+K L P + + + RG+
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSY 327
LH I+HRDLK N+LLV + D +K+GD G+SK++K K +T G+
Sbjct: 118 ALHE--QKILHRDLKSANILLVAN--DLVKIGDLGISKVLK--------KNMAKTQIGTP 165
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
YMAPEV+K R Y K D++S +LYEM PP
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 73/220 (33%), Positives = 113/220 (51%), Gaps = 19/220 (8%)
Query: 164 IIGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRL------VIQDFRHEVNLLVKLRH 214
+IGKG++G + A G +A+K++ LP+ R +++ R E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
NIVQ+LG T + L + EY+ GG + L+ G F + G+AYLH++
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 275 PNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
I+HRDLK N+L+ AD + K+ DFG+SK K + +D + GS +MAPE
Sbjct: 128 G--ILHRDLKADNLLV---DADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 334 VF--KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
V + Y KVD++S ++ EM G P ++ E A
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 79/264 (29%), Positives = 126/264 (47%), Gaps = 39/264 (14%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDR 196
LP +WE+ L + +G+G+FG+++KA G VA+K + ++
Sbjct: 1 LPLDPEWELPRDRL--TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58
Query: 197 LVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------ 249
L D E+ ++ + +H NI+ LG T+ PL ++ EY G+L +L+ +
Sbjct: 59 LS--DLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEY 116
Query: 250 ----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-L 298
L+ V+FA +ARGM +L IHRDL RNVL+ + DH +
Sbjct: 117 ASPDDPRPPEETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLV---TEDHVM 171
Query: 299 KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYE-M 356
K+ DFGL++ I + D Y+ T ++MAPE R Y + DV+SF ++L+E
Sbjct: 172 KIADFGLARDI---HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
Query: 357 LEGEPPLANYEPYEAAKYVAEGHR 380
G P E K + EG+R
Sbjct: 229 TLGGSPYPGIPVEELFKLLKEGYR 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-30
Identities = 75/226 (33%), Positives = 118/226 (52%), Gaps = 11/226 (4%)
Query: 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKL 212
+++ ++G+G+FG + Y G +A K++ P + + E+ LL L
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 213 RHPNIVQFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+H IVQ+ G + +R K L + EY+ GG + LK GAL+ S + I GM+Y
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 121
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH+ N+I+HRD+K N+L SA ++K+GDFG SK ++ + TG+ +M
Sbjct: 122 LHS--NMIVHRDIKGANIL--RDSAGNVKLGDFGASKRLQTICMSGT-GIRSVTGTPYWM 176
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376
+PEV Y +K DV+S + EML +PP A YE A +A
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 9e-30
Identities = 69/234 (29%), Positives = 119/234 (50%), Gaps = 23/234 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRH 214
D +G G+FG + R A+K + +P + + Q +E +L ++ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVSH 60
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
P I++ +++ L ++ EY+ GG+L YL+ G S ST + +A +I + YLH++
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSYRYM 330
I++RDLKP N+LL H+K+ DFG +K K+ T G+ Y+
Sbjct: 121 E--IVYRDLKPENILL--DKEGHIKLTDFGFAK-----------KLRDRTWTLCGTPEYL 165
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384
APEV + + ++K VD ++ +++YEML G PP + P+ + + G F R
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR 219
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 65/224 (29%), Positives = 114/224 (50%), Gaps = 10/224 (4%)
Query: 164 IIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQDFR---HEVNLLVKLRHPNIVQ 219
++GKG++G + +G +A+K++ S+ +++ EV+LL L+H NIVQ
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+LG + + + E++ GG + L G L + I G+AYLHN N ++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN--NCVV 124
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK--MTGETGSYRYMAPEVFKH 337
HRD+K NV+L+ + +K+ DFG ++ + H + + G+ +MAPEV
Sbjct: 125 HRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
Y +K D++S ++EM G+PPLA+ + A Y+
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL 226
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 73/204 (35%), Positives = 105/204 (51%), Gaps = 33/204 (16%)
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242
VA+K + P SD+ +DF EV +L +L PNI + LG T PL +I EY+ GDL
Sbjct: 49 VAVKVLRPDASDNAR--EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 243 HKYLKE-----------KGALSPSTAVNFALDIARGMAYL--HNEPNVIIHRDLKPRNVL 289
+++L++ +LS ST + A IA GM YL N +HRDL RN
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN----FVHRDLATRNC- 161
Query: 290 LVNSSADHLKVGDFGLSKLIKVQN--SHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDV 346
LV + +K+ DFG+S+ N S D Y++ G R+MA E K+ K DV
Sbjct: 162 LVGKNY-TIKIADFGMSR-----NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215
Query: 347 FSFAMILYEMLEGEPPLANYEPYE 370
++F + L+E+L L +PYE
Sbjct: 216 WAFGVTLWEILT----LCREQPYE 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 73/212 (34%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 164 IIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG G++G + A G VAIK+I D + R E+ LL LRH NI+ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLL 65
Query: 222 GAVTERKP-----LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH--NE 274
+ P + ++TE + DLHK +K L+ F I RG+ YLH N
Sbjct: 66 DILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN- 123
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAP 332
+IHRDLKP N +LVNS+ D LK+ DFGL++ + + +T T YR AP
Sbjct: 124 ---VIHRDLKPSN-ILVNSNCD-LKICDFGLARGVDPDEDEKGF-LTEYVVTRWYR--AP 175
Query: 333 EV---FKHRKYDKKVDVFSFAMILYEMLEGEP 361
E+ Y K +D++S I E+L +P
Sbjct: 176 ELLLSSSR--YTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 73/209 (34%), Positives = 114/209 (54%), Gaps = 18/209 (8%)
Query: 164 IIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+IG G FGE+ + R VAIK + ++ + +DF E +++ + HPNI+
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPNII 68
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNV 277
G VT+ +P+M+ITE++ G L +L++ G + V IA GM YL +E N
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL-SEMNY 127
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS---YRYMAPEV 334
+HRDL RN+ LVNS+ KV DFGLS+ ++ S Y T G R+ APE
Sbjct: 128 -VHRDLAARNI-LVNSNL-VCKVSDFGLSRFLEDDTSDPTY--TSSLGGKIPIRWTAPEA 182
Query: 335 FKHRKYDKKVDVFSFAMILYEMLE-GEPP 362
+RK+ DV+S+ ++++E++ GE P
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 72/235 (30%), Positives = 111/235 (47%), Gaps = 28/235 (11%)
Query: 165 IGKGSFGEILKAYWRGT-------PVAIKRI--LPSLSDDRLVIQDFRHEVNLLVKLRHP 215
+G G+FGE+ + +RG VA+K + S D+ DF E ++ K H
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE----SDFLMEALIMSKFNHQ 69
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-------GALSPSTAVNFALDIARGM 268
NIV+ +G ER P ++ E + GGDL +L+E +L+ + A D+A+G
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGETG-S 326
YL E N IHRD+ RN LL + K+ DFG+++ I Y+ G
Sbjct: 130 KYL--EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY---RASYYRKGGRAMLP 184
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
++M PE F + K DV+SF ++L+E+ G P E ++V G R
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR 239
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 76/236 (32%), Positives = 126/236 (53%), Gaps = 29/236 (12%)
Query: 165 IGKGSFGEILKAY-WRGTPVAIKRILP--SLSDDRLVI-QDFRHEVNLLVKLRHPNIVQF 220
+G+G+FG++ A + +P K ++ +L D L +DF+ E LL L+H +IV+F
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLK----------------EKGALSPSTAVNFALDI 264
G + PL+++ EY++ GDL+K+L+ KG L S ++ A I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
A GM YL ++ +HRDL RN L+ + +K+GDFG+S+ + S D Y++ G T
Sbjct: 133 ASGMVYLASQH--FVHRDLATRNCLVGANLL--VKIGDFGMSRDVY---STDYYRVGGHT 185
Query: 325 G-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEG 378
R+M PE +RK+ + DV+SF +IL+E+ G+ P E + + +G
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 68/235 (28%), Positives = 106/235 (45%), Gaps = 31/235 (13%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +IG+G+FGE+ + T A+K + S R I R E ++L P
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
IV+ + + + L L+ EY+ GGDL L K TA + ++ + +H
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI--------KVQNSHDVYKMTGET--- 324
IHRD+KP N+L+ + H+K+ DFGL K + + +SH++
Sbjct: 122 --FIHRDIKPDNILI--DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 325 --------------GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN 365
G+ Y+APEV + Y + D +S +ILYEML G PP +
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-29
Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 165 IGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G+ + A VAIKRI L + + + R EV + + HPN+V++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRI--DLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 223 AVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ L L+ YL GG L K +G L + ++ +G+ YLH+ N I
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQI 124
Query: 280 HRDLKPRNVLLVNSSADH--LKVGDFGLSKLI--KVQNSHDVYKMTGETGSYRYMAPEVF 335
HRD+K N+LL + +K+ DFG+S + + V K G+ +MAPEV
Sbjct: 125 HRDIKAGNILL----GEDGSVKIADFGVSASLADGGDRTRKVRKTF--VGTPCWMAPEVM 178
Query: 336 K-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
+ YD K D++SF + E+ G P + Y P +
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-29
Identities = 76/241 (31%), Positives = 115/241 (47%), Gaps = 35/241 (14%)
Query: 164 IIGKGSFGEILKAYWRGT------------PVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
+G G+FGE+ + GT VA+K + +D +F E +L+
Sbjct: 2 FLGSGAFGEV----YEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSN 55
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------LSPSTAVNFALDI 264
HPNIV+ LG +P +I E + GGDL YL++ L+ ++ LD+
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIKVQNSHDVYKMT 321
A+G YL E IHRDL RN L+ D +K+GDFGL++ I D Y+
Sbjct: 116 AKGCVYL--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY---KSDYYRKE 170
Query: 322 GETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH 379
GE R+MAPE K+ + DV+SF ++++E+L G+ P E ++V G
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG 230
Query: 380 R 380
R
Sbjct: 231 R 231
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-29
Identities = 79/237 (33%), Positives = 123/237 (51%), Gaps = 31/237 (13%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP+ F +IG+G++G++ KA + G VAIK I+ + D+ ++ + E N+L
Sbjct: 3 DPTG-IFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDE---EEEIKEEYNILR 57
Query: 211 KL-RHPNIVQFLGAVTERKP------LMLITEYLRGG---DLHKYLKEKGALSPSTAVNF 260
K HPNI F GA ++ P L L+ E GG DL K L++KG + +
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 261 AL-DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
L + RG+AYLH N +IHRD+K +N+LL ++ +K+ DFG+S Q + +
Sbjct: 118 ILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNA--EVKLVDFGVSA----QLDSTLGR 169
Query: 320 MTGETGSYRYMAPEVF-----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
G+ +MAPEV YD + DV+S + E+ +G+PPL + P A
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA 226
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 9e-29
Identities = 81/246 (32%), Positives = 124/246 (50%), Gaps = 41/246 (16%)
Query: 165 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G+G+FG++ A VA+K + + R QDF+ E LL L+H +I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTVLQHQHI 69
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---------------GALSPSTAVNFAL 262
V+F G TE +PL+++ EY+R GDL+++L+ G L+ + A
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKM 320
IA GM YL + +HRDL RN L+ L K+GDFG+S+ I S D Y++
Sbjct: 130 QIASGMVYLASLH--FVHRDLATRNCLV----GQGLVVKIGDFGMSRDIY---STDYYRV 180
Query: 321 TGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPP---LANYEPYEAAKYV 375
G T R+M PE +RK+ + D++SF ++L+E+ G+ P L+N E E
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240
Query: 376 AEGHRP 381
E RP
Sbjct: 241 RELERP 246
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 78/237 (32%), Positives = 123/237 (51%), Gaps = 28/237 (11%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
W ++ +L IIG+G FG +L+ + G VA+K I ++ Q F E ++
Sbjct: 1 WLLNLQKLTLG--EIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT-----AQAFLEETAVM 53
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTA--VNFALDIARG 267
KL H N+V+ LG + L ++ E + G+L +L+ +G S + F+LD+A G
Sbjct: 54 TKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEG 112
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKL--IKVQNSHDVYKMTGET 324
M YL E ++HRDL RN+L+ S D + KV DFGL+++ + V NS K T
Sbjct: 113 MEYL--ESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGVDNSKLPVKWT--- 164
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
APE KH+K+ K DV+S+ ++L+E+ G P E + V +G+R
Sbjct: 165 ------APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR 215
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 74/215 (34%), Positives = 116/215 (53%), Gaps = 25/215 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 212
DF+ ++GKGSFG+++ A +GT AIK L D ++IQD E ++ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK----ILKKD-VIIQDDDVECTMVEKRVLA 55
Query: 213 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
+ P + Q L + EY+ GGDL ++++ G AV +A +IA G+
Sbjct: 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF 115
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSY 327
+LH++ II+RDLK NV+L + H+K+ DFG+ K + T T G+
Sbjct: 116 FLHSKG--IIYRDLKLDNVML--DAEGHIKIADFGMCK------ENIFGGKTTRTFCGTP 165
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
Y+APE+ ++ Y K VD ++F ++LYEML G+PP
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-28
Identities = 75/246 (30%), Positives = 117/246 (47%), Gaps = 40/246 (16%)
Query: 165 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
IG+G+FG + +A G T VA+K + S D + DF+ E L+ + HPNI
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFDHPNI 70
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE----------------------KGALSPS 255
V+ LG KP+ L+ EY+ GDL+++L+ LS +
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
+ A +A GMAYL +HRDL RN L+ + +K+ DFGLS+ I S
Sbjct: 131 EQLCIAKQVAAGMAYLSE--RKFVHRDLATRNCLVGENMV--VKIADFGLSRNIY---SA 183
Query: 316 DVYKMTG-ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 373
D YK + + R+M PE + +Y + DV+++ ++L+E+ G P E
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243
Query: 374 YVAEGH 379
YV +G+
Sbjct: 244 YVRDGN 249
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 8e-28
Identities = 74/235 (31%), Positives = 119/235 (50%), Gaps = 17/235 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
WEI + +G G FGE+ Y+ T VA+K + P + +Q F E NL
Sbjct: 1 WEIPRESIKLVKK--LGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEEANL 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
+ L+H +V+ VT+ +P+ +ITEY+ G L +LK E G + ++F+ IA
Sbjct: 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
GMAY+ E IHRDL+ NVL+ S + K+ DFGL+++I+ ++ G
Sbjct: 115 GMAYI--ERKNYIHRDLRAANVLV--SESLMCKIADFGLARVIE---DNEYTAREGAKFP 167
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
++ APE + K DV+SF ++LYE++ G+ P + + G+R
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR 222
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-28
Identities = 66/201 (32%), Positives = 109/201 (54%), Gaps = 17/201 (8%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+GKG+FG + + G VA+K++ S ++ ++DF E+ +L L+H NIV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH---LRDFEREIEILKSLQHDNIV 68
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
++ G R+ L L+ EYL G L YL K + L + +A I +GM YL ++
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
+HRDL RN+L+ + + +K+GDFGL+K++ + + GE+ + Y APE
Sbjct: 129 --YVHRDLATRNILVESEN--RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESL 183
Query: 336 KHRKYDKKVDVFSFAMILYEM 356
K+ DV+SF ++LYE+
Sbjct: 184 TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 9e-28
Identities = 79/232 (34%), Positives = 119/232 (51%), Gaps = 16/232 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP EL F+ IGKGSFGE+ K T VAIK I ++D I+D + E+ +L
Sbjct: 1 DPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLS 57
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+ P + ++ G+ + L +I EYL GG L E G L + +I +G+ Y
Sbjct: 58 QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDY 116
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRY 329
LH+E IHRD+K NVLL S +K+ DFG++ +L Q + + G+ +
Sbjct: 117 LHSEKK--IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNTF-----VGTPFW 167
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
MAPEV K YD K D++S + E+ +GEPP + P + + + + P
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP 219
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 67/238 (28%), Positives = 116/238 (48%), Gaps = 16/238 (6%)
Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IGKG F + KA G VA+K++ D QD E++LL +L HPN++++L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 223 AVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAV-NFALDIARGMAYLHNEPNVI 278
+ E L ++ E GDL K+ K++ L P + + + + + ++H++ I
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--I 127
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
+HRD+KP NV + + +K+GD GL + + + + G+ YM+PE
Sbjct: 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLV----GTPYYMSPERIHEN 181
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPLANYEP--YEAAKYVAEGHRPFFRAKGFTPELRE 394
Y+ K D++S +LYEM + P + Y K + + P A ++ ELR+
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 81/241 (33%), Positives = 120/241 (49%), Gaps = 16/241 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP EL F+ IGKGSFGE+ K T VAIK I ++D I+D + E+ +L
Sbjct: 1 DPEEL-FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLS 57
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+ P I ++ G+ + L +I EYL GG LK G L + +I +G+ Y
Sbjct: 58 QCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDY 116
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRY 329
LH+E IHRD+K NVLL S +K+ DFG++ +L Q + + G+ +
Sbjct: 117 LHSERK--IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTF-----VGTPFW 167
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389
MAPEV K YD K D++S + E+ +GEPP ++ P + + P +
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSK 227
Query: 390 P 390
P
Sbjct: 228 P 228
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 72/211 (34%), Positives = 113/211 (53%), Gaps = 17/211 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
WE+ L +G G FGE+ Y+ G T VAIK SL + + F E NL
Sbjct: 1 WEVPRETLKLVKK--LGAGQFGEVWMGYYNGHTKVAIK----SLKQGSMSPEAFLAEANL 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
+ +L+HP +V+ L AV ++P+ +ITEY+ G L +LK E L+ + ++ A IA
Sbjct: 55 MKQLQHPRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
GMA++ E IHRDL+ N+L+ S K+ DFGL++LI+ ++ G
Sbjct: 114 GMAFI--ERKNYIHRDLRAANILV--SETLCCKIADFGLARLIE---DNEYTAREGAKFP 166
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
++ APE + + K DV+SF ++L E++
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 25/216 (11%)
Query: 165 IGKGSFG--EILKAYWRGTPVAIKRILPSLSDDRLVIQDFR---H---EVNLLVKLRHPN 216
+G G FG E++K + A+K + + I + H E +L + HP
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV------KKRHIVETGQQEHIFSEKEILEECNHPF 54
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
IV+ ++K + ++ EY GG+L L+++G TA + + YLHN
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN--R 112
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
II+RDLKP N+LL S ++K+ DFG +K K+++ + G Y+APE+
Sbjct: 113 GIIYRDLKPENLLL--DSNGYVKLVDFGFAK--KLKSGQKTWTFCGTPE---YVAPEIIL 165
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPPLAN--YEPYE 370
++ YD VD +S ++LYE+L G PP +P E
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME 201
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 163 AIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL------RH 214
++GKGSFG++L A +GT A+K L D +++QD E + K +H
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVK----VLKKD-VILQDDDVECTMTEKRVLALAGKH 55
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
P + Q + L + EY+ GGDL +++ G A +A +I G+ +LH
Sbjct: 56 PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
II+RDLK NVLL S H+K+ DFG+ K + + G+ Y+APE+
Sbjct: 116 G--IIYRDLKLDNVLL--DSEGHIKIADFGMCK----EGILGGVTTSTFCGTPDYIAPEI 167
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPP 362
++ Y VD ++ ++LYEML G+ P
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 72/210 (34%), Positives = 107/210 (50%), Gaps = 25/210 (11%)
Query: 163 AIIGKGSFGEILKAYWRGTP--VAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIV 218
++GKGSFG+++ A +GT AIK + L DD + V L + HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRV-LALAWEHPFLT 59
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
++ L + EYL GGDL +++ G + A +A +I G+ +LH I
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK--KGI 117
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET------GSYRYMAP 332
I+RDLK NVLL H+K+ DFG+ K M GE G+ Y+AP
Sbjct: 118 IYRDLKLDNVLL--DKDGHIKIADFGMCKE----------NMNGEGKASTFCGTPDYIAP 165
Query: 333 EVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
E+ K +KY++ VD +SF ++LYEML G+ P
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 16/206 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 212
D + IG+G FG++ + + VA+K S V + F E ++ +
Sbjct: 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS--VREKFLQEAYIMRQF 64
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYL 271
HP+IV+ +G +TE P+ ++ E G+L YL K +L ++ + ++ ++ +AYL
Sbjct: 65 DHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
++ V HRD+ RNVL+ SS D +K+GDFGLS+ + YK + ++MA
Sbjct: 124 ESKRFV--HRDIAARNVLV--SSPDCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMA 176
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEML 357
PE R++ DV+ F + ++E+L
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRI---LPSLSD-DRLVIQDFRHEVNLLVKL-RHPNI 217
+G G+FG + A + G VAIK++ S + L EV L KL HPNI
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL------REVKSLRKLNEHPNI 60
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEP 275
V+ E L + EY+ G +L++ +K + S S + I +G+A++H
Sbjct: 61 VKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK-- 117
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR-YMAPEV 334
+ HRDLKP N+L+ S + +K+ DFGL++ I+ + + Y T R Y APE+
Sbjct: 118 HGFFHRDLKPENLLV--SGPEVVKIADFGLAREIRSRPPYTDYVST------RWYRAPEI 169
Query: 335 F-KHRKYDKKVDVFSFAMILYEMLEGEP 361
+ Y VD+++ I+ E+ P
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-27
Identities = 68/203 (33%), Positives = 112/203 (55%), Gaps = 23/203 (11%)
Query: 164 IIGKGSFGE-ILKAYWR---GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
++GKG+FGE L Y R + V K + L LS+ +D +E+ +L L+HPNI+
Sbjct: 7 VLGKGAFGEATL--YRRTEDDSLVVWKEVNLTRLSEK--ERRDALNEIVILSLLQHPNII 62
Query: 219 QFLGAVTERKPLMLITEYLRGGDLH-KYLKEKGALSPSTAVNFAL-DIARGMAYLHNEPN 276
+ + L++ EY GG L+ K +++KG L V + L I ++Y+H
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG- 121
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSYRYMAPEV 334
I+HRD+K N+ L + A +K+GDFG+SK++ + S ET G+ YM+PE+
Sbjct: 122 -ILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSM------AETVVGTPYYMSPEL 172
Query: 335 FKHRKYDKKVDVFSFAMILYEML 357
+ KY+ K D+++ +LYE+L
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 163 AIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
A IG+G++G++ KA + T VA+K+I + I R E+ LL KLRHPNIV+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPNIVRL 63
Query: 221 LGAVTERKP--LMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNV 277
VT + + ++ EY+ DL L + S + + G+ YLH+ N
Sbjct: 64 KEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS--NG 120
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV- 334
I+HRD+K N+L+ N LK+ DFGL++ +NS D T T YR PE+
Sbjct: 121 ILHRDIKGSNILINNDG--VLKLADFGLARPYTKRNSAD---YTNRVITLWYR--PPELL 173
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
+Y +VD++S IL E+ G+P
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-27
Identities = 78/230 (33%), Positives = 115/230 (50%), Gaps = 22/230 (9%)
Query: 156 ELDFSSS---AIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLV 210
E ++ + ++GKG++G + A T V AIK I D R V Q E+ L
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYV-QPLHEEIALHS 60
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSP--STAVNFALDIARG 267
L+H NIVQ+LG+ +E + E + GG L L+ K G L T + + I G
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK-LIKVQNSHDVYKMTGETGS 326
+ YLH+ N I+HRD+K NV LVN+ + +K+ DFG SK L + + + TG+
Sbjct: 121 LKYLHD--NQIVHRDIKGDNV-LVNTYSGVVKISDFGTSKRLAGINPCTETF-----TGT 172
Query: 327 YRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 374
+YMAPEV R Y D++S + EM G+PP +AA +
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF 222
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-27
Identities = 78/245 (31%), Positives = 122/245 (49%), Gaps = 17/245 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP EL F+ IGKGSFGE+ K T VAIK I ++D I+D + E+ +L
Sbjct: 1 DPEEL-FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLS 57
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+ P + ++ G+ + L +I EYL GG L+ G +I +G+ Y
Sbjct: 58 QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDY 116
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRY 329
LH+E IHRD+K NVLL S +K+ DFG++ +L Q + + G+ +
Sbjct: 117 LHSEKK--IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTF-----VGTPFW 167
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389
MAPEV + YD K D++S + E+ +GEPP ++ P + + + P + F+
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE-FS 226
Query: 390 PELRE 394
+E
Sbjct: 227 KPFKE 231
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 76/216 (35%), Positives = 116/216 (53%), Gaps = 25/216 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 212
DF+ ++GKGSFG+++ A +GT AIK L D +VIQD E ++ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK----ILKKD-VVIQDDDVECTMVEKRVLA 55
Query: 213 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
+ P + Q L + EY+ GGDL ++++ G AV +A +I+ G+
Sbjct: 56 LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF 115
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSY 327
+LH II+RDLK NV+L S H+K+ DFG+ K H V +T T G+
Sbjct: 116 FLHRRG--IIYRDLKLDNVML--DSEGHIKIADFGMCK------EHMVDGVTTRTFCGTP 165
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
Y+APE+ ++ Y K VD +++ ++LYEML G+PP
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 75/227 (33%), Positives = 109/227 (48%), Gaps = 21/227 (9%)
Query: 165 IGKGSFGEIL----KAYWRGTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+GKGSFG + K + + + +P L+ + V + E LL KL HP IV
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ--EAQLLSKLDHPAIV 65
Query: 219 QFLGAVTERKPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+F + ER +ITEY G DL + LS + + + + G+ Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I+HRDLK +N+ L N + LK+GDFG+S+L+ S D+ T TG+ YM+PE
Sbjct: 126 R--ILHRDLKAKNIFLKN---NLLKIGDFGVSRLL--MGSCDL--ATTFTGTPYYMSPEA 176
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
KH+ YD K D++S ILYEM + EG P
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 18/235 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
WEI L +G G FGE+ W G T VA+K + P + + F E +
Sbjct: 1 WEIPRESLQLIKK--LGNGQFGEVWMGTWNGNTKVAVKTLKPG----TMSPESFLEEAQI 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
+ KLRH +VQ L AV +P+ ++TEY+ G L +LK E AL V+ A +A
Sbjct: 55 MKKLRHDKLVQ-LYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
GMAY+ E IHRDL+ N+L+ + K+ DFGL++LI+ ++ G
Sbjct: 114 GMAYI--ERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIE---DNEYTARQGAKFP 166
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
++ APE + ++ K DV+SF ++L E++ +G P E + V G+R
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 77/230 (33%), Positives = 120/230 (52%), Gaps = 21/230 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 212
DF+ ++GKGSFG+++ A +GT AIK L D +VIQD E ++ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK----ILKKD-VVIQDDDVECTMVEKRVLA 55
Query: 213 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
+ P + Q L + EY+ GGDL +++ G AV +A +IA G+
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 329
+LH++ II+RDLK NV+L S H+K+ DFG+ K +N D G+ Y
Sbjct: 116 FLHSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDY 167
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 379
+APE+ ++ Y K VD ++F ++LYEML G+ P + E + + E +
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 217
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 13/209 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF IGKGSFG + K + A+K+I S +R ++ E +L KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS-KMNRREREEAIDEARVLAKLDSS 59
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAV-NFALDIARGMAYLHN 273
I+++ + ++ L ++ EY GDLHK LK ++G P V F + I G+A+LH+
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
I+HRD+K N+ L + D++K+GD G++KL+ + T G+ Y++PE
Sbjct: 120 --KKILHRDIKSLNLFL--DAYDNVKIGDLGVAKLLSDNT---NFANT-IVGTPYYLSPE 171
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
+ + + Y++K DV++ ++LYE G+ P
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 76/242 (31%), Positives = 126/242 (52%), Gaps = 35/242 (14%)
Query: 165 IGKGSFGEILKAY-WRGTP------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G+G+FG++ A + P VA+K + + + R +DF E LL L+H +I
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQHEHI 69
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------------LSPSTAVNFALDI 264
V+F G E PL+++ EY++ GDL+K+L+ G L+ S ++ A I
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
A GM YL ++ +HRDL RN L+ + +K+GDFG+S+ + S D Y++ G T
Sbjct: 130 AAGMVYLASQH--FVHRDLATRNCLVGENLL--VKIGDFGMSRDVY---STDYYRVGGHT 182
Query: 325 G-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEG---H 379
R+M PE +RK+ + DV+S ++L+E+ G+ P E + + +G
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ 242
Query: 380 RP 381
RP
Sbjct: 243 RP 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 76/219 (34%), Positives = 111/219 (50%), Gaps = 21/219 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKR----ILPSLSDDRLVIQDFRHEVNLLVK 211
DF +G+G +G++ A + T VA+KR +L L++ R V+ E ++L
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLT----ERDILTT 57
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
+ +V+ L A + + L L EY+ GGD L G LS A + ++ + L
Sbjct: 58 TKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL 117
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
H IHRDLKP N L+ ++ H+K+ DFGLSK I V ++ V GS YMA
Sbjct: 118 HELG--YIHRDLKPENFLI--DASGHIKLTDFGLSKGI-VTYANSV------VGSPDYMA 166
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
PEV + + YD VD +S +LYE L G PP + P E
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 71/214 (33%), Positives = 113/214 (52%), Gaps = 27/214 (12%)
Query: 162 SAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---H 214
A IG+G++G + KA R G VA+K++ LS++ + + R E+ LL +L H
Sbjct: 4 LAEIGEGAYGTVYKA--RDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEH 60
Query: 215 PNIVQFL----GAVTERK-PLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
PNIV+ L G T+R+ L L+ E++ DL YL + K L P T + + RG
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+ +LH+ + I+HRDLKP+N+L+ +S +K+ DFGL+++ + +T +
Sbjct: 120 VDFLHS--HRIVHRDLKPQNILV--TSDGQVKIADFGLARIYSFE-----MALTSVVVTL 170
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
Y APEV Y VD++S I E+ P
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 71/238 (29%), Positives = 115/238 (48%), Gaps = 19/238 (7%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G G+ G + K R T +A+K I ++ + Q R E+++L K P IV F G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILR-ELDILHKCNSPYIVGFYG 66
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
A + + EY+ GG L K LKE +G + A+ + +G+ YLH + IIHR
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK-IIHR 125
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+KP N+L+ +S +K+ DFG+S ++ NS G+ YMAPE + Y
Sbjct: 126 DVKPSNILV--NSRGQIKLCDFGVSG--QLVNS----LAKTFVGTSSYMAPERIQGNDYS 177
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYE-----PYEAAKYVAEGHRPFFRAKGFTPELRE 394
K D++S + L E+ G P +E +Y+ P + F+P+ ++
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 5e-26
Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 11/219 (5%)
Query: 164 IIGKGSFGEILKAYW--RGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
++G+G+FG + Y G +A+K++ P + + E+ LL L H IVQ
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 220 FLGAV--TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
+ G + + L + E++ GG + LK GAL+ + + I G++YLH+ N+
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS--NM 126
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
I+HRD+K N+L S ++K+GDFG SK ++ M TG+ +M+PEV
Sbjct: 127 IVHRDIKGANIL--RDSVGNVKLGDFGASKRLQTICLSGT-GMKSVTGTPYWMSPEVISG 183
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376
Y +K D++S + EML +PP A +E A +A
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 73/249 (29%), Positives = 121/249 (48%), Gaps = 40/249 (16%)
Query: 164 IIGKGSFGEILKAY---WRG----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
+G+G FG+++KA +G T VA+K + + S L +D E NLL ++ HP+
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSEL--RDLLSEFNLLKQVNHPH 64
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS--------------------- 255
+++ GA ++ PL+LI EY + G L +L+E + PS
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 256 ---TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
++FA I+RGM YL ++HRDL RNVL+ +K+ DFGLS+ + +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRK--MKISDFGLSRDVYEE 180
Query: 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEA 371
+S+ K + ++MA E Y + DV+SF ++L+E++ G P P
Sbjct: 181 DSY--VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238
Query: 372 AKYVAEGHR 380
+ G+R
Sbjct: 239 FNLLKTGYR 247
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-26
Identities = 65/221 (29%), Positives = 114/221 (51%), Gaps = 12/221 (5%)
Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G G+FG + K ++ VA+K IL + ++D + + E N++ +L +P IV+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+G + E + ML+ E G L+K+L++ ++ ++ GM YL E +H
Sbjct: 62 IG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYL--EETNFVH 118
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDL RNVLLV + + K+ DFGLSK + ++ K G+ ++ APE + K+
Sbjct: 119 RDLAARNVLLV--TQHYAKISDFGLSKALGADENYYKAKTHGKW-PVKWYAPECMNYYKF 175
Query: 341 DKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
K DV+SF ++++E G+ P + E + + G R
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER 216
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G++G +LK + T VAIK+ S DD V + EV +L +LRH NIV
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKES-EDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
A + L L+ EY+ L + L+ G L P ++ + + +AY H+ + IIHR
Sbjct: 68 AFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS--HNIIHR 124
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF-KHRKY 340
D+KP N+L+ S + LK+ DFG ++ ++ T YR APE+ Y
Sbjct: 125 DIKPENILV--SESGVLKLCDFGFARALR-ARPASPLTDYVATRWYR--APELLVGDTNY 179
Query: 341 DKKVDVFSFAMILYEMLEGEP 361
K VDV++ I+ E+L+GEP
Sbjct: 180 GKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
NK WE+ P + + + +G G++G++ A+ T VAIK++ + +R
Sbjct: 7 NKTVWEV-PDR--YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR 63
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
E+ LL + H N++ L T L L+T L G DL+ +K + LS
Sbjct: 64 -ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNIVKCQ-KLSDDHI 120
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
I RG+ Y+H+ IIHRDLKP N + VN + LK+ DFGL++
Sbjct: 121 QFLVYQILRGLKYIHSAG--IIHRDLKPSN-IAVNEDCE-LKILDFGLAR----HTDD-- 170
Query: 318 YKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+MTG + Y APE+ Y++ VD++S I+ E+L G+
Sbjct: 171 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 74/228 (32%), Positives = 119/228 (52%), Gaps = 24/228 (10%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSL- 192
P LP WE + L F +G G+FG++++A G VA+K + P+
Sbjct: 21 PTQLPYDLKWEFPRNNLSFGK--TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH 78
Query: 193 SDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA 251
S +R + E+ ++ L H NIV LGA T P+++ITEY GDL +L+ K
Sbjct: 79 SSER---EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE 135
Query: 252 --LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
L+ ++F+ +A+GMA+L IHRDL RNVLL + +K+ DFGL++ I
Sbjct: 136 SFLTLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNVLLTHGKI--VKICDFGLARDI 191
Query: 310 KVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
++ Y + G ++MAPE + Y + DV+S+ ++L+E+
Sbjct: 192 MNDSN---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 77/237 (32%), Positives = 118/237 (49%), Gaps = 22/237 (9%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
WEI L +G+G FGE+ W GT VAIK + P + + F E +
Sbjct: 1 WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQV 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIAR 266
+ KLRH +VQ V+E +P+ ++TEY+ G L +LK + L V+ A IA
Sbjct: 55 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTGET 324
GMAY+ E +HRDL+ N+L+ ++L KV DFGL++LI+ ++ G
Sbjct: 114 GMAYV--ERMNYVHRDLRAANILV----GENLVCKVADFGLARLIE---DNEYTARQGAK 164
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM-LEGEPPLANYEPYEAAKYVAEGHR 380
++ APE + ++ K DV+SF ++L E+ +G P E V G+R
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 62/202 (30%), Positives = 114/202 (56%), Gaps = 19/202 (9%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPS---LSDDRLVIQDFRHEVNLLVKLRHPNIV 218
++G+G+FG + + V IK+I P D+RL Q+ E +L L HPNI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQN---ECQVLKLLSHPNII 62
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPN 276
++ E K LM++ EY GG L +Y++++ L T ++F + I + ++H +
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK-- 120
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
+I+HRDLK +N+LL + +K+GDFG+SK++ ++ K G+ Y++PE+ +
Sbjct: 121 LILHRDLKTQNILL-DKHKMVVKIGDFGISKILSSKS-----KAYTVVGTPCYISPELCE 174
Query: 337 HRKYDKKVDVFSFAMILYEMLE 358
+ Y++K D+++ +LYE+
Sbjct: 175 GKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 71/235 (30%), Positives = 123/235 (52%), Gaps = 18/235 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
WEI L +G G FGE+ + Y + T VA+K + P + ++ F E N+
Sbjct: 1 WEIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANV 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSP-STAVNFALDIAR 266
+ L+H +V+ L AV ++P+ +ITE++ G L +LK ++G+ P ++F+ IA
Sbjct: 55 MKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
GMA++ E IHRDL+ N+L+ S++ K+ DFGL+++I+ ++ G
Sbjct: 114 GMAFI--EQRNYIHRDLRAANILV--SASLVCKIADFGLARVIE---DNEYTAREGAKFP 166
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
++ APE + K DV+SF ++L E++ G P E + + G+R
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 67/203 (33%), Positives = 108/203 (53%), Gaps = 17/203 (8%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G++ + K R T VA+K I L + E++L+ +L+H NIV+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEI--HLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 223 AVTERKPLMLITEYLRGGDLHKYLK---EKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ LML+ EY+ DL KY+ +GAL P+T +F + +G+A+ H N ++
Sbjct: 66 VIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE--NRVL 122
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF-KHR 338
HRDLKP+N LL+N + LK+ DFGL++ + V + E + Y AP+V R
Sbjct: 123 HRDLKPQN-LLINKRGE-LKLADFGLARAFGIP----VNTFSNEVVTLWYRAPDVLLGSR 176
Query: 339 KYDKKVDVFSFAMILYEMLEGEP 361
Y +D++S I+ EM+ G P
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 75/254 (29%), Positives = 121/254 (47%), Gaps = 34/254 (13%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR----HEV 206
DP + IG+GS G + A + G VA+K++ L Q R +EV
Sbjct: 16 DPRS-YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM-------DLRKQQRRELLFNEV 67
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL-----HKYLKEKGALSPSTAVNFA 261
++ +HPNIV+ + L ++ E+L GG L H + E+ + AV A
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKA 127
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
L ++LH + +IHRD+K ++LL +S +K+ DFG Q S +V +
Sbjct: 128 L------SFLHAQG--VIHRDIKSDSILL--TSDGRVKLSDFGFCA----QVSKEVPRRK 173
Query: 322 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
G+ +MAPEV Y +VD++S +++ EM++GEPP N P +A K + + P
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPP 233
Query: 382 FFR-AKGFTPELRE 394
+ +P LR
Sbjct: 234 KLKNLHKVSPRLRS 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 69/232 (29%), Positives = 115/232 (49%), Gaps = 23/232 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRL-VIQDFRHEVNLLVKLRH 214
DF +G GSFG + A +GT AIK L ++ +Q E ++L++L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIK-CLKKREILKMKQVQHVAQEKSILMELSH 77
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
P IV + + + + + E++ GG+L +L++ G A + ++ YLH++
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSYRYM 330
II+RDLKP N+LL + H+KV DFG +K K+ T G+ Y+
Sbjct: 138 D--IIYRDLKPENLLL--DNKGHVKVTDFGFAK-----------KVPDRTFTLCGTPEYL 182
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
APEV + + + K VD ++ ++LYE + G PP + P+ + + G F
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF 234
|
Length = 329 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-25
Identities = 73/239 (30%), Positives = 110/239 (46%), Gaps = 37/239 (15%)
Query: 165 IGKGSFGEILKAYWRGTP---VAIKRIL---PSLSDDRL----VIQDFRHEVNLLVK-LR 213
+G G+FG + K + +A+K I P+ D+ I D EV ++ + LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRG---GDLHKYLKEKGALSPSTAV-NFALDIARGMA 269
HPNIV++ E L ++ + + G G+ LKEK + N + + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 329
YLH E I+HRDL P N++L D + + DFGL+K K S K+T G+ Y
Sbjct: 128 YLHKEKR-IVHRDLTPNNIML--GEDDKVTITDFGLAKQ-KQPES----KLTSVVGTILY 179
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL--------------ANYEPYEAAKY 374
PE+ K+ Y +K DV++F ILY+M +PP A YEP Y
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-25
Identities = 70/229 (30%), Positives = 108/229 (47%), Gaps = 32/229 (13%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVN 207
WEI EL G G+FG++ KA + T + A K I ++ ++DF E++
Sbjct: 7 WEI-IGEL--------GDGAFGKVYKAQHKETGLFAAAKIIQIESEEE---LEDFMVEID 54
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIA 265
+L + +HPNIV A L ++ E+ GG L + E+G P +
Sbjct: 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQML 113
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGET 324
+ +LH+ + +IHRDLK N+LL + +K+ DFG+S K D +
Sbjct: 114 EALNFLHS--HKVIHRDLKAGNILL--TLDGDVKLADFGVSAKNKSTLQKRDTF-----I 164
Query: 325 GSYRYMAPEV-----FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368
G+ +MAPEV FK YD K D++S + L E+ + EPP P
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 77/254 (30%), Positives = 123/254 (48%), Gaps = 44/254 (17%)
Query: 165 IGKGSFGEI-------LKAY-------WRGTP--VAIKRILPSLSDDRLVIQDFRHEVNL 208
+G+G FGE+ L + + G P VA+K + ++ + DF E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKI 70
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN--------- 259
+ +L++PNI++ LG PL +ITEY+ GDL+++L ++ S T N
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 260 ---FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
A+ IA GM YL + +HRDL RN L+ N +K+ DFG+S+ + S D
Sbjct: 131 LLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYT--IKIADFGMSRNLY---SGD 183
Query: 317 VYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE--AAK 373
Y++ G R+MA E K+ DV++F + L+EM L +PY + +
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LCKEQPYSLLSDE 239
Query: 374 YVAEGHRPFFRAKG 387
V E FFR +G
Sbjct: 240 QVIENTGEFFRNQG 253
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-24
Identities = 72/234 (30%), Positives = 118/234 (50%), Gaps = 30/234 (12%)
Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQ--DFRHEVNLLVKLRHPNIVQF 220
+G+ +FG+I K Y G A + +L D Q +F+ E +L+ +L HPNIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYL-----------------KEKGALSPSTAVNFALD 263
LG VT+ +P+ ++ EYL GDLH++L K +L ++ A+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
IA GM YL + + +H+DL RN+L+ H+K+ D GLS+ I S D Y++ +
Sbjct: 133 IAAGMEYLSS--HFFVHKDLAARNILI--GEQLHVKISDLGLSREIY---SADYYRVQPK 185
Query: 324 T-GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV 375
+ R+M PE + K+ D++SF ++L+E+ G P + E + V
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 84/267 (31%), Positives = 127/267 (47%), Gaps = 43/267 (16%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 194
LP WE L +G+G FG++++A G VA+K + + +D
Sbjct: 1 LPLDPKWEFPRDRLVLGKP--LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD 58
Query: 195 DRLVIQDFRHEVNLL-VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---- 249
L D E+ L+ + +H NI+ LG T+ PL +I EY G+L ++L+ +
Sbjct: 59 KDLA--DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPG 116
Query: 250 ------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
LS V+ A +ARGM YL E IHRDL RNVL+ + +
Sbjct: 117 PDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL--ESRRCIHRDLAARNVLV--TEDNV 172
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
+K+ DFGL++ + + D YK T ++MAPE R Y + DV+SF ++++E+
Sbjct: 173 MKIADFGLARGV---HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
Query: 357 --LEGEP-PLANYEPYEAAKYVAEGHR 380
L G P P E E K + EGHR
Sbjct: 230 FTLGGSPYPGIPVE--ELFKLLREGHR 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 76/203 (37%), Positives = 108/203 (53%), Gaps = 20/203 (9%)
Query: 165 IGKGSFGE-ILKAY-----WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+G+G FG+ L Y G VA+K + ++ E+N+L L H NIV
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHENIV 69
Query: 219 QFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
++ G +E+ K L LI EY+ G L YL K L+ + + FA I GMAYLH++
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP-KHKLNLAQLLLFAQQICEGMAYLHSQH- 127
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT--GETGSYRYMAPEV 334
IHRDL RNVLL N +K+GDFGL+K V H+ Y++ G++ + Y A E
Sbjct: 128 -YIHRDLAARNVLLDNDRL--VKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWY-AVEC 181
Query: 335 FKHRKYDKKVDVFSFAMILYEML 357
K K+ DV+SF + LYE+L
Sbjct: 182 LKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 16/202 (7%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+G+G FG++ + G VA+K + P + I D + E+ +L L H NIV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHENIV 69
Query: 219 QFLGAVTER--KPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
++ G TE + LI E+L G L +YL + K ++ + +A+ I +GM YL +
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
V HRDL RNVL+ + +K+GDFGL+K I+ + K ++ + Y APE
Sbjct: 130 YV--HRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 336 KHRKYDKKVDVFSFAMILYEML 357
K+ DV+SF + LYE+L
Sbjct: 185 IQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 63/197 (31%), Positives = 111/197 (56%), Gaps = 13/197 (6%)
Query: 165 IGKGSFGE--ILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+GSFG+ ++K+ G IK I S + ++ R EV +L ++HPNIVQ+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQYQE 66
Query: 223 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAV-NFALDIARGMAYLHNEPNVIIH 280
+ E L ++ +Y GGDL+K + ++G L P + ++ + I + ++H+ I+H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILH 124
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RD+K +N+ L +K+GDFG++ +V NS T G+ Y++PE+ ++R Y
Sbjct: 125 RDIKSQNIFLTKDGT--IKLGDFGIA---RVLNSTVELARTC-IGTPYYLSPEICENRPY 178
Query: 341 DKKVDVFSFAMILYEML 357
+ K D+++ +LYEM
Sbjct: 179 NNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 3e-24
Identities = 80/264 (30%), Positives = 123/264 (46%), Gaps = 37/264 (14%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 194
LP WE+ + L +G+G FG+++ A G VA+K + +D
Sbjct: 1 LPADPKWELSRTRLTLGKP--LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD 58
Query: 195 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---- 249
L D E+ ++ + +H NI+ LGA T+ PL ++ EY G+L +YL+ +
Sbjct: 59 KDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPG 116
Query: 250 ------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
L+ V+ A +ARGM YL ++ IHRDL RNVL+ +
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNV-- 172
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
+K+ DFGL++ V N K T ++MAPE R Y + DV+SF ++L+E+
Sbjct: 173 MKIADFGLAR--DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 230
Query: 358 E-GEPPLANYEPYEAAKYVAEGHR 380
G P E K + EGHR
Sbjct: 231 TLGGSPYPGIPVEELFKLLKEGHR 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-24
Identities = 71/223 (31%), Positives = 118/223 (52%), Gaps = 16/223 (7%)
Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G G+FG + K ++ VAIK +L + +++ V + E ++ +L +P IV+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKN-ENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+G V E + LML+ E GG L+K+L +K ++ S V ++ GM YL E +
Sbjct: 61 IG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL--EGKNFV 117
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM-TGETGSYRYMAPEVFKHR 338
HRDL RNVLLVN + K+ DFGLSK + +S+ YK + ++ APE R
Sbjct: 118 HRDLAARNVLLVNQH--YAKISDFGLSKALGADDSY--YKARSAGKWPLKWYAPECINFR 173
Query: 339 KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
K+ + DV+S+ + ++E G+ P + E ++ +G R
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR 216
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 70/220 (31%), Positives = 113/220 (51%), Gaps = 22/220 (10%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
++ P + + + IG+G++G + A + G VAIK+I P + + Q E+ +
Sbjct: 2 DVGP---RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKI 56
Query: 209 LVKLRHPNIVQFL-----GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
L + +H NI+ L + + ++ E + DL+K +K + LS F
Sbjct: 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQ 114
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
I RG+ Y+H+ NV+ HRDLKP N LL+N++ D LK+ DFGL+++ HD E
Sbjct: 115 ILRGLKYIHS-ANVL-HRDLKPSN-LLLNTNCD-LKICDFGLARIA--DPEHDHTGFLTE 168
Query: 324 TGSYR-YMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ R Y APE+ + Y K +D++S IL EML P
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 83/265 (31%), Positives = 125/265 (47%), Gaps = 39/265 (14%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 194
LP WE+ L +G+G FG+++ A G T VA+K + ++
Sbjct: 7 LPEDPRWEVPRDRLVLGKP--LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE 64
Query: 195 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-- 251
L D E+ ++ + +H NI+ LGA T+ PL +I EY G+L +YL+ +
Sbjct: 65 KDL--SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 122
Query: 252 --------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
LS V+ A +ARGM YL ++ IHRDL RNVL+ +
Sbjct: 123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV-- 178
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
+K+ DFGL++ I + D YK T ++MAPE R Y + DV+SF ++L+E+
Sbjct: 179 MKIADFGLARDI---HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
Query: 357 LE-GEPPLANYEPYEAAKYVAEGHR 380
G P E K + EGHR
Sbjct: 236 FTLGGSPYPGVPVEELFKLLKEGHR 260
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-24
Identities = 77/237 (32%), Positives = 120/237 (50%), Gaps = 22/237 (9%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNL 208
WEI L +G+G FGE+ W GT VAIK + P ++ + F E +
Sbjct: 1 WEIPRESLRLDVK--LGQGCFGEVWMGTWNGTTKVAIKTLKPG----TMMPEAFLQEAQI 54
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIAR 266
+ KLRH +V V+E +P+ ++TE++ G L +LKE L V+ A IA
Sbjct: 55 MKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTGET 324
GMAY+ E IHRDL+ N+L+ D+L K+ DFGL++LI+ ++ G
Sbjct: 114 GMAYI--ERMNYIHRDLRAANILV----GDNLVCKIADFGLARLIE---DNEYTARQGAK 164
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
++ APE + ++ K DV+SF ++L E++ +G P E + V G+R
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR 221
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 79/246 (32%), Positives = 111/246 (45%), Gaps = 18/246 (7%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP +L FS IG GSFG + A VAIK++ S QD EV L
Sbjct: 12 DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
KLRHPN +Q+ G L+ EY G K L +G+AY
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH+ +IHRD+K N+LL S +K+GDFG + ++ N G+ +M
Sbjct: 131 LHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPANXF--------VGTPYWM 178
Query: 331 APEV---FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
APEV +YD KVDV+S + E+ E +PPL N A ++A+ P ++
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 388 FTPELR 393
++ R
Sbjct: 239 WSEYFR 244
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 79/265 (29%), Positives = 124/265 (46%), Gaps = 39/265 (14%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 194
LP WE +L +G+G FG+++ A G VA+K + ++
Sbjct: 4 LPEDPRWEFSRDKLTLGKP--LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE 61
Query: 195 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS 253
L D E+ ++ + +H NI+ LGA T+ PL +I EY G+L +YL+ +
Sbjct: 62 KDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119
Query: 254 ----------PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
P + F +ARGM YL ++ IHRDL RNVL+ ++
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNV-- 175
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
+K+ DFGL++ + N+ D YK T ++MAPE R Y + DV+SF ++++E+
Sbjct: 176 MKIADFGLARDV---NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
Query: 357 LE-GEPPLANYEPYEAAKYVAEGHR 380
G P E K + EGHR
Sbjct: 233 FTLGGSPYPGIPVEELFKLLKEGHR 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 8e-24
Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHE-VNLLVKLRHPNIVQFL 221
I KG+FG + A R G AIK + S + + + + E ++++ P + +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ + L L+ EYL GGD +K G L A + ++ G+ LH IIHR
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ--RGIIHR 121
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+KP N+L+ HLK+ DFGLS+ G+ Y+APE D
Sbjct: 122 DIKPENLLI--DQTGHLKLTDFGLSRNGLENKKF--------VGTPDYLAPETILGVGDD 171
Query: 342 KKVDVFSFAMILYEMLEGEPP 362
K D +S +++E L G PP
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 1e-23
Identities = 71/226 (31%), Positives = 112/226 (49%), Gaps = 17/226 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF + +I G++G + + T A+K+I R IQ E ++L +P
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+V + ++ L ++ EY+ GGD LK GAL A + + + YLHN
Sbjct: 62 FVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG 121
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK--MTGET--------- 324
I+HRDLKP N+L+ +S H+K+ DFGLSK+ + + ++Y+ + +T
Sbjct: 122 --IVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
G+ Y+APEV + Y K VD ++ +ILYE L G P P E
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-23
Identities = 70/226 (30%), Positives = 118/226 (52%), Gaps = 16/226 (7%)
Query: 164 IIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+IGKG FG + + A+K L ++D V Q F E ++ HPN++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKS-LNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 219 QFLGAV--TERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
LG +E PL+++ Y++ GDL ++ E + + F L +A+GM YL ++
Sbjct: 60 SLLGICLPSEGSPLVVLP-YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
V HRDL RN +L S +KV DFGL++ I + + V+ TG ++MA E
Sbjct: 119 FV--HRDLAARNCMLDESF--TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 336 KHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
+ +K+ K DV+SF ++L+E++ G PP + + ++ Y+ +G R
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR 220
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 1e-23
Identities = 68/203 (33%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 164 IIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQF 220
+IGKGSFG++L A + A+K + + + E N+L+K ++HP +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ L + +Y+ GG+L +L+ + + A +A +IA + YLH+ II+
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIY 119
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
RDLKP N+LL S H+ + DFGL K I+ + + T E Y+APEV + +
Sbjct: 120 RDLKPENILL--DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE-----YLAPEVLRKQP 172
Query: 340 YDKKVDVFSFAMILYEMLEGEPP 362
YD+ VD + +LYEML G PP
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++G+GS+G ++K + G VAIK+ L S DD++V + E+ +L +LRH N+V +
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLES-EDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+K L L+ E++ L K L S + I RG+ + H+ + IIHR
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS--HNIIHR 124
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE-VFKHRKY 340
D+KP N+L+ S +K+ DFG ++ + +VY T YR APE + KY
Sbjct: 125 DIKPENILVSQSGV--VKLCDFGFARTLAAPG--EVYTDYVATRWYR--APELLVGDTKY 178
Query: 341 DKKVDVFSFAMILYEMLEGEP 361
+ VD+++ ++ EML GEP
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-23
Identities = 74/232 (31%), Positives = 115/232 (49%), Gaps = 17/232 (7%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKA--YWRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLL 209
DP + ++ IG+G+ G + A G VAIK+I L L+I +E+ ++
Sbjct: 16 DPKK-KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII----NEILVM 70
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
+L++PNIV FL + L ++ EYL GG L + E + + + + +
Sbjct: 71 KELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALE 129
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 329
+LH N +IHRD+K NVLL + +K+ DFG I + S K + G+ +
Sbjct: 130 FLH--ANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQS----KRSTMVGTPYW 181
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
MAPEV + Y KVD++S ++ EM+EGEPP N P A +A P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-23
Identities = 65/236 (27%), Positives = 130/236 (55%), Gaps = 17/236 (7%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD---FRHEVNLLVKLRHPNIVQF 220
IG+GSFG+I A + + ++ + ++ +++ + EV LL K++HPNIV F
Sbjct: 7 KIGEGSFGKIYLA--KAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYL-KEKGAL-SPSTAVNFALDIARGMAYLHNEPNVI 278
+ E L ++ EY GGDL K + +++G L S +++ + I+ G+ ++H+ I
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--I 122
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
+HRD+K +N+ L + + K+GDFG+++ + +S ++ G+ Y++PE+ ++R
Sbjct: 123 LHRDIKSQNIFL-SKNGMVAKLGDFGIARQL--NDSMELAYTC--VGTPYYLSPEICQNR 177
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH-RPFFRAKGFTPELR 393
Y+ K D++S +LYE+ + P ++ + +G+ P + F+ +LR
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI--SPNFSRDLR 231
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 2e-23
Identities = 69/225 (30%), Positives = 110/225 (48%), Gaps = 16/225 (7%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG+G+ G + A G VAIK++ L L+I +E+ ++ + +HPNIV +L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII----NEILVMRENKHPNIVNYL 82
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ L ++ EYL GG L + E + + + + +LH+ N +IHR
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS--NQVIHR 139
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+K N+LL + +K+ DFG I + S K + G+ +MAPEV + Y
Sbjct: 140 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYG 193
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK 386
KVD++S ++ EM+EGEPP N P A +A P +
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 2e-23
Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD-----FRHEVNLLVKLRHPN 216
++GKGSFG++L A +G A+K +L D ++I D + L + +P
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVK----ALKKDVVLIDDDVECTMVEKRVLALAWENPF 57
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
+ ++ L + E+L GGDL ++++KG A +A +I G+ +LH+
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS--K 115
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
II+RDLK NV+L H+K+ DFG+ K +N + + G+ Y+APE+ +
Sbjct: 116 GIIYRDLKLDNVML--DRDGHIKIADFGMCK----ENVFGDNRASTFCGTPDYIAPEILQ 169
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPPL 363
KY VD +SF ++LYEML G+ P
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-23
Identities = 73/243 (30%), Positives = 117/243 (48%), Gaps = 31/243 (12%)
Query: 159 FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVK 211
F+ ++GKG FG + +A + VA+K + + S D I++F E + +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD---IEEFLREAACMKE 57
Query: 212 LRHPNIVQFLGAVTERKPL------MLITEYLRGGDLHKYL------KEKGALSPSTAVN 259
HPN+++ +G + M+I +++ GDLH +L +E L T V
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
F +DIA GM YL ++ IHRDL RN +L + + V DFGLSK I S D Y+
Sbjct: 118 FMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMT--VCVADFGLSKKIY---SGDYYR 170
Query: 320 MTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYE-MLEGEPPLANYEPYEAAKYVAE 377
+ +++A E Y DV++F + ++E M G+ P A E E Y+ +
Sbjct: 171 QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK 230
Query: 378 GHR 380
G+R
Sbjct: 231 GNR 233
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 3e-23
Identities = 68/211 (32%), Positives = 112/211 (53%), Gaps = 13/211 (6%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQF 220
+IGKGSFG++L A + G A+K + + +R + E N+L+K ++HP +V
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ + L + +++ GG+L +L+ + + A +A +IA + YLH+ I++
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVY 119
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
RDLKP N+LL S H+ + DFGL K I ++ + G+ Y+APEV + +
Sbjct: 120 RDLKPENILL--DSQGHVVLTDFGLCKEGIAQSDTTTTF-----CGTPEYLAPEVIRKQP 172
Query: 340 YDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
YD VD + +LYEML G PP + E
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-23
Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 16/198 (8%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
++G+GSFG L + A+K I LP S ++D R E LL K++HPNIV F
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA---VEDSRKEAVLLAKMKHPNIVAF 63
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPS-TAVNFALDIARGMAYLHNEPNVI 278
+ L ++ EY GGDL + +K ++G L P T + + + + G+ ++H + +
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--V 121
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
+HRD+K +N+ L + +K+GDFG ++L+ + G+ Y+ PE++++
Sbjct: 122 LHRDIKSKNIFLTQNG--KVKLGDFGSARLL----TSPGAYACTYVGTPYYVPPEIWENM 175
Query: 339 KYDKKVDVFSFAMILYEM 356
Y+ K D++S ILYE+
Sbjct: 176 PYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 4e-23
Identities = 66/228 (28%), Positives = 113/228 (49%), Gaps = 23/228 (10%)
Query: 164 IIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV---KLRH 214
++G G FG + K W PVAIK I DR Q F+ + ++ L H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-----QDRSGRQTFQEITDHMLAMGSLDH 68
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHN 273
IV+ LG + L L+T+ G L ++++ + +L P +N+ + IA+GM YL
Sbjct: 69 AYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL-- 125
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
E + ++HR+L RN+LL S +++ DFG++ L+ + Y + ++MA E
Sbjct: 126 EEHRMVHRNLAARNILL--KSDSIVQIADFGVADLLYPDDKKYFY--SEHKTPIKWMALE 181
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
+Y + DV+S+ + ++EM+ G P A P+E + +G R
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 4e-23
Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG+G++G + +A + VA+K++ D + I R E+ LL+ LRHPNIV+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72
Query: 222 GAVTERK--PLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALDIARGMAYLHNEPNVI 278
V + + L+ EY DL L + V L + RG+ YLH N I
Sbjct: 73 EVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE--NFI 129
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKH 337
IHRDLK N+LL + LK+ DFGL++ MT + + Y APE+
Sbjct: 130 IHRDLKVSNLLLTDKG--CLKIADFGLARTY----GLPAKPMTPKVVTLWYRAPELLLGC 183
Query: 338 RKYDKKVDVFSFAMILYEMLEGEP 361
Y +D+++ IL E+L +P
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 5e-23
Identities = 58/160 (36%), Positives = 88/160 (55%), Gaps = 8/160 (5%)
Query: 203 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL 262
+ E N+L ++HP IV + A L LI EYL GG+L +L+ +G TA +
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
+I+ + +LH + II+RDLKP N+LL + H+K+ DFGL K ++ H+
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILL--DAQGHVKLTDFGLCK----ESIHEGTVTHT 159
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ YMAPE+ + K VD +S ++Y+ML G PP
Sbjct: 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 5e-23
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 13/205 (6%)
Query: 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQ 219
+IGKGSFG++L A + G+ A+K + + E N+L+K L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ + L + +Y+ GG+L +L+ + A +A ++A + YLH+ II
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--II 118
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
+RDLKP N+LL S H+ + DFGL K ++ + + + G+ Y+APEV +
Sbjct: 119 YRDLKPENILL--DSQGHVVLTDFGLCKEGVEPEETTSTF-----CGTPEYLAPEVLRKE 171
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPL 363
YD+ VD + +LYEML G PP
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 5e-23
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR-HEVNLLVKLRHPNIVQFL 221
IG+G++G + KA R VA+KR+ L DD + E+ LL +L+H NIV+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV--RLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ K L L+ EY DL KY G + P +F + +G+A+ H+ ++H
Sbjct: 66 DVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLH 122
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRK 339
RDLKP+N LL+N + + LK+ DFGL++ + V + E + Y P+V F +
Sbjct: 123 RDLKPQN-LLINKNGE-LKLADFGLARAFGIP----VRCYSAEVVTLWYRPPDVLFGAKL 176
Query: 340 YDKKVDVFSFAMILYEMLEGEPPL 363
Y +D++S I E+ PL
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 7e-23
Identities = 72/207 (34%), Positives = 111/207 (53%), Gaps = 17/207 (8%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
+G+G++ + KA + G VAIK+I + D + R E+ LL +L+HPNI+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIG 66
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVI 278
L + + L+ E++ DL K +K+K L+P+ ++ L RG+ YLH+ N I
Sbjct: 67 LLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS--NWI 123
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKH 337
+HRDLKP N+L+ +S LK+ DFGL++ N KMT + + Y APE+ F
Sbjct: 124 LHRDLKPNNLLI--ASDGVLKLADFGLARSFGSPN----RKMTHQVVTRWYRAPELLFGA 177
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLA 364
R Y VD++S I E+L P L
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRVPFLP 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 9e-23
Identities = 71/238 (29%), Positives = 112/238 (47%), Gaps = 31/238 (13%)
Query: 164 IIGKGSFGEILKAYWR---GTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
I+G+G FG +++ G+ VA+K + + I++F E + HPN++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS-EIEEFLSEAACMKDFDHPNVM 64
Query: 219 QFLGAVTERKPL------MLITEYLRGGDLHKYL-KEKGALSP-----STAVNFALDIAR 266
+ +G E L M+I +++ GDLH +L + P T + F +DIA
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK--VGDFGLSKLIKVQNSHDVYKMTGET 324
GM YL N IHRDL RN +L + + V DFGLSK I S D Y+
Sbjct: 125 GMEYLSNRN--FIHRDLAARNCML----REDMTVCVADFGLSKKIY---SGDYYRQGRIA 175
Query: 325 G-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
+++A E R Y K DV++F + ++E+ G+ P E +E Y+ G+R
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 9e-23
Identities = 69/224 (30%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 165 IGKGSFGEILKAYWRGTPV-AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
+G G+FG++ KA + T V A +++ + S++ L +D+ E+++L HPNIV+ L A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL--EDYMVEIDILASCDHPNIVKLLDA 70
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
L ++ E+ GG + + E + L+ + YLH N IIHRD
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE--NKIIHRD 128
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF-----KH 337
LK N+L +K+ DFG+S +N+ + + G+ +MAPEV K
Sbjct: 129 LKAGNILFTLDG--DIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
R YD K DV+S + L EM + EPP P +A+ P
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP 226
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 9e-23
Identities = 73/243 (30%), Positives = 122/243 (50%), Gaps = 40/243 (16%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-------VAIKRILPSLSD--DRLVIQD 201
EI+ S + F +G+ FG++ K + GT VAIK +L D + + ++
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK----TLKDKAEGPLREE 54
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL--------------- 246
F+HE + +L+HPNIV LG VT+ +PL +I Y DLH++L
Sbjct: 55 FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114
Query: 247 -KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
K L P+ V+ IA GM +L + ++H+DL RNVL+ + ++K+ D GL
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKL--NVKISDLGL 170
Query: 306 SKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPL 363
+ + + D YK+ G + R+M+PE + K+ D++S+ ++L+E+ G P
Sbjct: 171 FREVY---AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
Query: 364 ANY 366
Y
Sbjct: 228 CGY 230
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 80/246 (32%), Positives = 118/246 (47%), Gaps = 35/246 (14%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL- 212
D +IG+G+FG++LKA + AIKR+ S D +DF E+ +L KL
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 65
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPST 256
HPNI+ LGA R L L EY G+L +L++ LS
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
++FA D+ARGM YL + IHRDL RN+L+ + K+ DFGLS+ +
Sbjct: 126 LLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYV--AKIADFGLSR------GQE 175
Query: 317 VY-KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 374
VY K T R+MA E + Y DV+S+ ++L+E++ G P E +
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235
Query: 375 VAEGHR 380
+ +G+R
Sbjct: 236 LPQGYR 241
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 69/204 (33%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 164 IIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQD---FRHEVNLLVKLRHPNIVQ 219
++G+GSFG++ L G + L L ++D + E ++L ++ HP IV+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNEPNVI 278
A L LI ++LRGGDL L K + V F L ++A + +LH+ I
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLG--I 119
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
I+RDLKP N+LL H+K+ DFGLSK ++ K G+ YMAPEV R
Sbjct: 120 IYRDLKPENILL--DEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 339 KYDKKVDVFSFAMILYEMLEGEPP 362
+ + D +SF ++++EML G P
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-22
Identities = 67/198 (33%), Positives = 109/198 (55%), Gaps = 14/198 (7%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++GKGS+GE+ R G IK++ + R + E LL +L+HPNIV +
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYR 65
Query: 222 GAVT-ERKPLMLITEYLRGGDLHKYLKE-KGALSP-STAVNFALDIARGMAYLHNEPNVI 278
+ E L ++ + GGDL+ LKE KG L P + V + + IA + YLH + I
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--I 123
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
+HRDLK +NV L ++ +KVGD G++++++ Q + G+ YM+PE+F ++
Sbjct: 124 LHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCD----MASTLIGTPYYMSPELFSNK 177
Query: 339 KYDKKVDVFSFAMILYEM 356
Y+ K DV++ +YEM
Sbjct: 178 PYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-22
Identities = 69/224 (30%), Positives = 112/224 (50%), Gaps = 17/224 (7%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
+P E DF IG G++G++ KA G AIK I +D V+Q E+ ++
Sbjct: 6 NPQE-DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ---QEIIMMK 61
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+H NIV + G+ R L + E+ GG L G LS S + + +G+ Y
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH++ +HRD+K N+LL ++ H+K+ DFG+S Q + + K G+ +M
Sbjct: 122 LHSKGK--MHRDIKGANILLTDNG--HVKLADFGVS----AQITATIAKRKSFIGTPYWM 173
Query: 331 APEVFK-HRK--YDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
APEV RK Y++ D+++ + E+ E +PP+ + P A
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-22
Identities = 67/247 (27%), Positives = 117/247 (47%), Gaps = 20/247 (8%)
Query: 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
+F IG+G F E+ +A G PVA+K++ D D E++LL +L HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAV-NFALDIARGMAYL 271
N++++ + E L ++ E GDL K+ K++ L P V + + + + ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI--KVQNSHDVYKMTGETGSYRY 329
H+ ++HRD+KP NV + + +K+GD GL + K +H + G+ Y
Sbjct: 123 HSRR--VMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL------VGTPYY 172
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL--ANYEPYEAAKYVAEGHRPFFRAKG 387
M+PE Y+ K D++S +LYEM + P Y K + + P +
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 232
Query: 388 FTPELRE 394
++ ELR+
Sbjct: 233 YSEELRQ 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 70/202 (34%), Positives = 107/202 (52%), Gaps = 15/202 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G++G + KA + G VA+K+I ++D V E++LL +L HPNIV+ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLE-TEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 223 AVTERKPLMLITEYLRGGDLHKYL--KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
V L L+ E+L DL KY+ L P ++ + +G+AY H+ + ++H
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS--HRVLH 122
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRK 339
RDLKP+N LL++ LK+ DFGL++ V V T E + Y APE+ R+
Sbjct: 123 RDLKPQN-LLIDREGA-LKLADFGLARAFGVP----VRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 340 YDKKVDVFSFAMILYEMLEGEP 361
Y VD++S I EM+ P
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 67/233 (28%), Positives = 114/233 (48%), Gaps = 17/233 (7%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
E +F ++G G+FG + K W PVAIK + + S ++ E ++
Sbjct: 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 63
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
+ +P++ + LG + + LIT+ + G L Y++E K + +N+ + IA+GM
Sbjct: 64 ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
YL E ++HRDL RNVL+ H+K+ DFGL+KL+ Y G +
Sbjct: 123 NYL--EERRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGADEKE--YHAEGGKVPIK 176
Query: 329 YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
+MA E HR Y + DV+S+ + ++E++ G P E + + +G R
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 2e-22
Identities = 69/233 (29%), Positives = 118/233 (50%), Gaps = 17/233 (7%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
E + ++G G+FG + K W PVAIK IL + + ++ F E ++
Sbjct: 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVE-FMDEALIM 63
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
+ HP++V+ LG V + L+T+ + G L Y+ E K + +N+ + IA+GM
Sbjct: 64 ASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGM 122
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
YL E ++HRDL RNVL+ S +H+K+ DFGL++L+ + Y G +
Sbjct: 123 MYL--EERRLVHRDLAARNVLV--KSPNHVKITDFGLARLL--EGDEKEYNADGGKMPIK 176
Query: 329 YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
+MA E +RK+ + DV+S+ + ++E++ G P E + +G R
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ-- 219
IG G++G + A + VAIK+I P D + + E+ +L +H NI+
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 220 --FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
+ K + ++ + L DLH + L+ F + RG+ Y+H+
Sbjct: 71 DILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN-- 127
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FK 336
+IHRDLKP N LLVN L++GDFG+++ + + Y MT + Y APE+
Sbjct: 128 VIHRDLKPSN-LLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS 185
Query: 337 HRKYDKKVDVFSFAMILYEML 357
+Y +D++S I EML
Sbjct: 186 LPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 80/255 (31%), Positives = 115/255 (45%), Gaps = 34/255 (13%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP +L F+ IG GSFG + A T VAIK++ S QD EV L
Sbjct: 12 DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGG-----DLHKYLKEKGALSPSTAVNFA---L 262
+LRHPN +++ G L+ EY G ++HK P V A
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK--------KPLQEVEIAAICH 122
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
+G+AYLH+ IHRD+K N+LL + +K+ DFG + L+ NS
Sbjct: 123 GALQGLAYLHSHER--IHRDIKAGNILL--TEPGTVKLADFGSASLVSPANSF------- 171
Query: 323 ETGSYRYMAPEV---FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 379
G+ +MAPEV +YD KVDV+S + E+ E +PPL N A ++A+
Sbjct: 172 -VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND 230
Query: 380 RPFFRAKGFTPELRE 394
P + ++ R
Sbjct: 231 SPTLSSNDWSDYFRN 245
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-22
Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+GKG FGE+ + T A K++ R Q +E +L K+ IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
A + L L+ + GGDL ++ G + A+ +A I G+ +LH I++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--RIVY 118
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDLKP NVLL + ++++ D GL+ +K K+ G G+ YMAPEV + Y
Sbjct: 119 RDLKPENVLLDDHG--NVRISDLGLAVELKGGK-----KIKGRAGTPGYMAPEVLQGEVY 171
Query: 341 DKKVDVFSFAMILYEMLEGEPPLANY 366
D VD F+ LYEM+ G P
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-22
Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 11/203 (5%)
Query: 164 IIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQF 220
+IGKGSFG++L A + A+K + + + E N+L+K ++HP +V
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ L + +Y+ GG+L +L+ + A +A +IA + YLH+ I++
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVY 119
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDLKP N+LL S H+ + DFGL K +N + G+ Y+APEV + Y
Sbjct: 120 RDLKPENILL--DSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 341 DKKVDVFSFAMILYEMLEGEPPL 363
D+ VD + +LYEML G PP
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-22
Identities = 83/248 (33%), Positives = 120/248 (48%), Gaps = 39/248 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRG----TPVAIKRI--LPSLSDDRLVIQDFRHEVNLLVK 211
D +IG+G+FG++++A + AIK + S +D R DF E+ +L K
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR----DFAGELEVLCK 58
Query: 212 L-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-------------KEKGALSPSTA 257
L HPNI+ LGA R L + EY G+L +L KE G S T+
Sbjct: 59 LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 258 ---VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
+ FA D+A GM YL + IHRDL RNVL+ + A K+ DFGLS+
Sbjct: 119 QQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLAS--KIADFGLSR------G 168
Query: 315 HDVY-KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA 372
+VY K T R+MA E + Y K DV+SF ++L+E++ G P E
Sbjct: 169 EEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY 228
Query: 373 KYVAEGHR 380
+ + +G+R
Sbjct: 229 EKLPQGYR 236
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 3e-22
Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 18/214 (8%)
Query: 158 DFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
+F IG+G F E+ +A PVA+K++ D QD E++LL +L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAV-NFALDIARGMAYL 271
N++++L + E L ++ E GDL KY K++ L P V + + + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI--KVQNSHDVYKMTGETGSYRY 329
H+ ++HRD+KP NV + + +K+GD GL + K +H + G+ Y
Sbjct: 123 HSRR--VMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL------VGTPYY 172
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
M+PE Y+ K D++S +LYEM + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 5e-22
Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 13/211 (6%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
++GKGSFG++ A +GT AIK + L DD + V L + HP +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLTH 60
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
++ L + EYL GGDL +++ A +A +I G+ +LH++ I+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IV 118
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
+RDLK N+LL + H+K+ DFG+ K +N K G+ Y+APE+ +K
Sbjct: 119 YRDLKLDNILL--DTDGHIKIADFGMCK----ENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 340 YDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
Y+ VD +SF ++LYEML G+ P ++ E
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 8e-22
Identities = 74/246 (30%), Positives = 112/246 (45%), Gaps = 18/246 (7%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP +L F+ IG GSFG + A T VAIK++ S QD EV L
Sbjct: 22 DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+++HPN +++ G L+ EY G K L +G+AY
Sbjct: 81 RIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 140
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH+ + +IHRD+K N+LL + +K+ DFG + + NS G+ +M
Sbjct: 141 LHS--HNMIHRDIKAGNILL--TEPGQVKLADFGSASIASPANSF--------VGTPYWM 188
Query: 331 APEV---FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
APEV +YD KVDV+S + E+ E +PPL N A ++A+ P ++
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248
Query: 388 FTPELR 393
++ R
Sbjct: 249 WSDYFR 254
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 8e-22
Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 36/244 (14%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 212
+ S ++ +G+FG I V +K + S+ ++ + E LL L
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL--LLQESCLLYGL 65
Query: 213 RHPNIVQFLGAVTE-RKPLMLITEYLRGGDLHKYLK-----EKG---ALSPSTAVNFALD 263
H NI+ L E +P ++ Y+ G+L +L+ E ALS V+ A+
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT-- 321
IA GM+YLH +IH+D+ RN ++ +K+ D LS+ D++ M
Sbjct: 126 IACGMSYLHKRG--VIHKDIAARNCVIDEEL--QVKITDNALSR--------DLFPMDYH 173
Query: 322 ----GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVA 376
E ++MA E +++Y DV+SF ++L+E++ G+ P +P+E A Y+
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK 233
Query: 377 EGHR 380
+G+R
Sbjct: 234 DGYR 237
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-21
Identities = 75/246 (30%), Positives = 111/246 (45%), Gaps = 18/246 (7%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP E+ F IG GSFG + A T VA+K++ S QD EV L
Sbjct: 18 DPEEI-FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+L+HPN +++ G + L+ EY G K L +G+AY
Sbjct: 77 QLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 136
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH+ + +IHRD+K N+LL + +K+ DFG + NS G+ +M
Sbjct: 137 LHS--HNMIHRDIKAGNILL--TEPGQVKLADFGSASKSSPANSF--------VGTPYWM 184
Query: 331 APEV---FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
APEV +YD KVDV+S + E+ E +PPL N A ++A+ P ++
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE 244
Query: 388 FTPELR 393
+T R
Sbjct: 245 WTDSFR 250
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 70/214 (32%), Positives = 109/214 (50%), Gaps = 26/214 (12%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF-- 220
+G GS G + A VA+K+I L+D + V R E+ ++ +L H NIV+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALR-EIKIIRRLDHDNIVKVYE 69
Query: 221 ------------LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
+G++TE + ++ EY+ DL L E+G LS A F + RG+
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLSEEHARLFMYQLLRGL 127
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
Y+H+ NV+ HRDLKP NV +N+ LK+GDFGL++++ SH Y G +
Sbjct: 128 KYIHS-ANVL-HRDLKPANVF-INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW- 183
Query: 329 YMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEP 361
Y +P + Y K +D+++ I EML G+P
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-21
Identities = 70/248 (28%), Positives = 123/248 (49%), Gaps = 30/248 (12%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDF 202
WE+ ++ S +G+GSFG + + +G T VAIK + + S + +F
Sbjct: 1 WEVAREKITMSRE--LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EF 56
Query: 203 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSPS 255
+E +++ + ++V+ LG V++ +P ++I E + GDL YL+ +P
Sbjct: 57 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 256 T---AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
+ + A +IA GMAYL+ N +HRDL RN ++ +K+GDFG+++ I
Sbjct: 117 SLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIY-- 170
Query: 313 NSHDVYKMTGE-TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYE 370
D Y+ G+ R+M+PE K + DV+SF ++L+E+ E P +
Sbjct: 171 -ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
Query: 371 AAKYVAEG 378
++V EG
Sbjct: 230 VLRFVMEG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 4e-21
Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 16/220 (7%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG+G+ G + A G VAIK++ L L+I +E+ ++ + ++PNIV +L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII----NEILVMRENKNPNIVNYL 82
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ L ++ EYL GG L + E + + + + +LH+ N +IHR
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHS--NQVIHR 139
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+K N+LL + +K+ DFG I + S K + G+ +MAPEV + Y
Sbjct: 140 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYG 193
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
KVD++S ++ EM+EGEPP N P A +A P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 4e-21
Identities = 73/233 (31%), Positives = 114/233 (48%), Gaps = 37/233 (15%)
Query: 179 RGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236
+G P VA+K + P + + DF EV +L +L+ PNI++ LG + PL +ITEY
Sbjct: 43 KGRPLLVAVKILRPDANKN--ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEY 100
Query: 237 LRGGDLHKYLKEKG-------------------ALSPSTAVNFALDIARGMAYLHNEPNV 277
+ GDL+++L A+S S+ ++ AL IA GM YL +
Sbjct: 101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFK 336
+HRDL RN L+ +K+ DFG+S+ + + D Y++ G R+MA E
Sbjct: 159 FVHRDLATRNCLV--GENLTIKIADFGMSRNLY---AGDYYRIQGRAVLPIRWMAWECIL 213
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE--AAKYVAEGHRPFFRAKG 387
K+ DV++F + L+E+L L +PY + V E FFR +G
Sbjct: 214 MGKFTTASDVWAFGVTLWEILM----LCKEQPYGELTDEQVIENAGEFFRDQG 262
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G+FGE+ KA G VA+K+IL D I R E+ +L KL+HPN+V +
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74
Query: 223 AVTERKP--------LMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHN 273
ER + ++T Y+ DL L+ L+ S + L + G+ YLH
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE 133
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR----- 328
N I+HRD+K N+L+ N LK+ DFGL++ + G T Y
Sbjct: 134 --NHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189
Query: 329 --YMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLA 364
Y PE+ R+Y VD++ + EM P L
Sbjct: 190 RWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 5e-21
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G++G + KA + G VA+K+I + + R E++LL +L HPNIV+ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 66
Query: 223 AVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ L L+ E+L DL K++ + ++ + +G+A+ H+ + ++H
Sbjct: 67 VIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS--HRVLH 123
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRK 339
RDLKP+N LL+N+ +K+ DFGL++ V V T E + Y APE+ +
Sbjct: 124 RDLKPQN-LLINTEG-AIKLADFGLARAFGVP----VRTYTHEVVTLWYRAPEILLGCKY 177
Query: 340 YDKKVDVFSFAMILYEML 357
Y VD++S I EM+
Sbjct: 178 YSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 72/251 (28%), Positives = 116/251 (46%), Gaps = 37/251 (14%)
Query: 158 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF S +IG+G+FGE+ ++ G A+K + + ++ + R E ++LV+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+V+ + +++ L LI E+L GGD+ L +K LS + + + +H
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY----------------- 318
IHRD+KP N+LL + H+K+ DFGL +K + + Y
Sbjct: 122 --FIHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 319 -KMTGET-------------GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364
K ET G+ Y+APEVF Y+K D +S +I+YEML G PP
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 365 NYEPYEAAKYV 375
+ P E + V
Sbjct: 238 SETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV---KLR 213
F A++G+G FG++L A ++ T AIK + R ++ E + R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
HP +V + + EY GGDL ++ S AV +A + G+ YLH
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD-VFSEPRAVFYAACVVLGLQYLHE 119
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV-YKMTGET--GSYRYM 330
N I++RDLK N+LL + +K+ DFGL K + + T G+ ++
Sbjct: 120 --NKIVYRDLKLDNLLL--DTEGFVKIADFGLCK-------EGMGFGDRTSTFCGTPEFL 168
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
APEV Y + VD + +++YEML GE P
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 6e-21
Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 16/220 (7%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG+G+ G + A G VAI+++ L L+I +E+ ++ + ++PNIV +L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII----NEILVMRENKNPNIVNYL 83
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ L ++ EYL GG L + E + + + + +LH+ N +IHR
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS--NQVIHR 140
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+K N+LL + +K+ DFG I + S K + G+ +MAPEV + Y
Sbjct: 141 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYG 194
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
KVD++S ++ EM+EGEPP N P A +A P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 7e-21
Identities = 59/189 (31%), Positives = 86/189 (45%), Gaps = 11/189 (5%)
Query: 180 GTPVAIK--RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL-GAVTERKPLMLITEY 236
G VAIK R + ++ + FR E L +L HPNIV L L + EY
Sbjct: 3 GHEVAIKLLRTD-APEEEHQRAR-FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
+ G L + L GAL L + +A HN I+HRDLKP+N+++ +
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHN--QGIVHRDLKPQNIMVSQTGVR 118
Query: 297 -HLKVGDFGLSKLIKVQNSHDVYKMTGET---GSYRYMAPEVFKHRKYDKKVDVFSFAMI 352
H KV DFG+ L+ DV +T T G+ Y APE + D++++ +I
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 353 LYEMLEGEP 361
E L G+
Sbjct: 179 FLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 7e-21
Identities = 79/240 (32%), Positives = 118/240 (49%), Gaps = 35/240 (14%)
Query: 164 IIGKGSFGEILKAYWRGTPV----AIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIV 218
+IG+G+FG++LKA + + AIKR+ S D +DF E+ +L KL HPNI+
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNII 59
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFAL 262
LGA R L L EY G+L +L++ LS ++FA
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMT 321
D+ARGM YL + IHRDL RN+L+ + K+ DFGLS+ +VY K T
Sbjct: 120 DVARGMDYLSQKQ--FIHRDLAARNILVGENYVA--KIADFGLSR------GQEVYVKKT 169
Query: 322 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
R+MA E + Y DV+S+ ++L+E++ G P E + + +G+R
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 229
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 8e-21
Identities = 64/233 (27%), Positives = 116/233 (49%), Gaps = 17/233 (7%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
E + ++G G+FG + K W PVAIK + + S ++ E ++
Sbjct: 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK--ANKEILDEAYVM 63
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
+ P + + LG + + L+T+ + G L Y++E K + +N+ + IA+GM
Sbjct: 64 AGVGSPYVCRLLG-ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
+YL E ++HRDL RNVL+ S +H+K+ DFGL++L+ + + Y G +
Sbjct: 123 SYL--EEVRLVHRDLAARNVLV--KSPNHVKITDFGLARLLDIDETE--YHADGGKVPIK 176
Query: 329 YMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
+MA E HR++ + DV+S+ + ++E++ G P E + +G R
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 8e-21
Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 25/201 (12%)
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-----------KEK 249
DF E+ ++ +L+ PNI++ L PL +ITEY+ GDL+++L +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
+S ST + A IA GM YL + +HRDL RN L+ + +K+ DFG+S+ +
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYT--IKIADFGMSRNL 180
Query: 310 KVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368
S D Y++ G R+M+ E K+ DV++F + L+E+L L +P
Sbjct: 181 Y---SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT----LCKEQP 233
Query: 369 YE--AAKYVAEGHRPFFRAKG 387
Y + + V E FFR +G
Sbjct: 234 YSQLSDEQVIENTGEFFRDQG 254
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 68/202 (33%), Positives = 107/202 (52%), Gaps = 14/202 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G++G + KA R T +A+K+I D+ + R E++LL +++H NIV+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQD 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAVNFALDIARGMAYLHNEPNVIIH 280
V K L L+ EYL DL K++ + P + I RG+AY H+ + ++H
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS--HRVLH 125
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRK 339
RDLKP+N LL++ + LK+ DFGL++ + V T E + Y APE+ R
Sbjct: 126 RDLKPQN-LLIDRRTNALKLADFGLARAFGIP----VRTFTHEVVTLWYRAPEILLGSRH 180
Query: 340 YDKKVDVFSFAMILYEMLEGEP 361
Y VD++S I EM+ +P
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 72/239 (30%), Positives = 116/239 (48%), Gaps = 20/239 (8%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPV-AIKRILPSLSDDRLVIQDFRHEVNLL 209
++DP+E+ + +G G+FG++ KA + T A +++ + S++ L +D+ E+ +L
Sbjct: 7 DLDPNEV-WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYMVEIEIL 63
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
HP IV+ LGA L ++ E+ GG + + E +G P V +
Sbjct: 64 ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEA 122
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+ YLH+ IIHRDLK NVLL +K+ DFG+S +N + + G+
Sbjct: 123 LQYLHSMK--IIHRDLKAGNVLLTLDG--DIKLADFGVS----AKNVKTLQRRDSFIGTP 174
Query: 328 RYMAPEV-----FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
+MAPEV K YD K D++S + L EM + EPP P +A+ P
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP 233
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 73/251 (29%), Positives = 115/251 (45%), Gaps = 37/251 (14%)
Query: 158 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF S +IG+G+FGE+ ++ G A+K + + ++ + R E ++LV+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+V+ + ++ L LI E+L GGD+ L +K L+ + + + +H
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY----------------- 318
IHRD+KP N+LL S H+K+ DFGL +K + + Y
Sbjct: 122 --FIHRDIKPDNLLL--DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 319 -KMTGET-------------GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364
K ET G+ Y+APEVF Y+K D +S +I+YEML G PP
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 365 NYEPYEAAKYV 375
+ P E K V
Sbjct: 238 SETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
D++ IG+G++G + K + T VA+K+I S++ V E++LL +L+HP
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE-SEEEGVPSTAIREISLLKELQHP 59
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYL---KEKGALSPSTAVNFALDIARGMAYLH 272
NIV + + L LI E+L DL KYL + + ++ I +G+ + H
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
+ ++HRDLKP+N+L+ N +K+ DFGL++ + V T E + Y AP
Sbjct: 119 SRR--VLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIP----VRVYTHEVVTLWYRAP 170
Query: 333 EVF-KHRKYDKKVDVFSFAMILYEMLEGEP 361
EV +Y VD++S I EM +P
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 70/255 (27%), Positives = 113/255 (44%), Gaps = 52/255 (20%)
Query: 158 DFSSSAIIGKGSFGE--ILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF S +IG+G+FGE +++ G A+K++ S ++ + R E ++L + +P
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF------ALDIARGMA 269
+V+ + + L LI EYL GGD+ L +K + + A+D +
Sbjct: 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----- 324
Y IHRD+KP N+LL H+K+ DFGL +K + + Y++
Sbjct: 122 Y--------IHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 325 -----------------------------GSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 355
G+ Y+APEVF Y+K+ D +S +I+YE
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 356 MLEGEPPLANYEPYE 370
ML G PP + P E
Sbjct: 232 MLVGYPPFCSDNPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-20
Identities = 70/235 (29%), Positives = 114/235 (48%), Gaps = 28/235 (11%)
Query: 165 IGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G+G FG +++ VA+K + ++ R ++DF E + + HPN+++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRL 65
Query: 221 LGAV---TERKPL---MLITEYLRGGDLHKYL------KEKGALSPSTAVNFALDIARGM 268
+G E + ++I +++ GDLH +L L V F DIA GM
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY- 327
YL ++ IHRDL RN +L N + + + V DFGLSK K+ N D Y+ G
Sbjct: 126 EYLSSKS--FIHRDLAARNCML-NENMN-VCVADFGLSK--KIYNG-DYYRQ-GRIAKMP 177
Query: 328 -RYMAPEVFKHRKYDKKVDVFSFAMILYEM-LEGEPPLANYEPYEAAKYVAEGHR 380
+++A E R Y K DV+SF + ++E+ G+ P E E Y+ +G+R
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR 232
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 4e-20
Identities = 67/200 (33%), Positives = 102/200 (51%), Gaps = 10/200 (5%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IGKGSFG++++ R T A+K I + R + E +L ++ P IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ + L L+ ++ GG+L +L+ +G S A + ++ + LH + NVI +RD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLH-KFNVI-YRD 118
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK 342
LKP N+LL H+ + DFGL KL N D K G+ Y+APE+ Y K
Sbjct: 119 LKPENILL--DYQGHIALCDFGLCKL----NMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 343 KVDVFSFAMILYEMLEGEPP 362
VD ++ ++LYEML G PP
Sbjct: 173 AVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 13/213 (6%)
Query: 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
F ++GKG FGE+ R G A K++ R +E +L K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+V A + L L+ + GGDL H Y AV +A +I G+ LH E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I++RDLKP N+LL + H+++ D GL+ I + + G G+ YMAPEV
Sbjct: 122 R--IVYRDLKPENILLDDYG--HIRISDLGLAVEIP-----EGETIRGRVGTVGYMAPEV 172
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367
K+ +Y D + ++YEM+EG+ P +
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-20
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVK------LRHP 215
++GKGSFG+++ A +GT AIK L D +++QD + + K +HP
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIK----VLKKD-VILQDDDVDCTMTEKRILALAAKHP 56
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+ + L + EY+ GGDL ++ + +A ++ + +LH
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR-- 114
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
+ +I+RDLK N+LL + H K+ DFG+ K + + T G+ Y+APE+
Sbjct: 115 HGVIYRDLKLDNILL--DAEGHCKLADFGMCK----EGILNGVTTTTFCGTPDYIAPEIL 168
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPP 362
+ +Y VD ++ +++YEM+ G+PP
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 6e-20
Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 165 IGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQ 219
+G+G++G + A T VAIK+I S L + R E+ LL R H NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNITC 66
Query: 220 -------FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
F G E + + E L DLH+ ++ L+ + +F I G+ Y+H
Sbjct: 67 LYDMDIVFPGNFNE----LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
+ NV+ HRDLKP N LLVN+ + LK+ DFGL++ + MT + Y AP
Sbjct: 123 S-ANVL-HRDLKPGN-LLVNADCE-LKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 333 EV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
E+ + Y K +DV+S IL E+L +P
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 14/224 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRG---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
DF+ +G GSFG ++ A ++ PVAIKR S + + E +L + H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
P V G+ + L L+ E++ GG+ +L+ +A I YL +
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL 150
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I++RDLKP N+LL +K+ DFG +K++ + Y + G + Y+APE+
Sbjct: 151 N--IVYRDLKPENLLL--DKDGFIKMTDFGFAKVVDTRT----YTLCG---TPEYIAPEI 199
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378
+ + K D ++ + +YE+L G PP EP + + EG
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG 243
|
Length = 340 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 6e-20
Identities = 70/229 (30%), Positives = 108/229 (47%), Gaps = 33/229 (14%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+G+G+ G + K + G A+K I + D L Q R E+ + + P IV++
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-LQKQILR-ELEINKSCKSPYIVKYY 65
Query: 222 GAVTERKPLML--ITEYLRGGDL---HKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEP 275
GA + + EY GG L +K +K++G + A + +G++YLH+
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE-TGSYRYMAPEV 334
IIHRD+KP N+LL + +K+ DFG+S V + G TG+ YMAPE
Sbjct: 126 --IIHRDIKPSNILL--TRKGQVKLCDFGVS-------GELVNSLAGTFTGTSFYMAPER 174
Query: 335 FKHRKYDKKVDVFSFAMILYEML--------EGEPPLANYEPYEAAKYV 375
+ + Y DV+S + L E+ EGEPPL P E Y+
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG---PIELLSYI 220
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 66/205 (32%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 221
+GKG++G + KA R T VA+K+I + + + FR E+ L +L HPNIV+ L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73
Query: 222 G---AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
A ++ + L+ EY+ DLH ++ L + + + Y+H+ +
Sbjct: 74 NVIKAENDKD-IYLVFEYMET-DLHAVIR-ANILEDVHKRYIMYQLLKALKYIHSGN--V 128
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLI-KVQNSHDVYKMTGETGSYRYMAPEV-FK 336
IHRDLKP N+LL +S +K+ DFGL++ + +++ + + +T + Y APE+
Sbjct: 129 IHRDLKPSNILL--NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG 186
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEP 361
+Y K VD++S IL EML G+P
Sbjct: 187 STRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 69/243 (28%), Positives = 111/243 (45%), Gaps = 19/243 (7%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
F ++GKG FGE+ R T A K++ R +E +L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+V A + L L+ + GGDL H Y + AV +A +I G+ LH E
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I++RDLKP N+LL + H+++ D GL+ + + + G G+ YMAPEV
Sbjct: 122 R--IVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQT-----IKGRVGTVGYMAPEV 172
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----EAAKYVAEGHRPFFRAKGFTP 390
K+ +Y D ++ +LYEM+ G+ P + E + V E + ++ F+P
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY--SEKFSP 230
Query: 391 ELR 393
+ R
Sbjct: 231 DAR 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 14/219 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+GS G + A + G VA+K++ R ++ + EV ++ H N+V
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYHHENVVDMYN 86
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ L ++ E+L GG L + ++ L + R ++YLHN+ +IHRD
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQG--VIHRD 143
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK 342
+K ++LL +S +K+ DFG Q S +V K G+ +MAPEV Y
Sbjct: 144 IKSDSILL--TSDGRIKLSDFGFC----AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197
Query: 343 KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
+VD++S +++ EM++GEPP N P +A + + + P
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
I +G++G + +A + G VA+K++ + I R E+N+L+KL+HPNIV
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVKE 71
Query: 223 AV--TERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVII 279
V + + ++ EY+ DL ++ K S L + G+A+LH+ N I+
Sbjct: 72 VVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD--NWIL 128
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHR 338
HRDLK N+LL N LK+ DFGL++ + + T + Y APE+ +
Sbjct: 129 HRDLKTSNLLLNNRGI--LKICDFGLAR----EYGSPLKPYTQLVVTLWYRAPELLLGAK 182
Query: 339 KYDKKVDVFSFAMILYEMLEGEP 361
+Y +D++S I E+L +P
Sbjct: 183 EYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-19
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 13/209 (6%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
F ++GKG FGE+ R T A KR+ R +E +L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+V A + L L+ + GGDL H Y A+ +A +I G+ LH E
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
++RDLKP N+LL + H+++ D GL+ +K+ + G G+ YMAPEV
Sbjct: 122 N--TVYRDLKPENILLDDYG--HIRISDLGLA--VKIPEGESI---RGRVGTVGYMAPEV 172
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
+++Y D + ++YEM+EG+ P
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 15/216 (6%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
++ +L+ S G G +K GT +A K + + V + E+ ++
Sbjct: 1 DLRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVH--IGAKSSVRKQILRELQIMH 58
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+ R P IV F GA + + E++ G L + K+ G + A+ + G+ Y
Sbjct: 59 ECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTY 118
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNS-HDVYKMTGETGSYR 328
L+N I+HRD+KP N+ LVN S +K+ DFG+S +LI NS D + G+
Sbjct: 119 LYNVHR-IMHRDIKPSNI-LVN-SRGQIKLCDFGVSGELI---NSIADTF-----VGTST 167
Query: 329 YMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364
YM+PE + KY K DV+S + + E+ G+ P A
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 31/210 (14%)
Query: 165 IGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
IG G+FG + W G VA+K+ +P++ + + + E+ +L +H N+
Sbjct: 8 IGYGAFGVV----WSVTDPRDGKRVALKK-MPNVFQNLVSCKRVFRELKMLCFFKHDNV- 61
Query: 219 QFLGAVTERKP--------LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
L A+ +P + ++TE ++ DLHK + LS F I RG+ Y
Sbjct: 62 --LSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH+ I+HRD+KP N LLVNS+ LK+ DFGL+ +V+ + MT E + Y
Sbjct: 119 LHSAG--ILHRDIKPGN-LLVNSNC-VLKICDFGLA---RVEEPDESKHMTQEVVTQYYR 171
Query: 331 APEVFK-HRKYDKKVDVFSFAMILYEMLEG 359
APE+ R Y VD++S I E+L
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 63/205 (30%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+GKG FGE+ R T A K++ R + E +L K+ IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 223 AVTERKPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
A + L L+ + GGDL ++ +E A + I G+ +LH I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRI 118
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
I+RDLKP NVLL N ++++ D GL+ +K S K G G+ +MAPE+ +
Sbjct: 119 IYRDLKPENVLLDN--DGNVRISDLGLAVELKDGQS----KTKGYAGTPGFMAPELLQGE 172
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPL 363
+YD VD F+ + LYEM+ P
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 72/247 (29%), Positives = 121/247 (48%), Gaps = 33/247 (13%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRH---PN 216
+G+G++G + K GT +A+KRI + S RL++ +L + +R P
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLM-------DLDISMRSVDCPY 61
Query: 217 IVQFLGAVTERKPLMLITEYLRGG--DLHKYLKEKGALSPSTAVN-FALDIARGMAYLHN 273
V F GA+ + + E + +K + +KG P + A+ I + + YLH+
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRYMAP 332
+ +VI HRD+KP NVL+ + +K+ DFG+S L+ D T + G YMAP
Sbjct: 122 KLSVI-HRDVKPSNVLI--NRNGQVKLCDFGISGYLV------DSVAKTIDAGCKPYMAP 172
Query: 333 EVF----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPFFRAKG 387
E + YD K DV+S + + E+ G P +++ P++ K V E P A+
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK 232
Query: 388 FTPELRE 394
F+PE ++
Sbjct: 233 FSPEFQD 239
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 3e-19
Identities = 66/232 (28%), Positives = 107/232 (46%), Gaps = 33/232 (14%)
Query: 165 IGKGSFGEILKA-YWRGTPVA---IKRILPSLSDDRLVIQD-FRHEVNLLVKLRHPNIVQ 219
IG G FG++L RG A +K + S + D Q F EV +L HPN++Q
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE---QLLFLQEVQPYRELNHPNVLQ 59
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLHNE 274
LG E P +L+ E+ GDL YL+ A ++A G+ +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118
Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSY--RYMA 331
IH DL RN L +AD +K+GD+GL+ ++ + Y +T + + R++A
Sbjct: 119 -ADFIHSDLALRNCQL---TADLSVKIGDYGLA----LEQYPEDYYITKDCHAVPLRWLA 170
Query: 332 PEVFKHRKYD-------KKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV 375
PE+ + R D KK +++S + ++E+ + P + + K V
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-19
Identities = 70/256 (27%), Positives = 123/256 (48%), Gaps = 27/256 (10%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
DP+ + F ++G G++G++ K + + +A +++ D+ ++ + E+N+L K
Sbjct: 3 DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKK 58
Query: 212 L-RHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLKE-KG-ALSPSTAVNFAL 262
H NI + GA ++ P L L+ E+ G + +K KG L
Sbjct: 59 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
+I RG+++LH +IHRD+K +NVLL ++ +K+ DFG+S Q V +
Sbjct: 119 EILRGLSHLHQHK--VIHRDIKGQNVLLTENA--EVKLVDFGVS----AQLDRTVGRRNT 170
Query: 323 ETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377
G+ +MAPEV YD K D++S + EM EG PPL + P A +
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 230
Query: 378 GHRPFFRAKGFTPELR 393
P ++K ++ + +
Sbjct: 231 NPAPRLKSKKWSKKFQ 246
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-19
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQF 220
IG+G++G++ KA + G VA+K+ + ++ + R E++LL L IV+
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVRL 66
Query: 221 LGAV-TERKP----LMLITEYLRGGDLHKYLKEKG-----ALSPSTAVNFALDIARGMAY 270
L E K L L+ EYL DL K++ G L T +F + +G+A+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
H ++HRDLKP+N LLV+ LK+ D GL + + V T E + Y
Sbjct: 126 CHKHG--VMHRDLKPQN-LLVDKQKGLLKIADLGLGRAFSIP----VKSYTHEIVTLWYR 178
Query: 331 APEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
APEV Y VD++S I EM +P
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 66/233 (28%), Positives = 116/233 (49%), Gaps = 15/233 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+GS G + A + G VA+K + R ++ + EV ++ +H N+V+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHQNVVEMYK 85
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ + L ++ E+L+GG L + + L+ + + + YLH++ +IHRD
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLHSQG--VIHRD 142
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK 342
+K ++LL +K+ DFG Q S DV K G+ +MAPEV Y
Sbjct: 143 IKSDSILLTLDG--RVKLSDFGFC----AQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 343 KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELRE 394
+VD++S +++ EM++GEPP + P +A K + + P + A +P LR+
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRD 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 7e-19
Identities = 63/219 (28%), Positives = 109/219 (49%), Gaps = 16/219 (7%)
Query: 158 DFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
D+ +G G++G++ KA G A+K I DD +IQ E+ ++ + +H
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ---QEIFMVKECKHC 66
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
NIV + G+ R+ L + EY GG L G LS + +G+AYLH++
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
+HRD+K N+LL ++ +K+ DFG++ I + + K G+ +MAPEV
Sbjct: 127 K--MHRDIKGANILLTDNG--DVKLADFGVAAKI----TATIAKRKSFIGTPYWMAPEVA 178
Query: 336 ---KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
K+ Y++ D+++ + E+ E +PP+ + P A
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 9e-19
Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 19/235 (8%)
Query: 156 ELDFSS---SAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVN 207
ELD S I+G G FGE+ + R PVAI + SD + + F E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR--RGFLAEAL 58
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIAR 266
L + H NIV+ G +T +M++TEY+ G L +L K +G L + +A
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLAS 118
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
GM YL +H+ L V LVNS K+ F + K + +Y
Sbjct: 119 GMKYLSEMG--YVHKGLAAHKV-LVNSDLV-CKISGFRRLQEDKSEA---IYTTMSGKSP 171
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYE-MLEGEPPLANYEPYEAAKYVAEGHR 380
+ APE ++ + DV+SF ++++E M GE P + + K V +G R
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 74/236 (31%), Positives = 114/236 (48%), Gaps = 30/236 (12%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DPS+ + IGKG++G++ K + G+ A+K IL + D + ++ E N+L
Sbjct: 15 DPSD-TWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHD---IDEEIEAEYNILK 69
Query: 211 KLR-HPNIVQFLGA-----VTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFA 261
L HPN+V+F G V L L+ E GG DL K ++G + +
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 262 LDIA-RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
L A G+ +LH N IHRD+K N+LL +K+ DFG+S Q + +
Sbjct: 130 LHEALMGLQHLHV--NKTIHRDVKGNNILLTTEGG--VKLVDFGVS----AQLTSTRLRR 181
Query: 321 TGETGSYRYMAPEVFKHRK-----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
G+ +MAPEV + YD + DV+S + E+ +G+PPLA+ P A
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 71/252 (28%), Positives = 123/252 (48%), Gaps = 27/252 (10%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
DP+ + F ++G G++G++ K + + +A +++ D+ ++ + E+N+L K
Sbjct: 13 DPAGI-FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE---EEIKLEINMLKK 68
Query: 212 L-RHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLKE-KG-ALSPSTAVNFAL 262
H NI + GA ++ P L L+ E+ G + +K KG AL
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
+I RG+A+LH + +IHRD+K +NVLL ++ +K+ DFG+S Q V +
Sbjct: 129 EILRGLAHLH--AHKVIHRDIKGQNVLLTENA--EVKLVDFGVS----AQLDRTVGRRNT 180
Query: 323 ETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377
G+ +MAPEV YD + D++S + EM EG PPL + P A +
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240
Query: 378 GHRPFFRAKGFT 389
P ++K ++
Sbjct: 241 NPPPKLKSKKWS 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 13/208 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
DF +G G+ G + K R + + + R L L + E+ +L + P I
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
V F GA + + E++ GG L + LK+ G + + ++ + RG+ YL + +
Sbjct: 62 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK-HK 120
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLI-KVQNSHDVYKMTGETGSYRYMAPEVF 335
I+HRD+KP N+L VNS + +K+ DFG+S +LI + NS G+ YM+PE
Sbjct: 121 IMHRDVKPSNIL-VNSRGE-IKLCDFGVSGQLIDSMANSF--------VGTRSYMSPERL 170
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPL 363
+ Y + D++S + L EM G P+
Sbjct: 171 QGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ-------DFRHEVNLLVKLRHPN 216
IIG+G FGE+ R + L R+ ++ + R ++L+ P
Sbjct: 1 IIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
IV A L I + + GGDLH +L + G S + +A +I G+ ++HN
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR-- 116
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF- 335
+++RDLKP N+LL H+++ D GL+ + H G++ YMAPEV
Sbjct: 117 FVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPH------ASVGTHGYMAPEVLQ 168
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPP 362
K YD D FS +L+++L G P
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 67/204 (32%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+GS+ + K + T VA+K I L + E +LL L+H NIV
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI--RLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 223 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ +K L L+ EYL DL +Y+ G LS F + RG+AY H ++HR
Sbjct: 71 IIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHR 127
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN---SHDVYKMTGETGSYRYMAPEVF-KH 337
DLKP+N+L+ S LK+ DFGL++ V + S++V T YR P+V
Sbjct: 128 DLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVV-----TLWYR--PPDVLLGS 178
Query: 338 RKYDKKVDVFSFAMILYEMLEGEP 361
+Y +D++ I YEM G P
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 64/227 (28%), Positives = 96/227 (42%), Gaps = 33/227 (14%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+GKG G + +GT A+K + R ++ E +L L HP +
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ L L+ +Y GG+L + L+ LS A +A ++ + YLH I++
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL--LGIVY 126
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK------------LIKVQNSHDVYKMTGET---- 324
RDLKP N+LL S H+ + DF LSK L K V + ET
Sbjct: 127 RDLKPENILLHESG--HIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184
Query: 325 ---------GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APEV + VD ++ ++LYEML G P
Sbjct: 185 PSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 22/210 (10%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+IGKGS+G + A G VAIK+I +SD +++ E+ LL LRHP+IV
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDIV 62
Query: 219 QFLGAV-----TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
+ + E K + ++ E L DLH+ +K L+P F + R + Y+H
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
+ HRDLKP+N+ L N+ LK+ DFGL+++ ++ T + Y APE
Sbjct: 122 --ANVFHRDLKPKNI-LANADCK-LKICDFGLARVAFNDTPTAIF-WTDYVATRWYRAPE 176
Query: 334 VFK--HRKYDKKVDVFSFAMILYEMLEGEP 361
+ KY +D++S I E+L G+P
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G++G + A T VAIK+I + D+R+ + E+ LL L H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKD 71
Query: 223 AVT-----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
+ + ++ E L DLH+ ++ LS F + RG+ Y+H+
Sbjct: 72 IMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN-- 128
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FK 336
++HRDLKP N LL+N++ D LK+ DFGL++ S MT + Y APE+
Sbjct: 129 VLHRDLKPSN-LLLNANCD-LKICDFGLART----TSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEP 361
+Y +DV+S I E+L +P
Sbjct: 183 CSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 5e-18
Identities = 70/224 (31%), Positives = 104/224 (46%), Gaps = 24/224 (10%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
NK WE+ D +G G++G + A R G VAIK++ + + +R
Sbjct: 7 NKTIWEVPDRYRDLKQ---VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY-----LRGGDLHKYLKEKGALSPSTAV 258
E+ LL ++H N++ L T L ++ G DL K +K + LS
Sbjct: 64 -ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE-KLSEDRIQ 121
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
+ +G+ Y+H IIHRDLKP N L VN + LK+ DFGL++
Sbjct: 122 FLVYQMLKGLKYIHAAG--IIHRDLKPGN-LAVNEDCE-LKILDFGLAR-------QTDS 170
Query: 319 KMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+MTG + Y APEV Y + VD++S I+ EML G+P
Sbjct: 171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-18
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ-------DFRHEVNLLVKLRHPN 216
IIG+G FGE+ R + L R+ ++ + R ++L+ P
Sbjct: 1 IIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
IV A L I + + GGDLH +L + G S +A +I G+ ++HN
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR-- 116
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF- 335
+++RDLKP N+LL H+++ D GL+ + H G++ YMAPEV
Sbjct: 117 FVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPH------ASVGTHGYMAPEVLQ 168
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367
K YD D FS +L+++L G P ++
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 8e-18
Identities = 66/234 (28%), Positives = 117/234 (50%), Gaps = 30/234 (12%)
Query: 165 IGKGSFGE----ILKAYWRGTP---VAIKRILPSLS-DDRLVIQDFRHEVNLLVKLRHPN 216
+G+GSFG + +G VA+K + S S +R+ +F +E +++ +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI---EFLNEASVMKGFTCHH 70
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLK--------EKGALSPS--TAVNFALDIAR 266
+V+ LG V++ +P +++ E + GDL YL+ G P+ + A +IA
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE-TG 325
GMAYL+ + +HRDL RN ++ + +K+GDFG+++ I D Y+ G+
Sbjct: 131 GMAYLNAKK--FVHRDLAARNCMVAHDFT--VKIGDFGMTRDIY---ETDYYRKGGKGLL 183
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEG 378
R+MAPE K + D++SF ++L+E+ E P + K+V +G
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 8e-18
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 9/204 (4%)
Query: 164 IIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++GKG+FG+++ K G A+K + + + + E +L RHP +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ L + EY GG+L +L + S A + +I + YLH+E NV+ +R
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV-YR 120
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
DLK N++L H+K+ DFGL K + D M G+ Y+APEV + Y
Sbjct: 121 DLKLENLML--DKDGHIKITDFGLCK----EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174
Query: 342 KKVDVFSFAMILYEMLEGEPPLAN 365
+ VD + +++YEM+ G P N
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYN 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 164 IIGKGSFGEIL----KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
++GKG+FG+++ KA R + I R ++ D + E +L RHP +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTRHPFLTA 59
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
A L + EY GG+L +L + + A + +I + YLH+ ++
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VV 117
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
+RD+K N++L H+K+ DFGL K + D M G+ Y+APEV +
Sbjct: 118 YRDIKLENLMLDKDG--HIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 340 YDKKVDVFSFAMILYEMLEGEPPLAN 365
Y + VD + +++YEM+ G P N
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 24/212 (11%)
Query: 163 AIIGKGSFGEILKAY---WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPN 216
A IG+G++G++ KA G VA+KR+ ++ + + R EV +L L HPN
Sbjct: 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPN 65
Query: 217 IVQFLGAVT-----ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMA 269
+V+ T L L+ E++ DL YL + + + T + + RG+
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 329
+LH+ + ++HRDLKP+N+L+ +S+ +K+ DFGL+++ Q + +T Y
Sbjct: 125 FLHS--HRVVHRDLKPQNILV--TSSGQIKLADFGLARIYSFQMALTSVVVT-----LWY 175
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
APEV Y VD++S I EM +P
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 72/224 (32%), Positives = 111/224 (49%), Gaps = 29/224 (12%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFL 221
IGKG++G++ K + G+ A+K IL +SD V ++ E N+L L HPN+V+F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISD---VDEEIEAEYNILQSLPNHPNVVKFY 85
Query: 222 GAVTERK-----PLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDIAR-GMAYLH 272
G + L L+ E GG +L K L G +++ L A G+ +LH
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
N N IIHRD+K N+LL +K+ DFG+S Q + + G+ +MAP
Sbjct: 146 N--NRIIHRDVKGNNILLTTEGG--VKLVDFGVS----AQLTSTRLRRNTSVGTPFWMAP 197
Query: 333 EVFKHRK-----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
EV + YD + DV+S + E+ +G+PPL + P +
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
F ++GKG FGE+ R T A K++ R +E +L K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+V A + L L+ + GGDL H Y A+ +A ++ G+ L E
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I++RDLKP N+LL + H+++ D GL+ I + + G G+ YMAPEV
Sbjct: 122 R--IVYRDLKPENILLDDRG--HIRISDLGLAVQIP-----EGETVRGRVGTVGYMAPEV 172
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367
+ KY D + ++YEM++G+ P +
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+GS+ + K R G VA+K I S+ + V E +LL L+H NIV
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVI--SMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 223 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ ++ L + EY+ DL +Y+ + G L P F + RG+AY+H + I+HR
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHR 127
Query: 282 DLKPRNVLLVNSSADHLKVGDFGL--SKLIKVQNSHDVYKMTGETGSYRYMAPEVF-KHR 338
DLKP+N+L+ S LK+ DFGL +K I Q + E + Y P+V
Sbjct: 128 DLKPQNLLI--SYLGELKLADFGLARAKSIPSQT------YSSEVVTLWYRPPDVLLGAT 179
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPLA 364
Y +D++ I EML+G+P
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 164 IIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++GKG+FG+++ + G A+K + + + + E +L RHP +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ + L + EY+ GG+L +L + S + +I + YLH+ I++R
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS--GKIVYR 119
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
DLK N++L H+K+ DFGL K + D M G+ Y+APEV + Y
Sbjct: 120 DLKLENLML--DKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYE 367
+ VD + +++YEM+ G P N +
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 28/217 (12%)
Query: 165 IGKGSFGEILKAYW----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
IG+G++G + KA G AIK+ + Q E+ LL +L+H N+V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 221 LGAV---TERKPLMLI--TEYLRGGDL-----HKYLKEKGALSPSTAVNFALDIARGMAY 270
+ ++ +L E+ DL ++ ++ PS + I G+ Y
Sbjct: 68 VEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
LH+ N ++HRDLKP N+L++ + +K+GD GL++L + + +
Sbjct: 124 LHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLADLDPVVVTIW 180
Query: 329 YMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPP 362
Y APE+ +H Y K +D+++ I E+L EP
Sbjct: 181 YRAPELLLGARH--YTKAIDIWAIGCIFAELLTLEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 70/220 (31%), Positives = 104/220 (47%), Gaps = 32/220 (14%)
Query: 158 DFSSSAIIGKGSFGEI-LKAYWRGTPV-AIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
DF +IG+G+FGE+ L + V A+K LS ++ + F E +++
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKL----LSKFEMIKRSDSAFFWEERDIMAH 99
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIAR 266
IVQ A + K L ++ EY+ GGDL + EK A + V ALD
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH 159
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
M + IHRD+KP N+LL + HLK+ DFG +K+ + V T G+
Sbjct: 160 SMGF--------IHRDVKPDNMLL--DKSGHLKLADFG--TCMKMDANGMVRCDTA-VGT 206
Query: 327 YRYMAPEVFK----HRKYDKKVDVFSFAMILYEMLEGEPP 362
Y++PEV K Y ++ D +S + LYEML G+ P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNI 217
A IG G++G + KA G VA+K + ++D L + R EV LL +L HPNI
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNI 64
Query: 218 VQFL----GAVTERK-PLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAY 270
V+ + + T+R+ + L+ E++ DL YL + L T + RG+ +
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH N I+HRDLKP N+L+ +S +K+ DFGL+++ Q + +T Y
Sbjct: 124 LHA--NCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVT-----LWYR 174
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
APEV Y VD++S I EM +P
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 68/235 (28%), Positives = 112/235 (47%), Gaps = 16/235 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
DF + +G G+ G + K + + + + R L L + E+ +L + P I
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
V F GA + + E++ GG L + LKE + ++ + RG+AYL E +
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR-EKHQ 124
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLI-KVQNSHDVYKMTGETGSYRYMAPEVF 335
I+HRD+KP N+ LVNS + +K+ DFG+S +LI + NS G+ YM+PE
Sbjct: 125 IMHRDVKPSNI-LVNSRGE-IKLCDFGVSGQLIDSMANSF--------VGTRSYMSPERL 174
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390
+ Y + D++S + L E+ G P+ P +A + A RP + P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPIP---PPDAKELEAIFGRPVVDGEEGEP 226
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 66/201 (32%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G++ + K + T VA+K I L + EV+LL L+H NIV
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALDIARGMAYLHNEPNVIIHR 281
+ + L L+ EYL DL +YL G L V F + RG++Y H I+HR
Sbjct: 71 IIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHR 127
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 340
DLKP+N LL+N + LK+ DFGL++ V + E + Y P+V +Y
Sbjct: 128 DLKPQN-LLINEKGE-LKLADFGLARAKSVPTK----TYSNEVVTLWYRPPDVLLGSTEY 181
Query: 341 DKKVDVFSFAMILYEMLEGEP 361
+D++ ILYEM G P
Sbjct: 182 STPIDMWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 164 IIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQD-FRH---EVNLLVKLRHPNI 217
++GKG+FG+++ + G A+K L + ++ +D H E +L RHP +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMK----ILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
+ L + EY GG+L +L + S A + +I + YLH+
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD-- 115
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
+++RDLK N++L H+K+ DFGL K + D M G+ Y+APEV +
Sbjct: 116 VVYRDLKLENLML--DKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLAN 365
Y + VD + +++YEM+ G P N
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 5e-17
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 34/215 (15%)
Query: 162 SAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
A IG+G+FGE+ KA + T VA+K++L + I R E+ +L L+H N+V
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN 75
Query: 220 FLGAVTERKPLM---------LITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIAR--- 266
L + K L+ E+ DL L + V F L +I +
Sbjct: 76 -LIEICRTKATPYNRYKGSFYLVFEFCEH-DL-------AGLLSNKNVKFTLSEIKKVMK 126
Query: 267 ----GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
G+ Y+H N I+HRD+K N+L+ LK+ DFGL++ + + + T
Sbjct: 127 MLLNGLYYIHR--NKILHRDMKAANILITKDGI--LKLADFGLARAFSLSKNSKPNRYTN 182
Query: 323 ETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEM 356
+ Y PE+ R Y +D++ I+ EM
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 5e-17
Identities = 61/232 (26%), Positives = 113/232 (48%), Gaps = 15/232 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+GS G + A + G VA+K++ R ++ + EV ++ +H N+V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 84
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ L ++ E+L GG L + ++ L + + ++ LH + +IHRD
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQG--VIHRD 141
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDK 342
+K ++LL + +K+ DFG Q S +V + G+ +MAPE+ Y
Sbjct: 142 IKSDSILLTHDG--RVKLSDFGFC----AQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195
Query: 343 KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELR 393
+VD++S +++ EM++GEPP N P +A K + + P + +P L+
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLK 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 7e-17
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 165 IGKGSFGEI--LKAYWRGTPVAIKRI----LPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+GKG FGE+ ++ G A K++ L S +++ + E +L K+ P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL----EKEILEKVNSPFIV 56
Query: 219 QFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
A + L L+ + GGDL H Y + L ++++ I G+ +LH+
Sbjct: 57 NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD- 115
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
I++RD+KP NVLL + ++ D GL+ +K D +T G+ YMAPE+ K
Sbjct: 116 -IVYRDMKPENVLL--DDQGNCRLSDLGLAVELK-----DGKTITQRAGTNGYMAPEILK 167
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367
Y VD F+ +YEM+ G P +++
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 7e-17
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 10/205 (4%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
F ++G+G++G +LK + T VAIK+ S ++ + R E+ +L L+ N
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQEN 61
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
IV+ A R L L+ EY+ L + + P ++ + + + + H N
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK--N 119
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
I+HRD+KP N+L+ S D LK+ DFG ++ + ++ + T + Y +PE+
Sbjct: 120 DIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNAN---YTEYVATRWYRSPELLL 174
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEP 361
Y K VD++S IL E+ +G+P
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 13/208 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
DF + +G G+ G + K + + + + R L L + E+ +L + P I
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
V F GA + + E++ GG L + LK+ G + ++ + +G+ YL E +
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 124
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLI-KVQNSHDVYKMTGETGSYRYMAPEVF 335
I+HRD+KP N+ LVNS + +K+ DFG+S +LI + NS G+ YM+PE
Sbjct: 125 IMHRDVKPSNI-LVNSRGE-IKLCDFGVSGQLIDSMANSF--------VGTRSYMSPERL 174
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPL 363
+ Y + D++S + L EM G P+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFL 221
IG+G+FG + K + GT +A+KRI + D + +++++++ P IV+F
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 222 GAV-TERKPLM---LITEYLRGGDLHK--YLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
GA+ E + L+ L +K Y K + A+ + + YL E
Sbjct: 70 GALFREGDCWICMELMDISLD--KFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE-- 333
IIHRD+KP N+LL + ++K+ DFG+S ++ +S + K T + G YMAPE
Sbjct: 128 K-IIHRDVKPSNILLDRNG--NIKLCDFGISG--QLVDS--IAK-TRDAGCRPYMAPERI 179
Query: 334 -VFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
YD + DV+S + LYE+ G+ P
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 65/201 (32%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G++ + K + T VA+K I L + EV+LL L+H NIV
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALDIARGMAYLHNEPNVIIHR 281
V K L L+ EYL DL +Y+ + G + V F I RG+AY H ++HR
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHR 128
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 340
DLKP+N LL+N + LK+ DFGL++ V + E + Y P+V +Y
Sbjct: 129 DLKPQN-LLINERGE-LKLADFGLARAKSVPTK----TYSNEVVTLWYRPPDVLLGSSEY 182
Query: 341 DKKVDVFSFAMILYEMLEGEP 361
++D++ I +EM G P
Sbjct: 183 STQIDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 29/223 (13%)
Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRI------LPSLSDDRLVIQDFRH-----EVNLL 209
A +G+G++G++ KAY G VAIK++ D +LV H E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
+++H NI+ + E + L+ + + DL K + K L+ S L I G+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLN 133
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS----------KLIKVQNSHDVYK 319
LH +HRDL P N+ + +S K+ DFGL+ L K + +
Sbjct: 134 VLHK--WYFMHRDLSPANIFI--NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 320 MTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
MT + + Y APE+ KY VD++S I E+L G+P
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 221
IG+G+F E+LKA R G AIK + V R E+ L +L HPNI++ +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LR-EIQALRRLSPHPNILRLI 64
Query: 222 GAVTERKP--LMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
+ +RK L L+ E L +L++ +K K L ++ + + + ++H N I
Sbjct: 65 EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR--NGI 121
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR-YMAPE-VFK 336
HRD+KP N+L+ D LK+ DFG + I + + Y T R Y APE +
Sbjct: 122 FHRDIKPENILI---KDDILKLADFGSCRGIYSKPPYTEYIST------RWYRAPECLLT 172
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEP 361
Y K+D+++ + +E+L P
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 67/225 (29%), Positives = 109/225 (48%), Gaps = 16/225 (7%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVK---LRHPNIVQ 219
IGKG+FG++ + + T A+K + + + E N+LV+ P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ L L+T+Y+ GG+L +L+++G S A + ++ + +LH I+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK--YDIV 118
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE-TGSYRYMAPEVFKHR 338
+RDLKP N+LL + H+ + DFGLSK N K T G+ Y+APEV
Sbjct: 119 YRDLKPENILL--DATGHIALCDFGLSKANLTDN-----KTTNTFCGTTEYLAPEVLLDE 171
Query: 339 K-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
K Y K VD +S ++++EM G P + + + +A G F
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF 216
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK------LRHP 215
++GKGSFG+++ A + G A+K L D +++QD E + K HP
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVK----VLKKD-VILQDDDVECTMTEKRILSLARNHP 56
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+ Q L + E++ GGDL ++++ + A +A +I + +LH++
Sbjct: 57 FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
II+RDLK NVLL + H K+ DFG+ K + + + G+ Y+APE+
Sbjct: 117 --IIYRDLKLDNVLLDHEG--HCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAPEIL 168
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPL 363
+ Y VD ++ ++LYEML G P
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (198), Expect = 3e-16
Identities = 78/264 (29%), Positives = 126/264 (47%), Gaps = 49/264 (18%)
Query: 165 IGKGSFGEILKAYWRGTP-----VAIK-RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
IG G FGE+ + T AI R L +LVI EVN++ +L+H NIV
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-----EVNVMRELKHKNIV 75
Query: 219 QFLGAVTER--KPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALDIARGMAYLH 272
+++ + + L ++ E+ GDL K K G + V+ + +AY H
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135
Query: 273 N---EPN--VIIHRDLKPRNVLL---------VNSSADHL------KVGDFGLSKLIKVQ 312
N PN ++HRDLKP+N+ L + + A++L K+GDFGLSK I ++
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE 195
Query: 313 N-SHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 369
+ +H G+ Y +PE+ H + YD K D+++ I+YE+ G+ P +
Sbjct: 196 SMAHSC------VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249
Query: 370 EAAKYVAEGHR-PFFRAKGFTPEL 392
++ ++E R P KG + EL
Sbjct: 250 --SQLISELKRGPDLPIKGKSKEL 271
|
Length = 1021 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
NK WE+ + S +G G++G + A+ G VA+K++ + +R
Sbjct: 9 NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 65
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
E+ LL ++H N++ L T + L + + +L G DL+ +K + L+
Sbjct: 66 -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 123
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
I RG+ Y+H+ IIHRDLKP N L VN + LK+ DFGL++ H
Sbjct: 124 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 172
Query: 319 KMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEG 359
+MTG + Y APE+ + Y++ VD++S I+ E+L G
Sbjct: 173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+GS+G + K R G VAIK+ + S DD ++ + E+ +L +L+HPN+V +
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVES-EDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
++ L L+ EY L++ K + + + + H + IHRD
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRD 125
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF-KHRKYD 341
+KP N+L+ + +K+ DFG ++++ D Y T YR APE+ +Y
Sbjct: 126 VKPENILI--TKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYR--APELLVGDTQYG 179
Query: 342 KKVDVFSFAMILYEMLEGEP 361
VDV++ + E+L G+P
Sbjct: 180 PPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 62/196 (31%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 192 LSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY----LK 247
L+D+R R E++ L H IV+ L+LI EY GGDL+K LK
Sbjct: 103 LNDERQAAYA-RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK 161
Query: 248 EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
E I + +H+ ++HRDLK N+ L+ + +K+GDFG SK
Sbjct: 162 EHLPFQEYEVGLLFYQIVLALDEVHSR--KMMHRDLKSANIFLMPTGI--IKLGDFGFSK 217
Query: 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367
S DV + G+ Y+APE+++ ++Y KK D++S +ILYE+L P
Sbjct: 218 QYSDSVSLDV--ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275
Query: 368 PYEAAKYVAEG-HRPF 382
E + V G + PF
Sbjct: 276 QREIMQQVLYGKYDPF 291
|
Length = 478 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 9e-16
Identities = 65/233 (27%), Positives = 106/233 (45%), Gaps = 35/233 (15%)
Query: 165 IGKGSFGEIL----KAYWRGTPVAIKRILPSLSDDRLVIQDFRH---EVNLLVKLRHPNI 217
IG G FG+++ + + V +K + S S +Q+ E L+H N+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-----VQEQMKFLEEAQPYRSLQHSNL 57
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLH 272
+Q LG TE P +L+ E+ GDL YL+ E P+T A +IA G+ +LH
Sbjct: 58 LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG--SYRYM 330
N IH DL RN LL ++ +K+GD+GLS + Y +T + R++
Sbjct: 118 K--NNFIHSDLALRNCLL--TADLTVKIGDYGLSHN----KYKEDYYVTPDQLWVPLRWI 169
Query: 331 APEVFKHRKYD-------KKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV 375
APE+ + K+ +V+S + ++E+ E G P + + Y
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
+IG+GS+ ++L + T A+K + L +D I + E ++ + HP +V
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
L + EY+ GGDL +++ + L A ++ +I+ + YLH II+
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIY 119
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
RDLK NVLL S H+K+ D+G+ K ++ ++ + G+ Y+APE+ +
Sbjct: 120 RDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGDTTSTF-----CGTPNYIAPEILRGED 172
Query: 340 YDKKVDVFSFAMILYEMLEGEPPL 363
Y VD ++ ++++EM+ G P
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 50/191 (26%), Positives = 80/191 (41%), Gaps = 14/191 (7%)
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALD 263
E LL + HP++++ + + + DL+ YL K L A+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV-SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
I G+ YLH + IIHRD+K N+ + + D + +GD G ++ V + G
Sbjct: 166 ILEGLRYLHAQR--IIHRDVKTENIFI--NDVDQVCIGDLGAAQF-PVVAPAFL----GL 216
Query: 324 TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH---R 380
G+ APEV KY+ K D++S ++L+EML + P +YV H
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276
Query: 381 PFFRAKGFTPE 391
PE
Sbjct: 277 KIISTLKVHPE 287
|
Length = 357 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 49/154 (31%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
R P +V A L LI +Y+ GG+L +L ++ + S + +I + +LH
Sbjct: 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH 122
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
II+RD+K N+LL S H+ + DFGLSK + Y G + YMAP
Sbjct: 123 QLG--IIYRDIKLENILL--DSEGHVVLTDFGLSKEFLAEEEERAYSFCG---TIEYMAP 175
Query: 333 EVFK--HRKYDKKVDVFSFAMILYEMLEGEPPLA 364
EV + +DK VD +S ++ +E+L G P
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 54/159 (33%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALD 263
EV+LL L+H NIV + K L L+ EYL DL +YL + G V F
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
+ RG+ Y H ++HRDLKP+N LL+N + LK+ DFGL++ S + E
Sbjct: 113 LLRGLNYCHRRK--VLHRDLKPQN-LLINERGE-LKLADFGLAR----AKSIPTKTYSNE 164
Query: 324 TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ Y P++ Y ++D++ I YEM G P
Sbjct: 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 1e-15
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+GS+ + K + G VA+K I L ++ E +LL L+H NIV
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI--RLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 223 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ ++ L L+ EY+ DL +Y+ K G L P F + RG++Y+H I+HR
Sbjct: 71 IIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR--YILHR 127
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKY 340
DLKP+N+L+ S LK+ DFGL++ V + + + E + Y P+V +Y
Sbjct: 128 DLKPQNLLI--SDTGELKLADFGLARAKSVPS----HTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 341 DKKVDVFSFAMILYEMLEG 359
+D++ I EM++G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+IGKG GE+ AY VA+K+I LS++ L+ + F E + L HP IV
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLK---EKGALSP----STAVNFALDI----ARGMAY 270
++ P+ Y+ G L LK +K +LS T+V L I + Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN--------------SHD 316
+H++ ++HRDLKP N+LL + + D+G + K++
Sbjct: 129 VHSKG--VLHRDLKPDNILLGLFG--EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
+ G+ YMAPE + D+++ +ILY+ML
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 28/219 (12%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD----FRHEVNLLVKLR 213
D+ +IG+G+FGE+ + T L LS ++ + F E +++
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGM 268
P +VQ A + + L ++ EY+ GGDL + EK A + V ALD M
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM 161
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
+ IHRD+KP N+LL S HLK+ DFG + N + + G+
Sbjct: 162 GF--------IHRDVKPDNMLLDKSG--HLKLADFGTCMKM---NKEGMVRCDTAVGTPD 208
Query: 329 YMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPL 363
Y++PEV K + Y ++ D +S + LYEML G+ P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-15
Identities = 38/86 (44%), Positives = 55/86 (63%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A N V KLL E+ + V+A+D D RTPLH+A+ +G +++ K L+E GADVNA+D
Sbjct: 11 LHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARD 70
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHG 124
+ NTPL A ++++LL HG
Sbjct: 71 KDGNTPLHLAARNGNLDVVKLLLKHG 96
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-15
Identities = 36/87 (41%), Positives = 51/87 (58%), Gaps = 2/87 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
RT L A V+ LLE+ V+ARD D TPLH+A+ +G +DV K L+++GAD
Sbjct: 41 RTPLH-LAAKNGHLEIVKLLLEKGAD-VNARDKDGNTPLHLAARNGNLDVVKLLLKHGAD 98
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELL 120
VNA+D+ TPL A +++LL
Sbjct: 99 VNARDKDGRTPLHLAAKNGHLEVVKLL 125
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 27/224 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
NK WE+ ++S +G G++G + A + G VAIK++ + + +R
Sbjct: 7 NKTVWEL---PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63
Query: 204 HEVNLLVKLRHPNIVQFLGAVT------ERKPLMLITEYLRGGDLHKYLKEKGALSPSTA 257
E+ LL ++H N++ L T E + L+ Y++ DL K + LS
Sbjct: 64 -ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKV 119
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ G+ Y+H+ IIHRDLKP N L VN + LK+ DFGL++ H
Sbjct: 120 QYLVYQMLCGLKYIHSAG--IIHRDLKPGN-LAVNEDCE-LKILDFGLAR-------HAD 168
Query: 318 YKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGE 360
+MTG + Y APEV Y++ VD++S I+ EML G+
Sbjct: 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRHPNIVQF 220
+IG+GS+ ++L + T A+K I L +D I + E ++ HP +V
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
L + E++ GGDL +++ + L A ++ +I+ + +LH II+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIY 119
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDLK NVLL + H+K+ D+G+ K + + G+ Y+APE+ + Y
Sbjct: 120 RDLKLDNVLL--DAEGHIKLTDYGMCK----EGIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 341 DKKVDVFSFAMILYEMLEGEPP 362
VD ++ ++++EM+ G P
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 32/221 (14%)
Query: 158 DFSSSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSL-----SDDRLVIQDFRHEVNLLVK 211
D+ +IG+G+FGE+ L + V ++L SD F E +++
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF----FWEERDIMAF 99
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIAR 266
P +VQ A + K L ++ EY+ GGDL + EK A + V ALD
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH 159
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
M +IHRD+KP N+LL HLK+ DFG +K+ + V T G+
Sbjct: 160 SMG--------LIHRDVKPDNMLL--DKHGHLKLADFG--TCMKMDETGMVRCDTA-VGT 206
Query: 327 YRYMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPL 363
Y++PEV K + Y ++ D +S + L+EML G+ P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 16/216 (7%)
Query: 158 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +++G+G FGE+ ++ G A+K + S+ + + F E ++L P
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNE 274
I Q A ++ L L+ EY GGDL L + + A + ++ + +H
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
V HRD+KP NVL+ H+K+ DFG + + N K+ G+ Y+APEV
Sbjct: 122 GYV--HRDIKPENVLI--DRTGHIKLADFGSAARLTA-NKMVNSKLP--VGTPDYIAPEV 174
Query: 335 FK------HRKYDKKVDVFSFAMILYEMLEGEPPLA 364
Y + D +S +I YEM+ G P
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 6e-15
Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 11/154 (7%)
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
+PN ++ +VT K +LI +Y++ GDL LK++G LS + + + LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
+ IIH D+K NVL + + D + + D+GL K+I + +D G+ Y +PE
Sbjct: 128 --HNIIHNDIKLENVLY-DRAKDRIYLCDYGLCKIIGTPSCYD--------GTLDYFSPE 176
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367
K YD D ++ ++ YE+L G+ P E
Sbjct: 177 KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 6e-15
Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
PS +F I +G+FG++ A+K + + ++ ++ + E + L
Sbjct: 1 PSIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL 60
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
+ P IV ++ + L+ EYL GGD+ L G AV + ++A + YL
Sbjct: 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYL 120
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
H IIHRDLKP N+L+ N H+K+ DFGLSK+
Sbjct: 121 HRHG--IIHRDLKPDNMLISNEG--HIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 64/258 (24%), Positives = 109/258 (42%), Gaps = 49/258 (18%)
Query: 158 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF + +IGKG+FGE+ ++ G A+K +L S + + + E ++L + P
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+V + + + L LI E+L GGDL L + S + + + +H
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG 121
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK--MTGET--------- 324
IHRD+KP N+L+ H+K+ DFGLS Q+ Y+ + G++
Sbjct: 122 --FIHRDIKPDNILI--DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 325 --------------------------------GSYRYMAPEVFKHRKYDKKVDVFSFAMI 352
G+ Y+APE+F + Y ++ D +S I
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237
Query: 353 LYEMLEGEPPLANYEPYE 370
++E L G PP + +E
Sbjct: 238 MFECLIGWPPFCSENSHE 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 36/246 (14%)
Query: 127 SYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVA 184
S + S P L SEL+ IG G+ G + K R T A
Sbjct: 57 SSSSSASGSAP-SAAKSL----------SELE--RVNRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 185 IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLH- 243
+K I + +D + Q R E+ +L + HPN+V+ + ++ E++ GG L
Sbjct: 104 LKVIYGN-HEDTVRRQICR-EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG 161
Query: 244 KYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
++ ++ L+ + A I G+AYLH I+HRD+KP N LL+N SA ++K+ DF
Sbjct: 162 THIADEQFLA-----DVARQILSGIAYLHRRH--IVHRDIKPSN-LLIN-SAKNVKIADF 212
Query: 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEV----FKHRKYDKKV-DVFSFAMILYEMLE 358
G+S+++ + + G+ YM+PE H YD D++S + + E
Sbjct: 213 GVSRIL----AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL 268
Query: 359 GEPPLA 364
G P
Sbjct: 269 GRFPFG 274
|
Length = 353 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 165 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+GKG++G + K R T V A+K I L + + E+++L K P IV F G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF--NQIIMELDILHKAVSPYIVDFYG 66
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAVNF-ALDIARGMAYLHNEPNVII 279
A + + EY+ G L K A P + + +G+ +L E N II
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-II 125
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGETGSYRYMAPEVFK-- 336
HRD+KP NVL+ + +K+ DFG+S L+ ++ G YMAPE K
Sbjct: 126 HRDVKPTNVLV--NGNGQVKLCDFGVSGNLVASLAKTNI-------GCQSYMAPERIKSG 176
Query: 337 ----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368
+ Y + DV+S + + EM G P Y P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYP---YPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 47/130 (36%), Positives = 72/130 (55%), Gaps = 10/130 (7%)
Query: 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFA--LDIARGMAYLHNEPNVIIHRDLKPRNVL 289
L+ +Y GDL + +K + + + + A L I +A H +IHRD+K N+L
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANIL 175
Query: 290 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSYRYMAPEVFKHRKYDKKVDVF 347
L S +K+GDFG SK+ S DV G T G+ Y+APE+++ + Y KK D+F
Sbjct: 176 LC--SNGLVKLGDFGFSKMYAATVSDDV----GRTFCGTPYYVAPEIWRRKPYSKKADMF 229
Query: 348 SFAMILYEML 357
S ++LYE+L
Sbjct: 230 SLGVLLYELL 239
|
Length = 496 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-14
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
D I+G G+ G + KAY +A+K I ++ + + + E+ +L K
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDS 58
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
P I+ F GA + + TE++ GG L Y + A+ + +G+ YL +
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSL 114
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I+HRD+KP N +LVN+ +K+ DFG+S + V + Y G+ YMAPE
Sbjct: 115 K--ILHRDVKPSN-MLVNTRG-QVKLCDFGVSTQL-VNSIAKTY-----VGTNAYMAPER 164
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPP 362
+Y DV+S + E+ G P
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 69/227 (30%), Positives = 112/227 (49%), Gaps = 32/227 (14%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRI---LPSLSDDRLVIQ 200
NK WE+ P + + +G G++G + AY VA+K++ SL R +
Sbjct: 7 NKTVWEV-PER--YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR 63
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVT------ERKPLMLITEYLRGGDLHKYLKEKGALSP 254
+ R LL ++H N++ L T + L+T L G DL+ +K + LS
Sbjct: 64 ELR----LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIVKCQ-KLSD 117
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
+ RG+ Y+H+ IIHRDLKP NV VN + L++ DFGL++ +
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNV-AVNEDCE-LRILDFGLAR-----QA 168
Query: 315 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGE 360
D +MTG + Y APE+ + Y++ VD++S I+ E+L+G+
Sbjct: 169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 8e-14
Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 3/83 (3%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
A + V+ LLE+ + D T LH+A+ +G +++ K L+E+GADVNA+D+
Sbjct: 5 AKNGNLELVKLLLEKGADV---NLGDTDTALHLAARNGNLEIVKLLLEHGADVNAKDKDG 61
Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
NT L A +++LL HG
Sbjct: 62 NTALHLAARNGNLEIVKLLLEHG 84
|
Length = 91 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 8/159 (5%)
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
E ++L + HP+I+Q G T K LI + DL+ YL K ++ + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
R + YLH N IIHRD+K N+ +N D + +GDFG + N++ Y G
Sbjct: 192 LRAIQYLHE--NRIIHRDIKAENIF-INHPGD-VCLGDFGAACFPVDINANKYY---GWA 244
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
G+ APE+ Y VD++S ++L+EM L
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 10/164 (6%)
Query: 203 RHEVNLLVKLRH-PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
R E +L +R P +V A L LI +Y+ GG+L +L ++ ++
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
+I + +LH II+RD+K N+LL S H+ + DFGLSK Y
Sbjct: 112 GEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEFHEDEVERAYSFC 167
Query: 322 GETGSYRYMAPEVFK--HRKYDKKVDVFSFAMILYEMLEGEPPL 363
G + YMAP++ + +DK VD +S +++YE+L G P
Sbjct: 168 G---TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQF 220
+IG+GS+ ++L + A+K + L D I + E ++ + +P +V
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
L L+ EY+ GGDL +++ + L A +A +I + +LH II+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIY 119
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
RDLK NVLL + H+K+ D+G+ K + ++ + G+ Y+APE+ + +
Sbjct: 120 RDLKLDNVLL--DADGHIKLTDYGMCKEGLGPGDTTSTF-----CGTPNYIAPEILRGEE 172
Query: 340 YDKKVDVFSFAMILYEMLEGEPPL 363
Y VD ++ ++++EM+ G P
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIK----RIL--PSLSDDRLVIQDFRHEVNLLVK 211
+F ++G G++G++ K ++L +L ++ R E N+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 212 LRH-PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+R P +V A L LI +Y+ GG++ +L ++ S ++ +I + +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH I++RD+K N+LL S H+ + DFGLSK + Y G YM
Sbjct: 121 LHKLG--IVYRDIKLENILL--DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI---EYM 173
Query: 331 APEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPL 363
APE+ + + + K VD +S ++++E+L G P
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 45/228 (19%)
Query: 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
F IG+G++G++ KA + G VA+K++ + I R E+ +L +L H N
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--------------LSPSTAVNFAL 262
IV VT+++ D + K+KGA L S V+F+
Sbjct: 68 IVNLKEIVTDKQ------------DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 263 D--------IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
D + G+ Y H + +HRD+K N+LL N +K+ DFGL++L NS
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKG--QIKLADFGLARLY---NS 168
Query: 315 HDVYKMTGETGSYRYMAPE-VFKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ T + + Y PE + +Y +DV+S IL E+ +P
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +IG+G+FGE+ + T A+K + R FR E N+LV
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNE 274
I A + L L+ +Y GGDL L + P F + ++ + +H
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121
Query: 275 PNVIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
V HRD+KP NVLL +N H+++ DFG +K+ V + + G+ Y++PE
Sbjct: 122 HYV--HRDIKPDNVLLDMNG---HIRLADFG--SCLKMNQDGTV-QSSVAVGTPDYISPE 173
Query: 334 VFKHR-----KYDKKVDVFSFAMILYEMLEGEPPL 363
+ + KY + D +S + +YEML GE P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 29/228 (12%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL--VIQDFRHE 205
+ D ++L+ IG G+ G++ K ++ G +A+K++ + + + ++ D
Sbjct: 10 YPADLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD-- 65
Query: 206 VNLLVKLRH--PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 262
+V H P IV+ G + I L L K LK +G + +
Sbjct: 66 ---VVLKSHDCPYIVKCYGYFI-TDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTV 121
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMT 321
I + + YL + VI HRD+KP N+LL ++S + +K+ DFG+S +L+ D T
Sbjct: 122 AIVKALHYLKEKHGVI-HRDVKPSNILL-DASGN-VKLCDFGISGRLV------DSKAKT 172
Query: 322 GETGSYRYMAPEVF----KHRKYDKKVDVFSFAMILYEMLEGEPPLAN 365
G YMAPE + KYD + DV+S + L E+ G+ P N
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 68/218 (31%), Positives = 100/218 (45%), Gaps = 41/218 (18%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRIL--PSLSDDRLVIQDFRHEVNLL---------- 209
IIG GSFG + +A T VAIK++L P + L+I + +N++
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTEC 132
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIA 265
K NI FL V E P + HKY+K AL ++ +
Sbjct: 133 FKKNEKNI--FLNVVMEFIPQTV----------HKYMKHYARNNHALPLFLVKLYSYQLC 180
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK-LIKVQNSHDVYKMTGET 324
R +AY+H++ I HRDLKP+N LL++ + LK+ DFG +K L+ Q S
Sbjct: 181 RALAYIHSK--FICHRDLKPQN-LLIDPNTHTLKLCDFGSAKNLLAGQRS------VSYI 231
Query: 325 GSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
S Y APE+ Y +D++S I+ EM+ G P
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 9e-12
Identities = 67/285 (23%), Positives = 116/285 (40%), Gaps = 96/285 (33%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIK--RILPSLSDDRLVIQ 200
WE L +G+G+FG++++A G VA+K + + S+ + ++
Sbjct: 2 WEFPRDRLKLGKP--LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMT 59
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITE---------YLRG---------- 239
E+ +L+ + H N+V LGA T+ PLM+I E YLR
Sbjct: 60 ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRN 115
Query: 240 --------------------------GDLHKYLKEKGA----------------LSPSTA 257
++++K L+
Sbjct: 116 KSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDL 175
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
++++ +ARGM +L + IHRDL RN+LL ++ +K+ DFGL++ D+
Sbjct: 176 ISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNV--VKICDFGLAR--------DI 223
Query: 318 YKMTG--ETGSYR----YMAPEVFKHRKYDKKVDVFSFAMILYEM 356
YK G R +MAPE + Y + DV+SF ++L+E+
Sbjct: 224 YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 57/247 (23%), Positives = 97/247 (39%), Gaps = 45/247 (18%)
Query: 165 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G+FGE+ T A+K + + R + E ++L + + +V+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ ++ L + +Y+ GGD+ L G A + ++ + +H IHRD
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRD 126
Query: 283 LKPRNVLLVNSSADHLKVGDFGLS------------------------------------ 306
+KP N+L+ H+K+ DFGL
Sbjct: 127 IKPDNILI--DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184
Query: 307 -KLIKVQNSHDVYKMTGET--GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
K ++ + + + G+ Y+APEV Y + D +S +ILYEML G+PP
Sbjct: 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244
Query: 364 ANYEPYE 370
P E
Sbjct: 245 LADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 42/122 (34%), Positives = 55/122 (45%), Gaps = 6/122 (4%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
A DA R LL + RDYD RTPLH+A +G + V + L+E+GAD D+
Sbjct: 90 AASGDAVGARILLTGGAD-PNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDG 148
Query: 102 NTPLADAEGAKKFNMMELLNAHG--GLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDF 159
TPL AE +++LL+ H G N PP L D I DF
Sbjct: 149 KTPLELAEENGFREVVQLLSRHSQCHFELGANAKPDSFTGKPPSLE---DSPISSHHPDF 205
Query: 160 SS 161
S+
Sbjct: 206 SA 207
|
Length = 664 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +IG+G+FGE+ + T A+K + R FR E ++LV
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNE 274
I A + L L+ +Y GGDL L + P F L ++ + +H
Sbjct: 62 WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL 121
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFG----LSKLIKVQNSHDVYKMTGETGSYRYM 330
V HRD+KP NVLL H+++ DFG L VQ++ V G+ Y+
Sbjct: 122 GYV--HRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGTVQSNVAV-------GTPDYI 170
Query: 331 APEVFKHR-----KYDKKVDVFSFAMILYEMLEGEPP 362
+PE+ + +Y + D +S + +YEML GE P
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 41/213 (19%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G+ G + AY G VAIK++ + + +R E+ L+ + H NI+ L
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLN 82
Query: 223 AVTERKPL------MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR---------- 266
T +K L L+ E L +L + + LD R
Sbjct: 83 VFTPQKSLEEFQDVYLVME-LMDANLCQ------------VIQMDLDHERMSYLLYQMLC 129
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
G+ +LH+ IIHRDLKP N+ +V S LK+ DFGL++ + + MT +
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNI-VVKSDCT-LKILDFGLAR-----TAGTSFMMTPYVVT 180
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG 359
Y APEV Y + VD++S I+ EM+ G
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G+ G + A+ G VA+K++ + + +R E+ LL + H NI+ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL---------HN 273
T +K L E+ D++ ++ A + ++ LD R M+YL H
Sbjct: 88 VFTPQKSL---EEF---QDVYLVMELMDA-NLCQVIHMELDHER-MSYLLYQMLCGIKHL 139
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
IIHRDLKP N+++ + LK+ DFGL++ + MT + Y APE
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTN-----FMMTPYVVTRYYRAPE 192
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEG 359
V Y + VD++S I+ E+++G
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-11
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 165 IGKGSFGE-ILKAYWRGTPVA---IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
IG G FG+ +L + T VA +K + + S +F + + L+HPNI+Q
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ--NEFLQQGDPYRILQHPNILQC 60
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAV----NFALDIARGMAYLHNEPN 276
LG E P +L+ EY GDL YL ++ ++ + A +IA G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN- 119
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY--RYMAPEV 334
+H DL RN L +S +KVGD+G I + Y T + R++APE+
Sbjct: 120 -FLHSDLALRNCFL--TSDLTVKVGDYG----IGPSRYKEDYIETEDDKCVPLRWLAPEL 172
Query: 335 FKHR-------KYDKKVDVFSFAMILYEMLE 358
+ K +V++ + L+E+ E
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFE 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-10
Identities = 24/68 (35%), Positives = 39/68 (57%), Gaps = 2/68 (2%)
Query: 32 VSRTSLILWHA-HQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY 90
+ T L A + V+ LLE V+A+D D T LH+A+ +G +++ K L+E+
Sbjct: 25 LGDTDTALHLAARNGNLEIVKLLLEHGAD-VNAKDKDGNTALHLAARNGNLEIVKLLLEH 83
Query: 91 GADVNAQD 98
GAD+N +D
Sbjct: 84 GADINLKD 91
|
Length = 91 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +IG+G+FGE+ + A+K + R FR E ++LV +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF-------ALDIARGM 268
I A + L L+ +Y GGDL L + P F A+D +
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
Y +HRD+KP N+L+ H+++ DFG +K+ V + + G+
Sbjct: 122 HY--------VHRDIKPDNILM--DMNGHIRLADFG--SCLKLMEDGTV-QSSVAVGTPD 168
Query: 329 YMAPEVFKHR-----KYDKKVDVFSFAMILYEMLEGEPPL 363
Y++PE+ + KY + D +S + +YEML GE P
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 51/223 (22%), Positives = 100/223 (44%), Gaps = 22/223 (9%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
I+ ++D +S +I + I K + V I+ +++I +E+ L +
Sbjct: 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRR 74
Query: 212 LRHPNIVQFLG----AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
+ NI++ G V + L LI EY G L + L ++ LS T ++ A+D +G
Sbjct: 75 IDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKG 134
Query: 268 MAYLH---NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
+ L+ N+P +++L + L+ + LK+ GL K++ +V M
Sbjct: 135 LYNLYKYTNKP----YKNLTSVSFLVTENYK--LKIICHGLEKILSSPPFKNVNFMV--- 185
Query: 325 GSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLAN 365
Y + ++ +Y K D++S ++L+E+ G+ P N
Sbjct: 186 ----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 61/259 (23%), Positives = 104/259 (40%), Gaps = 53/259 (20%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD----FRHEVNLLVKLRH 214
F +G G+FGE+ A R + +L +++++ + E ++L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLA--RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+V+ + ++ L + +Y+ GGD+ L G A + ++ + +H
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGL---------SKLIKV-----QNSHDVYKM 320
IHRD+KP N+L+ H+K+ DFGL SK + Q+S D
Sbjct: 121 G--FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 321 TGETGSYR-----------------------------YMAPEVFKHRKYDKKVDVFSFAM 351
G+ + R Y+APEV Y + D +S +
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 352 ILYEMLEGEPPLANYEPYE 370
ILYEML G+PP P E
Sbjct: 237 ILYEMLVGQPPFLAQTPLE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 52/240 (21%), Positives = 100/240 (41%), Gaps = 42/240 (17%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD----------FRHEVNLLVKLRH 214
+G+G+F I K R + I+ + +V++ F +L+ +L H
Sbjct: 3 LGQGTFTNIYKGVLR--VQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHN 273
++V+ G V R +++ EY++ G L +L +EK +S ++ A +A + YL
Sbjct: 61 KHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL-- 117
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-----LKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
E ++H ++ +N+L+ + +K+ D G +T + R
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG-------------IPITVLSREER 164
Query: 329 -----YMAPEVFK--HRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
++APE + D +SF L E+ GE PL+ E ++ + HR
Sbjct: 165 VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR 224
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-10
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV---QFL 221
+G+G++G + KA + + L + + + R E+ LL +L+HPN++ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKHPNVIALQKVF 67
Query: 222 GAVTERKPLMLITEYLRGGDLH--------KYLKEKGALSPSTAVNFALDIARGMAYLHN 273
+ ++RK + L+ +Y H K K+ L S + I G+ YLH
Sbjct: 68 LSHSDRK-VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH- 125
Query: 274 EPNVIIHRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
N ++HRDLKP N+L++ + +K+ D G ++L + + ++ Y A
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVVTFWYRA 183
Query: 332 PE-VFKHRKYDKKVDVFSFAMILYEMLEGEP 361
PE + R Y K +D+++ I E+L EP
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 17/154 (11%)
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
KL+HPNIV+ +G K LI EY+ G +L + L+ LS A+ IA+ + +
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRF 795
Query: 271 LHN--EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
LH P V++ +L P +++ HL++ L L+ + S
Sbjct: 796 LHCRCSPAVVVG-NLSPEKIIIDGKDEPHLRLS---LPGLLCTDTKCFI--------SSA 843
Query: 329 YMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
Y+APE + + +K D++ F +IL E+L G+ P
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 58/257 (22%), Positives = 101/257 (39%), Gaps = 49/257 (19%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
F +G G+FGE+ A T A+K + +R + + E ++L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
+V+ + ++ L + +Y+ GGD+ L A + ++ + +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG- 121
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK----------------- 319
IHRD+KP N+L+ H+K+ DFGL + ++ Y+
Sbjct: 122 -FIHRDIKPDNILI--DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 320 -----------MTGE---------------TGSYRYMAPEVFKHRKYDKKVDVFSFAMIL 353
T E G+ Y+APEV + Y + D +S +IL
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 354 YEMLEGEPPLANYEPYE 370
+EML G+PP P E
Sbjct: 239 FEMLVGQPPFLAPTPTE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 40/115 (34%), Positives = 61/115 (53%), Gaps = 21/115 (18%)
Query: 252 LSPSTA---VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
SP T + ++ +ARGM +L + IHRDL RN+LL S + +K+ DFGL++
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLAR- 222
Query: 309 IKVQNSHDVYKMTG--ETGSYR----YMAPEVFKHRKYDKKVDVFSFAMILYEML 357
D+YK GS R +MAPE + Y + DV+SF ++L+E+
Sbjct: 223 -------DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 7/153 (4%)
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
E+++L + H I+ + A + + ++ + DL Y+ G L A+ +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRL 194
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
+AYLH IIHRD+K N+ L ++ +GDFG + K+ D + G +
Sbjct: 195 LEALAYLHGRG--IIHRDVKTENIFLDEP--ENAVLGDFGAA--CKLDAHPDTPQCYGWS 248
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
G+ +PE+ Y K D++S ++L+EM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 40/118 (33%), Positives = 60/118 (50%), Gaps = 14/118 (11%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSL- 192
P LP WE L F +G G+FG++++A G VA+K + S
Sbjct: 24 PTQLPYNEKWEFPRDNLQFGK--TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH 81
Query: 193 SDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK 249
+D+R + E+ +L L +H NIV LGA T P+++ITEY GDL +L++K
Sbjct: 82 TDER---EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224
+G+G++G + KA + L + + + R E+ LL +L+HPN++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKVF 67
Query: 225 TER--KPLMLITEYLRGGDLH--------KYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+ + L+ +Y H K K+ L + I G+ YLH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-- 125
Query: 275 PNVIIHRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
N ++HRDLKP N+L++ + +K+ D G ++L + + ++ Y AP
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVVTFWYRAP 184
Query: 333 E-VFKHRKYDKKVDVFSFAMILYEMLEGEP 361
E + R Y K +D+++ I E+L EP
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 90/286 (31%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIK--RILPSLSDDRLVIQ 200
WE L +G+G+FG++++A G VA+K + + S+ R ++
Sbjct: 2 WEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 59
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLI---------TEYLRG---------- 239
E+ +L+ + H N+V LGA T+ PLM+I + YLR
Sbjct: 60 ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKT 115
Query: 240 ------------GDLHKYLKE------------------------------------KGA 251
GD+ + LK K
Sbjct: 116 KDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKV 175
Query: 252 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
L+ + ++ +A+GM +L + IHRDL RN+LL S + +K+ DFGL++ +
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLAR--DI 229
Query: 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
D + ++MAPE R Y + DV+SF ++L+E+
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G+ G + AY VAIK++ + + +R E+ L+ + H NI+ L
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 90
Query: 223 AVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
T +K L + I L +L + ++ + L + G+ +LH+
Sbjct: 91 VFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG-- 146
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
IIHRDLKP N+++ + LK+ DFGL++ + + MT + Y APEV
Sbjct: 147 IIHRDLKPSNIVVKSDCT--LKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 338 RKYDKKVDVFSFAMILYEMLEG 359
Y + VD++S I+ EM++G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 7e-09
Identities = 28/58 (48%), Positives = 38/58 (65%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
ARD D RTPLH+A+ +G ++V K L+E GADVNA+D TPL A +++LL
Sbjct: 2 ARDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLL 59
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 43/126 (34%), Positives = 67/126 (53%), Gaps = 10/126 (7%)
Query: 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
+ E ALS V F+ +A GM +L ++ V HRDL RNVL+ +
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV--HRDLAARNVLICEGKL--V 278
Query: 299 KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM- 356
K+ DFGL++ I +++S+ + K G T ++MAPE + Y DV+SF ++L+E+
Sbjct: 279 KICDFGLARDI-MRDSNYISK--GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF 335
Query: 357 -LEGEP 361
L G P
Sbjct: 336 TLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 42/133 (31%), Positives = 73/133 (54%), Gaps = 10/133 (7%)
Query: 251 ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
AL ++F+ +A+GM++L ++ IHRDL RN+LL + K+ DFGL++ I+
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRIT--KICDFGLARDIR 265
Query: 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 369
+S+ V K ++MAPE + Y + DV+S+ ++L+E+ G P P
Sbjct: 266 -NDSNYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM-PV 322
Query: 370 EAA--KYVAEGHR 380
++ K + EG+R
Sbjct: 323 DSKFYKMIKEGYR 335
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 2e-08
Identities = 18/33 (54%), Positives = 26/33 (78%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
D TPLH+A+ +G ++V K L+E GADVNA+D+
Sbjct: 1 DGNTPLHLAARNGHLEVVKLLLEAGADVNARDK 33
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 204 HEVNLLVKLRHPNIVQFL-----GAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTA 257
HE LL +L HP ++ L G +T +++ +Y DL+ YL L +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLT----CLVLPKY--RSDLYTYLGARLRPLGLAQV 262
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
A + + Y+H E IIHRD+K NV LVN D + +GDFG + + S
Sbjct: 263 TAVARQLLSAIDYIHGEG--IIHRDIKTENV-LVNGPED-ICLGDFGAACFARGSWSTPF 318
Query: 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYE 355
+ G G+ APEV Y VD++S ++++E
Sbjct: 319 H--YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G+ G + AY VAIK++ + + +R E+ L+ + H NI+ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 83
Query: 223 AVTERKPL------MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
T +K L L+ E L +L + ++ + L + G+ +LH+
Sbjct: 84 VFTPQKSLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG- 139
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
IIHRDLKP N+++ + LK+ DFGL++ + + MT + Y APEV
Sbjct: 140 -IIHRDLKPSNIVVKSDCT--LKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 337 HRKYDKKVDVFSFAMILYEML 357
Y + VD++S I+ EM+
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 51.4 bits (122), Expect = 2e-07
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 2/87 (2%)
Query: 41 HAHQNDAAAVRKLLE--EDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
+ + + + LLE D + + RD D TPLH A+L+G D+ + L+E GAD N+++
Sbjct: 118 NPPEGNIEVAKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRN 177
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHGG 125
+ T L A + +++LL G
Sbjct: 178 SYGVTALDPAAKNGRIELVKLLLDKGL 204
|
Length = 235 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 38/121 (31%), Positives = 64/121 (52%), Gaps = 10/121 (8%)
Query: 240 GDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
++ L + G+ L+ ++F +ARGM +L ++ V HRDL RNVLL +
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV--HRDLAARNVLL--AQGKI 275
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
+K+ DFGL++ I ++ Y G T ++MAPE Y DV+S+ ++L+E+
Sbjct: 276 VKICDFGLARDIMHDSN---YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
Query: 357 L 357
Sbjct: 333 F 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 40/118 (33%), Positives = 57/118 (48%), Gaps = 14/118 (11%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSL- 192
P LP WE + L F +G G+FG++++A G VA+K + PS
Sbjct: 21 PTQLPYDHKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH 78
Query: 193 SDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK 249
+R + E+ +L L H NIV LGA T P ++ITEY GDL +L+ K
Sbjct: 79 LTER---EALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 38/145 (26%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
PN+V + + L+ ++ GG L ++ + + +A ++ + LH E
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I+ RDL P N+LL H+++ F + +V++S D GE Y APEV
Sbjct: 105 G--IVCRDLNPNNILL--DDRGHIQLTYFS--RWSEVEDSCD-----GEAVENMYCAPEV 153
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEG 359
+ + D +S IL+E+L G
Sbjct: 154 GGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 53/232 (22%), Positives = 91/232 (39%), Gaps = 50/232 (21%)
Query: 165 IGKGSFG----EILKAYWRGTPVAIKRI-LPSLSDDRLV-IQDFRHEVNLLVKLRHPNIV 218
IGK + K T VA+K+I L S S + L +Q E+ +L+HPNI+
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQ---EIITSRQLQHPNIL 62
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFAL-DIARGMAYLHNEP 275
++ + L +++ + G LK L P A+ F L D+ + Y+H+
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGL-PELAIAFILKDVLNALDYIHS-- 119
Query: 276 NVIIHRDLKPRNVLL-----------------VNSSADHLKVGDFGLSKLIKVQNSHDVY 318
IHR +K ++LL + V DF S +K
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS-VKNLP----- 173
Query: 319 KMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368
+++PEV + + Y++K D++S + E+ G P +
Sbjct: 174 ----------WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 39/155 (25%), Positives = 62/155 (40%), Gaps = 29/155 (18%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIK-RI-----LPSLSDDRLVIQDFRHEVNLLVKLRH--- 214
+I KG+ I + G IK R+ P L D+R+ + R+E LL + R
Sbjct: 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPEL-DERIRRERTRNEARLLSRARKAGV 59
Query: 215 --PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
P + + ++ EY+ G L ++E +I R + LH
Sbjct: 60 NTPVVYDV-----DPDNKTIVMEYIEGKPLKDVIEEGN-------DELLREIGRLVGKLH 107
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
I+H DL N+++ D L + DFGL K
Sbjct: 108 K--AGIVHGDLTTSNIIV---RDDKLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 12/114 (10%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS 193
P LP WE+ L + +G G+FG +++A G VA+K + +
Sbjct: 23 PMQLPYDSAWEMPRDNLVLGRT--LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR 80
Query: 194 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL 246
Q E+ ++ L H NIV LGA T+ P+ +ITEY R GDL YL
Sbjct: 81 SSE--KQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 40/114 (35%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILK--AYW--RGTPV---AIKRILPSLS 193
P LP WE L I+G G+FG++++ AY R PV A+K + P+
Sbjct: 23 PMQLPYDSRWEFPRDGLVLGR--ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR 80
Query: 194 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL 246
Q E+ ++ L H NIV LGA T+ P+ +ITEY GDL YL
Sbjct: 81 SSEK--QALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 50/235 (21%), Positives = 103/235 (43%), Gaps = 33/235 (14%)
Query: 165 IGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
+G+G+F +I K R T V +K + S R + F +++ +L H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHK 59
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-- 273
++V G +++ EY++ G L YLK+ L + + L++A+ +A+ +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS---WKLEVAKQLAWALHFL 116
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH------LKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
E + H ++ +NVLL+ +K+ D G+S I V ++
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVL-PKEIL-----LERI 168
Query: 328 RYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEG-EPPLANYEPYEAAKYVAEGHR 380
++ PE ++ + D +SF L+E+ G + PL+ + + ++ + H+
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQ 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|205784 pfam13606, Ank_3, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 5e-06
Identities = 15/30 (50%), Positives = 24/30 (80%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
D TPLH+A+ +G +++ K L+E+GAD+NA
Sbjct: 1 DGNTPLHLAARNGNLELVKLLLEHGADINA 30
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Length = 30 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 7e-06
Identities = 16/38 (42%), Positives = 23/38 (60%)
Query: 68 NRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
RT LH A++ G +++ K L+E G D+N D NT L
Sbjct: 1 GRTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTAL 38
|
Length = 54 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 46.4 bits (109), Expect = 9e-06
Identities = 39/126 (30%), Positives = 55/126 (43%), Gaps = 14/126 (11%)
Query: 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG--- 79
D+ + + A + D V+ LL V+A+D D TPLH+A+L+G
Sbjct: 62 VDRHLAARDLDGRLPLHSAASKGDDKIVKLLLASGAD-VNAKDADGDTPLHLAALNGNPP 120
Query: 80 --WIDVAKCLIEYGA---DVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG-----LSYG 129
I+VAK L+E GA N +D NTPL A +++ELL G SYG
Sbjct: 121 EGNIEVAKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRNSYG 180
Query: 130 QNGSHF 135
Sbjct: 181 VTALDP 186
|
Length = 235 |
| >gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 9e-06
Identities = 18/53 (33%), Positives = 32/53 (60%)
Query: 53 LLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
LLE ++A D + TPLH+A+ +G +++ + L++ G D+N +D T L
Sbjct: 1 LLEHGPIDLNATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTAL 53
|
Length = 56 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 20/151 (13%)
Query: 165 IGKGSFGEILKAYWRGTPVAIK-------RILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
I +G+ EI + G IK R P L D+R+ + R E ++ + R +
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKWRIPKRYRH-PEL-DERIRRERTRREARIMSRARKAGV 61
Query: 218 -VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
V + V + ++ EY+ G + LK+ + + + +I R + LH+
Sbjct: 62 NVPAVYFVDPENFI-IVMEYIEG----EPLKDLINSNGMEELELSREIGRLVGKLHS--A 114
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
IIH DL N++L S + + DFGL++
Sbjct: 115 GIIHGDLTTSNMIL---SGGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 18/194 (9%)
Query: 180 GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238
GT V ++ L + +++ L ++EV L RHPNI+ T L +I+ ++
Sbjct: 25 GTLVTVRITDLENCTEEHLKA--LQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 239 GGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
G + LK +S + N RG+ YLH N IHR++K ++L+ S D
Sbjct: 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILI---SGD 137
Query: 297 HLKVGDFGLSKLIKV----QNSHDVYKMTG-ETGSYRYMAPEVFKH--RKYDKKVDVFSF 349
L V GLS L + Q + VY T +++PE+ + Y+ K D++S
Sbjct: 138 GL-VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196
Query: 350 AMILYEMLEGEPPL 363
+ E+ G P
Sbjct: 197 GITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 2e-05
Identities = 15/55 (27%), Positives = 27/55 (49%), Gaps = 1/55 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI 88
+ + A V+ LLE+ ++ D D T LH+A+ +G ++V K L+
Sbjct: 1 GRTALHKAAISGRLELVKYLLEKGVD-INRTDEDGNTALHIAAENGNLEVLKLLL 54
|
Length = 54 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 15/33 (45%), Positives = 22/33 (66%)
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
MAPEV + + Y +K D++S + LYE L+ E P
Sbjct: 71 MAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 41/153 (26%), Positives = 63/153 (41%), Gaps = 23/153 (15%)
Query: 163 AIIGKGSFGEILKAYWRGTPVAIK-RI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
+I +G+ I + G P +K RI P L D++L + R E +L K R
Sbjct: 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPEL-DEKLRRERTRREARILAKAREAG 60
Query: 217 I-VQFLGAVTERKPLMLIT-EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+ V + V LI EY+ G L L+E + ++ R + LH
Sbjct: 61 VPVPIVYDVDP--DNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHK- 110
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
I+H DL N++L S + DFGL +
Sbjct: 111 -AGIVHGDLTTSNIIL---SGGRIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 2/96 (2%)
Query: 29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI 88
K +T L +A + K+L E + V+ D + P+H+A H + D+ K L+
Sbjct: 120 KDAELKT--FLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLL 177
Query: 89 EYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
E GA N +D +PL +A + ++LL HG
Sbjct: 178 EKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHG 213
|
Length = 434 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 9e-05
Identities = 18/49 (36%), Positives = 29/49 (59%), Gaps = 2/49 (4%)
Query: 72 LHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
LH+A+ +G +++ K L+E GADVN D +T L A +++LL
Sbjct: 1 LHLAAKNGNLELVKLLLEKGADVNLGD--TDTALHLAARNGNLEIVKLL 47
|
Length = 91 |
| >gnl|CDD|197603 smart00248, ANK, ankyrin repeats | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 2e-04
Identities = 16/30 (53%), Positives = 24/30 (80%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
D RTPLH+A+ +G ++V K L++ GAD+NA
Sbjct: 1 DGRTPLHLAAENGNLEVVKLLLDKGADINA 30
|
Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure. Length = 30 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 24/65 (36%), Positives = 37/65 (56%), Gaps = 1/65 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA-KKFNMMEL 119
V+ D N +PLH A H + L+E GA +A+D+ NTPL + G K +++++L
Sbjct: 194 VNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKL 253
Query: 120 LNAHG 124
L HG
Sbjct: 254 LLEHG 258
|
Length = 477 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 31/111 (27%), Positives = 57/111 (51%), Gaps = 17/111 (15%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRIL--PSLSDDRLVIQ 200
WE L ++G G+FG++++A G VA+K + + S+ + ++
Sbjct: 2 WEFPRDRLRLGK--VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMS 59
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTE-RKPLMLITEYLRGGDLHKYLKEK 249
E+ +L+ + H N+V LGA T+ PLM+I E+ + G+L +L+ K
Sbjct: 60 ----ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 53/241 (21%), Positives = 95/241 (39%), Gaps = 52/241 (21%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRHEV 206
+ID S F +++G+G+FG++++A+ R V I R +P + +D + E+
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYT------RDAKIEI 176
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLH------KY-------LKEKGALS 253
+ K+R + +R PLM I Y + H KY + + G S
Sbjct: 177 QFMEKVRQAD-------PADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFS 229
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD--------------HLK 299
+ Y H E + ++H DLKP N+L+ S ++
Sbjct: 230 HRHLAQIIFQTGVALDYFHTELH-LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVR 288
Query: 300 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG 359
+ D G + + T + Y +PEV + D++S I+YE+ G
Sbjct: 289 ICDLG-------GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341
Query: 360 E 360
+
Sbjct: 342 K 342
|
Length = 467 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 26/80 (32%), Positives = 39/80 (48%)
Query: 44 QNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT 103
+ D AV +LL+ + D TPLH+A++ +D+ K LI GAD + + K +
Sbjct: 78 EGDVKAVEELLDLGKFADDVFYKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFS 137
Query: 104 PLADAEGAKKFNMMELLNAH 123
PL A +ELL H
Sbjct: 138 PLHLAVMMGDIKGIELLIDH 157
|
Length = 413 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 4e-04
Identities = 19/47 (40%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI 88
A + V+ LL+ + V+ARD D RTPLH+A+ +G ++V K L+
Sbjct: 81 ARNGNLDVVKLLLKHG-ADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 50 VRKLLEEDQSLVHARDY-DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
+ KLL E V+A+ Y T LH S+ K L+EYGAD+N+ + +K TPL+ A
Sbjct: 250 ILKLLLEHGVDVNAKSYILGLTALHS-SIKS-ERKLKLLLEYGADINSLNSYKLTPLSSA 307
|
Length = 477 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 29/73 (39%), Positives = 41/73 (56%), Gaps = 4/73 (5%)
Query: 39 LWHAHQNDAAA--VRKLLEEDQSLVHARDYDNRTPLHVASLHGW-IDVAKCLIEYGADVN 95
L HA Q + + V KLLE V+A++ TPL++ + +G+ + + LI GADVN
Sbjct: 277 LHHASQAPSLSRLVPKLLERGAD-VNAKNIKGETPLYLMAKNGYDTENIRTLIMLGADVN 335
Query: 96 AQDRWKNTPLADA 108
A DR TPL A
Sbjct: 336 AADRLYITPLHQA 348
|
Length = 682 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 23/64 (35%), Positives = 35/64 (54%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+ +D + +T LH A G ++ K L EYGADVN +D P+ A F++++LL
Sbjct: 117 VNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLL 176
Query: 121 NAHG 124
G
Sbjct: 177 LEKG 180
|
Length = 434 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.002
Identities = 42/159 (26%), Positives = 64/159 (40%), Gaps = 38/159 (23%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIK-RI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+IGKG+ +I K + G IK R+ P L D+RL + R E LL + R +
Sbjct: 340 LIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPEL-DERLRTERTRAEARLLSEARRAGV 398
Query: 218 VQFLGAVTERKPLM---------LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
P++ ++ EY+ G DL L+ + +
Sbjct: 399 ---------PTPVIYDVDPEEKTIVMEYIGGKDLKDVLEG--------NPELVRKVGEIV 441
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
A LH I+H DL N ++ + D L + DFGL K
Sbjct: 442 AKLHK--AGIVHGDLTTSNFIVRD---DRLYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 26/65 (40%), Positives = 36/65 (55%), Gaps = 2/65 (3%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW-IDVAKCLIEYGADVNAQDRW 100
+ + VR LLE V+A + TPLH+ + +DV K LI+ GADVNA+D+
Sbjct: 58 SSEKVKDIVRLLLEAGAD-VNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAKDKV 116
Query: 101 KNTPL 105
TPL
Sbjct: 117 GRTPL 121
|
Length = 471 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 19/52 (36%), Positives = 29/52 (55%)
Query: 44 QNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN 95
Q D + ++L E + V+A+D TP+H A+ G + L+ YGADVN
Sbjct: 154 QQDELLIAEMLLEGGADVNAKDIYCITPIHYAAERGNAKMVNLLLSYGADVN 205
|
Length = 682 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 24/71 (33%), Positives = 38/71 (53%), Gaps = 7/71 (9%)
Query: 61 VHARDYDNRTPLHVASLHGWI-----DVAKCLIEYGADVNAQDRWKNTPLADAEGAKK-- 113
+++ +N TPLH S + ++ K L+EYGA+VNA D TPL A K
Sbjct: 61 INSSTKNNSTPLHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAISKKSNS 120
Query: 114 FNMMELLNAHG 124
++++E L +G
Sbjct: 121 YSIVEYLLDNG 131
|
Length = 422 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 394 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.77 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.76 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.74 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.74 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.74 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.74 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.72 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.72 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.7 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.69 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.69 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.69 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.69 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.68 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.68 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.68 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.68 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.68 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.67 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.67 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.67 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.67 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.66 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| PF13857 | 56 | Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A | 99.65 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.64 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.64 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.64 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.64 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.64 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.63 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.63 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.63 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.63 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.62 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.62 | |
| KOG4214 | 117 | consensus Myotrophin and similar proteins [Transcr | 99.62 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.6 | |
| KOG0502 | 296 | consensus Integral membrane ankyrin-repeat protein | 99.6 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 99.6 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.6 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.59 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.58 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.56 | |
| PHA02792 | 631 | ankyrin-like protein; Provisional | 99.56 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.55 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 99.55 | |
| PF13637 | 54 | Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A | 99.55 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.53 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.53 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.52 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 99.52 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.5 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.5 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.49 | |
| KOG0505 | 527 | consensus Myosin phosphatase, regulatory subunit [ | 99.49 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.49 | |
| PTZ00322 | 664 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatas | 99.48 | |
| KOG0502 | 296 | consensus Integral membrane ankyrin-repeat protein | 99.47 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 99.47 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=369.96 Aligned_cols=215 Identities=37% Similarity=0.674 Sum_probs=195.1
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|...+.||+|+|++||+|+++ +..||||.+.+... .....+.+..|+.+|+.++|||||.+++++..++.+|+|||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 7888899999999999999975 78999999977653 33445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CC---CcEEEeecCCcccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SA---DHLKVGDFGLSKLIKV 311 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~---~~~kl~DFg~a~~~~~ 311 (394)
||+||+|.+|++.++.+++.+++.++.|++.||++||+++ ||||||||.|||++.. .+ ..+||+|||+|+.+..
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999999999999999999999999999999999988 9999999999999543 22 5799999999999875
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
.. ...+.+|+|.|||||++..+.|+.|+|+||+|+++|++++|++||+..+..|....+.+|..
T Consensus 168 ~~-----~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~ 231 (429)
T KOG0595|consen 168 GS-----MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE 231 (429)
T ss_pred hh-----HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc
Confidence 43 34568999999999999999999999999999999999999999999999999999987643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=364.96 Aligned_cols=228 Identities=33% Similarity=0.554 Sum_probs=206.9
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|+++++||+|+||.||.++.+ ++.+|+|++.+.........+....|..+|.+++||+||+++..|++.+.+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 38999999999999999999864 7789999998887766666788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+.||.|...+++++.+++..++.++.+|+.||.|||++| ||||||||+|||+ +..|+++|+|||+++.....+.
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILL--d~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILL--DEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeee--cCCCcEEEeccccchhcccCCC
Confidence 99999999999999999999999999999999999999999 9999999999999 9999999999999985443322
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
...+++||+.|||||++.+.+|+..+|+||||+++|||++|.+||.+.+..+.+++|.+++.+.++. -++++.|
T Consensus 181 ----~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~-~ls~~ar 254 (357)
T KOG0598|consen 181 ----ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG-YLSEEAR 254 (357)
T ss_pred ----ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc-cCCHHHH
Confidence 3456899999999999999999999999999999999999999999999999999999998666663 2455544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=359.37 Aligned_cols=225 Identities=30% Similarity=0.520 Sum_probs=206.4
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe-eEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~-~~lv~ 234 (394)
+.+.++.||+|..|+||++.++ +..+|+|.+. ...+....+++.+|+++++..+||+||++|+.|..+.. +.++|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~--~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL--LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec--ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 5677889999999999999986 7789999983 33445666889999999999999999999999999985 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|||++|||.++++.-+++++.....++.+|++||.|||. .+ ||||||||+|||+ +..|+|||||||.+..+..+
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLv--NskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLV--NSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeee--ccCCCEEeccccccHHhhhh-
Confidence 999999999999988999999999999999999999996 66 9999999999999 89999999999999887654
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHcCCCCCCCCCCC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-----EPYEAAKYVAEGHRPFFRAKGF 388 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~-----~~~~~~~~i~~g~~p~~~~~~~ 388 (394)
...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||... +..+++..|..+.+|.++..-|
T Consensus 233 -----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f 307 (364)
T KOG0581|consen 233 -----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF 307 (364)
T ss_pred -----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence 346789999999999999999999999999999999999999999774 7899999999999999998889
Q ss_pred CccccC
Q 016152 389 TPELRE 394 (394)
Q Consensus 389 ~~~~~~ 394 (394)
|+||++
T Consensus 308 S~ef~~ 313 (364)
T KOG0581|consen 308 SPEFRS 313 (364)
T ss_pred CHHHHH
Confidence 999974
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=370.82 Aligned_cols=226 Identities=28% Similarity=0.469 Sum_probs=207.9
Q ss_pred ccCCCCcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 151 ~i~~~~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
..++...+|...+.||+|||+.+|++.. .|+.||+|++.+.........+.+.+|+++.+.++|||||+++++|++.+
T Consensus 12 i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~ 91 (592)
T KOG0575|consen 12 IEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN 91 (592)
T ss_pred eecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence 3444457899999999999999999987 58999999998877666777788999999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
++|+|+|+|..++|..++++++++++.+++.+++||+.||.|||+.+ |+|||||..|+++ +++.+|||+|||||..
T Consensus 92 nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL--~~~~~VKIgDFGLAt~ 167 (592)
T KOG0575|consen 92 NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFL--NENMNVKIGDFGLATQ 167 (592)
T ss_pred ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheee--cCcCcEEecccceeee
Confidence 99999999999999999999999999999999999999999999998 9999999999999 8888999999999999
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~ 384 (394)
+..++. ...+.||||.|+|||++.+..++..+||||+||+||-|++|+|||...+-.+.+++|+...+.+..
T Consensus 168 le~~~E----rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~ 239 (592)
T KOG0575|consen 168 LEYDGE----RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS 239 (592)
T ss_pred ecCccc----ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc
Confidence 875543 356789999999999999999999999999999999999999999999999999999987666543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=341.92 Aligned_cols=225 Identities=31% Similarity=0.564 Sum_probs=205.0
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|+..+.||.|+||.|++++.+ |..+|+|++.+...-.....+...+|..+|+.+.||+++++.+.+.+...+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 38999999999999999999864 8899999997776666666678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||++||.|++++++.++++++.++.++.||+.||+|||+++ |++|||||+|||+ +.+|.+||+|||+|......
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLl--D~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLL--DQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeee--ccCCcEEEEeccceEEecCc--
Confidence 99999999999999999999999999999999999999998 9999999999999 99999999999999987633
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccccC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~~ 394 (394)
.-+.||||.|+|||++...+|..++|+|||||++|||+.|.+||...++.+++++|.+|..-+..- |++++||
T Consensus 198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~--fs~~~kd 270 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY--FSSDAKD 270 (355)
T ss_pred -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc--cCHHHHH
Confidence 235799999999999999999999999999999999999999999999999999999987654433 5665553
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-51 Score=349.21 Aligned_cols=231 Identities=30% Similarity=0.520 Sum_probs=205.0
Q ss_pred CcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEe-EEEeCCe-eE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG-AVTERKP-LM 231 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~-~~~~~~~-~~ 231 (394)
..+|+++++||+|+||.||++.+ +|..+|.|.+. ....+....+....|+.+|++++|||||++++ .|.++.. ++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 34799999999999999999976 58899999887 44445667788999999999999999999999 4544444 89
Q ss_pred EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHc--CCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 232 LITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHN--EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~--~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
+|||+|++|+|...++. +..+++.++++++.|++.||..||+ ..+.|+||||||.||++ +.+|.|||+|||+
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl--~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL--TANGVVKLGDFGL 174 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE--cCCCceeeccchh
Confidence 99999999999999873 4569999999999999999999999 33459999999999999 8999999999999
Q ss_pred ccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~ 385 (394)
++.+..... ...+.+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+.+-.++.++|.+|..|.+++
T Consensus 175 ~r~l~s~~t----fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 175 GRFLSSKTT----FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred HhHhcchhH----HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence 998875432 3456899999999999999999999999999999999999999999999999999999999999998
Q ss_pred CCCCcccc
Q 016152 386 KGFTPELR 393 (394)
Q Consensus 386 ~~~~~~~~ 393 (394)
+.||.+++
T Consensus 251 ~~YS~~l~ 258 (375)
T KOG0591|consen 251 EHYSTDLR 258 (375)
T ss_pred HHhhhHHH
Confidence 88887765
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-49 Score=353.63 Aligned_cols=222 Identities=31% Similarity=0.465 Sum_probs=193.7
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcH----HHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDR----LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
..|.+.+.||+|+||.|-+|.. +|+.||||++.+...... .......+|+++|++++|||||+++++|...+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 3578899999999999999986 488999999987654431 1234457999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCcccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLI 309 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a~~~ 309 (394)
|+||||++||.|.+.+-.++.+.+....-+++|++.|+.|||++| |+||||||+|||+..+ .+-.+||+|||+|+..
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999998 9999999999999544 3457999999999987
Q ss_pred ccccccccccccCCccCccccCccccCCCCC---CCcchHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHcCCCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKY---DKKVDVFSFAMILYEMLEGEPPLANYEPYE-AAKYVAEGHRPFFRA 385 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslGv~l~el~~g~~Pf~~~~~~~-~~~~i~~g~~p~~~~ 385 (394)
.... ...+.||||.|.|||++.+..+ ..++|+|||||++|-+++|.+||.+..... +.++|.+|.+++.+.
T Consensus 330 g~~s-----fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 330 GEGS-----FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred ccce-----ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 6333 4678999999999999987653 348899999999999999999998876555 899999999998865
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=349.65 Aligned_cols=235 Identities=45% Similarity=0.751 Sum_probs=202.5
Q ss_pred CCcccCCCCcCccccceeecCCceEEEEEEECCcc-EEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe
Q 016152 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226 (394)
Q Consensus 148 ~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g~~-~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 226 (394)
..|.++... ....+.||+|+||.||++.+.|+. +|||.+......... .+.|.+|+.+|.+++|||||+++|++.+
T Consensus 34 ~~~~i~~~~--l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 34 PEEEIDPDE--LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred cceecChHH--hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 345555443 345566999999999999999998 999998776555444 7899999999999999999999999998
Q ss_pred CC-eeEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC-cEEEee
Q 016152 227 RK-PLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGD 302 (394)
Q Consensus 227 ~~-~~~lv~e~~~~~sL~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~-~~kl~D 302 (394)
.. .+++||||+++|+|.+++.. +..++...++.++.||++||.|||++++ ||||||||+|||+ +..+ ++||+|
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv--~~~~~~~KI~D 187 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILV--DLKGKTLKIAD 187 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEE--cCCCCEEEECC
Confidence 87 79999999999999999987 5789999999999999999999999764 9999999999999 8886 999999
Q ss_pred cCCccccccccccccccccCCccCccccCccccC--CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCC
Q 016152 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK--HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGH 379 (394)
Q Consensus 303 Fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~-~g~ 379 (394)
||+++...... .......||+.|||||++. ...|+.++||||||+++|||+||+.||.+.++.++...+. .+.
T Consensus 188 FGlsr~~~~~~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~ 263 (362)
T KOG0192|consen 188 FGLSREKVISK----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL 263 (362)
T ss_pred Cccceeecccc----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC
Confidence 99998765432 1233478999999999999 6699999999999999999999999999999877776665 899
Q ss_pred CCCCCCCCCCcccc
Q 016152 380 RPFFRAKGFTPELR 393 (394)
Q Consensus 380 ~p~~~~~~~~~~~~ 393 (394)
||.++.. +++.+.
T Consensus 264 Rp~~p~~-~~~~l~ 276 (362)
T KOG0192|consen 264 RPPIPKE-CPPHLS 276 (362)
T ss_pred CCCCCcc-CCHHHH
Confidence 9999876 666653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=345.32 Aligned_cols=235 Identities=31% Similarity=0.467 Sum_probs=203.7
Q ss_pred CCcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
+..+|++++.||+|+||.||+|.. +|+.+|+|++.++...........+.|-.+|....+|.||+++..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 444899999999999999999986 488999999988776667777889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||||++||++..+|.+.+.+++..++.++.+++-||+.+|+.| +|||||||+|+|| +..|++||+||||+..+...
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLi--D~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLI--DAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheee--cCCCCEeeccccccchhhhh
Confidence 9999999999999999999999999999999999999999998 9999999999999 99999999999998644220
Q ss_pred c--------------------cccc-----------------------ccccCCccCccccCccccCCCCCCCcchHHHH
Q 016152 313 N--------------------SHDV-----------------------YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSF 349 (394)
Q Consensus 313 ~--------------------~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 349 (394)
. .... ....+.+|||.|||||++.+.+|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 0000 01124569999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCCcccc
Q 016152 350 AMILYEMLEGEPPLANYEPYEAAKYVAEGH--RPFFRAKGFTPELR 393 (394)
Q Consensus 350 Gv~l~el~~g~~Pf~~~~~~~~~~~i~~g~--~p~~~~~~~~~~~~ 393 (394)
|||+|||+.|.+||...++.+++++|.... -.+.....+++|-+
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~ 420 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAK 420 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHH
Confidence 999999999999999999999999998543 33444444555543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=346.66 Aligned_cols=232 Identities=33% Similarity=0.580 Sum_probs=202.9
Q ss_pred CCCcccCCCCcCccccceeecCCceEEEEEEECCc-cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 016152 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (394)
Q Consensus 147 ~~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g~-~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 225 (394)
...|+++... +..++.||+|.||.||.|.++++ .||+|.+...... -+.|.+|+.+|++++|++||++++++.
T Consensus 198 ~d~wei~r~~--l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 198 RDPWEIPREE--LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred cCCeeecHHH--HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 5677777653 45678999999999999999987 8999988664322 267889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 226 ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 226 ~~~~~~lv~e~~~~~sL~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
.+++++||||||..|+|.++++. ++.++..+.+.++.||++|++||.+++ +|||||.++|||| +.+..+||+||
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV--~~~~~vKIsDF 347 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILV--DEDLVVKISDF 347 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheee--ccCceEEEccc
Confidence 99999999999999999999987 456999999999999999999999988 9999999999999 88889999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~ 382 (394)
|||+...++.. ....+..-++.|.|||++..+.++.+||||||||+||||+| |+.||.+++..+++++|.+|+|-.
T Consensus 348 GLAr~~~d~~Y---~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp 424 (468)
T KOG0197|consen 348 GLARLIGDDEY---TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP 424 (468)
T ss_pred ccccccCCCce---eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC
Confidence 99995433221 12233445788999999999999999999999999999999 999999999999999999999988
Q ss_pred CCCCCCCccc
Q 016152 383 FRAKGFTPEL 392 (394)
Q Consensus 383 ~~~~~~~~~~ 392 (394)
-|.. ||+++
T Consensus 425 ~P~~-CP~~v 433 (468)
T KOG0197|consen 425 RPEG-CPDEV 433 (468)
T ss_pred CCCC-CCHHH
Confidence 8854 77664
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=346.91 Aligned_cols=234 Identities=28% Similarity=0.489 Sum_probs=206.2
Q ss_pred CCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCee
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~ 230 (394)
..-.+|..++.||.|+|++|++|... +..+|||++.+.....+...+....|-.+|.+| .||.|++++..|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34458999999999999999999864 788999999877665555556677899999999 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
|+|+||+++|+|.++|++.|.+++..++.++.||+.||+|||++| ||||||||+|||+ +.+++++|.|||.|..+.
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILL--d~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILL--DKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeE--cCCCcEEEeeccccccCC
Confidence 999999999999999999999999999999999999999999998 9999999999999 999999999999999886
Q ss_pred ccccc------cc-cc--ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 016152 311 VQNSH------DV-YK--MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 311 ~~~~~------~~-~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
..... .. .. ..+++||..|.+||++.....++.+|+|+|||++|+|+.|++||.+.+...+.++|..-.++
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~ 305 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE 305 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence 53321 11 11 25689999999999999999999999999999999999999999999999999999986666
Q ss_pred CCCCCCCCcccc
Q 016152 382 FFRAKGFTPELR 393 (394)
Q Consensus 382 ~~~~~~~~~~~~ 393 (394)
+.+. ||+..+
T Consensus 306 fp~~--fp~~a~ 315 (604)
T KOG0592|consen 306 FPEG--FPEDAR 315 (604)
T ss_pred CCCC--CCHHHH
Confidence 5543 666544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=311.95 Aligned_cols=352 Identities=28% Similarity=0.421 Sum_probs=283.6
Q ss_pred cchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCC
Q 016152 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (394)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (394)
..-|.|.-|+.|..++ || |+++++..+++.|++.|+-||+++.-..||||+||..||-++|+.||+..||||+.|..|
T Consensus 23 tehdln~gddhgfspl-hw-aakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehg 100 (448)
T KOG0195|consen 23 TEHDLNVGDDHGFSPL-HW-AAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHG 100 (448)
T ss_pred cccccccccccCcchh-hh-hhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccC
Confidence 4556677777777765 34 667888999999999999999999999999999999999999999999999999999999
Q ss_pred CchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCCCCC-------------------CCCCCC-CCcccCC-------
Q 016152 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVP-------------------PPLPNK-CDWEIDP------- 154 (394)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~~~~-------------------~~~~~~-~~~~i~~------- 154 (394)
.||||+|+.+|...|.+-|+..|+.++..++...+|.... ...+.+ ..|.-..
T Consensus 101 ntplhyacfwgydqiaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdat 180 (448)
T KOG0195|consen 101 NTPLHYACFWGYDQIAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDAT 180 (448)
T ss_pred CCchhhhhhhcHHHHHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCcccccccccccccccccccc
Confidence 9999999999999999999999999999888888774321 122222 1343211
Q ss_pred ----CCcC---ccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC
Q 016152 155 ----SELD---FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (394)
Q Consensus 155 ----~~~~---~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 227 (394)
+..+ .....+|.....|..|+|+++|..+++|++..... .....++|..|...++-+.||||+.+++.+...
T Consensus 181 lsr~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 181 LSRYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred cccccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 1111 22344678889999999999999999998754332 233347899999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEE--eec
Q 016152 228 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV--GDF 303 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl--~DF 303 (394)
.++.++..||+.|||...++... ..+..++.+++.++++|+.|||+..+.|.---|....+++ +++-+.+| +|-
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi--dedltarismad~ 337 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI--DEDLTARISMADT 337 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe--cchhhhheecccc
Confidence 99999999999999999998754 3688899999999999999999986544445788899999 55555444 443
Q ss_pred CCccccccccccccccccCCccCccccCccccCCCCCC---CcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCC
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD---KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGH 379 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~-~g~ 379 (394)
-++. ...+..-.|.||+||.+...+-+ ..+|+|||++++|||.|+..||.+.+++|...+|. +|.
T Consensus 338 kfsf-----------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl 406 (448)
T KOG0195|consen 338 KFSF-----------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL 406 (448)
T ss_pred eeee-----------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc
Confidence 3332 12334457889999999876543 68999999999999999999999999999998886 899
Q ss_pred CCCCCCCCCCc
Q 016152 380 RPFFRAKGFTP 390 (394)
Q Consensus 380 ~p~~~~~~~~~ 390 (394)
++.++. +.++
T Consensus 407 rv~ipp-gis~ 416 (448)
T KOG0195|consen 407 RVHIPP-GISR 416 (448)
T ss_pred cccCCC-CccH
Confidence 998874 3443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=320.54 Aligned_cols=228 Identities=26% Similarity=0.442 Sum_probs=201.3
Q ss_pred CCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 153 ~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
.+....|++..+||.|..+.||+|++. ++.||||++.-..-. .....+.+|+..++.++||||++++..|..+..+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 344458999999999999999999984 789999998654433 3368899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 231 MLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
|+||.||.+||+.++++.. ..+++..+..+++++++||.|||++| .||||||+.|||| +.+|.|||+|||.+..
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi--~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILI--DSDGTVKLADFGVSAS 175 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEE--cCCCcEEEcCceeeee
Confidence 9999999999999999863 34999999999999999999999988 9999999999999 9999999999998877
Q ss_pred cccccccccccccCCccCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK 386 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~ 386 (394)
+.....+......+++||+.|||||++.. .+|+.|+||||||++.+||.+|+.||...++++++-.-.+|.+|.+...
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS 255 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence 76655444444477899999999999643 5799999999999999999999999999999999999899999965543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=333.26 Aligned_cols=229 Identities=32% Similarity=0.516 Sum_probs=197.1
Q ss_pred CcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcH--HHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCee
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDR--LVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPL 230 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~ 230 (394)
...|.+++.||+|+||.|+.|.+ .+..||+|++........ ...+.+.+|+.+++++. ||||++++.++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 34789999999999999999976 478999997655422211 23355668999999999 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCC-CcEEEeecCCcccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDFGLSKLI 309 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~-~~~kl~DFg~a~~~ 309 (394)
++||||+.||+|.+++.+.+++.+..++.+++|++.|++|||++| |+||||||+|||+ +.+ +++||+|||++...
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENill--d~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILL--DGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEe--cCCCCCEEEecccccccc
Confidence 999999999999999999999999999999999999999999998 9999999999999 777 99999999999877
Q ss_pred ccccccccccccCCccCccccCccccCCCC-CC-CcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRK-YD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~ 387 (394)
.. ......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+...++..|.+|.......-.
T Consensus 172 ~~----~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~ 247 (370)
T KOG0583|consen 172 PG----EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL 247 (370)
T ss_pred CC----CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC
Confidence 41 112456789999999999999877 85 8999999999999999999999999999999999988666544311
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
|++.+
T Consensus 248 -S~~~~ 252 (370)
T KOG0583|consen 248 -SPEAR 252 (370)
T ss_pred -CHHHH
Confidence 55543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=335.42 Aligned_cols=224 Identities=33% Similarity=0.547 Sum_probs=199.1
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|.+.+.||+|+||.||+|+.+ .+.||+|++.+..... ...+.+.+|+++++.++||||+.++++|+....+|+|.|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 6888889999999999999875 5689999988766554 346789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+.| +|..++...+.++++.++.++.|++.||.|||+.+ |+|||+||.|||+ +..+.+|+||||+|+......
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl--~~~~~~KlcdFg~Ar~m~~~t-- 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILL--EKGGTLKLCDFGLARAMSTNT-- 154 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeee--cCCCceeechhhhhhhcccCc--
Confidence 9977 99999999999999999999999999999999988 9999999999999 999999999999998765432
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
...+...|||.|||||...+++|+..+|+|||||++||+++|++||-..+..++.+.|.....+... ..+.+|+
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~--~~S~~f~ 228 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS--TASSSFV 228 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc--cccHHHH
Confidence 2345678999999999999999999999999999999999999999999999999999876544443 2455553
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=338.95 Aligned_cols=225 Identities=30% Similarity=0.475 Sum_probs=202.4
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
-|+.++.||+|+.|.|-+|.+ +|+.+|||++.+...-.......+.+|+-+|+.+.||||+++++++++...+|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 367789999999999999987 599999999987644444445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|++||-|++++..+|++++.++.++++||+.|+.|||..+ |+||||||+|+|+ +..+++||+|||+|.....+.
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLL--d~~~nIKIADFGMAsLe~~gk-- 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLL--DVKNNIKIADFGMASLEVPGK-- 166 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhh--hcccCEeeeccceeecccCCc--
Confidence 9999999999999999999999999999999999999988 9999999999999 888889999999998765443
Q ss_pred ccccccCCccCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
...+.||+|.|.|||++.+.+| +.++||||.||+||.|+||+.||++.+...++.++.+|.+-+. ..+|++-+
T Consensus 167 ---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP--s~Is~eaQ 240 (786)
T KOG0588|consen 167 ---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP--SNISSEAQ 240 (786)
T ss_pred ---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC--CcCCHHHH
Confidence 4567899999999999999998 5899999999999999999999999999999999999988765 34666644
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=334.87 Aligned_cols=225 Identities=32% Similarity=0.557 Sum_probs=202.1
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|.....||+|+.|.||.|.. .++.||||.+........ +-+.+|+.+|+..+|+|||.+++.|...+.+|+|||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 477788999999999999986 467899999876654432 567899999999999999999999988899999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
||+||+|.+.+... .+++.++..+++++++||+|||.+| |+|||||.+|||+ ..+|.+||+|||++..+.....
T Consensus 351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL--~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILL--TMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEe--ccCCcEEEeeeeeeeccccccC-
Confidence 99999999998754 5999999999999999999999998 9999999999999 8888999999999988765432
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCCccccC
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFTPELRE 394 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~~~~~~~ 394 (394)
...+.+|||.|||||++....|+++.||||||++++||+-|++||-+.++..++.+|.....|.+.. +.+|++|||
T Consensus 425 ---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 425 ---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD 501 (550)
T ss_pred ---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence 3456899999999999999999999999999999999999999999999999999999888888877 578899885
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=317.67 Aligned_cols=221 Identities=29% Similarity=0.543 Sum_probs=205.4
Q ss_pred CcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
..+|++.+.||+|.||.|-+|.. .|+.||||.+.+....+.+.+-.+++|+++|..++||||+.++.+|+..+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 34799999999999999999975 4899999999999888888888899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|||..+|.|.+|+.+.+.+++.+++.+++||..|+.|||.++ ++|||||.+|||+ +.++++||+|||++-.+....
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILL--D~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILL--DQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheee--cCCCCeeeeccchhhhhcccc
Confidence 999999999999999999999999999999999999999988 9999999999999 999999999999998876543
Q ss_pred ccccccccCCccCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~ 385 (394)
...++||+|-|.+||++.+.+| .+.+|.|||||+||.|+.|..||++.+...+.++|..|.+-+.+.
T Consensus 208 -----fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~ 275 (668)
T KOG0611|consen 208 -----FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET 275 (668)
T ss_pred -----HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC
Confidence 3567999999999999999998 589999999999999999999999999999999999987665543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=332.31 Aligned_cols=219 Identities=30% Similarity=0.483 Sum_probs=194.2
Q ss_pred CCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCe
Q 016152 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKP 229 (394)
Q Consensus 153 ~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~ 229 (394)
.....+|..+++||+|.||.|+++..+ ++.+|||++.+...-.....+..+.|.+++.... ||.++.++..|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345568999999999999999999875 5689999998876666666677888999888775 9999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
+|+||||+.||++..+ ...+.+++..++.++..|+.||.|||++| |||||||.+|||+ +..|.+||+|||+++..
T Consensus 444 l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLL--D~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLL--DTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEE--cccCcEEeccccccccc
Confidence 9999999999995543 34467999999999999999999999988 9999999999999 99999999999999865
Q ss_pred ccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
-.... ...+++|||.|||||++.+..|+..+|+|||||+||||+.|++||.+.+.+|+.+.|+...+
T Consensus 519 m~~g~----~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~ 585 (694)
T KOG0694|consen 519 MGQGD----RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV 585 (694)
T ss_pred CCCCC----ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC
Confidence 43322 45679999999999999999999999999999999999999999999999999999986543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=299.48 Aligned_cols=220 Identities=33% Similarity=0.531 Sum_probs=198.7
Q ss_pred CCCCCcccCCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEe
Q 016152 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222 (394)
Q Consensus 145 ~~~~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 222 (394)
+....|.++ +|++++.||+|-||.||.|+.+ +.-+|+|++.++........+++.+|+++...++||||+++++
T Consensus 14 ~~~~~~~l~----dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~ 89 (281)
T KOG0580|consen 14 RATKTWTLD----DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYG 89 (281)
T ss_pred ccccccchh----hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhh
Confidence 345678887 8999999999999999999875 5579999998876555555678999999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEE
Q 016152 223 AVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300 (394)
Q Consensus 223 ~~~~~~~~~lv~e~~~~~sL~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl 300 (394)
+|.+...+|+++||..+|+|...+. ...++++..+..++.|++.||.|+|.++ ||||||||+|+|+ +..+.+||
T Consensus 90 ~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLl--g~~~~lki 165 (281)
T KOG0580|consen 90 YFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLL--GSAGELKI 165 (281)
T ss_pred heeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhcc--CCCCCeec
Confidence 9999999999999999999999998 4567999999999999999999999988 9999999999999 89999999
Q ss_pred eecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 016152 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (394)
Q Consensus 301 ~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g 378 (394)
+|||.+..-+.. ...+.+||.-|++||+..+..++..+|+|++|++.||++.|.+||...+..+.+++|.+-
T Consensus 166 AdfGwsV~~p~~------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~ 237 (281)
T KOG0580|consen 166 ADFGWSVHAPSN------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV 237 (281)
T ss_pred cCCCceeecCCC------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc
Confidence 999998765422 235689999999999999999999999999999999999999999999999999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=329.05 Aligned_cols=217 Identities=32% Similarity=0.508 Sum_probs=188.1
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++... ++.+|+|++.+...........+..|+.+++.++||+|+++++.+.+...+++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 6888999999999999999874 77899998865433333444677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++|+|.+++.+++.+++..++.++.|++.||+|||++| |+||||||+|||+ +.++.+||+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi--~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLL--DSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEE--CCCCCEEEeeccCcccccccccc
Confidence 9999999999998889999999999999999999999988 9999999999999 88899999999998765321100
Q ss_pred c-------------------------------cccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 016152 316 D-------------------------------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364 (394)
Q Consensus 316 ~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~ 364 (394)
. .......+||+.|+|||++.+..++.++|||||||++|||++|++||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0 000124579999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHcC
Q 016152 365 NYEPYEAAKYVAEG 378 (394)
Q Consensus 365 ~~~~~~~~~~i~~g 378 (394)
..+..+..+.|...
T Consensus 238 ~~~~~~~~~~i~~~ 251 (363)
T cd05628 238 SETPQETYKKVMNW 251 (363)
T ss_pred CCCHHHHHHHHHcC
Confidence 99988999888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=305.87 Aligned_cols=210 Identities=25% Similarity=0.487 Sum_probs=183.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|+.+.++|+|+||.||+++++ |+-||||.+..+. ++....+-..+|+++|++++|+|+|.++.+|.....+++|+|
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 5788889999999999999874 8899999887654 445556777899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+. ++.+-+.. ...++...+..+++|++.|+.|+|+.+ +|||||||+|||+ ..++.+||||||+|+.+..++.
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILi--t~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILI--TQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEE--ecCCcEEeccchhhHhhcCCcc
Confidence 9988 54444544 345899999999999999999999987 9999999999999 8899999999999998874332
Q ss_pred cccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
.++..+.|.+|.|||.+.+ .+|++.+||||+||++.||++|.+.|.+.++-+.+-.|.+
T Consensus 157 ----~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k 216 (396)
T KOG0593|consen 157 ----NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK 216 (396)
T ss_pred ----hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH
Confidence 3566889999999999987 7899999999999999999999999999988777766654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=319.54 Aligned_cols=213 Identities=27% Similarity=0.467 Sum_probs=185.8
Q ss_pred CCcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--Cee
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPL 230 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~ 230 (394)
....|+.++.||+|.||.||+|+. +|..||+|.+.-...+.. ...-..+|+.+|++++||||+++.+...+. ..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 334688899999999999999987 478899998865543322 234567899999999999999999988776 689
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 231 MLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
|+|+|||++ +|.-++...+ .|++.++..+++||+.||+|||++| |+|||||.+|||| +.+|.+||+|||||+++
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLi--dn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILI--DNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEE--cCCCCEEeccccceeec
Confidence 999999988 9988887654 6999999999999999999999998 9999999999999 99999999999999987
Q ss_pred ccccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
...... .++..+-|.+|.|||.+.+. .|+..+|+||.||||.||++|++.|.+.+..+.+.+|-
T Consensus 269 ~~~~~~---~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIf 333 (560)
T KOG0600|consen 269 TPSGSA---PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIF 333 (560)
T ss_pred cCCCCc---ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHH
Confidence 655432 35667889999999999875 79999999999999999999999999999988888875
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=324.44 Aligned_cols=226 Identities=32% Similarity=0.555 Sum_probs=205.1
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|+....||+|.||.||+|.+. ++.||+|++.-....+ ...++.+|+.++..++++||.++|+.+..+..+|++||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 5777789999999999999875 7789999986554433 35788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
||.||++.+.++....+++..+..++++++.||.|||+++ .+|||||+.|||+ ...|.+||+|||.+..+.....
T Consensus 92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~--s~~g~vkl~DfgVa~ql~~~~~- 166 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILL--SESGDVKLADFGVAGQLTNTVK- 166 (467)
T ss_pred HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeE--eccCcEEEEecceeeeeechhh-
Confidence 9999999999998888899999999999999999999998 9999999999999 6669999999999988765432
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccccC
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~~ 394 (394)
...+++|||.|||||++....|+.++||||||++++||.+|.+||....++.+...|-+..+|.+.. .||+.|||
T Consensus 167 ---rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~-~~S~~~kE 241 (467)
T KOG0201|consen 167 ---RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG-DFSPPFKE 241 (467)
T ss_pred ---ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc-ccCHHHHH
Confidence 2367899999999999998899999999999999999999999999999999999999999999987 79998875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=312.98 Aligned_cols=228 Identities=31% Similarity=0.566 Sum_probs=187.1
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC--eeEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK--PLML 232 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--~~~l 232 (394)
.+|..++.||+|+||.||++... |...|||....... .. .+.+.+|+.+|.+++|||||+++|...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 36788899999999999999875 78999998755421 11 577889999999999999999999744444 6899
Q ss_pred EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC-CCcEEEeecCCccccc
Q 016152 233 ITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIK 310 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~-~~~~kl~DFg~a~~~~ 310 (394)
+|||+.+|+|.+++.+.+ .+++..++.+.+|+++||.|||++| ||||||||+|||+ +. ++.+||+|||++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl--~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILL--DPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEE--eCCCCeEEeccCccccccc
Confidence 999999999999999877 7999999999999999999999988 9999999999999 77 6899999999998766
Q ss_pred cccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHH-cCCCCCCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVA-EGHRPFFRAKG 387 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~-~~~~~~~~~i~-~g~~p~~~~~~ 387 (394)
... ..........||+.|||||++..+ ...+++|||||||++.||+||++||.. ....+..-+|. .+.-|.++..
T Consensus 170 ~~~-~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~- 247 (313)
T KOG0198|consen 170 SKG-TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDS- 247 (313)
T ss_pred ccc-ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcc-
Confidence 311 111123357899999999999853 344699999999999999999999998 56666666665 4446666644
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
+|++.+
T Consensus 248 ls~~a~ 253 (313)
T KOG0198|consen 248 LSDEAK 253 (313)
T ss_pred cCHHHH
Confidence 666544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=315.76 Aligned_cols=223 Identities=30% Similarity=0.518 Sum_probs=193.4
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++... ++.+|+|.+...........+.+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 6888999999999999999875 78899998865433233344668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli--~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILL--DKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEE--CCCCCEEEEecCcchhccCC---
Confidence 9999999999998888999999999999999999999988 9999999999999 78889999999998765422
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..+.+..+..+... .++++++
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~ 226 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR--HLDLYAK 226 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc--cCCHHHH
Confidence 12356899999999999999999999999999999999999999999999999999887544322 2455544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.39 Aligned_cols=213 Identities=30% Similarity=0.539 Sum_probs=190.3
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|... ++.+|+|++...........+.+.+|+.++++++||||+++++.+.+++.+++|||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 7899999999999999999875 67899998865432233344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+.+++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++.......
T Consensus 99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLL--DNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEE--CCCCCEEEeeccCceEcCCCc--
Confidence 9999999999998888999999999999999999999988 9999999999999 888999999999998654321
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+..+.|..+..+
T Consensus 173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 233 (329)
T PTZ00263 173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK 233 (329)
T ss_pred -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcC
Confidence 2357899999999999999999999999999999999999999999999999999887544
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=307.31 Aligned_cols=230 Identities=27% Similarity=0.411 Sum_probs=198.8
Q ss_pred CccccceeecCCceEEEEEEECC--ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g--~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|+.++.||+|.-|.||++..++ ..+|+|++.+..........+...|-+||+.++||.++.+|..|+.+...|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 68889999999999999999876 6899999988766666677888899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
||.||+|...++++ +.+++..++.++.+|+-||+|||-.| ||+|||||+|||| .++|++.|+||.|+.......
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILv--redGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILV--REDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEE--ecCCcEEeeeccccccCCCCC
Confidence 99999999999864 46999999999999999999999999 9999999999999 899999999999976542100
Q ss_pred -------------------------------c-c--------------------ccccccCCccCccccCccccCCCCCC
Q 016152 314 -------------------------------S-H--------------------DVYKMTGETGSYRYMAPEVFKHRKYD 341 (394)
Q Consensus 314 -------------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 341 (394)
. . ......+++||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 00123457799999999999999999
Q ss_pred CcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCC-CCCccc
Q 016152 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK-GFTPEL 392 (394)
Q Consensus 342 ~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~-~~~~~~ 392 (394)
.++|+|+|||++|||+.|..||.+.+..+.+..|+. +++.|+.. ..+-..
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-~~l~Fp~~~~vs~~a 364 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-QPLKFPEEPEVSSAA 364 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-CCCcCCCCCcchhHH
Confidence 999999999999999999999999999999999875 35555553 344333
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=325.11 Aligned_cols=232 Identities=25% Similarity=0.405 Sum_probs=190.6
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|+.++.||+|+||.||+|... +..+|+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999874 67899999865443334445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++|+|.+++.+.+.+++..+..++.|++.||+|||+.+ |+||||||+|||+ +..+.+||+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili--~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILI--DLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEE--CCCCCEEEeeCcCCccccccccc
Confidence 9999999999998888999999999999999999999988 9999999999999 88889999999997643211000
Q ss_pred c-------------------------------------------cccccCCccCccccCccccCCCCCCCcchHHHHHHH
Q 016152 316 D-------------------------------------------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMI 352 (394)
Q Consensus 316 ~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~ 352 (394)
. .......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 0 000123579999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHHcC-CCCCCC-CCCCCcccc
Q 016152 353 LYEMLEGEPPLANYEPYEAAKYVAEG-HRPFFR-AKGFTPELR 393 (394)
Q Consensus 353 l~el~~g~~Pf~~~~~~~~~~~i~~g-~~p~~~-~~~~~~~~~ 393 (394)
+|||++|++||...+..+....+... ....++ ...++++++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 280 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAV 280 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHH
Confidence 99999999999988877777666532 222222 234566554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=323.80 Aligned_cols=232 Identities=30% Similarity=0.522 Sum_probs=193.4
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++... ++.+|||++.............+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 6888999999999999999874 78899999865432233344667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+.+|+|.+++..++.+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.++|+|||++..+......
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEE--CCCCCEEEeecccceeccccccc
Confidence 9999999999998888999999999999999999999988 9999999999999 88899999999998765322110
Q ss_pred cc----------------------------------ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCC
Q 016152 316 DV----------------------------------YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361 (394)
Q Consensus 316 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~ 361 (394)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 00 00113469999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCC-CCCC-CCCCcccc
Q 016152 362 PLANYEPYEAAKYVAEGHRP-FFRA-KGFTPELR 393 (394)
Q Consensus 362 Pf~~~~~~~~~~~i~~g~~p-~~~~-~~~~~~~~ 393 (394)
||...+..+....+...... .++. ..++++++
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 271 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAK 271 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHH
Confidence 99999988888888754322 2222 24566554
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=325.00 Aligned_cols=232 Identities=25% Similarity=0.417 Sum_probs=191.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|+.++.||+|+||.||+|... ++.+|+|.+.+...........+.+|+.+++.++||||+++++.+.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999874 67899998865433334445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++|+|.+++.+.+.+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl--~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEEeECCCCccccccccc
Confidence 9999999999988888999999999999999999999988 9999999999999 88899999999997543210000
Q ss_pred -------------------------------------------ccccccCCccCccccCccccCCCCCCCcchHHHHHHH
Q 016152 316 -------------------------------------------DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMI 352 (394)
Q Consensus 316 -------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~ 352 (394)
........+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0000123579999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCC-CCCCCcccc
Q 016152 353 LYEMLEGEPPLANYEPYEAAKYVAEGH-RPFFR-AKGFTPELR 393 (394)
Q Consensus 353 l~el~~g~~Pf~~~~~~~~~~~i~~g~-~p~~~-~~~~~~~~~ 393 (394)
+|||++|++||...++.+....+.... ...++ ...++++++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 280 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEAS 280 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHH
Confidence 999999999999988888777776432 22222 234565543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=324.79 Aligned_cols=216 Identities=29% Similarity=0.479 Sum_probs=185.2
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++.. .++.+|||.+.+.........+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 688899999999999999987 477899998865433333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++|+|.+++...+.+++..++.++.|++.||+|||++| |+||||||+|||+ +.++.+||+|||+++.+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll--~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILI--DRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--CCCCCEEEeeccccccccccccc
Confidence 9999999999988888999999999999999999999988 9999999999999 88889999999998643211000
Q ss_pred c----------c---------------------------------ccccCCccCccccCccccCCCCCCCcchHHHHHHH
Q 016152 316 D----------V---------------------------------YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMI 352 (394)
Q Consensus 316 ~----------~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~ 352 (394)
. . ......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0 0 00012469999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 353 LYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 353 l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
+|||++|.+||...+..+....|..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~ 262 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIIN 262 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHc
Confidence 9999999999999888888887765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=289.48 Aligned_cols=209 Identities=32% Similarity=0.530 Sum_probs=183.9
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|...+++|+|.||.||+|.+ +|+.||||.+......+... ....+|+..|+.++|+||+.++++|...+.+.+|+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc-HHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 678889999999999999987 48899999987654443222 345679999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+. +|...++.+. .++..++..++.++++||+|||++. |+||||||.|+|+ +.+|.+||+|||+|+.+.....
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLi--s~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLI--SSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEE--cCCCcEEeecccchhccCCCCc
Confidence 9976 9999998654 6999999999999999999999987 9999999999999 8999999999999998875543
Q ss_pred cccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
. ....+-|.+|.|||.+.+ +.|+..+||||.||++.||+-|.+-|.+.++-+.+..|-
T Consensus 157 ~----~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If 215 (318)
T KOG0659|consen 157 I----QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIF 215 (318)
T ss_pred c----cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHH
Confidence 2 223478999999999876 579999999999999999999999999999888887775
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=316.01 Aligned_cols=221 Identities=26% Similarity=0.461 Sum_probs=188.1
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 240 (394)
+.||+|+||.||++... |+.+|+|++.+...........+.+|+.++++++||||+++++.+...+.+++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 7889999886543333344466778999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccc
Q 016152 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320 (394)
Q Consensus 241 sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~ 320 (394)
+|.+++...+.+++..+..++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll--~~~~~~kl~DfG~a~~~~~~~~----~~ 152 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLML--DKDGHIKITDFGLCKEGISDGA----TM 152 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEE--CCCCCEEEeeCCCCcccccCCC----cc
Confidence 99999998888999999999999999999999988 9999999999999 8888999999999875332211 22
Q ss_pred cCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..+.+..+... ++ ..++++++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-~p-~~~~~~~~ 223 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-FP-RTLSPEAK 223 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC-CC-CCCCHHHH
Confidence 3467999999999999999999999999999999999999999998888888888765433 33 23565554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=318.56 Aligned_cols=214 Identities=29% Similarity=0.504 Sum_probs=188.9
Q ss_pred CcCccccceeecCCceEEEEEEECC---ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWRG---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~g---~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
..+|++.+.||+|+||.||+|.+.+ ..+|+|.+...........+.+.+|+.+++.++||||+++++++.+...+++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3378999999999999999998642 4799998865433333345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||||+.+|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl--~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLL--DKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEE--CCCCCEEEecCCCCeecCCC
Confidence 9999999999999998888999999999999999999999988 9999999999999 88899999999999765321
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
.....||+.|+|||++.+..++.++|||||||++|||++|.+||...++....+.+..+..
T Consensus 185 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~ 245 (340)
T PTZ00426 185 -------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII 245 (340)
T ss_pred -------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Confidence 1245799999999999988899999999999999999999999999998888899888754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=319.74 Aligned_cols=259 Identities=31% Similarity=0.530 Sum_probs=210.0
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCcCccccceeecCCceEEEEEEEC---C--cc-EEEEE
Q 016152 114 FNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR---G--TP-VAIKR 187 (394)
Q Consensus 114 ~~~~~~L~~~ga~~~~~~~s~~~p~~~~~~~~~~~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~---g--~~-~avK~ 187 (394)
.+++.+.....+.+...+.....|. ....|++.-....+. +.||+|+||.||+|..+ + .. ||||.
T Consensus 123 ~~li~~~~~~~~~~~~~~~~L~~PI-------~r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~ 193 (474)
T KOG0194|consen 123 SELVNYYKFSKLEITGKNFFLKRPI-------PRQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKT 193 (474)
T ss_pred HHHHHHHHhcccceeccceeecccc-------cccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEe
Confidence 3556666655555554433222222 245688887766554 89999999999999863 2 13 89998
Q ss_pred eccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHH
Q 016152 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIAR 266 (394)
Q Consensus 188 l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~ 266 (394)
...........+.++.+|++++++++|||||+++|+.....++++|||+|.||+|.+++++.+ .++..+...++.+.+.
T Consensus 194 ~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~ 273 (474)
T KOG0194|consen 194 TKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAAR 273 (474)
T ss_pred ecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHh
Confidence 765444567778999999999999999999999999999999999999999999999999877 4999999999999999
Q ss_pred HHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccccc-CCccCccccCccccCCCCCCCcch
Q 016152 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT-GETGSYRYMAPEVFKHRKYDKKVD 345 (394)
Q Consensus 267 ~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~D 345 (394)
||+|||+++ +|||||..+|+|+ ..++.+||+|||+++....- .... ...-+..|+|||.+....|+.++|
T Consensus 274 Gl~YLh~k~--~IHRDIAARNcL~--~~~~~vKISDFGLs~~~~~~-----~~~~~~~klPirWLAPEtl~~~~~s~kTD 344 (474)
T KOG0194|consen 274 GLEYLHSKN--CIHRDIAARNCLY--SKKGVVKISDFGLSRAGSQY-----VMKKFLKKLPIRWLAPETLNTGIFSFKTD 344 (474)
T ss_pred HHHHHHHCC--CcchhHhHHHhee--cCCCeEEeCccccccCCcce-----eeccccccCcceecChhhhccCccccccc
Confidence 999999988 9999999999999 77778999999998754311 1111 123578999999999999999999
Q ss_pred HHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCCcc
Q 016152 346 VFSFAMILYEMLE-GEPPLANYEPYEAAKYV-AEGHRPFFRAKGFTPE 391 (394)
Q Consensus 346 vwslGv~l~el~~-g~~Pf~~~~~~~~~~~i-~~g~~p~~~~~~~~~~ 391 (394)
||||||++||+++ |..||.+....++..+| ..|.+..++.. -|++
T Consensus 345 V~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~-~p~~ 391 (474)
T KOG0194|consen 345 VWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSK-TPKE 391 (474)
T ss_pred hhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCC-CHHH
Confidence 9999999999999 99999999999999999 56776666653 3444
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=294.64 Aligned_cols=228 Identities=29% Similarity=0.494 Sum_probs=195.6
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|++-++||+|+|+.|+++.+ .|+.+++|++........ ..+++.+|+.+-+.++||||+++++.+......|+|+|
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 688889999999999998876 488899998755433322 34778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-CCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
+|+|++|..=|-.+-.+++..+..+++||+++|.|+|.++ |||||+||+|+++.. +...-+||+|||+|..+..+.
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~- 167 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE- 167 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCcc-
Confidence 9999999766655566899999999999999999999988 999999999999954 334469999999999887322
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~~ 392 (394)
...+..|||.|||||+++..+|+..+|||+.||+||-|+.|.+||.+.+...++++|.+|....... +.++|+-
T Consensus 168 ----~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 168 ----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred ----ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 4567899999999999999999999999999999999999999999999999999999987765542 3455554
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
|
T Consensus 244 k 244 (355)
T KOG0033|consen 244 K 244 (355)
T ss_pred H
Confidence 4
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.99 Aligned_cols=221 Identities=26% Similarity=0.462 Sum_probs=187.2
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 240 (394)
+.||+|+||.||++... |..+|+|.+.............+.+|+.+++.++||||+++++++...+.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999864 7889999986543333344566778999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccc
Q 016152 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320 (394)
Q Consensus 241 sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~ 320 (394)
+|..++...+.+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~~~----~~ 152 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGA----TM 152 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEE--cCCCCEEecccHHhccccCCCC----cc
Confidence 99999988888999999999999999999999988 9999999999999 8888999999999875322211 22
Q ss_pred cCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..+.+..+... ++ ..++++++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~-~p-~~~~~~~~ 223 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-FP-RTLSPEAK 223 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CC-CCCCHHHH
Confidence 3467999999999999999999999999999999999999999998888888887765433 22 23565554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=311.38 Aligned_cols=219 Identities=30% Similarity=0.488 Sum_probs=187.5
Q ss_pred eecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCCCH
Q 016152 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (394)
Q Consensus 165 iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~sL 242 (394)
||+|+||.||++... +..+|+|.+.............+..|+.++++++||||+++++++.+.+.+++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 689999999999875 678999988654333334456778899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccC
Q 016152 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~ 322 (394)
.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~----~~~~ 152 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDD----KTNT 152 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEE--CCCCcEEEEECcccccCccCCC----cccc
Confidence 999988888999999999999999999999988 9999999999999 8888999999999875432211 1234
Q ss_pred CccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 323 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
..||+.|+|||++.+..++.++|||||||++|||++|++||...+..+..+.+..+..+ ++ ..++++++
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~ 221 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR-FP-DGFDRDAK 221 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCC-CC-CcCCHHHH
Confidence 67999999999999999999999999999999999999999998888888888876433 33 23566554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=322.06 Aligned_cols=216 Identities=26% Similarity=0.430 Sum_probs=183.9
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++... ++.+|||++.+...........+.+|+.+++.++||||+++++.+.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6889999999999999999874 77899998865332222334667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++|+|.+++.+.+.+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++..+......
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill--~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEE--CCCCCEEEEeCCCCccccccccc
Confidence 9999999999998888999999999999999999999988 9999999999999 88889999999997533210000
Q ss_pred ---------------------------------------ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHH
Q 016152 316 ---------------------------------------DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356 (394)
Q Consensus 316 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el 356 (394)
........+||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00001235799999999999999999999999999999999
Q ss_pred HcCCCCCCCCCHHHHHHHHHc
Q 016152 357 LEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 357 ~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
++|+.||...+..+....+..
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~ 258 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVIN 258 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhc
Confidence 999999999888877777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=319.87 Aligned_cols=217 Identities=31% Similarity=0.518 Sum_probs=187.1
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++... ++.+|+|++.............+..|+.++..++||+|+++++.+.+.+.+++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5788899999999999999874 77899998865332233345678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++|+|.+++.+.+.+++..++.++.|++.||+|||++| |+||||||+|||+ +.++.++|+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli--~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEE--CCCCCEEEeeccCCccccccccc
Confidence 9999999999998888999999999999999999999988 9999999999999 88899999999998755321100
Q ss_pred c-------------------------------cccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 016152 316 D-------------------------------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364 (394)
Q Consensus 316 ~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~ 364 (394)
. .......+||+.|+|||++.+..++.++|||||||++|||++|++||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0 000123579999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHcC
Q 016152 365 NYEPYEAAKYVAEG 378 (394)
Q Consensus 365 ~~~~~~~~~~i~~g 378 (394)
..++.+....|...
T Consensus 238 ~~~~~~~~~~i~~~ 251 (360)
T cd05627 238 SETPQETYRKVMNW 251 (360)
T ss_pred CCCHHHHHHHHHcC
Confidence 99988888888753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=312.41 Aligned_cols=221 Identities=25% Similarity=0.458 Sum_probs=187.7
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 240 (394)
+.||+|+||.||++... ++.+|+|++.+...........+.+|+.+++.++||||+++++++...+.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999864 7889999987654333444567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccc
Q 016152 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320 (394)
Q Consensus 241 sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~ 320 (394)
+|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll--~~~~~~kL~DfG~~~~~~~~~~----~~ 152 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLML--DKDGHIKITDFGLCKEGITDAA----TM 152 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEE--CCCCcEEEecCcCCccCCCccc----cc
Confidence 99999988888999999999999999999999988 9999999999999 8888999999999875332111 22
Q ss_pred cCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+..+.+..+..+. + ..++++++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~-p-~~~~~~~~ 223 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF-P-RTLSADAK 223 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccC-C-CCCCHHHH
Confidence 34579999999999999999999999999999999999999999888888888887654432 2 23555443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=314.27 Aligned_cols=209 Identities=34% Similarity=0.531 Sum_probs=186.7
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|... ++.+|+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 6888999999999999999874 78899999865433333345678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLI--DASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--CCCCCEEEEeCcCCccccc----
Confidence 9999999999998888999999999999999999999988 9999999999999 8888999999999976543
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
......||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+....+..
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 212 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh
Confidence 12346799999999999999999999999999999999999999999988888877764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=311.47 Aligned_cols=219 Identities=33% Similarity=0.543 Sum_probs=197.1
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~l 232 (394)
...|++.+.||+|.||.||++..+ |+.+|+|.+.+.............+|+.+|+++. ||||+.++++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 346888999999999999999874 7889999998876655545578899999999999 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC--CCcEEEeecCCccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS--ADHLKVGDFGLSKLIK 310 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~--~~~~kl~DFg~a~~~~ 310 (394)
|||++.||.|.+.+... .+++..+..+++|++.++.|||+.| |+||||||+|+|+.... ++.+|++|||++....
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999999999877 4999999999999999999999988 99999999999996543 3579999999999877
Q ss_pred cccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~ 382 (394)
.+. .....+||+.|+|||++....|+..+||||+||++|.|++|.+||.+.+..+....|..|...+
T Consensus 191 ~~~-----~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f 257 (382)
T KOG0032|consen 191 PGE-----RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDF 257 (382)
T ss_pred CCc-----eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCC
Confidence 522 3566899999999999999999999999999999999999999999999999999999987743
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=307.12 Aligned_cols=233 Identities=27% Similarity=0.454 Sum_probs=187.4
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCC-----------cHHHHHHHHHHHHHHHhCCCCceeeEEeE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-----------DRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 223 (394)
..|++.+.||+|.||.|-+|+.. ++.||||++.+.... .....++..+|+.+|+++.|||||+++.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 47999999999999999999874 788999998654211 11123578899999999999999999998
Q ss_pred EEeC--CeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEe
Q 016152 224 VTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (394)
Q Consensus 224 ~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~ 301 (394)
..+. +.+|+|+|||..|.+...-.....+++.+++.++++++.||+|||.+| ||||||||+|+|+ +.+|+|||+
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl--~~~g~VKIs 252 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLL--SSDGTVKIS 252 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEE--cCCCcEEee
Confidence 8664 579999999998887654333333999999999999999999999998 9999999999999 888999999
Q ss_pred ecCCcccccccccc-ccccccCCccCccccCccccCCC---CC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 302 DFGLSKLIKVQNSH-DVYKMTGETGSYRYMAPEVFKHR---KY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 302 DFg~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~-~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
|||.+.....+... ........+|||.|+|||.+.++ .+ +.+.||||+||+||.|+.|+.||-+....+++.+|+
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 99998866433211 11123447899999999998763 23 589999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCcccc
Q 016152 377 EGHRPFFRAKGFTPELR 393 (394)
Q Consensus 377 ~g~~p~~~~~~~~~~~~ 393 (394)
...--+...+.+.++++
T Consensus 333 n~pL~fP~~pe~~e~~k 349 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLK 349 (576)
T ss_pred cCcccCCCcccccHHHH
Confidence 75433333333455554
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=309.38 Aligned_cols=225 Identities=31% Similarity=0.490 Sum_probs=189.1
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCC-ceeeEEeEEEeCCeeEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP-NIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~-~Iv~~~~~~~~~~~~~lv~ 234 (394)
+|++.+.||+|+||.||+|... ++.+|||++.+.........+.+..|..+++.++|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999875 568999988654332333446677899999999765 6888999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill--~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVML--DAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--cCCCCEEEeecCcceecCCCCC
Confidence 99999999999988888999999999999999999999988 9999999999999 7888999999999864322111
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....|.++..+ ++ ..+++++
T Consensus 157 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~-~~-~~~~~~~ 228 (324)
T cd05587 157 ----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS-YP-KSLSKEA 228 (324)
T ss_pred ----ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CC-CCCCHHH
Confidence 123457999999999999999999999999999999999999999999988888888876543 22 2355544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=309.40 Aligned_cols=225 Identities=31% Similarity=0.484 Sum_probs=189.2
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
+|.+.+.||+|+||.||++... ++.+|+|.+.+..............|..++..+ +|++|+++++++.+.+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999875 568999988754333333345566778888777 4899999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++|+|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill--~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEE--CCCCcEEEccCCCceecCCCCC
Confidence 99999999999988888999999999999999999999988 9999999999999 8889999999999875432211
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++.+.|.++..+. + ..+++++
T Consensus 157 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-p-~~~s~~~ 228 (323)
T cd05616 157 ----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-P-KSMSKEA 228 (323)
T ss_pred ----ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-C-CcCCHHH
Confidence 2234679999999999999999999999999999999999999999999989988888765432 2 2355544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=302.37 Aligned_cols=230 Identities=21% Similarity=0.336 Sum_probs=193.0
Q ss_pred cCCCCcCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe----C
Q 016152 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----R 227 (394)
Q Consensus 152 i~~~~~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~ 227 (394)
++....+......||+|+++.||+|.++|+.||||.+...........+.+.+|+.++++++||||+++++++.+ .
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 333434444456899999999999999999999999876555455556778899999999999999999999876 3
Q ss_pred CeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCCEEEeeCCCCcEEEeecCCc
Q 016152 228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a 306 (394)
..+++||||+++|+|.+++.+++.+++.....++.|++.||.|||+. + ++||||||+||++ +.++.+||+|||++
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill--~~~~~~kl~dfg~~ 170 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLV--TENYKLKIICHGLE 170 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEE--CCCCcEEEcccchH
Confidence 46899999999999999999888899999999999999999999985 6 8899999999999 88899999999998
Q ss_pred cccccccccccccccCCccCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCCCCC
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE-GHRPFF 383 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~-g~~p~~ 383 (394)
..+.... ....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..++...+.. +.++.+
T Consensus 171 ~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 243 (283)
T PHA02988 171 KILSSPP-------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL 243 (283)
T ss_pred hhhcccc-------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 7654321 13468899999999976 6899999999999999999999999999998888888754 444444
Q ss_pred CCCCCCcccc
Q 016152 384 RAKGFTPELR 393 (394)
Q Consensus 384 ~~~~~~~~~~ 393 (394)
+ ..+|++++
T Consensus 244 ~-~~~~~~l~ 252 (283)
T PHA02988 244 P-LDCPLEIK 252 (283)
T ss_pred C-CcCcHHHH
Confidence 4 23677665
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=311.88 Aligned_cols=208 Identities=27% Similarity=0.446 Sum_probs=181.6
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCC-eeEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERK-PLML 232 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~-~~~l 232 (394)
.+|.+.+.||.|.||.||+|.. .|..||||.+.+.... .+.. .-.+|+..|+++. ||||+++.+++.+.+ .+++
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4799999999999999999986 4888999998765543 3222 2346999999999 999999999998888 8999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
|||||+. +|.++++.+ ..+++..++.|+.||++||+|+|..| +.|||+||+|||+ ..+..+||+|||+|+....
T Consensus 88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi--~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILI--SGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEe--cccceeEeccccccccccc
Confidence 9999976 999999875 46999999999999999999999988 9999999999999 6677899999999998765
Q ss_pred ccccccccccCCccCccccCccccC-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
.. +++..+.|.+|.|||++. .+.|+.+.||||+||+++|+.+-++.|.+.+..+.+-+|-
T Consensus 163 kp-----PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc 223 (538)
T KOG0661|consen 163 KP-----PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKIC 223 (538)
T ss_pred CC-----CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHH
Confidence 43 467788999999999975 5678999999999999999999999999988777776664
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=317.52 Aligned_cols=235 Identities=32% Similarity=0.545 Sum_probs=197.3
Q ss_pred CCcccCCCCcCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC
Q 016152 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (394)
Q Consensus 148 ~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 227 (394)
..|+|.+. ...++..||+|.||+||+|.|.|. ||||++....... ...+.|++|+.++++-+|.||+-+.|++..+
T Consensus 385 ~~WeIp~~--ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPE--EVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHH--Hhhccceeccccccceeecccccc-eEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 46777665 346788999999999999999876 9999887665544 4779999999999999999999999999887
Q ss_pred CeeEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCc
Q 016152 228 KPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a 306 (394)
.. .+|+.+|+|-+|..+++- +..+...+.+.|++|+++|+.|||.++ |||||||..||++ .+++.|||+|||++
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl--~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFL--HEDLKVKIGDFGLA 535 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEE--ccCCcEEEecccce
Confidence 76 999999999999999974 456999999999999999999999998 9999999999999 77789999999998
Q ss_pred cccccccccccccccCCccCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---CC
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG---HR 380 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g---~~ 380 (394)
..-..=... .......|..-|||||+++. .+|++++||||||+|+|||+||..||...+.++++-++-+| .+
T Consensus 536 tvk~~w~g~--~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd 613 (678)
T KOG0193|consen 536 TVKTRWSGE--QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD 613 (678)
T ss_pred eeeeeeccc--cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc
Confidence 754322111 12344568889999999864 47999999999999999999999999988888888888888 44
Q ss_pred CCCCCCCCCcccc
Q 016152 381 PFFRAKGFTPELR 393 (394)
Q Consensus 381 p~~~~~~~~~~~~ 393 (394)
+......++++++
T Consensus 614 ~s~~~s~~pk~mk 626 (678)
T KOG0193|consen 614 LSKIRSNCPKAMK 626 (678)
T ss_pred chhhhccCHHHHH
Confidence 4444456666655
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=314.91 Aligned_cols=231 Identities=25% Similarity=0.422 Sum_probs=190.9
Q ss_pred CCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
...+|++.+.||+|+||.||++... ++.+|+|++.+...........+.+|+.+++.++||||+++++.+.++..+++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3458999999999999999999875 67899998854332223334567789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++..+...
T Consensus 121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll--~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEE--CCCCCEEEEeCCceeEcCcC
Confidence 99999999999998754 5899999999999999999999988 9999999999999 88899999999999866432
Q ss_pred cccccccccCCccCccccCccccCCC----CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCC-C
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHR----KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-PFFRA-K 386 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~-p~~~~-~ 386 (394)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|++||...+..+....|..... ..++. .
T Consensus 196 ~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (371)
T cd05622 196 GM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272 (371)
T ss_pred Cc---ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcC
Confidence 21 122356799999999998654 378999999999999999999999999998888888876432 22332 3
Q ss_pred CCCcccc
Q 016152 387 GFTPELR 393 (394)
Q Consensus 387 ~~~~~~~ 393 (394)
.++++++
T Consensus 273 ~~s~~~~ 279 (371)
T cd05622 273 DISKEAK 279 (371)
T ss_pred CCCHHHH
Confidence 4666554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=316.34 Aligned_cols=232 Identities=30% Similarity=0.483 Sum_probs=194.5
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|... ++.+|+|++.............+..|+.+++.++||||+++++++.+++.+++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 6888999999999999999986 88999999865433232344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc-
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS- 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~- 314 (394)
|+.+++|.+++.+.+.+++..++.++.|++.||+|||++| |+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILI--DADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEeecCCCCccCcccCcc
Confidence 9999999999998888999999999999999999999988 9999999999999 8889999999999986654320
Q ss_pred ------------------------cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH
Q 016152 315 ------------------------HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370 (394)
Q Consensus 315 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~ 370 (394)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 00011234569999999999999999999999999999999999999999998888
Q ss_pred HHHHHHc--CCCCCCCCCCCCcccc
Q 016152 371 AAKYVAE--GHRPFFRAKGFTPELR 393 (394)
Q Consensus 371 ~~~~i~~--g~~p~~~~~~~~~~~~ 393 (394)
....+.. ..........+|++++
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~ 262 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAI 262 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHH
Confidence 8888775 2222222223566554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=315.60 Aligned_cols=215 Identities=26% Similarity=0.438 Sum_probs=184.2
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||++... ++.+|+|++.+...........+.+|+.+++.++||||+++++++.++..+++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999875 6789999885433222333456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++........
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl--~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLL--DKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEE--CCCCCEEEEecccceecccCCc
Confidence 999999999998654 5899999999999999999999988 9999999999999 8889999999999986643221
Q ss_pred cccccccCCccCccccCccccCCC----CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHR----KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 379 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~ 379 (394)
.......||+.|+|||++.+. .++.++|+|||||++|||++|++||...+..+....|....
T Consensus 198 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~ 263 (370)
T cd05621 198 ---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263 (370)
T ss_pred ---eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 122356799999999998754 37899999999999999999999999998888888887543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=291.40 Aligned_cols=215 Identities=28% Similarity=0.449 Sum_probs=184.0
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--CeeEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLML 232 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~l 232 (394)
..|+.++.|++|.||.||+|.++ ++-||+|.+.......-..+. ..+|+.+|.+++|||||.+-.+.... +.+|+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIt-sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPIT-SLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcch-hHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 37999999999999999999875 678999998765533322222 35799999999999999999887543 57999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
|||||++ +|..++..- .++...++..++.|+++|++|||.+. |+||||||+|+|+ ...|.+||+|||+|+.+.+
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm--~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLL--SHKGILKIADFGLAREYGS 229 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheee--ccCCcEEecccchhhhhcC
Confidence 9999988 999999864 48999999999999999999999977 9999999999999 8899999999999998865
Q ss_pred ccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--cCCCC
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA--EGHRP 381 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~--~g~~p 381 (394)
+- ...+..+-|.+|.|||.+.+ ..|+...|+||+||++.||+++++.|.+.+....+.+|- -|.+.
T Consensus 230 p~----k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPt 298 (419)
T KOG0663|consen 230 PL----KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPS 298 (419)
T ss_pred Cc----ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCc
Confidence 42 24566788999999999886 479999999999999999999999999998888888775 35444
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=310.55 Aligned_cols=221 Identities=26% Similarity=0.458 Sum_probs=186.8
Q ss_pred ceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCC
Q 016152 163 AIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 240 (394)
+.||+|+||.||++.. .+..+|+|++.+...........+..|+.+++.++||||+++++++...+.+++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 47789999986544333344566778999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 241 sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
+|.+++...+.+++..+..++.||+.||.|||+ ++ |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll--~~~~~~kL~Dfg~~~~~~~~~~----~ 152 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDGA----T 152 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEE--CCCCCEEEecCCCCeecCCCCc----c
Confidence 999999888889999999999999999999997 67 9999999999999 8888999999999875432211 1
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..+.+..+... ++ ..++++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~~~~~~ 224 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-FP-RTLSPEAK 224 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC-CC-CCCCHHHH
Confidence 23457999999999999999999999999999999999999999998888888887765433 22 23565554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=307.65 Aligned_cols=211 Identities=31% Similarity=0.512 Sum_probs=181.9
Q ss_pred ceeecCCceEEEEEEE-----CCccEEEEEeccCCC-CcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 163 AIIGKGSFGEILKAYW-----RGTPVAIKRILPSLS-DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~-----~g~~~avK~l~~~~~-~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
+.||+|+||.||++.. .++.+|+|.+..... ........+..|+.+++.++||||+++++.+..++.+++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999875 367899998864321 1122235577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccc
Q 016152 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316 (394)
Q Consensus 237 ~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~ 316 (394)
+.+++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~-- 155 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILL--DAQGHVKLTDFGLCKESIHEGT-- 155 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCCEEEeeCcCCeecccCCC--
Confidence 999999999998888999999999999999999999988 9999999999999 8889999999999875432221
Q ss_pred cccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 016152 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 317 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
......||+.|+|||++.+..++.++|||||||++|||++|++||...+..+....+..+..+
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 218 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN 218 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 123457999999999999888999999999999999999999999999988888888877543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=305.94 Aligned_cols=220 Identities=32% Similarity=0.524 Sum_probs=182.4
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHh-CCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
+.||+|+||.||+|... ++.||+|++...........+....|..++.. .+||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 66799998865432222233445556666664 4799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill--~~~~~~kL~Dfg~a~~~~~~~~----~ 152 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLL--DKDGHIKIADFGMCKENMNGEG----K 152 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEE--CCCCCEEEccCcCCeECCCCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999975432221 2
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.+..++...+... .|.++. .+++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~-~~~~~~ 223 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFPR-WISKEA 223 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCC-CCCHHH
Confidence 33467999999999999999999999999999999999999999999888888887654 344442 245544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=306.85 Aligned_cols=221 Identities=26% Similarity=0.426 Sum_probs=185.3
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
+.||+|+||.||+|..+ ++.+|+|.+.+...........+..|..+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999875 678999988654322223345667788888776 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli--~~~~~~kL~DfG~~~~~~~~~~----~ 152 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLL--DHEGHCKLADFGMCKEGIFNGK----T 152 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEE--CCCCcEEEeeCCCCeecCcCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999875432211 2
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++.+.|..+..+. + ..++++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-~-~~~~~~~~ 224 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY-P-TWLSQDAV 224 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-C-CCCCHHHH
Confidence 234579999999999999999999999999999999999999999999989999988765432 2 22455543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=311.02 Aligned_cols=210 Identities=37% Similarity=0.587 Sum_probs=181.5
Q ss_pred CCCcccCCCCcCccccceeecCCceEEEEEEECC-ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 016152 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (394)
Q Consensus 147 ~~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g-~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 225 (394)
++..++...+.+|.....||+|+||.||+|...+ ..+|||.+....... ..+|.+|+.++.+++|||+|+++|+|.
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 4445666677789999999999999999999875 889999775543321 355999999999999999999999999
Q ss_pred eCC-eeEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCC-CCeEecCCCCCCEEEeeCCCCcEEEe
Q 016152 226 ERK-PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEP-NVIIHRDLKPRNVLLVNSSADHLKVG 301 (394)
Q Consensus 226 ~~~-~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~-~~ivH~Dikp~Nilv~~~~~~~~kl~ 301 (394)
+.+ ..++|+|||..|+|.+++.... +++|....+|+.++++||+|||... ++||||||||+|||+ |.+.++||+
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL--D~~~~aKls 219 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL--DEDFNAKLS 219 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE--CCCCCEEcc
Confidence 988 5999999999999999998654 8999999999999999999999964 479999999999999 999999999
Q ss_pred ecCCcccccc-ccccccccccCC-ccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 302 DFGLSKLIKV-QNSHDVYKMTGE-TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 302 DFg~a~~~~~-~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
|||+|...+. ... .... .||.+|+|||++..+..+.++|||||||++.||+||+.|.+..
T Consensus 220 DFGLa~~~~~~~~~-----~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTS-----VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CccCcccCCccccc-----eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 9999966553 211 1112 7999999999999999999999999999999999999988753
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=307.24 Aligned_cols=211 Identities=25% Similarity=0.448 Sum_probs=182.2
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
+.||+|+||.||+|... ++.+|+|.+.+.........+.+..|..++..+ +||+|+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999875 668999988654332333345667788888865 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
++|..++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill--~~~~~~kL~Dfg~~~~~~~~~~----~ 152 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILL--DAEGHCKLADFGMCKEGILNGV----T 152 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEEeecccceecccCCc----c
Confidence 999999988888999999999999999999999988 9999999999999 8889999999999875432221 1
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..+.|..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~ 214 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL 214 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 23457899999999999999999999999999999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=325.72 Aligned_cols=225 Identities=34% Similarity=0.572 Sum_probs=193.7
Q ss_pred CccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
+....+.||+|+||+||+|... .+.||||.+.... +....++|++|++++..++|||||+++|++..++++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 3455678999999999999864 2459999875433 344568999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC
Q 016152 231 MLITEYLRGGDLHKYLKEK--------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~--------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~ 296 (394)
++|+|||+.|+|..|+... ++++..+.+.|+.||+.||+||-+.. +|||||..+|+|| +++-
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLV--ge~l 640 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLV--GENL 640 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhcee--ccce
Confidence 9999999999999999742 23888999999999999999999987 9999999999999 8888
Q ss_pred cEEEeecCCcccccccccccccccc-CCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 016152 297 HLKVGDFGLSKLIKVQNSHDVYKMT-GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 374 (394)
Q Consensus 297 ~~kl~DFg~a~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~ 374 (394)
.|||+||||++.....+ .+... ...-+++||+||.|..+.||.+|||||+||+|||+++ |+.||.+.+..|+++.
T Consensus 641 ~VKIsDfGLsRdiYssD---YYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSD---YYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred EEEecccccchhhhhhh---hhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 99999999998776443 33333 2345789999999999999999999999999999998 9999999999999999
Q ss_pred HHcCCCCCCCCCCCCccc
Q 016152 375 VAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 375 i~~g~~p~~~~~~~~~~~ 392 (394)
|.+|.-=.-+ +++|.++
T Consensus 718 i~~g~lL~~P-e~CP~~v 734 (774)
T KOG1026|consen 718 IRAGQLLSCP-ENCPTEV 734 (774)
T ss_pred HHcCCcccCC-CCCCHHH
Confidence 9999883333 5678765
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.75 Aligned_cols=215 Identities=31% Similarity=0.496 Sum_probs=184.2
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
+|+..+.||+|+||.||+|... |+.||+|++.+.........+.+..|..+++.+. |++|+++++++.+.+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999874 7789999886543222333456777888888886 577888999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++++|.+++...+.+++.++..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++........
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill--~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVML--DSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEEeccccccccCCCCc
Confidence 99999999999988888999999999999999999999988 9999999999999 8888999999999875432211
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
......||+.|+|||++.+..++.++|+|||||++|||++|++||...+..+..+.|..+..
T Consensus 157 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 218 (323)
T cd05615 157 ----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV 218 (323)
T ss_pred ----cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 22345689999999999999999999999999999999999999999988888888877544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=286.17 Aligned_cols=218 Identities=27% Similarity=0.492 Sum_probs=191.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccC-----CCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPS-----LSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKP 229 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~-----~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~ 229 (394)
.|.--++||.|..+.|-++.++ |+.+|+|++... .......++.-.+|+.+|+++ .||+|+++.++++.+..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 4556678999999999887764 778999987432 112233445667899999998 59999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
+++|+|.|+.|.|+|++++.-.++++..+++++|++.|++|||.++ ||||||||+|||+ +.+.++||+|||+++.+
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILl--ddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILL--DDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheee--ccccceEEeccceeecc
Confidence 9999999999999999999989999999999999999999999988 9999999999999 88999999999999998
Q ss_pred ccccccccccccCCccCccccCccccCC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH------RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~ 383 (394)
..+. .....+|||+|+|||.+.. .+|+..+|+||+||+||.|+.|.+||.......+++.|.+|++-+-
T Consensus 174 ~~Ge-----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~ 248 (411)
T KOG0599|consen 174 EPGE-----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR 248 (411)
T ss_pred CCch-----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence 8665 3567899999999999853 4688999999999999999999999999888899999999987654
Q ss_pred C
Q 016152 384 R 384 (394)
Q Consensus 384 ~ 384 (394)
.
T Consensus 249 s 249 (411)
T KOG0599|consen 249 S 249 (411)
T ss_pred C
Confidence 3
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=299.60 Aligned_cols=201 Identities=28% Similarity=0.484 Sum_probs=173.6
Q ss_pred ccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 159 FSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
|+..+.||+|+||.||++.. .++.+|+|.+.+...........+.+|+.+++.++|++|+++++.+.+.+.+++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999986 4889999988654433333335577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 237 ~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill--~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILL--DDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEE--CCCCCEEEeeCCCcEEcCCCC-
Confidence 9999999887643 35899999999999999999999988 9999999999999 888899999999997654221
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~ 368 (394)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 157 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 157 ----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred ----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 12345789999999999999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=306.06 Aligned_cols=211 Identities=32% Similarity=0.512 Sum_probs=178.9
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHH-HHHhCCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN-LLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~-~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
+.||+|+||.||++... |+.+|+|.+.+...........+..|.. +++.++||||+++++.+.+.+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999884 7889999986543222222344444544 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
++|..++..++.+++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILL--DSQGHVVLTDFGLCKEGIEHSK----T 152 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEE--CCCCcEEEeccCCCcccccCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999875332211 2
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
.....||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+..+.+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 214 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR 214 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 23457999999999999999999999999999999999999999999888888888776433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=308.91 Aligned_cols=227 Identities=29% Similarity=0.496 Sum_probs=201.2
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe-eEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLI 233 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~-~~lv 233 (394)
.+|..++.+|+|+||.++.++++ +..+++|.+.-.......+ +...+|+.++++++|||||.+++.|..++. +++|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 37899999999999999988775 6689999987766665544 467889999999999999999999998888 9999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 234 TEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
|+||+||+|.+.+.+. .-++++.+..++.|++.|+.|||++. |+|||||+.||++ ..++.|||+|||+|+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifl--tk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFL--TKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhc--cccCceeecchhhhhhcCC
Confidence 9999999999999864 35899999999999999999999877 9999999999999 7777899999999998875
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
... ...+.+||+.||+||++.+.+|..|+|||||||++|||++=+++|...+......+|.++..+.++ .+++.+
T Consensus 159 ~~~----~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp-~~ys~e 233 (426)
T KOG0589|consen 159 EDS----LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP-SMYSSE 233 (426)
T ss_pred chh----hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-ccccHH
Confidence 542 235678999999999999999999999999999999999999999999999999999998866555 457877
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
|+
T Consensus 234 l~ 235 (426)
T KOG0589|consen 234 LR 235 (426)
T ss_pred HH
Confidence 75
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=304.94 Aligned_cols=223 Identities=28% Similarity=0.484 Sum_probs=184.2
Q ss_pred ccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHH---HhCCCCceeeEEeEEEeCCeeEEE
Q 016152 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL---VKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l---~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
|++.+.||+|+||.||++... ++.+|||++.+.........+.+..|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999874 778999998654322223345566666554 567899999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|||+++++|..++.. +.+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill--~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLL--DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEE--CCCCcEEeCcccCCccCCCCC
Confidence 999999999988864 46999999999999999999999988 9999999999999 888999999999987533221
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.+..++...+..+... ++ ..+|+++
T Consensus 156 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~-~p-~~~~~~~ 228 (324)
T cd05589 156 D----RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR-YP-RFLSREA 228 (324)
T ss_pred C----cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CC-CCCCHHH
Confidence 1 123467999999999999999999999999999999999999999999988888888776543 22 2355544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.11 Aligned_cols=230 Identities=26% Similarity=0.412 Sum_probs=189.5
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
..+|++.+.||+|+||.||++... +..+|+|.+.+...........+.+|+.+++.++||||+++++++.++..+++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 347999999999999999999874 778999988543222223335577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl--~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 122 MEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLL--DKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE--cCCCCEEEEeccceeeccCCC
Confidence 9999999999988654 5889999999999999999999988 9999999999999 888999999999997654321
Q ss_pred ccccccccCCccCccccCccccCCC----CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCC-CC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHR----KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR-PFFRA-KG 387 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~-p~~~~-~~ 387 (394)
. .......||+.|+|||++.+. .++.++|||||||++|||++|++||...+..+.+..|..+.. ..++. ..
T Consensus 197 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (370)
T cd05596 197 M---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE 273 (370)
T ss_pred c---ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCC
Confidence 1 122346799999999998653 478999999999999999999999999988888888876532 22232 23
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
+|++++
T Consensus 274 ~s~~~~ 279 (370)
T cd05596 274 ISKQAK 279 (370)
T ss_pred CCHHHH
Confidence 565554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=305.59 Aligned_cols=221 Identities=31% Similarity=0.476 Sum_probs=181.4
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHH-HHHHhCCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEV-NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~-~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
+.||+|+||.||++... ++.+|+|++.+...........+..|. .+++.++||||+++++++...+.+++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 567999988653322222223344444 456788999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
++|.+++...+.+++..+..++.||++||.|||++| |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili--~~~~~~kl~DfG~a~~~~~~~~----~ 152 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILL--DSQGHIVLTDFGLCKENIEHNG----T 152 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--CCCCCEEEccCCCCcccccCCC----C
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999875432211 2
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+.++.+..+..+.. ..++++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~ 224 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK--PNITNSAR 224 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC--CCCCHHHH
Confidence 2346799999999999999999999999999999999999999999998888888876543322 23555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=302.77 Aligned_cols=221 Identities=30% Similarity=0.490 Sum_probs=182.8
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHh-CCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
+.||+|+||.||++... |..+|+|.+.+..............|..++.. .+||+|+++++++.+.+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 67899998865432212223455667777765 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
++|.+++..++.+++.++..++.|++.||+|||++| |+||||||+|||+ +.++.++|+|||++........ .
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVML--DRDGHIKIADFGMCKENVFGDN----R 152 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--CCCCCEEeCccCCCeecccCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999864322111 2
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..+.+..+. |.++. .++++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~ 224 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT-PHYPR-WITKESK 224 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCC-CCCHHHH
Confidence 234679999999999999999999999999999999999999999988888888887654 33332 2455443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=303.52 Aligned_cols=210 Identities=31% Similarity=0.494 Sum_probs=178.0
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHH-HHHHhCCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEV-NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~-~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
++||+|+||.||+|... ++.+|+|++.+...........+..|. .+++.++||||+++++.+.+.+.+++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999874 778999988654322222234444554 467889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
++|...+.....+++..+..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILL--DSQGHVVLTDFGLCKEGVEPEE----T 152 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEE--CCCCCEEEccCCCCccCCCCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8889999999999875322211 1
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
.....||+.|+|||.+.+..++.++|||||||++|||++|.+||...+..+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC
Confidence 2345789999999999988999999999999999999999999999888888888877643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=291.69 Aligned_cols=215 Identities=27% Similarity=0.436 Sum_probs=195.8
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
..+|+.+++||+|.||.|-+++.+ |+.+|+|++.+...-.......-..|-++|+..+||.+..+...|+..+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 447899999999999999988764 889999999887766666677788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|||..||.|.-.+.+...+++...+.+-..|+.||.|||+++ ||+||||.+|+|+ +.+|++||.|||+++.-....
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlL--DkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLL--DKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhhee--ccCCceEeeecccchhccccc
Confidence 999999999999988888999999999999999999999988 9999999999999 999999999999997543222
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g 378 (394)
....+++|||.|+|||++....|+..+|+|.+||+||||+||+.||.+.+...+.+.|..+
T Consensus 323 ----~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e 383 (516)
T KOG0690|consen 323 ----DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME 383 (516)
T ss_pred ----ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh
Confidence 2456899999999999999999999999999999999999999999999999999999864
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=297.36 Aligned_cols=223 Identities=28% Similarity=0.508 Sum_probs=198.7
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
..|.++.+||+|+||.||+|.++ |+-+|+|.+... ..++++..|+.++++++.|+||++||.+.....+|+||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 35889999999999999999875 889999976432 22578899999999999999999999999899999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|||..||+.++++. +.++++.++..+++..++||+|||... -||||||..|||+ +-.|..||+|||.|..+.+.-
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILL--NT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILL--NTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEE--cccchhhhhhccccchhhhhH
Confidence 99999999999985 568999999999999999999999987 8999999999999 888999999999998776443
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCC-CCCccc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK-GFTPEL 392 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~-~~~~~~ 392 (394)
. ...+..|||.|||||++..-.|+.++||||||++..||..|++||.+..++.++..|-...+|.|... .+|.+|
T Consensus 184 A----KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F 259 (502)
T KOG0574|consen 184 A----KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEF 259 (502)
T ss_pred H----hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHH
Confidence 2 34567899999999999999999999999999999999999999999999999999999999988762 344444
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=304.02 Aligned_cols=210 Identities=33% Similarity=0.520 Sum_probs=178.7
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHH-HHHhCCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN-LLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~-~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
+.||+|+||.||++... |+.+|+|++.+...........+..|.. +++.++||||+++++.+...+.+++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36899999999999874 7899999886543322233344555554 56779999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
++|..++...+.+++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll--~~~~~~kL~DfG~~~~~~~~~~----~ 152 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILL--DSQGHVVLTDFGLCKEGIAQSD----T 152 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEE--CCCCCEEEeecCCcccCCCCCC----C
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999875332211 1
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
.....||+.|+|||++.+..++.++|||||||++|||++|.+||...+..++.+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~ 213 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL 213 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 2345799999999999999999999999999999999999999999888888888877643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=304.96 Aligned_cols=214 Identities=28% Similarity=0.429 Sum_probs=183.4
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++... ++.+|+|.+.+...........+.+|..+++.++|++|+++++++.+.+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 6888999999999999999875 67899998865322223334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+.||+|.+++.+ .+.+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEE--cCCCCEEEEeccceeeccCCCc
Confidence 9999999999987 467999999999999999999999988 9999999999999 8888999999999876543221
Q ss_pred cccccccCCccCccccCccccCC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g 378 (394)
.......||+.|+|||++.+ +.++.++|+|||||++|||++|+.||...+..+....|...
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~ 223 (331)
T cd05624 158 ---VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223 (331)
T ss_pred ---eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC
Confidence 11223569999999999875 46789999999999999999999999998888888888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=300.29 Aligned_cols=209 Identities=30% Similarity=0.487 Sum_probs=177.6
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHh-CCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
+.||+|+||.||+|... ++.+|||.+................|..++.. ++||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 56899998865432212223455667777775 5899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
|+|.+++.....+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILL--DTDGHIKIADFGMCKENMLGDA----K 152 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEE--CCCCCEEEccCCcceECCCCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999875322211 1
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 379 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~ 379 (394)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..+.+..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~ 212 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN 212 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 234578999999999999999999999999999999999999999988888888877654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=303.17 Aligned_cols=213 Identities=27% Similarity=0.444 Sum_probs=182.3
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++... ++.+|+|++.+.........+.+.+|+.+++.++|++|+++++++.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 6888999999999999999874 77899999864332233344668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++++|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEE--CCCCCEEEEECCceeecCCCCC
Confidence 9999999999976 457999999999999999999999988 9999999999999 8888999999999876543221
Q ss_pred cccccccCCccCccccCccccCC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
. ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+..+....|..
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~ 222 (331)
T cd05597 158 V---QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222 (331)
T ss_pred c---cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence 1 1223468999999999863 4578899999999999999999999999888888877764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=311.27 Aligned_cols=223 Identities=33% Similarity=0.491 Sum_probs=202.9
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|.-++.||.|+||.||.|++. .+.||||.+.-......+..+++..|+.+|+++.|||++.+.++|..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 5778899999999999999874 66799999987777777777999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||-| |-.|++. .+.++.+-++..|..+.+.||.|||+.+ .||||||..|||+ ...|.|||+|||.|....
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILL--se~g~VKLaDFGSAsi~~---- 177 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILL--SEPGLVKLADFGSASIMA---- 177 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEe--cCCCeeeeccccchhhcC----
Confidence 9955 8888876 3567999999999999999999999988 9999999999999 888999999999997665
Q ss_pred cccccccCCccCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
+..+++|||.|||||++. .+.|+-++||||||++.+||..++||+-+++.+.++--|.+...|.+....+|.+
T Consensus 178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~ 253 (948)
T KOG0577|consen 178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY 253 (948)
T ss_pred ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHH
Confidence 345689999999999975 5789999999999999999999999999999999999999999999999888888
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
|+
T Consensus 254 F~ 255 (948)
T KOG0577|consen 254 FR 255 (948)
T ss_pred HH
Confidence 86
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=302.62 Aligned_cols=194 Identities=27% Similarity=0.489 Sum_probs=170.2
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
++||+|+||.||++... ++.+|+|++.+...........+..|..+++.+ +||||+++++++.+...+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999874 778999998765444444456678899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili--~~~~~~kL~Dfg~~~~~~~~~~----~ 152 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLL--DAEGHIKLTDYGMCKEGIRPGD----T 152 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--CCCCCEEECcCccccccccCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999864321111 2
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~ 364 (394)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 234679999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=303.71 Aligned_cols=215 Identities=26% Similarity=0.432 Sum_probs=183.3
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++..+ ++.+|+|++.+...........+.+|+.++..++|++|+++++.+.+...+++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 6888999999999999999875 56799998754322223334557889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+.+|+|.+++.+ .+.+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili--~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEE--CCCCCEEEeecchheecccCCc
Confidence 9999999999986 467899999999999999999999988 9999999999999 8888999999999876543221
Q ss_pred cccccccCCccCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 379 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~ 379 (394)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+.+..|....
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~ 224 (332)
T cd05623 158 ---VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224 (332)
T ss_pred ---ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Confidence 1123457999999999986 3468899999999999999999999999999889888887543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=293.21 Aligned_cols=206 Identities=29% Similarity=0.491 Sum_probs=175.5
Q ss_pred CCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC----
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK---- 228 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~---- 228 (394)
....|...+++|+|+||.||+|... ++.+|||........ -.+|+.+|+.++|||||+++.+|....
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 3446888999999999999999874 678999987665432 246999999999999999999885432
Q ss_pred -eeEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 229 -PLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 229 -~~~lv~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
.+.+|||||+. +|.++++. +..++.-.++-+.+||++||.|||+.| |+||||||.|+|+. ...|.+|||||
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD-~~tg~LKicDF 170 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVD-PDTGVLKICDF 170 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEc-CCCCeEEeccC
Confidence 35789999987 99998874 567899999999999999999999988 99999999999982 34589999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
|.|+.+..++. ..+...|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.+...+++.|.
T Consensus 171 GSAK~L~~~ep-----niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIi 239 (364)
T KOG0658|consen 171 GSAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEII 239 (364)
T ss_pred CcceeeccCCC-----ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHH
Confidence 99998875542 345678999999999876 579999999999999999999999999998887777765
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=298.03 Aligned_cols=205 Identities=28% Similarity=0.454 Sum_probs=179.0
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
..+|++.+.||+|+||.||++... +..+|+|.+.... .......+.+|+.+++.++||||+++++++..++.+++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 347999999999999999999885 6789999875432 233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|||+++++|.+++.....+++..+..++.|++.||.|||+++ +|+||||||+|||+ +.++.+||+|||++..+....
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEE--cCCCcEEEccCcccccccccc
Confidence 999999999999998888999999999999999999999852 39999999999999 788899999999987654321
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~ 371 (394)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.
T Consensus 159 ------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 210 (331)
T cd06649 159 ------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210 (331)
T ss_pred ------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2345689999999999999999999999999999999999999987665444
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=311.42 Aligned_cols=228 Identities=26% Similarity=0.392 Sum_probs=192.3
Q ss_pred CcCccccceeecCCceEEEEEEEC---CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~---g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
...|.+.+.||+|++|.||+|... +..+|+|.+... .......+.+|+.+++.++||||+++++++...+.+++
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 335889999999999999999763 456888865332 33344567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 233 ITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
||||+++|+|.+++.. ..++++.++..++.|++.||.|||+++ |+||||||+|||+ +..+.+||+|||++..
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll--~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFL--MPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEE--CCCCcEEEEeCcCcee
Confidence 9999999999988753 356899999999999999999999988 9999999999999 8888999999999987
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~ 388 (394)
+...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+..+..+.++. .+
T Consensus 219 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~ 295 (478)
T PTZ00267 219 YSDSVSL--DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPC-PV 295 (478)
T ss_pred cCCcccc--ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc-cC
Confidence 6433211 12334679999999999999999999999999999999999999999999889999988877765543 35
Q ss_pred Ccccc
Q 016152 389 TPELR 393 (394)
Q Consensus 389 ~~~~~ 393 (394)
+++++
T Consensus 296 s~~~~ 300 (478)
T PTZ00267 296 SSGMK 300 (478)
T ss_pred CHHHH
Confidence 66554
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=300.02 Aligned_cols=221 Identities=29% Similarity=0.484 Sum_probs=185.2
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
+.||+|+||.||++... ++.+|+|.+.+...........+..|..+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 678999988654332333345667888888877 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
++|.+++.+.+.+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++........ .
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLL--DSEGHIKIADFGMCKEGILGGV----T 152 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEE--CCCCcEEecccCCCeecCcCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999864322211 1
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+..+... ++ ..++++++
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~-~~-~~~~~~~~ 224 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR-YP-RWLSKEAK 224 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-CC-CcCCHHHH
Confidence 23456899999999999999999999999999999999999999998888888888765443 33 23555543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=302.13 Aligned_cols=228 Identities=29% Similarity=0.523 Sum_probs=182.0
Q ss_pred cCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeC-
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER- 227 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~- 227 (394)
.+|++.+.||+|+||.||+|.+. +..||||.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 47899999999999999999742 4579999875432 223346788999999999 899999999987654
Q ss_pred CeeEEEEeccCCCCHHHHHHhc----------------------------------------------------------
Q 016152 228 KPLMLITEYLRGGDLHKYLKEK---------------------------------------------------------- 249 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~---------------------------------------------------------- 249 (394)
..++++|||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999998742
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCcc
Q 016152 250 ----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325 (394)
Q Consensus 250 ----~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~g 325 (394)
.++++.++..++.|+++||+|||+++ |+||||||+|||+ +.++.+||+|||+++....... ........+
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~--~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~ 238 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLARDIYKDPD--YVRKGSARL 238 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEE--cCCCcEEEeecccccccccCcc--hhcccCCCC
Confidence 24778889999999999999999988 9999999999999 7788999999999986543221 111223446
Q ss_pred CccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEP-YEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 326 t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~-~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
++.|+|||++.+..++.++|||||||++|||++ |..||..... .+....+..+.++..+ ..++++++
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~ 307 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAP-ENATPEIY 307 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCC-CCCCHHHH
Confidence 788999999999999999999999999999997 9999987653 3455666666665554 34565554
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=305.52 Aligned_cols=215 Identities=27% Similarity=0.441 Sum_probs=186.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|.+.+.||+|+||.||++... ++.+|+|.+...........+.+.+|+.+++.++||+|+++++++.+...+++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 6888999999999999999874 77899999865443333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++++|.+++.+. +.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll--~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLI--DRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEE--CCCCCEEeccCCCCeECCCCCc
Confidence 99999999999876 67999999999999999999999988 9999999999999 8889999999999987643321
Q ss_pred cccccccCCccCccccCccccC------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFK------HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 379 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~ 379 (394)
. ......||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+.+..|....
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~ 225 (330)
T cd05601 158 V---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ 225 (330)
T ss_pred e---eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC
Confidence 1 123356899999999986 4567899999999999999999999999988888888887543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=289.91 Aligned_cols=212 Identities=33% Similarity=0.523 Sum_probs=182.6
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe-----CCee
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-----RKPL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-----~~~~ 230 (394)
.|...+.||+|+||.|+.|..+ |+.||||.+...... ....++..+|+.+++.++|+||+.+++.+.. -..+
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~-~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFEN-QIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhc-hHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4555789999999999999874 789999988754443 3345778889999999999999999998865 2458
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
|+|+|+| +.+|...++.++.+++..++-++.|+++||.|+|+.+ |+||||||+|+++ +.+..+||+|||+|+...
T Consensus 102 YiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~--n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLL--NADCDLKICDFGLARYLD 176 (359)
T ss_pred EEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheee--ccCCCEEeccccceeecc
Confidence 9999999 4599999999888999999999999999999999988 9999999999999 888899999999999876
Q ss_pred cccccccccccCCccCccccCccccC-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
.. . .....+..+.|.+|.|||++. ...||...||||+||++.||++|++.|.+.+....++.|.+
T Consensus 177 ~~-~-~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~ 242 (359)
T KOG0660|consen 177 KF-F-EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE 242 (359)
T ss_pred cc-C-cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence 44 1 112356788999999999875 56899999999999999999999999999887777777763
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=303.01 Aligned_cols=220 Identities=30% Similarity=0.464 Sum_probs=185.8
Q ss_pred ceeecCCceEEEEEEE-----CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEecc
Q 016152 163 AIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~-----~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 237 (394)
+.||+|+||.||++.. .|+.+|+|++...... ......+..|+.++++++||||+++++++.+++.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999998864 4678999988653322 122345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccc
Q 016152 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317 (394)
Q Consensus 238 ~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~ 317 (394)
++++|.+++.+...+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~~~~~~~--- 153 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHEK--- 153 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEE--CCCCcEEEeeccCCcccCCCCC---
Confidence 99999999988888999999999999999999999988 9999999999999 8888999999999876543211
Q ss_pred ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 318 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+.++..... ..++++++
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p--~~~~~~~~ 226 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP--QFLSPEAQ 226 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHH
Confidence 12346789999999999988899999999999999999999999999998888888877654322 22455543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=287.09 Aligned_cols=209 Identities=33% Similarity=0.537 Sum_probs=180.2
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCc-eeeEEeEEEeCC------
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERK------ 228 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~------ 228 (394)
.|..+++||+|+||.||+|+. .|+.||+|.+...... +..-....+|+.+++.++|+| |+.+++++....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 577788899999999999986 4889999998655432 111134578999999999999 999999998877
Q ss_pred eeEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecC
Q 016152 229 PLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg 304 (394)
.+++|+||++. +|..++...+ .++...++.+++||+.||.|||+.+ |+||||||.|||| ++.|.+||+|||
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi--~~~G~lKlaDFG 165 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLI--SSSGVLKLADFG 165 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEE--CCCCcEeeeccc
Confidence 78999999966 9999998654 4788899999999999999999988 9999999999999 889999999999
Q ss_pred CccccccccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
+|+.+..+. ......++|.+|.|||++.+. .|+...||||+||++.||+++++.|.+.+..+.+.+|-
T Consensus 166 lAra~~ip~----~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If 234 (323)
T KOG0594|consen 166 LARAFSIPM----RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIF 234 (323)
T ss_pred hHHHhcCCc----ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 998655332 135667899999999999876 78999999999999999999999999999888887774
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=301.38 Aligned_cols=227 Identities=26% Similarity=0.456 Sum_probs=183.4
Q ss_pred CccccceeecCCceEEEEEEE-----CCccEEEEEeccCCC-CcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCee
Q 016152 158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLS-DDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~-----~g~~~avK~l~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~ 230 (394)
+|++.+.||+|+||.||++.. .+..+|+|++.+... ......+.+..|+.+++.++ ||+|+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999875 467899998864322 12233456778999999995 89999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
++||||+.+|+|.+++..++.+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili--~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILL--DSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEE--CCCCCEEEeeCcCCcccc
Confidence 999999999999999988888999999999999999999999988 9999999999999 888899999999997654
Q ss_pred cccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCCCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANY----EPYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~----~~~~~~~~i~~g~~p~~~~ 385 (394)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||... ...++...+....++ ++
T Consensus 157 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~- 231 (332)
T cd05614 157 SEEKE---RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP-FP- 231 (332)
T ss_pred ccCCC---ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC-CC-
Confidence 32211 12245799999999999865 4789999999999999999999999642 334455555554433 32
Q ss_pred CCCCcccc
Q 016152 386 KGFTPELR 393 (394)
Q Consensus 386 ~~~~~~~~ 393 (394)
..++++++
T Consensus 232 ~~~~~~~~ 239 (332)
T cd05614 232 SFIGPEAQ 239 (332)
T ss_pred CCCCHHHH
Confidence 23555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=308.24 Aligned_cols=203 Identities=35% Similarity=0.590 Sum_probs=180.1
Q ss_pred CCCCcccCCCCcCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 016152 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (394)
Q Consensus 146 ~~~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 225 (394)
....|+|++..+ .-+.-||+|+.|.||+|...++.||||.+. +.-..++.-|++|+||||+.+.|+|.
T Consensus 115 q~e~WeiPFe~I--sELeWlGSGaQGAVF~Grl~netVAVKKV~----------elkETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 115 QEELWEIPFEEI--SELEWLGSGAQGAVFLGRLHNETVAVKKVR----------ELKETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred hhhhccCCHHHh--hhhhhhccCcccceeeeeccCceehhHHHh----------hhhhhhHHHHHhccCcceeeEeeeec
Confidence 345788876543 346679999999999999999999999652 22235788999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 226 ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 226 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
....+|||||||..|-|..+++...+++......|..+|+.|+.|||... |||||||.-|||| ..+..|||+|||-
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLI--s~~d~VKIsDFGT 258 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILI--SYDDVVKISDFGT 258 (904)
T ss_pred CCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEe--eccceEEeccccc
Confidence 99999999999999999999999999999999999999999999999987 9999999999999 7777899999999
Q ss_pred ccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 369 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~ 369 (394)
++.+.... ....++||..|||||+++..+.+.|+||||||||||||+||..||.+.+..
T Consensus 259 S~e~~~~S-----TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss 317 (904)
T KOG4721|consen 259 SKELSDKS-----TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS 317 (904)
T ss_pred hHhhhhhh-----hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh
Confidence 98766442 345689999999999999999999999999999999999999999876643
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=299.43 Aligned_cols=194 Identities=28% Similarity=0.504 Sum_probs=169.8
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
+.||+|+||.||++... ++.+|+|++.+...........+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999874 678999998765444444556677888888776 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
++|..++...+.+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++........ .
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili--~~~~~~kL~DfG~~~~~~~~~~----~ 152 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGD----T 152 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEE--CCCCCEEEeeCCccccccCCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8889999999999875332211 1
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~ 364 (394)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 234679999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=299.21 Aligned_cols=195 Identities=28% Similarity=0.481 Sum_probs=170.4
Q ss_pred ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
+.||+|+||.||++... ++.+|+|++.+.........+.+..|+.++.++ +||+|+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999874 678999998765444444556788899999888 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
++|..++...+.+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++........ .
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~----~ 152 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLL--DADGHIKLTDYGMCKEGLGPGD----T 152 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE--eCCCCEEEeccccceeccCCCC----c
Confidence 999999988888999999999999999999999988 9999999999999 8888999999999875322111 1
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN 365 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~ 365 (394)
.....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 2346799999999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=306.65 Aligned_cols=210 Identities=34% Similarity=0.490 Sum_probs=184.6
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-C-----CceeeEEeEEEeCCe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-H-----PNIVQFLGAVTERKP 229 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~Iv~~~~~~~~~~~ 229 (394)
+|.+.+.||+|.||.|-+|.+. ++.||||++.... ...++...|+.+|..++ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 7899999999999999999874 7889999875443 33455667999999886 3 489999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 230 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
+|+|+|.+.. +|.++++.+. .++...++.++.||+.+|.+||+.+ |||+||||+|||+.+.....|||+|||.|+
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999999855 9999999764 5899999999999999999999988 999999999999987777799999999998
Q ss_pred ccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--cCCCC
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA--EGHRP 381 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~--~g~~p 381 (394)
..... ....+-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+.+..+.+.+|. .|.+|
T Consensus 340 ~~~q~-------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 340 FESQR-------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred ccCCc-------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 75432 125677889999999999999999999999999999999999999999999999987 47666
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=297.11 Aligned_cols=215 Identities=30% Similarity=0.507 Sum_probs=191.9
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
-|...+.||+|.|+.|-+|++ +|..||||++.+.+.+.. ....+.+|++.|+.++|||||++|.+......+|+|+|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 488899999999999998864 799999999987665543 34667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
.-++|+|++||-++ ..+++..+.+++.||+.|+.|||+.. +|||||||+|+.+. ..-|-|||.|||++-.+.++.
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFF-EKlGlVKLTDFGFSNkf~PG~- 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFF-EKLGLVKLTDFGFSNKFQPGK- 173 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEe-eecCceEeeeccccccCCCcc-
Confidence 99999999998764 45999999999999999999999987 99999999998774 566899999999998776543
Q ss_pred cccccccCCccCccccCccccCCCCCC-CcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
...+.+|+..|.|||++.+..|+ +++|||||||+||-|+||++||...++.|.+..|...++.
T Consensus 174 ----kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt 237 (864)
T KOG4717|consen 174 ----KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT 237 (864)
T ss_pred ----hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc
Confidence 46779999999999999999996 7999999999999999999999999999999999876654
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=309.91 Aligned_cols=234 Identities=26% Similarity=0.414 Sum_probs=194.7
Q ss_pred cCCCCcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC-
Q 016152 152 IDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK- 228 (394)
Q Consensus 152 i~~~~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~- 228 (394)
+.....+|.+.+.||+|+||.||++.. .|+.+|||.+...... ......+.+|+.++..++|++|++++..+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 344455899999999999999999986 4889999988654433 334466788999999999999999988765332
Q ss_pred -------eeEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCc
Q 016152 229 -------PLMLITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297 (394)
Q Consensus 229 -------~~~lv~e~~~~~sL~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~ 297 (394)
.+++||||+.+|+|.+++..+ ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl--~~~~~ 181 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILL--CSNGL 181 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--eCCCC
Confidence 368999999999999998752 46899999999999999999999988 9999999999999 78889
Q ss_pred EEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 298 ~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+..
T Consensus 182 vkL~DFGls~~~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~ 259 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDD--VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA 259 (496)
T ss_pred EEEEecccCeecccccccc--ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 9999999998664322111 12346799999999999999999999999999999999999999999998899988888
Q ss_pred CCCCCCCCCCCCcccc
Q 016152 378 GHRPFFRAKGFTPELR 393 (394)
Q Consensus 378 g~~p~~~~~~~~~~~~ 393 (394)
+.++.++. .++++++
T Consensus 260 ~~~~~~~~-~~~~~l~ 274 (496)
T PTZ00283 260 GRYDPLPP-SISPEMQ 274 (496)
T ss_pred CCCCCCCC-CCCHHHH
Confidence 77765553 3666654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=287.06 Aligned_cols=227 Identities=26% Similarity=0.450 Sum_probs=189.3
Q ss_pred cCccccceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 231 (394)
.+|++.+.||+|+||.||+|.+. +..+|+|.+..... ......+.+|+.++++++||||+++++++...+.++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 46888999999999999999753 45799998765432 333467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 232 LITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
+||||+.+++|.+++... +.+++.+++.++.|++.||+|||+++ ++||||||+||++ +.++.++++|||.+....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili--~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLV--NSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEE--cCCCcEEECCCccccccc
Confidence 999999999999999874 57899999999999999999999988 9999999999999 788899999999876543
Q ss_pred cccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~ 389 (394)
... ........++..|+|||.+.+..++.++|||||||++||+++ |..||...+..+..+.+.++.++..+ ..+|
T Consensus 159 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 234 (266)
T cd05064 159 SEA---IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP-RNCP 234 (266)
T ss_pred ccc---hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC-CCCC
Confidence 221 111122345678999999999999999999999999999875 99999999988888988887665554 3466
Q ss_pred cccc
Q 016152 390 PELR 393 (394)
Q Consensus 390 ~~~~ 393 (394)
++++
T Consensus 235 ~~~~ 238 (266)
T cd05064 235 NLLH 238 (266)
T ss_pred HHHH
Confidence 5553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=305.11 Aligned_cols=216 Identities=27% Similarity=0.461 Sum_probs=200.0
Q ss_pred cCccccceeecCCceEEEEEEECCcc--EEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~g~~--~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.++..+..||-|+||.|-++..+++. +|+|++.+....+....+....|-.+|...+.|.||++|..|.+++.+|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 36777889999999999998877665 8999998887777777788899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|-|-||.|+..+++++.+++.+++.++..+++|++|||++| ||+|||||+|+|+ +.+|.+||.|||+|+.+..+..
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllL--d~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLL--DNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheee--ccCCceEEeehhhHHHhccCCc
Confidence 99999999999999999999999999999999999999998 9999999999999 9999999999999998875542
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
.-+++|||.|.|||++.++..+..+|.||||+++|||++|++||.+.+++..++.|.+|-.-
T Consensus 576 -----TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~ 637 (732)
T KOG0614|consen 576 -----TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK 637 (732)
T ss_pred -----eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh
Confidence 34689999999999999999999999999999999999999999999999999999988543
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=290.83 Aligned_cols=204 Identities=30% Similarity=0.491 Sum_probs=175.4
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|++.+.||+|+||.||++... ++.+|+|.+.............+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999874 78899998865433333334556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILL--DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEE--CCCCCEEEeeCCCceecCCCC
Confidence 99999999888653 45899999999999999999999988 9999999999999 888899999999987654221
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~ 370 (394)
......|++.|+|||.+.+..++.++|+||+|+++|||++|+.||.+.+...
T Consensus 157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~ 208 (285)
T cd05605 157 -----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV 208 (285)
T ss_pred -----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh
Confidence 1234578999999999998899999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=306.27 Aligned_cols=234 Identities=30% Similarity=0.554 Sum_probs=197.4
Q ss_pred cCCCCcCccccceeecCCceEEEEEEEC--CccEEEEEecc-CCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 152 IDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILP-SLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 152 i~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~-~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
.++...-.+...+||+|+|-+||+|.+. |-.||--.+.. ........++++..|+.+|+.|+||||+++++.+.+..
T Consensus 35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred cCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence 3444443455678999999999999875 44554332211 22334555689999999999999999999999987765
Q ss_pred e--eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCc
Q 016152 229 P--LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (394)
Q Consensus 229 ~--~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a 306 (394)
. +.+|+|.+..|+|..|+++.+.++.+.+..|++||++||.|||++.++|||||||.+||+|. +..|.|||+|+|||
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin-G~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN-GNLGEVKIGDLGLA 193 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc-CCcCceeecchhHH
Confidence 5 88999999999999999999999999999999999999999999999999999999999984 67789999999999
Q ss_pred cccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCCCCCC
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~-~~~~~~~~~i~~g~~p~~~~ 385 (394)
+...... ..+.+|||.|||||++. ..|+..+||||||++|+||+|+.+||.. .++.++++++..|..|.-..
T Consensus 194 tl~r~s~------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 194 TLLRKSH------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS 266 (632)
T ss_pred HHhhccc------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh
Confidence 9876443 23468999999999997 8899999999999999999999999976 57889999999999998777
Q ss_pred CCCCcccc
Q 016152 386 KGFTPELR 393 (394)
Q Consensus 386 ~~~~~~~~ 393 (394)
+-=.||.|
T Consensus 267 kV~dPevr 274 (632)
T KOG0584|consen 267 KVKDPEVR 274 (632)
T ss_pred ccCCHHHH
Confidence 64456654
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=301.39 Aligned_cols=220 Identities=30% Similarity=0.455 Sum_probs=181.0
Q ss_pred eecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC---CCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 165 iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
||+|+||.||+|... ++.+|+|++.+..............|..++... +||+|+++++.+.+...+++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 689999999999874 789999988543322222334455566776655 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
++|.+++.+++.+++..+..++.|+++||+|||+++ |+||||||+|||+ +.++.++|+|||++........ .
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili--~~~~~~kl~Dfg~a~~~~~~~~----~ 152 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILL--DATGHIALCDFGLSKANLTDNK----T 152 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEE--CCCCCEEEecCCcCcCCCCCCC----C
Confidence 999999998888999999999999999999999988 9999999999999 8888999999999875432211 2
Q ss_pred ccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 320 MTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+..+.|..+.... +...++++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~ 226 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF-PKNVLSDEGR 226 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC-CCccCCHHHH
Confidence 2346799999999998754 58999999999999999999999999998888888888765433 3333555443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=293.49 Aligned_cols=202 Identities=27% Similarity=0.472 Sum_probs=176.6
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
..+|++.+.||+|+||.||++... +..+|+|.+.... .......+.+|+.+++.++||||+++++++.+++.+++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 347999999999999999999885 6678889775432 233446788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|||+.+++|.+++...+.+++..+..++.|++.||.|||++ + |+||||||+|||+ +.++.+||+|||++..+...
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili--~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEE--cCCCCEEEeeCCcchhhhhh
Confidence 99999999999999888899999999999999999999975 5 9999999999999 77889999999998765322
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 369 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~ 369 (394)
. .....||..|+|||.+.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 158 ~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 158 M------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred c------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 1 23356899999999999889999999999999999999999999865543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=288.93 Aligned_cols=208 Identities=30% Similarity=0.524 Sum_probs=176.9
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|... +..+|+|.+....... ....+.+|+.++++++||||+++++++......++|||
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 6899999999999999999874 6789999885433221 12456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++ +|.+++...+ .+++..+..++.|++.||+|||++| |+||||||+|||+ +.++.+||+|||++........
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~--~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLI--NEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEECcCcceeeccCCCc
Confidence 9975 9999887654 5789999999999999999999988 9999999999999 8888999999999875532221
Q ss_pred cccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+..+....+.
T Consensus 159 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~ 217 (288)
T cd07871 159 ----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217 (288)
T ss_pred ----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 1234568999999999865 568999999999999999999999999888777776664
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=286.84 Aligned_cols=227 Identities=31% Similarity=0.528 Sum_probs=192.1
Q ss_pred CccccceeecCCceEEEEEEECC-------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g-------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
+|++.+.||+|+||.||+|...+ ..+++|.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 68889999999999999998643 358999875432 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC
Q 016152 231 MLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~ 294 (394)
+++|||+++++|.+++... +.+++.++..++.|++.||.|||+++ ++||||||+||++ +.
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~--~~ 159 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV--GE 159 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEE--cC
Confidence 9999999999999999764 45788999999999999999999988 9999999999999 77
Q ss_pred CCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 016152 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 373 (394)
Q Consensus 295 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~ 373 (394)
++.++|+|||++........ ........+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+..+
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADY--YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred CCcEEECCCcceeecccccc--ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 88999999999876543221 111223456889999999988899999999999999999998 999999999999999
Q ss_pred HHHcCCCCCCCCCCCCcccc
Q 016152 374 YVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 374 ~i~~g~~p~~~~~~~~~~~~ 393 (394)
.|..+..+..+ ..+|++++
T Consensus 238 ~i~~~~~~~~~-~~~~~~~~ 256 (283)
T cd05048 238 MIRSRQLLPCP-EDCPARVY 256 (283)
T ss_pred HHHcCCcCCCc-ccCCHHHH
Confidence 99888777665 34777664
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=288.67 Aligned_cols=195 Identities=31% Similarity=0.495 Sum_probs=168.0
Q ss_pred eecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCCCH
Q 016152 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (394)
Q Consensus 165 iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~sL 242 (394)
||+|+||.||++... ++.+|+|.+...........+.+..|+.+++.++||+|+++++++.....+++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999864 778999988654333333345677899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccc
Q 016152 243 HKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (394)
Q Consensus 243 ~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~ 318 (394)
.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.++|+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~~~~~~---- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLL--DNDGNVRISDLGLAVELKDGQS---- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEeeCccceecCCCCc----
Confidence 888743 346899999999999999999999988 9999999999999 7888999999999976543321
Q ss_pred cccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
......||+.|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 1234578999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=288.83 Aligned_cols=211 Identities=27% Similarity=0.455 Sum_probs=178.9
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++.++ ++.+|+|.+...... ......+.+|+.+++.++||||+++++++..++.+++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 6888999999999999999985 678999988654332 2234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|++++.+..+......+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCcEEEeeccCcccccccccc
Confidence 9998777666555567999999999999999999999988 9999999999999 88889999999999876433211
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
......||+.|+|||++.+..++.++|+|||||++|||++|++||...+..+....+.
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~ 214 (287)
T cd07848 157 ---NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214 (287)
T ss_pred ---cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 1234568999999999998889999999999999999999999998877655544443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=299.11 Aligned_cols=236 Identities=30% Similarity=0.454 Sum_probs=185.2
Q ss_pred CCCcccCCCCcCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCcee
Q 016152 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIV 218 (394)
Q Consensus 147 ~~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv 218 (394)
...|.++. .+|++.+.||+|+||.||++... +..||+|.+..... ......+.+|+.+++.+ +|+||+
T Consensus 30 ~~~~~~~~--~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv 105 (374)
T cd05106 30 NEKWEFPR--DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIV 105 (374)
T ss_pred cccccccH--HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCcee
Confidence 34455433 37889999999999999998752 24699998865432 23346788999999999 899999
Q ss_pred eEEeEEEeCCeeEEEEeccCCCCHHHHHHhc-------------------------------------------------
Q 016152 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK------------------------------------------------- 249 (394)
Q Consensus 219 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~------------------------------------------------- 249 (394)
++++++.....+++||||+.+|+|.+++...
T Consensus 106 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (374)
T cd05106 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMR 185 (374)
T ss_pred eEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccC
Confidence 9999999999999999999999999998642
Q ss_pred ---------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 250 ---------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 250 ---------------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.++++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~--~~~~~~kL~DfGla~~ 261 (374)
T cd05106 186 PVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLL--TDGRVAKICDFGLARD 261 (374)
T ss_pred CccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEE--eCCCeEEEeeceeeee
Confidence 23678889999999999999999988 9999999999999 7788999999999876
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHH-HHHHHcCCCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEA-AKYVAEGHRPFFRAK 386 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~-~~~i~~g~~p~~~~~ 386 (394)
+...... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+. ...+..+..+..+ .
T Consensus 262 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~-~ 338 (374)
T cd05106 262 IMNDSNY--VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP-D 338 (374)
T ss_pred ccCCcce--eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC-C
Confidence 5433211 11122345678999999998999999999999999999997 9999987655443 3444455444443 2
Q ss_pred CCCcccc
Q 016152 387 GFTPELR 393 (394)
Q Consensus 387 ~~~~~~~ 393 (394)
.+|++++
T Consensus 339 ~~~~~l~ 345 (374)
T cd05106 339 FAPPEIY 345 (374)
T ss_pred CCCHHHH
Confidence 3456554
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=293.84 Aligned_cols=232 Identities=29% Similarity=0.463 Sum_probs=198.1
Q ss_pred cCCCCcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 152 IDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 152 i~~~~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
++.....|..-++||+|+||.||-+.. +|..+|.|.+.+...+...-.....+|-.+|++++.+.||.+-.+|+..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 345666789999999999999997754 688999999877665555445567789999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 230 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
+++|+..|.||+|.-+|.+.+ .+++..++.++.+|+.||++||+++ ||+||+||+|||+ |..|+++|+|.|+|.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILL--Dd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILL--DDHGHVRISDLGLAV 335 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheee--ccCCCeEeeccceEE
Confidence 999999999999998887655 6999999999999999999999998 9999999999999 999999999999999
Q ss_pred ccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCCCCC
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY----EPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~----~~~~~~~~i~~g~~p~~ 383 (394)
.++... ...+.+||.+|||||++.++.|+...|+|||||++|||+.|+.||... ...|+-+++.+. ....
T Consensus 336 ei~~g~-----~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~-~~ey 409 (591)
T KOG0986|consen 336 EIPEGK-----PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED-PEEY 409 (591)
T ss_pred ecCCCC-----ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-hhhc
Confidence 887553 345568999999999999999999999999999999999999999754 234555666553 3344
Q ss_pred CCCCCCccccC
Q 016152 384 RAKGFTPELRE 394 (394)
Q Consensus 384 ~~~~~~~~~~~ 394 (394)
+ +.||++.|+
T Consensus 410 ~-~kFS~eaks 419 (591)
T KOG0986|consen 410 S-DKFSEEAKS 419 (591)
T ss_pred c-cccCHHHHH
Confidence 4 568887653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=287.31 Aligned_cols=219 Identities=33% Similarity=0.498 Sum_probs=189.9
Q ss_pred CCcCccccceeecCCceEEEEEEECCc--cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~g~--~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~ 231 (394)
...+|..+.+||+|+||.|.+|..+|. .+|||++.+...-.....+--..|-++|.... -|.+++++.+|+.-+++|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 344788899999999999999988764 69999987654332222233456777777664 679999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
+||||+.||+|-..+++-+.+-++.+..++.+|+-||-+||++| ||+||||.+|||+ +..|++||.|||++..--.
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmL--d~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEe--ccCCceEeeeccccccccc
Confidence 99999999999999999999999999999999999999999999 9999999999999 9999999999999974332
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
. .....+++|||.|+|||++..++|+..+|+||+||+||||+.|++||++.+..|+.+.|.+....
T Consensus 503 ~----~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs 568 (683)
T KOG0696|consen 503 D----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS 568 (683)
T ss_pred C----CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc
Confidence 2 23467899999999999999999999999999999999999999999999999999999865433
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=283.87 Aligned_cols=219 Identities=29% Similarity=0.473 Sum_probs=177.4
Q ss_pred eecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCCCH
Q 016152 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (394)
Q Consensus 165 iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~sL 242 (394)
||+|+||.||++... |+.+|+|.+................|+.++++++||||+++++.+..+..+++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999999999864 789999988643332222234456799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccc
Q 016152 243 HKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320 (394)
Q Consensus 243 ~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~ 320 (394)
.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.++|+|||++....... ..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili--~~~~~~~l~Dfg~~~~~~~~~-----~~ 151 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLL--DDQGNCRLSDLGLAVELKDGK-----TI 151 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEE--cCCCCEEEeeceeeeecCCCc-----ee
Confidence 98886543 4889999999999999999999988 9999999999999 788899999999987664322 12
Q ss_pred cCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE----PYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~----~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
....|++.|+|||++.+..++.++|+|||||++|||++|+.||.... ..++...+..+..+. ....++++++
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 227 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESK 227 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHH
Confidence 23568999999999998889999999999999999999999997643 234445554444332 2345676655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=293.17 Aligned_cols=208 Identities=30% Similarity=0.495 Sum_probs=173.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC-----Cee
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KPL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~ 230 (394)
+|++.+.||+|+||.||+|... +..||||.+....... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV-SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc-hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 4788899999999999999864 7889999886433222 2235678899999999999999999987543 247
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
++||||+. ++|.+++...+.+++..+..++.|+++||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll--~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILA--NADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCcEEEccCccccccc
Confidence 99999995 699999988888999999999999999999999988 9999999999999 888999999999997654
Q ss_pred cccccccccccCCccCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~ 372 (394)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+..
T Consensus 155 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~ 217 (338)
T cd07859 155 NDTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 217 (338)
T ss_pred cccCcc-ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Confidence 322111 12234679999999999875 67899999999999999999999999877654443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=296.42 Aligned_cols=228 Identities=31% Similarity=0.484 Sum_probs=182.8
Q ss_pred cCccccceeecCCceEEEEEEE-------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCC
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW-------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERK 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~-------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~ 228 (394)
.+|++.+.||+|+||.||+|.+ .+..+|||.+..... ....+.+.+|+.+++.+ +||||+++++++.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 3788999999999999999864 244799998754332 22346688899999999 7999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhcC----------------------------------------------------------
Q 016152 229 PLMLITEYLRGGDLHKYLKEKG---------------------------------------------------------- 250 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~---------------------------------------------------------- 250 (394)
..++||||+++|+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999986421
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 251 -----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 251 -----------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill--~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILL--THGRITKICDFGLARDIRNDS 268 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEE--ECCCcEEEecCccceeccCcc
Confidence 4678889999999999999999988 9999999999999 777889999999998664332
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCCcc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEP-YEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~-~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...+. ....+.+..+.++..+. ..|++
T Consensus 269 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 345 (375)
T cd05104 269 NYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPE-CAPSE 345 (375)
T ss_pred ccc--ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCC-CCCHH
Confidence 111 1122345678999999999999999999999999999998 9999987654 45556666666555442 34555
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 346 l~ 347 (375)
T cd05104 346 MY 347 (375)
T ss_pred HH
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=258.47 Aligned_cols=224 Identities=27% Similarity=0.502 Sum_probs=189.9
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
+...+..||+|++|.|-+.++ .|+-.|+|.+..... .+..+++.+|+++..+. ..|.+|.++|...+...+|+.|
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 445577899999999876655 689999998865544 33346777888887765 5899999999999999999999
Q ss_pred eccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 235 EYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 235 e~~~~~sL~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
|.|+- ||..+-+ ..+.+++..+-+++..+++||.|||++ -.+||||+||+|||+ +..|+||+||||.+..+.
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLI--n~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILI--NYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEE--ccCCcEEEcccccceeeh
Confidence 99954 8876654 467799999999999999999999998 359999999999999 999999999999998876
Q ss_pred cccccccccccCCccCccccCccccCC----CCCCCcchHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKH----RKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGv~l~el~~g~~Pf~~~-~~~~~~~~i~~g~~p~~~~ 385 (394)
++-. .+.-.|.-.|||||.+.. ..|+-++||||||+++.||.++++||+.. ++++.++++++...|.++.
T Consensus 201 dSiA-----kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 201 DSIA-----KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred hhhH-----HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 5422 223457888999999853 47999999999999999999999999764 8999999999999999999
Q ss_pred CCCCccc
Q 016152 386 KGFTPEL 392 (394)
Q Consensus 386 ~~~~~~~ 392 (394)
+-||+||
T Consensus 276 ~~FS~e~ 282 (282)
T KOG0984|consen 276 DTFSPEF 282 (282)
T ss_pred cccCCCC
Confidence 9999986
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=285.08 Aligned_cols=223 Identities=31% Similarity=0.563 Sum_probs=192.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|++|.||++... ++.+|+|.+.............+.+|+.++++++||||+++++.+.+...+++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 5788899999999999999874 78899998865443333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+.+++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++ +.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili--~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLL--DSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEE--CCCCCEEEeeCCCccccCCC---
Confidence 9999999999998888999999999999999999999988 9999999999999 78889999999998765432
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+..+.+..+..+... .+++.++
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~ 226 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS--FFSPDAK 226 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc--cCCHHHH
Confidence 22356899999999998888899999999999999999999999988887888888766544322 2455443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=314.25 Aligned_cols=211 Identities=27% Similarity=0.446 Sum_probs=177.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|... ++.||+|.+...........+++.+|+.++++++||||+++++++.+.+..+++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 7889999999999999999874 78899999876555445556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecC
Q 016152 236 YLRGGDLHKYLKEK-----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (394)
Q Consensus 236 ~~~~~sL~~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg 304 (394)
|++|++|.+++... ..++...+..++.|+++||+|||++| |+||||||+||++ +.++.++|+|||
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILL--d~dg~vKLiDFG 158 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILL--GLFGEVVILDWG 158 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEE--cCCCCEEEEecC
Confidence 99999999988641 23566778899999999999999988 9999999999999 888899999999
Q ss_pred Ccccccccccc--------------ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH
Q 016152 305 LSKLIKVQNSH--------------DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370 (394)
Q Consensus 305 ~a~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~ 370 (394)
++......... .........||+.|+|||.+.+..++.++|||||||++|||++|++||...+..+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99866211100 0001123469999999999999999999999999999999999999998765544
Q ss_pred HH
Q 016152 371 AA 372 (394)
Q Consensus 371 ~~ 372 (394)
..
T Consensus 239 i~ 240 (932)
T PRK13184 239 IS 240 (932)
T ss_pred hh
Confidence 43
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=304.01 Aligned_cols=225 Identities=28% Similarity=0.460 Sum_probs=195.1
Q ss_pred ccccceeecCCceEEEEEEECCc--cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 159 FSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~g~--~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
|.++..||.|+||.||+|..+.. ..|.|++.. .....+.++.-|+++|..++||+||++++.|.-++.+|++.||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 55667899999999999987643 356676632 3455678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 237 ~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|.||-+..++-. ...+++.++..+++|++.||.|||+++ |||||||..|||+ ..+|.++|+|||.+......
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~--TldGdirLADFGVSAKn~~t--- 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILL--TLDGDIRLADFGVSAKNKST--- 183 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEE--EecCcEeeecccccccchhH---
Confidence 999999888765 557999999999999999999999987 9999999999999 77889999999988654432
Q ss_pred ccccccCCccCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCC
Q 016152 316 DVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFT 389 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~~ 389 (394)
.....+++|||.|||||+.. ..+|+.++||||||++|.||..+.+|....+++.++-+|.+..+|.+.. ..++
T Consensus 184 -~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws 262 (1187)
T KOG0579|consen 184 -RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWS 262 (1187)
T ss_pred -HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhh
Confidence 22456799999999999864 5689999999999999999999999999999999999999999998887 4667
Q ss_pred ccccC
Q 016152 390 PELRE 394 (394)
Q Consensus 390 ~~~~~ 394 (394)
..|+|
T Consensus 263 ~~F~D 267 (1187)
T KOG0579|consen 263 RSFSD 267 (1187)
T ss_pred hHHHH
Confidence 77764
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=298.67 Aligned_cols=214 Identities=33% Similarity=0.533 Sum_probs=193.8
Q ss_pred CcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
...|.+.+.||+|.|+.|.++.+ ++..||||.+.+...+.... +.+.+|++++..++|||||+++.+......+|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~-~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR-QKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH-HHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 33688999999999999999987 48899999888766655443 4588999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|||+.+|.+++++.+++.+.+.++..++.|+.++++|||+++ |+|||||++|||+ +.+.++||+|||++..+....
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL--~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILL--DENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhccc--ccccceeeeccccceeecccc
Confidence 999999999999999999999999999999999999999998 9999999999999 888899999999999887554
Q ss_pred ccccccccCCccCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 379 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~ 379 (394)
...+++|++.|.|||++.+..| ++++|+||+|+++|-|++|..||++.+..+...+.+.|.
T Consensus 210 -----~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk 271 (596)
T KOG0586|consen 210 -----MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK 271 (596)
T ss_pred -----cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee
Confidence 3457899999999999999887 589999999999999999999999998888887776554
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=277.82 Aligned_cols=226 Identities=30% Similarity=0.498 Sum_probs=194.4
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|++|.||++... ++.+++|.+...... ......+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 4677789999999999999874 788999987654333 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||++ +.++.++|+|||++..+....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili--~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFL--DAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEE--eCCCCEEEcccccceeccCcc
Confidence 99999999999864 56899999999999999999999988 9999999999999 778899999999988665432
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
. ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+....+.++.+|.++. .++++++
T Consensus 156 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 230 (256)
T cd08529 156 N----FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ-MYSQQLA 230 (256)
T ss_pred c----hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc-ccCHHHH
Confidence 2 1234568899999999999999999999999999999999999999988888888898888887764 4666554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=277.59 Aligned_cols=230 Identities=32% Similarity=0.570 Sum_probs=189.4
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCC--cHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~--~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
+|.+.+.||+|++|.||.+.. .++.+++|.+...... .....+.+.+|+.++++++||||+++++++.++..++++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 588899999999999999976 4789999987654322 222346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
+||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++..+....
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv--~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILR--DSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeecccceeccccc
Confidence 999999999999988888999999999999999999999988 9999999999999 788899999999987654322
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCCccc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG-HRPFFRAKGFTPEL 392 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g-~~p~~~~~~~~~~~ 392 (394)
.. ........++..|+|||.+.+..++.++||||||+++|||++|+.||...+..+....+... ..+.++ ..+++++
T Consensus 159 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 236 (263)
T cd06625 159 SS-GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP-SHVSPDA 236 (263)
T ss_pred cc-cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCC-ccCCHHH
Confidence 11 11112356788999999999988999999999999999999999999888777666555533 333333 3355554
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 237 ~ 237 (263)
T cd06625 237 R 237 (263)
T ss_pred H
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=308.77 Aligned_cols=231 Identities=33% Similarity=0.571 Sum_probs=200.6
Q ss_pred ccCCCCcCccccceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 016152 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (394)
Q Consensus 151 ~i~~~~~~~~~~~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 225 (394)
+|+++ ...+.++||.|.||.|++|..+ ...||||.++.-. ....+.+|..|+.||-+++||||+++.|+..
T Consensus 625 EId~s--~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 625 EIDPS--CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hcChh--heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 45544 3467889999999999999864 3469999885433 3445688999999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecC
Q 016152 226 ERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (394)
Q Consensus 226 ~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg 304 (394)
...++++|.|||+.|+|+.|++.+ +.++..++..+++.|+.|+.||-+++ +|||||..+|||| +.+-..|++|||
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILV--NsnLvCKVsDFG 776 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILV--NSNLVCKVSDFG 776 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheee--ccceEEEecccc
Confidence 999999999999999999999864 67999999999999999999999988 9999999999999 888899999999
Q ss_pred CccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCC
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~ 383 (394)
+++.+.+.. ...+...+..-+++|.|||.+..+.+|.++||||+||+|||.++ |..||.+++..++++.|.+|+|-..
T Consensus 777 LSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp 855 (996)
T KOG0196|consen 777 LSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP 855 (996)
T ss_pred ceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC
Confidence 999887654 33344444556789999999999999999999999999999887 9999999999999999999988665
Q ss_pred CCCCCCcc
Q 016152 384 RAKGFTPE 391 (394)
Q Consensus 384 ~~~~~~~~ 391 (394)
|-+ ||..
T Consensus 856 PmD-CP~a 862 (996)
T KOG0196|consen 856 PMD-CPAA 862 (996)
T ss_pred CCC-CcHH
Confidence 544 5543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=287.10 Aligned_cols=200 Identities=30% Similarity=0.540 Sum_probs=169.5
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|... ++.+|+|.+....... ......+|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 37899999999999999999874 7889999886443221 1245678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
||+. ++|.+++... +.+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEECCCCcceeccCCC
Confidence 9995 5888877654 56899999999999999999999988 9999999999999 888899999999987543221
Q ss_pred ccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+..
T Consensus 158 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 158 H----TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred c----cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1 2234568999999999865 468899999999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=279.24 Aligned_cols=228 Identities=27% Similarity=0.512 Sum_probs=191.7
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|.. .++.+|||.+.............+.+|+.+++.++||||+++++++.+.+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 688899999999999999986 478999998765444445555678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 236 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 236 ~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
|+++++|.+++.. ...+++.++..++.|++.||.|||+++ ++|+||||+||++ +.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~--~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFI--TATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEE--cCCCCEEECccccceeccc
Confidence 9999999988853 345899999999999999999999988 9999999999999 7788999999999887643
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCCCCCCCCCCC
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY--EPYEAAKYVAEGHRPFFRAKGFT 389 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~--~~~~~~~~i~~g~~p~~~~~~~~ 389 (394)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|..||... +..+....+..+.+|..+.+.++
T Consensus 159 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred hhH----HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 221 123456889999999998888999999999999999999999999654 44567777777666666655566
Q ss_pred cccc
Q 016152 390 PELR 393 (394)
Q Consensus 390 ~~~~ 393 (394)
.+++
T Consensus 235 ~~~~ 238 (267)
T cd08228 235 EKLR 238 (267)
T ss_pred HHHH
Confidence 5554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=284.43 Aligned_cols=211 Identities=31% Similarity=0.507 Sum_probs=175.3
Q ss_pred cCccccceeecCCceEEEEEEEC------------------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCcee
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR------------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~------------------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 218 (394)
.+|.+.+.||+|+||.||++.+. +..+|+|.+.... .......+.+|+.++.+++||||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCee
Confidence 37888899999999999999752 2369999876532 233456788999999999999999
Q ss_pred eEEeEEEeCCeeEEEEeccCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeE
Q 016152 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-------------------ALSPSTAVNFALDIARGMAYLHNEPNVII 279 (394)
Q Consensus 219 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-------------------~~~~~~~~~~~~ql~~~l~~lH~~~~~iv 279 (394)
++++++.+.+..++||||+.+++|.+++.... .+++.++..++.|++.||.|||+.+ |+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--iv 160 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FV 160 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--cc
Confidence 99999999999999999999999999986532 3677889999999999999999988 99
Q ss_pred ecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-
Q 016152 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE- 358 (394)
Q Consensus 280 H~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~- 358 (394)
||||||+|||+ +.++.+||+|||++..+...... .......++..|+|||++....++.++||||||+++|||++
T Consensus 161 H~dlkp~Nill--~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 161 HRDLATRNCLV--GENLTIKIADFGMSRNLYAGDYY--RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred ccCcchhheEE--cCCccEEECCCccceecccCcee--EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 99999999999 78889999999999765433211 11223446788999999988899999999999999999986
Q ss_pred -CCCCCCCCCHHHHHHHH
Q 016152 359 -GEPPLANYEPYEAAKYV 375 (394)
Q Consensus 359 -g~~Pf~~~~~~~~~~~i 375 (394)
+..||...+..+....+
T Consensus 237 ~~~~p~~~~~~~~~~~~~ 254 (304)
T cd05096 237 CKEQPYGELTDEQVIENA 254 (304)
T ss_pred cCCCCCCcCCHHHHHHHH
Confidence 77899888777666554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=282.23 Aligned_cols=200 Identities=31% Similarity=0.514 Sum_probs=172.8
Q ss_pred ccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
|+..+.||+|+||.||++... ++.+|+|.+.............+.+|+.++++++|++|+.+++.+.+.+.+++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999875 678999988655443333345567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 237 ~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
+.+++|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~--~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILL--DDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEE--CCCCCEEEeeccceeecCCCc-
Confidence 9999999988653 35899999999999999999999988 9999999999999 788899999999987654222
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 157 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 157 ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred ----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 1234578999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=282.08 Aligned_cols=205 Identities=29% Similarity=0.486 Sum_probs=175.2
Q ss_pred ccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
|+..+.||+|+||.||++... ++.+|+|.+.............+.+|+.+++.++|++|+++++.+..++.++++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999874 778999988654333333335567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 237 ~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
+.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili--~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILL--DDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEE--CCCCCEEEecCCcceecCCCC-
Confidence 9999999888653 36999999999999999999999988 9999999999999 778899999999987654221
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~ 372 (394)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......+..
T Consensus 157 ----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~ 210 (285)
T cd05632 157 ----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR 210 (285)
T ss_pred ----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 123456899999999999889999999999999999999999999877654433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=276.12 Aligned_cols=222 Identities=27% Similarity=0.491 Sum_probs=185.7
Q ss_pred eeecCCceEEEEEEE----CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 164 IIGKGSFGEILKAYW----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~----~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
.||+|+||.||+|.+ .+..+|+|++.... ......+.+.+|+.+++.++||||+++++++. .+..++||||+.+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999965 36789999875433 33445577889999999999999999999875 4567999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
++|.+++.....+++..+..++.|++.||+|||+++ |+||||||.||++ +.++.+||+|||++.......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill--~~~~~~kl~Dfg~~~~~~~~~~~~-~~ 154 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLL--VTQHYAKISDFGLSKALGADENYY-KA 154 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEE--cCCCeEEECCCccccccCCCCCee-ee
Confidence 999999988778999999999999999999999988 9999999999999 778899999999998664332211 11
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....++..|+|||.+....++.++|+||||+++|||++ |++||...+..++.+.+.++.++..+. .+|++++
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~-~~~~~l~ 228 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQ-RCPPEMY 228 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCC-CCCHHHH
Confidence 122344678999999988889999999999999999998 999999998889999999888777664 3677665
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=276.32 Aligned_cols=217 Identities=34% Similarity=0.643 Sum_probs=185.1
Q ss_pred CccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
+|++.+.||+|+||.||++.++ +..+|+|.+...... ...+.+|+.++++++||||+++++++.....+++||||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 5788899999999999999876 457999976533221 25678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 237 ~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
+++++|.+++.. .+.+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i--~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLV--SSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEE--cCCCeEEECCCCCccccCCCcee
Confidence 999999999875 356899999999999999999999988 9999999999999 77889999999998765432211
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~ 385 (394)
......++..|+|||.+.+..++.++|+||||+++|||++ |++||...+..+..+.+.++.++..+.
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 224 (256)
T cd05114 157 ---SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK 224 (256)
T ss_pred ---ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Confidence 1123345678999999998889999999999999999999 999999999889999999887765543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=280.49 Aligned_cols=228 Identities=30% Similarity=0.517 Sum_probs=190.5
Q ss_pred CcCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
..+|.+.+.||+|+||.||++... +..+++|.+... .....+.+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 347888999999999999999742 235788876432 2334567889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCC
Q 016152 229 PLMLITEYLRGGDLHKYLKEKG-------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 295 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~-------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~ 295 (394)
.+++||||+.+++|.+++...+ .+++.++..++.|++.+|+|||++| ++||||||+||++ +.+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili--~~~ 156 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV--GEN 156 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEE--ccC
Confidence 9999999999999999997543 3899999999999999999999988 9999999999999 888
Q ss_pred CcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 016152 296 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 374 (394)
Q Consensus 296 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~ 374 (394)
+.++|+|||++........ ........+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..+..+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred CcEEeccCCccccccCCce--eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 8999999999876543221 111223446788999999998899999999999999999998 9999999988889999
Q ss_pred HHcCCCCCCCCCCCCcccc
Q 016152 375 VAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 375 i~~g~~p~~~~~~~~~~~~ 393 (394)
+.++..+..+. .++++++
T Consensus 235 i~~~~~~~~~~-~~~~~l~ 252 (288)
T cd05093 235 ITQGRVLQRPR-TCPKEVY 252 (288)
T ss_pred HHcCCcCCCCC-CCCHHHH
Confidence 99988766553 3666654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=279.15 Aligned_cols=229 Identities=28% Similarity=0.454 Sum_probs=187.9
Q ss_pred CcCccccceeecCCceEEEEEEECC-------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~g-------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
..+|++.+.||+|+||.||+|.+.+ ..+|+|.+... ........+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3478899999999999999987643 46999987432 22233466889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcE
Q 016152 229 PLMLITEYLRGGDLHKYLKEKG----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~ 298 (394)
..++||||+.+++|.+++.+.. .++...+..++.|++.||.|||+.+ ++||||||+||++ +.++.+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~--~~~~~~ 158 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV--AEDFTV 158 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEE--cCCCCE
Confidence 9999999999999999987532 3577889999999999999999988 9999999999999 778899
Q ss_pred EEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc
Q 016152 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 299 kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~ 377 (394)
+|+|||++..+....... ......+++.|+|||.+.+..++.++|+|||||++|||++ |..||...+..+..+.+..
T Consensus 159 ~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 159 KIGDFGMTRDIYETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred EECCCCCccccCCcceee--cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999987654322110 1122345788999999998899999999999999999999 7999999988888888888
Q ss_pred CCCCCCCCCCCCcccc
Q 016152 378 GHRPFFRAKGFTPELR 393 (394)
Q Consensus 378 g~~p~~~~~~~~~~~~ 393 (394)
+..+.++. .++++++
T Consensus 237 ~~~~~~~~-~~~~~~~ 251 (277)
T cd05062 237 GGLLDKPD-NCPDMLF 251 (277)
T ss_pred CCcCCCCC-CCCHHHH
Confidence 76666553 3555554
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=288.02 Aligned_cols=223 Identities=26% Similarity=0.410 Sum_probs=178.4
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
..+|+..+.||+|+||.||++.+. ++.||||.+.... .......+.+|+.+++.++|+||+++++++...+.+++|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 346888899999999999999875 7899999885433 233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|||+++++|.+. ...++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..+....
T Consensus 151 ~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 151 LEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLI--NSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEE--cCCCCEEEcccccceeccccc
Confidence 999999998653 34567888899999999999999988 9999999999999 788899999999998664321
Q ss_pred ccccccccCCccCccccCccccCC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHcCCCCCCCC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYE---PYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~~g~~Pf~~~~---~~~~~~~i~~g~~p~~~~ 385 (394)
. ......||..|+|||.+.. ...+.++|||||||++|||++|+.||.... .......+..+..+..+.
T Consensus 223 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (353)
T PLN00034 223 D----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPA 298 (353)
T ss_pred c----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCC
Confidence 1 1234579999999998743 234578999999999999999999997432 233444454555555443
Q ss_pred CCCCcccc
Q 016152 386 KGFTPELR 393 (394)
Q Consensus 386 ~~~~~~~~ 393 (394)
.++++++
T Consensus 299 -~~~~~l~ 305 (353)
T PLN00034 299 -TASREFR 305 (353)
T ss_pred -ccCHHHH
Confidence 3566554
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=312.13 Aligned_cols=218 Identities=35% Similarity=0.641 Sum_probs=185.9
Q ss_pred CccccceeecCCceEEEEEEEC---Cc----cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR---GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~---g~----~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
..+..+.||+|+||.||.|.+. |. .||||.+.+ ..+.+...+|.+|..+|+.++|||||+++|++.+....
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4566789999999999999874 32 378887754 33456668899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 231 MLITEYLRGGDLHKYLKEK-------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
++++|||+||+|..||++. ..++..+.+.++.||++|+.||+++. +|||||..+|+|+ +....|||+||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL--~~~r~VKIaDF 846 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLL--DERRVVKIADF 846 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheee--cccCcEEEccc
Confidence 9999999999999999864 35899999999999999999999988 9999999999999 77789999999
Q ss_pred CCccccccccccccccccCC-ccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC
Q 016152 304 GLSKLIKVQNSHDVYKMTGE-TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
|+|+.+... ..+..... .-+.+|||||.+..+.+|.|+|||||||++||++| |..||.+.+..++.....+|.|-
T Consensus 847 GlArDiy~~---~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 847 GLARDIYDK---DYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL 923 (1025)
T ss_pred chhHhhhhc---hheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence 999954432 22222222 34678999999999999999999999999999999 99999999999999977766544
Q ss_pred CCC
Q 016152 382 FFR 384 (394)
Q Consensus 382 ~~~ 384 (394)
..|
T Consensus 924 ~~P 926 (1025)
T KOG1095|consen 924 DPP 926 (1025)
T ss_pred CCC
Confidence 433
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=281.95 Aligned_cols=209 Identities=30% Similarity=0.533 Sum_probs=172.5
Q ss_pred CccccceeecCCceEEEEEEEC---CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC---CCCceeeEEeEEE-----e
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVT-----E 226 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~---g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~-----~ 226 (394)
+|++.+.||+|+||.||+|... +..+|+|.+......... ...+.+|+.+++.+ +||||+++++++. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc-hHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 6888999999999999999863 567999987654332211 23345566666655 6999999999875 2
Q ss_pred CCeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecC
Q 016152 227 RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg 304 (394)
...+++|||++. ++|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~--~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILV--TSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEE--cCCCCEEEcccc
Confidence 456899999996 5999998753 35899999999999999999999988 9999999999999 788899999999
Q ss_pred CccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
++....... ......||+.|+|||.+.+..++.++|||||||++|||++|++||.+.+..+.+..|..
T Consensus 156 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 156 LARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred ceEeccCCc-----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 997654321 22345689999999999888999999999999999999999999999888888777764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=275.90 Aligned_cols=231 Identities=32% Similarity=0.548 Sum_probs=192.4
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCc------HHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDD------RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~------~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
+|.+.+.||+|++|.||+|.. .++.+++|.+....... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999986 36789999876543322 1223567889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
.+++|||+++++|.+++...+.+++..+..++.|++.||+|||+.+ ++||||+|+||++ +.++.++|+|||++..+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~--~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILV--DNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEE--cCCCCEEecccCCCccc
Confidence 9999999999999999998888999999999999999999999988 9999999999999 88889999999998876
Q ss_pred cccccccc--ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 016152 310 KVQNSHDV--YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (394)
Q Consensus 310 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~ 387 (394)
........ .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..+.+|.++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 235 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSN- 235 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcc-
Confidence 53221111 112234688999999999988899999999999999999999999998887777777777767766643
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
++.+++
T Consensus 236 ~~~~~~ 241 (267)
T cd06628 236 ISSEAI 241 (267)
T ss_pred cCHHHH
Confidence 555543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=276.14 Aligned_cols=224 Identities=32% Similarity=0.579 Sum_probs=188.6
Q ss_pred CccccceeecCCceEEEEEEECCc-cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g~-~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
+|++.+.||+|+||.||.+.+.+. .+|+|.+..... ....+.+|+.++++++||||+++++++.....++++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 678889999999999999987654 599998754322 125688899999999999999999999988999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 237 ~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
+.+++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||++ +.++.+||+|||++.........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili--~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLV--DDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEE--cCCCCEEECCCccceecCCCcee
Confidence 9999999999864 46899999999999999999999988 9999999999999 77889999999998765432211
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.++.++..+. .++++++
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (256)
T cd05113 157 ---SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPH-LASEKVY 231 (256)
T ss_pred ---ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCC-CCCHHHH
Confidence 1122345678999999988889999999999999999998 999999988888888888887776553 3455543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=304.56 Aligned_cols=234 Identities=22% Similarity=0.393 Sum_probs=187.6
Q ss_pred ccCCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeE-EEe
Q 016152 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGA-VTE 226 (394)
Q Consensus 151 ~i~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~-~~~ 226 (394)
.+.....++++.+.|.+|||+.||+|... |..+|+|.+... +...++..++|+++|++|+ |+|||.+++. ...
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 34555667889999999999999999875 378999998654 5667788999999999997 9999999993 221
Q ss_pred ------CCeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcE
Q 016152 227 ------RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298 (394)
Q Consensus 227 ------~~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~ 298 (394)
...++|.||||.||+|-++++.+ ..|++.++++|+.|+++|+.+||...++|||||||-+|||+ ..+++.
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl--s~~g~~ 185 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL--SADGNY 185 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE--cCCCCE
Confidence 13478999999999999999853 45999999999999999999999999999999999999999 888899
Q ss_pred EEeecCCcccccccc-ccccc----cccCCccCccccCcccc---CCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH
Q 016152 299 KVGDFGLSKLIKVQN-SHDVY----KMTGETGSYRYMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370 (394)
Q Consensus 299 kl~DFg~a~~~~~~~-~~~~~----~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~ 370 (394)
||||||.++...... ..... ..-...-|+.|.|||++ .+..++.|+|||+|||+||-|+....||++.-.
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-- 263 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-- 263 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--
Confidence 999999987443221 10000 01123469999999987 577899999999999999999999999977532
Q ss_pred HHHHHHcCCCCCCCCCCCCcccc
Q 016152 371 AAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 371 ~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
-+|..|.+-+.+...|+..|+
T Consensus 264 --laIlng~Y~~P~~p~ys~~l~ 284 (738)
T KOG1989|consen 264 --LAILNGNYSFPPFPNYSDRLK 284 (738)
T ss_pred --eeEEeccccCCCCccHHHHHH
Confidence 455666666665555665554
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=279.26 Aligned_cols=228 Identities=30% Similarity=0.505 Sum_probs=191.0
Q ss_pred cCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
.+|.+.+.||+|+||.||+|... +..+|+|.+..... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 36888999999999999999753 35799998754322 3344778899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCC
Q 016152 230 LMLITEYLRGGDLHKYLKEKG--------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 295 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~--------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~ 295 (394)
.+++|||+++++|.+++...+ .+++.++..++.|++.+|.|||+++ ++||||||+||++ +.+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili--~~~ 158 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLV--GYD 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEE--cCC
Confidence 999999999999999997542 3788899999999999999999988 9999999999999 788
Q ss_pred CcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 016152 296 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 374 (394)
Q Consensus 296 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~ 374 (394)
+.++|+|||++......... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...+..+..+.
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred CeEEECCcccceecccCcce--ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999999998755322110 01123346788999999999999999999999999999998 9999999888899999
Q ss_pred HHcCCCCCCCCCCCCcccc
Q 016152 375 VAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 375 i~~g~~p~~~~~~~~~~~~ 393 (394)
+..+..+..+. .+|++++
T Consensus 237 ~~~~~~~~~~~-~~~~~~~ 254 (280)
T cd05049 237 ITQGRLLQRPR-TCPSEVY 254 (280)
T ss_pred HHcCCcCCCCC-CCCHHHH
Confidence 98887766653 3666554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=273.24 Aligned_cols=219 Identities=29% Similarity=0.467 Sum_probs=183.2
Q ss_pred cceeecCCceEEEEEE--ECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEEEEeccC
Q 016152 162 SAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLR 238 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~--~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~~ 238 (394)
.++||+|+++.|..+. .+|..+|||++.+.. ...+.+..+|++++...+ |+||+++++||+++..+|+|||-|.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 5689999999998775 469999999986652 233477888999999986 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-CCCCcEEEeecCCccccccccccc-
Q 016152 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSHD- 316 (394)
Q Consensus 239 ~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-~~~~~~kl~DFg~a~~~~~~~~~~- 316 (394)
||+|...|.++..+++.++.++.++|+.||.|||.+| |.||||||+|||-.. +...-||||||.++..+.....-.
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999999999999999999999999999999999999 999999999999732 233459999999887654433222
Q ss_pred --cccccCCccCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCC---------------HHHHHHH
Q 016152 317 --VYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYE---------------PYEAAKY 374 (394)
Q Consensus 317 --~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~---------------~~~~~~~ 374 (394)
.....+.+|+..|||||+.. ...|+.+.|+|||||++|-|++|.+||.+.= ...+.+.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 12345678999999999852 3468999999999999999999999996531 3567788
Q ss_pred HHcCCCCCCCC
Q 016152 375 VAEGHRPFFRA 385 (394)
Q Consensus 375 i~~g~~p~~~~ 385 (394)
|.+|++.+...
T Consensus 318 IQEGkYeFPdk 328 (463)
T KOG0607|consen 318 IQEGKYEFPDK 328 (463)
T ss_pred HhccCCcCChh
Confidence 99998876553
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=278.47 Aligned_cols=227 Identities=30% Similarity=0.506 Sum_probs=187.7
Q ss_pred CccccceeecCCceEEEEEEE------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeE
Q 016152 158 DFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 231 (394)
+|++.+.||+|+||.||+|.. .+..+++|.+.... .......+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 678889999999999999974 34678999875432 2334467888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC
Q 016152 232 LITEYLRGGDLHKYLKEK-----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~-----------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~ 294 (394)
++|||+.+++|.+++..+ ..+++.++..++.|++.||+|||+++ ++||||||+|||+ +.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili--~~ 159 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI--GE 159 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEE--cC
Confidence 999999999999998632 24788889999999999999999988 9999999999999 77
Q ss_pred CCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 016152 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 373 (394)
Q Consensus 295 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~ 373 (394)
++.+||+|||++......... .......++..|+|||.+.+..++.++|+||||+++|||++ |.+||.+.+..++.+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYY--RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred CCcEEeccccccccccCCcce--ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 889999999999865432211 11233446778999999988889999999999999999998 999999988888888
Q ss_pred HHHcCCCCCCCCCCCCcccc
Q 016152 374 YVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 374 ~i~~g~~p~~~~~~~~~~~~ 393 (394)
.+..+..+..+ +.++++++
T Consensus 238 ~~~~~~~~~~~-~~~~~~~~ 256 (283)
T cd05090 238 MVRKRQLLPCS-EDCPPRMY 256 (283)
T ss_pred HHHcCCcCCCC-CCCCHHHH
Confidence 88876655544 34666554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=274.92 Aligned_cols=224 Identities=32% Similarity=0.596 Sum_probs=187.8
Q ss_pred CccccceeecCCceEEEEEEECC-ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g-~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
+|++.+.||+|+||.||++.+.+ ..+++|.+...... ...+.+|+.+++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 68889999999999999998764 47999987543222 24577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 237 ~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
+++++|.+++..+ +.+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i--~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLV--GEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEE--CCCCcEEECCcccceeccccccc
Confidence 9999999999764 46899999999999999999999988 9999999999999 78889999999998765432110
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+.++..+. .+|++++
T Consensus 157 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (256)
T cd05059 157 ---SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPK-LAPTEVY 231 (256)
T ss_pred ---ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCC-CCCHHHH
Confidence 1112234567999999998999999999999999999999 899999888888888888887666553 3666654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=281.02 Aligned_cols=232 Identities=30% Similarity=0.464 Sum_probs=192.2
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++... ++.+++|.+.............+.+|+.+++.++||||+++++.+..+..+++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999875 57899998765433333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|++|++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||||+||++ +..+.++|+|||++.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll--~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEE--CCCCCEEEeeCCCccccCcCccc
Confidence 9999999999988888999999999999999999999988 9999999999999 88889999999988632111000
Q ss_pred -----------ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 016152 316 -----------DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 316 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~ 384 (394)
.........++..|+|||.+.+..++.++|+||||+++|||++|..||.+.+..+....+..+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 000112345788999999998888999999999999999999999999998888888888776544333
Q ss_pred C-CCCCcccc
Q 016152 385 A-KGFTPELR 393 (394)
Q Consensus 385 ~-~~~~~~~~ 393 (394)
. ..+|++++
T Consensus 238 ~~~~~~~~~~ 247 (305)
T cd05609 238 GDEALPADAQ 247 (305)
T ss_pred ccccCCHHHH
Confidence 2 24666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=290.24 Aligned_cols=235 Identities=30% Similarity=0.490 Sum_probs=187.1
Q ss_pred CCcccCCCCcCccccceeecCCceEEEEEEECC-------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceee
Q 016152 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQ 219 (394)
Q Consensus 148 ~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g-------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~ 219 (394)
..|+.+ ..+|++++.||+|+||.||+|.+.+ ..||||.+.... .....+.+.+|+.+++++. ||||++
T Consensus 30 ~~~~~~--~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~ 105 (400)
T cd05105 30 SRWEFP--RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVN 105 (400)
T ss_pred Cceecc--ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeee
Confidence 345544 3478899999999999999998632 359999885432 2333467889999999996 999999
Q ss_pred EEeEEEeCCeeEEEEeccCCCCHHHHHHhc--------------------------------------------------
Q 016152 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEK-------------------------------------------------- 249 (394)
Q Consensus 220 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-------------------------------------------------- 249 (394)
+++++.+...+++||||+++|+|.+++...
T Consensus 106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 106 LLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred EEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 999999999999999999999999988642
Q ss_pred ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 016152 250 ----------------------------------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 283 (394)
Q Consensus 250 ----------------------------------------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Di 283 (394)
..+++.++..++.|+++||.|||+.+ |+||||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~di 263 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDL 263 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCC
Confidence 13677888999999999999999988 999999
Q ss_pred CCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCC
Q 016152 284 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPP 362 (394)
Q Consensus 284 kp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~P 362 (394)
||+|||+ +.++.+||+|||++..+...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus 264 kp~Nill--~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P 339 (400)
T cd05105 264 AARNVLL--AQGKIVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339 (400)
T ss_pred ChHhEEE--eCCCEEEEEeCCcceeccccccc--cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999 77888999999999865432211 11223457788999999998899999999999999999997 9999
Q ss_pred CCCCCH-HHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 363 LANYEP-YEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 363 f~~~~~-~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
|..... ......+..+.++..+ ..+|++++
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~ 370 (400)
T cd05105 340 YPGMIVDSTFYNKIKSGYRMAKP-DHATQEVY 370 (400)
T ss_pred CcccchhHHHHHHHhcCCCCCCC-ccCCHHHH
Confidence 987643 3455666666655544 34666654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=283.30 Aligned_cols=232 Identities=27% Similarity=0.439 Sum_probs=192.1
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|+..+.||+|++|.||++... ++.+|+|.+...........+.+..|+.+++.++||+|+++++.+.+....++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6888899999999999999874 68899999876544443455778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILL--HESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEE--cCCCCEEEeecchhhcccccc
Confidence 99999999998754 46899999999999999999999988 9999999999999 778899999999987553221
Q ss_pred ccc-------------------------cccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH
Q 016152 314 SHD-------------------------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368 (394)
Q Consensus 314 ~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~ 368 (394)
... ........||..|+|||++.+..++.++||||||+++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 100 0112234688999999999988899999999999999999999999998887
Q ss_pred HHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 369 YEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 369 ~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.+....+.....+......++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (316)
T cd05574 238 DETFSNILKKEVTFPGSPPVSSSAR 262 (316)
T ss_pred HHHHHHHhcCCccCCCccccCHHHH
Confidence 7777777654444333333565554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=278.58 Aligned_cols=228 Identities=28% Similarity=0.528 Sum_probs=192.8
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++.. .+..++||.+.............+.+|+.+++.++||||+++++++..++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 678889999999999999986 578999998765444444455778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 236 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 236 ~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
|+++++|.+++.. ...+++.++..++.|++.||.|||+++ ++|+||||+||++ +.++.++|+|||++..+..
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFI--TATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCCEEECcchhhhcccc
Confidence 9999999998863 345899999999999999999999988 9999999999999 7888999999999876643
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCC
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--PYEAAKYVAEGHRPFFRAKGFT 389 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~--~~~~~~~i~~g~~p~~~~~~~~ 389 (394)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+..+.+.....|..+...++
T Consensus 159 ~~~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08229 159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234 (267)
T ss_pred CCc----ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccccc
Confidence 321 1234568899999999998899999999999999999999999996543 3566677777777766666677
Q ss_pred cccc
Q 016152 390 PELR 393 (394)
Q Consensus 390 ~~~~ 393 (394)
++++
T Consensus 235 ~~~~ 238 (267)
T cd08229 235 EELR 238 (267)
T ss_pred HHHH
Confidence 7665
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=274.67 Aligned_cols=227 Identities=33% Similarity=0.558 Sum_probs=189.9
Q ss_pred CccccceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
+|++.+.||+|+||.||+|.+. ...+++|.+.... .......+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 6888999999999999999874 3468999775432 33345678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
+|||+++++|.+++... +.+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.++|+|||++..+..
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili--~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE--cCCCCEEECccchhhcccc
Confidence 99999999999999764 46899999999999999999999988 9999999999999 7888999999999987752
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCc
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~ 390 (394)
... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..+.+..+.++..+ ..+|+
T Consensus 159 ~~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 235 (266)
T cd05033 159 SEA--TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP-MDCPS 235 (266)
T ss_pred ccc--ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCH
Confidence 211 111223345678999999998999999999999999999998 99999988888888888877655444 33565
Q ss_pred ccc
Q 016152 391 ELR 393 (394)
Q Consensus 391 ~~~ 393 (394)
+++
T Consensus 236 ~l~ 238 (266)
T cd05033 236 ALY 238 (266)
T ss_pred HHH
Confidence 554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=282.94 Aligned_cols=219 Identities=30% Similarity=0.590 Sum_probs=181.0
Q ss_pred CcCccccceeecCCceEEEEEEEC--Cc----cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~----~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
..+|+..+.||+|+||.||+|.+. +. .+|+|.+... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 347899999999999999999863 33 3899987532 2233456788999999999999999999988764 5
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 230 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.++++||+.+|+|.+++... ..++...+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill--~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLV--KTPQHVKITDFGLAKL 158 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEe--cCCCcEEEcccccccc
Confidence 78999999999999999874 46889999999999999999999988 9999999999999 7888999999999987
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~ 383 (394)
+..... .........+..|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+..+.++..
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (316)
T cd05108 159 LGADEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 232 (316)
T ss_pred ccCCCc--ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCC
Confidence 653322 111223345678999999999999999999999999999997 9999999888777766666655433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=277.72 Aligned_cols=225 Identities=33% Similarity=0.534 Sum_probs=195.6
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||.|++|.||++... ++.+++|.+.... .......+.+|+.+++.++|+||+++++.+.++..+++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 6788899999999999999874 7789999875432 22334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+.+++|.+++... ++++..+..++.|++.+|.|||+.+ ++||||+|+||++ +.++.++|+|||++..+.....
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILL--SEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEEcccccceeeccccc-
Confidence 99999999999765 7899999999999999999999988 9999999999999 8888999999999987754321
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
......+++.|+|||.+.+..++.++||||||+++|+|++|++||...++.+....+..+..|.+....++++++
T Consensus 154 ---~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (274)
T cd06609 154 ---KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFK 228 (274)
T ss_pred ---ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHH
Confidence 123456888999999999888999999999999999999999999988888888888888888877665777665
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=276.26 Aligned_cols=224 Identities=29% Similarity=0.569 Sum_probs=188.9
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|++|.||+|.+. ++.+++|.+.... .....+.+|+.++++++||||+++++++..+..++++||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 5778889999999999999874 7789999875332 224668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|+++++|.+++... ..+++..++.++.|++++|.|||+++ ++||||||+||++ +.++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~--~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEE--cCCCcEEeCCCccccccccce
Confidence 99999999999763 35899999999999999999999988 9999999999999 788899999999998665332
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+..+.++..+. .+|+++
T Consensus 159 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 234 (263)
T cd05052 159 YT---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPE-GCPPKV 234 (263)
T ss_pred ee---ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCC-CCCHHH
Confidence 11 1112234678999999998999999999999999999998 999999988888888888877666653 466665
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 235 ~ 235 (263)
T cd05052 235 Y 235 (263)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=316.04 Aligned_cols=216 Identities=29% Similarity=0.444 Sum_probs=190.6
Q ss_pred CCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
...+|.++++||+|+||.|+.++++ ++-||+|++.+-..-......-|+.|-.+|..-+.+=|+.++..|.++.++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 3448999999999999999999885 66799998865222222223568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||||++||+|-.++.+.+++++..++.++..|+-||..||+.| +|||||||+|||+ +..|++||+|||.+-.+...
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLl--d~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLL--DKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEe--cccCcEeeccchhHHhcCCC
Confidence 9999999999999999889999999999999999999999999 9999999999999 99999999999998877644
Q ss_pred cccccccccCCccCccccCccccC----C-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFK----H-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
+ .......+|||-|.+||++. + +.|++.+|+||+||++|||++|..||...+..+.+-+|..
T Consensus 229 G---~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~ 295 (1317)
T KOG0612|consen 229 G---TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMN 295 (1317)
T ss_pred C---cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhc
Confidence 3 22456678999999999985 3 5689999999999999999999999999999999999985
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=291.10 Aligned_cols=210 Identities=29% Similarity=0.482 Sum_probs=177.9
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC-----ee
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-----PL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-----~~ 230 (394)
+|++.+.||+|+||.||++.. .++.+|+|.+..... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 477889999999999999986 478999998754332 2333467889999999999999999999988776 78
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
++||||+. ++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili--~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLV--NSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEE--CCCCCEEeccccceeecc
Confidence 99999996 589998888888999999999999999999999988 9999999999999 888899999999997654
Q ss_pred cccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
.... .......+|+.|+|||.+.+. .++.++|||||||++|||++|++||.+.++.+..+.|.
T Consensus 155 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 218 (372)
T cd07853 155 PDES---KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218 (372)
T ss_pred cCcc---ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 3221 122345688999999998774 57899999999999999999999999888777666654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=292.81 Aligned_cols=194 Identities=27% Similarity=0.387 Sum_probs=168.6
Q ss_pred CCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
...+|++.+.||+|+||.||++... ++.+|+|... ...+.+|+.++++++||||+++++++......++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 3347999999999999999999874 7789999532 1346789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|+|++. ++|..++.....+++.+++.++.|++.||.|||+++ |+||||||+|||+ +..+.+||+|||++......
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll--~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFI--NHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEE--cCCCCEEEEeCCcccccccc
Confidence 999995 699999988888999999999999999999999988 9999999999999 78889999999999754322
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN 365 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~ 365 (394)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 236 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 236 NA---NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cc---cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 11 122346799999999999999999999999999999999999988743
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=272.84 Aligned_cols=221 Identities=30% Similarity=0.539 Sum_probs=182.1
Q ss_pred eeecCCceEEEEEEEC----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 164 IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
.||+|+||.||+|.+. +..+|+|.+.... .....+.+.+|+.++++++||||+++++++. ...+++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999999764 3468999875432 2334467889999999999999999999875 4578999999999
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccc
Q 016152 240 GDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (394)
Q Consensus 240 ~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~ 318 (394)
++|.+++.. .+.+++.++..++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++..+....... .
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~--~~~~~~kl~dfg~~~~~~~~~~~~-~ 153 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLL--VNQHYAKISDFGLSKALGADDSYY-K 153 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEE--cCCCcEEeccCCccccccCCccce-e
Confidence 999999975 457899999999999999999999988 9999999999999 778899999999997654332211 1
Q ss_pred cccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
......++..|+|||.+....++.++||||||+++||+++ |..||...+..++...+..|.++.++. .++++++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 228 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPA-ECPPEMY 228 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCC-CCCHHHH
Confidence 1122334678999999988889999999999999999996 999999999989988888888776654 3566654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=273.52 Aligned_cols=230 Identities=33% Similarity=0.586 Sum_probs=187.9
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCC--CCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--CeeE
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLM 231 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~--~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~ 231 (394)
+|++.+.||+|+||.||++.. .+..+++|.+.... .........+.+|+.++++++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 688899999999999999986 47789999875332 12234456788999999999999999999988664 4688
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
+++||+.+++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++.....
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILR--DSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--cCCCCEEECcccccccccc
Confidence 99999999999999988778999999999999999999999988 9999999999999 7788999999999986542
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCCc
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE-GHRPFFRAKGFTP 390 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~-g~~p~~~~~~~~~ 390 (394)
.... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+...++.. ..+|.++ ..+++
T Consensus 159 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p-~~~~~ 236 (264)
T cd06653 159 ICMS-GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP-DGVSD 236 (264)
T ss_pred cccc-CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCC-cccCH
Confidence 2110 1112345688999999999988899999999999999999999999988877666666553 3445554 33565
Q ss_pred ccc
Q 016152 391 ELR 393 (394)
Q Consensus 391 ~~~ 393 (394)
+++
T Consensus 237 ~~~ 239 (264)
T cd06653 237 ACR 239 (264)
T ss_pred HHH
Confidence 544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=273.42 Aligned_cols=215 Identities=31% Similarity=0.549 Sum_probs=179.6
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCC--CCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--CeeE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLM 231 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~--~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~ 231 (394)
+|++.+.||+|+||.||++... +..+++|.+.... .......+.+.+|+.++++++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 6888999999999999999864 6789999875332 22234456788999999999999999999988764 4688
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
++|||+++++|.+++.+.+.+++..+..++.|++.+|.|||+++ ++|+||||+||++ +.++.++|+|||++.....
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILR--DSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEe--cCCCCEEECcCcccccccc
Confidence 99999999999999988778999999999999999999999988 9999999999999 7888999999999876542
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
... .........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..
T Consensus 159 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 223 (265)
T cd06652 159 ICL-SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT 223 (265)
T ss_pred ccc-cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc
Confidence 111 00012234688899999999888899999999999999999999999988776666555543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=279.18 Aligned_cols=223 Identities=39% Similarity=0.708 Sum_probs=186.1
Q ss_pred ccceeecCCceEEEEEEEC------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 161 SSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 161 ~~~~iG~G~~g~V~~a~~~------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
+.+.||.|.||.||+|.+. +..|+||.+.. .......+.+.+|+..+++++||||+++++++...+..++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 4568999999999999887 56799998843 233444688999999999999999999999999888899999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 235 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 235 e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||+++|+|.+++... ..+++.++..++.|+++||.|||+++ ++|++|+++||++ +.++.+||+|||++......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill--~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILL--DSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEE--ETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccc--cccccccccccccccccccc
Confidence 999999999999986 67999999999999999999999988 9999999999999 77889999999999866322
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
.. ............|+|||.+....++.++||||||+++||+++ |+.||.+.+..++...+.++.++.++. .+|..
T Consensus 157 ~~--~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 233 (259)
T PF07714_consen 157 SK--YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPD-NCPKD 233 (259)
T ss_dssp SS--EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBT-TSBHH
T ss_pred cc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceecc-chhHH
Confidence 11 112233457788999999988889999999999999999999 789999999999999999888877654 35655
Q ss_pred c
Q 016152 392 L 392 (394)
Q Consensus 392 ~ 392 (394)
+
T Consensus 234 ~ 234 (259)
T PF07714_consen 234 I 234 (259)
T ss_dssp H
T ss_pred H
Confidence 4
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=273.54 Aligned_cols=224 Identities=33% Similarity=0.562 Sum_probs=186.3
Q ss_pred cCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.+|++.+.||+|++|.||++... ++.+|+|.+..... ..+.+.+|+.++++++||||+++++++...+.++++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 36888999999999999999864 56799998754322 23567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.++|+|||++..+....
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLV--GENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEE--cCCCCEEECCcceEEEccCCc
Confidence 999999999997654 6899999999999999999999988 9999999999999 788899999999998765321
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.. .......+..|+|||.+.+..++.++|+||||+++|||++ |+.||.+.+..++...+..+.++..+ ..+++++
T Consensus 158 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 233 (261)
T cd05068 158 YE---AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCP-PGCPKEL 233 (261)
T ss_pred cc---ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-CcCCHHH
Confidence 11 1112233467999999998899999999999999999999 99999998888888888776544333 2345544
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=275.09 Aligned_cols=225 Identities=32% Similarity=0.562 Sum_probs=188.1
Q ss_pred cCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.+|++.+.||+|+||.||+|... +..+++|.+.... ...+.+.+|+.+++.++|+||+++++.+.+....+++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 37889999999999999999865 5678999765422 224678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|+.+++|.+++... ..++...+..++.|++.||+|||+.+ ++||||||+||++ +.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLV--SESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEe--cCCCcEEECCCccceecCCCc
Confidence 99999999999753 45888999999999999999999988 9999999999999 788899999999998764322
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.. ......++..|+|||.+....++.++|+||||+++|+|++ |..||...+..+....+.++.++... ..+|.++
T Consensus 158 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 233 (261)
T cd05072 158 YT---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM-ENCPDEL 233 (261)
T ss_pred ee---ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCHHH
Confidence 11 1223346778999999988889999999999999999998 99999998888888888877554433 3356554
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 234 ~ 234 (261)
T cd05072 234 Y 234 (261)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=280.75 Aligned_cols=234 Identities=34% Similarity=0.556 Sum_probs=190.3
Q ss_pred CcccCCCCcCccccceeecCCceEEEEEEECC---------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCcee
Q 016152 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIV 218 (394)
Q Consensus 149 ~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g---------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv 218 (394)
.|++.. .+|.+.+.||+|+||.||++...+ ..+|+|.+.... .......+..|+.+++.+ +||||+
T Consensus 12 ~~~~~~--~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (307)
T cd05098 12 RWEVPR--DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNII 87 (307)
T ss_pred cceeeh--HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEe
Confidence 444442 378999999999999999997532 359999876432 223346688899999999 799999
Q ss_pred eEEeEEEeCCeeEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecC
Q 016152 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282 (394)
Q Consensus 219 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~----------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~D 282 (394)
++++++......++||||+.+++|.+++...+ .++..+++.++.|++.||+|||++| ++|||
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~d 165 (307)
T cd05098 88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRD 165 (307)
T ss_pred eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--ccccc
Confidence 99999999999999999999999999997642 4788999999999999999999988 99999
Q ss_pred CCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCC
Q 016152 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEP 361 (394)
Q Consensus 283 ikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~ 361 (394)
|||+||++ +.++.++|+|||++.......... ......+++.|+|||.+.+..++.++|+|||||++|||++ |..
T Consensus 166 lkp~Nill--~~~~~~kL~dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~ 241 (307)
T cd05098 166 LAARNVLV--TEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 241 (307)
T ss_pred ccHHheEE--cCCCcEEECCCcccccccccchhh--ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 99999999 788899999999987654321100 1112234578999999998889999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 362 PLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 362 Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
||...+..+..+.+..+.++.++. .++++++
T Consensus 242 p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 272 (307)
T cd05098 242 PYPGVPVEELFKLLKEGHRMDKPS-NCTNELY 272 (307)
T ss_pred CCCcCCHHHHHHHHHcCCCCCCCC-cCCHHHH
Confidence 999988888888888877666553 3566554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.79 Aligned_cols=229 Identities=28% Similarity=0.505 Sum_probs=181.2
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe--CCeeEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLML 232 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~l 232 (394)
.+|++++.||+|+||.||++.+. +..+|+|.+...... ......+..|+.+++.++||||++++++|.+ ...+|+
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 38999999999999999999875 567899987654333 3344678899999999999999999998854 356899
Q ss_pred EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCeEecCCCCCCEEEeeC----------
Q 016152 233 ITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEP-----NVIIHRDLKPRNVLLVNS---------- 293 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~-----~~ivH~Dikp~Nilv~~~---------- 293 (394)
||||+.+++|.++|.. .+.+++..++.|+.||+.||.|||+.+ .+||||||||+|||+..+
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 9999999999999875 357999999999999999999999843 239999999999999431
Q ss_pred -----CCCcEEEeecCCccccccccccccccccCCccCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 294 -----SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 294 -----~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
..+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s-----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIES-----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccCCCCceEEccCCccccccccc-----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 23459999999997654322 1234578999999999864 45889999999999999999999999876
Q ss_pred CHHH-HHHHHHcCCCCCCCCCCCCcccc
Q 016152 367 EPYE-AAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 367 ~~~~-~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
+... +...+..+ |.++...++++|+
T Consensus 247 ~~~~qli~~lk~~--p~lpi~~~S~eL~ 272 (1021)
T PTZ00266 247 NNFSQLISELKRG--PDLPIKGKSKELN 272 (1021)
T ss_pred CcHHHHHHHHhcC--CCCCcCCCCHHHH
Confidence 5544 34444443 4444445666654
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=294.96 Aligned_cols=204 Identities=29% Similarity=0.459 Sum_probs=168.2
Q ss_pred CcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC------
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------ 227 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------ 227 (394)
..+|++.+.||+|+||.||+|.. .++.+|||.+.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 34799999999999999999987 47789999875432 2234699999999999999999876432
Q ss_pred --CeeEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCC-CcEEE
Q 016152 228 --KPLMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKV 300 (394)
Q Consensus 228 --~~~~lv~e~~~~~sL~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~-~~~kl 300 (394)
..+++||||+.+ +|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.. +.+||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl--~~~~~~vkL 212 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLI--DPNTHTLKL 212 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEE--cCCCCceee
Confidence 246799999975 7877765 3457999999999999999999999988 9999999999999 644 47999
Q ss_pred eecCCccccccccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 301 ~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
+|||+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+....+.
T Consensus 213 ~DFGla~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 284 (440)
T PTZ00036 213 CDFGSAKNLLAGQ-----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284 (440)
T ss_pred eccccchhccCCC-----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9999998765332 12345789999999998764 68999999999999999999999999887776666554
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=273.15 Aligned_cols=228 Identities=29% Similarity=0.521 Sum_probs=193.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|... |+.+++|.+.............+.+|+.++++++|++|+++++.+...+..+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 6888999999999999999875 88999998865444444445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 236 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 236 ~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
|+++++|.+++.. ...+++.++..++.|+++||.|||+.| ++||||+|+||++ +.++.++|+|||++..+..
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~--~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFI--TATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEE--CCCCcEEEeccceeeeccC
Confidence 9999999998864 345899999999999999999999988 9999999999999 7888999999999876543
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCCCCCCCCCCC
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY--EPYEAAKYVAEGHRPFFRAKGFT 389 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~--~~~~~~~~i~~g~~p~~~~~~~~ 389 (394)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||... +..+..+.+..+..+..+.+.++
T Consensus 159 ~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08224 159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234 (267)
T ss_pred CCc----ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence 221 122356888999999999889999999999999999999999999544 45567777777777777765666
Q ss_pred cccc
Q 016152 390 PELR 393 (394)
Q Consensus 390 ~~~~ 393 (394)
.+++
T Consensus 235 ~~~~ 238 (267)
T cd08224 235 EELR 238 (267)
T ss_pred HHHH
Confidence 6654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=271.17 Aligned_cols=222 Identities=30% Similarity=0.502 Sum_probs=183.1
Q ss_pred ceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEecc
Q 016152 163 AIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 237 (394)
+.||+|+||.||+|.+. +..+++|.+...... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 36899999999999763 256999987654432 33467889999999999999999999776 45689999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccc
Q 016152 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317 (394)
Q Consensus 238 ~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~ 317 (394)
.+++|.+++...+.+++..+..++.|++.+|.|||+.+ ++||||||+||++ +.++.+||+|||++......... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili--~~~~~~kl~df~~~~~~~~~~~~-~ 152 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLL--VNRHQAKISDFGMSRALGAGSDY-Y 152 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEE--cCCCcEEeccccccceeecCCcc-c
Confidence 99999999998888999999999999999999999988 9999999999999 78889999999999876533221 1
Q ss_pred ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 318 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.......++..|+|||.+.+..++.++|+||||+++|++++ |.+||...+..+..+.+..+.++..+ ..++++++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~ 228 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP-EECPQEIY 228 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCC-CCCCHHHH
Confidence 11112234568999999998899999999999999999998 99999999888888888877655444 33565554
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=272.02 Aligned_cols=219 Identities=33% Similarity=0.601 Sum_probs=186.5
Q ss_pred CccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE-eCCeeEEEEec
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT-ERKPLMLITEY 236 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-~~~~~~lv~e~ 236 (394)
+|++.+.||+|+||.||++...|..+++|.+.... ..+.+.+|+.++++++|++++++++++. .....+++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 78888999999999999999999999999874321 2356889999999999999999999754 45678999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 237 LRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 237 ~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
+++++|.+++.+.+ .+++..+..++.|++.+|+|||++| ++||||||+||++ +.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~--~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLV--SEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEE--cCCCcEEecCCccceeccccC-
Confidence 99999999998643 4889999999999999999999988 9999999999999 888899999999987543221
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.++..+..+ ..+|++++
T Consensus 157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 229 (256)
T cd05082 157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP-DGCPPVVY 229 (256)
T ss_pred ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC-CCCCHHHH
Confidence 12334668999999998899999999999999999997 99999998888888888887766555 34666654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=272.11 Aligned_cols=225 Identities=28% Similarity=0.504 Sum_probs=190.6
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++... +..+++|.+..... ....+.+.+|+.+++.++||||+++++.+.+...++++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4778899999999999999874 77899998754322 2334677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFL--TQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEE--CCCCcEEEcccCcceeecccc
Confidence 99999999988753 35899999999999999999999988 9999999999999 888899999999987654322
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
. ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..+.++.++. .++++++
T Consensus 155 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 229 (255)
T cd08219 155 A----YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPS-HYSYELR 229 (255)
T ss_pred c----ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCc-ccCHHHH
Confidence 1 1234568899999999998889999999999999999999999999988888888888877766553 3555543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=270.69 Aligned_cols=226 Identities=31% Similarity=0.530 Sum_probs=188.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe-CCeeEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKPLMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~lv~ 234 (394)
+|++.+.||+|++|.||++... ++.+++|.+...... ....+.+.+|+.++++++|+|++++++.+.. +..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 4788999999999999999874 678999988543322 3334668889999999999999999998764 44689999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 235 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 235 e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||+++++|.+++... ..+++.++..++.|++.+|.+||+++ ++||||||+||++ +.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~--~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFL--TRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEE--ecCCcEEEecccceEEeccc
Confidence 999999999999763 45899999999999999999999988 9999999999999 77889999999999866433
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.. ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..+..|..+. .+++++
T Consensus 156 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 230 (257)
T cd08223 156 CD----MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPK-DYSPEL 230 (257)
T ss_pred CC----ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCcc-ccCHHH
Confidence 22 2234568999999999999999999999999999999999999999888877777788877766553 355554
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 231 ~ 231 (257)
T cd08223 231 G 231 (257)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=271.95 Aligned_cols=222 Identities=37% Similarity=0.622 Sum_probs=190.0
Q ss_pred ceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEecc
Q 016152 163 AIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 237 (394)
+.||+|+||.||++... +..+++|.+....... ..+.+.+|+.+++.++|+||+++++++.....++++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 36899999999999875 6789999886543332 4577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 238 RGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 238 ~~~sL~~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
++++|.+++... ..+++.++..++.|++.||.|||+++ ++||||||+||++ +.++.++|+|||.+..
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili--~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLV--GEDLVVKISDFGLSRD 154 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEE--CCCCcEEEcccccccc
Confidence 999999999875 67999999999999999999999988 9999999999999 8889999999999987
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~ 387 (394)
...... ........+++.|+|||.+....++.++|+||||+++|+|++ |..||...+..+..+.+..+.++..+. .
T Consensus 155 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 231 (262)
T cd00192 155 VYDDDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPE-Y 231 (262)
T ss_pred cccccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCc-c
Confidence 654321 112334567889999999988889999999999999999999 699999999989999998876665553 3
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
+|++++
T Consensus 232 ~~~~~~ 237 (262)
T cd00192 232 CPDELY 237 (262)
T ss_pred CChHHH
Confidence 566554
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=278.72 Aligned_cols=230 Identities=32% Similarity=0.531 Sum_probs=189.6
Q ss_pred CCcCccccceeecCCceEEEEEEEC---------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAV 224 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~---------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~ 224 (394)
...+|.+.+.||+|+||.||++... +..+++|.+.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 3457889999999999999999742 2368999775432 233346788999999999 799999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCE
Q 016152 225 TERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNV 288 (394)
Q Consensus 225 ~~~~~~~lv~e~~~~~sL~~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Ni 288 (394)
.....++++|||+.+++|.+++.+. ..++..++..++.|+++||.|||++| ++||||||+||
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Ni 168 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNV 168 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceE
Confidence 9999999999999999999999763 24678889999999999999999988 99999999999
Q ss_pred EEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCC
Q 016152 289 LLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYE 367 (394)
Q Consensus 289 lv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~ 367 (394)
++ +.++.+||+|||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+
T Consensus 169 li--~~~~~~kl~D~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 169 LV--TENNVMKIADFGLARDVNNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EE--cCCCcEEECCCccceecccccccc--cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99 778899999999998664332111 1223446778999999988889999999999999999998 899999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 368 PYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 368 ~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
..+..+.+..+.++..+. .++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~-~~~~~~~ 269 (304)
T cd05101 245 VEELFKLLKEGHRMDKPA-NCTNELY 269 (304)
T ss_pred HHHHHHHHHcCCcCCCCC-CCCHHHH
Confidence 999999998877665543 4565554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=277.22 Aligned_cols=227 Identities=31% Similarity=0.515 Sum_probs=188.5
Q ss_pred cCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
.+|.+.+.||+|+||.||++... +..+++|.+... .....+.+.+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 36788889999999999999753 235788876432 23334668899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC
Q 016152 230 LMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS 293 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~----------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~ 293 (394)
+++||||+++++|.+++...+ .+++..++.++.|++.||+|||+++ |+||||||+||++ +
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~--~ 157 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV--G 157 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEE--c
Confidence 999999999999999997543 3789999999999999999999988 9999999999999 7
Q ss_pred CCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 016152 294 SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA 372 (394)
Q Consensus 294 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~ 372 (394)
.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+..
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 235 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235 (291)
T ss_pred cCCcEEECCCCcccccCCCcee--ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 8889999999999765432211 11223456788999999999999999999999999999998 99999999988899
Q ss_pred HHHHcCCCCCCCCCCCCcccc
Q 016152 373 KYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 373 ~~i~~g~~p~~~~~~~~~~~~ 393 (394)
+.+..+..+..+. .+|++++
T Consensus 236 ~~~~~~~~~~~~~-~~~~~~~ 255 (291)
T cd05094 236 ECITQGRVLERPR-VCPKEVY 255 (291)
T ss_pred HHHhCCCCCCCCc-cCCHHHH
Confidence 9888887776553 3565554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=274.67 Aligned_cols=224 Identities=29% Similarity=0.487 Sum_probs=186.2
Q ss_pred ccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
|++.+.||+|+||.||++... +..+++|.+... .....+.+.+|+.+++.++||||+++++.+......++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 577889999999999999885 556788877432 233456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 237 ~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
+.+++|..++.+ .+++++..+..++.|+++||.|||+.+ ++||||||+||++ +.++.++|+|||++........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili--~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILF--TLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEE--ccCCCEEEcccccccccccccc-
Confidence 999999988765 457999999999999999999999988 9999999999999 7888999999999876542211
Q ss_pred ccccccCCccCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCC
Q 016152 316 DVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFT 389 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~~ 389 (394)
......+++.|+|||.+. +..++.++|+|||||++|+|++|++||...+..+....+..+.++.... ..++
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd06643 159 ---RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 235 (282)
T ss_pred ---ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccC
Confidence 223456899999999984 4557889999999999999999999999988888877777766654432 3466
Q ss_pred cccc
Q 016152 390 PELR 393 (394)
Q Consensus 390 ~~~~ 393 (394)
.+++
T Consensus 236 ~~~~ 239 (282)
T cd06643 236 SEFK 239 (282)
T ss_pred HHHH
Confidence 6654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=276.34 Aligned_cols=225 Identities=28% Similarity=0.458 Sum_probs=190.9
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||.|+||.||++... +..+++|.+... .....+.+..|+.++++++||||+++++.+..+..+++|||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 6889999999999999999874 778999987532 33345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++++|.+++.+. ..+++..+..++.|++.+|.|||+++ |+|+||||+||++ +.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili--~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILL--TLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEE--CCCCCEEEccCccchhhccccc
Confidence 99999999998764 56999999999999999999999988 9999999999999 8888999999998876543221
Q ss_pred cccccccCCccCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGF 388 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~ 388 (394)
......+++.|+|||.+. ...++.++|+||||+++|+|++|++||...+..+....+..+.+|.+.. ..+
T Consensus 159 ----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (280)
T cd06611 159 ----KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW 234 (280)
T ss_pred ----ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccC
Confidence 123356899999999974 3457789999999999999999999999988888888888887776544 346
Q ss_pred Ccccc
Q 016152 389 TPELR 393 (394)
Q Consensus 389 ~~~~~ 393 (394)
+++++
T Consensus 235 ~~~~~ 239 (280)
T cd06611 235 SSSFN 239 (280)
T ss_pred CHHHH
Confidence 66554
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=277.53 Aligned_cols=227 Identities=27% Similarity=0.466 Sum_probs=188.6
Q ss_pred CccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
+|++.+.||+|+||.||+|... +..+|+|.+.... .......+.+|+.++..++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 5788899999999999999863 3579999875432 233346688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC
Q 016152 231 MLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~ 294 (394)
++++||+.+++|.+++..+ ..+++..+..++.|++.||.|||+++ |+||||||+||++ ..
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~--~~ 159 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLV--FD 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEe--cC
Confidence 9999999999999998532 34788889999999999999999988 9999999999999 77
Q ss_pred CCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 016152 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 373 (394)
Q Consensus 295 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~ 373 (394)
++.+||+|||++......... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+..+
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYY--KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237 (283)
T ss_pred CCceEecccccccccccchhe--eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 788999999998765432211 11223446789999999988889999999999999999998 999999999989999
Q ss_pred HHHcCCCCCCCCCCCCcccc
Q 016152 374 YVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 374 ~i~~g~~p~~~~~~~~~~~~ 393 (394)
.+..+..+..+. .+|+++.
T Consensus 238 ~i~~~~~~~~~~-~~~~~~~ 256 (283)
T cd05091 238 MIRNRQVLPCPD-DCPAWVY 256 (283)
T ss_pred HHHcCCcCCCCC-CCCHHHH
Confidence 998887665553 4666543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=270.57 Aligned_cols=221 Identities=35% Similarity=0.632 Sum_probs=191.4
Q ss_pred cCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
.+|++.+.||+|+||.||++...|+.+++|.+..... ..+.+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 3788899999999999999999999999998854322 346788999999999999999999999988999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 237 LRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 237 ~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili--~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLV--SEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEE--eCCCCEEEccccccccccccc-
Confidence 99999999998765 6899999999999999999999988 9999999999999 888899999999998663221
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....+..|+|||.+....++.++|+||||+++|++++ |..||...+..+..+.+..+.++..+ +.+|+++.
T Consensus 157 ------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 229 (256)
T cd05039 157 ------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAP-EGCPPEVY 229 (256)
T ss_pred ------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCc-cCCCHHHH
Confidence 12334667999999988889999999999999999997 99999999888888888877666555 34666553
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=273.14 Aligned_cols=228 Identities=32% Similarity=0.565 Sum_probs=188.1
Q ss_pred CccccceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
+|++.+.||+|+||.||+|... +..+++|.+..... ......+.+|+.++++++||||+++++++..++.+++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 6888999999999999999763 23689998754332 3335678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
||||+++++|.+++... +.++..++..++.|++.||.|||+++ ++||||||+||++ +.++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili--~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILV--NSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEE--CCCCeEEeCCCCccccccc
Confidence 99999999999999865 46899999999999999999999988 9999999999999 7888999999999987653
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCc
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~ 390 (394)
.... ........++..|+|||.+.+..++.++|+||||+++||+++ |..||...+..+....+.++.++..+ ..+|+
T Consensus 159 ~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 236 (267)
T cd05066 159 DPEA-AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP-MDCPA 236 (267)
T ss_pred ccce-eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCC-CCCCH
Confidence 3211 111122334678999999998899999999999999999886 99999998888888888877654433 23565
Q ss_pred ccc
Q 016152 391 ELR 393 (394)
Q Consensus 391 ~~~ 393 (394)
+++
T Consensus 237 ~~~ 239 (267)
T cd05066 237 ALH 239 (267)
T ss_pred HHH
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=270.10 Aligned_cols=226 Identities=26% Similarity=0.462 Sum_probs=192.2
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|+..+.||.|+||.||.+.. .++.+++|.+....... .....+.+|+.++++++|+||+++++++.+...++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 478899999999998888775 47889999875443332 334667899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|+++++|.+++.+. ..+++.++..++.|++.+|.|||+.+ ++|+||+|+||++ +.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~--~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEE--eCCCCEEECcCcceEEccccc
Confidence 99999999999865 46899999999999999999999988 9999999999999 778899999999987664332
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
. ......+++.|+|||.+.+..++.++|+||||+++|||++|..||...+..+....+..+.++..+ ..++++++
T Consensus 156 ~----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 230 (256)
T cd08221 156 S----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV-SVYSSELI 230 (256)
T ss_pred c----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc-cccCHHHH
Confidence 1 123456899999999998888999999999999999999999999998888888888887766554 44565553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=280.13 Aligned_cols=224 Identities=35% Similarity=0.540 Sum_probs=182.3
Q ss_pred CccccceeecCCceEEEEEEEC--Ccc--EEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~--~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~l 232 (394)
+|++.+.||+|+||.||+|.++ +.. +++|.+... ........+.+|+.++.++ +||||+++++++..++.+++
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 7888899999999999999864 443 466655432 2233446788899999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC
Q 016152 233 ITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~----------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~ 296 (394)
||||+++++|.+++...+ .+++.+++.++.|++.||+|||++| ++||||||+|||+ +.++
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili--~~~~ 161 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GENY 161 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEe--cCCC
Confidence 999999999999997542 4789999999999999999999988 9999999999999 7888
Q ss_pred cEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 016152 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV 375 (394)
Q Consensus 297 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i 375 (394)
.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+..+.+
T Consensus 162 ~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 162 VAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred cEEeCccccCcccchhh-----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 99999999986432111 1112234667999999988889999999999999999998 99999988888888888
Q ss_pred HcCCCCCCCCCCCCcccc
Q 016152 376 AEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 376 ~~g~~p~~~~~~~~~~~~ 393 (394)
..+.++..+. .++++++
T Consensus 237 ~~~~~~~~~~-~~~~~~~ 253 (303)
T cd05088 237 PQGYRLEKPL-NCDDEVY 253 (303)
T ss_pred hcCCcCCCCC-CCCHHHH
Confidence 7765554443 3555543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=275.65 Aligned_cols=228 Identities=27% Similarity=0.439 Sum_probs=185.9
Q ss_pred cCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
.+|++.+.||+|+||.||+|..+ +..+|+|.+.... .......+.+|+.+++.++||||+++++++.+...
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 37889999999999999998653 3478999765332 22233567789999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEE
Q 016152 230 LMLITEYLRGGDLHKYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK 299 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~k 299 (394)
.++||||+.+|+|.+++... ..++...+..++.|++.||.|||+++ |+||||||+||++ +.++.++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili--~~~~~~~ 159 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMV--AHDFTVK 159 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEE--cCCCcEE
Confidence 99999999999999999752 23466788999999999999999988 9999999999999 7788999
Q ss_pred EeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC
Q 016152 300 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEG 378 (394)
Q Consensus 300 l~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g 378 (394)
|+|||+++........ .......++..|+|||.+.+..++.++|+|||||++|||++ |.+||...+..+..+.+..+
T Consensus 160 L~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (288)
T cd05061 160 IGDFGMTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237 (288)
T ss_pred ECcCCccccccccccc--cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999998765432211 11122345678999999998899999999999999999998 89999999888888888877
Q ss_pred CCCCCCCCCCCcccc
Q 016152 379 HRPFFRAKGFTPELR 393 (394)
Q Consensus 379 ~~p~~~~~~~~~~~~ 393 (394)
..+.++. .++++++
T Consensus 238 ~~~~~~~-~~~~~~~ 251 (288)
T cd05061 238 GYLDQPD-NCPERVT 251 (288)
T ss_pred CCCCCCC-CCCHHHH
Confidence 6666553 3455554
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=274.29 Aligned_cols=229 Identities=30% Similarity=0.497 Sum_probs=184.5
Q ss_pred cCccccceeecCCceEEEEEEECC-------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~g-------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
.+|.+.+.||+|++|.||+|.+.+ ..+++|.+.... .......+..|+.+++.++|+||+++++++.+...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 368889999999999999998754 467888664332 23334668889999999999999999999998889
Q ss_pred eEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC-CCcEEEe
Q 016152 230 LMLITEYLRGGDLHKYLKEKG-------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVG 301 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~-~~~~kl~ 301 (394)
.++||||+++++|.+++...+ .+++..++.++.|++.||+|||+++ ++||||||+||++.... ...+||+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEec
Confidence 999999999999999997643 4899999999999999999999988 99999999999994322 3469999
Q ss_pred ecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC
Q 016152 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 302 DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
|||++........ .........+..|+|||++.+..++.++|||||||++|||++ |..||...+..+..+.+..+.+
T Consensus 162 dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 239 (277)
T cd05036 162 DFGMARDIYRASY--YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR 239 (277)
T ss_pred cCccccccCCccc--eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999986632211 001112234568999999998899999999999999999997 9999999888888888877666
Q ss_pred CCCCCCCCCccc
Q 016152 381 PFFRAKGFTPEL 392 (394)
Q Consensus 381 p~~~~~~~~~~~ 392 (394)
+..+. .+|+++
T Consensus 240 ~~~~~-~~~~~~ 250 (277)
T cd05036 240 LDPPK-GCPGPV 250 (277)
T ss_pred CCCCC-CCCHHH
Confidence 55543 355544
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=273.49 Aligned_cols=220 Identities=26% Similarity=0.482 Sum_probs=182.3
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++.+ .++.+|+|.+.... .....+.+.+|+.++++++||||+++++.+...+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 577888999999999999986 47789999875432 23334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++++|..+ ..+++..+..++.|++.||.|||+.+ |+|+||||+||++ +.++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill--~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLV--NTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEE--CCCCCEEEeeCCcceeccccc--
Confidence 9999999754 35788999999999999999999988 9999999999999 888999999999997654321
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHcCCCCCCCCCCC
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-------PYEAAKYVAEGHRPFFRAKGF 388 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~-------~~~~~~~i~~g~~p~~~~~~~ 388 (394)
.....+|..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..+..+.+....++.++...+
T Consensus 150 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQF 225 (279)
T ss_pred ----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcC
Confidence 234578999999999999999999999999999999999999996532 234445555555555555556
Q ss_pred Ccccc
Q 016152 389 TPELR 393 (394)
Q Consensus 389 ~~~~~ 393 (394)
+++++
T Consensus 226 ~~~~~ 230 (279)
T cd06619 226 SEKFV 230 (279)
T ss_pred CHHHH
Confidence 66654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=285.56 Aligned_cols=203 Identities=27% Similarity=0.401 Sum_probs=170.4
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC------
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------ 228 (394)
.+|++.+.||+|+||.||++... |..+|+|.+...... ......+.+|+.+++.++||||+++++++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 37999999999999999999874 788999988654332 233466778999999999999999999886543
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.+++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~--~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 172 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEEecCCCccc
Confidence 47999999965 67776643 4889999999999999999999988 9999999999999 8889999999999975
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~ 372 (394)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 173 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~ 231 (359)
T cd07876 173 ACTNF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQW 231 (359)
T ss_pred cccCc-----cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 43221 123457899999999999999999999999999999999999999887654443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=273.95 Aligned_cols=208 Identities=28% Similarity=0.483 Sum_probs=176.8
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|.. .++.+|+|.+...... ....+.+|+.++++++||||+++++.+...+..++||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 3789999999999999999986 4778999987543222 2245778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+.+++|.+++..++.+++.++..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill--~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILL--TDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--CCCCCEEECcCccceeeccccc
Confidence 99999999999988888999999999999999999999988 9999999999999 7888999999999986643211
Q ss_pred cccccccCCccCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 016152 315 HDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 375 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i 375 (394)
......+++.|+|||.+. ...++.++|+||||+++|||++|+.||...++.+....+
T Consensus 162 ----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~ 221 (267)
T cd06646 162 ----KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221 (267)
T ss_pred ----ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee
Confidence 123356889999999884 345788999999999999999999999877665544443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=274.22 Aligned_cols=228 Identities=29% Similarity=0.483 Sum_probs=189.6
Q ss_pred cCccccceeecCCceEEEEEEECC-------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~g-------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
.+|++.+.||+|+||.||++...+ ..+++|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 478889999999999999998642 569999875432 22334567889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEE
Q 016152 230 LMLITEYLRGGDLHKYLKEKG----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK 299 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~k 299 (394)
.++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+|
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill--~~~~~~k 159 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMV--AEDLTVK 159 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEE--cCCCCEE
Confidence 999999999999999987532 3678899999999999999999988 9999999999999 8889999
Q ss_pred EeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC
Q 016152 300 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEG 378 (394)
Q Consensus 300 l~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g 378 (394)
|+|||+++....... ........++..|+|||.+.+..++.++||||||+++||+++ |..||...+..+..+.+..+
T Consensus 160 l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05032 160 IGDFGMTRDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237 (277)
T ss_pred ECCcccchhhccCcc--cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence 999999876543321 111223456789999999988889999999999999999998 99999999988988888877
Q ss_pred CCCCCCCCCCCcccc
Q 016152 379 HRPFFRAKGFTPELR 393 (394)
Q Consensus 379 ~~p~~~~~~~~~~~~ 393 (394)
..+.++.. ++++++
T Consensus 238 ~~~~~~~~-~~~~~~ 251 (277)
T cd05032 238 GHLDLPEN-CPDKLL 251 (277)
T ss_pred CCCCCCCC-CCHHHH
Confidence 77666643 566553
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=263.85 Aligned_cols=226 Identities=27% Similarity=0.499 Sum_probs=189.7
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
+.+.+..||+|.-|.|+++.++ |+..|||.+..... .+..+++...+++..... .|+||+++|+|..+..+++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N--kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC--HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 4456778999999999999886 58899999865443 444577777787766654 899999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|.| ...+..+++. ++++++.-+-++..-+++||.||.++ -+|+|||+||+|||+ +..|++||||||++.++.++.
T Consensus 171 elM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILl--De~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 171 ELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILL--DERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEE--ccCCCEEeecccccceeeccc
Confidence 988 3366666654 56789988889999999999999887 249999999999999 999999999999998887554
Q ss_pred ccccccccCCccCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCCCCCCC-CC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRAK-GF 388 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~~g~~Pf~~~-~~~~~~~~i~~g~~p~~~~~-~~ 388 (394)
. .....|.+.|||||.+.- ..|+.++||||||++++||.||++||.+. +.++++.+|....+|.++.. +|
T Consensus 247 A-----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gF 321 (391)
T KOG0983|consen 247 A-----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGF 321 (391)
T ss_pred c-----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCc
Confidence 2 344678999999999853 46899999999999999999999999874 57899999999999998884 59
Q ss_pred CccccC
Q 016152 389 TPELRE 394 (394)
Q Consensus 389 ~~~~~~ 394 (394)
||.|++
T Consensus 322 Sp~F~~ 327 (391)
T KOG0983|consen 322 SPDFQS 327 (391)
T ss_pred CHHHHH
Confidence 998864
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=271.03 Aligned_cols=231 Identities=29% Similarity=0.554 Sum_probs=188.4
Q ss_pred CccccceeecCCceEEEEEEE-CCccEEEEEeccCCCC---cHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYW-RGTPVAIKRILPSLSD---DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~-~g~~~avK~l~~~~~~---~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
+|++.+.||+|+||.||+|.. .++.+|+|.+...... .......+.+|+.+++.++|+||+++++++.+...++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999976 5778999987543322 123345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
+||+.+++|.+++.+.+.+++..+..++.|++.+|+|||+.+ |+|+||+|+||++ +.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVML--MPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEE--CCCCeEEeccchhhHhhhhcc
Confidence 999999999999988788999999999999999999999988 9999999999999 788899999999987653221
Q ss_pred cc--ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCCC
Q 016152 314 SH--DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE--GHRPFFRAKGFT 389 (394)
Q Consensus 314 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~--g~~p~~~~~~~~ 389 (394)
.. .........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.. +..|.++. .++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 235 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPD-SFS 235 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCC-CCC
Confidence 11 01112345689999999999988899999999999999999999999988776655555543 34444443 356
Q ss_pred cccc
Q 016152 390 PELR 393 (394)
Q Consensus 390 ~~~~ 393 (394)
++++
T Consensus 236 ~~~~ 239 (265)
T cd06631 236 AAAI 239 (265)
T ss_pred HHHH
Confidence 5543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=274.14 Aligned_cols=224 Identities=29% Similarity=0.466 Sum_probs=186.3
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|++.+.||+|+||.||++... +..+++|.+... .....+.+.+|+.+++.++||||+++++.+..+..+++|||
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 6889999999999999999874 678999987543 33445778889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++++|..++.+ ...+++..+..++.|++.+|.|||+.+ ++||||||+||++ +.++.++|+|||++........
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLL--TLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEE--cCCCCEEEccCccceecccccc
Confidence 9999999988765 456899999999999999999999988 9999999999999 7788999999998875432211
Q ss_pred cccccccCCccCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGF 388 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~ 388 (394)
......+++.|+|||.+. ...++.++|+|||||++|||++|.+||...+..+....+..+..|.... ..+
T Consensus 166 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T cd06644 166 ----RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKW 241 (292)
T ss_pred ----ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCccc
Confidence 123456888999999984 3457889999999999999999999998888777777777666654433 345
Q ss_pred Cccc
Q 016152 389 TPEL 392 (394)
Q Consensus 389 ~~~~ 392 (394)
+.++
T Consensus 242 ~~~~ 245 (292)
T cd06644 242 SMEF 245 (292)
T ss_pred CHHH
Confidence 5544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=276.96 Aligned_cols=224 Identities=34% Similarity=0.516 Sum_probs=183.9
Q ss_pred CccccceeecCCceEEEEEEEC--Cc--cEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~--~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~l 232 (394)
+|++.+.||+|+||.||+|..+ +. .+++|.+.... .....+.+.+|+.+++++ +||||+++++++.....+++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 6888899999999999999864 33 36777664322 223346788899999999 69999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC
Q 016152 233 ITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~----------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~ 296 (394)
+|||+++++|.+++...+ .+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill--~~~~ 156 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV--GENL 156 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEE--CCCC
Confidence 999999999999997532 4788999999999999999999988 9999999999999 7788
Q ss_pred cEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 016152 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV 375 (394)
Q Consensus 297 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i 375 (394)
.+||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||...+..++.+.+
T Consensus 157 ~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 157 ASKIADFGLSRGEEVYV-----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred eEEECCcCCCcccccee-----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999986432110 1111233567999999998899999999999999999997 99999999988888888
Q ss_pred HcCCCCCCCCCCCCcccc
Q 016152 376 AEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 376 ~~g~~p~~~~~~~~~~~~ 393 (394)
..+..+..+. .++++++
T Consensus 232 ~~~~~~~~~~-~~~~~~~ 248 (297)
T cd05089 232 PQGYRMEKPR-NCDDEVY 248 (297)
T ss_pred hcCCCCCCCC-CCCHHHH
Confidence 8876665553 4666654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=268.90 Aligned_cols=221 Identities=29% Similarity=0.524 Sum_probs=181.5
Q ss_pred eeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCCC
Q 016152 164 IIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGD 241 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~s 241 (394)
.||+|+||.||+|.. .++.+|+|.+.... .......+.+|+.+++.++||||+++++++......++||||+.+++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 589999999999987 47889999775432 23344678899999999999999999999999999999999999999
Q ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccc
Q 016152 242 LHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320 (394)
Q Consensus 242 L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~ 320 (394)
|.+++...+ .+++.++..++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++........ ....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~~~--~~~~ 153 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLV--TEKNVLKISDFGMSREEEDGVY--ASTG 153 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEE--cCCCcEEECccccCcccccccc--cccC
Confidence 999997644 5899999999999999999999988 9999999999999 7888999999999875442211 0001
Q ss_pred cCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....+..|+|||.+.+..++.++|+||||+++|||++ |.+||...+..+....+..+.++..+. .+|++++
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 226 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPE-LCPDAVY 226 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcc-cCCHHHH
Confidence 11223567999999998889999999999999999997 999999888877777777765555443 3555543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=285.84 Aligned_cols=208 Identities=27% Similarity=0.393 Sum_probs=175.7
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC------C
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~ 228 (394)
.+|++.+.||+|+||.||++... ++.+|||.+...... ......+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47999999999999999999874 778999988654332 23346677899999999999999999987543 3
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.+++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 175 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEE--CCCCcEEEEeCCCccc
Confidence 57999999965 78877754 4788999999999999999999988 9999999999999 8888999999999976
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.+
T Consensus 176 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 239 (364)
T cd07875 176 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239 (364)
T ss_pred cCCCC-----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 53221 12345789999999999999999999999999999999999999998887777766654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=275.82 Aligned_cols=209 Identities=30% Similarity=0.519 Sum_probs=178.4
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|++|.||++.. .+..+++|.+....... ...+.+|+.+++.++||||+++++.+......++||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 4789999999999999999986 47789999886543322 356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++++|.+++.. ..+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.++|+|||++........
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill--~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--cCCCCEEECccccchhcccccc
Confidence 99999999999864 46899999999999999999999988 9999999999999 7888999999999876543221
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
......+++.|+|||.+.+..++.++|+|||||++|+|++|++||...++.+....+..
T Consensus 172 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~ 230 (296)
T cd06654 172 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230 (296)
T ss_pred ----ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc
Confidence 12235688999999999988899999999999999999999999988776554444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=270.95 Aligned_cols=230 Identities=28% Similarity=0.501 Sum_probs=192.0
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||.|+||.||++.. .+..+++|++....... ..+.+.+|+.+++.++|+||+++++.+......+++||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 688899999999999999986 46789999885443322 45778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 236 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 236 ~~~~~sL~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
++++++|.+++... +.+++..+..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++..+...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~--~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILL--GEDGSVKIADFGVSASLADG 155 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEE--cCCCCEEEcccchHHHhccC
Confidence 99999999999764 45899999999999999999999988 9999999999999 77889999999998876644
Q ss_pred cccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCC----C
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK----G 387 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~----~ 387 (394)
............++..|+|||.+... .++.++|+||||+++|+|++|+.||...+..+....+.++.++.+... .
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence 32211112334688999999998776 789999999999999999999999999888887877777666655442 3
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
++++++
T Consensus 236 ~~~~~~ 241 (267)
T cd06610 236 YSKSFR 241 (267)
T ss_pred ccHHHH
Confidence 455543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=274.73 Aligned_cols=225 Identities=31% Similarity=0.534 Sum_probs=187.8
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||.|++|.||++.. .++.+++|.+...... ..+.+.+|+.+++.++||||+++++.+...+.+++|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 4789999999999999999985 4789999988543322 2356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+.+++|..++... .+++.++..++.|++.+|.|||+.+ ++||||||+||++ +.++.++|+|||++..+.....
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili--~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 96 EYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLL--GMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEccCccchhcccccc
Confidence 999999999988654 5899999999999999999999988 9999999999999 7788999999999876543221
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~~~~~~ 393 (394)
......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+..+..|.+.. ..++++++
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06655 171 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246 (296)
T ss_pred ----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHH
Confidence 1223568899999999998889999999999999999999999999888776666665544443322 34555543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=288.56 Aligned_cols=222 Identities=27% Similarity=0.559 Sum_probs=191.6
Q ss_pred cccceeecCCceEEEEEEEC----Cc--cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 160 SSSAIIGKGSFGEILKAYWR----GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 160 ~~~~~iG~G~~g~V~~a~~~----g~--~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
+..++||.|.||.||+|.+. |. .||||....... ....+.|..|+.++++++||||++++|++.+ .+.|+|
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 34668999999999999874 33 478887655443 3336889999999999999999999998875 568999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 234 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||.+.-|.|..|++.+. .++..+...++.|++.+|.|||++. +|||||..+|||| .....|||+|||+++.+..+
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLV--sSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILV--SSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheee--cCcceeeecccchhhhcccc
Confidence 99999999999998654 5999999999999999999999988 9999999999999 77779999999999988754
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
. .+......-++.|||||.+.-+.++.++|||.|||++||++. |..||.+....+++-.|.+|.|+..|.. |||-
T Consensus 545 ~---yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~n-CPp~ 620 (974)
T KOG4257|consen 545 A---YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPN-CPPA 620 (974)
T ss_pred c---hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCC-CChH
Confidence 3 333444456788999999999999999999999999999887 9999999999999999999999998855 6664
Q ss_pred c
Q 016152 392 L 392 (394)
Q Consensus 392 ~ 392 (394)
|
T Consensus 621 L 621 (974)
T KOG4257|consen 621 L 621 (974)
T ss_pred H
Confidence 3
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=267.73 Aligned_cols=213 Identities=30% Similarity=0.515 Sum_probs=178.7
Q ss_pred Cccc-cceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeC----Ce
Q 016152 158 DFSS-SAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER----KP 229 (394)
Q Consensus 158 ~~~~-~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~----~~ 229 (394)
+|.+ -.+||-|-.|.|..+.++ |+.+|+|++... ...++|+++.... .|||||.++++|++. ..
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4554 358999999999988774 889999987432 4556788876665 599999999988643 56
Q ss_pred eEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-CCCCcEEEeecCCc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLS 306 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~--~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-~~~~~~kl~DFg~a 306 (394)
+.+|||.|+||.|++.|.+++. +++.++..|++||..|+.|||+.+ |.||||||+|+|.+. ..+..+||+|||+|
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccc
Confidence 8999999999999999998764 999999999999999999999988 999999999999954 45668999999999
Q ss_pred cccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCCCCC
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE----PYEAAKYVAEGHRPF 382 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~----~~~~~~~i~~g~~p~ 382 (394)
+...... ...+.+-||.|.|||++....|+...|+||+||++|-|+||.+||.... ...+..+|..|++.+
T Consensus 212 K~t~~~~-----~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 212 KETQEPG-----DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred cccCCCc-----cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 8654322 3567889999999999999999999999999999999999999997543 346678899888766
Q ss_pred CCC
Q 016152 383 FRA 385 (394)
Q Consensus 383 ~~~ 385 (394)
...
T Consensus 287 P~p 289 (400)
T KOG0604|consen 287 PEP 289 (400)
T ss_pred CCh
Confidence 543
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=276.31 Aligned_cols=200 Identities=29% Similarity=0.482 Sum_probs=174.1
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++.+. +..+++|.+.... .......+.+|+.++++++||||+++++.+.+++.+++|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 6888999999999999999875 6678888775432 23344668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++++|.+++...+.+++..+..++.|+++||.|||+ .+ ++||||||+||++ +.++.++|+|||++.......
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEE--ecCCcEEEccCCCcccccccc-
Confidence 99999999999888889999999999999999999998 46 9999999999999 778899999999987553221
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 369 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~ 369 (394)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 155 -----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 204 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK 204 (308)
T ss_pred -----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh
Confidence 23457899999999998888999999999999999999999999765533
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=282.40 Aligned_cols=226 Identities=31% Similarity=0.540 Sum_probs=179.7
Q ss_pred CccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEe-CC
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE-RK 228 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~-~~ 228 (394)
+|++.+.||+|+||.||+|... ++.||+|.+..... ....+.+..|+.+++++ +|+||+++++++.. +.
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 7899999999999999999643 35799998754322 23345677899999999 79999999998754 45
Q ss_pred eeEEEEeccCCCCHHHHHHhc-----------------------------------------------------------
Q 016152 229 PLMLITEYLRGGDLHKYLKEK----------------------------------------------------------- 249 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~----------------------------------------------------------- 249 (394)
.++++|||+.+++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 789999999999999998642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCc
Q 016152 250 --GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327 (394)
Q Consensus 250 --~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~ 327 (394)
..+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.++|+|||++..+...... .......++.
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill--~~~~~vkL~DfG~a~~~~~~~~~--~~~~~~~~~~ 239 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLARDIYKDPDY--VRKGDARLPL 239 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEE--eCCCcEEEeccccchhcccCcch--hhccCCCCCc
Confidence 25789999999999999999999988 9999999999999 77889999999999876432211 1122345677
Q ss_pred cccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCCccc
Q 016152 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYE-AAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 328 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~-~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.|+|||.+.+..++.++|||||||++|||++ |..||.+....+ ....+..+.++..+ ..+++++
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 305 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP-EYATPEI 305 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCC-ccCCHHH
Confidence 8999999999999999999999999999998 999998755433 34555566555544 3345544
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=273.13 Aligned_cols=207 Identities=30% Similarity=0.495 Sum_probs=176.8
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|.+.+.||+|+||.||+|.. .++.+++|.+..... .....+.+|+.+++.++||||+++++.+...+.++++||
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 788899999999999999987 477899998754322 223557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++++|.+++...+.+++.++..++.|++.||.|||+.| ++|+||||+||++ +..+.++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili--~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILL--TDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEECcceeeeEccCccc-
Confidence 9999999999988889999999999999999999999988 9999999999999 7888999999999876542211
Q ss_pred ccccccCCccCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 016152 316 DVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 375 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i 375 (394)
......|++.|+|||.+. ...++.++|+|||||++|+|++|..||....+.+....+
T Consensus 162 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~ 221 (267)
T cd06645 162 ---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221 (267)
T ss_pred ---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh
Confidence 223457899999999974 456889999999999999999999999776654444443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=269.34 Aligned_cols=222 Identities=32% Similarity=0.573 Sum_probs=182.1
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCC--cHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe--CCeeE
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLM 231 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~--~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~ 231 (394)
+|+..+.||+|+||.||++.. .+..+++|.+...... .......+.+|+.++++++||||+++++++.+ ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 688899999999999999986 4778999987544322 23344678899999999999999999998865 35689
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
+++||+++++|.+++...+.+++.....++.|++.||+|||+.+ |+||||||+||++ +.++.++|+|||++..+..
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~--~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILR--DSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--CCCCCEEEccCCCcccccc
Confidence 99999999999999988778999999999999999999999988 9999999999999 7888999999999876542
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HcCCCCCCC
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV-AEGHRPFFR 384 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i-~~g~~p~~~ 384 (394)
..... .......++..|+|||.+.+..++.++|+|||||++|||++|+.||...+..+....+ .....|.++
T Consensus 159 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd06651 159 ICMSG-TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231 (266)
T ss_pred ccccC-CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCc
Confidence 21100 0122345889999999999888999999999999999999999999877655544443 344445544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=271.84 Aligned_cols=226 Identities=27% Similarity=0.563 Sum_probs=185.3
Q ss_pred cCccccceeecCCceEEEEEEEC--Cc----cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~----~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
.+|++.+.||+|+||.||+|.+. ++ .||+|.+.... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 37888999999999999999863 44 47899875432 23344678899999999999999999998875 457
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 231 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
++++|++++|+|.+++..+ +.+++.++..++.|++.||.|||+++ |+||||||+||++ ..++.+||+|||++...
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~--~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLV--KSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEE--cCCCcEEECCCCceeec
Confidence 8999999999999999764 56899999999999999999999988 9999999999999 77788999999999876
Q ss_pred ccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~ 388 (394)
...... .......+++.|+|||.+.+..++.++||||||+++|||++ |.+||...+..+....+..+.++..+. .+
T Consensus 160 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 236 (279)
T cd05109 160 DIDETE--YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPP-IC 236 (279)
T ss_pred ccccce--eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCc-cC
Confidence 532211 11222345678999999998899999999999999999998 999999888888888888776665542 35
Q ss_pred Cccc
Q 016152 389 TPEL 392 (394)
Q Consensus 389 ~~~~ 392 (394)
++++
T Consensus 237 ~~~~ 240 (279)
T cd05109 237 TIDV 240 (279)
T ss_pred CHHH
Confidence 5544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=270.58 Aligned_cols=227 Identities=30% Similarity=0.487 Sum_probs=185.8
Q ss_pred ccccceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe----
Q 016152 159 FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP---- 229 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~---- 229 (394)
|.+++.||+|+||.||+|... +..+|+|.+...... ......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 567889999999999999863 256999987654332 3345678899999999999999999998765554
Q ss_pred --eEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEe
Q 016152 230 --LMLITEYLRGGDLHKYLKEK------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (394)
Q Consensus 230 --~~lv~e~~~~~sL~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~ 301 (394)
.+++|||+++++|..++... ..+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.+||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~ 155 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCML--REDMTVCVA 155 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEE--CCCCeEEEC
Confidence 79999999999999888542 35899999999999999999999988 9999999999999 788899999
Q ss_pred ecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC
Q 016152 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 302 DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
|||++......... ........+..|+|||.+.+..++.++||||||+++|||++ |.+||.+.+..+..+.+..+..
T Consensus 156 dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05035 156 DFGLSKKIYSGDYY--RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233 (273)
T ss_pred Cccceeeccccccc--cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999866433211 11122335678999999988899999999999999999999 9999999998899999888877
Q ss_pred CCCCCCCCCcccc
Q 016152 381 PFFRAKGFTPELR 393 (394)
Q Consensus 381 p~~~~~~~~~~~~ 393 (394)
+..+. .+++++.
T Consensus 234 ~~~~~-~~~~~~~ 245 (273)
T cd05035 234 LKQPE-DCLDELY 245 (273)
T ss_pred CCCCc-CCCHHHH
Confidence 66553 4565553
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=272.42 Aligned_cols=226 Identities=32% Similarity=0.557 Sum_probs=190.9
Q ss_pred CcCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
..+|++.+.||.|+||.||+|... +..+++|.+.... ......+..|+.+++.++||||+++++++.+...+++||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 347899999999999999999875 5788999875432 223466888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 235 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 235 e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||+++++|.+++.+. ..+++..+..++.|++.||.|||+++ ++|+||||+||++ +.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv--~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILV--GEDLVCKVADFGLARLIKED 157 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEE--cCCceEEEccccchhhcCCc
Confidence 999999999999853 35899999999999999999999988 9999999999999 78889999999999766432
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+..+.++..+ ..+|++
T Consensus 158 ~~----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 232 (261)
T cd05148 158 VY----LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP-AKCPQE 232 (261)
T ss_pred cc----cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCC-CCCCHH
Confidence 21 1123446778999999998899999999999999999998 89999998888888888877666554 345655
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
+.
T Consensus 233 ~~ 234 (261)
T cd05148 233 IY 234 (261)
T ss_pred HH
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=287.27 Aligned_cols=232 Identities=29% Similarity=0.571 Sum_probs=200.5
Q ss_pred CCCCCcccCCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEe
Q 016152 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222 (394)
Q Consensus 145 ~~~~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 222 (394)
|+...|+.+... ...-.+||-|.||.||.|.|+ ...||||.+.. +....++|..|+.+|+.++|||+|+++|
T Consensus 257 Pn~DkWEmeRtd--ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE----DtMeveEFLkEAAvMKeikHpNLVqLLG 330 (1157)
T KOG4278|consen 257 PNADKWEMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLG 330 (1157)
T ss_pred CCcchhhccchh--eeeeeccCCCcccceeeeeeeccceeeehhhhhh----cchhHHHHHHHHHHHHhhcCccHHHHhh
Confidence 455678887553 355678999999999999997 45799998754 3455689999999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEE
Q 016152 223 AVTERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300 (394)
Q Consensus 223 ~~~~~~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl 300 (394)
+|..+.++|||+|||..|+|.+|+++. ..++.-..+.++.||..|++||..++ +|||||..+|+|| +++..||+
T Consensus 331 VCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLV--gEnhiVKv 406 (1157)
T KOG4278|consen 331 VCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHIVKV 406 (1157)
T ss_pred hhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccc--cccceEEe
Confidence 999999999999999999999999863 34677777888999999999999987 9999999999999 88999999
Q ss_pred eecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC
Q 016152 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH 379 (394)
Q Consensus 301 ~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~ 379 (394)
+|||++++...+.. ...-+-.-++.|.|||-+....++.++|||+|||+|||+.| |..||.+.+..+++..+.+|+
T Consensus 407 ADFGLsRlMtgDTY---TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy 483 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY 483 (1157)
T ss_pred eccchhhhhcCCce---ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc
Confidence 99999998864422 12223345788999999999999999999999999999998 999999999999999999999
Q ss_pred CCCCCCCCCCc
Q 016152 380 RPFFRAKGFTP 390 (394)
Q Consensus 380 ~p~~~~~~~~~ 390 (394)
|..-+.. |||
T Consensus 484 RM~~PeG-CPp 493 (1157)
T KOG4278|consen 484 RMDGPEG-CPP 493 (1157)
T ss_pred cccCCCC-CCH
Confidence 9988854 665
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=269.78 Aligned_cols=224 Identities=31% Similarity=0.519 Sum_probs=186.3
Q ss_pred cCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.+|++.++||+|+||.||+|... ++.+|+|.+...... ...+.+|+.++++++||||+++++++. .+..+++||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 36888999999999999999874 678999988654332 256788999999999999999999864 456899999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|+.+++|.+++... ..++..++..++.|++.+|+|||+.+ ++||||||+||++ +.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILV--SETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEE--cCCCCEEEccCcceeecCCCC
Confidence 99999999998753 35899999999999999999999988 9999999999999 788899999999987665222
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.. ......++..|+|||.+....++.++|+||||+++||+++ |++||.+.+..+..+.+..+.++..+ ..+|.++
T Consensus 157 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 232 (260)
T cd05067 157 YT---AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRP-DNCPEEL 232 (260)
T ss_pred cc---cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC-CCCCHHH
Confidence 11 1123346778999999998899999999999999999999 99999988888888888777665544 3355555
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 233 ~ 233 (260)
T cd05067 233 Y 233 (260)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=272.59 Aligned_cols=227 Identities=32% Similarity=0.540 Sum_probs=187.7
Q ss_pred cCccccceeecCCceEEEEEEE-------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW-------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~-------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
.+|+..+.||+|+||.||++.. .+..+++|.+... .......+.+|+.+++.++|+||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 3677888999999999999864 2446888876432 23344678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC
Q 016152 230 LMLITEYLRGGDLHKYLKEKG---------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~ 294 (394)
.+++|||+.+++|.+++...+ .+++..+..++.|++.||+|||+.+ ++||||||+||++ +.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~--~~ 157 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLV--GQ 157 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEE--cC
Confidence 999999999999999997643 4788999999999999999999988 9999999999999 77
Q ss_pred CCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 016152 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 373 (394)
Q Consensus 295 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~ 373 (394)
++.++|+|||++......... .......+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+..+...
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235 (280)
T ss_pred CCCEEECCCCceeEcCCCcee--ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 889999999998755422110 01122345788999999998999999999999999999998 999999888888888
Q ss_pred HHHcCCCCCCCCCCCCcccc
Q 016152 374 YVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 374 ~i~~g~~p~~~~~~~~~~~~ 393 (394)
.+..+.++..+. .+|++++
T Consensus 236 ~~~~~~~~~~~~-~~~~~~~ 254 (280)
T cd05092 236 CITQGRELERPR-TCPPEVY 254 (280)
T ss_pred HHHcCccCCCCC-CCCHHHH
Confidence 888887666553 4666554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=276.70 Aligned_cols=227 Identities=32% Similarity=0.531 Sum_probs=186.6
Q ss_pred cCccccceeecCCceEEEEEEEC---------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE 226 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~---------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~ 226 (394)
.+|.+.+.||+|+||.||++... ...+|+|.+..... ......+..|+.+++++ +||||+++++++.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 47889999999999999998752 34588998754322 33346688899999999 59999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEE
Q 016152 227 RKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 290 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv 290 (394)
....+++|||+.+++|.+++... ..+++.++..++.|++.||.|||++| ++||||||+||++
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill 167 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLV 167 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEE
Confidence 89999999999999999999753 34788999999999999999999988 9999999999999
Q ss_pred eeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHH
Q 016152 291 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 369 (394)
Q Consensus 291 ~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~ 369 (394)
+.++.+||+|||++.......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 168 --TEDNVMKIADFGLARGVHDIDYYK--KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred --cCCCcEEEcccccccccccccccc--ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 778899999999998664322111 1112234567999999998899999999999999999999 99999999988
Q ss_pred HHHHHHHcCCCCCCCCCCCCccc
Q 016152 370 EAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 370 ~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
+..+.+..+..+..+. .++.++
T Consensus 244 ~~~~~~~~~~~~~~~~-~~~~~l 265 (314)
T cd05099 244 ELFKLLREGHRMDKPS-NCTHEL 265 (314)
T ss_pred HHHHHHHcCCCCCCCC-CCCHHH
Confidence 9999998877665543 345444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=271.90 Aligned_cols=220 Identities=29% Similarity=0.550 Sum_probs=182.0
Q ss_pred cCccccceeecCCceEEEEEEEC--Cc----cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~----~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
.+|++.+.||+|+||.||+|.+. ++ .+++|.+... .......++..|+..++.++||||+++++++. ....
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence 36888899999999999999873 44 3677765322 22333466778888999999999999999875 4567
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 231 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
++++||+.+|+|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++...
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili--~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILL--KSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEE--cCCCcEEEcCCccceec
Confidence 8999999999999999764 56899999999999999999999988 9999999999999 78889999999999866
Q ss_pred ccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~ 385 (394)
..... ........++..|+|||.+.+..++.++||||||+++||+++ |..||.+..+.+..+.+..+.++..+.
T Consensus 160 ~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (279)
T cd05111 160 YPDDK--KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQ 234 (279)
T ss_pred cCCCc--ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCC
Confidence 43321 112234557788999999998899999999999999999998 999999988888888888887766543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=293.90 Aligned_cols=198 Identities=31% Similarity=0.531 Sum_probs=168.4
Q ss_pred ccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC------ee
Q 016152 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------PL 230 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~~ 230 (394)
|...+.||+|+||.||+++++ |+.+|||.+.+.... ...+...+|++++++++|||||++++.-++.. ..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 334568999999999999864 999999988664422 23466788999999999999999998654433 35
Q ss_pred EEEEeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC--cEEEeecCC
Q 016152 231 MLITEYLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD--HLKVGDFGL 305 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~--~~kl~DFg~ 305 (394)
.+|||||.||||...+++. -.+++.+.+.++.++..||.|||++| |+||||||.||++..+.+| .-||+|||.
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 8999999999999999753 34999999999999999999999987 9999999999999554433 589999999
Q ss_pred ccccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLAN 365 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~ 365 (394)
|+.+.+++ ...+.+||+.|++||.+.+ +.|+..+|.|||||++||++||..||..
T Consensus 171 Arel~d~s-----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 171 ARELDDNS-----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccCCCCC-----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 99887654 4567899999999999985 7889999999999999999999999953
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=274.94 Aligned_cols=226 Identities=27% Similarity=0.441 Sum_probs=188.8
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
..+|++.+.||+|+||.||++... +..+|+|.+.... .......+.+|+.+++.++||||+++++.+.....+++|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 347889999999999999999875 7889999875432 233346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|||+++++|.+++.+.+.+++..+..++.|++.+|.|||+. + ++||||||+||++ +.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~--~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILV--NSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEE--CCCCcEEEccCCcccchhhh
Confidence 99999999999998888899999999999999999999974 6 9999999999999 78889999999998654322
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH-----------HHHHHHHHcCCCC
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-----------YEAAKYVAEGHRP 381 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~-----------~~~~~~i~~g~~p 381 (394)
. .....++..|+|||.+.+..++.++|+|||||++|++++|..||...+. .+....+....+|
T Consensus 158 ~------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd06620 158 I------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP 231 (284)
T ss_pred c------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC
Confidence 1 1235689999999999888999999999999999999999999986554 2444555555556
Q ss_pred CCCCCCCCcccc
Q 016152 382 FFRAKGFTPELR 393 (394)
Q Consensus 382 ~~~~~~~~~~~~ 393 (394)
.++...++++++
T Consensus 232 ~~~~~~~~~~~~ 243 (284)
T cd06620 232 RLPSSDFPEDLR 243 (284)
T ss_pred CCCchhcCHHHH
Confidence 555554665543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=271.51 Aligned_cols=225 Identities=29% Similarity=0.515 Sum_probs=183.9
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeC------
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER------ 227 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~------ 227 (394)
..|++.+.||+|+||.||+|... ++.+|+|.+...... ...+..|+.+++++ +||||+++++.+...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 36888899999999999999874 678999987543221 25677899999998 699999999998653
Q ss_pred CeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 228 KPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
..++++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili--~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLL--TENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEE--CCCCCEEEccCCC
Confidence 4589999999999999998863 46899999999999999999999988 9999999999999 7888999999999
Q ss_pred ccccccccccccccccCCccCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
+........ ......|++.|+|||.+. +..++.++|+|||||++|||++|..||...+.......+.....
T Consensus 158 ~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 233 (272)
T cd06637 158 SAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 233 (272)
T ss_pred ceecccccc----cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCC
Confidence 876543221 223456899999999986 34688899999999999999999999988777666666665555
Q ss_pred CCCCCCCCCcccc
Q 016152 381 PFFRAKGFTPELR 393 (394)
Q Consensus 381 p~~~~~~~~~~~~ 393 (394)
+......++++++
T Consensus 234 ~~~~~~~~~~~~~ 246 (272)
T cd06637 234 PRLKSKKWSKKFQ 246 (272)
T ss_pred CCCCCCCcCHHHH
Confidence 5555556676664
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=269.44 Aligned_cols=223 Identities=31% Similarity=0.534 Sum_probs=185.0
Q ss_pred CccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
+|++.+.||+|+||.||++... +..+++|.+...... .+.+.+|+.++++++|++++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 6889999999999999999875 567899987654332 246889999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 237 ~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
+.+++|.+++... ..+++.++..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++..+.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili--~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILV--GDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEE--eCCceEEeCCceeeeeccCccc
Confidence 9999999999763 35899999999999999999999988 9999999999999 7788999999999976643221
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
. ......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..+..+.+..+.++..+ +.+|.+++
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 233 (260)
T cd05070 158 T---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCP-QDCPISLH 233 (260)
T ss_pred c---cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-CcCCHHHH
Confidence 1 1122345678999999988889999999999999999999 99999998888888888877655444 34555543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=294.08 Aligned_cols=210 Identities=20% Similarity=0.348 Sum_probs=169.6
Q ss_pred CCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC------CCceeeEEeEE
Q 016152 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR------HPNIVQFLGAV 224 (394)
Q Consensus 153 ~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~------h~~Iv~~~~~~ 224 (394)
+....+|++.+.||+|+||.||+|.+. ++.||||++.... ........|+.+++.++ |++++++++++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 334568999999999999999999874 6789999885321 12234556777776664 45688999888
Q ss_pred EeC-CeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCCEEEeeCC--------
Q 016152 225 TER-KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSS-------- 294 (394)
Q Consensus 225 ~~~-~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~ivH~Dikp~Nilv~~~~-------- 294 (394)
... ..+++|||++ +++|.+++.+.+.+++..+..++.||+.||.|||+ .| ||||||||+|||+..+.
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccc
Confidence 764 5689999988 77999999888889999999999999999999998 47 99999999999993221
Q ss_pred ------CCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH
Q 016152 295 ------ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368 (394)
Q Consensus 295 ------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~ 368 (394)
...+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||...+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 12599999998754321 12346799999999999999999999999999999999999999998887
Q ss_pred HHHHHHHH
Q 016152 369 YEAAKYVA 376 (394)
Q Consensus 369 ~~~~~~i~ 376 (394)
.+....+.
T Consensus 351 ~~~~~~i~ 358 (467)
T PTZ00284 351 LEHLHLME 358 (467)
T ss_pred HHHHHHHH
Confidence 77666654
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=284.18 Aligned_cols=237 Identities=31% Similarity=0.503 Sum_probs=187.8
Q ss_pred CCCCcccCCCCcCccccceeecCCceEEEEEEECC-------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCce
Q 016152 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNI 217 (394)
Q Consensus 146 ~~~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g-------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~I 217 (394)
....|+++.. +|.+.+.||+|+||.||+|.+.+ ..||+|.+..... ....+.+.+|+.++.++. ||||
T Consensus 28 ~~~~~~~~~~--~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~ni 103 (401)
T cd05107 28 YDSAWEMPRD--NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNI 103 (401)
T ss_pred CCCcceecHH--HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCe
Confidence 3344666544 67788999999999999998643 4799999865432 223356889999999997 9999
Q ss_pred eeEEeEEEeCCeeEEEEeccCCCCHHHHHHhcC-----------------------------------------------
Q 016152 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------------------------------------- 250 (394)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~----------------------------------------------- 250 (394)
+++++++.....+++||||+.+|+|.+++...+
T Consensus 104 v~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (401)
T cd05107 104 VNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSK 183 (401)
T ss_pred EEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCC
Confidence 999999999999999999999999999986431
Q ss_pred ---------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeE
Q 016152 251 ---------------------------------------------------ALSPSTAVNFALDIARGMAYLHNEPNVII 279 (394)
Q Consensus 251 ---------------------------------------------------~~~~~~~~~~~~ql~~~l~~lH~~~~~iv 279 (394)
.+++..++.++.|++.||.|||+++ ++
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iv 261 (401)
T cd05107 184 DESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CV 261 (401)
T ss_pred ccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cC
Confidence 2566778889999999999999988 99
Q ss_pred ecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-
Q 016152 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE- 358 (394)
Q Consensus 280 H~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~- 358 (394)
||||||+|||+ +..+.+||+|||++..+...... .......+++.|+|||.+.+..++.++||||||+++|||++
T Consensus 262 Hrdlkp~NiLl--~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~ 337 (401)
T cd05107 262 HRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL 337 (401)
T ss_pred cccCCcceEEE--eCCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHc
Confidence 99999999999 67789999999999865432211 11223457889999999998889999999999999999998
Q ss_pred CCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCCcccc
Q 016152 359 GEPPLANYEPYEA-AKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 359 g~~Pf~~~~~~~~-~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
|..||...+..+. .+.+..+.++..+. .++++++
T Consensus 338 g~~P~~~~~~~~~~~~~~~~~~~~~~p~-~~~~~l~ 372 (401)
T cd05107 338 GGTPYPELPMNEQFYNAIKRGYRMAKPA-HASDEIY 372 (401)
T ss_pred CCCCCCCCCchHHHHHHHHcCCCCCCCC-CCCHHHH
Confidence 9999987665554 45566666665543 3555554
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=275.57 Aligned_cols=228 Identities=32% Similarity=0.549 Sum_probs=188.4
Q ss_pred CcCccccceeecCCceEEEEEEECC-------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeC
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER 227 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~g-------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~ 227 (394)
..+|++.+.||+|+||.||++...+ ..+++|.+..... ......+.+|+.+++++ +|+||+++++++..+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3478889999999999999998642 4689998764322 23346688999999999 799999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEe
Q 016152 228 KPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 291 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~ 291 (394)
+.++++|||+.+++|..++... +.+++..+..++.|++.||.|||+.+ |+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~- 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLV- 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEE-
Confidence 9999999999999999998642 35889999999999999999999988 9999999999999
Q ss_pred eCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 016152 292 NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYE 370 (394)
Q Consensus 292 ~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~ 370 (394)
+.++.+||+|||++..+....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+
T Consensus 166 -~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 166 -TEDHVMKIADFGLARDIHHIDYYR--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred -cCCCeEEeCcccccccccccccee--ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 788899999999998765332110 1122335678999999988899999999999999999998 999999998888
Q ss_pred HHHHHHcCCCCCCCCCCCCccc
Q 016152 371 AAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 371 ~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
..+.+..+..+..+.. +++++
T Consensus 243 ~~~~~~~~~~~~~~~~-~~~~~ 263 (293)
T cd05053 243 LFKLLKEGYRMEKPQN-CTQEL 263 (293)
T ss_pred HHHHHHcCCcCCCCCC-CCHHH
Confidence 8888888776665542 44444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=273.49 Aligned_cols=227 Identities=31% Similarity=0.541 Sum_probs=186.1
Q ss_pred CccccceeecCCceEEEEEEECC-------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g-------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
+|++.+.||+|+||.||+|.... ..+++|.+.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 36778899999999999998642 357888765432 233346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 016152 231 MLITEYLRGGDLHKYLKEK------------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR 286 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~------------------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~ 286 (394)
++++||+.+++|.+++... ..+++.++..++.|++.||.|||+.+ ++||||||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~ 156 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAAR 156 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhh
Confidence 9999999999999998642 24788899999999999999999988 999999999
Q ss_pred CEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCC
Q 016152 287 NVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLAN 365 (394)
Q Consensus 287 Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~ 365 (394)
||++ +.++.+||+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.+
T Consensus 157 nill--~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 157 NVLV--AEGRKMKISDFGLSRDVYEEDSY--VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred eEEE--cCCCcEEeccccccccccCccch--hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 9999 77889999999998765432211 11223345778999999988889999999999999999998 9999999
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 366 YEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 366 ~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.++.++.+.+.++..+..+ ..++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 259 (290)
T cd05045 233 IAPERLFNLLKTGYRMERP-ENCSEEMY 259 (290)
T ss_pred CCHHHHHHHHhCCCCCCCC-CCCCHHHH
Confidence 9888888888877666554 34565554
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=268.95 Aligned_cols=226 Identities=32% Similarity=0.523 Sum_probs=188.8
Q ss_pred CcCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
..+|++.+.||+|+||.||+|... +..++||.+...... ...+.+|+.++++++||||+++++++......+++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 347889999999999999999875 467899987643322 256888999999999999999999999889999999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 235 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 235 e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||+++++|.+++... ..++..++..++.|++.||.|||+++ ++|+||||+||++ +.++.++|+|||++..+...
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili--~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILV--GENLVCKIADFGLARLIEDD 156 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEE--cCCCCEEECccccceeccch
Confidence 999999999999764 36899999999999999999999988 9999999999999 78899999999998766432
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
.. ........+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+..+..+.+..+.++..+. .+|++
T Consensus 157 ~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 232 (261)
T cd05034 157 EY---TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPP-NCPEE 232 (261)
T ss_pred hh---hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCHH
Confidence 11 11122335678999999998899999999999999999998 999999988888888888776554443 34555
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 233 ~~ 234 (261)
T cd05034 233 LY 234 (261)
T ss_pred HH
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=269.29 Aligned_cols=204 Identities=31% Similarity=0.519 Sum_probs=180.0
Q ss_pred eecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCCCH
Q 016152 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (394)
Q Consensus 165 iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~sL 242 (394)
||.|++|.||++... ++.+++|.+.+.........+.+.+|+.+++.++||||+++++.+.++..+++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999986 789999998765544444557789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccC
Q 016152 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~ 322 (394)
.+++.+...+++..+..++.|++.||.|||+++ ++|+||+|+||++ +.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv--~~~~~~~l~df~~~~~~~~~~-----~~~~ 151 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQ-----KTWT 151 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEE--cCCCCEEEeeCCcccccCccc-----cccc
Confidence 999988878999999999999999999999988 9999999999999 778899999999998765432 1223
Q ss_pred CccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHc
Q 016152 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--PYEAAKYVAE 377 (394)
Q Consensus 323 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~--~~~~~~~i~~ 377 (394)
..+++.|++||.+.+..++.++|+||||+++|+|++|..||...+ ..+....+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 208 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK 208 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc
Confidence 468889999999988889999999999999999999999998776 6777777764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=269.00 Aligned_cols=210 Identities=32% Similarity=0.541 Sum_probs=182.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++... ++.+++|.+...... ..+.+.+|+.++++++||||+++++.+.+...++++||
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 6888999999999999999874 678999988654322 34778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+.+++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILL--TEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEE--CCCCCEEECccccchhhhhhhh
Confidence 99999999999876 78999999999999999999999988 9999999999999 7888999999999876653221
Q ss_pred cccccccCCccCccccCccccCCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHR---KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g 378 (394)
......++..|+|||.+... .++.++|+||||+++|+|++|++||...+..+....+...
T Consensus 157 ----~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 219 (262)
T cd06613 157 ----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS 219 (262)
T ss_pred ----ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 12335688899999999776 8899999999999999999999999988777666655544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=270.02 Aligned_cols=226 Identities=29% Similarity=0.481 Sum_probs=182.2
Q ss_pred cccceeecCCceEEEEEEECCc----cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC------Ce
Q 016152 160 SSSAIIGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------KP 229 (394)
Q Consensus 160 ~~~~~iG~G~~g~V~~a~~~g~----~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~ 229 (394)
.+++.||+|+||.||+|..... .+|+|.+..... .....+.+..|+.+++.++||||+++++.+... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4678899999999999987532 588997754432 334457788899999999999999999976432 24
Q ss_pred eEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 230 LMLITEYLRGGDLHKYLKE------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~------~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
.+++|||+.+++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.++|+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Df 156 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCML--NENMNVCVADF 156 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEE--cCCCCEEECCC
Confidence 6899999999999988742 234789999999999999999999988 9999999999999 78889999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~ 382 (394)
|++......... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+..+.+..+..+.
T Consensus 157 g~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd05075 157 GLSKKIYNGDYY--RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK 234 (272)
T ss_pred CcccccCcccce--ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999866432210 01122346778999999999999999999999999999999 899999988888889998877655
Q ss_pred CCCCCCCcccc
Q 016152 383 FRAKGFTPELR 393 (394)
Q Consensus 383 ~~~~~~~~~~~ 393 (394)
.+. .++++++
T Consensus 235 ~~~-~~~~~~~ 244 (272)
T cd05075 235 QPP-DCLDGLY 244 (272)
T ss_pred CCC-CCCHHHH
Confidence 443 3555543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=277.31 Aligned_cols=209 Identities=29% Similarity=0.503 Sum_probs=174.4
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|.+.+.||+|+||.||++... +..+|+|.+....... ....+.+|+.++++++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 36889999999999999999874 6789999886443222 1245678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
||+++ +|.+++... ..++...+..++.|++.||.|||++| |+||||||+||++ +..+.+||+|||++.......
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLI--NERGELKLADFGLARAKSVPT 158 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEECccccceecCCCc
Confidence 99975 888888754 45899999999999999999999988 9999999999999 888899999999987543222
Q ss_pred ccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
. ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|++||.+.+..+....+.
T Consensus 159 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 218 (309)
T cd07872 159 K----TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218 (309)
T ss_pred c----ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 1 1223467899999999865 468899999999999999999999998887666555543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=268.97 Aligned_cols=218 Identities=32% Similarity=0.604 Sum_probs=185.6
Q ss_pred CccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEecc
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 237 (394)
+|++.+.||+|+||.||++...++.+++|.+.... ....+.+|+.++++++||||+++++++..+ ..+++|||+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 68889999999999999999899999999874422 235678899999999999999999988654 479999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 238 RGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 238 ~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
.+++|.+++...+ .+++..+..++.|++.||.|||+.| ++||||||+||++ +.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili--~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILV--SEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEE--cCCCcEEECCCccceeccccC--
Confidence 9999999997643 4889999999999999999999988 9999999999999 778899999999987543221
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....+..|+|||.+.+..++.++|+||||+++|||++ |++||...+..+....+.++.++..+ +.+|++++
T Consensus 155 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 227 (254)
T cd05083 155 -----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP-EGCPADVY 227 (254)
T ss_pred -----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCC-CcCCHHHH
Confidence 12334567999999998899999999999999999997 99999999988888888888766654 44666654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=269.71 Aligned_cols=227 Identities=28% Similarity=0.555 Sum_probs=186.7
Q ss_pred CcCccccceeecCCceEEEEEEECC-----ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~g-----~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
..+|.+.+.||+|+||.||+|.+.. ..+++|...... .....+.+.+|+.++++++||||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 3467888999999999999998642 368888764432 23345678899999999999999999998875 557
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 231 MLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
++||||+++++|.+++.... .+++.++..++.|++.||.|||+.+ ++||||||+||++ +..+.++|+|||++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili--~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLV--SSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEE--ecCCCeEEccCceeeec
Confidence 89999999999999998644 5899999999999999999999988 9999999999999 77889999999998765
Q ss_pred ccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~ 388 (394)
..... .......++..|+|||.+....++.++||||||+++||+++ |..||...+..+....+.++.++..+. .+
T Consensus 158 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 233 (270)
T cd05056 158 EDESY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPP-NC 233 (270)
T ss_pred ccccc---eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCC-CC
Confidence 43321 11122335578999999988889999999999999999986 999999988888888888887776553 46
Q ss_pred Ccccc
Q 016152 389 TPELR 393 (394)
Q Consensus 389 ~~~~~ 393 (394)
|++++
T Consensus 234 ~~~~~ 238 (270)
T cd05056 234 PPTLY 238 (270)
T ss_pred CHHHH
Confidence 66554
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=269.71 Aligned_cols=223 Identities=32% Similarity=0.523 Sum_probs=183.6
Q ss_pred CccccceeecCCceEEEEEEECC-ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g-~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
+|++.+.||+|+||.||+|.+.+ ..+++|.+...... ...+.+|+.+++.++||||+++++.+. ....++||||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 68999999999999999998754 46899987643322 256788999999999999999999775 4568999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 237 ~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
+.+++|.+++.+. ..+++..+..++.|+++||.|||+++ ++||||||+||++ +.++.++|+|||.+..+.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill--~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEE--cCCCcEEeccCCceeecccccc
Confidence 9999999999763 35889999999999999999999988 9999999999999 7788999999999976643321
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
. ......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||.+.+..+....+..+.++... ..+|+++.
T Consensus 158 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~ 233 (262)
T cd05071 158 T---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP-PECPESLH 233 (262)
T ss_pred c---cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCc-cccCHHHH
Confidence 1 1123346778999999988899999999999999999999 99999998888888888776544333 33555543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=268.86 Aligned_cols=227 Identities=34% Similarity=0.603 Sum_probs=186.0
Q ss_pred CccccceeecCCceEEEEEEEC--Cc---cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GT---PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~---~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
+|+..+.||+|+||.||+|... +. .+++|.+.... .....+.+.+|+.+++.++||||+++.+++...+..++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 6778899999999999999864 32 58888775432 23334678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
||||+.+++|.+++..+ +.+++.++..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILV--NSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEE--cCCCcEEECCCccceeccc
Confidence 99999999999999764 57899999999999999999999988 9999999999999 7788999999999876643
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCc
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~ 390 (394)
..... ........++.|+|||.+....++.++||||||+++|||++ |+.||...+..+....|..+.++..+. .+++
T Consensus 160 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~-~~~~ 237 (268)
T cd05063 160 DPEGT-YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPM-DCPS 237 (268)
T ss_pred ccccc-eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCC-CCCH
Confidence 32111 11112233567999999998889999999999999999997 999999888888888888765443332 3454
Q ss_pred cc
Q 016152 391 EL 392 (394)
Q Consensus 391 ~~ 392 (394)
++
T Consensus 238 ~~ 239 (268)
T cd05063 238 AV 239 (268)
T ss_pred HH
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=274.12 Aligned_cols=223 Identities=32% Similarity=0.491 Sum_probs=189.5
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|+..+.||+|+||.||++.. .++.+++|.+...........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 688899999999999999986 478899998865544444555678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+.+ +|.+++.. .+.+++.++..++.|++.+|.|||+.+ |+||||+|+||++ +.++.++|+|||++......
T Consensus 96 ~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~--~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 96 YCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILL--TEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred hhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEE--CCCCCEEEeecCcceecCCC--
Confidence 9974 88777764 457999999999999999999999988 9999999999999 78889999999998755322
Q ss_pred cccccccCCccCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
....+++.|+|||.+. ...++.++||||||+++|||++|++||...+.......+..+.+|.+....++++
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDY 242 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHH
Confidence 2356788999999874 4568899999999999999999999999888877777777777777766666666
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 243 ~~ 244 (307)
T cd06607 243 FR 244 (307)
T ss_pred HH
Confidence 54
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=269.44 Aligned_cols=228 Identities=31% Similarity=0.541 Sum_probs=186.0
Q ss_pred CccccceeecCCceEEEEEEEC--C---ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--G---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g---~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
+|++.+.||+|+||.||+|... + ..+++|.+.... .......+..|+.+++.++||||+++++++.++...++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 5778899999999999999864 2 359999875432 34445778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
||||+++++|.+++... +.+++.++..++.|++.||.|||++| ++|+||||+||++ +.++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili--~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEE--cCCCcEEECCCcccccccc
Confidence 99999999999999764 56899999999999999999999988 9999999999999 7888999999999876654
Q ss_pred cccccccc-ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 016152 312 QNSHDVYK-MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389 (394)
Q Consensus 312 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~ 389 (394)
........ ......+..|+|||.+.+..++.++||||||+++||+++ |..||...+..+..+.+..+.+...+ ..+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-~~~~ 237 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPP-MDCP 237 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc-ccCC
Confidence 32211111 111112457999999998999999999999999999886 99999998888888888765443333 2355
Q ss_pred ccc
Q 016152 390 PEL 392 (394)
Q Consensus 390 ~~~ 392 (394)
+++
T Consensus 238 ~~~ 240 (269)
T cd05065 238 TAL 240 (269)
T ss_pred HHH
Confidence 554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=269.95 Aligned_cols=206 Identities=29% Similarity=0.565 Sum_probs=175.0
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCC---cHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSD---DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~---~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
+|+..+.||+|++|.||++.. .++.+++|.+...... .....+.+.+|+.++++++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 377788999999999999975 4788999988643322 12345778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC-cEEEeecCCcccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKV 311 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~-~~kl~DFg~a~~~~~ 311 (394)
|+||+++++|.+++.+.+++++..+..++.|++.||.|||+++ ++|+||+|+||++ +.++ .++|+|||++..+..
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~--~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLI--DSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEEccccccccccc
Confidence 9999999999999988888999999999999999999999988 9999999999999 5554 699999999887654
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
.............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 32111111223568899999999988889999999999999999999999997544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=271.11 Aligned_cols=231 Identities=28% Similarity=0.467 Sum_probs=189.7
Q ss_pred CCCcCccccceeecCCceEEEEEEECC------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe-
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE- 226 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~~g------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~- 226 (394)
....+|++.+.||+|+||.||+|.+.. ..+++|.+... ........+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 344578899999999999999998753 67888876533 234445778899999999999999999998765
Q ss_pred CCeeEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcE
Q 016152 227 RKPLMLITEYLRGGDLHKYLKEK--------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~ 298 (394)
....++++||+.+++|.+++... ..+++.++..++.|++.||.|||+.+ ++||||||+||++ +..+.+
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~--~~~~~~ 156 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVI--DEELQV 156 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEE--cCCCcE
Confidence 56789999999999999998753 45899999999999999999999988 9999999999999 777899
Q ss_pred EEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc
Q 016152 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 299 kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~ 377 (394)
||+|||+++.+....... ......++..|+|||.+.+..++.++||||||+++||+++ |++||...++.+....+..
T Consensus 157 kl~d~g~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 234 (280)
T cd05043 157 KITDNALSRDLFPMDYHC--LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD 234 (280)
T ss_pred EECCCCCcccccCCceEE--eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc
Confidence 999999998654332111 1122346778999999988889999999999999999999 9999999898888888888
Q ss_pred CCCCCCCCCCCCcccc
Q 016152 378 GHRPFFRAKGFTPELR 393 (394)
Q Consensus 378 g~~p~~~~~~~~~~~~ 393 (394)
+.++.... .+|++++
T Consensus 235 ~~~~~~~~-~~~~~~~ 249 (280)
T cd05043 235 GYRLAQPI-NCPDELF 249 (280)
T ss_pred CCCCCCCC-cCCHHHH
Confidence 76655443 3566654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=271.45 Aligned_cols=216 Identities=32% Similarity=0.534 Sum_probs=186.5
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|+..+.||.|+||.||+|... +..+|+|.+..... ......+.+|+.+++.+.||||+++++.+.++...++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 5778889999999999999874 67899998754322 3345778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++++|.+++.. +++++.++..++.|++.+|.|||+.+ ++|+||+|+||++ +.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~--~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEE--cCCCCEEEcccccceeccCCcc-
Confidence 9999999998865 56899999999999999999999988 9999999999999 7888999999999976543221
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~ 384 (394)
......++..|+|||.+.+..++.++|+||||+++|||++|.+||...++.+....+..+.+|.+.
T Consensus 157 ---~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (277)
T cd06640 157 ---KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLT 222 (277)
T ss_pred ---ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCc
Confidence 123346788999999999888999999999999999999999999988888888777777666654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=274.16 Aligned_cols=229 Identities=31% Similarity=0.480 Sum_probs=184.1
Q ss_pred CcCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeC
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER 227 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~ 227 (394)
..+|.+.+.||+|+||.||++... +..+|+|.+..... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 347889999999999999998742 34689997754322 33346788999999999 799999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 228 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
+..+++|||+.+++|.+++.... .+++.++..++.|++.||.|||+++ |+|+||||+||++ +.++.++|+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLL--THGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEE--cCCCeEEECCCcc
Confidence 99999999999999999997643 3899999999999999999999988 9999999999999 7788999999999
Q ss_pred ccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHH-HHHHcCCCCCC
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA-KYVAEGHRPFF 383 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~-~~i~~g~~p~~ 383 (394)
+..+...... .......++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..+.. +.+..+.++..
T Consensus 188 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 188 ARDIMNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred cccccCCCce--eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 9866433211 11222346788999999998999999999999999999998 99999887655444 44445544433
Q ss_pred CCCCCCcccc
Q 016152 384 RAKGFTPELR 393 (394)
Q Consensus 384 ~~~~~~~~~~ 393 (394)
+ ...+++++
T Consensus 266 ~-~~~~~~~~ 274 (302)
T cd05055 266 P-EHAPAEIY 274 (302)
T ss_pred C-CCCCHHHH
Confidence 3 33455554
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=271.54 Aligned_cols=202 Identities=29% Similarity=0.498 Sum_probs=179.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||.|+||.||++... ++.+++|.+.+.........+.+.+|+.++++++||||+++++.+.+...+++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999875 78899999876554444456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++++|.+++.....+++.++..++.|++++|.|||+.+ ++|+||+|+||++ +.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~--~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILL--DEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEE--cCCCCEEEeecccccccCCCc--
Confidence 9999999999988878999999999999999999999988 9999999999999 888899999999988665332
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~ 368 (394)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 12345688899999999888899999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=272.87 Aligned_cols=213 Identities=32% Similarity=0.506 Sum_probs=179.9
Q ss_pred cCccccceeecCCceEEEEEEECC------------------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCcee
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWRG------------------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~g------------------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 218 (394)
.+|++.+.||+|+||.||++.... ..+|+|.+..... ......+.+|+.++++++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCEe
Confidence 478899999999999999987642 3479998764432 23456788999999999999999
Q ss_pred eEEeEEEeCCeeEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCC
Q 016152 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 287 (394)
Q Consensus 219 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-----------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~N 287 (394)
++++++..+..++++||++.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRN 160 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhc
Confidence 99999999999999999999999999998755 6899999999999999999999988 9999999999
Q ss_pred EEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc--CCCCCCC
Q 016152 288 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE--GEPPLAN 365 (394)
Q Consensus 288 ilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~--g~~Pf~~ 365 (394)
|++ +..+.++|+|||++.......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 161 ili--~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLV--GKNYTIKIADFGMSRNLYSSDYYR--VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eee--cCCCceEEccccceeecccCccee--ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999 777899999999987654332111 1223456788999999988889999999999999999998 8899988
Q ss_pred CCHHHHHHHHHc
Q 016152 366 YEPYEAAKYVAE 377 (394)
Q Consensus 366 ~~~~~~~~~i~~ 377 (394)
.+..+..+.+..
T Consensus 237 ~~~~~~~~~~~~ 248 (296)
T cd05051 237 LTDQQVIENAGH 248 (296)
T ss_pred cChHHHHHHHHh
Confidence 887777766654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=277.89 Aligned_cols=233 Identities=33% Similarity=0.552 Sum_probs=189.2
Q ss_pred CcccCCCCcCccccceeecCCceEEEEEEEC---------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCcee
Q 016152 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIV 218 (394)
Q Consensus 149 ~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~---------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv 218 (394)
.|++. ..+|++++.||+|+||.||++... +..+|+|.+.... .....+.+.+|+.+++++ +||||+
T Consensus 6 ~~~~~--~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv 81 (334)
T cd05100 6 KWELS--RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNII 81 (334)
T ss_pred ccccC--HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCee
Confidence 44443 347899999999999999999752 1258999765332 233456788999999999 799999
Q ss_pred eEEeEEEeCCeeEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecC
Q 016152 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282 (394)
Q Consensus 219 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~----------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~D 282 (394)
++++++.....++++|||+.+++|.+++.... .++..++..++.|++.||.|||++| ++|||
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~d 159 (334)
T cd05100 82 NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRD 159 (334)
T ss_pred eeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccc
Confidence 99999999999999999999999999997532 3778889999999999999999988 99999
Q ss_pred CCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCC
Q 016152 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEP 361 (394)
Q Consensus 283 ikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~ 361 (394)
|||+||++ +.++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..
T Consensus 160 lkp~Nill--~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 235 (334)
T cd05100 160 LAARNVLV--TEDNVMKIADFGLARDVHNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235 (334)
T ss_pred cccceEEE--cCCCcEEECCcccceeccccccc--ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCC
Confidence 99999999 77889999999998765432211 01122334568999999999999999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 362 PLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 362 Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
||...+..+..+.+..+.++..+. .+++++
T Consensus 236 p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l 265 (334)
T cd05100 236 PYPGIPVEELFKLLKEGHRMDKPA-NCTHEL 265 (334)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCC-CCCHHH
Confidence 999999889888888877666553 345554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=266.55 Aligned_cols=226 Identities=26% Similarity=0.487 Sum_probs=191.8
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.+|.+.. .|+.+++|.+....... .....+.+|+.++++++||||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 478889999999999999886 47789999876443322 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|+.+++|.+++.... .+++.++..++.|++.+|.|||+++ ++|+||+|+||++ +.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~--~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFL--TKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--cCCCCEEEeeccceeecCcch
Confidence 999999999987643 5789999999999999999999988 9999999999999 778899999999997664332
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..+.+|..+. .++++++
T Consensus 156 ~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 230 (256)
T cd08218 156 E----LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSS-HYSYDLR 230 (256)
T ss_pred h----hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcc-cCCHHHH
Confidence 1 1223457889999999998889999999999999999999999999888888888888888776654 3565543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=282.63 Aligned_cols=205 Identities=26% Similarity=0.377 Sum_probs=171.9
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC------C
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~ 228 (394)
.+|++.+.||+|+||.||++... ++.+|||.+...... ......+.+|+.+++.++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 37999999999999999999864 778999988654332 33346677899999999999999999988643 3
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.+++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill--~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 168 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEE--CCCCCEEEeeCccccc
Confidence 47999999976 77777654 4889999999999999999999988 9999999999999 8888999999999976
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 374 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~ 374 (394)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 169 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 229 (355)
T cd07874 169 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229 (355)
T ss_pred CCCcc-----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 53221 22345789999999999999999999999999999999999999988776555443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=267.93 Aligned_cols=213 Identities=26% Similarity=0.424 Sum_probs=169.0
Q ss_pred eeecCCceEEEEEEEC----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 164 IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
.||+|+||.||+|... ...+++|.+.... .......+.+|+.+++.++||||+++++.+.....+++||||+.+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 5899999999998642 2357888664322 233346678899999999999999999999999999999999999
Q ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 240 GDLHKYLKEKG-----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 240 ~sL~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
++|.+++.... ..++..+..++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQL--TADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEe--cCCCcEEEeccccccccccchh
Confidence 99999997642 2467788999999999999999988 9999999999999 7888999999999865432211
Q ss_pred cccccccCCccCccccCccccCC-------CCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKH-------RKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~ 384 (394)
. .......+++.|+|||++.. ..++.++|||||||++|||++ |..||...+..+....+.....+.++
T Consensus 156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd05042 156 Y--ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231 (269)
T ss_pred e--eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCC
Confidence 0 01123346778999998742 456889999999999999999 89999988877777666554443333
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=263.27 Aligned_cols=220 Identities=33% Similarity=0.567 Sum_probs=182.1
Q ss_pred eeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCCCH
Q 016152 164 IIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~sL 242 (394)
+||+|+||.||++... +..+|+|.+.... .......+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 6899999999999864 5679999775433 233345688999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccccc
Q 016152 243 HKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321 (394)
Q Consensus 243 ~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~ 321 (394)
.+++... ..+++.++..++.|++.+|.|+|+++ ++||||||+||++ +.++.++|+|||++......... ...
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili--~~~~~~~l~d~g~~~~~~~~~~~---~~~ 152 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLV--GENNVLKISDFGMSRQEDDGIYS---SSG 152 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEE--cCCCeEEECCCccceeccccccc---cCC
Confidence 9998754 46899999999999999999999988 9999999999999 78889999999998754322110 111
Q ss_pred CCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 322 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 322 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
...++..|+|||++.+..++.++|+||||+++|++++ |..||...+..+....+..+.++.++. .++++++
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 224 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQ-KCPDDVY 224 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCHHHH
Confidence 2234677999999998889999999999999999998 999999888888888888877665543 3555543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=265.85 Aligned_cols=223 Identities=30% Similarity=0.543 Sum_probs=186.8
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|.+.+.||+|+||.||++.. .+..+++|.+...... ....+.+..|+.+++.++|+||+++++.+.....+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 477889999999999999986 4778999988655433 3456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++ +.++.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~--~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEcccccccccCCCCCc
Confidence 9999999999988777999999999999999999999988 9999999999999 77889999999999876544322
Q ss_pred ccccccCCccCccccCccccCCCC---CCCcchHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCCCCCC
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGv~l~el~~g~~Pf~~~-~~~~~~~~i~~g~~p~~~~ 385 (394)
.........+++.|+|||.+.+.. ++.++||||||+++|++++|+.||... +.......+..+..|.++.
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 229 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPD 229 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCc
Confidence 111122456889999999998766 889999999999999999999999766 3444444555565665554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=269.47 Aligned_cols=200 Identities=36% Similarity=0.625 Sum_probs=174.1
Q ss_pred ccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
|++++.||+|+||.||++... ++.+|+|.+........ ......+|+.++++++||||+++++++.+....+++||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 677889999999999999986 44699999876543322 223445699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccc
Q 016152 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316 (394)
Q Consensus 237 ~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~ 316 (394)
+.+++|.+++...+.+++.++..++.|+++||.+||+++ ++|+||||+||++ +.++.++|+|||.+......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~--~~~~~~~l~Dfg~~~~~~~~---- 151 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILL--DENGEVKLIDFGSSVKLSEN---- 151 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEE--STTSEEEESSGTTTEESTST----
T ss_pred ccccccccccccccccccccccccccccccccccccccc--ccccccccccccc--cccccccccccccccccccc----
Confidence 999999999997888999999999999999999999988 9999999999999 88899999999998754111
Q ss_pred cccccCCccCccccCccccC-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 317 VYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 317 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
........++..|+|||.+. +..++.++|+||||+++|+|++|..||...+
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~ 203 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN 203 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 11334567899999999998 7889999999999999999999999999873
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=274.22 Aligned_cols=213 Identities=30% Similarity=0.513 Sum_probs=179.9
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||++.. .++.+|+|.+...... ..+.+.+|+.+++.++||||+++++.+..+..+++||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 4789999999999999999986 4789999988543322 2356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++++|.+++.+ ..+++.++..++.|++.+|.|||+.+ ++||||||+|||+ +.++.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili--~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEECcCccceEccCCcc
Confidence 99999999999865 45899999999999999999999988 9999999999999 7888999999999876543221
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
......+++.|+|||.+.+..++.++|+||||+++|++++|..||...++.+....+..+..|
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 233 (297)
T cd06656 171 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233 (297)
T ss_pred ----CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC
Confidence 122356889999999999888999999999999999999999999877665544444443333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=268.13 Aligned_cols=219 Identities=31% Similarity=0.598 Sum_probs=183.4
Q ss_pred cCccccceeecCCceEEEEEEEC--Cc----cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~----~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
.+|++.+.||+|+||.||+|... |. .+++|.+..... ......+.+|+.++++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 47888999999999999999863 32 588887654432 3445678899999999999999999998887 788
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 231 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
++||||+.+++|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++..+
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~--~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLV--KTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEE--cCCCeEEECCCcccccc
Confidence 9999999999999999864 46899999999999999999999988 9999999999999 77889999999999876
Q ss_pred ccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~ 384 (394)
...... .......++..|+|||.+....++.++|+||||+++||+++ |+.||...+..++...+..+..+..+
T Consensus 160 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (279)
T cd05057 160 DVDEKE--YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP 233 (279)
T ss_pred cCcccc--eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCC
Confidence 533221 11222334678999999988899999999999999999998 99999999888888888876554443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=266.11 Aligned_cols=224 Identities=28% Similarity=0.531 Sum_probs=178.8
Q ss_pred ceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE-eCCeeEEEEec
Q 016152 163 AIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT-ERKPLMLITEY 236 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-~~~~~~lv~e~ 236 (394)
+.||+|+||.||+|... ...+|+|.+... ......+.+.+|+.+++.++||||+++++++. .+...+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 36899999999999853 246899976432 22334567888999999999999999999765 45568999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 237 ~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
+.+++|.+++.+. ..++...+..++.|+++||.|||+.+ ++||||||+|||+ +..+.+||+|||++.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili--~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCML--DESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEE--cCCCcEEECCccccccccCCcce
Confidence 9999999999764 35678888999999999999999988 9999999999999 77889999999998765432211
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.........++..|+|||.+.+..++.++||||||+++|||++ |.+||...+..+..+.+..+.++..+ ..+|++++
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP-EYCPDPLY 232 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC-CcCCHHHH
Confidence 1111223446778999999988899999999999999999999 67889888888888888887666554 33565543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=268.72 Aligned_cols=228 Identities=31% Similarity=0.517 Sum_probs=190.0
Q ss_pred cCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
.+|++...||+|+||.||+|..+ ...+++|.+.... .......+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 37888999999999999999863 3468888764322 23345678899999999999999999999999899
Q ss_pred eEEEEeccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEE
Q 016152 230 LMLITEYLRGGDLHKYLKEKG---------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl 300 (394)
.++||||+++++|.+++.... .+++..+..++.|++.+|.|||+++ |+||||||+||++ +..+.++|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili--~~~~~~~l 158 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLV--SSQREVKV 158 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEE--eCCCcEEE
Confidence 999999999999999998655 6899999999999999999999988 9999999999999 77889999
Q ss_pred eecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC
Q 016152 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH 379 (394)
Q Consensus 301 ~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~ 379 (394)
+|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+.
T Consensus 159 ~~~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~ 235 (275)
T cd05046 159 SLLSLSKDVYNSE---YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235 (275)
T ss_pred cccccccccCccc---ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC
Confidence 9999987543221 112234456788999999988888999999999999999998 899998888888888888776
Q ss_pred CCCCCCCCCCcccc
Q 016152 380 RPFFRAKGFTPELR 393 (394)
Q Consensus 380 ~p~~~~~~~~~~~~ 393 (394)
.++.....+|++++
T Consensus 236 ~~~~~~~~~~~~l~ 249 (275)
T cd05046 236 LELPVPEGCPSRLY 249 (275)
T ss_pred cCCCCCCCCCHHHH
Confidence 66554455666654
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=271.60 Aligned_cols=208 Identities=31% Similarity=0.505 Sum_probs=168.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC---CCCceeeEEeEEEe-----C
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTE-----R 227 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~-----~ 227 (394)
+|++.+.||+|+||.||+|... ++.+|+|.+........ ......+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 4788899999999999999874 77899998865432211 112344566666554 79999999998764 2
Q ss_pred CeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 228 KPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
..++++||++.+ +|.+++... ..+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||+
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili--~~~~~~kl~dfg~ 154 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILV--TSGGQVKLADFGL 154 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEECccCc
Confidence 458999999975 898888763 34899999999999999999999988 9999999999999 8888999999999
Q ss_pred ccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
+....... ......+|+.|+|||++.+..++.++|||||||++|+|++|++||...+..+....+.
T Consensus 155 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~ 220 (288)
T cd07863 155 ARIYSCQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 220 (288)
T ss_pred cccccCcc-----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHH
Confidence 97664322 1233568999999999998899999999999999999999999998877666555543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=284.02 Aligned_cols=195 Identities=23% Similarity=0.415 Sum_probs=169.2
Q ss_pred cCccccceeecCCceEEEEEEEC----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
.+|.+.+.||+|+||.||++... +..+++|.+... ....+|+.+++.++||||+++++++.....+++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 47999999999999999998754 356888876432 234579999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
+||++. ++|.+++...+.+++.+++.++.||+.||.|||++| |+||||||+|||+ +..+.++|+|||++..+...
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill--~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFL--DEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--cCCCCEEEccCccccccCcc
Confidence 999995 599999977788999999999999999999999988 9999999999999 88889999999999765533
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 239 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 239 PD--TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred cc--cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 21 11223467999999999999999999999999999999999999999664
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=265.41 Aligned_cols=226 Identities=29% Similarity=0.529 Sum_probs=193.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|++|.||++... +..+++|.+...... .....+.+|+..+++++|+||+++++++......+++||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 5788899999999999999875 788999988654332 445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++++|.+++.....+++..+..++.|++++|.|||+ .+ ++||||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~--~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLI--NSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEE--CCCCCEEEccCccceecccCCC
Confidence 99999999999888889999999999999999999999 98 9999999999999 8889999999999886653322
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~---~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
. .....++..|+|||.+....++.++|+||||+++|+|++|++||... +..+..+.+.....+.+....+|+.
T Consensus 156 ~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (264)
T cd06623 156 Q----CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPE 231 (264)
T ss_pred c----ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHH
Confidence 1 12345788999999999889999999999999999999999999777 5567777777766666655446655
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 232 l~ 233 (264)
T cd06623 232 FR 233 (264)
T ss_pred HH
Confidence 54
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=264.43 Aligned_cols=224 Identities=39% Similarity=0.666 Sum_probs=190.2
Q ss_pred cccceeecCCceEEEEEEECC------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 160 SSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 160 ~~~~~iG~G~~g~V~~a~~~g------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
++.+.||.|+||.||++.... ..+|+|.+..... ....+.+..|+.+++.++|+||+++++++.+.+..+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 466789999999999998864 7799998854432 22457788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 234 TEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~--~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
|||+.+++|.+++..... +++.++..++.|++.+|.+||+.+ ++|+||||+||++ +.++.++|+|||++.....
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~--~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLV--GENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEE--ccCCeEEEcccCCceeccc
Confidence 999999999999986544 899999999999999999999988 9999999999999 8888999999999987654
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCc
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~ 390 (394)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..+..+.+..+.++..+.. +|+
T Consensus 156 ~~~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 231 (258)
T smart00219 156 DDYY---KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPEN-CPP 231 (258)
T ss_pred cccc---ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCc-CCH
Confidence 3211 1112336789999999988889999999999999999998 8999999998899999988887766644 666
Q ss_pred ccc
Q 016152 391 ELR 393 (394)
Q Consensus 391 ~~~ 393 (394)
+++
T Consensus 232 ~~~ 234 (258)
T smart00219 232 EIY 234 (258)
T ss_pred HHH
Confidence 554
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=269.57 Aligned_cols=224 Identities=30% Similarity=0.536 Sum_probs=192.2
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|+..+.||+|++|.||++... ++.+++|.+..... ......+.+|+.++++++||||+++++.+......++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 5778889999999999999885 77899998865433 2445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~-~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|+.+++|.+++... ..+++..+..++.|++.+|.|||+ .+ ++|+||||+||++ +.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~--~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILV--NSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEE--CCCCCEEEeecccchhhHHHH
Confidence 99999999999875 789999999999999999999999 88 9999999999999 778899999999987654322
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHcCCCCCCCCCCC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-----EPYEAAKYVAEGHRPFFRAKGF 388 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~-----~~~~~~~~i~~g~~p~~~~~~~ 388 (394)
. ....++..|+|||.+.+..++.++|+||||+++|+|++|..||... ...+..+.+..+..|.++...+
T Consensus 156 ~------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06605 156 A------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKF 229 (265)
T ss_pred h------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhc
Confidence 1 1266888999999999889999999999999999999999999764 3556667777777777776657
Q ss_pred Ccccc
Q 016152 389 TPELR 393 (394)
Q Consensus 389 ~~~~~ 393 (394)
+++++
T Consensus 230 ~~~~~ 234 (265)
T cd06605 230 SPDFQ 234 (265)
T ss_pred CHHHH
Confidence 76664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=281.44 Aligned_cols=212 Identities=28% Similarity=0.488 Sum_probs=181.0
Q ss_pred cceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 162 SAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
.++||+|.||+||-|.+ .|+.||||++.+.....+.. ..+++|+.+|+++.||.||.+--.|+..+.+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 56899999999999976 49999999997765554433 7789999999999999999999999999999999999966
Q ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-CCCCcEEEeecCCccccccccccc
Q 016152 240 GDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSHD 316 (394)
Q Consensus 240 ~sL~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-~~~~~~kl~DFg~a~~~~~~~~~~ 316 (394)
++...|- +++++++..-..++.||+.||.|||-++ |+|+||||+|||+.. ++-.++||||||+|+.+.+...
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 6555553 4688999999999999999999999988 999999999999943 3446899999999998876542
Q ss_pred cccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 016152 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 317 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~ 384 (394)
.++.+|||.|+|||+++++.|...-|+||+||++|--+.|..||... +++-++|....+...+
T Consensus 723 ---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp 785 (888)
T KOG4236|consen 723 ---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPP 785 (888)
T ss_pred ---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCC
Confidence 35678999999999999999999999999999999999999999764 3566777665444433
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=271.65 Aligned_cols=223 Identities=27% Similarity=0.476 Sum_probs=183.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++... +..+|+|.+.... .......+.+|+.++++++||||+++++.+...+.+++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 5788999999999999999885 7889999875432 22334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 236 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 236 ~~~~~sL~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~-~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
|+++++|..++... ..+++..+..++.|++.||.|||+. + |+||||||+||++ +.++.++|+|||++..+..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLV--NGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEE--CCCCCEEEeecCCcccccC
Confidence 99999999988763 3689999999999999999999964 6 9999999999999 7788999999999876542
Q ss_pred ccccccccccCCccCccccCccccCCC------CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHcCCCCC
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHR------KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA---KYVAEGHRPF 382 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~---~~i~~g~~p~ 382 (394)
.. .....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..... ..+..+.+|.
T Consensus 156 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd06622 156 SL------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT 229 (286)
T ss_pred Cc------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC
Confidence 21 2234678899999998543 3588999999999999999999999766554433 4455666666
Q ss_pred CCCCCCCcccc
Q 016152 383 FRAKGFTPELR 393 (394)
Q Consensus 383 ~~~~~~~~~~~ 393 (394)
++.. ++++++
T Consensus 230 ~~~~-~~~~~~ 239 (286)
T cd06622 230 LPSG-YSDDAQ 239 (286)
T ss_pred CCcc-cCHHHH
Confidence 6644 666654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=264.72 Aligned_cols=225 Identities=29% Similarity=0.509 Sum_probs=187.9
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCC--CcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~--~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
+|+..+.||+|++|.||+|... ++.+++|.+..... ......+.+.+|+.+++.++|+||+++++++.+...++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999874 78999998755332 2234456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
+||+++++|.+++.+.+.+++..+..++.|++.+|.|||+.+ ++|+||+|+||++ +.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~--~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILV--DTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEccCccceeccccc
Confidence 999999999999988888999999999999999999999988 9999999999999 788899999999987654332
Q ss_pred ccccccccCCccCccccCccccCCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCCcc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE-GHRPFFRAKGFTPE 391 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~-g~~p~~~~~~~~~~ 391 (394)
......+++.|++||.+.... ++.++|+||||+++|+|++|++||...+..+....+.. +..|.++. .++++
T Consensus 157 -----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 230 (258)
T cd06632 157 -----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPD-HLSDE 230 (258)
T ss_pred -----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCC-CcCHH
Confidence 123456889999999987766 89999999999999999999999988776665555554 44555443 34554
Q ss_pred c
Q 016152 392 L 392 (394)
Q Consensus 392 ~ 392 (394)
+
T Consensus 231 ~ 231 (258)
T cd06632 231 A 231 (258)
T ss_pred H
Confidence 4
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=266.77 Aligned_cols=224 Identities=32% Similarity=0.543 Sum_probs=189.2
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
-|+..+.||+|+||.||++.. .+..+|+|.+.... .......+.+|+.++++++||||+++++++..+...++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 367788999999999999986 46789999874332 23334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+.+++|.+++.. +.+++..+..++.|++.++.|||+.+ ++|+||+|+||++ +.++.++|+|||++..+.....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i--~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEE--CCCCCEEEeecccceecccchh-
Confidence 9999999998864 46899999999999999999999988 9999999999999 7888999999999876543221
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..+.+|.+.. .++++++
T Consensus 157 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 230 (277)
T cd06641 157 ---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG-NYSKPLK 230 (277)
T ss_pred ---hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCc-ccCHHHH
Confidence 1233568889999999988888999999999999999999999999888888888887777776553 3555543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=266.09 Aligned_cols=207 Identities=33% Similarity=0.602 Sum_probs=175.9
Q ss_pred ceeecCCceEEEEEEEC---Cc--cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEecc
Q 016152 163 AIIGKGSFGEILKAYWR---GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~---g~--~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 237 (394)
+.||+|++|.||+|.+. +. .+|+|.+...... ...+.+.+|+.++++++||||+++++.+.+ ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 36899999999999863 22 5899988654432 455788899999999999999999999888 8899999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 238 RGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 238 ~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
++++|.+++.... .+++..+..++.|++.||+|||+++ ++|+||||+||++ +.++.+||+|||++..+......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~--~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEE--ecCCEEEeccccccccccccccc
Confidence 9999999998754 6899999999999999999999988 9999999999999 77789999999999876543221
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~ 377 (394)
. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+..+.+..
T Consensus 154 ~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 215 (257)
T cd05040 154 Y-VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK 215 (257)
T ss_pred e-ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 1 11123457788999999998899999999999999999998 9999998888887777663
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=269.34 Aligned_cols=225 Identities=29% Similarity=0.580 Sum_probs=188.9
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC---CCceeeEEeEEEeCCeeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~~~~l 232 (394)
.|+..+.||+|+||.||+|.+ .+..+++|.+..... ......+.+|+.+++.++ |||++++++++......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 477788999999999999987 478899998754322 223456778999999986 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||||+++++|.+++.. +.+++..+..++.|++.+|.|||+.+ ++|+||+|+||++ +..+.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILV--TNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEE--cCCCCEEEccCCceeecCCC
Confidence 9999999999999865 47899999999999999999999988 9999999999999 77889999999999876543
Q ss_pred cccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
.. ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.......+....+|.+....++++
T Consensus 155 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (277)
T cd06917 155 SS----KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKL 230 (277)
T ss_pred cc----ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHH
Confidence 21 1233568899999999865 457899999999999999999999999888777777776666777766557766
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 231 ~~ 232 (277)
T cd06917 231 LR 232 (277)
T ss_pred HH
Confidence 54
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=265.51 Aligned_cols=223 Identities=32% Similarity=0.543 Sum_probs=183.6
Q ss_pred CccccceeecCCceEEEEEEECC-ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g-~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
+|.+...||+|++|.||++...+ ..+++|.+..... ..+.+.+|+.++++++|||++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 57888899999999999998764 4789997654322 2256788999999999999999998875 4568999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 237 ~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill--~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILV--GDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEE--cCCCeEEECCCccceEccCCcc
Confidence 9999999999764 34789999999999999999999988 9999999999999 7888999999999976543221
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
. ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+..+.+..+.++..+ ..+|++++
T Consensus 158 ~---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 233 (260)
T cd05069 158 T---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCP-QGCPESLH 233 (260)
T ss_pred c---ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-cccCHHHH
Confidence 1 1122346778999999988889999999999999999999 99999998888888888877655443 34565554
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=265.11 Aligned_cols=226 Identities=30% Similarity=0.526 Sum_probs=190.2
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe--CCeeEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLI 233 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~lv 233 (394)
+|++.+.||+|+||.||++.. .+..+++|.+..... .....+.+..|+.+++.++||||+++++.+.. ...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 477889999999999999986 467899998765433 23445678899999999999999999997754 4568999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCeEecCCCCCCEEEeeCCCCcEEEeecC
Q 016152 234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLH-----NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH-----~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg 304 (394)
|||+++++|.+++.. ...+++.+++.++.|++.||.||| +.+ ++|+||+|+||++ +.++.+||+|||
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili--~~~~~~kl~d~g 155 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFL--DANNNVKLGDFG 155 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEE--ecCCCEEEeccc
Confidence 999999999999875 357899999999999999999999 766 9999999999999 778899999999
Q ss_pred CccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~ 384 (394)
++..+..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+..+.+..+..+.++
T Consensus 156 ~~~~~~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd08217 156 LAKILGHDSS----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIP 231 (265)
T ss_pred ccccccCCcc----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCc
Confidence 9987654322 123356899999999999888999999999999999999999999998888888888888777665
Q ss_pred CCCCCcccc
Q 016152 385 AKGFTPELR 393 (394)
Q Consensus 385 ~~~~~~~~~ 393 (394)
. .++++++
T Consensus 232 ~-~~~~~~~ 239 (265)
T cd08217 232 Y-RYSSELN 239 (265)
T ss_pred c-ccCHHHH
Confidence 3 4565553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=263.83 Aligned_cols=225 Identities=27% Similarity=0.492 Sum_probs=189.6
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|+..+.||+|++|.||++.. .++.+++|.+...... ....+.+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 477889999999999999886 4778999988654333 2335778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC-CCcEEEeecCCccccccc
Q 016152 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 236 ~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~-~~~~kl~DFg~a~~~~~~ 312 (394)
|+++++|.+++... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||++ +. ++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~--~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILL--DKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEEccCCCceecCCC
Confidence 99999999999864 35899999999999999999999988 9999999999999 43 446899999999876533
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..+..+.++. .+++++
T Consensus 156 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l 229 (256)
T cd08220 156 SK-----AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD-RYSPDL 229 (256)
T ss_pred cc-----ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCC-CcCHHH
Confidence 21 223568889999999998889999999999999999999999999988888888887766665553 356655
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 230 ~ 230 (256)
T cd08220 230 R 230 (256)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=272.08 Aligned_cols=223 Identities=33% Similarity=0.527 Sum_probs=187.9
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|+..+.||+|+||.||+|... +..+|+|.+..... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4777889999999999999864 67899998754322 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+.+++|.+++.. +.+++..+..++.|++.||.|||+++ ++|+||+|+||++ +.++.++|+|||++..+.....
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEE--eCCCCEEEccccccccccCcch-
Confidence 9999999998864 56899999999999999999999988 9999999999999 7788999999999876643221
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||....+.+....+..+.+|.+.. .++.++
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 229 (277)
T cd06642 157 ---KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG-QYSKPF 229 (277)
T ss_pred ---hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCc-ccCHHH
Confidence 1223467889999999998899999999999999999999999998887777777777776666553 345444
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=264.42 Aligned_cols=223 Identities=34% Similarity=0.619 Sum_probs=186.7
Q ss_pred CccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
+|++.+.||+|+||.||++.+. +..+++|.+...... ...+.+|+.++++++||+|+++++++......+++|||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 5777889999999999999875 778999987543322 24678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 237 ~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
+++++|.+++... +.+++..+..++.|++.+|.|||+.+ ++||||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~~~~- 155 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLV--GENQVVKVSDFGMTRFVLDDQY- 155 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEE--cCCCeEEECCCcceeecccCcc-
Confidence 9999999999764 56899999999999999999999988 9999999999999 7788999999999876542211
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.......++..|+|||.+.++.++.++|+||||+++|||++ |..||...+..+..+.+.++.++..+. ..++++
T Consensus 156 --~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 230 (256)
T cd05112 156 --TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPR-LASQSV 230 (256)
T ss_pred --cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCC-CCCHHH
Confidence 11223345678999999998889999999999999999998 999999888888888888876665442 244443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=268.44 Aligned_cols=193 Identities=31% Similarity=0.469 Sum_probs=160.8
Q ss_pred eeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHH---hCCCCceeeEEeEEEeCCeeEEEEeccC
Q 016152 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV---KLRHPNIVQFLGAVTERKPLMLITEYLR 238 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~---~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 238 (394)
.||+|+||.||++... ++.+|+|.+.+.............+|..+++ ...||+|+++++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 7889999886654332222233344444333 3479999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccc
Q 016152 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (394)
Q Consensus 239 ~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~ 318 (394)
+++|.+++...+.+++..+..++.|++.||+|||+++ |+||||||+||++ +.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~--~~~~~~~l~dfg~~~~~~~~~----- 151 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK----- 151 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEE--CCCCCEEEccCCcceeccccC-----
Confidence 9999999988888999999999999999999999988 9999999999999 888899999999987553221
Q ss_pred cccCCccCccccCccccC-CCCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 319 KMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
.....||+.|+|||.+. +..++.++|+||+||++|+|++|..||...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 12346899999999986 456899999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=266.96 Aligned_cols=224 Identities=33% Similarity=0.503 Sum_probs=188.3
Q ss_pred eecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCCCH
Q 016152 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (394)
Q Consensus 165 iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~sL 242 (394)
||+|+||.||++... |+.+++|.+.............+.+|+.++++++||||+++++.+......++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999985 889999988655443344557788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccc----cc
Q 016152 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD----VY 318 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~----~~ 318 (394)
.+++.+.+.+++..+..++.|++.||.|||+++ ++|+||+|+||++ +.++.++|+|||++.......... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILI--DSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEE--cCCCCEEEEecccchhcccCcccccccccc
Confidence 999988778999999999999999999999988 9999999999999 888899999999987654332110 01
Q ss_pred cccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
......++..|+|||.+....++.++|+||||+++|+|++|..||...+..+....+..+..+......+++++
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEA 230 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHH
Confidence 12335578899999999888899999999999999999999999999888888888887665544433345544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=269.49 Aligned_cols=229 Identities=31% Similarity=0.500 Sum_probs=188.3
Q ss_pred CcCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
..+|++.+.||+|+||.||++... +..+++|.+.... .......+.+|+.+++.++||||+++++++.++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 347889999999999999999863 4679999875432 2334467889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 016152 229 PLMLITEYLRGGDLHKYLKEKG----------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR 286 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~----------------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~ 286 (394)
.++++|||+.+++|.+++.... .+++.++..++.|++.||.|||+++ ++||||||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~ 159 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATR 159 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHh
Confidence 9999999999999999997432 3678888999999999999999988 999999999
Q ss_pred CEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCC
Q 016152 287 NVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLAN 365 (394)
Q Consensus 287 Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~ 365 (394)
||++ +.++.++|+|||++..+...... ........+..|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 160 nil~--~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 160 NCLV--GENMVVKIADFGLSRNIYSADYY--KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred heEe--cCCCceEECccccceecccCccc--cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999 78889999999998755322110 01122345678999999998899999999999999999997 9999998
Q ss_pred CCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 366 YEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 366 ~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.+..+....+..+..+..+ +.+|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-~~~~~~l~ 262 (288)
T cd05050 236 MAHEEVIYYVRDGNVLSCP-DNCPLELY 262 (288)
T ss_pred CCHHHHHHHHhcCCCCCCC-CCCCHHHH
Confidence 8888888888877765544 34666554
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=265.04 Aligned_cols=223 Identities=29% Similarity=0.517 Sum_probs=186.8
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||++... +..+++|.+..... .+.+.+|+.+++.++||||+++++.+.+...+++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 37889999999999999999875 67899998754321 578889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~--~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILL--NEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEE--CCCCcEEEcccccchhcccCc
Confidence 99999999999975 456899999999999999999999988 9999999999999 778899999999988765432
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCCccc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFTPEL 392 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~~~~~ 392 (394)
. ......++..|+|||.+.+..++.++||||||+++|+|++|++||...+..+....+.....+.+.. ..+++++
T Consensus 154 ~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd06612 154 A----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEF 229 (256)
T ss_pred c----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHH
Confidence 1 1223457889999999998899999999999999999999999998877766665555444443332 2344444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=265.42 Aligned_cols=217 Identities=35% Similarity=0.542 Sum_probs=176.6
Q ss_pred eeecCCceEEEEEEECC--c--cEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEEEeccC
Q 016152 164 IIGKGSFGEILKAYWRG--T--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLR 238 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~g--~--~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~ 238 (394)
.||+|+||.||++...+ . .+++|.+.... .....+.+.+|+.+++++ +||||+++++++.....++++|||+.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 58999999999998753 3 46777664322 233346788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEee
Q 016152 239 GGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (394)
Q Consensus 239 ~~sL~~~~~~~~----------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~D 302 (394)
+++|.+++...+ .+++.++..++.|++.||+|||+.+ ++||||||+||++ +.++.+||+|
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili--~~~~~~kl~d 155 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GENYVAKIAD 155 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEE--cCCCeEEECC
Confidence 999999997543 3788999999999999999999988 9999999999999 8888999999
Q ss_pred cCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC
Q 016152 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 303 Fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
||++....... .......+..|+|||.+....++.++|+||||+++|||++ |..||...+..+..+.+..+.++
T Consensus 156 fgl~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 230 (270)
T cd05047 156 FGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 230 (270)
T ss_pred CCCccccchhh-----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC
Confidence 99985322110 1112234667999999988899999999999999999997 99999988888888888777665
Q ss_pred CCCCCCCCccc
Q 016152 382 FFRAKGFTPEL 392 (394)
Q Consensus 382 ~~~~~~~~~~~ 392 (394)
..+. .+++++
T Consensus 231 ~~~~-~~~~~~ 240 (270)
T cd05047 231 EKPL-NCDDEV 240 (270)
T ss_pred CCCC-cCCHHH
Confidence 5443 245444
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=263.90 Aligned_cols=224 Identities=29% Similarity=0.517 Sum_probs=184.9
Q ss_pred cCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.+|++.+.||+|+||.||++... +..+++|.+... ......+.+|+.++++++|+||+++++.+.. ...+++||
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 37889999999999999999864 567999976532 2234678889999999999999999998887 77899999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|+.+++|.+++.+. ..++..++..++.|++.||.|||+.+ ++|+||||+||++ +..+.++|+|||++..+....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILV--SASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEE--cCCCcEEECCCcceeeccCCC
Confidence 99999999999763 35788899999999999999999988 9999999999999 788899999999997664322
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.. ......++..|+|||.+....++.++|+||||+++|++++ |+.||...+..+....+..+..+... ..++.++
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 232 (260)
T cd05073 157 YT---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP-ENCPEEL 232 (260)
T ss_pred cc---cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCc-ccCCHHH
Confidence 11 1122345678999999998889999999999999999998 99999998888888888777554433 3355554
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 233 ~ 233 (260)
T cd05073 233 Y 233 (260)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=270.39 Aligned_cols=223 Identities=31% Similarity=0.491 Sum_probs=188.2
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|...+.||+|+||.||++.. .+..+++|.+.............+.+|+.+++.++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 478888999999999999987 477899998865544444455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+.+ +|.+.+.. ..++++.++..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~--~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILL--TEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEE--CCCCCEEEecCCCccccCCc--
Confidence 9975 78777754 556899999999999999999999988 9999999999999 77889999999988654321
Q ss_pred cccccccCCccCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
....+++.|+|||.+. .+.++.++|+||||+++|||++|.+||...+..+....+..+..+......++++
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY 252 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHH
Confidence 2346888999999974 4568899999999999999999999999888878788887776666666666666
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 253 l~ 254 (317)
T cd06635 253 FR 254 (317)
T ss_pred HH
Confidence 54
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=267.30 Aligned_cols=224 Identities=30% Similarity=0.540 Sum_probs=190.7
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|+..+.||+|++|.||++.+. +..+++|.+..... ....+.+|+.+++.++|+||+++++.+......++++|
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 6888899999999999999886 78899998864332 34678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++++|.+++.... .++...+..++.|++.+|.|||+.| ++|+||+|+||++ +.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILL--SKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEE--cCCCCEEECccchhhhhccchh
Confidence 999999999998876 8999999999999999999999988 9999999999999 7888999999998875543221
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCC-CCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK-GFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~-~~~~~~~ 393 (394)
......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...++.+....+..+..+.+... .++.+++
T Consensus 172 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 172 ----KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247 (286)
T ss_pred ----hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence 12334578899999999888899999999999999999999999998888777777765555544433 3666654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=263.74 Aligned_cols=206 Identities=29% Similarity=0.440 Sum_probs=173.5
Q ss_pred ceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHH-HhCCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 163 AIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l-~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
+.||+|+||.||+|.. .++.+|+|.+.+...........+..|..++ ...+|+|++++++.+...+.+++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999987 4789999987544322222223344454444 455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccccc
Q 016152 240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319 (394)
Q Consensus 240 ~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~ 319 (394)
++|.+++...+.+++..+..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~-------- 149 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLI--DQTGHLKLTDFGLSRNGLE-------- 149 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCcEEEeecccceeccc--------
Confidence 999999988888999999999999999999999988 9999999999999 7788999999998875432
Q ss_pred ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q 016152 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 320 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||...+..+....+..+..
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 210 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI 210 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc
Confidence 2234688899999999888899999999999999999999999999888888877766543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=266.86 Aligned_cols=218 Identities=30% Similarity=0.456 Sum_probs=171.3
Q ss_pred eeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHH---HHHHhCCCCceeeEEeEEEeCCeeEEEEeccC
Q 016152 164 IIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEV---NLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~---~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 238 (394)
+||+|+||.||++.. .++.+|+|.+.+...........+..|. ..++...||+|+++++.+...+.+++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999986 4778999988664433222112233333 34445679999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccc
Q 016152 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (394)
Q Consensus 239 ~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~ 318 (394)
|++|.+++...+.+++..+..++.|+++||.|||+.+ |+||||||+||++ +.++.++|+|||++..+....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili--~~~~~~kl~dfg~~~~~~~~~----- 151 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK----- 151 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEE--CCCCCEEEccCcCccccCccC-----
Confidence 9999999988888999999999999999999999988 9999999999999 788899999999987554221
Q ss_pred cccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 319 KMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~---~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....|+..|+|||.+.++ .++.++|+||+|+++|+|++|+.||... ...+..+.+ ....+.++. .+|++++
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~-~~s~~~~ 227 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPD-SFSPELR 227 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCC-cCCHHHH
Confidence 1235689999999998754 6899999999999999999999999876 333333333 333444443 2455543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=269.41 Aligned_cols=212 Identities=29% Similarity=0.511 Sum_probs=175.7
Q ss_pred cCccccceeecCCceEEEEEEECC----------------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWRG----------------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~g----------------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 220 (394)
.+|++.+.||+|+||.||++...+ ..+|+|.+.... .......+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 478899999999999999987532 248899875432 23345678899999999999999999
Q ss_pred EeEEEeCCeeEEEEeccCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCE
Q 016152 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKG------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNV 288 (394)
Q Consensus 221 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Ni 288 (394)
++++......++||||+.+++|.+++.... .+++.++..++.|++.||.|||+.+ ++||||||+||
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNC 160 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhE
Confidence 999999999999999999999999986532 3688899999999999999999988 99999999999
Q ss_pred EEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc--CCCCCCCC
Q 016152 289 LLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE--GEPPLANY 366 (394)
Q Consensus 289 lv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~--g~~Pf~~~ 366 (394)
++ +.++.+||+|||++........ ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 161 ll--~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 161 LV--GNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred EE--cCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 99 7778999999999876543221 111222345778999999998899999999999999999988 78899888
Q ss_pred CHHHHHHHHH
Q 016152 367 EPYEAAKYVA 376 (394)
Q Consensus 367 ~~~~~~~~i~ 376 (394)
+..+....+.
T Consensus 237 ~~~~~~~~~~ 246 (295)
T cd05097 237 SDEQVIENTG 246 (295)
T ss_pred ChHHHHHHHH
Confidence 7777665543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=288.53 Aligned_cols=194 Identities=37% Similarity=0.591 Sum_probs=168.7
Q ss_pred eeecCCceEEEEEEECCc--cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCCC
Q 016152 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGD 241 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~g~--~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~s 241 (394)
+||+|.||+||.|++..+ ..|||-+..... ...+-+.+|+.+.+.++|.|||+++|.+..++.+-+.||-++|||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 799999999999987644 578887755432 234778899999999999999999999999999999999999999
Q ss_pred HHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccc
Q 016152 242 LHKYLKE-KGAL--SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (394)
Q Consensus 242 L~~~~~~-~~~~--~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~ 318 (394)
|.++++. .|++ ++.+.-.+-+||++||.|||++. |||||||-+|+||. ...|.+||+|||-++++..-+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvN-TySGvlKISDFGTsKRLAginP---- 731 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVN-TYSGVLKISDFGTSKRLAGINP---- 731 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEe-eccceEEecccccchhhccCCc----
Confidence 9999986 4777 88889999999999999999977 99999999999984 4668999999999988763322
Q ss_pred cccCCccCccccCccccCCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 319 KMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
...++.||..|||||++..+ +|++++|||||||++.||.||++||-..-
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence 34568899999999999754 68999999999999999999999997653
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=278.24 Aligned_cols=205 Identities=28% Similarity=0.515 Sum_probs=171.4
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC------Ce
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------KP 229 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~ 229 (394)
+|++.+.||+|+||.||+|... +..+|||.+...... ......+.+|+.+++.++||||+++++++... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 7899999999999999999864 678999987654322 22335577899999999999999999987543 34
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
.++++|++ +++|.+++.. +.+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++...
T Consensus 95 ~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~--~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAV--NEDCELRILDFGLARQA 168 (343)
T ss_pred EEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEE--CCCCCEEEcCCccceec
Confidence 68999988 7799887754 46999999999999999999999988 9999999999999 88889999999999765
Q ss_pred ccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.
T Consensus 169 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07878 169 DDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM 229 (343)
T ss_pred CCC-------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 422 234578999999999876 568999999999999999999999998877666555543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=267.63 Aligned_cols=224 Identities=29% Similarity=0.519 Sum_probs=181.4
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHH-HHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL-LVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~-l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
+|++.+.||+|+||.||++... |+.||+|.+....... . ...+..|+.. ++.++||||+++++++..+..++++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-E-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-H-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 6888899999999999999874 7899999886543222 2 2344455554 66678999999999999999999999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 235 EYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 235 e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
||++ ++|.+++.. ...+++..+..++.|++.||.|||++ + ++||||||+||++ +.++.+||+|||++..+
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~--~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLI--NRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEE--CCCCCEEEeeccccccc
Confidence 9996 588887764 24689999999999999999999996 7 9999999999999 88889999999998765
Q ss_pred ccccccccccccCCccCccccCccccCC----CCCCCcchHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH----RKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGv~l~el~~g~~Pf~~~-~~~~~~~~i~~g~~p~~~ 384 (394)
.... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||... +..+....+..+..|.++
T Consensus 155 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd06617 155 VDSV-----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP 229 (283)
T ss_pred cccc-----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC
Confidence 4221 1123467889999998864 45689999999999999999999999753 445666666777778877
Q ss_pred CCCCCcccc
Q 016152 385 AKGFTPELR 393 (394)
Q Consensus 385 ~~~~~~~~~ 393 (394)
...+|++|+
T Consensus 230 ~~~~~~~l~ 238 (283)
T cd06617 230 AEKFSPEFQ 238 (283)
T ss_pred ccccCHHHH
Confidence 777887765
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=282.63 Aligned_cols=215 Identities=27% Similarity=0.445 Sum_probs=185.4
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
-|..++.||-|+||.|.++... ...+|+|.+.+...-........+.|-+||..-+.+-||+++..|.+.+.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4778899999999999998754 45689999877655455555677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc-
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS- 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~- 314 (394)
|+.||++-.++-+.+-+.+..++.++.++..|+++.|..| +|||||||+|||| +.+|++||.||||++-+.....
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILI--DrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEE--ccCCceeeeeccccccceecccc
Confidence 9999999999999999999999999999999999999999 9999999999999 9999999999999876532111
Q ss_pred -------------------------------------cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHH
Q 016152 315 -------------------------------------HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357 (394)
Q Consensus 315 -------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~ 357 (394)
+........+||+.|+|||++....|+..+|+||.||+||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 0111123456999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHH
Q 016152 358 EGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 358 ~g~~Pf~~~~~~~~~~~i~ 376 (394)
.|++||-..++-+...+|.
T Consensus 866 ~g~~pf~~~tp~~tq~kv~ 884 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVI 884 (1034)
T ss_pred hCCCCccCCCCCcceeeee
Confidence 9999998877766655544
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=267.73 Aligned_cols=210 Identities=25% Similarity=0.470 Sum_probs=178.1
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|++|.||++... ++.+|+|.+....... ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 5888899999999999999874 7889999876543222 223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++++|..++.....+++.++..++.|++.+|.|||+.+ ++||||||+||++ +.++.++|+|||++..+.....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILI--TKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEE--cCCCcEEECccccceecCCCcc-
Confidence 9999888888777677999999999999999999999988 9999999999999 7888999999999987654321
Q ss_pred ccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 316 DVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||.+.+..+....+.
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~ 214 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIR 214 (286)
T ss_pred ---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 1223457889999999876 457899999999999999999999998877666555443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=266.07 Aligned_cols=224 Identities=28% Similarity=0.503 Sum_probs=187.5
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|...+.||+|++|.||++... ++.+++|.+... .....+.+.+|+.+++.++||||+++++++...+..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4555678999999999999864 678999987432 22234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+.+++|.+++.. +.+++..+..++.|++.+|.|||+.+ ++||||+|+||++ +.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILL--TSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEE--cCCCcEEEcccccchhhccCCc-
Confidence 9999999999877 67899999999999999999999988 9999999999999 7888999999998875542211
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCC-CCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK-GFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~-~~~~~~~ 393 (394)
......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+....+..+.+|..... .++++++
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 246 (285)
T cd06648 171 ---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLR 246 (285)
T ss_pred ---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHH
Confidence 12335688999999999988899999999999999999999999998888888888887765555432 2555543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=270.08 Aligned_cols=208 Identities=27% Similarity=0.517 Sum_probs=174.6
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++... +..+|+|.+....... ....+.+|+.+++.++||||+++++++......++|||
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 7899999999999999999874 6789999875433221 12456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+.+ +|.+++... ..+++..+..++.|+++||+|||+.+ |+|+||||+||++ +.++.++|+|||++........
T Consensus 85 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 85 YLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLI--NERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEE--CCCCcEEECcCcchhccCCCCC
Confidence 9974 999888754 46899999999999999999999988 9999999999999 7888999999999875432221
Q ss_pred cccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
......+++.|+|||.+.+ ..++.++||||||+++|+|++|++||...+..+....+.
T Consensus 160 ----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~ 218 (301)
T cd07873 160 ----TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF 218 (301)
T ss_pred ----cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 1233457899999999865 457899999999999999999999999888766665543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=273.28 Aligned_cols=196 Identities=26% Similarity=0.485 Sum_probs=158.9
Q ss_pred cceeecCCceEEEEEEEC----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe--CCeeEEEEe
Q 016152 162 SAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITE 235 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~~----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~lv~e 235 (394)
+++||+|+||.||+|... +..+|+|.+...... ....+|+.++++++||||+++++++.. +..++++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 457999999999999863 467999987543321 346689999999999999999998854 456899999
Q ss_pred ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee--CCCCcEEEeecC
Q 016152 236 YLRGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFG 304 (394)
Q Consensus 236 ~~~~~sL~~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~--~~~~~~kl~DFg 304 (394)
|+.+ +|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+.. +..+.+||+|||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 9854 898887532 24889999999999999999999988 999999999999943 345689999999
Q ss_pred CccccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
++........ .........+|+.|+|||++.+ ..++.++||||+||++|+|++|++||...
T Consensus 158 ~a~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 158 FARLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCCc-cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9986643221 1112345678999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=271.39 Aligned_cols=222 Identities=27% Similarity=0.468 Sum_probs=183.5
Q ss_pred ccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 159 FSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
|.....||+|+||.||++.. .++.+++|.+..... ...+.+.+|+.+++.++||||+++++++..++..+++|||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 44455799999999999986 478899998754322 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccc
Q 016152 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316 (394)
Q Consensus 237 ~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~ 316 (394)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++..+.....
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill--~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILL--TLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEE--ccCCcEEEeechhHhhcccccc--
Confidence 999999987754 46899999999999999999999988 9999999999999 8888999999999875543221
Q ss_pred cccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCCccc
Q 016152 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFTPEL 392 (394)
Q Consensus 317 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~~~~~ 392 (394)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||...+..+....+.....+.... ..+++++
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 247 (297)
T cd06659 173 --KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVL 247 (297)
T ss_pred --cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHH
Confidence 1234568999999999998889999999999999999999999998888777777776554443332 2344444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=265.89 Aligned_cols=200 Identities=34% Similarity=0.536 Sum_probs=165.8
Q ss_pred ccccceeecCCceEEEEEEE------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--Cee
Q 016152 159 FSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPL 230 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~ 230 (394)
|++.+.||+|+||.||++.+ .+..+|+|.+..... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 37889999999999988653 356799998754422 23346678899999999999999999987653 458
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
+++|||+.+++|.+++... .+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.++|+|||++..+.
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLL--DNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEE--cCCCcEEEeecccccccC
Confidence 9999999999999999764 5999999999999999999999988 9999999999999 778899999999998765
Q ss_pred cccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
....... ......++..|+|||.+....++.++||||||+++|||++|..||...
T Consensus 159 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 159 EGHEYYR-VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred Ccchhhc-cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 3321110 112234567799999998888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=265.21 Aligned_cols=225 Identities=30% Similarity=0.521 Sum_probs=185.5
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCC-----
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERK----- 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~----- 228 (394)
.+|++.+.||+|++|.||+|... ++.+++|.+..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 48999999999999999999874 67899998754322 236688999999998 6999999999986644
Q ss_pred -eeEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 229 -PLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 229 -~~~lv~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
.+++||||+++++|.+++.. +..+++..+..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~--~~~~~~~l~d~ 157 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILL--TKNAEVKLVDF 157 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEE--ccCCeEEECCC
Confidence 48999999999999998864 357899999999999999999999988 9999999999999 77889999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g 378 (394)
|++........ ......++..|+|||.+.. ..++.++||||||+++|+|++|++||...+..+....+..+
T Consensus 158 ~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 158 GVSAQLDSTLG----RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred ccceecccchh----hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence 99876543221 1234568899999998753 34678999999999999999999999887777777777777
Q ss_pred CCCCCCCC-CCCcccc
Q 016152 379 HRPFFRAK-GFTPELR 393 (394)
Q Consensus 379 ~~p~~~~~-~~~~~~~ 393 (394)
.++.+... .++++++
T Consensus 234 ~~~~~~~~~~~~~~~~ 249 (275)
T cd06608 234 PPPTLKSPENWSKKFN 249 (275)
T ss_pred CCCCCCchhhcCHHHH
Confidence 76665543 2555554
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=267.75 Aligned_cols=225 Identities=29% Similarity=0.494 Sum_probs=184.1
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEe------C
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE------R 227 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~------~ 227 (394)
..|++.+.||+|+||.||+|... ++.+++|.+.... .....+..|+.+++++ +|+||+++++++.. .
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 37888899999999999999874 6789999874421 2235677899999988 69999999998853 4
Q ss_pred CeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 228 KPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
..++++|||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++ +.++.++|+|||+
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili--~~~~~~~l~dfg~ 167 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLL--TENAEVKLVDFGV 167 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEeeCcc
Confidence 5789999999999999998753 45888899999999999999999988 9999999999999 7888999999999
Q ss_pred ccccccccccccccccCCccCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
+........ ......+++.|+|||.+. ...++.++|+|||||++|||++|.+||....+.+....+.+...
T Consensus 168 ~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 243 (282)
T cd06636 168 SAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 243 (282)
T ss_pred hhhhhcccc----CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC
Confidence 876542211 123456899999999985 35678899999999999999999999988777666666666666
Q ss_pred CCCCCCCCCcccc
Q 016152 381 PFFRAKGFTPELR 393 (394)
Q Consensus 381 p~~~~~~~~~~~~ 393 (394)
+....+.+|++|.
T Consensus 244 ~~~~~~~~~~~~~ 256 (282)
T cd06636 244 PKLKSKKWSKKFI 256 (282)
T ss_pred CCCcccccCHHHH
Confidence 6666666777664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=270.88 Aligned_cols=215 Identities=28% Similarity=0.494 Sum_probs=181.2
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|.....||+|+||.||++.. .+..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 345567799999999999986 47789999874322 2334668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++++|.+++.. +.+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.++|+|||++........
T Consensus 100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill--~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILL--TSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEE--cCCCCEEEccCcchhhcccccc-
Confidence 9999999998754 46899999999999999999999988 9999999999999 7788999999999876542221
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~ 384 (394)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||...+..+....+.....+.++
T Consensus 174 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T cd06658 174 ---KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK 239 (292)
T ss_pred ---cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc
Confidence 123356889999999998888999999999999999999999999988887777777665544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=262.63 Aligned_cols=207 Identities=29% Similarity=0.451 Sum_probs=166.5
Q ss_pred eeecCCceEEEEEEEC----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 164 IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
.||+|+||.||+|... +..+++|.+..... ......+.+|+.++++++||||+++++++.+...+++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 5899999999999764 34688887754432 22335688899999999999999999999998999999999999
Q ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 240 GDLHKYLKEKG-----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 240 ~sL~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
++|.+++.... ..++..++.++.|++.||.|||+++ ++||||||+||++ +..++++|+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~--~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLL--TADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEE--cCCCcEEECCccccccccCcce
Confidence 99999997532 3567788899999999999999988 9999999999999 7788999999999865432211
Q ss_pred cccccccCCccCccccCccccCCC-------CCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHR-------KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEG 378 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g 378 (394)
........++..|+|||.+.+. .++.++|+||||+++|||++ |+.||...+..+.......+
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 225 (269)
T cd05087 156 --YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE 225 (269)
T ss_pred --eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc
Confidence 1112234578889999998642 35789999999999999996 99999888776665554433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=271.66 Aligned_cols=218 Identities=17% Similarity=0.319 Sum_probs=175.4
Q ss_pred ccceeecC--CceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 161 SSAIIGKG--SFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 161 ~~~~iG~G--~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
++++||+| +|+.||++..+ |+.+|+|.+...... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 45689999 77899999874 788999988554332 33445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 237 ~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.++++||+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~--~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILI--SVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEE--ecCCcEEEcccchhhccccccc
Confidence 9999999999753 45899999999999999999999988 9999999999999 7788999999986554332111
Q ss_pred ccc---ccccCCccCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 016152 315 HDV---YKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 315 ~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~ 383 (394)
... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.......+..|..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 230 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccc
Confidence 000 00122356778999999976 4689999999999999999999999998776666655555555533
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=263.50 Aligned_cols=227 Identities=27% Similarity=0.502 Sum_probs=188.8
Q ss_pred CccccceeecCCceEEEEEEEC---CccEEEEEeccCC-------CCcHHHHHHHHHHHHHHHh-CCCCceeeEEeEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSL-------SDDRLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTE 226 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~---g~~~avK~l~~~~-------~~~~~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~ 226 (394)
.|++.+.||+|+||.||++... +..+++|.+.... ........++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778889999999999999875 4679999875332 1223344567788888865 789999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCCEEEeeCCCCcEEEe
Q 016152 227 RKPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~ivH~Dikp~Nilv~~~~~~~~kl~ 301 (394)
++..+++|||+++++|.+++.. ...+++..++.++.|++.+|.|||+ .+ ++|+||+|+||++ +..+.++|+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~--~~~~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIML--GEDDKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEE--CCCCcEEEe
Confidence 9999999999999999988743 3468999999999999999999996 56 9999999999999 888899999
Q ss_pred ecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 016152 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 302 DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|++||...+.......+..+..+
T Consensus 157 dfg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 157 DFGLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred cccceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 999998654332 223456889999999999888999999999999999999999999988888888888777666
Q ss_pred CCCCCCCCcccc
Q 016152 382 FFRAKGFTPELR 393 (394)
Q Consensus 382 ~~~~~~~~~~~~ 393 (394)
....+.++++++
T Consensus 232 ~~~~~~~~~~l~ 243 (269)
T cd08528 232 PLPEGMYSEDVT 243 (269)
T ss_pred cCCcccCCHHHH
Confidence 555555676664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=267.17 Aligned_cols=194 Identities=33% Similarity=0.520 Sum_probs=167.6
Q ss_pred eecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCCCH
Q 016152 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (394)
Q Consensus 165 iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~sL 242 (394)
||+|+||.||++... |+.+++|.+.............+..|+.++++++||||+++++.+...+.+++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999764 788999988654333333345667899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccc
Q 016152 243 HKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320 (394)
Q Consensus 243 ~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~ 320 (394)
.+++.+.+ .+++.++..++.|++.+|.|||+++ ++||||+|+||++ +.++.++|+|||++....... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~--~~~~~~~l~dfg~~~~~~~~~-----~~ 151 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLL--DDHGNVRISDLGLAVELKGGK-----KI 151 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEEccCcchhhhccCC-----cc
Confidence 99998755 6899999999999999999999988 9999999999999 888899999999987654321 12
Q ss_pred cCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 33567889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=273.49 Aligned_cols=210 Identities=28% Similarity=0.420 Sum_probs=175.4
Q ss_pred CcccCCCCcCccccceeecCCceEEEEEEECC-ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEe
Q 016152 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTE 226 (394)
Q Consensus 149 ~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g-~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~ 226 (394)
...|..+...|++++.||+||.+.||++...+ +-+|+|.+... ..+...+..+.+|+..|.+++ |.+|++++++-..
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 34567777889999999999999999998764 45677655433 345667799999999999996 8999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 227 RKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
++.+|+|||+=+ .+|..+++++.. +....++.+..||+.++.++|+.| |||.||||.|+|++ .|.+||+|||+
T Consensus 432 d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV---kG~LKLIDFGI 505 (677)
T KOG0596|consen 432 DGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV---KGRLKLIDFGI 505 (677)
T ss_pred CceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE---eeeEEeeeech
Confidence 999999999764 499999998765 343578888999999999999999 99999999999984 46899999999
Q ss_pred ccccccccccccccccCCccCccccCccccCCC-----------CCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-----------KYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
|..+..... .....+.+||+.||+||.+... ..++++|||||||++|+|+.|++||....
T Consensus 506 A~aI~~DTT--sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 506 ANAIQPDTT--SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred hcccCcccc--ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 998775532 2335678999999999998532 25689999999999999999999998764
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=283.73 Aligned_cols=217 Identities=30% Similarity=0.577 Sum_probs=186.2
Q ss_pred CccccceeecCCceEEEEEEEC---Cc--cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR---GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~---g~--~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
.....+.||+|.||.|++|.|+ |+ .||||++...... ....+|.+|+.+|.+++|+|++++||++.+ ...++
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 3456788999999999999986 33 6899998654433 267899999999999999999999999987 78899
Q ss_pred EEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 233 ITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
|||.+..|||.+.+++ +..|-......++.||++||.||.+++ +|||||..+|+|+ .....|||+||||.+-+.
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlll--asprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLL--ASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhhee--cccceeeeecccceeccC
Confidence 9999999999999987 345888899999999999999999998 9999999999999 667799999999999887
Q ss_pred cccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~ 382 (394)
..+..-+ ......-.+.|.|||.++...++.++|||++||++|||++ |.-||-+.+..++++.|.+|.+-.
T Consensus 264 ~ned~Yv-m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLp 335 (1039)
T KOG0199|consen 264 ENEDMYV-MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLP 335 (1039)
T ss_pred CCCcceE-ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCC
Confidence 5543211 1223345677999999999999999999999999999998 999999999999999998765533
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=310.69 Aligned_cols=230 Identities=30% Similarity=0.504 Sum_probs=197.7
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|..+..||.|.||.||.|.. +|...|||-+...... ........+|..++..++|||+|+++|+-.+.+.+++.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 677788999999999999985 5888999987654443 4445677899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
||++|+|.+.+...+..++.....+-.|++.|+.|||+.| ||||||||.||++ +.+|.+|++|||.|..+......
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~L--d~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILL--DFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceee--ecCCcEEeecccceeEecCchhc
Confidence 9999999999987777788888888899999999999999 9999999999999 88899999999999988765432
Q ss_pred ccccccCCccCccccCccccCCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHR---KYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGv~l~el~~g~~Pf~~~~-~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
-.....+..||+.|||||++.+. +...++||||||||..||+||+.||...+ ...+.-.+..|..|-+|.+ +|++
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~-ls~~ 1469 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER-LSSE 1469 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh-hhHh
Confidence 23345577899999999999753 46689999999999999999999998875 4577778889999999987 7765
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
=+
T Consensus 1470 g~ 1471 (1509)
T KOG4645|consen 1470 GR 1471 (1509)
T ss_pred HH
Confidence 43
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=259.17 Aligned_cols=222 Identities=29% Similarity=0.522 Sum_probs=182.6
Q ss_pred ceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCCC
Q 016152 163 AIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGD 241 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~s 241 (394)
+.||+|+||.||++... ++.+++|.+...... .....+.+|+.++++++||||+++++++.+....++||||+.+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 36899999999999875 789999987554332 344678899999999999999999999999999999999999999
Q ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccc
Q 016152 242 LHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320 (394)
Q Consensus 242 L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~ 320 (394)
|.+++.. ...++...+..++.|++.+|.|||+++ ++||||||+||++ +.++.++|+|||++......... ...
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili--~~~~~~~l~d~g~~~~~~~~~~~--~~~ 152 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLV--GENNVLKISDFGMSREEEGGIYT--VSD 152 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEE--cCCCcEEEeeccccccccCCcce--ecc
Confidence 9999976 346899999999999999999999988 9999999999999 88889999999998765422110 011
Q ss_pred cCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....+..|+|||.+.++.++.++|+||||+++|+|++ |..||...+..+....+..+.++..+ +.+|.+++
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 225 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAP-QLCPEEIY 225 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCC-ccCCHHHH
Confidence 12234667999999988899999999999999999999 89999988887777777766544443 33555553
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=254.16 Aligned_cols=207 Identities=26% Similarity=0.424 Sum_probs=171.8
Q ss_pred CCCcCccccceeecCCceEEEEEE--ECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC---
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK--- 228 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~--~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--- 228 (394)
....+|++.+.||.|||+-||++. .+++.+|+|.+.... .+..+...+|++..++++||||++++++...+.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 445689999999999999999886 468889999987654 334477889999999999999999998754333
Q ss_pred --eeEEEEeccCCCCHHHHHHh---cC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEee
Q 016152 229 --PLMLITEYLRGGDLHKYLKE---KG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (394)
Q Consensus 229 --~~~lv~e~~~~~sL~~~~~~---~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~D 302 (394)
..|++++|...|||.+.++. ++ .+++.++++++.++++||++||+..+++.||||||.|||+ ...+.++|.|
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl--s~~~~~vl~D 172 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL--SDSGLPVLMD 172 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe--cCCCceEEEe
Confidence 48999999999999999874 33 6999999999999999999999988889999999999999 6678999999
Q ss_pred cCCccccccc--cc---cccccccCCccCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 016152 303 FGLSKLIKVQ--NS---HDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLAN 365 (394)
Q Consensus 303 Fg~a~~~~~~--~~---~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~~g~~Pf~~ 365 (394)
||.++..+-. +. .....+.....|..|.|||.+. +...+.++|||||||++|.|+.|..||+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 9998754321 11 1111233445799999999985 45678999999999999999999999964
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=274.26 Aligned_cols=220 Identities=30% Similarity=0.525 Sum_probs=175.9
Q ss_pred cCccccceeecCCceEEEEEEE-------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEe-C
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW-------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE-R 227 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~-------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~-~ 227 (394)
.+|++.+.||+|+||.||+|.+ .++.+|||.+..... ......+.+|+.+++++ +||||+++++++.. +
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 3799999999999999999974 356899998854332 23346788899999999 68999999997755 4
Q ss_pred CeeEEEEeccCCCCHHHHHHhc----------------------------------------------------------
Q 016152 228 KPLMLITEYLRGGDLHKYLKEK---------------------------------------------------------- 249 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~---------------------------------------------------------- 249 (394)
..++++|||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 5689999999999999998642
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccc
Q 016152 250 ---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320 (394)
Q Consensus 250 ---------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~ 320 (394)
..+++.++..++.|+++||.|||+++ |+||||||+||++ +.++.+||+|||++........ ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~dfg~~~~~~~~~~--~~~~ 238 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLARDIYKDPD--YVRK 238 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEE--cCCCcEEEEecccccccccCcc--hhhc
Confidence 13677888999999999999999988 9999999999999 7888999999999876533221 1111
Q ss_pred cCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHHcCCCCCCC
Q 016152 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY-EAAKYVAEGHRPFFR 384 (394)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~-~~~~~i~~g~~p~~~ 384 (394)
....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...... +....+..+.++..+
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 304 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP 304 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC
Confidence 22345678999999988899999999999999999997 99999876533 445556666655544
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=266.71 Aligned_cols=217 Identities=29% Similarity=0.487 Sum_probs=175.8
Q ss_pred CCcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEE-----e
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVT-----E 226 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~-----~ 226 (394)
...+|++.+.||+|+||.||++.. .++.+++|.+.... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 344789999999999999999987 47789999764321 1125577899999998 6999999999873 3
Q ss_pred CCeeEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEee
Q 016152 227 RKPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~D 302 (394)
+..+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++ +..+.++|+|
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili--~~~~~~kl~d 167 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILL--TTEGGVKLVD 167 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEE--CCCCCEEEcc
Confidence 4568999999999999988753 346889999999999999999999988 9999999999999 7788899999
Q ss_pred cCCccccccccccccccccCCccCccccCccccCC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 303 Fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
||++..+..... ......|++.|+|||.+.. ..++.++|||||||++|||++|+.||...+..+....+..
T Consensus 168 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 168 FGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred CCceeecccCCC----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 999876643211 1234568999999999753 4578999999999999999999999988876666555555
Q ss_pred CCCCCC
Q 016152 378 GHRPFF 383 (394)
Q Consensus 378 g~~p~~ 383 (394)
+.++.+
T Consensus 244 ~~~~~~ 249 (286)
T cd06638 244 NPPPTL 249 (286)
T ss_pred cCCCcc
Confidence 544433
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=262.64 Aligned_cols=212 Identities=31% Similarity=0.518 Sum_probs=176.6
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCC-------cHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSD-------DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
+|.+.+.||+|+||.||+|.. .++.+|+|.+...... .....+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 577888999999999999976 4788999987432111 1112356788999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.+++||||+.+++|.+++...+.+++..+..++.|++.+|.|||+++ ++||||+|+||++ +.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~--~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLV--DADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEE--cCCCeEEEeecccccc
Confidence 99999999999999999988888999999999999999999999988 9999999999999 7889999999999876
Q ss_pred cccccccccccccCCccCccccCccccCCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 375 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i 375 (394)
....... .......++..|+|||.+.... ++.++|+||||+++|++++|..||...+..+....+
T Consensus 158 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 224 (272)
T cd06629 158 SDDIYDN--DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL 224 (272)
T ss_pred ccccccc--cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHh
Confidence 5422111 1123456889999999987654 789999999999999999999999877665555443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=268.16 Aligned_cols=225 Identities=29% Similarity=0.505 Sum_probs=184.3
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|.+.+.||+|+||.||++.. .++.+++|.+..... ...+.+.+|+.+++.++||||+++++.+...+..++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 4788999999999999999976 467899998743322 22366788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++++|.+++.+. .+++..+..++.|++.||.|||+++ ++||||||+||++ +..+.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili--~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEE--cCCCCEEEccCcceeccccccc
Confidence 999999999998754 5789999999999999999999988 9999999999999 7788999999998876543321
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~-~~~~~~~~~ 393 (394)
......+++.|+|||.+.+..++.++|+||||+++|++++|+.||...+..+....+..+..|.+. .+.++++++
T Consensus 171 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 246 (293)
T cd06647 171 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246 (293)
T ss_pred ----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHH
Confidence 123356889999999998888999999999999999999999999887765555444444444333 233454443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=266.31 Aligned_cols=222 Identities=32% Similarity=0.495 Sum_probs=187.1
Q ss_pred ccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 159 FSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
|...+.||+|+||.||+|.. .+..+++|.+.............+.+|+.+++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56677899999999999986 4788999988655444444556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 237 ~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
+.+ +|.+++.. ..++++.++..++.|++.+|.|||++| ++|+||+|+||++ +.++.++|+|||++.....
T Consensus 103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili--~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILL--TEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEE--CCCCCEEEeecCCCcccCC----
Confidence 964 88777765 456899999999999999999999988 9999999999999 7788999999998864321
Q ss_pred ccccccCCccCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.....++..|+|||.+. ...++.++|+||||+++|+|++|.+||...+.......+..+..|......++.++
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF 249 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHH
Confidence 22456889999999984 45688999999999999999999999998888777777777777777666676665
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 250 ~ 250 (313)
T cd06633 250 R 250 (313)
T ss_pred H
Confidence 4
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=264.34 Aligned_cols=216 Identities=30% Similarity=0.500 Sum_probs=178.5
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeC-----
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER----- 227 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~----- 227 (394)
..+|.+.+.||+|+||.||++... ++.+++|.+..... ....+.+|+.+++++ +||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 447999999999999999999874 77899998754321 235567889999998 799999999988653
Q ss_pred CeeEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 228 KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
..+++||||+++++|.++++. ...+++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.++|+||
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili--~~~~~~kl~df 172 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILL--TTEGGVKLVDF 172 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--cCCCCEEEeec
Confidence 358999999999999998863 356899999999999999999999988 9999999999999 77889999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-----KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g 378 (394)
|++........ ......++..|+|||.+... .++.++|+|||||++|||++|++||...+..+....+.++
T Consensus 173 g~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 248 (291)
T cd06639 173 GVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248 (291)
T ss_pred ccchhcccccc----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence 99876543221 12234688999999998643 3689999999999999999999999988877777777776
Q ss_pred CCCCC
Q 016152 379 HRPFF 383 (394)
Q Consensus 379 ~~p~~ 383 (394)
.++.+
T Consensus 249 ~~~~~ 253 (291)
T cd06639 249 PPPTL 253 (291)
T ss_pred CCCCC
Confidence 66554
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=277.59 Aligned_cols=210 Identities=31% Similarity=0.538 Sum_probs=181.0
Q ss_pred CccccceeecCCceEEEEEEECC-ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g-~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
...+.++||+|-||.|+++...+ ..||||.+..... .....+|..|+.+|.+++||||++++++|..++++++++||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34568899999999999998876 8999998865433 23358899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 237 LRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 237 ~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+.|+|.+|+.++. .+..+...+++.||+.||+||.+.+ +|||||.++|+|+ +.+.++||+|||+++-+..+..
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv--~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLV--DGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceee--cCcccEEecCcccccccccCCc
Confidence 99999999998763 3456667789999999999999988 9999999999999 9999999999999997765543
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHH--cCCCCCCCCCHHHHHHHH
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML--EGEPPLANYEPYEAAKYV 375 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~--~g~~Pf~~~~~~~~~~~i 375 (394)
-.. ....+-+++|||||.+.-+++|.++|+|+||+++||++ |...||...+.+++.+..
T Consensus 693 y~v--qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~ 753 (807)
T KOG1094|consen 693 YRV--QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA 753 (807)
T ss_pred eee--ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh
Confidence 221 12345678999999999999999999999999999976 599999999887777553
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=264.18 Aligned_cols=205 Identities=30% Similarity=0.510 Sum_probs=170.7
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|++|.||+|... ++.+|+|.+...... ......+.+|+.++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 4778889999999999999874 788999987543322 1223567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 236 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 236 ~~~~~sL~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|+. ++|.+++... ..+++.++..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLI--DNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEE--cCCCcEEECcccceeecCCC
Confidence 997 5898888642 46899999999999999999999988 9999999999999 88889999999998755322
Q ss_pred cccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~ 372 (394)
.. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|++||.+.+.....
T Consensus 155 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~ 211 (285)
T cd07861 155 VR----VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211 (285)
T ss_pred cc----cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 11 12334678899999988654 5789999999999999999999999877654333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=266.48 Aligned_cols=220 Identities=30% Similarity=0.593 Sum_probs=179.8
Q ss_pred CcCccccceeecCCceEEEEEEE--CCc----cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYW--RGT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~--~g~----~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
..+|+..+.||+|+||.||++.+ .+. .+|+|.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 34678889999999999999986 344 468887754322 33335688899999999999999999988654 4
Q ss_pred eEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.++++||+.+|+|.+++..+. .+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++..
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill--~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLV--KSPNHVKITDFGLARL 158 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeee--cCCCceEEcccccccc
Confidence 678999999999999997654 5899999999999999999999988 9999999999999 7778899999999986
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~ 384 (394)
+..... ........++..|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+..+.+..+..+..+
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd05110 159 LEGDEK--EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQP 233 (303)
T ss_pred ccCccc--ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC
Confidence 643221 111223446778999999998899999999999999999997 99999988877777777776655443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=256.35 Aligned_cols=226 Identities=30% Similarity=0.573 Sum_probs=192.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|++|.||++... +..+++|.+...... ......+.+|++++++++|||++++++++.+....+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 4778899999999999999874 678999988665432 2345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
++++++|.+++...+.+++..+..++.|++.+|.|||+.| ++||||+|+||++ +.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILT--TKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEE--CCCCCEEEeccccceecCCCccc
Confidence 9999999999988888999999999999999999999988 9999999999999 77889999999999876543321
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....++..|+|||...+..++.++|+||||+++|+|++|..||...+.......+.....+.++. .++++++
T Consensus 156 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 228 (254)
T cd06627 156 ----DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPE-GISPELK 228 (254)
T ss_pred ----ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCC-CCCHHHH
Confidence 234568899999999988888999999999999999999999998887766666666655665543 3555543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=255.96 Aligned_cols=224 Identities=34% Similarity=0.571 Sum_probs=190.1
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|+..+.||+|++|.||++... +..+++|.+..... ...+.+.+|+.+++.++|++|+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4777889999999999999885 77899998865433 234778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++++|.+++... ..+++..+..++.|++.+|.+||+.+ ++||||+|+||++ +.++.++|+|||.+........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILL--TSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEE--ccCCeEEEeecccccccccccc
Confidence 99999999999876 57999999999999999999999988 9999999999999 7788999999999887654321
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC-CCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG-FTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~-~~~~~~ 393 (394)
.....++..|++||.+.+..++.++|+||||+++|+|++|+.||...+..+....+.....+.++... ++++++
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFK 228 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHH
Confidence 23356888999999998888999999999999999999999999988777776666655566555432 255543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=264.09 Aligned_cols=221 Identities=31% Similarity=0.536 Sum_probs=179.3
Q ss_pred eeecCCceEEEEEEECC--------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 164 IIGKGSFGEILKAYWRG--------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~g--------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.||+|+||.||++.... ..+++|.+..... ......+.+|+.+++.++||||+++++++......+++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 68999999999998642 4688897754321 2234678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC-----cEEEeec
Q 016152 236 YLRGGDLHKYLKEK-------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-----HLKVGDF 303 (394)
Q Consensus 236 ~~~~~sL~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~-----~~kl~DF 303 (394)
|+++++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||||+||++ +.++ .++|+||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~~~~~~l~df 155 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLV--SEKGYDADRVVKIGDF 155 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEE--ecCCCCCCcceEECCc
Confidence 99999999998742 23788999999999999999999988 9999999999999 5444 8999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~ 382 (394)
|++......... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+..+.++.
T Consensus 156 g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05044 156 GLARDIYKSDYY--RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ 233 (269)
T ss_pred cccccccccccc--ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccC
Confidence 998765432211 11123345788999999998999999999999999999998 999999888888888887766555
Q ss_pred CCCCCCCcccc
Q 016152 383 FRAKGFTPELR 393 (394)
Q Consensus 383 ~~~~~~~~~~~ 393 (394)
.+. .+|++++
T Consensus 234 ~~~-~~~~~~~ 243 (269)
T cd05044 234 KPE-NCPDKIY 243 (269)
T ss_pred Ccc-cchHHHH
Confidence 443 3555543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=265.39 Aligned_cols=210 Identities=29% Similarity=0.484 Sum_probs=173.5
Q ss_pred CccccceeecCCceEEEEEEEC------------------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceee
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR------------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~------------------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 219 (394)
+|++.+.||+|+||.||++.+. +..+|+|.+.... .......+.+|+.+++.++|+||++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 6889999999999999998543 2358888775432 2334567889999999999999999
Q ss_pred EEeEEEeCCeeEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCE
Q 016152 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG-----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNV 288 (394)
Q Consensus 220 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-----------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Ni 288 (394)
+++++...+..+++|||+.+++|.+++.... .+++.++..++.|++.||+|||+++ ++||||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheE
Confidence 9999999999999999999999999997642 3667789999999999999999988 99999999999
Q ss_pred EEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc--CCCCCCCC
Q 016152 289 LLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE--GEPPLANY 366 (394)
Q Consensus 289 lv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~--g~~Pf~~~ 366 (394)
++ +.++.++|+|||++..+...... .......+++.|++||....+.++.++|+|||||++|||++ |..||...
T Consensus 162 li--~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LV--GKNYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EE--cCCCCEEeccCcccccccCCcce--eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99 77889999999998765432211 01122345678999999888889999999999999999998 88999888
Q ss_pred CHHHHHHHH
Q 016152 367 EPYEAAKYV 375 (394)
Q Consensus 367 ~~~~~~~~i 375 (394)
+..+.....
T Consensus 238 ~~~~~~~~~ 246 (296)
T cd05095 238 SDEQVIENT 246 (296)
T ss_pred ChHHHHHHH
Confidence 776665543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=259.58 Aligned_cols=209 Identities=27% Similarity=0.442 Sum_probs=166.6
Q ss_pred eeecCCceEEEEEEEC-Cc---cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 164 IIGKGSFGEILKAYWR-GT---PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~-g~---~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
.||+|+||.||++... +. .+++|.+.... .....+.+.+|+.+++.++||||+++++.+.+....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 5899999999998643 22 35666654332 223456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 240 GDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 240 ~sL~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
++|.+++.+. ...+...+..++.|++.||.|||+.+ ++||||||+|||+ +.++.++|+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~--~~~~~~~l~Dfg~~~~~~~~~~- 154 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFL--TSDLTVKVGDYGIGPSRYKEDY- 154 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEE--cCCccEEecccccccccCcchh-
Confidence 9999999753 24667778899999999999999988 9999999999999 7888999999998764321111
Q ss_pred ccccccCCccCccccCccccCC-------CCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC
Q 016152 316 DVYKMTGETGSYRYMAPEVFKH-------RKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
........++..|+|||++.. ..++.++||||||+++|||++ |.+||...+..+....+.++..
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (268)
T cd05086 155 -IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ 226 (268)
T ss_pred -hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc
Confidence 011234567889999998743 245789999999999999996 6889988888887777655443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=264.11 Aligned_cols=217 Identities=26% Similarity=0.446 Sum_probs=177.1
Q ss_pred CccccceeecCCceEEEEEEE-----CCccEEEEEeccCCCC-cHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCee
Q 016152 158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~-----~g~~~avK~l~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~ 230 (394)
+|++.+.||+|+||.||++.. .|..+|+|++...... .....+.+.+|+.+++++ +|++|+++++.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367888999999999999875 4788999988543221 122335677899999999 589999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
++||||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++||||+|+|||+ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEE--CCCCCEEEeeCccceecc
Confidence 999999999999999988888999999999999999999999988 9999999999999 788899999999987654
Q ss_pred cccccccccccCCccCccccCccccCCC--CCCCcchHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANY----EPYEAAKYVAEGHRP 381 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~Pf~~~----~~~~~~~~i~~g~~p 381 (394)
..... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||... ...+..+.+..+.+|
T Consensus 157 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (290)
T cd05613 157 EDEVE---RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 230 (290)
T ss_pred ccccc---ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC
Confidence 32211 12235688999999998753 4688999999999999999999999643 234444555444443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=279.65 Aligned_cols=192 Identities=27% Similarity=0.405 Sum_probs=164.2
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
...|.+.+.||+|+||.||++.+. ++.||||... ...+.+|+.++++++|+||+++++++...+..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 346899999999999999999985 6779999531 13356799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 234 TEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||++. ++|.+++... +.+++.+++.++.|++.||.|||++| |+||||||+|||+ +..+.+||+|||+++.+...
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl--~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLV--NGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEE--CCCCCEEEcccCCceecccc
Confidence 99995 5898888754 46999999999999999999999988 9999999999999 78889999999999866432
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCC
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf 363 (394)
... .......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 314 ~~~--~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 314 WST--PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccc--ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 211 1122457999999999999999999999999999999999977654
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=256.87 Aligned_cols=226 Identities=30% Similarity=0.555 Sum_probs=193.5
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|++|.||++... +..+++|.+...... ......+.+|+++++.++|||++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 4778889999999999999986 788999988654332 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 236 YLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 236 ~~~~~sL~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
++++++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~--~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFL--TSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEE--cCCCcEEECCccceeeccc
Confidence 99999999999763 67999999999999999999999988 9999999999999 7788999999999976654
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..++...+.++..+.++. .++.+
T Consensus 156 ~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 230 (258)
T cd08215 156 TVD----LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPS-QYSSE 230 (258)
T ss_pred Ccc----eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCC-CCCHH
Confidence 321 1233568899999999988889999999999999999999999999988888888887776666654 45655
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 231 ~~ 232 (258)
T cd08215 231 LR 232 (258)
T ss_pred HH
Confidence 53
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=264.22 Aligned_cols=219 Identities=29% Similarity=0.526 Sum_probs=187.5
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
+|.+.+.||+|++|.||++.. .++.+++|++.............+.+|+.++++++ ||||+++++++.+.+.+++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 688889999999999999987 47899999886644434444567888999999998 999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|++++++|.+++.+.+.+++.++..++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i--~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILL--DKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEE--CCCCCEEecCCccccccCCccc
Confidence 99999999999998888999999999999999999999988 9999999999999 7888999999999886653321
Q ss_pred cc----------------cccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 016152 315 HD----------------VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (394)
Q Consensus 315 ~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g 378 (394)
.. ........++..|+|||.+....++.++|+||||++++++++|..||...+..+..+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 10 01223456789999999998888999999999999999999999999988877777776654
Q ss_pred CC
Q 016152 379 HR 380 (394)
Q Consensus 379 ~~ 380 (394)
..
T Consensus 238 ~~ 239 (280)
T cd05581 238 EY 239 (280)
T ss_pred CC
Confidence 33
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=262.53 Aligned_cols=199 Identities=32% Similarity=0.542 Sum_probs=167.0
Q ss_pred CccccceeecCCceEEEEEEE------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--Ce
Q 016152 158 DFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KP 229 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~ 229 (394)
-|++.+.||+|+||.||.+.+ .+..+++|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 468899999999999999874 36679999875432 233346788999999999999999999988775 56
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 230 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
+++||||+++++|.+++.+. ..+++.++..++.|++.+|.|||++| ++||||||+||++ +.++.++|+|||++..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~--~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV--ESEHQVKIGDFGLTKA 158 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEE--cCCCCEEECCCccccc
Confidence 89999999999999999765 35899999999999999999999988 9999999999999 7788999999999987
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf 363 (394)
+....... .......++..|+|||.+.+..++.++||||||+++|||+++..|+
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 159 IETDKEYY-TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccCccce-eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 65332211 1122345677899999998888999999999999999999987665
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=265.95 Aligned_cols=210 Identities=32% Similarity=0.510 Sum_probs=177.1
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCC--cHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~--~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
+|++.+.||+|++|.||+|... ++.+++|.+...... .......+..|+.++++++|+||+++++++.+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999874 789999998654432 122235567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 234 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|||+ +++|.+++.... .+++..+..++.||++||.|||+++ |+|+||+|+||++ +.++.++|+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill--~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLI--ASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEE--cCCCCEEEccceeeeeccCC
Confidence 9999 889999998766 7999999999999999999999988 9999999999999 78889999999999866533
Q ss_pred cccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
.. ......+++.|+|||.+.+ ..++.++|+|||||++|||++|.+||...+..+..+.+.
T Consensus 156 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~ 216 (298)
T cd07841 156 NR----KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF 216 (298)
T ss_pred Cc----cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHH
Confidence 21 1233456888999999854 467899999999999999999999998877766665554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=266.28 Aligned_cols=223 Identities=34% Similarity=0.499 Sum_probs=187.7
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|+..+.||+|+||.||+|... +..+++|.+...........+.+.+|+.+++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 5778889999999999999874 67899998765433334445678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+. ++|.+++.. ...+++.++..++.|++.+|.|||+.+ ++||||+|+||++ +.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEE--CCCCcEEECCcccceeecCc--
Confidence 996 588877754 456899999999999999999999988 9999999999999 77889999999998765422
Q ss_pred cccccccCCccCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
....+++.|+|||.+. ...++.++|||||||++|+|++|..||...+..+....+.++..|......++++
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHH
Confidence 2346888999999974 3567889999999999999999999998888777777777777777766667766
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 243 ~~ 244 (308)
T cd06634 243 FR 244 (308)
T ss_pred HH
Confidence 54
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=267.76 Aligned_cols=196 Identities=27% Similarity=0.483 Sum_probs=158.1
Q ss_pred cceeecCCceEEEEEEEC----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe--CCeeEEEEe
Q 016152 162 SAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITE 235 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~~----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~lv~e 235 (394)
+..||+|+||.||+|... +..+|+|.+..... ...+.+|+.+++.++||||+++++++.. +..+++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 357999999999999864 35799998754322 1346789999999999999999998853 567899999
Q ss_pred ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee--CCCCcEEEeecC
Q 016152 236 YLRGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFG 304 (394)
Q Consensus 236 ~~~~~sL~~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~--~~~~~~kl~DFg 304 (394)
|+.+ +|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+.. +.++.+||+|||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 9865 888877521 24788999999999999999999988 999999999999942 345689999999
Q ss_pred CccccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
++........ .........+|+.|+|||.+.+ ..++.++|||||||++|||+||++||...
T Consensus 158 ~a~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 158 FARLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCcc-cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9986643321 1112334578999999999876 45799999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=258.78 Aligned_cols=224 Identities=31% Similarity=0.516 Sum_probs=191.7
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|++|.||++... ++.+++|.+...... ......+.+|+.+++.++|+||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 4778889999999999999764 678999988654333 2334667789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 236 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 236 ~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
|+++++|.+++.+ ...+++..+..++.|++.||.|||+.| ++|+||+|+||++ +..+.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~--~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILL--VANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEE--ecCCcEEEeeccchhhhcc
Confidence 9999999999876 356899999999999999999999988 9999999999999 6678899999999977654
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
. ......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..+..|.++. .++.+
T Consensus 156 ~------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 228 (256)
T cd08530 156 N------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPP-IYSQD 228 (256)
T ss_pred C------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCch-hhCHH
Confidence 3 1223457889999999998899999999999999999999999999999888888888888777664 46655
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 229 ~~ 230 (256)
T cd08530 229 LQ 230 (256)
T ss_pred HH
Confidence 54
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=265.38 Aligned_cols=210 Identities=30% Similarity=0.529 Sum_probs=177.7
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++.++ ++.+|+|.+....... ...+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 5788899999999999999984 7789999876543332 334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++++|..+......+++.++..++.|++.+|.|||+.+ ++|+||+|+||++ +.++.++|+|||++..+.....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~--~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--CCCCcEEEEeeeeeeeccCCcc-
Confidence 9999999888776667999999999999999999999988 9999999999999 7888999999999886643321
Q ss_pred ccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 316 DVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
......++..|+|||.+.+ ..++.++||||||+++|||++|++||...+..+....+.
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 214 (286)
T cd07846 156 ---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214 (286)
T ss_pred ---ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 2234567899999999875 457889999999999999999999998776555444433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=259.43 Aligned_cols=194 Identities=22% Similarity=0.398 Sum_probs=160.1
Q ss_pred eeecCCceEEEEEEEC--------------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 164 IIGKGSFGEILKAYWR--------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~--------------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
.||+|+||.||+|... ...+++|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 5899999999999743 2247888764432 2234567889999999999999999999998889
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC-------cEEEe
Q 016152 230 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-------HLKVG 301 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~-------~~kl~ 301 (394)
.+++|||+++++|..++..+ +.+++..+..++.|+++||+|||+++ |+||||||+|||+ +..+ .++++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill--~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILL--AREGIDGECGPFIKLS 154 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEE--ecCCccCCCCceeEeC
Confidence 99999999999999988754 56899999999999999999999988 9999999999999 3333 38999
Q ss_pred ecCCccccccccccccccccCCccCccccCccccC-CCCCCCcchHHHHHHHHHHHH-cCCCCCCCCCHHHHH
Q 016152 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAA 372 (394)
Q Consensus 302 DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~-~g~~Pf~~~~~~~~~ 372 (394)
|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+..
T Consensus 155 d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~ 219 (262)
T cd05077 155 DPGIPITVLSR--------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE 219 (262)
T ss_pred CCCCCccccCc--------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH
Confidence 99998654321 2345788899999986 467899999999999999998 599999877655443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=263.55 Aligned_cols=208 Identities=15% Similarity=0.206 Sum_probs=157.8
Q ss_pred CCcCccccceeecCCceEEEEEEECCc-----cEEEEEeccCCCCcHHH--------HHHHHHHHHHHHhCCCCceeeEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWRGT-----PVAIKRILPSLSDDRLV--------IQDFRHEVNLLVKLRHPNIVQFL 221 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~g~-----~~avK~l~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~Iv~~~ 221 (394)
...+|.+.+.||+|+||.||+|...+. .+++|............ ......+...+..++|++|++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 345799999999999999999987543 56666532221111000 01122334455667899999999
Q ss_pred eEEEeCC----eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCc
Q 016152 222 GAVTERK----PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297 (394)
Q Consensus 222 ~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~ 297 (394)
+...... ..++++|++. .++.+.+......++..+..++.|++.||.|||+++ |+||||||+|||+ +..+.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill--~~~~~ 164 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMV--DGNNR 164 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCc
Confidence 8765443 3477888774 478777776656788999999999999999999988 9999999999999 78889
Q ss_pred EEEeecCCcccccccccccc---ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 298 LKVGDFGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 298 ~kl~DFg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
++|+|||+++.+........ .......||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999987643221111 11233569999999999999999999999999999999999999998763
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=259.23 Aligned_cols=226 Identities=29% Similarity=0.500 Sum_probs=180.9
Q ss_pred ccccceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC-----
Q 016152 159 FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----- 228 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----- 228 (394)
|.+.+.||+|+||.||+|... +..+|||.+...... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 567788999999999999753 568999988654433 334567888999999999999999999876532
Q ss_pred -eeEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEe
Q 016152 229 -PLMLITEYLRGGDLHKYLKEK------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (394)
Q Consensus 229 -~~~lv~e~~~~~sL~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~ 301 (394)
..++++||+.+++|.+++... ..++...+..++.|++.||+|||+++ |+||||||+||++ +.++.+||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili--~~~~~~kl~ 155 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCML--NENMTVCVA 155 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEE--cCCCCEEEC
Confidence 247899999999999887532 24788999999999999999999988 9999999999999 778899999
Q ss_pred ecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC
Q 016152 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 302 DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
|||++......... .......+++.|++||.+....++.++||||||+++|+|++ |++||...+..+....+..+..
T Consensus 156 dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05074 156 DFGLSKKIYSGDYY--RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233 (273)
T ss_pred cccccccccCCcce--ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99998866432211 01123345678999999998889999999999999999999 9999998888888888877655
Q ss_pred CCCCCCCCCccc
Q 016152 381 PFFRAKGFTPEL 392 (394)
Q Consensus 381 p~~~~~~~~~~~ 392 (394)
+..+. .+++++
T Consensus 234 ~~~~~-~~~~~~ 244 (273)
T cd05074 234 LKQPP-DCLEDV 244 (273)
T ss_pred CCCCC-CCCHHH
Confidence 44332 344444
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=258.03 Aligned_cols=198 Identities=33% Similarity=0.551 Sum_probs=165.2
Q ss_pred ccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
+.....||+|+||.||++... +..+++|.+.... ....+.+.+|+.++++++|+||+++++++..++.+++++||
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 334458999999999999864 5679999775432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC-CCcEEEeecCCccccccc
Q 016152 237 LRGGDLHKYLKEK-GAL--SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 237 ~~~~sL~~~~~~~-~~~--~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~-~~~~kl~DFg~a~~~~~~ 312 (394)
+.+++|.+++... +.+ ++..+..++.|++.||.|||+++ |+||||||+||++ +. .+.++|+|||++......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~--~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLV--NTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEE--cCCCCeEEEecchhheecccC
Confidence 9999999999864 455 88889999999999999999988 9999999999999 54 568999999998765432
Q ss_pred cccccccccCCccCccccCccccCCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
.. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||....
T Consensus 163 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 163 NP----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred CC----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 21 12234578999999998654 37899999999999999999999997654
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=261.00 Aligned_cols=210 Identities=29% Similarity=0.497 Sum_probs=178.6
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|++|.||+|.. .|..+++|.+....... .....+.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 478889999999999999987 47889999886543322 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+ +++|.+++.. ...+++.++..++.|++++|.|||+.+ ++|+||||+||++ +.++.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~--~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEE--cCCCcEEEeeeeecccccCCCC
Confidence 99 9999999865 456899999999999999999999988 9999999999999 7788999999999886653321
Q ss_pred cccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
.......++..|+|||.+.+. .++.++||||||+++|||++|.+||...+..+....+.
T Consensus 155 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 214 (286)
T cd07832 155 ---RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVF 214 (286)
T ss_pred ---CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHH
Confidence 123345689999999998654 46899999999999999999999998887766666554
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=267.72 Aligned_cols=228 Identities=29% Similarity=0.460 Sum_probs=183.4
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHH----HHHHHHHHHHHHhCCCCceeeEEeEEE-eCCee
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLV----IQDFRHEVNLLVKLRHPNIVQFLGAVT-ERKPL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~----~~~~~~E~~~l~~l~h~~Iv~~~~~~~-~~~~~ 230 (394)
+|-.+..||+|||+.||+|.+ ..+.||||+-..++....+. .+...+|.++.+.++||.||++|++|. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 577888999999999999975 46789999765554433222 234558999999999999999999884 56789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCcccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLI 309 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a~~~ 309 (394)
|-|+|||+|.+|.-|++.+.-+++++++.|+.||+.||.||....++|||=||||.|||+.++ ..|.+||.|||++...
T Consensus 544 CTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM 623 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM 623 (775)
T ss_pred eeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence 999999999999999999989999999999999999999999998999999999999999653 4578999999999988
Q ss_pred ccccccc--cc-cccCCccCccccCccccCC----CCCCCcchHHHHHHHHHHHHcCCCCCCCC-CHHHHH--HHHHcCC
Q 016152 310 KVQNSHD--VY-KMTGETGSYRYMAPEVFKH----RKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAA--KYVAEGH 379 (394)
Q Consensus 310 ~~~~~~~--~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGv~l~el~~g~~Pf~~~-~~~~~~--~~i~~g~ 379 (394)
...+... .. ......||.+|++||++.- ..++.++||||+||++|+++.|+.||... +...++ +-|.+..
T Consensus 624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAt 703 (775)
T KOG1151|consen 624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKAT 703 (775)
T ss_pred cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcce
Confidence 7554321 11 2345679999999999742 24689999999999999999999999764 333333 3355444
Q ss_pred CCCCCC
Q 016152 380 RPFFRA 385 (394)
Q Consensus 380 ~p~~~~ 385 (394)
.-.||.
T Consensus 704 EVqFP~ 709 (775)
T KOG1151|consen 704 EVQFPP 709 (775)
T ss_pred eccCCC
Confidence 444444
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=264.48 Aligned_cols=208 Identities=30% Similarity=0.528 Sum_probs=171.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|.+. |..+++|.+...... ......+.+|+.++++++||||+++++++.+...+++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 4778899999999999999874 788999988653222 1222456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+.+ +|.+++.. .+.+++..+..++.||++||.|||+++ |+||||||+||++ +.++.++|+|||++..+.....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~--~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLI--NKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEE--cCCCcEEECccchhhccCCCCC
Confidence 9975 88888765 567999999999999999999999988 9999999999999 7888999999999876543211
Q ss_pred cccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHH
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYV 375 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf-~~~~~~~~~~~i 375 (394)
......+++.|+|||.+.+. .++.++|||||||++|+|++|..|| ...+..+..+.+
T Consensus 155 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~ 213 (284)
T cd07839 155 ----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 213 (284)
T ss_pred ----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHH
Confidence 12335678899999998764 4789999999999999999988875 555555554444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=261.47 Aligned_cols=200 Identities=32% Similarity=0.556 Sum_probs=168.4
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|++|.||++..+ ++.+++|.+....... ....+.+|+.++++++||||+++++++.+....++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 37889999999999999999874 7889999886543221 1234567999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
||+.+ +|.+++... ..+++..+..++.|+++||.|||+++ |+||||||+||++ +.++.+||+|||++.......
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLI--SERGELKLADFGLARAKSVPS 157 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEE--cCCCCEEECccccccccCCCC
Confidence 99975 999988764 46899999999999999999999988 9999999999999 888899999999987543221
Q ss_pred ccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
. ......++..|+|||.+.+ ..++.++||||+|+++|+|++|++||...+
T Consensus 158 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 158 K----TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred c----cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1 1223356889999999875 458899999999999999999999997665
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=259.13 Aligned_cols=203 Identities=32% Similarity=0.550 Sum_probs=167.0
Q ss_pred CcCccccceeecCCceEEEEEEE------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe--C
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--R 227 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~ 227 (394)
..+|++.+.||+|+||.||++.. .+..+++|.+... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 34788899999999999999874 3678999987543 23334678899999999999999999997643 3
Q ss_pred CeeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCc
Q 016152 228 KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a 306 (394)
..+++||||+++++|.+++... ..+++..+..++.|++.||.|||++| ++||||||+||++ +.++.++|+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili--~~~~~~~l~dfg~~ 155 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILV--ESENRVKIGDFGLT 155 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEE--CCCCeEEECCCccc
Confidence 4689999999999999999764 46899999999999999999999988 9999999999999 78889999999999
Q ss_pred cccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
........... ......++..|+|||.+.+..++.++|+||||+++|||++|..|+...
T Consensus 156 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 214 (284)
T cd05081 156 KVLPQDKEYYK-VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214 (284)
T ss_pred ccccCCCccee-ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence 87654322100 111223455699999999888999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=262.09 Aligned_cols=200 Identities=31% Similarity=0.558 Sum_probs=167.0
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|.+.+.||+|+||.||+|.. .+..+++|.+....... ....+.+|+.+++.++|+||+++++++..+...++||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3788999999999999999986 47899999885543222 1234568999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||++ +.++.++|+|||++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~--~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLI--SYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEE--cCCCcEEEeccccccccCCCC
Confidence 9996 588777654 356788899999999999999999988 9999999999999 788899999999987543221
Q ss_pred ccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+
T Consensus 158 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 158 Q----TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred C----CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 1 12334578899999998754 57889999999999999999999997664
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=257.75 Aligned_cols=217 Identities=29% Similarity=0.465 Sum_probs=180.2
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
+.+-+..||.|+||.|++..++ |+..|||.+..... ....+++..|.++.++- +.||||+++|....++.-|+.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 4455678999999999999886 88899999865443 44457788888876655 5899999999999999999999
Q ss_pred eccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 235 EYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 235 e~~~~~sL~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
|.|+- ||..+.+ ++..+++.-+-.+....+.||.||-.. -.|||||+||+|||+ +..|.+||||||++..+
T Consensus 143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILl--dr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILL--DRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEE--ecCCCEeeecccchHhH
Confidence 99954 8766543 345688888888888999999999776 249999999999999 99999999999999877
Q ss_pred ccccccccccccCCccCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~Pf~~~~-~~~~~~~i~~g~~p~~~~ 385 (394)
..+- ..+.-.|...|||||.+.. .+|+-+||+||||++|||+.||..||.+.+ .++.+.++..|.+|.+..
T Consensus 219 v~Si-----AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 219 VDSI-----AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF 292 (361)
T ss_pred HHHH-----HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence 6442 2344578899999999853 469999999999999999999999998864 578888899999998776
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=272.87 Aligned_cols=191 Identities=27% Similarity=0.446 Sum_probs=162.3
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
..+|++.+.||+|+||.||+|... +..+|+|..... ....|+.++++++||||+++++++......++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 347999999999999999999985 457899964322 224589999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||++. ++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||++......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFI--NDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEEecCccccccccC
Confidence 99995 488888865 456999999999999999999999988 9999999999999 88889999999998753322
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcC-CCCCCC
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EPPLAN 365 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g-~~Pf~~ 365 (394)
. ......||+.|+|||++.+..++.++|||||||++|||+++ .++|..
T Consensus 211 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 211 P-----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred c-----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 1 12345689999999999999999999999999999999984 455543
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=257.42 Aligned_cols=226 Identities=29% Similarity=0.498 Sum_probs=186.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||++..+ |..+++|.+....... ...+.+.+|+.+++.++|+||+++++.+......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4778899999999999999874 6789999875532222 223567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC-cEEEeecCCccccccc
Q 016152 236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~-~~kl~DFg~a~~~~~~ 312 (394)
|+.+++|.+++.... .+++..+..++.|+++||.|||+.+ ++|+||||+||++ +.++ .++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~--~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFL--SKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEE--cCCCCeEEecccccchhccCC
Confidence 999999999987643 4799999999999999999999988 9999999999999 5554 5799999998766533
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.. ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..+..+.+.. .++.++
T Consensus 156 ~~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 230 (257)
T cd08225 156 ME----LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISP-NFSRDL 230 (257)
T ss_pred cc----cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCC-CCCHHH
Confidence 21 1123458899999999988889999999999999999999999999888777777777766555442 345444
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 231 ~ 231 (257)
T cd08225 231 R 231 (257)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=261.76 Aligned_cols=222 Identities=26% Similarity=0.475 Sum_probs=184.0
Q ss_pred ccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 159 FSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
|.....||+|+||.||++.. +++.+|+|.+... .......+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 33456799999999999987 4778999986432 223346688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccc
Q 016152 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316 (394)
Q Consensus 237 ~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~ 316 (394)
+++++|.+++.. +.+++..+..++.|++.+|+|||+.| ++||||+|+||++ +.++.++|+|||++........
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv--~~~~~~~l~dfg~~~~~~~~~~-- 171 (292)
T cd06657 99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKEVP-- 171 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEEcccccceecccccc--
Confidence 999999987754 46899999999999999999999988 9999999999999 7888999999998876543221
Q ss_pred cccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCCccc
Q 016152 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFTPEL 392 (394)
Q Consensus 317 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~~~~~ 392 (394)
......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....+..+.++.+.. ..+++++
T Consensus 172 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (292)
T cd06657 172 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSL 246 (292)
T ss_pred --cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHH
Confidence 1233568899999999988889999999999999999999999999888777777777666555433 3345544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=258.75 Aligned_cols=200 Identities=23% Similarity=0.408 Sum_probs=162.2
Q ss_pred eeecCCceEEEEEEEC--------------------------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCce
Q 016152 164 IIGKGSFGEILKAYWR--------------------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~--------------------------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~I 217 (394)
.||+|+||.||+|... ...+++|.+... .......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 6899999999998641 124788876432 22334568889999999999999
Q ss_pred eeEEeEEEeCCeeEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC---
Q 016152 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS--- 293 (394)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~--- 293 (394)
+++++++.+....++||||+++++|..++.. .+.+++..+..++.|+++||+|||+++ |+||||||+|||+...
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999999875 467899999999999999999999988 9999999999999432
Q ss_pred --CCCcEEEeecCCccccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHH-cCCCCCCCCCHH
Q 016152 294 --SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEML-EGEPPLANYEPY 369 (394)
Q Consensus 294 --~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~-~g~~Pf~~~~~~ 369 (394)
....++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||...++.
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cCccceeeecCCccccccccc--------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 1234899999987543221 12357788999998865 56899999999999999985 699999887766
Q ss_pred HHHHHHH
Q 016152 370 EAAKYVA 376 (394)
Q Consensus 370 ~~~~~i~ 376 (394)
+....+.
T Consensus 229 ~~~~~~~ 235 (274)
T cd05076 229 EKERFYE 235 (274)
T ss_pred HHHHHHH
Confidence 6544433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=256.36 Aligned_cols=195 Identities=22% Similarity=0.421 Sum_probs=161.8
Q ss_pred ceeecCCceEEEEEEECCcc------------EEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 163 AIIGKGSFGEILKAYWRGTP------------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~g~~------------~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
+.||+|+||.||+|...... +++|.+..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999875332 67776533221 14678899999999999999999999887 778
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC-------cEEEee
Q 016152 231 MLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-------HLKVGD 302 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~-------~~kl~D 302 (394)
++||||+++++|.+++...+ .++...+..++.|++.||.|||+++ |+||||||+||++ +..+ .+||+|
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill--~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILV--ARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEE--ecCccccCCceeEEeCC
Confidence 99999999999999998766 7899999999999999999999988 9999999999999 4444 799999
Q ss_pred cCCccccccccccccccccCCccCccccCccccCCC--CCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 016152 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 374 (394)
Q Consensus 303 Fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~ 374 (394)
||++...... ....++..|+|||.+... .++.++|+||||+++|+|++ |..||...+..+....
T Consensus 152 fg~a~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~ 218 (259)
T cd05037 152 PGIPITVLSR--------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218 (259)
T ss_pred CCcccccccc--------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH
Confidence 9998765431 224467789999999876 78999999999999999999 6889977754444433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=261.18 Aligned_cols=224 Identities=29% Similarity=0.532 Sum_probs=177.7
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
+|+..+.||+|+||.||++... ++.+|+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 5667788999999999999874 678999987654322 33467888999999996 999999999999889999999
Q ss_pred eccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 235 EYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 235 e~~~~~sL~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
|++.. +|.++.. ....+++..+..++.|++.||+|||+. + ++||||||+||++ +..+.++|+|||++..
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILL--DRNGNIKLCDFGISGQ 157 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEE--ccCCcEEEeecchhHH
Confidence 99854 6655432 235799999999999999999999975 6 9999999999999 7788999999999876
Q ss_pred cccccccccccccCCccCccccCccccCCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHR---KYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGv~l~el~~g~~Pf~~~~-~~~~~~~i~~g~~p~~~ 384 (394)
+.... ......+++.|+|||.+.+. .++.++||||||+++|+|++|++||...+ ..+....+..+.+|.+.
T Consensus 158 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd06616 158 LVDSI-----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232 (288)
T ss_pred hccCC-----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCC
Confidence 54322 11234588899999998765 68999999999999999999999997654 33444555556666554
Q ss_pred CC---CCCcccc
Q 016152 385 AK---GFTPELR 393 (394)
Q Consensus 385 ~~---~~~~~~~ 393 (394)
.. .+++++.
T Consensus 233 ~~~~~~~~~~l~ 244 (288)
T cd06616 233 NSEEREFSPSFV 244 (288)
T ss_pred CcCCCccCHHHH
Confidence 43 2555543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=252.70 Aligned_cols=228 Identities=29% Similarity=0.551 Sum_probs=187.3
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--CeeEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI 233 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~lv 233 (394)
+|+..+.||+|++|.||+|... +..+++|.+...... ....+.+.+|+.++++++||||+++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 4677889999999999999986 788999988654432 34457888999999999999999999999888 889999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
+|++.+++|.+++.+...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++ ..++.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILV--DSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--cCCCCEEEcccccEEeccccc
Confidence 999999999999988778999999999999999999999988 9999999999999 778899999999988765443
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHc-CCCCCCCCCCCCcc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAE-GHRPFFRAKGFTPE 391 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~-~~~~~~~i~~-g~~p~~~~~~~~~~ 391 (394)
.. .......++..|+|||.+....++.++|+||||+++|+|++|..||...+ .......+.. +..+.++ ..++++
T Consensus 156 ~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 232 (260)
T cd06606 156 TG--EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIP-EHLSEE 232 (260)
T ss_pred cc--ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCC-cccCHH
Confidence 21 01234568899999999988889999999999999999999999998765 3344444432 3334433 234554
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 233 l~ 234 (260)
T cd06606 233 AK 234 (260)
T ss_pred HH
Confidence 43
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=291.82 Aligned_cols=217 Identities=33% Similarity=0.568 Sum_probs=175.9
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--------
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-------- 227 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-------- 227 (394)
+|+.+..||+||||.||+++. +|+.||||.+.... .......+.+|+.++.+++|||||+++..+.+.
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 688899999999999999986 59999999997665 344557788999999999999999997322100
Q ss_pred --------------------------------------------------------------------------------
Q 016152 228 -------------------------------------------------------------------------------- 227 (394)
Q Consensus 228 -------------------------------------------------------------------------------- 227 (394)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeeEEEEeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHcCC
Q 016152 228 -------------------------------KPLMLITEYLRGGDLHKYLKEKGAL-SPSTAVNFALDIARGMAYLHNEP 275 (394)
Q Consensus 228 -------------------------------~~~~lv~e~~~~~sL~~~~~~~~~~-~~~~~~~~~~ql~~~l~~lH~~~ 275 (394)
-.+|+-||||+...|.+++..+... ....++++++||++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0158899999997777878776654 57788999999999999999998
Q ss_pred CCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc--------------cccccccccccCCccCccccCccccCCC---
Q 016152 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK--------------VQNSHDVYKMTGETGSYRYMAPEVFKHR--- 338 (394)
Q Consensus 276 ~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~--------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~--- 338 (394)
||||||||.||++ +....|||+|||+|.... ..........++.+||.-|+|||.+.+.
T Consensus 718 --iIHRDLKP~NIFL--d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 718 --IIHRDLKPRNIFL--DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred --eeeccCCcceeEE--cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 9999999999999 888999999999998722 0011111235667899999999999765
Q ss_pred CCCCcchHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHcCCCCCC
Q 016152 339 KYDKKVDVFSFAMILYEMLEGEPPLA-NYEPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 339 ~~~~~~DvwslGv~l~el~~g~~Pf~-~~~~~~~~~~i~~g~~p~~ 383 (394)
.|+.|+|+||||||++||+. ||. .++...++..+++|..|+.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~ 836 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP 836 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC
Confidence 49999999999999999995 463 4566677788888888877
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=285.93 Aligned_cols=147 Identities=31% Similarity=0.519 Sum_probs=134.1
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|.+.+.||+|+||.||+|.+. ++.||||++.............+..|+.+++.++||||+++++.+.....+|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 37899999999999999999986 7899999986654444555577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||++.
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl--~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLI--SNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEE--cCCCCEEEEeCCCCc
Confidence 99999999999988888999999999999999999999988 9999999999999 778899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=273.10 Aligned_cols=207 Identities=28% Similarity=0.435 Sum_probs=179.1
Q ss_pred CcccCCCC-cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHH-----HHHHHHHHHhCC---CCce
Q 016152 149 DWEIDPSE-LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQD-----FRHEVNLLVKLR---HPNI 217 (394)
Q Consensus 149 ~~~i~~~~-~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~-----~~~E~~~l~~l~---h~~I 217 (394)
.|+..... .+|.....+|.|+||.|++|.++ ...|+||.+.+.+.-...+.++ .-.|+.+|..++ |+||
T Consensus 552 ~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 552 GCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred cceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 45544433 37999999999999999999986 4568999887765433222222 347999999997 9999
Q ss_pred eeEEeEEEeCCeeEEEEecc-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC
Q 016152 218 VQFLGAVTERKPLMLITEYL-RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (394)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~-~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~ 296 (394)
+|++++|++++.+|++||.. +|.+|+++|..++.+++.++.-|++|++.|+++||+.| |||||||-+|+++ +.+|
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenviv--d~~g 707 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIV--DSNG 707 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEE--ecCC
Confidence 99999999999999999965 45699999999999999999999999999999999998 9999999999999 9999
Q ss_pred cEEEeecCCccccccccccccccccCCccCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCC
Q 016152 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLAN 365 (394)
Q Consensus 297 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~Pf~~ 365 (394)
-+||+|||.+.....++ ...++||..|.|||++.+..| ....|||+||+++|.++....||.+
T Consensus 708 ~~klidfgsaa~~ksgp------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTKSGP------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eEEEeeccchhhhcCCC------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999999998776553 456889999999999999887 6889999999999999999999975
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=260.37 Aligned_cols=210 Identities=31% Similarity=0.528 Sum_probs=177.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|++|.||+|... ++.+++|.+...... ....+.+.+|+.++++++|+||+++++++...+.++++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 6888999999999999999875 678999987543322 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|++++.+..+..+...+++.++..++.|++.||.|||+.+ ++|+||+|+||++ +.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~--~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILV--SESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCCEEEEeeecccccCCCcc-
Confidence 9998777766666667999999999999999999999988 9999999999999 7889999999999887654332
Q ss_pred ccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 375 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i 375 (394)
.......++..|+|||++.+. .++.++|+||||+++|+|++|++||...+..+....+
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 214 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLI 214 (288)
T ss_pred --ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 122345678899999999887 8899999999999999999999999877655544433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=258.76 Aligned_cols=208 Identities=30% Similarity=0.582 Sum_probs=174.6
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||.|++|.||+|... |..+|+|.+....... ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4788899999999999999974 7889999886543221 23456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 236 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 236 ~~~~~sL~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|+.+ +|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.++|+|||++......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~--~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLI--NKRGELKLADFGLARAFGIP 153 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEE--CCCCcEEEeecchhhhhcCC
Confidence 9985 898888754 35899999999999999999999988 9999999999999 78889999999998755432
Q ss_pred cccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
.. ......++..|++||++.+ ..++.++|+||||+++|+|++|++||.+.+..+....+.
T Consensus 154 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 214 (284)
T cd07836 154 VN----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF 214 (284)
T ss_pred cc----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 11 1233457889999999865 457899999999999999999999998887766665544
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=253.64 Aligned_cols=207 Identities=35% Similarity=0.565 Sum_probs=181.6
Q ss_pred eecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCCCH
Q 016152 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (394)
Q Consensus 165 iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~sL 242 (394)
||.|+||.||++... ++.+++|.+.............+..|+.++++++||||+++++.+..+...+++||++.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999875 788999988765554444567788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccC
Q 016152 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322 (394)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~ 322 (394)
.+++...+.+++..+..++.|++.+|.|||+.+ ++|+||+|+||++ +..+.++|+|||++........ ....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~--~~~~~~~l~d~~~~~~~~~~~~----~~~~ 152 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILL--DADGHIKLTDFGLAKELSSEGS----RTNT 152 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEE--cCCCcEEEeecCcceecccCCC----cccC
Confidence 999998878999999999999999999999988 9999999999999 7788999999999876643321 1234
Q ss_pred CccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Q 016152 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH 379 (394)
Q Consensus 323 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~ 379 (394)
..++..|+|||.+.+..++.++|+||||+++|++++|+.||...+..+..+.+.++.
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~ 209 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP 209 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 568889999999988889999999999999999999999998888777777777643
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=256.12 Aligned_cols=191 Identities=27% Similarity=0.444 Sum_probs=158.8
Q ss_pred Ccccccee--ecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEE
Q 016152 158 DFSSSAII--GKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 158 ~~~~~~~i--G~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~l 232 (394)
.|++.+.+ |+|+||.||++... +..+++|.+....... .|+.....+ +||||+++++.+...+.+++
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34454554 99999999999864 6789999875432211 122222222 69999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC-cEEEeecCCcccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKV 311 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~-~~kl~DFg~a~~~~~ 311 (394)
||||+++++|.+++..+..+++.++..++.|+++||.|||+.+ ++||||||+||++ +..+ .++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLY--DRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--eCCCCeEEEecCccceecCC
Confidence 9999999999999988878999999999999999999999988 9999999999999 6666 899999999876542
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~ 368 (394)
. ....++..|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 163 ~--------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 211 (267)
T PHA03390 163 P--------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211 (267)
T ss_pred C--------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence 2 234688999999999998999999999999999999999999976543
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=258.09 Aligned_cols=215 Identities=27% Similarity=0.468 Sum_probs=177.5
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--CeeEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI 233 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~lv 233 (394)
+|+..+.||.|++|.||++... ++.+|+|.+..... ......+.+|++++++++||||+++++++.+. ..+++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 5777889999999999999974 67899998764432 23446788999999999999999999988653 468999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
|||+++++|.+++.. ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++ +..+.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~--~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILL--TRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--ecCCeEEEeeccccccc
Confidence 999999999988753 345899999999999999999999988 9999999999999 77788999999998755
Q ss_pred ccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHcCCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-----EPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~-----~~~~~~~~i~~g~~p~~~ 384 (394)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||... ...+....+.....|.+.
T Consensus 156 ~~~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd06621 156 VNSL------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229 (287)
T ss_pred cccc------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence 4221 12345788999999999899999999999999999999999999765 345666666654444443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=255.85 Aligned_cols=204 Identities=27% Similarity=0.475 Sum_probs=168.4
Q ss_pred CccccceeecCCceEEEEEEEC------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe-CCee
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKPL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~ 230 (394)
.|+....||+|.||.||+|..+ ...+|+|.+......+ .......+|+.+++.++||||+.+..+|.. +..+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 5888889999999999999643 2368999876553322 222445679999999999999999998877 8899
Q ss_pred EEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC--CCCcEEEeec
Q 016152 231 MLITEYLRGGDLHKYLKEK-----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS--SADHLKVGDF 303 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~--~~~~~kl~DF 303 (394)
++++||.+. +|+.+|+-+ ..++...+..+++||+.|+.|||++ .|+||||||.||||..+ +.|.|||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N--WvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN--WVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh--heeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999988 999998632 3589999999999999999999995 59999999999999432 4589999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
|+++.+.+.- ..-+.....+-|++|.|||.+.+. .||++.||||+||++.||+|-++.|.+.
T Consensus 181 GlaR~~~~pl-kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 181 GLARLFNNPL-KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cHHHHhhccc-cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999886542 222244566789999999998875 6899999999999999999999999654
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=267.08 Aligned_cols=206 Identities=27% Similarity=0.403 Sum_probs=173.1
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC------C
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~ 228 (394)
.+|++.+.||+|+||.||++.. .++.+|+|.+...... ......+.+|+.++++++||||+++++++... .
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 3789999999999999999986 4788999987544332 22335677899999999999999999988644 3
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
..++||||+.+ +|.+.+... ++...+..++.|++.||+|||++| |+||||||+||++ +.++.+||+|||++..
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 167 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--CCCCCEEEccCcccee
Confidence 57999999965 898888654 899999999999999999999988 9999999999999 8888999999999976
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 375 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i 375 (394)
..... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+
T Consensus 168 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 229 (353)
T cd07850 168 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229 (353)
T ss_pred CCCCC-----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 54322 123356789999999999999999999999999999999999999887765555544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=259.83 Aligned_cols=209 Identities=27% Similarity=0.422 Sum_probs=175.7
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--CeeEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI 233 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~lv 233 (394)
+|++.+.||+|+||.||+|... ++.+++|.+...... ......+.+|+.++++++||||+++++++... ..+++|
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 6888999999999999999985 678999988654332 22224566899999999999999999998877 889999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 234 TEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|||+.+ +|.+++... ..+++..+..++.|++.||+|||+++ ++|+||||+||++ +.++.++|+|||++......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili--~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLL--NNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEE--CCCCcEEEeecCceeeccCC
Confidence 999975 999988764 35899999999999999999999988 9999999999999 88899999999998866543
Q ss_pred cccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
.. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..+....+.
T Consensus 160 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~ 220 (293)
T cd07843 160 LK----PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF 220 (293)
T ss_pred cc----ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 21 12335578899999998754 46899999999999999999999999888777666654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=260.61 Aligned_cols=214 Identities=24% Similarity=0.433 Sum_probs=173.1
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC------
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------ 228 (394)
.+|++.+.||+|+||.||+|... ++.+|||.+........ ......+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC-chhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 37899999999999999999874 78899998754432221 1234567999999999999999999876554
Q ss_pred --eeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 229 --PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 229 --~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
..++||||+.+ +|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||++ +.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILI--TKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE--CCCCcEEECcCCC
Confidence 35999999965 888887654 36899999999999999999999988 9999999999999 8888999999999
Q ss_pred ccccccccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
+..................++..|+|||.+.+. .++.++|+||||+++|||++|.+||...+..+....+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~ 237 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 986654332211122345678899999988664 47889999999999999999999998887766555544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=257.75 Aligned_cols=202 Identities=32% Similarity=0.554 Sum_probs=170.7
Q ss_pred CccccceeecCCceEEEEEEEC------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe--CCe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKP 229 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~ 229 (394)
.|++.+.||+|+||.||++.+. +..+|+|.+...... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 5778899999999999999864 568999988654432 345778999999999999999999998877 557
Q ss_pred eEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.+++|||+++++|.+++.... .+++..+..++.|++.||+|||+++ ++|+||||+||++ +.++.++|+|||++..
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILV--ESEDLVKISDFGLAKV 158 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEE--cCCCCEEEcccccccc
Confidence 899999999999999997654 5899999999999999999999988 9999999999999 7788999999999987
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
....... ........++..|+|||.+....++.++|+||||+++|||++|..||...
T Consensus 159 ~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 159 LPEDKDY-YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccCCcc-eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 6533211 11112234566799999998889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=280.63 Aligned_cols=201 Identities=21% Similarity=0.339 Sum_probs=158.7
Q ss_pred CcCccccceeecCCceEEEEEEEC---CccEEEE--------------EeccCCCCcHHHHHHHHHHHHHHHhCCCCcee
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR---GTPVAIK--------------RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~---g~~~avK--------------~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 218 (394)
..+|++.+.||+|+||.||++..+ +...+.| .+.+...........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 347999999999999999998653 1112222 11111112223345678999999999999999
Q ss_pred eEEeEEEeCCeeEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC
Q 016152 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK-----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS 293 (394)
Q Consensus 219 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~ 293 (394)
++++++...+..++++|++. ++|..++... .......+..++.||+.||.|||+++ |+||||||+|||+ +
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl--~ 301 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFL--N 301 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--C
Confidence 99999999999999999985 4787776542 22446678889999999999999988 9999999999999 8
Q ss_pred CCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCC-CCC
Q 016152 294 SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP-PLA 364 (394)
Q Consensus 294 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~-Pf~ 364 (394)
.++.+||+|||++..+..... .......||+.|+|||++.+..++.++|||||||++|||++|.. ||.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE---AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CCCCEEEEeCCCceecCcccc---cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 888999999999987653321 11234679999999999999999999999999999999999875 553
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=261.57 Aligned_cols=211 Identities=32% Similarity=0.519 Sum_probs=175.5
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--CeeEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLML 232 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~l 232 (394)
.+|++.+.||+|+||.||++... |+.||+|.+........ ......+|+.++++++|+||+++++++.+. +.+++
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG-IPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC-CcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 37899999999999999999874 78899998864432221 113456799999999999999999998765 56899
Q ss_pred EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 233 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
||||+.+ +|.+++.. ...+++.++..++.|++.||.|||+.+ ++||||||+||++ +..+.+||+|||++.....
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLL--TDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEECccceeeecCC
Confidence 9999965 89888875 457899999999999999999999988 9999999999999 7888999999999986653
Q ss_pred ccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
... ......+++.|+|||.+.+ ..++.++|+||||+++|||++|++||...+..+....+..
T Consensus 161 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 223 (309)
T cd07845 161 PAK----PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223 (309)
T ss_pred ccC----CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 321 1223345788999999865 5678999999999999999999999999988888877664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=233.02 Aligned_cols=209 Identities=31% Similarity=0.537 Sum_probs=179.9
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|...++||+|.||+||+|+.. ++.||+|...-...+. ..-....+|+-+++.++|.|||++++....++.+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 4666788999999999999864 6679999876543332 222456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+. +|..++.+ ++.++.+.++.++.|+++||.++|+.+ +.|||+||.|+|+ +.+|++|++|||+++.+..+
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnlli--n~ngelkladfglarafgip-- 154 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLI--NRNGELKLADFGLARAFGIP-- 154 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEe--ccCCcEEecccchhhhcCCc--
Confidence 9976 99988875 788999999999999999999999988 9999999999999 99999999999999876432
Q ss_pred cccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~ 376 (394)
+......+-|.+|.+|.++.+. -|+...|+||.||++.|+.. |++.|.+.+-.+..++|-
T Consensus 155 --vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif 216 (292)
T KOG0662|consen 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_pred --eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHH
Confidence 2245567789999999998875 58999999999999999997 999999998888888774
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=256.58 Aligned_cols=197 Identities=23% Similarity=0.420 Sum_probs=160.3
Q ss_pred eeecCCceEEEEEEECC---------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 164 IIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~g---------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.||+|+||.||+|.... ..+++|.+... .....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 58999999999997642 24777765322 2233466788999999999999999999999989999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCC------CcEEEeecCCcc
Q 016152 235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA------DHLKVGDFGLSK 307 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~------~~~kl~DFg~a~ 307 (394)
||+.+|+|.+++..++ .+++..+..++.|++.||.|||+++ |+||||||+||++..+.. +.++++|||++.
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999999998654 5899999999999999999999988 999999999999943221 137999999886
Q ss_pred ccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcC-CCCCCCCCHHHHHH
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEG-EPPLANYEPYEAAK 373 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g-~~Pf~~~~~~~~~~ 373 (394)
..... ....+++.|+|||.+.+ ..++.++||||||+++|||++| .+||...+......
T Consensus 157 ~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~ 216 (258)
T cd05078 157 TVLPK--------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ 216 (258)
T ss_pred ccCCc--------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH
Confidence 54321 23467889999999986 4579999999999999999998 57777766655443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=263.01 Aligned_cols=204 Identities=29% Similarity=0.505 Sum_probs=168.1
Q ss_pred CccccceeecCCceEEEEEEE----CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--CeeE
Q 016152 158 DFSSSAIIGKGSFGEILKAYW----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLM 231 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~----~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~ 231 (394)
+|++.+.||+|+||.||+|.. .+..+|+|.+.............+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 477888999999999999987 4578999988764322222235677899999999999999999999888 7899
Q ss_pred EEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC----CCcEEEee
Q 016152 232 LITEYLRGGDLHKYLKEK-----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS----ADHLKVGD 302 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~----~~~~kl~D 302 (394)
+||||+++ +|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||++ +. .+.+||+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~--~~~~~~~~~~kl~D 155 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILV--MGEGPERGVVKIGD 155 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEE--cCCCCccceEEECC
Confidence 99999975 777776532 36899999999999999999999988 9999999999999 66 88999999
Q ss_pred cCCccccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 303 Fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
||++......... ........+++.|+|||.+.+ ..++.++||||||+++|+|++|++||...+
T Consensus 156 fg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 156 LGLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred CccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 9999866433221 112334568899999998866 457899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=265.80 Aligned_cols=212 Identities=26% Similarity=0.459 Sum_probs=174.9
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe----CCee
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RKPL 230 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~~ 230 (394)
.+|++.+.||+|++|.||++... +..+++|.+...... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 37888899999999999999864 789999988654322 2234567789999999999999999988753 3468
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
++||||+. ++|.+++...+.+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~--~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLV--NEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCcEEecccccceeec
Confidence 99999995 599999987778999999999999999999999988 9999999999999 888999999999997664
Q ss_pred cccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 374 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~ 374 (394)
..............++..|+|||.+.+ ..++.++|+||||+++|+|++|++||...+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~ 223 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL 223 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHH
Confidence 433221112234578999999999865 4688999999999999999999999988765544433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=278.61 Aligned_cols=216 Identities=32% Similarity=0.625 Sum_probs=188.5
Q ss_pred CcCccccceeecCCceEEEEEEEC--C----ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--G----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g----~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
+......++||+|+||.||+|.+- | -+||+|++...... ....++..|+.+|.+++|||++++++++....
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence 344567889999999999999873 3 37899988655433 33478899999999999999999999988766
Q ss_pred eEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 230 LMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
+.||++|+++|+|.++++. ++.+-....+.|..||++||.|||.++ +|||||..+|+|| .....+||.|||+++.
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLV--ksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLV--KSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheee--cCCCeEEEEecchhhc
Confidence 8999999999999999986 457999999999999999999999988 9999999999999 7777999999999998
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
+..... .+......-.+.|||-|.+....|+.++||||+||++||++| |..||++.+..|+.+.+..|.|
T Consensus 848 l~~d~~--ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR 918 (1177)
T KOG1025|consen 848 LAPDEK--EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER 918 (1177)
T ss_pred cCcccc--cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc
Confidence 875432 334455556788999999999999999999999999999999 9999999999999999999887
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=257.22 Aligned_cols=207 Identities=29% Similarity=0.517 Sum_probs=171.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|+..+.||.|++|.||+|... ++.++||.+...... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 4778889999999999999874 788999987543322 2223567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|+. ++|.+++.. .+.+++.++..++.|++.||.|||+.+ ++||||+|+||++ +.++.++|+|||++..+....
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill--~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEEeeccchhhcccCc
Confidence 996 589988865 356899999999999999999999988 9999999999999 888899999999987654221
Q ss_pred ccccccccCCccCccccCccccCCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 374 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~ 374 (394)
. ......+++.|+|||.+.+.. ++.++|+||||+++|+|+||+.||...+..+...+
T Consensus 155 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 212 (284)
T cd07860 155 R----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212 (284)
T ss_pred c----ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 1 123345788999999887644 68899999999999999999999987765544433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=257.62 Aligned_cols=216 Identities=27% Similarity=0.434 Sum_probs=175.4
Q ss_pred CccccceeecCCceEEEEEEE-----CCccEEEEEeccCCCC-cHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCee
Q 016152 158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~-----~g~~~avK~l~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~ 230 (394)
+|++.+.||+|++|.||++.. .+..+|||.+.+.... .....+.+.+|+.++.++ +||+|+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999875 3567999987643221 122345677899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
++||||+.+++|.+++.....+++..+..++.|++++|.|||+.+ ++||||+|+||++ +.++.++|+|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILL--DSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEEEECccccccc
Confidence 999999999999999988778999999999999999999999988 9999999999999 788899999999987654
Q ss_pred cccccccccccCCccCccccCccccCCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPPLANYE----PYEAAKYVAEGHR 380 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~~g~~Pf~~~~----~~~~~~~i~~g~~ 380 (394)
..... ......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||.... ..+..+.+....+
T Consensus 157 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd05583 157 AEEEE---RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP 229 (288)
T ss_pred ccccc---ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC
Confidence 33211 122346889999999987654 7889999999999999999999996432 3344444444433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=256.18 Aligned_cols=226 Identities=26% Similarity=0.481 Sum_probs=180.0
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~l 232 (394)
..+|++.+.||+|+||.||++.+. ++.+|||.+...... .....+..|+.++.+.. ||||+++++++.+...+++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 347889999999999999999986 889999988654322 22345566776666664 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 233 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
+|||+.+ +|.+++.. .+.+++..+..++.|+++||.|||+. + |+||||+|+||++ +.++.++|+|||++..+.
T Consensus 92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill--~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILL--DASGNVKLCDFGISGRLV 166 (296)
T ss_pred EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEE--cCCCCEEECccccchhcc
Confidence 9999854 88877765 45789999999999999999999974 6 9999999999999 788899999999987654
Q ss_pred cccccccccccCCccCccccCccccCCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCCCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGv~l~el~~g~~Pf~~~~-~~~~~~~i~~g~~p~~~~ 385 (394)
.... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.... ..+....+..+..+.++.
T Consensus 167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06618 167 DSKA-----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP 241 (296)
T ss_pred CCCc-----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC
Confidence 3221 12235788999999987553 7899999999999999999999997643 356667777666555544
Q ss_pred C-CCCcccc
Q 016152 386 K-GFTPELR 393 (394)
Q Consensus 386 ~-~~~~~~~ 393 (394)
. .++++++
T Consensus 242 ~~~~~~~l~ 250 (296)
T cd06618 242 NEGFSPDFC 250 (296)
T ss_pred CCCCCHHHH
Confidence 3 3666654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=255.19 Aligned_cols=207 Identities=32% Similarity=0.542 Sum_probs=172.3
Q ss_pred ccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 159 FSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
|++.+.||.|++|.||++.. .|..+++|.+...... ......+.+|+.+++.++|||++++++++.+.+..+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 56778999999999999986 4889999988654322 12225577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 237 LRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 237 ~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
+. ++|.+++.... .+++..+..++.|++++|.|||+++ ++||||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~--~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLI--DREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEE--cCCCcEEEeecccccccCCCcc
Confidence 95 59999988765 6899999999999999999999988 9999999999999 7788999999999875532211
Q ss_pred cccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 375 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i 375 (394)
......+++.|+|||.+.+. .++.++|+||||+++|+|++|++||...+.......+
T Consensus 155 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 212 (283)
T cd07835 155 ----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212 (283)
T ss_pred ----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 12234568899999988654 5789999999999999999999999887765544443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=261.37 Aligned_cols=213 Identities=27% Similarity=0.440 Sum_probs=172.4
Q ss_pred CccccceeecCCceEEEEEEEC----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeC----C
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER----K 228 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~----~ 228 (394)
+|++.+.||+|+||.||++... +..+|+|.+...... ....+.+.+|+.+++++ +||||+++++..... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 4778889999999999999875 558999987543322 22345677899999999 599999999865322 4
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.+++++|++. ++|.+++.....+++..++.++.|++.||+|||+.| |+||||||+|||+ +.++.++|+|||++..
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili--~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLV--NADCELKICDFGLARG 154 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEE--cCCCCEEeCcCCCcee
Confidence 5788999885 599999988788999999999999999999999988 9999999999999 7888999999999987
Q ss_pred cccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
+...............||..|+|||.+.+ ..++.++|+||||+++|+|++|++||...+.......+.
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~ 223 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQIL 223 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHH
Confidence 65332211112234578999999998765 568999999999999999999999998877655555444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=255.48 Aligned_cols=208 Identities=32% Similarity=0.523 Sum_probs=170.4
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|++|.||++..+ ++.+++|.+...... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 6888999999999999999864 778999987543222 1223567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCccccccc
Q 016152 236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a~~~~~~ 312 (394)
|+. ++|.+++.... .+++..+..++.|++.||+|||+++ ++||||+|+||++ + .++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill--~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLI--DRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEE--ECCCCEEEEcccccccccCCC
Confidence 996 48888876543 3578888999999999999999988 9999999999999 4 3457999999999765422
Q ss_pred cccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 375 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i 375 (394)
.. ......+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||...+..+....+
T Consensus 157 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~ 216 (294)
T PLN00009 157 VR----TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216 (294)
T ss_pred cc----ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 11 1233467889999999866 45789999999999999999999999887766555443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=252.86 Aligned_cols=202 Identities=27% Similarity=0.471 Sum_probs=178.8
Q ss_pred CCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~ 231 (394)
...+|..+++||+|+|+.|..+... .+.+|+|++.+...++.+.+.....|-.+..+. +||.+|-++.+|..+.+++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3447999999999999999988764 677999998887766655556666777777655 5999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
+|.||+.||+|--.+++...++++.++.+...|+-||.|||++| ||+||||.+|+|+ +..|++||.|||+++.--.
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvll--daeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLL--DAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEE--ccCCceeecccchhhcCCC
Confidence 99999999999888888888999999999999999999999999 9999999999999 9999999999999874332
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~ 364 (394)
+. -...+++|||.|.|||++++..|...+|+|+|||+|+||+.|+.||+
T Consensus 404 ~g----d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 404 PG----DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CC----cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 22 13567999999999999999999999999999999999999999996
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=256.98 Aligned_cols=220 Identities=30% Similarity=0.541 Sum_probs=178.4
Q ss_pred CccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHh--CCCCceeeEEeEEEeCC----eeE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK--LRHPNIVQFLGAVTERK----PLM 231 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~--l~h~~Iv~~~~~~~~~~----~~~ 231 (394)
.....+.||+|.||.||+|.|+|+.||||++..... +.+.+|.++.+. ++|+||+.+++.-..+. .+|
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred eeEEEEEecCccccceeeccccCCceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 346688999999999999999999999998854322 345667777775 59999999998764433 589
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-----CC-CCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-----EP-NVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-----~~-~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
||++|.+.|||+||+.+ ..++....++++..++.||++||- +| +.|.|||||..|||| ..++..-|+|+||
T Consensus 286 LvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV--Kkn~~C~IADLGL 362 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGL 362 (513)
T ss_pred EeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE--ccCCcEEEeecee
Confidence 99999999999999987 579999999999999999999995 22 459999999999999 8999999999999
Q ss_pred ccccccccccccccccCCccCccccCccccCCCC----C--CCcchHHHHHHHHHHHHcC----------CCCCCCC---
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK----Y--DKKVDVFSFAMILYEMLEG----------EPPLANY--- 366 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwslGv~l~el~~g----------~~Pf~~~--- 366 (394)
|.........-.......+||-+|||||++...- + -..+||||||+++||+..+ ++||.+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9887766544444566788999999999986431 2 2579999999999998763 5788543
Q ss_pred -CHHHHHHHHH--cCCCCCCCCC
Q 016152 367 -EPYEAAKYVA--EGHRPFFRAK 386 (394)
Q Consensus 367 -~~~~~~~~i~--~g~~p~~~~~ 386 (394)
+.+|..+.+. +..||.++..
T Consensus 443 DPs~eeMrkVVCv~~~RP~ipnr 465 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIPNR 465 (513)
T ss_pred CCCHHHHhcceeecccCCCCCcc
Confidence 4556666654 6778888753
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=262.23 Aligned_cols=207 Identities=30% Similarity=0.528 Sum_probs=169.3
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC-----e
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-----P 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-----~ 229 (394)
.+|++.+.||+|+||.||++.. .|+.||+|.+.... .......+.+|+.+++.++||||+++++++.... .
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3789999999999999999986 47889999875322 2233456778999999999999999998865443 5
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
+++++||+.+ +|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++...
T Consensus 83 ~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill--~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 83 VYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL--NTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--CCCCCEEECcccceeec
Confidence 7999999965 88887754 46999999999999999999999988 9999999999999 88889999999998765
Q ss_pred ccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~ 372 (394)
........ ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|++||...+.....
T Consensus 157 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~ 219 (336)
T cd07849 157 DPEHDHTG-FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL 219 (336)
T ss_pred cccccccC-CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 43322111 2234568999999998754 56899999999999999999999999876544433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=253.49 Aligned_cols=226 Identities=32% Similarity=0.504 Sum_probs=183.9
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCC--cHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~--~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
+|.+.+.||+|+||.||++... +..+++|.+...... .......+..|+.+++.++||||+++++.+.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778889999999999999875 345666655432211 112224566789999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
+||+.+++|.+++.. ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++ +. +.++|+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili--~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFL--KN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEe--ec-CCEeecccCceeec
Confidence 999999999988864 356899999999999999999999988 9999999999999 43 56999999998766
Q ss_pred ccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~ 389 (394)
..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..+..|.++ +.++
T Consensus 156 ~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 230 (260)
T cd08222 156 MGSCD----LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLP-ETYS 230 (260)
T ss_pred CCCcc----cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCc-chhc
Confidence 43321 122356788999999998888999999999999999999999999888888888888888777765 3466
Q ss_pred cccc
Q 016152 390 PELR 393 (394)
Q Consensus 390 ~~~~ 393 (394)
++++
T Consensus 231 ~~~~ 234 (260)
T cd08222 231 RQLN 234 (260)
T ss_pred HHHH
Confidence 6553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=255.63 Aligned_cols=208 Identities=28% Similarity=0.467 Sum_probs=169.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCe-----
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKP----- 229 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~----- 229 (394)
+|++.+.||+|+||.||++... ++.+|+|.+...... ......+.+|+.+++.+. ||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 5788899999999999999874 778999987543322 112356778999999995 6999999998877665
Q ss_pred eEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC-CCcEEEeec
Q 016152 230 LMLITEYLRGGDLHKYLKEK-----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDF 303 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~-~~~~kl~DF 303 (394)
.+++|||+++ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||++ +. ++.+||+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~--~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLV--DKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEE--ecCCCeEEEeec
Confidence 8999999986 898888642 35799999999999999999999988 9999999999999 65 789999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 375 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i 375 (394)
|++..+..... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+..+....+
T Consensus 156 g~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 224 (295)
T cd07837 156 GLGRAFSIPVK----SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224 (295)
T ss_pred ccceecCCCcc----ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 99876543211 1223457889999998865 45789999999999999999999999887766655544
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=253.03 Aligned_cols=205 Identities=26% Similarity=0.441 Sum_probs=168.6
Q ss_pred ccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeC--CeeEEE
Q 016152 159 FSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER--KPLMLI 233 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~--~~~~lv 233 (394)
|++.+.||+|+||.||++.. .+..+|+|.+........ . ....+|+.+++++. |+||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-Q-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-h-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 56778999999999999987 477899998765433222 1 23446888888885 99999999999887 889999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|||+.+ +|.+++.. .+.+++.++..++.|++.||+|||+.+ ++||||+|+||++ +. +.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l--~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILI--KD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEE--cC-CCeEEEecccccccccC
Confidence 999975 88888875 457899999999999999999999988 9999999999999 66 89999999999866433
Q ss_pred cccccccccCCccCccccCccccC-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
.. .....++..|+|||.+. +..++.++|+|||||++|||++|.+||...+..+....+.
T Consensus 153 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~ 212 (282)
T cd07831 153 PP-----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIH 212 (282)
T ss_pred CC-----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHH
Confidence 21 22345788999999764 4567899999999999999999999999887766655554
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=278.93 Aligned_cols=232 Identities=35% Similarity=0.613 Sum_probs=194.8
Q ss_pred CcccCCCCcCccccceeecCCceEEEEEEEC---------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCcee
Q 016152 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIV 218 (394)
Q Consensus 149 ~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~---------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv 218 (394)
.|+++.... .+.+.||+|.||.|++|... ...||||.+...... ...+.+..|+.+++.+. |+||+
T Consensus 290 ~~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 290 KWEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred ceeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchh
Confidence 677776655 55569999999999998743 235899977655443 44588999999999986 99999
Q ss_pred eEEeEEEeCCeeEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecC
Q 016152 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282 (394)
Q Consensus 219 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~----------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~D 282 (394)
.+++++...+.+++|+||++.|+|..+++.++ .++..+...++.||+.|++||+++. +||||
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRD 443 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRD 443 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchh
Confidence 99999999999999999999999999998755 4889999999999999999999988 99999
Q ss_pred CCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCc--cCccccCccccCCCCCCCcchHHHHHHHHHHHHc-C
Q 016152 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-G 359 (394)
Q Consensus 283 ikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g 359 (394)
|..+|||+ ..+..+||+|||+|+....... +...... -+..|||||.+....|+.++||||+||+|||+++ |
T Consensus 444 LAaRNVLi--~~~~~~kIaDFGlar~~~~~~~---y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG 518 (609)
T KOG0200|consen 444 LAARNVLI--TKNKVIKIADFGLARDHYNKDY---YRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLG 518 (609)
T ss_pred hhhhhEEe--cCCCEEEEccccceeccCCCCc---eEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCC
Confidence 99999999 7778999999999986543321 1112222 3556999999999999999999999999999999 9
Q ss_pred CCCCCCCC-HHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 360 EPPLANYE-PYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 360 ~~Pf~~~~-~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
..||.+.. ..++++.+.+|++...|.. +++++
T Consensus 519 ~~PYp~~~~~~~l~~~l~~G~r~~~P~~-c~~ei 551 (609)
T KOG0200|consen 519 GTPYPGIPPTEELLEFLKEGNRMEQPEH-CSDEI 551 (609)
T ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCC-CCHHH
Confidence 99999876 7788899999999998865 46654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=274.52 Aligned_cols=224 Identities=31% Similarity=0.547 Sum_probs=192.5
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEE-----eCCe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVT-----ERKP 229 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~-----~~~~ 229 (394)
-|++..+||.|.+|.||++.. .++..|+|++......+ .++..|.++++... |||++.++++|. .++.
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 467778999999999998864 58899999886654433 56677889999885 999999999874 3467
Q ss_pred eEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 230 LMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
+|||||||.|||..|+++. ...+.+..+.-|++.++.|+.+||... ++|||||-.|||+ ..++.|||+|||.+.
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLL--T~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLL--TENAEVKLVDFGVSA 171 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEE--eccCcEEEeeeeeee
Confidence 9999999999999999975 456999999999999999999999976 9999999999999 788899999999998
Q ss_pred ccccccccccccccCCccCccccCccccCC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~ 382 (394)
.+..+.. ...+.+|||.|||||++.. ..|+.++|+||||++..||.-|.+|+.++.+..++-+|-+.++|.
T Consensus 172 QldsT~g----rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 172 QLDSTVG----RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred eeecccc----cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 7765543 3456889999999999864 357889999999999999999999999999999999999999999
Q ss_pred CCC-CCCCcccc
Q 016152 383 FRA-KGFTPELR 393 (394)
Q Consensus 383 ~~~-~~~~~~~~ 393 (394)
+.. +.++++|-
T Consensus 248 Lkrp~kWs~~Fn 259 (953)
T KOG0587|consen 248 LKRPKKWSKKFN 259 (953)
T ss_pred ccchhhHHHHHH
Confidence 884 55666653
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=256.69 Aligned_cols=209 Identities=18% Similarity=0.285 Sum_probs=171.3
Q ss_pred ccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccC
Q 016152 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 238 (394)
+.+++.+|.|+++.|+++..+++.+|||.+..... .......+.+|+.+++.++||||+++++++.+....+++|||+.
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 45566667777777777777899999999865422 23345778999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc-
Q 016152 239 GGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH- 315 (394)
Q Consensus 239 ~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~- 315 (394)
+++|.+++... ..+++..+..++.|+++||.|||+++ |+||||||+||++ +.++.++|+|||.+..+......
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili--~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILL--SGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEE--ecCCceEEecCccceeeccccccc
Confidence 99999999863 45899999999999999999999988 9999999999999 77789999999988765432211
Q ss_pred --ccccccCCccCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 016152 316 --DVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372 (394)
Q Consensus 316 --~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~ 372 (394)
.........++..|+|||.+.. ..++.++|+|||||++|||++|+.||...+..+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~ 219 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML 219 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0001123457788999999876 35889999999999999999999999877654443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=253.88 Aligned_cols=209 Identities=31% Similarity=0.500 Sum_probs=175.8
Q ss_pred ccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--CeeEEEE
Q 016152 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLIT 234 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~lv~ 234 (394)
|++.+.||+|++|.||++... ++.+++|.+.... ........+.+|+.+++.++|||++++++++... +..++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 567789999999999999875 5789999987654 2222335677899999999999999999999887 7899999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
||+.+ +|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++ +.++.++|+|||++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~--~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILI--NNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEE--cCCCCEEEccccceeeccCCC
Confidence 99975 999888765 57999999999999999999999988 9999999999999 888999999999998765432
Q ss_pred ccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+....+.
T Consensus 155 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~ 215 (287)
T cd07840 155 S---ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIF 215 (287)
T ss_pred c---ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 1 11223456888999998765 467899999999999999999999998888766666554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=261.79 Aligned_cols=213 Identities=31% Similarity=0.512 Sum_probs=181.5
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC-----ee
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-----PL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-----~~ 230 (394)
+|++.+.||.|++|.||++... ++.+++|.+..... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 4788899999999999999874 68899998865432 2333467888999999999999999999987765 78
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
+++|||+.+ +|.+++.+.+.+++..+..++.|++.||.|||+.| |+||||||+||++ +.++.++|+|||++....
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili--~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILV--NSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEcccCceEeec
Confidence 999999974 89999988778999999999999999999999988 9999999999999 778999999999998765
Q ss_pred cccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
..... ........+++.|+|||.+.+. .++.++|+||||+++|+|++|++||...+..+..+.+..
T Consensus 155 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 221 (330)
T cd07834 155 PDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVE 221 (330)
T ss_pred ccccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 44211 1123345688999999999887 789999999999999999999999999888777776653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=257.74 Aligned_cols=210 Identities=21% Similarity=0.328 Sum_probs=168.6
Q ss_pred eeecC--CceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 164 IIGKG--SFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 164 ~iG~G--~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
.||+| +|+.||++.+ .|+.||+|++...... ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 46666 9999999987 5889999987654333 33457788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccc
Q 016152 240 GDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317 (394)
Q Consensus 240 ~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~ 317 (394)
++|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+||++ +.++.++++||+.+...........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill--~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILI--SGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--eCCCcEEEechHHHhhhhccCcccc
Confidence 9999998864 34899999999999999999999988 9999999999999 7778999999986543322111110
Q ss_pred c--c-ccCCccCccccCccccCCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 016152 318 Y--K-MTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (394)
Q Consensus 318 ~--~-~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g 378 (394)
. . .....++..|+|||++.+. .++.++|||||||++|+|++|++||......+....+..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 225 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKG 225 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcC
Confidence 0 0 0112346679999999764 4789999999999999999999999887766655554443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=260.96 Aligned_cols=208 Identities=27% Similarity=0.482 Sum_probs=172.9
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC-----Cee
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KPL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~ 230 (394)
+|.+.+.||+|+||.||++... +..+|||.+....... .....+.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 6889999999999999999864 7899999886543222 2235567899999999999999999987644 347
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
++++||+. ++|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLL--NANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--cCCCCEEECcCccccccC
Confidence 99999995 699999988888999999999999999999999988 9999999999999 778899999999998664
Q ss_pred cccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 375 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i 375 (394)
.... ......++..|+|||.+.. ..++.++|+||||+++|+|++|++||.+.+..+....+
T Consensus 160 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 221 (337)
T cd07858 160 EKGD----FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLI 221 (337)
T ss_pred CCcc----cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Confidence 3321 1234567889999998865 46889999999999999999999999877654444333
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=258.69 Aligned_cols=214 Identities=27% Similarity=0.420 Sum_probs=174.7
Q ss_pred Ccc-ccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHH-----------HHHHHHHHHHHHHhCCCCceeeEEeE
Q 016152 158 DFS-SSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL-----------VIQDFRHEVNLLVKLRHPNIVQFLGA 223 (394)
Q Consensus 158 ~~~-~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~Iv~~~~~ 223 (394)
+|. +.+.||.|+||.||+|... ++.+|||.+......... ....+.+|+.+++.++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 454 4578999999999999864 788999987543322100 01246789999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 224 VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 224 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
+...+..+++|||+. ++|.+++.....+++..+..++.|++.||+|||+.+ ++|+||+|+||++ +.++.++|+||
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill--~~~~~~kl~df 163 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFI--NSKGICKIADF 163 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEE--CCCCCEEECCc
Confidence 999999999999996 599999988888999999999999999999999988 9999999999999 78889999999
Q ss_pred CCcccccccccc----------ccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 016152 304 GLSKLIKVQNSH----------DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372 (394)
Q Consensus 304 g~a~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~ 372 (394)
|++......... .........+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998765421100 01112234568899999998764 4689999999999999999999999988877766
Q ss_pred HHHH
Q 016152 373 KYVA 376 (394)
Q Consensus 373 ~~i~ 376 (394)
..+.
T Consensus 244 ~~i~ 247 (335)
T PTZ00024 244 GRIF 247 (335)
T ss_pred HHHH
Confidence 6554
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=251.03 Aligned_cols=207 Identities=31% Similarity=0.541 Sum_probs=172.8
Q ss_pred ccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC---CCCceeeEEeEEEeCCe----
Q 016152 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTERKP---- 229 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~~~~---- 229 (394)
|++.+.||+|+||.||++..+ ++.+|+|.+........ ....+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-IPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch-hhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 567789999999999999975 78899998865443222 224455677777665 59999999999988776
Q ss_pred -eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCc
Q 016152 230 -LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (394)
Q Consensus 230 -~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a 306 (394)
++++||++.+ +|.+++.... .+++..+..++.|+++||.|||+.+ ++|+||+|+||++ +.++.++|+|||++
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili--~~~~~~~l~dfg~~ 154 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILV--TSDGQVKIADFGLA 154 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEE--ccCCCEEEeccCcc
Confidence 9999999975 8998887643 4899999999999999999999988 9999999999999 77799999999998
Q ss_pred cccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
..+..... .....++..|+|||.+.+..++.++|+||||+++|+|++|++||...+..+....+.
T Consensus 155 ~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07838 155 RIYSFEMA-----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIF 219 (287)
T ss_pred eeccCCcc-----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHH
Confidence 77643321 223457889999999998899999999999999999999999999888777776664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=259.13 Aligned_cols=212 Identities=30% Similarity=0.507 Sum_probs=174.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeC--CeeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER--KPLML 232 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~--~~~~l 232 (394)
+|++.+.||+|+||.||+|... ++.+++|.+........ ....+.+|+.+++++ +||||+++++++... ..+++
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT-DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch-hhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 7889999999999999999874 77899998865433322 235567899999999 999999999987643 36899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||||+.+ +|..++... .+++..+..++.|++.||.|||+.| |+||||||+||++ +.++.+||+|||++..+...
T Consensus 87 v~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill--~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 87 VFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILL--NSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred Eeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCcEEEeeccchhccccc
Confidence 9999975 999988765 7889999999999999999999988 9999999999999 88899999999999866543
Q ss_pred cccc-cccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 313 NSHD-VYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 313 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
.... ........+|+.|+|||.+.+ ..++.++|+||||+++|+|++|++||...+..+....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~ 226 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII 226 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 2210 112234568999999998765 567899999999999999999999998777665555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=257.51 Aligned_cols=206 Identities=30% Similarity=0.520 Sum_probs=171.6
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC------
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------ 228 (394)
.+|++.+.||+|+||.||++... +..||||.+..... .......+.+|+.+++.++||||+++++++..+.
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 36899999999999999999864 78899998754332 2333456788999999999999999999887654
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.+++|||++ +++|.+++.. ..+++..+..++.|++.||.|||+.| |+||||||+||++ +.++.++|+|||++..
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill--~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAV--NEDCELKILDFGLARQ 167 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeecccccc
Confidence 358999998 7799888864 56899999999999999999999988 9999999999999 7788999999999876
Q ss_pred cccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
.... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|++||...+.......+.
T Consensus 168 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07880 168 TDSE-------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIM 229 (343)
T ss_pred cccC-------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5322 223467889999999876 458899999999999999999999998877655554443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=254.78 Aligned_cols=217 Identities=32% Similarity=0.502 Sum_probs=174.1
Q ss_pred CccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHh--CCCCceeeEEeEEEeCC----eeE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK--LRHPNIVQFLGAVTERK----PLM 231 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~--l~h~~Iv~~~~~~~~~~----~~~ 231 (394)
.......||+|.||.||+|..+++.||||++.. +..+.+.+|-++.+. ++|+||++++++-.... .++
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345677899999999999999999999998743 334667778777765 57999999999876555 789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC-------CCeEecCCCCCCEEEeeCCCCcEEEeecC
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP-------NVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~-------~~ivH~Dikp~Nilv~~~~~~~~kl~DFg 304 (394)
||++|.+.|||.+|++.+ .+++....+++..+++||+|||+.- ++|+|||||..|||| ..+.+.-|+|||
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv--K~DlTccIaDFG 361 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV--KNDLTCCIADFG 361 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE--ccCCcEEeeccc
Confidence 999999999999999876 6899999999999999999999742 349999999999999 888899999999
Q ss_pred CccccccccccccccccCCccCccccCccccCCCC-C-----CCcchHHHHHHHHHHHHcCC------------CCCC--
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK-Y-----DKKVDVFSFAMILYEMLEGE------------PPLA-- 364 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DvwslGv~l~el~~g~------------~Pf~-- 364 (394)
+|..+....... ..-..+||.+|||||++.+.. + -.+.||||+|.|+||++++- .||.
T Consensus 362 LAl~~~p~~~~~--d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 362 LALRLEPGKPQG--DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred eeEEecCCCCCc--chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999887543322 234578999999999986532 2 26899999999999999853 3443
Q ss_pred ---CCCHHHHHHHHH-cCCCCCCCC
Q 016152 365 ---NYEPYEAAKYVA-EGHRPFFRA 385 (394)
Q Consensus 365 ---~~~~~~~~~~i~-~g~~p~~~~ 385 (394)
..+..++.+.++ +..||.++.
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~ 464 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPD 464 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChh
Confidence 123445554443 677888876
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=253.75 Aligned_cols=212 Identities=27% Similarity=0.463 Sum_probs=173.4
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC------
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------ 228 (394)
.+|++.+.||+|+||.||+|... ++.+++|.+....... .....+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 37889999999999999999974 7789999885433221 12245678999999999999999999887654
Q ss_pred ----eeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 229 ----PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 229 ----~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
.+++|+||+++ +|.+.+... ..+++.++..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili--~~~~~~kl~df 160 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILL--NNKGQIKLADF 160 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCcEEeCcc
Confidence 78999999976 777777654 46899999999999999999999988 9999999999999 88889999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
|++..+...... ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...+..+..+.+.+
T Consensus 161 g~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 161 GLARLYNSEESR---PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred cccccccCCccc---ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999866533211 1223356788999998865 4578999999999999999999999988877666655543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=256.30 Aligned_cols=206 Identities=28% Similarity=0.518 Sum_probs=169.8
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC------C
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~ 228 (394)
.+|++.+.||+|+||.||++.. .++.+|+|.+...... ....+.+.+|+.++++++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 4799999999999999999975 4788999988653222 22345677899999999999999999987543 3
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
..+++++++ +++|.+++..+ .+++..+..++.|+++||.|||+.+ |+||||||+||++ +.++.++|+|||++..
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll--~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAV--NEDCELKILDFGLARH 169 (345)
T ss_pred cEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEE--cCCCCEEEeccccccc
Confidence 467888876 77998887654 6899999999999999999999988 9999999999999 7888999999999875
Q ss_pred cccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
.... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|++||...+..+....+.
T Consensus 170 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 170 TDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred cccc-------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4321 223567889999999866 568899999999999999999999998777655555443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=255.25 Aligned_cols=214 Identities=29% Similarity=0.501 Sum_probs=172.3
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC------
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------ 228 (394)
.+|++.+.||+|+||.||+|... ++.+++|.+........ ......+|+.+++.++||||+++++++....
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 48999999999999999999874 77899998865432221 1234568999999999999999999875433
Q ss_pred --eeEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 229 --PLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 229 --~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
.+++|+||+.+ +|...+.. ...+++..+..++.|+++||.|||+++ |+|+||||+||++ +.++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILI--DNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEECcCcc
Confidence 46999999965 77777664 457999999999999999999999988 9999999999999 8889999999999
Q ss_pred cccccccccccc-------ccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 306 SKLIKVQNSHDV-------YKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 306 a~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
+........... .......+++.|+|||.+.+ ..++.++||||||+++|||++|++||.+.+.....+.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 976543221110 11223457888999998765 457899999999999999999999999888776666554
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=248.89 Aligned_cols=208 Identities=29% Similarity=0.496 Sum_probs=176.0
Q ss_pred ccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
|++.+.||+|++|.||++... ++.+++|.+....... .....+.+|+.++++++|++|+++++++..+..+++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 566788999999999999874 7789999876543332 2346777899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 237 ~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
+.+ +|.+++..+ ..+++.++..++.|++.+|.|||+.+ |+|+||||+||++ +.++.++|+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili--~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLI--NTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEE--CCCCcEEEeeeeeeEecCCCcc-
Confidence 976 888888763 57999999999999999999999988 9999999999999 7788999999999877654321
Q ss_pred ccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+.
T Consensus 154 ---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 212 (283)
T cd05118 154 ---PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF 212 (283)
T ss_pred ---cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 12234578899999998776 78999999999999999999999998887766665554
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=262.99 Aligned_cols=216 Identities=28% Similarity=0.448 Sum_probs=178.7
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~l 232 (394)
...|.....+|.|+|+.|..+.+. ++..+||++.+...+ -.+|+.++.+. +||||+++.+.+.+....|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 456778888999999999888764 778999988665322 23567666555 69999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|||.+.|+-|.+.+.....+. ..+..|+.+|+.++.|||++| +|||||||+|||+. +..++++|+|||.++.....
T Consensus 394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~-~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLD-GSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeec-CCCCcEEEEEechhhhCchh
Confidence 999999998888887766555 788889999999999999988 99999999999994 47788999999999877644
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCcc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~-~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
..+.+-|..|.|||++....|+.++|+||||++||+|++|+.||...+.. ++..+|..|.+- ...|++
T Consensus 470 -------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s----~~vS~~ 538 (612)
T KOG0603|consen 470 -------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS----ECVSDE 538 (612)
T ss_pred -------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc----cccCHH
Confidence 33456789999999999999999999999999999999999999877655 777887765433 445555
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
.|
T Consensus 539 AK 540 (612)
T KOG0603|consen 539 AK 540 (612)
T ss_pred HH
Confidence 44
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=249.31 Aligned_cols=208 Identities=33% Similarity=0.568 Sum_probs=176.0
Q ss_pred ccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
|+..+.||+|++|.||+|... ++.+++|.+...... ......+..|+.+++.++|+||+++++++.+....++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc-ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 456678999999999999875 788999988765422 22235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 237 ~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
+.+ +|.+++.+. ..+++..+..++.|++.+|.|||+.+ |+||||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~--~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILI--NRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEE--cCCCCEEEecCCcccccCCCcc-
Confidence 974 999999876 57999999999999999999999988 9999999999999 7788999999999876643321
Q ss_pred ccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
......++..|+|||.+.+. .++.++|+||||+++||+++|.+||...+..+....+.
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 212 (282)
T cd07829 154 ---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF 212 (282)
T ss_pred ---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 22334567889999998766 78999999999999999999999998887666665554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=251.70 Aligned_cols=200 Identities=35% Similarity=0.584 Sum_probs=167.7
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe-CCeeEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKPLML 232 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~l 232 (394)
..+|++.+.||.|+||.||++... ++.+|+|.+.+..... ...+.+..|+.+++.++||||+++++++.. ....++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 347999999999999999999864 7789999876543222 233667789999999999999999998865 557899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
++||+ +++|.++++. .++++..+..++.|+++||.|||+++ |+||||+|+||++ +.++.++|+|||++......
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili--~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILI--NENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeE--CCCCCEEeCccccccccCCC
Confidence 99998 5689888764 45888999999999999999999988 9999999999999 78889999999998754321
Q ss_pred cccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 369 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~ 369 (394)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|++||...+..
T Consensus 162 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~ 212 (328)
T cd07856 162 -------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212 (328)
T ss_pred -------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 123467889999998765 57899999999999999999999999876653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=255.95 Aligned_cols=212 Identities=28% Similarity=0.498 Sum_probs=170.6
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC-------
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------- 227 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------- 227 (394)
.+|.+.+.||.|+||.||+|... +..+++|.+..... ...+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 47899999999999999999874 77899998755433 2236677899999999999999999776543
Q ss_pred -------CeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEE
Q 016152 228 -------KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300 (394)
Q Consensus 228 -------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl 300 (394)
...++||||+. ++|.+++.. +.+++..+..++.|++.||.|||+.| ++||||||+||++. ..++.++|
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~-~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFIN-TEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEc-CCCceEEE
Confidence 35799999997 499888864 46899999999999999999999988 99999999999992 24457899
Q ss_pred eecCCccccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 301 ~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
+|||++..+........ ......++..|+|||.+.. ..++.++|+|||||++|+|++|+.||...++.+....+..
T Consensus 157 ~dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 157 GDFGLARIVDPHYSHKG-YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred CCcccceecCCcccccc-ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999876543211111 1123457889999998754 5678999999999999999999999988877666665543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=247.84 Aligned_cols=205 Identities=29% Similarity=0.474 Sum_probs=171.1
Q ss_pred ccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEEEEe
Q 016152 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
|++.+.||+|++|.||+|... ++.+++|.+....... ......+|+..+++++ ||||+++++++.+++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 567789999999999999974 6789999876543321 1233456899999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|+ +++|.+++.... .+++.++..++.|++.+|.|||+++ ++|+||+|+||++ +.++.++|+|||++.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i--~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLV--SGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEE--cCCCCEEEeecccceeccCCC
Confidence 99 779999887754 6899999999999999999999988 9999999999999 888999999999997654322
Q ss_pred ccccccccCCccCccccCccccC-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFK-HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 375 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i 375 (394)
......++..|+|||.+. ...++.++|+||||+++|+|++|++||...+..+....+
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~ 211 (283)
T cd07830 154 -----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKI 211 (283)
T ss_pred -----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHH
Confidence 123356788999999875 456789999999999999999999999877665554443
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=254.29 Aligned_cols=205 Identities=29% Similarity=0.507 Sum_probs=169.3
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC------e
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------P 229 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~ 229 (394)
+|.+.+.||+|+||.||+|.. .|+.+|+|.+....... .....+.+|+.+++.++||||+++++++.... .
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 788899999999999999986 47899999886543222 22355778999999999999999999886543 4
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
+++|+||+.. +|.+++ ...+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++...
T Consensus 95 ~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll--~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAV--NEDCELKILDFGLARHA 167 (342)
T ss_pred EEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEeeCCCCcCC
Confidence 6999999964 777665 346899999999999999999999988 9999999999999 78889999999998754
Q ss_pred ccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 168 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~ 229 (342)
T cd07879 168 DAE-------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229 (342)
T ss_pred CCC-------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 321 223467889999999876 4688999999999999999999999998876665555443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=254.22 Aligned_cols=207 Identities=29% Similarity=0.517 Sum_probs=173.9
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe-----
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP----- 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~----- 229 (394)
.+|++.+.||+|++|.||+|... ++.+|+|.+...... ......+.+|+.+++.++||||+++++++...+.
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 37899999999999999999874 678999987543322 2233567789999999999999999998766554
Q ss_pred -eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 230 -LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 230 -~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
+++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.| |+||||||+||++ +.++.++|+|||++..
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill--~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAV--NEDCELKILDFGLARH 167 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCCEEEcccccccc
Confidence 89999998 6699998875 46999999999999999999999988 9999999999999 7788999999999876
Q ss_pred cccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
.... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+.+
T Consensus 168 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 230 (343)
T cd07851 168 TDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230 (343)
T ss_pred cccc-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 5322 233467889999999865 4678999999999999999999999988887776666554
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-31 Score=232.21 Aligned_cols=217 Identities=34% Similarity=0.599 Sum_probs=184.6
Q ss_pred ccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
|.+.+.||.|+++.||++... ++.+++|.+...... ...+.+.+|+..+++++|+|++++++++......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 456778999999999999885 588999988654332 2457788999999999999999999999988999999999
Q ss_pred cCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 237 LRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 237 ~~~~sL~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
+.+++|.+++..... +++..+..++.+++.++.+||+.+ ++|+||+|.||++ +..+.++|+|||.+.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v--~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILL--GMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeeCceeeEecCcccc
Confidence 999999999987766 899999999999999999999988 9999999999999 77789999999998876543210
Q ss_pred ccccccCCccCccccCcccc-CCCCCCCcchHHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHHcCCCCCCC
Q 016152 316 DVYKMTGETGSYRYMAPEVF-KHRKYDKKVDVFSFAMILYEMLEGEPPLAN--YEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGv~l~el~~g~~Pf~~--~~~~~~~~~i~~g~~p~~~ 384 (394)
......++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .+..++.+.|..|.++..+
T Consensus 155 ---~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 155 ---LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred ---cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 12335678889999998 667788899999999999999999999987 4445888999988765443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=238.20 Aligned_cols=180 Identities=22% Similarity=0.335 Sum_probs=154.0
Q ss_pred CCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCCCHHHH
Q 016152 168 GSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY 245 (394)
Q Consensus 168 G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~sL~~~ 245 (394)
|.++.||++.. .++.+|+|.+.... ...+|...+....||||+++++++.+....+++|||+++++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 88999999987 47889999885532 123344555566799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCcc
Q 016152 246 LKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325 (394)
Q Consensus 246 ~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~g 325 (394)
+.+...+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.++++|||.+...... .....+
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~l~df~~~~~~~~~-------~~~~~~ 144 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILL--DDRGHIQLTYFSRWSEVEDS-------CDGEAV 144 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--cCCCCEEEecccchhccccc-------cccCCc
Confidence 988778999999999999999999999988 9999999999999 88889999999987655322 123445
Q ss_pred CccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 326 t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
+..|+|||.+.+..++.++|+||+|+++|||++|..||...
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 77899999998888999999999999999999999887643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-34 Score=240.72 Aligned_cols=213 Identities=26% Similarity=0.460 Sum_probs=173.9
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe--------C
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--------R 227 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--------~ 227 (394)
.|+....||+|.||.||+|+.+ |+.||+|...-........ ....+|+.+|..++|+|++.++..+.. .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp-italreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc-HHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4677789999999999999864 6778887654322211111 234579999999999999988876532 2
Q ss_pred CeeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCc
Q 016152 228 KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a 306 (394)
..+|+||.+|+. +|.-++... .+++..++.+++.++..||.|+|+.. |+|||+||+|+|| +.++.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLI--t~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLI--TKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEE--cCCceEEeeccccc
Confidence 348999999988 888888764 57999999999999999999999987 9999999999999 88899999999999
Q ss_pred cccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
+.+..........+...+-|.+|.+||.+.+ +.|+++.|||..||++.||.+|++-+.+.+..+.+..|.
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 8765443333223455667999999999876 579999999999999999999999999998888887775
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=245.35 Aligned_cols=212 Identities=26% Similarity=0.412 Sum_probs=174.5
Q ss_pred CCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC--CC----ceeeEEeEEEe
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--HP----NIVQFLGAVTE 226 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~--h~----~Iv~~~~~~~~ 226 (394)
...+|.+++.+|+|.||.|.++.+. +..+|||++..- ....+.-+-|+++++++. .| -++++.++|.-
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 3558999999999999999998764 668999977432 223345567999999984 22 37788889999
Q ss_pred CCeeEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-----------
Q 016152 227 RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS----------- 293 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~----------- 293 (394)
.++.|+|+|.+ |.|+.+++++++ +++..+++.++.|+++++.+||+.+ ++|-||||+|||+++.
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCc
Confidence 99999999988 669999998764 5899999999999999999999988 9999999999999521
Q ss_pred -------CCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 294 -------SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 294 -------~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
....|+|+|||.|++-... ....+.|..|.|||++.+-+++.++||||+||+|+||.+|...|...
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH-------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC-------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 1336999999999865432 24567899999999999999999999999999999999999999888
Q ss_pred CHHH---HHHHHHcCCCC
Q 016152 367 EPYE---AAKYVAEGHRP 381 (394)
Q Consensus 367 ~~~~---~~~~i~~g~~p 381 (394)
++.| +.++|. |++|
T Consensus 313 en~EHLaMMerIl-Gp~P 329 (415)
T KOG0671|consen 313 ENLEHLAMMERIL-GPIP 329 (415)
T ss_pred CcHHHHHHHHHhh-CCCc
Confidence 7666 445554 4555
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-33 Score=241.25 Aligned_cols=210 Identities=30% Similarity=0.514 Sum_probs=176.8
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC-----ee
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-----PL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-----~~ 230 (394)
+.+-.+.||-|+||.||.+.+ .|+.+++|.+...... ....+++.+|+.++..++|.||+..++...... .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~-L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN-LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHH-HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 334456799999999998876 5889999987654332 333467888999999999999999998765432 36
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
|+++|.|.. +|..+|-+...++...+..++.||++||.|||+.+ |.||||||.|+|+ +.+-.+||||||+++...
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLV--NSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLV--NSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEe--ccCceEEecccccccccc
Confidence 888998844 99999998889999999999999999999999988 9999999999999 889999999999998654
Q ss_pred cccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
.... ...+..+-|-.|.|||++.+. .|+...||||+||++.||+.++..|...++.+.++.|.
T Consensus 208 ~d~~---~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt 271 (449)
T KOG0664|consen 208 QRDR---LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII 271 (449)
T ss_pred hhhh---hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH
Confidence 3322 234456678999999999874 68999999999999999999999999999988888875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=227.81 Aligned_cols=213 Identities=39% Similarity=0.639 Sum_probs=178.5
Q ss_pred CceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCCCHHHHH
Q 016152 169 SFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL 246 (394)
Q Consensus 169 ~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~sL~~~~ 246 (394)
+||.||++... ++.+++|.+........ .+.+.+|+..+++++|++|+++++.+......++++|++.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58899999985 58899998865443322 478889999999999999999999999989999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccC
Q 016152 247 KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326 (394)
Q Consensus 247 ~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt 326 (394)
.....++...+..++.+++.++.+||+.+ ++|+||+|+||++ +.++.++|+|||.+....... ......++
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~--~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~ 149 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILL--DEDGHVKLADFGLARQLDPGG-----LLTTFVGT 149 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEE--CCCCcEEEccccceeeecccc-----ccccccCC
Confidence 87766899999999999999999999988 9999999999999 777899999999998766432 22345688
Q ss_pred ccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCCCCCCCC-CCccc
Q 016152 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVAEGHRPFFRAKG-FTPEL 392 (394)
Q Consensus 327 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~-~~~~~~~~~i~~g~~p~~~~~~-~~~~~ 392 (394)
..|++||.+....++.++|+||||+++|++++|..||.. .+.....+.+..+..+...... ++.++
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEA 217 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHH
Confidence 899999999988899999999999999999999999988 5666666666665555433322 45444
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=274.01 Aligned_cols=187 Identities=28% Similarity=0.452 Sum_probs=155.1
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.+...+.||+|+||.||+|.. .+..||||.+...... ...|+.++++++||||+++++++.+....++|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 455677899999999999986 4788999987543221 1245888999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++|+|.++++ .+++..+..++.|+++||+|||.. .++|+||||||+||++ +..+..++. ||.......
T Consensus 764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~--~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII--DGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE--CCCCceEEE-ecccccccc---
Confidence 999999999996 378999999999999999999943 1339999999999999 666666665 655433221
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN 365 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~ 365 (394)
.....+|+.|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus 835 -----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 835 -----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred -----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 1123678999999999999999999999999999999999999954
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=247.85 Aligned_cols=212 Identities=25% Similarity=0.366 Sum_probs=179.5
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC------CCceeeEEeEEEeC
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR------HPNIVQFLGAVTER 227 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~------h~~Iv~~~~~~~~~ 227 (394)
..+|.+....|+|-|+.|..|... |+.||||++..+... .+....|+++|++|+ --++++++..|...
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 347888889999999999999874 789999998654322 245667999999995 24899999999999
Q ss_pred CeeEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecC
Q 016152 228 KPLMLITEYLRGGDLHKYLKEKGA---LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~~~---~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg 304 (394)
+++|||+|.+ ..+|..++++.|. +....+..++.|+.-||..|-.+| |+|.||||.||||. .....+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVN-E~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVN-ESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEec-cCcceeeeccCc
Confidence 9999999988 4599999998653 889999999999999999999988 99999999999984 344579999999
Q ss_pred CccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--cCCCC
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA--EGHRP 381 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~--~g~~p 381 (394)
.|....... ...+.-+..|.|||++.+-+|+...|+||+||+||||.||+..|.+.+...+++... +|.+|
T Consensus 583 SA~~~~ene------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 583 SASFASENE------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred ccccccccc------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 998765443 223446778999999999999999999999999999999999999988777776654 67777
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=219.95 Aligned_cols=203 Identities=24% Similarity=0.475 Sum_probs=168.6
Q ss_pred CcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeC--Cee
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER--KPL 230 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~--~~~ 230 (394)
..+|++.+.+|+|-++.||.|.. +.+.++||++.+- ..+.+.+|+.+|+.+. ||||+++++...+. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 34799999999999999999984 5778999987542 3477889999999997 99999999998765 467
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC-CCcEEEeecCCcccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLI 309 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~-~~~~kl~DFg~a~~~ 309 (394)
.+|+|+++..+...+. +.++..+++-++.++++||.|||++| |+|||+||.|+|+ +. .-.++|+|+|+|.++
T Consensus 111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmI--dh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMI--DHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeee--chhhceeeeeecchHhhc
Confidence 8999999886665544 46889999999999999999999999 9999999999999 43 346999999999988
Q ss_pred ccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHH
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVA 376 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf-~~~~~~~~~~~i~ 376 (394)
.... ...-.+.+..|--||.+.. +.|+..-|+|||||++..|+..+-|| .+.+....+.+|.
T Consensus 184 Hp~~-----eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIa 247 (338)
T KOG0668|consen 184 HPGK-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIA 247 (338)
T ss_pred CCCc-----eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHH
Confidence 6543 2334567888999999865 56889999999999999999988777 5666666666664
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=225.28 Aligned_cols=230 Identities=24% Similarity=0.345 Sum_probs=192.6
Q ss_pred CcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~l 232 (394)
...|.++++||+|+||.++.|.. ++++||||.- +.+... -.++.|.+..+.|. .++|...+.|..++.+-.+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-PrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-PRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEec-cccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 34799999999999999999974 7999999954 333332 45677888888875 6899999999999989999
Q ss_pred EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC---CCCcEEEeecCCccc
Q 016152 233 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS---SADHLKVGDFGLSKL 308 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~---~~~~~kl~DFg~a~~ 308 (394)
|+|.+ |.||.|++.- ...++.+++..++.|++.-++|+|++. +|+|||||+|+||... ....+.|+|||+|+.
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99988 8899998874 456999999999999999999999988 9999999999999432 223589999999999
Q ss_pred cccccccccccc---cCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCCCC
Q 016152 309 IKVQNSHDVYKM---TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVAEGHRPF 382 (394)
Q Consensus 309 ~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~---~~~~~~~~i~~g~~p~ 382 (394)
+.++.....+++ .+..||.+||+-..+.++..+.+.|+-|||-++++.+.|..||.+. +..+-+++|-+.++-.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 988766555443 4567999999999999999999999999999999999999999764 6789999998666655
Q ss_pred CCC---CCCCcccc
Q 016152 383 FRA---KGFTPELR 393 (394)
Q Consensus 383 ~~~---~~~~~~~~ 393 (394)
... .+||.||.
T Consensus 259 ~i~~Lc~g~P~efa 272 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFA 272 (449)
T ss_pred CHHHHHhcCHHHHH
Confidence 444 57887763
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=253.90 Aligned_cols=198 Identities=31% Similarity=0.544 Sum_probs=164.4
Q ss_pred CccccceeecCCce-EEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFG-EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g-~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
-|...+++|.|+.| .||+|.+.|+.||||.+..... ....+|+..|+.-+ ||||+++++.-.+....|+..|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFF------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhH------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 45556788999887 5799999999999998865432 34568999998875 9999999998889999999999
Q ss_pred ccCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee---CCCCcEEEeecCCccc
Q 016152 236 YLRGGDLHKYLKEKGA----LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSKL 308 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~----~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~---~~~~~~kl~DFg~a~~ 308 (394)
.|.. +|.+++...+. ......+.++.|+++||++||+.+ ||||||||.||||.. +....++|+|||+++.
T Consensus 584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9976 99999986311 122456788999999999999988 999999999999954 2345799999999999
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLAN 365 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~ 365 (394)
+..+.+.-. ...+..||-+|+|||++.....+.++|||||||++|+.++ |++||..
T Consensus 661 l~~~~sS~~-r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 661 LAGGKSSFS-RLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred cCCCcchhh-cccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 876544322 3566789999999999998888889999999999999998 5999975
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=241.49 Aligned_cols=204 Identities=24% Similarity=0.335 Sum_probs=149.0
Q ss_pred CCcCccccceeecCCceEEEEEEE------------------CCccEEEEEeccCCCCcHH-----------HHHHHHHH
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYW------------------RGTPVAIKRILPSLSDDRL-----------VIQDFRHE 205 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~------------------~g~~~avK~l~~~~~~~~~-----------~~~~~~~E 205 (394)
+..+|++.++||+|+||.||+|.. .++.||||.+......... ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 344899999999999999999863 2457999987543211100 01123346
Q ss_pred HHHHHhCCCCce-----eeEEeEEEe--------CCeeEEEEeccCCCCHHHHHHhc-----------------------
Q 016152 206 VNLLVKLRHPNI-----VQFLGAVTE--------RKPLMLITEYLRGGDLHKYLKEK----------------------- 249 (394)
Q Consensus 206 ~~~l~~l~h~~I-----v~~~~~~~~--------~~~~~lv~e~~~~~sL~~~~~~~----------------------- 249 (394)
+.++.+++|.++ +++++++.. .+..++||||+.+++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766544 667776643 34689999999999999988642
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCcc
Q 016152 250 -GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328 (394)
Q Consensus 250 -~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~ 328 (394)
..+++..+..++.|++.+|.|||+++ |+||||||+|||+ +.++.+||+|||++........ .......+|+.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl--~~~~~~kL~DFGla~~~~~~~~---~~~~~g~~tp~ 375 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLV--TVDGQVKIIDFGAAVDMCTGIN---FNPLYGMLDPR 375 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEE--CCCCcEEEEeCcCccccccCCc---cCccccCCCcc
Confidence 12356678889999999999999988 9999999999999 7778999999999975532211 11112345889
Q ss_pred ccCccccCCCC--------------------CC--CcchHHHHHHHHHHHHcCCC-CCCC
Q 016152 329 YMAPEVFKHRK--------------------YD--KKVDVFSFAMILYEMLEGEP-PLAN 365 (394)
Q Consensus 329 y~aPE~~~~~~--------------------~~--~~~DvwslGv~l~el~~g~~-Pf~~ 365 (394)
|+|||.+.... +. .+.|+||+||++|+|++|.. ||..
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99999875432 11 34799999999999999885 8764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=223.62 Aligned_cols=205 Identities=27% Similarity=0.424 Sum_probs=172.3
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC------e
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------P 229 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~ 229 (394)
+|.-++.+|.|.- .|..|.+ .++++|+|.+......... .++..+|..++..++|+||++++.+|.-.. .
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~-akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTH-AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCcc-chhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 6777888999988 5666654 4889999988766555332 355677999999999999999999986554 3
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
+|+|||+|.. +|...+.. .++-.++..++.|++.|+.|||+.| |+||||||+||++ .....+||.|||+|..-
T Consensus 96 ~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv--~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVV--NSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCccccee--cchhheeeccchhhccc
Confidence 6999999965 99988874 3678889999999999999999988 9999999999999 88899999999999754
Q ss_pred ccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
... ...+..+.|..|.|||++.+..|...+||||+||++.||++|+..|.+.+......+|.
T Consensus 169 ~~~-----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~ 230 (369)
T KOG0665|consen 169 DTD-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKII 230 (369)
T ss_pred Ccc-----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHH
Confidence 322 24556788999999999999889999999999999999999999999887766666654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=225.57 Aligned_cols=231 Identities=25% Similarity=0.434 Sum_probs=189.4
Q ss_pred CCCCcCccccceeecCCceEEEEEEECC-------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 016152 153 DPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (394)
Q Consensus 153 ~~~~~~~~~~~~iG~G~~g~V~~a~~~g-------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 225 (394)
.....+++....+-+|.||.||.|.+.. +.+.+|.+.... .......+..|...+..+.|||++.+.++..
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 3344467778889999999999997642 346677654332 3455678889999999999999999999864
Q ss_pred -eCCeeEEEEeccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC
Q 016152 226 -ERKPLMLITEYLRGGDLHKYLKE--------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (394)
Q Consensus 226 -~~~~~~lv~e~~~~~sL~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~ 296 (394)
+....++++.++.-|+|..|+.. .+.++..+...++.|++.|++|||+.+ |||.||..+|.+| ++.-
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvI--dd~L 433 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVI--DDQL 433 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhccee--hhhe
Confidence 45678999999988999999972 124677788889999999999999998 9999999999999 8888
Q ss_pred cEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 016152 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV 375 (394)
Q Consensus 297 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i 375 (394)
+|||+|=.+++.+-+....- .-.....+..||+||.+....|+..+|+|||||+||||+| |+.||.+.+++|+...+
T Consensus 434 qVkltDsaLSRDLFP~DYhc--LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHC--LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred eEEeccchhccccCcccccc--cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 99999999998765432211 1123456788999999999999999999999999999999 99999999999999999
Q ss_pred HcCCCCCCCCCCCCccc
Q 016152 376 AEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 376 ~~g~~p~~~~~~~~~~~ 392 (394)
+.|+|---|.. ||.||
T Consensus 512 kdGyRlaQP~N-CPDeL 527 (563)
T KOG1024|consen 512 KDGYRLAQPFN-CPDEL 527 (563)
T ss_pred hccceecCCCC-CcHHH
Confidence 99999777754 66654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=245.34 Aligned_cols=196 Identities=20% Similarity=0.276 Sum_probs=139.0
Q ss_pred CCcCccccceeecCCceEEEEEEEC------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeE-----
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA----- 223 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~----- 223 (394)
...+|.+.+.||+|+||.||+|.+. +..+|+|.+...... +....+ .++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 3448999999999999999999874 568999986532211 111111 1122222222222211
Q ss_pred -EEeCCeeEEEEeccCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHcCCCCeEecC
Q 016152 224 -VTERKPLMLITEYLRGGDLHKYLKEKGA--------------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282 (394)
Q Consensus 224 -~~~~~~~~lv~e~~~~~sL~~~~~~~~~--------------------~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~D 282 (394)
...+...++|+||+.+++|.+++..... .....+..++.|++.||.|||+++ |+|||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRD 280 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRD 280 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCc
Confidence 2455678999999999999999875321 123446679999999999999988 99999
Q ss_pred CCCCCEEEeeCC-CCcEEEeecCCccccccccccccccccCCccCccccCccccCCC----------------------C
Q 016152 283 LKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR----------------------K 339 (394)
Q Consensus 283 ikp~Nilv~~~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~ 339 (394)
|||+|||+ +. .+.+||+|||++..+..... .......+|+.|+|||.+... .
T Consensus 281 LKP~NILl--~~~~~~~KL~DFGlA~~l~~~~~---~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 281 VKPQNIIF--SEGSGSFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred CCHHHEEE--eCCCCcEEEEeCCCccccccccc---cCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 99999999 53 57899999999986543221 123456789999999976322 2
Q ss_pred CCCcchHHHHHHHHHHHHcCCCCCC
Q 016152 340 YDKKVDVFSFAMILYEMLEGEPPLA 364 (394)
Q Consensus 340 ~~~~~DvwslGv~l~el~~g~~Pf~ 364 (394)
++.++|||||||++|||+++..|++
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCc
Confidence 3446799999999999999877754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=209.54 Aligned_cols=227 Identities=23% Similarity=0.297 Sum_probs=185.6
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC-CceeeEEeEEEeCCeeEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.|.+++.||+|+||.+|.|.. .|..||||+-...... ..+..|..+.+.+++ ..|..+..+..+...-.+||
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 689999999999999999975 5899999964333222 346678899998874 68888888888888889999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCccccccc
Q 016152 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 235 e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a~~~~~~ 312 (394)
+.+ |.||.+.++- ...++.++++-++-|++.-++|+|.++ +|||||||+|+|+.-+ ....+.|+|||+|..+.+.
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 988 8899999873 556999999999999999999999998 9999999999999422 3346999999999988765
Q ss_pred cccccccc---cCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHcCCCCCCCC-
Q 016152 313 NSHDVYKM---TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE---PYEAAKYVAEGHRPFFRA- 385 (394)
Q Consensus 313 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~---~~~~~~~i~~g~~p~~~~- 385 (394)
......+. ....||.+|.+-..+.+...+.+.|+-|+|.++.++..|..||.+.. ..+-+++|.+.+-.....
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~ 247 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEV 247 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHH
Confidence 54433332 34679999999999988889999999999999999999999998864 456678887654444333
Q ss_pred --CCCCccc
Q 016152 386 --KGFTPEL 392 (394)
Q Consensus 386 --~~~~~~~ 392 (394)
++||.||
T Consensus 248 LC~G~P~EF 256 (341)
T KOG1163|consen 248 LCKGFPAEF 256 (341)
T ss_pred HhCCCcHHH
Confidence 7888877
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=222.59 Aligned_cols=129 Identities=29% Similarity=0.425 Sum_probs=108.8
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-----C---CceeeEEeEEEe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----H---PNIVQFLGAVTE 226 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~Iv~~~~~~~~ 226 (394)
.+|.+.++||.|.|++||+|.+. .+.||+|+.... ....+....|+.+|++++ | .+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 68999999999999999999875 567999976433 233456678999999873 2 479999999965
Q ss_pred C----CeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEe
Q 016152 227 R----KPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 291 (394)
Q Consensus 227 ~----~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~ 291 (394)
. .++++|+|++ |.+|..+|... ..++...+..|++||+.||.|||.+ .+|||.||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeeee
Confidence 4 4799999999 77999998753 4599999999999999999999998 3599999999999995
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-29 Score=213.97 Aligned_cols=214 Identities=22% Similarity=0.412 Sum_probs=166.4
Q ss_pred CccccceeecCCceEEEEEEECC--ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEe-EEEeCCeeEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLG-AVTERKPLMLI 233 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g--~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~-~~~~~~~~~lv 233 (394)
.|.+.+.+|+|-||.+.++.+++ +.+++|.+.... ....+|.+|...--.|. |.||+.-++ .|+..+..+++
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 68999999999999999999874 578999775543 34577888887666665 889998877 47778888999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
+||++.|+|.+-+...| +-+.....++.|+++||+|+|+++ +||||||.+||||.+.....|||||||+.+.....-
T Consensus 101 qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred eccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 99999999999887654 678888999999999999999988 999999999999976666689999999987543211
Q ss_pred ccccccccCCccCccccCccccCC---C--CCCCcchHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCCCCCCC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKH---R--KYDKKVDVFSFAMILYEMLEGEPPLANYE----PYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwslGv~l~el~~g~~Pf~~~~----~~~~~~~i~~g~~p~~~ 384 (394)
.-...+..|.+||.... + ...+.+|+|.||++++.++||.+||.... +.--..+-.++.-|..|
T Consensus 178 -------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 178 -------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred -------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 11224556899997632 2 34689999999999999999999997432 23333333455555444
Q ss_pred C
Q 016152 385 A 385 (394)
Q Consensus 385 ~ 385 (394)
.
T Consensus 251 ~ 251 (378)
T KOG1345|consen 251 K 251 (378)
T ss_pred h
Confidence 3
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=236.51 Aligned_cols=218 Identities=30% Similarity=0.521 Sum_probs=189.1
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|+.+.++|+|.+|.||+|++ +++..|+|++.-.-.++- .-..+|+-+++..+||||+.+++.+...+.+|++||
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~---~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF---SGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccc---cccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 788899999999999999987 488999998765544432 456689999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
||.||+|.+...--+++++.++.-+++..++||.|||++| -+|||||-.||++ ...|.+|+.|||.+..+...
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanill--td~gDvklaDfgvsaqitat--- 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILL--TDEGDVKLADFGVSAQITAT--- 165 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceee--cccCceeecccCchhhhhhh---
Confidence 9999999998887889999999999999999999999998 8999999999999 78889999999998766532
Q ss_pred ccccccCCccCccccCcccc---CCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--CCCCCCCCC
Q 016152 316 DVYKMTGETGSYRYMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE--GHRPFFRAK 386 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~--g~~p~~~~~ 386 (394)
+.....+.||+.|||||+- +.+.|...+|+|++|+...|+-.-++|--...++++.....+ -++|.+..+
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk 240 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK 240 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC
Confidence 2245678999999999985 467899999999999999999999999888888888877764 345566554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=216.55 Aligned_cols=205 Identities=24% Similarity=0.325 Sum_probs=165.2
Q ss_pred CccccceeecCCceEEEEEEECCc---cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC----CCceeeEEeEE-EeCCe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRGT---PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR----HPNIVQFLGAV-TERKP 229 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g~---~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~----h~~Iv~~~~~~-~~~~~ 229 (394)
+|.+.+.||+|+||.||.+..... .+|+|.......... ..+..|..++..+. .+++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 789999999999999999997643 588887654322211 14667888888876 26899999988 47778
Q ss_pred eEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC-C--CcEEEeecC
Q 016152 230 LMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-A--DHLKVGDFG 304 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~-~--~~~kl~DFg 304 (394)
.|+||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.| ++||||||.|+++.... . ..+.|.|||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 89999977 88999988654 57999999999999999999999999 99999999999994322 1 469999999
Q ss_pred Ccc--cccccccc---cccc-ccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH
Q 016152 305 LSK--LIKVQNSH---DVYK-MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368 (394)
Q Consensus 305 ~a~--~~~~~~~~---~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~ 368 (394)
+++ .+...... .... ...+.||..|.++.++.+...+++.|+|||+.++.|++.|..||...+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 998 43322221 1111 2345699999999999999999999999999999999999999987764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=196.23 Aligned_cols=182 Identities=42% Similarity=0.728 Sum_probs=157.8
Q ss_pred eecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCCCCH
Q 016152 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242 (394)
Q Consensus 165 iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~sL 242 (394)
||+|++|.||++... ++.+++|.+....... ..+.+.+|+..++.++|++|+++++++......++++|++.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999987 8899999886543321 346788999999999999999999999998999999999998999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC-CCcEEEeecCCccccccccccccccc
Q 016152 243 HKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQNSHDVYKM 320 (394)
Q Consensus 243 ~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~-~~~~kl~DFg~a~~~~~~~~~~~~~~ 320 (394)
.+++... ..++...+..++.++++++.+||+.+ ++|+||+|.||++ +. .+.++|+|||.+........ ..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~--~~~~~~~~l~d~~~~~~~~~~~~----~~ 150 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILL--DSDNGKVKLADFGLSKLLTSDKS----LL 150 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEE--eCCCCcEEEecCCceEEccCCcc----hh
Confidence 9999876 57899999999999999999999988 9999999999999 66 68899999999986654321 12
Q ss_pred cCCccCccccCccccCCC-CCCCcchHHHHHHHHHHH
Q 016152 321 TGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEM 356 (394)
Q Consensus 321 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el 356 (394)
....+...|++||.+... .++.++|+|++|++++++
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 235578889999999877 888999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=209.28 Aligned_cols=168 Identities=21% Similarity=0.316 Sum_probs=129.0
Q ss_pred CCcCccccceeecCCceEEEEEEEC---CccEEEEEeccCCC--CcHHHHHHHHHHHHHHHhCCCCceee-EEeEEEeCC
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNIVQ-FLGAVTERK 228 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~---g~~~avK~l~~~~~--~~~~~~~~~~~E~~~l~~l~h~~Iv~-~~~~~~~~~ 228 (394)
...+|.+.+.||+|+||.||+|.+. ++.+|||.+..... ........+.+|+.++++++|+|++. +++ .+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TG 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cC
Confidence 3447999999999999999999863 56679998753321 12334567899999999999999985 443 24
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC-CCCCEEEeeCCCCcEEEeecCCcc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL-KPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Di-kp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
..++||||++|++|... .. .. ...++.|++++|.|||++| |+|||| ||+|||+ +.++.+||+|||+|+
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv--~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLM--GPDGEAAVIDFQLAS 160 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEE--cCCCCEEEEECccce
Confidence 57999999999999732 11 11 1467899999999999988 999999 9999999 777899999999999
Q ss_pred ccccccccccc----cccCCccCccccCccccCC
Q 016152 308 LIKVQNSHDVY----KMTGETGSYRYMAPEVFKH 337 (394)
Q Consensus 308 ~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~ 337 (394)
.+......... ......+++.|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 87654422221 1235668889999999853
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=209.56 Aligned_cols=197 Identities=24% Similarity=0.392 Sum_probs=160.7
Q ss_pred CccccceeecCCceEEEEEEE-----CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeE
Q 016152 158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~-----~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~ 231 (394)
.|..+++||.|.|+.||++.. +.+.||+|.+...... .++.+|+++|..+. +.||+++.+++..++.+.
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 678899999999999999864 3568999987543332 55788999999986 899999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
+|+||+++....++... ++..++..+++.++.||.++|.+| ||||||||+|+|.. ...+.-.|+|||+|.....
T Consensus 112 ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n-~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYN-RRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred EEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccc-cccCCceEEechhHHHHHh
Confidence 99999999888887754 678999999999999999999988 99999999999973 4556778999999983210
Q ss_pred cc----------------------------------------ccccccccCCccCccccCccccCC-CCCCCcchHHHHH
Q 016152 312 QN----------------------------------------SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFA 350 (394)
Q Consensus 312 ~~----------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG 350 (394)
.. .......-...||++|.|||++.. ...++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 000000112349999999999865 4578999999999
Q ss_pred HHHHHHHcCCCCCCC
Q 016152 351 MILYEMLEGEPPLAN 365 (394)
Q Consensus 351 v~l~el~~g~~Pf~~ 365 (394)
|++.-++++++||-.
T Consensus 266 VI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFK 280 (418)
T ss_pred ceeehhhcccccccc
Confidence 999999999999954
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-23 Score=194.55 Aligned_cols=218 Identities=35% Similarity=0.557 Sum_probs=183.3
Q ss_pred ccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCC-ceeeEEeEEEeCCeeEEEEecc
Q 016152 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP-NIVQFLGAVTERKPLMLITEYL 237 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~-~Iv~~~~~~~~~~~~~lv~e~~ 237 (394)
|.+...||.|+|+.||++... ..+++|.+.............+.+|+.+++.+.|+ +++++++.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 567788999999999999888 78899988776655544567888999999999988 7999999998777789999999
Q ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC-cEEEeecCCcccccccc
Q 016152 238 RGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 238 ~~~sL~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~-~~kl~DFg~a~~~~~~~ 313 (394)
.+++|.+++.... .++......++.|++.++.|+|+.+ ++|||+||+||++ +..+ .++++|||.+..+....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~--~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeee--cCCCCeEEEeccCcceecCCCC
Confidence 9999998887664 7999999999999999999999988 9999999999999 7666 69999999998655433
Q ss_pred cccc--ccccCCccCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHcCCCC
Q 016152 314 SHDV--YKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYE----PYEAAKYVAEGHRP 381 (394)
Q Consensus 314 ~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~~g~~Pf~~~~----~~~~~~~i~~g~~p 381 (394)
.... .......||..|++||.+.+ ..+....|+||+|++++++++|..||.... ..+....+.....+
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 2211 12456789999999999987 578899999999999999999999998776 35666666665544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-25 Score=231.40 Aligned_cols=148 Identities=14% Similarity=0.216 Sum_probs=113.0
Q ss_pred CceeeEEeEE-------EeCCeeEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 016152 215 PNIVQFLGAV-------TERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR 286 (394)
Q Consensus 215 ~~Iv~~~~~~-------~~~~~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~ 286 (394)
+||+++++++ .....+++++|++ +++|.+++.. ...+++.+++.+++||++||.|||++| |+||||||+
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlKP~ 109 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNVRPS 109 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeeccCCch
Confidence 4666777766 3335678889987 5599999975 346999999999999999999999988 999999999
Q ss_pred CEEEee-----------------CCCCcEEEeecCCcccccccccc------c------cccccCCccCccccCccccCC
Q 016152 287 NVLLVN-----------------SSADHLKVGDFGLSKLIKVQNSH------D------VYKMTGETGSYRYMAPEVFKH 337 (394)
Q Consensus 287 Nilv~~-----------------~~~~~~kl~DFg~a~~~~~~~~~------~------~~~~~~~~gt~~y~aPE~~~~ 337 (394)
|||+.. +..+.+||+|||+++........ . ........||+.|||||++.+
T Consensus 110 NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 189 (793)
T PLN00181 110 CFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG 189 (793)
T ss_pred hEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc
Confidence 999932 22345667777766542210000 0 000112458999999999999
Q ss_pred CCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 016152 338 RKYDKKVDVFSFAMILYEMLEGEPPLAN 365 (394)
Q Consensus 338 ~~~~~~~DvwslGv~l~el~~g~~Pf~~ 365 (394)
..|+.++|||||||++|||++|.+|+..
T Consensus 190 ~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 190 SSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred CCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 9999999999999999999999999864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-24 Score=184.69 Aligned_cols=171 Identities=12% Similarity=0.181 Sum_probs=135.4
Q ss_pred CccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHH------HHHHHHHHHhCCCCceeeEEeEEEeC----
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD------FRHEVNLLVKLRHPNIVQFLGAVTER---- 227 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~------~~~E~~~l~~l~h~~Iv~~~~~~~~~---- 227 (394)
+|.+.+++|.|+||.||++..++..+|+|.+.+.....+..... +.+|+..+.++.|++|..+.+++...
T Consensus 32 ~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~ 111 (232)
T PRK10359 32 NIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKT 111 (232)
T ss_pred ceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccc
Confidence 78999999999999999987778899999997766555544444 57899999999999999999886643
Q ss_pred ----CeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 228 ----KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 228 ----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
...+++|||++|.+|.++.. +++ ....+++.+|..+|+.| ++|||+||+||++ ++++ ++|+||
T Consensus 112 ~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili--~~~g-i~liDf 178 (232)
T PRK10359 112 LRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIV--SKNG-LRIIDL 178 (232)
T ss_pred ccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEE--eCCC-EEEEEC
Confidence 35799999999999988732 333 24569999999999988 9999999999999 6666 999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHH
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~ 357 (394)
|........... ........|..++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a~----------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK----------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH----------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988655322111 01334556778999999999987664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=175.47 Aligned_cols=142 Identities=21% Similarity=0.161 Sum_probs=109.3
Q ss_pred cceeecCCceEEEEEEE-CCccEEEEEeccCCCCcHH-----------------------HHHHHHHHHHHHHhCCCCce
Q 016152 162 SAIIGKGSFGEILKAYW-RGTPVAIKRILPSLSDDRL-----------------------VIQDFRHEVNLLVKLRHPNI 217 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~-~g~~~avK~l~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~~I 217 (394)
...||+|++|.||+|.. +|++||||++......... .......|+..++++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999987 4889999998654321110 01223459999999988776
Q ss_pred eeEEeEEEeCCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HcCCCCeEecCCCCCCEEEeeCCCC
Q 016152 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL-HNEPNVIIHRDLKPRNVLLVNSSAD 296 (394)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~l-H~~~~~ivH~Dikp~Nilv~~~~~~ 296 (394)
......... ..++||||+.|+++...+...+.++..++..++.|++.+|.++ |+.| |+||||||+|||+ + ++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli--~-~~ 154 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLY--H-DG 154 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--E-CC
Confidence 543332222 2389999999887766554556799999999999999999999 7888 9999999999999 4 36
Q ss_pred cEEEeecCCccccc
Q 016152 297 HLKVGDFGLSKLIK 310 (394)
Q Consensus 297 ~~kl~DFg~a~~~~ 310 (394)
.++|+|||+|....
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-24 Score=204.13 Aligned_cols=201 Identities=28% Similarity=0.416 Sum_probs=171.5
Q ss_pred eeecCCceEEEEEE-----ECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEEEEecc
Q 016152 164 IIGKGSFGEILKAY-----WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYL 237 (394)
Q Consensus 164 ~iG~G~~g~V~~a~-----~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~ 237 (394)
++|+|.||.|+++. ..|+.+++|++.+......... ....|..++...+ ||.++++...++.+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 36899999998653 3577899998876654433332 5667888888887 999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccc
Q 016152 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317 (394)
Q Consensus 238 ~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~ 317 (394)
.||.|...+.+...+++.....+...++-+++++|+.+ |+|||+|++||++ +..|.+++.|||+++..-...
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enill--d~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLL--LLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceee--cccCccccCCchhhhHhHhhh----
Confidence 99999999988888899999999999999999999988 9999999999999 999999999999998665332
Q ss_pred ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 016152 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 318 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~ 383 (394)
..+||..|||||++. .....+|.||+|++++||++|..||.. ++...|.+...++.
T Consensus 152 ----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p 207 (612)
T KOG0603|consen 152 ----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP 207 (612)
T ss_pred ----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc
Confidence 128999999999998 677889999999999999999999988 77777776544443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-22 Score=168.81 Aligned_cols=191 Identities=17% Similarity=0.086 Sum_probs=139.7
Q ss_pred ccceeecCCceEEEEEEECCccEEEEEeccCCCCcH-HHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEEEEeccC
Q 016152 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR-LVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLR 238 (394)
Q Consensus 161 ~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~~ 238 (394)
+...|++|+||+|+.+...+.+++.+.+........ .....+.+|+.+|++++ +++|++++++ ...+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 456899999999998887788888776543322111 11225789999999996 5789999885 44699999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC-CCCCEEEeeCCCCcEEEeecCCcccccccccc--
Q 016152 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL-KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH-- 315 (394)
Q Consensus 239 ~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Di-kp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~-- 315 (394)
|.+|...... ....++.|++.+|+++|+.| |+|||| ||+|||+ +.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv--~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 82 GAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLV--QEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred CccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEE--cCCCCEEEEECCCceecCCcchHHH
Confidence 9999764321 12357789999999999998 999999 7999999 77789999999999865433210
Q ss_pred -----ccc--cccCCccCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 316 -----DVY--KMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 316 -----~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
+.. .......++.|++|+...- ..--.+.++++.|.-+|.++||..|+...
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 000 0011226778888876432 22236789999999999999998887554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=170.56 Aligned_cols=122 Identities=25% Similarity=0.335 Sum_probs=100.6
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccc
Q 016152 240 GDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (394)
Q Consensus 240 ~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~ 318 (394)
|+|.+++..+ ..+++.+++.++.|++.||.|||+++ ||+|||+ +.++.+++ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~--~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILL--TWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeE--cCccceee--ccceEeeccc------
Confidence 6899999874 46999999999999999999999964 9999999 88888998 9998765422
Q ss_pred cccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCCCC
Q 016152 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAEGHRPF 382 (394)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~-~~~~~~i~~g~~p~ 382 (394)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+..+..+.
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 124 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD 124 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC
Confidence 12588999999999999999999999999999999999999976543 34444444443433
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=169.80 Aligned_cols=142 Identities=17% Similarity=0.148 Sum_probs=111.4
Q ss_pred cceeecCCceEEEEEEEC-CccEEEEEeccCCCCc-----------------------HHHHHHHHHHHHHHHhCCCCce
Q 016152 162 SAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDD-----------------------RLVIQDFRHEVNLLVKLRHPNI 217 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~-----------------------~~~~~~~~~E~~~l~~l~h~~I 217 (394)
...||+|++|.||+|... |+.||||++....... .........|...+.++.+++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999875 9999999987652210 0112234578999999999987
Q ss_pred eeEEeEEEeCCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCCEEEeeCCCC
Q 016152 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSAD 296 (394)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~ivH~Dikp~Nilv~~~~~~ 296 (394)
.....+.... .++||||++|+++.........++..++..++.|++.++.++|+ .| |+||||||+||++ + ++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll--~-~~ 154 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILY--H-DG 154 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEE--E-CC
Confidence 5544443332 48999999987655443344568889999999999999999999 88 9999999999999 5 67
Q ss_pred cEEEeecCCccccc
Q 016152 297 HLKVGDFGLSKLIK 310 (394)
Q Consensus 297 ~~kl~DFg~a~~~~ 310 (394)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 89999999998665
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=163.51 Aligned_cols=116 Identities=28% Similarity=0.334 Sum_probs=86.4
Q ss_pred CcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhc-CCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccC
Q 016152 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED-QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (394)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~-g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~ 99 (394)
..+..+|.+|+.|+||+|+ |+..+..++++-|+.. |+|+|+++..|.||||||+.+|+.+|+++|+++||.|+++|+
T Consensus 60 q~nv~~ddkDdaGWtPlhi--a~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~ 137 (226)
T KOG4412|consen 60 QPNVKPDDKDDAGWTPLHI--AASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDK 137 (226)
T ss_pred cCCCCCCCccccCCchhhh--hhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCccccc
Confidence 4666777777888887765 5445555555555555 788888888888888888888888888888888888888888
Q ss_pred CCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCC
Q 016152 100 WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (394)
Q Consensus 100 ~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~ 138 (394)
.|.||||.|+..|+.+++++|+..|+.++.++...++|.
T Consensus 138 ~~qtplHRAAavGklkvie~Li~~~a~~n~qDk~G~TpL 176 (226)
T KOG4412|consen 138 QGQTPLHRAAAVGKLKVIEYLISQGAPLNTQDKYGFTPL 176 (226)
T ss_pred ccCchhHHHHhccchhhHHHHHhcCCCCCcccccCccHH
Confidence 888888888888888888888888877777766666554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-23 Score=206.42 Aligned_cols=203 Identities=30% Similarity=0.460 Sum_probs=162.3
Q ss_pred cccceeecCCceEEEEEEEC--CccEEEEEecc---CCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 160 SSSAIIGKGSFGEILKAYWR--GTPVAIKRILP---SLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 160 ~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~---~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
....++|.|++|.|+.+... ...++.|.... ...........+..|+.+-..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999977766542 22233332211 12222222233677888889999999988887776666555569
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|||++ +|+.++...+.+...++..++.|++.|+.|+|+.| |.|||+|++|+++ ...+.+||+|||.+..+.-...
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~--~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLV--TENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEE--ecCCceEEeecCcceeeccCcc
Confidence 99999 99999998888999999999999999999999999 9999999999999 7888999999999987765554
Q ss_pred cccccccCCccCccccCccccCCCCCC-CcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
.......+.+|+..|+|||.+.+..|+ +..||||.|++++.|++|+.||....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 434456778999999999999999997 57999999999999999999996543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.9e-22 Score=196.72 Aligned_cols=201 Identities=19% Similarity=0.287 Sum_probs=158.1
Q ss_pred CccccceeecCCceEEEEEEECCccEEEEEeccCCCC-cHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~-~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
++...+.||++.|-.|.+|.++.-.++||++.+.... .-....+...|+. ....++||++.+.-+...+..-|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4667789999999999999987556999999876532 2212223333444 6667899999999887888888999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc--ccc-c
Q 016152 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI--KVQ-N 313 (394)
Q Consensus 237 ~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~--~~~-~ 313 (394)
+.+ +|.|.+..++.+...+..+|+.|++.||..+|..| |+|||||.+|||| .....+.|+||...+.. +.+ +
T Consensus 103 vkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILi--TSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILI--TSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEE--eeechhhhhcccccCCccCCCCCc
Confidence 977 99999998888999999999999999999999998 9999999999999 77778999999866532 222 2
Q ss_pred ccccccccCCccCccccCccccCCC----------C-CCCcchHHHHHHHHHHHHc-CCCCCC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHR----------K-YDKKVDVFSFAMILYEMLE-GEPPLA 364 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslGv~l~el~~-g~~Pf~ 364 (394)
.+..+-..+.....-|+|||.+... . .+++.||||+||++.||++ |++||.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 2222233444455569999987431 2 5789999999999999998 899994
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-19 Score=158.14 Aligned_cols=141 Identities=19% Similarity=0.253 Sum_probs=105.7
Q ss_pred ccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-----CCCceeeEEeEEEeCC---e-
Q 016152 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-----RHPNIVQFLGAVTERK---P- 229 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~Iv~~~~~~~~~~---~- 229 (394)
+.-...||+|+|+.||. .-.....+||++...... ..+.+.+|+.+++.+ .||||+++++++.++. .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQRCIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCeEEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34456899999999996 222233478887553222 236689999999999 5799999999998874 3
Q ss_pred eEEEEec--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHcCCCCeEecCCCCCCEEEeeC--CCCcEEEee-c
Q 016152 230 LMLITEY--LRGGDLHKYLKEKGALSPSTAVNFALDIARGM-AYLHNEPNVIIHRDLKPRNVLLVNS--SADHLKVGD-F 303 (394)
Q Consensus 230 ~~lv~e~--~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l-~~lH~~~~~ivH~Dikp~Nilv~~~--~~~~~kl~D-F 303 (394)
+.+|+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||+.+ |+||||||+|||+... ....++|+| |
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3378999 5578999999764 46555 35678888777 9999988 9999999999999432 334799999 5
Q ss_pred CCccc
Q 016152 304 GLSKL 308 (394)
Q Consensus 304 g~a~~ 308 (394)
|....
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 54444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.1e-21 Score=189.95 Aligned_cols=200 Identities=33% Similarity=0.513 Sum_probs=146.7
Q ss_pred cccCCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC
Q 016152 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (394)
Q Consensus 150 ~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 227 (394)
|...+.+.+|..++.|..|++|.||..+++ .+++|+| +.+.. .. +++ ++.....|.+|
T Consensus 76 s~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~----li---lRn---ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 76 SRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN----LI---LRN---ILTFAGNPFVV--------- 135 (1205)
T ss_pred cccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccc----hh---hhc---cccccCCccee---------
Confidence 566777889999999999999999999886 6788885 32211 00 111 33333444444
Q ss_pred CeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
|+=...++.-++++.. ++.+++|+|+.| |+|||+||+|.+| ...|.+|+.|||+++
T Consensus 136 ------------gDc~tllk~~g~lPvd--------mvla~Eylh~yg--ivhrdlkpdnllI--T~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 136 ------------GDCATLLKNIGPLPVD--------MVLAVEYLHSYG--IVHRDLKPDNLLI--TSMGHIKLTDFGLSK 191 (1205)
T ss_pred ------------chhhhhcccCCCCcch--------hhHHhHhhccCC--eecCCCCCCccee--eecccccccchhhhh
Confidence 3434444444444432 267899999988 9999999999999 888999999999976
Q ss_pred ccccccc-----------cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 308 LIKVQNS-----------HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 308 ~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
..-.... .........+|||.|.|||++..+.|...+|+|++|+++||.+.|..||.+.+++|++.+++
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 4321110 01112345689999999999999999999999999999999999999999999999998877
Q ss_pred c--CCCCCCCCCCCCccccC
Q 016152 377 E--GHRPFFRAKGFTPELRE 394 (394)
Q Consensus 377 ~--g~~p~~~~~~~~~~~~~ 394 (394)
. ...|+- ...+++|.+|
T Consensus 272 sd~i~wpE~-dea~p~Ea~d 290 (1205)
T KOG0606|consen 272 SDDIEWPEE-DEALPPEAQD 290 (1205)
T ss_pred hhhcccccc-CcCCCHHHHH
Confidence 4 334444 3567777664
|
|
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=151.73 Aligned_cols=114 Identities=25% Similarity=0.316 Sum_probs=105.1
Q ss_pred CCCCc-chhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCC
Q 016152 18 GATSS-ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96 (394)
Q Consensus 18 ~~~~~-~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~ 96 (394)
.++.. |+|+|+..+.|.|++|+ |+..+..+|.++|+++|+.|+.+|.+|.||||-||..|.++++++|+..||.+|.
T Consensus 90 ~Ll~r~~advna~tn~G~T~LHy--AagK~r~eIaqlLle~ga~i~~kD~~~qtplHRAAavGklkvie~Li~~~a~~n~ 167 (226)
T KOG4412|consen 90 ELLNRSGADVNATTNGGQTCLHY--AAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHRAAAVGKLKVIEYLISQGAPLNT 167 (226)
T ss_pred HHhcCCCCCcceecCCCcceehh--hhcCChhhHHHHHHhcCCCCcccccccCchhHHHHhccchhhHHHHHhcCCCCCc
Confidence 34444 99999999999998854 7777889999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCC
Q 016152 97 QDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (394)
Q Consensus 97 ~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s 133 (394)
+|+.|+||||.|...|+.++..+|+.+||+.+..++.
T Consensus 168 qDk~G~TpL~~al~e~~~d~a~lLV~~gAd~~~edke 204 (226)
T KOG4412|consen 168 QDKYGFTPLHHALAEGHPDVAVLLVRAGADTDREDKE 204 (226)
T ss_pred ccccCccHHHHHHhccCchHHHHHHHhccceeecccc
Confidence 9999999999998889999999999999999877664
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-19 Score=159.93 Aligned_cols=138 Identities=23% Similarity=0.404 Sum_probs=115.5
Q ss_pred ceeecCCceEEEEEEECCccEEEEEeccCCCCcH-----HHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEecc
Q 016152 163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR-----LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 237 (394)
+.||+|++|.||+|.+.|..+++|.......... .....+.+|+.++..+.|++|+....++.+....+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 4789999999999999999999998654332211 12345778999999999999887777777778889999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 238 ~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
+|++|.+++..... ....++.+++.+|.++|+.+ ++|||++|.|||+ + .+.++|+|||++...
T Consensus 82 ~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~--~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 82 EGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMIL--S-GGKIYLIDFGLAEFS 144 (211)
T ss_pred CCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEE--E-CCCEEEEECCcccCC
Confidence 99999999875432 78889999999999999988 9999999999999 4 678999999998753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-20 Score=189.39 Aligned_cols=201 Identities=26% Similarity=0.332 Sum_probs=159.1
Q ss_pred ccCCCCcCccccceeecCCceEEEEEEE-CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC---CCceeeEEeEEEe
Q 016152 151 EIDPSELDFSSSAIIGKGSFGEILKAYW-RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQFLGAVTE 226 (394)
Q Consensus 151 ~i~~~~~~~~~~~~iG~G~~g~V~~a~~-~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~ 226 (394)
........|.+.+.||+|+||.||+|.. +|+.+|+|+-.+.....-.. -..++.+|+ -+.|..+..+..-
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI------~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI------CLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee------hHHHHHhhchhhhcchHHHHHHHcc
Confidence 3444556789999999999999999986 48899999866554432111 122333333 2445555555555
Q ss_pred CCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-----CCCCcEEEe
Q 016152 227 RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-----SSADHLKVG 301 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-----~~~~~~kl~ 301 (394)
.+.-++|+||.+.|+|.++++..+.+++..+..+..|++..++.||..+ |||+||||+|+|+.. ....-++|+
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEE
Confidence 6667899999999999999998888999999999999999999999998 999999999999943 223459999
Q ss_pred ecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCC
Q 016152 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361 (394)
Q Consensus 302 DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~ 361 (394)
|||.+..+..-... ......++|-.+-.+|+..++.|++++|.|.|+-+++-|+.|++
T Consensus 844 DfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99998766543322 24566778999999999999999999999999999999999964
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.3e-19 Score=153.61 Aligned_cols=134 Identities=26% Similarity=0.391 Sum_probs=109.2
Q ss_pred eeecCCceEEEEEEECCccEEEEEeccCCCCc-----HHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccC
Q 016152 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-----RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 238 (394)
.||+|+||.||++.+.+..+++|......... .....++.+|+.+++.+.|+++.....++......+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 37999999999999999999999865432111 1223567789999999998876655555566677899999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 239 ~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
|++|.+++..... .++.|++.+|.+||+.| ++|+|++|.||++ + .+.++++|||++...
T Consensus 81 g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~--~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIV--R-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEE--E-CCcEEEEECCCCcCC
Confidence 9999998765321 78899999999999988 9999999999999 5 678999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-18 Score=171.59 Aligned_cols=148 Identities=26% Similarity=0.378 Sum_probs=119.3
Q ss_pred CcccCCCC-cCccccceeecCCceEEEEEEECCccEEEEEeccCCCC-----cHHHHHHHHHHHHHHHhCCCCceeeEEe
Q 016152 149 DWEIDPSE-LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLRHPNIVQFLG 222 (394)
Q Consensus 149 ~~~i~~~~-~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 222 (394)
.|...... ..|...+.||+|+||.||++.+.+..+++|........ .....+.+.+|+.+++.++|++++....
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 45554443 34567889999999999999998887777765432211 1123456889999999999999998877
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEee
Q 016152 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (394)
Q Consensus 223 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~D 302 (394)
+..+....++||||++|++|.+++. ....++.|++.+|.+||+.+ ++||||||+|||+ + ++.++|+|
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl--~-~~~~~liD 470 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV--R-DDRLYLID 470 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE--E-CCcEEEEe
Confidence 7777778899999999999999885 35678999999999999988 9999999999999 3 46799999
Q ss_pred cCCcccc
Q 016152 303 FGLSKLI 309 (394)
Q Consensus 303 Fg~a~~~ 309 (394)
||+++..
T Consensus 471 FGla~~~ 477 (535)
T PRK09605 471 FGLGKYS 477 (535)
T ss_pred CcccccC
Confidence 9999754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.5e-19 Score=158.86 Aligned_cols=198 Identities=20% Similarity=0.305 Sum_probs=128.2
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC----------CCceeeEEeEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR----------HPNIVQFLGAVT 225 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~----------h~~Iv~~~~~~~ 225 (394)
.+..+..||.|+++.||.+.+. ++.++||+............+.+++|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456789999999999999986 5899999886655444445667776665444432 222333333221
Q ss_pred ---------eC---C-----eeEEEEeccCCCCHHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHcCCCCeEec
Q 016152 226 ---------ER---K-----PLMLITEYLRGGDLHKYLK---EKGAL----SPSTAVNFALDIARGMAYLHNEPNVIIHR 281 (394)
Q Consensus 226 ---------~~---~-----~~~lv~e~~~~~sL~~~~~---~~~~~----~~~~~~~~~~ql~~~l~~lH~~~~~ivH~ 281 (394)
.. . +.+++|+-+ .++|.+++. ..... .......+-.|+++.+++||+.| ++|+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHg 169 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHG 169 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEES
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEec
Confidence 11 1 236788877 458888764 22222 12222334479999999999999 9999
Q ss_pred CCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCC--------CCCCCcchHHHHHHHH
Q 016152 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH--------RKYDKKVDVFSFAMIL 353 (394)
Q Consensus 282 Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGv~l 353 (394)
||+|+|+++ +.+|.++|+||+......... .....+..|.+||.... -.++.+.|.|+||+++
T Consensus 170 di~~~nfll--~~~G~v~Lg~F~~~~r~g~~~-------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 170 DIKPENFLL--DQDGGVFLGDFSSLVRAGTRY-------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp T-SGGGEEE---TTS-EEE--GGGEEETTEEE-------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred ccceeeEEE--cCCCCEEEcChHHHeecCcee-------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 999999999 889999999998766543221 11234577999997643 2578999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 016152 354 YEMLEGEPPLANYE 367 (394)
Q Consensus 354 ~el~~g~~Pf~~~~ 367 (394)
|.|.||..||....
T Consensus 241 y~lWC~~lPf~~~~ 254 (288)
T PF14531_consen 241 YSLWCGRLPFGLSS 254 (288)
T ss_dssp HHHHHSS-STCCCG
T ss_pred HHHHHccCCCCCCC
Confidence 99999999998654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.9e-19 Score=160.19 Aligned_cols=176 Identities=26% Similarity=0.356 Sum_probs=124.3
Q ss_pred CCCceeeEEeEEEeC---------------------------CeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 016152 213 RHPNIVQFLGAVTER---------------------------KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIA 265 (394)
Q Consensus 213 ~h~~Iv~~~~~~~~~---------------------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~ 265 (394)
+|||||++..+|.++ ..+|+||..... +|..++-.+. .+......++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence 599999999887542 237999998866 9998886553 67788888999999
Q ss_pred HHHHHHHcCCCCeEecCCCCCCEEEeeC--CCCcEEEeecCCccccccccccccc--cccCCccCccccCccccCCCC--
Q 016152 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNS--SADHLKVGDFGLSKLIKVQNSHDVY--KMTGETGSYRYMAPEVFKHRK-- 339 (394)
Q Consensus 266 ~~l~~lH~~~~~ivH~Dikp~Nilv~~~--~~~~~kl~DFg~a~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-- 339 (394)
+|+.|||..| |.|||+|.+|||+--+ .-..+.|+|||++---..-.-+-.+ ......|....||||+....+
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999998 9999999999999433 3446889999987533221111111 112345778899999985432
Q ss_pred ---C-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCCcccc
Q 016152 340 ---Y-DKKVDVFSFAMILYEMLEGEPPLANYEPYEA-AKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 340 ---~-~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~-~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
. -.++|.|+.|.+.||+++...||...-.+-+ ...-.+.+-|-+++. +||.+|
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~-vpp~~r 487 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSR-VPPVAR 487 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCccc-CChHHH
Confidence 1 2589999999999999999999977321110 111234555666643 555443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=155.56 Aligned_cols=145 Identities=19% Similarity=0.161 Sum_probs=110.8
Q ss_pred CccccceeecCCceEEEEEE---ECCccEEEEEeccCCCCc---------------------HHHHHHHHHHHHHHHhCC
Q 016152 158 DFSSSAIIGKGSFGEILKAY---WRGTPVAIKRILPSLSDD---------------------RLVIQDFRHEVNLLVKLR 213 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~---~~g~~~avK~l~~~~~~~---------------------~~~~~~~~~E~~~l~~l~ 213 (394)
.|.+.+.||+|++|.||+|. ..|+.||+|.+....... ......+..|+..++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46788899999999999998 358999999886532110 011234568999999997
Q ss_pred CC--ceeeEEeEEEeCCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEe
Q 016152 214 HP--NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 291 (394)
Q Consensus 214 h~--~Iv~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~ 291 (394)
+. .+++++.. ...++||||+.|.+|.........+...++..++.|++.+|.+||+.| .++||||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli- 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILV- 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEE-
Confidence 53 34445542 234899999999888776544556677778899999999999999953 39999999999999
Q ss_pred eCCCCcEEEeecCCccccc
Q 016152 292 NSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 292 ~~~~~~~kl~DFg~a~~~~ 310 (394)
+ .+.++|+|||.+....
T Consensus 183 -~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 -H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred -E-CCCEEEEEChhhhccC
Confidence 5 6789999999987543
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8e-19 Score=140.50 Aligned_cols=103 Identities=33% Similarity=0.458 Sum_probs=94.5
Q ss_pred eeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHH
Q 016152 37 LILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNM 116 (394)
Q Consensus 37 ~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~ 116 (394)
+++|||..+...+|.++|.+..--||.+|.+|.||||-|+.+||++||+.|+..||+++++...||||||-|+.+++.++
T Consensus 66 l~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~v 145 (228)
T KOG0512|consen 66 LLLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEV 145 (228)
T ss_pred HHHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhH
Confidence 45788888989999998877777799999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCCCCC
Q 016152 117 MELLNAHGGLSYGQNGSHFEPKP 139 (394)
Q Consensus 117 ~~~L~~~ga~~~~~~~s~~~p~~ 139 (394)
+.+|+++|++++.+.....+|..
T Consensus 146 a~~LLqhgaDVnA~t~g~ltpLh 168 (228)
T KOG0512|consen 146 AGRLLQHGADVNAQTKGLLTPLH 168 (228)
T ss_pred HHHHHhccCcccccccccchhhH
Confidence 99999999999988776666654
|
|
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-18 Score=145.89 Aligned_cols=111 Identities=21% Similarity=0.193 Sum_probs=91.7
Q ss_pred CCcchhhhhhccccCcceeeehhhcCCH--HHHHHHHHhcCCCCcccc-CCCCCHHHHHHhcCcHHHHHHHHH-cCCCCC
Q 016152 20 TSSADKQKEKARVSRTSLILWHAHQNDA--AAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIE-YGADVN 95 (394)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~--~~~~~~L~~~g~~vn~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~ 95 (394)
+..|++++.+|..|+|++++ ||..+.. ..++++|++.|+++|.+| ..|+||||+|+..++.+++++|++ .|++++
T Consensus 44 ~~~g~~~~~~d~~g~t~Lh~-Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~ 122 (166)
T PHA02743 44 SGDGHLLHRYDHHGRQCTHM-VAWYDRANAVMKIELLVNMGADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLG 122 (166)
T ss_pred hhcchhhhccCCCCCcHHHH-HHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCcc
Confidence 35788888888888888753 4443332 345788999999999998 489999999999999999999995 799999
Q ss_pred CccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCC
Q 016152 96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131 (394)
Q Consensus 96 ~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~ 131 (394)
.+|..|+||||+|+..++.+++++|+.+|++++..+
T Consensus 123 ~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~ 158 (166)
T PHA02743 123 AINYQHETAYHIAYKMRDRRMMEILRANGAVCDDPL 158 (166)
T ss_pred CcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999999999999998876443
|
|
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.4e-18 Score=154.73 Aligned_cols=112 Identities=23% Similarity=0.161 Sum_probs=98.6
Q ss_pred hhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCcccc----CCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc-cCC
Q 016152 26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD----YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ-DRW 100 (394)
Q Consensus 26 ~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d----~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~-~~~ 100 (394)
+.++|+++.|++++ +|++.+..+++++|+++|+|+|.++ ..|.||||+|+..++.+++++|+++|||+|.+ +..
T Consensus 25 ~~~~d~~~~~~lL~-~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~ 103 (300)
T PHA02884 25 IKKKNKICIANILY-SSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEA 103 (300)
T ss_pred hhccCcCCCCHHHH-HHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCC
Confidence 56789999999865 4556777899999999999999974 58999999999999999999999999999996 468
Q ss_pred CCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCC
Q 016152 101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (394)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~ 138 (394)
|.||||+|+..++.+++++|+..|++++..+....+|.
T Consensus 104 g~TpLh~Aa~~~~~eivklLL~~GAdin~kd~~G~TpL 141 (300)
T PHA02884 104 KITPLYISVLHGCLKCLEILLSYGADINIQTNDMVTPI 141 (300)
T ss_pred CCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHH
Confidence 99999999999999999999999999987766555543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=145.61 Aligned_cols=139 Identities=19% Similarity=0.163 Sum_probs=106.6
Q ss_pred CccccceeecCCceEEEEEEE-CCccEEEEEeccCCCCc-------------------HHHHHHHHHHHHHHHhCCCC--
Q 016152 158 DFSSSAIIGKGSFGEILKAYW-RGTPVAIKRILPSLSDD-------------------RLVIQDFRHEVNLLVKLRHP-- 215 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~-~g~~~avK~l~~~~~~~-------------------~~~~~~~~~E~~~l~~l~h~-- 215 (394)
.|.+.+.||+|+||.||++.. .|+.+|||++....... .........|..++..+.++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 366778999999999999987 48899999865432110 01112356788888888776
Q ss_pred ceeeEEeEEEeCCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCC
Q 016152 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 295 (394)
Q Consensus 216 ~Iv~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~ 295 (394)
.+++.++ ....+++|||++|++|...... .....++.+++.++.++|+.| |+||||||+||++ +.+
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill--~~~ 161 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILV--DDD 161 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEE--cCC
Confidence 4445543 2456899999999998765421 345678899999999999988 9999999999999 778
Q ss_pred CcEEEeecCCccccc
Q 016152 296 DHLKVGDFGLSKLIK 310 (394)
Q Consensus 296 ~~~kl~DFg~a~~~~ 310 (394)
+.++|+|||++..+.
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 899999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.7e-18 Score=148.25 Aligned_cols=124 Identities=19% Similarity=0.109 Sum_probs=98.0
Q ss_pred CCCCCCCCCcchhhhhhcc-ccCcceeeehhhc--CCHHHHHHHHHhcCCCCccccCCCCCHHHHHHh--cCcHHHHHHH
Q 016152 13 TPCKGGATSSADKQKEKAR-VSRTSLILWHAHQ--NDAAAVRKLLEEDQSLVHARDYDNRTPLHVASL--HGWIDVAKCL 87 (394)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~a~~--~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~--~~~~~~~~~L 87 (394)
..+.+-++.+|+++|.+++ .|.|++++ |+.. ++..+++++|+++|+++|.+|.+|.||||+|+. .++.+++++|
T Consensus 66 ~eiv~~Ll~~gadvn~~~~~~g~TpLh~-a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~L 144 (209)
T PHA02859 66 VEILKFLIENGADVNFKTRDNNLSALHH-YLSFNKNVEPEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKLL 144 (209)
T ss_pred HHHHHHHHHCCCCCCccCCCCCCCHHHH-HHHhCccccHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHHH
Confidence 3445557788999998874 67777654 3332 346788899999999999999999999998875 4678999999
Q ss_pred HHcCCCCCCccCCCCchhhH-HHhcChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 88 IEYGADVNAQDRWKNTPLAD-AEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 88 l~~ga~~~~~~~~g~t~l~~-A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
+++|+|+|.+|.+|.||||. |+..++.+++++|++.|++++..+....+|
T Consensus 145 i~~gadin~~d~~g~t~Lh~~a~~~~~~~iv~~Ll~~Gadi~~~d~~g~tp 195 (209)
T PHA02859 145 IDSGVSFLNKDFDNNNILYSYILFHSDKKIFDFLTSLGIDINETNKSGYNC 195 (209)
T ss_pred HHcCCCcccccCCCCcHHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCCH
Confidence 99999999999999999995 556788999999999999887666554444
|
|
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=126.05 Aligned_cols=87 Identities=32% Similarity=0.396 Sum_probs=78.3
Q ss_pred ehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHH
Q 016152 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119 (394)
Q Consensus 40 ~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~ 119 (394)
|.|++.+..+++++|++.+.+++. |+||||+||.+|+.+++++|+++|+++|.+|.+|+||||+|+..++.+++++
T Consensus 2 ~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~ 77 (89)
T PF12796_consen 2 HIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVKL 77 (89)
T ss_dssp HHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHHH
T ss_pred HHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHHH
Confidence 347777788888888899988887 9999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCC
Q 016152 120 LNAHGGLSYGQ 130 (394)
Q Consensus 120 L~~~ga~~~~~ 130 (394)
|+++|++++..
T Consensus 78 Ll~~g~~~~~~ 88 (89)
T PF12796_consen 78 LLEHGADVNIR 88 (89)
T ss_dssp HHHTTT-TTSS
T ss_pred HHHcCCCCCCc
Confidence 99999987654
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.6e-18 Score=154.61 Aligned_cols=110 Identities=13% Similarity=-0.014 Sum_probs=61.6
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCC-CHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNR-TPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~-t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
+++.|++++.+|.+|.|++++ |+..+..+++++|++.|+++|.++..|+ ||||+|+..|+.++|++|+++|++. .
T Consensus 80 LL~~Gadvn~~d~~G~TpLh~--Aa~~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~eivk~LL~~~~~~--~ 155 (284)
T PHA02791 80 LLFSGMDDSQFDDKGNTALYY--AVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPST--F 155 (284)
T ss_pred HHHCCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCHHHHHHHHhcCCcc--c
Confidence 445566666666666666543 5555556666666666666665555553 4555555555555555555544322 1
Q ss_pred c-CCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCC
Q 016152 98 D-RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNG 132 (394)
Q Consensus 98 ~-~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~ 132 (394)
| ..|.||||+|+..|+.+++++|+++|++++..+.
T Consensus 156 d~~~g~TpLh~Aa~~g~~eiv~lLL~~gAd~n~~d~ 191 (284)
T PHA02791 156 DLAILLSCIHITIKNGHVDMMILLLDYMTSTNTNNS 191 (284)
T ss_pred ccccCccHHHHHHHcCCHHHHHHHHHCCCCCCcccC
Confidence 2 1355666666666666666666666666554443
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.4e-18 Score=162.10 Aligned_cols=119 Identities=26% Similarity=0.257 Sum_probs=105.3
Q ss_pred CCCc-chhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCcccc-CCCCCHHHHHHhcCcHHHHHHHHHcCCCCCC
Q 016152 19 ATSS-ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96 (394)
Q Consensus 19 ~~~~-~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~ 96 (394)
++.. |.+++..|++|-|.+ || |+.+++.+++++|+++||+||+.+ ..|.|||||||.+|+..+|++|+++|||++.
T Consensus 63 lve~~g~~v~~~D~~g~tlL-HW-AAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~ 140 (600)
T KOG0509|consen 63 LVESEGESVNNPDREGVTLL-HW-AAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTL 140 (600)
T ss_pred HHhhcCcCCCCCCcCCccce-eH-HHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCce
Confidence 3445 888888888665554 55 555788999999999999999998 6899999999999999999999999999999
Q ss_pred ccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 016152 97 QDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKP 139 (394)
Q Consensus 97 ~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~~ 139 (394)
+|..|.||+|.|++.++.-+|-+|+..+++++..+....+|..
T Consensus 141 ~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~D~~grTpLm 183 (600)
T KOG0509|consen 141 KDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTPLM 183 (600)
T ss_pred ecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCHHH
Confidence 9999999999999999999999999999999988888777643
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-18 Score=159.53 Aligned_cols=119 Identities=26% Similarity=0.304 Sum_probs=105.6
Q ss_pred CCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCC
Q 016152 17 GGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96 (394)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~ 96 (394)
+.++.+|+++|....-..||+ .+||..++.+++++|+++|+|++..|..|.|.||+||.+||.+|+++|++.|||+|.
T Consensus 101 k~L~~~ga~VN~tT~TNStPL--raACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ 178 (615)
T KOG0508|consen 101 KLLLRRGASVNDTTRTNSTPL--RAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNA 178 (615)
T ss_pred HHHHHhcCccccccccCCccH--HHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcch
Confidence 346778999998777777776 568889999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCC
Q 016152 97 QDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (394)
Q Consensus 97 ~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~ 138 (394)
++..|+|+||.|+..|+.+++++|+.+|+..... +..++|.
T Consensus 179 ks~kGNTALH~caEsG~vdivq~Ll~~ga~i~~d-~~GmtPL 219 (615)
T KOG0508|consen 179 KSYKGNTALHDCAESGSVDIVQLLLKHGAKIDVD-GHGMTPL 219 (615)
T ss_pred hcccCchHHHhhhhcccHHHHHHHHhCCceeeec-CCCCchH
Confidence 9999999999999999999999999999876543 3355554
|
|
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.8e-17 Score=140.35 Aligned_cols=106 Identities=21% Similarity=0.221 Sum_probs=93.8
Q ss_pred CcchhhhhhccccCcceeeehhhcCCH---HHHHHHHHhcCCCCccccC-CCCCHHHHHHhcCcHHHHHHHHH-cCCCCC
Q 016152 21 SSADKQKEKARVSRTSLILWHAHQNDA---AAVRKLLEEDQSLVHARDY-DNRTPLHVASLHGWIDVAKCLIE-YGADVN 95 (394)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~---~~~~~~L~~~g~~vn~~d~-~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~ 95 (394)
..|++++.+|..|+|++++ |+..++. .+++++|++.|+++|.++. .|+||||+|+..++.+++++|++ .|++++
T Consensus 48 ~~ga~in~~d~~g~T~Lh~-A~~~g~~~~~~~ii~~Ll~~gadin~~~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~ 126 (169)
T PHA02741 48 CHAAALNATDDAGQMCIHI-AAEKHEAQLAAEIIDHLIELGADINAQEMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLH 126 (169)
T ss_pred hhhhhhhccCCCCCcHHHH-HHHcCChHHHHHHHHHHHHcCCCCCCCCcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCC
Confidence 4578999999999998754 3444443 5888999999999999985 99999999999999999999998 599999
Q ss_pred CccCCCCchhhHHHhcChHHHHHHHHhcCCCC
Q 016152 96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLS 127 (394)
Q Consensus 96 ~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~ 127 (394)
.+|.+|+||||+|...++.+++++|+++++..
T Consensus 127 ~~n~~g~tpL~~A~~~~~~~iv~~L~~~~~~~ 158 (169)
T PHA02741 127 FCNADNKSPFELAIDNEDVAMMQILREIVATS 158 (169)
T ss_pred cCCCCCCCHHHHHHHCCCHHHHHHHHHHHHHh
Confidence 99999999999999999999999999988754
|
|
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.8e-17 Score=136.29 Aligned_cols=101 Identities=23% Similarity=0.242 Sum_probs=87.4
Q ss_pred hhhhccccCcceeeehhhcCCH--HHHHHHHHhcCCCCcccc-CCCCCHHHHHHhcCcHHHHHHHHH-cCCCCCCccCCC
Q 016152 26 QKEKARVSRTSLILWHAHQNDA--AAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQDRWK 101 (394)
Q Consensus 26 ~~~~~~~~~~~~~~~~a~~~~~--~~~~~~L~~~g~~vn~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~~~~~~g 101 (394)
++.+|++|.|+++. |+..+.. .+++++|++.|+++|.+| .+|+||||+|+..|+.+++++|+. .|+++|.+|..|
T Consensus 48 ~~~~d~~g~t~Lh~-a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g 126 (154)
T PHA02736 48 VLEYNRHGKQCVHI-VSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAF 126 (154)
T ss_pred HHHhcCCCCEEEEe-ecccCchhHHHHHHHHHHcCCCccccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCC
Confidence 44567888888754 4443332 357889999999999998 499999999999999999999998 599999999999
Q ss_pred CchhhHHHhcChHHHHHHHHhcCCCC
Q 016152 102 NTPLADAEGAKKFNMMELLNAHGGLS 127 (394)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~ga~~ 127 (394)
+||||+|+..++.+++++|+..|++.
T Consensus 127 ~tpL~~A~~~~~~~i~~~Ll~~ga~~ 152 (154)
T PHA02736 127 KTPYYVACERHDAKMMNILRAKGAQC 152 (154)
T ss_pred CCHHHHHHHcCCHHHHHHHHHcCCCC
Confidence 99999999999999999999999865
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.3e-16 Score=140.81 Aligned_cols=139 Identities=22% Similarity=0.237 Sum_probs=106.9
Q ss_pred cceee-cCCceEEEEEEECCccEEEEEeccCC----------CCcHHHHHHHHHHHHHHHhCCCCce--eeEEeEEEeCC
Q 016152 162 SAIIG-KGSFGEILKAYWRGTPVAIKRILPSL----------SDDRLVIQDFRHEVNLLVKLRHPNI--VQFLGAVTERK 228 (394)
Q Consensus 162 ~~~iG-~G~~g~V~~a~~~g~~~avK~l~~~~----------~~~~~~~~~~~~E~~~l~~l~h~~I--v~~~~~~~~~~ 228 (394)
..+|| .|+.|.||.+...+..++||.+.... .........+.+|+.++..+.|++| ++.+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 45687 89999999998889999999874321 1112334567889999999998775 67777643322
Q ss_pred ----eeEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 229 ----PLMLITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 229 ----~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
..++|||+++| .+|.+++.. ..+++.. +.|++.+|.+||+.| |+||||||.|||+ +.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv--~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILL--DPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEE--cCCCCEEEEEC
Confidence 23599999997 699988865 3455543 568999999999998 9999999999999 66778999999
Q ss_pred CCcccc
Q 016152 304 GLSKLI 309 (394)
Q Consensus 304 g~a~~~ 309 (394)
|.+...
T Consensus 187 g~~~~~ 192 (239)
T PRK01723 187 DRGELR 192 (239)
T ss_pred CCcccC
Confidence 988653
|
|
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.7e-17 Score=149.59 Aligned_cols=107 Identities=19% Similarity=0.082 Sum_probs=93.8
Q ss_pred CCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 18 GATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
-.+++|+ +..|.+|.|++++ |+..+..+++++|++.|+++|..+ |+||||+|+..|+.++|++|+++|+++|.+
T Consensus 17 ~Lis~~a--~~~D~~G~TpLh~--Aa~~g~~eiv~~Ll~~ga~~n~~d--~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~ 90 (284)
T PHA02791 17 FLSSKDA--FKADVHGHSALYY--AIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGMDDSQF 90 (284)
T ss_pred HHHhCCC--CCCCCCCCcHHHH--HHHcCCHHHHHHHHHCcCCCcCCC--CCCHHHHHHHCCCHHHHHHHHHCCCCCCCC
Confidence 3455555 4578889998754 777788899999999999998864 799999999999999999999999999999
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcCCCCCCC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQ 130 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~ 130 (394)
|..|+||||+|+..|+.+++++|+++|++++..
T Consensus 91 d~~G~TpLh~Aa~~g~~eivk~Ll~~gadin~~ 123 (284)
T PHA02791 91 DDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFY 123 (284)
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCcc
Confidence 999999999999999999999999999987543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.9e-17 Score=138.29 Aligned_cols=138 Identities=20% Similarity=0.224 Sum_probs=97.1
Q ss_pred cceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHH---------------------HHHHHHHHHhCCCC--ce
Q 016152 162 SAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQD---------------------FRHEVNLLVKLRHP--NI 217 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~--~I 217 (394)
.+.||+|+||.||+|... ++.+|||++............. ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999876 8899999876543221111111 13455556555433 34
Q ss_pred eeEEeEEEeCCeeEEEEeccCCCCHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCCEEEeeCCC
Q 016152 218 VQFLGAVTERKPLMLITEYLRGGDLH-KYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSA 295 (394)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~~~~sL~-~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~ivH~Dikp~Nilv~~~~~ 295 (394)
.++++. ...++||||+.++++. ..+.... . ...+..++.+++.++.++|. .+ |+||||||+||++ + +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili--~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILV--D-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEE--E-C
Confidence 455543 2459999999985432 1121111 1 16678899999999999999 88 9999999999999 5 7
Q ss_pred CcEEEeecCCccccc
Q 016152 296 DHLKVGDFGLSKLIK 310 (394)
Q Consensus 296 ~~~kl~DFg~a~~~~ 310 (394)
+.++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 889999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.5e-17 Score=137.94 Aligned_cols=119 Identities=22% Similarity=0.228 Sum_probs=99.9
Q ss_pred CCCCcchhhhhhccccCcceeeehhhcCCHH---HHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHH---HHHHHHcC
Q 016152 18 GATSSADKQKEKARVSRTSLILWHAHQNDAA---AVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDV---AKCLIEYG 91 (394)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~---~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~---~~~Ll~~g 91 (394)
|.-.++++++..+.++++++ ++||..++.. +++++|.+.|+++|.+|..|+||||+||.+|+.+. +++|+++|
T Consensus 5 ~~~~~~~~~~~~~~~~~~~l-~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~G 83 (166)
T PHA02743 5 GTAGNNLGAVEIDEDEQNTF-LRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMG 83 (166)
T ss_pred cCcccchHHhhhccCCCcHH-HHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcC
Confidence 45568999999998888775 4567777765 45557788999999999999999999999998654 89999999
Q ss_pred CCCCCcc-CCCCchhhHHHhcChHHHHHHHHh-cCCCCCCCCCCCCCC
Q 016152 92 ADVNAQD-RWKNTPLADAEGAKKFNMMELLNA-HGGLSYGQNGSHFEP 137 (394)
Q Consensus 92 a~~~~~~-~~g~t~l~~A~~~~~~~~~~~L~~-~ga~~~~~~~s~~~p 137 (394)
+++|.+| ..|+||||+|+..++.+++++|+. .|+++...+....+|
T Consensus 84 adin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~tp 131 (166)
T PHA02743 84 ADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAINYQHETA 131 (166)
T ss_pred CCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcCCCCCCH
Confidence 9999998 589999999999999999999995 798887665544444
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.3e-17 Score=161.06 Aligned_cols=114 Identities=29% Similarity=0.325 Sum_probs=103.4
Q ss_pred CCCCCCcchhhhhhccc-cCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCC
Q 016152 16 KGGATSSADKQKEKARV-SRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94 (394)
Q Consensus 16 ~~~~~~~~~~~~~~~~~-~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~ 94 (394)
.+.++..|++++..+.. |.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++||++
T Consensus 150 v~~Ll~~gadin~~~~~~g~tpLh~--A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~i 227 (477)
T PHA02878 150 TKLLLSYGADINMKDRHKGNTALHY--ATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGAST 227 (477)
T ss_pred HHHHHHcCCCCCccCCCCCCCHHHH--HHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCC
Confidence 34466789999999998 8888754 77778889999999999999999999999999999999999999999999999
Q ss_pred CCccCCCCchhhHHHhc-ChHHHHHHHHhcCCCCCCCC
Q 016152 95 NAQDRWKNTPLADAEGA-KKFNMMELLNAHGGLSYGQN 131 (394)
Q Consensus 95 ~~~~~~g~t~l~~A~~~-~~~~~~~~L~~~ga~~~~~~ 131 (394)
|.+|..|+||||+|+.. ++.+++++|++.|++++..+
T Consensus 228 n~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~ 265 (477)
T PHA02878 228 DARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKS 265 (477)
T ss_pred CCCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccC
Confidence 99999999999999975 68999999999999987654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8e-17 Score=153.92 Aligned_cols=164 Identities=32% Similarity=0.485 Sum_probs=133.6
Q ss_pred HHhCCCCceeeEEeEEEeCCeeEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCC
Q 016152 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 287 (394)
Q Consensus 209 l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~N 287 (394)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. .-.++......+++++++||.|+|.-. ...|+.+++.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeecccc
Confidence 3568899999999999999999999999999999999987 446888999999999999999999974 23999999999
Q ss_pred EEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCC---C----CCCcchHHHHHHHHHHHHcCC
Q 016152 288 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR---K----YDKKVDVFSFAMILYEMLEGE 360 (394)
Q Consensus 288 ilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~~~~~DvwslGv~l~el~~g~ 360 (394)
.++ +....+||+|||+......... ........-..-|.|||.+... . .+.+.|+||+|++++|+++.+
T Consensus 80 Clv--d~~w~lklt~~Gl~~~~~~~~~--~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 80 CLV--DSRWVLKLTDFGLNSLLEETAE--PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred cee--eeeEEEEechhhhccccccccc--ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999 9999999999999887653110 0011112234569999998753 1 467899999999999999999
Q ss_pred CCCCCC----CHHHHHHHHHc
Q 016152 361 PPLANY----EPYEAAKYVAE 377 (394)
Q Consensus 361 ~Pf~~~----~~~~~~~~i~~ 377 (394)
.||+.. ++.|+..++..
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK 176 (484)
T ss_pred CccccccccCChHHHHHHHHh
Confidence 999763 34577777776
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.7e-17 Score=155.83 Aligned_cols=119 Identities=23% Similarity=0.229 Sum_probs=104.4
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
.+++|+++|+...+.+.+++|| |+++++..++++|+++|||++.+|.+|.||||+||..|+.-+|-+||.+|+|+|.+|
T Consensus 97 li~~gadvn~~gG~l~stPLHW-Aar~G~~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~D 175 (600)
T KOG0509|consen 97 LISHGADVNAIGGVLGSTPLHW-AARNGHISVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLRD 175 (600)
T ss_pred HHHcCCCccccCCCCCCCcchH-HHHcCcHHHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCcC
Confidence 5789999999996666555555 556778889999999999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCCCCCCC-CCCCCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN-GSHFEPK 138 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~-~s~~~p~ 138 (394)
.+|+||||||+..|+...+..|+..|+.+...+ ....+|.
T Consensus 176 ~~grTpLmwAaykg~~~~v~~LL~f~a~~~~~d~~~g~TpL 216 (600)
T KOG0509|consen 176 NNGRTPLMWAAYKGFALFVRRLLKFGASLLLTDDNHGNTPL 216 (600)
T ss_pred CCCCCHHHHHHHhcccHHHHHHHHhcccccccccccCCchH
Confidence 999999999999999888999999999887665 4444443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-16 Score=131.09 Aligned_cols=135 Identities=21% Similarity=0.227 Sum_probs=111.5
Q ss_pred ccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC--CceeeEEeEEEeCCeeEEEEeccC
Q 016152 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGAVTERKPLMLITEYLR 238 (394)
Q Consensus 161 ~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~~~~~~~~~~~~~lv~e~~~ 238 (394)
+.+.||+|.++.||++...+..+++|....... ...+..|+.+++.+++ ..+++++.++...+..+++|||+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 356799999999999999888999998754432 3567889999999976 589999988888788999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC-CCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP-NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 239 ~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~-~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
++++..+ +......++.+++++|.++|... .+++|+|++|+||++ ++.+.++++|||.+...
T Consensus 77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~--~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV--DDGKILGIIDWEYAGYG 139 (155)
T ss_pred CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE--ECCcEEEEEecccccCC
Confidence 8777654 45667778899999999999842 239999999999999 56788999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.7e-17 Score=136.13 Aligned_cols=111 Identities=22% Similarity=0.166 Sum_probs=91.7
Q ss_pred hhhhhccccCcceeeehhhcCCHHHHHHHHH------hcCCCCccccCCCCCHHHHHHhcCc----HHHHHHHHHcCCCC
Q 016152 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLE------EDQSLVHARDYDNRTPLHVASLHGW----IDVAKCLIEYGADV 94 (394)
Q Consensus 25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~------~~g~~vn~~d~~g~t~Lh~A~~~~~----~~~~~~Ll~~ga~~ 94 (394)
.++.++.+|.|+++. |++.+..+++++|+ ..|+++|.+|..|+||||+|+..|+ .+++++|+++|+++
T Consensus 13 ~~~~~~~~g~t~Lh~--Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadi 90 (169)
T PHA02741 13 MIAEKNSEGENFFHE--AARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADI 90 (169)
T ss_pred HhhccccCCCCHHHH--HHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCC
Confidence 356677888888754 66666666766653 3478999999999999999999999 58999999999999
Q ss_pred CCccC-CCCchhhHHHhcChHHHHHHHHh-cCCCCCCCCCCCCCC
Q 016152 95 NAQDR-WKNTPLADAEGAKKFNMMELLNA-HGGLSYGQNGSHFEP 137 (394)
Q Consensus 95 ~~~~~-~g~t~l~~A~~~~~~~~~~~L~~-~ga~~~~~~~s~~~p 137 (394)
|.+|. .|+||||+|+..++.+++++|+. .|++++..+....+|
T Consensus 91 n~~~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~tp 135 (169)
T PHA02741 91 NAQEMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKSP 135 (169)
T ss_pred CCCCcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCCH
Confidence 99995 99999999999999999999997 588877665544444
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.4e-17 Score=152.50 Aligned_cols=89 Identities=25% Similarity=0.162 Sum_probs=78.4
Q ss_pred hhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcC--------
Q 016152 41 HAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAK-------- 112 (394)
Q Consensus 41 ~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~-------- 112 (394)
.|+.++..+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|||+|.+|..|+||||+|+..|
T Consensus 194 ~a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa~~g~~~~~~~~ 273 (437)
T PHA02795 194 LVDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCLDVAVDRGSVIARRET 273 (437)
T ss_pred HHHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCCccccccc
Confidence 366777889999999999999999999999999999999999999999999999999999999999999888
Q ss_pred hHHHHHHHHhcCCCCCC
Q 016152 113 KFNMMELLNAHGGLSYG 129 (394)
Q Consensus 113 ~~~~~~~L~~~ga~~~~ 129 (394)
+.+++++|++.|+++..
T Consensus 274 ~~eIvelLL~~gadI~~ 290 (437)
T PHA02795 274 HLKILEILLREPLSIDC 290 (437)
T ss_pred HHHHHHHHHhCCCCCCc
Confidence 46899999998887653
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.4e-17 Score=157.92 Aligned_cols=117 Identities=26% Similarity=0.306 Sum_probs=105.1
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
.+..|++++.++..|.|+++. |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|
T Consensus 110 ll~~g~d~n~~~~~g~T~Lh~--A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~ 187 (434)
T PHA02874 110 ILDCGIDVNIKDAELKTFLHY--AIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKD 187 (434)
T ss_pred HHHCcCCCCCCCCCCccHHHH--HHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCC
Confidence 456788999999999998754 777778889999999999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
..|+||||+|+..|+.+++++|++.|+++...+....+|
T Consensus 188 ~~g~tpL~~A~~~g~~~iv~~Ll~~g~~i~~~~~~g~Tp 226 (434)
T PHA02874 188 NNGESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGFTP 226 (434)
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHhCCCCCcCCCCCCCCH
Confidence 999999999999999999999999999887665544443
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=139.72 Aligned_cols=110 Identities=16% Similarity=0.130 Sum_probs=92.3
Q ss_pred hhhhccccCcceeeehhhc-CCHHHHHHHHHhcCCCCcccc-CCCCCHHHHHHhc---CcHHHHHHHHHcCCCCCCccCC
Q 016152 26 QKEKARVSRTSLILWHAHQ-NDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLH---GWIDVAKCLIEYGADVNAQDRW 100 (394)
Q Consensus 26 ~~~~~~~~~~~~~~~~a~~-~~~~~~~~~L~~~g~~vn~~d-~~g~t~Lh~A~~~---~~~~~~~~Ll~~ga~~~~~~~~ 100 (394)
.+..++.|.|+++. |+.. .+..+++++|++.|+++|.++ ..|+||||+|+.. ++.+++++|+++|||+|.+|..
T Consensus 44 ~n~~~~~g~TpLh~-a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~ 122 (209)
T PHA02859 44 VNDCNDLYETPIFS-CLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDED 122 (209)
T ss_pred hhccCccCCCHHHH-HHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCC
Confidence 56778889998864 3332 347899999999999999997 4899999998864 4799999999999999999999
Q ss_pred CCchhhHHHh--cChHHHHHHHHhcCCCCCCCCCCCCC
Q 016152 101 KNTPLADAEG--AKKFNMMELLNAHGGLSYGQNGSHFE 136 (394)
Q Consensus 101 g~t~l~~A~~--~~~~~~~~~L~~~ga~~~~~~~s~~~ 136 (394)
|.||||+|+. .++.+++++|++.|++++..+....+
T Consensus 123 G~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d~~g~t 160 (209)
T PHA02859 123 GKNLLHMYMCNFNVRINVIKLLIDSGVSFLNKDFDNNN 160 (209)
T ss_pred CCCHHHHHHHhccCCHHHHHHHHHcCCCcccccCCCCc
Confidence 9999999876 46899999999999998766544433
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.8e-17 Score=130.39 Aligned_cols=99 Identities=30% Similarity=0.285 Sum_probs=89.1
Q ss_pred cchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCC
Q 016152 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (394)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (394)
..-.+|.+|.++.|++|- |+++++..+++.|+..||+++++...||||||-||.+++.+++-+||.+|||||+..+..
T Consensus 86 ~an~vNtrD~D~YTpLHR--AaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va~~LLqhgaDVnA~t~g~ 163 (228)
T KOG0512|consen 86 KANHVNTRDEDEYTPLHR--AAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVAGRLLQHGADVNAQTKGL 163 (228)
T ss_pred ccccccccccccccHHHH--HHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHHHHHHhccCccccccccc
Confidence 345689999999999876 889999999999999999999999999999999999999999999999999999999999
Q ss_pred CchhhHHHhcChH-HHHHHHHh
Q 016152 102 NTPLADAEGAKKF-NMMELLNA 122 (394)
Q Consensus 102 ~t~l~~A~~~~~~-~~~~~L~~ 122 (394)
+||||+|+...+. ..+.+|+.
T Consensus 164 ltpLhlaa~~rn~r~t~~~Ll~ 185 (228)
T KOG0512|consen 164 LTPLHLAAGNRNSRDTLELLLH 185 (228)
T ss_pred chhhHHhhcccchHHHHHHHhh
Confidence 9999999987655 44555554
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.1e-17 Score=168.38 Aligned_cols=119 Identities=21% Similarity=0.167 Sum_probs=103.3
Q ss_pred CCCCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHh----------------
Q 016152 14 PCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASL---------------- 77 (394)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~---------------- 77 (394)
.+.+.++..|+++|..|.+|+|++|+ |+..++.+++++|+++|+|+|.+|.+|+||||+|+.
T Consensus 539 ~~l~~Ll~~G~d~n~~d~~G~TpLh~--Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~~~iv~~L~~~~~~ 616 (823)
T PLN03192 539 ALLEELLKAKLDPDIGDSKGRTPLHI--AASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHKIFRILYHFASI 616 (823)
T ss_pred HHHHHHHHCCCCCCCCCCCCCCHHHH--HHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHhcCcc
Confidence 34445677899999999999999865 777788999999999999999999999999986554
Q ss_pred ---------------cCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCC
Q 016152 78 ---------------HGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSH 134 (394)
Q Consensus 78 ---------------~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~ 134 (394)
+|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++..+...
T Consensus 617 ~~~~~~~~~L~~Aa~~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~~~~~~g 688 (823)
T PLN03192 617 SDPHAAGDLLCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDKANTDD 688 (823)
T ss_pred cCcccCchHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCCCCCC
Confidence 455566777889999999999999999999999999999999999999998766544
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=7e-17 Score=159.89 Aligned_cols=117 Identities=20% Similarity=0.148 Sum_probs=104.0
Q ss_pred CCCCCCCCCcchhhhhhccccCcceeeehhhc-----CCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcC---cHHHH
Q 016152 13 TPCKGGATSSADKQKEKARVSRTSLILWHAHQ-----NDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG---WIDVA 84 (394)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~-----~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~---~~~~~ 84 (394)
..+.+-++.+|+++|..|.+|.|+++. ++. .+..+++++|+++|+|+|.+|.+|+||||+|+.++ +.+++
T Consensus 51 ~~iv~~Ll~~Gadvn~~d~~g~TpL~~--~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv 128 (489)
T PHA02798 51 TDIVKLFINLGANVNGLDNEYSTPLCT--ILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEIL 128 (489)
T ss_pred HHHHHHHHHCCCCCCCCCCCCCChHHH--HHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHH
Confidence 344556788999999999999999855 332 25689999999999999999999999999999875 78999
Q ss_pred HHHHHcCCCCCCccCCCCchhhHHHhcCh---HHHHHHHHhcCCCCCCCC
Q 016152 85 KCLIEYGADVNAQDRWKNTPLADAEGAKK---FNMMELLNAHGGLSYGQN 131 (394)
Q Consensus 85 ~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~---~~~~~~L~~~ga~~~~~~ 131 (394)
++|+++|||+|.+|.+|.||||+|+..++ .+++++|++.|++++..+
T Consensus 129 ~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~~ 178 (489)
T PHA02798 129 LFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTHN 178 (489)
T ss_pred HHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCccccc
Confidence 99999999999999999999999999987 999999999999987553
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.4e-17 Score=162.14 Aligned_cols=121 Identities=13% Similarity=0.042 Sum_probs=97.3
Q ss_pred CCCCCcc-hhhhhh-ccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCc--HHHHHHHHHcCC
Q 016152 17 GGATSSA-DKQKEK-ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW--IDVAKCLIEYGA 92 (394)
Q Consensus 17 ~~~~~~~-~~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~--~~~~~~Ll~~ga 92 (394)
+-+++.| +++|.+ |..|.|+++..++...+..+++++|++.|+++|.+|..|+||||+|+..|+ .++|++|+++||
T Consensus 159 k~LLe~G~ADIN~~~d~~G~TpLH~A~~n~~~~~eIVklLLe~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GA 238 (764)
T PHA02716 159 KYMVDVGIVNLNYVCKKTGYGILHAYLGNMYVDIDILEWLCNNGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGG 238 (764)
T ss_pred HHHHHCCCCCcccccCCCCCcHHHHHHHhccCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCC
Confidence 3467788 999998 888888886422233456789999999999999999999999999999995 599999999999
Q ss_pred CCCCccCCCCchhhHHH-------------------------------------hcChHHHHHHHHhcCCCCCCCCCCCC
Q 016152 93 DVNAQDRWKNTPLADAE-------------------------------------GAKKFNMMELLNAHGGLSYGQNGSHF 135 (394)
Q Consensus 93 ~~~~~~~~g~t~l~~A~-------------------------------------~~~~~~~~~~L~~~ga~~~~~~~s~~ 135 (394)
|+|.+|..|+||||.|+ ..|+.+++++|++.|++++..+....
T Consensus 239 DVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~ 318 (764)
T PHA02716 239 DMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNKVKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGR 318 (764)
T ss_pred CCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhccccccccchhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCC
Confidence 99999999999999753 34566777777777777765554444
Q ss_pred CC
Q 016152 136 EP 137 (394)
Q Consensus 136 ~p 137 (394)
+|
T Consensus 319 TP 320 (764)
T PHA02716 319 TC 320 (764)
T ss_pred CH
Confidence 43
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.1e-16 Score=155.85 Aligned_cols=119 Identities=18% Similarity=0.089 Sum_probs=95.5
Q ss_pred CCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCc--HHHHHHHHHcCCC
Q 016152 16 KGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW--IDVAKCLIEYGAD 93 (394)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~--~~~~~~Ll~~ga~ 93 (394)
.+-+++.|+++|.+|.+|.|++++ |+..+..+++++|+++|+++|.+|.+|+||||+|+..++ .+++++|+++||+
T Consensus 55 v~~Ll~~Gadvn~~d~~G~TpLh~--Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gad 132 (446)
T PHA02946 55 VEELLHRGYSPNETDDDGNYPLHI--ASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAK 132 (446)
T ss_pred HHHHHHCcCCCCccCCCCCCHHHH--HHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCC
Confidence 334667889999999999888754 666777888888889999999999999999999887654 7889999999999
Q ss_pred CCC-ccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 94 VNA-QDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 94 ~~~-~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
+|. .|..|.|||| |+..++.+++++|++.|++++..+....+|
T Consensus 133 in~~~d~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~G~t~ 176 (446)
T PHA02946 133 INNSVDEEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDKFGKNH 176 (446)
T ss_pred cccccCCCCCcHHH-HHHCCChHHHHHHHhccccccccCCCCCCH
Confidence 985 6888889987 556688888888888888877666554444
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.3e-16 Score=157.63 Aligned_cols=121 Identities=26% Similarity=0.222 Sum_probs=105.6
Q ss_pred CCCCCCCcchhhhhhccccCcceeeehhhcC---CHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcC-cHHHHHHHHHc
Q 016152 15 CKGGATSSADKQKEKARVSRTSLILWHAHQN---DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG-WIDVAKCLIEY 90 (394)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~---~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~-~~~~~~~Ll~~ 90 (394)
..+-++..|++++.++..|.|+++. |+.. +..+++++|++.|+++|.+|..|+||||+|+..| +.+++++|+++
T Consensus 29 ~v~~Ll~~ga~vn~~~~~g~t~Lh~--a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~lLl~~ 106 (471)
T PHA03095 29 EVRRLLAAGADVNFRGEYGKTPLHL--YLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKA 106 (471)
T ss_pred HHHHHHHcCCCcccCCCCCCCHHHH--HHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHHHHHHc
Confidence 3445778899999999999998855 4443 4899999999999999999999999999999999 59999999999
Q ss_pred CCCCCCccCCCCchhhHHH--hcChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 91 GADVNAQDRWKNTPLADAE--GAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 91 ga~~~~~~~~g~t~l~~A~--~~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
||++|.+|..|+||||+|+ ..++.+++++|++.|++++..+....+|
T Consensus 107 ga~in~~~~~g~tpLh~a~~~~~~~~~iv~~Ll~~gad~~~~d~~g~tp 155 (471)
T PHA03095 107 GADVNAKDKVGRTPLHVYLSGFNINPKVIRLLLRKGADVNALDLYGMTP 155 (471)
T ss_pred CCCCCCCCCCCCCHHHHHhhCCcCCHHHHHHHHHcCCCCCccCCCCCCH
Confidence 9999999999999999999 5668899999999999988766655444
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.1e-16 Score=161.34 Aligned_cols=120 Identities=13% Similarity=0.008 Sum_probs=102.9
Q ss_pred CCCCcchhhhhhccccCcceeeehhhcCC-HHHHHHHHHhcCCCCccccCCCCCHHHHH---------------------
Q 016152 18 GATSSADKQKEKARVSRTSLILWHAHQND-AAAVRKLLEEDQSLVHARDYDNRTPLHVA--------------------- 75 (394)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~a~~~~-~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A--------------------- 75 (394)
-++++|+++|.+|.+|.||++. |+..++ ..+++++|++.|||+|.+|..|+||||+|
T Consensus 197 lLLe~GADVN~kD~~G~TPLH~-Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~ 275 (764)
T PHA02716 197 WLCNNGVNVNLQNNHLITPLHT-YLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDG 275 (764)
T ss_pred HHHHcCCCCCCCCCCCCCHHHH-HHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhccc
Confidence 3677999999999999998854 444443 46899999999999999999999999975
Q ss_pred ----------------HhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHh--cChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 76 ----------------SLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG--AKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 76 ----------------~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~--~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
+..|+.+++++|+++||++|.+|..|+||||+|+. .++.+++++|++.|++++..+....+|
T Consensus 276 n~~~~~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD~~G~TP 355 (764)
T PHA02716 276 NKVKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPDNIGNTV 355 (764)
T ss_pred cccccchhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCCCCCCCH
Confidence 44578899999999999999999999999999764 468899999999999998877766666
Q ss_pred C
Q 016152 138 K 138 (394)
Q Consensus 138 ~ 138 (394)
.
T Consensus 356 L 356 (764)
T PHA02716 356 L 356 (764)
T ss_pred H
Confidence 4
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.9e-16 Score=156.40 Aligned_cols=118 Identities=25% Similarity=0.215 Sum_probs=105.4
Q ss_pred CCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhc-CcHHHHHHHHHcCCCCC
Q 016152 17 GGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLH-GWIDVAKCLIEYGADVN 95 (394)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~-~~~~~~~~Ll~~ga~~~ 95 (394)
+-++..|++++..|..|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+.. ++.+++++|+++|+|+|
T Consensus 185 ~~Ll~~gad~n~~d~~g~tpLh~--A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn 262 (477)
T PHA02878 185 ELLLSYGANVNIPDKTNNSPLHH--AVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVN 262 (477)
T ss_pred HHHHHCCCCCCCcCCCCCCHHHH--HHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCC
Confidence 33677899999999999999865 7777889999999999999999999999999999976 78999999999999999
Q ss_pred CccC-CCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCC
Q 016152 96 AQDR-WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (394)
Q Consensus 96 ~~~~-~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~ 138 (394)
.++. .|.||||+| .++.+++++|+++|++++..+....+|.
T Consensus 263 ~~~~~~g~TpLh~A--~~~~~~v~~Ll~~gadin~~d~~g~TpL 304 (477)
T PHA02878 263 AKSYILGLTALHSS--IKSERKLKLLLEYGADINSLNSYKLTPL 304 (477)
T ss_pred ccCCCCCCCHHHHH--ccCHHHHHHHHHCCCCCCCcCCCCCCHH
Confidence 9986 799999999 5678999999999999998877666654
|
|
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.9e-16 Score=144.06 Aligned_cols=106 Identities=23% Similarity=0.205 Sum_probs=92.7
Q ss_pred CCCCCCCcchhhhhhc----cccCcceeeehhhcCCHHHHHHHHHhcCCCCccc-cCCCCCHHHHHHhcCcHHHHHHHHH
Q 016152 15 CKGGATSSADKQKEKA----RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHAR-DYDNRTPLHVASLHGWIDVAKCLIE 89 (394)
Q Consensus 15 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~-d~~g~t~Lh~A~~~~~~~~~~~Ll~ 89 (394)
..+-++.+|+++|.++ .+|.|+++. |+..+..+++++|+++|||+|.+ +..|.||||+|+..++.+++++|++
T Consensus 48 ivk~LL~~GAdiN~~~~~sd~~g~TpLh~--Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~~~eivklLL~ 125 (300)
T PHA02884 48 IIDAILKLGADPEAPFPLSENSKTNPLIY--AIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHGCLKCLEILLS 125 (300)
T ss_pred HHHHHHHCCCCccccCcccCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcCCHHHHHHHHH
Confidence 3445778999999874 578888754 66777889999999999999996 4689999999999999999999999
Q ss_pred cCCCCCCccCCCCchhhHHHhcChHHHHHHHHh
Q 016152 90 YGADVNAQDRWKNTPLADAEGAKKFNMMELLNA 122 (394)
Q Consensus 90 ~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~ 122 (394)
+|||+|.+|.+|+||||+|+..++.+++..+..
T Consensus 126 ~GAdin~kd~~G~TpL~~A~~~~~~~~~~~~~~ 158 (300)
T PHA02884 126 YGADINIQTNDMVTPIELALMICNNFLAFMICD 158 (300)
T ss_pred CCCCCCCCCCCCCCHHHHHHHhCChhHHHHhcC
Confidence 999999999999999999999898888876653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.7e-17 Score=155.78 Aligned_cols=143 Identities=29% Similarity=0.503 Sum_probs=112.9
Q ss_pred eeEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 229 PLMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
.+|+.|++|+..+|.+++..+. ..+....+.++.|++.+++| ++ .+|+|+||.||+. ..+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~--~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFF--SDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhcccccccc--ccchhhhhhhhhh
Confidence 4799999999999999997543 36778889999999999999 77 8999999999998 6666899999999
Q ss_pred ccccccccc--cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC
Q 016152 306 SKLIKVQNS--HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 306 a~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
.+....... ..........||..||+||.+.+..|+.++||||||++|+||+. =..+| .......-|..|..|
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip 478 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGIIP 478 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCC
Confidence 887664441 11123456789999999999999999999999999999999987 22222 222334455566666
|
|
| >PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-16 Score=108.72 Aligned_cols=55 Identities=42% Similarity=0.484 Sum_probs=33.7
Q ss_pred HHhcC-CCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHH
Q 016152 54 LEEDQ-SLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108 (394)
Q Consensus 54 L~~~g-~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A 108 (394)
|++.| +++|.+|..|.||||+||.+|+.++|++|++.|+|++.+|.+|+||||+|
T Consensus 1 LL~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A 56 (56)
T PF13857_consen 1 LLEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA 56 (56)
T ss_dssp -----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred CCccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence 45667 89999999999999999999999999999999999999999999999997
|
|
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-16 Score=157.21 Aligned_cols=111 Identities=14% Similarity=0.142 Sum_probs=76.2
Q ss_pred CCCCCCcchhhhhhccccCcceeeehhhc------CCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhc---CcHHHHHH
Q 016152 16 KGGATSSADKQKEKARVSRTSLILWHAHQ------NDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLH---GWIDVAKC 86 (394)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~a~~------~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~---~~~~~~~~ 86 (394)
.+-++.+|+++|.++ .+.|+++ +|+. .+..+++++|+++|+|+|.+|..|+||||.|+.. |+.+++++
T Consensus 53 v~~Ll~~GAdvn~~~-~~~tpL~--~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~ 129 (494)
T PHA02989 53 VKLLIDNGADVNYKG-YIETPLC--AVLRNREITSNKIKKIVKLLLKFGADINLKTFNGVSPIVCFIYNSNINNCDMLRF 129 (494)
T ss_pred HHHHHHcCCCccCCC-CCCCcHH--HHHhccCcchhhHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHH
Confidence 444666777777664 4556553 2322 2346677777777777777777777777776654 56777777
Q ss_pred HHHcCCCC-CCccCCCCchhhHHHhc--ChHHHHHHHHhcCCCCCC
Q 016152 87 LIEYGADV-NAQDRWKNTPLADAEGA--KKFNMMELLNAHGGLSYG 129 (394)
Q Consensus 87 Ll~~ga~~-~~~~~~g~t~l~~A~~~--~~~~~~~~L~~~ga~~~~ 129 (394)
|+++|||+ +.+|..|+||||+|+.. ++.+++++|+++|++++.
T Consensus 130 Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~ 175 (494)
T PHA02989 130 LLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFE 175 (494)
T ss_pred HHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccc
Confidence 77777777 67777777887776543 467777777777777665
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.4e-16 Score=159.42 Aligned_cols=112 Identities=19% Similarity=0.131 Sum_probs=98.1
Q ss_pred CCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccC---CC-----------CCHHHHHHh----
Q 016152 16 KGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDY---DN-----------RTPLHVASL---- 77 (394)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~---~g-----------~t~Lh~A~~---- 77 (394)
.+-++++|+++|.+|..|.|+++.++++.+++.+++++|+++|+++|.+|. .| .||||+|+.
T Consensus 119 vk~Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~~d~~~~~g~~~~~~~~~~~~t~L~~a~~~~~~ 198 (661)
T PHA02917 119 IKVLVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLYEDEDDEYGYAYDDYQPRNCGTVLHLYIISHLY 198 (661)
T ss_pred HHHHHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccccccccccccccccccccccccHHHHHHhhccc
Confidence 344778999999999999999987677788999999999999999987653 34 599999986
Q ss_pred -------cCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChH--HHHHHHHhcCCCCC
Q 016152 78 -------HGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF--NMMELLNAHGGLSY 128 (394)
Q Consensus 78 -------~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~--~~~~~L~~~ga~~~ 128 (394)
+++.++|++|+++|||+|.+|.+|.||||+|+..|+. ++|++|++ |+++.
T Consensus 199 ~~~~~~~~~~~eiv~~Li~~Gadvn~~d~~G~TpLh~A~~~g~~~~eivk~Li~-g~d~~ 257 (661)
T PHA02917 199 SESDTRAYVRPEVVKCLINHGIKPSSIDKNYCTALQYYIKSSHIDIDIVKLLMK-GIDNT 257 (661)
T ss_pred ccccccccCcHHHHHHHHHCCCCcccCCCCCCcHHHHHHHcCCCcHHHHHHHHh-CCccc
Confidence 5689999999999999999999999999999999985 79999975 77654
|
|
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.4e-16 Score=150.07 Aligned_cols=101 Identities=24% Similarity=0.159 Sum_probs=84.3
Q ss_pred hccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHH
Q 016152 29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108 (394)
Q Consensus 29 ~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A 108 (394)
.+.+|.|++++ |+..+..+++++|++.|+++|.++.+|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|
T Consensus 98 ~~~~g~tpL~~--A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A 175 (413)
T PHA02875 98 FYKDGMTPLHL--ATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIA 175 (413)
T ss_pred ccCCCCCHHHH--HHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Confidence 34556676643 5566677888888889999999888999999999999999999999999999999999999999999
Q ss_pred HhcChHHHHHHHHhcCCCCCCCC
Q 016152 109 EGAKKFNMMELLNAHGGLSYGQN 131 (394)
Q Consensus 109 ~~~~~~~~~~~L~~~ga~~~~~~ 131 (394)
+..|+.+++++|++.|++++..+
T Consensus 176 ~~~g~~eiv~~Ll~~ga~~n~~~ 198 (413)
T PHA02875 176 MAKGDIAICKMLLDSGANIDYFG 198 (413)
T ss_pred HHcCCHHHHHHHHhCCCCCCcCC
Confidence 99999999999999988876543
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.1e-16 Score=151.73 Aligned_cols=117 Identities=15% Similarity=0.042 Sum_probs=79.3
Q ss_pred CCCCcchhhhh-hccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCc--HHHHHHHHHcCCCC
Q 016152 18 GATSSADKQKE-KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW--IDVAKCLIEYGADV 94 (394)
Q Consensus 18 ~~~~~~~~~~~-~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~--~~~~~~Ll~~ga~~ 94 (394)
-+++.|++++. .|.+|.|++ +||.. +..+++++|++.|+++|.+|..|+||||+|+..++ .+++++|+++|||+
T Consensus 125 lLl~~Gadin~~~d~~g~tpL--~aa~~-~~~~vv~~Ll~~gad~~~~d~~G~t~Lh~A~~~~~~~~~~v~~Ll~~Gadi 201 (446)
T PHA02946 125 LLVQYGAKINNSVDEEGCGPL--LACTD-PSERVFKKIMSIGFEARIVDKFGKNHIHRHLMSDNPKASTISWMMKLGISP 201 (446)
T ss_pred HHHHcCCCcccccCCCCCcHH--HHHHC-CChHHHHHHHhccccccccCCCCCCHHHHHHHhcCCCHHHHHHHHHcCCCC
Confidence 36667777774 456666665 23443 44566777777777777777777777777766443 57777777777777
Q ss_pred CCccCCCCchhhHHHhcC--hHHHHHHHHhcCCCCCCCCCCCCCCC
Q 016152 95 NAQDRWKNTPLADAEGAK--KFNMMELLNAHGGLSYGQNGSHFEPK 138 (394)
Q Consensus 95 ~~~~~~g~t~l~~A~~~~--~~~~~~~L~~~ga~~~~~~~s~~~p~ 138 (394)
|.+|.+|+||||+|+..+ +.+++++|+. |++++..+....+|.
T Consensus 202 n~~d~~G~TpLH~Aa~~~~~~~~iv~lLl~-gadin~~d~~G~TpL 246 (446)
T PHA02946 202 SKPDHDGNTPLHIVCSKTVKNVDIINLLLP-STDVNKQNKFGDSPL 246 (446)
T ss_pred cccCCCCCCHHHHHHHcCCCcHHHHHHHHc-CCCCCCCCCCCCCHH
Confidence 777777777777777664 6677777764 677776666665554
|
|
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.2e-16 Score=151.33 Aligned_cols=110 Identities=19% Similarity=0.157 Sum_probs=101.0
Q ss_pred CCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 18 GATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
-++..|++++..+.+|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++||++|..
T Consensus 120 ~Ll~~gad~~~~~~~g~tpLh~--A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga~~n~~ 197 (413)
T PHA02875 120 LLIARGADPDIPNTDKFSPLHL--AVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANIDYF 197 (413)
T ss_pred HHHhCCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcC
Confidence 3667899999999999998854 66777788999999999999999999999999999999999999999999999999
Q ss_pred cCCCC-chhhHHHhcChHHHHHHHHhcCCCCCC
Q 016152 98 DRWKN-TPLADAEGAKKFNMMELLNAHGGLSYG 129 (394)
Q Consensus 98 ~~~g~-t~l~~A~~~~~~~~~~~L~~~ga~~~~ 129 (394)
+..|. ||+|+|+..++.+++++|+++|++++.
T Consensus 198 ~~~~~~t~l~~A~~~~~~~iv~~Ll~~gad~n~ 230 (413)
T PHA02875 198 GKNGCVAALCYAIENNKIDIVRLFIKRGADCNI 230 (413)
T ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHCCcCcch
Confidence 99885 789999999999999999999999864
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.3e-16 Score=153.28 Aligned_cols=119 Identities=19% Similarity=0.099 Sum_probs=88.2
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcH--HHHHHHHHcCCCCCC
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWI--DVAKCLIEYGADVNA 96 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~--~~~~~Ll~~ga~~~~ 96 (394)
++..|++++..|..|.|++++.+....+...++++|++.|++++.+|..|+||||+||..|+. .+++.|++.|+++|.
T Consensus 173 Ll~~g~~~~~~d~~g~t~Lh~~~~~~~~~~~i~~~Ll~~g~~~~~~d~~g~tpLh~Aa~~~~~~~~~v~~ll~~g~din~ 252 (471)
T PHA03095 173 LIDAGADVYAVDDRFRSLLHHHLQSFKPRARIVRELIRAGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINA 252 (471)
T ss_pred HHHcCCCCcccCCCCCCHHHHHHHHCCCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHhcCCchHHHHHHHHHcCCCCCC
Confidence 455677777776677777655444445667777777788888888888888888888887764 577778888888888
Q ss_pred ccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 97 QDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 97 ~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
+|..|+||||+|+..|+.+++++|++.|++++..+....+|
T Consensus 253 ~d~~g~TpLh~A~~~~~~~~v~~LL~~gad~n~~~~~g~tp 293 (471)
T PHA03095 253 RNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDGNTP 293 (471)
T ss_pred cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCH
Confidence 88888888888888888888888888888877665554444
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=8e-16 Score=152.37 Aligned_cols=114 Identities=19% Similarity=0.240 Sum_probs=97.3
Q ss_pred CCCCcchhhhhhccccCcceeeehhh--cCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcC--cHHHHHHHHHcCCC
Q 016152 18 GATSSADKQKEKARVSRTSLILWHAH--QNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG--WIDVAKCLIEYGAD 93 (394)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~a~--~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~--~~~~~~~Ll~~ga~ 93 (394)
-++..|++++..|..|.|+++. |+ ..+..+++++|++.|++++..|..|.||||+|+..| +.+++++|+++|++
T Consensus 91 ~Ll~~ga~i~~~d~~g~tpL~~--A~~~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~d 168 (480)
T PHA03100 91 LLLEYGANVNAPDNNGITPLLY--AISKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVD 168 (480)
T ss_pred HHHHCCCCCCCCCCCCCchhhH--HHhcccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCC
Confidence 3566788888888888888754 55 778888888898999999999999999999999999 89999999999999
Q ss_pred CCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCC
Q 016152 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (394)
Q Consensus 94 ~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s 133 (394)
+|.+|..|.||||+|+..|+.+++++|+++|++++..+..
T Consensus 169 in~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~ 208 (480)
T PHA03100 169 INAKNRYGYTPLHIAVEKGNIDVIKFLLDNGADINAGDIE 208 (480)
T ss_pred cccccCCCCCHHHHHHHhCCHHHHHHHHHcCCCccCCCCC
Confidence 9999999999999999999999999999999887755433
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=6.2e-16 Score=153.17 Aligned_cols=111 Identities=19% Similarity=0.147 Sum_probs=81.2
Q ss_pred CCCCCCcchhhhhhccccCcceeeehhhcC---CHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCc---HHHHHHHHH
Q 016152 16 KGGATSSADKQKEKARVSRTSLILWHAHQN---DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW---IDVAKCLIE 89 (394)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~---~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~---~~~~~~Ll~ 89 (394)
.+-++.+|+++|.+|.+|.|+++. |+.+ +..+++++|++.|+++|.+|.+|.||||+|+..++ .+++++|++
T Consensus 92 v~~Ll~~GadiN~~d~~G~TpLh~--a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~ 169 (489)
T PHA02798 92 VKILIENGADINKKNSDGETPLYC--LLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLE 169 (489)
T ss_pred HHHHHHCCCCCCCCCCCcCcHHHH--HHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHH
Confidence 334677899999999999998854 4433 47889999999999999999999999999999887 888888888
Q ss_pred cCCCCCCcc-CCCCchhhHHHhc----ChHHHHHHHHhcCCCCC
Q 016152 90 YGADVNAQD-RWKNTPLADAEGA----KKFNMMELLNAHGGLSY 128 (394)
Q Consensus 90 ~ga~~~~~~-~~g~t~l~~A~~~----~~~~~~~~L~~~ga~~~ 128 (394)
+|+|+|.++ ..|.||||.+... ++.+++++|+++|++++
T Consensus 170 ~gadin~~~~~~~~t~Lh~~~~~~~~~~~~~ivk~Li~~Ga~i~ 213 (489)
T PHA02798 170 KGVDINTHNNKEKYDTLHCYFKYNIDRIDADILKLFVDNGFIIN 213 (489)
T ss_pred hCCCcccccCcCCCcHHHHHHHhccccCCHHHHHHHHHCCCCcc
Confidence 888877664 3455555554432 24555555555554443
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.7e-16 Score=153.40 Aligned_cols=113 Identities=25% Similarity=0.290 Sum_probs=60.9
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCC------CCHHHHHHhcCc--HHHHHHHHHc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDN------RTPLHVASLHGW--IDVAKCLIEY 90 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g------~t~Lh~A~~~~~--~~~~~~Ll~~ 90 (394)
++..|++++..+..|.|+++. |+..+..+++++|++.|++++..+..| .||||+|+..|+ .+++++|+++
T Consensus 162 Ll~~g~din~~d~~g~tpL~~--A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~iv~~Ll~~ 239 (480)
T PHA03100 162 LIDKGVDINAKNRYGYTPLHI--AVEKGNIDVIKFLLDNGADINAGDIETLLFTIFETPLHIAACYNEITLEVVNYLLSY 239 (480)
T ss_pred HHHCCCCcccccCCCCCHHHH--HHHhCCHHHHHHHHHcCCCccCCCCCCCcHHHHHhHHHHHHHhCcCcHHHHHHHHHc
Confidence 344455555555555554432 444444555555555555555555555 555555555555 5555555555
Q ss_pred CCCCCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCC
Q 016152 91 GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (394)
Q Consensus 91 ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s 133 (394)
|+++|.+|..|.||||+|+..++.+++++|++.|++++..+..
T Consensus 240 g~din~~d~~g~TpL~~A~~~~~~~iv~~Ll~~gad~n~~d~~ 282 (480)
T PHA03100 240 GVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKY 282 (480)
T ss_pred CCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCC
Confidence 5555555666666666666666666666666666655544433
|
|
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.1e-16 Score=153.39 Aligned_cols=113 Identities=12% Similarity=0.070 Sum_probs=67.9
Q ss_pred CCCCCcchhhhhhccccCcceeeeh-hhcCCHHHHHHHHHhcCCCC-ccccCCCCCHHHHHHhc--CcHHHHHHHHHcCC
Q 016152 17 GGATSSADKQKEKARVSRTSLILWH-AHQNDAAAVRKLLEEDQSLV-HARDYDNRTPLHVASLH--GWIDVAKCLIEYGA 92 (394)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~-a~~~~~~~~~~~L~~~g~~v-n~~d~~g~t~Lh~A~~~--~~~~~~~~Ll~~ga 92 (394)
+.++.+|+++|.+|.+|.|+++..+ ++..+..+++++|+++|+|+ +.+|..|+||||+|+.. ++.++|++|+++||
T Consensus 92 ~~Ll~~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Ga 171 (494)
T PHA02989 92 KLLLKFGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGV 171 (494)
T ss_pred HHHHHCCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCC
Confidence 3456677777777777766664311 12234566667777777777 56666777777766543 45666666666666
Q ss_pred CCCC-ccCCCCchhhHHHhcC----hHHHHHHHHhcCCCCCC
Q 016152 93 DVNA-QDRWKNTPLADAEGAK----KFNMMELLNAHGGLSYG 129 (394)
Q Consensus 93 ~~~~-~~~~g~t~l~~A~~~~----~~~~~~~L~~~ga~~~~ 129 (394)
|++. .+..|.||||+|+..+ +.+++++|++.|++++.
T Consensus 172 di~~~~~~~g~tpL~~a~~~~~~~~~~~iv~~Ll~~Ga~vn~ 213 (494)
T PHA02989 172 NLFEKTSLYGLTPMNIYLRNDIDVISIKVIKYLIKKGVNIET 213 (494)
T ss_pred CccccccccCCChHHHHHhcccccccHHHHHHHHhCCCCccc
Confidence 6665 4555666666554432 55666666666655543
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.6e-16 Score=149.67 Aligned_cols=92 Identities=21% Similarity=0.170 Sum_probs=76.6
Q ss_pred CCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCC
Q 016152 17 GGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96 (394)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~ 96 (394)
+.++..|++++.+|..|.|++++ |+..+..+++++|++.|+++|..|..|+||||+|+..|+.+++++|+++|++++.
T Consensus 141 ~~Ll~~gad~n~~d~~g~tpLh~--A~~~~~~~iv~~Ll~~g~~~n~~~~~g~tpL~~A~~~g~~~iv~~Ll~~g~~i~~ 218 (434)
T PHA02874 141 KMLFEYGADVNIEDDNGCYPIHI--AIKHNFFDIIKLLLEKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHGNHIMN 218 (434)
T ss_pred HHHHhCCCCCCCcCCCCCCHHHH--HHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCcC
Confidence 34667899999999999998754 7777788999999999999999999999999999999999999999999877665
Q ss_pred ccCCCCchhhHHHh
Q 016152 97 QDRWKNTPLADAEG 110 (394)
Q Consensus 97 ~~~~g~t~l~~A~~ 110 (394)
++..|.||||.|+.
T Consensus 219 ~~~~g~TpL~~A~~ 232 (434)
T PHA02874 219 KCKNGFTPLHNAII 232 (434)
T ss_pred CCCCCCCHHHHHHH
Confidence 55555544444444
|
|
| >KOG4214 consensus Myotrophin and similar proteins [Transcription] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-15 Score=108.95 Aligned_cols=88 Identities=25% Similarity=0.385 Sum_probs=79.5
Q ss_pred eehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHH
Q 016152 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMME 118 (394)
Q Consensus 39 ~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~ 118 (394)
.|+...|...++.+.. ..|-|||..- .|+|||||||-+|+.+++++|+..||+|+.+|++|-|||--|.+.||.++|+
T Consensus 7 ~W~vkNG~~DeVk~~v-~~g~nVn~~~-ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVk 84 (117)
T KOG4214|consen 7 AWNVKNGEIDEVKQSV-NEGLNVNEIY-GGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVK 84 (117)
T ss_pred hhhhccCcHHHHHHHH-HccccHHHHh-CCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHH
Confidence 5767777777777777 4568898875 8999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCC
Q 016152 119 LLNAHGGLSY 128 (394)
Q Consensus 119 ~L~~~ga~~~ 128 (394)
+|++.||+-.
T Consensus 85 lLL~~GAdrt 94 (117)
T KOG4214|consen 85 LLLQNGADRT 94 (117)
T ss_pred HHHHcCcccc
Confidence 9999999754
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.2e-16 Score=145.46 Aligned_cols=123 Identities=11% Similarity=-0.022 Sum_probs=104.1
Q ss_pred CCCCCCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCC-ccc-----cCCCCCHHHHHHhcCcHHHHH
Q 016152 12 TTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLV-HAR-----DYDNRTPLHVASLHGWIDVAK 85 (394)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~v-n~~-----d~~g~t~Lh~A~~~~~~~~~~ 85 (394)
...+.+-++++|++++..+ +.|+++ .|+.++..+++++|+++|++. |.. +..|.|++|.|+..++.++++
T Consensus 130 ~~eiV~~LI~~GADIn~~~--~~t~lh--~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a~~~~~~eIve 205 (437)
T PHA02795 130 EIDIVDFMVDHGAVIYKIE--CLNAYF--RGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLVDEPTVLEIYK 205 (437)
T ss_pred CHHHHHHHHHCCCCCCCCC--CCCHHH--HHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHHHhcCHHHHHH
Confidence 4445667899999999844 466654 477788899999999999854 333 235889999999999999999
Q ss_pred HHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCC
Q 016152 86 CLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (394)
Q Consensus 86 ~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~ 138 (394)
+|+++|||+|.+|..|.||||+|+..|+.+++++|+++|++++..+....+|.
T Consensus 206 ~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpL 258 (437)
T PHA02795 206 LCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCL 258 (437)
T ss_pred HHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHH
Confidence 99999999999999999999999999999999999999999988877666654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4e-17 Score=162.90 Aligned_cols=206 Identities=29% Similarity=0.436 Sum_probs=164.8
Q ss_pred cCccccceeecCCceEEEEEEEC---CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~---g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~l 232 (394)
..|.+.+.||+|+|+.|-..... ...+++|.+.... ...........|..+-..+. |+|++++++...+....++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 35777788999999999776653 2345666544332 22333455667888888887 9999999999999999999
Q ss_pred EEeccCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-cCCCCeEecCCCCCCEEEeeCCCC-cEEEeecCCccc
Q 016152 233 ITEYLRGGDLHKYL-KEKG-ALSPSTAVNFALDIARGMAYLH-NEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKL 308 (394)
Q Consensus 233 v~e~~~~~sL~~~~-~~~~-~~~~~~~~~~~~ql~~~l~~lH-~~~~~ivH~Dikp~Nilv~~~~~~-~~kl~DFg~a~~ 308 (394)
++++.+|+++.+.+ .... ..+...+..++.|+..++.|+| ..+ +.||||||+|.++ +..+ .+++.|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l--~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLL--DESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchh--ccCCCcccCCCchhhcc
Confidence 99999999999888 5444 5788889999999999999999 877 9999999999999 6777 899999999998
Q ss_pred cccccccccccccCCcc-CccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCH
Q 016152 309 IKVQNSHDVYKMTGETG-SYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEP 368 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~ 368 (394)
+..... ........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||.....
T Consensus 175 ~~~~~g-~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 175 YRNKNG-AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred ccccCC-cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 876211 1223445667 9999999999885 446899999999999999999999976543
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-15 Score=140.33 Aligned_cols=102 Identities=25% Similarity=0.283 Sum_probs=94.3
Q ss_pred cceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChH
Q 016152 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF 114 (394)
Q Consensus 35 ~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~ 114 (394)
.++.+|||+--++.+|+++|++.|++||.+.....|||--||+.|+.|+|++|+++|||+++.|+.|.|-||+|+..|+.
T Consensus 84 gappLWaAsaAGHl~vVk~L~~~ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~ 163 (615)
T KOG0508|consen 84 GAPPLWAASAAGHLEVVKLLLRRGASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHV 163 (615)
T ss_pred CCchhhHHhccCcHHHHHHHHHhcCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCch
Confidence 34457999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCCCCCCCC
Q 016152 115 NMMELLNAHGGLSYGQNGSHFE 136 (394)
Q Consensus 115 ~~~~~L~~~ga~~~~~~~s~~~ 136 (394)
+|+++|++.|++++...-...+
T Consensus 164 ~I~qyLle~gADvn~ks~kGNT 185 (615)
T KOG0508|consen 164 DIAQYLLEQGADVNAKSYKGNT 185 (615)
T ss_pred HHHHHHHHhCCCcchhcccCch
Confidence 9999999999999876554443
|
|
| >KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.6e-16 Score=128.18 Aligned_cols=109 Identities=23% Similarity=0.251 Sum_probs=97.6
Q ss_pred chhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCC
Q 016152 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN 102 (394)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 102 (394)
...+|.-|..|.|++ +|||+. ++..++++|++.|+|++...++..|+|.+|+..|+.++|++||+++.|||..|-+|-
T Consensus 150 ~n~VN~~De~GfTpL-iWAaa~-G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGg 227 (296)
T KOG0502|consen 150 NNKVNACDEFGFTPL-IWAAAK-GHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGG 227 (296)
T ss_pred hccccCccccCchHh-HHHHhc-CchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCC
Confidence 345778889999987 566664 567788899999999999999999999999999999999999999999999999999
Q ss_pred chhhHHHhcChHHHHHHHHhcCCCCCCCCCC
Q 016152 103 TPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (394)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s 133 (394)
|||-+|+.-++.++++.|+..||++...+.+
T Consensus 228 TpLlyAvrgnhvkcve~Ll~sGAd~t~e~ds 258 (296)
T KOG0502|consen 228 TPLLYAVRGNHVKCVESLLNSGADVTQEDDS 258 (296)
T ss_pred ceeeeeecCChHHHHHHHHhcCCCccccccc
Confidence 9999999999999999999999998765543
|
|
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.1e-16 Score=159.15 Aligned_cols=112 Identities=27% Similarity=0.227 Sum_probs=104.8
Q ss_pred CCCCCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCC
Q 016152 13 TPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92 (394)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga 92 (394)
..+....+.+|++++.++..+.|+++. |+..++..++++|+++|+|++++|+.|+||||.||..|+.+++.+|+++||
T Consensus 520 v~~~~~l~~~ga~v~~~~~r~~TpLh~--A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA 597 (1143)
T KOG4177|consen 520 VKVAKILLEHGANVDLRTGRGYTPLHV--AVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGA 597 (1143)
T ss_pred HHHHHHHhhcCCceehhcccccchHHH--HHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCC
Confidence 345666788999999999999999866 888888999999999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCchhhHHHhcChHHHHHHHHhcCCC
Q 016152 93 DVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGL 126 (394)
Q Consensus 93 ~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~ 126 (394)
++|+.|.+|.|||++|...|+.++++.|...++.
T Consensus 598 ~vna~d~~g~TpL~iA~~lg~~~~~k~l~~~~~~ 631 (1143)
T KOG4177|consen 598 SVNAADLDGFTPLHIAVRLGYLSVVKLLKVVTAT 631 (1143)
T ss_pred CCCcccccCcchhHHHHHhcccchhhHHHhccCc
Confidence 9999999999999999999999999999999988
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-15 Score=151.44 Aligned_cols=118 Identities=15% Similarity=0.119 Sum_probs=97.9
Q ss_pred CCCCCCCCCcchhhhhhccccCcceeeehhhcCCH---HHHHHHHHhcCC--CCccccCCCCCHHHH---HHhcC-----
Q 016152 13 TPCKGGATSSADKQKEKARVSRTSLILWHAHQNDA---AAVRKLLEEDQS--LVHARDYDNRTPLHV---ASLHG----- 79 (394)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~---~~~~~~L~~~g~--~vn~~d~~g~t~Lh~---A~~~~----- 79 (394)
....+.++++|+++|.. +.|.||++. ||..++. .+++++|+++|+ ++|.+|..|.||||. |...+
T Consensus 359 ieIvelLIs~GAdIN~k-~~G~TpLH~-Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~ 436 (672)
T PHA02730 359 IPILRCMLDNGATMDKT-TDNNYPLHD-YFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHC 436 (672)
T ss_pred HHHHHHHHHCCCCCCcC-CCCCcHHHH-HHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhccccccc
Confidence 34456688999999985 788888754 4444433 899999999998 699999999999994 43332
Q ss_pred ----cHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCC
Q 016152 80 ----WIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNG 132 (394)
Q Consensus 80 ----~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~ 132 (394)
..+++++|+++|||+|.+|..|+||||+|+..++.+++++|+++||+++..+.
T Consensus 437 ~e~~~~~ivk~LIs~GADINakD~~G~TPLh~Aa~~~~~eive~LI~~GAdIN~~d~ 493 (672)
T PHA02730 437 YETILIDVFDILSKYMDDIDMIDNENKTLLYYAVDVNNIQFARRLLEYGASVNTTSR 493 (672)
T ss_pred cchhHHHHHHHHHhcccchhccCCCCCCHHHHHHHhCCHHHHHHHHHCCCCCCCCCC
Confidence 23679999999999999999999999999999999999999999999876653
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.9e-15 Score=155.68 Aligned_cols=116 Identities=22% Similarity=0.194 Sum_probs=65.2
Q ss_pred CCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCc-HHHHHHHHHcCCCCCCcc
Q 016152 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW-IDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~-~~~~~~Ll~~ga~~~~~~ 98 (394)
+..|++++.+|..|.|++++ |+..+..+++++|++.|++++..+..|.||||+|+..++ ..++++|+++|+++|.+|
T Consensus 362 l~~gadin~~d~~G~TpLh~--Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~~~~~~vk~Ll~~gadin~~d 439 (682)
T PHA02876 362 LELGANVNARDYCDKTPIHY--AAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVNSKN 439 (682)
T ss_pred HHcCCCCccCCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcCCHHHHHHHHHhCCCCCCcCC
Confidence 33445555555555554432 333444455555555555555555555555555554333 345566666666666677
Q ss_pred CCCCchhhHHHhcC-hHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 99 RWKNTPLADAEGAK-KFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 99 ~~g~t~l~~A~~~~-~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
.+|+||||+|+..+ +.+++++|++.|++++..+....+|
T Consensus 440 ~~G~TpLh~Aa~~~~~~~iv~lLl~~Gad~n~~d~~g~tp 479 (682)
T PHA02876 440 KDLSTPLHYACKKNCKLDVIEMLLDNGADVNAINIQNQYP 479 (682)
T ss_pred CCCChHHHHHHHhCCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 77777777776655 4677777777777666555444443
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.4e-15 Score=147.91 Aligned_cols=113 Identities=21% Similarity=0.157 Sum_probs=96.6
Q ss_pred CCCCCCcch--hhhhhccccCcceee-ehhhcCC---------HHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHH
Q 016152 16 KGGATSSAD--KQKEKARVSRTSLIL-WHAHQND---------AAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDV 83 (394)
Q Consensus 16 ~~~~~~~~~--~~~~~~~~~~~~~~~-~~a~~~~---------~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~ 83 (394)
.+-++++|+ ++|.+|+.|.|+++. +++...+ ..+++++|+++|+|+|++|..|.||||+|+..++.++
T Consensus 398 velLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~~e~~~~~ivk~LIs~GADINakD~~G~TPLh~Aa~~~~~ei 477 (672)
T PHA02730 398 VRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHCYETILIDVFDILSKYMDDIDMIDNENKTLLYYAVDVNNIQF 477 (672)
T ss_pred HHHHHHcCCCccccccccCCCchHhHHHHHHhccccccccchhHHHHHHHHHhcccchhccCCCCCCHHHHHHHhCCHHH
Confidence 445677887 689999999999852 2343221 2357999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCccC-CCCchhhHHHhc--ChHHHHHHHHhcCCCCC
Q 016152 84 AKCLIEYGADVNAQDR-WKNTPLADAEGA--KKFNMMELLNAHGGLSY 128 (394)
Q Consensus 84 ~~~Ll~~ga~~~~~~~-~g~t~l~~A~~~--~~~~~~~~L~~~ga~~~ 128 (394)
+++|+++||++|.+|. .|.||||+|+.. ++.+++++|+++|+...
T Consensus 478 ve~LI~~GAdIN~~d~~~g~TaL~~Aa~~~~~~~eIv~~LLs~ga~i~ 525 (672)
T PHA02730 478 ARRLLEYGASVNTTSRSIINTAIQKSSYRRENKTKLVDLLLSYHPTLE 525 (672)
T ss_pred HHHHHHCCCCCCCCCCcCCcCHHHHHHHhhcCcHHHHHHHHHcCCCHH
Confidence 9999999999999997 599999999974 78999999999998753
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.5e-15 Score=131.29 Aligned_cols=65 Identities=35% Similarity=0.384 Sum_probs=57.6
Q ss_pred CCccccC-CCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHHhcC
Q 016152 60 LVHARDY-DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124 (394)
Q Consensus 60 ~vn~~d~-~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g 124 (394)
|||++-. .|+|+|++|+.+|+.++|+.||..|||||.+|.+|-|+|++|+.+||+||+++|+...
T Consensus 331 nVNaKAsQ~gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p 396 (452)
T KOG0514|consen 331 DVNAKASQHGQTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVP 396 (452)
T ss_pred CcchhhhhhcchhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccC
Confidence 3555443 4788888888999999999999999999999999999999999999999999999754
|
|
| >PHA02792 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.4e-15 Score=145.65 Aligned_cols=111 Identities=14% Similarity=0.088 Sum_probs=83.0
Q ss_pred CCCCCcchhhhhhccccCcceeeehhhcCCHH---HHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCC
Q 016152 17 GGATSSADKQKEKARVSRTSLILWHAHQNDAA---AVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93 (394)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~---~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~ 93 (394)
+-++++|++++.+|++|.+.+++|+|+.+... .++++|+++|+|+|.+|..|+||||+|+..++.+++++|+++|||
T Consensus 356 elLIs~GADIN~kD~~g~~~TpLh~A~~n~~~~v~~IlklLIs~GADIN~kD~~G~TPLh~Aa~~~n~eivelLLs~GAD 435 (631)
T PHA02792 356 EYILKNGNVVVEDDDNIINIMPLFPTLSIHESDVLSILKLCKPYIDDINKIDKHGRSILYYCIESHSVSLVEWLIDNGAD 435 (631)
T ss_pred HHHHHcCCchhhhcCCCCChhHHHHHHHhccHhHHHHHHHHHhcCCccccccccCcchHHHHHHcCCHHHHHHHHHCCCC
Confidence 34677888888888776544444445544433 456777888888888888888888888888888888888888888
Q ss_pred CCCccCCCCchhhHHHh----------cChHHHHHHHHhcCCCC
Q 016152 94 VNAQDRWKNTPLADAEG----------AKKFNMMELLNAHGGLS 127 (394)
Q Consensus 94 ~~~~~~~g~t~l~~A~~----------~~~~~~~~~L~~~ga~~ 127 (394)
+|.+|..|.|||++|+. ....++++.|++.|+++
T Consensus 436 IN~kD~~G~TpL~~A~~~~~~~~~~i~~~~~~il~lLLs~~p~i 479 (631)
T PHA02792 436 INITTKYGSTCIGICVILAHACIPEIAELYIKILEIILSKLPTI 479 (631)
T ss_pred CCCcCCCCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHhcCCCh
Confidence 88888888888888865 12346677788777654
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=9.1e-15 Score=150.72 Aligned_cols=116 Identities=25% Similarity=0.152 Sum_probs=81.3
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhc-CcHHHHHHHHHcCCCCCCc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLH-GWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~-~~~~~~~~Ll~~ga~~~~~ 97 (394)
++..|++++..|..|.|++++ |+..+...+++++|+..|+++|.+|..|+||||+|+.. ++.+++++|++.|+++|.+
T Consensus 293 Ll~~gadin~~d~~g~TpLh~-Aa~~g~~~~~v~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~iv~lLl~~gadin~~ 371 (682)
T PHA02876 293 LLERGADVNAKNIKGETPLYL-MAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNAR 371 (682)
T ss_pred HHHCCCCCCCcCCCCCCHHHH-HHHhCCCHHHHHHHHHcCCCCCCcccCCCcHHHHHHHhCCcHHHHHHHHHcCCCCccC
Confidence 556777777777777777643 34444456677777777777777777777777777764 3567777777777777777
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~ 135 (394)
|..|.||||+|+..++.+++++|+++|++++..+....
T Consensus 372 d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~ 409 (682)
T PHA02876 372 DYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIG 409 (682)
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCC
Confidence 77777777777777777777777777777765554433
|
|
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.1e-15 Score=150.98 Aligned_cols=114 Identities=36% Similarity=0.427 Sum_probs=97.8
Q ss_pred hhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCc
Q 016152 24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT 103 (394)
Q Consensus 24 ~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 103 (394)
+..+...+.+-+++++ +...+...+.+.+++.|++++.++.+|.||||+||.+|+.++|++||++|||++.+++.|+|
T Consensus 498 ~~~~~~~~~~l~~lhl--a~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~T 575 (1143)
T KOG4177|consen 498 ANDNLDAKKGLTPLHL--AADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYT 575 (1143)
T ss_pred CccCccchhccchhhh--hhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCC
Confidence 3344444455555544 55566677777788889999999999999999999999999999999999999999999999
Q ss_pred hhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 016152 104 PLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKP 139 (394)
Q Consensus 104 ~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~~ 139 (394)
|||.|+..|+.+|+.+|+++|++++..+...++|..
T Consensus 576 PLH~Aa~~G~~~i~~LLlk~GA~vna~d~~g~TpL~ 611 (1143)
T KOG4177|consen 576 PLHQAAQQGHNDIAELLLKHGASVNAADLDGFTPLH 611 (1143)
T ss_pred hhhHHHHcChHHHHHHHHHcCCCCCcccccCcchhH
Confidence 999999999999999999999999998888777754
|
|
| >PF13637 Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A 3B7B_A 3F6Q_A 2KBX_A 3IXE_A 2DWZ_C 2DVW_A 3AJI_A 1S70_B 2HE0_A | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.1e-14 Score=98.28 Aligned_cols=54 Identities=41% Similarity=0.574 Sum_probs=46.5
Q ss_pred CCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHH
Q 016152 68 NRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLN 121 (394)
Q Consensus 68 g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~ 121 (394)
|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+
T Consensus 1 g~t~lh~A~~~g~~~~~~~Ll~~~~din~~d~~g~t~lh~A~~~g~~~~~~~Ll 54 (54)
T PF13637_consen 1 GRTPLHWAARSGNLEIVKLLLEHGADINAQDEDGRTPLHYAAKNGNIDIVKFLL 54 (54)
T ss_dssp SSBHHHHHHHTT-HHHHHHHHHTTSGTT-B-TTS--HHHHHHHTT-HHHHHHHH
T ss_pred CChHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHccCHHHHHHHC
Confidence 789999999999999999999999999999999999999999999999999985
|
... |
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.7e-15 Score=123.63 Aligned_cols=109 Identities=23% Similarity=0.239 Sum_probs=83.1
Q ss_pred hhhhhccccCcceeeehhhcCCHHHHHHHHHhcCC-------CCccccCCCCCHHHHHHhcCcH---HHHHHHHHcCCCC
Q 016152 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQS-------LVHARDYDNRTPLHVASLHGWI---DVAKCLIEYGADV 94 (394)
Q Consensus 25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~-------~vn~~d~~g~t~Lh~A~~~~~~---~~~~~Ll~~ga~~ 94 (394)
..+..|.+|.|+++ +|+..|+ +++++...+. .++.+|.+|+||||+|+..|+. +++++|++.|+++
T Consensus 9 ~~~~~d~~g~tpLh-~A~~~g~---~~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadi 84 (154)
T PHA02736 9 FASEPDIEGENILH-YLCRNGG---VTDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADI 84 (154)
T ss_pred HHHhcCCCCCCHHH-HHHHhCC---HHHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCc
Confidence 35567788888864 4555554 3444443332 2345789999999999999987 4688999999999
Q ss_pred CCcc-CCCCchhhHHHhcChHHHHHHHHh-cCCCCCCCCCCCCCC
Q 016152 95 NAQD-RWKNTPLADAEGAKKFNMMELLNA-HGGLSYGQNGSHFEP 137 (394)
Q Consensus 95 ~~~~-~~g~t~l~~A~~~~~~~~~~~L~~-~ga~~~~~~~s~~~p 137 (394)
|.+| ..|+||||+|+..++.+++++|+. .|++++..+....+|
T Consensus 85 n~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~tp 129 (154)
T PHA02736 85 NGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKTP 129 (154)
T ss_pred cccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCCH
Confidence 9998 599999999999999999999997 588876555444433
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.1e-15 Score=126.83 Aligned_cols=108 Identities=27% Similarity=0.307 Sum_probs=94.0
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
+++.|+.+|+.+.-.+|++++ |+..++.++++.|++..+|||+.+..|+|||||||++|+-.+++-|+..||-|+..|
T Consensus 53 ll~rgarvn~tnmgddtplhl--aaahghrdivqkll~~kadvnavnehgntplhyacfwgydqiaedli~~ga~v~icn 130 (448)
T KOG0195|consen 53 LLSRGARVNSTNMGDDTPLHL--AAAHGHRDIVQKLLSRKADVNAVNEHGNTPLHYACFWGYDQIAEDLISCGAAVNICN 130 (448)
T ss_pred HHhcccccccccCCCCcchhh--hhhcccHHHHHHHHHHhcccchhhccCCCchhhhhhhcHHHHHHHHHhccceeeecc
Confidence 678999999988888888866 444556677777779999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSY 128 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~ 128 (394)
++|.|||..|...-...+.++..++|..++
T Consensus 131 k~g~tpldkakp~l~~~l~e~aek~gq~~n 160 (448)
T KOG0195|consen 131 KKGMTPLDKAKPMLKNTLLEIAEKHGQSPN 160 (448)
T ss_pred cCCCCchhhhchHHHHHHHHHHHHhCCCCC
Confidence 999999999977767777777777887665
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.6e-14 Score=144.65 Aligned_cols=106 Identities=15% Similarity=0.073 Sum_probs=92.5
Q ss_pred cchhhhhhccccCcceeeehhhc----------------------CCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcC
Q 016152 22 SADKQKEKARVSRTSLILWHAHQ----------------------NDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG 79 (394)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~a~~----------------------~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~ 79 (394)
.|++++.++++|.||+++ |+.. .+..+++++|+++|+|+|.+|..|+||||+|+..+
T Consensus 385 ~ga~~~~~~~~G~TpL~~-a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~Ll~~GAdIN~kd~~G~TpLh~Aa~~~ 463 (661)
T PHA02917 385 EGGDAVNHLDDGEIPIGH-LCKSNYGCYNFYTYTYKKGLCDMSYACPILSTINICLPYLKDINMIDKRGETLLHKAVRYN 463 (661)
T ss_pred cCCCccccCCCCCChhHH-HHHhcccchhhhhhhhhhccchhhhhhhhHHHHHHHHHCCCCCCCCCCCCcCHHHHHHHcC
Confidence 678777778889999865 2211 11456789999999999999999999999999999
Q ss_pred cHHHHHHHHHcCCCCCCccCCCCchhhHHHh-cChHHHHHHHHhcCCCCC
Q 016152 80 WIDVAKCLIEYGADVNAQDRWKNTPLADAEG-AKKFNMMELLNAHGGLSY 128 (394)
Q Consensus 80 ~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~-~~~~~~~~~L~~~ga~~~ 128 (394)
+.+++++|+++|||+|.+|..|+||||+|+. .++.+++++|+.+|+++.
T Consensus 464 ~~~~v~~Ll~~GAdin~~d~~G~T~L~~A~~~~~~~~iv~~LL~~ga~i~ 513 (661)
T PHA02917 464 KQSLVSLLLESGSDVNIRSNNGYTCIAIAINESRNIELLKMLLCHKPTLD 513 (661)
T ss_pred CHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHhCCCHHHHHHHHHcCCChh
Confidence 9999999999999999999999999999996 678999999999998764
|
|
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.4e-14 Score=141.34 Aligned_cols=110 Identities=25% Similarity=0.222 Sum_probs=91.0
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcC-CCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCC--
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQ-SLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN-- 95 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g-~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~-- 95 (394)
.+..|++++.+.+++.|++|. ||..|+...|.++|.+.| ..+|..|-.|.||||+|+..||.+++++||+.||+.+
T Consensus 292 Ll~~Ga~I~~kn~d~~spLH~-AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa~~gH~~v~qlLl~~GA~~~~~ 370 (929)
T KOG0510|consen 292 LLGFGASINSKNKDEESPLHF-AAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAAKSGHDRVVQLLLNKGALFLNM 370 (929)
T ss_pred HHHcCCcccccCCCCCCchHH-HHHcccHHHHHHHHhCcCccccccccccCCCchhhhhhcCHHHHHHHHHhcChhhhcc
Confidence 566899999999888888754 555556666666665243 5678999999999999999999999999999999887
Q ss_pred -CccCCCCchhhHHHhcChHHHHHHHHhcCCCCCC
Q 016152 96 -AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYG 129 (394)
Q Consensus 96 -~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~ 129 (394)
..|.+|.||||.|+..|+..+|++|+.+|+++..
T Consensus 371 ~e~D~dg~TaLH~Aa~~g~~~av~~Li~~Ga~I~~ 405 (929)
T KOG0510|consen 371 SEADSDGNTALHLAAKYGNTSAVQKLISHGADIGV 405 (929)
T ss_pred cccccCCchhhhHHHHhccHHHHHHHHHcCCceee
Confidence 5699999999999999999999999999998844
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.4e-14 Score=143.11 Aligned_cols=225 Identities=25% Similarity=0.360 Sum_probs=167.5
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
..+.+.+-+-+|+++.++.+.-. |+..+.|+....-.-.....+....+-.++-...+|.++....-+....+.++++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 35667778889999999876543 4444555332111000111122233333333345677776665566677899999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc----
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK---- 310 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~---- 310 (394)
++..+++|...++.-++.+..-++..+..+..++++||+.. +.|+|++|.|++. ...+..++.|||......
T Consensus 884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~--~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLI--AYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhh--cccCCcccCccccccccccccC
Confidence 99999999999998888888888888999999999999976 8999999999999 888899999998432211
Q ss_pred -----------------ccccc------ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 311 -----------------VQNSH------DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 311 -----------------~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
..... .........+|+.|++||...+......+|+|++|++++|.++|.+||...+
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 00000 0011334568999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCC
Q 016152 368 PYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 368 ~~~~~~~i~~g~~p~~~~ 385 (394)
+.++.+-|..+..|+...
T Consensus 1040 pq~~f~ni~~~~~~~p~g 1057 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEG 1057 (1205)
T ss_pred hhhhhhccccCCCCCCCC
Confidence 999999999999888776
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.3e-13 Score=111.60 Aligned_cols=134 Identities=25% Similarity=0.404 Sum_probs=105.5
Q ss_pred eeecCCceEEEEEEECCccEEEEEeccCC-----CCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccC
Q 016152 164 IIGKGSFGEILKAYWRGTPVAIKRILPSL-----SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~g~~~avK~l~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 238 (394)
.+++|+-+.++.+.+.|.++++|.-.+.. .+......+..+|+.++.++.--.|....-++.+.+.-.++|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 57899999999999988888888654432 2223345567789999999876666665656677777899999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 239 ~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
|..|.+++... ...+++.+-.-+.-||..| |+|+||.++||++ .. +.+.++||||+..-
T Consensus 83 G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl--~~-~~i~~IDfGLg~~s 141 (204)
T COG3642 83 GELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIIL--SG-GRIYFIDFGLGEFS 141 (204)
T ss_pred ChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEE--eC-CcEEEEECCccccc
Confidence 99999888765 2556777777888999988 9999999999999 33 34999999999743
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.2e-14 Score=146.82 Aligned_cols=86 Identities=27% Similarity=0.335 Sum_probs=75.5
Q ss_pred hhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHH
Q 016152 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLN 121 (394)
Q Consensus 42 a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~ 121 (394)
|+..+..++++.|++.|+|+|.+|..|+||||+||.+|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+
T Consensus 532 Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~~~iv~~L~ 611 (823)
T PLN03192 532 VASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHKIFRILY 611 (823)
T ss_pred HHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHH
Confidence 44455677788888999999999999999999999999999999999999999999999999999888888888777777
Q ss_pred hcCCCC
Q 016152 122 AHGGLS 127 (394)
Q Consensus 122 ~~ga~~ 127 (394)
..++..
T Consensus 612 ~~~~~~ 617 (823)
T PLN03192 612 HFASIS 617 (823)
T ss_pred hcCccc
Confidence 655543
|
|
| >KOG0505 consensus Myosin phosphatase, regulatory subunit [Posttranslational modification, protein turnover, chaperones; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.2e-14 Score=134.31 Aligned_cols=125 Identities=22% Similarity=0.169 Sum_probs=104.1
Q ss_pred CCCCCCCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccc--------------------------
Q 016152 11 STTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHAR-------------------------- 64 (394)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~-------------------------- 64 (394)
++-.|..-.++.|+++|..|++++|++| +|+..++..++++|+++|+++-+.
T Consensus 84 ~~~e~v~~l~e~ga~Vn~~d~e~wtPlh--aaascg~~~i~~~li~~gA~~~avNsdg~~P~dl~e~ea~~~~l~~~~~r 161 (527)
T KOG0505|consen 84 DNLEMVKFLVENGANVNAQDNEGWTPLH--AAASCGYLNIVEYLIQHGANLLAVNSDGNMPYDLAEDEATLDVLETEMAR 161 (527)
T ss_pred ccHHHHHHHHHhcCCccccccccCCcch--hhcccccHHHHHHHHHhhhhhhhccCCCCCccccccCcchhHHHHHHHHH
Confidence 3344555578899999999999999984 477777888899999988753211
Q ss_pred ---------------------------------cCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhc
Q 016152 65 ---------------------------------DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111 (394)
Q Consensus 65 ---------------------------------d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~ 111 (394)
+..|-|+||+|+.+|+.++.++|++.|.+++.+|.+||||||.|+.+
T Consensus 162 ~gi~iea~R~~~e~~ml~D~~q~l~~G~~~d~~~~rG~T~lHvAaa~Gy~e~~~lLl~ag~~~~~~D~dgWtPlHAAA~W 241 (527)
T KOG0505|consen 162 QGIDIEAARKAEEQTMLDDARQWLNAGAELDARHARGATALHVAAANGYTEVAALLLQAGYSVNIKDYDGWTPLHAAAHW 241 (527)
T ss_pred hcccHHHHhhhhHHHHHHHHHHHHhccccccccccccchHHHHHHhhhHHHHHHHHHHhccCcccccccCCCcccHHHHh
Confidence 34489999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 112 KKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 112 ~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
|..++.++|+++|++....+....+|
T Consensus 242 g~~~~~elL~~~ga~~d~~t~~g~~p 267 (527)
T KOG0505|consen 242 GQEDACELLVEHGADMDAKTKMGETP 267 (527)
T ss_pred hhHhHHHHHHHhhcccchhhhcCCCC
Confidence 99999999999999876554443333
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.7e-14 Score=126.51 Aligned_cols=97 Identities=27% Similarity=0.275 Sum_probs=87.3
Q ss_pred hhhhh-ccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHc-CCCCCCccCCCC
Q 016152 25 KQKEK-ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY-GADVNAQDRWKN 102 (394)
Q Consensus 25 ~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~-ga~~~~~~~~g~ 102 (394)
|+|++ ...|+|+|++ |...+..++++.|+..|||||.+|.+|.|+|++||.+||.|+|++||.. +.|+...|.+|-
T Consensus 331 nVNaKAsQ~gQTALML--AVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgS 408 (452)
T KOG0514|consen 331 DVNAKASQHGQTALML--AVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGS 408 (452)
T ss_pred Ccchhhhhhcchhhhh--hhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCc
Confidence 45543 4678888877 8888899999999999999999999999999999999999999999974 899999999999
Q ss_pred chhhHHHhcChHHHHHHHHhc
Q 016152 103 TPLADAEGAKKFNMMELLNAH 123 (394)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~~~ 123 (394)
|+|.+|...|+.||.-+|-.+
T Consensus 409 TAl~IAleagh~eIa~mlYa~ 429 (452)
T KOG0514|consen 409 TALSIALEAGHREIAVMLYAH 429 (452)
T ss_pred hhhhhHHhcCchHHHHHHHHH
Confidence 999999999999998887653
|
|
| >PTZ00322 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.1e-13 Score=141.00 Aligned_cols=93 Identities=32% Similarity=0.454 Sum_probs=82.0
Q ss_pred eeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHH
Q 016152 38 ILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117 (394)
Q Consensus 38 ~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~ 117 (394)
++++|..| ..+++++|++.|+++|.+|.+|+||||+||.+|+.+++++|+++|||+|.+|.+|+||||+|+..++.+++
T Consensus 86 L~~aa~~G-~~~~vk~LL~~Gadin~~d~~G~TpLh~Aa~~g~~eiv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~iv 164 (664)
T PTZ00322 86 LCQLAASG-DAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREVV 164 (664)
T ss_pred HHHHHHcC-CHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHH
Confidence 34455544 56677888899999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhc-------CCCCCCCC
Q 016152 118 ELLNAH-------GGLSYGQN 131 (394)
Q Consensus 118 ~~L~~~-------ga~~~~~~ 131 (394)
++|+.+ |++....+
T Consensus 165 ~~Ll~~~~~~~~~ga~~~~~~ 185 (664)
T PTZ00322 165 QLLSRHSQCHFELGANAKPDS 185 (664)
T ss_pred HHHHhCCCcccccCCCCCccc
Confidence 999998 66554443
|
|
| >KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2e-14 Score=119.83 Aligned_cols=111 Identities=19% Similarity=0.191 Sum_probs=101.5
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
++..|+++.+.-++..+++.+ |++++..+++++|+..+.|||.-|-+|-|||-||+..||.++|+.||..|||++..+
T Consensus 179 LL~~GAdp~~lgk~resALsL--At~ggytdiV~lLL~r~vdVNvyDwNGgTpLlyAvrgnhvkcve~Ll~sGAd~t~e~ 256 (296)
T KOG0502|consen 179 LLNSGADPDALGKYRESALSL--ATRGGYTDIVELLLTREVDVNVYDWNGGTPLLYAVRGNHVKCVESLLNSGADVTQED 256 (296)
T ss_pred HHHcCCChhhhhhhhhhhHhH--HhcCChHHHHHHHHhcCCCcceeccCCCceeeeeecCChHHHHHHHHhcCCCccccc
Confidence 567899999999999999988 999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNG 132 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~ 132 (394)
..|.+++..|...|.. +|+.+++.-++...+++
T Consensus 257 dsGy~~mdlAValGyr-~Vqqvie~h~lkl~Q~~ 289 (296)
T KOG0502|consen 257 DSGYWIMDLAVALGYR-IVQQVIEKHALKLCQDS 289 (296)
T ss_pred ccCCcHHHHHHHhhhH-HHHHHHHHHHHHHhhcc
Confidence 9999999999999988 77777766665555443
|
|
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.4e-14 Score=136.75 Aligned_cols=102 Identities=22% Similarity=0.251 Sum_probs=94.4
Q ss_pred hhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHH-cC-CCCCCccCCCCc
Q 016152 26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YG-ADVNAQDRWKNT 103 (394)
Q Consensus 26 ~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~-~g-a~~~~~~~~g~t 103 (394)
+|..|++|.|++|+ |++.+..+.++.|+..|+++|.++.++.||||.||.+|+.++|+-||+ .| ...|..|-.|.|
T Consensus 266 v~~~d~dg~tpLH~--a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~t 343 (929)
T KOG0510|consen 266 VNDEDNDGCTPLHY--AARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMT 343 (929)
T ss_pred hhcccccCCchHHH--HHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCC
Confidence 56678889998754 888899999999999999999999999999999999999999999998 54 788999999999
Q ss_pred hhhHHHhcChHHHHHHHHhcCCCCCC
Q 016152 104 PLADAEGAKKFNMMELLNAHGGLSYG 129 (394)
Q Consensus 104 ~l~~A~~~~~~~~~~~L~~~ga~~~~ 129 (394)
|||.|+..||..+++.|++.||+...
T Consensus 344 pLHlaa~~gH~~v~qlLl~~GA~~~~ 369 (929)
T KOG0510|consen 344 PLHLAAKSGHDRVVQLLLNKGALFLN 369 (929)
T ss_pred chhhhhhcCHHHHHHHHHhcChhhhc
Confidence 99999999999999999999998874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 394 | ||||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-33 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-33 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-33 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-32 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-31 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-31 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-31 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-31 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-31 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-31 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-29 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-28 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-28 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-28 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-27 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-27 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-27 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-27 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-27 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-27 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-27 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-27 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-27 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-27 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-27 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-27 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-27 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-26 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-26 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-26 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-26 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-26 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-26 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-26 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-26 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-26 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-26 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-26 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-25 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-25 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-25 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-25 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-25 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-25 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-25 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-25 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-25 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-25 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-25 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-25 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-25 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-25 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-25 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-25 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-25 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-25 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-25 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-25 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-25 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-25 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-25 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-25 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-25 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-24 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-24 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-24 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-24 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-24 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-24 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-24 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-24 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-24 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-24 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-24 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-24 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-24 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-24 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-24 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-24 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-24 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-24 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-24 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-24 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-24 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-24 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-24 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-24 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-24 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-24 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-23 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-23 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-23 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-23 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-23 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-23 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-23 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-23 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-23 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-23 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-23 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-23 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-23 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-23 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-23 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-23 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-23 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-22 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-22 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-22 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-22 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-22 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-22 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-22 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-22 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-22 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-22 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-22 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-22 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-22 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-22 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-22 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-22 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-22 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-22 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-22 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-22 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-22 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-22 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-22 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-22 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-21 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-21 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-21 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-21 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-21 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-21 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-21 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-21 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-21 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-21 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-21 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-21 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-21 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-21 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-21 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-21 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-21 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-21 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-21 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-21 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-21 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-21 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-21 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-21 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-21 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-21 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-20 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-20 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-20 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-20 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-20 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-20 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-20 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-20 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-20 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-20 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-20 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-20 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-20 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-20 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-20 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-20 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-20 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-20 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-20 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-20 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-20 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-20 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-20 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-20 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-20 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-20 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-20 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-20 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-20 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-20 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-20 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-20 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-20 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-20 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-20 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-20 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-20 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-20 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-20 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-20 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-20 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-20 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-20 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-20 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-20 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-20 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-20 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-20 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-20 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-20 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-20 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-20 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-20 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-20 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-20 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-20 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-20 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-20 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-20 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-20 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-20 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-20 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-20 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-20 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-20 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-20 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-20 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-20 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-20 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-20 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-20 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-19 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-19 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-19 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-19 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-19 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-19 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-19 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-19 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-19 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-19 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-19 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-19 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-19 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-19 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-19 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-19 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-19 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-19 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-19 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-19 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-19 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-19 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-19 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-19 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-19 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-19 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-19 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-19 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-19 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-19 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-19 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-19 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-19 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-19 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-19 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-19 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-19 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-19 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-19 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-19 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-19 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-19 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-19 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-19 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-19 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-19 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-19 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-19 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-19 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-18 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-18 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-18 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-18 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-18 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-18 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-18 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-18 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-18 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-18 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-18 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-18 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-18 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-18 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-18 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-18 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-18 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-18 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-18 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-18 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-18 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-18 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-18 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-18 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-18 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-18 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-18 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-18 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-18 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-18 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-18 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-18 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-18 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-18 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-18 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-18 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-18 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-18 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-18 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-18 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-18 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-18 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-18 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-18 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-18 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-17 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-17 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-17 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-17 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-17 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-17 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-17 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-17 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-17 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-17 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-17 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-17 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-17 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-17 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-17 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-17 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-17 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-17 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-17 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-17 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-17 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-17 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-17 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-17 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-17 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-17 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-17 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-17 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-17 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-17 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-17 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-17 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-17 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-17 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-17 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-17 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-17 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-16 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-16 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-16 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-16 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-16 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-16 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-16 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-16 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-16 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-16 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-16 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-16 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-16 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-16 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-16 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-16 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-16 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-16 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-15 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-15 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-15 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-15 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-15 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-15 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-15 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-15 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-15 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-15 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-15 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-15 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-15 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-15 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-14 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-14 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-14 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-14 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-14 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-14 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-13 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-13 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-11 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 9e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-09 | ||
| 1n0r_A | 126 | 4ank: A Designed Ankyrin Repeat Protein With Four I | 4e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-09 |
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1N0R|A Chain A, 4ank: A Designed Ankyrin Repeat Protein With Four Identical Consensus Repeats Length = 126 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-105
Identities = 84/249 (33%), Positives = 129/249 (51%), Gaps = 13/249 (5%)
Query: 137 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR 196
+ D +I +L+ IG GSFG + +A W G+ VA+K ++
Sbjct: 19 ENLYFQGAMDGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE 76
Query: 197 LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA---LS 253
+ +F EV ++ +LRHPNIV F+GAVT+ L ++TEYL G L++ L + GA L
Sbjct: 77 R-VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD 135
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
++ A D+A+GM YLHN I+HR+LK N+L+ +KV DFGLS+L
Sbjct: 136 ERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTVKVCDFGLSRLK---- 189
Query: 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK 373
+ G+ +MAPEV + ++K DV+SF +IL+E+ + P N P +
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA 249
Query: 374 YVA-EGHRP 381
V + R
Sbjct: 250 AVGFKCKRL 258
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-101
Identities = 88/253 (34%), Positives = 128/253 (50%), Gaps = 17/253 (6%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR-LVIQDFRHEVNL 208
EID +EL IIG G FG++ +A+W G VA+K +D I++ R E L
Sbjct: 2 LEIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
L+HPNI+ G + L L+ E+ RGG L++ L K + P VN+A+ IARGM
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGM 118
Query: 269 AYLHNE-PNVIIHRDLKPRNVLLVNSSADH------LKVGDFGLSKLIKVQNSHDVYKMT 321
YLH+E IIHRDLK N+L++ + LK+ DFGL++ H KM+
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-----HRTTKMS 173
Query: 322 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381
G+Y +MAPEV + + K DV+S+ ++L+E+L GE P + A VA
Sbjct: 174 A-AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 382 FFRAKGFTPELRE 394
+
Sbjct: 233 LPIPSTCPEPFAK 245
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 2e-99
Identities = 79/254 (31%), Positives = 124/254 (48%), Gaps = 26/254 (10%)
Query: 143 PLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRL--- 197
P + +E+++ IGKG FG + K + VAIK ++ S+
Sbjct: 7 EFPKSRLPTLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 198 -VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPS 255
Q+F+ EV ++ L HPNIV+ G + P ++ E++ GDL+ L + + S
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD---HLKVGDFGLSKLIKVQ 312
+ LDIA G+ Y+ N+ I+HRDL+ N+ L + + KV DFGLS+
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---- 178
Query: 313 NSHDVYKMTGETGSYRYMAPEVF--KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
V+ ++G G++++MAPE + Y +K D +SFAMILY +L GE P Y +
Sbjct: 179 ---SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
Query: 371 AAKYVA---EGHRP 381
EG RP
Sbjct: 236 IKFINMIREEGLRP 249
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 3e-98
Identities = 73/269 (27%), Positives = 116/269 (43%), Gaps = 20/269 (7%)
Query: 137 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR 196
P+ +W+I +L+ +IGKG FG++ W G VAI+ I D+
Sbjct: 15 PRKASQTSIFLQEWDIPFEQLEIGE--LIGKGRFGQVYHGRWHGE-VAIRLIDIE-RDNE 70
Query: 197 LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPS 255
++ F+ EV + RH N+V F+GA L +IT +G L+ + K L +
Sbjct: 71 DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVN 130
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV-QNS 314
A +I +GM YLH + I+H+DLK +NV N + + DFGL + V Q
Sbjct: 131 KTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYDN---GKVVITDFGLFSISGVLQAG 185
Query: 315 HDVYKMTGETGSYRYMAPEVFKHRK---------YDKKVDVFSFAMILYEMLEGEPPLAN 365
K+ + G ++APE+ + + K DVF+ I YE+ E P
Sbjct: 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
Query: 366 YEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
+ G +P G E+ +
Sbjct: 246 QPAEAIIWQMGTGMKPNLSQIGMGKEISD 274
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 8e-98
Identities = 83/238 (34%), Positives = 126/238 (52%), Gaps = 23/238 (9%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
ID E++ ++G+G+FG + KA WR VAIK+I S+ + F E+ L
Sbjct: 3 HMIDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQIE---SES--ERKAFIVELRQL 55
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL---KEKGALSPSTAVNFALDIAR 266
++ HPNIV+ GA P+ L+ EY GG L+ L + + + A+++ L ++
Sbjct: 56 SRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 267 GMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
G+AYLH+ +P +IHRDLKP N LL+ + LK+ DFG + I+ MT G
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPN-LLLVAGGTVLKICDFGTACDIQTH-------MTNNKG 165
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE--PYEAAKYVAEGHRP 381
S +MAPEVF+ Y +K DVFS+ +IL+E++ P + V G RP
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP 223
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 2e-95
Identities = 66/241 (27%), Positives = 108/241 (44%), Gaps = 22/241 (9%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
ID +L+F + + + GE+ K W+G + +K + R +DF E
Sbjct: 4 HSGIDFKQLNFLT--KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPR 60
Query: 209 LVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYL--KEKGALSPSTAVNFALDI 264
L HPN++ LGA LIT ++ G L+ L + S AV FALD+
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
ARGMA+LH +I L R+V++ ++ + ++ G
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDED--MTARISMADVKF---------SFQSPGRM 169
Query: 325 GSYRYMAPEVFKHRKYD---KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHR 380
+ ++APE + + D + D++SFA++L+E++ E P A+ E VA EG R
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR 229
Query: 381 P 381
P
Sbjct: 230 P 230
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 2e-86
Identities = 80/248 (32%), Positives = 123/248 (49%), Gaps = 24/248 (9%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVN 207
PS+L ++GKG FG+ +K R T + +K ++ + + + F EV
Sbjct: 5 RIFRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVK 59
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIAR 266
++ L HPN+++F+G + + K L ITEY++GG L + S V+FA DIA
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI----------KVQNSHD 316
GMAYLH+ IIHRDL N LV + ++ V DFGL++L+ + D
Sbjct: 120 GMAYLHSMN--IIHRDLNSHN-CLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY--EAAKY 374
K G+ +MAPE+ R YD+KVDVFSF ++L E++ +Y P +
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235
Query: 375 VAEGHRPF 382
V +
Sbjct: 236 VRGFLDRY 243
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 3e-85
Identities = 76/238 (31%), Positives = 120/238 (50%), Gaps = 16/238 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
DWEI ++ IG GSFG + K W G VA+K + + + +Q F++EV +
Sbjct: 18 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGV 73
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 267
L K RH NI+ F+G T L ++T++ G L+ +L + ++ A ARG
Sbjct: 74 LRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
M YLH + IIHRDLK N+ L + +K+GDFGL+ + + +GS
Sbjct: 133 MDYLHAKS--IIHRDLKSNNIFL--HEDNTVKIGDFGLATEKSRWSGSH--QFEQLSGSI 186
Query: 328 RYMAPEVFKHR---KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY-VAEGHRP 381
+MAPEV + + Y + DV++F ++LYE++ G+ P +N + V G
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 3e-80
Identities = 64/251 (25%), Positives = 97/251 (38%), Gaps = 25/251 (9%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
++ IGKG +GE+ WRG VA+K + E+
Sbjct: 31 VQRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWF----RETEIYQ 84
Query: 209 LVKLRHPNIVQFLGAVTE----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
V +RH NI+ F+ A + L LIT+Y G L+ YLK L + + A
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSS 143
Query: 265 ARGMAYLHNEP------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
G+ +LH E I HRDLK +N+L+ + D GL+ +
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 319 KMTGETGSYRYMAPEV------FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372
G+ RYM PEV H + D++SF +IL+E+ E Y+
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261
Query: 373 KYVAEGHRPFF 383
+ P +
Sbjct: 262 YHDLVPSDPSY 272
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 1e-76
Identities = 66/238 (27%), Positives = 103/238 (43%), Gaps = 27/238 (11%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHE--VNLLVKLRHPNIVQFL 221
+GKG +GE+ + W+G VA+K + + E + V LRH NI+ F+
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGFI 68
Query: 222 GAVT----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP-- 275
+ L LIT Y G L+ YL+ L + + L IA G+A+LH E
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 276 ----NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
I HRDLK +N+L+ + + D GL+ + + G+ RYMA
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 332 PEVFKHR------KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383
PEV K+VD+++F ++L+E+ E Y+ Y + P F
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 1e-76
Identities = 65/251 (25%), Positives = 98/251 (39%), Gaps = 25/251 (9%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
+ IGKG FGE+ + WRG VA+K E+
Sbjct: 36 VQRTIARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSSREERS----WFREAEIYQ 89
Query: 209 LVKLRHPNIVQFLGAVT----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
V LRH NI+ F+ A L L+++Y G L YL + ++ + AL
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALST 148
Query: 265 ARGMAYLHNEPN------VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
A G+A+LH E I HRDLK +N+L+ + D GL+
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLAVRHDSATDTIDI 206
Query: 319 KMTGETGSYRYMAPEV------FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372
G+ RYMAPEV KH + K+ D+++ ++ +E+ +E Y+
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
Query: 373 KYVAEGHRPFF 383
Y P
Sbjct: 267 YYDLVPSDPSV 277
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 6e-68
Identities = 72/263 (27%), Positives = 110/263 (41%), Gaps = 39/263 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVN- 207
+ +D L +IG+G +G + K PVA+K + + Q+F +E N
Sbjct: 7 EPSLDLDNLKLLE--LIGRGRYGAVYKGSLDERPVAVK-VFSFANR-----QNFINEKNI 58
Query: 208 -LLVKLRHPNIVQFLGAVTE-----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
+ + H NI +F+ R +L+ EY G L KYL ++ A
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLA 117
Query: 262 LDIARGMAYLHNEPN-------VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI----K 310
+ RG+AYLH E I HRDL RNVL+ N + DFGLS +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRL 175
Query: 311 VQNSHDVYKMTGETGSYRYMAPEVFK-------HRKYDKKVDVFSFAMILYEML---EGE 360
V+ + E G+ RYMAPEV + K+VD+++ +I +E+
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 361 PPLANYEPYEAAKYVAEGHRPFF 383
P + Y+ A G+ P F
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTF 258
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 3e-67
Identities = 73/264 (27%), Positives = 110/264 (41%), Gaps = 38/264 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
+ L + +G FG + KA VA+K I P +EV
Sbjct: 18 NLYFQSMPLQLLE--VKARGRFGCVWKAQLLNEYVAVK-IFPIQDKQS---WQNEYEVYS 71
Query: 209 LVKLRHPNIVQFLGAVTE----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
L ++H NI+QF+GA L LIT + G L +LK +S + + A +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHIAETM 130
Query: 265 ARGMAYLHNEPN--------VIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQNSH 315
ARG+AYLH + I HRD+K +NVLL N +A + DFGL+ + S
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA---CIADFGLALKFEAGKSA 187
Query: 316 DVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
G+ G+ RYMAPEV + R ++D+++ ++L+E+
Sbjct: 188 GD--THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD-- 243
Query: 371 AAKYVAEGHRPFFRAKGFTPELRE 394
E PF G P L +
Sbjct: 244 ------EYMLPFEEEIGQHPSLED 261
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 8e-67
Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 29/276 (10%)
Query: 115 NMMELLNAH----GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSF 170
++ L++ L+ + +P W ++ +L IG+G+F
Sbjct: 77 SIPLLIDHLLSTQQPLTKK------SGVVLHRAVPKD-KWVLNHEDLVLGE--QIGRGNF 127
Query: 171 GEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228
GE+ R T VA+K +L D + F E +L + HPNIV+ +G T+++
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185
Query: 229 PLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 287
P+ ++ E ++GGD +L+ +G L T + D A GM YL ++ IHRDL RN
Sbjct: 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARN 243
Query: 288 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS--YRYMAPEVFKHRKYDKKVD 345
L+ + + LK+ DFG+S+ VY +G ++ APE + +Y + D
Sbjct: 244 CLV--TEKNVLKISDFGMSREEA----DGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 346 VFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
V+SF ++L+E G P N + ++V +G R
Sbjct: 298 VWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR 333
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 7e-65
Identities = 72/248 (29%), Positives = 111/248 (44%), Gaps = 23/248 (9%)
Query: 145 PNKCD-WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLV 198
P + I +L +G GSFG + + W VA+K + P +
Sbjct: 7 PLQSLTCLIGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 64
Query: 199 IQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTA 257
+ DF EVN + L H N+++ G V P+ ++TE G L L++ +G T
Sbjct: 65 MDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTL 123
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+A+ +A GM YL E IHRDL RN+LL ++ D +K+GDFGL + + + D
Sbjct: 124 SRYAVQVAEGMGYL--ESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQND--DH 177
Query: 318 YKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAK 373
Y M + + APE K R + D + F + L+EM G+ P +
Sbjct: 178 YVMQ--EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 235
Query: 374 YV-AEGHR 380
+ EG R
Sbjct: 236 KIDKEGER 243
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 9e-65
Identities = 79/250 (31%), Positives = 121/250 (48%), Gaps = 23/250 (9%)
Query: 137 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDD 195
P L WEIDP +L F +G G FG + WRG VAIK I +
Sbjct: 7 NAPSTAGLG-YGSWEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE 63
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSP 254
+F E +++ L H +VQ G T+++P+ +ITEY+ G L YL+E +
Sbjct: 64 ----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 119
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
+ D+ M YL E +HRDL RN L+ + +KV DFGLS+ +
Sbjct: 120 QQLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCLV--NDQGVVKVSDFGLSRYVL---- 171
Query: 315 HDVYKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYE 370
D Y T GS R+ PEV + K+ K D+++F ++++E+ G+ P + E
Sbjct: 172 DDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229
Query: 371 AAKYVAEGHR 380
A+++A+G R
Sbjct: 230 TAEHIAQGLR 239
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-64
Identities = 85/237 (35%), Positives = 124/237 (52%), Gaps = 22/237 (9%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
W IDPSEL F IG G FG + YW VAIK I + +DF E +
Sbjct: 3 WVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEV 56
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARG 267
++KL HP +VQ G E+ P+ L+TE++ G L YL+ +G + T + LD+ G
Sbjct: 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS- 326
MAYL E +IHRDL RN L+ +KV DFG+++ + D Y T TG+
Sbjct: 117 MAYL--EEACVIHRDLAARNCLV--GENQVIKVSDFGMTRFVL----DDQY--TSSTGTK 166
Query: 327 --YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
++ +PEVF +Y K DV+SF ++++E+ EG+ P N E + ++ G R
Sbjct: 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR 223
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 2e-64
Identities = 75/237 (31%), Positives = 118/237 (49%), Gaps = 22/237 (9%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
E+ E+ +G G FG + W+G VA+K I + +F E
Sbjct: 3 MELKREEITLLK--ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQT 56
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARG 267
++KL HP +V+F G ++ P+ ++TEY+ G L YL+ G L PS + D+ G
Sbjct: 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS- 326
MA+L E + IHRDL RN L+ +KV DFG+++ + D Y G+
Sbjct: 117 MAFL--ESHQFIHRDLAARNCLV--DRDLCVKVSDFGMTRYVL----DDQY--VSSVGTK 166
Query: 327 --YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
++ APEVF + KY K DV++F ++++E+ G+ P Y E V++GHR
Sbjct: 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR 223
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 3e-64
Identities = 70/245 (28%), Positives = 121/245 (49%), Gaps = 24/245 (9%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQD 201
PN WE++ +++ +G G +GE+ + W+ VA+K + + ++
Sbjct: 2 SPNYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EE 55
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVN 259
F E ++ +++HPN+VQ LG T P +ITE++ G+L YL+ + +S +
Sbjct: 56 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 115
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
A I+ M YL E IHRDL RN L+ +KV DFGLS+L+ D Y
Sbjct: 116 MATQISSAMEYL--EKKNFIHRDLAARNCLV--GENHLVKVADFGLSRLMT----GDTY- 166
Query: 320 MTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYV 375
T G+ ++ APE + K+ K DV++F ++L+E+ G P + + + +
Sbjct: 167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
Query: 376 AEGHR 380
+ +R
Sbjct: 226 EKDYR 230
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 6e-64
Identities = 77/247 (31%), Positives = 121/247 (48%), Gaps = 28/247 (11%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ 200
+ W ++ EL IGKG FG+++ +RG VA+K I + Q
Sbjct: 7 AQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA-----Q 59
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLITEYLRGGDLHKYLKEKG--ALSPSTA 257
F E +++ +LRH N+VQ LG + E K L ++TEY+ G L YL+ +G L
Sbjct: 60 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL 119
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ F+LD+ M YL E N +HRDL RNVL+ S + KV DFGL+K +
Sbjct: 120 LKFSLDVCEAMEYL--EGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTK--------EA 167
Query: 318 YKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAK 373
+ + ++ APE + +K+ K DV+SF ++L+E+ G P +
Sbjct: 168 S--STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 225
Query: 374 YVAEGHR 380
V +G++
Sbjct: 226 RVEKGYK 232
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 6e-64
Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 37/268 (13%)
Query: 139 PVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSL 192
+ ++ + + L F +GKG+FG + + VA+K++ S
Sbjct: 25 AMGSAFEDRDPTQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 82
Query: 193 SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKE-K 249
+ +DF E+ +L L+H NIV++ G R+ L LI EYL G L YL++ K
Sbjct: 83 EEHL---RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK 139
Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
+ + + I +GM YL IHRDL RN+L+ + + +K+GDFGL+K++
Sbjct: 140 ERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILV--ENENRVKIGDFGLTKVL 195
Query: 310 KVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML----------- 357
+ YK+ S + APE K+ DV+SF ++LYE+
Sbjct: 196 P--QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253
Query: 358 -----EGEPPLANYEPYEAAKYVAEGHR 380
G + + + R
Sbjct: 254 EFMRMIGNDKQGQMIVFHLIELLKNNGR 281
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 7e-64
Identities = 69/246 (28%), Positives = 119/246 (48%), Gaps = 20/246 (8%)
Query: 143 PLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLV 198
+ K + +D L +G G+FG + K Y++ VA+K IL + ++D +
Sbjct: 5 EIRPK-EVYLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVK-ILKNEANDPAL 61
Query: 199 IQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAV 258
+ E N++ +L +P IV+ +G + ML+ E G L+KYL++ + +
Sbjct: 62 KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
++ GM YL E + +HRDL RNVLL + + K+ DFGLSK ++ + Y
Sbjct: 121 ELVHQVSMGMKYL--EESNFVHRDLAARNVLL--VTQHYAKISDFGLSKALRADE--NYY 174
Query: 319 KMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKY 374
K T ++ APE + K+ K DV+SF ++++E G+ P + E
Sbjct: 175 KAQ--THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232
Query: 375 VAEGHR 380
+ +G R
Sbjct: 233 LEKGER 238
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 1e-63
Identities = 68/245 (27%), Positives = 117/245 (47%), Gaps = 20/245 (8%)
Query: 145 PNKCDWE-IDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRL 197
PN+ + +E ++G G+FG + K W PVAIK + + S
Sbjct: 4 PNQALLRILKETEFKKIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-- 59
Query: 198 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPST 256
++ E ++ + +P++ + LG + LIT+ + G L Y++E K +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
+N+ + IA+GM YL E ++HRDL RNVL+ + H+K+ DFGL+KL+
Sbjct: 119 LLNWCVQIAKGMNYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL--GAEEK 172
Query: 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYV 375
Y G ++MA E HR Y + DV+S+ + ++E++ G P E + +
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
Query: 376 AEGHR 380
+G R
Sbjct: 233 EKGER 237
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-63
Identities = 72/267 (26%), Positives = 112/267 (41%), Gaps = 35/267 (13%)
Query: 139 PVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSL 192
P + L +G+G FG++ + G VA+K + P
Sbjct: 5 SEKKPATEVDPTHFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES 62
Query: 193 SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEK 249
+ I D + E+ +L L H NIV++ G TE + LI E+L G L +YL K K
Sbjct: 63 GGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK 120
Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
++ + +A+ I +GM YL +HRDL RNVL+ S +K+GDFGL+K I
Sbjct: 121 NKINLKQQLKYAVQICKGMDYL--GSRQYVHRDLAARNVLV--ESEHQVKIGDFGLTKAI 176
Query: 310 KVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML---------EG 359
+ + Y + + S + APE K+ DV+SF + L+E+L
Sbjct: 177 --ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA 234
Query: 360 EPPLANYEPY------EAAKYVAEGHR 380
+ + EG R
Sbjct: 235 LFLKMIGPTHGQMTVTRLVNTLKEGKR 261
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 4e-63
Identities = 68/257 (26%), Positives = 112/257 (43%), Gaps = 37/257 (14%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFR 203
+ + L F +GKG+FG + + VA+K++ S + +DF
Sbjct: 5 TQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFE 59
Query: 204 HEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNF 260
E+ +L L+H NIV++ G R+ L LI EYL G L YL++ K + + +
Sbjct: 60 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
I +GM YL IHRDL RN+L+ + + +K+GDFGL+K++ + +K+
Sbjct: 120 TSQICKGMEYL--GTKRYIHRDLATRNILV--ENENRVKIGDFGLTKVLP--QDKEFFKV 173
Query: 321 TGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML----------------EGEPPL 363
S + APE K+ DV+SF ++LYE+ G
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233
Query: 364 ANYEPYEAAKYVAEGHR 380
+ + + R
Sbjct: 234 GQMIVFHLIELLKNNGR 250
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 5e-63
Identities = 72/278 (25%), Positives = 130/278 (46%), Gaps = 26/278 (9%)
Query: 115 NMMELLNAHGGLSYG--QNGSHFEPKPVPPPLPNKC----DWEIDPSELDFSSSAIIGKG 168
+ EL++ H ++ G + PK P + WE++ +++ +G G
Sbjct: 174 TLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKH--KLGGG 231
Query: 169 SFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226
+GE+ + W+ VA+K + + ++F E ++ +++HPN+VQ LG T
Sbjct: 232 QYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 227 RKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK 284
P +ITE++ G+L YL+ + +S + A I+ M YL E IHR+L
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKNFIHRNLA 345
Query: 285 PRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKK 343
RN L+ +KV DFGLS+L+ D Y ++ APE + K+ K
Sbjct: 346 ARNCLV--GENHLVKVADFGLSRLMT----GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 344 VDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
DV++F ++L+E+ G P + + + + + +R
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 437
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 1e-62
Identities = 78/252 (30%), Positives = 122/252 (48%), Gaps = 28/252 (11%)
Query: 136 EPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD 195
E + W ++ EL IGKG FG+++ +RG VA+K I +
Sbjct: 174 EGTVAAQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA- 230
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLITEYLRGGDLHKYLKEKG--AL 252
Q F E +++ +LRH N+VQ LG + E K L ++TEY+ G L YL+ +G L
Sbjct: 231 ----QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 286
Query: 253 SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
+ F+LD+ M YL E N +HRDL RNVL+ S + KV DFGL+K
Sbjct: 287 GGDCLLKFSLDVCEAMEYL--EGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTK----- 337
Query: 313 NSHDVYKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEP 368
+ + + ++ APE + +K+ K DV+SF ++L+E+ G P
Sbjct: 338 ---EAS--STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392
Query: 369 YEAAKYVAEGHR 380
+ V +G++
Sbjct: 393 KDVVPRVEKGYK 404
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-62
Identities = 70/274 (25%), Positives = 117/274 (42%), Gaps = 38/274 (13%)
Query: 132 GSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAI 185
G H + + L + S +GKG+FG + + VA+
Sbjct: 2 GHHHHHHAQLYACQDP--TIFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAV 57
Query: 186 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLH 243
K++ S D + +DF+ E+ +L L IV++ G R+ L L+ EYL G L
Sbjct: 58 KQLQHSGPDQQ---RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114
Query: 244 KYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
+L+ + L S + ++ I +GM YL +HRDL RN+L+ S H+K+ D
Sbjct: 115 DFLQRHRARLDASRLLLYSSQICKGMEYL--GSRRCVHRDLAARNILV--ESEAHVKIAD 170
Query: 303 FGLSKLIKVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGE 360
FGL+KL+ D Y + S + APE + ++ DV+SF ++LYE+ +
Sbjct: 171 FGLAKLL--PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228
Query: 361 PPLANYEPY--------------EAAKYVAEGHR 380
+ + + + EG R
Sbjct: 229 KSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR 262
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-62
Identities = 71/239 (29%), Positives = 122/239 (51%), Gaps = 19/239 (7%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFR 203
+ I ++ + I+G+G FGE+ + + VA+K + D + F
Sbjct: 6 QYGIAREDVVLNR--ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFM 61
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 262
E ++ L HP+IV+ +G + E +P +I E G+L YL+ K +L T V ++L
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
I + MAYL E +HRD+ RN+L+ +S + +K+GDFGLS+ I+ D YK +
Sbjct: 121 QICKAMAYL--ESINCVHRDIAVRNILV--ASPECVKLGDFGLSRYIE---DEDYYKASV 173
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
++M+PE R++ DV+ FA+ ++E+L G+ P E + + +G R
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR 232
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 2e-62
Identities = 77/247 (31%), Positives = 116/247 (46%), Gaps = 16/247 (6%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDD 195
P EI+ S + IIG G GE+ R PVAIK + ++
Sbjct: 35 PGRAGRSFTREIEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER 92
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSP 254
+ +DF E +++ + HPNI++ G VT + M++TEY+ G L +L+ G +
Sbjct: 93 QR--RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
V + GM YL +HRDL RNVL+ S KV DFGLS++++ +
Sbjct: 151 MQLVGMLRGVGAGMRYL--SDLGYVHRDLAARNVLV--DSNLVCKVSDFGLSRVLE-DDP 205
Query: 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAK 373
Y TG R+ APE R + DV+SF ++++E+L GE P N +
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS 265
Query: 374 YVAEGHR 380
V EG+R
Sbjct: 266 SVEEGYR 272
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-62
Identities = 70/239 (29%), Positives = 119/239 (49%), Gaps = 19/239 (7%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFR 203
D+EI ++ IG+G FG++ + + VAIK SD V + F
Sbjct: 9 DYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFL 64
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 262
E + + HP+IV+ +G +TE P+ +I E G+L +L+ K +L ++ + +A
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
++ +AYL E +HRD+ RNVL+ SS D +K+GDFGLS+ ++ YK +
Sbjct: 124 QLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME---DSTYYKASK 176
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
++MAPE R++ DV+ F + ++E+L G P + + + G R
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 235
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-61
Identities = 73/252 (28%), Positives = 116/252 (46%), Gaps = 18/252 (7%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVN 207
+ IG+GSF + K VA + L+ Q F+ E
Sbjct: 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER--QRFKEEAE 77
Query: 208 LLVKLRHPNIVQFLGA----VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
+L L+HPNIV+F + V +K ++L+TE + G L YLK + ++
Sbjct: 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ 137
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
I +G+ +LH IIHRDLK N+ + +K+GD GL+ L + + V
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCDNI-FITGPTGSVKIGDLGLATLKRASFAKAV------ 190
Query: 324 TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA-KYVAEGHRPF 382
G+ +MAPE+++ KYD+ VDV++F M + EM E P + + + V G +P
Sbjct: 191 IGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249
Query: 383 FRAKGFTPELRE 394
K PE++E
Sbjct: 250 SFDKVAIPEVKE 261
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-61
Identities = 81/251 (32%), Positives = 125/251 (49%), Gaps = 17/251 (6%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPS 191
P K EI PS + +IG G FGE+ K + PVAIK +
Sbjct: 27 GSDPNQAVLKFTTEIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG 84
Query: 192 LSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KG 250
++ + DF E ++ + H NI++ G +++ KP+M+ITEY+ G L K+L+E G
Sbjct: 85 YTEKQR--VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG 142
Query: 251 ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
S V IA GM YL +HRDL RN+L+ +S KV DFGLS++++
Sbjct: 143 EFSVLQLVGMLRGIAAGMKYL--ANMNYVHRDLAARNILV--NSNLVCKVSDFGLSRVLE 198
Query: 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPY 369
+ Y +G R+ APE +RK+ DV+SF ++++E++ GE P +
Sbjct: 199 -DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257
Query: 370 EAAKYVAEGHR 380
E K + +G R
Sbjct: 258 EVMKAINDGFR 268
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-61
Identities = 70/240 (29%), Positives = 112/240 (46%), Gaps = 21/240 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFR 203
+EL ++G G FG + K W PV IK I Q
Sbjct: 8 RIFKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVT 63
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 262
+ + L H +IV+ LG L L+T+YL G L ++++ +GAL P +N+ +
Sbjct: 64 DHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
IA+GM YL E + ++HR+L RNVLL S ++V DFG++ L+ D +
Sbjct: 123 QIAKGMYYL--EEHGMVHRNLAARNVLL--KSPSQVQVADFGVADLL---PPDDKQLLYS 175
Query: 323 ETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
E + ++MA E KY + DV+S+ + ++E++ G P A E + +G R
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER 235
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 6e-61
Identities = 72/247 (29%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDD 195
P ++ E+D + + ++G G FGE+ + VAIK + ++
Sbjct: 31 PTQTVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSP 254
+ +DF E +++ + HPNI++ G VT+ KP+M++TEY+ G L +L++ +
Sbjct: 89 QR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
V IA GM YL +HRDL RN+L+ +S KV DFGL ++++ +
Sbjct: 147 IQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILI--NSNLVCKVSDFGLGRVLE-DDP 201
Query: 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAK 373
Y G R+ +PE +RK+ DV+S+ ++L+E++ GE P + K
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK 261
Query: 374 YVAEGHR 380
V EG+R
Sbjct: 262 AVDEGYR 268
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 8e-61
Identities = 75/239 (31%), Positives = 119/239 (49%), Gaps = 24/239 (10%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
+WE+ L +G G FGE+ Y+ G T VA+K SL + F E N
Sbjct: 7 EWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 60
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIA 265
L+ +L+H +V+ VT+ P+ +ITEY+ G L +LK L+ + ++ A IA
Sbjct: 61 LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
GMA++ E IHRDL+ N+L+ S K+ DFGL++LI+ + Y T G
Sbjct: 120 EGMAFI--EERNYIHRDLRAANILV--SDTLSCKIADFGLARLIE----DNEY--TAREG 169
Query: 326 S---YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
+ ++ APE + + K DV+SF ++L E++ G P E + + G+R
Sbjct: 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 228
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 9e-61
Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 22/305 (7%)
Query: 86 CLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG-GLSYGQNGSHFEPKPVPPP- 143
C + GA + R + K E +S + + E
Sbjct: 318 CRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTY 377
Query: 144 -LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRL 197
+P+ D+EI ++ IG+G FG++ + + VAIK SD
Sbjct: 378 TMPSTRDYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR 435
Query: 198 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPST 256
+ F E + + HP+IV+ +G +TE P+ +I E G+L +L+ K +L ++
Sbjct: 436 --EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLAS 492
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
+ +A ++ +AYL E +HRD+ RNVL+ SS D +K+GDFGLS+ ++
Sbjct: 493 LILYAYQLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME---DST 545
Query: 317 VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYV 375
YK + ++MAPE R++ DV+ F + ++E+L G P + + +
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
Query: 376 AEGHR 380
G R
Sbjct: 606 ENGER 610
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-60
Identities = 68/259 (26%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 134 HFEPKPVPPPLPNK-CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKR 187
H + + P L I PS L + +IG+G FG + A+K
Sbjct: 1 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK- 59
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYL 246
L ++D + F E ++ HPN++ LG + +++ Y++ GDL ++
Sbjct: 60 SLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118
Query: 247 -KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
E + + F L +A+GM YL +HRDL RN +L +KV DFGL
Sbjct: 119 RNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCML--DEKFTVKVADFGL 174
Query: 306 SKLIKVQNSHDVYKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEP 361
++ + + Y + +TG+ ++MA E + +K+ K DV+SF ++L+E++ G P
Sbjct: 175 ARDM---YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231
Query: 362 PLANYEPYEAAKYVAEGHR 380
P + ++ Y+ +G R
Sbjct: 232 PYPDVNTFDITVYLLQGRR 250
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-60
Identities = 68/254 (26%), Positives = 110/254 (43%), Gaps = 28/254 (11%)
Query: 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRL 197
E+ + +G G+FGE+ + G VA+K + S+
Sbjct: 20 SISDLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 77
Query: 198 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-------EKG 250
DF E ++ K H NIV+ +G + P ++ E + GGDL +L+ +
Sbjct: 78 --LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS 135
Query: 251 ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKL 308
+L+ ++ A DIA G YL E N IHRD+ RN L+ K+GDFG+++
Sbjct: 136 SLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNC-LLTCPGPGRVAKIGDFGMARD 192
Query: 309 IKVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANY 366
I Y+ G ++M PE F + K D +SF ++L+E+ G P +
Sbjct: 193 I---YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 367 EPYEAAKYVAEGHR 380
E ++V G R
Sbjct: 250 SNQEVLEFVTSGGR 263
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-60
Identities = 64/239 (26%), Positives = 108/239 (45%), Gaps = 17/239 (7%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRH 204
+ L + +G G+FG + + +R VAIK + ++
Sbjct: 3 KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMR 59
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALD 263
E ++ +L +P IV+ +G + LML+ E GG LHK+L ++ + S
Sbjct: 60 EAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
++ GM YL E +HRDL RNVLL + + K+ DFGLSK + + Y
Sbjct: 119 VSMGMKYL--EEKNFVHRDLAARNVLL--VNRHYAKISDFGLSKALGADD--SYYTARSA 172
Query: 324 TGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
++ APE RK+ + DV+S+ + ++E L G+ P + E ++ +G R
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 231
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 4e-60
Identities = 76/261 (29%), Positives = 123/261 (47%), Gaps = 37/261 (14%)
Query: 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRL 197
I ++ +G+G+FG++ A VA+K + R
Sbjct: 5 SGIHVQHIKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR- 61
Query: 198 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK---------- 247
+DF+ E LL L+H +IV+F G + PL+++ EY++ GDL+K+L+
Sbjct: 62 --KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 248 ------EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301
KG L S ++ A IA GM YL +HRDL RN L+ + +K+G
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLV--GANLLVKIG 175
Query: 302 DFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EG 359
DFG+S+ + S D Y++ G T R+M PE +RK+ + DV+SF +IL+E+ G
Sbjct: 176 DFGMSRDV---YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 232
Query: 360 EPPLANYEPYEAAKYVAEGHR 380
+ P E + + +G
Sbjct: 233 KQPWFQLSNTEVIECITQGRV 253
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 6e-60
Identities = 54/249 (21%), Positives = 108/249 (43%), Gaps = 33/249 (13%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
+I +L F+ +G+G+F +I K R T V +K + + + +
Sbjct: 3 HKIRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---E 57
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVN 259
F +++ KL H ++V G +L+ E+++ G L YLK+ K ++ +
Sbjct: 58 SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE 117
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL------KVGDFGLSKLIKVQN 313
A +A M +L E N +IH ++ +N+LL+ K+ D G+S +
Sbjct: 118 VAKQLAAAMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL--- 172
Query: 314 SHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEML-EGEPPLANYEPYEA 371
D+ + ++ PE ++ K + D +SF L+E+ G+ PL+ +
Sbjct: 173 PKDILQE-----RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227
Query: 372 AKYVAEGHR 380
++ + H+
Sbjct: 228 LQFYEDRHQ 236
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 6e-60
Identities = 70/244 (28%), Positives = 118/244 (48%), Gaps = 18/244 (7%)
Query: 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLV 198
PN+ I E +F ++G G+FG + K W PVAIK + + S
Sbjct: 4 PNQALLRILK-ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--A 60
Query: 199 IQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTA 257
++ E ++ + +P++ + LG + LIT+ + G L Y++E K +
Sbjct: 61 NKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+N+ + IA+GM YL E ++HRDL RNVL+ + H+K+ DFGL+KL+
Sbjct: 120 LNWCVQIAKGMNYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL--GAEEKE 173
Query: 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVA 376
Y G ++MA E HR Y + DV+S+ + ++E++ G P E + +
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
Query: 377 EGHR 380
+G R
Sbjct: 234 KGER 237
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 8e-60
Identities = 68/258 (26%), Positives = 110/258 (42%), Gaps = 28/258 (10%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS 193
E+ + +G G+FGE+ + G VA+K + S
Sbjct: 57 GKTSSISDLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 114
Query: 194 DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK------ 247
+ DF E ++ K H NIV+ +G + P ++ E + GGDL +L+
Sbjct: 115 EQDE--LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 172
Query: 248 -EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFG 304
+ +L+ ++ A DIA G YL E N IHRD+ RN L+ K+GDFG
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNC-LLTCPGPGRVAKIGDFG 229
Query: 305 LSKLIKVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPP 362
+++ I Y+ G ++M PE F + K D +SF ++L+E+ G P
Sbjct: 230 MARDIY---RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
Query: 363 LANYEPYEAAKYVAEGHR 380
+ E ++V G R
Sbjct: 287 YPSKSNQEVLEFVTSGGR 304
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-59
Identities = 84/290 (28%), Positives = 132/290 (45%), Gaps = 45/290 (15%)
Query: 124 GGLSYGQNGSHFEPKPV---------PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEIL 174
G + G + S E K P + C I ++ +G+G+FG++
Sbjct: 1 GAMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKW--ELGEGAFGKVF 58
Query: 175 KAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227
A VA+K + + R QDF+ E LL L+H +IV+F G TE
Sbjct: 59 LAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTMLQHQHIVRFFGVCTEG 115
Query: 228 KPLMLITEYLRGGDLHKYLKE---------------KGALSPSTAVNFALDIARGMAYLH 272
+PL+++ EY+R GDL+++L+ G L + A +A GM YL
Sbjct: 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL- 174
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMA 331
+HRDL RN L+ +K+GDFG+S+ I S D Y++ G T R+M
Sbjct: 175 -AGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSRDI---YSTDYYRVGGRTMLPIRWMP 228
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
PE +RK+ + DV+SF ++L+E+ G+ P EA + +G
Sbjct: 229 PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE 278
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-59
Identities = 86/276 (31%), Positives = 128/276 (46%), Gaps = 24/276 (8%)
Query: 114 FNMMELLNAH-----GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKG 168
FN ++ L A+ GL + KP L K WEI L +G+G
Sbjct: 139 FNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGL-AKDAWEIPRESLRLEV--KLGQG 195
Query: 169 SFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227
FGE+ W G T VAIK +L + + F E ++ KLRH +VQ V+E
Sbjct: 196 CFGEVWMGTWNGTTRVAIK----TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250
Query: 228 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKP 285
+P+ ++TEY+ G L +LK + L V+ A IA GMAY+ E +HRDL+
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMNYVHRDLRA 308
Query: 286 RNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVD 345
N+L+ KV DFGL++LI ++ G ++ APE + ++ K D
Sbjct: 309 ANILV--GENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 346 VFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
V+SF ++L E+ +G P E V G+R
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 399
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-59
Identities = 67/275 (24%), Positives = 110/275 (40%), Gaps = 36/275 (13%)
Query: 131 NGSHFEPKPVPPPLPNKCD-WEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPV 183
+ H + D L +G+G FG++ + V
Sbjct: 6 HHHHHHHGALEVLFQGPGDPTVFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMV 63
Query: 184 AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGD 241
A+K + ++ E+++L L H +I+++ G + L L+ EY+ G
Sbjct: 64 AVKALKADAGPQ--HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121
Query: 242 LHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301
L YL + ++ + + FA I GMAYL IHRDL RNVLL + +K+G
Sbjct: 122 LRDYLP-RHSIGLAQLLLFAQQICEGMAYL--HAQHYIHRDLAARNVLL--DNDRLVKIG 176
Query: 302 DFGLSKLIKVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML--- 357
DFGL+K + H+ Y++ + S + APE K K+ DV+SF + LYE+L
Sbjct: 177 DFGLAKAVP--EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC 234
Query: 358 ------EGEPPLANYEPY------EAAKYVAEGHR 380
+ + + G R
Sbjct: 235 DSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-59
Identities = 75/269 (27%), Positives = 127/269 (47%), Gaps = 34/269 (12%)
Query: 131 NGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPV 183
N +F V P +WE+ ++ S +G+GSFG + + +G T V
Sbjct: 5 NPEYFSAADVYVPD----EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRV 58
Query: 184 AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLH 243
AIK + + S +F +E +++ + ++V+ LG V++ +P ++I E + GDL
Sbjct: 59 AIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 116
Query: 244 KYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS 293
YL+ S S + A +IA GMAYL N +HRDL RN ++ +
Sbjct: 117 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL--NANKFVHRDLAARNCMV--A 172
Query: 294 SADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMI 352
+K+GDFG+++ I D Y+ G+ R+M+PE K + DV+SF ++
Sbjct: 173 EDFTVKIGDFGMTRDI---YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 229
Query: 353 LYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
L+E+ E P + ++V EG
Sbjct: 230 LWEIATLAEQPYQGLSNEQVLRFVMEGGL 258
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 3e-59
Identities = 71/248 (28%), Positives = 116/248 (46%), Gaps = 18/248 (7%)
Query: 137 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDD 195
P K WEI L +G G FGE+ A + T VA+K + P
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV 227
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALS 253
+ F E N++ L+H +V+ VT+ +P+ +ITE++ G L +LK E
Sbjct: 228 ----EAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQP 282
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
++F+ IA GMA++ E IHRDL+ N+L+ S++ K+ DFGL+++I
Sbjct: 283 LPKLIDFSAQIAEGMAFI--EQRNYIHRDLRAANILV--SASLVCKIADFGLARVI---E 335
Query: 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAA 372
++ G ++ APE + K DV+SF ++L E++ G P E
Sbjct: 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 395
Query: 373 KYVAEGHR 380
+ + G+R
Sbjct: 396 RALERGYR 403
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 7e-59
Identities = 66/251 (26%), Positives = 120/251 (47%), Gaps = 20/251 (7%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDD 195
L D I + S +IGKG FG + + AIK L +++
Sbjct: 5 SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK-SLSRITEM 63
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLITEYLRGGDLHKYLK-EKGALS 253
+ ++ F E L+ L HPN++ +G + + ++ Y+ GDL ++++ + +
Sbjct: 64 Q-QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPT 122
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
++F L +ARGM YL +HRDL RN +L + +KV DFGL++ I
Sbjct: 123 VKDLISFGLQVARGMEYL--AEQKFVHRDLAARNCML--DESFTVKVADFGLARDI---L 175
Query: 314 SHDVYKMTGETGS---YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 369
+ Y + + ++ A E + ++ K DV+SF ++L+E+L G PP + +P+
Sbjct: 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235
Query: 370 EAAKYVAEGHR 380
+ ++A+G R
Sbjct: 236 DLTHFLAQGRR 246
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 8e-59
Identities = 75/271 (27%), Positives = 117/271 (43%), Gaps = 28/271 (10%)
Query: 128 YGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TP 182
+ + S P+ D ID + L I+G+G FG +++ +
Sbjct: 7 HHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLK 64
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-----LMLITEYL 237
VA+K + S R + ++F E + HPN+++ LG E M+I ++
Sbjct: 65 VAVKTMKLDNSSQREI-EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 238 RGGDLHKYLK------EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 291
+ GDLH YL + T + F +DIA GM YL +HRDL RN +L
Sbjct: 124 KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCML- 180
Query: 292 NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFA 350
+ V DFGLSK I S D Y+ +++A E R Y K DV++F
Sbjct: 181 -RDDMTVCVADFGLSKKI---YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 236
Query: 351 MILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
+ ++E+ G P + +E Y+ GHR
Sbjct: 237 VTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-58
Identities = 69/289 (23%), Positives = 125/289 (43%), Gaps = 15/289 (5%)
Query: 101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNK-CDWEIDPSELDF 159
+ ++ + + G N H + + P L I PS L
Sbjct: 32 PGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIV 91
Query: 160 SSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
+ +IG+G FG + A+K L ++D + F E ++ H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK-SLNRITDIG-EVSQFLTEGIIMKDFSH 149
Query: 215 PNIVQFLGAVTERK-PLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLH 272
PN++ LG + +++ Y++ GDL ++ E + + F L +A+GM +L
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
+HRDL RN +L +KV DFGL++ + + V+ TG ++MA
Sbjct: 209 -ASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 333 EVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
E + +K+ K DV+SF ++L+E++ G PP + ++ Y+ +G R
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 314
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-58
Identities = 79/249 (31%), Positives = 117/249 (46%), Gaps = 19/249 (7%)
Query: 137 PKPVPPP-LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSD 194
P P K WEI L +G+G FGE+ W G T VAIK +L
Sbjct: 248 PTSKPQTQGLAKDAWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIK----TLKP 301
Query: 195 DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--AL 252
+ + F E ++ KLRH +VQ V+E +P+ ++TEY+ G L +LK + L
Sbjct: 302 GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL 360
Query: 253 SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
V+ A IA GMAY+ E +HRDL+ N+L+ KV DFGL++LI
Sbjct: 361 RLPQLVDMAAQIASGMAYV--ERMNYVHRDLRAANILV--GENLVCKVADFGLARLI--- 413
Query: 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEA 371
++ G ++ APE + ++ K DV+SF ++L E+ +G P E
Sbjct: 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 473
Query: 372 AKYVAEGHR 380
V G+R
Sbjct: 474 LDQVERGYR 482
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-58
Identities = 75/257 (29%), Positives = 118/257 (45%), Gaps = 38/257 (14%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDF 202
EI S + F +G+ FG++ K + G VAIK + ++F
Sbjct: 4 KEISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR--EEF 59
Query: 203 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------------- 248
RHE L +L+HPN+V LG VT+ +PL +I Y GDLH++L
Sbjct: 60 RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 249 --KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
K AL P V+ IA GM YL + ++H+DL RNVL+ ++K+ D GL
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYL--SSHHVVHKDLATRNVLV--YDKLNVKISDLGLF 175
Query: 307 KLIKVQNSHDVYKMTGETGSY--RYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPL 363
+ + + D YK+ G R+MAPE + K+ D++S+ ++L+E+ G P
Sbjct: 176 REV---YAADYYKLLGN-SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231
Query: 364 ANYEPYEAAKYVAEGHR 380
Y + + +
Sbjct: 232 CGYSNQDVVEMIRNRQV 248
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-57
Identities = 83/275 (30%), Positives = 123/275 (44%), Gaps = 42/275 (15%)
Query: 131 NGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIK 186
H P P +D +++ F +IG+G+FG++LKA + AIK
Sbjct: 2 KKHHHHHHGKNNPDPTI-YPVLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIK 58
Query: 187 RILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY 245
R+ S D +DF E+ +L KL HPNI+ LGA R L L EY G+L +
Sbjct: 59 RMKEYASKDDH--RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116
Query: 246 LKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL 289
L++ LS ++FA D+ARGM YL IHRDL RN+L
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNIL 174
Query: 290 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS---YRYMAPEVFKHRKYDKKVDV 346
+ K+ DFGLS+ +VY T R+MA E + Y DV
Sbjct: 175 V--GENYVAKIADFGLSR------GQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDV 224
Query: 347 FSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
+S+ ++L+E++ G P E + + +G+R
Sbjct: 225 WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 259
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-57
Identities = 76/276 (27%), Positives = 122/276 (44%), Gaps = 44/276 (15%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILP 190
+ P E + +++ IG+G+FG + +A G T VA+K +L
Sbjct: 30 RMPLLLNPKLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVK-MLK 86
Query: 191 SLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK- 249
+ + DF+ E L+ + +PNIV+ LG KP+ L+ EY+ GDL+++L+
Sbjct: 87 EEASADM-QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMS 145
Query: 250 -----------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR 286
LS + + A +A GMAYL +HRDL R
Sbjct: 146 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATR 203
Query: 287 NVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVD 345
N L+ +K+ DFGLS+ I S D YK G R+M PE + +Y + D
Sbjct: 204 NCLV--GENMVVKIADFGLSRNI---YSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 258
Query: 346 VFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
V+++ ++L+E+ G P E YV +G+
Sbjct: 259 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI 294
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 5e-57
Identities = 81/282 (28%), Positives = 125/282 (44%), Gaps = 46/282 (16%)
Query: 129 GQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------T 181
G N + +P +P WE + L F +G G+FG++++A G
Sbjct: 1 GNNYVYIDPTQLPYDH----KWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAM 54
Query: 182 PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGG 240
VA+K + PS + E+ +L L H NIV LGA T P ++ITEY G
Sbjct: 55 TVAVKMLKPSAHLTER--EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG 112
Query: 241 DLHKYLKEK------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
DL +L+ K AL ++F+ +A+GMA+L IHRD
Sbjct: 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRD 170
Query: 283 LKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKY 340
L RN+LL + + K+ DFGL++ I + Y + G ++MAPE + Y
Sbjct: 171 LAARNILL---THGRITKICDFGLARDI---KNDSNYVVKGNARLPVKWMAPESIFNCVY 224
Query: 341 DKKVDVFSFAMILYEMLE-GEPPLANYEP-YEAAKYVAEGHR 380
+ DV+S+ + L+E+ G P + K + EG R
Sbjct: 225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-56
Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 46/272 (16%)
Query: 143 PLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDD 195
+ WE L +G+G FG+++KA T VA+K + + S
Sbjct: 11 KILEDPKWEFPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS 68
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------ 249
L +D E N+L ++ HP++++ GA ++ PL+LI EY + G L +L+E
Sbjct: 69 EL--RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 250 ------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 291
AL+ ++FA I++GM YL ++HRDL RN+L+
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILV- 183
Query: 292 NSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSF 349
+ +K+ DFGLS+ + D Y + ++MA E Y + DV+SF
Sbjct: 184 --AEGRKMKISDFGLSRDV---YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238
Query: 350 AMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
++L+E++ G P P + GHR
Sbjct: 239 GVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR 270
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-56
Identities = 69/251 (27%), Positives = 112/251 (44%), Gaps = 29/251 (11%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFR 203
D I + ++GKG FG + +A + VA+K +L + I++F
Sbjct: 17 DVLIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVK-MLKADIIASSDIEEFL 73
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLK------EKGA 251
E + + HP++ + +G + M+I +++ GDLH +L
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 252 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
L T V F +DIA GM YL IHRDL RN +L + + V DFGLS+ I
Sbjct: 134 LPLQTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCML--AEDMTVCVADFGLSRKI-- 187
Query: 312 QNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 369
S D Y+ + +++A E Y DV++F + ++E++ G+ P A E
Sbjct: 188 -YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246
Query: 370 EAAKYVAEGHR 380
E Y+ G+R
Sbjct: 247 EIYNYLIGGNR 257
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-56
Identities = 81/288 (28%), Positives = 127/288 (44%), Gaps = 45/288 (15%)
Query: 123 HGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-- 180
H + Q+ P K WE +L +G+G+FG+++ A G
Sbjct: 5 HHHHHHSQDPMLAGVSEYELPEDPK--WEFPRDKLTLGK--PLGEGAFGQVVMAEAVGID 60
Query: 181 -------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232
VA+K + ++ L D E+ ++ + +H NI+ LGA T+ PL +
Sbjct: 61 KDKPKEAVTVAVKMLKDDATEKDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118
Query: 233 ITEYLRGGDLHKYLK----------------EKGALSPSTAVNFALDIARGMAYLHNEPN 276
I EY G+L +YL+ + ++ V+ +ARGM YL
Sbjct: 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQ 176
Query: 277 VIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPE 333
IHRDL RNVL+ ++ K+ DFGL++ I N+ D YK T ++MAPE
Sbjct: 177 KCIHRDLAARNVLV----TENNVMKIADFGLARDI---NNIDYYKKTTNGRLPVKWMAPE 229
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
R Y + DV+SF ++++E+ G P E K + EGHR
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 277
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 9e-56
Identities = 79/266 (29%), Positives = 124/266 (46%), Gaps = 41/266 (15%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 194
LP WE +L +G+G FG+++ A G VA+K + ++
Sbjct: 70 LPEDPKWEFPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE 127
Query: 195 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK------ 247
L D E+ ++ + +H NI+ LGA T+ PL +I EY G+L +YL+
Sbjct: 128 KDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185
Query: 248 ----------EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
+ ++ V+ +ARGM YL IHRDL RNVL+ + ++
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLV---TENN 240
Query: 298 -LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYE 355
+K+ DFGL++ I N+ D YK T ++MAPE R Y + DV+SF ++++E
Sbjct: 241 VMKIADFGLARDI---NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 297
Query: 356 MLE-GEPPLANYEPYEAAKYVAEGHR 380
+ G P E K + EGHR
Sbjct: 298 IFTLGGSPYPGIPVEELFKLLKEGHR 323
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 4e-55
Identities = 86/300 (28%), Positives = 132/300 (44%), Gaps = 46/300 (15%)
Query: 115 NMMELLNAHGGLSYGQNGSHFEPKPVPPP-----LPNKCDWEIDPSELDFSSSAIIGKGS 169
M + H + + + LP WE+ L +G+G+
Sbjct: 24 GMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGK--PLGEGA 81
Query: 170 FGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQ 219
FG+++ A G T VA+K + ++ L D E+ ++ + +H NI+
Sbjct: 82 FGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--SDLISEMEMMKMIGKHKNIIN 139
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALD 263
LGA T+ PL +I EY G+L +YL+ + LS V+ A
Sbjct: 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 199
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTG 322
+ARGM YL IHRDL RNVL+ + D+ +K+ DFGL++ I + D YK T
Sbjct: 200 VARGMEYL--ASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDI---HHIDYYKKTT 251
Query: 323 ETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380
++MAPE R Y + DV+SF ++L+E+ G P E K + EGHR
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 311
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 9e-55
Identities = 81/269 (30%), Positives = 128/269 (47%), Gaps = 44/269 (16%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS 193
P LP WE + L F +G G+FG++++A G VA+K + +
Sbjct: 32 PTQLPYNEKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 194 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-- 250
D + E+ ++ L +H NIV LGA T P+++ITEY GDL +L+ K
Sbjct: 90 ADEK--EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147
Query: 251 ------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
S ++F+ +A+GMA+L IHRD+ RNVLL + H+
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLL---TNGHV 202
Query: 299 -KVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEM 356
K+GDFGL++ I + Y + G ++MAPE Y + DV+S+ ++L+E+
Sbjct: 203 AKIGDFGLARDI---MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259
Query: 357 LE-GEPP----LANYEPYEAAKYVAEGHR 380
G P L N + Y K V +G++
Sbjct: 260 FSLGLNPYPGILVNSKFY---KLVKDGYQ 285
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-53
Identities = 67/251 (26%), Positives = 112/251 (44%), Gaps = 18/251 (7%)
Query: 137 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSL 192
P P L +K + L + +G G+FG + + +R VAIK +
Sbjct: 318 PFSDPEELKDK-KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT 375
Query: 193 SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGA 251
++ E ++ +L +P IV+ +G + LML+ E GG LHK+L +
Sbjct: 376 EKA--DTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE 432
Query: 252 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
+ S ++ GM YL E +HR+L RNVLL + + K+ DFGLSK +
Sbjct: 433 IPVSNVAELLHQVSMGMKYL--EEKNFVHRNLAARNVLL--VNRHYAKISDFGLSKALGA 488
Query: 312 QNSHDVYKMTGETGS-YRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPY 369
+ Y ++ APE RK+ + DV+S+ + ++E L G+ P +
Sbjct: 489 DD--SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546
Query: 370 EAAKYVAEGHR 380
E ++ +G R
Sbjct: 547 EVMAFIEQGKR 557
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-53
Identities = 71/254 (27%), Positives = 117/254 (46%), Gaps = 22/254 (8%)
Query: 154 PSELD-FSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLL 209
PS + + IG GS+G K + G + K + S+++ Q EVNLL
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK--QMLVSEVNLL 59
Query: 210 VKLRHPNIVQFLGAVTERKP--LMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALD 263
+L+HPNIV++ + +R L ++ EY GGDL + + + L +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 264 IARGMAYLHNE---PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
+ + H + ++HRDLKP NV L ++K+GDFGL++++ +HD
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFGLARIL----NHDTSFA 173
Query: 321 TGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380
G+ YM+PE Y++K D++S +LYE+ PP + E A + EG
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233
Query: 381 PFFRAKGFTPELRE 394
++ EL E
Sbjct: 234 RRI-PYRYSDELNE 246
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 4e-53
Identities = 77/304 (25%), Positives = 121/304 (39%), Gaps = 51/304 (16%)
Query: 112 KKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFG 171
+ +L S + + + L WE L+F ++G G+FG
Sbjct: 6 QFRYESQLQMVQVTGSSDNEYFYVDFREYEYDL----KWEFPRENLEFGK--VLGSGAFG 59
Query: 172 EILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGA 223
+++ A G VA+K + + E+ ++ +L H NIV LGA
Sbjct: 60 KVMNATAYGISKTGVSIQVAVKMLKEKADSSER--EALMSELKMMTQLGSHENIVNLLGA 117
Query: 224 VTERKPLMLITEYLRGGDLHKYLKEK-----------------------GALSPSTAVNF 260
T P+ LI EY GDL YL+ K L+ + F
Sbjct: 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 177
Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYK 319
A +A+GM +L E +HRDL RNVL+ + + K+ DFGL++ I S Y
Sbjct: 178 AYQVAKGMEFL--EFKSCVHRDLAARNVLV---THGKVVKICDFGLARDI---MSDSNYV 229
Query: 320 MTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEP-YEAAKYVA 376
+ G ++MAPE Y K DV+S+ ++L+E+ G P K +
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 289
Query: 377 EGHR 380
G +
Sbjct: 290 NGFK 293
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-53
Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 16/218 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RH 214
F + +G GS+GE+ K + G A+KR + + EV K+ +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQH 116
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHN 273
P V+ A E L L TE G L ++ + GA L + + D +A+LH+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
++H D+KP N+ L K+GDFGL + + +V + G RYMAPE
Sbjct: 176 --QGLVHLDVKPANIFL--GPRGRCKLGDFGLLVELGTAGAGEVQE-----GDPRYMAPE 226
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
+ + Y DVFS + + E+ E ++
Sbjct: 227 LLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ 263
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 8e-53
Identities = 71/250 (28%), Positives = 108/250 (43%), Gaps = 35/250 (14%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRH 214
DF +G+G FG + +A + AIKRI LP+ R + EV L KL H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR---EKVMREVKALAKLEH 62
Query: 215 PNIVQFLGAVTERKP------------LMLITEYLRGGDLHKYLKEKGALSP---STAVN 259
P IV++ A E+ L + + R +L ++ + + S ++
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK--------V 311
L IA + +LH+ ++HRDLKP N+ + D +KVGDFGL + +
Sbjct: 123 IFLQIAEAVEFLHS--KGLMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
+ TG+ G+ YM+PE Y KVD+FS +IL+E+L P E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRT 236
Query: 372 AKYVAEGHRP 381
V P
Sbjct: 237 LTDVRNLKFP 246
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 8e-53
Identities = 58/236 (24%), Positives = 113/236 (47%), Gaps = 16/236 (6%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
IG+GSFG+ + G IK I + +S ++ R EV +L ++HPNIVQ+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER--EESRREVAVLANMKHPNIVQY 88
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVI 278
+ E L ++ +Y GGDL K + +++ + I + ++H+ I
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD--RKI 146
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
+HRD+K +N+ L + +++GDFG+++++ NS G+ Y++PE+ +++
Sbjct: 147 LHRDIKSQNIFL--TKDGTVQLGDFGIARVL---NSTVELARA-CIGTPYYLSPEICENK 200
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
Y+ K D+++ +LYE+ + + G P ++ +LR
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVS-LHYSYDLRS 255
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-52
Identities = 76/277 (27%), Positives = 123/277 (44%), Gaps = 49/277 (17%)
Query: 136 EPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRI 188
E P +K WE L +G+G+FG++++A G VA+K +
Sbjct: 10 EHCERLPYDASK--WEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKML 65
Query: 189 LPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER-KPLMLITEYLRGGDLHKYL 246
+ + E+ +L+ + H N+V LGA T+ PLM+I E+ + G+L YL
Sbjct: 66 KEGATHSEH--RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 247 KE----------------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 290
+ K L+ + ++ +A+GM +L IHRDL RN+LL
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILL 181
Query: 291 VNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFS 348
S + +K+ DFGL++ I Y G+ ++MAPE R Y + DV+S
Sbjct: 182 ---SEKNVVKICDFGLARDI---YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235
Query: 349 FAMILYEMLE-GEPPLANY----EPYEAAKYVAEGHR 380
F ++L+E+ G P Y E + + EG R
Sbjct: 236 FGVLLWEIFSLGASP---YPGVKIDEEFCRRLKEGTR 269
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-52
Identities = 69/257 (26%), Positives = 113/257 (43%), Gaps = 42/257 (16%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +IG G FG++ KA R G IKR+ + + EV L KL H
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLDHV 64
Query: 216 NIVQFLGA----------------VTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTA 257
NIV + G ++ K L + E+ G L ++++++ L A
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ I +G+ Y+H+ +I+RDLKP N+ L +K+GDFGL +K
Sbjct: 125 LELFEQITKGVDYIHS--KKLINRDLKPSNIFL--VDTKQVKIGDFGLVTSLKNDG---- 176
Query: 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377
K T G+ RYM+PE + Y K+VD+++ +IL E+L +E +K+ +
Sbjct: 177 -KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFTD 230
Query: 378 GHRPFFRAKGFTPELRE 394
+ F + +
Sbjct: 231 LRDGII-SDIFDKKEKT 246
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 7e-52
Identities = 68/273 (24%), Positives = 120/273 (43%), Gaps = 18/273 (6%)
Query: 131 NGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI 188
G P P P + +F IG+G F E+ +A G PVA+K++
Sbjct: 6 QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 189 -LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK 247
+ L D + D E++LL +L HPN++++ + E L ++ E GDL + +K
Sbjct: 66 QIFDLMDAKA-RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124
Query: 248 EKGA----LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
+ T + + + + ++H+ ++HRD+KP NV + ++ +K+GD
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFI--TATGVVKLGDL 180
Query: 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP- 362
GL + S G+ YM+PE Y+ K D++S +LYEM + P
Sbjct: 181 GLGRFF----SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236
Query: 363 -LANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
Y K + + P + ++ ELR+
Sbjct: 237 YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 7e-52
Identities = 61/290 (21%), Positives = 117/290 (40%), Gaps = 40/290 (13%)
Query: 121 NAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR- 179
+ G+ G +F+ V + I IG G ++ +
Sbjct: 6 HHSSGVDLGTENLYFQSMSV-----KGRIYSIL---------KQIGSGGSSKVFQVLNEK 51
Query: 180 GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPN--IVQFLGAVTERKPLMLITEY 236
AIK + +L + D + +R+E+ L KL+ + I++ + + ++ E
Sbjct: 52 KQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 109
Query: 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
DL+ +LK+K ++ P ++ ++ + +H + I+H DLKP N L+V+
Sbjct: 110 -GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVDGM-- 164
Query: 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-----------HRKYDKKVD 345
LK+ DFG++ ++ ++ V K + + G+ YM PE K K K D
Sbjct: 165 -LKLIDFGIANQMQ-PDTTSVVKDS-QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 346 VFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRAKGFTPELRE 394
V+S ILY M G+ P + + + +L++
Sbjct: 222 VWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 271
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-51
Identities = 56/246 (22%), Positives = 107/246 (43%), Gaps = 26/246 (10%)
Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPN--IVQF 220
IG G ++ + AIK + +L + D + +R+E+ L KL+ + I++
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ + ++ E DL+ +LK+K ++ P ++ ++ + +H + I+H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVH 131
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK---- 336
DLKP N L+V+ LK+ DFG++ ++ ++ V K + + G+ YM PE K
Sbjct: 132 SDLKPANFLIVD---GMLKLIDFGIANQMQ-PDTTSVVKDS-QVGTVNYMPPEAIKDMSS 186
Query: 337 -------HRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRAKGF 388
K K DV+S ILY M G+ P + + +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246
Query: 389 TPELRE 394
+L++
Sbjct: 247 EKDLQD 252
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-50
Identities = 61/263 (23%), Positives = 100/263 (38%), Gaps = 42/263 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKL-R 213
+F IG G FG + K R G AIKR P Q+ EV L +
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD--EQNALREVYAHAVLGQ 69
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMA 269
H ++V++ A E +++ EY GG L + E + + L + RG+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 270 YLHNEPNVIIHRDLKPRNVLL-----------------VNSSADHLKVGDFGLSKLIKVQ 312
Y+H+ ++H D+KP N+ + S+ K+GD G I
Sbjct: 130 YIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 313 NSHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
E G R++A EV + + K D+F+ A+ + EP N + +
Sbjct: 188 QV--------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239
Query: 372 AKYVAEGHRPFFRAKGFTPELRE 394
+ +G P + + E E
Sbjct: 240 ---IRQGRLPRI-PQVLSQEFTE 258
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-50
Identities = 66/251 (26%), Positives = 101/251 (40%), Gaps = 17/251 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHE 205
D+E + +G+GSFGE+ + + T A+K++ L + E
Sbjct: 50 DYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---------E 100
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIA 265
+ L P IV GAV E + + E L GG L + +K+ G L A+ +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK-LIKVQNSHDVYKMTGET 324
G+ YLH I+H D+K NVLL +S + DFG + L +
Sbjct: 161 EGLEYLHT--RRILHGDVKADNVLL-SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384
G+ +MAPEV + D KVD++S ++ ML G P Y +A P
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIRE 277
Query: 385 AK-GFTPELRE 394
P +
Sbjct: 278 IPPSCAPLTAQ 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-50
Identities = 64/252 (25%), Positives = 109/252 (43%), Gaps = 37/252 (14%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF A++G+G+FG+++KA AIK+I ++++ + EV LL L H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEK--LSTILSEVMLLASLNHQ 62
Query: 216 NIVQFLGAVTERKP-------------LMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFA 261
+V++ A ER+ L + EY G L+ + +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY--- 318
I ++Y+H+ IIHRDLKP N+ + + ++K+GDFGL+K +
Sbjct: 123 RQILEALSYIHS--QGIIHRDLKPMNIFI--DESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 319 -------KMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
+T G+ Y+A EV Y++K+D++S +I +EM+ P E
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVN 236
Query: 371 AAKYVAEGHRPF 382
K + F
Sbjct: 237 ILKKLRSVSIEF 248
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 9e-50
Identities = 56/246 (22%), Positives = 107/246 (43%), Gaps = 26/246 (10%)
Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPN--IVQF 220
IG G ++ + AIK + +L + D + +R+E+ L KL+ + I++
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ + ++ E DL+ +LK+K ++ P ++ ++ + +H + I+H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVH 178
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK---- 336
DLKP N L+V+ LK+ DFG++ ++ ++ V K + + G+ YM PE K
Sbjct: 179 SDLKPANFLIVDGM---LKLIDFGIANQMQ-PDTTSVVKDS-QVGAVNYMPPEAIKDMSS 233
Query: 337 -------HRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRAKGF 388
K K DV+S ILY M G+ P + + +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293
Query: 389 TPELRE 394
+L++
Sbjct: 294 EKDLQD 299
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 7e-49
Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 23/235 (9%)
Query: 141 PPPLPNKCDWE---IDPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDR 196
P + D E + ++ F ++G G+ G I+ + VA+KRILP
Sbjct: 5 PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---- 60
Query: 197 LVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSP 254
EV LL + HPN++++ +R+ + E L +Y+++K A
Sbjct: 61 --FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLG 117
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIKV 311
+ G+A+LH+ I+HRDLKP N+L+ +A + DFGL K +
Sbjct: 118 LEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA- 174
Query: 312 QNSHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEML-EGEPP 362
H + +G G+ ++APE+ VD+FS + Y ++ EG P
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-48
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRIL-PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+GKG+F + + + T A K I LS Q E + KL+HPNIV+
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKLEREARICRKLQHPNIVRL 70
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
++ E L+ + + GG+L + + + S + A + I +AY H+ N I+H
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS--NGIVH 128
Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
R+LKP N+LL + + +K+ DFGL+ + G G+ Y++PEV K
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-----AWHGFAGTPGYLSPEVLKKDP 183
Query: 340 YDKKVDVFSFAMILYEMLEGEPP 362
Y K VD+++ +ILY +L G PP
Sbjct: 184 YSKPVDIWACGVILYILLVGYPP 206
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 9e-48
Identities = 69/202 (34%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++GKGSFGE++ + T A+K I + + EV LL +L HPNI++
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
++ L+ E GG+L + + S A + G+ Y+H N I+HR
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK--NKIVHR 150
Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
DLKP N+LL + S D ++++ DFGLS + KM + G+ Y+APEV Y
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASK-----KMKDKIGTAYYIAPEVLH-GTY 204
Query: 341 DKKVDVFSFAMILYEMLEGEPP 362
D+K DV+S +ILY +L G PP
Sbjct: 205 DEKCDVWSTGVILYILLSGCPP 226
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-47
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
I+G+G+ + + + G AIK + E +L KL H NIV+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKKLNHKNIVKLF 73
Query: 222 GAVTERKP--LMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPN 276
E +LI E+ G L+ L+E L S + D+ GM +L N
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--N 131
Query: 277 VIIHRDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I+HR++KP N++ V K+ DFG ++ ++ + G+ Y+ P++
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-----QFVSLYGTEEYLHPDM 186
Query: 335 FK--------HRKYDKKVDVFSFAMILYEMLEGEPP 362
++ +KY VD++S + Y G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-47
Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++G G+F E+ R T A+K I S + +E+ +L K++H NIV
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKHENIVTLE 72
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
L+ + + GG+L + E+G + A + + YLH N I+HR
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE--NGIVHR 130
Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
DLKP N+L + + + + DFGLSK+ + M+ G+ Y+APEV + Y
Sbjct: 131 DLKPENLLYLTPEENSKIMITDFGLSKMEQNG------IMSTACGTPGYVAPEVLAQKPY 184
Query: 341 DKKVDVFSFAMILYEMLEGEPP 362
K VD +S +I Y +L G PP
Sbjct: 185 SKAVDCWSIGVITYILLCGYPP 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 2e-47
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG+GS+GE+ A +GT A K+I +D + F+ E+ ++ L HPNI++
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLY 72
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ + L+ E GG+L + + K S A D+ +AY H + HR
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK--LNVAHR 130
Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
DLKP N L + S D LK+ DFGL+ K M + G+ Y++P+V + Y
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-----MMRTKVGTPYYVSPQVLE-GLY 184
Query: 341 DKKVDVFSFAMILYEMLEGEPP 362
+ D +S +++Y +L G PP
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPP 206
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-47
Identities = 66/212 (31%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+G G FG +L+ + G VAIK+ LS + + E+ ++ KL HPN+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKKLNHPNVVSAR 78
Query: 222 ------GAVTERKPLMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLH 272
+ +L EY GGDL KYL + L DI+ + YLH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 273 NEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
N IIHRDLKP N++L K+ D G +K + Q T G+ +Y+A
Sbjct: 139 E--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGE----LCTEFVGTLQYLA 191
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
PE+ + +KY VD +SF + +E + G P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-47
Identities = 74/241 (30%), Positives = 115/241 (47%), Gaps = 20/241 (8%)
Query: 130 QNGSHFEPKPVPPPLPNKCDWEIDPSELD-----FSSSAIIGKGSFGEILKAYWRGT--P 182
Q+ S P D+ ID S D F + +G+G+ + + +GT P
Sbjct: 21 QSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKP 80
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242
A+K + + + R E+ +L++L HPNI++ + L+ E + GG+L
Sbjct: 81 YALKVL-----KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVG 301
+ EKG S A + I +AYLH N I+HRDLKP N+L + D LK+
Sbjct: 136 FDRIVEKGYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIA 193
Query: 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
DFGLSK+++ Q M G+ Y APE+ + Y +VD++S +I Y +L G
Sbjct: 194 DFGLSKIVEHQV-----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE 248
Query: 362 P 362
P
Sbjct: 249 P 249
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-47
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G G+ GE+ A+ R T VAI+ I + + + E+ +L KL HP I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
++ ++ E + GG+L + L +T + + + YLH N
Sbjct: 203 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--NG 259
Query: 278 IIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF- 335
IIHRDLKP NVLL + D +K+ DFG SK++ + M G+ Y+APEV
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-----ETSLMRTLCGTPTYLAPEVLV 314
Query: 336 --KHRKYDKKVDVFSFAMILYEMLEGEPP 362
Y++ VD +S +IL+ L G PP
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 6e-47
Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 16/238 (6%)
Query: 132 GSHFEPKPVPPPLPNKCDWEIDPSELDFSSS----AIIGKGSFGEILKAYWRGT--PVAI 185
G H + ++ ++ S FS + +GKG+F + + + T A
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNAST-KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAA 59
Query: 186 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY 245
K I R Q E + KL+HPNIV+ ++ E L+ + + GG+L +
Sbjct: 60 KIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFED 118
Query: 246 LKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFG 304
+ + S + A + I +AY H+ N I+HR+LKP N+LL + + +K+ DFG
Sbjct: 119 IVAREFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFG 176
Query: 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
L+ + G G+ Y++PEV K Y K VD+++ +ILY +L G PP
Sbjct: 177 LAIEVNDSE-----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 7e-47
Identities = 57/284 (20%), Positives = 104/284 (36%), Gaps = 26/284 (9%)
Query: 130 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKR 187
+ H + + +G+G F + G A+KR
Sbjct: 2 GSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR 61
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP----LMLITEYLRGGDLH 243
IL DR ++ + E ++ HPNI++ + + L+ + + G L
Sbjct: 62 ILCHEQQDR---EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118
Query: 244 KYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK 299
++ L+ + L I RG+ +H + HRDLKP N+LL
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILL--GDEGQPV 174
Query: 300 VGDFGLSKL--IKVQNSHDVYKM---TGETGSYRYMAPEVF---KHRKYDKKVDVFSFAM 351
+ D G I V+ S + + + Y APE+F H D++ DV+S
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGC 234
Query: 352 ILYEMLEGEPP-LANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
+LY M+ GE P ++ ++ + ++ + L +
Sbjct: 235 VLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQ 278
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 2e-46
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 28/217 (12%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
I+G+G+ + + + G AIK S V E +L KL H NIV+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ---MREFEVLKKLNHKNIVKL 72
Query: 221 LGAVTERKP--LMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEP 275
E +LI E+ G L+ L+E L S + D+ GM +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 276 NVIIHRDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
N I+HR++KP N++ V K+ DFG ++ ++ D + G+ Y+ P+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-----DDEQFVSLYGTEEYLHPD 185
Query: 334 VFK--------HRKYDKKVDVFSFAMILYEMLEGEPP 362
+++ +KY VD++S + Y G P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-46
Identities = 72/203 (35%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
++GKGSFGE+LK R T A+K I S + EV LL KL HPNI++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHPNIMKL 86
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ + ++ E GG+L + ++ S A + G+ Y+H + I+H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK--HNIVH 144
Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
RDLKP N+LL + D +K+ DFGLS + KM G+ Y+APEV +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-----KMKDRIGTAYYIAPEVLR-GT 198
Query: 340 YDKKVDVFSFAMILYEMLEGEPP 362
YD+K DV+S +ILY +L G PP
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP 221
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 4e-46
Identities = 72/203 (35%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRIL-PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
++GKGSFGE+LK R T A+K I S + EV LL KL HPNI++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHPNIMKL 86
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ + ++ E GG+L + ++ S A + G+ Y+H + I+H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK--HNIVH 144
Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
RDLKP N+LL + D +K+ DFGLS + KM G+ Y+APEV +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-----KMKDRIGTAYYIAPEVLR-GT 198
Query: 340 YDKKVDVFSFAMILYEMLEGEPP 362
YD+K DV+S +ILY +L G PP
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP 221
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-46
Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 21/212 (9%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI----------LPSLSDDRLVIQDFRHEVNLLVK 211
+G G++GE+L + AIK I + ++ +E++LL
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
L HPNI++ ++K L+TE+ GG+L + + + A N I G+ YL
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYL 162
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
H + I+HRD+KP N+LL N ++ ++K+ DFGLS K+ G+ Y+
Sbjct: 163 HK--HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-----KLRDRLGTAYYI 215
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
APEV K +KY++K DV+S +I+Y +L G PP
Sbjct: 216 APEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-46
Identities = 72/245 (29%), Positives = 113/245 (46%), Gaps = 26/245 (10%)
Query: 134 HFEPKPVPPPLPNKCDWEIDPSELDFSSSA------------IIGKGSFGEILKAYWRGT 181
H ++ + F +S +G G++GE+L + T
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 182 --PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238
AIK I S+S EV +L L HPNI++ +++ L+ E +
Sbjct: 62 HVERAIKIIRKTSVSTSS--NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-H 297
GG+L + + + A + G+ YLH + I+HRDLKP N+LL + D
Sbjct: 120 GGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDAL 177
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
+K+ DFGLS + + Q KM G+ Y+APEV + +KYD+K DV+S +IL+ +L
Sbjct: 178 IKIVDFGLSAVFENQK-----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILL 231
Query: 358 EGEPP 362
G PP
Sbjct: 232 AGYPP 236
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-46
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRIL-PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+GKG+F + + A I LS Q E + L+HPNIV+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD--HQKLEREARICRLLKHPNIVRL 75
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+++E LI + + GG+L + + + S + A + I + + H ++H
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ--MGVVH 133
Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
R+LKP N+LL + +K+ DFGL+ ++ + G G+ Y++PEV +
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ----AWFGFAGTPGYLSPEVLRKDP 189
Query: 340 YDKKVDVFSFAMILYEMLEGEPP 362
Y K VD+++ +ILY +L G PP
Sbjct: 190 YGKPVDLWACGVILYILLVGYPP 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-46
Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
+G G F + K +GT A K I S S + ++ EVN+L ++RHPNI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ ++LI E + GG+L +L EK +L+ A F I G+ YLH+ I
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS--KRIA 130
Query: 280 HRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
H DLKP N++L++ + +K+ DFG++ I+ N + G+ ++APE+ +
Sbjct: 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-----EFKNIFGTPEFVAPEIVNY 185
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPP 362
+ D++S +I Y +L G P
Sbjct: 186 EPLGLEADMWSIGVITYILLSGASP 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
+G G F + K + T A K I S + ++ EV++L ++ HPNI+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
R ++LI E + GG+L +L +K +LS A +F I G+ YLH I
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT--KKIA 137
Query: 280 HRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
H DLKP N++L++ + H+K+ DFGL+ I+ + G+ ++APE+ +
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-----EFKNIFGTPEFVAPEIVNY 192
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPP 362
+ D++S +I Y +L G P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-45
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
+G G+ GE+ A+ R T VAIK I + + + E+ +L KL HP
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
I++ ++ E + GG+L + L +T + + + YLH N
Sbjct: 77 IIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--N 133
Query: 277 VIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
IIHRDLKP NVLL + D +K+ DFG SK++ + M G+ Y+APEV
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-----LMRTLCGTPTYLAPEVL 188
Query: 336 ---KHRKYDKKVDVFSFAMILYEMLEGEPP 362
Y++ VD +S +IL+ L G PP
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-45
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+G G F + K + T A K I S + ++ EV++L ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
R ++LI E + GG+L +L +K +LS A +F I G+ YLH I
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT--KKI 136
Query: 279 IHRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
H DLKP N++L++ + H+K+ DFGL+ I+ + G+ ++APE+
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-----EFKNIFGTPEFVAPEIVN 191
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPP 362
+ + D++S +I Y +L G P
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASP 217
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-45
Identities = 60/232 (25%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 159 FSSSAIIGKGSFGEILKAY-WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPN 216
S I+G GS G ++ ++G PVA+KR+L E+ LL + HPN
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPN 70
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPST-------AVNFALDIARGMA 269
++++ + T + L + E +L ++ K + ++ IA G+A
Sbjct: 71 VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADH-----------LKVGDFGLSKLIKVQNSHDVY 318
+LH+ IIHRDLKP+N+L+ SS + + DFGL K + S
Sbjct: 130 HLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 319 KMTGETGSYRYMAPEVFK-------HRKYDKKVDVFSFAMILYEML-EGEPP 362
+ +G+ + APE+ + R+ + +D+FS + Y +L +G+ P
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 41/242 (16%), Positives = 91/242 (37%), Gaps = 30/242 (12%)
Query: 142 PPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-------VAIKRILPSLSD 194
P + K ++++ + ++G+G+F ++ +A +K P+
Sbjct: 52 PAIKPKTEFQLGSKLVYVHH--LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW 109
Query: 195 DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--- 251
+ + + L ++F A + +L+ E G L +
Sbjct: 110 EFYIG---TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166
Query: 252 --LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD---------HLKV 300
+ ++FA+ + + +H+ IIH D+KP N +L N + L +
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224
Query: 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE 360
D G S +K+ + T + + + E+ ++ ++ ++D F A +Y ML G
Sbjct: 225 IDLGQSIDMKLFPKGTI--FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
Query: 361 PP 362
Sbjct: 283 YM 284
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-45
Identities = 73/226 (32%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++GKG++G + +AIK I D R Q E+ L L+H NIVQ+L
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRY-SQPLHEEIALHKHLKHKNIVQYL 85
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAV--NFALDIARGMAYLHNEPNVI 278
G+ +E + + E + GG L L+ K G L + + I G+ YLH+ N I
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--NQI 143
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
+HRD+K NV L+N+ + LK+ DFG SK + N TG+ +YMAPE+
Sbjct: 144 VHRDIKGDNV-LINTYSGVLKISDFGTSKRLAGINP----CTETFTGTLQYMAPEIIDKG 198
Query: 339 K--YDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRP 381
Y K D++S + EM G+PP EP A V
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH 244
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-45
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G G+FG++ R + IK I S ++ E+ +L L HPNI++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVI 278
+ + ++ E GG+L + + ALS + +AY H+ +
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--QHV 145
Query: 279 IHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
+H+DLKP N+L ++S +K+ DFGL++L K T G+ YMAPEVFK
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-----HSTNAAGTALYMAPEVFK- 199
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPP 362
R K D++S +++Y +L G P
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-45
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 16/209 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +GKG FG + A + + +A+K + + + V R EV + LRHP
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
NI++ G + + LI EY G +++ L++ + ++A ++Y H+
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-- 127
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET--GSYRYMAPE 333
+IHRD+KP N+LL SA LK+ DFG S + G+ Y+ PE
Sbjct: 128 KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAP-SSRRT-------DLCGTLDYLPPE 177
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
+ + R +D+KVD++S ++ YE L G+PP
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-45
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPS-LSDDRLVIQD 201
K + ID DF +GKG FG + A + +A+K + S L + + Q
Sbjct: 6 MPKRKFTID----DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ- 60
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
R E+ + LRHPNI++ +RK + L+ E+ G+L+K L++ G + F
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
++A + Y H +IHRD+KP N+L+ LK+ DFG S
Sbjct: 121 EELADALHYCHE--RKVIHRDIKPENLLM--GYKGELKIADFGWSVHAPSLRRR------ 170
Query: 322 GET--GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
T G+ Y+ PE+ + + +D+KVD++ ++ YE L G PP
Sbjct: 171 --TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-45
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
+G G F + K + T A K I S + +D EV++L +++HPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ ++LI E + GG+L +L EK +L+ A F I G+ YLH+ I
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS--LQIA 136
Query: 280 HRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
H DLKP N++L++ + +K+ DFGL+ I N + G+ ++APE+ +
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-----EFKNIFGTPEFVAPEIVNY 191
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPP 362
+ D++S +I Y +L G P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-45
Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQF 220
+G+GSF K + + A+K I + + + + E+ L HPNIV+
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKII------SKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
++ L+ E L GG+L + +K+K S + A + ++++H+ ++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD--VGVVH 129
Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
RDLKP N+L + + + +K+ DFG ++L N + + Y APE+
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ----PLKTPCFTLHYAAPELLNQNG 185
Query: 340 YDKKVDVFSFAMILYEMLEGEPP 362
YD+ D++S +ILY ML G+ P
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVP 208
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-44
Identities = 57/236 (24%), Positives = 106/236 (44%), Gaps = 13/236 (5%)
Query: 130 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKR 187
N ++ P + + D + +G G+FG + + R T A K
Sbjct: 130 SNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF 189
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL-HKYL 246
++ D+ + R E+ + LRHP +V A + +++I E++ GG+L K
Sbjct: 190 VMTPHESDK---ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 246
Query: 247 KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
E +S AV + + +G+ ++H N +H DLKP N++ ++ LK+ DFGL+
Sbjct: 247 DEHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304
Query: 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
+ + + TG+ + APEV + + D++S ++ Y +L G P
Sbjct: 305 AHLDPKQ-----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-44
Identities = 42/201 (20%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G FG + + + K + +D + E+++L RH NI+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHE 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ + L++I E++ G D+ + + L+ V++ + + +LH+ + I H
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS--HNIGHF 126
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D++P N++ + +K+ +FG ++ +K + + Y APEV +H
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-----NFRLLFTAPEYYAPEVHQHDVVS 181
Query: 342 KKVDVFSFAMILYEMLEGEPP 362
D++S ++Y +L G P
Sbjct: 182 TATDMWSLGTLVYVLLSGINP 202
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-44
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
IG GS+ + + T A+K I D D E+ +L++ +HPNI+
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKII-----DKSKR--DPTEEIEILLRYGQHPNIITL 81
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ K + ++TE ++GG+L + + S A I + + YLH ++H
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA--QGVVH 139
Query: 281 RDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR 338
RDLKP N+L V+ S + +++ DFG +K ++ +N + + ++APEV + +
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG----LLMTPCYTANFVAPEVLERQ 195
Query: 339 KYDKKVDVFSFAMILYEMLEGEPP 362
YD D++S ++LY ML G P
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-44
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
+IGKG F + + R T A+K + + S L +D + E ++ L+HP+IV+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEP 275
L + L ++ E++ G DL + ++ S + A ++ I + Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148
Query: 276 NVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
N IIHRD+KP VLL + +K+G FG++ + G G+ +MAPEV
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL----VAGGRVGTPHFMAPEV 204
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPP 362
K Y K VDV+ +IL+ +L G P
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-43
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 13/208 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
S + I+G G FG++ K T +A K I D+ ++ ++E++++ +L H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNE 274
N++Q A + ++L+ EY+ GG+L + ++ L+ + F I G+ ++H
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ- 205
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I+H DLKP N+L VN A +K+ DFGL++ K + K+ G+ ++APEV
Sbjct: 206 -MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-----KLKVNFGTPEFLAPEV 259
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPP 362
+ D++S +I Y +L G P
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-43
Identities = 81/234 (34%), Positives = 115/234 (49%), Gaps = 16/234 (6%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSD 194
PV LP + + DP EL F+ IGKGSFGE+ K T VAIK I L D
Sbjct: 4 SPVQSGLPGMQNLKADPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED 62
Query: 195 DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP 254
+ I+D + E+ +L + P + ++ G+ + L +I EYL GG L+
Sbjct: 63 E---IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET 119
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
A +I +G+ YLH+E IHRD+K NVLL S +K+ DFG++ Q +
Sbjct: 120 QIAT-ILREILKGLDYLHSEK--KIHRDIKAANVLL--SEHGEVKLADFGVAG----QLT 170
Query: 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368
K G+ +MAPEV K YD K D++S + E+ GEPP + P
Sbjct: 171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 224
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-43
Identities = 71/220 (32%), Positives = 111/220 (50%), Gaps = 18/220 (8%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
+F +IG G FG++ K R G VA+KR P + I++F E+ L RHP+
Sbjct: 40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP---ESSQGIEEFETEIETLSFCRHPH 96
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMAYLH 272
+V +G ER ++LI +Y+ G+L ++L ++S + + ARG+ YLH
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 273 NEPNVIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQ-NSHDVYKMTGETGSYRYM 330
IIHRD+K N+LL N K+ DFG+SK +H + T G+ Y+
Sbjct: 157 TRA--IIHRDVKSINILLDENFVP---KITDFGISKKGTELDQTH-L--STVVKGTLGYI 208
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
PE F + +K DV+SF ++L+E+L + P E
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-43
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQF 220
++G+G+ + T A+K I R EV +L + + H N+++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLEL 76
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ E L+ E +RGG + ++ ++ + A D+A + +LHN I H
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN--KGIAH 134
Query: 281 RDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSH---DVYKMTGETGSYRYMAPEVFK 336
RDLKP N+L + + +K+ DF L IK+ ++ GS YMAPEV +
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 337 -----HRKYDKKVDVFSFAMILYEMLEGEPP 362
YDK+ D++S +ILY +L G PP
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-43
Identities = 45/201 (22%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G G+FG + + + T K I D+ ++E++++ +L HP ++
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHD 115
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
A ++ ++LI E+L GG+L + + +S + +N+ G+ ++H + I+H
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE--HSIVHL 173
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D+KP N++ A +K+ DFGL+ + + T + + APE+
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDE-----IVKVTTATAEFAAPEIVDREPVG 228
Query: 342 KKVDVFSFAMILYEMLEGEPP 362
D+++ ++ Y +L G P
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSP 249
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-43
Identities = 63/244 (25%), Positives = 96/244 (39%), Gaps = 48/244 (19%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
IG+GS+G + A T AIK + + + ++ + EV L+ KL HPNI +
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKG------------------------------ 250
+ + + L+ E GG L L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 251 ----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300
N I + YLHN I HRD+KP N L + + +K+
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKL 211
Query: 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK--HRKYDKKVDVFSFAMILYEMLE 358
DFGLSK N+ + Y MT + G+ ++APEV + Y K D +S ++L+ +L
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
Query: 359 GEPP 362
G P
Sbjct: 272 GAVP 275
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-43
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI------LPSLSDDRLVIQDFRHEVNLLVKL-RH 214
I+G+G + + + T A+K I S + + + + EV++L K+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
PNI+Q L+ + ++ G+L YL EK LS + + LH
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK- 142
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I+HRDLKP N+LL + ++K+ DFG S + K+ G+ Y+APE+
Sbjct: 143 -LNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGE-----KLREVCGTPSYLAPEI 194
Query: 335 FK------HRKYDKKVDVFSFAMILYEMLEGEPP 362
+ H Y K+VD++S +I+Y +L G PP
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-42
Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 165 IGKGSFGEILKAYWRGTPVAIK--------------RILPSLSDDRLVIQDFRHEVNLLV 210
+ +G F +I+ A+K + + DF++E+ ++
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR---- 266
+++ + G +T + +I EY+ + K+ + L + + + +
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 267 ----GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
+Y+HNE N I HRD+KP N+L+ +K+ DFG S+ + + K+ G
Sbjct: 159 SVLNSFSYIHNEKN-ICHRDVKPSNILM--DKNGRVKLSDFGESEY--MVDK----KIKG 209
Query: 323 ETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPP 362
G+Y +M PE F + KVD++S + LY M P
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-42
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+GKG F + + T A K I+P L + E+++ L H ++V F
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 80
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
G + + ++ E R L + K + AL+ A + I G YLH N +IH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR--NRVIH 138
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDLK N+ L + +K+GDFGL+ ++ K G+ Y+APEV + +
Sbjct: 139 RDLKLGNLFL--NEDLEVKIGDFGLATKVEYDGE---RKKV-LCGTPNYIAPEVLSKKGH 192
Query: 341 DKKVDVFSFAMILYEMLEGEPP 362
+VDV+S I+Y +L G+PP
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPP 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-42
Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 15/227 (6%)
Query: 141 PPPLPNKCDWEIDPSEL-DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILP--SLSDD 195
PP + +DP + +GKG F + + T A K I+P L
Sbjct: 24 APPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKP 82
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS 255
+ E+++ L H ++V F G + + ++ E R L + K + AL+
Sbjct: 83 HQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP 141
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
A + I G YLH N +IHRDLK N+ L + +K+GDFGL+ ++
Sbjct: 142 EARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYDGE- 196
Query: 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
K G+ Y+APEV + + +VDV+S I+Y +L G+PP
Sbjct: 197 --RKKV-LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-42
Identities = 67/245 (27%), Positives = 115/245 (46%), Gaps = 16/245 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP + ++ IG+G+ G + A T VAI+++ + +I + E+ ++
Sbjct: 17 DPKKK-YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMR 72
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+ ++PNIV +L + L ++ EYL GG L + E A + + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEF 131
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH+ +IHRD+K N+LL +K+ DFG Q + + K + G+ +M
Sbjct: 132 LHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCA----QITPEQSKRSTMVGTPYWM 183
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG-FT 389
APEV + Y KVD++S ++ EM+EGEPP N P A +A P + +
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 390 PELRE 394
R+
Sbjct: 244 AIFRD 248
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 23/213 (10%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI-----LPSLSDDRLVIQDFRHEVNLLVKLR-HP 215
+IG+G + + R T A+K + S V + R E ++L ++ HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+I+ + + + L+ + +R G+L YL EK ALS + + +++LH
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA-- 218
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
N I+HRDLKP N+LL ++ +++ DFG S ++ K+ G+ Y+APE+
Sbjct: 219 NNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLEPGE-----KLRELCGTPGYLAPEIL 271
Query: 336 K------HRKYDKKVDVFSFAMILYEMLEGEPP 362
K H Y K+VD+++ +IL+ +L G PP
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
++G G G++L+ + R T A+K + D R EV+ + P+IV
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLL-----YDS---PKARQEVDHHWQASGGPHIVCI 87
Query: 221 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 274
L ++ L++I E + GG+L ++E+G A + A DI + +LH+
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS- 146
Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
+ I HRD+KP N+L + D LK+ DFG +K + + Y+APE
Sbjct: 147 -HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN------ALQTPCYTPYYVAPE 199
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
V KYDK D++S +I+Y +L G PP
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 69/245 (28%), Positives = 120/245 (48%), Gaps = 16/245 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP L S IG+GS G + A + + VA+K + R ++ + EV ++
Sbjct: 42 DPRLL-LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMR 97
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+H N+V+ + + L ++ E+L+GG L + + L+ + + +AY
Sbjct: 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAY 156
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH + +IHRD+K ++LL + +K+ DFG Q S DV K G+ +M
Sbjct: 157 LHAQG--VIHRDIKSDSILL--TLDGRVKLSDFGFCA----QISKDVPKRKSLVGTPYWM 208
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG-FT 389
APEV Y +VD++S +++ EM++GEPP + P +A K + + P + +
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVS 268
Query: 390 PELRE 394
P LR+
Sbjct: 269 PVLRD 273
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-41
Identities = 69/201 (34%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IGKG+F ++ A G VAIK I+ + +Q EV ++ L HPNIV+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ K L LI EY GG++ YL G + A + I + Y H I+HRD
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ--KRIVHRD 139
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD- 341
LK N+LL + ++K+ DFG S K+ G+ Y APE+F+ +KYD
Sbjct: 140 LKAENLLL--DADMNIKIADFGFSNEFT-----VGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 342 KKVDVFSFAMILYEMLEGEPP 362
+VDV+S +ILY ++ G P
Sbjct: 193 PEVDVWSLGVILYTLVSGSLP 213
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-41
Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 29/222 (13%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 221
+ +G F + +A G A+KR+L + + + EV + KL HPNIVQF
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMKKLSGHPNIVQFC 92
Query: 222 GAVTERKPLM-------LITEYLRGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYL 271
A + K L+ L G L ++LK+ +G LS T + R + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET------- 324
H + IIHRDLK N+LL S+ +K+ DFG + I +
Sbjct: 153 HRQKPPIIHRDLKVENLLL--SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 325 -GSYRYMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPP 362
+ Y PE+ + +K D+++ ILY + + P
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
+G+G F + + + T A K + D R + HE+ +L + P ++
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR---AEILHEIAVLELAKSCPRVIN 93
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYL--KEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
++LI EY GG++ + +S + + I G+ YLH N
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--NN 151
Query: 278 IIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
I+H DLKP+N+LL + +K+ DFG+S+ I ++ G+ Y+APE+
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-----ELREIMGTPEYLAPEILN 206
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPP 362
+ D+++ +I Y +L P
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
++G G G++L+ + + T A+K + D R EV L + + P+IV+
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKML-----QDC---PKARREVELHWRASQCPHIVRI 120
Query: 221 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 274
+ RK L+++ E L GG+L ++++G A + A I + YLH+
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 179
Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
I HRD+KP N+L + + LK+ DFG +K N +T + Y+APE
Sbjct: 180 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-----SLTTPCYTPYYVAPE 233
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
V KYDK D++S +I+Y +L G PP
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-40
Identities = 60/203 (29%), Positives = 108/203 (53%), Gaps = 15/203 (7%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+GKGSF + +A T VAIK ++ ++ +V + ++EV + +L+HP+I++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIK-MIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILEL 76
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ + L+ E G++++YLK + S + A +F I GM YLH+ + I+
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS--HGIL 134
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
HRDL N+LL + ++K+ DFGL+ +K+ + T G+ Y++PE+
Sbjct: 135 HRDLTLSNLLL--TRNMNIKIADFGLATQLKMPHE---KHYT-LCGTPNYISPEIATRSA 188
Query: 340 YDKKVDVFSFAMILYEMLEGEPP 362
+ + DV+S + Y +L G PP
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPP 211
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 69/217 (31%), Positives = 110/217 (50%), Gaps = 23/217 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAY-WRGTPVAIKRILPSLSDDRL--VIQDFRHEVNLLVKLRH 214
+FS+ I+G+G FG++ K GT VA+KR L ++R F+ EV ++ H
Sbjct: 31 NFSNKNILGRGGFGKVYKGRLADGTLVAVKR----LKEERTQGGELQFQTEVEMISMAVH 86
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP----STAVNFALDIARGMAY 270
N+++ G +L+ Y+ G + L+E+ P AL ARG+AY
Sbjct: 87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 146
Query: 271 LHNEPNV-IIHRDLKPRNVLLVNSSAD---HLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
LH+ + IIHRD+K N+LL D VGDFGL+KL+ +++H + G G
Sbjct: 147 LHDHCDPKIIHRDVKAANILL-----DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG- 200
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
++APE K +K DVF + ++L E++ G+
Sbjct: 201 --HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 7e-40
Identities = 83/277 (29%), Positives = 118/277 (42%), Gaps = 25/277 (9%)
Query: 130 QNGSHFEPKPVPPPLPNKCDWEI-------DPSELDFSSSAIIGKGSFGEILKAYWRGT- 181
+P P + D ++ DP +L FS IG GSFG + A
Sbjct: 21 YFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKL-FSDLREIGHGSFGAVYFARDVRNS 79
Query: 182 -PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240
VAIK++ S QD EV L KLRHPN +Q+ G L+ EY G
Sbjct: 80 EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS 139
Query: 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300
K L +G+AYLH+ +IHRD+K N+LL S +K+
Sbjct: 140 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKL 195
Query: 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEML 357
GDFG + ++ NS G+ +MAPEV YD KVDV+S + E+
Sbjct: 196 GDFGSASIMAPANSF--------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247
Query: 358 EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
E +PPL N A ++A+ P ++ ++ R
Sbjct: 248 ERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 284
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 21/224 (9%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
P E+ F +G+GS+G + KA + T VAIK++ + D +Q+ E++++
Sbjct: 26 QPEEV-FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESD---LQEIIKEISIMQ 79
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDIARG 267
+ P++V++ G+ + L ++ EY G D+ + L+ +G
Sbjct: 80 QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKG 137
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+ YLH IHRD+K N+LL ++ H K+ DFG++ Q + + K G+
Sbjct: 138 LEYLHFMR--KIHRDIKAGNILL--NTEGHAKLADFGVAG----QLTDTMAKRNTVIGTP 189
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371
+MAPEV + Y+ D++S + EM EG+PP A+ P A
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 70/262 (26%), Positives = 117/262 (44%), Gaps = 21/262 (8%)
Query: 142 PPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVI 199
++DP+E+ + +G G+FG++ KA + T A K I ++ +
Sbjct: 5 SREYEHVRRDLDPNEV-WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---L 60
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAV 258
+D+ E+ +L HP IV+ LGA L ++ E+ GG + + E L+
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
+ + +LH+ IIHRDLK NVL+ + +++ DFG+S +N +
Sbjct: 121 VVCRQMLEALNFLHS--KRIIHRDLKAGNVLM--TLEGDIRLADFGVS----AKNLKTLQ 172
Query: 319 KMTGETGSYRYMAPEV-----FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK 373
K G+ +MAPEV K YD K D++S + L EM + EPP P
Sbjct: 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 232
Query: 374 YVAEGHRPFFRAKG-FTPELRE 394
+A+ P ++ E R+
Sbjct: 233 KIAKSDPPTLLTPSKWSVEFRD 254
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 69/237 (29%), Positives = 104/237 (43%), Gaps = 32/237 (13%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEV 206
W I+ D+ +IG G+ + AY + VAIKRI L + + E+
Sbjct: 10 WSINRD--DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS---MDELLKEI 64
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALD 263
+ + HPNIV + + + L L+ + L GG D+ K++ KG LD
Sbjct: 65 QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-----LD 119
Query: 264 ---IA-------RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQ 312
IA G+ YLH N IHRD+K N+LL +++ DFG+S L
Sbjct: 120 ESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILL--GEDGSVQIADFGVSAFLATGG 175
Query: 313 NSHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEP 368
+ G+ +MAPEV + + YD K D++SF + E+ G P Y P
Sbjct: 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ---DFRHEVNLLVK 211
+G+G FG + K Y T VA+K+ + D + F E+ ++ K
Sbjct: 29 ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK--LAAMVDITTEELKQQFDQEIKVMAK 86
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP---STAVNFALDIARGM 268
+H N+V+ LG ++ L L+ Y+ G L L P A A G+
Sbjct: 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 146
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSAD---HLKVGDFGLSKLIKV-QNSHDVYKMTGET 324
+LH IHRD+K N+LL D K+ DFGL++ + + MT +
Sbjct: 147 NFLHENH--HIHRDIKSANILL-----DEAFTAKISDFGLARASEKFAQTV----MT--S 193
Query: 325 ---GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368
G+ YMAPE + K D++SF ++L E++ G P + +
Sbjct: 194 RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-39
Identities = 67/203 (33%), Positives = 101/203 (49%), Gaps = 11/203 (5%)
Query: 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G G + A VAIK I + ++ F EV+ +L H NIV
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+ E L+ EY+ G L +Y++ G LS TA+NF I G+ + H+ I+H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD--MRIVH 134
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-GSYRYMAPEVFKHRK 339
RD+KP+N+L+ S LK+ DFG++K + S T G+ +Y +PE K
Sbjct: 135 RDIKPQNILI--DSNKTLKIFDFGIAKAL----SETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 340 YDKKVDVFSFAMILYEMLEGEPP 362
D+ D++S ++LYEML GEPP
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-38
Identities = 71/201 (35%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG G+FG + VA+K I + ++ + E+ LRHPNIV+F
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI----ERGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ L +I EY GG+L++ + G S A F + G++Y H+ I HRD
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS--MQICHRD 141
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD- 341
LK N LL S A LK+ DFG SK H K T G+ Y+APEV ++YD
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKSSV---LHSQPKST--VGTPAYIAPEVLLRQEYDG 196
Query: 342 KKVDVFSFAMILYEMLEGEPP 362
K DV+S + LY ML G P
Sbjct: 197 KIADVWSCGVTLYVMLVGAYP 217
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
++G+G G++ +A R VA+K + +LS D + + E +L+ P++V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
L + + G DL L+ +G L+P AV I + H H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA--AGATH 157
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT--GET-GSYRYMAPEVFKH 337
RD+KP N+L+ S+ D + DFG++ K+T G T G+ YMAPE F
Sbjct: 158 RDVKPENILV--SADDFAYLVDFGIASAT------TDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPP 362
+ D+++ +LYE L G PP
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G++GE+ A R T VA+K I+ + E+ + L H N+V+F G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG 72
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
E L EY GG+L ++ + A F + G+ YLH I HRD
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRD 130
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD- 341
+KP N+LL D+LK+ DFGL+ + + N + G+ Y+APE+ K R++
Sbjct: 131 IKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLKRREFHA 186
Query: 342 KKVDVFSFAMILYEMLEGEPP 362
+ VDV+S ++L ML GE P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-38
Identities = 74/259 (28%), Positives = 122/259 (47%), Gaps = 31/259 (11%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP+ + F ++G G++G++ K T AIK ++ D+ ++ + E+N+L
Sbjct: 21 DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDE---EEEIKQEINMLK 75
Query: 211 KL-RHPNIVQFLGAVTERKP------LMLITEYLRGG---DLHKYLKEKGALSPSTAVNF 260
K H NI + GA ++ P L L+ E+ G DL K K A
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-I 134
Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
+I RG+++LH + +IHRD+K +NVLL + +K+ DFG+S Q V +
Sbjct: 135 CREILRGLSHLHQ--HKVIHRDIKGQNVLL--TENAEVKLVDFGVSA----QLDRTVGRR 186
Query: 321 TGETGSYRYMAPEVFKHRK-----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 375
G+ +MAPEV + YD K D++S + EM EG PPL + P A +
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246
Query: 376 AEGHRPFFRAKGFTPELRE 394
P ++K ++ + +
Sbjct: 247 PRNPAPRLKSKKWSKKFQS 265
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 62/252 (24%), Positives = 104/252 (41%), Gaps = 20/252 (7%)
Query: 121 NAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR- 179
+ H GSH P E +P E + ++G G FG +
Sbjct: 7 HHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVS 66
Query: 180 -GTPVAIKRI----LPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGAVTERKPLML 232
PVAIK + + + + EV LL K+ +++ L +L
Sbjct: 67 DNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125
Query: 233 ITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 291
I E DL ++ E+GAL A +F + + + HN ++HRD+K N +L+
Sbjct: 126 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDEN-ILI 182
Query: 292 NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFA 350
+ + LK+ DFG L+K D G+ Y PE ++ +Y + V+S
Sbjct: 183 DLNRGELKLIDFGSGALLKDTVYTDF------DGTRVYSPPEWIRYHRYHGRSAAVWSLG 236
Query: 351 MILYEMLEGEPP 362
++LY+M+ G+ P
Sbjct: 237 ILLYDMVCGDIP 248
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-38
Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 17/229 (7%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
+ + DF + +G G+ G + K G +A K I L + E+
Sbjct: 25 QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIREL 82
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
+L + P IV F GA + + E++ GG L + LK+ G + ++ + +
Sbjct: 83 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 142
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIK-VQNSHDVYKMTGET 324
G+ YL + I+HRD+KP N+L+ +S +K+ DFG+S +LI + NS
Sbjct: 143 GLTYLREKHK-IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDSMANSF--------V 191
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK 373
G+ YM+PE + Y + D++S + L EM G P+ + E
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G++GE+ A R VA+K I+ + E+ + L H N+V+F G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG 72
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
E L EY GG+L ++ + A F + G+ YLH I HRD
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRD 130
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD- 341
+KP N+LL D+LK+ DFGL+ + + N + G+ Y+APE+ K R++
Sbjct: 131 IKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLKRREFHA 186
Query: 342 KKVDVFSFAMILYEMLEGEPP 362
+ VDV+S ++L ML GE P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-37
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRI----LPSLSDDRLVIQDFRHEVNLLVKLR----H 214
+GKG FG + + VAIK I + S + EV LL K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGH 97
Query: 215 PNIVQFLGAVTERKPLMLITEY-LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
P +++ L ++ ML+ E L DL Y+ EKG L + F + + + H+
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
++HRD+K N +L++ K+ DFG L+ + D G+ Y PE
Sbjct: 158 --RGVVHRDIKDEN-ILIDLRRGCAKLIDFGSGALLHDEPYTDF------DGTRVYSPPE 208
Query: 334 VFKHRKYD-KKVDVFSFAMILYEMLEGEPP 362
+Y V+S ++LY+M+ G+ P
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 5e-37
Identities = 48/219 (21%), Positives = 90/219 (41%), Gaps = 18/219 (8%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIK-----RILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
+G G+FG + A + V +K ++L + + E+ +L ++ H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 218 VQFLGAVTERKPLMLITE-YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
++ L + L+ E + G DL ++ L A + + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL--K 149
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
IIHRD+K N+++ + +K+ DFG + ++ + G+ Y APEV
Sbjct: 150 DIIHRDIKDENIVI--AEDFTIKLIDFGSAAYLERGKLFYTF-----CGTIEYCAPEVLM 202
Query: 337 HRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 374
Y +++++S + LY ++ E P E A
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAI 241
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 57/268 (21%), Positives = 96/268 (35%), Gaps = 72/268 (26%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKR------------------ILPSLSDDRL 197
DF +G+G FG + +A + AIKR L L +
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 198 V-------------------------------------IQDFRHEVNLLVKLRHPNIVQF 220
V + ++ + N V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP---STAVNFALDIARGMAYLHNEPNV 277
L + + L + + R +L ++ + +L ++ + IA + +LH+
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--KG 184
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK--------VQNSHDVYKMTGETGSYRY 329
++HRDLKP N+ + D +KVGDFGL + + TG+ G+ Y
Sbjct: 185 LMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEML 357
M+PE Y KVD+FS +IL+E+L
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-36
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
I+G G E+ A VA+K + L+ D FR E L HP IV
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 221 L--GAVTERKPLM--LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
G + ++ EY+ G L + +G ++P A+ D + + + H N
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ--N 135
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-GSYRYMAPEVF 335
IIHRD+KP N+++ S+ + +KV DFG+++ + +S + T G+ +Y++PE
Sbjct: 136 GIIHRDVKPANIMI--SATNAVKVMDFGIARA--IADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPP 362
+ D + DV+S +LYE+L GEPP
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-36
Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G G+FG++ + G VA+K IL + +V + R E+ L RHP+I++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKL 76
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
++ ++ EY+ GG+L Y+ + G + A I + Y H ++++H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR--HMVVH 134
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDLKP NVLL + + K+ DFGLS ++ D + GS Y APEV R Y
Sbjct: 135 RDLKPENVLL--DAHMNAKIADFGLSNMMS-----DGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 341 D-KKVDVFSFAMILYEMLEGEPP 362
+VD++S +ILY +L G P
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLP 210
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 8e-36
Identities = 58/255 (22%), Positives = 113/255 (44%), Gaps = 23/255 (9%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
E+ +L+ +G+G++G + K G +A+KRI + + + ++++
Sbjct: 3 EVKADDLEPIME--LGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDI 58
Query: 209 LVKL-RHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDI 264
++ P V F GA+ + + E + + + + + A+ I
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
+ + +LH++ + +IHRD+KP NVL+ ++ +K+ DFG+S DV K +
Sbjct: 119 VKALEHLHSKLS-VIHRDVKPSNVLI--NALGQVKMCDFGISG----YLVDDVAKDI-DA 170
Query: 325 GSYRYMAPEVFK----HRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEGH 379
G YMAPE + Y K D++S + + E+ P ++ P++ K V E
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP 230
Query: 380 RPFFRAKGFTPELRE 394
P A F+ E +
Sbjct: 231 SPQLPADKFSAEFVD 245
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 41/229 (17%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIK-----------------------RILPSLSDDRLVI 199
IGKGS+G + AY T A+K R I
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 200 QDFRHEVNLLVKLRHPNIVQF---LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPST 256
+ E+ +L KL HPN+V+ L E L ++ E + G + + LS
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPVMEVPT-LKPLSEDQ 138
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
A + D+ +G+ YLH IIHRD+KP N+L+ H+K+ DFG+S K ++
Sbjct: 139 ARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLV--GEDGHIKIADFGVSNEFKGSDAL- 193
Query: 317 VYKMTGETGSYRYMAPEVF--KHRKYD-KKVDVFSFAMILYEMLEGEPP 362
++ G+ +MAPE + + K +DV++ + LY + G+ P
Sbjct: 194 ---LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 38/226 (16%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRH---EVNL 208
+ E+ +++ +IG GSFG + +A + VAIK++L QD R E+ +
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL----------QDKRFKNRELQI 85
Query: 209 LVKLRHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYL----KEKGALSPSTAV 258
+ ++HPN+V L L+ EY+ +++ K K +
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIK 144
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
+ + R +AY+H+ I HRD+KP+N LL++ + LK+ DFG +K++
Sbjct: 145 LYMYQLLRSLAYIHS--IGICHRDIKPQN-LLLDPPSGVLKLIDFGSAKILIAGEP---- 197
Query: 319 KMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ YR APE+ F Y +D++S ++ E+++G+P
Sbjct: 198 -NVSYICSRYYR--APELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 57/258 (22%), Positives = 104/258 (40%), Gaps = 22/258 (8%)
Query: 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHE 205
D + +G G+ G++ K G +A+K++ S ++ + +
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMD 73
Query: 206 VNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
+++++K P IVQ G + + E + + +G + + I
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAI 133
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTGE 323
+ + YL + +IHRD+KP N+LL +K+ DFG+S +L+ D
Sbjct: 134 VKALYYLKEKHG-VIHRDVKPSNILL--DERGQIKLCDFGISGRLV------DDKAKDRS 184
Query: 324 TGSYRYMAPEVFKHRK-----YDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAE 377
G YMAPE YD + DV+S + L E+ G+ P N + +E V +
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244
Query: 378 GHRPFFRAK-GFTPELRE 394
P GF+ + +
Sbjct: 245 EEPPLLPGHMGFSGDFQS 262
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 17/203 (8%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G+GSFG++ A VA+K + L + ++ R E++ L LRHP+I++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALK-FISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKL 74
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+T ++++ EY GG+L Y+ EK ++ F I + Y H + I+H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR--HKIVH 131
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDLKP N+LL ++K+ DFGLS ++ D + GS Y APEV + Y
Sbjct: 132 RDLKPENLLL--DDNLNVKIADFGLSNIMT-----DGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 341 D-KKVDVFSFAMILYEMLEGEPP 362
+VDV+S ++LY ML G P
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-35
Identities = 72/241 (29%), Positives = 111/241 (46%), Gaps = 21/241 (8%)
Query: 130 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKR 187
G+ P + + + +G+G++GE+ KA T VAIKR
Sbjct: 8 HMGTLEAQTQGPGSMSVSAAPSATSID-RYRRITKLGEGTYGEVYKAIDTVTNETVAIKR 66
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK 247
I ++ + R EV+LL +L+H NI++ + L LI EY DL KY+
Sbjct: 67 IRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMD 124
Query: 248 EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDF 303
+ +S +F + G+ + H+ +HRDLKP+N LL++ S LK+GDF
Sbjct: 125 KNPDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQN-LLLSVSDASETPVLKIGDF 181
Query: 304 GLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGE 360
GL++ + + + T E T YR PE+ R Y VD++S A I EML
Sbjct: 182 GLARAFGIP----IRQFTHEIITLWYR--PPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
Query: 361 P 361
P
Sbjct: 236 P 236
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 65/244 (26%), Positives = 105/244 (43%), Gaps = 25/244 (10%)
Query: 131 NGSHFEPKPVPPPLPNKCDWEIDP----SELDFSSSAIIGKGSFGEILKAYWRGTPV--A 184
+ + F W+ ++ F ++GKG FGE+ R T A
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA 213
Query: 185 IKRILPSLSDDRLVIQD----FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240
K L R+ + +E +L K+ +V A + L L+ + GG
Sbjct: 214 CK----KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 269
Query: 241 DL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
DL H Y + + AV +A +I G+ LH I++RDLKP N+LL H+
Sbjct: 270 DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILL--DDHGHI 325
Query: 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE 358
++ D GL+ + + + G G+ YMAPEV K+ +Y D ++ +LYEM+
Sbjct: 326 RISDLGLAVHVP-----EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
Query: 359 GEPP 362
G+ P
Sbjct: 381 GQSP 384
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
F ++G+G FGE+ + T A K L+ RL + E +L K
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACK----KLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALDIARG 267
+ IV A + L L+ + GGD+ + ++ A+ + I G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+ +LH II+RDLKP NVLL ++++ D GL+ + K G G+
Sbjct: 302 LEHLHQ--RNIIYRDLKPENVLL--DDDGNVRISDLGLAV----ELKAGQTKTKGYAGTP 353
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
+MAPE+ +YD VD F+ + LYEM+ P
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 62/265 (23%), Positives = 112/265 (42%), Gaps = 35/265 (13%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
W+ +L IG+G++G + K G +A+KRI ++ + + ++
Sbjct: 16 HWDFTAEDLKDLG--EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDL 71
Query: 207 NLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPST------AVN 259
+++++ P IVQF GA+ + E + K+ K ++
Sbjct: 72 DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS-FDKFYKYVYSVLDDVIPEEILGK- 129
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIK-VQNSHDV 317
L + + +L IIHRD+KP N+LL + ++K+ DFG+S +L+ + + D
Sbjct: 130 ITLATVKALNHLKENLK-IIHRDIKPSNILL--DRSGNIKLCDFGISGQLVDSIAKTRDA 186
Query: 318 YKMTGETGSYRYMAPEVFK----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAA 372
G YMAPE + YD + DV+S + LYE+ G P + ++
Sbjct: 187 -------GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL 239
Query: 373 KYVAEGHRPFFRA---KGFTPELRE 394
V +G P + F+P
Sbjct: 240 TQVVKGDPPQLSNSEEREFSPSFIN 264
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 67/226 (29%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 151 EIDPSELD-FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
E E+D F + G+G+FG + + G VAIK+++ D R ++ + +
Sbjct: 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI---QDPRFRNRELQ-IMQ 71
Query: 208 LLVKLRHPNIVQ---FLGAVTERKP----LMLITEYLRGGDLHKYLK----EKGALSPST 256
L L HPNIVQ + + ER L ++ EY+ LH+ + + A P
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPIL 130
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
F + R + LH + HRD+KP N +LVN + LK+ DFG +K +
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN-VLVNEADGTLKLCDFGSAKKLSPSEP-- 187
Query: 317 VYKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
S Y APE+ F ++ Y VD++S I EM+ GEP
Sbjct: 188 ---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 42/230 (18%), Positives = 86/230 (37%), Gaps = 23/230 (10%)
Query: 153 DPSELDFSSSAIIGKG--SFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVN 207
+ +IGKG + A G V ++RI L + S++ + + E++
Sbjct: 22 PEGG-CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM--VTFLQGELH 78
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDI 264
+ HPNIV + L ++T ++ G DL G ++ +
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-MNELAIAYILQGV 137
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG----LSKLIKVQNSHDVYKM 320
+ + Y+H+ +HR +K ++L+ S + + + + Q +
Sbjct: 138 LKALDYIHH--MGYVHRSVKASHILI--SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 321 TGETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPPLANYEP 368
+++PEV + YD K D++S + E+ G P +
Sbjct: 194 Y-SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+GS+G + K R T VAIK+ L S D + R E+ +L +L+HPN+V L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLE 69
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
++ L L+ EY + L + + + + + + H + IHR
Sbjct: 70 VFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK--HNCIHR 126
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHR 338
D+KP N +L+ +K+ DFG ++L+ + E T YR +PE+
Sbjct: 127 DVKPEN-ILITKH-SVIKLCDFGFARLLTGPSD----YYDDEVATRWYR--SPELLVGDT 178
Query: 339 KYDKKVDVFSFAMILYEMLEGEP 361
+Y VDV++ + E+L G P
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVP 201
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+GS+G ++K + T VAIK+ L S D + R E+ LL +LRH N+V L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLE 91
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
++K L+ E++ + L+ L + I G+ + H+ + IIHR
Sbjct: 92 VCKKKKRWYLVFEFVD-HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS--HNIIHR 148
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHR 338
D+KP N +LV+ S +K+ DFG ++ + E T YR APE+
Sbjct: 149 DIKPEN-ILVSQS-GVVKLCDFGFARTLAAP----GEVYDDEVATRWYR--APELLVGDV 200
Query: 339 KYDKKVDVFSFAMILYEMLEGEP 361
KY K VDV++ ++ EM GEP
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEP 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-34
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G G+FG++ G VA+K IL + +V + R E+ L RHP+I++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKL 81
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
++ + ++ EY+ GG+L Y+ + G L + I G+ Y H ++++H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR--HMVVH 139
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-----GSYRYMAPEVF 335
RDLKP NVLL + + K+ DFGLS ++ GE GS Y APEV
Sbjct: 140 RDLKPENVLL--DAHMNAKIADFGLSNMMS----------DGEFLRTSCGSPNYAAPEVI 187
Query: 336 KHRKYD-KKVDVFSFAMILYEMLEGEPP 362
R Y +VD++S +ILY +L G P
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 68/251 (27%), Positives = 118/251 (47%), Gaps = 34/251 (13%)
Query: 124 GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-- 181
G + + G+ PPP P K E DF I+G+GSF ++ A T
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPE------DFKFGKILGEGSFSTVVLARELATSR 56
Query: 182 PVAIKRILPSLSDDRLVIQD-----FRHEVNLLVKLRHPNIVQFLGAV-TERKPLMLITE 235
AIK IL + R +I++ E +++ +L HP V+ + K L
Sbjct: 57 EYAIK-IL----EKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK-LYFGLS 110
Query: 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 295
Y + G+L KY+++ G+ + + +I + YLH IIHRDLKP N+LL +
Sbjct: 111 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILL--NED 166
Query: 296 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY----RYMAPEVFKHRKYDKKVDVFSFAM 351
H+++ DFG +K++ ++ S+ +Y++PE+ + K D+++
Sbjct: 167 MHIQITDFGTAKVLSPESK------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 220
Query: 352 ILYEMLEGEPP 362
I+Y+++ G PP
Sbjct: 221 IIYQLVAGLPP 231
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 39/226 (17%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH---EVNL 208
P E+ ++ + +IG GSFG + +A G VAIK++L QD R E+ +
Sbjct: 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFKNRELQI 100
Query: 209 LVKLRHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLK----EKGALSPSTAV 258
+ KL H NIV+ L L+ +Y+ +++ + K L
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVK 159
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
+ + R +AY+H+ I HRD+KP+N LL++ LK+ DFG +K +
Sbjct: 160 LYMYQLFRSLAYIHS--FGICHRDIKPQN-LLLDPDTAVLKLCDFGSAKQLVRGE----- 211
Query: 319 KMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ YR APE+ F Y +DV+S +L E+L G+P
Sbjct: 212 PNVSYICSRYYR--APELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (324), Expect = 5e-34
Identities = 27/283 (9%), Positives = 57/283 (20%), Gaps = 47/283 (16%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDD 195
P D + E + G + A+K +
Sbjct: 43 TVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS 102
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-------------------------- 229
R ++ +L + + P
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162
Query: 230 LMLITEYLRG------GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 283
+L+ L +G + R A L + ++H
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS--KGLVHGHF 220
Query: 284 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK--YD 341
P N+ + L +GD + + Y E +
Sbjct: 221 TPDNLFI--MPDGRLMLGDVSALW-------KVGTRGPASSVPVTYAPREFLNASTATFT 271
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384
++ + + +Y + P P + R
Sbjct: 272 HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGT 314
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD-FRH---EVNLLVK 211
DF ++GKG+FG+++ + T A+K L + ++ +D H E +L
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMK----ILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 212 LRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
RHP + A T + L + EY GG+L +L + + A + +I + Y
Sbjct: 62 TRHPFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET------ 324
LH+ +++RD+K N++L H+K+ DFGL K ++
Sbjct: 121 LHS--RDVVYRDIKLENLML--DKDGHIKITDFGLCKE----------GISDGATMKTFC 166
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APEV + Y + VD + +++YEM+ G P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD-FRH---EVNLLVK 211
+F ++GKG+FG+++ + T A+K L + +V +D H E +L
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMK----ILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
RHP + + L + EY GG+L +L + S A + +I + YL
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
H+E N +++RDLK N++L H+K+ DFGL K + D M G+ Y+A
Sbjct: 265 HSEKN-VVYRDLKLENLML--DKDGHIKITDFGLCK----EGIKDGATMKTFCGTPEYLA 317
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
PEV + Y + VD + +++YEM+ G P
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 71/221 (32%), Positives = 109/221 (49%), Gaps = 36/221 (16%)
Query: 158 DFSSSAIIGKGSFGEIL---KAYWRGTPV--AIKRILPSLSDDRLVIQDFRH---EVNLL 209
F ++G+GSFG++ K A+K L L ++D E ++L
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMK----VLKKATLKVRDRVRTKMERDIL 80
Query: 210 VKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
V++ HP IV+ A TE K L LI ++LRGGDL L ++ + + ++A +
Sbjct: 81 VEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+LH+ II+RDLKP N+LL + H+K+ DFGLSK + E +Y
Sbjct: 140 DHLHS--LGIIYRDLKPENILL---DEEGHIKLTDFGLSKE----------SIDHEKKAY 184
Query: 328 ------RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
YMAPEV R + + D +SF ++++EML G P
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 26/232 (11%)
Query: 140 VPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRL 197
+PP D D F IGKGSFG++ T A+K ++ +
Sbjct: 2 MPPVFDENEDVNFD----HFEILRAIGKGSFGKVCIVQKNDTKKMYAMK----YMNKQKC 53
Query: 198 VIQD-FRH---EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS 253
V ++ R+ E+ ++ L HP +V + + + + ++ + L GGDL +L++
Sbjct: 54 VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK 113
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
T F ++ + YL N IIHRD+KP N+LL H+ + DF ++ ++
Sbjct: 114 EETVKLFICELVMALDYLQN--QRIIHRDMKPDNILL--DEHGHVHITDFNIAAMLP--- 166
Query: 314 SHDVYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPP 362
++T G+ YMAPE+F RK Y VD +S + YE+L G P
Sbjct: 167 --RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-33
Identities = 73/202 (36%), Positives = 111/202 (54%), Gaps = 17/202 (8%)
Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
IG+G++G + KA G A+K+I D+ + R E+++L +L+H NIV+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ +K L+L+ E+L DL K L +G L TA +F L + G+AY H+ ++HRD
Sbjct: 69 IHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRD 125
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRK 339
LKP+N LL+N LK+ DFGL++ + V K T E T YR AP+V +K
Sbjct: 126 LKPQN-LLINREG-ELKIADFGLARAFGIP----VRKYTHEIVTLWYR--APDVLMGSKK 177
Query: 340 YDKKVDVFSFAMILYEMLEGEP 361
Y +D++S I EM+ G P
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTP 199
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-33
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 46/209 (22%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
++G G G++L+ + + T A+K + D R EV L + + P+IV+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-----QDC---PKARREVELHWRASQCPHIVRI 76
Query: 221 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 274
+ RK L+++ E L GG+L ++++G A + A I + YLH+
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 135
Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
I HRD+KP N+L + + LK+ DFG A E
Sbjct: 136 -INIAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------------AKE 169
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
KYDK D++S +I+Y +L G PP
Sbjct: 170 TTG-EKYDKSCDMWSLGVIMYILLCGYPP 197
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 74/202 (36%), Positives = 109/202 (53%), Gaps = 17/202 (8%)
Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
+G+G++G + KA G VA+KRI D+ + R E++LL +L HPNIV +
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDV 87
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ + L L+ E++ DL K L E K L S + + RG+A+ H + I+HRD
Sbjct: 88 IHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRD 144
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRK 339
LKP+N LL+NS LK+ DFGL++ + V T E T YR AP+V +K
Sbjct: 145 LKPQN-LLINSDG-ALKLADFGLARAFGIP----VRSYTHEVVTLWYR--APDVLMGSKK 196
Query: 340 YDKKVDVFSFAMILYEMLEGEP 361
Y VD++S I EM+ G+P
Sbjct: 197 YSTSVDIWSIGCIFAEMITGKP 218
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 66/235 (28%), Positives = 111/235 (47%), Gaps = 33/235 (14%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
N +++ + +G G G + A VAIK+I L+D + V R
Sbjct: 3 NIHGFDLGS---RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALR 57
Query: 204 HEVNLLVKLRHPNIVQFL--------------GAVTERKPLMLITEYLRGGDLHKYLKEK 249
E+ ++ +L H NIV+ G++TE + ++ EY+ DL L+ +
Sbjct: 58 -EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLE-Q 114
Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
G L A F + RG+ Y+H+ ++HRDLKP N L +N+ LK+GDFGL++++
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPAN-LFINTEDLVLKIGDFGLARIM 171
Query: 310 KVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
SH + ++ T YR +P + Y K +D+++ I EML G+
Sbjct: 172 DPHYSHKGH-LSEGLVTKWYR--SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 71/223 (31%), Positives = 108/223 (48%), Gaps = 38/223 (17%)
Query: 158 DFSSSAIIGKGSFGEIL---KAYWRGTPV--AIKRILPSLSDDRLV--IQDFRH---EVN 207
F ++GKG +G++ K T A+K L +V +D H E N
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMK----VLKKAMIVRNAKDTAHTKAERN 73
Query: 208 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
+L +++HP IV + A T K L LI EYL GG+L L+ +G TA + +I+
Sbjct: 74 ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM 132
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGET- 324
+ +LH II+RDLKP N++L + H+K+ DFGL K + T
Sbjct: 133 ALGHLHQ--KGIIYRDLKPENIML---NHQGHVKLTDFGLCKE----------SIHDGTV 177
Query: 325 -----GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ YMAPE+ +++ VD +S ++Y+ML G PP
Sbjct: 178 THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 70/222 (31%), Positives = 109/222 (49%), Gaps = 39/222 (17%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 207
DF ++GKGSFG++ A ++ T AIK +L D +++ D +V
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIK----ALKKDVVLMDD---DVECTMVEKRV 70
Query: 208 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
L + HP + T+ L + EYL GGDL +++ S A +A +I
Sbjct: 71 LSLAWEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-- 324
G+ +LH+ I++RDLK N+LL H+K+ DFG+ K M G+
Sbjct: 130 GLQFLHS--KGIVYRDLKLDNILL--DKDGHIKIADFGMCKE----------NMLGDAKT 175
Query: 325 ----GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APE+ +KY+ VD +SF ++LYEML G+ P
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G++G + KA R T VA+KR+ D+ + R E+ LL +L+H NIV+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ K L L+ E+ DL KY G L P +F + +G+ + H+ ++HR
Sbjct: 69 VLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHR 125
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHR 338
DLKP+N LL+N + LK+ +FGL++ V + E T YR P+V F +
Sbjct: 126 DLKPQN-LLINRNG-ELKLANFGLARAF----GIPVRCYSAEVVTLWYR--PPDVLFGAK 177
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPL 363
Y +D++S I E+ PL
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 68/222 (30%), Positives = 111/222 (50%), Gaps = 39/222 (17%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 207
DF+ ++GKGSFG+++ + +GT A+K L D ++ D +V
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVK----ILKKDVVIQDD---DVECTMVEKRV 73
Query: 208 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
L + + P + Q T + L + EY+ GGDL ++++ G AV +A +IA
Sbjct: 74 LALPGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-- 324
G+ +L + II+RDLK NV+L S H+K+ DFG+ K +
Sbjct: 133 GLFFLQS--KGIIYRDLKLDNVML--DSEGHIKIADFGMCKE----------NIWDGVTT 178
Query: 325 ----GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APE+ ++ Y K VD ++F ++LYEML G+ P
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH---------EVNLLVKLR 213
+G+G F + KA + VAIK+I +L + E+ LL +L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKI-------KLGHRSEAKDGINRTALREIKLLQELS 70
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLH 272
HPNI+ L A + + L+ +++ DL +K+ L+PS + L +G+ YLH
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYM 330
+ I+HRDLKP N LL++ + LK+ DFGL+K N T + T YR
Sbjct: 130 Q--HWILHRDLKPNN-LLLDENG-VLKLADFGLAKSFGSPNR----AYTHQVVTRWYR-- 179
Query: 331 APEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
APE+ F R Y VD+++ IL E+L P
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLLRVP 211
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-32
Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
DF +IG+GS+ ++L + T A+K + + + + + E ++ +
Sbjct: 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMK----VVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 212 -LRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
HP +V TE + L + EY+ GGDL +++ + L A ++ +I+ +
Sbjct: 66 ASNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----- 324
YLH II+RDLK NVLL S H+K+ D+G+ K +
Sbjct: 125 YLHE--RGIIYRDLKLDNVLL--DSEGHIKLTDYGMCKE----------GLRPGDTTSTF 170
Query: 325 -GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APE+ + Y VD ++ ++++EM+ G P
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-32
Identities = 80/261 (30%), Positives = 121/261 (46%), Gaps = 46/261 (17%)
Query: 125 GLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSEL------DFSSSAIIGKGSFGEILKAYW 178
G+S Q P PPP P++ + PS DF +IGKGSFG++L A
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQ-QINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARH 59
Query: 179 RGTPV--AIKRILPSLSDDRLVIQDFRHEVN--------LLVKLRHPNIVQFLGAV-TER 227
+ V A+K L +++ + E LL ++HP +V + T
Sbjct: 60 KAEEVFYAVK----VLQKK-AILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112
Query: 228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 287
K L + +Y+ GG+L +L+ + A +A +IA + YLH+ I++RDLKP N
Sbjct: 113 K-LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPEN 169
Query: 288 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET------GSYRYMAPEVFKHRKYD 341
+LL S H+ + DFGL K + + G+ Y+APEV + YD
Sbjct: 170 ILL--DSQGHIVLTDFGLCKE----------NIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 342 KKVDVFSFAMILYEMLEGEPP 362
+ VD + +LYEML G PP
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPP 238
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 9e-32
Identities = 67/215 (31%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVI-QDFRH---EVNLLVK 211
DFS IIG+G FGE+ T A+K L R+ + Q E +L
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK----CLDKKRIKMKQGETLALNERIMLSL 245
Query: 212 L---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
+ P IV A L I + + GGDLH +L + G S + +A +I G+
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
++HN +++RDLKP N+LL H+++ D GL+ + K G++
Sbjct: 306 EHMHN--RFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKK------KPHASVGTHG 355
Query: 329 YMAPEVF-KHRKYDKKVDVFSFAMILYEMLEGEPP 362
YMAPEV K YD D FS +L+++L G P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
DF +IG+G+FGE+ + A+K L+ ++ + FR E ++LV
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMK----ILNKWEMLKRAETACFREERDVLVN 130
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAY 270
I A + L L+ +Y GGDL L K + L A + ++ +
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
+H +HRD+KP N+L+ H+++ DFG + + G Y+
Sbjct: 191 VHQ--LHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP---DYI 243
Query: 331 APEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPP 362
+PE+ + +Y + D +S + +YEML GE P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
DF +IG+GS+ ++L + T A++ + + + + + E ++ +
Sbjct: 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMR----VVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 212 -LRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
HP +V TE + L + EY+ GGDL +++ + L A ++ +I+ +
Sbjct: 109 ASNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----- 324
YLH II+RDLK NVLL S H+K+ D+G+ K +
Sbjct: 168 YLHE--RGIIYRDLKLDNVLL--DSEGHIKLTDYGMCKE----------GLRPGDTTSTF 213
Query: 325 -GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APE+ + Y VD ++ ++++EM+ G P
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 27/225 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
NK WE+ + + S +G G++G + A + G VAIK++ + + +R
Sbjct: 16 NKTAWELPKT---YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR 72
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
E+ LL ++H N++ L T L L+ ++ DL K + K S
Sbjct: 73 -ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKI 128
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ +G+ Y+H+ ++HRDLKP N L VN + LK+ DFGL++ +
Sbjct: 129 QYLVYQMLKGLKYIHSAG--VVHRDLKPGN-LAVNEDCE-LKILDFGLARHADAE----- 179
Query: 318 YKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
MTG + Y APEV Y++ VD++S I+ EML G+
Sbjct: 180 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 68/222 (30%), Positives = 111/222 (50%), Gaps = 39/222 (17%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 207
DF+ ++GKGSFG+++ + +GT A+K L D ++ D +V
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVK----ILKKDVVIQDD---DVECTMVEKRV 394
Query: 208 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
L + + P + Q T + L + EY+ GGDL ++++ G AV +A +IA
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 453
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-- 324
G+ +L + II+RDLK NV+L S H+K+ DFG+ K +
Sbjct: 454 GLFFLQS--KGIIYRDLKLDNVML--DSEGHIKIADFGMCKE----------NIWDGVTT 499
Query: 325 ----GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APE+ ++ Y K VD ++F ++LYEML G+ P
Sbjct: 500 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 39/222 (17%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 207
+F ++GKGSFG+++ A + T A+K L D ++ D +V
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVK----VLKKDVILQDD---DVECTMTEKRI 76
Query: 208 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
L + HP + Q T + L + E++ GGDL ++++ + A +A +I
Sbjct: 77 LSLARNHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS 135
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-- 324
+ +LH+ II+RDLK NVLL H K+ DFG+ K +
Sbjct: 136 ALMFLHD--KGIIYRDLKLDNVLL--DHEGHCKLADFGMCKE----------GICNGVTT 181
Query: 325 ----GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
G+ Y+APE+ + Y VD ++ ++LYEML G P
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 29/215 (13%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLV----IQDFRHEVNLLVK 211
F +G GSFG ++ + + A+K L ++V I+ +E +L
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
+ P +V+ + + L ++ EY+ GG++ +L+ G S A +A I YL
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSY 327
H+ +I+RDLKP N+L+ +++V DFG +K ++ G T G+
Sbjct: 158 HS--LDLIYRDLKPENLLI--DQQGYIQVTDFGFAK-----------RVKGRTWTLCGTP 202
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
+APE+ + Y+K VD ++ +++YEM G PP
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-31
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 33/210 (15%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQD------FRHEVNLLVKLRHPN 216
+G+G++ + K + T VA+K I RL ++ R EV+LL L+H N
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIR-EVSLLKDLKHAN 61
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEP 275
IV + K L L+ EYL DL +YL + G ++ F + RG+AY H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR-- 118
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN---SHDVYKMTGETGSYRYMAP 332
++HRDLKP+N LL+N LK+ DFGL++ + ++V T YR P
Sbjct: 119 QKVLHRDLKPQN-LLINERG-ELKLADFGLARAKSIPTKTYDNEVV-----TLWYR--PP 169
Query: 333 EV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
++ Y ++D++ I YEM G P
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRP 199
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-31
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 24/224 (10%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
+ + + + IG G+ G + AY VAIK++ + + +R
Sbjct: 17 GDSTFTVLK---RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR 73
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
E+ L+ + H NI+ L T +K L ++ E + +L + ++ + L
Sbjct: 74 -ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERM 129
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ G+ +LH+ IIHRDLKP N ++V S LK+ DFGL++
Sbjct: 130 SYLLYQMLCGIKHLHS--AGIIHRDLKPSN-IVVKSDCT-LKILDFGLARTAGTSFM--- 182
Query: 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
MT + Y APEV Y + VD++S I+ EM++G
Sbjct: 183 --MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 26/225 (11%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
K WE+ + +G G++G + A G VAIK++ + + +R
Sbjct: 17 TKTAWEVRA---VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 73
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
E+ LL +RH N++ L T + L L+ ++ G DL K +K + L
Sbjct: 74 -ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE-KLGEDRI 130
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ +G+ Y+H IIHRDLKP N L VN + LK+ DFGL++ +
Sbjct: 131 QFLVYQMLKGLRYIHAAG--IIHRDLKPGN-LAVNEDCE-LKILDFGLARQADSE----- 181
Query: 318 YKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
MTG + Y APEV +Y + VD++S I+ EM+ G+
Sbjct: 182 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
DF +IG+G+F E+ + T A+K ++ ++ + FR E ++LV
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMK----IMNKWDMLKRGEVSCFREERDVLVN 117
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAY 270
I Q A + L L+ EY GGDL L + G + A + +I +
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
+H +HRD+KP N+LL H+++ DFG K++ V + G+ Y+
Sbjct: 178 VHR--LGYVHRDIKPDNILL--DRCGHIRLADFGSCL--KLRADGTVRSLVA-VGTPDYL 230
Query: 331 APEVFK-------HRKYDKKVDVFSFAMILYEMLEGEPP 362
+PE+ + Y + D ++ + YEM G+ P
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-31
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
DF +G GSFG + R A+K L + +V E +L
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMK----VLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
+ HP I++ G + + + +I +Y+ GG+L L++ A +A ++ + YL
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET----GSY 327
H+ II+RDLKP N+LL H+K+ DFG +K + T G+
Sbjct: 123 HS--KDIIYRDLKPENILL--DKNGHIKITDFGFAK-----------YVPDVTYTLCGTP 167
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
Y+APEV + Y+K +D +SF +++YEML G P
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 70/246 (28%), Positives = 115/246 (46%), Gaps = 34/246 (13%)
Query: 134 HFEPKPVPPPLP------NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAI 185
H + +++ P +++ + IG+G++G + AY VAI
Sbjct: 1 HHHHHHMAAAAAAGPEMVRGQVFDVGP---RYTNLSYIGEGAYGMVCSAYDNLNKVRVAI 57
Query: 186 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-----LMLITEYLRGG 240
K+I P + R E+ +L++ RH NI+ + + ++ + +
Sbjct: 58 KKISP-FEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ET 114
Query: 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHL 298
DL+K LK LS F I RG+ Y+H N ++HRDLKP N LL+N++ D L
Sbjct: 115 DLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSAN----VLHRDLKPSN-LLLNTTCD-L 167
Query: 299 KVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYE 355
K+ DFGL+++ + H + +T T YR APE+ + Y K +D++S IL E
Sbjct: 168 KICDFGLARVADPDHDHTGF-LTEYVATRWYR--APEIMLNSKGYTKSIDIWSVGCILAE 224
Query: 356 MLEGEP 361
ML P
Sbjct: 225 MLSNRP 230
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
D+ +IG+G+FGE+ + T A+K LS ++ + F E +++
Sbjct: 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK----LLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
P +VQ A + + L ++ EY+ GGDL + + A + ++ + +
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAI 184
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
H+ IHRD+KP N+LL + HLK+ DFG + + G Y++
Sbjct: 185 HS--MGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP---DYIS 237
Query: 332 PEVFK----HRKYDKKVDVFSFAMILYEMLEGEPP 362
PEV K Y ++ D +S + LYEML G+ P
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G+GS+G++ + A+K IL L + + E+ LL +LRH N++Q
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 221 ---LGAVTERKPLMLITEYLRGG--DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
L ++K + ++ EY G ++ + EK A + + G+ YLH+
Sbjct: 72 VDVLYNEEKQK-MYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLEYLHS-- 127
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
I+H+D+KP N+LL ++ LK+ G+++ + + D + + GS + PE+
Sbjct: 128 QGIVHKDIKPGNLLL--TTGGTLKISALGVAEALHPFAADDTCRTS--QGSPAFQPPEIA 183
Query: 336 KHRK-YD-KKVDVFSFAMILYEMLEGEPP 362
+ KVD++S + LY + G P
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 28/226 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
+ + + + IG G+ G + AY VAIK++ + + +R
Sbjct: 54 GDSTFTVLK---RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR 110
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
E+ L+ + H NI+ L T +K L L+ E + +L + ++ + L
Sbjct: 111 -ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERM 166
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ G+ +LH+ IIHRDLKP N ++V S LK+ DFGL++
Sbjct: 167 SYLLYQMLCGIKHLHSAG--IIHRDLKPSN-IVVKSDCT-LKILDFGLARTAGTSFM--- 219
Query: 318 YKMTGE--TGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
MT T YR APEV Y + VD++S I+ EM+ +
Sbjct: 220 --MTPYVVTRYYR--APEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 54/233 (23%), Positives = 91/233 (39%), Gaps = 31/233 (13%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRH 204
+ ++ I GS+G + G PVAIKR+ + D +
Sbjct: 14 IAELHAMQS---PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRV-FNTVSDGRTVNILSD 69
Query: 205 ---------EVNLLVKLRHPNIVQFLGAVTERKP-----LMLITEYLRGGDLHKYLK-EK 249
E+ LL HPNI+ + L L+TE + DL + + ++
Sbjct: 70 SFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQR 128
Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
+SP F I G+ LH ++HRDL P N +L+ + D + + DF L++
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHE--AGVVHRDLHPGN-ILLADNND-ITICDFNLARED 184
Query: 310 KVQNSHDVYKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
T Y APE+ + + + K VD++S ++ EM +
Sbjct: 185 TADA-----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 47/210 (22%), Positives = 82/210 (39%), Gaps = 34/210 (16%)
Query: 165 IGKGSFGEILKAYWRGT-------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
I G G I + PV +K ++ S D E L ++ HP+I
Sbjct: 88 IAHGGLGWI----YLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSI 141
Query: 218 VQFLGAVTERKPLM-----LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
VQ V ++ EY+ G L + L + A+ + L+I ++YLH
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLH 199
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
+ +++ DLKP N++L + + LK+ D G I +Y G+ + AP
Sbjct: 200 SIG--LVYNDLKPENIML---TEEQLKLIDLGAVSRINSFGY--LY------GTPGFQAP 246
Query: 333 EVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
E+ + D+++ L + P
Sbjct: 247 EIVRTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-30
Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 38/215 (17%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRI-------LPSLSDDRLVIQDFRHEVNLLVKLRHP 215
+G G++ + K + T VA+K + PS + R E++L+ +L+H
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--------IR-EISLMKELKHE 63
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE------KGALSPSTAVNFALDIARGMA 269
NIV+ + L L+ E++ DL KY+ L + F + +G+A
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSY 327
+ H N I+HRDLKP+N LL+N LK+GDFGL++ + V + E T Y
Sbjct: 123 FCHE--NKILHRDLKPQN-LLINKRG-QLKLGDFGLARAFGIP----VNTFSSEVVTLWY 174
Query: 328 RYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
R AP+V R Y +D++S IL EM+ G+P
Sbjct: 175 R--APDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 66/225 (29%), Positives = 108/225 (48%), Gaps = 26/225 (11%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
NK WE+ + + + +G G++G + A+ G VA+K++ + +R
Sbjct: 21 NKTIWEVPE---RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 77
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
E+ LL ++H N++ L T + L L+T + G DL+ +K + L+
Sbjct: 78 -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHV 134
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
I RG+ Y+H+ IIHRDLKP N L VN + LK+ DFGL++ +
Sbjct: 135 QFLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLARHTADE----- 185
Query: 318 YKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
MTG + Y APE+ Y++ VD++S I+ E+L G
Sbjct: 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 71/236 (30%), Positives = 108/236 (45%), Gaps = 33/236 (13%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQD 201
+P + + I DF +++G+G++G + A + G VAIK+I P ++
Sbjct: 1 MPKRIVYNISS---DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFALRT 56
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVT-----ERKPLMLITEYLRGGDLHKYLKEKGALSPST 256
R E+ +L +H NI+ + +I E + DLH+ + + LS
Sbjct: 57 LR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQ-MLSDDH 113
Query: 257 AVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI----- 309
F R + LH N +IHRDLKP N LL+NS+ D LKV DFGL+++I
Sbjct: 114 IQYFIYQTLRAVKVLHGSN----VIHRDLKPSN-LLINSNCD-LKVCDFGLARIIDESAA 167
Query: 310 -KVQNSHDVYKMTGE--TGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ + M T YR APEV KY + +DV+S IL E+ P
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYR--APEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 34/291 (11%), Positives = 80/291 (27%), Gaps = 58/291 (19%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD 195
P + + E+ ++G+ L+A + G + +
Sbjct: 54 SLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP 113
Query: 196 RLVIQDFRHEVNLLVKLR-------------------------HPNIVQFLGAVTERK-- 228
I+ + EV L LR +++ +
Sbjct: 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 173
Query: 229 ------PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
P M G L + +L + L + R +A LH+ ++H
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTY 231
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR---- 338
L+P +++L + + F + S + PE+ R
Sbjct: 232 LRPVDIVL--DQRGGVFLTGFEHLVRDG--------ARVVSSVSRGFEPPELEARRATIS 281
Query: 339 -------KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
D ++ +++Y + + P+ ++++ +
Sbjct: 282 YHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNI 332
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G+FGE+ KA R T VA+K++L + I R E+ +L L+H N+V +
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 83
Query: 223 AVTERKP--------LMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHN 273
+ + L+ ++ DL L + S + G+ Y+H
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 142
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRYMA 331
N I+HRD+K NVL+ LK+ DFGL++ + + + T T YR
Sbjct: 143 --NKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR--P 196
Query: 332 PEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
PE+ R Y +D++ I+ EM P
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 56/246 (22%), Positives = 102/246 (41%), Gaps = 67/246 (27%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH---EVNLLVKLRHPNIV 218
+G GSFG + + + G A+K++L QD R+ E++++ L H NI+
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVL----------QDPRYKNRELDIMKVLDHVNII 63
Query: 219 QFL--------------------------------------GAVTERKPLMLITEYLRGG 240
+ + ++ K L +I EY+
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PD 122
Query: 241 DLHK----YLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
LHK +++ ++ + + + R + ++H+ I HRD+KP+N LLVNS +
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS--LGICHRDIKPQN-LLVNSKDN 179
Query: 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYE 355
LK+ DFG +K + S Y APE+ +Y +D++S + E
Sbjct: 180 TLKLCDFGSAKKLIPSEP-----SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 356 MLEGEP 361
++ G+P
Sbjct: 235 LILGKP 240
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-29
Identities = 59/263 (22%), Positives = 98/263 (37%), Gaps = 48/263 (18%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEV 206
+ + ++ +IG+GS+G + AY + VAIK++ D + R E+
Sbjct: 21 NVHVPD---NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EI 76
Query: 207 NLLVKLRHPNIVQFLGAVT-----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
+L +L+ I++ + + L ++ E DL K K L+
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL 135
Query: 262 LDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
++ G ++H IIHRDLKP N L+N +KV DFGL++ I + ++
Sbjct: 136 YNLLLGENFIHESG----IIHRDLKPAN-CLLNQDCS-VKVCDFGLARTINSEKDTNIVN 189
Query: 320 MTGETGSYR------------------YMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGE 360
E Y APE+ Y K +D++S I E+L
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249
Query: 361 PPLANYEPYEAAKYVAEGHRPFF 383
N P F
Sbjct: 250 QSHINDPT---------NRFPLF 263
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-29
Identities = 47/224 (20%), Positives = 97/224 (43%), Gaps = 26/224 (11%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
+ +W D+ +G+G + E+ +A V +K + P + ++ R
Sbjct: 28 HVVEWGNQD---DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKI----KR 79
Query: 204 HEVNLLVKLR-HPNIVQFLGAVT--ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF 260
E+ +L LR PNI+ V + L+ E++ D + + L+ +
Sbjct: 80 -EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFY 135
Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
+I + + Y H+ I+HRD+KP N ++++ L++ D+GL++ H +
Sbjct: 136 MYEILKALDYCHS--MGIMHRDVKPHN-VMIDHEHRKLRLIDWGLAEFY-----HPGQEY 187
Query: 321 TGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEPPL 363
S + PE+ ++ YD +D++S +L M+ + P
Sbjct: 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 69/263 (26%), Positives = 106/263 (40%), Gaps = 48/263 (18%)
Query: 130 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKR 187
Q H KP DW+I + +IG GS+G + +AY + VAIK+
Sbjct: 29 QRKQHHSSKPTASMPRPHSDWQIPD---RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK 85
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL-----GAVTERKPLMLITEYLRGGDL 242
IL D + R E+ +L +L H ++V+ L V + L ++ E D
Sbjct: 86 ILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF 143
Query: 243 HKYLKEKGALSPSTAVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKV 300
K + L+ ++ G+ Y+H I+HRDLKP N LVN +KV
Sbjct: 144 KKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG----ILHRDLKPAN-CLVNQDCS-VKV 197
Query: 301 GDFGLSKLIKVQNSHDVYK-----------------------MTGE--TGSYRYMAPEV- 334
DFGL++ + + + +TG T YR APE+
Sbjct: 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR--APELI 255
Query: 335 FKHRKYDKKVDVFSFAMILYEML 357
Y + +DV+S I E+L
Sbjct: 256 LLQENYTEAIDVWSIGCIFAELL 278
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 31/266 (11%), Positives = 73/266 (27%), Gaps = 49/266 (18%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD 195
P + + E+ ++G+ L+A + G + +
Sbjct: 59 SLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP 118
Query: 196 RLVIQDFRHEVNLLVKLR----------------------HPNIVQFLGAVTERKPLMLI 233
I+ + EV L LR P + + + + + ++
Sbjct: 119 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 178
Query: 234 TEYL-----------RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ + G L + +L + L + R +A LH+ ++H
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTY 236
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-GSYRYMAPEVFK----- 336
L+P +++L + + F G A +
Sbjct: 237 LRPVDIVL--DQRGGVFLTGFEHLVRD----GASAVSPIGRGFAPPETTAERMLPFGQHH 290
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPP 362
D ++ + +Y + + P
Sbjct: 291 PTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-28
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 165 IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIV 218
IG+G++G++ KA G VA+KR+ ++ + + R EV +L L HPN+V
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 77
Query: 219 QFLGAVTERKP-----LMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYL 271
+ T + L L+ E++ DL YL + + T + + RG+ +L
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSYRY 329
H+ + ++HRDLKP+N +LV SS +K+ DFGL+++ Q +T T YR
Sbjct: 137 HS--HRVVHRDLKPQN-ILVTSSG-QIKLADFGLARIYSFQM-----ALTSVVVTLWYR- 186
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
APEV Y VD++S I EM +P
Sbjct: 187 -APEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-28
Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLV---IQDFRHEVNLLVKLR---HPN 216
IG G++G + KA G VA+K + I R EV LL +L HPN
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPN 75
Query: 217 IVQFLGAVTERKP-----LMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMA 269
+V+ + + + L+ E++ DL YL + L T + RG+
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TGSY 327
+LH N I+HRDLKP N +LV S +K+ DFGL+++ Q +T T Y
Sbjct: 135 FLHA--NCIVHRDLKPEN-ILVTSGG-TVKLADFGLARIYSYQM-----ALTPVVVTLWY 185
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
R APEV Y VD++S I EM +P
Sbjct: 186 R--APEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 158 DFSSSAIIGKGSFGEIL---KAYWRGTPV--AIKRILPSLSDDRLVIQ--DFRH---EVN 207
+F ++G G++G++ K T A+K L +V + H E
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK----VLKKATIVQKAKTTEHTRTERQ 110
Query: 208 LLVKLRH-PNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIA 265
+L +R P +V A TE K L LI +Y+ GG+L +L ++ + + +I
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 169
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGET 324
+ +LH II+RD+K N+LL ++ H+ + DFGLSK + D +
Sbjct: 170 LALEHLHK--LGIIYRDIKLENILL---DSNGHVVLTDFGLSK----EFVADETERAY-D 219
Query: 325 --GSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPP 362
G+ YMAP++ + +DK VD +S +++YE+L G P
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 37/240 (15%)
Query: 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH 204
+ D + + +GKG++G + K+ R G VA+K+I + + + FR
Sbjct: 2 RVDRHVLR---KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR- 57
Query: 205 EVNLLVKLR-HPNIVQFLGAVT--ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
E+ +L +L H NIV L + + + L+ +Y+ DLH ++ L P
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRAN-ILEPVHKQYVV 115
Query: 262 LDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
+ + + YLH ++HRD+KP N +L+N+ +KV DFGLS+
Sbjct: 116 YQLIKVIKYLHSGG----LLHRDMKPSN-ILLNAECH-VKVADFGLSRSFVNIRRVTNNI 169
Query: 320 MTGETGSYR-----------------YMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ Y APE+ KY K +D++S IL E+L G+P
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 32/207 (15%), Positives = 59/207 (28%), Gaps = 47/207 (22%)
Query: 163 AIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
G + W+ VA+ + P V+Q+ L ++ P
Sbjct: 37 IFHGGVPPLQF----WQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
+ + L V R +++ E++RGG L + + SP A+ +A H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336
+ P V + S + + M
Sbjct: 150 -VALSIDHPSRVRV--SIDGDVVLAYPA------------------------TMPDA--- 179
Query: 337 HRKYDKKVDVFSFAMILYEMLEGEPPL 363
+ + D+ LY +L PL
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWPL 202
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 39/221 (17%)
Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G+G++G + KA + A+K+I + + R E+ LL +L+HPN++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACR-EIALLRELKHPNVISL 83
Query: 221 LGAVTER--KPLMLITEYLRGGDLHKYLKEKGA---------LSPSTAVNFALDIARGMA 269
+ + L+ +Y DL +K A L + I G+
Sbjct: 84 QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
YLH N ++HRDLKP N +LV +K+ D G ++L + +
Sbjct: 143 YLHA--NWVLHRDLKPAN-ILVMGEGPERGRVKIADMGFARLFNS----PLKPLADLDPV 195
Query: 327 -----YRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEP 361
YR APE+ R Y K +D+++ I E+L EP
Sbjct: 196 VVTFWYR--APELLLGARHYTKAIDIWAIGCIFAELLTSEP 234
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 40/217 (18%)
Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVI---QDFRH----EVNLLVKLR 213
+IGKGSFG+++KAY VA+K ++ + F E+ +L LR
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALK-----------MVRNEKRFHRQAAEEIRILEHLR 151
Query: 214 H------PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAVNFALDI 264
N++ L T R + + E L +L++ +K+ +G S FA I
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQG-FSLPLVRKFAHSI 209
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
+ + LH N IIH DLKP N+LL +KV DFG S ++ ++
Sbjct: 210 LQCLDALHK--NRIIHCDLKPENILLKQQGRSGIKVIDFGSS-------CYEHQRVYTYI 260
Query: 325 GSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
S Y APEV +Y +D++S IL E+L G P
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 36/216 (16%)
Query: 163 AIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVI---QDFRH----EVNLLVKLR 213
++IGKGSFG+++KAY R VAIK +I + F + EV LL +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK-----------IIKNKKAFLNQAQIEVRLLELMN 108
Query: 214 HP------NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIA 265
IV R L L+ E L +L+ L+ +S + FA +
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
+ +L IIH DLKP N+LL N +K+ DFG S ++ Y ++
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYI---QSR 222
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
YR +PEV YD +D++S IL EM GEP
Sbjct: 223 FYR--SPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 46/222 (20%), Positives = 84/222 (37%), Gaps = 36/222 (16%)
Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR------- 213
+G G F + A T VA+K I+ + E+ LL ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYT---EAAEDEIKLLQRVNDADNTKE 80
Query: 214 ----HPNIVQFLGAVTERKPLM----LITEYLRGGDLHKYLK--EKGALSPSTAVNFALD 263
+I++ L + P ++ E L G +L +K E + +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLL----VNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
+ G+ Y+H IIH D+KP NVL+ + +K+ D G +
Sbjct: 140 LLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-------CWYDEH 191
Query: 320 MTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
T + Y +PEV + D++S A +++E++ G+
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 5e-21
Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 16/139 (11%)
Query: 248 EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
K L+ + ++ +A+GM +L IHRDL RN+LL S + +K+ DFGL++
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILL--SEKNVVKICDFGLAR 241
Query: 308 LIKVQNSHDVYKMTGETG-SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPP--- 362
I Y G+ ++MAPE R Y + DV+SF ++L+E+ G P
Sbjct: 242 DI---YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298
Query: 363 -LANYEPYEAAKYVAEGHR 380
+ E + + EG R
Sbjct: 299 VKIDEEFC---RRLKEGTR 314
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 41/161 (25%), Positives = 67/161 (41%), Gaps = 20/161 (12%)
Query: 144 LPNKCD-WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDD 195
LP WE L +G+G+FG++++A G VA+K + +
Sbjct: 10 LPYDASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 67
Query: 196 RLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKGALS 253
+ E+ +L+ + H N+V LGA T+ PLM+I E+ + G+L YL+ K
Sbjct: 68 --EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNE 124
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294
+G Y+ I DLK R + +S
Sbjct: 125 FVPYKTKGARFRQGKDYVGA-----IPVDLKRRLDSITSSQ 160
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 54/231 (23%), Positives = 85/231 (36%), Gaps = 50/231 (21%)
Query: 163 AIIGKGSFGEILKAYWRGT---PVAIKRILPSLSDDRLVIQDFRH----EVNLLVKLRHP 215
+G+G+FG++++ VA+K I+ + + + E+ +L L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVK-IVKN-------VDRYCEAARSEIQVLEHLNTT 71
Query: 216 ------NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARG 267
VQ L + ++ E L G + ++KE G A I +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----------------LKVGDFGLSKLIK 310
+ +LH+ N + H DLKP N+L V S +KV DFG +
Sbjct: 131 VNFLHS--NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TY 186
Query: 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
H T YR APEV + + DV+S IL E G
Sbjct: 187 DDEHHSTLV---STRHYR--APEVILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 51/231 (22%), Positives = 88/231 (38%), Gaps = 50/231 (21%)
Query: 163 AIIGKGSFGEILKAYWRGT---PVAIKRILPSLSDDRLVIQDFRH----EVNLLVKLRHP 215
+G+G+FG++++ VA+K I+ + + +R E+N+L K++
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALK-IIRN-------VGKYREAARLEINVLKKIKEK 76
Query: 216 ------NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARG 267
V + + E L G + ++LKE + A +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----------------LKVGDFGLSKLIK 310
+ +LH N + H DLKP N+L VNS + ++V DFG +
Sbjct: 136 LRFLHE--NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---- 189
Query: 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ + T YR PEV + + DV+S IL+E G
Sbjct: 190 TFDHEHHTTIV-ATRHYR--PPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 51/235 (21%), Positives = 90/235 (38%), Gaps = 54/235 (22%)
Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRH----EVNLLVKLRH-- 214
+G G+FG +L A+K ++ + I+ + E ++L K+++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVK-VVRN-------IKKYTRSAKIEADILKKIQNDD 92
Query: 215 ---PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMA 269
NIV++ G + LI E L G L++ + + ++I + +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADH-----------------------LKVGDFGLS 306
YL + H DLKP N+LL + + +K+ DFG +
Sbjct: 152 YLRK--MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEP 361
+ H T YR APEV + +D D++SF +L E+ G
Sbjct: 210 --TFKSDYHGSII---NTRQYR--APEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 6e-18
Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L + + D +V LL+ + +D+ TPLH A HG + V + L+++ A
Sbjct: 11 ETLLH-IASIKGDIPSVEYLLQNGSD-PNVKDHAGWTPLHEACNHGHLKVVELLLQHKAL 68
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
VN ++PL DA ++++LL ++G
Sbjct: 69 VNTTGYQNDSPLHDAAKNGHVDIVKLLLSYG 99
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 74.0 bits (183), Expect = 3e-16
Identities = 18/64 (28%), Positives = 33/64 (51%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+ Y N +PLH A+ +G +D+ K L+ YGA NA + + P+ + +++ L
Sbjct: 69 VNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLP 128
Query: 121 NAHG 124
+
Sbjct: 129 EKNE 132
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 63.2 bits (155), Expect = 2e-12
Identities = 15/43 (34%), Positives = 24/43 (55%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
++ T LH+AS+ G I + L++ G+D N +D TPL
Sbjct: 5 FTNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPL 47
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 41.3 bits (98), Expect = 9e-05
Identities = 3/36 (8%), Positives = 9/36 (25%), Gaps = 1/36 (2%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
+A + P+ + + +A
Sbjct: 102 RNAVNIFGLRPVDYTDDESMKSLLLLPEK-NESSSA 136
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 75.9 bits (188), Expect = 1e-16
Identities = 20/72 (27%), Positives = 36/72 (50%), Gaps = 1/72 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
S+ A Q + +++ L + +LV+ D TPL AS G I+ + L+E+GAD
Sbjct: 3 SLSIH-QLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGAD 61
Query: 94 VNAQDRWKNTPL 105
+ + + + L
Sbjct: 62 PHILAKERESAL 73
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 69.4 bits (171), Expect = 3e-14
Identities = 22/102 (21%), Positives = 40/102 (39%), Gaps = 3/102 (2%)
Query: 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWID 82
AD A+ ++L + V LLE D ++ D++ TPL A +
Sbjct: 60 ADP-HILAKERESALS-LASTGGYTDIVGLLLERDVD-INIYDWNGGTPLLYAVRGNHVK 116
Query: 83 VAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ L+ GAD+ + TP+ A + +++ H
Sbjct: 117 CVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHI 158
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 64.7 bits (159), Expect = 1e-12
Identities = 13/73 (17%), Positives = 24/73 (32%), Gaps = 6/73 (8%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
T L+ + N V LL D + TP+ +A G+ V + + +
Sbjct: 103 GTPLL-YAVRGNHVKCVEALLARGAD---LTTEADSGYTPMDLAVALGYRKVQQVIENHI 158
Query: 92 ADVNAQDRWKNTP 104
+ + P
Sbjct: 159 LKLFQSNLVPADP 171
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 54.0 bits (131), Expect = 6e-09
Identities = 11/39 (28%), Positives = 17/39 (43%), Gaps = 1/39 (2%)
Query: 68 NRTPLHVASLHGWIDVAKCLIEYGAD-VNAQDRWKNTPL 105
+ +H + G +D K + G + VN D TPL
Sbjct: 2 DSLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPL 40
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 75.5 bits (187), Expect = 2e-16
Identities = 24/93 (25%), Positives = 44/93 (47%), Gaps = 5/93 (5%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+ + +A AVR L+ ++ ++ D +PLH A G V + LI GA
Sbjct: 6 MDDIFTQ-CREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGAR 64
Query: 94 VNAQDRWKNTPL--ADAEGAKKFNMMELLNAHG 124
+N +R +TPL A + G + ++++ L +
Sbjct: 65 INVMNRGDDTPLHLAASHGHR--DIVQKLLQYK 95
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 71.3 bits (176), Expect = 6e-15
Identities = 17/66 (25%), Positives = 29/66 (43%), Gaps = 4/66 (6%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMME 118
++A + PLH A G VA+ L+ GA V+ +++ P+ A A + + E
Sbjct: 98 INAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKAPLREL--LRE 155
Query: 119 LLNAHG 124
G
Sbjct: 156 RAEKMG 161
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 69.4 bits (171), Expect = 3e-14
Identities = 22/64 (34%), Positives = 37/64 (57%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
++ + + TPLH+A+ HG D+ + L++Y AD+NA + N PL A + + E L
Sbjct: 65 INVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDL 124
Query: 121 NAHG 124
A+G
Sbjct: 125 VANG 128
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 54.7 bits (133), Expect = 4e-09
Identities = 7/48 (14%), Positives = 14/48 (29%), Gaps = 6/48 (12%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
V + P+ A + + + G ++N P D
Sbjct: 131 VSICNKYGEMPVDKAKAPLRELLRERAEKMGQNLNR------IPYKDT 172
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 54.4 bits (132), Expect = 5e-09
Identities = 10/61 (16%), Positives = 21/61 (34%), Gaps = 1/61 (1%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGA-DVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
+ + G + ++ D+N D +PL A + ++E+L
Sbjct: 2 SPEFMDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMR 61
Query: 124 G 124
G
Sbjct: 62 G 62
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 73.2 bits (181), Expect = 4e-16
Identities = 22/77 (28%), Positives = 35/77 (45%), Gaps = 6/77 (7%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
+ W D V+ + + D V+ R PLH A+ G +++ + L+ G
Sbjct: 8 DKEFM-WALKNGDLDEVKDYVAKGED---VNRTLEGGRKPLHYAADCGQLEILEFLLLKG 63
Query: 92 ADVNAQDRWKNTPLADA 108
AD+NA D+ TPL A
Sbjct: 64 ADINAPDKHHITPLLSA 80
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 65.5 bits (161), Expect = 2e-13
Identities = 13/48 (27%), Positives = 19/48 (39%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
++A D + TPL A G + K L+ GAD + T
Sbjct: 66 INAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTAFEAT 113
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 59.3 bits (145), Expect = 3e-11
Identities = 14/62 (22%), Positives = 20/62 (32%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNA 122
A +G +D K + G DVN PL A + ++E L
Sbjct: 2 PLGSMCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLL 61
Query: 123 HG 124
G
Sbjct: 62 KG 63
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 74.4 bits (184), Expect = 9e-16
Identities = 27/89 (30%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A+Q D V+++L++ V D + TPL++A + I++AK LI+ GAD+N Q+
Sbjct: 10 LEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQN 69
Query: 99 RWKNTPL--ADAEGAKKFNMMELLNAHGG 125
++P A A+G + ++ + H
Sbjct: 70 SISDSPYLYAGAQGRTE--ILAYMLKHAT 96
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 64.0 bits (157), Expect = 3e-12
Identities = 22/106 (20%), Positives = 41/106 (38%), Gaps = 6/106 (5%)
Query: 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASL----- 77
+ R +LI A + V+ LLE+ + + ++ T L A
Sbjct: 96 TPDLNKHNRYGGNALI-PAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGN 154
Query: 78 HGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
+ D+ K L+E GAD + +D T + A + ++L +
Sbjct: 155 QLYQDIVKLLMENGADQSIKDNSGRTAMDYANQKGYTEISKILAQY 200
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 63.6 bits (156), Expect = 4e-12
Identities = 14/61 (22%), Positives = 22/61 (36%)
Query: 64 RDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
+ Y+ L A+ V + L + V+ D NTPL A + + L
Sbjct: 2 KTYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDR 61
Query: 124 G 124
G
Sbjct: 62 G 62
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 9e-12
Identities = 18/84 (21%), Positives = 35/84 (41%), Gaps = 3/84 (3%)
Query: 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWID 82
AD + +S + + + Q + +L+ ++ + L A+ G ID
Sbjct: 63 ADI-NLQNSISDSPYL-YAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHID 120
Query: 83 VAKCLIEYG-ADVNAQDRWKNTPL 105
K L+E G D++ Q+ + T L
Sbjct: 121 NVKLLLEDGREDIDFQNDFGYTAL 144
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 16/85 (18%), Positives = 29/85 (34%), Gaps = 2/85 (2%)
Query: 42 AHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
+ LL + ++ +T LH+A++ G + L GA V +R
Sbjct: 17 VIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAER 76
Query: 100 WKNTPLADAEGAKKFNMMELLNAHG 124
+T L A + +L
Sbjct: 77 GGHTALHLACRVRAHTCACVLLQPR 101
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 5e-15
Identities = 26/87 (29%), Positives = 42/87 (48%), Gaps = 1/87 (1%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
+ N E+ + + A +YD TPLHVA +H ++ + L + GAD+N +
Sbjct: 129 AVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPE 188
Query: 99 R-WKNTPLADAEGAKKFNMMELLNAHG 124
TPL A A+ +++ELL G
Sbjct: 189 PTCGRTPLHLAVEAQAASVLELLLKAG 215
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 4e-13
Identities = 22/67 (32%), Positives = 31/67 (46%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A + AA+V +LL + + AR Y RTPL A L +A+ L +GA
Sbjct: 196 LHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDG 255
Query: 99 RWKNTPL 105
K +P
Sbjct: 256 GDKLSPC 262
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 3e-12
Identities = 21/65 (32%), Positives = 30/65 (46%), Gaps = 1/65 (1%)
Query: 61 VHARDYDN-RTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
++ + RTPLH+A V + L++ GAD A+ TPL A + L
Sbjct: 184 LNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARL 243
Query: 120 LNAHG 124
L AHG
Sbjct: 244 LRAHG 248
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 7e-11
Identities = 12/86 (13%), Positives = 23/86 (26%), Gaps = 5/86 (5%)
Query: 42 AHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
A +A+ V KL V + T LH+A A L++
Sbjct: 53 AILGEASTVEKLYAAGAG---VLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDAS 109
Query: 100 WKNTPLADAEGAKKFNMMELLNAHGG 125
+ + +++
Sbjct: 110 DTYLTQSQDCTPDTSHAPAAVDSQPN 135
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 8e-10
Identities = 16/65 (24%), Positives = 26/65 (40%), Gaps = 3/65 (4%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIEYGAD---VNAQDRWKNTPLADAEGAKKFNMMEL 119
D T LH+A +H L+ + A ++ Q+ T L A + + +E
Sbjct: 4 YVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEK 63
Query: 120 LNAHG 124
L A G
Sbjct: 64 LYAAG 68
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 8e-05
Identities = 17/96 (17%), Positives = 30/96 (31%), Gaps = 13/96 (13%)
Query: 42 AHQNDAAAVRKLLE---------EDQSLVHARDYDNRTPLHVASLH----GWIDVAKCLI 88
LL+ D L ++D T A++ +
Sbjct: 86 CRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDE 145
Query: 89 EYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
++ + A++ +TPL A K M+ LL G
Sbjct: 146 DWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAG 181
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 6e-04
Identities = 5/31 (16%), Positives = 7/31 (22%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
D +P + D EY
Sbjct: 251 EPEDGGDKLSPCSSSGSDSDSDNRDEGDEYD 281
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 2e-15
Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 1/97 (1%)
Query: 28 EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
+ L L A + + LL HA D TPLH+A+ + + + + L
Sbjct: 19 LTGEYKKDEL-LEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLL 77
Query: 88 IEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+++GADV+A+D+ PL +A + + ELL HG
Sbjct: 78 LQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHG 114
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 9e-15
Identities = 26/64 (40%), Positives = 38/64 (59%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
VHA+D PLH A +G +V + L+++GA VNA D W+ TPL +A + + LL
Sbjct: 84 VHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLL 143
Query: 121 NAHG 124
+HG
Sbjct: 144 LSHG 147
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 72.1 bits (178), Expect = 3e-14
Identities = 28/93 (30%), Positives = 41/93 (44%), Gaps = 3/93 (3%)
Query: 34 RTSLIL--WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
T+L H LL + + V+ ++ D TPLHVA+ DV + L ++G
Sbjct: 212 ETALHCAVASLHPKRKQVAELLLRKG-ANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHG 270
Query: 92 ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
A +NA D T L A A LL ++G
Sbjct: 271 AKMNALDSLGQTALHRAALAGHLQTCRLLLSYG 303
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 67.5 bits (166), Expect = 1e-12
Identities = 14/64 (21%), Positives = 25/64 (39%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A D TPLH A+ ++V L+ +GAD + + + A + +
Sbjct: 117 VNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYE 176
Query: 121 NAHG 124
Sbjct: 177 FKGH 180
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 64.4 bits (158), Expect = 1e-11
Identities = 13/45 (28%), Positives = 22/45 (48%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
++A D +T LH A+L G + + L+ YG+D + T
Sbjct: 273 MNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAA 317
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 1e-08
Identities = 16/65 (24%), Positives = 26/65 (40%), Gaps = 1/65 (1%)
Query: 61 VHARDYDNRTPLHVASLHG-WIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
+ L A+ G + L + +A D K+TPL A G + +++L
Sbjct: 17 AVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQL 76
Query: 120 LNAHG 124
L HG
Sbjct: 77 LLQHG 81
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 48.6 bits (117), Expect = 2e-06
Identities = 9/88 (10%), Positives = 20/88 (22%), Gaps = 24/88 (27%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEY---------------------GADVNAQDR 99
+ ++ + +A + + Q +
Sbjct: 150 PTLVNCHGKSAVDMAPTPELRERLTYEFKGHSLLQAAREADLAKVKKTLALEIINFKQPQ 209
Query: 100 WKNTPL---ADAEGAKKFNMMELLNAHG 124
T L + K+ + ELL G
Sbjct: 210 SHETALHCAVASLHPKRKQVAELLLRKG 237
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 46.3 bits (111), Expect = 9e-06
Identities = 4/48 (8%), Positives = 13/48 (27%), Gaps = 7/48 (14%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
T + + + + ++ + D + L +A
Sbjct: 306 PSIISLQGFTAAQMGN-----EAVQQILSESTPMRTSD--VDYRLLEA 346
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 72.0 bits (178), Expect = 3e-15
Identities = 28/64 (43%), Positives = 39/64 (60%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
VHA+D PLH A +G +VA+ L+++GA VN D WK TPL +A K+ + +LL
Sbjct: 68 VHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLL 127
Query: 121 NAHG 124
HG
Sbjct: 128 LQHG 131
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 69.7 bits (172), Expect = 2e-14
Identities = 21/65 (32%), Positives = 33/65 (50%), Gaps = 3/65 (4%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA-EGAKKFNMMEL 119
V+ D TPLH A+ G ++ K L+++GAD ++R NTPL +G + +L
Sbjct: 101 VNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLVKDGDTD--IQDL 158
Query: 120 LNAHG 124
L
Sbjct: 159 LRGDA 163
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 67.4 bits (166), Expect = 1e-13
Identities = 26/83 (31%), Positives = 41/83 (49%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
A D V+KL + TPLH A+ + + V + L+++GADV+A+D+
Sbjct: 16 AKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGG 75
Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
PL +A + + ELL HG
Sbjct: 76 LVPLHNACSYGHYEVAELLVKHG 98
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 53.5 bits (130), Expect = 8e-09
Identities = 14/61 (22%), Positives = 27/61 (44%), Gaps = 1/61 (1%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEY-GADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
+ + L A+ G ++ K L + + ++TPL A G + +++E L H
Sbjct: 5 NSEADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQH 64
Query: 124 G 124
G
Sbjct: 65 G 65
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 40.1 bits (95), Expect = 3e-04
Identities = 8/32 (25%), Positives = 12/32 (37%), Gaps = 1/32 (3%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
++ D TPL + G D+ L A
Sbjct: 134 PTKKNRDGNTPLDLVK-DGDTDIQDLLRGDAA 164
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 70.9 bits (175), Expect = 5e-15
Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 2/90 (2%)
Query: 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
L A + D VR+LL + A + +T L V G +A L++ GA
Sbjct: 4 DRL-SGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASP 61
Query: 95 NAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
N QD +P+ DA + +++L HG
Sbjct: 62 NVQDTSGTSPVHDAARTGFLDTLKVLVEHG 91
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 69.4 bits (171), Expect = 2e-14
Identities = 21/65 (32%), Positives = 33/65 (50%), Gaps = 4/65 (6%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMME 118
+ +D +P+H A+ G++D K L+E+GADVN D P+ A EG ++
Sbjct: 61 PNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTA--VVS 118
Query: 119 LLNAH 123
L A
Sbjct: 119 FLAAE 123
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 60.5 bits (148), Expect = 2e-11
Identities = 16/63 (25%), Positives = 28/63 (44%), Gaps = 1/63 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+ D P+H+A G V L +D++ +D TPL A +++++L
Sbjct: 94 VNVPDGTGALPIHLAVQEGHTAVVSFLAA-ESDLHRRDARGLTPLELALQRGAQDLVDIL 152
Query: 121 NAH 123
H
Sbjct: 153 QGH 155
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-15
Identities = 18/91 (19%), Positives = 36/91 (39%), Gaps = 1/91 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T+L W H V L + ++ ++ T LH A+ G+ D+ + L+ GA
Sbjct: 107 STALY-WACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGAR 165
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ ++ K A A ++++
Sbjct: 166 TDLRNIEKKLAFDMATNAACASLLKKKQGTD 196
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-12
Identities = 15/87 (17%), Positives = 28/87 (32%), Gaps = 5/87 (5%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
W + V + PLH A+ G + + ++ VN D
Sbjct: 49 WWKGTSKGRTGLIPSN-----YVAEQAESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLD 103
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHGG 125
+ +T L A +++E+L
Sbjct: 104 KAGSTALYWACHGGHKDIVEMLFTQPN 130
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 5/50 (10%), Positives = 14/50 (28%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG 110
R+ + + +A+ + K A + D++
Sbjct: 166 TDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSNAEDYLDDEDSDL 215
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 9e-07
Identities = 4/47 (8%), Positives = 8/47 (17%)
Query: 62 HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
+ + A L D+ +T
Sbjct: 6 PKPVKPGQVKVFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKG 52
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 5e-15
Identities = 25/83 (30%), Positives = 43/83 (51%), Gaps = 1/83 (1%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
A ++R L+ + + V+ D+ +PLH A L G + K L+++GA VN
Sbjct: 67 AIHGHQLSLRNLISQGWA-VNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADW 125
Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
+TPL +A + ++ + LL HG
Sbjct: 126 HTPLFNACVSGSWDCVNLLLQHG 148
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 67.1 bits (165), Expect = 1e-12
Identities = 17/77 (22%), Positives = 31/77 (40%), Gaps = 1/77 (1%)
Query: 48 AAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLAD 107
+ L+ + +P+H A++HG + LI G VN +PL +
Sbjct: 40 RDFPGIRLLSNPLM-GDAVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHE 98
Query: 108 AEGAKKFNMMELLNAHG 124
A + +++L HG
Sbjct: 99 ACLGGHLSCVKILLKHG 115
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 3e-11
Identities = 20/85 (23%), Positives = 31/85 (36%), Gaps = 7/85 (8%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
A V+KLLE V+ +PLH ++A L+++GAD A++
Sbjct: 198 CENQQRACVKKLLESGAD-VNQGK-GQDSPLHAVVRTASEELACLLMDFGADTQAKNAEG 255
Query: 102 NTPL--ADAEGAKKFNMMELLNAHG 124
P+ E L G
Sbjct: 256 KRPVELVPPESPLA---QLFLEREG 277
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 62.1 bits (152), Expect = 4e-11
Identities = 21/85 (24%), Positives = 38/85 (44%), Gaps = 6/85 (7%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
+ V+ LL+ + V+ D TPL A + G D L+++GA V +
Sbjct: 100 CLGGHLSCVKILLKHG-AQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPESD-L 157
Query: 102 NTPLADAEGAKK--FNMMELLNAHG 124
+P+ +A A++ + L A+G
Sbjct: 158 ASPIHEA--ARRGHVECVNSLIAYG 180
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 7e-11
Identities = 20/86 (23%), Positives = 33/86 (38%), Gaps = 1/86 (1%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
+ A + L + + TPL++A + K L+E GADVN Q
Sbjct: 161 IHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVN-QG 219
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHG 124
+ +++PL + LL G
Sbjct: 220 KGQDSPLHAVVRTASEELACLLMDFG 245
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 59.4 bits (145), Expect = 4e-10
Identities = 16/64 (25%), Positives = 29/64 (45%), Gaps = 1/64 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V D +P+H A+ G ++ LI YG +++ + TPL A ++ ++ L
Sbjct: 151 VQPES-DLASPIHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKL 209
Query: 121 NAHG 124
G
Sbjct: 210 LESG 213
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 2e-05
Identities = 8/58 (13%), Positives = 21/58 (36%), Gaps = 1/58 (1%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
L + + + LL + + A++ + + P+ + + L GA +
Sbjct: 226 LHAVVRTASEELACLLMDFGADTQAKNAEGKRPVELVPPESPL-AQLFLEREGASLPK 282
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 43.2 bits (103), Expect = 6e-05
Identities = 7/64 (10%), Positives = 20/64 (31%), Gaps = 10/64 (15%)
Query: 74 VASLHGWIDVAKCLIEYGADVNAQDRWK-----NTPLADAEGAKKFNMMELLNAHGGLSY 128
+ S H + L+ G+ + + D + + P + L ++ +
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMASMDGKQGGMDGSKPAGPRDFPG-----IRLLSNPLMGD 55
Query: 129 GQNG 132
+
Sbjct: 56 AVSD 59
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 6e-15
Identities = 22/85 (25%), Positives = 32/85 (37%), Gaps = 4/85 (4%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
+ R+ L T LHVA+ G+ +V K LI+ DVN +D
Sbjct: 173 EERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDG 232
Query: 102 NTPL--ADAEGAKKFNMMELLNAHG 124
TPL A G + +L +
Sbjct: 233 WTPLHAAAHWGKE--EACRILVENL 255
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 8e-15
Identities = 24/83 (28%), Positives = 37/83 (44%), Gaps = 1/83 (1%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
D V +LLE ++ + D T LH A + +D+ K L+E GA++N D
Sbjct: 48 CSSGDTEEVLRLLERGAD-INYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEG 106
Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
PL A ++ E L + G
Sbjct: 107 WIPLHAAASCGYLDIAEYLISQG 129
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 4e-13
Identities = 19/66 (28%), Positives = 30/66 (45%), Gaps = 4/66 (6%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMME 118
V+ +DYD TPLH A+ G + + L+E D+ A ++ T AD + + E
Sbjct: 225 VNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADEDILGY--LEE 282
Query: 119 LLNAHG 124
L
Sbjct: 283 LQKKQN 288
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 6e-13
Identities = 23/68 (33%), Positives = 35/68 (51%), Gaps = 7/68 (10%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMME-- 118
++ D + PLH A+ G++D+A+ LI GA V A + +TPL AE + M E
Sbjct: 99 INQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAE---EEAMEELL 155
Query: 119 --LLNAHG 124
+N G
Sbjct: 156 QNEVNRQG 163
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 1e-09
Identities = 17/98 (17%), Positives = 32/98 (32%), Gaps = 3/98 (3%)
Query: 27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKC 86
K + + L + + + + D+ A G +
Sbjct: 2 KMADAKQKRNEQL--KRWIGSETDLEPPVVKRKKTKVKF-DDGAVFLAACSSGDTEEVLR 58
Query: 87 LIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
L+E GAD+N + T L A +M++ L +G
Sbjct: 59 LLERGADINYANVDGLTALHQACIDDNVDMVKFLVENG 96
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 3e-08
Identities = 15/81 (18%), Positives = 27/81 (33%), Gaps = 4/81 (4%)
Query: 46 DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
D A + E Q+ V+ + D D + L + + T L
Sbjct: 144 DIAEEEAMEELLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTAL 203
Query: 106 --ADAEGAKKFNMMELLNAHG 124
A A+G + +++LL
Sbjct: 204 HVAAAKGYTE--VLKLLIQAR 222
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 52.1 bits (126), Expect = 8e-08
Identities = 6/64 (9%), Positives = 13/64 (20%), Gaps = 1/64 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ D + + G + + + LA + L
Sbjct: 1 MKMADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDT-EEVLRL 59
Query: 121 NAHG 124
G
Sbjct: 60 LERG 63
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 8e-15
Identities = 22/95 (23%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 34 RTSLIL--WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
+ L L H + V + ++ D + ++ ++ +TPLH+A + ++A+ L+ G
Sbjct: 9 DSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAG 68
Query: 92 ADVNAQDRWKNTPL--ADAEGAKKFNMMELLNAHG 124
D +D NTPL A +G + +L
Sbjct: 69 CDPELRDFRGNTPLHLACEQGCL--ASVGVLTQSC 101
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 6e-13
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 6/89 (6%)
Query: 42 AHQNDAAAVRKLLE-----EDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
Q A+V L + S++ A +Y+ T LH+AS+HG++ + + L+ GADVNA
Sbjct: 86 CEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNA 145
Query: 97 QDRWK-NTPLADAEGAKKFNMMELLNAHG 124
Q+ T L A + +++ LL G
Sbjct: 146 QEPCNGRTALHLAVDLQNPDLVSLLLKCG 174
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 2e-12
Identities = 18/65 (27%), Positives = 28/65 (43%), Gaps = 1/65 (1%)
Query: 61 VHARDYDN-RTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
V+A++ N RT LH+A D+ L++ GADVN +P G + +
Sbjct: 143 VNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQ 202
Query: 120 LNAHG 124
L
Sbjct: 203 LGQLT 207
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 3e-10
Identities = 17/70 (24%), Positives = 27/70 (38%), Gaps = 6/70 (8%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD------VNAQDRWKNTPLADAEGAKKF 114
RD+ TPLH+A G + L + + A + +T L A
Sbjct: 71 PELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYL 130
Query: 115 NMMELLNAHG 124
++ELL + G
Sbjct: 131 GIVELLVSLG 140
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 6e-10
Identities = 10/75 (13%), Positives = 21/75 (28%), Gaps = 2/75 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
RT+L + V LL+ V+ Y +P + + + L + +
Sbjct: 152 RTALH-LAVDLQNPDLVSLLLKCGAD-VNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 209
Query: 94 VNAQDRWKNTPLADA 108
+
Sbjct: 210 NLQMLPESEDEESYD 224
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 2e-09
Identities = 16/67 (23%), Positives = 28/67 (41%), Gaps = 4/67 (5%)
Query: 62 HARDYDNRTPLHVASLHGW----IDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
D + LH+A +H ++V + + A +N Q+ + TPL A + +
Sbjct: 2 QQLTEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIA 61
Query: 118 ELLNAHG 124
E L G
Sbjct: 62 EALLGAG 68
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 71.7 bits (177), Expect = 1e-14
Identities = 24/93 (25%), Positives = 38/93 (40%), Gaps = 5/93 (5%)
Query: 34 RTSLILWH--AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
RT L H + + L+ + + AR +D TPL +A+ + + LI
Sbjct: 91 RTPL---HAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSH 147
Query: 92 ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
ADVNA D + L A + +L +G
Sbjct: 148 ADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNG 180
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 69.4 bits (171), Expect = 1e-13
Identities = 21/92 (22%), Positives = 42/92 (45%), Gaps = 2/92 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+++L W A N+ A LL+ + ++ TPL +A+ G + AK L+++ A+
Sbjct: 158 KSALH-WAAAVNNVDAAVVLLKNG-ANKDMQNNREETPLFLAAREGSYETAKVLLDHFAN 215
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
+ D P A+ +++ LL+
Sbjct: 216 RDITDHMDRLPRDIAQERMHHDIVRLLDLEHH 247
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 3e-13
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 4/88 (4%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
++ A + + + SL + D T LH+A+ + D AK L+E AD N QD
Sbjct: 29 SEEEEDAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDN 88
Query: 100 WKNTPL--ADAEGAKKFNMMELLNAHGG 125
TPL A + A+ + ++L +
Sbjct: 89 MGRTPLHAAVSADAQG--VFQILIRNRA 114
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 3e-12
Identities = 20/66 (30%), Positives = 35/66 (53%), Gaps = 4/66 (6%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMME 118
V+A D ++ LH A+ +D A L++ GA+ + Q+ + TPL A EG+ + +
Sbjct: 150 VNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYE--TAK 207
Query: 119 LLNAHG 124
+L H
Sbjct: 208 VLLDHF 213
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 50.9 bits (123), Expect = 2e-07
Identities = 20/80 (25%), Positives = 25/80 (31%), Gaps = 18/80 (22%)
Query: 61 VHARDYDNRTPLHVASLHGW-------------IDVAKCLIEYGADV-NAQDRWKNTPL- 105
V+ R D TPL +AS G V I GA + N DR T L
Sbjct: 3 VNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETALH 62
Query: 106 -ADAEGAKKFNMMELLNAHG 124
A + + L
Sbjct: 63 LAARYSRS--DAAKRLLEAS 80
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 48.6 bits (117), Expect = 9e-07
Identities = 6/37 (16%), Positives = 12/37 (32%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97
D+ +R P +A D+ + L +
Sbjct: 216 RDITDHMDRLPRDIAQERMHHDIVRLLDLEHHHHHHH 252
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 71.7 bits (177), Expect = 1e-14
Identities = 20/88 (22%), Positives = 32/88 (36%), Gaps = 7/88 (7%)
Query: 42 AHQNDAAAVRKLLEEDQSL---VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
Q + AV +L+ Q + + +TPLH+A + V + L+ GA A D
Sbjct: 17 VVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALD 76
Query: 99 RWKNTPL--ADAEGAKKFNMMELLNAHG 124
R T A + + L
Sbjct: 77 RHGQTAAHLACEHRSPT--CLRALLDSA 102
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 69.8 bits (172), Expect = 6e-14
Identities = 16/64 (25%), Positives = 31/64 (48%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A+ Y + LH AS G + + + L+ GAD + ++ +TPL A + +++
Sbjct: 176 VNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILRGK 235
Query: 121 NAHG 124
Sbjct: 236 ATRP 239
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 65.9 bits (162), Expect = 1e-12
Identities = 18/65 (27%), Positives = 33/65 (50%), Gaps = 1/65 (1%)
Query: 61 VHARDYDN-RTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
+ A D + R+PL A + + + + L+++GA+VNAQ ++ L A G ++
Sbjct: 142 IDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRT 201
Query: 120 LNAHG 124
L G
Sbjct: 202 LVRSG 206
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 64.8 bits (159), Expect = 3e-12
Identities = 28/88 (31%), Positives = 42/88 (47%), Gaps = 6/88 (6%)
Query: 42 AHQNDAAAVRKLLE---EDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
+R LL+ + AR+YD T LHVA + + L+E GAD++A D
Sbjct: 87 CEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVD 146
Query: 99 RWKN--TPLADAEGAKKFNMMELLNAHG 124
K+ +PL A +M++LL HG
Sbjct: 147 I-KSGRSPLIHAVENNSLSMVQLLLQHG 173
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 1e-11
Identities = 17/69 (24%), Positives = 30/69 (43%), Gaps = 4/69 (5%)
Query: 60 LVHARDYDNRTPLHVASLHGWIDVAKCLIEY----GADVNAQDRWKNTPLADAEGAKKFN 115
+ D D TPLH+A + G + L+ G +++ + + TPL A +
Sbjct: 1 MATRADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPS 60
Query: 116 MMELLNAHG 124
++ LL G
Sbjct: 61 VVRLLVTAG 69
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 59.0 bits (144), Expect = 3e-10
Identities = 16/68 (23%), Positives = 27/68 (39%), Gaps = 4/68 (5%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA----DVNAQDRWKNTPLADAEGAKKFNM 116
A D +T H+A H + L++ A D+ A++ T L A +
Sbjct: 72 PMALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQET 131
Query: 117 MELLNAHG 124
++LL G
Sbjct: 132 VQLLLERG 139
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 47.1 bits (113), Expect = 3e-06
Identities = 9/32 (28%), Positives = 13/32 (40%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
++ N TPL VA ID+ + A
Sbjct: 209 SSLKNCHNDTPLMVARSRRVIDILRGKATRPA 240
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 70.1 bits (173), Expect = 2e-14
Identities = 26/93 (27%), Positives = 37/93 (39%), Gaps = 6/93 (6%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
T L+ W A A V LL+ D + L +A G+ D+ K L++ G
Sbjct: 37 FTPLM-WAAAHGQIAVVEFLLQNGAD---PQLLGKGRESALSLACSKGYTDIVKMLLDCG 92
Query: 92 ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
DVN D TPL A +++L G
Sbjct: 93 VDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESG 125
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 69.7 bits (172), Expect = 2e-14
Identities = 18/72 (25%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
S+ A Q + + +E++ ++ D + TPL A+ HG I V + L++ GAD
Sbjct: 4 SLSVH-QLAAQGEMLYLATRIEQENV-INHTDEEGFTPLMWAAAHGQIAVVEFLLQNGAD 61
Query: 94 VNAQDRWKNTPL 105
+ + + L
Sbjct: 62 PQLLGKGRESAL 73
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 69.0 bits (170), Expect = 4e-14
Identities = 19/93 (20%), Positives = 37/93 (39%), Gaps = 6/93 (6%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
++L + V+ LL+ D V+ D++ TPL A + K L+E G
Sbjct: 70 ESALS-LACSKGYTDIVKMLLDCGVD---VNEYDWNGGTPLLYAVHGNHVKCVKMLLESG 125
Query: 92 ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
AD + + A ++ +++ +H
Sbjct: 126 ADPTIETDSGYNSMDLAVALGYRSVQQVIESHL 158
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 60.1 bits (147), Expect = 4e-11
Identities = 16/60 (26%), Positives = 23/60 (38%), Gaps = 4/60 (6%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMMELLNAHG 124
N +H + G + IE +N D TPL A A G ++E L +G
Sbjct: 2 ANSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQI--AVVEFLLQNG 59
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 58.9 bits (144), Expect = 1e-10
Identities = 12/68 (17%), Positives = 23/68 (33%), Gaps = 6/68 (8%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
T L+ + H N V+ LLE D + +A G+ V + + +
Sbjct: 103 GTPLL-YAVHGNHVKCVKMLLESGAD---PTIETDSGYNSMDLAVALGYRSVQQVIESHL 158
Query: 92 ADVNAQDR 99
+ +
Sbjct: 159 LKLLQNIK 166
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 70.9 bits (175), Expect = 2e-14
Identities = 25/91 (27%), Positives = 43/91 (47%), Gaps = 1/91 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L A + V+ LL Q V+ +D TP+ A+ + +D+ K L+ G+D
Sbjct: 78 STCLH-LAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSD 136
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+N +D +N L A + ++ E+L A
Sbjct: 137 INIRDNEENICLHWAAFSGCVDIAEILLAAK 167
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 69.7 bits (172), Expect = 5e-14
Identities = 16/64 (25%), Positives = 30/64 (46%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ R+PLH A+ G +D+ L++ GA+++ + TPL +A ++ L
Sbjct: 4 FKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYL 63
Query: 121 NAHG 124
G
Sbjct: 64 IKAG 67
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 69.0 bits (170), Expect = 1e-13
Identities = 13/64 (20%), Positives = 26/64 (40%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+HA + +PLH+A+ D + +DV +++ TPL A + +
Sbjct: 170 LHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLNSQVWSALQM 229
Query: 121 NAHG 124
+
Sbjct: 230 SKAL 233
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 67.8 bits (167), Expect = 3e-13
Identities = 15/64 (23%), Positives = 33/64 (51%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
++ RD + LH A+ G +D+A+ L+ D++A + ++PL A +++ + L
Sbjct: 137 INIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLF 196
Query: 121 NAHG 124
+
Sbjct: 197 LSRD 200
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 66.7 bits (164), Expect = 6e-13
Identities = 18/64 (28%), Positives = 33/64 (51%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ D RTPL A+ + ++ K LI+ GA V+ +D +T L A + +++ L
Sbjct: 37 IDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYL 96
Query: 121 NAHG 124
++G
Sbjct: 97 LSNG 100
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 61.3 bits (150), Expect = 5e-11
Identities = 22/65 (33%), Positives = 35/65 (53%), Gaps = 1/65 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA-DVNAQDRWKNTPLADAEGAKKFNMMEL 119
V +D + T LH+A+ G +V + L+ G DVN QD TP+ A K ++++L
Sbjct: 70 VDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKL 129
Query: 120 LNAHG 124
L + G
Sbjct: 130 LLSKG 134
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 48.2 bits (116), Expect = 1e-06
Identities = 9/33 (27%), Positives = 16/33 (48%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
V ++ + TPL ASL+ + A + + D
Sbjct: 203 VTLKNKEGETPLQCASLNSQVWSALQMSKALQD 235
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 68.6 bits (169), Expect = 2e-14
Identities = 13/45 (28%), Positives = 23/45 (51%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
+H + L A+ G ++ + L+E GAD NA +R+ P+
Sbjct: 5 IHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPI 49
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 68.2 bits (168), Expect = 3e-14
Identities = 20/89 (22%), Positives = 33/89 (37%), Gaps = 6/89 (6%)
Query: 39 LWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRT-PLHVASLHGWIDVAKCLIEYGADVN 95
+ A LL + + D T P+H A+ G++D L GA ++
Sbjct: 49 IQVMMMGSAQVAELLLLHGAE---PNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLD 105
Query: 96 AQDRWKNTPLADAEGAKKFNMMELLNAHG 124
D W P+ AE ++ L+A
Sbjct: 106 VCDAWGRLPVDLAEEQGHRDIARYLHAAT 134
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 4e-12
Identities = 26/94 (27%), Positives = 40/94 (42%), Gaps = 8/94 (8%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
L A + VR+LLE D +A + R P+ V G VA+ L+ +G
Sbjct: 13 DAGLA-TAAARGQVETVRQLLEAGAD---PNALNRFGRRPIQVMM-MGSAQVAELLLLHG 67
Query: 92 ADVNAQDRWKNT-PLADAEGAKKFNMMELLNAHG 124
A+ N D T P+ DA + + +L+ G
Sbjct: 68 AEPNCADPATLTRPVHDAAREGFLDTLVVLHRAG 101
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 51.7 bits (125), Expect = 2e-08
Identities = 9/33 (27%), Positives = 14/33 (42%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+ D R P+ +A G D+A+ L D
Sbjct: 104 LDVCDAWGRLPVDLAEEQGHRDIARYLHAATGD 136
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 67.0 bits (165), Expect = 3e-14
Identities = 33/74 (44%), Positives = 45/74 (60%), Gaps = 6/74 (8%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
RT L A V+ LLE D V+A+D + RTPLH+A+ +G ++V K L+E G
Sbjct: 3 RTPLH-LAARNGHLEVVKLLLEAGAD---VNAKDKNGRTPLHLAARNGHLEVVKLLLEAG 58
Query: 92 ADVNAQDRWKNTPL 105
ADVNA+D+ TPL
Sbjct: 59 ADVNAKDKNGRTPL 72
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 61.6 bits (151), Expect = 2e-12
Identities = 25/58 (43%), Positives = 37/58 (63%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ RTPLH+A+ +G ++V K L+E GADVNA+D+ TPL A +++LL G
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAG 58
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 49.3 bits (119), Expect = 4e-08
Identities = 24/54 (44%), Positives = 35/54 (64%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
L A +N V KLL E + V+A+D + RTPLH+A+ +G ++V K L+E GA
Sbjct: 39 LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 92
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 72.9 bits (180), Expect = 3e-14
Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L L A Q A + LL Q+ + + TPLH+ + G + VA LI++G
Sbjct: 246 VTPLHL--AAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVM 303
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
V+A R TPL A +++ L H
Sbjct: 304 VDATTRMGYTPLHVASHYGNIKLVKFLLQHQ 334
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 72.1 bits (178), Expect = 6e-14
Identities = 25/91 (27%), Positives = 35/91 (38%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L A LLE D +A + TPLHVA H +D+ K L+ G
Sbjct: 147 FTPLH-VAAKYGKVRVAELLLERDAH-PNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGS 204
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
++ TPL A + + L +G
Sbjct: 205 PHSPAWNGYTPLHIAAKQNQVEVARSLLQYG 235
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 8e-14
Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
H N+ V+ LL S H+ ++ TPLH+A+ ++VA+ L++YG NA+
Sbjct: 187 VHHNNLDIVKLLLPRGGS-PHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQG 245
Query: 102 NTPL--ADAEGAKKFNMMELLNAHG 124
TPL A EG + M+ LL +
Sbjct: 246 VTPLHLAAQEGHAE--MVALLLSKQ 268
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 2e-13
Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 5/85 (5%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
+ V+ LL+ S + + TPLH+A+ G +VAK L++ A VNA+ +
Sbjct: 22 SFMGHLPIVKNLLQRGAS-PNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDD 80
Query: 102 NTPL--ADAEGAKKFNMMELLNAHG 124
TPL A G M++LL +
Sbjct: 81 QTPLHCAARIGHTN--MVKLLLENN 103
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 2e-13
Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L L Q V +L + +V A TPLHVAS +G I + K L+++ AD
Sbjct: 279 LTPLHL--VAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQAD 336
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
VNA+ + +PL A +++ LL +G
Sbjct: 337 VNAKTKLGYSPLHQAAQQGHTDIVTLLLKNG 367
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 69.4 bits (171), Expect = 4e-13
Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L A + LL+ + V+A+ D++TPLH A+ G ++ K L+E A+
Sbjct: 48 ETPLH-MAARAGHTEVAKYLLQNK-AKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNAN 105
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
N +TPL A + L
Sbjct: 106 PNLATTAGHTPLHIAAREGHVETVLALLEKE 136
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 6e-13
Identities = 28/91 (30%), Positives = 42/91 (46%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L A + V LLE+ ++ TPLHVA+ +G + VA+ L+E A
Sbjct: 114 HTPLH-IAAREGHVETVLALLEK-EASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAH 171
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
NA + TPL A ++++LL G
Sbjct: 172 PNAAGKNGLTPLHVAVHHNNLDIVKLLLPRG 202
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 6e-13
Identities = 24/91 (26%), Positives = 41/91 (45%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L +H + V+ LL+ + V+A+ +PLH A+ G D+ L++ GA
Sbjct: 312 YTPLH-VASHYGNIKLVKFLLQHQ-ADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGAS 369
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
N TPLA A+ ++ ++L
Sbjct: 370 PNEVSSDGTTPLAIAKRLGYISVTDVLKVVT 400
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 9e-13
Identities = 24/91 (26%), Positives = 36/91 (39%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+T L A V+ LLE + + + TPLH+A+ G ++ L+E A
Sbjct: 81 QTPLH-CAARIGHTNMVKLLLENN-ANPNLATTAGHTPLHIAAREGHVETVLALLEKEAS 138
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ TPL A K + ELL
Sbjct: 139 QACMTKKGFTPLHVAAKYGKVRVAELLLERD 169
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 5e-12
Identities = 19/64 (29%), Positives = 27/64 (42%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
TPLHVAS G + + K L++ GA N + TPL A A + + L
Sbjct: 7 GGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYL 66
Query: 121 NAHG 124
+
Sbjct: 67 LQNK 70
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 6e-12
Identities = 16/64 (25%), Positives = 28/64 (43%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+A TPLH+A+ G ++ L+ A+ N ++ TPL + ++L
Sbjct: 238 ANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVL 297
Query: 121 NAHG 124
HG
Sbjct: 298 IKHG 301
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 1e-08
Identities = 17/71 (23%), Positives = 27/71 (38%), Gaps = 4/71 (5%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL---IEYGADVNAQD 98
A Q V LL+ S + D TPL +A G+I V L + + V D
Sbjct: 352 AQQGHTDIVTLLLKNGAS-PNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 410
Query: 99 RWKNTPLADAE 109
+ + + +
Sbjct: 411 KHRMSFPETVD 421
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 3e-14
Identities = 22/96 (22%), Positives = 38/96 (39%), Gaps = 4/96 (4%)
Query: 32 VSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
+S L +N+ V++LL SL+ +D D R PLH + ++ L+
Sbjct: 1 MSNYPLH-QACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKM 59
Query: 92 ADVNAQDRWKN---TPLADAEGAKKFNMMELLNAHG 124
+VN D + TP A +++ L
Sbjct: 60 ENVNLDDYPDDSGWTPFHIACSVGNLEVVKSLYDRP 95
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 68.2 bits (168), Expect = 2e-13
Identities = 20/64 (31%), Positives = 31/64 (48%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
++ T LH+A W +V++ LIE GA V +D++ PL A ++ELL
Sbjct: 100 LNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELL 159
Query: 121 NAHG 124
G
Sbjct: 160 CGLG 163
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 66.3 bits (163), Expect = 8e-13
Identities = 21/97 (21%), Positives = 35/97 (36%), Gaps = 5/97 (5%)
Query: 28 EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
K + ++ L A + L +S V+ +D TPL A G D A L
Sbjct: 135 IKDKFNQIPLH-RAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLL 193
Query: 88 IE-YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
+E YGA+ + D A + + + +
Sbjct: 194 VEKYGAEYDLVDNKGAKAEDVA--LNE-QVKKFFLNN 227
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 57.5 bits (140), Expect = 9e-10
Identities = 19/64 (29%), Positives = 27/64 (42%), Gaps = 2/64 (3%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIE--YGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
D TP H+A G ++V K L + D+N T L A G K F + + L
Sbjct: 67 YPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFL 126
Query: 121 NAHG 124
+G
Sbjct: 127 IENG 130
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 4e-14
Identities = 29/93 (31%), Positives = 42/93 (45%), Gaps = 6/93 (6%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE-DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
T A + D A+ +LLE+ D V A D + RT L + G + L E GA
Sbjct: 45 ETPWW-TAARKADEQALSQLLEDRD---VDAVDENGRTALLFVAGLGSDKCVRLLAEAGA 100
Query: 93 DVNAQD-RWKNTPLADAEGAKKFNMMELLNAHG 124
D++ +D R T L A G + ++E L G
Sbjct: 101 DLDHRDMRGGLTALHMAAGYVRPEVVEALVELG 133
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 67.5 bits (166), Expect = 1e-13
Identities = 27/94 (28%), Positives = 39/94 (41%), Gaps = 7/94 (7%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEY 90
RT+L+ + A VR L E D + RD T LH+A+ + +V + L+E
Sbjct: 77 RTALL-FVAGLGSDKCVRLLAEAGAD---LDHRDMRGGLTALHMAAGYVRPEVVEALVEL 132
Query: 91 GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
GAD+ +D T L A K G
Sbjct: 133 GADIEVEDERGLTALELAREILKTTPKGNPMQFG 166
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 8e-09
Identities = 16/92 (17%), Positives = 27/92 (29%), Gaps = 4/92 (4%)
Query: 33 SRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
++ ++ + + V + TP A+ L+E
Sbjct: 12 GEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEY---ETPWWTAARKADEQALSQLLE-DR 67
Query: 93 DVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
DV+A D T L G + LL G
Sbjct: 68 DVDAVDENGRTALLFVAGLGSDKCVRLLAEAG 99
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 51.3 bits (124), Expect = 5e-08
Identities = 12/67 (17%), Positives = 21/67 (31%), Gaps = 6/67 (8%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
T+L A V L+E D + D T L +A +++G
Sbjct: 111 LTALH-MAAGYVRPEVVEALVELGAD---IEVEDERGLTALELAREILKTTPKGNPMQFG 166
Query: 92 ADVNAQD 98
+ +
Sbjct: 167 RRIGLEK 173
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 47.5 bits (114), Expect = 1e-06
Identities = 8/51 (15%), Positives = 15/51 (29%), Gaps = 4/51 (7%)
Query: 56 EDQSLVHAR-DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
E ++ +R + + G ADV ++ TP
Sbjct: 1 EVNKIIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPW 48
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 68.2 bits (168), Expect = 4e-14
Identities = 25/64 (39%), Positives = 38/64 (59%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
AR +RTPLH+A+ G ++ + L+++GADVNA+D K T L A ++ELL
Sbjct: 60 RDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELL 119
Query: 121 NAHG 124
+G
Sbjct: 120 IKYG 123
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 66.6 bits (164), Expect = 2e-13
Identities = 18/45 (40%), Positives = 27/45 (60%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
V+A+D T LH A+ H +V + LI+YGADV+ Q ++ T
Sbjct: 93 VNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAF 137
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 63.2 bits (155), Expect = 3e-12
Identities = 18/60 (30%), Positives = 31/60 (51%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
D+ +PLH+A+ +G + L+ G +A+ + TPL A N++E+L HG
Sbjct: 31 DWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHG 90
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 53.2 bits (129), Expect = 8e-09
Identities = 16/60 (26%), Positives = 21/60 (35%), Gaps = 5/60 (8%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMMELLNAHG 124
D L A+ G D + L+ GA D +PL A G E+L G
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFTT-DWLGTSPLHLAAQYGHFS--TTEVLLRAG 57
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 67.8 bits (167), Expect = 4e-14
Identities = 25/64 (39%), Positives = 38/64 (59%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A+D TPL++A+ HG +++ + L++ GADVNA D TPL A + E+L
Sbjct: 40 VNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVL 99
Query: 121 NAHG 124
HG
Sbjct: 100 LKHG 103
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 65.1 bits (160), Expect = 3e-13
Identities = 23/63 (36%), Positives = 39/63 (61%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A D TPLH+A+ G +++A+ L+++GADVNAQD++ T + G ++ E+L
Sbjct: 73 VNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEIL 132
Query: 121 NAH 123
Sbjct: 133 QKL 135
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 58.6 bits (143), Expect = 8e-11
Identities = 20/58 (34%), Positives = 29/58 (50%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
D L A+ G D + L+ GADVNA+D + TPL A ++E+L +G
Sbjct: 13 DLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNG 70
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 69.7 bits (172), Expect = 4e-14
Identities = 20/83 (24%), Positives = 34/83 (40%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
+ + L+ + + AR +D TPL +A+ + + LI ADVNA D
Sbjct: 66 VSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLG 125
Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
+ L A + +L +G
Sbjct: 126 KSALHWAAAVNNVDAAVVLLKNG 148
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 69.0 bits (170), Expect = 8e-14
Identities = 14/64 (21%), Positives = 30/64 (46%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
++ TPL +A+ G + AK L+++ A+ + D P A+ +++ LL
Sbjct: 151 KDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLL 210
Query: 121 NAHG 124
+ +
Sbjct: 211 DEYN 214
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 67.8 bits (167), Expect = 2e-13
Identities = 23/76 (30%), Positives = 35/76 (46%)
Query: 50 VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAE 109
+ + + SL + D T LH+A+ + D AK L+E AD N QD TPL A
Sbjct: 7 ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 66
Query: 110 GAKKFNMMELLNAHGG 125
A + ++L +
Sbjct: 67 SADAQGVFQILIRNRA 82
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 67.0 bits (165), Expect = 4e-13
Identities = 18/64 (28%), Positives = 32/64 (50%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A D ++ LH A+ +D A L++ GA+ + Q+ + TPL A + ++L
Sbjct: 118 VNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVL 177
Query: 121 NAHG 124
H
Sbjct: 178 LDHF 181
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 63.2 bits (155), Expect = 8e-12
Identities = 29/103 (28%), Positives = 42/103 (40%), Gaps = 3/103 (2%)
Query: 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWID 82
A + R T+L A + + A ++LLE + +D RTPLH A
Sbjct: 15 ASLHNQTDRTGETALH-LAARYSRSDAAKRLLEASAD-ANIQDNMGRTPLHAAVSADAQG 72
Query: 83 VAKCLIEYGA-DVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
V + LI A D++A+ TPL A M+E L
Sbjct: 73 VFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSH 115
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 52.0 bits (126), Expect = 5e-08
Identities = 9/38 (23%), Positives = 15/38 (39%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
D+ +R P +A D+ + L EY + Q
Sbjct: 184 RDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRSPQL 221
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 6e-14
Identities = 23/87 (26%), Positives = 40/87 (45%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
A+ +++ + D+SL D D+RT LH A G ++ + L++ G VN +D
Sbjct: 11 CNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKD 70
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHGG 125
+PL A A +++ L G
Sbjct: 71 DAGWSPLHIAASAGXDEIVKALLVKGA 97
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-10
Identities = 20/65 (30%), Positives = 33/65 (50%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+ +D +PLH+A+ G ++ K L+ GA VNA ++ TPL A + + +L
Sbjct: 66 VNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVML 125
Query: 121 NAHGG 125
G
Sbjct: 126 LEGGA 130
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-10
Identities = 22/86 (25%), Positives = 39/86 (45%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A + K L + V+A + + TPLH A+ ++A L+E GA+ +A+D
Sbjct: 77 LHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKD 136
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHG 124
+ T + A M+ +L +
Sbjct: 137 HYDATAMHRAAAKGNLKMVHILLFYK 162
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 4e-10
Identities = 20/86 (23%), Positives = 40/86 (46%), Gaps = 2/86 (2%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
+ A + +L ++ + +D + TPLH+A ++ AK L+ GA + ++
Sbjct: 143 MHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQGASIYIEN 202
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHG 124
+ + TPL A+G ++ A G
Sbjct: 203 KEEKTPLQVAKGGL--GLILKRLAEG 226
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 5e-10
Identities = 10/58 (17%), Positives = 21/58 (36%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
N ++A ++ + ++ + D+ T L A A ++E L G
Sbjct: 6 SNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLG 63
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 8e-10
Identities = 26/99 (26%), Positives = 43/99 (43%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L +A + + +L E + A+D+ + T +H A+ G + + L+ Y A N QD
Sbjct: 110 LHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQD 169
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137
NTPL A ++ + L G Y +N P
Sbjct: 170 TEGNTPLHLACDEERVEEAKFLVTQGASIYIENKEEKTP 208
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 7e-06
Identities = 10/57 (17%), Positives = 22/57 (38%), Gaps = 2/57 (3%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN 95
L A + K L + ++ + + +TPL VA + + + G + +
Sbjct: 176 LHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAKGG--LGLILKRLAEGEEAS 230
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-14
Identities = 24/99 (24%), Positives = 37/99 (37%), Gaps = 3/99 (3%)
Query: 28 EKARVSRTSLILWH--AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAK 85
+ R L+L A + V++ ++E + + T LH A +
Sbjct: 13 KARRARLNPLVLLLDAALTGELEVVQQAVKEMND-PSQPNEEGITALHNAICGANYSIVD 71
Query: 86 CLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
LI GA+VN+ D TPL A + L HG
Sbjct: 72 FLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHG 110
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-12
Identities = 13/67 (19%), Positives = 25/67 (37%), Gaps = 3/67 (4%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR-WKNTPLADAEGAKK--FNMM 117
V++ D TPLH A+ + L+++GA + A T + ++ +
Sbjct: 80 VNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCA 139
Query: 118 ELLNAHG 124
L
Sbjct: 140 TYLADVE 146
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 12/67 (17%), Positives = 20/67 (29%), Gaps = 6/67 (8%)
Query: 61 VHARD-YDNRTPLHVASLH--GWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
+ A D T + G+ D A L + + + L D + +
Sbjct: 113 IFATTLSDGATAFEKCDPYREGYADCATYLADVEQSMGLMNSGAVYALWDY--SAE-FGD 169
Query: 118 ELLNAHG 124
EL G
Sbjct: 170 ELSFREG 176
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 66.6 bits (164), Expect = 7e-14
Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
V+AR D TPLH+A+ +G ++ K L+ GADVNA+ + NTP
Sbjct: 35 VNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPE 79
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 65.9 bits (162), Expect = 1e-13
Identities = 17/45 (37%), Positives = 24/45 (53%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
V+AR D TP H+A +G ++ K L GADVNA+ +
Sbjct: 68 VNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNARSWGSSHHH 112
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 63.9 bits (157), Expect = 5e-13
Identities = 24/60 (40%), Positives = 33/60 (55%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
D TPLH A+ +G + K L+ GADVNA+ + NTPL A +++LL A G
Sbjct: 6 SKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKG 65
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 7e-14
Identities = 23/100 (23%), Positives = 38/100 (38%), Gaps = 6/100 (6%)
Query: 39 LWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRT-PLHVASLHGWIDVAKCLIEYGADVN 95
+ A LL + + D T P+H A+ G++D L GA ++
Sbjct: 49 IQVMMMGSARVAELLLLHGAE---PNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLD 105
Query: 96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135
+D W P+ AE ++ L A G + G N +
Sbjct: 106 VRDAWGRLPVDLAEELGHRDVARYLRAAAGGTRGSNHARI 145
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 2e-12
Identities = 26/99 (26%), Positives = 40/99 (40%), Gaps = 8/99 (8%)
Query: 29 KARVSRTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKC 86
S L A + VR LLE + +A + R P+ V G VA+
Sbjct: 8 SMEPSADWLA-TAAARGRVEEVRALLEAGAN---PNAPNSYGRRPIQVMM-MGSARVAEL 62
Query: 87 LIEYGADVNAQDRWKNT-PLADAEGAKKFNMMELLNAHG 124
L+ +GA+ N D T P+ DA + + +L+ G
Sbjct: 63 LLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAG 101
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 3e-11
Identities = 10/43 (23%), Positives = 21/43 (48%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
+ + L A+ G ++ + L+E GA+ NA + + P+
Sbjct: 7 SSMEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPI 49
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 7e-14
Identities = 20/87 (22%), Positives = 33/87 (37%), Gaps = 4/87 (4%)
Query: 42 AHQNDAAAVRKLLEEDQSL----VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97
+ A+ +++ S + + + LH A L W DVA +E G DVN +
Sbjct: 181 MEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDVNME 240
Query: 98 DRWKNTPLADAEGAKKFNMMELLNAHG 124
D PL + A + + L
Sbjct: 241 DNEHTVPLYLSVRAAMVLLTKELLQKT 267
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-13
Identities = 18/64 (28%), Positives = 27/64 (42%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
D +N +HVA+ G D + LIE G Q+R+ T L A + + L
Sbjct: 13 RIKSDDENMEKIHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLACKFGCVDTAKYL 72
Query: 121 NAHG 124
+ G
Sbjct: 73 ASVG 76
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 5e-12
Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 10/105 (9%)
Query: 29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW--IDVAKC 86
+ ++ D V ++ H + +T LH G +++ K
Sbjct: 107 AKERGQMPES--LLNECDEREVNEIG------SHVKHCKGQTALHWCVGLGPEYLEMIKI 158
Query: 87 LIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131
L++ GA A+D+ TPL A + ++L+
Sbjct: 159 LVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLR 203
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 7/64 (10%), Positives = 15/64 (23%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V + A+ +V + L E +V + + +
Sbjct: 283 VLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRKKKAAPAVKRMK 342
Query: 121 NAHG 124
A
Sbjct: 343 LAPS 346
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 15/64 (23%), Positives = 24/64 (37%), Gaps = 2/64 (3%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
++ T LH+A G +D AK L G + P+ A A K +++ L
Sbjct: 46 PTIQNRFGCTALHLACKFGCVDTAKYLASVGEVHSLWHGQ--KPIHLAVMANKTDLVVAL 103
Query: 121 NAHG 124
Sbjct: 104 VEGA 107
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 12/82 (14%), Positives = 21/82 (25%), Gaps = 2/82 (2%)
Query: 28 EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
V + A V +LL+E V V +
Sbjct: 285 PDRVVWLDFVPA--AADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRKKKAAPAVKRMK 342
Query: 88 IEYGADVNAQDRWKNTPLADAE 109
+ A V + R + A ++
Sbjct: 343 LAPSAPVRTRSRSRARSSAVSK 364
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 4e-10
Identities = 10/69 (14%), Positives = 23/69 (33%), Gaps = 5/69 (7%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEY-----GADVNAQDRWKNTPLADAEGAKKFN 115
A+D + TPL A + +++ ++ ++ N+ L A +
Sbjct: 166 PTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWED 225
Query: 116 MMELLNAHG 124
+ G
Sbjct: 226 VAMRFVEMG 234
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 3e-08
Identities = 12/83 (14%), Positives = 26/83 (31%), Gaps = 23/83 (27%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGAD---------------------VNAQDRWKNT 103
+ + P+H+A + D+ L+E + + + T
Sbjct: 81 LWHGQKPIHLAVMANKTDLVVALVEGAKERGQMPESLLNECDEREVNEIGSHVKHCKGQT 140
Query: 104 PL--ADAEGAKKFNMMELLNAHG 124
L G + M+++L G
Sbjct: 141 ALHWCVGLGPEYLEMIKILVQLG 163
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 12/77 (15%), Positives = 26/77 (33%), Gaps = 13/77 (16%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIE-------------YGADVNAQDRWKNTPLAD 107
V+ D ++ PL+++ + + K L++ G V +
Sbjct: 237 VNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACPYHNGTTVLPDRVVWLDFVPA 296
Query: 108 AEGAKKFNMMELLNAHG 124
A K +++LL
Sbjct: 297 AADPSKQEVLQLLQEKL 313
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 67.0 bits (165), Expect = 7e-14
Identities = 28/64 (43%), Positives = 42/64 (65%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A+D + RTPLH+A+ +G ++V K L+E GADVNA+D+ TPL A +++LL
Sbjct: 61 VNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLL 120
Query: 121 NAHG 124
G
Sbjct: 121 LEAG 124
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 65.4 bits (161), Expect = 2e-13
Identities = 24/45 (53%), Positives = 35/45 (77%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
V+A+D + RTPLH+A+ +G ++V K L+E GADVNA+D+ TPL
Sbjct: 28 VNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPL 72
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 61.6 bits (151), Expect = 5e-12
Identities = 25/58 (43%), Positives = 37/58 (63%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ RTPLH+A+ +G ++V K L+E GADVNA+D+ TPL A +++LL G
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAG 58
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 48.5 bits (117), Expect = 2e-07
Identities = 16/32 (50%), Positives = 25/32 (78%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
V+A+D + RTPLH+A+ +G ++V K L+E GA
Sbjct: 94 VNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 125
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 67.8 bits (167), Expect = 9e-14
Identities = 19/64 (29%), Positives = 30/64 (46%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+D +H A+ G++D + L+E+ ADVN +D N PL A ++E L
Sbjct: 63 PDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFL 122
Query: 121 NAHG 124
H
Sbjct: 123 VKHT 126
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 64.3 bits (158), Expect = 1e-12
Identities = 16/65 (24%), Positives = 34/65 (52%), Gaps = 1/65 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA-DVNAQDRWKNTPLADAEGAKKFNMMEL 119
V+ D + PLH+A+ G + V + L+++ A +V ++ +T A + ++ L
Sbjct: 96 VNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSL 155
Query: 120 LNAHG 124
+ A+G
Sbjct: 156 MQANG 160
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 61.6 bits (151), Expect = 1e-11
Identities = 17/64 (26%), Positives = 31/64 (48%), Gaps = 1/64 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A++ RT L V G ++A+ L+ GA+ + +DR + DA A + ++ L
Sbjct: 31 VNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTL 89
Query: 121 NAHG 124
Sbjct: 90 LEFQ 93
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 58.9 bits (144), Expect = 9e-11
Identities = 13/59 (22%), Positives = 23/59 (38%), Gaps = 3/59 (5%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL-ADAEGAKKFNMMELLNAHG 124
L A+ G ++ L++ +VNAQ+ + T L G + + L G
Sbjct: 4 PWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMKLGNPE--IARRLLLRG 60
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 48.5 bits (117), Expect = 3e-07
Identities = 14/59 (23%), Positives = 23/59 (38%), Gaps = 1/59 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
L A + V L++ S V R++ T +A L+G +V + GA
Sbjct: 104 NLPLH-LAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGA 161
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 1/91 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
RT+L + A ++ V+ L+ E S +D D +TP+ +A+ G I+V LI+ GA
Sbjct: 280 RTALH-YAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGAS 338
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
V A D +T A+ N++++ +
Sbjct: 339 VEAVDATDHTARQLAQANNHHNIVDIFDRCR 369
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 25/94 (26%), Positives = 39/94 (41%), Gaps = 8/94 (8%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSL-------VHARDYDNRTPLHVASLHGWIDVAKC 86
RT L W A + A L+ + V+A D D TPL +A L +
Sbjct: 126 RTVLH-WIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAY 184
Query: 87 LIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
L++ GAD ++ + + L A + F MM +
Sbjct: 185 LMKAGADPTIYNKSERSALHQAAANRDFGMMVYM 218
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 24/103 (23%), Positives = 47/103 (45%), Gaps = 14/103 (13%)
Query: 34 RTSLIL--WHAHQNDAAAVRKLLE-------EDQSLVHARDYDNRTPLHVASLHGWIDVA 84
T+L++ + ++ A+ + L+E + + + Y RT LH A+ + +
Sbjct: 236 MTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIV 295
Query: 85 KCLI-EYGADVNAQDRWKNTPL--ADAEGAKKFNMMELLNAHG 124
K L+ E G++ + QD TP+ A EG + ++ L G
Sbjct: 296 KYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIE--VVMYLIQQG 336
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 15/70 (21%), Positives = 25/70 (35%), Gaps = 6/70 (8%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIE---YGADVNAQDRWKNTPL---ADAEGAKKF 114
+ R+ LH A+ + + ++ D+ DR T L A EG +
Sbjct: 192 PTIYNKSERSALHQAAANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQV 251
Query: 115 NMMELLNAHG 124
+LL G
Sbjct: 252 ASAKLLVEKG 261
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 13/101 (12%), Positives = 26/101 (25%), Gaps = 14/101 (13%)
Query: 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVA 84
K + S+ SL L ++ R L + + P +G +
Sbjct: 29 KNHQSITSSQHSL-LEASYDGYIKRQRNEL----------QHYSLYPNPQGYGNGNDFLG 77
Query: 85 KCLIEYGADVNAQDRWKNTPL-ADAEGAKKFNMMELLNAHG 124
+ L +A G+ + E +
Sbjct: 78 DFNHTNLQIPTEPEPESPIKLHTEAAGSYA--ITEPITRES 116
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 25/94 (26%), Positives = 38/94 (40%), Gaps = 10/94 (10%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI--------EY 90
L A + E ++ NRT LH + + + ++ LI
Sbjct: 98 LHTEAAGSYAITEPITRESVNI--IDPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAA 155
Query: 91 GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
GADVNA D +NTPL A A++ ++ L G
Sbjct: 156 GADVNAMDCDENTPLMLAVLARRRRLVAYLMKAG 189
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 5/34 (14%), Positives = 11/34 (32%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
V A D + T +A + ++ +
Sbjct: 339 VEAVDATDHTARQLAQANNHHNIVDIFDRCRPER 372
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 69.8 bits (172), Expect = 1e-13
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 3/94 (3%)
Query: 34 RTSLIL--WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-Y 90
R +LI + +D A+ LL + + V+ R +TPL +A + + + L+E
Sbjct: 183 RNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQE 242
Query: 91 GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
++N D T L A K + ELL G
Sbjct: 243 HIEINDTDSDGKTALLLAVELKLKKIAELLCKRG 276
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 69.8 bits (172), Expect = 1e-13
Identities = 17/64 (26%), Positives = 28/64 (43%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
R + TP +A++ G + + K + GADVN D + T +A K ++ L
Sbjct: 65 PVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFL 124
Query: 121 NAHG 124
G
Sbjct: 125 YKRG 128
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 2e-12
Identities = 23/91 (25%), Positives = 38/91 (41%), Gaps = 1/91 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
LI D V++LLE ++ + TPLH A D+ + L+ +GAD
Sbjct: 6 NHLLI-KAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGAD 64
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ + TP A A +++L + G
Sbjct: 65 PVLRKKNGATPFLLAAIAGSVKLLKLFLSKG 95
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 2e-11
Identities = 17/65 (26%), Positives = 31/65 (47%), Gaps = 1/65 (1%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+T LI + V++LLE++ ++ D D +T L +A +A+ L + GA
Sbjct: 220 KTPLI-LAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAS 278
Query: 94 VNAQD 98
+ D
Sbjct: 279 TDCGD 283
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 62.1 bits (152), Expect = 5e-11
Identities = 25/96 (26%), Positives = 41/96 (42%), Gaps = 5/96 (5%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG----WIDVAKCLIE 89
T+L+ A + ++ LL+E + V+A D R L A L + L++
Sbjct: 149 ATALM-DAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLD 207
Query: 90 YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
+GADVN + TPL A K +++ L
Sbjct: 208 HGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEH 243
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 61.3 bits (150), Expect = 7e-11
Identities = 18/75 (24%), Positives = 32/75 (42%), Gaps = 10/75 (13%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK----------NTPLADAEG 110
V+ D+ T A+++G + K L + GA+VN + + K T L DA
Sbjct: 98 VNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAE 157
Query: 111 AKKFNMMELLNAHGG 125
++++L G
Sbjct: 158 KGHVEVLKILLDEMG 172
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 59.4 bits (145), Expect = 3e-10
Identities = 19/61 (31%), Positives = 33/61 (54%), Gaps = 1/61 (1%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR-WKNTPLADAEGAKKFNMMELLNAH 123
++ L A + +D+ + L+E GA+VN Q+ TPL +A + +++ELL H
Sbjct: 2 AVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRH 61
Query: 124 G 124
G
Sbjct: 62 G 62
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 27/94 (28%), Positives = 39/94 (41%), Gaps = 7/94 (7%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEY 90
RT+L+ + A VR L E D + RD T LH+A+ + +V + L+E
Sbjct: 78 RTALL-FVAGLGSDKCVRLLAEAGAD---LDHRDMRGGLTALHMAAGYVRPEVVEALVEL 133
Query: 91 GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
GAD+ +D T L A K G
Sbjct: 134 GADIEVEDERGLTALELAREILKTTPKGNPMQFG 167
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 29/93 (31%), Positives = 42/93 (45%), Gaps = 6/93 (6%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE-DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
T A + D A+ +LLE+ D V A D + RT L + G + L E GA
Sbjct: 46 ETPWW-TAARKADEQALSQLLEDRD---VDAVDENGRTALLFVAGLGSDKCVRLLAEAGA 101
Query: 93 DVNAQD-RWKNTPLADAEGAKKFNMMELLNAHG 124
D++ +D R T L A G + ++E L G
Sbjct: 102 DLDHRDMRGGLTALHMAAGYVRPEVVEALVELG 134
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 17/104 (16%), Positives = 33/104 (31%), Gaps = 9/104 (8%)
Query: 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGW 80
AD R T+L A V L+E D + D T L +A
Sbjct: 101 ADLDHRDMRGGLTALH-MAAGYVRPEVVEALVELGAD---IEVEDERGLTALELAREILK 156
Query: 81 IDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+++G + + + + + + + E++ G
Sbjct: 157 TTPKGNPMQFGRRIGLEK---VINVLEGQVFEYAEVDEIVEKRG 197
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 1e-08
Identities = 16/86 (18%), Positives = 26/86 (30%), Gaps = 4/86 (4%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
++ + + V + + TP A+ L+E DV+A D
Sbjct: 19 YLIEWKDGHSPSWVPSSYIAADVVS---EYETPWWTAARKADEQALSQLLE-DRDVDAVD 74
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHG 124
T L G + LL G
Sbjct: 75 ENGRTALLFVAGLGSDKCVRLLAEAG 100
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 11/74 (14%), Positives = 23/74 (31%), Gaps = 12/74 (16%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
+ + A V +++E+ + ++ D + A+ A+D
Sbjct: 178 VLEGQVFEYAEVDEIVEKRG--------KGKDVEYLVRWKDGGDCEWVKGVHVAEDVAKD 229
Query: 99 RWKNTPL--ADAEG 110
L A AE
Sbjct: 230 --YEDGLEYAVAES 241
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 6/39 (15%), Positives = 10/39 (25%), Gaps = 3/39 (7%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
+ + G ADV ++ TP
Sbjct: 14 EGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPW 49
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 67.0 bits (165), Expect = 2e-13
Identities = 21/63 (33%), Positives = 38/63 (60%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A D + TPLH+A++ G +++ + L++ GADVNAQD++ T + ++ E+L
Sbjct: 106 VNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEIL 165
Query: 121 NAH 123
Sbjct: 166 QKL 168
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 66.2 bits (163), Expect = 3e-13
Identities = 24/64 (37%), Positives = 38/64 (59%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A D TPLH+A+ +G +++ + L++ GADVNA D TPL A ++E+L
Sbjct: 40 VNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVL 99
Query: 121 NAHG 124
+G
Sbjct: 100 LKNG 103
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 66.2 bits (163), Expect = 3e-13
Identities = 24/64 (37%), Positives = 39/64 (60%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+A D+ TPL +A+L G +++ + L++ GADVNA D +TPL A ++E+L
Sbjct: 73 VNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVL 132
Query: 121 NAHG 124
+G
Sbjct: 133 LKNG 136
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 60.8 bits (149), Expect = 2e-11
Identities = 22/65 (33%), Positives = 31/65 (47%), Gaps = 4/65 (6%)
Query: 62 HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMMEL 119
H D L A+ G D + L+ GADVNA+D TPL A G + ++E+
Sbjct: 8 HHHGSDLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLE--IVEV 65
Query: 120 LNAHG 124
L +G
Sbjct: 66 LLKNG 70
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 2e-13
Identities = 39/210 (18%), Positives = 62/210 (29%), Gaps = 50/210 (23%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-----RLVIQDFRH 204
+ IG+G FGE+ + TPVAIK I D + ++
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 205 EVNLLVKL---------RHPNIVQFLGA--VTERKP------------------------ 229
E+ + +L R + V P
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 230 ----LMLITEYLRGG-DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK 284
L ++ E+ GG DL + + S +TA + + +A HRDL
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLR-FEHRDLH 189
Query: 285 PRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
NVLL K+ K + +
Sbjct: 190 WGNVLL--KKTSLKKLHYTLNGKSSTIPSC 217
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 43/186 (23%), Positives = 70/186 (37%), Gaps = 23/186 (12%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI------LPSLSD-----DRLVIQDFRHEVNLLVK 211
IG G FG I A+ + A + L R+ +D + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 212 LRHPNIVQFLG----AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
L + I F G R ++ E L G DL K + G ST + + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDV 163
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM---TGET 324
+ Y+H N +H D+K N+LL + D + + D+GLS +H Y+ G
Sbjct: 164 LEYIHE--NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN 221
Query: 325 GSYRYM 330
G+ +
Sbjct: 222 GTIEFT 227
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 66.6 bits (164), Expect = 4e-13
Identities = 20/60 (33%), Positives = 35/60 (58%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+ R+ + TPL VAS +G ++ K L+E GAD++A+D T A A + ++++
Sbjct: 127 VNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARDLTGLTAEASARIFGRQEVIKIF 186
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 65.9 bits (162), Expect = 6e-13
Identities = 20/65 (30%), Positives = 30/65 (46%)
Query: 60 LVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
L + RD NRTPL VA + G + L+E + +D +T L A + + E
Sbjct: 27 LRNYRDSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEK 86
Query: 120 LNAHG 124
L + G
Sbjct: 87 LLSKG 91
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 65.5 bits (161), Expect = 1e-12
Identities = 17/64 (26%), Positives = 29/64 (45%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ +D + T L A + + +A+ L+ G++VN +D TPL + M L
Sbjct: 61 LEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFL 120
Query: 121 NAHG 124
HG
Sbjct: 121 LEHG 124
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 63.9 bits (157), Expect = 3e-12
Identities = 18/64 (28%), Positives = 37/64 (57%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+ +D+ +TPL + + G+ +++ L+E+GA+VN ++ TPL A + +++ L
Sbjct: 94 VNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKL 153
Query: 121 NAHG 124
G
Sbjct: 154 LELG 157
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 42.0 bits (100), Expect = 1e-04
Identities = 9/32 (28%), Positives = 12/32 (37%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
+ ARD T A + G +V K E
Sbjct: 160 ISARDLTGLTAEASARIFGRQEVIKIFTEVRR 191
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 5e-13
Identities = 23/60 (38%), Positives = 37/60 (61%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V A+D + TPLH+A+ +G ++V K L+E GADV AQD++ T + ++ E+L
Sbjct: 50 VAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDISIDNGNEDLAEIL 109
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-12
Identities = 19/60 (31%), Positives = 28/60 (46%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
D L A+ G D + L+ GADV A+D+ +TPL A +++LL G
Sbjct: 21 GSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAG 80
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 9e-05
Identities = 5/31 (16%), Positives = 10/31 (32%), Gaps = 3/31 (9%)
Query: 75 ASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
S H + L+ G+ + + L
Sbjct: 1 GSSHHHHHHSSGLVPRGSHMGSDL---GKKL 28
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-13
Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 5/88 (5%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV-----NA 96
A +ND A+ KLL+ + VH R T LH+A+L+ ++ A L+E ++ +
Sbjct: 11 AKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTS 70
Query: 97 QDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ T L A + N++ L A G
Sbjct: 71 ELYEGQTALHIAVINQNVNLVRALLARG 98
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 7e-12
Identities = 23/68 (33%), Positives = 32/68 (47%), Gaps = 4/68 (5%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKF--NM 116
H Y PL A+ G ++ + LIE+GAD+ AQD NT L + K F M
Sbjct: 114 PHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQM 173
Query: 117 MELLNAHG 124
LL ++
Sbjct: 174 YNLLLSYD 181
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 6e-08
Identities = 14/74 (18%), Positives = 21/74 (28%), Gaps = 10/74 (13%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVA----KCLIEYGADVNA------QDRWKNTPLADAEG 110
+ A+D T LH+ L A L+ Y + + TP A
Sbjct: 147 IRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDHLKSLELVPNNQGLTPFKLAGV 206
Query: 111 AKKFNMMELLNAHG 124
M + L
Sbjct: 207 EGNIVMFQHLMQKR 220
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 3e-07
Identities = 11/56 (19%), Positives = 21/56 (37%), Gaps = 1/56 (1%)
Query: 70 TPLHVASLHGWID-VAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+PL +A+ + ++K L G +V+ + T L A +L
Sbjct: 5 SPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAA 60
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 66.7 bits (164), Expect = 7e-13
Identities = 28/92 (30%), Positives = 41/92 (44%), Gaps = 2/92 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGA 92
T L+ W A++ + +LL V+ D Y T LH A L G V L+E GA
Sbjct: 143 MTPLM-WAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGA 201
Query: 93 DVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+V+AQ+ + L A+ K M+ L
Sbjct: 202 NVDAQNIKGESALDLAKQRKNVWMINHLQEAR 233
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 66.3 bits (163), Expect = 9e-13
Identities = 24/106 (22%), Positives = 40/106 (37%), Gaps = 9/106 (8%)
Query: 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGW 80
A + ++ T L W Q + V +L++ D D + + +H+A+ G
Sbjct: 66 AIVDQLGGDLNSTPLH-WATRQGHLSMVVQLMKYGAD---PSLIDGEGCSCIHLAAQFGH 121
Query: 81 IDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMMELLNAHG 124
+ LI G DV+ D+ TPL A + LL
Sbjct: 122 TSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSV-DPTRLLLTFN 166
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 64.8 bits (159), Expect = 3e-12
Identities = 25/94 (26%), Positives = 39/94 (41%), Gaps = 7/94 (7%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
++ R+L+E D V D +N T LH A+++ ID+ K I G
Sbjct: 10 TWDIV-KATQYGIYERCRELVEAGYD---VRQPDKENVTLLHWAAINNRIDLVKYYISKG 65
Query: 92 ADVNAQDR-WKNTPLADAEGAKKFNMMELLNAHG 124
A V+ +TPL A +M+ L +G
Sbjct: 66 AIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYG 99
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 64.0 bits (157), Expect = 6e-12
Identities = 11/43 (25%), Positives = 19/43 (44%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
D + + A+ +G + + L+E G DV D+ T L
Sbjct: 4 HIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLL 46
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 51.7 bits (125), Expect = 8e-08
Identities = 12/65 (18%), Positives = 23/65 (35%), Gaps = 2/65 (3%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T+L W + + LLE + V A++ + L +A + + L E
Sbjct: 178 NTALH-WAVLAGNTTVISLLLEAG-ANVDAQNIKGESALDLAKQRKNVWMINHLQEARQA 235
Query: 94 VNAQD 98
+
Sbjct: 236 KGYDN 240
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-12
Identities = 14/99 (14%), Positives = 32/99 (32%), Gaps = 12/99 (12%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDV------AKCLIEYGA 92
L + + + L + + +R + T G D+ K +E GA
Sbjct: 46 LRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGA 105
Query: 93 DVNAQDRWKNTPLADA------EGAKKFNMMELLNAHGG 125
D+ A + + + + + +L+ + G
Sbjct: 106 DITALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSG 144
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-12
Identities = 12/105 (11%), Positives = 33/105 (31%), Gaps = 17/105 (16%)
Query: 34 RTSLIL--WHAHQN---DAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKC 86
T + + LE+ D + A + + + ++D +
Sbjct: 76 TTLFFPLFQGGGNDITGTTELCKIFLEKGAD---ITALYKPYKIVVFKNIFNYFVDENEM 132
Query: 87 -------LIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ G + +D+W T L + +K ++++ +
Sbjct: 133 IPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYI 177
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-11
Identities = 6/70 (8%), Positives = 21/70 (30%), Gaps = 5/70 (7%)
Query: 34 RTSLIL--WHAHQNDAAA---VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI 88
+ + ++ ++ + + + + +D T L K +
Sbjct: 115 KIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMME 174
Query: 89 EYGADVNAQD 98
+Y N ++
Sbjct: 175 DYIKKYNLKE 184
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-11
Identities = 12/101 (11%), Positives = 29/101 (28%), Gaps = 8/101 (7%)
Query: 32 VSRTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE 89
+S + A +L E+ + + L + ++ LI
Sbjct: 4 MSEYRTVSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLIN 63
Query: 90 YGADVNAQDRWKNTPLADA------EGAKKFNMMELLNAHG 124
GAD+ ++ + T + + ++ G
Sbjct: 64 KGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKG 104
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 9/65 (13%), Positives = 19/65 (29%), Gaps = 3/65 (4%)
Query: 63 ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN---TPLADAEGAKKFNMMEL 119
+ + A++ G + L E G + N L + ++ +
Sbjct: 1 SNAMSEYRTVSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMF 60
Query: 120 LNAHG 124
L G
Sbjct: 61 LINKG 65
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-12
Identities = 18/64 (28%), Positives = 28/64 (43%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ + T LH A G ++ K L+++G +VNA D TPL A + + L
Sbjct: 63 PSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFL 122
Query: 121 NAHG 124
G
Sbjct: 123 VESG 126
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 19/67 (28%), Positives = 25/67 (37%), Gaps = 3/67 (4%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ---DRWKNTPLADAEGAKKFNMM 117
V+A D D TPLH A+ + V K L+E GA V A D +
Sbjct: 96 VNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCS 155
Query: 118 ELLNAHG 124
+ L
Sbjct: 156 QFLYGVQ 162
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 13/60 (21%), Positives = 24/60 (40%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ L +SL G D+ + +I D + + T L +A A +++ L G
Sbjct: 34 NPLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFG 93
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 9e-10
Identities = 16/93 (17%), Positives = 26/93 (27%), Gaps = 6/93 (6%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
T L A N+ + L+E + D G+ ++ L
Sbjct: 104 WTPLH-CAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQ 162
Query: 92 ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ ++ L D E N EL G
Sbjct: 163 EKMGIMNKGVIYALWDYE---PQNDDELPMKEG 192
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 7/60 (11%), Positives = 17/60 (28%), Gaps = 1/60 (1%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+ + L I +G V L D+ +F++++ +
Sbjct: 2 EITGQVSLPPGKRTNLRKTGSERIAHGMRVKFNPL-PLALLLDSSLEGEFDLVQRIIYEV 60
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 2e-12
Identities = 12/84 (14%), Positives = 27/84 (32%), Gaps = 4/84 (4%)
Query: 41 HAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100
+ + ++ L D + + A + + L+ GA N +
Sbjct: 6 RINTWKSKQLKSFLSSKD--TFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE-- 61
Query: 101 KNTPLADAEGAKKFNMMELLNAHG 124
PL A + ++++L G
Sbjct: 62 NEFPLHQAATLEDTKIVKILLFSG 85
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 3e-12
Identities = 15/59 (25%), Positives = 23/59 (38%)
Query: 66 YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+N PLH A+ + K L+ G D + D NT L A + ++L
Sbjct: 60 LENEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKN 118
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 3e-12
Identities = 16/94 (17%), Positives = 32/94 (34%), Gaps = 8/94 (8%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+TS ND + V L + + +H+ +G +D+ L++Y
Sbjct: 130 KTSFY-HAVMLNDVSIVSYFLS--EIPSTFDLAILLSCIHITIKNGHVDMMILLLDYMTS 186
Query: 94 VNAQDRWKNTPL---ADAEGAKKFNMMELLNAHG 124
N + P A + M++ L +
Sbjct: 187 TNTNNSLLFIPDIKLAIDNKDIE--MLQALFKYD 218
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 1e-11
Identities = 8/65 (12%), Positives = 18/65 (27%), Gaps = 1/65 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR-WKNTPLADAEGAKKFNMMEL 119
D T L+ A G + K ++ + + T A +++
Sbjct: 88 DSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSY 147
Query: 120 LNAHG 124
+
Sbjct: 148 FLSEI 152
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 6/45 (13%), Positives = 15/45 (33%)
Query: 70 TPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF 114
+ L ++AK +IE + + K+ + +
Sbjct: 223 SANLENVLLDDAEIAKMIIEKHVEYKSDSYTKDLDIVKNNKLDEI 267
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 4e-08
Identities = 10/87 (11%), Positives = 25/87 (28%), Gaps = 2/87 (2%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97
L++A + KL + + +T + A + + + +
Sbjct: 99 LYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPS-TFD 157
Query: 98 DRWKNTPLADAEGAKKFNMMELLNAHG 124
+ + +MM LL +
Sbjct: 158 LAILLSCIHITIKNGHVDMMILLLDYM 184
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 6e-08
Identities = 5/41 (12%), Positives = 18/41 (43%), Gaps = 1/41 (2%)
Query: 61 VHARDYDNRTP-LHVASLHGWIDVAKCLIEYGADVNAQDRW 100
+ + P + +A + I++ + L +Y ++ + +
Sbjct: 187 TNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDINIYSANLE 227
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 19/104 (18%), Positives = 32/104 (30%), Gaps = 12/104 (11%)
Query: 23 ADKQKEKARVSRTSLIL--WHAHQNDAAAVRKLLEEDQSL----------VHARDYDNRT 70
D + + +T L+ + H + LL+ + Y +T
Sbjct: 44 TDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQT 103
Query: 71 PLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF 114
LH+A + + L+E GADV A F
Sbjct: 104 ALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYF 147
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 13/51 (25%), Positives = 22/51 (43%), Gaps = 3/51 (5%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYG---ADVNAQDRWKNTPLADA 108
Y PL +A+ + + K L++ AD++A+D NT L
Sbjct: 141 GRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHAL 191
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 12/78 (15%), Positives = 23/78 (29%), Gaps = 7/78 (8%)
Query: 28 EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
E A + + + N+ + L L + TPL +A+ G I V +
Sbjct: 193 EVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYI 252
Query: 88 IEYGADVNAQDRWKNTPL 105
++
Sbjct: 253 LQREIHE-------PECR 263
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 20/101 (19%), Positives = 30/101 (29%), Gaps = 18/101 (17%)
Query: 42 AHQNDAAAVRKLLEEDQSL--VHARDYDNRTPLHVASLHG----------------WIDV 83
A N A V+ LL+ + ARD T LH + +
Sbjct: 156 ACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILIL 215
Query: 84 AKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
L +R TPLA A + K ++ +
Sbjct: 216 GAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQRE 256
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 26/189 (13%), Positives = 55/189 (29%), Gaps = 26/189 (13%)
Query: 165 IGKGSFGEI----------LKAYWRGTPVAIK-------RILPSLSDDRLVIQDFRHEVN 207
+ + G + + + ++K R ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 208 LLVKLRHPNIVQFLG-AVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDI 264
L I +G V + K L+ L G L L K LS + + A +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRL 168
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM---T 321
+ +LH N +H ++ N+ + + + +G + H Y +
Sbjct: 169 LDALEFLHE--NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRS 226
Query: 322 GETGSYRYM 330
G ++
Sbjct: 227 PHEGDLEFI 235
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 23/128 (17%), Positives = 44/128 (34%), Gaps = 25/128 (19%)
Query: 23 ADKQKEKARVSRTSLIL--WHAHQNDAAAVRKLLEEDQSL----------VHARDYDNRT 70
D + +T L+ + A + LL+ D+ Y +
Sbjct: 33 TDSAYTEGSTGKTCLMKAVLNLQDGVNACIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHS 92
Query: 71 PLHVASLHGWIDVAKCLIEYGADVNAQDR-------------WKNTPLADAEGAKKFNMM 117
LH+A + K L+E GADV+ + + PL+ A K+++++
Sbjct: 93 ALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVV 152
Query: 118 ELLNAHGG 125
L +
Sbjct: 153 TYLLENPH 160
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 11/72 (15%), Positives = 21/72 (29%), Gaps = 5/72 (6%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ A + + L + G + + L + TPL A K + +
Sbjct: 181 MIADNSPENSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHI 240
Query: 121 NAHGGLSYGQNG 132
L +G
Sbjct: 241 -----LQREFSG 247
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 14/48 (29%), Positives = 18/48 (37%), Gaps = 3/48 (6%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYG---ADVNAQDRWKNTPL 105
Y PL +A+ DV L+E A + A D NT L
Sbjct: 129 QGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVL 176
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 10/71 (14%), Positives = 26/71 (36%), Gaps = 2/71 (2%)
Query: 26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAK 85
++L++ + + L L ++ TPL +A+ G I++ +
Sbjct: 181 MIADNSPENSALVI--HMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFR 238
Query: 86 CLIEYGADVNA 96
+++ A
Sbjct: 239 HILQREFSGAA 249
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 9e-12
Identities = 54/279 (19%), Positives = 95/279 (34%), Gaps = 79/279 (28%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----HPN- 216
+G G F + ++ VA+K ++ S + E+ LL +R PN
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYT---ETALDEIRLLKSVRNSDPNDPNR 100
Query: 217 --IVQFLGAVTERKP----LMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGM 268
+VQ L + ++ E L G L K++ L + +G+
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 269 AYLHNEPNVIIHRDLKPRNVLLV------------------------------------- 291
YLH + IIH D+KP N+LL
Sbjct: 160 DYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 292 ----------NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
N+ +K+ D G + + + D+ +T YR + EV Y+
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDI-----QTRQYR--SLEVLIGSGYN 271
Query: 342 KKVDVFSFAMILYEMLEGEP---PLANYEPYEAAKYVAE 377
D++S A + +E+ G+ P + E ++A
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL 310
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 44/174 (25%), Positives = 69/174 (39%), Gaps = 16/174 (9%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 221
IG GSFGEI VAIK +L +E + L+ I
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL-----LYESKIYRILQGGTGIPNVR 69
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
E +L+ + L G L LS T + A + + ++H+ +H
Sbjct: 70 WFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--KSFLH 126
Query: 281 RDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQNSHDVYKMT---GETGSYRYM 330
RD+KP N L+ + A+ + + DFGL+K + ++H TG+ RY
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 44/179 (24%), Positives = 66/179 (36%), Gaps = 26/179 (14%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKR-----ILPSLSDDRLVIQDFRHEVNLLVKLRH-PN 216
IG GSFG+I G VAIK P L E + ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL----------HIESKIYKMMQGGVG 66
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEP 275
I E +++ E L G L S T + A + + Y+H+
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-- 123
Query: 276 NVIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQNSHDVYKMT---GETGSYRYM 330
IHRD+KP N L+ + + + + DFGL+K + +H TG+ RY
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 43/176 (24%), Positives = 66/176 (37%), Gaps = 18/176 (10%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFL 221
IG G+FGE+ + VAIK L + E +L I Q
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVY 71
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
K ++ E L G L S T + A+ + M Y+H++ +I+
Sbjct: 72 YFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK--NLIY 128
Query: 281 RDLKPRNVLL---VNSSADHLKVGDFGLSKLIKVQNSHDVYKMT---GETGSYRYM 330
RD+KP N L+ N + + + DF L+K + TG+ RYM
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 39/196 (19%), Positives = 66/196 (33%), Gaps = 40/196 (20%)
Query: 165 IGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
IG+G FG I A P +K + + L E+ + P
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVK--VEPSDNGPL-----FTELKFYQRAAKPEQ 95
Query: 218 VQFLGAVTERKPL-------------------MLITEYLRGGDLHKYLKEKG-ALSPSTA 257
+Q + K L +I + G DL K + S T
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTV 154
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
+ +L I + Y+H + +H D+K N+LL + D + + D+GL+ + H
Sbjct: 155 LQLSLRILDILEYIHE--HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 318 YKM---TGETGSYRYM 330
Y G+ +
Sbjct: 213 YAADPKRCHDGTIEFT 228
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 15/84 (17%), Positives = 33/84 (39%)
Query: 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWI 81
+ Q ++ L ++++A+D + T L++A+ G I
Sbjct: 237 NRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARLGNI 296
Query: 82 DVAKCLIEYGADVNAQDRWKNTPL 105
+ L++YGAD ++ P+
Sbjct: 297 SIVDALLDYGADPFIANKSGLRPV 320
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 13/64 (20%), Positives = 24/64 (37%), Gaps = 4/64 (6%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA----EGAKKFNMMELL 120
D TPLH + +++ K L+++G++ D + L A LL
Sbjct: 128 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALL 187
Query: 121 NAHG 124
+
Sbjct: 188 DYLY 191
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 12/76 (15%), Positives = 20/76 (26%), Gaps = 6/76 (7%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG----WIDVAKCLIE 89
T L W + V+ L++ + D + L A L
Sbjct: 132 NTPLH-WLTSIANLELVKHLVKHGSN-RLYGDNMGESCLVKAVKSVNNYDSGTFEALLDY 189
Query: 90 YGADVNAQDRWKNTPL 105
+ +D T L
Sbjct: 190 LYPCLILEDSMNRTIL 205
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 43/176 (24%), Positives = 65/176 (36%), Gaps = 18/176 (10%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFL 221
IG+GSFG I + VAIK R R E L I
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF-----EPRRSDAPQLRDEYRTYKLLAGCTGIPNVY 72
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
E +L+ + L G L L G S T A + + +H +++
Sbjct: 73 YFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE--KSLVY 129
Query: 281 RDLKPRNVLL---VNSSADHLKVGDFGLSKLIKVQNSHDVYKMT---GETGSYRYM 330
RD+KP N L+ + +A+ + V DFG+ K + + +G+ RYM
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 9e-10
Identities = 10/67 (14%), Positives = 18/67 (26%), Gaps = 3/67 (4%)
Query: 41 HAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100
+ + LL D +V +N +A+ +G + V L E
Sbjct: 102 TGCSSALDTLCLLLTSD-EIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQ 160
Query: 101 KN--TPL 105
Sbjct: 161 AENYHAF 167
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 13/114 (11%), Positives = 27/114 (23%), Gaps = 7/114 (6%)
Query: 15 CKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL----VHARDYDNRT 70
G K + ++ + +R LL D
Sbjct: 262 NPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANE 321
Query: 71 PLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
L +A G L+ + + N + + G ++ + H
Sbjct: 322 LLRLALRLGNQGACALLLSIPSVLALTKA-NNYYINETGGR--LDLRAVALEHH 372
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 9/59 (15%), Positives = 18/59 (30%), Gaps = 3/59 (5%)
Query: 50 VRKLLEEDQSLVHA-RDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD--RWKNTPL 105
+ +L E + + A +N +A+ +G + V L E
Sbjct: 144 LNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAF 202
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 9e-10
Identities = 24/127 (18%), Positives = 47/127 (37%), Gaps = 26/127 (20%)
Query: 24 DKQKEKARVSRTSLIL--WHAHQNDAAAVRKLLE------EDQSLVHA----RDYDNRTP 71
D++ + +T L + + LL+ + +++ Y +T
Sbjct: 37 DEEFREPSTGKTCLPKALLNLSAGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTA 96
Query: 72 LHVASLHGWIDVAKCLIEYGADVNAQDR--------------WKNTPLADAEGAKKFNMM 117
LH+A + L+E GADV+AQ R + PL+ A + +++
Sbjct: 97 LHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIV 156
Query: 118 ELLNAHG 124
L +G
Sbjct: 157 HYLTENG 163
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 4e-09
Identities = 19/93 (20%), Positives = 25/93 (26%), Gaps = 10/93 (10%)
Query: 62 HARDYDNRTPLHVASLHGWIDVAKCLIEYG---ADVNAQDRWKNTPL--ADAEGAKKFNM 116
Y PL +A+ + L E G AD+ QD NT L A
Sbjct: 134 GGYFYFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTREN 193
Query: 117 MELLNAHGG--LSYGQNGSHFEPKPVPPPLPNK 147
+ + L P L N
Sbjct: 194 TKFVTKMYDLLLIKCAKL---FPDTNLEALLNN 223
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 9e-06
Identities = 11/45 (24%), Positives = 19/45 (42%)
Query: 54 LEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L D +L + D +PL +A+ G I + + +I A
Sbjct: 211 LFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADAAAH 255
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 21/119 (17%), Positives = 36/119 (30%), Gaps = 1/119 (0%)
Query: 3 SGNSSPGDSTTPCKGGATSSADKQKEKARVSRTSLILW-HAHQNDAAAVRKLLEEDQSLV 61
G G + T+L L + + + L ++ +
Sbjct: 139 KTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNL 198
Query: 62 HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ T LH L + K L+ A + + TPL A+ K + ELL
Sbjct: 199 DKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELL 257
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 10/61 (16%), Positives = 22/61 (36%), Gaps = 3/61 (4%)
Query: 67 DNRTPLHVASLHG---WIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
+ T LH+A + + L++ +++ Q +T L ++LL
Sbjct: 168 PDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRG 227
Query: 124 G 124
Sbjct: 228 K 228
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 2e-08
Identities = 66/382 (17%), Positives = 109/382 (28%), Gaps = 117/382 (30%)
Query: 27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYD-NRTPLHVASLHGWIDVAK 85
K VS T + W V+K +EE V +Y +P+ +
Sbjct: 56 MSKDAVSGTLRLFWTLLSKQEEMVQKFVEE----VLRINYKFLMSPIKTEQ----RQPSM 107
Query: 86 CLIEYGADVNAQDRWKNTPLADAEGAKKFN------MMELLNA------------HGGLS 127
Y + +DR N D + K+N ++L A G L
Sbjct: 108 MTRMY---IEQRDRLYN----DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG 160
Query: 128 YGQN-------------------------GSHFEPKPVPPPLPNKCDWEIDP---SELDF 159
G+ + P+ V L ++IDP S D
Sbjct: 161 SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL-YQIDPNWTSRSDH 219
Query: 160 SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNI 217
SS+ + S L+ + P + L L + + F +L+ R +
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKP--YENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV 277
Query: 218 VQFLGAVTERKPLMLITEYLRGG---D-----LHKYLKEKGALSPSTAVN---FALD-IA 265
FL A T + ++ D L KYL + P + L IA
Sbjct: 278 TDFLSAATTTHISL---DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIA 334
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
+ + D N VN L+ +I+
Sbjct: 335 ---ESIRDGLA---TWD----NWKHVNCDK---------LTTIIES-------------- 361
Query: 326 SYRYMAPEVFKHRKYDKKVDVF 347
S + P ++ +D+ VF
Sbjct: 362 SLNVLEPAEYRKM-FDRLS-VF 381
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 18/60 (30%), Positives = 25/60 (41%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ A+ D T LH A+L+ D K L++ A V + T L A ELL
Sbjct: 219 LDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELL 278
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 14/74 (18%), Positives = 27/74 (36%), Gaps = 3/74 (4%)
Query: 67 DNRTPLHVASLHGW---IDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
LH+A + + +I+ G ++A+ NT L A + + ++LL
Sbjct: 189 PEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKG 248
Query: 124 GGLSYGQNGSHFEP 137
L N +
Sbjct: 249 RALVGTVNEAGETA 262
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 20/108 (18%), Positives = 35/108 (32%), Gaps = 9/108 (8%)
Query: 39 LWHA-HQNDAAAVRKLLEEDQSL-----VHARDYDNRTPLHVASLH---GWIDVAKCLIE 89
LW A D +V + Q LH+A + + +I+
Sbjct: 136 LWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQ 195
Query: 90 YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137
G ++A+ NT L A + + ++LL L N +
Sbjct: 196 NGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETA 243
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 18/60 (30%), Positives = 25/60 (41%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+ A+ D T LH A+L+ D K L++ A V + T L A ELL
Sbjct: 200 LDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELL 259
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 2e-05
Identities = 33/155 (21%), Positives = 54/155 (34%), Gaps = 14/155 (9%)
Query: 6 SSPGDSTTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD 65
P T A + + + T LI N A L ++ + V+ D
Sbjct: 208 GHPPSLPTMADALAHGADVNWVNGGQDNATPLI-QATAANSLLACE-FLLQNGANVNQAD 265
Query: 66 YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
R PLH A++ G +A ++ GAD+ A+D PL A +++ LL
Sbjct: 266 SAGRGPLHHATILGHTGLACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLR---- 321
Query: 126 LSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS 160
L+ + + + D DFS
Sbjct: 322 LAKMREAEAAQGQAG--------DETYLDIFRDFS 348
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 32/165 (19%), Positives = 56/165 (33%), Gaps = 22/165 (13%)
Query: 150 WEIDPSELDFSS-SAIIGKGSFGEILKAYWRGTPVAIKRIL------PSLSDDRLVIQDF 202
W + +IGKG+ +I + + V IK + L D+ +
Sbjct: 328 WIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERL-DENIRKSRT 386
Query: 203 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL 262
E L ++ I + ++ Y+ G +++ ++ A
Sbjct: 387 AREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDN--------LDIAY 438
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
I + LH N +IH DL N + L + DFGL K
Sbjct: 439 KIGEIVGKLHK--NDVIHNDLTTSNFIF----DKDLYIIDFGLGK 477
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 394 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.89 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.89 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.85 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.83 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.83 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.82 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.82 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.82 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.81 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.81 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.81 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.81 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.81 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.8 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.8 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.8 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.79 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.79 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.79 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.79 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.79 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.79 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.78 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.78 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.78 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.78 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.78 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.78 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.77 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.77 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.77 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.77 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.76 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.76 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.76 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.76 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.76 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.76 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.76 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.76 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.75 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.75 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.75 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.75 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.75 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.75 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.75 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.74 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.74 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.74 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.74 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.74 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.74 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.73 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.73 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.73 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.73 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.73 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.73 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.73 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.73 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.73 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.73 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.73 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.73 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.72 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.72 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.72 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.72 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.72 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.72 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.72 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.72 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.72 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.71 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.71 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.71 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.71 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.71 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.71 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.71 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.71 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.71 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.71 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.71 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.7 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.7 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.7 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.7 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.7 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.7 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.7 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.69 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.69 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.69 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.68 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.68 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.67 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.67 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.67 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.66 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.64 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.63 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.62 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.61 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.61 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.6 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.6 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.59 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.52 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.47 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.42 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.26 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.09 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.84 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.64 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.55 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.31 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.16 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.15 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.94 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.83 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.51 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.49 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.19 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.1 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.09 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.07 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.95 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.95 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.81 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.69 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.23 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.09 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.09 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.46 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-56 Score=407.97 Aligned_cols=230 Identities=25% Similarity=0.460 Sum_probs=202.8
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++++.||+|+||.||+|.+. |+.||||++.+.........+.+.+|+.++++++|||||+++++|.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 37999999999999999999975 7899999986543222223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|||+||+|.+++.+.+.+++.+++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl--~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEE--cCCCCEEEEEcCCceecCCCCC
Confidence 99999999999999999999999999999999999999988 9999999999999 8889999999999987754322
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccccC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~~ 394 (394)
. ....+.+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..++.++|.++..+ ++ +.+|++++|
T Consensus 188 ~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~p-~~~s~~~~d 263 (311)
T 4aw0_A 188 Q--ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD-FP-EKFFPKARD 263 (311)
T ss_dssp C--CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-CC-TTCCHHHHH
T ss_pred c--ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CC-cccCHHHHH
Confidence 1 1345678999999999999999999999999999999999999999999999999999988654 34 347887653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=405.84 Aligned_cols=228 Identities=25% Similarity=0.465 Sum_probs=197.1
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++++.||+|+||.||+|.+. |+.||||++.+.... ....+.+.+|+.++++++|||||++++++.+++.+|+||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 37999999999999999999975 889999999766544 334578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 235 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 235 e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|||+||+|.+++..+ ..+++.+++.++.||+.||+|||++| ||||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFL--TKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEE--CTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEE--CCCCCEEEcccccceeecCC
Confidence 999999999999754 35799999999999999999999988 9999999999999 88899999999999876543
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.. .....+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..+++.+|.++.+|.++ ..+|+++
T Consensus 179 ~~----~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~-~~~s~~~ 253 (350)
T 4b9d_A 179 VE----LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVS-LHYSYDL 253 (350)
T ss_dssp HH----HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC-TTSCHHH
T ss_pred cc----cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCC-ccCCHHH
Confidence 21 223467999999999999999999999999999999999999999999999999999999888766 3478877
Q ss_pred cC
Q 016152 393 RE 394 (394)
Q Consensus 393 ~~ 394 (394)
+|
T Consensus 254 ~~ 255 (350)
T 4b9d_A 254 RS 255 (350)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-54 Score=401.56 Aligned_cols=226 Identities=26% Similarity=0.478 Sum_probs=200.9
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
..|++.+.||+|+||.||+|.++ |+.||||++........ +.+.+|+.+++.++|||||+++++|.+++.+|+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSG---GGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHH---HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999985 88999999865443332 55788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|||+||+|.+++.+ +.+++.++..++.||+.||+|||++| ||||||||+|||+ +.++.+||+|||+|+.+.....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSSSC
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEE--CCCCCEEEecCcCceecCCCCC
Confidence 99999999999875 56999999999999999999999988 9999999999999 8889999999999987654322
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~~~~~~ 393 (394)
...+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++++.|..+.+|.++. ..+|++++
T Consensus 226 ----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 301 (346)
T 4fih_A 226 ----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLK 301 (346)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHH
T ss_pred ----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 2356789999999999999999999999999999999999999999999999999999887776654 45777765
Q ss_pred C
Q 016152 394 E 394 (394)
Q Consensus 394 ~ 394 (394)
|
T Consensus 302 d 302 (346)
T 4fih_A 302 G 302 (346)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=387.07 Aligned_cols=225 Identities=31% Similarity=0.526 Sum_probs=185.2
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|.+. |+.||||++.+...........+.+|+.++++++|||||++++++.+++.+|+|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 7999999999999999999874 88999999976655444445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+ +|+|.+++.+++.+++.+++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+|+......
T Consensus 94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl--~~~~~vkl~DFGla~~~~~~~-- 166 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLL--DEHLNVKIADFGLSNIMTDGN-- 166 (275)
T ss_dssp CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEE--CTTCCEEECCSSCC---------
T ss_pred CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEE--CCCCCEEEeecCCCeecCCCC--
Confidence 99 6799999999999999999999999999999999988 9999999999999 888999999999998765332
Q ss_pred ccccccCCccCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccccC
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~~ 394 (394)
...+.+||+.|||||++.+..| +.++|||||||++|||+||++||.+.+..++.+.|.++.++. + +.+|++++|
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~-p-~~~s~~~~~ 241 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL-P-KFLSPGAAG 241 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-C-TTSCHHHHH
T ss_pred ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-C-CCCCHHHHH
Confidence 2345789999999999998876 589999999999999999999999999999999999886553 3 347877653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=397.25 Aligned_cols=226 Identities=30% Similarity=0.462 Sum_probs=191.7
Q ss_pred CccccceeecCCceEEEEEEE-----CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~-----~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
+|++++.||+|+||.||+|.. .++.||||++.+....... ...+.+|+.++++++|||||++++++.+++.+|+
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 799999999999999999986 2567999998654322111 1356789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILL--DEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEE--CTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEE--cCCCCEEecccccceeccCC
Confidence 9999999999999999999999999999999999999999988 9999999999999 88899999999999865433
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.. ...+.+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..++..+|.++..+. + +.+|+++
T Consensus 180 ~~----~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-p-~~~s~~~ 253 (304)
T 3ubd_A 180 EK----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM-P-QFLSPEA 253 (304)
T ss_dssp -C----CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-C-TTSCHHH
T ss_pred Cc----cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC-C-CcCCHHH
Confidence 22 2345789999999999999999999999999999999999999999999999999999886654 3 3478776
Q ss_pred cC
Q 016152 393 RE 394 (394)
Q Consensus 393 ~~ 394 (394)
+|
T Consensus 254 ~~ 255 (304)
T 3ubd_A 254 QS 255 (304)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=385.76 Aligned_cols=226 Identities=31% Similarity=0.520 Sum_probs=192.7
Q ss_pred ccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe----CCeeEE
Q 016152 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RKPLML 232 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~~~l 232 (394)
|+..+.||+|+||.||+|.+. +..||+|.+...... ....+.+.+|+.++++++|||||++++++.+ +..+|+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 366778999999999999985 678999998765443 3445789999999999999999999999865 356899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCcccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a~~~~~ 311 (394)
|||||+||+|.+++.+.+.+++..+..++.||+.||+|||+++++||||||||+|||+ + .++.+||+|||+|+....
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl--~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEE--SSTTSCEEECCTTGGGGCCT
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeE--ECCCCCEEEEeCcCCEeCCC
Confidence 9999999999999999899999999999999999999999986679999999999999 5 468999999999975432
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCCc
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRAKGFTP 390 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~-~~~~~~~~i~~g~~p~~~~~~~~~ 390 (394)
. ...+.+||+.|||||++.+ .|+.++|||||||++|||+||++||.+. +..++.+.|..+.+|....+.+++
T Consensus 185 ~------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (290)
T 3fpq_A 185 S------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp T------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred C------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCH
Confidence 2 2345789999999999864 6999999999999999999999999765 556777888888777655566777
Q ss_pred cccC
Q 016152 391 ELRE 394 (394)
Q Consensus 391 ~~~~ 394 (394)
+++|
T Consensus 258 ~~~~ 261 (290)
T 3fpq_A 258 EVKE 261 (290)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-53 Score=402.60 Aligned_cols=226 Identities=26% Similarity=0.478 Sum_probs=201.5
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
..|++.+.||+|+||.||+|.+. |+.||||.+........ +.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSG---GGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHH---HHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 36999999999999999999985 88999999876544332 56789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|||+||+|.++++. +.+++.++..++.||+.||+|||++| ||||||||+|||+ +.++.+||+|||+|..+.....
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl--~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEE--CTTCCEEECCCTTCEECCSSCC
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEE--cCCCCEEEecCccceECCCCCc
Confidence 99999999999865 46999999999999999999999988 9999999999999 8889999999999987654322
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~~~~~~ 393 (394)
...+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++..|..+.+|.+.. ..+|++++
T Consensus 303 ----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 378 (423)
T 4fie_A 303 ----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLK 378 (423)
T ss_dssp ----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHH
T ss_pred ----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHH
Confidence 2356789999999999999999999999999999999999999999999999999999887776654 46788776
Q ss_pred C
Q 016152 394 E 394 (394)
Q Consensus 394 ~ 394 (394)
|
T Consensus 379 d 379 (423)
T 4fie_A 379 G 379 (423)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=390.28 Aligned_cols=228 Identities=29% Similarity=0.504 Sum_probs=198.0
Q ss_pred CcCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
..+|.+.+.||+|+||.||+|.+. +..||||.+... .....+.+.+|+.++++++|||||++++++.+++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 347888999999999999999863 567999998543 3445578999999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCC
Q 016152 229 PLMLITEYLRGGDLHKYLKEK-------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 295 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~ 295 (394)
.+++|||||++|+|.+++.+. ..+++.++..++.|+++||.|||+++ ||||||||+|||+ +.+
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl--~~~ 164 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV--GEN 164 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEE--CCC
Confidence 999999999999999999764 35999999999999999999999988 9999999999999 888
Q ss_pred CcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 016152 296 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 374 (394)
Q Consensus 296 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~ 374 (394)
+.+||+|||+|+........ .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~--~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 242 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 242 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCE--EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred CcEEECCcccceecCCCCce--eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 89999999999866543221 11233569999999999999999999999999999999998 9999999999999999
Q ss_pred HHcCCCCCCCCCCCCcccc
Q 016152 375 VAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 375 i~~g~~p~~~~~~~~~~~~ 393 (394)
|.+|.+|..+. .+|++++
T Consensus 243 i~~~~~~~~p~-~~~~~~~ 260 (299)
T 4asz_A 243 ITQGRVLQRPR-TCPQEVY 260 (299)
T ss_dssp HHHTCCCCCCT-TCCHHHH
T ss_pred HHcCCCCCCCc-cchHHHH
Confidence 99999888774 4787765
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=395.20 Aligned_cols=228 Identities=28% Similarity=0.390 Sum_probs=193.5
Q ss_pred CCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeE
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 231 (394)
.....|++.++||+|+||.||+|.++ |+.||||++...... .+|+.+++.++|||||++++++.+++.+|
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 33446888999999999999999975 889999998654322 36999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC-cEEEeecCCccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIK 310 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~-~~kl~DFg~a~~~~ 310 (394)
+|||||+||+|.+++++.+.+++.+++.++.||+.||+|||+++ ||||||||+|||+ +.++ .+||+|||+|+.+.
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLL--SSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEE--CTTSCCEEECCCTTCEEC-
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEE--eCCCCEEEEeeCCCCeEcc
Confidence 99999999999999999899999999999999999999999988 9999999999999 7666 69999999998775
Q ss_pred cccccc-cccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCC
Q 016152 311 VQNSHD-VYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR-AKGF 388 (394)
Q Consensus 311 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~-~~~~ 388 (394)
...... .......+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..++..+|..+.+|... ...+
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 282 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC 282 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTS
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccC
Confidence 433211 11234468999999999999999999999999999999999999999998888888999887765432 2457
Q ss_pred Ccccc
Q 016152 389 TPELR 393 (394)
Q Consensus 389 ~~~~~ 393 (394)
|++++
T Consensus 283 s~~~~ 287 (336)
T 4g3f_A 283 APLTA 287 (336)
T ss_dssp CHHHH
T ss_pred CHHHH
Confidence 77765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=388.35 Aligned_cols=228 Identities=32% Similarity=0.539 Sum_probs=192.6
Q ss_pred CcCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
..+|.+.+.||+|+||.||+|.+. ++.||||.+... .....+.|.+|+.++++++|||||++++++.+.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 346778899999999999999864 567999998542 3445678999999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC
Q 016152 229 PLMLITEYLRGGDLHKYLKEK---------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS 293 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~ 293 (394)
.+++|||||++|+|.+++++. +++++.+++.++.|+++||.|||+++ ||||||||+|||+ +
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl--~ 192 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLV--G 192 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--E
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEE--C
Confidence 999999999999999999753 45899999999999999999999988 9999999999999 8
Q ss_pred CCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 016152 294 SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA 372 (394)
Q Consensus 294 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~ 372 (394)
.++.+||+|||+++........ .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~--~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 270 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270 (329)
T ss_dssp TTTEEEECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred CCCcEEEcccccceeccCCCcc--eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 8899999999999876533221 12234679999999999999999999999999999999999 99999999999999
Q ss_pred HHHHcCCCCCCCCCCCCcccc
Q 016152 373 KYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 373 ~~i~~g~~p~~~~~~~~~~~~ 393 (394)
..|.+|.++..+. .+|++++
T Consensus 271 ~~i~~g~~~~~p~-~~~~~~~ 290 (329)
T 4aoj_A 271 DCITQGRELERPR-ACPPEVY 290 (329)
T ss_dssp HHHHHTCCCCCCT-TCCHHHH
T ss_pred HHHHcCCCCCCcc-cccHHHH
Confidence 9999999888874 4788765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=384.83 Aligned_cols=227 Identities=29% Similarity=0.488 Sum_probs=196.8
Q ss_pred CccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
++++.+.||+|+||.||+|.+. ++.||||.+...... ...+.|.+|+.++++++|||||++++++.+++.+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 4566889999999999999863 467999998654322 2346799999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC
Q 016152 231 MLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~ 294 (394)
++|||||++|+|.+++..+ ..+++.++..++.||++||+|||+++ ||||||||+|||+ +.
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl--~~ 180 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLV--YD 180 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEE--CC
Confidence 9999999999999999643 35899999999999999999999988 9999999999999 88
Q ss_pred CCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 016152 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAK 373 (394)
Q Consensus 295 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~ 373 (394)
++.+||+|||+++.+..... ........||+.|||||++.++.|+.++|||||||++|||+| |..||.+.+..++.+
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADY--YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGC--BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCEEECCcccceeccCCCc--eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 88999999999987654322 112345679999999999999999999999999999999998 999999999999999
Q ss_pred HHHcCCCCCCCCCCCCcccc
Q 016152 374 YVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 374 ~i~~g~~p~~~~~~~~~~~~ 393 (394)
.|..|.++..+. .+|++++
T Consensus 259 ~i~~~~~~~~p~-~~~~~~~ 277 (308)
T 4gt4_A 259 MIRNRQVLPCPD-DCPAWVY 277 (308)
T ss_dssp HHHTTCCCCCCT-TCCHHHH
T ss_pred HHHcCCCCCCcc-cchHHHH
Confidence 999998887764 4777664
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=377.86 Aligned_cols=236 Identities=33% Similarity=0.568 Sum_probs=188.3
Q ss_pred CCCcccCCCCcCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe
Q 016152 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226 (394)
Q Consensus 147 ~~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 226 (394)
...|+|+.. ++++.+.||+|+||.||+|.+++ .+|||++.... ......+.+.+|+.++++++|||||++++++.+
T Consensus 28 ~~~Wei~~~--~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 103 (307)
T 3omv_A 28 SYYWEIEAS--EVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103 (307)
T ss_dssp -CCCBCCTT--SCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CcCcEEcHH--HeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC
Confidence 346888776 56778999999999999998776 59999875443 334556889999999999999999999998754
Q ss_pred CCeeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 227 RKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
+.+++|||||++|+|.+++... +.+++.++..++.|+++||+|||+++ ||||||||+|||+ +.++.+||+|||+
T Consensus 104 -~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl--~~~~~~Ki~DFGl 178 (307)
T 3omv_A 104 -DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFL--HEGLTVKIGDFGL 178 (307)
T ss_dssp -SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEE--ETTEEEEECCCSS
T ss_pred -CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEE--CCCCcEEEeeccC
Confidence 5689999999999999999764 57999999999999999999999988 9999999999999 8888999999999
Q ss_pred ccccccccccccccccCCccCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHcCCC-
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA-KYVAEGHR- 380 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~-~~i~~g~~- 380 (394)
|+........ ......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.+..+.. ..+.++..
T Consensus 179 a~~~~~~~~~--~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~ 256 (307)
T 3omv_A 179 ATVKSRWSGS--QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS 256 (307)
T ss_dssp CBC--------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC
T ss_pred ceecccCCcc--eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence 9876533221 12345789999999999864 46899999999999999999999999887655444 55555543
Q ss_pred CCCCC--CCCCcccc
Q 016152 381 PFFRA--KGFTPELR 393 (394)
Q Consensus 381 p~~~~--~~~~~~~~ 393 (394)
|.++. ..+|++++
T Consensus 257 p~~~~~~~~~~~~l~ 271 (307)
T 3omv_A 257 PDLSKLYKNCPKAMK 271 (307)
T ss_dssp CCSTTSCTTSCHHHH
T ss_pred CCcccccccchHHHH
Confidence 33222 45666654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=377.84 Aligned_cols=234 Identities=31% Similarity=0.533 Sum_probs=197.0
Q ss_pred CcccCCCCcCccccceeecCCceEEEEEEECC-------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC-CceeeE
Q 016152 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQF 220 (394)
Q Consensus 149 ~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g-------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~ 220 (394)
.|+|+. .+|++.+.||+|+||.||+|.+.+ +.||||.+.... .....+.+.+|+.++++++| ||||++
T Consensus 58 ~wEi~~--~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 58 KWEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHBCCG--GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccEecH--HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 477764 478999999999999999998753 469999886543 23445779999999999975 899999
Q ss_pred EeEEEeC-CeeEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 016152 221 LGAVTER-KPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 283 (394)
Q Consensus 221 ~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Di 283 (394)
++++.+. ..+++|||||++|+|.++++.. ..+++.++..++.||++||+|||+++ ||||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDL 211 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 211 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCcc
Confidence 9998664 5789999999999999999752 34899999999999999999999988 999999
Q ss_pred CCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCC
Q 016152 284 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPP 362 (394)
Q Consensus 284 kp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~P 362 (394)
||+|||+ +.++.+||+|||+|+.+..... ........||+.|||||++.+..|+.++|||||||++|||+| |+.|
T Consensus 212 K~~NILl--~~~~~vKi~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P 287 (353)
T 4ase_A 212 AARNILL--SEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287 (353)
T ss_dssp SGGGEEE--CGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred Cccceee--CCCCCEEECcchhhhhcccCCC--ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence 9999999 8888999999999987654322 112345679999999999999999999999999999999998 9999
Q ss_pred CCCCC-HHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 363 LANYE-PYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 363 f~~~~-~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
|.+.+ ..++.+.+.+|.+|..+. .+|++++
T Consensus 288 f~~~~~~~~~~~~i~~g~~~~~p~-~~~~~~~ 318 (353)
T 4ase_A 288 YPGVKIDEEFCRRLKEGTRMRAPD-YTTPEMY 318 (353)
T ss_dssp STTCCCSHHHHHHHHHTCCCCCCT-TCCHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCCCCCc-cCCHHHH
Confidence 98875 456678888999888875 4777765
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=369.69 Aligned_cols=214 Identities=26% Similarity=0.463 Sum_probs=184.9
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe------CCe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------RKP 229 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~------~~~ 229 (394)
+|++++.||+|+||.||+|.+. |+.||||++...... ....+.+.+|+.+|+.++|||||++++++.. .+.
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 6999999999999999999975 889999998655433 3445678899999999999999999998754 357
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
+|+|||||+ |+|.+++.+++.+++.++..++.||+.||.|||++| ||||||||+|||+ +.++.+||+|||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~--~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLV--NENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCcccccc--CCCCCEEEeecceeeec
Confidence 899999996 589999998889999999999999999999999988 9999999999999 88899999999999877
Q ss_pred ccccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
............+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+.+..|.+
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~ 277 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 277 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 54433333345568999999999998875 569999999999999999999999999999999888863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=355.69 Aligned_cols=216 Identities=31% Similarity=0.541 Sum_probs=169.3
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC-------
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------- 228 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------- 228 (394)
+|++++.||+|+||.||+|.++ |+.||||.+.... .....+.+.+|+.++++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 6889999999999999999975 8899999986543 3445577899999999999999999999987544
Q ss_pred -----eeEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEE
Q 016152 229 -----PLMLITEYLRGGDLHKYLKEKGA---LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300 (394)
Q Consensus 229 -----~~~lv~e~~~~~sL~~~~~~~~~---~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl 300 (394)
.+|+|||||++|+|.+++..++. .+...++.++.||++||+|||++| |+||||||+|||+ +.++.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl--~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFF--TMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEE--CCCCcEEE
Confidence 37999999999999999987654 456678899999999999999988 9999999999999 88899999
Q ss_pred eecCCcccccccccccc--------ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHH
Q 016152 301 GDFGLSKLIKVQNSHDV--------YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEA 371 (394)
Q Consensus 301 ~DFg~a~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~-~~~~ 371 (394)
+|||+|+.+........ ....+.+||+.|||||++.+..|+.++|||||||++|||++ ||.... ..+.
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 99999987754332111 12245679999999999999999999999999999999996 786532 3344
Q ss_pred HHHHHcCCCCC
Q 016152 372 AKYVAEGHRPF 382 (394)
Q Consensus 372 ~~~i~~g~~p~ 382 (394)
...+..+..|.
T Consensus 237 ~~~~~~~~~p~ 247 (299)
T 4g31_A 237 LTDVRNLKFPP 247 (299)
T ss_dssp HHHHHTTCCCH
T ss_pred HHHHhcCCCCC
Confidence 55566665553
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=384.18 Aligned_cols=230 Identities=30% Similarity=0.469 Sum_probs=192.9
Q ss_pred CCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCC---CCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC
Q 016152 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSL---SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (394)
Q Consensus 153 ~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~---~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 227 (394)
..+..+|+++++||+|+||.||+|.+. |+.||||++.+.. ............++.+++.++|||||+++++|.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 344558999999999999999999985 7899999986432 11222223344556777888999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
+.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| ||||||||+|||+ +.+|.+||+|||+|.
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILl--d~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLAC 340 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEE--eCCCCEEecccceee
Confidence 999999999999999999999999999999999999999999999998 9999999999999 889999999999998
Q ss_pred ccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCCCCC
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~---~~~~~~~~i~~g~~p~~ 383 (394)
.+.... ..+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+. +..++.+.+..+..+ +
T Consensus 341 ~~~~~~------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~-~ 413 (689)
T 3v5w_A 341 DFSKKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-L 413 (689)
T ss_dssp ECSSCC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC-C
T ss_pred ecCCCC------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC-C
Confidence 765332 345789999999999974 57999999999999999999999999753 455677777765444 3
Q ss_pred CCCCCCccccC
Q 016152 384 RAKGFTPELRE 394 (394)
Q Consensus 384 ~~~~~~~~~~~ 394 (394)
+ ..+|++++|
T Consensus 414 p-~~~S~~a~d 423 (689)
T 3v5w_A 414 P-DSFSPELRS 423 (689)
T ss_dssp C-TTSCHHHHH
T ss_pred C-ccCCHHHHH
Confidence 3 347877653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=355.64 Aligned_cols=200 Identities=30% Similarity=0.459 Sum_probs=162.3
Q ss_pred CccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC----eeEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PLMLI 233 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----~~~lv 233 (394)
+|.+.+.||+|+||.||+|.++|+.||||++.... ........|+..+.+++|||||++++++.+++ .+|+|
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 57788999999999999999999999999885421 11122334666667889999999999987654 57999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC------CCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~------~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
||||++|+|.++++.+ .+++..+..++.|+++||.|||++ .++||||||||+|||+ +.++++||+|||+|+
T Consensus 80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl--~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE--CTTSCEEECCCTTCE
T ss_pred ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE--CCCCCEEEEeCCCCc
Confidence 9999999999999764 589999999999999999999986 1239999999999999 889999999999998
Q ss_pred ccccccccccccccCCccCccccCccccCCC------CCCCcchHHHHHHHHHHHHcCCCCCC
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHR------KYDKKVDVFSFAMILYEMLEGEPPLA 364 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGv~l~el~~g~~Pf~ 364 (394)
................+||+.|||||++.+. .++.++|||||||++|||+||.+||.
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 7764433222223456899999999999754 46789999999999999999977653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=380.96 Aligned_cols=227 Identities=23% Similarity=0.447 Sum_probs=197.8
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|.++ |+.||+|.+.... ....+.+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 37999999999999999999985 7899999886543 233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|||+||+|.+++.. .+.+++.++..++.||+.||.|||+++ |+||||||+|||+..+..+.+||+|||+|+.+....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999999964 467999999999999999999999988 999999999999954456899999999998875432
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCCcc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AKGFTPE 391 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~--~~~~~~~ 391 (394)
.....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++..|..+...... ...+|++
T Consensus 312 -----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 312 -----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp -----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred -----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 234568999999999999999999999999999999999999999999999999999987554332 2456766
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 387 ~~ 388 (573)
T 3uto_A 387 GK 388 (573)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=350.23 Aligned_cols=207 Identities=21% Similarity=0.350 Sum_probs=171.5
Q ss_pred CccccceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~ 231 (394)
+|++.+.||+|+||.||+|.++ ++.||+|.+.+... ..++.+|+.+++.+ +||||++++++|.+.+.+|
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 6999999999999999999763 56799998865432 24567899999988 5999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCC-CcEEEeecCCccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDFGLSKLIK 310 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~-~~~kl~DFg~a~~~~ 310 (394)
+||||++||+|.++++ .+++.+++.++.||+.||+|||++| |+||||||+|||+ +.+ +.+||+|||+|+...
T Consensus 97 lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl--~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLY--NRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--ETTTTEEEECCCTTCEECT
T ss_pred EEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEE--eCCCCeEEECcCCCCcccC
Confidence 9999999999999983 5999999999999999999999988 9999999999999 544 799999999997654
Q ss_pred ccccc------------------------ccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCC-
Q 016152 311 VQNSH------------------------DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLA- 364 (394)
Q Consensus 311 ~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~- 364 (394)
..... ........+||+.|+|||++.+. .|+.++||||+||++|||++|++||.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 32110 00112346799999999999875 58999999999999999999999995
Q ss_pred CCCHHHHHHHHH
Q 016152 365 NYEPYEAAKYVA 376 (394)
Q Consensus 365 ~~~~~~~~~~i~ 376 (394)
+.+..+.+..|.
T Consensus 250 ~~~~~~~l~~I~ 261 (361)
T 4f9c_A 250 ASDDLTALAQIM 261 (361)
T ss_dssp CSSHHHHHHHHH
T ss_pred CCCHHHHHHHHH
Confidence 445555555553
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=336.98 Aligned_cols=227 Identities=26% Similarity=0.458 Sum_probs=196.0
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||++... |+.+|+|++.+...........+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 47999999999999999999875 7899999986432111122356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||++||+|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++........
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCSCCTTC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEE--CCCCCEEEeeccchhhcccCCC
Confidence 99999999999998889999999999999999999999988 9999999999999 8889999999999975432221
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....+||+.|+|||++.+..++.++|||||||++|||++|++||...+..++.+.|..+... ++ ..+|++++
T Consensus 161 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s~~~~ 233 (337)
T 1o6l_A 161 ----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-FP-RTLSPEAK 233 (337)
T ss_dssp ----CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CC-TTSCHHHH
T ss_pred ----cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CC-CCCCHHHH
Confidence 234578999999999999999999999999999999999999999999999999998876543 33 24666654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=340.78 Aligned_cols=227 Identities=26% Similarity=0.406 Sum_probs=192.1
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv 233 (394)
.+|++.+.||+|+||.||+|.+. ++.||||++.+...........+.+|..+++.+ +||||+++++++.+.+.+|+|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 38999999999999999999875 788999998653222222345677899999988 699999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|||++||+|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++.......
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl--~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLL--DHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCSCC--
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEE--CCCCCEEEccccceeecccCC
Confidence 999999999999998889999999999999999999999988 9999999999999 888999999999997543222
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
. .....+||+.|+|||++.+..++.++|||||||++|||++|++||...+..++.+.|..+...... .++++++
T Consensus 179 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~ 252 (353)
T 3txo_A 179 V----TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--WLHEDAT 252 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred c----cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHH
Confidence 1 234568999999999999889999999999999999999999999999999999999987654432 2555543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=332.00 Aligned_cols=224 Identities=33% Similarity=0.523 Sum_probs=196.8
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|.+ .|+.||||++...... ....+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 3799999999999999999997 4889999998665433 344577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++++|.+++...+.+++.++..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLL--DADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECSTTCCGGGSSSC-
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEE--cCCCCEEEeeccCceecCCCC-
Confidence 99999999999998889999999999999999999999988 9999999999999 888999999999997665332
Q ss_pred cccccccCCccCccccCccccCCCCCC-CcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYD-KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|++||.+.+..++.+.+..+..+... .+|+++
T Consensus 169 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~ 241 (328)
T 3fe3_A 169 ----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--YMSTDC 241 (328)
T ss_dssp ----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHH
T ss_pred ----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHH
Confidence 23456899999999999888775 7999999999999999999999999999999999887654332 245544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=337.98 Aligned_cols=230 Identities=31% Similarity=0.480 Sum_probs=189.4
Q ss_pred CCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHH-HHhCCCCceeeEEeEEEeCCee
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL-LVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~-l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
....+|++.+.||+|+||.||+|.++ +..+|||++.+...........+..|..+ ++.++||||+++++++.+.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34458999999999999999999985 67899999876544333344556667776 5678999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILL--DSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCCBCGGGB
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEE--CCCCCEEEeeCccccccc
Confidence 999999999999999998888999999999999999999999988 9999999999999 888999999999997643
Q ss_pred cccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCc
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~ 390 (394)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|.+||...+..++.+.|..+.... + ..+++
T Consensus 191 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~-~-~~~~~ 264 (373)
T 2r5t_A 191 EHNS----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL-K-PNITN 264 (373)
T ss_dssp CCCC----CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCC-C-SSSCH
T ss_pred cCCC----ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCC-C-CCCCH
Confidence 2221 2345789999999999999999999999999999999999999999999999999998864432 2 23666
Q ss_pred ccc
Q 016152 391 ELR 393 (394)
Q Consensus 391 ~~~ 393 (394)
+++
T Consensus 265 ~~~ 267 (373)
T 2r5t_A 265 SAR 267 (373)
T ss_dssp HHH
T ss_pred HHH
Confidence 554
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=327.15 Aligned_cols=232 Identities=36% Similarity=0.603 Sum_probs=190.7
Q ss_pred CCCcCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
....+|++.+.||+|+||.||+|.++|+.+|||++..... .....+.+.+|+.++++++||||+++++++.+...+++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3445899999999999999999999999999998865543 344557789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 234 TEYLRGGDLHKYLKEKGA---LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~---~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
|||+++++|.+++...+. +++..+..++.|++.||.|||+++++|+||||||+|||+ +.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll--~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE--CTTCCEEECCCC------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE--eCCCcEEECCCCCCcccc
Confidence 999999999999986543 999999999999999999999976569999999999999 888899999999997544
Q ss_pred cccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRPFFRAKGFT 389 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~-~g~~p~~~~~~~~ 389 (394)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+. ...++.++ ..+|
T Consensus 191 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~ 265 (309)
T 3p86_A 191 STFL----SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP-RNLN 265 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC-TTSC
T ss_pred cccc----ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-ccCC
Confidence 3211 2334679999999999999999999999999999999999999999999888888776 34444444 4577
Q ss_pred cccc
Q 016152 390 PELR 393 (394)
Q Consensus 390 ~~~~ 393 (394)
++++
T Consensus 266 ~~l~ 269 (309)
T 3p86_A 266 PQVA 269 (309)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7664
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=335.62 Aligned_cols=230 Identities=29% Similarity=0.461 Sum_probs=195.2
Q ss_pred CCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCee
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~ 230 (394)
....+|++.+.||+|+||.||+|.++ |+.||||.+.+...........+..|..+++.+ +||||+++++++.+...+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34458999999999999999999985 778999998653211111235567888888876 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
++||||++||+|.+++...+.+++..+..++.|++.||+|||++| |+||||||+|||+ +.++.+||+|||++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILL--DKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEE--CCCCCEEEeEChhhhhcc
Confidence 999999999999999998888999999999999999999999988 9999999999999 888999999999997543
Q ss_pred cccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCc
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~ 390 (394)
.... .....+||+.|+|||++.+..++.++|+|||||++|||++|++||.+.+..++.+.|..+.+. ++ ..+|+
T Consensus 170 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s~ 243 (345)
T 1xjd_A 170 LGDA----KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF-YP-RWLEK 243 (345)
T ss_dssp CTTC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CC-TTSCH
T ss_pred cCCC----cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC-CC-cccCH
Confidence 2221 234578999999999999999999999999999999999999999999999999999876543 33 23666
Q ss_pred ccc
Q 016152 391 ELR 393 (394)
Q Consensus 391 ~~~ 393 (394)
+++
T Consensus 244 ~~~ 246 (345)
T 1xjd_A 244 EAK 246 (345)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=330.92 Aligned_cols=224 Identities=28% Similarity=0.527 Sum_probs=195.1
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||++... |+.+|+|++.+.........+.+.+|..+++.++||||+++++++.+...+++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 47999999999999999999874 7899999986432111122356778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||++|++|.+++...+.+++..+..++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++......
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILL--DKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CTTSCEEECCCSSCEECSSC--
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEE--cCCCCEEEeecCcceecCCc--
Confidence 99999999999998888999999999999999999999988 9999999999999 88899999999999865422
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
....+||+.|+|||++.+..++.++|+|||||++|||++|++||...+..+..+.|..+..+. + ..++++++
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-p-~~~~~~~~ 231 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF-P-PFFNEDVK 231 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC-C-TTSCHHHH
T ss_pred -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-C-CCCCHHHH
Confidence 234679999999999999999999999999999999999999999999999999998875433 2 23566554
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=325.91 Aligned_cols=230 Identities=30% Similarity=0.480 Sum_probs=195.7
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|.+. +..+|+|.+...........+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 37999999999999999999874 7889999987766666677788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++++|.+++...+++++.++..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++........
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILI--DSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCSSSTTC-----
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEEeCCCccccccccc
Confidence 99999999999998889999999999999999999999988 9999999999999 8888999999999987653321
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC---CCCCcc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA---KGFTPE 391 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~---~~~~~~ 391 (394)
.......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+.......+..|.+.. ..+|++
T Consensus 167 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 167 ---TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred ---cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 12234579999999999999999999999999999999999999999998888777777666665422 345655
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 244 l~ 245 (294)
T 4eqm_A 244 LS 245 (294)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=335.03 Aligned_cols=228 Identities=29% Similarity=0.457 Sum_probs=195.8
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~l 232 (394)
..+|++.+.||+|+||.||+|... ++.||||++.+.........+.+..|..++..+ +||+|+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 348999999999999999999986 568999998653211112235677899999887 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||||++||+|.+++...+.+++..++.++.|++.||+|||++| |+||||||+|||+ +.++.+||+|||++......
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEE--cCCCcEEEEeCCcccccccC
Confidence 9999999999999998888999999999999999999999988 9999999999999 88899999999999754322
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|++||...+..++.+.|..+..+. + ..+|+++
T Consensus 175 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~-p-~~~s~~~ 248 (353)
T 2i0e_A 175 GV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-P-KSMSKEA 248 (353)
T ss_dssp TC----CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-C-TTSCHHH
T ss_pred Cc----ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC-C-CCCCHHH
Confidence 21 2345789999999999999999999999999999999999999999999999999998875443 3 2466665
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 249 ~ 249 (353)
T 2i0e_A 249 V 249 (353)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=329.16 Aligned_cols=227 Identities=26% Similarity=0.431 Sum_probs=194.5
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv 233 (394)
.+|++.+.||+|+||.||++..+ ++.+|+|++.+.........+.+.+|..+++++ +||||+++++++.+...+++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 47999999999999999999985 778999999876655566667788999999987 899999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|||+++|+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++.......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCGGGCBCSCCTT
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEE--CCCCCEEEEeccccccccCCC
Confidence 999999999999998888999999999999999999999988 9999999999999 888999999999997543222
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCC---------CCHHHHHHHHHcCCCCCCC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN---------YEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~---------~~~~~~~~~i~~g~~p~~~ 384 (394)
. .....+||+.|+|||++.+..++.++|||||||++|||++|++||.. .+...+.+.|..+..+ ++
T Consensus 165 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-~p 239 (345)
T 3a8x_A 165 D----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-IP 239 (345)
T ss_dssp C----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-CC
T ss_pred C----cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-CC
Confidence 1 23456899999999999999999999999999999999999999975 3344566677665443 33
Q ss_pred CCCCCcccc
Q 016152 385 AKGFTPELR 393 (394)
Q Consensus 385 ~~~~~~~~~ 393 (394)
..+|++++
T Consensus 240 -~~~s~~~~ 247 (345)
T 3a8x_A 240 -RSLSVKAA 247 (345)
T ss_dssp -TTSCHHHH
T ss_pred -CCCCHHHH
Confidence 23565554
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=334.03 Aligned_cols=224 Identities=27% Similarity=0.477 Sum_probs=196.5
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||++.+. |+.+|||++.+.........+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 38999999999999999999985 7899999985432211122356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||++|++|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++......
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECSSC--
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEE--CCCCCEEEcccccceeccCC--
Confidence 99999999999998888999999999999999999999988 9999999999999 88899999999999865432
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
....+||+.|+|||++.+..++.++|||||||++|||++|.+||...+..++.+.|..+..+. + ..+|++++
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-p-~~~~~~~~ 266 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-P-SHFSSDLK 266 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-C-TTCCHHHH
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCC-C-CCCCHHHH
Confidence 234679999999999999999999999999999999999999999999999999999886543 3 24676654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=337.07 Aligned_cols=228 Identities=25% Similarity=0.420 Sum_probs=190.8
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~l 232 (394)
..+|++.++||+|+||.||+|..+ ++.+|+|++.+.........+.+..|..+++++ +||||+++++++.+...+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 348999999999999999999875 678999999766544444456678899999876 89999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||||++||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++......
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl--~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEE--CCCCCEEEeecceeeecccC
Confidence 9999999999999998889999999999999999999999998 9999999999999 88899999999999753322
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHHHcCCCCCC
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY---------EPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~---------~~~~~~~~i~~g~~p~~ 383 (394)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|++||... ....+.+.|..+..+ +
T Consensus 207 ~~----~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-~ 281 (396)
T 4dc2_A 207 GD----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-I 281 (396)
T ss_dssp TC----CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-C
T ss_pred CC----ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-C
Confidence 21 244678999999999999999999999999999999999999999632 234466667665443 3
Q ss_pred CCCCCCcccc
Q 016152 384 RAKGFTPELR 393 (394)
Q Consensus 384 ~~~~~~~~~~ 393 (394)
+. .+|++++
T Consensus 282 p~-~~s~~~~ 290 (396)
T 4dc2_A 282 PR-SLSVKAA 290 (396)
T ss_dssp CT-TSCHHHH
T ss_pred CC-cCCHHHH
Confidence 32 3666554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=322.37 Aligned_cols=225 Identities=28% Similarity=0.511 Sum_probs=193.6
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|.+ .++.||||.+........ +.+.+|+.+++.++||||+++++++...+.+++||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCH---HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHH---HHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 4799999999999999999986 478999999865444332 56788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++++|.+++... .+++.++..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++........
T Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSTTC
T ss_pred ECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEE--CCCCCEEEeeCCCceecCCccc
Confidence 999999999999765 6999999999999999999999988 9999999999999 8888999999999987654322
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~~~~~~ 393 (394)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+....+.....|.+.. ..+|++++
T Consensus 172 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 172 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (297)
T ss_dssp ----CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred ----ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence 2345679999999999999999999999999999999999999999998888777776554544432 44666554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=331.71 Aligned_cols=228 Identities=27% Similarity=0.434 Sum_probs=196.8
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcH---HHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 231 (394)
..|++.+.||+|+||.||+|... |+.+|+|++.+...... ...+.+.+|+.+++.++||||+++++++.+...++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 46999999999999999999985 78999999876543211 12367889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC----cEEEeecCCcc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSK 307 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~----~~kl~DFg~a~ 307 (394)
+||||++|++|.+++...+.+++..+..++.||+.||.|||++| |+||||||+|||+ ...+ .+||+|||++.
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIML--LDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SCTTSSSCCEEECCCSSCE
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--eCCCCCccCEEEEecCCce
Confidence 99999999999999988888999999999999999999999988 9999999999999 5444 79999999998
Q ss_pred ccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-- 385 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-- 385 (394)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....|..+..++...
T Consensus 168 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 168 EIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp ECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred EcCCCC-----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 765432 2345679999999999999999999999999999999999999999999999999998876554322
Q ss_pred CCCCcccc
Q 016152 386 KGFTPELR 393 (394)
Q Consensus 386 ~~~~~~~~ 393 (394)
..+|++++
T Consensus 243 ~~~s~~~~ 250 (361)
T 2yab_A 243 SQTSELAK 250 (361)
T ss_dssp TTSCHHHH
T ss_pred cCCCHHHH
Confidence 34565554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=337.72 Aligned_cols=229 Identities=26% Similarity=0.427 Sum_probs=197.5
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|... |+.+|+|.+...... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 6899999999999999999874 788999988765433 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+.||+|.+.+..++.+++..+..++.||+.||.|||++| |+||||||+|||+... .++.+||+|||++........
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 9999999999999889999999999999999999999988 9999999999999432 467899999999976653321
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~~ 392 (394)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....|..+..+.... +.+|+++
T Consensus 169 ----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 169 ----AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp ----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred ----eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 2345679999999999999999999999999999999999999999999999999999876554332 4567666
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 245 ~ 245 (444)
T 3soa_A 245 K 245 (444)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=342.42 Aligned_cols=231 Identities=25% Similarity=0.419 Sum_probs=192.5
Q ss_pred CCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
...+|++.+.||+|+||.||+|.+. ++.+|+|++.+...........+.+|+.+++.++||||+++++++.+...+|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3448999999999999999999985 67899998854211000011346789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||||++||+|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++......
T Consensus 147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl--~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCTT
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeE--CCCCCEEEeccceeEeeccC
Confidence 9999999999999875 46999999999999999999999988 9999999999999 88899999999999866533
Q ss_pred cccccccccCCccCccccCccccCCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--CCCCCCC
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRK----YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH--RPFFRAK 386 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~--~p~~~~~ 386 (394)
.. ......+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+....|..+. .+.....
T Consensus 222 ~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 298 (410)
T 3v8s_A 222 GM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298 (410)
T ss_dssp SE---EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTC
T ss_pred Cc---ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcc
Confidence 21 1234678999999999997655 7899999999999999999999999999999999998653 2222223
Q ss_pred CCCcccc
Q 016152 387 GFTPELR 393 (394)
Q Consensus 387 ~~~~~~~ 393 (394)
.+|++++
T Consensus 299 ~~s~~~~ 305 (410)
T 3v8s_A 299 DISKEAK 305 (410)
T ss_dssp CCCHHHH
T ss_pred cccHHHH
Confidence 5777664
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=345.26 Aligned_cols=217 Identities=25% Similarity=0.417 Sum_probs=186.9
Q ss_pred CCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeE
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 231 (394)
....+|++.++||+|+||.||++... ++.+|+|++.+...........+.+|..++..++||||+++++++.+.+.++
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 34458999999999999999999985 6789999885421111111133778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 232 LITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
+||||+++|+|.+++.+ .+.+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl--~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILM--DMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECC
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeE--cCCCCEEEcchhhhhhcc
Confidence 99999999999999987 568999999999999999999999988 9999999999999 888999999999997665
Q ss_pred cccccccccccCCccCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
.... ......+||+.|+|||++. ...++.++|||||||++|||++|++||.+.+..+.+..|..
T Consensus 227 ~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 295 (437)
T 4aw2_A 227 EDGT---VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295 (437)
T ss_dssp TTSC---EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred cCCC---cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhh
Confidence 3322 1234468999999999986 56789999999999999999999999999999999988875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=328.98 Aligned_cols=228 Identities=28% Similarity=0.482 Sum_probs=197.2
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|.+. +..+|+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 6899999999999999999875 789999998765443 3445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+.+++|.+++..++.+++.++..++.||+.||.|||+++ |+||||||+|||+..+ ..+.+||+|||++.......
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~- 185 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 185 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-
Confidence 9999999999988888999999999999999999999988 9999999999999432 23569999999998765332
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~~ 392 (394)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+....|..+..+.... ..+|+++
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 186 ----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp ----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred ----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 2345679999999999999999999999999999999999999999999999999998876544322 3456665
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 262 ~ 262 (362)
T 2bdw_A 262 K 262 (362)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=332.66 Aligned_cols=227 Identities=26% Similarity=0.451 Sum_probs=189.9
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
..+|++.+.||+|+||.||++... ++.+|+|++.+.........+.+.+|+.+++.++||||+++++++.+...+++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 348999999999999999999875 678999988543221222246788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|||+.||+|.+++...+.+++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++..+....
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILL--DEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEE--CCCCCEEEeccceeeeccCCC
Confidence 999999999999998888999999999999999999999988 9999999999999 888999999999998765332
Q ss_pred ccccccccCCccCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHcCCCCCCCCCC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLAN---YEPYEAAKYVAEGHRPFFRAKG 387 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~~g~~Pf~~---~~~~~~~~~i~~g~~p~~~~~~ 387 (394)
.....+||+.|+|||++.. ..++.++|||||||++|||++|+.||.. .+..+....+.....+. + ..
T Consensus 170 -----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-p-~~ 242 (384)
T 4fr4_A 170 -----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY-P-SA 242 (384)
T ss_dssp -----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCC-C-TT
T ss_pred -----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCC-C-Cc
Confidence 2345789999999999864 4589999999999999999999999974 34556666666544333 2 23
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
+|++++
T Consensus 243 ~s~~~~ 248 (384)
T 4fr4_A 243 WSQEMV 248 (384)
T ss_dssp SCHHHH
T ss_pred CCHHHH
Confidence 555543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=324.21 Aligned_cols=227 Identities=29% Similarity=0.470 Sum_probs=186.2
Q ss_pred cCccccceeecCCceEEEEEEE-----CCccEEEEEeccCCCC-cHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~-----~g~~~avK~l~~~~~~-~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
.+|++.+.||+|+||.||++.. .++.+|+|++.+.... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4799999999999999999986 4778999998764322 122335677899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
++||||+++++|.+++...+.+++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill--~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIML--NHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEE--CTTSCEEECCCSCC----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEE--CCCCcEEEEeCCcccccc
Confidence 999999999999999998888999999999999999999999988 9999999999999 888999999999987543
Q ss_pred cccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCc
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~ 390 (394)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+..+.|.++..+.. ..+++
T Consensus 173 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p--~~~~~ 246 (327)
T 3a62_A 173 HDGT----VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--PYLTQ 246 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC--TTSCH
T ss_pred cCCc----cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCH
Confidence 2221 23356799999999999999999999999999999999999999999999999999887654432 23566
Q ss_pred ccc
Q 016152 391 ELR 393 (394)
Q Consensus 391 ~~~ 393 (394)
+++
T Consensus 247 ~~~ 249 (327)
T 3a62_A 247 EAR 249 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=340.43 Aligned_cols=231 Identities=26% Similarity=0.423 Sum_probs=192.4
Q ss_pred CCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
...+|++.+.||+|+||.||++..+ |+.||||++.+.........+.+.+|..++..++||||+++++++.+.+.+|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3448999999999999999999984 88999999854221111122347789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 233 ITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
||||++||+|.+++.+.+ .+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl--d~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILL--DRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeee--cCCCCEEEeechhheeccC
Confidence 999999999999998754 7999999999999999999999988 9999999999999 8889999999999987654
Q ss_pred ccccccccccCCccCccccCccccC-------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----C
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFK-------HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGH----R 380 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~----~ 380 (394)
... ......+||+.|+|||++. ...++.++|||||||++|||++|++||...+..+.+..|..+. .
T Consensus 215 ~~~---~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 215 DGT---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp TSC---EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred CCc---cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC
Confidence 321 1223468999999999986 4578999999999999999999999999999999998887532 2
Q ss_pred CCCCCCCCCcccc
Q 016152 381 PFFRAKGFTPELR 393 (394)
Q Consensus 381 p~~~~~~~~~~~~ 393 (394)
|.. ...+|++++
T Consensus 292 p~~-~~~~s~~~~ 303 (412)
T 2vd5_A 292 PLV-DEGVPEEAR 303 (412)
T ss_dssp C-----CCCHHHH
T ss_pred Ccc-ccCCCHHHH
Confidence 222 245777665
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=322.68 Aligned_cols=233 Identities=32% Similarity=0.527 Sum_probs=196.7
Q ss_pred CCCCcCccccceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC
Q 016152 153 DPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (394)
Q Consensus 153 ~~~~~~~~~~~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 227 (394)
+....+|++.+.||+|+||.||+|.+. +..||||.+.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 344558999999999999999999874 3459999886432 344457789999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCc
Q 016152 228 KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a 306 (394)
...++||||+++++|.+++... +.+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLV--DSNLVCKVSDFGLS 198 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCSSC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEE--CCCCCEEECCCCcc
Confidence 9999999999999999999754 57999999999999999999999988 9999999999999 88899999999999
Q ss_pred cccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~ 385 (394)
......... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||...+..++...+..+.++..+.
T Consensus 199 ~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (325)
T 3kul_A 199 RVLEDDPDA-AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPM 277 (325)
T ss_dssp EECC----C-CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred cccccCccc-eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCC
Confidence 876543221 112334456889999999998899999999999999999999 999999999999999999887766553
Q ss_pred CCCCcccc
Q 016152 386 KGFTPELR 393 (394)
Q Consensus 386 ~~~~~~~~ 393 (394)
.+|++++
T Consensus 278 -~~~~~l~ 284 (325)
T 3kul_A 278 -GCPHALH 284 (325)
T ss_dssp -TCCHHHH
T ss_pred -CcCHHHH
Confidence 4677664
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=326.70 Aligned_cols=229 Identities=32% Similarity=0.528 Sum_probs=196.8
Q ss_pred CcCccccceeecCCceEEEEEEEC---------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVT 225 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~---------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 225 (394)
..+|++.+.||+|+||.||+|.+. +..||||.+... ......+.+.+|+.+++.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 347899999999999999999863 346999988544 2344567889999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEE
Q 016152 226 ERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL 289 (394)
Q Consensus 226 ~~~~~~lv~e~~~~~sL~~~~~~~~----------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nil 289 (394)
+.+.+++||||+++|+|.+++...+ .+++.++..++.||+.||+|||+++ |+||||||+|||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIl 235 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVL 235 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEE
Confidence 9999999999999999999998643 4789999999999999999999988 999999999999
Q ss_pred EeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCH
Q 016152 290 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEP 368 (394)
Q Consensus 290 v~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~ 368 (394)
+ +.++.+||+|||++......... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.
T Consensus 236 l--~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 236 V--TENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp E--CTTCCEEECCCSSCEETTCCCTT--CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred E--CCCCCEEEccccCCcccCcccce--ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9 88899999999999866533211 12234567889999999999999999999999999999999 9999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 369 YEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 369 ~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.++...+..+.++..+. .++++++
T Consensus 312 ~~~~~~~~~~~~~~~~~-~~~~~l~ 335 (370)
T 2psq_A 312 EELFKLLKEGHRMDKPA-NCTNELY 335 (370)
T ss_dssp GGHHHHHHTTCCCCCCT-TSCHHHH
T ss_pred HHHHHHHhcCCCCCCCC-CCCHHHH
Confidence 89999999988877764 4676654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=322.10 Aligned_cols=226 Identities=19% Similarity=0.335 Sum_probs=194.3
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||++.+. +..+|+|.+... ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 37999999999999999999985 778999987533 223356789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
||+++++|.+++... ..+++.++..++.|++.||.|||++| |+||||||+|||+....++.+||+|||++..+....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 999999999999765 46999999999999999999999988 999999999999943337899999999998765432
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCcc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPE 391 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~ 391 (394)
......||+.|+|||++.+..++.++||||||+++|+|++|.+||...+..+..+.+..+..+.... ..+|++
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 159 -----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp -----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred -----ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence 1234578999999999998889999999999999999999999999999999999998876654432 345655
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 234 ~~ 235 (321)
T 1tki_A 234 AM 235 (321)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=324.05 Aligned_cols=232 Identities=28% Similarity=0.487 Sum_probs=188.0
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe----e
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP----L 230 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~----~ 230 (394)
.+|++.+.||+|+||.||+|.+ .++.||||++.............+.+|+.++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 3799999999999999999996 478899999987666666667789999999999999999999999876553 4
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
++||||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++..+.
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI--SATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--ETTSCEEECCCSCC----
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEE--cCCCCEEEeeccCccccc
Confidence 999999999999999998889999999999999999999999988 9999999999999 778899999999998765
Q ss_pred cccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAKGF 388 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~--~~~~~ 388 (394)
..... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+..+..... ....+
T Consensus 168 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 168 DSGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred ccccc-cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 43221 1123345799999999999999999999999999999999999999999988877766654433221 12346
Q ss_pred Ccccc
Q 016152 389 TPELR 393 (394)
Q Consensus 389 ~~~~~ 393 (394)
|++++
T Consensus 247 ~~~l~ 251 (311)
T 3ork_A 247 SADLD 251 (311)
T ss_dssp CHHHH
T ss_pred CHHHH
Confidence 66553
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=339.05 Aligned_cols=228 Identities=26% Similarity=0.441 Sum_probs=187.3
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
..+|++.+.||+|+||.||+|... |+.||||++.............+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 347999999999999999999874 789999998654322333346677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|||+++++|.+++...+.+++..+..++.|++.||+|||+ +| |+||||||+|||+ +.++.+||+|||++......
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLML--DKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEE--CSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEE--CCCCCEEEccCCCceeccCC
Confidence 9999999999999988899999999999999999999998 88 9999999999999 88889999999999754332
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.+.|..+..+.. ..+++++
T Consensus 303 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~ 376 (446)
T 4ejn_A 303 GA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RTLGPEA 376 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHH
T ss_pred Cc----ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC--ccCCHHH
Confidence 21 23457899999999999999999999999999999999999999999999999999887654432 2366665
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 377 ~ 377 (446)
T 4ejn_A 377 K 377 (446)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=319.96 Aligned_cols=227 Identities=27% Similarity=0.452 Sum_probs=193.8
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCc---HHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD---RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 231 (394)
.+|++.+.||+|+||.||+|... |+.+|+|.+....... ....+.+.+|+.+++.++||||+++++++.+...++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 36899999999999999999985 7899999986643321 112367889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC----cEEEeecCCcc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSK 307 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~----~~kl~DFg~a~ 307 (394)
+||||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++ .+||+|||++.
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll--~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIML--LDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--SCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEE--ecCCCCCCCEEEEECCCCe
Confidence 99999999999999988888999999999999999999999988 9999999999999 5555 79999999998
Q ss_pred ccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-- 385 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-- 385 (394)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|.+||.+.+..+....+..+..+....
T Consensus 167 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (326)
T 2y0a_A 167 KIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241 (326)
T ss_dssp ECCTTS-----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred ECCCCC-----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence 765332 1234679999999999999999999999999999999999999999999888888887665443321
Q ss_pred CCCCccc
Q 016152 386 KGFTPEL 392 (394)
Q Consensus 386 ~~~~~~~ 392 (394)
..+|+++
T Consensus 242 ~~~~~~~ 248 (326)
T 2y0a_A 242 SNTSALA 248 (326)
T ss_dssp TTSCHHH
T ss_pred ccCCHHH
Confidence 3345544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=322.28 Aligned_cols=230 Identities=31% Similarity=0.427 Sum_probs=181.4
Q ss_pred CCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 153 ~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
.....+|++.+.||+|+||.||++... ++.||||++....... +.+.+|+.+++.++||||+++++++.+...+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 344558999999999999999999984 7889999986544333 4577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
++||||+++++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+|||+..+..+.+||+|||++....
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 999999999999999988888999999999999999999999988 999999999999943334459999999987443
Q ss_pred cccccccccccCCccCccccCccccCCCCCCCc-chHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHcCCCCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKK-VDVFSFAMILYEMLEGEPPLANYEP----YEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~Pf~~~~~----~~~~~~i~~g~~p~~~~ 385 (394)
... ......||+.|+|||++.+..++.+ +|||||||++|+|++|++||...+. .+..+.+..........
T Consensus 170 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (361)
T 3uc3_A 170 LHS-----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT
T ss_pred ccC-----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc
Confidence 221 1234579999999999988887655 9999999999999999999987543 45566666655544444
Q ss_pred CCCCcccc
Q 016152 386 KGFTPELR 393 (394)
Q Consensus 386 ~~~~~~~~ 393 (394)
..+|++++
T Consensus 245 ~~~s~~~~ 252 (361)
T 3uc3_A 245 IRISPECC 252 (361)
T ss_dssp SCCCHHHH
T ss_pred CCCCHHHH
Confidence 45676654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=322.20 Aligned_cols=235 Identities=34% Similarity=0.553 Sum_probs=200.5
Q ss_pred CCcccCCCCcCccccceeecCCceEEEEEEECC---------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCce
Q 016152 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNI 217 (394)
Q Consensus 148 ~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g---------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~I 217 (394)
..|++. ..+|.+.+.||+|+||.||+|.+.+ ..+|||++... ......+.+.+|+.+++++ +||||
T Consensus 62 ~~~~i~--~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnI 137 (382)
T 3tt0_A 62 PRWELP--RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNI 137 (382)
T ss_dssp TTTBCC--GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccccc--hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchh
Confidence 344443 3489999999999999999998632 46999988654 2344557788999999999 89999
Q ss_pred eeEEeEEEeCCeeEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEec
Q 016152 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281 (394)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~----------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~ 281 (394)
+++++++...+.+++||||+++++|.+++.... .+++.+++.++.|++.||.|||+++ |+||
T Consensus 138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~ 215 (382)
T 3tt0_A 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHR 215 (382)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred hhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecC
Confidence 999999999999999999999999999998753 4899999999999999999999988 9999
Q ss_pred CCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CC
Q 016152 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GE 360 (394)
Q Consensus 282 Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~ 360 (394)
||||+|||+ +.++.+||+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 216 Dlkp~NIll--~~~~~~kL~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~ 291 (382)
T 3tt0_A 216 DLAARNVLV--TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291 (382)
T ss_dssp CCCGGGEEE--CTTCCEEECSCSCCCCSSCCCTT--CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCcceEEE--cCCCcEEEcccCccccccccccc--ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 999999999 88889999999999866533211 12334567899999999999999999999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 361 PPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 361 ~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.||...+..++.+.+..+.++..+. .++++++
T Consensus 292 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 323 (382)
T 3tt0_A 292 SPYPGVPVEELFKLLKEGHRMDKPS-NCTNELY 323 (382)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCS-SCCHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCc-cCCHHHH
Confidence 9999999999999999988877764 4677664
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=327.64 Aligned_cols=211 Identities=32% Similarity=0.524 Sum_probs=181.2
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|.+.+.||+|+||.||+|.+ .++.||+|++.............+.+|+.+++.++||||+++++++.....+++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 799999999999999999997 478999998854321111112467899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+ +|+|.+++...+.+++.++..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++.......
T Consensus 90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll--~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLL--DDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEE--CTTCCEEECCSSCTBTTTTSB--
T ss_pred CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEE--cCCCCEEEEEeccceeccCCc--
Confidence 99 6799999988889999999999999999999999988 9999999999999 888899999999998665332
Q ss_pred ccccccCCccCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g 378 (394)
.....+||+.|+|||++.+..+ ++++||||||+++|+|++|+.||...+..+..+.+..+
T Consensus 163 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~ 223 (336)
T 3h4j_B 163 ---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC 223 (336)
T ss_dssp ---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS
T ss_pred ---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC
Confidence 2345679999999999988776 78999999999999999999999876655554444443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=324.64 Aligned_cols=233 Identities=30% Similarity=0.531 Sum_probs=184.7
Q ss_pred CCCCcCccccceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC
Q 016152 153 DPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (394)
Q Consensus 153 ~~~~~~~~~~~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 227 (394)
.....+|++.+.||+|+||.||+|... +..||||.+.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 444558999999999999999999864 6679999885432 344557899999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCc
Q 016152 228 KPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a 306 (394)
..+++||||+++++|.+++...+ .+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILI--NSNLVCKVSDFGLG 194 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCC---
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEE--cCCCCEEECcCccc
Confidence 99999999999999999998754 6999999999999999999999988 9999999999999 88899999999999
Q ss_pred cccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~ 385 (394)
......... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+..++.+.+..+.++..+.
T Consensus 195 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 273 (373)
T 2qol_A 195 RVLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCT
T ss_pred cccccCCcc-ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 876543221 112223446788999999998999999999999999999998 999999999999999998876555443
Q ss_pred CCCCcccc
Q 016152 386 KGFTPELR 393 (394)
Q Consensus 386 ~~~~~~~~ 393 (394)
.+|++++
T Consensus 274 -~~~~~l~ 280 (373)
T 2qol_A 274 -DCPAALY 280 (373)
T ss_dssp -TCBHHHH
T ss_pred -cccHHHH
Confidence 3565543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=315.30 Aligned_cols=230 Identities=26% Similarity=0.392 Sum_probs=200.1
Q ss_pred CCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeE
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 231 (394)
....+|.+.+.||+|+||.||++.+. ++.+|+|++...........+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34568999999999999999999985 6789999987665555566678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
+||||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEE--cCCCCEEEeeccCceeccc
Confidence 99999999999999998888999999999999999999999988 9999999999999 8888999999999987643
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+..+.... + ..++++
T Consensus 194 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~-~~~~~~ 267 (335)
T 2owb_A 194 DGE----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI-P-KHINPV 267 (335)
T ss_dssp TTC----CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-C-TTSCHH
T ss_pred Ccc----cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCC-C-ccCCHH
Confidence 321 2334679999999999998899999999999999999999999999998888888887765432 2 235655
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 268 ~~ 269 (335)
T 2owb_A 268 AA 269 (335)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=349.69 Aligned_cols=229 Identities=29% Similarity=0.451 Sum_probs=196.1
Q ss_pred CCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~ 231 (394)
...+|++.+.||+|+||.||+|.+. ++.||||++.+.........+.+..|..++..+ +||+|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3447999999999999999999985 667999998643211111235677889999887 6999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
+||||++||+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl--~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEE--CSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEE--cCCCcEEEeecceeecccc
Confidence 99999999999999998889999999999999999999999988 9999999999999 8889999999999985432
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..++.+.|.++..++. +.+|++
T Consensus 495 ~~~----~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~ 568 (674)
T 3pfq_A 495 DGV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--KSMSKE 568 (674)
T ss_dssp TTC----CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC--TTSCHH
T ss_pred CCc----ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC--ccCCHH
Confidence 221 23467899999999999999999999999999999999999999999999999999998765433 236666
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 569 ~~ 570 (674)
T 3pfq_A 569 AV 570 (674)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=322.77 Aligned_cols=227 Identities=22% Similarity=0.434 Sum_probs=193.7
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|... ++.+|+|++.... ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 37999999999999999999875 7789999885432 233457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
||+++++|.+++...+ .+++.++..++.||+.||.|||++| |+||||||+|||+..+..+.+||+|||++.......
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999999999997654 6999999999999999999999988 999999999999944456789999999998765332
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCcc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPE 391 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~ 391 (394)
. .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+..+..+.... ..+|++
T Consensus 206 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 206 I-----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp C-----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred c-----eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 1 233579999999999999999999999999999999999999999999888888888765443322 346666
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 281 ~~ 282 (387)
T 1kob_A 281 AK 282 (387)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=318.56 Aligned_cols=223 Identities=34% Similarity=0.504 Sum_probs=196.8
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|...+.||+|+||.||+|.. .++.||||.+...........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 588899999999999999986 478899999876655555566788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+. |+|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEE--ETTTEEEECCCTTCBSSSSB--
T ss_pred cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--CCCCCEEEeeccCceecCCC--
Confidence 997 588888764 567999999999999999999999988 9999999999999 78889999999999765422
Q ss_pred cccccccCCccCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
....||+.|+|||++. ...++.++|||||||++|||++|++||...+..+....+.++..|.+....+|++
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 281 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2457999999999984 5678999999999999999999999999999888888888888888777778877
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 282 l~ 283 (348)
T 1u5q_A 282 FR 283 (348)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=335.26 Aligned_cols=225 Identities=29% Similarity=0.501 Sum_probs=194.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|.+++.||+|+||.||+|.+. |+.||||++.............+.+|+.+++.++||||+++++++.....+++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 7999999999999999999975 88999999854321111223578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++++|.+++.+++.+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++.......
T Consensus 97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll--~~~~~vkL~DFG~a~~~~~~~-- 170 (476)
T 2y94_A 97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLL--DAHMNAKIADFGLSNMMSDGE-- 170 (476)
T ss_dssp CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEE--CTTCCEEECCCSSCEECCTTC--
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEE--ecCCCeEEEeccchhhccccc--
Confidence 9999999999988888999999999999999999999988 9999999999999 888899999999998765332
Q ss_pred ccccccCCccCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..+..+.|..+..+.. ..++++++
T Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~ 244 (476)
T 2y94_A 171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP--QYLNPSVI 244 (476)
T ss_dssp ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC--TTCCHHHH
T ss_pred ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC--ccCCHHHH
Confidence 2345689999999999988765 6899999999999999999999999988899999988765432 23566554
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=313.70 Aligned_cols=224 Identities=28% Similarity=0.466 Sum_probs=194.3
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|...+.||+|+||.||+|... |+.||||++....... .+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 3667779999999999999874 8899999986544332 3567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++++|.+++.. ..+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++........
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~~- 196 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILL--TLDGRVKLSDFGFCAQISKDVP- 196 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSSSC-
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCcEEEeeeeeeeecccCcc-
Confidence 9999999998864 46999999999999999999999988 9999999999999 8888999999999986653321
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~~~~~~ 393 (394)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+....+..+.+|.+.. ..+|++++
T Consensus 197 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 272 (321)
T 2c30_A 197 ---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLR 272 (321)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHH
T ss_pred ---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHH
Confidence 2235679999999999999999999999999999999999999999999999999988887776554 34566554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=336.37 Aligned_cols=229 Identities=29% Similarity=0.461 Sum_probs=193.2
Q ss_pred CCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
...+|.+.+.||+|+||.||+|... |+.||+|++.+.........+.+.+|+.++++++||||+++++++.+...+|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3458999999999999999999984 78999999865322211223567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 233 ITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
||||++||+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl--~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLL--DDDGNVRISDLGLAVE 338 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCCTTCEE
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEE--eCCCCEEEeecceeee
Confidence 99999999999999763 36999999999999999999999988 9999999999999 8889999999999987
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY----EPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~----~~~~~~~~i~~g~~p~~~ 384 (394)
+..... .....+||+.|+|||++.+..++.++|||||||++|||++|++||... +..++.+.|..+..+. +
T Consensus 339 ~~~~~~----~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~-p 413 (543)
T 3c4z_A 339 LKAGQT----KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY-P 413 (543)
T ss_dssp CCTTCC----CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC-C
T ss_pred ccCCCc----ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC-C
Confidence 654321 123468999999999999999999999999999999999999999765 4567778887764433 3
Q ss_pred CCCCCcccc
Q 016152 385 AKGFTPELR 393 (394)
Q Consensus 385 ~~~~~~~~~ 393 (394)
..+|++++
T Consensus 414 -~~~s~~~~ 421 (543)
T 3c4z_A 414 -DKFSPASK 421 (543)
T ss_dssp -TTSCHHHH
T ss_pred -cccCHHHH
Confidence 34666654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=308.48 Aligned_cols=225 Identities=32% Similarity=0.600 Sum_probs=195.0
Q ss_pred cCccccceeecCCceEEEEEEE-CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW-RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~-~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.+|++.+.||+|+||.||++.+ .+..+|+|.+....... +.+.+|+.++++++||||+++++++.+....++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 4789999999999999999998 57789999986544322 568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++++|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CGGGCEEECCTTGGGGBCCHHH
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEE--cCCCCEEecccccccccccccc
Confidence 99999999999754 46899999999999999999999988 9999999999999 7778999999999986643321
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.......+|+.|+|||.+.+..++.++||||||+++|+|++ |++||...+..+....+..+.++..+. .+|++++
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 237 (269)
T 4hcu_A 162 ---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR-LASTHVY 237 (269)
T ss_dssp ---HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT-TSCHHHH
T ss_pred ---ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCC-cCCHHHH
Confidence 12334567889999999998899999999999999999999 999999999999999999887776653 3566553
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=329.18 Aligned_cols=226 Identities=33% Similarity=0.607 Sum_probs=195.3
Q ss_pred CcccCCCCcCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 149 ~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
.|++. ..+|++.+.||+|+||.||++.++++.||||.+.... ..+.+.+|+.++++++||||+++++++....
T Consensus 187 ~~~i~--~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 187 GWALN--MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp TCBCC--GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred ccccC--hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 35444 3478899999999999999999999999999986543 2367889999999999999999999987665
Q ss_pred -eeEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 229 -PLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 229 -~~~lv~e~~~~~sL~~~~~~~~~--~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
.+++||||+++|+|.+++...+. +++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~DfG~ 335 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFGL 335 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTSCEEECCCTT
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEE--CCCCCEEEeeCCC
Confidence 79999999999999999987653 799999999999999999999988 9999999999999 8888999999999
Q ss_pred ccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCC
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~ 384 (394)
+...... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+..++...+.+|.++..+
T Consensus 336 a~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p 408 (450)
T 1k9a_A 336 TKEASST-------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 408 (450)
T ss_dssp CEECC-------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCC
T ss_pred ccccccc-------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9754321 122357889999999999999999999999999999998 99999999988999999999887776
Q ss_pred CCCCCcccc
Q 016152 385 AKGFTPELR 393 (394)
Q Consensus 385 ~~~~~~~~~ 393 (394)
. .+|++++
T Consensus 409 ~-~~~~~l~ 416 (450)
T 1k9a_A 409 D-GCPPAVY 416 (450)
T ss_dssp T-TCCHHHH
T ss_pred C-cCCHHHH
Confidence 4 4777764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=319.01 Aligned_cols=223 Identities=26% Similarity=0.447 Sum_probs=186.4
Q ss_pred ccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccC
Q 016152 161 SSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238 (394)
Q Consensus 161 ~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 238 (394)
..+.||+|+||.||+|... |..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+.+++||||++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 3668999999999999874 7899999886532 2344678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccc
Q 016152 239 GGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317 (394)
Q Consensus 239 ~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~ 317 (394)
+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+..+..+.+||+|||++..+....
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---- 243 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---- 243 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC----
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc----
Confidence 99999988754 46999999999999999999999988 999999999999976677899999999998765432
Q ss_pred ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCcccc
Q 016152 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELR 393 (394)
Q Consensus 318 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~~~ 393 (394)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....|..+..+.... ..+|++++
T Consensus 244 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 320 (373)
T 2x4f_A 244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320 (373)
T ss_dssp -BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHH
T ss_pred -ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHH
Confidence 1234579999999999999999999999999999999999999999999999998888765443322 34666654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=328.62 Aligned_cols=231 Identities=29% Similarity=0.521 Sum_probs=196.9
Q ss_pred CCcccCCCCcCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe
Q 016152 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226 (394)
Q Consensus 148 ~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 226 (394)
..|++. ..+|++.+.||+|+||.||+|.++ +..||||.+...... .+.+.+|+.++++++||||+++++++.
T Consensus 181 ~~~~i~--~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~- 253 (454)
T 1qcf_A 181 DAWEIP--RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT- 253 (454)
T ss_dssp TCSBCC--GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred cceeec--hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence 456554 347889999999999999999986 678999998654322 367889999999999999999999886
Q ss_pred CCeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecC
Q 016152 227 RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg 304 (394)
.+.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~DFG 329 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILV--SASLVCKIADFG 329 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEE--CTTCCEEECSTT
T ss_pred CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEE--CCCCcEEEeeCC
Confidence 66789999999999999999753 36899999999999999999999988 9999999999999 888899999999
Q ss_pred CccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCC
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~ 383 (394)
+++....... .......+|+.|+|||++....++.++||||||+++|||++ |+.||.+.+..++...+..+.++..
T Consensus 330 ~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 406 (454)
T 1qcf_A 330 LARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 406 (454)
T ss_dssp GGGGBCCHHH---HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC
T ss_pred CceEcCCCce---eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9987643221 11233457889999999998899999999999999999999 9999999999999999998877666
Q ss_pred CCCCCCcccc
Q 016152 384 RAKGFTPELR 393 (394)
Q Consensus 384 ~~~~~~~~~~ 393 (394)
+ ..+|++++
T Consensus 407 ~-~~~~~~l~ 415 (454)
T 1qcf_A 407 P-ENCPEELY 415 (454)
T ss_dssp C-TTSCHHHH
T ss_pred C-CCCCHHHH
Confidence 5 34777664
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=317.62 Aligned_cols=233 Identities=30% Similarity=0.490 Sum_probs=199.5
Q ss_pred cCCCCcCccccceeecCCceEEEEEEECC-------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEE
Q 016152 152 IDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224 (394)
Q Consensus 152 i~~~~~~~~~~~~iG~G~~g~V~~a~~~g-------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 224 (394)
......+|++.+.||+|+||.||+|.+.+ +.||||.+.... .....+.+.+|+.++++++||||+++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34455689999999999999999998754 679999886443 344557789999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEe
Q 016152 225 TERKPLMLITEYLRGGDLHKYLKEK------------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIH 280 (394)
Q Consensus 225 ~~~~~~~lv~e~~~~~sL~~~~~~~------------------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH 280 (394)
.+.+.+++||||+++++|.+++... ..+++.+++.++.||+.||.|||+++ |+|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH 197 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 197 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 9999999999999999999999863 56899999999999999999999988 999
Q ss_pred cCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-C
Q 016152 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-G 359 (394)
Q Consensus 281 ~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g 359 (394)
|||||+|||+ +.++.+||+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|||++ |
T Consensus 198 ~Dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 198 RDLATRNCLV--GENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp SCCSGGGEEE--CGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CCCCcceEEE--CCCCeEEEeecCCCcccccCccc--cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 9999999999 78889999999999866433211 12234568999999999998899999999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 360 EPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 360 ~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
..||...+..++...+.++..+.++. .+|++++
T Consensus 274 ~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 306 (343)
T 1luf_A 274 LQPYYGMAHEEVIYYVRDGNILACPE-NCPLELY 306 (343)
T ss_dssp CCTTTTSCHHHHHHHHHTTCCCCCCT-TCCHHHH
T ss_pred CCcCCCCChHHHHHHHhCCCcCCCCC-CCCHHHH
Confidence 99999999999999999988877664 4677664
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=305.15 Aligned_cols=227 Identities=31% Similarity=0.585 Sum_probs=196.0
Q ss_pred CCcCccccceeecCCceEEEEEEECC-ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~g-~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
...+|++.+.||+|+||.||++...+ ..+|+|.+....... +.+.+|+.++++++||||+++++++.+....++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 44589999999999999999998874 479999886544322 5688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 234 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|||+++++|.+++...+ .+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLV--DRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEE--CTTCCEEECCTTCEEECCTT
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEE--CCCCCEEEccCccceecchh
Confidence 99999999999998754 5999999999999999999999988 9999999999999 88899999999999866543
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
.. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+..+.++..+. .+|++
T Consensus 158 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 233 (268)
T 3sxs_A 158 QY---VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH-LASDT 233 (268)
T ss_dssp CE---EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT-TSCHH
T ss_pred hh---hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCC-cChHH
Confidence 21 12234557888999999998889999999999999999999 999999999999999998887766654 35665
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 234 l~ 235 (268)
T 3sxs_A 234 IY 235 (268)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=321.32 Aligned_cols=229 Identities=27% Similarity=0.456 Sum_probs=187.6
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCC--CCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~--~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
+|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 6899999999999999999874 7899999885321 00011236688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCccc
Q 016152 234 TEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKL 308 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a~~ 308 (394)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+..+ ....+||+|||++..
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 9999999998887643 35899999999999999999999988 9999999999999332 234599999999987
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--C
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--K 386 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~ 386 (394)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+. ..+..+.+.++..+..+. .
T Consensus 183 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 183 LGESGL----VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp CCTTSC----BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred ecCCCe----eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence 654321 233567999999999999999999999999999999999999999875 457777777776554432 3
Q ss_pred CCCcccc
Q 016152 387 GFTPELR 393 (394)
Q Consensus 387 ~~~~~~~ 393 (394)
.+|++++
T Consensus 258 ~~s~~~~ 264 (351)
T 3c0i_A 258 HISESAK 264 (351)
T ss_dssp TSCHHHH
T ss_pred cCCHHHH
Confidence 4565554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=308.81 Aligned_cols=232 Identities=30% Similarity=0.575 Sum_probs=195.7
Q ss_pred CCcccCCCCcCccccceeecCCceEEEEEEECC-ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe
Q 016152 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226 (394)
Q Consensus 148 ~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g-~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 226 (394)
..|.+. ..+|++.+.||+|+||.||++.+.+ ..+|+|.+....... +.+.+|+.++++++||||+++++++.+
T Consensus 17 ~~~~~~--~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 17 GSWEID--PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CTTBCC--GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCccCC--HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 455554 4489999999999999999998874 479999886543322 568899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 227 RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
....++||||+++++|.+++.. .+.+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili--~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLV--NDQGVVKVSDFGL 166 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEE--CTTSCEEECSTTG
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEE--cCCCCEEEccccc
Confidence 9999999999999999999986 567999999999999999999999988 9999999999999 8888999999999
Q ss_pred ccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCC
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~ 384 (394)
+........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+..+.+.++.++..+
T Consensus 167 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T 3gen_A 167 SRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 243 (283)
T ss_dssp GGGBCCHHH---HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred ccccccccc---ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC
Confidence 986643321 12234557889999999998899999999999999999998 99999999999999999988776665
Q ss_pred CCCCCcccc
Q 016152 385 AKGFTPELR 393 (394)
Q Consensus 385 ~~~~~~~~~ 393 (394)
. .++++++
T Consensus 244 ~-~~~~~l~ 251 (283)
T 3gen_A 244 H-LASEKVY 251 (283)
T ss_dssp T-TCCHHHH
T ss_pred C-cCCHHHH
Confidence 3 3565553
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=336.96 Aligned_cols=229 Identities=30% Similarity=0.494 Sum_probs=192.1
Q ss_pred CCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeE
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 231 (394)
....+|++.+.||+|+||.||+|... |+.||||.+.+...........+.+|+.+++.++||||+++++++.+.+.++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34457999999999999999999984 8899999985432111112356788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 232 LITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
+||||++||+|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILl--d~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILL--DDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEE--eCCCCeEEEecccceec
Confidence 9999999999999998754 3999999999999999999999988 9999999999999 88899999999999876
Q ss_pred ccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY----EPYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~----~~~~~~~~i~~g~~p~~~~ 385 (394)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|++||... ...++.+.+.... +.++
T Consensus 337 ~~~~-----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~-~~~p- 409 (576)
T 2acx_A 337 PEGQ-----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP-EEYS- 409 (576)
T ss_dssp CTTC-----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC-CCCC-
T ss_pred ccCc-----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc-ccCC-
Confidence 5332 123468999999999999999999999999999999999999999875 3456667776543 3333
Q ss_pred CCCCcccc
Q 016152 386 KGFTPELR 393 (394)
Q Consensus 386 ~~~~~~~~ 393 (394)
..+|++++
T Consensus 410 ~~~s~~~~ 417 (576)
T 2acx_A 410 ERFSPQAR 417 (576)
T ss_dssp TTSCHHHH
T ss_pred ccCCHHHH
Confidence 44676664
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=318.13 Aligned_cols=226 Identities=28% Similarity=0.462 Sum_probs=176.3
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
..+|++.+.||+|+||.||+|.+. ++.||||++.... ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 346999999999999999999985 6689999886532 125677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-CCCCcEEEeecCCccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-~~~~~~kl~DFg~a~~~~~~ 312 (394)
|||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||+.. +.++.+||+|||++......
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 999999999999988888999999999999999999999988 999999999999943 23789999999999865432
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHcCCCCCCCC--CCCC
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE-AAKYVAEGHRPFFRA--KGFT 389 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~-~~~~i~~g~~p~~~~--~~~~ 389 (394)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||......+ ..+.+..+..+.... ..+|
T Consensus 205 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 205 V-----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred c-----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 2 1234679999999999999999999999999999999999999997765444 667777765543322 3456
Q ss_pred cccc
Q 016152 390 PELR 393 (394)
Q Consensus 390 ~~~~ 393 (394)
++++
T Consensus 280 ~~~~ 283 (349)
T 2w4o_A 280 LNAK 283 (349)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5554
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=310.93 Aligned_cols=227 Identities=27% Similarity=0.460 Sum_probs=186.7
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCc-----------------------HHHHHHHHHHHHHHHhC
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD-----------------------RLVIQDFRHEVNLLVKL 212 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~-----------------------~~~~~~~~~E~~~l~~l 212 (394)
+|++.+.||+|+||.||+|... ++.||||++....... ....+.+.+|+.+++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 7999999999999999999874 7789999986543211 11235688999999999
Q ss_pred CCCceeeEEeEEEe--CCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEE
Q 016152 213 RHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 290 (394)
Q Consensus 213 ~h~~Iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv 290 (394)
+||||+++++++.+ ...+++||||+++++|.+++. .+.+++.++..++.|++.||.|||+++ |+||||||+|||+
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLV 170 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE
Confidence 99999999999986 568999999999999987653 457999999999999999999999988 9999999999999
Q ss_pred eeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCC---CCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 291 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 291 ~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
+.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+
T Consensus 171 --~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 171 --GEDGHIKIADFGVSNEFKGSDA----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp --CTTSCEEECCCTTCEECSSSSC----EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --CCCCCEEEecCCCccccccccc----cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 8888999999999987653321 223467999999999997665 3788999999999999999999999998
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 368 PYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 368 ~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
..+....+..+..+......+|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~ 270 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFPDQPDIAEDLK 270 (298)
T ss_dssp HHHHHHHHHHCCCCCCSSSCCCHHHH
T ss_pred HHHHHHHHhcccCCCCCccccCHHHH
Confidence 88888888876655544456777664
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=305.27 Aligned_cols=229 Identities=26% Similarity=0.395 Sum_probs=199.4
Q ss_pred CCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
...+|.+.+.||+|+||.||++... ++.+|+|.+...........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3457999999999999999999985 67899999876655556666788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||||+++++|.+++...+.+++.++..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEE--cCCCCEEEEeccCceecccC
Confidence 9999999999999998888999999999999999999999988 9999999999999 88889999999999876432
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+..+..+. + ..+++++
T Consensus 169 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~ 242 (294)
T 2rku_A 169 GE----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI-P-KHINPVA 242 (294)
T ss_dssp TC----CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC-C-TTSCHHH
T ss_pred cc----ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCC-c-cccCHHH
Confidence 21 2234678999999999999899999999999999999999999999998888888887765433 2 2356554
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 243 ~ 243 (294)
T 2rku_A 243 A 243 (294)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.29 Aligned_cols=235 Identities=29% Similarity=0.515 Sum_probs=198.2
Q ss_pred CCcccCCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 016152 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (394)
Q Consensus 148 ~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 225 (394)
..|.+. ..+|.+.+.||+|+||.||+|.+. ++.||||.+.... .....+.+.+|+.++++++||||+++++++.
T Consensus 107 ~~~~~~--~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 182 (377)
T 3cbl_A 107 DKWVLN--HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182 (377)
T ss_dssp CTTBCC--GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccEEc--hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 345554 347889999999999999999985 7889999876432 3344567889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecC
Q 016152 226 ERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (394)
Q Consensus 226 ~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg 304 (394)
..+.+++||||+++|+|.+++...+ .+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 183 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~--~~~~~~kl~DfG 258 (377)
T 3cbl_A 183 QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLV--TEKNVLKISDFG 258 (377)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCGG
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEE--cCCCcEEECcCC
Confidence 9999999999999999999998654 5999999999999999999999988 9999999999999 888899999999
Q ss_pred CccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCC
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~ 383 (394)
++........ ........+++.|+|||++.+..++.++||||||+++|||++ |..||...+..++.+.+..+.++..
T Consensus 259 ~s~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 336 (377)
T 3cbl_A 259 MSREEADGVY--AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC 336 (377)
T ss_dssp GCEECTTSEE--ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC
T ss_pred CceecCCCce--eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9975432211 001112335778999999998889999999999999999998 9999999999999999998887766
Q ss_pred CCCCCCcccc
Q 016152 384 RAKGFTPELR 393 (394)
Q Consensus 384 ~~~~~~~~~~ 393 (394)
+. .+|++++
T Consensus 337 ~~-~~~~~l~ 345 (377)
T 3cbl_A 337 PE-LCPDAVF 345 (377)
T ss_dssp CT-TCCHHHH
T ss_pred CC-CCCHHHH
Confidence 64 4676654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=304.43 Aligned_cols=229 Identities=28% Similarity=0.474 Sum_probs=196.1
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|.+. ++.+|+|++...... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 47999999999999999999875 778999988655433 344577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a~~~~~~~ 313 (394)
||+++++|.+.+...+.+++..+..++.|++.||.|||+++ |+||||||+||++..+ ..+.+||+|||++.......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 99999999999988888999999999999999999999988 9999999999999322 22459999999997665332
Q ss_pred ccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCcc
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPE 391 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~ 391 (394)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+..+....... ..+|++
T Consensus 163 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T 3kk8_A 163 -----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237 (284)
T ss_dssp -----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred -----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHH
Confidence 2334679999999999999999999999999999999999999999999999999888765443322 356666
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 238 ~~ 239 (284)
T 3kk8_A 238 AK 239 (284)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=318.19 Aligned_cols=223 Identities=27% Similarity=0.515 Sum_probs=188.9
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
+|++.+.||+|+||.||++.++ ++.+|||++.+.... ..+|+.++.++ +||||+++++++.+...+++||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 6899999999999999999985 778999998665433 23577788777 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCC--CcEEEeecCCccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA--DHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~--~~~kl~DFg~a~~~~~~ 312 (394)
||++||+|.+++...+.+++..+..++.||+.||.|||++| |+||||||+|||+.+... +.+||+|||++......
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99999999999998888999999999999999999999988 999999999999843222 35999999999876543
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHcCCCCCCCC--CC
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN---YEPYEAAKYVAEGHRPFFRA--KG 387 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~---~~~~~~~~~i~~g~~p~~~~--~~ 387 (394)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|.+||.. .+..++...|..+..+.... ..
T Consensus 174 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 174 NG----LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp TC----CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred CC----ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 22 23456799999999999888899999999999999999999999975 46778888998887665432 34
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
+|++++
T Consensus 250 ~s~~~~ 255 (342)
T 2qr7_A 250 VSDTAK 255 (342)
T ss_dssp SCHHHH
T ss_pred CCHHHH
Confidence 666654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=307.96 Aligned_cols=225 Identities=31% Similarity=0.500 Sum_probs=190.7
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|.+. +..+|+|++.............+.+|+.++++++||||+++++++.+....++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 38999999999999999999875 5679999885432222222456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+||++ +.++.++|+|||++.......
T Consensus 89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili--~~~~~~~l~Dfg~~~~~~~~~- 163 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL--GSAGELKIADFGWSVHAPSSR- 163 (279)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEE--CTTSCEEECSCCEESCC-----
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEE--cCCCCEEEEeccccccCCccc-
Confidence 99999999999998888999999999999999999999988 9999999999999 888999999999986544321
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+..+.+.....+.. ..++++++
T Consensus 164 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 235 (279)
T 3fdn_A 164 -----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGAR 235 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--TTSCHHHH
T ss_pred -----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC--CcCCHHHH
Confidence 2345789999999999999999999999999999999999999999999888888887654433 23555543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=317.47 Aligned_cols=204 Identities=31% Similarity=0.528 Sum_probs=175.9
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|.+. ++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 47999999999999999999875 788999988544322 22356789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++++|.+++.....+++.++..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEECEETTE
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEE--eCCCCEEEEEeeccceeccCCc
Confidence 99999999999988778999999999999999999999988 9999999999999 8888999999999987653322
Q ss_pred cccccccCCccCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCH
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEP 368 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~Pf~~~~~ 368 (394)
. .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+.
T Consensus 161 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 161 E--RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp E--CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred c--cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 1 12345689999999999987765 7899999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=321.02 Aligned_cols=231 Identities=28% Similarity=0.433 Sum_probs=194.2
Q ss_pred CcCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
..+|++.+.||+|+||.||+|.+. +..||||.+.... .......+.+|+.++++++||||+++++++.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 447899999999999999999853 4579999885432 3344467889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEE
Q 016152 229 PLMLITEYLRGGDLHKYLKEK-------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKV 300 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl 300 (394)
..++||||+++|+|.+++... ..+++.+++.++.|++.||.|||++| |+||||||+|||+..+ ....+||
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999999864 34899999999999999999999988 9999999999999221 3345999
Q ss_pred eecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC
Q 016152 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH 379 (394)
Q Consensus 301 ~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~ 379 (394)
+|||++..+...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...+..++.+.+..+.
T Consensus 226 ~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 226 GDFGMARDIYRAGYY--RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp CCCHHHHHHHHHSSC--TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred CCCcccccccccccc--ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999865433211 12234567999999999998999999999999999999998 999999999999999999888
Q ss_pred CCCCCCCCCCcccc
Q 016152 380 RPFFRAKGFTPELR 393 (394)
Q Consensus 380 ~p~~~~~~~~~~~~ 393 (394)
++..+. .+|++++
T Consensus 304 ~~~~~~-~~~~~l~ 316 (367)
T 3l9p_A 304 RMDPPK-NCPGPVY 316 (367)
T ss_dssp CCCCCT-TCCHHHH
T ss_pred CCCCCc-cCCHHHH
Confidence 776654 4676654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=304.16 Aligned_cols=225 Identities=28% Similarity=0.499 Sum_probs=194.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|.+. +..+|+|.+....... .+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 6899999999999999999986 5578999886654433 3678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-CCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+||++.. +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~- 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence 9999999999998888999999999999999999999988 999999999999943 356789999999998765332
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~~ 392 (394)
......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||...+..+....+.++..+.... ..+|+++
T Consensus 164 ----~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 164 ----MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238 (277)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred ----chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence 23446799999999998754 8999999999999999999999999999999999998876654432 2456655
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 239 ~ 239 (277)
T 3f3z_A 239 E 239 (277)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=305.41 Aligned_cols=231 Identities=35% Similarity=0.612 Sum_probs=183.3
Q ss_pred CcCccccceeecCCceEEEEEEECCccEEEEEeccCCCCc-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~-~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
..+|++.+.||+|+||.||+|.+.++.+|||++....... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 4479999999999999999999999999999886543322 233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeEecCCCCCCEEEeeC------CCCcEEEeecCCcc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN-VIIHRDLKPRNVLLVNS------SADHLKVGDFGLSK 307 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~-~ivH~Dikp~Nilv~~~------~~~~~kl~DFg~a~ 307 (394)
||+++++|.+++. .+.+++..+..++.|++.||.|||+++. +|+||||||+||++... ..+.+||+|||++.
T Consensus 86 e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 86 EFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp ECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 9999999999885 4579999999999999999999999762 28899999999999321 26789999999998
Q ss_pred ccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~ 387 (394)
...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+..+..+......
T Consensus 165 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 165 EWHRTT------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred cccccc------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 654332 22456899999999999889999999999999999999999999999988888777766555444456
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
+|++++
T Consensus 239 ~~~~~~ 244 (271)
T 3dtc_A 239 CPEPFA 244 (271)
T ss_dssp CCHHHH
T ss_pred cCHHHH
Confidence 777664
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=314.87 Aligned_cols=220 Identities=28% Similarity=0.483 Sum_probs=166.7
Q ss_pred cceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEEEEeccC
Q 016152 162 SAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLR 238 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~~ 238 (394)
.+.||+|+||.||+|.+. ++.+|||.+... ......+|+.+++.+. ||||+++++++.+....++||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 478999999999999985 788999988542 2256778999999997 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCcccccccccccc
Q 016152 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNSHDV 317 (394)
Q Consensus 239 ~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a~~~~~~~~~~~ 317 (394)
+++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||+..+ ....+||+|||++........
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--- 164 (325)
T 3kn6_A 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--- 164 (325)
T ss_dssp SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC---
Confidence 9999999999889999999999999999999999988 9999999999999432 223799999999986543322
Q ss_pred ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHcCCCCCCCC--CCC
Q 016152 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-------PYEAAKYVAEGHRPFFRA--KGF 388 (394)
Q Consensus 318 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~-------~~~~~~~i~~g~~p~~~~--~~~ 388 (394)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+ ..++.+.+..+..+.... ..+
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC
Confidence 2345678999999999999999999999999999999999999997643 457778887776554332 245
Q ss_pred Ccccc
Q 016152 389 TPELR 393 (394)
Q Consensus 389 ~~~~~ 393 (394)
|++++
T Consensus 244 s~~~~ 248 (325)
T 3kn6_A 244 SQEAK 248 (325)
T ss_dssp CHHHH
T ss_pred CHHHH
Confidence 65554
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=311.67 Aligned_cols=228 Identities=26% Similarity=0.418 Sum_probs=194.6
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcH---HHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 231 (394)
.+|++.+.||+|+||.||+|... |+.+|+|.+........ ...+.+.+|+.+++.++||||+++++++.+...++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 36899999999999999999985 78899999866543221 12467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC----cEEEeecCCcc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSK 307 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~----~~kl~DFg~a~ 307 (394)
+||||+++++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+||++ +.++ .+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~--~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIML--LDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SCTTSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEE--ecCCCCcCCEEEccCccce
Confidence 99999999999999998888999999999999999999999988 9999999999999 5555 79999999998
Q ss_pred ccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-- 385 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-- 385 (394)
...... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..+..+..+.
T Consensus 168 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 168 EIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp ECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred ecCccc-----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 765432 2234579999999999999999999999999999999999999999999888888888765443321
Q ss_pred CCCCcccc
Q 016152 386 KGFTPELR 393 (394)
Q Consensus 386 ~~~~~~~~ 393 (394)
..+|++++
T Consensus 243 ~~~~~~~~ 250 (321)
T 2a2a_A 243 SHTSELAK 250 (321)
T ss_dssp TTCCHHHH
T ss_pred cccCHHHH
Confidence 34555443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=312.55 Aligned_cols=232 Identities=33% Similarity=0.555 Sum_probs=189.1
Q ss_pred CCCcCccccceeecCCceEEEEEEECC------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~~g------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 227 (394)
....+|++.+.||+|+||.||+|.... ..||||.+.... .......+.+|+.++++++||||+++++++.+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 344578889999999999999998642 249999886433 334456788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCc
Q 016152 228 KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a 306 (394)
+..++||||+++++|.+++... +.+++.++..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILV--NSNLVCKVSDFGLS 194 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCCCC-
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEE--CCCCcEEECCCCcc
Confidence 9999999999999999999865 57999999999999999999999988 9999999999999 88889999999999
Q ss_pred cccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~ 385 (394)
......... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+..++.+.+..+.++..+.
T Consensus 195 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 273 (333)
T 1mqb_A 195 RVLEDDPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM 273 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred hhhcccccc-ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcc
Confidence 876543221 112233456889999999998999999999999999999999 999999999999999998886665543
Q ss_pred CCCCcccc
Q 016152 386 KGFTPELR 393 (394)
Q Consensus 386 ~~~~~~~~ 393 (394)
.+|++++
T Consensus 274 -~~~~~l~ 280 (333)
T 1mqb_A 274 -DCPSAIY 280 (333)
T ss_dssp -TCBHHHH
T ss_pred -cCCHHHH
Confidence 3666554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=311.19 Aligned_cols=231 Identities=29% Similarity=0.515 Sum_probs=197.6
Q ss_pred CCCcCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 226 (394)
....+|.+.+.||+|+||.||+|... +..+|||.+.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 34558999999999999999999862 3679999886432 34455788999999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHcCCCCeEecC
Q 016152 227 RKPLMLITEYLRGGDLHKYLKEKGA------------------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~~~~------------------------~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~D 282 (394)
.+..++||||+++++|.+++..... +++.++..++.|++.||.|||+++ |+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~d 175 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRD 175 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccccc
Confidence 9999999999999999999986543 899999999999999999999988 99999
Q ss_pred CCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCC
Q 016152 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEP 361 (394)
Q Consensus 283 ikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~ 361 (394)
|||+||++ +.++.+||+|||++........ ........+|+.|+|||.+.+..++.++||||||+++|||++ |..
T Consensus 176 ikp~NIli--~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 176 LAARNILV--AEGRKMKISDFGLSRDVYEEDS--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CSGGGEEE--ETTTEEEECCCTTCEECTTTSC--EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cchheEEE--cCCCCEEEcccccccccccccc--ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999 7788999999999986653322 112234567889999999998889999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 362 PLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 362 Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
||...+..++.+.+..+.++..+. .+|++++
T Consensus 252 p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 282 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGHRMERPD-NCSEEMY 282 (314)
T ss_dssp SSTTCCGGGHHHHHHTTCCCCCCT-TCCHHHH
T ss_pred CCCCCCHHHHHHHhhcCCcCCCCc-cCCHHHH
Confidence 999999888999998887776664 4677664
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=332.78 Aligned_cols=228 Identities=32% Similarity=0.563 Sum_probs=196.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|... ++.+|||++.............+.+|+.++++++||||+++++++.+...+++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 7999999999999999999984 78999999876544333334778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-CCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+.+++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+|||+.. +.++.+||+|||++..+....
T Consensus 107 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 183 (484)
T 3nyv_A 107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK- 183 (484)
T ss_dssp CCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC-
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc-
Confidence 9999999999998889999999999999999999999988 999999999999943 346789999999998765332
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~~ 392 (394)
......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..++...|.++..+.... +.+|+++
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 184 ----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp ----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred ----ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 1234579999999999875 68999999999999999999999999999999999999876554322 3466665
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 259 ~ 259 (484)
T 3nyv_A 259 K 259 (484)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=329.10 Aligned_cols=228 Identities=32% Similarity=0.570 Sum_probs=191.7
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcH----------HHHHHHHHHHHHHHhCCCCceeeEEeE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR----------LVIQDFRHEVNLLVKLRHPNIVQFLGA 223 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 223 (394)
..+|.+.+.||+|+||.||+|... ++.+|+|++........ ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 347999999999999999999975 67899999865432211 224678899999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC---cEEE
Q 016152 224 VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD---HLKV 300 (394)
Q Consensus 224 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~---~~kl 300 (394)
+.+...+++||||+++|+|.+++...+.+++..+..++.||+.||.|||++| |+||||||+|||+ +..+ .+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~--~~~~~~~~~kl 190 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILL--ENKNSLLNIKI 190 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--SSTTCCSSEEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEE--ecCCCCccEEE
Confidence 9999999999999999999999998889999999999999999999999988 9999999999999 4443 6999
Q ss_pred eecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q 016152 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 301 ~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..++...|..+..
T Consensus 191 ~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 264 (504)
T 3q5i_A 191 VDFGLSSFFSKDY-----KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264 (504)
T ss_dssp CCCTTCEECCTTS-----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EECCCCEEcCCCC-----ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999998765332 234567999999999987 4689999999999999999999999999999999999998865
Q ss_pred CCCCC--CCCCcccc
Q 016152 381 PFFRA--KGFTPELR 393 (394)
Q Consensus 381 p~~~~--~~~~~~~~ 393 (394)
+.... +.+|++++
T Consensus 265 ~~~~~~~~~~s~~~~ 279 (504)
T 3q5i_A 265 YFDFNDWKNISDEAK 279 (504)
T ss_dssp CCCHHHHTTSCHHHH
T ss_pred CCCccccCCCCHHHH
Confidence 54322 45666654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=329.02 Aligned_cols=227 Identities=31% Similarity=0.523 Sum_probs=190.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++++.||+|+||.||+|.+. +..+|+|++.+...... ....+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 6999999999999999999985 77899999865432211 13668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-CCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+.+|+|.+++.....+++..+..++.||+.||.|||++| |+||||||+|||+.. +..+.+||+|||++.......
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~- 193 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK- 193 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence 9999999999988888999999999999999999999988 999999999999933 224569999999998765332
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~~ 392 (394)
......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..++...+..+..+.... +.+|+++
T Consensus 194 ----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 268 (494)
T 3lij_A 194 ----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268 (494)
T ss_dssp ----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred ----cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence 234567999999999986 568999999999999999999999999999999999999876654433 4566665
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 269 ~ 269 (494)
T 3lij_A 269 K 269 (494)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=305.08 Aligned_cols=231 Identities=27% Similarity=0.516 Sum_probs=187.8
Q ss_pred CCcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
...+|++.+.||+|+||.||+|.. .|..+|||.+.............+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 344799999999999999999986 488999999876555556666788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 233 ITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++..
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~--~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFI--TATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCC-----
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEE--cCCCCEEEEeccceee
Confidence 9999999999999874 456999999999999999999999988 9999999999999 8888999999999886
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY--EPYEAAKYVAEGHRPFFRAK 386 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~--~~~~~~~~i~~g~~p~~~~~ 386 (394)
...... ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||.+. +..+..+.+..+..|.++..
T Consensus 186 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (310)
T 2wqm_A 186 FSSKTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 261 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTT
T ss_pred ecCCCc----cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccc
Confidence 653321 123456899999999999999999999999999999999999999654 55677788888888877767
Q ss_pred CCCcccc
Q 016152 387 GFTPELR 393 (394)
Q Consensus 387 ~~~~~~~ 393 (394)
.+|++++
T Consensus 262 ~~~~~l~ 268 (310)
T 2wqm_A 262 HYSEELR 268 (310)
T ss_dssp TSCHHHH
T ss_pred ccCHHHH
Confidence 7887765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=324.23 Aligned_cols=231 Identities=32% Similarity=0.527 Sum_probs=191.5
Q ss_pred CCcccCCCCcCccccceeecCCceEEEEEEECC-ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe
Q 016152 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226 (394)
Q Consensus 148 ~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g-~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 226 (394)
..|++. ..+|++.+.||+|+||.||+|.+.+ ..||||.+...... .+.+.+|+.++++++||||+++++++.+
T Consensus 177 ~~~~i~--~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 177 DAWEIP--RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp TCSBCC--GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccC--hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 456654 3478899999999999999999875 57999988654322 2568899999999999999999998876
Q ss_pred CCeeEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecC
Q 016152 227 RKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg 304 (394)
+.+++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~DfG 325 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADFG 325 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECCCC
T ss_pred -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEE--CCCCCEEECCCc
Confidence 678999999999999999974 356999999999999999999999988 9999999999999 778899999999
Q ss_pred CccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCC
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~ 383 (394)
++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+.+..++...+..+.++..
T Consensus 326 ~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 402 (452)
T 1fmk_A 326 LARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 402 (452)
T ss_dssp TTC-----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred cceecCCCce---ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9987653221 11233457889999999998899999999999999999999 9999999999999999999887766
Q ss_pred CCCCCCcccc
Q 016152 384 RAKGFTPELR 393 (394)
Q Consensus 384 ~~~~~~~~~~ 393 (394)
+. .+|++++
T Consensus 403 ~~-~~~~~l~ 411 (452)
T 1fmk_A 403 PP-ECPESLH 411 (452)
T ss_dssp CT-TSCHHHH
T ss_pred CC-CCCHHHH
Confidence 54 4677664
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=305.70 Aligned_cols=229 Identities=28% Similarity=0.524 Sum_probs=183.1
Q ss_pred CCCcCccccceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
....+|++.+.||+|+||.||+|.+. +..+|+|.+... ......+.+.+|+.++++++||||+++++++. ++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 34458999999999999999999874 345899987543 23445577899999999999999999999874 56
Q ss_pred eeEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
..++||||+++++|.+++...+ .+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGDFGLSR 164 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECC-----
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEE--CCCCCEEECcccccc
Confidence 7899999999999999998654 6999999999999999999999988 9999999999999 677899999999998
Q ss_pred ccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAK 386 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~ 386 (394)
....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...+..+....+..+.++.++.
T Consensus 165 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~- 240 (281)
T 1mp8_A 165 YMEDSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP- 240 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT-
T ss_pred ccCcccc---cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCC-
Confidence 7653321 11233457889999999988899999999999999999997 999999998888899998887766653
Q ss_pred CCCcccc
Q 016152 387 GFTPELR 393 (394)
Q Consensus 387 ~~~~~~~ 393 (394)
.+|++++
T Consensus 241 ~~~~~l~ 247 (281)
T 1mp8_A 241 NCPPTLY 247 (281)
T ss_dssp TCCHHHH
T ss_pred CCCHHHH
Confidence 4677664
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=302.40 Aligned_cols=224 Identities=29% Similarity=0.460 Sum_probs=191.1
Q ss_pred cCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--CeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|.++++.+|||.+..... .....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 3789999999999999999999999999999876543 344457789999999999999999999999877 7889999
Q ss_pred eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 235 EYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||+++++|.+++...+ .+++.++..++.|++.||.|||++++.|+||||||+||++ +.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~--~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI--DEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE--CTTSCEEEEGGGSCCTTS--
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE--cCCcceeEEeccceeeec--
Confidence 9999999999998765 4899999999999999999999976669999999999999 888899999998875432
Q ss_pred cccccccccCCccCccccCccccCCCCCCC---cchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDK---KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA-EGHRPFFRAKGF 388 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~-~g~~p~~~~~~~ 388 (394)
.....+|+.|+|||.+.+..++. ++||||||+++|||++|+.||...+..+....+. .+.+|.++ ..+
T Consensus 165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 236 (271)
T 3kmu_A 165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP-PGI 236 (271)
T ss_dssp -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC-TTC
T ss_pred -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC-CCC
Confidence 22356899999999998765544 7999999999999999999999998888776665 55556555 457
Q ss_pred Ccccc
Q 016152 389 TPELR 393 (394)
Q Consensus 389 ~~~~~ 393 (394)
|++++
T Consensus 237 ~~~~~ 241 (271)
T 3kmu_A 237 SPHVS 241 (271)
T ss_dssp CHHHH
T ss_pred CHHHH
Confidence 77664
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=317.89 Aligned_cols=223 Identities=17% Similarity=0.314 Sum_probs=186.8
Q ss_pred CCcCccccceeecC--CceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 155 SELDFSSSAIIGKG--SFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 155 ~~~~~~~~~~iG~G--~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
...+|++.+.||+| +||.||+|.+. ++.||||.+...... ....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 34489999999999 99999999985 789999998665433 44567788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 231 MLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
++||||+++++|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILI--SVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCGGGCEE
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEccccccee
Confidence 9999999999999999875 67999999999999999999999988 9999999999999 8888999999999876
Q ss_pred ccccccccc---ccccCCccCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC
Q 016152 309 IKVQNSHDV---YKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382 (394)
Q Consensus 309 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~ 382 (394)
......... .......||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+....+..+..|.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 543321111 11223478999999999987 678999999999999999999999999887777777666665553
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=307.57 Aligned_cols=230 Identities=23% Similarity=0.387 Sum_probs=185.1
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||++... ++.+|+|++...........+.+.+|+.++++++||||+++++++..++.+++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 37999999999999999999874 7789999987665555556678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++........
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 114 RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECSCCC---------
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEE--cCCCCEEEecCccCcccccccc
Confidence 99999999999998888999999999999999999999988 9999999999999 7888999999999976653321
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP-FFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p-~~~~~~~~~~~~ 393 (394)
.......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+....++ ......+|++++
T Consensus 190 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 190 ---TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred ---ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHH
Confidence 1223457899999999999999999999999999999999999999988766555555543322 122245676664
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=304.61 Aligned_cols=225 Identities=28% Similarity=0.486 Sum_probs=192.8
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|... +..+|+|.+...........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 37999999999999999999985 6679999885432111112356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLM--GYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECSSSC-
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEE--cCCCCEEEecccccccCcccc-
Confidence 99999999999998888999999999999999999999988 9999999999999 888899999999987554321
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..+..+.. ..+|++++
T Consensus 169 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 240 (284)
T 2vgo_A 169 -----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP--PFLSDGSK 240 (284)
T ss_dssp -----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--TTSCHHHH
T ss_pred -----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC--CcCCHHHH
Confidence 2346789999999999999999999999999999999999999999988888888887654332 23565554
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=328.40 Aligned_cols=232 Identities=28% Similarity=0.553 Sum_probs=199.0
Q ss_pred CCcccCCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 016152 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (394)
Q Consensus 148 ~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 225 (394)
..|++. ..+|++.+.||+|+||.||+|.+. +..||||.+...... .+.+.+|+.++++++||||+++++++.
T Consensus 213 ~~~~~~--~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~ 286 (495)
T 1opk_A 213 DKWEME--RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCT 286 (495)
T ss_dssp SCCBCC--GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccC--HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 445554 447889999999999999999986 678999988654322 367889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 226 ERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 226 ~~~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
+...+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+||
T Consensus 287 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~DF 362 (495)
T 1opk_A 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLV--GENHLVKVADF 362 (495)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CGGGCEEECCT
T ss_pred cCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEE--CCCCcEEEeec
Confidence 999999999999999999999864 45899999999999999999999988 9999999999999 78889999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~ 382 (394)
|++........ .......+|+.|+|||++....++.++|||||||++|||++ |..||.+.+..++.+.+..+.++.
T Consensus 363 G~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 439 (495)
T 1opk_A 363 GLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 439 (495)
T ss_dssp TCEECCTTCCE---ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred ccceeccCCce---eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99987643221 12234456789999999998899999999999999999999 999999999889999998887776
Q ss_pred CCCCCCCcccc
Q 016152 383 FRAKGFTPELR 393 (394)
Q Consensus 383 ~~~~~~~~~~~ 393 (394)
.+. .+|++++
T Consensus 440 ~~~-~~~~~l~ 449 (495)
T 1opk_A 440 RPE-GCPEKVY 449 (495)
T ss_dssp CCT-TCCHHHH
T ss_pred CCC-CCCHHHH
Confidence 664 4677664
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=329.39 Aligned_cols=227 Identities=33% Similarity=0.578 Sum_probs=192.4
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|.+. ++.||||++........ ....+.+|+.++++++||||+++++++.+...+++|||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 7999999999999999999985 78999999854321111 13668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-CCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+.+++|.+.+...+.+++.++..++.|++.||.|||++| |+||||||+|||+.. +..+.+||+|||++.......
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 178 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-
Confidence 9999999999988889999999999999999999999988 999999999999943 234579999999998665332
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~~ 392 (394)
......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..++...+..+..+.... +.+|+++
T Consensus 179 ----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 253 (486)
T 3mwu_A 179 ----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (486)
T ss_dssp -------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred ----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence 2345679999999999875 58999999999999999999999999999999999999876654332 3456555
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 254 ~ 254 (486)
T 3mwu_A 254 K 254 (486)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=301.70 Aligned_cols=232 Identities=30% Similarity=0.494 Sum_probs=192.9
Q ss_pred cCCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe---
Q 016152 152 IDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--- 226 (394)
Q Consensus 152 i~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--- 226 (394)
.......|.+.+.||+|+||.||+|.+. +..+|+|.+...... ....+.+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence 3444556888999999999999999885 667999988654433 3445778999999999999999999998865
Q ss_pred -CCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecC
Q 016152 227 -RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFG 304 (394)
Q Consensus 227 -~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg 304 (394)
...+++||||+++++|.+++...+.+++..+..++.|++.||.|||+++.+|+||||||+||++ + .++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~--~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLG 177 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE--SSTTSCEEECCTT
T ss_pred CCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEE--ECCCCCEEEeeCC
Confidence 3568999999999999999998888999999999999999999999976569999999999999 5 67899999999
Q ss_pred CccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCCCC
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~-~~~~~~~~i~~g~~p~~ 383 (394)
++....... .....||+.|+|||++. +.++.++||||||+++|+|++|+.||... +..+....+..+..|..
T Consensus 178 ~~~~~~~~~------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (290)
T 1t4h_A 178 LATLKRASF------AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 250 (290)
T ss_dssp GGGGCCTTS------BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred Ccccccccc------cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc
Confidence 997544321 23456899999999886 45899999999999999999999999874 55666677777766665
Q ss_pred CCCCCCcccc
Q 016152 384 RAKGFTPELR 393 (394)
Q Consensus 384 ~~~~~~~~~~ 393 (394)
....++++++
T Consensus 251 ~~~~~~~~l~ 260 (290)
T 1t4h_A 251 FDKVAIPEVK 260 (290)
T ss_dssp GGGCCCHHHH
T ss_pred cCCCCCHHHH
Confidence 5555666654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=307.19 Aligned_cols=237 Identities=27% Similarity=0.502 Sum_probs=196.2
Q ss_pred cccCCCCcCccccceeecCCceEEEEEEECC-----ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEE
Q 016152 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224 (394)
Q Consensus 150 ~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g-----~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 224 (394)
+.+.+...+|++.+.||+|+||.||+|.... ..+|+|.+.. .......+.+.+|+.++++++||||+++++++
T Consensus 18 ~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (298)
T 3f66_A 18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 95 (298)
T ss_dssp GBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT--CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred eecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc--CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence 4556667789999999999999999998642 2478888754 33445567889999999999999999999985
Q ss_pred -EeCCeeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEee
Q 016152 225 -TERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (394)
Q Consensus 225 -~~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~D 302 (394)
..++..++||||+++++|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|
T Consensus 96 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~D 171 (298)
T 3f66_A 96 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCML--DEKFTVKVAD 171 (298)
T ss_dssp CCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTCCEEECS
T ss_pred EcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEE--CCCCCEEECc
Confidence 4556789999999999999999864 46899999999999999999999988 9999999999999 8888999999
Q ss_pred cCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC
Q 016152 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 303 Fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
||++..................+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+.++.++
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 251 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC
Confidence 99998765443322223445668899999999998899999999999999999999 78899888888888888888777
Q ss_pred CCCCCCCCcccc
Q 016152 382 FFRAKGFTPELR 393 (394)
Q Consensus 382 ~~~~~~~~~~~~ 393 (394)
..+. .+|++++
T Consensus 252 ~~~~-~~~~~l~ 262 (298)
T 3f66_A 252 LQPE-YCPDPLY 262 (298)
T ss_dssp CCCT-TCCHHHH
T ss_pred CCCc-cCCHHHH
Confidence 6653 3666654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=309.84 Aligned_cols=236 Identities=32% Similarity=0.537 Sum_probs=199.0
Q ss_pred CCCcccCCCCcCccccceeecCCceEEEEEEEC---------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCc
Q 016152 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPN 216 (394)
Q Consensus 147 ~~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~---------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 216 (394)
...|.+ ...+|++.+.||+|+||.||+|.+. +..||||.+.... .....+.+.+|+.+++++ +|||
T Consensus 27 ~~~~~~--~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~ 102 (334)
T 2pvf_A 27 DPKWEF--PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKN 102 (334)
T ss_dssp CTTTBC--CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CccccC--CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCC
Confidence 344544 3458999999999999999999863 4579999886432 344557788999999999 8999
Q ss_pred eeeEEeEEEeCCeeEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEe
Q 016152 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280 (394)
Q Consensus 217 Iv~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~----------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH 280 (394)
|+++++++.+.+.+++||||+++++|.+++.... .+++.+++.++.|++.||.|||+++ |+|
T Consensus 103 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH 180 (334)
T 2pvf_A 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIH 180 (334)
T ss_dssp BCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred EeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeC
Confidence 9999999999999999999999999999998643 3899999999999999999999988 999
Q ss_pred cCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-C
Q 016152 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-G 359 (394)
Q Consensus 281 ~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g 359 (394)
|||||+||++ +.++.+||+|||++......... .......+|+.|+|||++.+..++.++||||||+++|||++ |
T Consensus 181 ~Dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 256 (334)
T 2pvf_A 181 RDLAARNVLV--TENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256 (334)
T ss_dssp SCCSGGGEEE--CTTCCEEECCCTTCEECTTTSSE--ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred CCCccceEEE--cCCCCEEEccccccccccccccc--cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCC
Confidence 9999999999 88889999999999866533211 12234567889999999988889999999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 360 EPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 360 ~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
..||.+.+..++...+..+.++..+. .++++++
T Consensus 257 ~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 289 (334)
T 2pvf_A 257 GSPYPGIPVEELFKLLKEGHRMDKPA-NCTNELY 289 (334)
T ss_dssp CCSSTTCCHHHHHHHHHHTCCCCCCT-TCCHHHH
T ss_pred CCCcCcCCHHHHHHHHhcCCCCCCCc-cCCHHHH
Confidence 99999999999999998887776664 4676654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=316.29 Aligned_cols=235 Identities=28% Similarity=0.403 Sum_probs=186.6
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCC--CcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~--~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
.+|++.+.||+|+||.||+|... +..+|+|++..... ......+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 47999999999999999999874 66899998854321 112234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 016152 233 ITEYLRGGDLHKYLKE----------------------------------------KGALSPSTAVNFALDIARGMAYLH 272 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~----------------------------------------~~~~~~~~~~~~~~ql~~~l~~lH 272 (394)
||||+++++|.+++.. ...+++..+..++.|++.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998842 112367788899999999999999
Q ss_pred cCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCC--CCCCCcchHHHHH
Q 016152 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFA 350 (394)
Q Consensus 273 ~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG 350 (394)
+++ |+||||||+|||+..+....+||+|||++..+...............||+.|+|||.+.+ ..++.++||||||
T Consensus 186 ~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 186 NQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 988 999999999999943333489999999998765433322223455679999999999975 6789999999999
Q ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCcccc
Q 016152 351 MILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELR 393 (394)
Q Consensus 351 v~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~~~ 393 (394)
+++|||++|+.||...+..+....+..+..+.... ..++++++
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLAR 308 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHH
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHH
Confidence 99999999999999999988888888765443322 23565554
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=313.97 Aligned_cols=202 Identities=20% Similarity=0.301 Sum_probs=173.5
Q ss_pred ccCCCCcCccccceeecCCceEEEEEE-------ECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC---CCceeeE
Q 016152 151 EIDPSELDFSSSAIIGKGSFGEILKAY-------WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQF 220 (394)
Q Consensus 151 ~i~~~~~~~~~~~~iG~G~~g~V~~a~-------~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~ 220 (394)
.+.....+|.+.+.||+|+||.||+|. ..++.||||.+.... ...+..|+.+++.++ |+||+++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 445556789999999999999999993 247899999985432 245677888888887 8999999
Q ss_pred EeEEEeCCeeEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC-
Q 016152 221 LGAVTERKPLMLITEYLRGGDLHKYLKE-----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS- 294 (394)
Q Consensus 221 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~- 294 (394)
++++...+..++||||+++|+|.+++.. .+.+++.++..++.||+.||+|||+++ |+||||||+|||+ +.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll--~~~ 208 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFIL--GNG 208 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEE--CGG
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEe--ccc
Confidence 9999999999999999999999999974 456999999999999999999999988 9999999999999 55
Q ss_pred ----------CCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 016152 295 ----------ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364 (394)
Q Consensus 295 ----------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~ 364 (394)
.+.+||+|||++..+...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKG--TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGSCTT--EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccCccccccccCCEEEeeCchhhhhhccCCC--ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 789999999999765432211 12345779999999999999999999999999999999999999984
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=311.34 Aligned_cols=231 Identities=29% Similarity=0.490 Sum_probs=179.7
Q ss_pred CCcCccccceeecCCceEEEEEEECCc-----cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWRGT-----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~g~-----~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
...+|++.+.||+|+||.||+|.+... .+|||.+....... ...+.+.+|+.++++++||||+++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 344899999999999999999986532 69999886543333 335778899999999999999999999987765
Q ss_pred e------EEEEeccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCc
Q 016152 230 L------MLITEYLRGGDLHKYLKEKG------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297 (394)
Q Consensus 230 ~------~lv~e~~~~~sL~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~ 297 (394)
. ++||||+++++|.+++.... .+++.++..++.|++.||.|||++| |+||||||+|||+ +.++.
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli--~~~~~ 175 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCML--AEDMT 175 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTSC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEE--cCCCC
Confidence 5 99999999999999997532 5899999999999999999999988 9999999999999 88889
Q ss_pred EEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 016152 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 298 ~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~ 376 (394)
+||+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.+.+..+....+.
T Consensus 176 ~kl~Dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYY--RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp EEECCCCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred EEEeeccccccccccccc--cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 999999999876543211 11233457889999999999999999999999999999999 999999999999999998
Q ss_pred cCCCCCCCCCCCCcccc
Q 016152 377 EGHRPFFRAKGFTPELR 393 (394)
Q Consensus 377 ~g~~p~~~~~~~~~~~~ 393 (394)
.+.++..+. .++++++
T Consensus 254 ~~~~~~~~~-~~~~~l~ 269 (323)
T 3qup_A 254 GGNRLKQPP-ECMEEVY 269 (323)
T ss_dssp TTCCCCCCT-TCCHHHH
T ss_pred cCCCCCCCC-ccCHHHH
Confidence 887666654 4676654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=303.40 Aligned_cols=229 Identities=28% Similarity=0.517 Sum_probs=193.9
Q ss_pred CcCccccc-eeecCCceEEEEEEE----CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 156 ELDFSSSA-IIGKGSFGEILKAYW----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 156 ~~~~~~~~-~iG~G~~g~V~~a~~----~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
..+|.+.. .||+|+||.||+|.+ .+..+|||.+... ......+.+.+|+.++++++||||+++++++ ..+..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 34666666 999999999999985 3667999988654 2344567889999999999999999999998 55678
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 231 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLL--VNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--EETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEE--cCCCCEEECcccceeee
Confidence 9999999999999999754 46999999999999999999999988 9999999999999 67789999999999876
Q ss_pred ccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~ 388 (394)
...... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+..+....+..+.++.++. .+
T Consensus 161 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~-~~ 238 (287)
T 1u59_A 161 GADDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP-EC 238 (287)
T ss_dssp TTCSCE-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT-TC
T ss_pred ccCcce-eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCC-Cc
Confidence 533221 112233457899999999988889999999999999999998 999999999889999999988887764 47
Q ss_pred Ccccc
Q 016152 389 TPELR 393 (394)
Q Consensus 389 ~~~~~ 393 (394)
|++++
T Consensus 239 ~~~l~ 243 (287)
T 1u59_A 239 PPELY 243 (287)
T ss_dssp CHHHH
T ss_pred CHHHH
Confidence 77664
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=305.30 Aligned_cols=231 Identities=28% Similarity=0.489 Sum_probs=193.0
Q ss_pred CCcCccccc-eeecCCceEEEEEEEC----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 155 SELDFSSSA-IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 155 ~~~~~~~~~-~iG~G~~g~V~~a~~~----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
...+|.+.+ .||+|+||.||+|.+. +..+|||.+...... ....+.+.+|+.+++.++||||+++++++ ..+.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 345788887 9999999999999652 567999988654332 33457789999999999999999999998 5677
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
.++||||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++...
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL--VTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEE--eCCCcEEEccCCcceee
Confidence 8999999999999999998888999999999999999999999988 9999999999999 67789999999999876
Q ss_pred ccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~ 388 (394)
....... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..++...+..+.++.++. .+
T Consensus 168 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 245 (291)
T 1xbb_A 168 RADENYY-KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA-GC 245 (291)
T ss_dssp CTTCSEE-EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT-TC
T ss_pred ccCCCcc-cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CC
Confidence 5432211 11223456789999999988889999999999999999999 999999999999999999988877764 47
Q ss_pred Ccccc
Q 016152 389 TPELR 393 (394)
Q Consensus 389 ~~~~~ 393 (394)
|++++
T Consensus 246 ~~~l~ 250 (291)
T 1xbb_A 246 PREMY 250 (291)
T ss_dssp CHHHH
T ss_pred CHHHH
Confidence 77664
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=313.52 Aligned_cols=203 Identities=28% Similarity=0.478 Sum_probs=179.7
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
..+|++.+.||+|+||.||++.+. +..+|+|++.... .....+.+.+|+.+++.++||||+++++++.+++.+++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 347999999999999999999986 7889999886543 344557789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|||+++++|.+++...+.+++..+..++.|++.||.|||++ | |+||||||+|||+ +.++.+||+|||++......
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEE--CTTCCEEECCCCCCHHHHHH
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEE--CCCCCEEEEECCCCcccccc
Confidence 99999999999999888899999999999999999999996 7 9999999999999 88889999999999765432
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~ 370 (394)
. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+
T Consensus 186 ~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 237 (360)
T 3eqc_A 186 M------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237 (360)
T ss_dssp C----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH
T ss_pred c------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 234579999999999999999999999999999999999999998766543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=319.93 Aligned_cols=239 Identities=27% Similarity=0.501 Sum_probs=187.6
Q ss_pred CCcccCCCCcCccccceeecCCceEEEEEEEC---C--ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEe
Q 016152 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR---G--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222 (394)
Q Consensus 148 ~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~---g--~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 222 (394)
..+.+......|.+.+.||+|+||.||+|... + ..+|+|.+... ......+.+.+|+.++++++||||+++++
T Consensus 80 ~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~ 157 (373)
T 3c1x_A 80 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLG 157 (373)
T ss_dssp TTTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCE
T ss_pred cccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 34556667778899999999999999999863 2 35889987543 23344578899999999999999999999
Q ss_pred EEE-eCCeeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEE
Q 016152 223 AVT-ERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300 (394)
Q Consensus 223 ~~~-~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl 300 (394)
++. .++..++||||+++++|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||
T Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~~~~kL 233 (373)
T 3c1x_A 158 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML--DEKFTVKV 233 (373)
T ss_dssp EECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEE
T ss_pred EEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEE--CCCCCEEE
Confidence 865 456789999999999999999865 45899999999999999999999988 9999999999999 88889999
Q ss_pred eecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCC
Q 016152 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGH 379 (394)
Q Consensus 301 ~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~ 379 (394)
+|||++..+...............+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...+..+....+.++.
T Consensus 234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~ 313 (373)
T 3c1x_A 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 313 (373)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC
T ss_pred eeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC
Confidence 9999998765433222222334567889999999999999999999999999999999 899999888888888888888
Q ss_pred CCCCCCCCCCcccc
Q 016152 380 RPFFRAKGFTPELR 393 (394)
Q Consensus 380 ~p~~~~~~~~~~~~ 393 (394)
++..+. .+|++++
T Consensus 314 ~~~~p~-~~~~~l~ 326 (373)
T 3c1x_A 314 RLLQPE-YCPDPLY 326 (373)
T ss_dssp CCCCCT-TCCHHHH
T ss_pred CCCCCC-CCCHHHH
Confidence 776653 4676654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=300.31 Aligned_cols=225 Identities=32% Similarity=0.595 Sum_probs=194.6
Q ss_pred cCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.+|++.+.||+|+||.||++.+. +..+|+|.+...... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 47899999999999999999984 668999998654432 2568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++++|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++........
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili--~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEE--CGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEE--CCCCCEEEcccccccccccccc
Confidence 99999999999865 56899999999999999999999988 9999999999999 7788999999999986643211
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.......+|+.|+|||.+.+..++.++||||||+++|+|++ |++||...+..+....+..+.++..+. .+|++++
T Consensus 160 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~-~~~~~l~ 235 (267)
T 3t9t_A 160 ---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR-LASTHVY 235 (267)
T ss_dssp ---HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT-TSCHHHH
T ss_pred ---cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCc-cCcHHHH
Confidence 12234567889999999988889999999999999999999 999999999999999999887766553 3566554
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=317.09 Aligned_cols=231 Identities=30% Similarity=0.502 Sum_probs=190.2
Q ss_pred CCCcCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEE
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVT 225 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 225 (394)
....+|++.+.||+|+||.||+|.+. ++.||||.+.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 34558999999999999999999842 4679999986432 344457789999999999 7899999999988
Q ss_pred eCC-eeEEEEeccCCCCHHHHHHhcCC-----------------------------------------------------
Q 016152 226 ERK-PLMLITEYLRGGDLHKYLKEKGA----------------------------------------------------- 251 (394)
Q Consensus 226 ~~~-~~~lv~e~~~~~sL~~~~~~~~~----------------------------------------------------- 251 (394)
+.+ .+++||||+++|+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 755 48999999999999999986432
Q ss_pred -------------CCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccc
Q 016152 252 -------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (394)
Q Consensus 252 -------------~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~ 318 (394)
+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++........ ..
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll--~~~~~~kl~Dfg~a~~~~~~~~--~~ 250 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNVVKICDFGLARDIYKDPD--YV 250 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECCCGGGSCTTSCTT--CE
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEE--cCCCcEEEEeccceeeeccccc--ch
Confidence 899999999999999999999988 9999999999999 7788999999999986643322 11
Q ss_pred cccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYE-PYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~-~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
......||+.|+|||++.+..++.++||||||+++|||++ |..||.+.+ .......+..+.++..+. .++++++
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 326 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD-YTTPEMY 326 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT-TCCHHHH
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCC-CCCHHHH
Confidence 2344568999999999998999999999999999999998 999998876 445556666776666653 4676664
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=306.25 Aligned_cols=230 Identities=28% Similarity=0.513 Sum_probs=189.9
Q ss_pred cCCCCcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEe--
Q 016152 152 IDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE-- 226 (394)
Q Consensus 152 i~~~~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~-- 226 (394)
+.....+|++.+.||+|+||.||+|.+ .++.+|||++....... ..+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT----HHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH----HHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 334455899999999999999999998 58899999886543322 5678899999998 79999999999876
Q ss_pred ----CCeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEE
Q 016152 227 ----RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300 (394)
Q Consensus 227 ----~~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl 300 (394)
...+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.| |+||||||+||++ +.++.+||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~--~~~~~~kl 170 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLL--TENAEVKL 170 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--CTTCCEEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEE--cCCCCEEE
Confidence 46789999999999999999864 56999999999999999999999988 9999999999999 88889999
Q ss_pred eecCCccccccccccccccccCCccCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 016152 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYV 375 (394)
Q Consensus 301 ~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i 375 (394)
+|||++........ ......||+.|+|||.+. +..++.++||||||+++|+|++|..||...+..+....+
T Consensus 171 ~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246 (326)
T ss_dssp CCCTTTC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred eeCcCceecCcCcc----ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence 99999986643221 123457899999999987 567899999999999999999999999999988888888
Q ss_pred HcCCCCCCCCCCCCcccc
Q 016152 376 AEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 376 ~~g~~p~~~~~~~~~~~~ 393 (394)
..+..|.+....+|++++
T Consensus 247 ~~~~~~~~~~~~~~~~l~ 264 (326)
T 2x7f_A 247 PRNPAPRLKSKKWSKKFQ 264 (326)
T ss_dssp HHSCCCCCSCSCSCHHHH
T ss_pred hcCccccCCccccCHHHH
Confidence 888888777777887765
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=304.55 Aligned_cols=225 Identities=28% Similarity=0.476 Sum_probs=191.7
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|.+.+.||+|+||.||++... |+.+|+|.+...... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 6889999999999999999975 889999998654322 23567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-CCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+||++.. +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 9999999999988888999999999999999999999988 999999999999843 45678999999998754322
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~~ 392 (394)
......||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+..+.+.++..+.... ..+|+++
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (304)
T 2jam_A 163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA 238 (304)
T ss_dssp ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence 1223468999999999999999999999999999999999999999999989999998876543322 4466665
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 239 ~ 239 (304)
T 2jam_A 239 K 239 (304)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=300.45 Aligned_cols=215 Identities=28% Similarity=0.496 Sum_probs=185.5
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcH---HHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
+|++.+.||+|+||.||++... ++.+|+|.+........ ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 6889999999999999999985 78999998865432211 124678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC----cEEEeecCCccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSKL 308 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~----~~kl~DFg~a~~ 308 (394)
||||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+||++ +.++ .+||+|||++..
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIML--LDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--SCSSSSSCCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEE--ecCCCCCCceEEEeccccee
Confidence 9999999999999998888999999999999999999999988 9999999999999 5444 799999999986
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
..... ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..+...
T Consensus 162 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 229 (283)
T 3bhy_A 162 IEAGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD 229 (283)
T ss_dssp CC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred ccCCC-----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC
Confidence 64332 123456899999999999999999999999999999999999999999988888888766544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=302.87 Aligned_cols=203 Identities=37% Similarity=0.637 Sum_probs=176.2
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|.+.+.||+|+||.||+|.+. +..+|+|.+.. ......+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 37899999999999999999985 78899998744 23455678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
||+++++|.+++.. .+.+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++.......
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLV--RENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEE--CTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEE--CCCCCEEEeecccceeccccc
Confidence 99999999999987 567999999999999999999999988 9999999999999 888899999999998765332
Q ss_pred cccc----------ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 314 SHDV----------YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 314 ~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
.... .......||+.|+|||++.+..++.++||||||+++|||++|..||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 2110 0112467999999999999999999999999999999999999999653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=303.36 Aligned_cols=238 Identities=28% Similarity=0.491 Sum_probs=197.8
Q ss_pred CcccCCCCcCccccceeecCCceEEEEEEEC--Cc---cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeE
Q 016152 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GT---PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223 (394)
Q Consensus 149 ~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~---~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 223 (394)
++.++.....|.+.+.||+|+||.||+|.+. +. .+|+|.+.. .......+.+.+|+.+++.++||||++++++
T Consensus 13 ~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 90 (298)
T 3pls_A 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVEAFLREGLLMRGLNHPNVLALIGI 90 (298)
T ss_dssp GGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT--CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred heEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc--cccHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3455556667888899999999999999863 22 689998754 2334456788899999999999999999999
Q ss_pred EEeCCee-EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEe
Q 016152 224 VTERKPL-MLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (394)
Q Consensus 224 ~~~~~~~-~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~ 301 (394)
+.+.+.. ++||||+.+++|.+++.. ...+++.++..++.|++.||.|||++| |+||||||+||++ +.++.+||+
T Consensus 91 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili--~~~~~~kl~ 166 (298)
T 3pls_A 91 MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCML--DESFTVKVA 166 (298)
T ss_dssp ECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTCCEEEC
T ss_pred EecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE--cCCCcEEeC
Confidence 9876655 999999999999999986 456899999999999999999999988 9999999999999 888899999
Q ss_pred ecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCC
Q 016152 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 302 DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
|||++..................+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+..+..
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T 3pls_A 167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR 246 (298)
T ss_dssp CTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC
T ss_pred cCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC
Confidence 999998665443222223345678999999999999999999999999999999999 6777888888888888888776
Q ss_pred CCCCCCCCCcccc
Q 016152 381 PFFRAKGFTPELR 393 (394)
Q Consensus 381 p~~~~~~~~~~~~ 393 (394)
+..+. .+|++++
T Consensus 247 ~~~~~-~~~~~l~ 258 (298)
T 3pls_A 247 LPQPE-YCPDSLY 258 (298)
T ss_dssp CCCCT-TCCHHHH
T ss_pred CCCCc-cchHHHH
Confidence 65553 4666654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=301.00 Aligned_cols=210 Identities=29% Similarity=0.512 Sum_probs=178.7
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|.+. ++.+|+|.+...... ......+.+|+.++++++||||+++++++.++..+++|||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 7899999999999999999984 778999998755433 3334677899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++ +|.+++.. .+.+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLI--NRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCSCCS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeecccceecCCccc
Confidence 9976 66655554 678999999999999999999999988 9999999999999 8889999999999986643221
Q ss_pred cccccccCCccCccccCccccCCCC-CCCcchHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPP-LANYEPYEAAKYVAE 377 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~P-f~~~~~~~~~~~i~~ 377 (394)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..| |...+..+....+.+
T Consensus 157 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~ 217 (292)
T 3o0g_A 157 ----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_dssp ----CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH
T ss_pred ----cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 234567899999999998765 79999999999999999987666 667777777776653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=305.55 Aligned_cols=210 Identities=29% Similarity=0.552 Sum_probs=168.5
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|... |+.||+|.+....... ..+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 37899999999999999999874 7889999886543221 1256778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 235 EYLRGGDLHKYLKEK------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 235 e~~~~~sL~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
||+++ +|.+++... ..+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLI--NKRGQLKLGDFGLARA 157 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCSSCEE
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEE--cCCCCEEECcCcccee
Confidence 99985 999998753 35899999999999999999999988 9999999999999 8889999999999986
Q ss_pred cccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
...... ......+|+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+....|.+
T Consensus 158 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 223 (317)
T 2pmi_A 158 FGIPVN----TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFD 223 (317)
T ss_dssp TTSCCC----CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cCCCcc----cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 643221 2334578999999999976 4689999999999999999999999999998888877753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=312.43 Aligned_cols=227 Identities=27% Similarity=0.522 Sum_probs=193.3
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCc-----HHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD-----RLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKP 229 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~-----~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~ 229 (394)
+|++.+.||+|+||.||+|... |+.||||++....... ....+.+.+|+.+++++ +||||+++++++.....
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 6888999999999999999985 8899999886543221 22345678999999999 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
.++||||+++++|.+++.....+++..+..++.|++.||.|||+.| |+||||||+|||+ +.++.+||+|||++..+
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~--~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILL--DDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEEEecCccccc
Confidence 9999999999999999998888999999999999999999999988 9999999999999 88899999999999876
Q ss_pred ccccccccccccCCccCccccCccccC------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFK------HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~ 383 (394)
.... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...+..+....+..+..+..
T Consensus 251 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 325 (365)
T 2y7j_A 251 EPGE-----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS 325 (365)
T ss_dssp CTTC-----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred CCCc-----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 5432 234567999999999985 33688999999999999999999999999988888888887765443
Q ss_pred CC--CCCCcccc
Q 016152 384 RA--KGFTPELR 393 (394)
Q Consensus 384 ~~--~~~~~~~~ 393 (394)
.. ..+|++++
T Consensus 326 ~~~~~~~~~~~~ 337 (365)
T 2y7j_A 326 SPEWDDRSSTVK 337 (365)
T ss_dssp HHHHSSSCHHHH
T ss_pred CcccccCCHHHH
Confidence 21 23455443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=306.58 Aligned_cols=211 Identities=32% Similarity=0.520 Sum_probs=177.6
Q ss_pred CcCccccceeecCCceEEEEEEE-CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYW-RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~-~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
..+|++.+.||+|+||.||+|.+ +|+.+|+|.+...... ......+.+|+.++++++||||+++++++.+...+++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 34899999999999999999998 4788999988654322 223467789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
||+++ +|.+++... ..+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++.......
T Consensus 99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLI--NSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEETTSCC
T ss_pred cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEE--CCCCCEEEccCcCceecCCCc
Confidence 99975 888888764 45999999999999999999999988 9999999999999 888899999999998664322
Q ss_pred ccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.
T Consensus 174 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 233 (311)
T 3niz_A 174 R----SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF 233 (311)
T ss_dssp C-------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH
T ss_pred c----cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 1 2334578999999999876 568999999999999999999999998877666665554
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.39 Aligned_cols=229 Identities=29% Similarity=0.522 Sum_probs=188.2
Q ss_pred CCcCccccceeecCCceEEEEEEEC--Ccc----EEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTP----VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~----~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
...+|++.+.||+|+||.||+|.+. ++. +++|.+...... ...+.+.+|+.++++++||||+++++++. +.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 3448999999999999999999874 444 777776433211 11245678999999999999999999886 56
Q ss_pred eeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 229 PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
..++||||+.+++|.+++... +.+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++.
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~--~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLL--KSPSQVQVADFGVAD 163 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEE--SSSSCEEECSCSGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEE--CCCCeEEECCCCccc
Confidence 689999999999999999864 57999999999999999999999988 9999999999999 888899999999998
Q ss_pred ccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAK 386 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~ 386 (394)
........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+..++...+..+.++..+..
T Consensus 164 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (325)
T 3kex_A 164 LLPPDDKQ--LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQI 241 (325)
T ss_dssp GSCCCTTC--CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTT
T ss_pred ccCccccc--ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCc
Confidence 76543321 12344568889999999998899999999999999999999 9999999988899999988877766543
Q ss_pred CCCcccc
Q 016152 387 GFTPELR 393 (394)
Q Consensus 387 ~~~~~~~ 393 (394)
++++++
T Consensus 242 -~~~~~~ 247 (325)
T 3kex_A 242 -CTIDVY 247 (325)
T ss_dssp -BCTTTT
T ss_pred -CcHHHH
Confidence 555543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=300.11 Aligned_cols=226 Identities=28% Similarity=0.480 Sum_probs=185.5
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|.+.+.||+|+||.||++... +..+|+|.+....... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 6899999999999999999875 7789999886654322 23678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-CCCCcEEEeecCCccccc
Q 016152 236 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 236 ~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-~~~~~~kl~DFg~a~~~~ 310 (394)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||++.. +..+.+||+|||++....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998864 367999999999999999999999988 999999999999943 335689999999998665
Q ss_pred cccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFT 389 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~~ 389 (394)
... ......||+.|+|||.+. ..++.++||||||+++|+|++|+.||.+.+..+....+..+.+..... ..++
T Consensus 179 ~~~-----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 179 SDE-----HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCC
T ss_pred Ccc-----cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCC
Confidence 332 123467899999999986 568999999999999999999999999999888888777654443332 3456
Q ss_pred cccc
Q 016152 390 PELR 393 (394)
Q Consensus 390 ~~~~ 393 (394)
++++
T Consensus 253 ~~~~ 256 (285)
T 3is5_A 253 PQAV 256 (285)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6554
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=300.91 Aligned_cols=225 Identities=32% Similarity=0.554 Sum_probs=196.8
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
..|++.+.||+|+||.||+|... ++.+|||++....... ..+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 36899999999999999999874 7889999886554332 2467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++++|.+++.. +.+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++........
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECBTTBC
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEE--CCCCCEEEeecccceecCcccc
Confidence 99999999999864 57999999999999999999999988 9999999999999 8888999999999987653321
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+..+.+|.++. .+|++++
T Consensus 175 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 248 (303)
T 3a7i_A 175 ----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG-NYSKPLK 248 (303)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCS-SCCHHHH
T ss_pred ----ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCcc-ccCHHHH
Confidence 2345678999999999999999999999999999999999999999999988888888887777664 4676654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=311.22 Aligned_cols=212 Identities=22% Similarity=0.287 Sum_probs=179.8
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv 233 (394)
.+|++.+.||+|+||.||+|.. .++.||||++...... +.+.+|+.+++++ +||||+++++++......++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 3799999999999999999996 4889999988654322 3477899999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCc-----EEEeecCCcc
Q 016152 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----LKVGDFGLSK 307 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~-----~kl~DFg~a~ 307 (394)
|||+ +++|.+++.. .+.+++.++..++.|++.||+|||+++ |+||||||+|||+ +.++. +||+|||++.
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill--~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLI--GRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CCGGGTCTTSEEECCCTTCE
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeee--ccCCCCCCceEEEEEcccce
Confidence 9999 8999999986 467999999999999999999999988 9999999999999 66665 9999999998
Q ss_pred ccccccccccc---cccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcC
Q 016152 308 LIKVQNSHDVY---KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVAEG 378 (394)
Q Consensus 308 ~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~---~~~~~~~~i~~g 378 (394)
.+......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+. +..+.+..+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 76543322111 124567999999999999999999999999999999999999999874 445555665443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=304.58 Aligned_cols=230 Identities=28% Similarity=0.496 Sum_probs=183.3
Q ss_pred CCcCccccceeecCCceEEEEEEE------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC-
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER- 227 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~- 227 (394)
...+|++.+.||+|+||.||++.+ .++.||||.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 345899999999999999999985 4778999988543 344557789999999999999999999998543
Q ss_pred -CeeEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 228 -KPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 228 -~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
..+++||||+++++|.+++...+ .+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~--~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV--ENENRVKIGDFGL 160 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCCCS
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEE--cCCCeEEEccCcc
Confidence 56899999999999999998754 5999999999999999999999988 9999999999999 7778999999999
Q ss_pred ccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH----------------H
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP----------------Y 369 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~----------------~ 369 (394)
+......... ........+|+.|+|||.+.+..++.++||||||+++|||++|..||..... .
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 161 TKVLPQDKEF-FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp CC--------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred cccccCCcce-eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 9876543221 1122334578889999999999999999999999999999999999875432 1
Q ss_pred HHHHHHHcCCCCCCCCCCCCcccc
Q 016152 370 EAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 370 ~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
...+.+..+.++..+ ..+|++++
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~~l~ 262 (295)
T 3ugc_A 240 HLIELLKNNGRLPRP-DGCPDEIY 262 (295)
T ss_dssp HHHHHHHTTCCCCCC-TTCCHHHH
T ss_pred HHHHHHhccCcCCCC-cCcCHHHH
Confidence 344555566555554 34677664
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=311.27 Aligned_cols=230 Identities=30% Similarity=0.457 Sum_probs=187.6
Q ss_pred CCcCccccceeecCCceEEEEEEE-------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEe
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYW-------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE 226 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~-------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~ 226 (394)
...+|.+.+.||+|+||.||+|.+ .+..||||.+.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 345889999999999999999986 24579999986432 222346788999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 016152 227 RKPLMLITEYLRGGDLHKYLKEKG-----------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 283 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~~~-----------------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Di 283 (394)
.+.+++||||+++++|.+++.... .+++..+..++.|++.||.|||++| |+||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Di 198 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDL 198 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTC
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCC
Confidence 999999999999999999998643 3799999999999999999999988 999999
Q ss_pred CCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCC
Q 016152 284 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPP 362 (394)
Q Consensus 284 kp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~P 362 (394)
||+|||+ +.++.+||+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 199 kp~NIll--~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 199 AARNVLV--THGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp SGGGEEE--ETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred ChhhEEE--cCCCcEEeCCCccCcccccCccc--eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999 78889999999999876543221 12234557889999999988899999999999999999998 9999
Q ss_pred CCCCCHHH-HHHHHHcCCCCCCCCCCCCcccc
Q 016152 363 LANYEPYE-AAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 363 f~~~~~~~-~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
|...+..+ ..+.+..+.++..+ ..+|++++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~ 305 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQP-FYATEEIY 305 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCC-TTCCHHHH
T ss_pred cccCCcHHHHHHHHhcCCCCCCC-CCCCHHHH
Confidence 98876444 44555566555544 33566654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=303.88 Aligned_cols=230 Identities=28% Similarity=0.444 Sum_probs=196.0
Q ss_pred CCcCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 227 (394)
...+|++.+.||+|+||.||+|.+. +..+|+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 3458999999999999999999764 5679999886432 334456788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCc
Q 016152 228 KPLMLITEYLRGGDLHKYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~ 297 (394)
...++||||+++++|.+++... ..+++..+..++.|++.||.|||++| |+||||||+||++ +.++.
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli--~~~~~ 176 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV--AEDFT 176 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEE--CTTCC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEE--cCCCe
Confidence 9999999999999999998752 45799999999999999999999988 9999999999999 88889
Q ss_pred EEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 016152 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 298 ~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~ 376 (394)
+||+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.
T Consensus 177 ~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp EEECCTTCCCGGGGGGCE--EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EEECcCcccccccccccc--ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 999999999866533211 12234567899999999998899999999999999999999 999999999999999998
Q ss_pred cCCCCCCCCCCCCcccc
Q 016152 377 EGHRPFFRAKGFTPELR 393 (394)
Q Consensus 377 ~g~~p~~~~~~~~~~~~ 393 (394)
.+..+..+. .+|++++
T Consensus 255 ~~~~~~~~~-~~~~~l~ 270 (322)
T 1p4o_A 255 EGGLLDKPD-NCPDMLF 270 (322)
T ss_dssp TTCCCCCCT-TCCHHHH
T ss_pred cCCcCCCCC-CCCHHHH
Confidence 887766653 4676654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=309.96 Aligned_cols=228 Identities=29% Similarity=0.558 Sum_probs=184.3
Q ss_pred CCcCccccceeecCCceEEEEEEEC--Ccc----EEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTP----VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~----~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
...+|++.+.||+|+||.||+|.+. ++. +|+|.+.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 3457999999999999999999874 443 5777664332 2223467889999999999999999999998754
Q ss_pred eeEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 229 PLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
.++|+|++.+|+|.+++.. .+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++.
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll--~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV--KTPQHVKITDFGLAK 165 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--EETTEEEECCTTHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEE--CCCCCEEEccCccee
Confidence 7899999999999999987 457999999999999999999999988 9999999999999 777899999999998
Q ss_pred ccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAK 386 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~ 386 (394)
....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+..++...+..+.++..+.
T Consensus 166 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 242 (327)
T 3poz_A 166 LLGAEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP- 242 (327)
T ss_dssp HHTTTCC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT-
T ss_pred EccCCcc--cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCc-
Confidence 7654332 112234567889999999999999999999999999999999 999999999888888888877665543
Q ss_pred CCCccc
Q 016152 387 GFTPEL 392 (394)
Q Consensus 387 ~~~~~~ 392 (394)
.+++++
T Consensus 243 ~~~~~~ 248 (327)
T 3poz_A 243 ICTIDV 248 (327)
T ss_dssp TBCHHH
T ss_pred cCCHHH
Confidence 355544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=304.92 Aligned_cols=231 Identities=32% Similarity=0.477 Sum_probs=191.1
Q ss_pred CCCcCccccceeecCCceEEEEEEE-------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEE
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYW-------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVT 225 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~-------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 225 (394)
....+|++.+.||+|+||.||+|.+ .+..+|||.+.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 3445899999999999999999985 25689999886543 234457789999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCC
Q 016152 226 ERKPLMLITEYLRGGDLHKYLKEKG------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 287 (394)
Q Consensus 226 ~~~~~~lv~e~~~~~sL~~~~~~~~------------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~N 287 (394)
+.+..++||||+++++|.+++.... .+++.++..++.|++.||.|||+++ |+||||||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~N 175 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARN 175 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccce
Confidence 9999999999999999999998653 4899999999999999999999988 9999999999
Q ss_pred EEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCC
Q 016152 288 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANY 366 (394)
Q Consensus 288 ilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~ 366 (394)
|++ +.++.+||+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...
T Consensus 176 il~--~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 176 ILL--THGRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp EEE--ETTTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred EEE--cCCCCEEEccccccccccccccc--eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 999 78889999999999876543221 11234557889999999988899999999999999999999 99999887
Q ss_pred CHH-HHHHHHHcCCCCCCCCCCCCcccc
Q 016152 367 EPY-EAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 367 ~~~-~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
+.. ...+.+..+.++..+ ..+|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~-~~~~~~l~ 278 (313)
T 1t46_A 252 PVDSKFYKMIKEGFRMLSP-EHAPAEMY 278 (313)
T ss_dssp CSSHHHHHHHHHTCCCCCC-TTSCHHHH
T ss_pred cchhHHHHHhccCCCCCCc-ccCCHHHH
Confidence 644 444555555555444 44676654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=303.78 Aligned_cols=214 Identities=30% Similarity=0.507 Sum_probs=159.7
Q ss_pred CcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
..+|++.+.||+|+||.||+|.. .|+.+|||.+...........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 34799999999999999999987 5889999988543211111236788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 234 TEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|||+++++|.+++... +.+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili--~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLL--TRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEE--CTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCCEEEEeecceeeccCC
Confidence 9999999999999875 57999999999999999999999988 9999999999999 88889999999999866533
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
.. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+..
T Consensus 166 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 226 (278)
T 3cok_A 166 HE----KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL 226 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS
T ss_pred CC----cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh
Confidence 21 12245689999999999988999999999999999999999999987766555555544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=326.43 Aligned_cols=232 Identities=33% Similarity=0.530 Sum_probs=196.9
Q ss_pred CCCcccCCCCcCccccceeecCCceEEEEEEECC-ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 016152 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (394)
Q Consensus 147 ~~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g-~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 225 (394)
...|++. ..+|++.+.||+|+||.||+|.+.+ ..||||.+...... .+.+.+|+.++++++||||+++++++.
T Consensus 259 ~~~~~i~--~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~ 332 (535)
T 2h8h_A 259 KDAWEIP--RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS 332 (535)
T ss_dssp TTCSBCC--GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccceecc--hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3456654 3478899999999999999999875 57999998654322 256889999999999999999999887
Q ss_pred eCCeeEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 226 ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 226 ~~~~~~lv~e~~~~~sL~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
+ +.+++||||+++|+|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+||
T Consensus 333 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~DF 407 (535)
T 2h8h_A 333 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADF 407 (535)
T ss_dssp S-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECCT
T ss_pred e-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEE--cCCCcEEEccc
Confidence 6 678999999999999999974 356999999999999999999999988 9999999999999 77889999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~ 382 (394)
|++........ .......+++.|+|||++....++.++|||||||++|||++ |+.||.+.+..++.+.+.++.++.
T Consensus 408 G~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 484 (535)
T 2h8h_A 408 GLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 484 (535)
T ss_dssp TSTTTCCCHHH---HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred ccceecCCCce---ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99987643211 11233457889999999998899999999999999999999 999999999999999999988776
Q ss_pred CCCCCCCcccc
Q 016152 383 FRAKGFTPELR 393 (394)
Q Consensus 383 ~~~~~~~~~~~ 393 (394)
.+. .+|++++
T Consensus 485 ~~~-~~~~~l~ 494 (535)
T 2h8h_A 485 CPP-ECPESLH 494 (535)
T ss_dssp CCT-TCCHHHH
T ss_pred CCC-CCCHHHH
Confidence 653 4777664
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=300.70 Aligned_cols=225 Identities=28% Similarity=0.480 Sum_probs=184.7
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|.+.+.||+|+||.||+|.+. |+.+|||.+...........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 7999999999999999999875 88999998854321111223578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLL--DAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEE--CTTSCEEECCCCGGGCCCC----
T ss_pred ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEE--CCCCCEEEeecccccccCCCc--
Confidence 9999999999998888999999999999999999999988 9999999999999 888899999999998664332
Q ss_pred ccccccCCccCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
......+|+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...+..+..+.+..+..+. + ..++++++
T Consensus 166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~-~~~~~~l~ 239 (276)
T 2h6d_A 166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI-P-EYLNRSVA 239 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-C-TTSCHHHH
T ss_pred ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC-c-hhcCHHHH
Confidence 1234568999999999988765 689999999999999999999999998888888888765443 2 23565543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=315.07 Aligned_cols=221 Identities=29% Similarity=0.511 Sum_probs=172.4
Q ss_pred Ccccc-ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHH-HhCCCCceeeEEeEEEe----CCe
Q 016152 158 DFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRHPNIVQFLGAVTE----RKP 229 (394)
Q Consensus 158 ~~~~~-~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l-~~l~h~~Iv~~~~~~~~----~~~ 229 (394)
+|.+. ++||+|+||.||++.+. ++.||||++... ..+.+|+.++ +..+||||+++++++.. ...
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 56665 68999999999999885 778999988531 3456788876 45589999999998875 567
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCc
Q 016152 230 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLS 306 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a 306 (394)
+|+||||++||+|.+++...+ .+++.++..++.||+.||.|||+++ |+||||||+|||+... .++.+||+|||++
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 899999999999999998753 5999999999999999999999988 9999999999999321 1688999999999
Q ss_pred cccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHcCCCCC
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY----EAAKYVAEGHRPF 382 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~----~~~~~i~~g~~p~ 382 (394)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .....|..+....
T Consensus 212 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 212 KETTSHN-----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp EECC----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred cccCCCC-----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 8654322 234567899999999999999999999999999999999999999776532 2455666554433
Q ss_pred CC--CCCCCcccc
Q 016152 383 FR--AKGFTPELR 393 (394)
Q Consensus 383 ~~--~~~~~~~~~ 393 (394)
.. ...+|++++
T Consensus 287 ~~~~~~~~s~~~~ 299 (400)
T 1nxk_A 287 PNPEWSEVSEEVK 299 (400)
T ss_dssp CTTTTTTSCHHHH
T ss_pred CCcccccCCHHHH
Confidence 22 244666654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=304.02 Aligned_cols=232 Identities=29% Similarity=0.551 Sum_probs=198.3
Q ss_pred CCcccCCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 016152 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (394)
Q Consensus 148 ~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 225 (394)
..|++. ..+|++.+.||+|+||.||+|.+. +..+|+|.+..... ..+.+.+|+.++++++||||+++++++.
T Consensus 6 ~~~~~~--~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 79 (288)
T 3kfa_A 6 DKWEME--RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCT 79 (288)
T ss_dssp CTTBCC--GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hccccc--ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 345543 457899999999999999999986 77899998864322 3467889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 226 ERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 226 ~~~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
+...+++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+||
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~~l~Df 155 (288)
T 3kfa_A 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHLVKVADF 155 (288)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEE--CGGGCEEECCC
T ss_pred cCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEE--cCCCCEEEccC
Confidence 999999999999999999999864 45999999999999999999999988 9999999999999 77889999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~ 382 (394)
|++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+..+.+..+.++.
T Consensus 156 g~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 3kfa_A 156 GLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232 (288)
T ss_dssp CGGGTSCSSSS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred ccceeccCCcc---ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC
Confidence 99987653321 12234557889999999998899999999999999999999 999999999888888888876666
Q ss_pred CCCCCCCcccc
Q 016152 383 FRAKGFTPELR 393 (394)
Q Consensus 383 ~~~~~~~~~~~ 393 (394)
.+ ..+|++++
T Consensus 233 ~~-~~~~~~l~ 242 (288)
T 3kfa_A 233 RP-EGCPEKVY 242 (288)
T ss_dssp CC-TTCCHHHH
T ss_pred CC-CCCCHHHH
Confidence 55 34677664
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=312.15 Aligned_cols=212 Identities=30% Similarity=0.512 Sum_probs=171.2
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCC--eeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERK--PLML 232 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~--~~~l 232 (394)
+|++.+.||+|+||.||+|.+. |+.||||.+...... ....+.+.+|+.+++.+. ||||+++++++...+ .+|+
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 7999999999999999999874 789999988654333 344567788999999997 999999999997544 6899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||||++ ++|.+++.. +.+++..+..++.|++.||.|||+.| |+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILL--NAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEESSSC
T ss_pred EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEE--cCCCCEEecCCccccccccc
Confidence 999997 499999876 47999999999999999999999988 9999999999999 88899999999999865421
Q ss_pred cc-----------------cccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 016152 313 NS-----------------HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 374 (394)
Q Consensus 313 ~~-----------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~ 374 (394)
.. .........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 10 00112345689999999999976 6789999999999999999999999999998888877
Q ss_pred HH
Q 016152 375 VA 376 (394)
Q Consensus 375 i~ 376 (394)
|.
T Consensus 243 i~ 244 (388)
T 3oz6_A 243 II 244 (388)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=302.35 Aligned_cols=209 Identities=32% Similarity=0.551 Sum_probs=177.3
Q ss_pred CccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
+|++.+.||+|+||.||+|... |+.+|+|.+...... ....+.+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 7899999999999999999885 788999988654322 11225677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 237 ~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
+.+ +|.+++... +.+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLI--NREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCCEEEeECccccccCcccc-
Confidence 976 999998764 67999999999999999999999988 9999999999999 8889999999999976543221
Q ss_pred ccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 316 DVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
......+|+.|+|||++.+ ..++.++||||||+++|||++|++||.+.+..+....+.
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 214 (288)
T 1ob3_A 156 ---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ---ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2234578999999999976 458999999999999999999999999988877776665
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=312.51 Aligned_cols=229 Identities=23% Similarity=0.363 Sum_probs=182.9
Q ss_pred CCcCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC--CCceeeEEeEEEeCCeeE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~~~~~ 231 (394)
...+|++.+.||+|+||.||++... ++.||||++..... .....+.+.+|+.+++.++ ||||+++++++...+.++
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3456999999999999999999875 77899998866543 3445678899999999997 599999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
+||| +.+++|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||+ + ++.+||+|||++..+..
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll--~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI--V-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEE--S-SSCEEECCCSSSCCC--
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEE--E-CCeEEEEecCccccccC
Confidence 9999 567899999998888999999999999999999999988 9999999999999 4 46899999999987653
Q ss_pred ccccccccccCCccCccccCccccCC-----------CCCCCcchHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCC
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKH-----------RKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGH 379 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGv~l~el~~g~~Pf~~~-~~~~~~~~i~~g~ 379 (394)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||... +..+....+..+.
T Consensus 207 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~ 284 (390)
T 2zmd_A 207 DTT--SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT
T ss_pred CCc--cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc
Confidence 321 112345679999999999864 46889999999999999999999999875 3445556665543
Q ss_pred CCCCCCCCCCccc
Q 016152 380 RPFFRAKGFTPEL 392 (394)
Q Consensus 380 ~p~~~~~~~~~~~ 392 (394)
........+++++
T Consensus 285 ~~~~~~~~~~~~~ 297 (390)
T 2zmd_A 285 HEIEFPDIPEKDL 297 (390)
T ss_dssp SCCCCCCCSCHHH
T ss_pred ccCCCCccchHHH
Confidence 3322223344444
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=308.52 Aligned_cols=217 Identities=24% Similarity=0.398 Sum_probs=176.5
Q ss_pred cCCCCcCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC--CceeeEEeEEEeCC
Q 016152 152 IDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGAVTERK 228 (394)
Q Consensus 152 i~~~~~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~~~~~~~~~~ 228 (394)
+.....+|++.+.||+|+||.||++... ++.||||.+..... .....+.+.+|+.+++.++| |||+++++++.+..
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 3445568999999999999999999874 67899998865543 34455778999999999986 99999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.+++||| +.+++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||+ + ++.+||+|||++..
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll--~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI--V-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--E-TTEEEECCCSSSCC
T ss_pred EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEE--E-CCcEEEeecccccc
Confidence 9999999 557899999999889999999999999999999999988 9999999999999 3 46899999999987
Q ss_pred cccccccccccccCCccCccccCccccCC-----------CCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHH
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-----------RKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVA 376 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGv~l~el~~g~~Pf~~~~-~~~~~~~i~ 376 (394)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+.
T Consensus 157 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 157 MQPDTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp C--------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cCccccc--ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 6533211 12335679999999999854 678899999999999999999999998753 334444444
Q ss_pred c
Q 016152 377 E 377 (394)
Q Consensus 377 ~ 377 (394)
.
T Consensus 235 ~ 235 (343)
T 3dbq_A 235 D 235 (343)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=301.46 Aligned_cols=210 Identities=26% Similarity=0.473 Sum_probs=179.5
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|.+. |+.+|+|.+..... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 7899999999999999999985 78899998865533 34445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILI--TKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEE--cCCCCEEEeeCCCchhccCccc-
Confidence 9999999999988888999999999999999999999988 9999999999999 8888999999999987653321
Q ss_pred ccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 316 DVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
......||+.|+|||.+.+ ..++.++||||||+++|+|++|++||.+.+..+....+.
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (311)
T 4agu_A 158 ---YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ---ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2234578999999999876 678999999999999999999999999988877776654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=298.93 Aligned_cols=230 Identities=31% Similarity=0.547 Sum_probs=194.2
Q ss_pred CcccCCCCcCccccceeecCCceEEEEEEECC-ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC
Q 016152 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (394)
Q Consensus 149 ~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g-~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 227 (394)
+|++. ..+|++.+.||+|+||.||+|...+ ..+|+|.+...... .+.+.+|+.+++.++||||+++++++. .
T Consensus 7 ~~~v~--~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 79 (279)
T 1qpc_A 7 EWEVP--RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (279)
T ss_dssp TTBCC--GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred hcccC--HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-C
Confidence 34443 3478999999999999999999864 57999988654322 256889999999999999999999876 4
Q ss_pred CeeEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 228 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
+..++||||+++++|.+++.... .+++.++..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILV--SDTLSCKIADFGL 155 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTT
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEE--cCCCCEEECCCcc
Confidence 56899999999999999997543 6999999999999999999999988 9999999999999 8888999999999
Q ss_pred ccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCC
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~ 384 (394)
+........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+.++.++..+
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (279)
T 1qpc_A 156 ARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232 (279)
T ss_dssp CEECSSSCE---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred cccccCccc---ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCc
Confidence 987653321 12234557889999999988889999999999999999999 99999999999999999888776665
Q ss_pred CCCCCcccc
Q 016152 385 AKGFTPELR 393 (394)
Q Consensus 385 ~~~~~~~~~ 393 (394)
..+|++++
T Consensus 233 -~~~~~~l~ 240 (279)
T 1qpc_A 233 -DNCPEELY 240 (279)
T ss_dssp -TTCCHHHH
T ss_pred -ccccHHHH
Confidence 34677664
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=307.43 Aligned_cols=201 Identities=31% Similarity=0.463 Sum_probs=171.2
Q ss_pred CCcCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC----ee
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PL 230 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----~~ 230 (394)
...+|++.+.||+|+||.||+|.+.++.||||++... .........|+.++++++||||+++++++.... .+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred chhhchhhheecccCceEEEEEEECCCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 3458999999999999999999999999999988542 222344566899999999999999999998754 37
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC----------CCCeEecCCCCCCEEEeeCCCCcEEE
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE----------PNVIIHRDLKPRNVLLVNSSADHLKV 300 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~----------~~~ivH~Dikp~Nilv~~~~~~~~kl 300 (394)
++||||+++|+|.+++..+ .+++..+..++.|++.||.|||+. + |+||||||+|||+ +.++.+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill--~~~~~~kL 172 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLL--KNNLTACI 172 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEE--CTTCCEEE
T ss_pred EEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEE--CCCCeEEE
Confidence 9999999999999999764 599999999999999999999998 7 9999999999999 88889999
Q ss_pred eecCCccccccccccccccccCCccCccccCccccCC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 301 ~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
+|||++..+...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 173 ~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 173 ADFGLALKFEAGKSA--GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CCCTTCEEECTTSCC--CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred ccCCcccccccccCc--cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 999999876543321 12334679999999999986 34567899999999999999999999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=304.57 Aligned_cols=217 Identities=25% Similarity=0.412 Sum_probs=180.7
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC--eeE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK--PLM 231 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--~~~ 231 (394)
..+|++.+.||+|+||.||+|.+. ++.||||++....... ..+.+.+|+.++++++||||+++++++.... .++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 457999999999999999999986 7899999986433221 2356778999999999999999999988765 789
Q ss_pred EEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee--CCCCcEEEeecCCc
Q 016152 232 LITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFGLS 306 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~--~~~~~~kl~DFg~a 306 (394)
+||||+++++|.+++.... .+++.++..++.|++.||.|||+++ |+||||||+|||+.. +..+.+||+|||++
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999998643 3999999999999999999999988 999999999999743 34456999999999
Q ss_pred cccccccccccccccCCccCccccCccccC--------CCCCCCcchHHHHHHHHHHHHcCCCCCCCC----CHHHHHHH
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFK--------HRKYDKKVDVFSFAMILYEMLEGEPPLANY----EPYEAAKY 374 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslGv~l~el~~g~~Pf~~~----~~~~~~~~ 374 (394)
....... ......||+.|+|||++. +..++.++|||||||++|||++|+.||... ...++...
T Consensus 164 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 164 RELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp EECCTTC-----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred eecCCCC-----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 8765432 223467999999999985 567899999999999999999999999643 33566677
Q ss_pred HHcCCCC
Q 016152 375 VAEGHRP 381 (394)
Q Consensus 375 i~~g~~p 381 (394)
+..+.++
T Consensus 239 ~~~~~p~ 245 (319)
T 4euu_A 239 IITGKPS 245 (319)
T ss_dssp HHHHCCT
T ss_pred HhcCCCc
Confidence 7666554
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=298.74 Aligned_cols=229 Identities=27% Similarity=0.467 Sum_probs=194.6
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCC------cHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEe
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD------DRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTE 226 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~------~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~ 226 (394)
..+|++.+.||+|+||.||+|.+. ++.||||.+...... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 448999999999999999999984 678999998654321 1233466789999999996 9999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCc
Q 016152 227 RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a 306 (394)
....++||||+++++|.+++..+..+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILL--DDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEE--cCCCcEEEecccch
Confidence 9999999999999999999998888999999999999999999999988 9999999999999 88889999999999
Q ss_pred cccccccccccccccCCccCccccCccccC------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFK------HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR 380 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~ 380 (394)
....... ......+|+.|+|||++. ...++.++||||||+++|+|++|..||...+..+....+..+..
T Consensus 172 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 172 CQLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp EECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred hhcCCCc-----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 8765332 233467899999999984 45688999999999999999999999999998888888887655
Q ss_pred CCCCC--CCCCcccc
Q 016152 381 PFFRA--KGFTPELR 393 (394)
Q Consensus 381 p~~~~--~~~~~~~~ 393 (394)
+.... ..+|++++
T Consensus 247 ~~~~~~~~~~~~~l~ 261 (298)
T 1phk_A 247 QFGSPEWDDYSDTVK 261 (298)
T ss_dssp CCCTTTGGGSCHHHH
T ss_pred ccCcccccccCHHHH
Confidence 43322 34566554
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=305.15 Aligned_cols=209 Identities=24% Similarity=0.367 Sum_probs=182.2
Q ss_pred CcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-----CCceeeEEeEEEeCC
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----HPNIVQFLGAVTERK 228 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~Iv~~~~~~~~~~ 228 (394)
..+|++.+.||+|+||.||+|.+ .++.||||++.. .....+....|+.+++.++ ||||+++++++...+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 34799999999999999999998 478899998853 2334466778999999986 999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee--------------
Q 016152 229 PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-------------- 292 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-------------- 292 (394)
.+++|||++ +++|.+++.... .+++.++..++.||+.||.|||++| |+||||||+|||+..
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhccc
Confidence 999999999 889999998754 5999999999999999999999988 999999999999932
Q ss_pred ---------CCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCC
Q 016152 293 ---------SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363 (394)
Q Consensus 293 ---------~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf 363 (394)
...+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY-------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC-------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccCCCCEEEEeccCceecCCC-------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 12778999999999764322 23467899999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHcC
Q 016152 364 ANYEPYEAAKYVAEG 378 (394)
Q Consensus 364 ~~~~~~~~~~~i~~g 378 (394)
...+..+....+...
T Consensus 260 ~~~~~~~~~~~~~~~ 274 (360)
T 3llt_A 260 RTHEHMEHLAMMESI 274 (360)
T ss_dssp CCSSHHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHh
Confidence 999888888777653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=301.13 Aligned_cols=221 Identities=33% Similarity=0.588 Sum_probs=185.6
Q ss_pred CcCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC-CeeEEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-KPLMLIT 234 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-~~~~lv~ 234 (394)
..+|++.+.||+|+||.||++.++|+.+|||.+.... ..+.+.+|+.++++++||||+++++++.+. +.+++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 4589999999999999999999999999999885432 236788999999999999999999987554 4789999
Q ss_pred eccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 235 EYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~--~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||+++++|.+++...+. +++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTSCEEECCCCC-------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEE--eCCCcEEEeecccccccccc
Confidence 99999999999986543 899999999999999999999988 9999999999999 88889999999998755432
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
. ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+.++.++.++. .+|++
T Consensus 171 ~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 242 (278)
T 1byg_A 171 Q-------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD-GCPPA 242 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCT-TCCHH
T ss_pred c-------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcc-cCCHH
Confidence 1 23457889999999988899999999999999999998 999999998888888888887776663 46776
Q ss_pred cc
Q 016152 392 LR 393 (394)
Q Consensus 392 ~~ 393 (394)
++
T Consensus 243 l~ 244 (278)
T 1byg_A 243 VY 244 (278)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=301.47 Aligned_cols=230 Identities=29% Similarity=0.489 Sum_probs=192.9
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe--CCeeE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLM 231 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~ 231 (394)
..+|++.+.||+|+||.||++... ++.+|+|.+...... ....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 348999999999999999999984 788999988654433 4445788999999999999999999998754 56899
Q ss_pred EEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCC---CCeEecCCCCCCEEEeeCCCCcEEEeecC
Q 016152 232 LITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEP---NVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---~~ivH~Dikp~Nilv~~~~~~~~kl~DFg 304 (394)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ .+|+||||||+||++ +.++.+||+|||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~--~~~~~~kl~dfg 161 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFG 161 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE--CSSSCEEECCCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE--cCCCCEEEecCc
Confidence 999999999999999753 34999999999999999999999964 239999999999999 888899999999
Q ss_pred CccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~ 384 (394)
++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..++...+..+.++.++
T Consensus 162 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 237 (279)
T 2w5a_A 162 LARILNHDTS----FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 237 (279)
T ss_dssp HHHHC---CH----HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC
T ss_pred hheeeccccc----cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC
Confidence 9976643221 122356899999999999889999999999999999999999999999999999999999887776
Q ss_pred CCCCCcccc
Q 016152 385 AKGFTPELR 393 (394)
Q Consensus 385 ~~~~~~~~~ 393 (394)
. .+|++++
T Consensus 238 ~-~~~~~l~ 245 (279)
T 2w5a_A 238 Y-RYSDELN 245 (279)
T ss_dssp T-TSCHHHH
T ss_pred c-ccCHHHH
Confidence 4 4777664
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=303.37 Aligned_cols=230 Identities=26% Similarity=0.424 Sum_probs=180.4
Q ss_pred cCcccc-ceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEE
Q 016152 157 LDFSSS-AIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 157 ~~~~~~-~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~l 232 (394)
..|++. +.||+|+||.||+|.. .++.||||++....... ...+.+|+.++.++ +||||+++++++.+.+.+++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh---HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 367774 7899999999999986 47899999986553322 35678899999885 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCc---EEEeecCCcccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLI 309 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~---~kl~DFg~a~~~ 309 (394)
||||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++. +||+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILC--EHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--SCSSSSCSEEECCTTCCC--
T ss_pred EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEE--ccCCCcCceEEEEccCcccc
Confidence 9999999999999998888999999999999999999999988 9999999999999 54444 999999998866
Q ss_pred ccccccc---cccccCCccCccccCccccCC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCC--------------
Q 016152 310 KVQNSHD---VYKMTGETGSYRYMAPEVFKH-----RKYDKKVDVFSFAMILYEMLEGEPPLANYE-------------- 367 (394)
Q Consensus 310 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~~g~~Pf~~~~-------------- 367 (394)
....... ........||+.|+|||++.+ ..++.++||||||+++|||++|++||...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 4322111 112234569999999999865 568899999999999999999999997754
Q ss_pred -HHHHHHHHHcCCCCCCCC--CCCCcccc
Q 016152 368 -PYEAAKYVAEGHRPFFRA--KGFTPELR 393 (394)
Q Consensus 368 -~~~~~~~i~~g~~p~~~~--~~~~~~~~ 393 (394)
..+..+.+..+..+.... ..+|++++
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAK 273 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHH
Confidence 245667777765443321 34555554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=299.55 Aligned_cols=226 Identities=27% Similarity=0.501 Sum_probs=189.0
Q ss_pred CCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
...+|++.+.||+|+||.||+|.+. |+.||+|.+..... .+.+.+|+.+++.++||||+++++++.....+++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3447999999999999999999885 78999998865432 2567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 233 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.| ++||||||+||++ +.++.+||+|||++.....
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILL--NTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECBT
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEE--CCCCCEEEeecccchhhhh
Confidence 9999999999999974 567999999999999999999999988 9999999999999 8888999999999976653
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCCc
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFTP 390 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~~~ 390 (394)
... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+..+..+.+.. ..+|+
T Consensus 178 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
T 3com_A 178 TMA----KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSD 253 (314)
T ss_dssp TBS----CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred hcc----ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCH
Confidence 321 2234578999999999999999999999999999999999999999988888777777766665543 34555
Q ss_pred ccc
Q 016152 391 ELR 393 (394)
Q Consensus 391 ~~~ 393 (394)
+++
T Consensus 254 ~l~ 256 (314)
T 3com_A 254 NFT 256 (314)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=299.04 Aligned_cols=229 Identities=25% Similarity=0.407 Sum_probs=178.3
Q ss_pred CCCcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeE
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 231 (394)
....+|++.+.||+|+||.||+|.+ .++.+|+|.+..... .....+.+.++...++.++||||+++++++.+.+..+
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 3445899999999999999999998 588999998865432 2333344555666688899999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCCEEEeeCCCCcEEEeecCCc
Q 016152 232 LITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a 306 (394)
+||||+++ +|.+++.. .+.+++..+..++.|++.||.|||++ | |+||||||+||++ +.++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLI--NALGQVKMCDFGIS 157 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEE--CTTCCEEBCCC---
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEE--CCCCCEEEeecCCc
Confidence 99999975 88777653 46799999999999999999999997 8 9999999999999 88889999999999
Q ss_pred cccccccccccccccCCccCccccCcccc----CCCCCCCcchHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCC
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVF----KHRKYDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVAEGHRP 381 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGv~l~el~~g~~Pf~~-~~~~~~~~~i~~g~~p 381 (394)
........ .....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||.. ....+....+.....+
T Consensus 158 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (290)
T 3fme_A 158 GYLVDDVA-----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 232 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC
T ss_pred cccccccc-----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC
Confidence 87654321 2334699999999996 556789999999999999999999999986 4556666666666677
Q ss_pred CCCCCCCCcccc
Q 016152 382 FFRAKGFTPELR 393 (394)
Q Consensus 382 ~~~~~~~~~~~~ 393 (394)
.++...+|++++
T Consensus 233 ~~~~~~~~~~~~ 244 (290)
T 3fme_A 233 QLPADKFSAEFV 244 (290)
T ss_dssp CCCTTTSCHHHH
T ss_pred CcccccCCHHHH
Confidence 777677887765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=301.58 Aligned_cols=221 Identities=27% Similarity=0.369 Sum_probs=173.4
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHH-HhCCCCceeeEEeEEEeCCeeEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l-~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
.+|++.+.||+|+||.||+|... ++.||||.+...........+ ...|+..+ +..+||||+++++++.+.+.+++|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~-~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRAR-KLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHH-HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHH-HHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 37999999999999999999985 789999988665544444333 44455444 445899999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 234 TEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
|||+ +++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll--~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFL--GPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEE--CCCCCEEEccceeeeecccC
Confidence 9999 66999888764 46999999999999999999999988 9999999999999 88889999999998766433
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..||... +....+..+..|......+++++
T Consensus 211 ~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l 281 (311)
T 3p1a_A 211 G-----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---EGWQQLRQGYLPPEFTAGLSSEL 281 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHTTTCCCHHHHTTSCHHH
T ss_pred C-----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHhccCCCcccccCCCHHH
Confidence 2 1234569999999999875 7899999999999999999997666543 22334444443322223345544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=299.28 Aligned_cols=229 Identities=31% Similarity=0.545 Sum_probs=175.7
Q ss_pred CcCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
..+|++.+.||+|+||.||++.+.+ .+|+|.+..... .....+.+.+|+.++++++||||++++++. .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4478999999999999999998765 499998865443 345567889999999999999999999954 5667899999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++++|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFL--HEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--ETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEE--CCCCCEEEccceeccccccccc
Confidence 9999999999964 456999999999999999999999988 9999999999999 7788999999999976543221
Q ss_pred cccccccCCccCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCCCCCCC---CC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAEGHRPFFRA---KG 387 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~-~~~~~~i~~g~~p~~~~---~~ 387 (394)
. .......||+.|+|||.+. +..++.++||||||+++|+|++|+.||...+. ..+.+.+..+..+.... ..
T Consensus 176 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 176 S--HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred c--ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 1 1233457999999999986 56788999999999999999999999987654 45556665554443322 35
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
+|++|+
T Consensus 254 ~~~~l~ 259 (289)
T 3og7_A 254 CPKRMK 259 (289)
T ss_dssp SCHHHH
T ss_pred CCHHHH
Confidence 666654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=319.83 Aligned_cols=208 Identities=27% Similarity=0.384 Sum_probs=174.8
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC------
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------ 228 (394)
.+|++++.||+|+||.||+|.+. ++.||||.+..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 37999999999999999999874 78899999865432 3444577889999999999999999999996553
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.+++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll--~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEE--eCCCCEEEEEEEeeee
Confidence 57999999976 67776643 4899999999999999999999998 9999999999999 8888999999999986
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....|.+
T Consensus 214 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~ 277 (464)
T 3ttj_A 214 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277 (464)
T ss_dssp ---CC-----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCCCc-----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 64322 23456899999999999999999999999999999999999999999998888877754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=296.78 Aligned_cols=226 Identities=36% Similarity=0.606 Sum_probs=182.7
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHH----HHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVI----QDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~----~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
..+|++.+.||+|+||.||+|.+. ++.+|+|.+........... +.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 447999999999999999999984 78899998866544332222 67889999999999999999999987655
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCc-----EEEeec
Q 016152 230 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----LKVGDF 303 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~-----~kl~DF 303 (394)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||||+||++ +..+. +||+||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~--~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL--QSLDENAPVCAKVADF 173 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEE--SCCCTTCSCCEEECCC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEE--eccCCCCceeEEeCCC
Confidence 7999999999999888754 46999999999999999999999976559999999999999 55554 999999
Q ss_pred CCccccccccccccccccCCccCccccCccccC--CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHH-cC
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK--HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY--EAAKYVA-EG 378 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~--~~~~~i~-~g 378 (394)
|++..... ......||+.|+|||.+. ...++.++||||||+++|+|++|+.||...+.. .....+. .+
T Consensus 174 g~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 174 GLSQQSVH-------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp TTCBCCSS-------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred Cccccccc-------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 99974432 123467999999999984 456789999999999999999999999876533 3344444 45
Q ss_pred CCCCCCCCCCCcccc
Q 016152 379 HRPFFRAKGFTPELR 393 (394)
Q Consensus 379 ~~p~~~~~~~~~~~~ 393 (394)
.+|.++ ..+|++++
T Consensus 247 ~~~~~~-~~~~~~l~ 260 (287)
T 4f0f_A 247 LRPTIP-EDCPPRLR 260 (287)
T ss_dssp CCCCCC-TTSCHHHH
T ss_pred CCCCCC-cccCHHHH
Confidence 555554 45777765
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=312.25 Aligned_cols=228 Identities=25% Similarity=0.437 Sum_probs=184.4
Q ss_pred cCccccceeecCCceEEEEEEE-----CCccEEEEEeccCCCC-cHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKP 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~-----~g~~~avK~l~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~ 229 (394)
.+|++.+.||+|+||.||++.. .++.||||++...... .......+.+|+.+++.+ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4899999999999999999987 5788999988643210 111124466789999999 69999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
+++||||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++..+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCcEEEeeCCCCeec
Confidence 9999999999999999998888999999999999999999999988 9999999999999 88889999999999866
Q ss_pred ccccccccccccCCccCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLANY----EPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~Pf~~~----~~~~~~~~i~~g~~p~~ 383 (394)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...++.+.+....++.
T Consensus 210 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 285 (355)
T 1vzo_A 210 VADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY- 285 (355)
T ss_dssp CGGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC-
T ss_pred ccCCCC---cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC-
Confidence 433221 2234679999999999985 35789999999999999999999999643 3455666666554443
Q ss_pred CCCCCCcccc
Q 016152 384 RAKGFTPELR 393 (394)
Q Consensus 384 ~~~~~~~~~~ 393 (394)
+ ..++++++
T Consensus 286 ~-~~~~~~~~ 294 (355)
T 1vzo_A 286 P-QEMSALAK 294 (355)
T ss_dssp C-TTSCHHHH
T ss_pred C-cccCHHHH
Confidence 2 23555543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=301.47 Aligned_cols=211 Identities=22% Similarity=0.309 Sum_probs=178.6
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv 233 (394)
.+|++.+.||+|+||.||+|.. .++.||||++...... +.+.+|+.+++.+ +|++++++++++.+....++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 3799999999999999999995 5889999988654322 3467899999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCc-----EEEeecCCcc
Q 016152 234 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----LKVGDFGLSK 307 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~-----~kl~DFg~a~ 307 (394)
|||+ +++|.+++...+ .+++.++..++.|++.||.|||+++ |+||||||+||++ +.++. +||+|||++.
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~--~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLI--GRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CCSSSTTTTCEEECCCTTCE
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEe--ccCCCCCCCeEEEEECcccc
Confidence 9999 889999998754 5999999999999999999999988 9999999999999 55544 9999999998
Q ss_pred cccccccccc---ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHc
Q 016152 308 LIKVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVAE 377 (394)
Q Consensus 308 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~---~~~~~~~~i~~ 377 (394)
.......... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||... +..+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence 7764432211 1234567999999999999999999999999999999999999999874 44555555543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=331.79 Aligned_cols=223 Identities=29% Similarity=0.509 Sum_probs=186.8
Q ss_pred ceeecCCceEEEEEEEC----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccC
Q 016152 163 AIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 238 (394)
+.||+|+||.||+|.+. +..||||++...... ....+.+.+|+.++++++||||+++++++.. +.+++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 47999999999999652 567999988654322 2334778999999999999999999998864 56899999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccc
Q 016152 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (394)
Q Consensus 239 ~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~ 318 (394)
+|+|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..+...... ..
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl--~~~~~~kL~DFGla~~~~~~~~~-~~ 527 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL--VTQHYAKISDFGLSKALRADENY-YK 527 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCTTHHHHTTC-------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEE--eCCCCEEEEEcCCccccccCccc-cc
Confidence 9999999998888999999999999999999999988 9999999999999 77789999999999876543221 11
Q ss_pred cccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+.++.++..+. .+|+++.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~-~~~~~l~ 602 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA-GCPREMY 602 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT-TCCHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCHHHH
Confidence 2233457889999999998999999999999999999998 999999999999999999998887774 4777764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=305.87 Aligned_cols=234 Identities=29% Similarity=0.480 Sum_probs=189.8
Q ss_pred CcccCCCCcCccccceeecCCceEEEEEEECC-------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeE
Q 016152 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220 (394)
Q Consensus 149 ~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g-------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~ 220 (394)
.|++. ..+|++.+.||+|+||.||+|.+.+ ..+|+|.+.... .....+.+.+|+.+++.+ +||||+++
T Consensus 40 ~~~~~--~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~ 115 (333)
T 2i1m_A 40 KWEFP--RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNL 115 (333)
T ss_dssp GGBCC--TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCC--HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 44443 4588999999999999999998753 369999886543 334457788999999999 89999999
Q ss_pred EeEEEeCCeeEEEEeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 016152 221 LGAVTERKPLMLITEYLRGGDLHKYLKEK--------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR 286 (394)
Q Consensus 221 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~--------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~ 286 (394)
++++.+.+.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+
T Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~ 193 (333)
T 2i1m_A 116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAAR 193 (333)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccc
Confidence 99999999999999999999999999753 35799999999999999999999988 999999999
Q ss_pred CEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCC
Q 016152 287 NVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLAN 365 (394)
Q Consensus 287 Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~ 365 (394)
|||+ +.++.+||+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 194 NIl~--~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 269 (333)
T 2i1m_A 194 NVLL--TNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269 (333)
T ss_dssp GCEE--EGGGEEEBCCCGGGCCGGGCTTS--EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred eEEE--CCCCeEEECccccccccccccce--eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999 77789999999999866543221 12234557889999999998899999999999999999998 9999987
Q ss_pred CCHHHHH-HHHHcCCCCCCCCCCCCcccc
Q 016152 366 YEPYEAA-KYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 366 ~~~~~~~-~~i~~g~~p~~~~~~~~~~~~ 393 (394)
....+.. +.+..+..+..+ ..+|++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~-~~~~~~l~ 297 (333)
T 2i1m_A 270 ILVNSKFYKLVKDGYQMAQP-AFAPKNIY 297 (333)
T ss_dssp CCSSHHHHHHHHHTCCCCCC-TTCCHHHH
T ss_pred cchhHHHHHHHhcCCCCCCC-CCCCHHHH
Confidence 7644444 444455444443 33565553
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=304.69 Aligned_cols=229 Identities=29% Similarity=0.559 Sum_probs=183.4
Q ss_pred CCcCccccceeecCCceEEEEEEEC--Ccc----EEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTP----VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~----~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
...+|++.+.||+|+||.||+|.+. ++. +++|.+...... ...+.+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC--CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 3458999999999999999999874 444 466766443222 22367889999999999999999999988755
Q ss_pred eeEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 229 PLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
.++|+|++.+++|.+++.. .+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++.
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~--~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV--KTPQHVKITDFGLAK 165 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--EETTEEEECCTTC--
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEE--cCCCCEEEccCccee
Confidence 7899999999999999986 457999999999999999999999988 9999999999999 777899999999998
Q ss_pred ccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAK 386 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~ 386 (394)
........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...+..+....+..+.++..+.
T Consensus 166 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 242 (327)
T 3lzb_A 166 LLGAEEKE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP- 242 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT-
T ss_pred EccCcccc--ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc-
Confidence 76543221 12234557889999999999999999999999999999999 999999999888888888877665553
Q ss_pred CCCcccc
Q 016152 387 GFTPELR 393 (394)
Q Consensus 387 ~~~~~~~ 393 (394)
.++++++
T Consensus 243 ~~~~~l~ 249 (327)
T 3lzb_A 243 ICTIDVY 249 (327)
T ss_dssp TBCHHHH
T ss_pred cCCHHHH
Confidence 3666554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.18 Aligned_cols=221 Identities=29% Similarity=0.528 Sum_probs=183.9
Q ss_pred eeecCCceEEEEEEEC----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccCC
Q 016152 164 IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG 239 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 239 (394)
.||+|+||.||+|.+. +..||||.+...... ...+.+.+|+.++++++||||+++++++.. +.+++||||+.+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence 7999999999999763 456999988654322 234678899999999999999999999876 569999999999
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccc
Q 016152 240 GDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (394)
Q Consensus 240 ~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~ 318 (394)
|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++..+...... ..
T Consensus 420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl--~~~~~vkL~DFGla~~~~~~~~~-~~ 494 (613)
T 2ozo_A 420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLL--VNRHYAKISDFGLSKALGADDSY-YT 494 (613)
T ss_dssp CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCCSTTTTCC--------
T ss_pred CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEE--cCCCcEEEeeccCcccccCCCce-ee
Confidence 9999999754 46999999999999999999999988 9999999999999 77789999999999876533211 11
Q ss_pred cccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...|.+|.++.++. .+|++++
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~-~~~~~l~ 569 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP-ECPPELY 569 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT-TCCHHHH
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC-cCCHHHH
Confidence 1223446789999999998999999999999999999998 999999999999999999998887774 4777764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=305.51 Aligned_cols=212 Identities=31% Similarity=0.477 Sum_probs=173.9
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|.+. ++.||||.+..... .....+.+.+|+.++++++||||+++++++.+...+++||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 37999999999999999999864 78899998865432 2233456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee---CCCCcEEEeecCCcccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~---~~~~~~kl~DFg~a~~~~~ 311 (394)
||+++ +|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||+.. +..+.+||+|||++.....
T Consensus 113 e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp ECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred ecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 99975 99999999888999999999999999999999988 999999999999942 2344599999999986643
Q ss_pred ccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||...+..+....+.
T Consensus 190 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 251 (329)
T 3gbz_A 190 PIR----QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF 251 (329)
T ss_dssp --------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccc----ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHH
Confidence 321 23345789999999999874 58999999999999999999999999988887777765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=300.63 Aligned_cols=218 Identities=36% Similarity=0.644 Sum_probs=178.7
Q ss_pred cCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
.+|++.+.||+|+||.||++.+.++.+|||.+... ...+.+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 47889999999999999999999999999987532 234678899999999999999999998763 47999999
Q ss_pred cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHc---CCCCeEecCCCCCCEEEeeCCCCc-EEEeecCCcccc
Q 016152 237 LRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHN---EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLI 309 (394)
Q Consensus 237 ~~~~sL~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~---~~~~ivH~Dikp~Nilv~~~~~~~-~kl~DFg~a~~~ 309 (394)
+++++|.+++.... .++...+..++.|+++||.|||+ ++ |+||||||+||++ +.++. +||+|||++...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll--~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLL--VAGGTVLKICDFGTACDI 156 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEE--ETTTTEEEECCCCC----
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEE--eCCCCEEEEccccccccc
Confidence 99999999998654 37899999999999999999999 66 9999999999999 55565 899999999755
Q ss_pred ccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCCCCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY--EPYEAAKYVAEGHRPFFRAKG 387 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~--~~~~~~~~i~~g~~p~~~~~~ 387 (394)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||... +..++...+..+.+|.+.. .
T Consensus 157 ~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~ 228 (307)
T 2eva_A 157 QTH-------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK-N 228 (307)
T ss_dssp ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBT-T
T ss_pred ccc-------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccc-c
Confidence 422 12346899999999999999999999999999999999999999854 3455666677777776663 4
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
+|++++
T Consensus 229 ~~~~l~ 234 (307)
T 2eva_A 229 LPKPIE 234 (307)
T ss_dssp CCHHHH
T ss_pred cCHHHH
Confidence 676654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=304.84 Aligned_cols=225 Identities=35% Similarity=0.531 Sum_probs=188.1
Q ss_pred cCccccceeecCCceEEEEEEEC--Ccc--EEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~--~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~ 231 (394)
.+|++.+.||+|+||.||+|... +.. +++|.+.... .....+.+.+|+.+++++ +||||+++++++.+.+.++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 47899999999999999999864 554 4888875432 223346688999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCC
Q 016152 232 LITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 295 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~----------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~ 295 (394)
+||||+++++|.+++...+ .+++.+++.++.|++.||.|||++| |+||||||+||++ +.+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~--~~~ 178 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GEN 178 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEE--cCC
Confidence 9999999999999998654 6999999999999999999999988 9999999999999 778
Q ss_pred CcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 016152 296 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKY 374 (394)
Q Consensus 296 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~ 374 (394)
+.+||+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+..+.
T Consensus 179 ~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~ 253 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253 (327)
T ss_dssp GCEEECCTTCEESSCEEC-----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CeEEEcccCcCccccccc-----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence 899999999987443221 1223457889999999988889999999999999999998 9999999999999999
Q ss_pred HHcCCCCCCCCCCCCcccc
Q 016152 375 VAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 375 i~~g~~p~~~~~~~~~~~~ 393 (394)
+..+.++..+. .+|++++
T Consensus 254 ~~~~~~~~~~~-~~~~~l~ 271 (327)
T 1fvr_A 254 LPQGYRLEKPL-NCDDEVY 271 (327)
T ss_dssp GGGTCCCCCCT-TBCHHHH
T ss_pred hhcCCCCCCCC-CCCHHHH
Confidence 98887766653 4666654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=296.13 Aligned_cols=228 Identities=30% Similarity=0.518 Sum_probs=188.0
Q ss_pred CCcCccccceeecCCceEEEEEEECC-----ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~g-----~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
...+|.+.+.||+|+||.||+|.+.+ ..+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+ +.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 34589999999999999999998642 249999876543 33445778999999999999999999998765 45
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 230 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++..
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILV--ASPECVKLGDFGLSRY 162 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--EETTEEEECCCCGGGC
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEE--CCCCcEEeCccCCCcc
Confidence 78999999999999999765 45999999999999999999999988 9999999999999 6778999999999987
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~ 387 (394)
...... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+..+.++..+. .
T Consensus 163 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 238 (281)
T 3cc6_A 163 IEDEDY---YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD-L 238 (281)
T ss_dssp C------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCT-T
T ss_pred cccccc---cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCC-C
Confidence 653321 11233557889999999988899999999999999999998 999999888888888888776665553 3
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
+|++++
T Consensus 239 ~~~~l~ 244 (281)
T 3cc6_A 239 CPPVLY 244 (281)
T ss_dssp CCHHHH
T ss_pred CCHHHH
Confidence 666654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=300.73 Aligned_cols=233 Identities=28% Similarity=0.523 Sum_probs=183.7
Q ss_pred CCcCccccceeecCCceEEEEEEEC---Cc--cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR---GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~---g~--~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
...+|++.+.||+|+||.||+|.+. +. .+|||++...........+.+.+|+.++++++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 3458999999999999999999863 22 58999886654444455678899999999999999999999988755
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 230 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.++||||+.+++|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++..
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili--~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLL--ATRDLVKIGDFGLMRA 170 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--EETTEEEECCCTTCEE
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEE--cCCCCEEEcccccccc
Confidence 89999999999999999764 56999999999999999999999988 9999999999999 6778999999999987
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~ 387 (394)
....... ........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+.....+......
T Consensus 171 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (291)
T 1u46_A 171 LPQNDDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249 (291)
T ss_dssp CCC-CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred ccccccc-hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcC
Confidence 6543321 112234567889999999988889999999999999999999 99999999998988888765444444455
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
+|++++
T Consensus 250 ~~~~l~ 255 (291)
T 1u46_A 250 CPQDIY 255 (291)
T ss_dssp CCHHHH
T ss_pred cCHHHH
Confidence 777664
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=293.18 Aligned_cols=221 Identities=27% Similarity=0.451 Sum_probs=185.4
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
+|++.+.||+|+||.||+|.+. ++.+|+|.+........ ....+.+|+..+..+ +||||+++++++.+.+.+++||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 6889999999999999999985 88999999876544433 346677899999998 8999999999999999999999
Q ss_pred eccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-----------------
Q 016152 235 EYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS----------------- 293 (394)
Q Consensus 235 e~~~~~sL~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~----------------- 293 (394)
||+++++|.+++... +.+++.++..++.|++.||.|||+++ |+||||||+||++..+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999999764 67999999999999999999999988 9999999999999321
Q ss_pred CCCcEEEeecCCccccccccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 016152 294 SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372 (394)
Q Consensus 294 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~ 372 (394)
....+||+|||++...... ....||+.|+|||.+.+. .++.++||||||+++|+|++|.+|+... ...
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~ 237 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP--------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQW 237 (289)
T ss_dssp -CCCEEECCCTTCEETTCS--------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHH
T ss_pred CceEEEEcccccccccCCc--------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHH
Confidence 3447999999999866432 224589999999999866 5678999999999999999999887654 345
Q ss_pred HHHHcCCCCCCCCCCCCcccc
Q 016152 373 KYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 373 ~~i~~g~~p~~~~~~~~~~~~ 393 (394)
..+.++..|.++. .+|++++
T Consensus 238 ~~~~~~~~~~~~~-~~~~~~~ 257 (289)
T 1x8b_A 238 HEIRQGRLPRIPQ-VLSQEFT 257 (289)
T ss_dssp HHHHTTCCCCCSS-CCCHHHH
T ss_pred HHHHcCCCCCCCc-ccCHHHH
Confidence 6677777777764 4677664
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=299.55 Aligned_cols=226 Identities=29% Similarity=0.476 Sum_probs=187.4
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|.+. +..+|+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 37999999999999999999985 778999988654322 2367888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
||+++++|.+++.. ...+++..+..++.|++.||.|||++| ++||||||+||++ +.++.+||+|||++.......
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLM--TLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--CTTSCEEECCCHHHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEE--CCCCCEEEEECCCCccccccc
Confidence 99999999999876 457999999999999999999999988 9999999999999 888899999999876433221
Q ss_pred ccccccccCCccCccccCcccc-----CCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CC
Q 016152 314 SHDVYKMTGETGSYRYMAPEVF-----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KG 387 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~ 387 (394)
. ......||+.|+|||.+ ....++.++||||||+++|+|++|..||...+..+....+..+.+|.... ..
T Consensus 172 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (302)
T 2j7t_A 172 Q----KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK 247 (302)
T ss_dssp H----C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGG
T ss_pred c----ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccc
Confidence 1 12345789999999998 46778999999999999999999999999999888888888777665432 44
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
+|++++
T Consensus 248 ~~~~l~ 253 (302)
T 2j7t_A 248 WSVEFR 253 (302)
T ss_dssp SCHHHH
T ss_pred cCHHHH
Confidence 666554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=295.81 Aligned_cols=228 Identities=29% Similarity=0.468 Sum_probs=186.9
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|... ++.+|||.+....... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh--hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 6889999999999999999875 7889999886543322 34678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++++|.+++.....+++.++..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++.........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEE--ccCCCEEEeeCCCccccCCCcch
Confidence 9999999999987778999999999999999999999988 9999999999999 88889999999999866533211
Q ss_pred ccccccCCccCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~Pf~~~~~~-~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...+.. .....+........+...+|++++
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 162 --RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (276)
T ss_dssp --CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred --hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence 12345679999999999987765 78999999999999999999999876542 333444443332222234555543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=312.70 Aligned_cols=211 Identities=19% Similarity=0.288 Sum_probs=171.2
Q ss_pred CCCCcCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHH--------HHHHHHHHHHHhCCCCce
Q 016152 153 DPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVI--------QDFRHEVNLLVKLRHPNI 217 (394)
Q Consensus 153 ~~~~~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~--------~~~~~E~~~l~~l~h~~I 217 (394)
+....+|++.+.||+|+||.||+|.+. ++.||||++........... .....|+..++.++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 345568999999999999999999874 36799998865432111110 123456667778899999
Q ss_pred eeEEeEEEeC----CeeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee
Q 016152 218 VQFLGAVTER----KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN 292 (394)
Q Consensus 218 v~~~~~~~~~----~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~ 292 (394)
+++++++... ...++||||+ +++|.+++... +.+++.++..++.||+.||.|||+++ |+||||||+|||+..
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNY 187 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEES
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEec
Confidence 9999998765 4589999999 99999999875 67999999999999999999999988 999999999999943
Q ss_pred CCCCcEEEeecCCccccccccccccc---cccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 293 SSADHLKVGDFGLSKLIKVQNSHDVY---KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 293 ~~~~~~kl~DFg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
+.++.+||+|||++..+......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 37889999999999877544322111 123456999999999999999999999999999999999999999853
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=301.10 Aligned_cols=233 Identities=30% Similarity=0.458 Sum_probs=185.5
Q ss_pred CCCCcCccccceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC
Q 016152 153 DPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (394)
Q Consensus 153 ~~~~~~~~~~~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 227 (394)
.....+|.+.+.||+|+||.||+|... +..+|+|.+..... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 344558999999999999999999763 33799998865433 344457788999999999999999999998765
Q ss_pred C-----eeEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC
Q 016152 228 K-----PLMLITEYLRGGDLHKYLKE------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (394)
Q Consensus 228 ~-----~~~lv~e~~~~~sL~~~~~~------~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~ 296 (394)
. ..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||++ +.++
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli--~~~~ 184 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCML--RDDM 184 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEE--CTTS
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE--cCCC
Confidence 5 35999999999999999853 356999999999999999999999988 9999999999999 8888
Q ss_pred cEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 016152 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV 375 (394)
Q Consensus 297 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i 375 (394)
.+||+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 262 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYY--RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262 (313)
T ss_dssp CEEECSCSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred cEEEeecCcceeccccccc--CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 9999999999876533211 11233457889999999999999999999999999999999 99999999988999999
Q ss_pred HcCCCCCCCCCCCCcccc
Q 016152 376 AEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 376 ~~g~~p~~~~~~~~~~~~ 393 (394)
..+.++..+. .+|++++
T Consensus 263 ~~~~~~~~~~-~~~~~l~ 279 (313)
T 3brb_A 263 LHGHRLKQPE-DCLDELY 279 (313)
T ss_dssp HTTCCCCCBT-TCCHHHH
T ss_pred HcCCCCCCCc-cccHHHH
Confidence 8888777764 4676654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=311.89 Aligned_cols=210 Identities=22% Similarity=0.292 Sum_probs=168.8
Q ss_pred CCCCcCccccceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHH--------HHHHHHHHHHHHHhCCCCceee
Q 016152 153 DPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRL--------VIQDFRHEVNLLVKLRHPNIVQ 219 (394)
Q Consensus 153 ~~~~~~~~~~~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~Iv~ 219 (394)
+....+|++.+.||+|+||.||+|... +..+|+|.+......... ....+.+|+..++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 345568999999999999999999984 568999988654322111 1123567888999999999999
Q ss_pred EEeEEEe----CCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCC
Q 016152 220 FLGAVTE----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 295 (394)
Q Consensus 220 ~~~~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~ 295 (394)
+++++.. ....++||||+ +++|.+++...+.+++.+++.++.|++.||.|||+++ |+||||||+|||+..+..
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSST
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCC
Confidence 9999887 67899999999 9999999988778999999999999999999999988 999999999999944333
Q ss_pred CcEEEeecCCcccccccccccc---ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 016152 296 DHLKVGDFGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN 365 (394)
Q Consensus 296 ~~~kl~DFg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~ 365 (394)
+.+||+|||++..+........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 4999999999987654332111 112456799999999999999999999999999999999999999954
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=297.96 Aligned_cols=229 Identities=30% Similarity=0.473 Sum_probs=184.7
Q ss_pred cCccccceeecCCceEEEEEEE------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--C
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--K 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~ 228 (394)
.+|++.+.||+|+||.||+|.+ .++.||+|.+...... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 4689999999999999999984 4778999998654322 2236788999999999999999999999876 6
Q ss_pred eeEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 229 PLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
.+++||||+++++|.+++.. .+.+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++.
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV--ESEHQVKIGDFGLTK 174 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCCTTCE
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEE--cCCCCEEECcccccc
Confidence 68999999999999999965 457999999999999999999999988 9999999999999 777899999999998
Q ss_pred ccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC---------------CHHHHH
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY---------------EPYEAA 372 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~---------------~~~~~~ 372 (394)
........ ........+|+.|+|||.+.+..++.++||||||+++|+|++|..||... ...+..
T Consensus 175 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 175 AIETDKEY-YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp ECCTTCCE-EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred cccCCCcc-eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 76543321 11234466888999999999888999999999999999999999876422 233445
Q ss_pred HHHHcCCCCCCCCCCCCcccc
Q 016152 373 KYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 373 ~~i~~g~~p~~~~~~~~~~~~ 393 (394)
..+..+.++..+ ..+|++++
T Consensus 254 ~~~~~~~~~~~~-~~~~~~l~ 273 (302)
T 4e5w_A 254 NTLKEGKRLPCP-PNCPDEVY 273 (302)
T ss_dssp HHHHTTCCCCCC-TTCCHHHH
T ss_pred HHHhccCCCCCC-CCCCHHHH
Confidence 556666655554 34676654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=302.73 Aligned_cols=233 Identities=27% Similarity=0.429 Sum_probs=191.7
Q ss_pred CCCcCccccceeecCCceEEEEEEE-------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYW-------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~-------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 226 (394)
....+|++.+.||+|+||.||+|.+ .+..||||.+.... .......+.+|+.++++++||||+++++++.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 3455899999999999999999984 35679999885432 34445678899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcE
Q 016152 227 RKPLMLITEYLRGGDLHKYLKEK-------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHL 298 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~ 298 (394)
....++||||+++++|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+|||+..+ ....+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999875 34899999999999999999999988 9999999999999321 34569
Q ss_pred EEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc
Q 016152 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 299 kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~ 377 (394)
||+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..+.+..
T Consensus 183 kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYY--RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EECCCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EECcccccccccccccc--ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 99999998765432211 11233567899999999988899999999999999999998 9999999999999999998
Q ss_pred CCCCCCCCCCCCcccc
Q 016152 378 GHRPFFRAKGFTPELR 393 (394)
Q Consensus 378 g~~p~~~~~~~~~~~~ 393 (394)
+.++.++. .+|++++
T Consensus 261 ~~~~~~~~-~~~~~l~ 275 (327)
T 2yfx_A 261 GGRMDPPK-NCPGPVY 275 (327)
T ss_dssp TCCCCCCT-TCCHHHH
T ss_pred CCCCCCCC-CCCHHHH
Confidence 87776653 4676654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=299.81 Aligned_cols=216 Identities=30% Similarity=0.515 Sum_probs=174.4
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC-------
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------- 228 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------- 228 (394)
+|++.+.||+|+||.||+|.+. |+.||||++..... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST--TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 6889999999999999999985 78999999865432 223477899999999999999999999886543
Q ss_pred --------------------------------------------------eeEEEEeccCCCCHHHHHHhcCC---CCHH
Q 016152 229 --------------------------------------------------PLMLITEYLRGGDLHKYLKEKGA---LSPS 255 (394)
Q Consensus 229 --------------------------------------------------~~~lv~e~~~~~sL~~~~~~~~~---~~~~ 255 (394)
.+++||||+++++|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 27999999999999999987543 5666
Q ss_pred HHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccc--------ccccCCccCc
Q 016152 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV--------YKMTGETGSY 327 (394)
Q Consensus 256 ~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~--------~~~~~~~gt~ 327 (394)
.+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++........... .......||+
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEE--eCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78999999999999999988 9999999999999 8888999999999987754322111 1234467999
Q ss_pred cccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 016152 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 328 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
.|+|||++.+..++.++||||||+++|||++|..|+.. ..+....+..+..|
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~ 292 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFP 292 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCC
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCC
Confidence 99999999999999999999999999999999877632 23344444454444
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=302.88 Aligned_cols=209 Identities=33% Similarity=0.564 Sum_probs=179.9
Q ss_pred cccCCCCcCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 150 ~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
.++.....+|++.+.||+|+||.||+|.+. ++.||||.+...... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ---GIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS---HHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH---HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 345556678999999999999999999875 789999987654332 3467889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecC
Q 016152 229 PLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg 304 (394)
..++||||+++++|.+++.... .+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg 184 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILL--DENFVPKITDFG 184 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEE--CTTCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEE--CCCCCEEEeecc
Confidence 9999999999999999986542 5899999999999999999999988 9999999999999 888999999999
Q ss_pred CccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
++......... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 185 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 185 ISKKGTELDQT--HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp TCEECSSSSCC--CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred ccccccccccc--ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 99765432211 11234568999999999988899999999999999999999999997654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=300.73 Aligned_cols=211 Identities=29% Similarity=0.498 Sum_probs=180.3
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|... |+.||||.+..... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 37999999999999999999986 78899998865543 3444567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++........
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEE--cCCCcEEEEeCCCceeecCCcc
Confidence 99999999988887778999999999999999999999988 9999999999999 8888999999999986653322
Q ss_pred cccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
......||+.|+|||.+.+. .++.++||||||+++|+|++|++||...+..+....+.
T Consensus 180 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 238 (331)
T 4aaa_A 180 ----VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ----ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 23346789999999999875 78999999999999999999999999988777666554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=315.92 Aligned_cols=205 Identities=28% Similarity=0.496 Sum_probs=161.3
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC-----Ce
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KP 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~ 229 (394)
.+|++.+.||+|+||.||+|.+. ++.||||.+..... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47999999999999999999875 78899998865433 344557788999999999999999999998443 56
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
+|+|||++ +++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl--~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLV--NQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTCCEEECCCTTCBCT
T ss_pred EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEE--CCCCCEeecccccchhc
Confidence 89999998 5699999998888999999999999999999999988 9999999999999 88899999999999876
Q ss_pred ccccccc-----------------------cccccCCccCccccCcccc-CCCCCCCcchHHHHHHHHHHHHc-------
Q 016152 310 KVQNSHD-----------------------VYKMTGETGSYRYMAPEVF-KHRKYDKKVDVFSFAMILYEMLE------- 358 (394)
Q Consensus 310 ~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGv~l~el~~------- 358 (394)
....... .......+||+.|+|||++ ....|+.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 4322110 0123456789999999986 56679999999999999999999
Q ss_pred ----CCCCCCCCC
Q 016152 359 ----GEPPLANYE 367 (394)
Q Consensus 359 ----g~~Pf~~~~ 367 (394)
|++||.+.+
T Consensus 287 ~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 287 YHADRGPLFPGSS 299 (458)
T ss_dssp SGGGCCCSCC---
T ss_pred ccccccccCCCCc
Confidence 778886654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=298.76 Aligned_cols=198 Identities=32% Similarity=0.555 Sum_probs=166.7
Q ss_pred cCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHh--CCCCceeeEEeEEEeC----Cee
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK--LRHPNIVQFLGAVTER----KPL 230 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~--l~h~~Iv~~~~~~~~~----~~~ 230 (394)
.+|++.+.||+|+||.||+|.++++.||||++.... ...+..|.+++.. ++||||+++++++... ..+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 479999999999999999999999999999885421 2445556666666 7899999999986543 458
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCeEecCCCCCCEEEeeCCCCcEEEee
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH--------NEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH--------~~~~~ivH~Dikp~Nilv~~~~~~~~kl~D 302 (394)
++||||+++|+|.++++. ..+++..+..++.|++.||.||| +.+ |+||||||+|||+ +.++.+||+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill--~~~~~~kl~D 156 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILV--KKNGQCCIAD 156 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEE--CTTSCEEECC
T ss_pred EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEE--cCCCCEEEee
Confidence 999999999999999954 57999999999999999999999 877 9999999999999 8888999999
Q ss_pred cCCccccccccccccccccCCccCccccCccccCCC------CCCCcchHHHHHHHHHHHHcC----------CCCCCC
Q 016152 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR------KYDKKVDVFSFAMILYEMLEG----------EPPLAN 365 (394)
Q Consensus 303 Fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGv~l~el~~g----------~~Pf~~ 365 (394)
||++..................||+.|+|||++.+. .++.++||||||+++|||++| +.||..
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999987654433222223445799999999999876 455799999999999999999 899955
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=304.79 Aligned_cols=215 Identities=25% Similarity=0.444 Sum_probs=181.6
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe--------
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-------- 226 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-------- 226 (394)
.+|++.+.||+|+||.||+|... |+.||||.+....... .....+.+|+.+++.++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 48999999999999999999984 7899999886554332 122456789999999999999999999877
Q ss_pred CCeeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 227 RKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
.+.+++||||+++ +|.+.+... ..+++.++..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLI--TRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEE--cCCCCEEEccchh
Confidence 3468999999976 887777653 57999999999999999999999988 9999999999999 8888999999999
Q ss_pred ccccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
+..+...............||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.+
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 98765433322333455678999999999876 5689999999999999999999999999988887777753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=317.27 Aligned_cols=228 Identities=28% Similarity=0.459 Sum_probs=177.0
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCC-----cHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
.+|.+.+.||+|+||.||+|... ++.||||++...... .......+.+|+.++++++||||+++++++. .+.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCc
Confidence 37899999999999999999875 678999998654211 1122235788999999999999999999875 456
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-CCCCcEEEeecCCccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKL 308 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-~~~~~~kl~DFg~a~~ 308 (394)
.++||||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||+.. +....+||+|||++..
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 8999999999999999988888999999999999999999999988 999999999999932 1234699999999987
Q ss_pred cccccccccccccCCccCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAEGHRPFFR 384 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~-~~~~~~i~~g~~p~~~ 384 (394)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||..... ....+.+..+..+..+
T Consensus 292 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 292 LGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp CC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred cCCCc-----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 65332 2345679999999999863 5788999999999999999999999976543 3455666676665544
Q ss_pred C--CCCCccc
Q 016152 385 A--KGFTPEL 392 (394)
Q Consensus 385 ~--~~~~~~~ 392 (394)
. ..+++++
T Consensus 367 ~~~~~~~~~~ 376 (419)
T 3i6u_A 367 EVWAEVSEKA 376 (419)
T ss_dssp HHHTTSCHHH
T ss_pred hhhcccCHHH
Confidence 3 3355544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=305.56 Aligned_cols=206 Identities=29% Similarity=0.511 Sum_probs=174.6
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC------
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------ 228 (394)
.+|++.+.||+|+||.||+|.+. |+.||||.+..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 47999999999999999999874 88999998865443 3444577889999999999999999999997663
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.+++||||+ +++|.+++.. +.+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAV--NEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEE--cCCCCEEEEeeecccc
Confidence 469999999 7899999876 56999999999999999999999988 9999999999999 8889999999999986
Q ss_pred cccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
.... .....+|+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+....|.
T Consensus 178 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~ 239 (367)
T 1cm8_A 178 ADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 239 (367)
T ss_dssp CCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccc-------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5422 234678999999999876 679999999999999999999999999998887777765
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=302.58 Aligned_cols=226 Identities=22% Similarity=0.395 Sum_probs=186.2
Q ss_pred Ccccc-ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEEE
Q 016152 158 DFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 158 ~~~~~-~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv 233 (394)
+|.+. +.||+|+||.||+|... ++.||+|++....... .....+.+|+.+++.+. ||||+++++++.+...+++|
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 56665 88999999999999885 8899999886543332 22366888999999995 69999999999999999999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC---CCcEEEeecCCccc
Q 016152 234 TEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS---ADHLKVGDFGLSKL 308 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~---~~~~kl~DFg~a~~ 308 (394)
|||+++++|.+++... +.+++.++..++.|++.||+|||++| |+||||||+|||+ +. .+.+||+|||++..
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~--~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILL--SSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--SCBTTBCCEEECCGGGCEE
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEE--ecCCCCCcEEEeeCccccc
Confidence 9999999999998643 67999999999999999999999988 9999999999999 44 67999999999987
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--C
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--K 386 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~ 386 (394)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.+...+.... .
T Consensus 184 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 258 (327)
T 3lm5_A 184 IGHAC-----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258 (327)
T ss_dssp C--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred cCCcc-----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhc
Confidence 65332 1234679999999999999999999999999999999999999999999888888877644333222 3
Q ss_pred CCCcccc
Q 016152 387 GFTPELR 393 (394)
Q Consensus 387 ~~~~~~~ 393 (394)
.++++++
T Consensus 259 ~~~~~~~ 265 (327)
T 3lm5_A 259 SVSQLAT 265 (327)
T ss_dssp TSCHHHH
T ss_pred ccCHHHH
Confidence 4566554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=294.45 Aligned_cols=227 Identities=33% Similarity=0.571 Sum_probs=192.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|... ++.+|+|++....... ...+.+.+|+.++++++||||+++++++.+...+++|||
T Consensus 23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 7999999999999999999984 7889999986543221 123678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a~~~~~~~~ 314 (394)
++.+++|.+++...+.+++.++..++.|++.||.|||++| |+||||||+||++..+ ....+||+|||++.......
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~- 178 (287)
T 2wei_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (287)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-
T ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-
Confidence 9999999999988888999999999999999999999988 9999999999999332 23479999999998664332
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~~ 392 (394)
......+|+.|+|||.+.+ .++.++||||||+++|+|++|..||...+..+..+.+..+..+.... ..+|+++
T Consensus 179 ----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 2wei_A 179 ----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (287)
T ss_dssp ----SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred ----ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence 1233458999999999875 48999999999999999999999999999999999998876554322 4566665
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 254 ~ 254 (287)
T 2wei_A 254 K 254 (287)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=296.10 Aligned_cols=211 Identities=29% Similarity=0.476 Sum_probs=175.9
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCc--HHHHHHHHHHHHHHHhC---CCCceeeEEeEEEeCC-
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDD--RLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTERK- 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~--~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~~~- 228 (394)
.+|++.+.||+|+||.||+|.+ .++.||||.+....... ......+.+|+.+++.+ +||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 4899999999999999999995 47899999886432111 00113345566666655 5999999999987755
Q ss_pred ----eeEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEee
Q 016152 229 ----PLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (394)
Q Consensus 229 ----~~~lv~e~~~~~sL~~~~~~~~~--~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~D 302 (394)
.+++|||++.+ +|.+++..... +++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~--~~~~~~kl~D 163 (308)
T 3g33_A 89 DREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILV--TSGGTVKLAD 163 (308)
T ss_dssp SSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEE--CTTSCEEECS
T ss_pred CCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--cCCCCEEEee
Confidence 48999999974 99999987654 999999999999999999999998 9999999999999 8888999999
Q ss_pred cCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 303 Fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+.+
T Consensus 164 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 164 FGLARIYSYQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp CSCTTTSTTCC-----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred CccccccCCCc-----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99998664332 22346789999999999999999999999999999999999999999998888877753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=318.75 Aligned_cols=208 Identities=13% Similarity=0.229 Sum_probs=166.6
Q ss_pred CcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHH---HHHHhCCCCceeeEE-------eE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEV---NLLVKLRHPNIVQFL-------GA 223 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~---~~l~~l~h~~Iv~~~-------~~ 223 (394)
..+|++.+.||+|+||.||+|.+ .|+.||||++...........+.+.+|+ .++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 34799999999999999999986 4889999998765444444557788999 455556899999998 66
Q ss_pred EEeCC-----------------eeEEEEeccCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHcCCCCeE
Q 016152 224 VTERK-----------------PLMLITEYLRGGDLHKYLKEKGALSP-------STAVNFALDIARGMAYLHNEPNVII 279 (394)
Q Consensus 224 ~~~~~-----------------~~~lv~e~~~~~sL~~~~~~~~~~~~-------~~~~~~~~ql~~~l~~lH~~~~~iv 279 (394)
+.+.+ ..++||||+ +|+|.+++...+.+++ ..+..++.||+.||+|||++| |+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 66553 279999999 5799999987555555 778889999999999999988 99
Q ss_pred ecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCC-----------CCCCcchHHH
Q 016152 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-----------KYDKKVDVFS 348 (394)
Q Consensus 280 H~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dvws 348 (394)
||||||+|||+ +.++.+||+|||++..... ......| +.|+|||++.+. .++.++||||
T Consensus 229 HrDikp~NIll--~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 229 HTYLRPVDIVL--DQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp CSCCCGGGEEE--CTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred cCCCCHHHEEE--cCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 99999999999 7888999999999985332 1234567 999999999877 8999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 349 FAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 349 lGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
|||++|||++|+.||...+..+....+.
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~~~~~~ 326 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGGSEWIF 326 (377)
T ss_dssp HHHHHHHHHHSSCCC------CCSGGGG
T ss_pred HHHHHHHHHHCCCCCcccccccchhhhh
Confidence 9999999999999998766544444443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=305.04 Aligned_cols=232 Identities=28% Similarity=0.476 Sum_probs=191.3
Q ss_pred CCcCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
...+|++.+.||+|+||.||+|.+.+ .+|+|.+....... ...+.+.+|+.++++++||||+++++++.+...+++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 34578999999999999999999876 59999886543221 11245678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
||+++++|.+++...+ .+++.++..++.|++.||.|||+++ |+||||||+||++ + ++.+||+|||++.......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~--~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFY--D-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEE--C---CCEECCCSCCC------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEE--e-CCCEEEeecCCcccccccc
Confidence 9999999999998654 6999999999999999999999988 9999999999999 5 5689999999987653221
Q ss_pred cc-ccccccCCccCccccCccccCC---------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 016152 314 SH-DVYKMTGETGSYRYMAPEVFKH---------RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 314 ~~-~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~ 383 (394)
.. .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+..+....+..+.+|.+
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 263 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence 11 1112334568999999999864 4578999999999999999999999999999999999999988888
Q ss_pred CCCCCCcccc
Q 016152 384 RAKGFTPELR 393 (394)
Q Consensus 384 ~~~~~~~~~~ 393 (394)
....+|++++
T Consensus 264 ~~~~~~~~l~ 273 (319)
T 2y4i_B 264 SQIGMGKEIS 273 (319)
T ss_dssp CCSSCCTTHH
T ss_pred CcCCCCHHHH
Confidence 8777887765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=296.81 Aligned_cols=207 Identities=23% Similarity=0.412 Sum_probs=174.6
Q ss_pred CcCccccceeecCCceEEEEEEEC--C-------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--G-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g-------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 226 (394)
..+|.+.+.||+|+||.||+|.+. + ..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 447999999999999999999864 3 4699998854322 234678899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCc--------
Q 016152 227 RKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-------- 297 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~-------- 297 (394)
.+..++||||+++++|.+++...+. +++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILL--IREEDRKTGNPPF 159 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--EECCBGGGTBCCE
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEE--ecCCcccccccce
Confidence 9999999999999999999987654 999999999999999999999988 9999999999999 44444
Q ss_pred EEEeecCCccccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 016152 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYV 375 (394)
Q Consensus 298 ~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i 375 (394)
+||+|||++...... ....+|+.|+|||++.+ ..++.++||||||+++|||++ |.+||...+........
T Consensus 160 ~kl~Dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 160 IKLSDPGISITVLPK--------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp EEECCCCSCTTTSCH--------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred eeeccCcccccccCc--------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 999999998755322 12457889999999987 678999999999999999999 66777777766555544
Q ss_pred Hc
Q 016152 376 AE 377 (394)
Q Consensus 376 ~~ 377 (394)
..
T Consensus 232 ~~ 233 (289)
T 4fvq_A 232 ED 233 (289)
T ss_dssp HT
T ss_pred hc
Confidence 43
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=299.81 Aligned_cols=226 Identities=28% Similarity=0.461 Sum_probs=185.4
Q ss_pred ccccceeecCCceEEEEEEE------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC--Cee
Q 016152 159 FSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPL 230 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~ 230 (394)
|++++.||+|+||.||++.+ .++.||||++... ......+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 48999999999999998865 4678999998654 2344557789999999999999999999999874 678
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
++||||+++++|.+++... .+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~--~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLL--DNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCGGGCEECC
T ss_pred EEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEE--cCCCCEEECCcccccccc
Confidence 9999999999999999765 4999999999999999999999988 9999999999999 888899999999998765
Q ss_pred cccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH---------------HHHHHHH
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP---------------YEAAKYV 375 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~---------------~~~~~~i 375 (394)
..... ........+|+.|+|||.+.+..++.++||||||+++|+|++|..||..... .+..+.+
T Consensus 186 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEY-YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSE-EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred ccccc-cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 43221 1123345688899999999988899999999999999999999999975432 2344555
Q ss_pred HcCCCCCCCCCCCCcccc
Q 016152 376 AEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 376 ~~g~~p~~~~~~~~~~~~ 393 (394)
..+.++..+ ..+|++++
T Consensus 265 ~~~~~~~~~-~~~~~~l~ 281 (318)
T 3lxp_A 265 ERGERLPRP-DKCPAEVY 281 (318)
T ss_dssp HTTCCCCCC-TTCCHHHH
T ss_pred hcccCCCCC-ccccHHHH
Confidence 566555554 34676664
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=302.63 Aligned_cols=209 Identities=28% Similarity=0.520 Sum_probs=172.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|... ++.||||.+...... .....+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 6899999999999999999985 778999988543221 111234579999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
|+++ +|.+++...+ .+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLI--NERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEE--CTTCCEEECSSSEEECC-----
T ss_pred cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEE--CCCCCEEEccCcccccccCCcc
Confidence 9975 9999888654 5999999999999999999999988 9999999999999 8888999999999976543221
Q ss_pred cccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
......+|+.|+|||++.+ ..++.++||||||+++|+|++|++||.+.+..+....+.+
T Consensus 156 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 215 (324)
T 3mtl_A 156 ----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2334578999999999876 5689999999999999999999999999998888877754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.49 Aligned_cols=203 Identities=28% Similarity=0.458 Sum_probs=169.5
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC-----Ce
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KP 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~ 229 (394)
.+|++.+.||+|+||.||+|.+. ++.||||.+..... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 37999999999999999999875 67899999865433 344557888999999999999999999998766 56
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
+|+|||++. ++|.+++.....+++..++.++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl--~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLL--NQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEE--CCCCCEEEccCCCcccc
Confidence 899999986 599999998888999999999999999999999988 9999999999999 88899999999999876
Q ss_pred cccccccc------------------ccccCCccCccccCcccc-CCCCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 016152 310 KVQNSHDV------------------YKMTGETGSYRYMAPEVF-KHRKYDKKVDVFSFAMILYEMLEGEPPLAN 365 (394)
Q Consensus 310 ~~~~~~~~------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGv~l~el~~g~~Pf~~ 365 (394)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..||..
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 54321100 123567899999999986 566799999999999999999996666544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=302.40 Aligned_cols=209 Identities=27% Similarity=0.390 Sum_probs=173.0
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC------
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------ 228 (394)
.+|++.+.||+|+||.||+|... ++.||||.+..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 37999999999999999999874 78899998865433 3444577889999999999999999999997665
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.+++||||+++ +|.+++. ..+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEE--cCCCCEEEEEeecccc
Confidence 68999999975 8888885 45899999999999999999999988 9999999999999 8888999999999986
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g 378 (394)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.+.
T Consensus 177 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 241 (371)
T 2xrw_A 177 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 241 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-
T ss_pred ccccc-----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 54321 223467999999999999999999999999999999999999999999988888877653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=300.46 Aligned_cols=230 Identities=28% Similarity=0.481 Sum_probs=189.2
Q ss_pred CCcCccccceeecCCceEEEEEEE------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE--e
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT--E 226 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~--~ 226 (394)
...+|++.+.||+|+||.||++.+ .+..||||.+... .....+.+.+|+.++++++||||+++++++. +
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 344899999999999999999985 4678999988643 3444577899999999999999999999886 4
Q ss_pred CCeeEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 227 RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
...+++||||+++++|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILV--ESEAHVKIADFGL 173 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCGGG
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEE--CCCCCEEEccccc
Confidence 5668999999999999999986 456999999999999999999999988 9999999999999 7788999999999
Q ss_pred ccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH---------------HH
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP---------------YE 370 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~---------------~~ 370 (394)
+......... ........+|+.|+|||.+.+..++.++||||||+++|+|++|..||..... .+
T Consensus 174 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 174 AKLLPLDKDY-YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp CEECCTTCSE-EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred ceecccCCcc-ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 9876543321 1123345688999999999988899999999999999999999999965432 34
Q ss_pred HHHHHHcCCCCCCCCCCCCcccc
Q 016152 371 AAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 371 ~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
..+.+..+.++..+ ..+|++++
T Consensus 253 ~~~~~~~~~~~~~~-~~~~~~l~ 274 (327)
T 3lxl_A 253 LLELLEEGQRLPAP-PACPAEVH 274 (327)
T ss_dssp HHHHHHTTCCCCCC-TTCCHHHH
T ss_pred HHHHhhcccCCCCC-CcccHHHH
Confidence 45556666655554 44676664
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=304.31 Aligned_cols=213 Identities=31% Similarity=0.467 Sum_probs=176.8
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCc--HHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD--RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 231 (394)
..+|++.+.||+|+||.||+|.+. |+.||||.+....... ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 347999999999999999999875 7889999886533221 111246778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 232 LITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
+||||+++ +|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++..+.
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~--~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLL--DENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECCCGGGSTTT
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEE--cCCCCEEEEecccceecc
Confidence 99999986 899888764 46899999999999999999999988 9999999999999 888899999999998764
Q ss_pred cccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
.... ......+|+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+....|.+
T Consensus 164 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~ 227 (346)
T 1ua2_A 164 SPNR----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 227 (346)
T ss_dssp SCCC----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCcc----cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 3321 23456789999999999764 589999999999999999999999999998888877764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=305.04 Aligned_cols=200 Identities=24% Similarity=0.408 Sum_probs=174.5
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcH-----HHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR-----LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
.+|++.+.||+|+||.||+|.+. ++.||||.+........ .....+.+|+.++++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 37999999999999999999864 77899999876532211 122356679999999999999999999999999
Q ss_pred eEEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 230 LMLITEYLRGG-DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 230 ~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
+++|||++.+| +|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVI--AEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTTCEE
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEE--cCCCcEEEeecccceE
Confidence 99999999766 99999998888999999999999999999999988 9999999999999 8888999999999987
Q ss_pred cccccccccccccCCccCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLAN 365 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~Pf~~ 365 (394)
..... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||..
T Consensus 180 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 180 LERGK-----LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CCTTC-----CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred CCCCC-----ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 65432 1234579999999999988776 7899999999999999999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=303.11 Aligned_cols=207 Identities=32% Similarity=0.552 Sum_probs=177.3
Q ss_pred CcccCCCCcCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC
Q 016152 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227 (394)
Q Consensus 149 ~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 227 (394)
..++.....+|++.+.||+|+||.||+|... ++.||||.+....... ....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 3455666778999999999999999999864 7899999886543221 113578899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHcC---CCCeEecCCCCCCEEEeeCCCCcEEE
Q 016152 228 KPLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNE---PNVIIHRDLKPRNVLLVNSSADHLKV 300 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~ivH~Dikp~Nilv~~~~~~~~kl 300 (394)
...++||||+++++|.+++.... .+++..+..++.|++.||.|||++ + |+||||||+|||+ +.++.+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~--~~~~~~kl 175 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILL--DEEFEAVV 175 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEE--CTTCCEEE
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEE--CCCCCEEe
Confidence 99999999999999999998643 499999999999999999999998 7 9999999999999 88889999
Q ss_pred eecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 016152 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLA 364 (394)
Q Consensus 301 ~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~ 364 (394)
+|||++......... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.
T Consensus 176 ~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 176 GDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCCSSCEECCSSSSC---EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccCccccccCccccc---ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999999876533221 2334569999999999988889999999999999999999999995
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=300.17 Aligned_cols=223 Identities=28% Similarity=0.506 Sum_probs=169.3
Q ss_pred CcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 233 (394)
..+|++.+.||+|+||.||++.+ +++.||||.+..... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 44899999999999999999986 578999998754322 22346678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 234 TEYLRGGDLHKYLKE--------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
|||+++++|.+++.. .+.+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILL--GEDGSVQIADFGV 167 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--CTTCCEEECCCHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEE--cCCCCEEEEeccc
Confidence 999999999999874 356999999999999999999999988 9999999999999 8888999999999
Q ss_pred ccccccccccc-cccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 016152 306 SKLIKVQNSHD-VYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383 (394)
Q Consensus 306 a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~ 383 (394)
+.......... ........||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+.......+.++.+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 87665332111 111234579999999999875 5689999999999999999999999998887777766666655544
Q ss_pred C
Q 016152 384 R 384 (394)
Q Consensus 384 ~ 384 (394)
.
T Consensus 248 ~ 248 (303)
T 2vwi_A 248 E 248 (303)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=299.86 Aligned_cols=231 Identities=30% Similarity=0.506 Sum_probs=190.3
Q ss_pred CCCcCccccceeecCCceEEEEEEE-------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEE
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYW-------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVT 225 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~-------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 225 (394)
....+|++.+.||+|+||.||+|.+ .++.+|||.+.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 3455899999999999999999985 24679999886543 334456788999999999 6999999999987
Q ss_pred eCC-eeEEEEeccCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCE
Q 016152 226 ERK-PLMLITEYLRGGDLHKYLKEKGA----------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNV 288 (394)
Q Consensus 226 ~~~-~~~lv~e~~~~~sL~~~~~~~~~----------------~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Ni 288 (394)
..+ .+++||||+++++|.+++..... +++..+..++.|++.||.|||+++ |+||||||+||
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Ni 179 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNI 179 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceE
Confidence 654 58999999999999999987543 899999999999999999999988 99999999999
Q ss_pred EEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCC
Q 016152 289 LLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYE 367 (394)
Q Consensus 289 lv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~ 367 (394)
++ +.++.+||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+
T Consensus 180 l~--~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 180 LL--SEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp EE--CGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EE--CCCCCEEECCCccccccccCcc--ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 99 7788999999999986643321 112234567899999999998999999999999999999998 999998765
Q ss_pred -HHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 368 -PYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 368 -~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
..+....+..+.++.++. .++++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~-~~~~~l~ 281 (316)
T 2xir_A 256 IDEEFCRRLKEGTRMRAPD-YTTPEMY 281 (316)
T ss_dssp CSHHHHHHHHHTCCCCCCT-TCCHHHH
T ss_pred hhHHHHHHhccCccCCCCC-CCCHHHH
Confidence 345566677776666553 3666654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=301.48 Aligned_cols=225 Identities=30% Similarity=0.488 Sum_probs=179.2
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCC-----cHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
+|.+.+.||+|+||.||+|.+. ++.||||.+...... .......+.+|+.++++++||||+++++++.... .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 6899999999999999999875 678999998654321 1122345789999999999999999999987655 8
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC---cEEEeecCCcc
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD---HLKVGDFGLSK 307 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~---~~kl~DFg~a~ 307 (394)
++||||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++ .+||+|||++.
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~--~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLL--SSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SSSSSSCCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE--ecCCCCCeEEEccCccce
Confidence 999999999999999988888999999999999999999999988 9999999999999 4433 59999999998
Q ss_pred ccccccccccccccCCccCccccCccccC---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCCCCC
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLEGEPPLANYEP-YEAAKYVAEGHRPFF 383 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~-~~~~~~i~~g~~p~~ 383 (394)
...... ......||+.|+|||++. ...++.++||||||+++|+|++|..||..... .+....+..+..+..
T Consensus 166 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 166 ILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240 (322)
T ss_dssp ECCCCH-----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred eccccc-----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence 664321 122356899999999973 56789999999999999999999999976543 245556666655544
Q ss_pred CC--CCCCccc
Q 016152 384 RA--KGFTPEL 392 (394)
Q Consensus 384 ~~--~~~~~~~ 392 (394)
+. ..+++++
T Consensus 241 ~~~~~~~~~~~ 251 (322)
T 2ycf_A 241 PEVWAEVSEKA 251 (322)
T ss_dssp HHHHTTSCHHH
T ss_pred chhhhhcCHHH
Confidence 32 2345544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=303.53 Aligned_cols=206 Identities=26% Similarity=0.437 Sum_probs=172.6
Q ss_pred CCCcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe-----
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----- 226 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----- 226 (394)
....+|++.+.||+|+||.||+|.+ .|+.||||.+...... ..+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3445899999999999999999987 4789999988654322 2369999999999999999999844
Q ss_pred ---------------------------------CCeeEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 016152 227 ---------------------------------RKPLMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGMA 269 (394)
Q Consensus 227 ---------------------------------~~~~~lv~e~~~~~sL~~~~~----~~~~~~~~~~~~~~~ql~~~l~ 269 (394)
...+++||||+++ +|.+.+. ..+.+++..+..++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3348999999985 8777665 3567999999999999999999
Q ss_pred HHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCccccccccccccccccCCccCccccCccccCCC-CCCCcchHH
Q 016152 270 YLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVF 347 (394)
Q Consensus 270 ~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvw 347 (394)
|||++| |+||||||+|||+ + .++.+||+|||++..+.... ......+|+.|+|||.+.+. .++.++|||
T Consensus 156 ~LH~~g--i~H~Dikp~Nil~--~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 156 FIHSLG--ICHRDIKPQNLLV--NSKDNTLKLCDFGSAKKLIPSE-----PSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHTTT--EECSCCCGGGEEE--ETTTTEEEECCCTTCEECCTTS-----CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHCc--CccCccCHHHEEE--cCCCCcEEEEECCCCcccCCCC-----CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 999988 9999999999999 5 56799999999998765332 23346789999999998765 589999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 348 SFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 348 slGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
||||++|||++|++||.+.+..+....|.
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~ 255 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRII 255 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999999999999998888777765
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=307.59 Aligned_cols=216 Identities=24% Similarity=0.467 Sum_probs=186.7
Q ss_pred CccccceeecCCceEEEEEEECCccEEEEEeccCCCCcH--------------HHHHHHHHHHHHHHhCCCCceeeEEeE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR--------------LVIQDFRHEVNLLVKLRHPNIVQFLGA 223 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 223 (394)
+|++.+.||+|+||.||+|.+.++.||||.+........ ...+.+.+|+.++++++||||++++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred ceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 899999999999999999999999999998854321111 112678899999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCCEEEeeCC
Q 016152 224 VTERKPLMLITEYLRGGDLHKY------LKE--KGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSS 294 (394)
Q Consensus 224 ~~~~~~~~lv~e~~~~~sL~~~------~~~--~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~ivH~Dikp~Nilv~~~~ 294 (394)
+.+.+.+++||||+++++|.++ +.. ...+++..+..++.|++.||.|||+ .| |+||||||+||++ +.
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~--~~ 187 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILM--DK 187 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEE--CT
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEE--cC
Confidence 9999999999999999999998 655 5679999999999999999999999 88 9999999999999 88
Q ss_pred CCcEEEeecCCccccccccccccccccCCccCccccCccccCCC-CCCC-cchHHHHHHHHHHHHcCCCCCCCCCH-HHH
Q 016152 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDK-KVDVFSFAMILYEMLEGEPPLANYEP-YEA 371 (394)
Q Consensus 295 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslGv~l~el~~g~~Pf~~~~~-~~~ 371 (394)
++.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||...+. .+.
T Consensus 188 ~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp TSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred CCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 889999999999876433 23446799999999999877 6665 99999999999999999999988776 788
Q ss_pred HHHHHcCCCCCC
Q 016152 372 AKYVAEGHRPFF 383 (394)
Q Consensus 372 ~~~i~~g~~p~~ 383 (394)
.+.+..+..+..
T Consensus 262 ~~~i~~~~~~~~ 273 (348)
T 2pml_X 262 FNNIRTKNIEYP 273 (348)
T ss_dssp HHHHTSCCCCCC
T ss_pred HHHHhccCcCCc
Confidence 888887755443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=292.75 Aligned_cols=227 Identities=23% Similarity=0.421 Sum_probs=185.1
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCC-cHHHHHHHHHHHHHHHhCCCCceeeEEeEEE--eCCeeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT--ERKPLML 232 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~-~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~--~~~~~~l 232 (394)
+|++.+.||+|+||.||++... ++.+|+|++...... .......+.+|+.++++++||||+++++++. +....++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 7999999999999999999874 678999988543211 1123467889999999999999999999984 4567899
Q ss_pred EEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 233 ITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
||||++++ |.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++....
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~--~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLL--TTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEECC
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEE--cCCCcEEeeccccccccC
Confidence 99999875 8777765 456999999999999999999999988 9999999999999 888899999999998764
Q ss_pred cccccccccccCCccCccccCccccCCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRK--YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~ 388 (394)
...... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...+..+..+.+.++..+.. ..+
T Consensus 161 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--~~~ 236 (305)
T 2wtk_C 161 PFAADD--TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP--GDC 236 (305)
T ss_dssp TTCSSC--EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC--SSS
T ss_pred cccccc--ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC--Ccc
Confidence 322111 233567999999999997654 37899999999999999999999999999899999888765433 235
Q ss_pred Ccccc
Q 016152 389 TPELR 393 (394)
Q Consensus 389 ~~~~~ 393 (394)
+++++
T Consensus 237 ~~~l~ 241 (305)
T 2wtk_C 237 GPPLS 241 (305)
T ss_dssp CHHHH
T ss_pred CHHHH
Confidence 66554
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=293.91 Aligned_cols=202 Identities=30% Similarity=0.511 Sum_probs=174.2
Q ss_pred ccccceeecCCceEEEEEEECCccEEEEEeccCCC-CcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEecc
Q 016152 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLS-DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~-~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~ 237 (394)
|..++.||+|+||.||+|..+++.+|||.+..... ......+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 45568999999999999999999999999865432 22334577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 238 RGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 238 ~~~sL~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++........
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILL--DEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEECCSCSS
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEE--cCCCcEEEeecccccccccccc
Confidence 99999999974 346999999999999999999999988 9999999999999 8888999999999986543221
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
........||+.|+|||.+.+ .++.++||||||+++|+|++|.+||...+
T Consensus 189 --~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 189 --TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp --CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred --cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 112234579999999999865 57899999999999999999999997654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=303.17 Aligned_cols=207 Identities=28% Similarity=0.510 Sum_probs=163.0
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC------C
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~ 228 (394)
.+|++.+.||+|+||.||+|.+. |+.||||.+..... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47999999999999999999864 78899998865433 344457788999999999999999999998654 5
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.+++|+|++ +++|.+++.. +.+++..+..++.||++||.|||++| |+||||||+|||+ +.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll--~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAV--NEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEE--CCCCCEEEeecccccc
Confidence 579999999 6799998875 57999999999999999999999988 9999999999999 8888999999999976
Q ss_pred cccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+....|.+
T Consensus 182 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 244 (367)
T 2fst_X 182 TADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccc-------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 5422 234679999999999877 6789999999999999999999999999988877777653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=308.63 Aligned_cols=218 Identities=25% Similarity=0.391 Sum_probs=181.2
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC--eeE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK--PLM 231 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--~~~ 231 (394)
..+|.+.+.||+|+||.||+|.+. |+.||||++....... ..+.+.+|+.++++++||||+++++++.... ..+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 457999999999999999999986 7899999986432221 2356778999999999999999999988765 789
Q ss_pred EEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee--CCCCcEEEeecCCc
Q 016152 232 LITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFGLS 306 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~--~~~~~~kl~DFg~a 306 (394)
+||||+++++|.+++.... .+++.+++.++.|++.||.|||+++ |+||||||+|||+.. +..+.+||+|||++
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999997543 3999999999999999999999988 999999999999843 34456999999999
Q ss_pred cccccccccccccccCCccCccccCccccCC--------CCCCCcchHHHHHHHHHHHHcCCCCCCC----CCHHHHHHH
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKH--------RKYDKKVDVFSFAMILYEMLEGEPPLAN----YEPYEAAKY 374 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGv~l~el~~g~~Pf~~----~~~~~~~~~ 374 (394)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ....++...
T Consensus 164 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 164 RELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp EECCCGG-----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred eEccCCC-----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 8765432 2334679999999999864 5678899999999999999999999964 334577777
Q ss_pred HHcCCCCC
Q 016152 375 VAEGHRPF 382 (394)
Q Consensus 375 i~~g~~p~ 382 (394)
+..+.++.
T Consensus 239 ~~~~~p~~ 246 (396)
T 4eut_A 239 IITGKPSG 246 (396)
T ss_dssp HHHSCCTT
T ss_pred HhcCCCcc
Confidence 77776653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=304.88 Aligned_cols=204 Identities=29% Similarity=0.424 Sum_probs=170.2
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC------
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------ 227 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------ 227 (394)
..+|++.+.||+|+||.||+|.+. |+.||||.+...... ..+|+.+++.++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-------HHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 447999999999999999999984 789999988654322 23699999999999999999988542
Q ss_pred CeeEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC-CCcEEEee
Q 016152 228 KPLMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGD 302 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~-~~~~kl~D 302 (394)
..+++||||+.+ +|.+.+. ....+++..++.++.||++||.|||+++ |+||||||+|||+ +. .+.+||+|
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl--~~~~~~~kl~D 200 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLL--DPDTAVLKLCD 200 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEE--ETTTTEEEECC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEE--eCCCCeEEecc
Confidence 236799999976 7766654 3567999999999999999999999988 9999999999999 53 45789999
Q ss_pred cCCccccccccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 303 Fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
||+++.+.... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..|.
T Consensus 201 FG~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~ 270 (420)
T 1j1b_A 201 FGSAKQLVRGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 270 (420)
T ss_dssp CTTCEECCTTC-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred chhhhhcccCC-----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99998764332 12346789999999998764 79999999999999999999999999988777666554
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=300.99 Aligned_cols=201 Identities=17% Similarity=0.254 Sum_probs=171.2
Q ss_pred CCCCcCccccceeecCCceEEEEEEEC----------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceee---
Q 016152 153 DPSELDFSSSAIIGKGSFGEILKAYWR----------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ--- 219 (394)
Q Consensus 153 ~~~~~~~~~~~~iG~G~~g~V~~a~~~----------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~--- 219 (394)
+....+|++.+.||+|+||.||+|... ++.+|||.+... +.+.+|+.++++++||||++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~ 109 (352)
T 2jii_A 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWK 109 (352)
T ss_dssp CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhh
Confidence 444568999999999999999999874 678999988643 35678999999999999887
Q ss_pred ------------EEeEEEe-CCeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 016152 220 ------------FLGAVTE-RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK 284 (394)
Q Consensus 220 ------------~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dik 284 (394)
+++++.. +...++||||+ +++|.+++... +.+++.++..++.|++.||.|||+++ |+|||||
T Consensus 110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dik 186 (352)
T 2jii_A 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVT 186 (352)
T ss_dssp HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCC
T ss_pred hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCC
Confidence 6677665 67899999999 99999999875 78999999999999999999999988 9999999
Q ss_pred CCCEEEeeCCCC--cEEEeecCCcccccccccccc---ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcC
Q 016152 285 PRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG 359 (394)
Q Consensus 285 p~Nilv~~~~~~--~~kl~DFg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g 359 (394)
|+|||+ +.++ .+||+|||++..+........ .......||+.|+|||++.+..++.++||||||+++|||++|
T Consensus 187 p~NIl~--~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 264 (352)
T 2jii_A 187 AENIFV--DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG 264 (352)
T ss_dssp GGGEEE--ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred HHHEEE--cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999 6666 899999999987654432111 112345799999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 016152 360 EPPLANY 366 (394)
Q Consensus 360 ~~Pf~~~ 366 (394)
+.||...
T Consensus 265 ~~pf~~~ 271 (352)
T 2jii_A 265 FLPWTNC 271 (352)
T ss_dssp CCTTGGG
T ss_pred CCCcccC
Confidence 9999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=297.07 Aligned_cols=211 Identities=30% Similarity=0.529 Sum_probs=179.5
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC-----Ce
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KP 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~ 229 (394)
.+|++.+.||+|+||.||+|... +..||||.+... ......+.+.+|+.++++++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 37999999999999999999875 778999988643 2344457788999999999999999999998655 36
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
.++|||++.+ +|.+++.. +.+++.++..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++...
T Consensus 105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL--NTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEE--CCCCCEEEEeCcceEec
Confidence 8999999975 99999875 46999999999999999999999988 9999999999999 88889999999999876
Q ss_pred ccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....|.
T Consensus 179 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 245 (364)
T 3qyz_A 179 DPDHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245 (364)
T ss_dssp CGGGCBC-CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH
T ss_pred CCCCCcc-ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 5432211 12345689999999998654 558999999999999999999999999988777776665
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=318.15 Aligned_cols=228 Identities=28% Similarity=0.531 Sum_probs=190.5
Q ss_pred CCcCccccceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
...+|++.+.||+|+||.||+|.+. +..+|+|.+... ......+.+.+|+.++++++||||+++++++. ++.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3457899999999999999999874 345899977543 23445577899999999999999999999885 466
Q ss_pred eEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.++||||+++|+|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl--~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGDFGLSRY 540 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCCCCCCS
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEE--eCCCCEEEEecCCCee
Confidence 899999999999999998654 6999999999999999999999988 9999999999999 7778999999999987
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKG 387 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~ 387 (394)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.+.+..++...+..+.++.++. .
T Consensus 541 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~ 616 (656)
T 2j0j_A 541 MEDSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP-N 616 (656)
T ss_dssp CCC-------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT-T
T ss_pred cCCCcc---eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc-c
Confidence 643321 12233457889999999988899999999999999999997 999999999999999999888777664 4
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
+|++++
T Consensus 617 ~~~~l~ 622 (656)
T 2j0j_A 617 CPPTLY 622 (656)
T ss_dssp CCHHHH
T ss_pred ccHHHH
Confidence 677664
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=302.70 Aligned_cols=204 Identities=30% Similarity=0.433 Sum_probs=176.4
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC------CCCceeeEEeEEEeCC
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL------RHPNIVQFLGAVTERK 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l------~h~~Iv~~~~~~~~~~ 228 (394)
.+|++.+.||+|+||.||+|.+. ++.||||++... ....+.+.+|+.+++.+ .|+||+++++++....
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 37999999999999999999875 678999988542 33345677788888776 5779999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCc--EEEeecC
Q 016152 229 PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH--LKVGDFG 304 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~--~kl~DFg 304 (394)
.+++|||++. ++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++. +||+|||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl--~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILL--KQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEE--SSTTSCCEEECCCT
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--ccCCCcceEEeecc
Confidence 9999999996 59999998654 4999999999999999999999988 9999999999999 66555 9999999
Q ss_pred CccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
++...... .....||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....+.
T Consensus 248 ~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~ 312 (429)
T 3kvw_A 248 SSCYEHQR-------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312 (429)
T ss_dssp TCEETTCC-------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cceecCCc-------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99654322 234679999999999999999999999999999999999999999998887776665
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=294.54 Aligned_cols=215 Identities=28% Similarity=0.451 Sum_probs=159.4
Q ss_pred ccCCCCcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEE--
Q 016152 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVT-- 225 (394)
Q Consensus 151 ~i~~~~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~-- 225 (394)
.++....+|++.+.||+|+||.||++.+ .++.||||.+... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 4455566899999999999999999998 5789999988543 3444567889999999996 999999999984
Q ss_pred ------eCCeeEEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC
Q 016152 226 ------ERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (394)
Q Consensus 226 ------~~~~~~lv~e~~~~~sL~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~ 296 (394)
....+++||||+. |+|.+++.. .+.+++.++..++.|++.||.|||+++++|+||||||+|||+ +.++
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~--~~~~ 175 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL--SNQG 175 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE--CTTS
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE--CCCC
Confidence 3345899999996 599998865 467999999999999999999999976569999999999999 8888
Q ss_pred cEEEeecCCccccccccccc--------cccccCCccCccccCcccc---CCCCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 016152 297 HLKVGDFGLSKLIKVQNSHD--------VYKMTGETGSYRYMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPPLAN 365 (394)
Q Consensus 297 ~~kl~DFg~a~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGv~l~el~~g~~Pf~~ 365 (394)
.+||+|||++.......... ........||+.|+|||++ .+..++.++||||||+++|+|++|+.||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999998765332111 0011245689999999998 566789999999999999999999999987
Q ss_pred CCHHHH
Q 016152 366 YEPYEA 371 (394)
Q Consensus 366 ~~~~~~ 371 (394)
....+.
T Consensus 256 ~~~~~~ 261 (337)
T 3ll6_A 256 GAKLRI 261 (337)
T ss_dssp ------
T ss_pred hhHHHh
Confidence 655443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=291.08 Aligned_cols=218 Identities=24% Similarity=0.392 Sum_probs=176.2
Q ss_pred ccCCCCcCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC--CCceeeEEeEEEeC
Q 016152 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLGAVTER 227 (394)
Q Consensus 151 ~i~~~~~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~ 227 (394)
.+.....+|++.+.||+|+||.||++... ++.+|||.+..... .....+.+.+|+.++++++ ||||+++++++...
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 44555668999999999999999999875 77899998865443 3445678899999999997 59999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
..+++||| +.+++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||++ + ++.+||+|||++.
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~--~-~~~~kL~Dfg~~~ 174 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI--V-DGMLKLIDFGIAN 174 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--E-TTEEEECCCSSSC
T ss_pred CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEE--E-CCeEEEeeccccc
Confidence 99999999 567899999998888999999999999999999999988 9999999999999 3 3789999999998
Q ss_pred ccccccccccccccCCccCccccCccccCC-----------CCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHH
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKH-----------RKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYV 375 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGv~l~el~~g~~Pf~~~~-~~~~~~~i 375 (394)
........ .......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.... .......+
T Consensus 175 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 175 QMQPDTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp C----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccCcccc--ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 76533211 11234578999999999875 468889999999999999999999998753 33444444
Q ss_pred Hc
Q 016152 376 AE 377 (394)
Q Consensus 376 ~~ 377 (394)
..
T Consensus 253 ~~ 254 (313)
T 3cek_A 253 ID 254 (313)
T ss_dssp HC
T ss_pred Hh
Confidence 43
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=293.00 Aligned_cols=199 Identities=30% Similarity=0.530 Sum_probs=164.6
Q ss_pred cCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC--CCCceeeEEeEEEeC----Cee
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL--RHPNIVQFLGAVTER----KPL 230 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l--~h~~Iv~~~~~~~~~----~~~ 230 (394)
.+|++.+.||+|+||.||+|.++++.||||++.... ......|.+++... +||||+++++++... ..+
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 379999999999999999999999999999884321 13344455555554 899999999999877 689
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC--------CCCeEecCCCCCCEEEeeCCCCcEEEee
Q 016152 231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE--------PNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~--------~~~ivH~Dikp~Nilv~~~~~~~~kl~D 302 (394)
++||||+++++|.++++.. .+++..+..++.|++.||.|||++ + |+||||||+|||+ +.++.+||+|
T Consensus 111 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill--~~~~~~kl~D 185 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILV--KKNGTCCIAD 185 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEE--CTTSCEEECC
T ss_pred EEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEE--CCCCCEEEEe
Confidence 9999999999999999754 699999999999999999999998 7 9999999999999 8888999999
Q ss_pred cCCccccccccccccccccCCccCccccCccccCCCCCCCc------chHHHHHHHHHHHHcC----------CCCCCCC
Q 016152 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKK------VDVFSFAMILYEMLEG----------EPPLANY 366 (394)
Q Consensus 303 Fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslGv~l~el~~g----------~~Pf~~~ 366 (394)
||++..+...............||+.|+|||++.+..++.+ +|||||||++|||++| +.||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99998765443322222345679999999999988776655 9999999999999999 7888653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=293.14 Aligned_cols=229 Identities=27% Similarity=0.493 Sum_probs=164.8
Q ss_pred CCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHH-HHHhCCCCceeeEEeEEEeCCe
Q 016152 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN-LLVKLRHPNIVQFLGAVTERKP 229 (394)
Q Consensus 153 ~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~-~l~~l~h~~Iv~~~~~~~~~~~ 229 (394)
.....+|++.+.||+|+||.||+|... |+.||||.+..... ......+..|+. +++.++||||+++++++...+.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 344558999999999999999999986 88999998865432 223344555555 7777899999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 230 LMLITEYLRGGDLHKYLKE-----KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
.++||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+. | |+||||||+||++ +.++.+||+||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll--~~~~~~kl~Df 170 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILL--DRSGNIKLCDF 170 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEE--ETTTEEEECCC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEE--cCCCCEEEccC
Confidence 9999999976 88888763 56799999999999999999999998 8 9999999999999 78889999999
Q ss_pred CCccccccccccccccccCCccCccccCcccc----CCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcC
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYE-PYEAAKYVAEG 378 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~-~~~~~~~i~~g 378 (394)
|++........ .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||...+ ..+....+..+
T Consensus 171 g~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (327)
T 3aln_A 171 GISGQLVDSIA-----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG 245 (327)
T ss_dssp SSSCC-----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS
T ss_pred CCceecccccc-----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC
Confidence 99987653321 2234689999999998 45678999999999999999999999998754 33555556667
Q ss_pred CCCCCCC---CCCCcccc
Q 016152 379 HRPFFRA---KGFTPELR 393 (394)
Q Consensus 379 ~~p~~~~---~~~~~~~~ 393 (394)
.+|.++. ..++++++
T Consensus 246 ~~~~~~~~~~~~~~~~l~ 263 (327)
T 3aln_A 246 DPPQLSNSEEREFSPSFI 263 (327)
T ss_dssp CCCCCCCCSSCCCCHHHH
T ss_pred CCCCCCCcccccCCHHHH
Confidence 6666554 34566554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=287.56 Aligned_cols=205 Identities=33% Similarity=0.573 Sum_probs=174.5
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe---------
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--------- 226 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--------- 226 (394)
+|++.+.||+|+||.||+|.+. ++.+|+|.+.... ..+.+|+.++++++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 6889999999999999999985 8899999886542 345689999999999999999998854
Q ss_pred -------CCeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCc
Q 016152 227 -------RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297 (394)
Q Consensus 227 -------~~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~ 297 (394)
...+++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFL--VDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEE--cCCCC
Confidence 44589999999999999999754 57999999999999999999999988 9999999999999 67789
Q ss_pred EEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 298 ~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
+||+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||.. ..+....+..
T Consensus 161 ~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~ 233 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG-----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRD 233 (284)
T ss_dssp EEECCCTTCEESSCCS-----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHT
T ss_pred EEECcchhheeccccc-----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhc
Confidence 9999999998765432 12345689999999999999999999999999999999999998853 2344455555
Q ss_pred CCC
Q 016152 378 GHR 380 (394)
Q Consensus 378 g~~ 380 (394)
+..
T Consensus 234 ~~~ 236 (284)
T 2a19_B 234 GII 236 (284)
T ss_dssp TCC
T ss_pred ccc
Confidence 443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=286.45 Aligned_cols=224 Identities=30% Similarity=0.463 Sum_probs=178.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|....+||+|+||.||+|.+. +..||||.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 3444558999999999999974 67899998865432 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC-CCcEEEeecCCcccccc
Q 016152 236 YLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~-~~~~kl~DFg~a~~~~~ 311 (394)
|+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||++ +. ++.+||+|||++.....
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLI--NTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTTCCEEECCTTTCEESCC
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEE--ECCCCCEEEeecccccccCC
Confidence 999999999998652 4678999999999999999999988 9999999999999 55 78999999999986643
Q ss_pred ccccccccccCCccCccccCccccCCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCCCCCCCCC
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYEPY--EAAKYVAEGHRPFFRAKG 387 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~--~~~~~i~~g~~p~~~~~~ 387 (394)
... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||...... ...........|.++ ..
T Consensus 176 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~ 250 (295)
T 2clq_A 176 INP----CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP-ES 250 (295)
T ss_dssp ---------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC-TT
T ss_pred CCC----cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc-cc
Confidence 221 12345789999999998764 3889999999999999999999999765322 222333344555554 33
Q ss_pred CCcccc
Q 016152 388 FTPELR 393 (394)
Q Consensus 388 ~~~~~~ 393 (394)
++++++
T Consensus 251 ~~~~~~ 256 (295)
T 2clq_A 251 MSAEAK 256 (295)
T ss_dssp SCHHHH
T ss_pred CCHHHH
Confidence 666554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=299.51 Aligned_cols=205 Identities=26% Similarity=0.448 Sum_probs=170.6
Q ss_pred CcCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC------
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------ 228 (394)
..+|++.+.||+|+||.||+|.+. +..+|+|.+....... .+|+.+++.++||||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~-------~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK-------NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSC-------CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchH-------HHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 347999999999999999999984 5568998876543222 36999999999999999999986543
Q ss_pred eeEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeec
Q 016152 229 PLMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDF 303 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DF 303 (394)
.+++||||+.+ ++.+.+. ....+++..++.++.|++.||.|||++| |+||||||+|||+ + .++.+||+||
T Consensus 112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill--~~~~~~~kL~DF 186 (394)
T 4e7w_A 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLL--DPPSGVLKLIDF 186 (394)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--ETTTTEEEECCC
T ss_pred EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEE--cCCCCcEEEeeC
Confidence 38899999987 4444333 3567999999999999999999999988 9999999999999 6 6789999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
|++..+.... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+....|.+
T Consensus 187 G~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~ 256 (394)
T 4e7w_A 187 GSAKILIAGE-----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256 (394)
T ss_dssp TTCEECCTTC-----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCcccccCCC-----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9998764332 22346789999999998765 589999999999999999999999999988777766653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=290.90 Aligned_cols=202 Identities=23% Similarity=0.294 Sum_probs=169.7
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeE-EEeCCeeEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA-VTERKPLMLI 233 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~-~~~~~~~~lv 233 (394)
.+|++.+.||+|+||.||+|.+ .++.||||++...... ..+.+|+.+++.++|++++..+.+ .......++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 3799999999999999999996 4889999988654433 347789999999998876655554 4667788999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEe-eCCCCcEEEeecCCcccccc
Q 016152 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~-~~~~~~~kl~DFg~a~~~~~ 311 (394)
|||+ +++|.+++.. .+.+++.++..++.|++.||.|||+++ |+||||||+|||+. .+.++.+||+|||++.....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 9999 8899999974 457999999999999999999999988 99999999999993 12567899999999987664
Q ss_pred cccccc---ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 312 QNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 312 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 432111 1124567999999999999999999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=289.80 Aligned_cols=205 Identities=25% Similarity=0.401 Sum_probs=176.7
Q ss_pred CccccceeecCCceEEEEEEE---CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCC------ceeeEEeEEEeCC
Q 016152 158 DFSSSAIIGKGSFGEILKAYW---RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP------NIVQFLGAVTERK 228 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~---~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~------~Iv~~~~~~~~~~ 228 (394)
+|++.+.||+|+||.||+|.. .++.||||++... ....+.+.+|+.+++.++|+ +++++++++...+
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 799999999999999999986 3778999988532 33446788899999888655 5999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC------------
Q 016152 229 PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS------------ 294 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~------------ 294 (394)
.+++||||+ +++|.+++...+ .+++.++..++.|++.||.|||+++ |+||||||+|||+....
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCccccc
Confidence 999999999 889999998765 6899999999999999999999988 99999999999993222
Q ss_pred -----CCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH
Q 016152 295 -----ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 369 (394)
Q Consensus 295 -----~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~ 369 (394)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|..||...+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH-------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC-------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccCCCceEeeCcccccCccc-------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999764322 23457899999999999999999999999999999999999999998877
Q ss_pred HHHHHHH
Q 016152 370 EAAKYVA 376 (394)
Q Consensus 370 ~~~~~i~ 376 (394)
+....+.
T Consensus 241 ~~~~~~~ 247 (339)
T 1z57_A 241 EHLAMME 247 (339)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7666554
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=292.62 Aligned_cols=230 Identities=28% Similarity=0.484 Sum_probs=185.0
Q ss_pred CCcCccccceeecCCceEEEEEEE------CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~------~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
...+|++.+.||+|+||.||++.+ .++.||||.+... .....+.+.+|+.++++++||||+++++++...+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 345789999999999999999985 4778999988653 2334577899999999999999999999886644
Q ss_pred --eeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 229 --PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 229 --~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
.+++||||+++++|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||+
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli--~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV--ENENRVKIGDFGL 191 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--EETTEEEECCCTT
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEE--cCCCcEEEecCcc
Confidence 789999999999999999875 46999999999999999999999988 9999999999999 7778999999999
Q ss_pred ccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH----------------H
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP----------------Y 369 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~----------------~ 369 (394)
+.......... .......++..|+|||.+.+..++.++||||||+++|||++|..||..... .
T Consensus 192 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 192 TKVLPQDKEYY-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp CEECCSSCSEE-ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred hhhcccccccc-ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 98765432211 112334578889999999888899999999999999999999999864311 1
Q ss_pred HHHHHHHcCCCCCCCCCCCCcccc
Q 016152 370 EAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 370 ~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
++.+.+..+.++..+ ..+|++++
T Consensus 271 ~~~~~~~~~~~~~~~-~~~~~~l~ 293 (326)
T 2w1i_A 271 HLIELLKNNGRLPRP-DGCPDEIY 293 (326)
T ss_dssp HHHHHHHTTCCCCCC-TTCCHHHH
T ss_pred HHHHHhhcCCCCCCC-CcccHHHH
Confidence 233445555555444 34676654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=291.62 Aligned_cols=205 Identities=24% Similarity=0.398 Sum_probs=169.9
Q ss_pred CCCcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe----C
Q 016152 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----R 227 (394)
Q Consensus 154 ~~~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~ 227 (394)
....+|++.+.||+|+||.||++.. .++.||||.+... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 3455899999999999999999996 4889999988543 34455778899999999999999999998863 3
Q ss_pred CeeEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 228 KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
...++||||+++++|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+||++ +.++.+||+||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~--~~~~~~kl~df 178 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILL--GDEGQPVLMDL 178 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCC
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--cCCCCEEEEec
Confidence 478999999999999999875 467999999999999999999999988 9999999999999 88889999999
Q ss_pred CCccccccccccc-----cccccCCccCccccCccccCCCC---CCCcchHHHHHHHHHHHHcCCCCCCC
Q 016152 304 GLSKLIKVQNSHD-----VYKMTGETGSYRYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPPLAN 365 (394)
Q Consensus 304 g~a~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGv~l~el~~g~~Pf~~ 365 (394)
|++.......... ........||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||..
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 9987653221100 00112345799999999987554 68999999999999999999999954
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=295.66 Aligned_cols=205 Identities=27% Similarity=0.495 Sum_probs=175.5
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee----
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL---- 230 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~---- 230 (394)
.+|.+.+.||+|+||.||+|.+. |+.||||.+..... .....+.+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 37899999999999999999875 78999998865443 344557788999999999999999999999877655
Q ss_pred --EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 231 --MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 231 --~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
++||||+. ++|.+++. ..+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll--~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAV--NEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEE--CCCCCEEEEecCcccc
Confidence 99999997 58888773 34999999999999999999999988 9999999999999 8888999999999976
Q ss_pred cccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
.... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 194 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 255 (371)
T 4exu_A 194 ADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 255 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccC-------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 5422 234678999999999987 688999999999999999999999999998888777765
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=288.28 Aligned_cols=191 Identities=24% Similarity=0.467 Sum_probs=166.7
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEe--CCeeE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTE--RKPLM 231 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~--~~~~~ 231 (394)
.+|++.+.||+|+||.||+|.. .++.+|||++.... .+.+.+|+.++++++ ||||+++++++.+ ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 4699999999999999999987 47899999885322 256889999999997 9999999999987 66789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC-cEEEeecCCccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIK 310 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~-~~kl~DFg~a~~~~ 310 (394)
+||||+.+++|.+++. .+++.++..++.|++.||.|||++| |+||||||+|||+ +.++ .+||+|||++....
T Consensus 110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~--~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTTTEEEECCCTTCEECC
T ss_pred EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--cCCCCEEEEEeCCCceEcC
Confidence 9999999999999874 3899999999999999999999988 9999999999999 5454 89999999998665
Q ss_pred cccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLAN 365 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~ 365 (394)
... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||..
T Consensus 183 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 183 PGQ-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp TTC-----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCC-----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 332 2334678999999999877 6789999999999999999999999943
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=294.17 Aligned_cols=209 Identities=32% Similarity=0.446 Sum_probs=178.4
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CC-----ceeeEEeEEEeCC
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HP-----NIVQFLGAVTERK 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~Iv~~~~~~~~~~ 228 (394)
.+|++.+.||+|+||.||+|... ++.||||++... ......+..|+.+++.++ |+ +|+++++++...+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 47999999999999999999875 778999988532 333466777888888775 44 4999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCc
Q 016152 229 PLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a 306 (394)
.+++||||+.+ +|.+++... +.+++..+..++.|++.||.|||+...+|+||||||+|||+..+..+.+||+|||++
T Consensus 130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99999999965 999999865 469999999999999999999995222399999999999995555778999999999
Q ss_pred cccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
...... .....||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....|.+
T Consensus 209 ~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 272 (382)
T 2vx3_A 209 CQLGQR-------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272 (382)
T ss_dssp EETTCC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eecccc-------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 866422 2346789999999999999999999999999999999999999999998888877764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=287.55 Aligned_cols=228 Identities=26% Similarity=0.442 Sum_probs=173.3
Q ss_pred CCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
...+|++.+.||+|+||.||+|.+. |+.||||.+..... .....+.+.++..+++.++||||+++++++.+.+.+++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 3448899999999999999999984 88999998865433 23333445556667888899999999999999999999
Q ss_pred EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 233 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
||||+ ++.+..+... .+.+++..+..++.|++.||.|||++ | |+||||||+||++ +.++.+||+|||++....
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILL--DERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEE--CTTSCEEECCCTTC----
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEE--CCCCCEEEEECCCchhcc
Confidence 99999 5566666554 56799999999999999999999995 8 9999999999999 888899999999997664
Q ss_pred cccccccccccCCccCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~~g~~Pf~~-~~~~~~~~~i~~g~~p~~~ 384 (394)
.... .....+|+.|+|||.+. ...++.++||||||+++|+|++|+.||.. .+..+....+..+.+|.++
T Consensus 177 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (318)
T 2dyl_A 177 DDKA-----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP 251 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC
T ss_pred CCcc-----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC
Confidence 3321 23456899999999984 45788999999999999999999999987 4567788888888877776
Q ss_pred C-CCCCcccc
Q 016152 385 A-KGFTPELR 393 (394)
Q Consensus 385 ~-~~~~~~~~ 393 (394)
. ..+|++++
T Consensus 252 ~~~~~~~~l~ 261 (318)
T 2dyl_A 252 GHMGFSGDFQ 261 (318)
T ss_dssp SSSCCCHHHH
T ss_pred ccCCCCHHHH
Confidence 5 35677664
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=290.50 Aligned_cols=212 Identities=30% Similarity=0.489 Sum_probs=176.6
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC-----Ce
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KP 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~ 229 (394)
.+|++.+.||+|+||.||+|.+. |+.||||.+... ........+.+|+.+++.++||||+++++++... ..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 47999999999999999999986 788999988543 3344456788999999999999999999987654 67
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
.++|||++. ++|.+++.. +.+++..+..++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++...
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~--~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLI--NSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--cCCCcEEEEeccccccc
Confidence 899999997 599999876 46999999999999999999999988 9999999999999 88889999999999876
Q ss_pred cccccccc------ccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 310 KVQNSHDV------YKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 310 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
........ .......||+.|+|||++.+ ..++.++||||||+++|+|++|++||.+.+..+....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 236 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 53321110 01234578999999998754 678999999999999999999999999988766665553
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=304.38 Aligned_cols=212 Identities=24% Similarity=0.297 Sum_probs=175.0
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC-CceeeEEeEEEeCCeeEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~~~~~~lv 233 (394)
.+|++.+.||+|+||.||+|.+. ++.||||++...... ..+..|+.+++.++| ++|..+..++......++|
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 37999999999999999999974 889999987654332 346789999999987 5666666677788889999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-CCCCcEEEeecCCcccccc
Q 016152 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-~~~~~~kl~DFg~a~~~~~ 311 (394)
|||+ +++|.+++.. .+.+++.+++.++.||+.||.|||+++ |+||||||+|||+.. +..+.+||+|||++..+..
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 9999 8899999985 567999999999999999999999988 999999999999932 2567899999999987765
Q ss_pred cccccc---ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHH
Q 016152 312 QNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE---PYEAAKYVA 376 (394)
Q Consensus 312 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~---~~~~~~~i~ 376 (394)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+.+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh
Confidence 432211 11235679999999999999999999999999999999999999998754 334444443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=290.52 Aligned_cols=216 Identities=29% Similarity=0.500 Sum_probs=177.5
Q ss_pred CccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHh--CCCCceeeEEeEEEeCC----eeE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK--LRHPNIVQFLGAVTERK----PLM 231 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~--l~h~~Iv~~~~~~~~~~----~~~ 231 (394)
+|++.+.||+|+||.||++.++++.||||.+... ....+.+|.++++. ++||||+++++++.... .++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 43 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred cEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 7899999999999999999999999999988532 12556778888887 78999999999998776 789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH--------NEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH--------~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
+||||+++++|.+++.+. .+++.++..++.|++.||.||| +.+ |+||||||+|||+ +.++.+||+||
T Consensus 117 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll--~~~~~~kL~Df 191 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILV--KKNGTCCIADL 191 (342)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEE--CTTSCEEECCC
T ss_pred EEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEE--CCCCCEEEEEC
Confidence 999999999999999764 6899999999999999999999 777 9999999999999 88889999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCCC------CCCCcchHHHHHHHHHHHHcC----------CCCCCCC-
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR------KYDKKVDVFSFAMILYEMLEG----------EPPLANY- 366 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGv~l~el~~g----------~~Pf~~~- 366 (394)
|++..................||+.|+|||++.+. .++.++||||||+++|||++| ..||...
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 99987654432221123456799999999999765 234789999999999999999 8899764
Q ss_pred ----CHHHHHHHHH-cCCCCCCC
Q 016152 367 ----EPYEAAKYVA-EGHRPFFR 384 (394)
Q Consensus 367 ----~~~~~~~~i~-~g~~p~~~ 384 (394)
...+..+.+. ...+|.++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~ 294 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIP 294 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCC
T ss_pred cCcccHHHHHHHHHHHHhCCCCc
Confidence 2344445443 34445444
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=298.47 Aligned_cols=198 Identities=12% Similarity=0.144 Sum_probs=154.7
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC--CCCceeeEE-------eEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL--RHPNIVQFL-------GAVTE 226 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l--~h~~Iv~~~-------~~~~~ 226 (394)
.|.+.+.||+|+||.||+|.+. ++.||||++...........+.+.+|+.+++.+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 5899999999999999999974 788999999876655556667788885544444 699988755 44443
Q ss_pred C-----------------CeeEEEEeccCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHcCCCCeEecC
Q 016152 227 R-----------------KPLMLITEYLRGGDLHKYLKEK-GALSPSTA------VNFALDIARGMAYLHNEPNVIIHRD 282 (394)
Q Consensus 227 ~-----------------~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~------~~~~~ql~~~l~~lH~~~~~ivH~D 282 (394)
. ..+++||||++ ++|.+++... ..+..... ..++.||+.||.|||+++ |+|||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrD 219 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGH 219 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETT
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCc
Confidence 3 33899999998 7999999864 33444555 577799999999999988 99999
Q ss_pred CCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCC
Q 016152 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGE 360 (394)
Q Consensus 283 ikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~ 360 (394)
|||+|||+ +.++.+||+|||++....... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 220 ikp~NIll--~~~~~~kL~DFG~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 220 FTPDNLFI--MPDGRLMLGDVSALWKVGTRG-------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp CSGGGEEE--CTTSCEEECCGGGEEETTCEE-------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CCHHHEEE--CCCCCEEEEecceeeecCCCc-------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999 888899999999998654221 13456799999999987 68999999999999999999999
Q ss_pred CCCCCCC
Q 016152 361 PPLANYE 367 (394)
Q Consensus 361 ~Pf~~~~ 367 (394)
.||...+
T Consensus 291 ~Pf~~~~ 297 (371)
T 3q60_A 291 LPFGLVT 297 (371)
T ss_dssp CSTTBCC
T ss_pred CCCCCcC
Confidence 9998764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=293.35 Aligned_cols=207 Identities=28% Similarity=0.416 Sum_probs=162.7
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe-----
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP----- 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~----- 229 (394)
.+|++.+.||+|+||.||+|.+. ++.||||.+....... ....+++..++.++||||+++++++.....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 37999999999999999999975 7899999886543322 345667888888999999999999865433
Q ss_pred --eEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--cCCCCeEecCCCCCCEEEeeCC-CCcEEE
Q 016152 230 --LMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSS-ADHLKV 300 (394)
Q Consensus 230 --~~lv~e~~~~~sL~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH--~~~~~ivH~Dikp~Nilv~~~~-~~~~kl 300 (394)
+++||||+.+ +|.+.+. ....+++..+..++.|++.||.||| ++| |+||||||+|||+ +. ++.+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll--~~~~~~~kl 173 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLV--NEADGTLKL 173 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEE--ETTTTEEEE
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEE--eCCCCcEEE
Confidence 8899999987 6554443 4567899999999999999999999 877 9999999999999 54 789999
Q ss_pred eecCCccccccccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 301 ~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|++||...+..+....+.+
T Consensus 174 ~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 174 CDFGSAKKLSPSEP-----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp CCCTTCBCCCTTSC-----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eeCCCceecCCCCC-----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 99999987654321 2345789999999998765 489999999999999999999999999988887777653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=293.90 Aligned_cols=210 Identities=28% Similarity=0.482 Sum_probs=171.4
Q ss_pred cCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCC--------cHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe-
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSD--------DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE- 226 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~- 226 (394)
.+|++.+.||+|+||.||+|... |..||||.+...... .....+.+.+|+.++++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 37999999999999999999764 788999988653322 23345778999999999999999999999854
Q ss_pred ----CCeeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEe
Q 016152 227 ----RKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (394)
Q Consensus 227 ----~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~ 301 (394)
...+++||||+. ++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~--~~~~~~kl~ 176 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILL--ADNNDITIC 176 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEEC
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEE--cCCCCEEEE
Confidence 236899999997 5888888754 46999999999999999999999988 9999999999999 888899999
Q ss_pred ecCCccccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 302 DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
|||++....... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 177 Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 177 DFNLAREDTADA-----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp CTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ecCccccccccc-----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999997544322 2234578999999999877 678999999999999999999999999998888777765
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=298.50 Aligned_cols=202 Identities=25% Similarity=0.467 Sum_probs=154.0
Q ss_pred Cccc-cceeecCCceEEEEEEEC----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe--CCee
Q 016152 158 DFSS-SAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPL 230 (394)
Q Consensus 158 ~~~~-~~~iG~G~~g~V~~a~~~----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~ 230 (394)
.|.+ +++||+|+||.||+|.+. +..||||.+...... ..+.+|+.+++.++||||+++++++.. ...+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 3555 568999999999999964 678999988654332 456789999999999999999999954 6789
Q ss_pred EEEEeccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee--CCCCcEE
Q 016152 231 MLITEYLRGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLK 299 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~--~~~~~~k 299 (394)
++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+.. +..+.+|
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEE
Confidence 999999965 888887632 24999999999999999999999988 999999999999943 3457899
Q ss_pred EeecCCccccccccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCH
Q 016152 300 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEP 368 (394)
Q Consensus 300 l~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~ 368 (394)
|+|||++..+..... .........||+.|+|||++.+. .++.++|||||||++|||++|++||...+.
T Consensus 173 l~Dfg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 173 IADMGFARLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp ECCTTCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EEECCCceecCCCCc-ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 999999987653221 11123456799999999999874 589999999999999999999999976543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=287.47 Aligned_cols=212 Identities=28% Similarity=0.499 Sum_probs=171.8
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE---------
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT--------- 225 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~--------- 225 (394)
.+|++.+.||+|+||.||+|... ++.||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 37999999999999999999986 788999988543 3445577889999999999999999999873
Q ss_pred -----eCCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEE
Q 016152 226 -----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLK 299 (394)
Q Consensus 226 -----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~k 299 (394)
+....++||||++ ++|.+++.. +.+++..+..++.|++.||+|||++| |+||||||+||++ + .++.+|
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~k 161 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFI--NTEDLVLK 161 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEE--ETTTTEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--cCCCCeEE
Confidence 3467899999997 599998864 57999999999999999999999988 9999999999999 4 456899
Q ss_pred EeecCCccccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Q 016152 300 VGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378 (394)
Q Consensus 300 l~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g 378 (394)
|+|||++.......... .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+....+.+.
T Consensus 162 l~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHK-GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp ECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EccCccccccCCCcccc-cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999998764322111 12234567999999998865 67899999999999999999999999999888877777654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=288.69 Aligned_cols=211 Identities=29% Similarity=0.528 Sum_probs=176.1
Q ss_pred CcCccccceeecCCceEEEEEEEC---CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC---CCCceeeEEeEEE----
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVT---- 225 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~---g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~---- 225 (394)
..+|++.+.||+|+||.||+|.+. ++.||+|.+........ ....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 347999999999999999999873 67899998864332211 012344566666555 8999999999987
Q ss_pred -eCCeeEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEee
Q 016152 226 -ERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (394)
Q Consensus 226 -~~~~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~D 302 (394)
....+++||||+. ++|.+++.... .+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili--~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILV--TSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEE--cCCCCEEEec
Confidence 5567899999997 59999998753 4999999999999999999999988 9999999999999 8888999999
Q ss_pred cCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 303 Fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
||++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|++||...+..+....+.+
T Consensus 164 fg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (326)
T 1blx_A 164 FGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233 (326)
T ss_dssp CCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CcccccccCCC-----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 99998664322 23456789999999999999999999999999999999999999999988887777753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=288.69 Aligned_cols=203 Identities=23% Similarity=0.295 Sum_probs=167.2
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeE-EEeCCeeEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA-VTERKPLMLI 233 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~-~~~~~~~~lv 233 (394)
.+|++.+.||+|+||.||+|.+ .++.||||++...... ..+.+|+.+++.++|++++..+.. +......++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3799999999999999999996 4788999986543322 346789999999998876666654 4677788999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEe-eCCCCcEEEeecCCcccccc
Q 016152 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~-~~~~~~~kl~DFg~a~~~~~ 311 (394)
|||+ +++|.+++.. .+.+++.++..++.|++.||.|||+++ |+||||||+|||+. .+..+.+||+|||++.....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 9999 8899999985 457999999999999999999999988 99999999999992 23567899999999987654
Q ss_pred cccccc---ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 312 QNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 312 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
...... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 432111 12235679999999999999999999999999999999999999997643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=291.83 Aligned_cols=199 Identities=30% Similarity=0.524 Sum_probs=143.6
Q ss_pred Cccccc-eeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe----CCee
Q 016152 158 DFSSSA-IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RKPL 230 (394)
Q Consensus 158 ~~~~~~-~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~~ 230 (394)
+|.+.+ .||+|+||.||+|.+. ++.||||++... . ....+....++.++||||+++++++.. ...+
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 688754 6999999999999986 889999988542 1 112223344667899999999999876 4558
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCcc
Q 016152 231 MLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSK 307 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a~ 307 (394)
++||||+++++|.+++...+ .+++.+++.++.|++.||.|||++| |+||||||+|||+..+ ..+.+||+|||++.
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999999999999998754 6999999999999999999999988 9999999999999432 24569999999997
Q ss_pred ccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~ 371 (394)
...... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||...+....
T Consensus 180 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 180 ETTQNA------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp EC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred eccccc------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh
Confidence 654321 2345689999999999888899999999999999999999999977665443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=294.15 Aligned_cols=195 Identities=24% Similarity=0.393 Sum_probs=166.9
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC--------CCceeeEEeEEE-
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--------HPNIVQFLGAVT- 225 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~Iv~~~~~~~- 225 (394)
.+|++.+.||+|+||.||+|... ++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 47999999999999999999874 778999988532 344567888999999885 788999999987
Q ss_pred ---eCCeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCCEEEeeCCCC---
Q 016152 226 ---ERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSAD--- 296 (394)
Q Consensus 226 ---~~~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~-~~~ivH~Dikp~Nilv~~~~~~--- 296 (394)
....+++||||+ +++|.+++... +.+++..++.++.||+.||.|||++ | |+||||||+|||+ +.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll--~~~~~~~ 187 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILL--SVNEQYI 187 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEE--CCCHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeE--eccchhh
Confidence 556799999999 55777766654 5699999999999999999999998 8 9999999999999 5443
Q ss_pred ----------------------------------------------cEEEeecCCccccccccccccccccCCccCcccc
Q 016152 297 ----------------------------------------------HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330 (394)
Q Consensus 297 ----------------------------------------------~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~ 330 (394)
.+||+|||++...... .....||+.|+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~gt~~y~ 260 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCSCGGGC
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCCCCccc
Confidence 7999999999866432 23457899999
Q ss_pred CccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 331 aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
|||++.+..++.++|||||||++|||++|++||...+
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999999999999999999999999999997654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=292.46 Aligned_cols=197 Identities=32% Similarity=0.509 Sum_probs=159.2
Q ss_pred CcCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHH--HHhCCCCceeeEEeEEEe-----CC
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL--LVKLRHPNIVQFLGAVTE-----RK 228 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~--l~~l~h~~Iv~~~~~~~~-----~~ 228 (394)
..+|++.+.||+|+||.||+|..+++.||||++.... ...+..|.++ +..++||||+++++.+.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 3489999999999999999999999999999885321 1333444444 445899999999986532 23
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC---------CCCeEecCCCCCCEEEeeCCCCcEE
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE---------PNVIIHRDLKPRNVLLVNSSADHLK 299 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---------~~~ivH~Dikp~Nilv~~~~~~~~k 299 (394)
.+++||||+++|+|.+++.... .++..+..++.|++.||.|||+. + |+||||||+|||+ +.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill--~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLV--KNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEE--CTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEE--cCCCcEE
Confidence 5789999999999999997654 58999999999999999999998 7 9999999999999 8888999
Q ss_pred EeecCCcccccccccc----ccccccCCccCccccCccccCC-------CCCCCcchHHHHHHHHHHHHcCCCCC
Q 016152 300 VGDFGLSKLIKVQNSH----DVYKMTGETGSYRYMAPEVFKH-------RKYDKKVDVFSFAMILYEMLEGEPPL 363 (394)
Q Consensus 300 l~DFg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGv~l~el~~g~~Pf 363 (394)
|+|||++..+...... .........||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 9999999876532211 1112234579999999999986 45678999999999999999997665
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=289.70 Aligned_cols=204 Identities=27% Similarity=0.496 Sum_probs=173.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe------
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP------ 229 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~------ 229 (394)
+|.+.+.||+|+||.||+|.+. |+.||||.+..... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 7999999999999999999874 78999999865443 34445778899999999999999999999987654
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
+++||||+. ++|.+++. ..+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++...
T Consensus 104 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~--~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAV--NEDCELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEE--CTTCCEEECSTTCTTC-
T ss_pred EEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeE--CCCCcEEEeecccccCC
Confidence 499999997 48888774 35999999999999999999999988 9999999999999 88889999999999765
Q ss_pred ccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 177 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~ 237 (353)
T 3coi_A 177 DAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237 (353)
T ss_dssp --------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHH
T ss_pred CCC-------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 422 234578999999999877 678999999999999999999999999988777766654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=292.28 Aligned_cols=205 Identities=28% Similarity=0.469 Sum_probs=173.1
Q ss_pred cCCCCcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcH---HHHHHHHHHHHHHHhCC--CCceeeEEeEE
Q 016152 152 IDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLR--HPNIVQFLGAV 224 (394)
Q Consensus 152 i~~~~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~ 224 (394)
.+....+|++.+.||+|+||.||+|.+ .++.||||.+........ ...+.+.+|+.++++++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 344455899999999999999999987 478899999865432210 01134567899999986 59999999999
Q ss_pred EeCCeeEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEee
Q 016152 225 TERKPLMLITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGD 302 (394)
Q Consensus 225 ~~~~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~D 302 (394)
...+..++|||++.+ ++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ + .++.+||+|
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~~kL~D 193 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILI--DLNRGELKLID 193 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTTTEEEECC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEE--eCCCCCEEEee
Confidence 999999999999976 899999998889999999999999999999999988 9999999999999 5 668999999
Q ss_pred cCCccccccccccccccccCCccCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCC
Q 016152 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANY 366 (394)
Q Consensus 303 Fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~Pf~~~ 366 (394)
||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus 194 fg~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 194 FGSGALLKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp CTTCEECCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred Ccccccccccc------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 99998765321 234579999999999876665 68899999999999999999999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=279.44 Aligned_cols=210 Identities=30% Similarity=0.522 Sum_probs=167.8
Q ss_pred CccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe---------
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--------- 226 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--------- 226 (394)
+|++.+.||+|+||.||+|.. .++.+|||.+.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 688999999999999999997 478899998843 23445778899999999999999999998765
Q ss_pred ----CCeeEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEe
Q 016152 227 ----RKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (394)
Q Consensus 227 ----~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~ 301 (394)
...+++||||+++++|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~--~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFI--DESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEE--cCCCCEEEe
Confidence 356899999999999999998654 5788999999999999999999988 9999999999999 888899999
Q ss_pred ecCCcccccccccc----------ccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCC-CCHH
Q 016152 302 DFGLSKLIKVQNSH----------DVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLAN-YEPY 369 (394)
Q Consensus 302 DFg~a~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~-~~~~ 369 (394)
|||++......... .........||+.|+|||++.+. .++.++||||||+++|+|++ ||.. .+..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 99999866432100 01122345689999999999864 68999999999999999998 5543 3444
Q ss_pred HHHHHHHcC
Q 016152 370 EAAKYVAEG 378 (394)
Q Consensus 370 ~~~~~i~~g 378 (394)
+....+...
T Consensus 236 ~~~~~~~~~ 244 (303)
T 1zy4_A 236 NILKKLRSV 244 (303)
T ss_dssp HHHHHHHST
T ss_pred HHHHhcccc
Confidence 556666554
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=284.63 Aligned_cols=206 Identities=25% Similarity=0.400 Sum_probs=175.3
Q ss_pred cCccccceeecCCceEEEEEEEC--C-ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCc------eeeEEeEEEeC
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--G-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN------IVQFLGAVTER 227 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g-~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~------Iv~~~~~~~~~ 227 (394)
.+|++.+.||+|+||.||+|... + ..||+|++... ....+.+.+|+.+++.++|++ ++.+++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 38999999999999999999874 3 67999988532 334467788999999987655 99999999999
Q ss_pred CeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-------------
Q 016152 228 KPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN------------- 292 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~------------- 292 (394)
+.+++||||+ +++|.+++... ..+++.++..++.||+.||.|||+++ |+||||||+|||+..
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccccccc
Confidence 9999999999 66887777664 36999999999999999999999988 999999999999932
Q ss_pred ----CCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCH
Q 016152 293 ----SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEP 368 (394)
Q Consensus 293 ----~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~ 368 (394)
+..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|..||...+.
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccCCCcEEEeecCcccccccc-------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 24678999999999764322 2346799999999999999999999999999999999999999999887
Q ss_pred HHHHHHHH
Q 016152 369 YEAAKYVA 376 (394)
Q Consensus 369 ~~~~~~i~ 376 (394)
.+....+.
T Consensus 245 ~~~~~~~~ 252 (355)
T 2eu9_A 245 REHLVMME 252 (355)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 77665554
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=287.70 Aligned_cols=203 Identities=28% Similarity=0.453 Sum_probs=164.6
Q ss_pred CCCCcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcH---HHHHHHHHHHHHHHhC----CCCceeeEEeE
Q 016152 153 DPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKL----RHPNIVQFLGA 223 (394)
Q Consensus 153 ~~~~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~---~~~~~~~~E~~~l~~l----~h~~Iv~~~~~ 223 (394)
+....+|++.+.||+|+||.||+|.+ .++.||||.+........ .....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34455899999999999999999987 477899999865433221 1123355788999888 89999999999
Q ss_pred EEeCCeeEEEEec-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEe
Q 016152 224 VTERKPLMLITEY-LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVG 301 (394)
Q Consensus 224 ~~~~~~~~lv~e~-~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~ 301 (394)
+...+..++|||+ +.+++|.+++..++.+++..+..++.|++.||.|||+++ |+||||||+||++ + .++.+||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~kl~ 182 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILI--DLRRGCAKLI 182 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEE--ETTTTEEEEC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEE--eCCCCeEEEE
Confidence 9999999999999 788999999998888999999999999999999999988 9999999999999 6 67899999
Q ss_pred ecCCccccccccccccccccCCccCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCC
Q 016152 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLAN 365 (394)
Q Consensus 302 DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~Pf~~ 365 (394)
|||++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..
T Consensus 183 dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 183 DFGSGALLHDEP------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp CCSSCEECCSSC------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EcchhhhcccCc------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 999998765332 234568999999999876665 4589999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=293.23 Aligned_cols=204 Identities=29% Similarity=0.500 Sum_probs=157.2
Q ss_pred CccccceeecCCceEEEEE-EECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a-~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|.+.+.||+|+||.||.+ ...|+.||||.+.... .+.+.+|+.+++++ +||||+++++++.+...+++|||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 4566789999999999654 4568999999885421 24567899999876 89999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-----------CCCc
Q 016152 236 YLRGGDLHKYLKEKGAL-------SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-----------SADH 297 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~-------~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-----------~~~~ 297 (394)
|+. |+|.+++...+.. ++..+..++.||+.||+|||+++ |+||||||+|||+..+ ....
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceE
Confidence 996 5999999865432 23345779999999999999988 9999999999999432 3458
Q ss_pred EEEeecCCccccccccccccccccCCccCccccCccccCC-------CCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHH
Q 016152 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-------RKYDKKVDVFSFAMILYEMLE-GEPPLANYEPY 369 (394)
Q Consensus 298 ~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~ 369 (394)
+||+|||++..................||+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998775433221112335679999999999965 678999999999999999999 99999776543
Q ss_pred H
Q 016152 370 E 370 (394)
Q Consensus 370 ~ 370 (394)
+
T Consensus 247 ~ 247 (434)
T 2rio_A 247 E 247 (434)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=293.57 Aligned_cols=208 Identities=27% Similarity=0.489 Sum_probs=163.6
Q ss_pred CCcCccccceeecCCceEE-EEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEE
Q 016152 155 SELDFSSSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V-~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~l 232 (394)
...+|.+.+.||+|+||.| +++...++.||||.+...... ...+|+.+++.+ +||||+++++++.+....++
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 4457999999999999985 556667999999998654322 245799999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee---CCCCcEEEeecCCccc
Q 016152 233 ITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSKL 308 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~---~~~~~~kl~DFg~a~~ 308 (394)
|||++. ++|.+++.... .+.+..+..++.||+.||.|||+++ |+||||||+|||+.. +....+||+|||++..
T Consensus 96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 999996 49999998654 4566677899999999999999988 999999999999932 2233688999999987
Q ss_pred cccccccccccccCCccCccccCccccC---CCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFK---HRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAA 372 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~ 372 (394)
+...... ........||+.|+|||++. ...++.++|||||||++|||++ |.+||......+..
T Consensus 173 ~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~ 239 (432)
T 3p23_A 173 LAVGRHS-FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN 239 (432)
T ss_dssp C-------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH
T ss_pred ccCCCcc-eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH
Confidence 6543211 11234567999999999997 4567889999999999999999 99999766544433
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=286.00 Aligned_cols=198 Identities=23% Similarity=0.385 Sum_probs=166.7
Q ss_pred CcCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-----------CCceeeEEe
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----------HPNIVQFLG 222 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~Iv~~~~ 222 (394)
..+|++.+.||+|+||.||+|.+ .++.||||++.. .......+.+|+.++++++ ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 34899999999999999999997 478999998853 2334466788999998876 899999999
Q ss_pred EEEeCC----eeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCCEEEee---
Q 016152 223 AVTERK----PLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVN--- 292 (394)
Q Consensus 223 ~~~~~~----~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~-~~~ivH~Dikp~Nilv~~--- 292 (394)
++.... .+++|||++ +++|.+++... ..+++..+..++.||+.||.|||++ | |+||||||+|||+..
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEET
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCC
Confidence 987654 789999999 88999999863 4599999999999999999999997 8 999999999999943
Q ss_pred -CCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 293 -SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 293 -~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
+..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcCcceEEEcccccccccCCC-------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 22347999999999766432 234578999999999999999999999999999999999999998654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=293.77 Aligned_cols=195 Identities=22% Similarity=0.257 Sum_probs=160.8
Q ss_pred CcCccccceeecCCceEEEEEEECCccEEEEEeccCCCC-----cHHHHHHHHHHHHHHHhCC---------CCceeeEE
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLR---------HPNIVQFL 221 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~~Iv~~~ 221 (394)
..+|++.+.||+|+||.||+|.++|+.||||++...... .....+.+.+|+.+++.++ ||||++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 457999999999999999999999999999998765321 1222366788999888875 77777777
Q ss_pred eEEE------------------------------eCCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 016152 222 GAVT------------------------------ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271 (394)
Q Consensus 222 ~~~~------------------------------~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~l 271 (394)
+.+. +...+++||||+++|++.+.+.+ +.+++.+++.++.||+.||.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Confidence 6542 26789999999999976666643 5689999999999999999999
Q ss_pred H-cCCCCeEecCCCCCCEEEeeCCCC--------------------cEEEeecCCccccccccccccccccCCccCcccc
Q 016152 272 H-NEPNVIIHRDLKPRNVLLVNSSAD--------------------HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330 (394)
Q Consensus 272 H-~~~~~ivH~Dikp~Nilv~~~~~~--------------------~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~ 330 (394)
| +++ |+||||||+|||+ +.++ .+||+|||+++..... ...||+.|+
T Consensus 178 H~~~~--ivHrDlKp~NILl--~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------~~~gt~~y~ 244 (336)
T 2vuw_A 178 EASLR--FEHRDLHWGNVLL--KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------IVVFCDVSM 244 (336)
T ss_dssp HHHHC--CBCSCCCGGGEEE--EECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------EEECCCCTT
T ss_pred HHhCC--EeECCCCHHHEEE--eccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------cEEEeeccc
Confidence 9 888 9999999999999 4443 8999999999876532 247999999
Q ss_pred CccccCCCCCCCcchHHHHHHH-HHHHHcCCCCCCC
Q 016152 331 APEVFKHRKYDKKVDVFSFAMI-LYEMLEGEPPLAN 365 (394)
Q Consensus 331 aPE~~~~~~~~~~~DvwslGv~-l~el~~g~~Pf~~ 365 (394)
|||++.+.. +.++|||||+++ .+++++|..||.+
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 999998766 889999998777 7778899999955
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=269.82 Aligned_cols=176 Identities=18% Similarity=0.181 Sum_probs=156.1
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++.+.||+|+||.||+|.+. ++.||||++...........+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 47999999999999999999986 7899999998776666666788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||++|++|.++++.. ....++..++.|++.||+|||++| |+||||||+|||+ +.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll--~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRV--SIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--ETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEE--cCCCCEEEEecc----------
Confidence 999999999999543 466788999999999999999988 9999999999999 778889987443
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 369 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~ 369 (394)
|++ .++.++||||||+++|||++|+.||.+.+..
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 333 3688999999999999999999999876543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=304.79 Aligned_cols=191 Identities=26% Similarity=0.396 Sum_probs=163.5
Q ss_pred cCccccceeecCCceEEEEEEEC---CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCe----
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP---- 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~---g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~---- 229 (394)
.+|++.+.||+|+||.||++.+. ++.||||.+... ........+.+|+.++++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 47999999999999999999873 688999987643 234455678899999999999999999999987665
Q ss_pred -eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 230 -LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 230 -~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.|+||||++|++|.+++.. .+++.+++.++.||+.||.|||++| |+||||||+|||+ +. +.+||+|||++..
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll--~~-~~~kl~DFG~a~~ 230 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIML--TE-EQLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CS-SCEEECCCTTCEE
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEE--eC-CcEEEEecccchh
Confidence 7999999999999988754 6999999999999999999999988 9999999999999 44 3899999999986
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLAN 365 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~ 365 (394)
.... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+
T Consensus 231 ~~~~--------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 231 INSF--------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp TTCC--------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred cccC--------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 5422 345799999999998755 48899999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.20 Aligned_cols=202 Identities=31% Similarity=0.493 Sum_probs=171.4
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe------CC
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------RK 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~------~~ 228 (394)
.+|++.+.||+|+||.||+|.+ .|+.||||.+.... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3799999999999999999987 47899999875432 34455778999999999999999999998755 66
Q ss_pred eeEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecC
Q 016152 229 PLMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFG 304 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg 304 (394)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.| |+||||||+||++..+ ....+||+|||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7899999999999999998643 5899999999999999999999988 9999999999999432 22349999999
Q ss_pred CccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 170 ~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~ 227 (676)
T 3qa8_A 170 YAKELDQGE-----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW 227 (676)
T ss_dssp CCCBTTSCC-----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred ccccccccc-----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc
Confidence 998765332 2234679999999999999999999999999999999999999997653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=288.56 Aligned_cols=206 Identities=14% Similarity=0.207 Sum_probs=157.6
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC-Cce---------ee-----
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNI---------VQ----- 219 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-~~I---------v~----- 219 (394)
..|...+.||+|+||.||+|.+. |+.||||++...........+.+.+|+.+++.++| ++. +.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 35788899999999999999986 88999998874444443445778899999999987 211 11
Q ss_pred -------EEeEEEe-----CCeeEEEEeccCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEe
Q 016152 220 -------FLGAVTE-----RKPLMLITEYLRGGDLHKYLKE-------KGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280 (394)
Q Consensus 220 -------~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~-------~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH 280 (394)
+..++.. ....+++|+.+ +++|.+++.. .+.+++..+..++.|+++||.|||+++ |+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiH 234 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVH 234 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence 1111111 12457777765 6799998851 234778889999999999999999988 999
Q ss_pred cCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCcccc----------CCCCCCCcchHHHHH
Q 016152 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF----------KHRKYDKKVDVFSFA 350 (394)
Q Consensus 281 ~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG 350 (394)
|||||+|||+ +.++.+||+|||++...... ....+| +.|+|||++ .+..++.++||||||
T Consensus 235 rDiKp~NILl--~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 235 TYLRPVDIVL--DQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp SCCCGGGEEE--CTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred CCcccceEEE--ecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 9999999999 88889999999998765432 234567 999999999 666788999999999
Q ss_pred HHHHHHHcCCCCCCCCCHHHHHHHH
Q 016152 351 MILYEMLEGEPPLANYEPYEAAKYV 375 (394)
Q Consensus 351 v~l~el~~g~~Pf~~~~~~~~~~~i 375 (394)
|++|||++|+.||...+..+..+.+
T Consensus 305 vil~elltg~~Pf~~~~~~~~~~~~ 329 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGGSEWI 329 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSCSGGG
T ss_pred HHHHHHHHCCCCCCCcchhhhHHHH
Confidence 9999999999999887654444444
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=265.03 Aligned_cols=176 Identities=32% Similarity=0.567 Sum_probs=147.9
Q ss_pred Ccccc-ceeecCCceEEEEEEE--CCccEEEEEeccCCCCcHHHHHHHHHHHHHH-HhCCCCceeeEEeEEEe----CCe
Q 016152 158 DFSSS-AIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRHPNIVQFLGAVTE----RKP 229 (394)
Q Consensus 158 ~~~~~-~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l-~~l~h~~Iv~~~~~~~~----~~~ 229 (394)
+|.+. +.||+|+||.||++.. .++.||+|.+... ....+|+.++ +..+||||+++++++.. ...
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 67776 7899999999999987 4788999988431 3466788887 66689999999999876 677
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC---CCcEEEeecC
Q 016152 230 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS---ADHLKVGDFG 304 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~---~~~~kl~DFg 304 (394)
+++||||+++++|.+++...+ .+++.++..++.|++.||.|||+++ |+||||||+||++ +. ++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLY--TSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SSSSTTCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--ecCCCCCcEEEeccc
Confidence 999999999999999998754 6999999999999999999999988 9999999999999 54 6789999999
Q ss_pred CccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 016152 305 LSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371 (394)
Q Consensus 305 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~ 371 (394)
++.... +..++.++||||||+++|||++|++||...+..+.
T Consensus 166 ~a~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 206 (299)
T 3m2w_A 166 FAKETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 206 (299)
T ss_dssp TCEECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------
T ss_pred cccccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh
Confidence 886432 24467899999999999999999999977655443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9e-34 Score=283.20 Aligned_cols=184 Identities=16% Similarity=0.133 Sum_probs=131.2
Q ss_pred eecCCceEEEEEE--ECCccEEEEEeccCCCC-------cHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeEEEE
Q 016152 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSD-------DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 165 iG~G~~g~V~~a~--~~g~~~avK~l~~~~~~-------~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+.|+++.+..++ +.|+.+++|++.+.... .....+++.+|+.+|+++ .|+||++++++++++..+||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4455665555433 35899999998765322 123346789999999999 6999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||++|++|.++|.+.++++.. .|+.||+.||+|+|++| ||||||||+|||+ +.++.+||+|||+|+.......
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL--~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMV--DARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEE--CTTSCEEECCCTTEESCC---C
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEE--CCCCCEEEeecccCeeCCCCCc
Confidence 999999999999998888765 47899999999999998 9999999999999 8889999999999987654322
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGE 360 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~ 360 (394)
...+.+||+.|||||++.+ .+..++|+||+|++++++.++.
T Consensus 395 ----~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 395 ----WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp ----CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred ----cccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 2345679999999999975 4567899999999987765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=255.50 Aligned_cols=202 Identities=18% Similarity=0.249 Sum_probs=151.7
Q ss_pred CcccCCCCcCc-cccceeecCCceEEEEEEECCccEEEEEeccCCCCcH-----HHHHHHHHHHHHHHhCCCCceeeEEe
Q 016152 149 DWEIDPSELDF-SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR-----LVIQDFRHEVNLLVKLRHPNIVQFLG 222 (394)
Q Consensus 149 ~~~i~~~~~~~-~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~Iv~~~~ 222 (394)
.|..+.....+ ...+.||+|+||.||++...+..+++|.......... ...+.+.+|+.++++++||||+++..
T Consensus 327 ~w~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~ 406 (540)
T 3en9_A 327 NWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYI 406 (540)
T ss_dssp CCC------------------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCE
T ss_pred cccccccccccCCCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEE
Confidence 34443333333 4466899999999999988899999998765443322 22456789999999999999996666
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEee
Q 016152 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (394)
Q Consensus 223 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~D 302 (394)
++...+..++||||+++++|.+++.. +..++.|++++|+|||+++ |+||||||+|||+ +. .+||+|
T Consensus 407 ~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl--~~--~~kL~D 472 (540)
T 3en9_A 407 FDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIF--DK--DLYIID 472 (540)
T ss_dssp EEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEE--SS--SEEECC
T ss_pred EEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEE--CC--eEEEEE
Confidence 66677788999999999999999865 6689999999999999988 9999999999999 55 999999
Q ss_pred cCCcccccccccccc---ccccCCccCccccCccccCC--CCCCCcchHHHHHHHHHHHHcCCCCCC
Q 016152 303 FGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVFKH--RKYDKKVDVFSFAMILYEMLEGEPPLA 364 (394)
Q Consensus 303 Fg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~Pf~ 364 (394)
||+++.......... .......||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 999987754322110 01235679999999999976 678888999999999999888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.4e-25 Score=200.48 Aligned_cols=146 Identities=18% Similarity=0.172 Sum_probs=114.7
Q ss_pred CccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcH---------------HHHHHHHHHHHHHHhCCCCceeeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDR---------------LVIQDFRHEVNLLVKLRHPNIVQFL 221 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~~Iv~~~ 221 (394)
.|.+.+.||+|+||.||+|.+. |+.+|||.+........ .....+.+|+.++++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 4556799999999999999984 78999999854321110 23467889999999999 4 5666
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEe
Q 016152 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301 (394)
Q Consensus 222 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~ 301 (394)
+++.. +..++||||++|++|.+ +. ......++.|++.||.|||+.| |+||||||+|||+ + ++.+||+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl--~-~~~vkl~ 234 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLV--S-EEGIWII 234 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEE--E-TTEEEEC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEE--E-CCcEEEE
Confidence 65443 56799999999999988 42 1335579999999999999988 9999999999999 6 8899999
Q ss_pred ecCCccccccccccccccccCCccCccccCccccC
Q 016152 302 DFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFK 336 (394)
Q Consensus 302 DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 336 (394)
|||++.. +..++|||.+.
T Consensus 235 DFG~a~~-----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVE-----------------VGEEGWREILE 252 (282)
T ss_dssp CCTTCEE-----------------TTSTTHHHHHH
T ss_pred ECCCCeE-----------------CCCCCHHHHHH
Confidence 9999863 23468888874
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=176.78 Aligned_cols=118 Identities=32% Similarity=0.337 Sum_probs=99.8
Q ss_pred CCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCC
Q 016152 16 KGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN 95 (394)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~ 95 (394)
.+.++..|+++|.+|.+|.|++++ |+..+..+++++|++.|+++|.+|.+|+||||+||..|+.++|++|+++|||+|
T Consensus 20 v~~Ll~~Gadvn~~d~~g~t~l~~--a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn 97 (169)
T 4gpm_A 20 VKDLIENGADVNASDSDGRTPLHH--AAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVN 97 (169)
T ss_dssp HHHHHHTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTT
T ss_pred HHHHHHCCCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCC
Confidence 344667889999999999988754 666777788888888999999999999999999999999999999999999999
Q ss_pred CccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCC
Q 016152 96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (394)
Q Consensus 96 ~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~ 135 (394)
.+|.+|+||||+|+..|+.+++++|++.|++++..+....
T Consensus 98 ~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~ 137 (169)
T 4gpm_A 98 AKDSDGRTPLHHAAENGHKEVVKLLISKGADVNTSDSDGR 137 (169)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred CCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCC
Confidence 9999999999999999999999999999988776554443
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=176.91 Aligned_cols=108 Identities=37% Similarity=0.404 Sum_probs=97.8
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
.+..|++++.+|.+|.|++++ |+..+..+++++|++.|+++|.+|.+|+||||+||..|+.++|++|+++|||++.+|
T Consensus 56 ll~~gad~~~~d~~g~TpLh~--A~~~g~~~~v~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d 133 (169)
T 4gpm_A 56 LISKGADVNAKDSDGRTPLHH--AAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNTSD 133 (169)
T ss_dssp HHHTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHhcccchhhhccCCCCHHHH--HHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccC
Confidence 556899999999999999855 777778899999999999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSY 128 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~ 128 (394)
.+|+||||+|+..|+.+++++|+++||++.
T Consensus 134 ~~G~TpL~~A~~~g~~~iv~~Ll~~GA~ie 163 (169)
T 4gpm_A 134 SDGRTPLDLAREHGNEEVVKLLEKQGGWLE 163 (169)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHTC-----
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHCCCCcC
Confidence 999999999999999999999999999874
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=9.8e-22 Score=148.24 Aligned_cols=93 Identities=42% Similarity=0.541 Sum_probs=84.6
Q ss_pred ccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhc
Q 016152 32 VSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111 (394)
Q Consensus 32 ~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~ 111 (394)
+|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|.+|+||||+|+..
T Consensus 1 ~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~ 78 (93)
T 1n0q_A 1 NGRTPLHL--AARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78 (93)
T ss_dssp --CCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred CCCcHHHH--HHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHc
Confidence 36777644 6666678899999999999999999999999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCC
Q 016152 112 KKFNMMELLNAHGGL 126 (394)
Q Consensus 112 ~~~~~~~~L~~~ga~ 126 (394)
|+.+++++|+++|++
T Consensus 79 ~~~~~~~~Ll~~ga~ 93 (93)
T 1n0q_A 79 GHLEVVKLLLEAGAY 93 (93)
T ss_dssp TCHHHHHHHHHTTCC
T ss_pred CCHHHHHHHHHcCCC
Confidence 999999999999974
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-21 Score=161.58 Aligned_cols=120 Identities=21% Similarity=0.281 Sum_probs=97.9
Q ss_pred CCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCC-HHHHHHhcCcHHHHHHHHHcCCCCC
Q 016152 17 GGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRT-PLHVASLHGWIDVAKCLIEYGADVN 95 (394)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t-~Lh~A~~~~~~~~~~~Ll~~ga~~~ 95 (394)
+-++..|++++..|..|.|+++. |+ .+..+++++|++.|+++|.+|..|+| |||+|+..|+.+++++|+++|+++|
T Consensus 29 ~~Ll~~g~~~~~~~~~g~t~L~~--A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A~~~~~~~~v~~Ll~~ga~~~ 105 (156)
T 1bi7_B 29 RALLEAGANPNAPNSYGRRPIQV--MM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLD 105 (156)
T ss_dssp HHHHTTTCCTTCCCSSSCCTTTS--SC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSS
T ss_pred HHHHHcCCCCCCCCCCCCCHHHH--HH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHHCCCHHHHHHHHHcCCCCc
Confidence 34667899999999999999854 54 66788999999999999999999999 9999999999999999999999999
Q ss_pred CccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 016152 96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKP 139 (394)
Q Consensus 96 ~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~~ 139 (394)
.+|.+|+||||+|+..++.+++++|+++|++++..+....++..
T Consensus 106 ~~d~~g~tpl~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~~~ 149 (156)
T 1bi7_B 106 VRDAWGRLPVDLAEELGHRDVARYLRAAAGGTRGSNHARIDAAE 149 (156)
T ss_dssp CCCTTCCCHHHHHHHHTCHHHHHHHSSCC---------------
T ss_pred ccCCCCCCHHHHHHHhCHHHHHHHHHHcCCCCCccCcCcCcccc
Confidence 99999999999999999999999999999998877665555443
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=7.6e-21 Score=171.33 Aligned_cols=139 Identities=18% Similarity=0.200 Sum_probs=106.0
Q ss_pred CccccceeecCCceEEEEEEE--CCcc--EEEEEeccCCCC---------------------cHHHHHHHHHHHHHHHhC
Q 016152 158 DFSSSAIIGKGSFGEILKAYW--RGTP--VAIKRILPSLSD---------------------DRLVIQDFRHEVNLLVKL 212 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~--~g~~--~avK~l~~~~~~---------------------~~~~~~~~~~E~~~l~~l 212 (394)
-|.+.+.||+|+||.||+|.. .|+. +|||++...... .......+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999987 7888 999987543211 012224678899999999
Q ss_pred CCCce--eeEEeEEEeCCeeEEEEeccCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-cCCCCeEecCCC
Q 016152 213 RHPNI--VQFLGAVTERKPLMLITEYLRG-G----DLHKYLKEKGALSPSTAVNFALDIARGMAYLH-NEPNVIIHRDLK 284 (394)
Q Consensus 213 ~h~~I--v~~~~~~~~~~~~~lv~e~~~~-~----sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH-~~~~~ivH~Dik 284 (394)
.|+++ +.++.. ...++||||+.+ | +|.++... .++..+..++.|++.+|.||| +.| |+|||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlk 198 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVHADLS 198 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCC
Confidence 88754 344432 356899999942 3 67765432 234567889999999999999 988 9999999
Q ss_pred CCCEEEeeCCCCcEEEeecCCcccc
Q 016152 285 PRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 285 p~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
|+|||+ +. .++|+|||+|...
T Consensus 199 p~NILl--~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMY--ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEE--SS--SEEECCCTTCEET
T ss_pred HHHEEE--cC--cEEEEECcccccC
Confidence 999999 55 8999999999754
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=2.5e-21 Score=156.78 Aligned_cols=105 Identities=22% Similarity=0.278 Sum_probs=79.1
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCC-CCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYD-NRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~-g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
++..|++++.+|..|.|++++ |+. +..+++++|++.|+++|.+|.. |+||||+|+..|+.+++++|+++|++++.+
T Consensus 31 Ll~~g~~~~~~~~~g~t~L~~--A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~ 107 (136)
T 1d9s_A 31 LLEAGADPNALNRFGRRPIQV--MMM-GSAQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVC 107 (136)
T ss_dssp HHHTTCCTTCCCTTCCTTTTT--STT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHHHHHHHTCHHHHHHHHHTCCCCCCC
T ss_pred HHHcCCCcCCcCCCCCCHHHH--HHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcc
Confidence 455677777777777777644 444 6677777777777777777777 788888888888888888887778888877
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcCCC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHGGL 126 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ga~ 126 (394)
|..|+||||+|+..++.+++++|+++|++
T Consensus 108 d~~g~tpl~~A~~~~~~~~~~~Ll~~Gad 136 (136)
T 1d9s_A 108 DAWGRLPVDLAEEQGHRDIARYLHAATGD 136 (136)
T ss_dssp SSSSSCHHHHHHHHTCHHHHHHHHHHHCC
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence 77788888888777777888877777764
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=8.6e-21 Score=153.74 Aligned_cols=113 Identities=24% Similarity=0.244 Sum_probs=98.1
Q ss_pred chhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCC
Q 016152 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN 102 (394)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 102 (394)
|+|+ .+|..|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+
T Consensus 1 G~d~-~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~ 77 (137)
T 3c5r_A 1 GIDP-FTNHRGETLLHI--ASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQND 77 (137)
T ss_dssp ---C-CCCTTCCCHHHH--HHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGC
T ss_pred CCCC-CcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCC
Confidence 4566 677888888754 5556677888889999999999999999999999999999999999999999999999999
Q ss_pred chhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCC
Q 016152 103 TPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (394)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~ 138 (394)
||||+|+..++.+++++|+++|++++..+....+|.
T Consensus 78 t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl 113 (137)
T 3c5r_A 78 SPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPV 113 (137)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCGG
T ss_pred CHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHH
Confidence 999999999999999999999999887766555543
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.9e-21 Score=150.83 Aligned_cols=108 Identities=31% Similarity=0.323 Sum_probs=95.3
Q ss_pred hhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhH
Q 016152 28 EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLAD 107 (394)
Q Consensus 28 ~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~ 107 (394)
-+|.+|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||||+
T Consensus 4 ~~d~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~ 81 (115)
T 2l6b_A 4 WGSKDGNTPLHN--AAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHL 81 (115)
T ss_dssp CCSCSSCCHHHH--HHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHH
T ss_pred ccCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHH
Confidence 356788888754 556667888889999999999999999999999999999999999999999999999999999999
Q ss_pred HHhcChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 108 AEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 108 A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
|+..++.+++++|+++|++++..+....+|
T Consensus 82 A~~~~~~~~~~~Ll~~ga~~n~~~~~~~~~ 111 (115)
T 2l6b_A 82 AKKNGHHEIVKLLDAKGADVNARSWGSSHH 111 (115)
T ss_dssp HHTTTCHHHHHHHHTTSSSHHHHSCCCC--
T ss_pred HHHCCCHHHHHHHHHcCCCCCcCCcccccc
Confidence 999999999999999999998766554444
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.82 E-value=5.6e-21 Score=154.77 Aligned_cols=110 Identities=20% Similarity=0.145 Sum_probs=99.4
Q ss_pred chhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCC-C
Q 016152 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW-K 101 (394)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~-g 101 (394)
+++++..+..+.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+. |+.+++++|+++|+++|.+|.. |
T Consensus 2 ~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g 78 (136)
T 1d9s_A 2 SPGIHMLGGSSDAGLAT--AAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATL 78 (136)
T ss_dssp CCCCSCCCCCCSCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTT
T ss_pred CCCccCCCCCCccHHHH--HHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCC
Confidence 46788899999998755 677777889999999999999999999999999999 9999999999999999999999 9
Q ss_pred CchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCC
Q 016152 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (394)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~ 135 (394)
+||||+|+..++.+++++|+++|++++..+....
T Consensus 79 ~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 112 (136)
T 1d9s_A 79 TRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGR 112 (136)
T ss_dssp BCHHHHHHHHTCHHHHHHHHHTCCCCCCCSSSSS
T ss_pred CCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCC
Confidence 9999999999999999999999998876554433
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-20 Score=153.09 Aligned_cols=104 Identities=28% Similarity=0.380 Sum_probs=64.6
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
++..|++++..|..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 33 Ll~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~ 110 (136)
T 2jab_A 33 LMANGADVNAKDEYGLTPLYL--ATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQD 110 (136)
T ss_dssp HHHTTCCTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHcCCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcCcC
Confidence 344556666666666665533 444445556666666666666666666666666666666666666666666666666
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHG 124 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~g 124 (394)
.+|+||||+|+..++.+++++|+++|
T Consensus 111 ~~g~tpl~~A~~~~~~~~~~~Ll~~G 136 (136)
T 2jab_A 111 KFGKTAFDISIGNGNEDLAEILQKLN 136 (136)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHC-
T ss_pred CCCCCHHHHHHHCCCHHHHHHHHHcC
Confidence 66666666666666666666666554
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.81 E-value=3e-20 Score=156.21 Aligned_cols=114 Identities=27% Similarity=0.308 Sum_probs=103.8
Q ss_pred CCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 18 GATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
-++..|++++..|..|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+
T Consensus 32 ~Ll~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~ 109 (169)
T 2y1l_E 32 ILMANGADVNAEDASGWTPLHL--AAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNAN 109 (169)
T ss_dssp HHHHTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred HHHHCCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCC
Confidence 3566889999999999998754 77777889999999999999999999999999999999999999999999999999
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s 133 (394)
|..|+||||+|+..++.+++++|+++|++++..+..
T Consensus 110 ~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 145 (169)
T 2y1l_E 110 DMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKF 145 (169)
T ss_dssp CTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCC
Confidence 999999999999999999999999999987655443
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.8e-20 Score=169.91 Aligned_cols=121 Identities=24% Similarity=0.222 Sum_probs=93.7
Q ss_pred CCCCCcchhhhhhccccCcceeeehhhcCCHH---------------------------------HHHHHHHhcCCCCcc
Q 016152 17 GGATSSADKQKEKARVSRTSLILWHAHQNDAA---------------------------------AVRKLLEEDQSLVHA 63 (394)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~---------------------------------~~~~~L~~~g~~vn~ 63 (394)
..++..|+++|..|.+|.|++++ |+..+.. +++++|++.|+++|.
T Consensus 70 ~~Ll~~Gadvn~~d~~G~TpLh~--A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~ 147 (269)
T 4b93_B 70 AKVPASGLGVNVTSQDGSSPLHV--AALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQGHFQVVKCLLDSNAKPNK 147 (269)
T ss_dssp -----CCCCTTCCCTTSCCHHHH--HHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCC
T ss_pred HHHHHCCCCCCCcCCCCCCHHHH--HHHcCcHHHHHHHHhcCCCcCccCCCCCCccccccccChHHHHHHHHHCCCCCCC
Confidence 44677888888888888888754 4444433 444555566677788
Q ss_pred ccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 016152 64 RDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKP 139 (394)
Q Consensus 64 ~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~~ 139 (394)
+|..|+||||+||..|+.++|++|+++|||+|.+|..|+||||+|+..|+.++|++|+++|++++..+....+|..
T Consensus 148 ~d~~g~TpL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g~t~Lh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL~ 223 (269)
T 4b93_B 148 KDLSGNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHVFVVELLLLHGASVQVLNKRQRTAVD 223 (269)
T ss_dssp CCTTCCCHHHHHHHTTCGGGHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCSGG
T ss_pred CCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCccccCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHH
Confidence 8888999999999999999999999999999999999999999999999999999999999988877766665543
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.81 E-value=7.8e-20 Score=155.15 Aligned_cols=114 Identities=26% Similarity=0.264 Sum_probs=101.9
Q ss_pred chhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCC
Q 016152 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN 102 (394)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 102 (394)
+.+++..|..|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|.+|+
T Consensus 29 ~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~ 106 (179)
T 3f6q_A 29 ENDLNQGDDHGFSPLHW--ACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGN 106 (179)
T ss_dssp TSCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred cccccccCCCCCCHHHH--HHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCC
Confidence 56788888899998754 6777778899999999999999999999999999999999999999999999999999999
Q ss_pred chhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCC
Q 016152 103 TPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (394)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~ 138 (394)
||||+|+..++.+++++|+++|++++..+....+|.
T Consensus 107 t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl 142 (179)
T 3f6q_A 107 VPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPV 142 (179)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTTCCSSBCCTTSCCGG
T ss_pred CHHHHHHHcCCHHHHHHHHHCCCCcchhccCCCCcH
Confidence 999999999999999999999999887666555543
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.81 E-value=4.8e-20 Score=146.47 Aligned_cols=105 Identities=23% Similarity=0.240 Sum_probs=90.3
Q ss_pred cccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHh
Q 016152 31 RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG 110 (394)
Q Consensus 31 ~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~ 110 (394)
..+.|+++. |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+.
T Consensus 5 ~~~~~~l~~--A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~ 82 (123)
T 3aaa_C 5 SMCDKEFMW--ALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVY 82 (123)
T ss_dssp --CHHHHHH--HHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHH
T ss_pred cccchHHHH--HHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHH
Confidence 344555533 666667788888889999999999999999999999999999999999999999999999999999999
Q ss_pred cChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 111 AKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 111 ~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
.++.+++++|+++|++++..+....+|
T Consensus 83 ~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 109 (123)
T 3aaa_C 83 EGHVSCVKLLLSKGADKTVKGPDGLTA 109 (123)
T ss_dssp HTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred cCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 999999999999999887665544433
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=151.91 Aligned_cols=115 Identities=30% Similarity=0.386 Sum_probs=102.6
Q ss_pred cchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCC
Q 016152 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (394)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (394)
.+.+.+..+..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|.+|
T Consensus 31 ~~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g 108 (165)
T 3twr_A 31 QSVNCRDIEGRQSTPLHF--AAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWK 108 (165)
T ss_dssp TTTTCCCTTTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTC
T ss_pred CCCCccccccCCCCHHHH--HHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCC
Confidence 445666777778888754 777778899999999999999999999999999999999999999999999999999999
Q ss_pred CchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCC
Q 016152 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (394)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~ 138 (394)
+||||+|+..++.+++++|+++|++++..+....+|.
T Consensus 109 ~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l 145 (165)
T 3twr_A 109 FTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPL 145 (165)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTG
T ss_pred CCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCChh
Confidence 9999999999999999999999999887766655554
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.80 E-value=8.2e-20 Score=152.13 Aligned_cols=107 Identities=21% Similarity=0.265 Sum_probs=98.8
Q ss_pred CCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 18 GATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
-++..|++++..+..|.|+++. |+. +..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+
T Consensus 23 ~Ll~~~~~~~~~~~~g~t~L~~--A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~ 99 (162)
T 1ihb_A 23 SLLQNNVNVNAQNGFGRTALQV--MKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIE 99 (162)
T ss_dssp HHTTSCCCTTCCCTTSCCHHHH--CCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCC
T ss_pred HHHhCCCCccccCccCccHHHH--HHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCc
Confidence 3567889999999999998854 666 7788999999999999999999999999999999999999999999999999
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcCCCC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLS 127 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~ 127 (394)
|..|+||||+|+..|+.+++++|++.|++.
T Consensus 100 ~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~ 129 (162)
T 1ihb_A 100 DNEGNLPLHLAAKEGHLRVVEFLVKHTASN 129 (162)
T ss_dssp CTTSCCHHHHHHHTTCHHHHHHHHHHSCCC
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHccCCC
Confidence 999999999999999999999999999874
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.80 E-value=4.8e-20 Score=152.28 Aligned_cols=112 Identities=28% Similarity=0.274 Sum_probs=97.3
Q ss_pred CCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccC
Q 016152 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (394)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~ 99 (394)
+..|++++ .+..|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|.
T Consensus 22 l~~g~~~~-~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~ 98 (153)
T 1awc_B 22 MANGAPFT-TDWLGTSPLHL--AAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDM 98 (153)
T ss_dssp HHHTCCCC-CCTTCCCHHHH--HHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCT
T ss_pred HHcCCCCC-cCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCC
Confidence 34555554 46677787644 6666678899999999999999999999999999999999999999999999999999
Q ss_pred CCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCC
Q 016152 100 WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSH 134 (394)
Q Consensus 100 ~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~ 134 (394)
.|+||||+|+..++.+++++|+++|++++..+...
T Consensus 99 ~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 133 (153)
T 1awc_B 99 LKMTALHWATEHNHQEVVELLIKYGADVHTQSKFC 133 (153)
T ss_dssp TSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred CCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCC
Confidence 99999999999999999999999999887655433
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.80 E-value=7.9e-20 Score=153.15 Aligned_cols=113 Identities=21% Similarity=0.239 Sum_probs=102.3
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
++..+.+++..|..|.|+++. |+..+..+++++|++.|++++.+|..|+||||+|+..|+.+++++|+++|+++|.+|
T Consensus 22 ll~~~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~ 99 (167)
T 3v31_A 22 RIEQENVINHTDEEGFTPLMW--AAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYD 99 (167)
T ss_dssp HHHHSSCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCC
T ss_pred HHHcCCCcCCCCCCCCCHHHH--HHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCC
Confidence 455678899999999998754 667777899999999999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s 133 (394)
..|+||||+|+..++.+++++|+++|++++..+..
T Consensus 100 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 134 (167)
T 3v31_A 100 WNGGTPLLYAVHGNHVKCVKMLLESGADPTIETDS 134 (167)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCC
Confidence 99999999999999999999999999987655443
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.1e-20 Score=157.58 Aligned_cols=116 Identities=24% Similarity=0.298 Sum_probs=100.5
Q ss_pred CCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCC
Q 016152 16 KGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN 95 (394)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~ 95 (394)
.+-++..|++++..+..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|
T Consensus 51 v~~Ll~~~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~ 128 (192)
T 2rfm_A 51 IDKLVENFDKLEDKDIEGSTALIW--AVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVN 128 (192)
T ss_dssp HHHHHHHHCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSS
T ss_pred HHHHHHhccccccccccCccHHHH--HHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCC
Confidence 334566788888888889888754 667777888999999999999999999999999999999999999999999999
Q ss_pred CccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCC
Q 016152 96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (394)
Q Consensus 96 ~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s 133 (394)
.+|..|+||||+|+..++.+++++|+++|++++..+..
T Consensus 129 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 166 (192)
T 2rfm_A 129 DRNLEGETPLIVASKYGRSEIVKKLLELGADISARDLT 166 (192)
T ss_dssp CCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTT
T ss_pred CCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCC
Confidence 99999999999999999999999999999887655433
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-19 Score=152.53 Aligned_cols=111 Identities=24% Similarity=0.220 Sum_probs=96.1
Q ss_pred Ccchh-hhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccC
Q 016152 21 SSADK-QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99 (394)
Q Consensus 21 ~~~~~-~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~ 99 (394)
..+.+ ++..|..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|.
T Consensus 23 ~~~~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~ 100 (172)
T 3v30_A 23 RKGDNLVNKPDERGFTPLIW--ASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDW 100 (172)
T ss_dssp TTCSGGGGCCCTTSCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCT
T ss_pred HcCcccccCCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCC
Confidence 34444 77888888888754 6677778888999999999999999999999999999999999999999999999999
Q ss_pred CCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCC
Q 016152 100 WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (394)
Q Consensus 100 ~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s 133 (394)
.|+||||+|+..++.+++++|+++|++++..+..
T Consensus 101 ~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 134 (172)
T 3v30_A 101 NGGTPLLYAVRGNHVKCVEALLARGADLTTEADS 134 (172)
T ss_dssp TSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred CCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCC
Confidence 9999999999999999999999999887655443
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.79 E-value=8.4e-20 Score=152.07 Aligned_cols=106 Identities=21% Similarity=0.183 Sum_probs=97.1
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCC-CCCc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD-VNAQ 97 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~-~~~~ 97 (394)
++..|++++..+..|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++ ++.+
T Consensus 56 Ll~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~ 133 (162)
T 1ihb_A 56 LLLRGANPDLKDRTGFAVIHD--AARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHR 133 (162)
T ss_dssp HHHTTCCTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCC
T ss_pred HHHcCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHccCCCCCCc
Confidence 566789999999999998754 6667778899999999999999999999999999999999999999999998 6999
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcCCC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHGGL 126 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ga~ 126 (394)
|..|+||||+|+..++.+++++|+++||+
T Consensus 134 ~~~g~t~l~~A~~~~~~~~~~~Ll~~GAd 162 (162)
T 1ihb_A 134 NHKGDTACDLARLYGRNEVVSLMQANGAG 162 (162)
T ss_dssp CTTSCCHHHHHHHTTCHHHHHHHHHTC--
T ss_pred CCCCCcHHHHHHHcCCHHHHHHHHHhCCC
Confidence 99999999999999999999999999984
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.6e-20 Score=155.37 Aligned_cols=113 Identities=19% Similarity=0.157 Sum_probs=102.9
Q ss_pred CCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 18 GATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
-++..|++++..+..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+
T Consensus 54 ~Ll~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~ 131 (172)
T 3v30_A 54 FLLEWGADPHILAKERESALSL--ASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTTE 131 (172)
T ss_dssp HHHHHTCCTTCCCTTCCCHHHH--HHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred HHHHcCCCchhhcccCCCHHHH--HHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccc
Confidence 3566899999999999998754 77788899999999999999999999999999999999999999999999999999
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNG 132 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~ 132 (394)
|.+|+||||+|+..++.+++++|++++++....+.
T Consensus 132 ~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~ 166 (172)
T 3v30_A 132 ADSGYTPMDLAVALGYRKVQQVIENHILKLFQSNL 166 (172)
T ss_dssp CTTSCCHHHHHHHHTCHHHHHHHHHHHHHHSCC--
T ss_pred CCCCCCHHHHHHHhCcHHHHHHHHHHHHHHhcccC
Confidence 99999999999999999999999999987765443
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.79 E-value=2.8e-19 Score=162.43 Aligned_cols=121 Identities=24% Similarity=0.223 Sum_probs=102.4
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccC-CCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDY-DNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~-~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
....+.+++..+..|.|++++ |+..+..+++++|++.|+++|.++. .|+||||+|+..|+.++|++|+++|+|+|.+
T Consensus 144 ~~~~~~~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~ 221 (282)
T 1oy3_D 144 DEDWRLQLEAENYDGHTPLHV--AVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTAR 221 (282)
T ss_dssp CCCGGGGTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred hhhhhhcCCCcCCCCcCHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCccc
Confidence 445678899999999998855 7777788999999999999999986 4999999999999999999999999999999
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCCCCC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVP 141 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~~~~ 141 (394)
|..|+||||+|+..++.+++++|+++|++++..+....+|....
T Consensus 222 d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~a 265 (282)
T 1oy3_D 222 MYGGRTPLGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSSS 265 (282)
T ss_dssp CTTSCCHHHHHHTSSCHHHHHHHHHTTCCCCCCC----------
T ss_pred ccCCCCHHHHHHHcCCcHHHHHHHHcCCCcCcCCCccccccccc
Confidence 99999999999999999999999999999998887777765433
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=144.23 Aligned_cols=106 Identities=38% Similarity=0.489 Sum_probs=92.5
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
++..|++++..+..|.|+++. |+..+..+++++|++.|++++.+|..|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 21 Ll~~~~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~g~~~~~~~ 98 (126)
T 1n0r_A 21 LLEAGADVNAKDKNGRTPLHL--AARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKD 98 (126)
T ss_dssp HHHHTCCTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHcCCCCCCcCCCCCcHHHH--HHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCcccC
Confidence 455677888888888888754 666667788888889999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGL 126 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~ 126 (394)
..|+|||++|+..++.+++++|+++|++
T Consensus 99 ~~g~t~l~~A~~~~~~~~~~~Ll~~Gad 126 (126)
T 1n0r_A 99 KNGRTPLHLAARNGHLEVVKLLLEAGAY 126 (126)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHHTCC
T ss_pred CCCCCHHHHHHHcCcHHHHHHHHHcCCC
Confidence 9999999999999999999999998874
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-19 Score=154.71 Aligned_cols=111 Identities=14% Similarity=0.104 Sum_probs=92.0
Q ss_pred hhhhc-cccCcceeeehhhcCCH---HHHHHHHHhcCCCCccccCCCCCHHHHHHhcCc------HHHHHHHHHcCCCCC
Q 016152 26 QKEKA-RVSRTSLILWHAHQNDA---AAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW------IDVAKCLIEYGADVN 95 (394)
Q Consensus 26 ~~~~~-~~~~~~~~~~~a~~~~~---~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~------~~~~~~Ll~~ga~~~ 95 (394)
.+..+ ..|+|+++ +|+..++. .+++++|++.|+++|.+|..|+||||+|+..++ .+++++|+++|||+|
T Consensus 30 ~~~~~~~~g~T~Lh-~A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin 108 (186)
T 3t8k_A 30 YEDKESVLKSNILY-DVLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADIT 108 (186)
T ss_dssp SSCHHHHHTTTHHH-HHTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSS
T ss_pred cccccccCCCCHHH-HHHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCC
Confidence 45555 66778764 44454543 469999999999999999999999999999987 688999999999999
Q ss_pred CccCCCC-chhhHHHhc-----ChHHHHHHHHh-cCCCCCCCCCCCCCC
Q 016152 96 AQDRWKN-TPLADAEGA-----KKFNMMELLNA-HGGLSYGQNGSHFEP 137 (394)
Q Consensus 96 ~~~~~g~-t~l~~A~~~-----~~~~~~~~L~~-~ga~~~~~~~s~~~p 137 (394)
.+|..|+ ||||+|+.. ++.+++++|++ .|++++..+....+|
T Consensus 109 ~~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~Tp 157 (186)
T 3t8k_A 109 ALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTA 157 (186)
T ss_dssp SCBGGGTBCTTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCCH
T ss_pred ccCCCcCchHHHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCCH
Confidence 9999999 999999994 45679999999 999998776655544
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-19 Score=160.53 Aligned_cols=111 Identities=17% Similarity=0.069 Sum_probs=81.3
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
++..|++++..|..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|++++.++
T Consensus 40 Ll~~g~~~~~~d~~g~tpLh~--A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~~ 117 (229)
T 2vge_A 40 AVKEMNDPSQPNEEGITALHN--AICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATT 117 (229)
T ss_dssp HHHHSSCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCC
T ss_pred HHhcCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccc
Confidence 445677777777777777644 555666777777777777777777777777777777777777777777777777775
Q ss_pred -CCCCchhhHH--HhcChHHHHHHHHhcCCCCCCCC
Q 016152 99 -RWKNTPLADA--EGAKKFNMMELLNAHGGLSYGQN 131 (394)
Q Consensus 99 -~~g~t~l~~A--~~~~~~~~~~~L~~~ga~~~~~~ 131 (394)
.+|+||||+| +..++.+++++|++.|++++..+
T Consensus 118 ~~~g~tpL~~A~a~~~~~~~~v~~Ll~~ga~~~~~~ 153 (229)
T 2vge_A 118 LSDGATAFEKCDPYREGYADCATYLADVEQSMGLMN 153 (229)
T ss_dssp SSTTCCTGGGCCTTSTTHHHHHHHHHHHHHHTTTSG
T ss_pred CCCCCCHHHHHHHHhcChHHHHHHHHHcCCCccccc
Confidence 5777777777 77777777777777777765544
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-19 Score=161.19 Aligned_cols=120 Identities=18% Similarity=0.184 Sum_probs=89.7
Q ss_pred CCCCCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCC
Q 016152 13 TPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92 (394)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga 92 (394)
....+.++.+|++++.. ..+.|+++. |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+
T Consensus 18 ~~~~~~ll~~g~~~~~~-~~~~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga 94 (239)
T 1ycs_B 18 RKTGSERIAHGMRVKFN-PLPLALLLD--SSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGV 94 (239)
T ss_dssp --------------------CHHHHHH--HHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTC
T ss_pred HHHHHHHhccCCCcccC-chhhHHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCC
Confidence 34456688899999854 455566533 555666788888889999999999999999999999999999999999999
Q ss_pred CCCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCC
Q 016152 93 DVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (394)
Q Consensus 93 ~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~ 135 (394)
|+|.+|..|+||||+|+..|+.+++++|+++|++++..+....
T Consensus 95 ~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~~ 137 (239)
T 1ycs_B 95 NVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDM 137 (239)
T ss_dssp CTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSSSC
T ss_pred CCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcceecCCCC
Confidence 9999999999999999999999999999999999886665443
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.9e-19 Score=163.21 Aligned_cols=114 Identities=22% Similarity=0.202 Sum_probs=70.2
Q ss_pred chhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCC
Q 016152 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN 102 (394)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 102 (394)
...++..+..+.|+++ +|+..++...++++|++.|+++|.+|.+|+||||+||..|+.++|++|+++|++++.++.+|.
T Consensus 42 ~~~~~~~~~~~~t~L~-~a~~~~~~~~~v~~Ll~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~ 120 (269)
T 4b93_B 42 EDTVSAADPEFCHPLC-QCPKCAPAQKRLAKVPASGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQA 120 (269)
T ss_dssp ----------------------------------CCCCTTCCCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCC
T ss_pred cccccccCccCCCHHH-HHHHhCCHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCC
Confidence 3446677788888875 455566677788999999999999999999999999999999999999999988888888888
Q ss_pred chhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 103 TPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
||+++|+..++.+++++|++.|++++..+....+|
T Consensus 121 t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~Tp 155 (269)
T 4b93_B 121 VPLHLACQQGHFQVVKCLLDSNAKPNKKDLSGNTP 155 (269)
T ss_dssp CHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCH
T ss_pred CccccccccChHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 88888888888888888888888877666655554
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.78 E-value=2.4e-19 Score=145.07 Aligned_cols=101 Identities=29% Similarity=0.319 Sum_probs=88.8
Q ss_pred cccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHh
Q 016152 31 RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG 110 (394)
Q Consensus 31 ~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~ 110 (394)
..+.|+++ + |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+.
T Consensus 12 ~~~~t~l~-~-A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~ 89 (136)
T 2jab_A 12 SDLGKKLL-E-AARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAF 89 (136)
T ss_dssp CHHHHHHH-H-HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHH
T ss_pred ccccHHHH-H-HHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHH
Confidence 34445553 3 666666778888889999999999999999999999999999999999999999999999999999999
Q ss_pred cChHHHHHHHHhcCCCCCCCCCC
Q 016152 111 AKKFNMMELLNAHGGLSYGQNGS 133 (394)
Q Consensus 111 ~~~~~~~~~L~~~ga~~~~~~~s 133 (394)
.++.+++++|+++|++++..+..
T Consensus 90 ~~~~~~v~~Ll~~g~~~~~~~~~ 112 (136)
T 2jab_A 90 IGHLEIAEVLLKHGADVNAQDKF 112 (136)
T ss_dssp HTCHHHHHHHHHTTCCTTCCCTT
T ss_pred cCCHHHHHHHHHcCCCCcCcCCC
Confidence 99999999999999988755543
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.78 E-value=6.8e-19 Score=145.63 Aligned_cols=107 Identities=22% Similarity=0.261 Sum_probs=94.3
Q ss_pred chhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCC
Q 016152 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN 102 (394)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 102 (394)
+.+++..+..|.|+++. | ..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..|+
T Consensus 26 ~~~~~~~~~~g~t~L~~--~-~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~ 102 (156)
T 1bd8_A 26 LVHPDALNRFGKTALQV--M-MFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGA 102 (156)
T ss_dssp CCCTTCCCTTSCCHHHH--S-CTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSC
T ss_pred CcCccccCCCCCcHHHH--H-HcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCC
Confidence 45788888899998754 4 45667788888899999999999999999999999999999999999999999999999
Q ss_pred chhhHHHhcChHHHHHHHHhcCCCCCCCCCC
Q 016152 103 TPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (394)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s 133 (394)
||||+|+..|+.+++++|++. ++++..+..
T Consensus 103 t~L~~A~~~~~~~~v~~Ll~~-~~~~~~~~~ 132 (156)
T 1bd8_A 103 LPIHLAVQEGHTAVVSFLAAE-SDLHRRDAR 132 (156)
T ss_dssp CHHHHHHHHTCHHHHHHHHTT-SCTTCCCTT
T ss_pred cHHHHHHHhChHHHHHHHHhc-cCCCCcCCC
Confidence 999999999999999999988 776654433
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-19 Score=164.21 Aligned_cols=101 Identities=19% Similarity=0.148 Sum_probs=90.5
Q ss_pred hhhhccccCcceeeehhhcC--CHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCc
Q 016152 26 QKEKARVSRTSLILWHAHQN--DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT 103 (394)
Q Consensus 26 ~~~~~~~~~~~~~~~~a~~~--~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 103 (394)
++..+..|.|++++ ||..+ +..+++++|++.|+++|.+|..|+||||+||..|+.++|++|+++|||+|.+|.+|+|
T Consensus 162 l~~~~~~g~t~Lh~-A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~g~t 240 (278)
T 1dcq_A 162 LANGHEPDETALHL-AVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGET 240 (278)
T ss_dssp CSSCSSTTCBHHHH-HHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred ccccccCCCCcchH-HHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCccCCCCC
Confidence 33447788888754 44432 7889999999999999999999999999999999999999999999999999999999
Q ss_pred hhhHHHhcChHHHHHHHHhcCCCC
Q 016152 104 PLADAEGAKKFNMMELLNAHGGLS 127 (394)
Q Consensus 104 ~l~~A~~~~~~~~~~~L~~~ga~~ 127 (394)
|||+|+..|+.+++++|+++|+..
T Consensus 241 pL~~A~~~~~~~~v~~Ll~~ga~~ 264 (278)
T 1dcq_A 241 PLDIAKRLKHEHCEELLTQALSGR 264 (278)
T ss_dssp HHHHHHHTTCHHHHHHHHHHHTTC
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCC
Confidence 999999999999999999999853
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.5e-19 Score=151.98 Aligned_cols=109 Identities=20% Similarity=0.192 Sum_probs=101.9
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
++..|++++..|..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 58 Ll~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~ 135 (179)
T 3f6q_A 58 LIMRGARINVMNRGDDTPLHL--AASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICN 135 (179)
T ss_dssp HHHTTCCTTCCCTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSSBCC
T ss_pred HHHcCCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcchhc
Confidence 566899999999999998855 777778899999999999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCCCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYG 129 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~ 129 (394)
..|.|||++|+..++.+++++|+++|++++.
T Consensus 136 ~~g~tpl~~A~~~~~~~~~~~L~~~g~~~~~ 166 (179)
T 3f6q_A 136 KYGEMPVDKAKAPLRELLRERAEKMGQNLNR 166 (179)
T ss_dssp TTSCCGGGGSCHHHHHHHHHHHHHTTCCCSC
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHhhcCccc
Confidence 9999999999999999999999999998763
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.1e-19 Score=149.27 Aligned_cols=105 Identities=25% Similarity=0.356 Sum_probs=97.2
Q ss_pred CCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 18 GATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
-++..|++++..|..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+|++.+
T Consensus 65 ~Ll~~g~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~ 142 (169)
T 2y1l_E 65 VLLKNGADVNAVDHAGMTPLRL--AALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQ 142 (169)
T ss_dssp HHHHTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred HHHHcCCCCCccCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCc
Confidence 3566889999999999998855 77777889999999999999999999999999999999999999999999999999
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHG 124 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~g 124 (394)
|..|.|||++|+..++.+++++|+++|
T Consensus 143 ~~~g~t~l~~A~~~~~~~~~~~L~~~G 169 (169)
T 2y1l_E 143 DKFGKTAFDISIDNGNEDLAEILQKLN 169 (169)
T ss_dssp CTTSCCHHHHHHHTTCHHHHHHHHTC-
T ss_pred CCCCCCHHHHHHHhCCHHHHHHHHHcC
Confidence 999999999999999999999999876
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.77 E-value=3e-19 Score=149.27 Aligned_cols=104 Identities=25% Similarity=0.289 Sum_probs=95.4
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
++..|++++..|..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 61 Ll~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~ 138 (165)
T 3twr_A 61 LLQHGADVHAKDKGGLVPLHN--ACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKN 138 (165)
T ss_dssp HHHTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHhcCCCCCccCCCCCCHHHH--HHHcCcHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccC
Confidence 566899999999999999855 777778889999999999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGG 125 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga 125 (394)
.+|+||||+|.. ++.+++++|++.|+
T Consensus 139 ~~g~t~l~~a~~-~~~~i~~~L~~~gA 164 (165)
T 3twr_A 139 RDGNTPLDLVKD-GDTDIQDLLRGDAA 164 (165)
T ss_dssp TTSCCTGGGSCT-TCHHHHHHHHTC--
T ss_pred CCCCChhHhHhc-CChHHHHHHhhccc
Confidence 999999999877 88999999999886
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.76 E-value=4.6e-19 Score=146.34 Aligned_cols=100 Identities=27% Similarity=0.369 Sum_probs=93.6
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
++..|++++..+..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 53 Ll~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~ 130 (153)
T 1awc_B 53 LLRAGVSRDARTKVDRTPLHM--AASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQS 130 (153)
T ss_dssp HHTTTCCTTCCCTTCCCHHHH--HHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHcCCCCCCCCCCCCCHHHH--HHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccC
Confidence 567889999999999998854 666777889999999999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHH
Q 016152 99 RWKNTPLADAEGAKKFNMMELL 120 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L 120 (394)
..|+||||+|+..|+.+++++|
T Consensus 131 ~~g~t~l~~A~~~~~~~i~~~L 152 (153)
T 1awc_B 131 KFCKTAFDISIDNGNEDLAEIL 152 (153)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHH
T ss_pred CCCCCHHHHHHHcCCHHHHHHh
Confidence 9999999999999999999987
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.76 E-value=5.5e-19 Score=146.20 Aligned_cols=103 Identities=19% Similarity=0.208 Sum_probs=95.7
Q ss_pred CCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 18 GATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
.++..|++++.+|..|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++ ++++.+
T Consensus 53 ~Ll~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~-~~~~~~ 129 (156)
T 1bd8_A 53 ELLKQGASPNVQDTSGTSPVHD--AARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRR 129 (156)
T ss_dssp HHHHTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTT-SCTTCC
T ss_pred HHHHCCCCCCCcCCCCCCHHHH--HHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHhChHHHHHHHHhc-cCCCCc
Confidence 3566899999999999998855 7777888999999999999999999999999999999999999999999 999999
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhc
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAH 123 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ 123 (394)
|.+|.||||+|+..|+.+++++|+++
T Consensus 130 ~~~g~t~l~~A~~~~~~~~v~~Ll~~ 155 (156)
T 1bd8_A 130 DARGLTPLELALQRGAQDLVDILQGH 155 (156)
T ss_dssp CTTSCCHHHHHHHSCCHHHHHHHHTT
T ss_pred CCCCCCHHHHHHHcCcHHHHHHHHhh
Confidence 99999999999999999999999864
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.76 E-value=7.1e-19 Score=154.53 Aligned_cols=110 Identities=20% Similarity=0.136 Sum_probs=95.9
Q ss_pred hhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHc-CCCCCCccCCCCch
Q 016152 26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY-GADVNAQDRWKNTP 104 (394)
Q Consensus 26 ~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~-ga~~~~~~~~g~t~ 104 (394)
++..+..|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+||..|+.++|++|+++ |+++|.+|.+|+||
T Consensus 66 v~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tp 143 (222)
T 3ehr_A 66 VAEQAESIDNPLHE--AAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTA 143 (222)
T ss_dssp HHHHEEEESCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCH
T ss_pred cccccccccccccc--ccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCH
Confidence 45566777887754 5556667888888899999999999999999999999999999999998 99999999999999
Q ss_pred hhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 105 LADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 105 l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
||+|+..|+.+++++|+++|++++..+....+|
T Consensus 144 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 176 (222)
T 3ehr_A 144 LHAAAWKGYADIVQLLLAKGARTDLRNIEKKLA 176 (222)
T ss_dssp HHHHHHHTCHHHHHHHHHHTCCSCCCCTTSCCH
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCccccCCCCCH
Confidence 999999999999999999999987665544433
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=153.62 Aligned_cols=121 Identities=20% Similarity=0.179 Sum_probs=96.3
Q ss_pred CCCcchhhhhhccccCcce-eeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 19 ATSSADKQKEKARVSRTSL-ILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~-~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
++..|++++..+..+.+.. .++.|+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+|+|.+
T Consensus 4 ll~~~~~~~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~ 83 (229)
T 2vge_A 4 VLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSP 83 (229)
T ss_dssp ------CCCCCCCTTSCHHHHHHHHHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred hhccCCCCccccccccchhHHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Confidence 4567777776665555432 123355566678888888999999999999999999999999999999999999999999
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCC-CCCCCCCC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN-GSHFEPKP 139 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~-~s~~~p~~ 139 (394)
|..|+||||+|+..|+.+++++|++.|++++..+ ....+|..
T Consensus 84 d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~tpL~ 126 (229)
T 2vge_A 84 DSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGATAFE 126 (229)
T ss_dssp CTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCSSTTCCTGG
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCCCCCCHHH
Confidence 9999999999999999999999999999988765 34555543
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.76 E-value=6.8e-19 Score=149.96 Aligned_cols=107 Identities=23% Similarity=0.153 Sum_probs=91.9
Q ss_pred hhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc-CCCCchh
Q 016152 27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD-RWKNTPL 105 (394)
Q Consensus 27 ~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~-~~g~t~l 105 (394)
...+..|.|+++. |+..+..+++++|++ |+++|.+|..|+||||+||..|+.+++++|+++|+++|.+| .+|+|||
T Consensus 38 ~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL 114 (183)
T 3deo_A 38 ADVVSEYETPWWT--AARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTAL 114 (183)
T ss_dssp HHHHHHHHHHHHH--HHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHH
T ss_pred ccCCCCCCCHHHH--HHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHH
Confidence 3345677777643 566666777777778 99999999999999999999999999999999999999999 8999999
Q ss_pred hHHHhcChHHHHHHHHhcCCCCCCCCCCCCC
Q 016152 106 ADAEGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (394)
Q Consensus 106 ~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~ 136 (394)
|+|+..|+.+++++|+++|++++..+....+
T Consensus 115 ~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t 145 (183)
T 3deo_A 115 HMAAGYVRPEVVEALVELGADIEVEDERGLT 145 (183)
T ss_dssp HHHHHTTCHHHHHHHHHHTCCTTCCCTTSCC
T ss_pred HHHHhcCcHHHHHHHHHcCCCCcCCCCCCCC
Confidence 9999999999999999999988765544443
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=153.24 Aligned_cols=118 Identities=24% Similarity=0.169 Sum_probs=101.5
Q ss_pred CCCcc--hhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcC-CCCC
Q 016152 19 ATSSA--DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG-ADVN 95 (394)
Q Consensus 19 ~~~~~--~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~g-a~~~ 95 (394)
++..| ++++..+..|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++| +++|
T Consensus 91 Ll~~g~~~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~ 168 (228)
T 2dzn_A 91 LYDRPLKPDLNKITNQGVTCLHL--AVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVN 168 (228)
T ss_dssp HHSSSSCCCTTCCCTTCCCHHHH--HHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCSC
T ss_pred HHhCCCCcccccCCcCCCCHHHH--HHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhcCccccc
Confidence 45566 7888888888888754 66777788899999999999999999999999999999999999999999 9999
Q ss_pred CccCCCCchhhHHHhcChHHHHHHHH-hcCCCCCCCCCCCCCCC
Q 016152 96 AQDRWKNTPLADAEGAKKFNMMELLN-AHGGLSYGQNGSHFEPK 138 (394)
Q Consensus 96 ~~~~~g~t~l~~A~~~~~~~~~~~L~-~~ga~~~~~~~s~~~p~ 138 (394)
.+|..|+||||+|+..++.+++++|+ ++|++++..+....+|.
T Consensus 169 ~~d~~g~t~L~~A~~~~~~~~v~~Ll~~~ga~~~~~~~~g~t~l 212 (228)
T 2dzn_A 169 WQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAE 212 (228)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCBCTTSCBGG
T ss_pred CcCCCCCCHHHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCcHH
Confidence 99999999999999999999999999 88998877666555443
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=153.84 Aligned_cols=111 Identities=23% Similarity=0.247 Sum_probs=70.5
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
++..|++++..+..|.|++++ |+..+..+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|+++|.+|
T Consensus 92 Ll~~g~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~ 169 (231)
T 3aji_A 92 LLVKGAHVNAVNQNGCTPLHY--AASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQD 169 (231)
T ss_dssp HHHTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCC
T ss_pred HHHcCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccC
Confidence 344556666666666665533 444555566666666666666666666666666666666666666666666666666
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCCCCCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~ 131 (394)
..|+||||+|+..++.+++++|+++|++++..+
T Consensus 170 ~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~ 202 (231)
T 3aji_A 170 TEGNTPLHLACDEERVEEAKFLVTQGASIYIEN 202 (231)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCC
T ss_pred CCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCC
Confidence 666666666666666666666666666655443
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.75 E-value=7e-19 Score=136.90 Aligned_cols=94 Identities=28% Similarity=0.381 Sum_probs=80.4
Q ss_pred hhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCch
Q 016152 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP 104 (394)
Q Consensus 25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 104 (394)
.....|.+|+|+++. |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+++|.+|..|+||
T Consensus 16 ~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tp 93 (110)
T 2zgd_A 16 RGSHMGSDLGKKLLE--AARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTA 93 (110)
T ss_dssp ------CCHHHHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred cccccCCccchHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcH
Confidence 344556777787643 555666778888889999999999999999999999999999999999999999999999999
Q ss_pred hhHHHhcChHHHHHHH
Q 016152 105 LADAEGAKKFNMMELL 120 (394)
Q Consensus 105 l~~A~~~~~~~~~~~L 120 (394)
||+|+..++.+++++|
T Consensus 94 l~~A~~~~~~~~~~~L 109 (110)
T 2zgd_A 94 FDISIDNGNEDLAEIL 109 (110)
T ss_dssp HHHHHHHTCHHHHHHH
T ss_pred HHHHHHcCCHHHHHHh
Confidence 9999999999999987
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.75 E-value=7.9e-20 Score=156.24 Aligned_cols=110 Identities=12% Similarity=0.045 Sum_probs=95.4
Q ss_pred CCCCCCcchhhhhhccccCcceeeehhhcCC-----HHHHHHHHHhcCCCCccccCCCC-CHHHHHHhcC-----cHHHH
Q 016152 16 KGGATSSADKQKEKARVSRTSLILWHAHQND-----AAAVRKLLEEDQSLVHARDYDNR-TPLHVASLHG-----WIDVA 84 (394)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~-----~~~~~~~L~~~g~~vn~~d~~g~-t~Lh~A~~~~-----~~~~~ 84 (394)
.+-++..|+++|.+|.+|.|++++ |+..+. ..+++++|+++|+|+|.+|..|+ ||||+|+..+ +.+++
T Consensus 58 v~~Ll~~Gadvn~~d~~g~TpLh~-a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~ttpLh~A~~~~~~~~~~~~iv 136 (186)
T 3t8k_A 58 SMFLINKGADIKSRTKEGTTLFFP-LFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLY 136 (186)
T ss_dssp HHHHHHTTCCSSCCCTTCCCTHHH-HHHHCTTCHHHHHHHHHHHHHTTCCSSSCBGGGTBCTTGGGGGCCSCHHHHHHHH
T ss_pred HHHHHHCCCCCCCCCCCCCcHHHH-HHHcCCcchhhHHHHHHHHHHCCCCCCccCCCcCchHHHHHHHcCCChhhHHHHH
Confidence 344678999999999999999865 444443 26889999999999999999999 9999999944 46799
Q ss_pred HHHHH-cCCCCCCccCCCCchhhHHHhcChHHHHHHHHhcCCC
Q 016152 85 KCLIE-YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGL 126 (394)
Q Consensus 85 ~~Ll~-~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~ 126 (394)
++|++ +|||+|.+|..|+||||+|+..++.+++++|.++...
T Consensus 137 ~~Ll~~~gad~~~~d~~G~TpL~~A~~~~~~~~v~~L~~~~~~ 179 (186)
T 3t8k_A 137 KLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKK 179 (186)
T ss_dssp HHHHTSTTCCTTCCCTTSCCHHHHHHTTTCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHHHHH
Confidence 99999 9999999999999999999999999999999976543
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.75 E-value=2.2e-18 Score=152.70 Aligned_cols=121 Identities=25% Similarity=0.309 Sum_probs=94.9
Q ss_pred CCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCC------CccccCCCCCHHHHHHhcCcHHHHHHHHH
Q 016152 16 KGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL------VHARDYDNRTPLHVASLHGWIDVAKCLIE 89 (394)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~------vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~ 89 (394)
.+-++..|++++..|..|.|++++ |+..+..+++++|++.|++ ++..|..|+||||+|+..|+.+++++|++
T Consensus 61 v~~Ll~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~ 138 (236)
T 1ikn_D 61 AEALLGAGCDPELRDFRGNTPLHL--ACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVS 138 (236)
T ss_dssp HHCCCSCCCCSCCCCTTCCCHHHH--HHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHH
T ss_pred HHHHHHcCCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHHHHHHcCCHHHHHHHHH
Confidence 344677888888888888887644 5556667777788787765 56777888888888888888888888888
Q ss_pred cCCCCCCccC-CCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCC
Q 016152 90 YGADVNAQDR-WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (394)
Q Consensus 90 ~ga~~~~~~~-~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~ 138 (394)
+|+++|.++. .|+||||+|+..|+.+++++|+++|++++..+....+|.
T Consensus 139 ~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl 188 (236)
T 1ikn_D 139 LGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPY 188 (236)
T ss_dssp HTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGG
T ss_pred cCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCCCCHH
Confidence 8888888887 888888888888888888888888888776665555443
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.75 E-value=3.9e-19 Score=141.11 Aligned_cols=97 Identities=18% Similarity=0.182 Sum_probs=86.4
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
.+..|++++..|..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 26 ll~~~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~ 103 (123)
T 3aaa_C 26 YVAKGEDVNRTLEGGRKPLHY--AADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKG 103 (123)
T ss_dssp HHHTTCCTTSCCTTSSCHHHH--HHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHcCCCcCccCCCCCcHHHH--HHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence 566788999999999998754 777778899999999999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHH
Q 016152 99 RWKNTPLADAEGAKKFNMM 117 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~ 117 (394)
.+|+||||+|...+..+++
T Consensus 104 ~~g~t~l~~A~~~~~~~ll 122 (123)
T 3aaa_C 104 PDGLTAFEATDNQAIKALL 122 (123)
T ss_dssp TTSCCHHHHCCCHHHHHHH
T ss_pred CCCCCHHHHhCCHHHHHHh
Confidence 9999999999655444443
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.75 E-value=7.7e-19 Score=157.56 Aligned_cols=105 Identities=23% Similarity=0.211 Sum_probs=62.3
Q ss_pred hhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCch
Q 016152 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP 104 (394)
Q Consensus 25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 104 (394)
+++..+..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..|+||
T Consensus 116 ~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp 193 (253)
T 1yyh_A 116 DLDARMHDGTTPLIL--AARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETP 193 (253)
T ss_dssp CTTCCCTTCCCHHHH--HHHHTCSSHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CccccCCCCCcHHHH--HHHcChHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 445555555555432 333444555555556666666666666666666666666666666666666666666666666
Q ss_pred hhHHHhcChHHHHHHHHhcCCCCCCCC
Q 016152 105 LADAEGAKKFNMMELLNAHGGLSYGQN 131 (394)
Q Consensus 105 l~~A~~~~~~~~~~~L~~~ga~~~~~~ 131 (394)
||+|+..|+.+++++|+++|++++..+
T Consensus 194 L~~A~~~~~~~~v~~Ll~~ga~~~~~d 220 (253)
T 1yyh_A 194 LFLAAREGSYETAKVLLDHFANRDITD 220 (253)
T ss_dssp HHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHHHHCCCHHHHHHHHHcCCCccccc
Confidence 666666666666666666666554443
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.75 E-value=5.2e-19 Score=146.62 Aligned_cols=107 Identities=21% Similarity=0.155 Sum_probs=91.0
Q ss_pred hhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCc-h
Q 016152 26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT-P 104 (394)
Q Consensus 26 ~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t-~ 104 (394)
.+..+..+.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+ .|+.+++++|+++|+++|.+|..|+| |
T Consensus 5 ~~~~~~~~~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttp 81 (156)
T 1bi7_B 5 AGSSMEPSADWLAT--AAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRP 81 (156)
T ss_dssp -----CCSTTHHHH--HHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCH
T ss_pred ccCCCccchHHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHH
Confidence 34556777887754 66666788888888999999999999999999985 99999999999999999999999999 9
Q ss_pred hhHHHhcChHHHHHHHHhcCCCCCCCCCCCC
Q 016152 105 LADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (394)
Q Consensus 105 l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~ 135 (394)
||+|+..|+.+++++|+++|++++..+....
T Consensus 82 L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 112 (156)
T 1bi7_B 82 VHDAAREGFLDTLVVLHRAGARLDVRDAWGR 112 (156)
T ss_dssp HHHHHHHTCHHHHHHHHHHTCCSSCCCTTCC
T ss_pred HHHHHHCCCHHHHHHHHHcCCCCcccCCCCC
Confidence 9999999999999999999999876554433
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.75 E-value=2.1e-19 Score=145.48 Aligned_cols=105 Identities=25% Similarity=0.359 Sum_probs=93.3
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
++..|++++..|..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 29 Ll~~g~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~ 106 (137)
T 3c5r_A 29 LLQNGSDPNVKDHAGWTPLHE--ACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVN 106 (137)
T ss_dssp HHHTTCCSCCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHcCCCCCcCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCC
Confidence 556788999999999998855 777788899999999999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGG 125 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga 125 (394)
..|.|||++|+..+..+++++|.+.++
T Consensus 107 ~~g~tpl~~A~~~~~~~~l~~l~~~~~ 133 (137)
T 3c5r_A 107 IFGLRPVDYTDDESMKSLLLLPEKNES 133 (137)
T ss_dssp TTSCCGGGGCCCHHHHHHHSCC-----
T ss_pred CCCCCHHHHHhhccHHHHHhhcccccc
Confidence 999999999999999999988876654
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.74 E-value=4.1e-19 Score=158.06 Aligned_cols=112 Identities=22% Similarity=0.085 Sum_probs=101.9
Q ss_pred CCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCC
Q 016152 17 GGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96 (394)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~ 96 (394)
+-++..|++++..|..|.|++++ |+..++.+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+|++.
T Consensus 54 ~~Ll~~g~~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~ 131 (239)
T 1ycs_B 54 QRIIYEVDDPSLPNDEGITALHN--AVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFA 131 (239)
T ss_dssp HHHTSTTSSCCCCCTTSCCHHHH--HHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTC
T ss_pred HHHHHcCCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcce
Confidence 34678899999999999999855 6667778899999999999999999999999999999999999999999999999
Q ss_pred ccCCCC-chhhHH--HhcChHHHHHHHHhcCCCCCCC
Q 016152 97 QDRWKN-TPLADA--EGAKKFNMMELLNAHGGLSYGQ 130 (394)
Q Consensus 97 ~~~~g~-t~l~~A--~~~~~~~~~~~L~~~ga~~~~~ 130 (394)
+|..|. ||||+| +..|+.+++++|+++|++++..
T Consensus 132 ~~~~~~~t~l~~a~~~~~g~~~~~~~Ll~~~a~~~~~ 168 (239)
T 1ycs_B 132 MTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKMGIM 168 (239)
T ss_dssp CCSSSCCCHHHHCCSSSTTCCCHHHHHHHHHHHTTTT
T ss_pred ecCCCCcchHHHHHHhhhccHHHHHHHHHhhhccccc
Confidence 998887 999999 7889999999999999887654
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.3e-18 Score=149.24 Aligned_cols=109 Identities=22% Similarity=0.170 Sum_probs=97.3
Q ss_pred chhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCC
Q 016152 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN 102 (394)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 102 (394)
...+|.+|..|.|+++. |+..+..+++++|++.|++++.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+
T Consensus 25 ~~~~n~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~ 102 (192)
T 2rfm_A 25 DFLRNYRDSYNRTPLMV--ACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGK 102 (192)
T ss_dssp HHHHTCCCTTCCCHHHH--HHHHTCGGGHHHHHHHHCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSC
T ss_pred HHHHhCcCCCCCCHHHH--HHHcCCHHHHHHHHHhccccccccccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Confidence 34567788899998754 6666677888888899999999999999999999999999999999999999999999999
Q ss_pred chhhHHHhcChHHHHHHHHhcCCCCCCCCCC
Q 016152 103 TPLADAEGAKKFNMMELLNAHGGLSYGQNGS 133 (394)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s 133 (394)
||||+|+..++.+++++|+++|++++..+..
T Consensus 103 t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 133 (192)
T 2rfm_A 103 TPLMWSIIFGYSEMSYFLLEHGANVNDRNLE 133 (192)
T ss_dssp CHHHHHHHHTCHHHHHHHHHTTCCSSCCCTT
T ss_pred cHHHHHHHcCCHHHHHHHHHCCCCCCCCCCC
Confidence 9999999999999999999999988755543
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.4e-18 Score=150.97 Aligned_cols=114 Identities=21% Similarity=0.289 Sum_probs=99.1
Q ss_pred CCCc-chhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCC-----ccccCCCCCHHHHHHhcCcHHHHHHHHHcCC
Q 016152 19 ATSS-ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLV-----HARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92 (394)
Q Consensus 19 ~~~~-~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~v-----n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga 92 (394)
++.. |++++.+|..|.|++++ |+..+..+++++|++.|+++ +.+|..|+||||+|+..|+.+++++|+++|+
T Consensus 22 Ll~~~g~~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~ 99 (232)
T 2rfa_A 22 LLKFEGCEVHQRGAMGETALHI--AALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGA 99 (232)
T ss_dssp HHTTTCSCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTC
T ss_pred HHHhcCCCcccCCCCCCCHHHH--HHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCC
Confidence 3444 88999999999998755 77777888999999999987 6778899999999999999999999999999
Q ss_pred CCCCccC-------------CCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCC
Q 016152 93 DVNAQDR-------------WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSH 134 (394)
Q Consensus 93 ~~~~~~~-------------~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~ 134 (394)
+++.++. +|+||||+|+..|+.+++++|+++|++++..+...
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g 154 (232)
T 2rfa_A 100 SVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLG 154 (232)
T ss_dssp CTTCCCCSGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred CCCcccCCcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Confidence 9999876 79999999999999999999999999887655433
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.74 E-value=4.2e-18 Score=135.12 Aligned_cols=100 Identities=39% Similarity=0.496 Sum_probs=88.9
Q ss_pred ccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhc
Q 016152 32 VSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111 (394)
Q Consensus 32 ~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~ 111 (394)
+|.|+++. |+..+..+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..
T Consensus 1 ~g~t~L~~--A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~ 78 (126)
T 1n0r_A 1 NGRTPLHL--AARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78 (126)
T ss_dssp CCCCHHHH--HHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred CCccHHHH--HHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHc
Confidence 36676644 6556677888888899999999999999999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCC
Q 016152 112 KKFNMMELLNAHGGLSYGQNGS 133 (394)
Q Consensus 112 ~~~~~~~~L~~~ga~~~~~~~s 133 (394)
++.+++++|++.|++++..+..
T Consensus 79 ~~~~~~~~Ll~~g~~~~~~~~~ 100 (126)
T 1n0r_A 79 GHLEVVKLLLEAGADVNAKDKN 100 (126)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTT
T ss_pred ChHHHHHHHHHcCCCCcccCCC
Confidence 9999999999999987655433
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.74 E-value=5.5e-19 Score=155.28 Aligned_cols=113 Identities=15% Similarity=0.163 Sum_probs=92.5
Q ss_pred CCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhc-CCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCC
Q 016152 17 GGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED-QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN 95 (394)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~-g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~ 95 (394)
+.++..|++++.+|..|.|++++ |+..+..+++++|++. |+++|.+|..|+||||+|+..|+.+++++|+++||+++
T Consensus 90 ~~Ll~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~ 167 (222)
T 3ehr_A 90 RECLDNRVGVNGLDKAGSTALYW--ACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTD 167 (222)
T ss_dssp HHHHHTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCSC
T ss_pred HHHHhCCCCccccCCCCCCHHHH--HHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCc
Confidence 33566889999999999999854 7777778899999998 99999999999999999999999999999999999999
Q ss_pred CccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCC
Q 016152 96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131 (394)
Q Consensus 96 ~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~ 131 (394)
.+|..|+|||++|+..++.++++.|+..++.....+
T Consensus 168 ~~~~~g~t~l~~A~~~~~~~~l~~l~~~~~~~~~~~ 203 (222)
T 3ehr_A 168 LRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSN 203 (222)
T ss_dssp CCCTTSCCHHHHCCSHHHHHHHC-------------
T ss_pred cccCCCCCHHHHhcchhHHHHHHHHhccchhhhccc
Confidence 999999999999999999999999999998775443
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.9e-18 Score=154.30 Aligned_cols=104 Identities=24% Similarity=0.155 Sum_probs=91.0
Q ss_pred ccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc-CCCCchhhHH
Q 016152 30 ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD-RWKNTPLADA 108 (394)
Q Consensus 30 ~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~-~~g~t~l~~A 108 (394)
+..|.|+++. |+..+..+++++|++ |+++|.+|..|+||||+||..|+.++|++|+++|+++|.+| ..|+||||+|
T Consensus 42 ~~~g~t~L~~--A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A 118 (244)
T 3ui2_A 42 VSEYETPWWT--AARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMA 118 (244)
T ss_dssp HHHHHHHHHH--HHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHH
T ss_pred ccCCCCHHHH--HHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHH
Confidence 3567777643 666667778888878 99999999999999999999999999999999999999999 8899999999
Q ss_pred HhcChHHHHHHHHhcCCCCCCCCCCCCC
Q 016152 109 EGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (394)
Q Consensus 109 ~~~~~~~~~~~L~~~ga~~~~~~~s~~~ 136 (394)
+..|+.+++++|+++|++++..+....+
T Consensus 119 ~~~g~~~~v~~Ll~~ga~~~~~d~~g~t 146 (244)
T 3ui2_A 119 AGYVRPEVVEALVELGADIEVEDERGLT 146 (244)
T ss_dssp HHTTCHHHHHHHHHTTCCTTCCCTTCCC
T ss_pred HHcCCHHHHHHHHHCCCCCCCCCCCCCc
Confidence 9999999999999999998766554443
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=9e-19 Score=161.25 Aligned_cols=105 Identities=20% Similarity=0.133 Sum_probs=94.7
Q ss_pred CCcchhhhh------hccccCcceeeehhhcC---CHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHc
Q 016152 20 TSSADKQKE------KARVSRTSLILWHAHQN---DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY 90 (394)
Q Consensus 20 ~~~~~~~~~------~~~~~~~~~~~~~a~~~---~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ 90 (394)
+..|++++. .+..|.|++++ |+.. +..+++++|++.|+++|.+|..|+||||+|+..|+.++|++|+++
T Consensus 171 l~~g~d~~~~~~~~~~~~~g~t~Lh~--A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~ 248 (301)
T 2b0o_E 171 FANGQDFGQPLPGPDAQAPEELVLHL--AVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKG 248 (301)
T ss_dssp HHTTCCTTSCEECSSSCSCEECHHHH--HHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHT
T ss_pred HhcCCcccccCCCcccCCCCccHHHH--HHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHc
Confidence 456777776 57788888754 5443 778999999999999999999999999999999999999999999
Q ss_pred CCCCCCccCCCCchhhHHHhcChHHHHHHHHhcCCC
Q 016152 91 GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGL 126 (394)
Q Consensus 91 ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~ 126 (394)
|||++.+|..|+||||+|+..++.+++++|+++|++
T Consensus 249 gad~~~~d~~G~TpL~~A~~~~~~~iv~~Ll~~ga~ 284 (301)
T 2b0o_E 249 RALVGTVNEAGETALDIARKKHHKECEELLEQAQAG 284 (301)
T ss_dssp TCCCSCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHH
T ss_pred CCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHhcCC
Confidence 999999999999999999999999999999999886
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=6.3e-19 Score=159.89 Aligned_cols=107 Identities=21% Similarity=0.168 Sum_probs=96.8
Q ss_pred CCCCCcchhhhhhcc--------------ccCcceeeehhhcCCHHHHHHHHHh---cCCCCccccCCCCCHHHHHHhcC
Q 016152 17 GGATSSADKQKEKAR--------------VSRTSLILWHAHQNDAAAVRKLLEE---DQSLVHARDYDNRTPLHVASLHG 79 (394)
Q Consensus 17 ~~~~~~~~~~~~~~~--------------~~~~~~~~~~a~~~~~~~~~~~L~~---~g~~vn~~d~~g~t~Lh~A~~~~ 79 (394)
+-++..|++++..+. .|.|++++ |+..+..+++++|++ .|+++|.+|..|+||||+|+..|
T Consensus 118 ~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~--A~~~g~~~~v~~Ll~~~~~gad~~~~d~~g~tpLh~A~~~~ 195 (273)
T 2pnn_A 118 TLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSL--AACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVA 195 (273)
T ss_dssp HHHHHTTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHH--HHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHC
T ss_pred HHHHHCCCCcCccccccccccccccccccCCCCHHHH--HHHcCCHHHHHHHHhcccCCCCceeeCCCCCcHHHHHHHcc
Confidence 335668899998887 68888754 777778899999999 99999999999999999999999
Q ss_pred c---------HHHHHHHHHcCCCCC-------CccCCCCchhhHHHhcChHHHHHHHHhcCC
Q 016152 80 W---------IDVAKCLIEYGADVN-------AQDRWKNTPLADAEGAKKFNMMELLNAHGG 125 (394)
Q Consensus 80 ~---------~~~~~~Ll~~ga~~~-------~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga 125 (394)
+ .+++++|+++|+++| .+|.+|+||||+|+..|+.+++++|+++|+
T Consensus 196 ~~~~~~~~~~~~~v~~Ll~~ga~~n~~~~~~~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga 257 (273)
T 2pnn_A 196 DNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREI 257 (273)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHT
T ss_pred CcchhHHHHHHHHHHHHHHhhhhcccccccccccCCCCCCHHHHHHHhChHHHHHHHHHCCC
Confidence 8 899999999999997 499999999999999999999999999999
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.73 E-value=6.4e-18 Score=149.75 Aligned_cols=101 Identities=24% Similarity=0.168 Sum_probs=94.0
Q ss_pred hhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccC-CCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCch
Q 016152 26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDY-DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP 104 (394)
Q Consensus 26 ~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~-~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 104 (394)
++..+..|.|++++ |+..+..+++++|++.|+++|.++. .|+||||+|+..|+.+++++|+++|||++.+|..|+||
T Consensus 110 ~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp 187 (236)
T 1ikn_D 110 LKATNYNGHTCLHL--ASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSP 187 (236)
T ss_dssp GGCCCTTCCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCG
T ss_pred hhccCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCCCCH
Confidence 57778888888754 7777788999999999999999998 99999999999999999999999999999999999999
Q ss_pred hhHHHhcChHHHHHHHHhcCCCCC
Q 016152 105 LADAEGAKKFNMMELLNAHGGLSY 128 (394)
Q Consensus 105 l~~A~~~~~~~~~~~L~~~ga~~~ 128 (394)
||+|+..++.+++++|+++|++..
T Consensus 188 l~~A~~~~~~~~~~~Ll~~ga~~~ 211 (236)
T 1ikn_D 188 YQLTWGRPSTRIQQQLGQLTLENL 211 (236)
T ss_dssp GGGCTTSSCHHHHHHHHTTSCGGG
T ss_pred HHHHHccCchHHHHHHHHcchhhh
Confidence 999999999999999999999765
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.73 E-value=6.6e-18 Score=149.76 Aligned_cols=112 Identities=24% Similarity=0.231 Sum_probs=97.6
Q ss_pred hhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCcccc-CCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCc
Q 016152 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT 103 (394)
Q Consensus 25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 103 (394)
+++..+..|.|+++. |+..+..+++++|++.|++++..+ ..|+||||+|+..|+.+++++|+++|+|+|.+|..|+|
T Consensus 108 ~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 185 (241)
T 1k1a_A 108 DLEARNYDGLTALHV--AVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSS 185 (241)
T ss_dssp CTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCB
T ss_pred cccccCcCCCcHHHH--HHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 677788888888754 666677888899999999999988 78999999999999999999999999999999999999
Q ss_pred hhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCC
Q 016152 104 PLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (394)
Q Consensus 104 ~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~ 138 (394)
|||+|+..|+.+++++|+++|++++..+....+|.
T Consensus 186 ~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl 220 (241)
T 1k1a_A 186 ALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPL 220 (241)
T ss_dssp HHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTT
T ss_pred HHHHHHHcCCHHHHHHHHhcCCCCCCcCCCCCCHH
Confidence 99999999999999999999999887666555554
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.73 E-value=3.5e-18 Score=149.85 Aligned_cols=102 Identities=24% Similarity=0.225 Sum_probs=48.9
Q ss_pred hhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCch
Q 016152 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP 104 (394)
Q Consensus 25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 104 (394)
+++..+..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..|+||
T Consensus 84 ~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 161 (223)
T 2f8y_A 84 DLDARMHDGTTPLIL--AARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETP 161 (223)
T ss_dssp CTTCCCTTCCCHHHH--HHHHTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCH
T ss_pred CcccCCCCCCcHHHH--HHHhCcHHHHHHHHHcCCCCcCcCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCcCH
Confidence 334444444444322 333333444444444555555555555555555555555555555555555555555555555
Q ss_pred hhHHHhcChHHHHHHHHhcCCCCC
Q 016152 105 LADAEGAKKFNMMELLNAHGGLSY 128 (394)
Q Consensus 105 l~~A~~~~~~~~~~~L~~~ga~~~ 128 (394)
||+|+..++.+++++|+++|++++
T Consensus 162 L~~A~~~~~~~~v~~Ll~~ga~~~ 185 (223)
T 2f8y_A 162 LFLAAREGSYETAKVLLDHFANRD 185 (223)
T ss_dssp HHHHHHHTCHHHHHHHHHTTCCTT
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCc
Confidence 555555555555555555554443
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.73 E-value=4.2e-18 Score=149.38 Aligned_cols=107 Identities=17% Similarity=0.200 Sum_probs=99.7
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
++..|++++..|..|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 111 Ll~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~ 188 (223)
T 2f8y_A 111 LINSHADVNAVDDLGKSALHW--AAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITD 188 (223)
T ss_dssp HHHTTCCTTCBCTTSCBHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHcCCCCcCcCCCCCcHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcccc
Confidence 556889999999999998754 777777889999999999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGLS 127 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~~ 127 (394)
..|.|||++|+..++.+++++|+++|+..
T Consensus 189 ~~g~t~l~~A~~~~~~~i~~~L~~~g~~~ 217 (223)
T 2f8y_A 189 HMDRLPRDIAQERMHHDIVRLLDEYNLVR 217 (223)
T ss_dssp TTCCCHHHHHHHTTCHHHHHHHHHTTCSS
T ss_pred ccCCCHHHHHHHhcchHHHHHHHHcCCCc
Confidence 99999999999999999999999999864
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.4e-18 Score=155.50 Aligned_cols=115 Identities=23% Similarity=0.159 Sum_probs=86.2
Q ss_pred CCCcch-hhhhhccccCcceeeehhh-----cCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCC
Q 016152 19 ATSSAD-KQKEKARVSRTSLILWHAH-----QNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92 (394)
Q Consensus 19 ~~~~~~-~~~~~~~~~~~~~~~~~a~-----~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga 92 (394)
++..|+ +++..+..|.|++++ |+ ..+..+++++|++.|++++..|..|+||||+||..|+.++|++|+++|+
T Consensus 130 Ll~~g~~~~~~~~~~g~tpL~~--a~~~~~~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpLh~A~~~g~~~~v~~Ll~~ga 207 (276)
T 4hbd_A 130 LLDSGVCKVDKQNRAGYSPIML--TALATLKTQDDIETVLQLFRLGNINAKASQAGQTALMLAVSHGRVDVVKALLACEA 207 (276)
T ss_dssp HHHTSCCCTTCCCTTSCCHHHH--GGGCCCCSHHHHHHHHHHHHHSCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTC
T ss_pred HHHCCCCcCCCCCCCCCCHHHH--HHHHHhhhhhhHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhCCC
Confidence 344554 666666666666543 22 3455566666666666667777778889999999999999999999999
Q ss_pred CCCCccCCCCchhhHHHhcChHHHHHHHHh-cCCCCCCCCCCCC
Q 016152 93 DVNAQDRWKNTPLADAEGAKKFNMMELLNA-HGGLSYGQNGSHF 135 (394)
Q Consensus 93 ~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~-~ga~~~~~~~s~~ 135 (394)
|+|.+|.+|+||||+|+..|+.+++++|++ .|++++..+....
T Consensus 208 d~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~ 251 (276)
T 4hbd_A 208 DVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGS 251 (276)
T ss_dssp CTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTTSC
T ss_pred CCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCCCC
Confidence 999999999999999999999999999998 7888765554433
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.3e-18 Score=156.59 Aligned_cols=104 Identities=24% Similarity=0.247 Sum_probs=94.8
Q ss_pred CCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHH-cCCCCCCcc
Q 016152 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQD 98 (394)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~~~~ 98 (394)
+..|.+.+..+..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|++ .|+|+|.+|
T Consensus 170 l~~g~~~~~~~~~g~tpLh~--A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d 247 (276)
T 4hbd_A 170 FRLGNINAKASQAGQTALML--AVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTD 247 (276)
T ss_dssp HHHSCTTCCCTTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCC
T ss_pred HHcCCCccccCCCCCCHHHH--HHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcC
Confidence 34566777788889998855 667778899999999999999999999999999999999999999999 899999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGG 125 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga 125 (394)
.+|+||||+|+..|+.+++++|+++.+
T Consensus 248 ~~g~TpL~~A~~~g~~~iv~~Ll~~~~ 274 (276)
T 4hbd_A 248 RDGSTALMVALDAGQSEIASMLYSRMN 274 (276)
T ss_dssp TTSCCHHHHHHHHTCHHHHHHHHHHCC
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHhccC
Confidence 999999999999999999999998764
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-18 Score=156.34 Aligned_cols=111 Identities=23% Similarity=0.194 Sum_probs=96.2
Q ss_pred CCCCCCCcchhhhhh-----------ccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCC-------------CCC
Q 016152 15 CKGGATSSADKQKEK-----------ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYD-------------NRT 70 (394)
Q Consensus 15 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~-------------g~t 70 (394)
+.+-++..|++++.. |..|.|++++ |+..+..+++++|++.|+++|.+|.. |+|
T Consensus 61 ~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~t 138 (256)
T 2etb_A 61 CIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHSALHI--AIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGEL 138 (256)
T ss_dssp THHHHHHHHHHTTCSSCGGGCCCCSTTTTTCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCSSSCCCSCSS
T ss_pred HHHHHHhcCCcccchhhhcccccccccccCCCHHHH--HHHcCCHHHHHHHHHcCCCCCcccccccccccccccccCCCC
Confidence 344455667766533 3668888754 77777889999999999999999886 999
Q ss_pred HHHHHHhcCcHHHHHHHHH---cCCCCCCccCCCCchhhHHHh--cChHH-------HHHHHHhcCCCC
Q 016152 71 PLHVASLHGWIDVAKCLIE---YGADVNAQDRWKNTPLADAEG--AKKFN-------MMELLNAHGGLS 127 (394)
Q Consensus 71 ~Lh~A~~~~~~~~~~~Ll~---~ga~~~~~~~~g~t~l~~A~~--~~~~~-------~~~~L~~~ga~~ 127 (394)
|||+|+..|+.+++++|++ +|+|+|.+|.+|+||||+|+. .++.+ ++++|+++|+++
T Consensus 139 pL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~ga~~ 207 (256)
T 2etb_A 139 PLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENSALVIHMYDGLLQMGARL 207 (256)
T ss_dssp HHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCHHHHHHHHhccccCCCcCccCCCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHcCCCc
Confidence 9999999999999999999 999999999999999999998 78888 999999999987
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=6.4e-18 Score=149.65 Aligned_cols=106 Identities=22% Similarity=0.260 Sum_probs=61.0
Q ss_pred hhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCc
Q 016152 24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT 103 (394)
Q Consensus 24 ~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 103 (394)
.+++..+..|.|+++. |+..+..+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|+++|.+|..|.|
T Consensus 102 ~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t 179 (237)
T 3b7b_A 102 MDVNCQDDGGWTPMIW--ATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDS 179 (237)
T ss_dssp CCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCHHHHHHHHTTTCCTTCCCTTCCC
T ss_pred CCcccCCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCCCccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 4455555555555432 44444555555555666666666666666666666666666666666666666666666666
Q ss_pred hhhHHHhcChHHHHHHHHhcCCCCCCCC
Q 016152 104 PLADAEGAKKFNMMELLNAHGGLSYGQN 131 (394)
Q Consensus 104 ~l~~A~~~~~~~~~~~L~~~ga~~~~~~ 131 (394)
|||+|+..++.+++++|+++|++++..+
T Consensus 180 ~L~~A~~~~~~~~v~~Ll~~gad~~~~d 207 (237)
T 3b7b_A 180 PLHIAARENRYDCVVLFLSRDSDVTLKN 207 (237)
T ss_dssp HHHHHHHTTCHHHHHHHHTTTCCTTCCC
T ss_pred HHHHHHHhCCHhHHHHHHHcCCCCCccC
Confidence 6666666666666666666665554433
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.73 E-value=6e-18 Score=149.39 Aligned_cols=108 Identities=26% Similarity=0.214 Sum_probs=95.7
Q ss_pred CCCcchhh-----hhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccC-------------CCCCHHHHHHhcCc
Q 016152 19 ATSSADKQ-----KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDY-------------DNRTPLHVASLHGW 80 (394)
Q Consensus 19 ~~~~~~~~-----~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~-------------~g~t~Lh~A~~~~~ 80 (394)
++..|+++ +..|..|.|++++ |+..+..+++++|++.|++++.++. .|+||||+|+..|+
T Consensus 56 Ll~~~~~~~~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~ 133 (232)
T 2rfa_A 56 LMEAAPELVFEPMTSELYEGQTALHI--AVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGS 133 (232)
T ss_dssp HHHHCGGGGGCCCCSTTTTTCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCTTCSCCCCSSHHHHHHHHTC
T ss_pred HHHcCchhccccccccCCCCcCHHHH--HHHcCCHHHHHHHHhCCCCCCcccCCcceeecccccccCCCCHHHHHHHcCC
Confidence 45566666 5667788888755 7777788999999999999998866 79999999999999
Q ss_pred HHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHH----HHHHhcCCCCC
Q 016152 81 IDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM----ELLNAHGGLSY 128 (394)
Q Consensus 81 ~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~----~~L~~~ga~~~ 128 (394)
.+++++|+++|+|+|.+|.+|+||||+|+..++.+++ ++|+++|++..
T Consensus 134 ~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~~~~~~~~~i~~~Ll~~g~~~~ 185 (232)
T 2rfa_A 134 EEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDH 185 (232)
T ss_dssp HHHHHHHHHTTCCTTCCCTTSCCHHHHHHTCSCHHHHHHHHHHHHHTTCSCS
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCChHHHHHHHHHHHhcCCchh
Confidence 9999999999999999999999999999999999988 99999999763
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.73 E-value=5.1e-18 Score=155.71 Aligned_cols=70 Identities=30% Similarity=0.200 Sum_probs=39.5
Q ss_pred CCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 68 NRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 68 g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
|.||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++..+....+|
T Consensus 199 g~t~L~~A~~~g~~~~v~~Ll~~g~d~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~t~ 268 (299)
T 1s70_B 199 GGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTA 268 (299)
T ss_dssp CCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCT
T ss_pred CCCHHHHHHHCCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHhcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 4455555555555555555555555666666666666666666666666666666665555444444333
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.72 E-value=4.9e-18 Score=149.78 Aligned_cols=106 Identities=22% Similarity=0.253 Sum_probs=56.8
Q ss_pred CcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCC
Q 016152 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (394)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (394)
..|++++..|..|.|++++ |+..+..+++++|++.|++++.+|..|+||||+|+..|+.+++++|+++|++++.+|..
T Consensus 61 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~ 138 (231)
T 3aji_A 61 QLGVPVNDKDDAGWSPLHI--AASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHY 138 (231)
T ss_dssp HTTCCSCCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HhCCCCCCcCCCCCCHHHH--HHHcCHHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCC
Confidence 3445555555555555432 33344445555555555555555555555555555555555555555555555555555
Q ss_pred CCchhhHHHhcChHHHHHHHHhcCCCCC
Q 016152 101 KNTPLADAEGAKKFNMMELLNAHGGLSY 128 (394)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~ga~~~ 128 (394)
|.||||+|+..|+.+++++|+++|++++
T Consensus 139 g~t~L~~A~~~~~~~~v~~Ll~~g~~~~ 166 (231)
T 3aji_A 139 DATAMHRAAAKGNLKMVHILLFYKASTN 166 (231)
T ss_dssp SCCHHHHHHHHTCHHHHHHHHHTTCCSC
T ss_pred CCcHHHHHHHcCCHHHHHHHHhcCCCcc
Confidence 5555555555555555555555555444
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.72 E-value=3.7e-18 Score=165.40 Aligned_cols=116 Identities=27% Similarity=0.283 Sum_probs=94.8
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
++..|++++..+..|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.++|++|+++|+|+|.+|
T Consensus 264 Ll~~~~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~n~~~ 341 (437)
T 1n11_A 264 LLSKQANGNLGNKSGLTPLHL--VAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKT 341 (437)
T ss_dssp HHTTTCCTTCCCTTCCCHHHH--HHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCC
T ss_pred HHhcCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHhCCccCCCCCCCCCCHHHHHHHcCcHHHHHHHHhcCCCCCCCC
Confidence 456777888888888887754 666667778888888888888888888888988888888888998888888888888
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~ 136 (394)
..|+||||+|+..|+.+++++|+++|++++..+....+
T Consensus 342 ~~g~t~L~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t 379 (437)
T 1n11_A 342 KLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTT 379 (437)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCSSSCC
T ss_pred CCCCCHHHHHHHCChHHHHHHHHHCcCCCCCCCCCCCC
Confidence 88889999988888888999888888887765544443
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.1e-17 Score=156.51 Aligned_cols=109 Identities=30% Similarity=0.359 Sum_probs=98.4
Q ss_pred CcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCC
Q 016152 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100 (394)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~ 100 (394)
..+.+++..|..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|.+
T Consensus 46 ~~~~~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~iv~~Ll~~g~~~~~~~~~ 123 (351)
T 3utm_A 46 PLNVNCHASDGRKSTPLHL--AAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLW 123 (351)
T ss_dssp TTTTTCCCSSTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred hcCCCcccCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCC
Confidence 4578888889999998755 77777888999999999999999999999999999999999999999999999999999
Q ss_pred CCchhhHHHhcChHHHHHHHHhcCCCCCCCC
Q 016152 101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131 (394)
Q Consensus 101 g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~ 131 (394)
|.||||+|+..|+.+++++|+++|++++..+
T Consensus 124 g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~ 154 (351)
T 3utm_A 124 QFTPLHEAASKNRVEVCSLLLSHGADPTLVN 154 (351)
T ss_dssp CCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred CCCHHHHHHHcCCHHHHHHHHHcCCCCcccc
Confidence 9999999999999999999999999876544
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.72 E-value=3.3e-18 Score=153.46 Aligned_cols=124 Identities=23% Similarity=0.136 Sum_probs=88.9
Q ss_pred CCCCCCCCCCcchhhhhh-ccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHc
Q 016152 12 TTPCKGGATSSADKQKEK-ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY 90 (394)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ 90 (394)
...+.+-++..|++++.. |..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++
T Consensus 35 ~~~~v~~Ll~~g~~~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ 112 (253)
T 1yyh_A 35 APAVISDFIYQGASLHNQTDRTGETALHL--AARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRN 112 (253)
T ss_dssp -----------------CCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHS
T ss_pred ChHHHHHHHHccCCcccccCCCCCcHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHc
Confidence 455666788888888654 7778887644 6666778888888899999999999999999999999999999999988
Q ss_pred CC-CCCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 91 GA-DVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 91 ga-~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
|+ +++.+|..|.||||+|+..++.+++++|++.|++++..+....+|
T Consensus 113 ~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~ 160 (253)
T 1yyh_A 113 RATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSA 160 (253)
T ss_dssp TTSCTTCCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBCTTSCBH
T ss_pred CCCCccccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 86 888888888888888888888888888888888887666555444
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.3e-18 Score=145.75 Aligned_cols=109 Identities=18% Similarity=0.229 Sum_probs=60.9
Q ss_pred hhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHH-HcCCCCCCccCCCCc
Q 016152 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI-EYGADVNAQDRWKNT 103 (394)
Q Consensus 25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll-~~ga~~~~~~~~g~t 103 (394)
+++..|.+|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+ ..+++++.+|..|.|
T Consensus 31 ~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t 108 (201)
T 3hra_A 31 QVDEVDTEGNTPLNI--AVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGN 108 (201)
T ss_dssp CTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCC
T ss_pred CCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCc
Confidence 555555555555433 44444455555555566666666666666666666666666666655 344556666666666
Q ss_pred hhhHHHhcChHHHHHHHHhcC-CCCCCCCCCCC
Q 016152 104 PLADAEGAKKFNMMELLNAHG-GLSYGQNGSHF 135 (394)
Q Consensus 104 ~l~~A~~~~~~~~~~~L~~~g-a~~~~~~~s~~ 135 (394)
|||+|+..++.+++++|++.| ++++..+....
T Consensus 109 ~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~ 141 (201)
T 3hra_A 109 ALIPAAEKGHIDNVKLLLEDGREDIDFQNDFGY 141 (201)
T ss_dssp SHHHHHHTTCHHHHHHHHHHCCCCTTCCCTTSC
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCcCCCCCCCC
Confidence 666666666666666666555 44444444333
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.72 E-value=7.4e-18 Score=157.12 Aligned_cols=119 Identities=18% Similarity=0.031 Sum_probs=95.0
Q ss_pred CCCCcchhhhh-hccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCc----------------
Q 016152 18 GATSSADKQKE-KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW---------------- 80 (394)
Q Consensus 18 ~~~~~~~~~~~-~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~---------------- 80 (394)
..+..|+++|. +|..|.|++++ |+..+..+++++|++.|+++|.+|.+|+||||+|+..|+
T Consensus 115 ~l~~~g~dvn~~~d~~g~TpLh~--Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~~~ll~~~~~ 192 (327)
T 1sw6_A 115 AFPNTQLNLNIPVDEHGNTPLHW--LTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYP 192 (327)
T ss_dssp HCTTSCCCSCSCCSTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGG
T ss_pred HHHhcCCCcccccCCCCCcHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHHHHHHHhhhc
Confidence 35667899998 88999988754 666777888999999999999998888888888887655
Q ss_pred -------------------------HHHHHHHHHcCC-------------------------------------------
Q 016152 81 -------------------------IDVAKCLIEYGA------------------------------------------- 92 (394)
Q Consensus 81 -------------------------~~~~~~Ll~~ga------------------------------------------- 92 (394)
.+++++|++.++
T Consensus 193 ~~~~~d~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll 272 (327)
T 1sw6_A 193 CLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWII 272 (327)
T ss_dssp GGGEECTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHH
T ss_pred cccCCCCCCCCHHHHHHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHH
Confidence 455555555432
Q ss_pred --CCCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCC
Q 016152 93 --DVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (394)
Q Consensus 93 --~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~ 138 (394)
++|.+|.+|+||||+|+..|+.+++++|+++|++++..+....+|.
T Consensus 273 ~~~~n~~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL 320 (327)
T 1sw6_A 273 ANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPV 320 (327)
T ss_dssp HHTTTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGG
T ss_pred HhCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHH
Confidence 5788888999999999999999999999999999887776655553
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=9.1e-18 Score=156.96 Aligned_cols=109 Identities=23% Similarity=0.228 Sum_probs=96.2
Q ss_pred cchhhhhhccccCcceeeeh--hhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHc-CCCCCCcc
Q 016152 22 SADKQKEKARVSRTSLILWH--AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY-GADVNAQD 98 (394)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~--a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~-ga~~~~~~ 98 (394)
.|+++|..|..|.|++++.+ +..++...++++|++.|+++|.+|..|+||||+|+..|+.++++.|++. |+++|.+|
T Consensus 191 ~gad~n~~d~~g~t~l~~~~~~~~~~~~~~i~~lLl~~gad~n~~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d 270 (337)
T 4g8k_A 191 MGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTD 270 (337)
T ss_dssp SCCCTTCCCTTSCCHHHHHHHHSCTTTHHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBC
T ss_pred cCCCcCccCCCCCcHHHHHHHHcCcccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcC
Confidence 58899999999999887543 2345667889999999999999999999999999999999999999985 89999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCCCCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQ 130 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~ 130 (394)
.+|+||||+|+..|+.++|++|+++|++++..
T Consensus 271 ~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~~ 302 (337)
T 4g8k_A 271 SDGKTALLLAVELKLKKIAELLCKRGASTDCG 302 (337)
T ss_dssp TTSCBHHHHHHHTTCHHHHHHHHTTSCSSTTC
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999999999987643
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.72 E-value=5.8e-18 Score=153.71 Aligned_cols=116 Identities=27% Similarity=0.272 Sum_probs=84.2
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCC--------------------------------------
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL-------------------------------------- 60 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~-------------------------------------- 60 (394)
++..|++++..+..|.|++++ |+..+..+++++|++.|++
T Consensus 64 Ll~~ga~~~~~~~~g~tpL~~--A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (282)
T 1oy3_D 64 LYAAGAGVLVAERGGHTALHL--ACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEE 141 (282)
T ss_dssp HHHTTCCSSCCCTTSCCHHHH--HTTTTCHHHHHHHSSSCCSSCCCC---------------------------------
T ss_pred HHHcCCCCCCCCCCCCCHHHH--HHHcCCcchhHhhhccCCCCchhhHHHHhhcccccCcchhcchhhhccccccchhhh
Confidence 455677777777777777644 5566666777777776643
Q ss_pred ---------CccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCC-CCchhhHHHhcChHHHHHHHHhcCCCCCCC
Q 016152 61 ---------VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW-KNTPLADAEGAKKFNMMELLNAHGGLSYGQ 130 (394)
Q Consensus 61 ---------vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~-g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~ 130 (394)
+|.+|..|+||||+|+..|+.+++++|+++|+++|.++.. |+||||+|+..|+.+++++|+++|++++..
T Consensus 142 ~~~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~ 221 (282)
T 1oy3_D 142 PRDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTAR 221 (282)
T ss_dssp --CCCGGGGTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred hhhhhhhhcCCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCccc
Confidence 5667777888888888888888888888888888887754 888888888888888888888888877665
Q ss_pred CCCCCC
Q 016152 131 NGSHFE 136 (394)
Q Consensus 131 ~~s~~~ 136 (394)
+....+
T Consensus 222 d~~g~t 227 (282)
T 1oy3_D 222 MYGGRT 227 (282)
T ss_dssp CTTSCC
T ss_pred ccCCCC
Confidence 544333
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=5.1e-18 Score=158.70 Aligned_cols=104 Identities=19% Similarity=0.213 Sum_probs=89.9
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHh-cCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE-DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~-~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
++..|+++|.+|..|.|++++ |+..+..+++++|+. .|+++|.+|.+|+||||+||..|+.++|++||++|||+|.+
T Consensus 225 Ll~~gad~n~~d~~g~t~L~~--a~~~~~~~~v~~Ll~~~~~~vn~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~~ 302 (337)
T 4g8k_A 225 LLDHGADVNVRGERGKTPLIL--AVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG 302 (337)
T ss_dssp HHHTTCCTTCCCGGGCCHHHH--HHHTTCHHHHHHHHTSTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHTTSCSSTTC
T ss_pred HHHCCCCCCCcCCCCCCHHHH--HHHhhhhHHHHHHHHhcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Confidence 466899999999999999854 555555556666655 68999999999999999999999999999999999999875
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcCCCCCC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYG 129 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~ 129 (394)
||||+|+..|+.++|++|+++||+++.
T Consensus 303 -----~~L~~A~~~~~~~iv~~Ll~~GA~~d~ 329 (337)
T 4g8k_A 303 -----DLVMTARRNYDHSLVKVLLSHGAKEDF 329 (337)
T ss_dssp -----CHHHHHHHTTCHHHHHHHHHTTCCC--
T ss_pred -----CHHHHHHHcCCHHHHHHHHHCcCCCCC
Confidence 599999999999999999999998864
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2.3e-18 Score=154.59 Aligned_cols=112 Identities=20% Similarity=0.178 Sum_probs=98.1
Q ss_pred Ccchhhhh----hccccCcceeeehhhcC---CHHHHHHHHHhcCCCCcc-----------ccCCCCCHHHHHHhcCcHH
Q 016152 21 SSADKQKE----KARVSRTSLILWHAHQN---DAAAVRKLLEEDQSLVHA-----------RDYDNRTPLHVASLHGWID 82 (394)
Q Consensus 21 ~~~~~~~~----~~~~~~~~~~~~~a~~~---~~~~~~~~L~~~g~~vn~-----------~d~~g~t~Lh~A~~~~~~~ 82 (394)
..|++++. .|..|.|++++ |+.. +..+++++|++.|++++. +|..|+||||+||..|+.+
T Consensus 27 ~~g~~i~~~~~~~d~~g~t~L~~--A~~~~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~ 104 (256)
T 2etb_A 27 WNSKYLTDSAYTEGSTGKTCLMK--AVLNLQDGVNACIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQ 104 (256)
T ss_dssp HHTCCTTSGGGSBTTTTBCHHHH--HHHTCBTTBCTTHHHHHHHHHHTTCSSCGGGCCCCSTTTTTCCHHHHHHHTTCHH
T ss_pred HcCCCcccccccCCCCCCCHHHH--HHHccccchHHHHHHHHhcCCcccchhhhcccccccccccCCCHHHHHHHcCCHH
Confidence 47888998 88999998755 6666 788999999999988764 3478999999999999999
Q ss_pred HHHHHHHcCCCCCCccCC-------------CCchhhHHHhcChHHHHHHHHh---cCCCCCCCCCCC
Q 016152 83 VAKCLIEYGADVNAQDRW-------------KNTPLADAEGAKKFNMMELLNA---HGGLSYGQNGSH 134 (394)
Q Consensus 83 ~~~~Ll~~ga~~~~~~~~-------------g~t~l~~A~~~~~~~~~~~L~~---~ga~~~~~~~s~ 134 (394)
++++|+++|+++|.+|.. |+||||+|+..|+.+++++|++ .|++++..+...
T Consensus 105 ~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d~~g 172 (256)
T 2etb_A 105 CVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLG 172 (256)
T ss_dssp HHHHHHHTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTS
T ss_pred HHHHHHHcCCCCCcccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCcCccCCCC
Confidence 999999999999999986 9999999999999999999999 899887655433
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.3e-17 Score=157.51 Aligned_cols=105 Identities=14% Similarity=-0.001 Sum_probs=91.7
Q ss_pred hhhhccccCcceeeehhhcCC--HHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCC-----CCCcc
Q 016152 26 QKEKARVSRTSLILWHAHQND--AAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD-----VNAQD 98 (394)
Q Consensus 26 ~~~~~~~~~~~~~~~~a~~~~--~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~-----~~~~~ 98 (394)
.+..|..|.|++++ |+..+ ..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++ +|.+|
T Consensus 131 ~~~~~~~g~t~L~~--A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~ 208 (364)
T 3ljn_A 131 SHVKHCKGQTALHW--CVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYAN 208 (364)
T ss_dssp TEEEEESCCCHHHH--HHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCC
T ss_pred cccCCCCCCCHHHH--HHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccC
Confidence 33488888888754 66666 88999999999999999999999999999999999999999999998 99999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNG 132 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~ 132 (394)
..|+||||+|+..|+.+++++|+++|++++..+.
T Consensus 209 ~~g~t~L~~A~~~g~~~~v~~Ll~~gad~~~~d~ 242 (364)
T 3ljn_A 209 KQGNSHLHWAILINWEDVAMRFVEMGIDVNMEDN 242 (364)
T ss_dssp TTCCCTTHHHHTTTCHHHHHHHHTTTCCTTCCCT
T ss_pred CCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999999999998765543
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.71 E-value=9.3e-18 Score=153.96 Aligned_cols=114 Identities=23% Similarity=0.198 Sum_probs=88.7
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
++..|++++..|..|.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 59 Ll~~g~~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~~~~~ 136 (299)
T 1s70_B 59 LLERGADINYANVDGLTALHQ--ACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVN 136 (299)
T ss_dssp HHHHCCCTTCBCTTCCBHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHcCCCCcccCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCCcC
Confidence 455778888888888887754 666677788888888888888888888888888888888888888888888888766
Q ss_pred CC------------------------------------------------------------CCchhhHHHhcChHHHHH
Q 016152 99 RW------------------------------------------------------------KNTPLADAEGAKKFNMME 118 (394)
Q Consensus 99 ~~------------------------------------------------------------g~t~l~~A~~~~~~~~~~ 118 (394)
.. |.||||+|+..|+.++++
T Consensus 137 ~~g~t~l~~A~~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~ 216 (299)
T 1s70_B 137 SEGDTPLDIAEEEAMEELLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLK 216 (299)
T ss_dssp TTSCCHHHHCCSHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCCCTTTCCCHHHHHHHHTCHHHHH
T ss_pred CCCCCHHHHHHhcchHHHHHHHHhhcCCCchhhhhhhhhHHHHHHHHHHhccCcchhhhcCCCCCHHHHHHHCCcHHHHH
Confidence 43 556677777777788888
Q ss_pred HHHhcCCCCCCCCCCC
Q 016152 119 LLNAHGGLSYGQNGSH 134 (394)
Q Consensus 119 ~L~~~ga~~~~~~~s~ 134 (394)
+|+++|++++..+...
T Consensus 217 ~Ll~~g~d~~~~d~~g 232 (299)
T 1s70_B 217 LLIQARYDVNIKDYDG 232 (299)
T ss_dssp HHHTTTCCTTCCCTTC
T ss_pred HHHHcCCCCCCcCCCC
Confidence 8888877776554433
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.71 E-value=5.8e-18 Score=159.66 Aligned_cols=105 Identities=24% Similarity=0.267 Sum_probs=84.3
Q ss_pred CCCcchhhhhhc--cccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCC
Q 016152 19 ATSSADKQKEKA--RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96 (394)
Q Consensus 19 ~~~~~~~~~~~~--~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~ 96 (394)
++..|+++|..+ ..|.|++++ |+..+..+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|||++.
T Consensus 219 LL~~Gadvn~~~~~~~g~TpLh~--Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~LL~~Gad~~~ 296 (368)
T 3jue_A 219 ALAHGADVNWVNGGQDNATPLIQ--ATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLKRGADLGA 296 (368)
T ss_dssp HHHTTCCTTCCCTTTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTC
T ss_pred HHHcCCCCCccccccCCCCHHHH--HHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHCcCCCCC
Confidence 355778888777 667776643 5566667788888888888888888888888888888888888888888888888
Q ss_pred ccCCCCchhhHHHhcChHHHHHHHHhcCC
Q 016152 97 QDRWKNTPLADAEGAKKFNMMELLNAHGG 125 (394)
Q Consensus 97 ~~~~g~t~l~~A~~~~~~~~~~~L~~~ga 125 (394)
+|.+|+||||+|+..++.+++++|+..+.
T Consensus 297 ~d~~G~TpL~~A~~~g~~~iv~lLl~~~~ 325 (368)
T 3jue_A 297 RDSEGRDPLTIAMETANADIVTLLRLAKM 325 (368)
T ss_dssp CCTTSCCHHHHHHHTTCHHHHHHHHHHHC
T ss_pred cCCCCCCHHHHHHHCCCHHHHHHHHHcCC
Confidence 88888888888888888888888887664
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=6.2e-18 Score=152.02 Aligned_cols=100 Identities=25% Similarity=0.247 Sum_probs=89.6
Q ss_pred hhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCcccc--------------CCCCCHHHHHHhcCcHHHHHHHHH---
Q 016152 27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD--------------YDNRTPLHVASLHGWIDVAKCLIE--- 89 (394)
Q Consensus 27 ~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d--------------~~g~t~Lh~A~~~~~~~~~~~Ll~--- 89 (394)
+..|..|.|++++ |+..+..+++++|++.|+++|.+| ..|+||||+|+..|+.++|++|++
T Consensus 87 ~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~ 164 (260)
T 3jxi_A 87 RDVYYRGQTALHI--AIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGH 164 (260)
T ss_dssp CCSSEESBCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCEECCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSS
T ss_pred cccccCCCCHHHH--HHHcCCHHHHHHHHhCCCCcCccccccccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhccc
Confidence 3344578888754 777778899999999999999998 689999999999999999999999
Q ss_pred cCCCCCCccCCCCchhhHHHhcCh---------HHHHHHHHhcCCCCC
Q 016152 90 YGADVNAQDRWKNTPLADAEGAKK---------FNMMELLNAHGGLSY 128 (394)
Q Consensus 90 ~ga~~~~~~~~g~t~l~~A~~~~~---------~~~~~~L~~~ga~~~ 128 (394)
+|+|+|.+|..|+||||+|+..++ .+++++|+++|++++
T Consensus 165 ~ga~~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~~ 212 (260)
T 3jxi_A 165 KQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLF 212 (260)
T ss_dssp CCCCTTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHHC
T ss_pred cCCCCcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCcccc
Confidence 999999999999999999998777 799999999999874
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.4e-18 Score=161.61 Aligned_cols=112 Identities=21% Similarity=0.192 Sum_probs=103.0
Q ss_pred CCCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCC-----CccccCCCCCHHHHHHhcCcHHHHHHHHH
Q 016152 15 CKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL-----VHARDYDNRTPLHVASLHGWIDVAKCLIE 89 (394)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~-----vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~ 89 (394)
+.+-++..|++++..|..|.|++++ |+..+..+++++|++.|++ +|.+|..|+||||+||..|+.++|++|++
T Consensus 155 ~v~~Ll~~ga~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~ 232 (364)
T 3ljn_A 155 MIKILVQLGASPTAKDKADETPLMR--AMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVE 232 (364)
T ss_dssp HHHHHHHHTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHT
T ss_pred HHHHHHHcCCCCcccCCCCCCHHHH--HHHcCCHHHHHHHHhcccccccccccccCCCCCcHHHHHHHcCCHHHHHHHHH
Confidence 3444667899999999999998855 7777889999999999998 99999999999999999999999999999
Q ss_pred cCCCCCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCC
Q 016152 90 YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSY 128 (394)
Q Consensus 90 ~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~ 128 (394)
+|||+|.+|.+|+||||+|+..|+.+++++|+++|+++.
T Consensus 233 ~gad~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~~~~~~ 271 (364)
T 3ljn_A 233 MGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFL 271 (364)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTCCHHHHHHHHHHSCHHH
T ss_pred cCCCCCCCCCCCCCHHHHHHHhChHHHHHHHHHcCCchh
Confidence 999999999999999999999999999999999998764
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2.4e-17 Score=137.91 Aligned_cols=98 Identities=19% Similarity=0.169 Sum_probs=87.2
Q ss_pred cCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcC
Q 016152 33 SRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAK 112 (394)
Q Consensus 33 ~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~ 112 (394)
|.|+++. |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..+
T Consensus 3 ~~t~L~~--A~~~g~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~ 80 (167)
T 3v31_A 3 NSLSVHQ--LAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKG 80 (167)
T ss_dssp TCCCHHH--HHHTTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHT
T ss_pred CcchHHH--HHHCCCHHHHHHHHHcCCCcCCCCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcC
Confidence 4555533 66666677888888999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhcCCCCCCCCC
Q 016152 113 KFNMMELLNAHGGLSYGQNG 132 (394)
Q Consensus 113 ~~~~~~~L~~~ga~~~~~~~ 132 (394)
+.+++++|+++|++++..+.
T Consensus 81 ~~~~v~~Ll~~g~~~~~~~~ 100 (167)
T 3v31_A 81 YTDIVKMLLDCGVDVNEYDW 100 (167)
T ss_dssp CHHHHHHHHHHTCCTTCCCT
T ss_pred CHHHHHHHHHCCCCCCcCCC
Confidence 99999999999998765543
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-17 Score=162.16 Aligned_cols=112 Identities=24% Similarity=0.204 Sum_probs=83.8
Q ss_pred cchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCC
Q 016152 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (394)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (394)
+|++++..+..|.|+++. |+..+..+++++|++.|+++|.+|..|.||||+||..|+.+++++|+++|+++|.+|.+|
T Consensus 3 ~g~~~~~~~~~g~t~L~~--Aa~~g~~~~v~~Ll~~g~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g 80 (437)
T 1n11_A 3 PGISGGGGGESGLTPLHV--ASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDD 80 (437)
T ss_dssp ------------CCHHHH--HHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTS
T ss_pred CCCCccccCCCCCCHHHH--HHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCC
Confidence 578888888888888754 666667778888888899999888889999999999999999999999999999999999
Q ss_pred CchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCC
Q 016152 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (394)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~ 135 (394)
+||||+|+..|+.+++++|+++|++++..+....
T Consensus 81 ~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~ 114 (437)
T 1n11_A 81 QTPLHCAARIGHTNMVKLLLENNANPNLATTAGH 114 (437)
T ss_dssp CCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCC
T ss_pred CCHHHHHHHCCCHHHHHHHHhCCCCCCCCCCCCC
Confidence 9999999999999999999998888765554433
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.71 E-value=9.4e-18 Score=142.87 Aligned_cols=90 Identities=24% Similarity=0.249 Sum_probs=82.1
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCcccc-CCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
.+. |++++..|..|.|++++ |+..+..+++++|++.|+++|.+| ..|+||||+|+..|+.+++++|+++|++++.+
T Consensus 63 Ll~-~~~~~~~d~~g~t~L~~--A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~ 139 (183)
T 3deo_A 63 LLE-DRDVDAVDENGRTALLF--VAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVE 139 (183)
T ss_dssp HTT-TSCTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHTTCHHHHHHHHHHTCCTTCC
T ss_pred HHh-cCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhcCcHHHHHHHHHcCCCCcCC
Confidence 455 88999999999999854 666677889999999999999998 89999999999999999999999999999999
Q ss_pred cCCCCchhhHHHhc
Q 016152 98 DRWKNTPLADAEGA 111 (394)
Q Consensus 98 ~~~g~t~l~~A~~~ 111 (394)
|.+|+||||+|+..
T Consensus 140 d~~g~tpl~~A~~~ 153 (183)
T 3deo_A 140 DERGLTALELAREI 153 (183)
T ss_dssp CTTSCCHHHHHHHH
T ss_pred CCCCCCHHHHHHHh
Confidence 99999999999876
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.2e-17 Score=142.38 Aligned_cols=110 Identities=18% Similarity=0.236 Sum_probs=66.4
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHH-hcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcC-CCCCC
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLE-EDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG-ADVNA 96 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~-~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~g-a~~~~ 96 (394)
++..|++++..+..|.|++++ |+..+..+++++|+ ..+++++.+|..|.||||+|+..|+.+++++|+++| +++|.
T Consensus 58 Ll~~g~~~~~~~~~g~t~l~~--A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~ 135 (201)
T 3hra_A 58 LIDRGADINLQNSISDSPYLY--AGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDF 135 (201)
T ss_dssp HHHTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHSCCCTTCCCTTSCCSHHHHHHTTCHHHHHHHHHHCCCCTTC
T ss_pred HHHcCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHhccCcccccccCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcCC
Confidence 344566666666666665533 44444444555544 455566666666666666666666666666666666 66666
Q ss_pred ccCCCCchhhHHHhcCh-----HHHHHHHHhcCCCCCCC
Q 016152 97 QDRWKNTPLADAEGAKK-----FNMMELLNAHGGLSYGQ 130 (394)
Q Consensus 97 ~~~~g~t~l~~A~~~~~-----~~~~~~L~~~ga~~~~~ 130 (394)
+|..|+||||+|+..++ .+++++|++.|++++..
T Consensus 136 ~~~~g~t~L~~A~~~~~~~~~~~~~v~~Ll~~ga~~~~~ 174 (201)
T 3hra_A 136 QNDFGYTALIEAVGLREGNQLYQDIVKLLMENGADQSIK 174 (201)
T ss_dssp CCTTSCCHHHHHHHSSCCSHHHHHHHHHHHHTTCCTTCC
T ss_pred CCCCCCCHHHHHHHhccchhhHHHHHHHHHHCCCCCCcc
Confidence 66666666666666555 66666666666655443
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.70 E-value=2.2e-17 Score=149.78 Aligned_cols=107 Identities=23% Similarity=0.232 Sum_probs=97.0
Q ss_pred chhhhhhccccCcceeeehhhcCCH----HHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHH-cCCCCCCc
Q 016152 23 ADKQKEKARVSRTSLILWHAHQNDA----AAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQ 97 (394)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~a~~~~~----~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~~~ 97 (394)
|++++..|..|.|++++ |+..+. .+++++|++.|+++|.+|..|+||||+|+..|+.+++++|++ .|+++|.+
T Consensus 172 ~~~~~~~~~~g~t~l~~--a~~~~~~~~~~~i~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~ 249 (285)
T 1wdy_A 172 GADVNACDNMGRNALIH--ALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDT 249 (285)
T ss_dssp CCCTTCCCTTSCCHHHH--HHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCC
T ss_pred CCCCCccCCCCCCHHHH--HHHccccchHHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhccCCCcccc
Confidence 88899999999998754 443444 889999999999999999999999999999999999999999 89999999
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~ 131 (394)
|..|+||||+|+..++.+++++|+++|++++..+
T Consensus 250 ~~~g~t~l~~A~~~~~~~i~~~Ll~~Ga~~~~~d 283 (285)
T 1wdy_A 250 DSDGKTALLLAVELKLKKIAELLCKRGASTDCGD 283 (285)
T ss_dssp CTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSS
T ss_pred CCCCCcHHHHHHHcCcHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999999999887543
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.3e-17 Score=148.83 Aligned_cols=105 Identities=22% Similarity=0.206 Sum_probs=94.5
Q ss_pred CCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCcccc-CCCCCHHHHHHhcCcHHHHHHHHHcCCCCCC
Q 016152 18 GATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96 (394)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~ 96 (394)
.++. |+++|..|..|.|++++ |+..++.+++++|++.|+++|.+| ..|+||||+||..|+.+++++|+++|+|+|.
T Consensus 63 ~Ll~-~~~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~ 139 (244)
T 3ui2_A 63 QLLE-DRDVDAVDENGRTALLF--VAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEV 139 (244)
T ss_dssp HTTT-TCCTTCBCTTSCBHHHH--HHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHTTCHHHHHHHHHTTCCTTC
T ss_pred HHHc-CCCCCCcCCCCCCHHHH--HHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCC
Confidence 3555 89999999999999855 666777889999999999999998 7899999999999999999999999999999
Q ss_pred ccCCCCchhhHHH----------------hcChHHHHHHHHhcCC
Q 016152 97 QDRWKNTPLADAE----------------GAKKFNMMELLNAHGG 125 (394)
Q Consensus 97 ~~~~g~t~l~~A~----------------~~~~~~~~~~L~~~ga 125 (394)
+|..|+||||+|+ ..|+.+++++|.+.+.
T Consensus 140 ~d~~g~t~l~~A~~~~~~~~~~~~l~~a~~~g~~~iv~~L~~~~~ 184 (244)
T 3ui2_A 140 EDERGLTALELAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVF 184 (244)
T ss_dssp CCTTCCCHHHHHHHHHTTCCCSSHHHHHHHHHHHHHHHHHHHHHE
T ss_pred CCCCCCcHHHHHHHHHhccCCCCHHHHHHHcChHHHHHHHHHhcc
Confidence 9999999999988 6688999999998654
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.70 E-value=8e-18 Score=153.78 Aligned_cols=103 Identities=17% Similarity=0.077 Sum_probs=93.3
Q ss_pred hhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCch
Q 016152 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP 104 (394)
Q Consensus 25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~ 104 (394)
+++.+|.+|.|++++ |+..+..+++++|++.|+++|.+| |+||||+||..|+.+++++|+++|+++|.+|..|+||
T Consensus 23 ~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~--g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~ 98 (285)
T 3kea_A 23 DTFKADVHGHSASYY--AIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTA 98 (285)
T ss_dssp TTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTGGGSCCT--TCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCCccCCCCCCHHHH--HHHcCCHHHHHHHHhCCCCCCCCC--CCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcH
Confidence 578899999998754 777778889999999999999884 9999999999999999999999999999999999999
Q ss_pred hhHHHhcChHHHHHHHHhcCCCCCCCC
Q 016152 105 LADAEGAKKFNMMELLNAHGGLSYGQN 131 (394)
Q Consensus 105 l~~A~~~~~~~~~~~L~~~ga~~~~~~ 131 (394)
||+|+..|+.+++++|+++|++++..+
T Consensus 99 L~~A~~~g~~~~v~~Ll~~ga~~~~~~ 125 (285)
T 3kea_A 99 LYYAVDSGNMQTVKLFVKKNWRLMFYG 125 (285)
T ss_dssp HHHHHHTTCHHHHHHHHHHCGGGGGCS
T ss_pred HHHHHHcCCHHHHHHHHhcCCCCCccC
Confidence 999999999999999999999876543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.7e-17 Score=154.36 Aligned_cols=142 Identities=13% Similarity=0.083 Sum_probs=98.0
Q ss_pred CccccceeecCCceEEEEEEE-CCccEEEEEeccCCCC--------------cH-HHH----HHHHHHHHHHHhCCCCce
Q 016152 158 DFSSSAIIGKGSFGEILKAYW-RGTPVAIKRILPSLSD--------------DR-LVI----QDFRHEVNLLVKLRHPNI 217 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~-~g~~~avK~l~~~~~~--------------~~-~~~----~~~~~E~~~l~~l~h~~I 217 (394)
-|.++..||+|++|.||+|.. .|+.+|||++...... .. ..+ -....|...+.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 478899999999999999986 4889999987532110 00 000 112346666666654443
Q ss_pred eeEEeEEEeCCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC-
Q 016152 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD- 296 (394)
Q Consensus 218 v~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~- 296 (394)
....-+.. ...++||||++|++|.++. ....+..++.|++.+|.+||+.| ||||||||.|||+..+..+
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCCcc
Confidence 32211111 2347999999998886543 22345678899999999999988 9999999999999544322
Q ss_pred -------cEEEeecCCcccc
Q 016152 297 -------HLKVGDFGLSKLI 309 (394)
Q Consensus 297 -------~~kl~DFg~a~~~ 309 (394)
.+.|+||+.+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 3899999977543
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3e-18 Score=154.17 Aligned_cols=109 Identities=16% Similarity=0.076 Sum_probs=97.2
Q ss_pred CCCCcchhhhhhc--------------cccCcceeeehhhcCCHHHHHHHHHh---cCCCCccccCCCCCHHHHHHhcCc
Q 016152 18 GATSSADKQKEKA--------------RVSRTSLILWHAHQNDAAAVRKLLEE---DQSLVHARDYDNRTPLHVASLHGW 80 (394)
Q Consensus 18 ~~~~~~~~~~~~~--------------~~~~~~~~~~~a~~~~~~~~~~~L~~---~g~~vn~~d~~g~t~Lh~A~~~~~ 80 (394)
-++..|++++..+ ..|.|++++ |+..+..+++++|++ .|+++|.+|..|+||||+||..++
T Consensus 111 ~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~--A~~~g~~~~v~~Ll~~~~~ga~~~~~d~~g~TpLh~A~~~~~ 188 (260)
T 3jxi_A 111 LLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSL--AACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIAD 188 (260)
T ss_dssp HHHHTTCCTTCCCEECCCSSSCCCCSCCSCSSHHHH--HHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCC
T ss_pred HHHhCCCCcCccccccccCcccccccccCCCCHHHH--HHHcCCHHHHHHHHhccccCCCCcccCCCCCcHHHHHHHhcc
Confidence 3566788888888 478888754 666777899999999 999999999999999999998888
Q ss_pred ---------HHHHHHHHHcCCCC-------CCccCCCCchhhHHHhcChHHHHHHHHhcCCCCC
Q 016152 81 ---------IDVAKCLIEYGADV-------NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSY 128 (394)
Q Consensus 81 ---------~~~~~~Ll~~ga~~-------~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~ 128 (394)
.+++++|+++||++ +.+|..|+||||+|+..|+.+++++|+++|+...
T Consensus 189 ~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~~ 252 (260)
T 3jxi_A 189 NTRENTKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADA 252 (260)
T ss_dssp SSHHHHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHHHhCcccccccchhhcccCCCCCHHHHHHHcCCHHHHHHHHHhCCCcc
Confidence 79999999999999 7899999999999999999999999999998653
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.3e-17 Score=145.08 Aligned_cols=112 Identities=24% Similarity=0.293 Sum_probs=78.9
Q ss_pred CCCcc--hhhhh-hccccCcceeeehhhcCCHHHHHHHHHhcC--CCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCC
Q 016152 19 ATSSA--DKQKE-KARVSRTSLILWHAHQNDAAAVRKLLEEDQ--SLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93 (394)
Q Consensus 19 ~~~~~--~~~~~-~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g--~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~ 93 (394)
++..| .+++. .+..|.|+++. |+..+..+++++|++.| ++++.+|..|+||||+|+..|+.+++++|+++|++
T Consensus 55 Ll~~~~~~~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~ 132 (228)
T 2dzn_A 55 LLSKMENVNLDDYPDDSGWTPFHI--ACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGAS 132 (228)
T ss_dssp HHHTCTTCCGGGCCCTTSCCHHHH--HHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCC
T ss_pred HHhccccccccccCCCCCCCHHHH--HHHcCCHHHHHHHHhCCCCcccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCC
Confidence 33445 44444 55666666543 55555667777777777 77777777788888888888888888888888888
Q ss_pred CCCccCCCCchhhHHHhcChHHHHHHHHhcC-CCCCCCCC
Q 016152 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG-GLSYGQNG 132 (394)
Q Consensus 94 ~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g-a~~~~~~~ 132 (394)
++.+|..|+||||+|+..|+.+++++|++.| ++++..+.
T Consensus 133 ~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~d~ 172 (228)
T 2dzn_A 133 VRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDK 172 (228)
T ss_dssp SCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCSCCCCT
T ss_pred ccccCCCCCCHHHHHHHcCCHHHHHHHHhcCcccccCcCC
Confidence 8888878888888888778888888887777 65554433
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=8.2e-18 Score=152.48 Aligned_cols=98 Identities=22% Similarity=0.198 Sum_probs=89.8
Q ss_pred hccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccC--------------CCCCHHHHHHhcCcHHHHHHHHH---cC
Q 016152 29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDY--------------DNRTPLHVASLHGWIDVAKCLIE---YG 91 (394)
Q Consensus 29 ~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~--------------~g~t~Lh~A~~~~~~~~~~~Ll~---~g 91 (394)
.|..|.|++++ |+..+..+++++|++.|+++|.++. .|+||||+|+..|+.+++++|++ +|
T Consensus 97 ~d~~g~tpL~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~g 174 (273)
T 2pnn_A 97 SYYKGQTALHI--AIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQP 174 (273)
T ss_dssp TTTTTCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCC
T ss_pred ccCCCCCHHHH--HHHcCCHHHHHHHHHCCCCcCccccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCC
Confidence 45678888754 7777788999999999999999997 79999999999999999999999 99
Q ss_pred CCCCCccCCCCchhhHHHhcCh---------HHHHHHHHhcCCCCC
Q 016152 92 ADVNAQDRWKNTPLADAEGAKK---------FNMMELLNAHGGLSY 128 (394)
Q Consensus 92 a~~~~~~~~g~t~l~~A~~~~~---------~~~~~~L~~~ga~~~ 128 (394)
+|+|.+|..|+||||+|+..++ .+++++|+++|++++
T Consensus 175 ad~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n 220 (273)
T 2pnn_A 175 ADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLH 220 (273)
T ss_dssp CCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHC
T ss_pred CCceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhcc
Confidence 9999999999999999999887 799999999999875
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=3.6e-17 Score=144.74 Aligned_cols=111 Identities=27% Similarity=0.323 Sum_probs=57.6
Q ss_pred CCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcC-CCCCCcc
Q 016152 20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG-ADVNAQD 98 (394)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~g-a~~~~~~ 98 (394)
+..|++++..+..|.|+++. |+..+..+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++| ++++.+|
T Consensus 31 l~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~~~~~~~~~~ 108 (237)
T 3b7b_A 31 VQAGANIDTCSEDQRTPLME--AAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQD 108 (237)
T ss_dssp HHTTCCTTCCCTTCCCHHHH--HHHTTCHHHHHHHHTTTCCCCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCTTCCC
T ss_pred HHcCCCcCccCCCCCCHHHH--HHHhCCHHHHHHHHhCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCcccCC
Confidence 33445555555555554432 44444445555555555555555555555555555555555555555554 5555555
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNG 132 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~ 132 (394)
..|+||||+|+..++.+++++|++.|++++..+.
T Consensus 109 ~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~ 142 (237)
T 3b7b_A 109 DGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDN 142 (237)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccCC
Confidence 5555555555555555555555555555444333
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.5e-17 Score=150.43 Aligned_cols=103 Identities=24% Similarity=0.223 Sum_probs=91.0
Q ss_pred hhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchh
Q 016152 26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105 (394)
Q Consensus 26 ~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l 105 (394)
.+..|..|.|+++. |+..+..+++++|++.|+++|.+|.+|+||||+||..|+.+++++|+++|++++.+|..|+|||
T Consensus 52 ~~~~~~~g~t~L~~--Aa~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L 129 (285)
T 3d9h_A 52 LMGDAVSDWSPMHE--AAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPL 129 (285)
T ss_dssp TCSSSCCSCCHHHH--HHHTTCHHHHHHHHHTTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHH
T ss_pred ccCCCccCCCHHHH--HHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHH
Confidence 46678888888754 6666677888888899999999999999999999999999999999999999999999999999
Q ss_pred hHHHhcChHHHHHHHHhcCCCCCCC
Q 016152 106 ADAEGAKKFNMMELLNAHGGLSYGQ 130 (394)
Q Consensus 106 ~~A~~~~~~~~~~~L~~~ga~~~~~ 130 (394)
|+|+..|+.+++++|++.|++++..
T Consensus 130 ~~A~~~~~~~~v~~Ll~~g~~~~~~ 154 (285)
T 3d9h_A 130 FNACVSGSWDCVNLLLQHGASVQPE 154 (285)
T ss_dssp HHHHHHTCHHHHHHHHHTTCCSSCS
T ss_pred HHHHHcCHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999887643
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.7e-17 Score=150.22 Aligned_cols=95 Identities=22% Similarity=0.193 Sum_probs=58.3
Q ss_pred hhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHH
Q 016152 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLN 121 (394)
Q Consensus 42 a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~ 121 (394)
|+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|. |..|+||||+|+..++.+++++|+
T Consensus 164 A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~-~~~g~t~L~~A~~~~~~~~v~~Ll 242 (285)
T 3d9h_A 164 AARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVNQ-GKGQDSPLHAVVRTASEELACLLM 242 (285)
T ss_dssp HHHHTCHHHHHHHHHTTCCTTCCBTTTBCHHHHHHHTTCHHHHHHHHHTTCCTTC-CBTTBCHHHHHHHTTCHHHHHHHH
T ss_pred HHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHCCCCCCC-CCCCCCHHHHHHHcCCHHHHHHHH
Confidence 4444445556666666666666666666666666666666666666666666663 666666666666666666666666
Q ss_pred hcCCCCCCCCCCCCCC
Q 016152 122 AHGGLSYGQNGSHFEP 137 (394)
Q Consensus 122 ~~ga~~~~~~~s~~~p 137 (394)
++|++++..+....+|
T Consensus 243 ~~gad~~~~d~~g~t~ 258 (285)
T 3d9h_A 243 DFGADTQAKNAEGKRP 258 (285)
T ss_dssp HTTCCTTCCCTTSCCG
T ss_pred HCCCCCCCcCCCCCCH
Confidence 6666665554444443
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.68 E-value=8.3e-17 Score=150.60 Aligned_cols=106 Identities=28% Similarity=0.253 Sum_probs=94.0
Q ss_pred hccccCcceeeehhhcC---CHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchh
Q 016152 29 KARVSRTSLILWHAHQN---DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105 (394)
Q Consensus 29 ~~~~~~~~~~~~~a~~~---~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l 105 (394)
.+..+.|+++. |+.. +..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..|+|||
T Consensus 207 ~~~~~~t~L~~--A~~~~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~t~L 284 (351)
T 3utm_A 207 QPQSHETALHC--AVASLHPKRKQVAELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTAL 284 (351)
T ss_dssp CTTTCCCHHHH--HHHCCSTTHHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHH
T ss_pred CCCCCCCHHHH--HHHHhCccHHHHHHHHHHcCCCcCCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHH
Confidence 45667777644 4444 678999999999999999999999999999999999999999999999999999999999
Q ss_pred hHHHhcChHHHHHHHHhcCCCCCCCCCCCCC
Q 016152 106 ADAEGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (394)
Q Consensus 106 ~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~ 136 (394)
|+|+..|+.+++++|+++|++++..+....+
T Consensus 285 ~~A~~~~~~~~v~~Ll~~gad~~~~~~~g~t 315 (351)
T 3utm_A 285 HRAALAGHLQTCRLLLSYGSDPSIISLQGFT 315 (351)
T ss_dssp HHHHHHTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred HHHHHcCcHHHHHHHHHcCCCCCCcCCCCCC
Confidence 9999999999999999999998766655444
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.68 E-value=2e-17 Score=151.15 Aligned_cols=106 Identities=11% Similarity=-0.020 Sum_probs=96.2
Q ss_pred CCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 18 GATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
-++..|++++..+ |.|++++ |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+
T Consensus 49 ~Ll~~g~~~~~~~--g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~ 124 (285)
T 3kea_A 49 TLLNAGALKNLLE--NEFPLHQ--AATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFY 124 (285)
T ss_dssp HHHHTTGGGSCCT--TCCHHHH--HTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGC
T ss_pred HHHhCCCCCCCCC--CCCHHHH--HHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCCCcc
Confidence 3566788888874 7887754 77778889999999999999999999999999999999999999999999999999
Q ss_pred cCCC-CchhhHHHhcChHHHHHHHHhcCCCC
Q 016152 98 DRWK-NTPLADAEGAKKFNMMELLNAHGGLS 127 (394)
Q Consensus 98 ~~~g-~t~l~~A~~~~~~~~~~~L~~~ga~~ 127 (394)
|..| .||||+|+..|+.+++++|++.|++.
T Consensus 125 ~~~g~~t~L~~A~~~~~~~~v~~Ll~~g~~~ 155 (285)
T 3kea_A 125 GKTGWKTSFYHAVMLNDVSIVSYFLSEIPST 155 (285)
T ss_dssp SSSGGGSHHHHHHHTTCHHHHHHHHTTSCTT
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHhCCCcc
Confidence 9999 79999999999999999999998754
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.67 E-value=4.3e-17 Score=154.77 Aligned_cols=106 Identities=25% Similarity=0.295 Sum_probs=91.0
Q ss_pred CCCcchhhhh--------hccccCcceeeehhhcCCHHHHHHHHHhcC-CCCccccCCCCCHHHHHHhcCcHHHHHHHHH
Q 016152 19 ATSSADKQKE--------KARVSRTSLILWHAHQNDAAAVRKLLEEDQ-SLVHARDYDNRTPLHVASLHGWIDVAKCLIE 89 (394)
Q Consensus 19 ~~~~~~~~~~--------~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g-~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~ 89 (394)
++..|++++. .|..|.|+++. |+..+..+++++|++.+ +++|.+|..|+||||+|+..|+.++|++|++
T Consensus 257 Ll~~g~~~~~~~~~~~~~~d~~g~t~Lh~--A~~~g~~~~v~~Ll~~~~~~~n~~d~~g~TpL~~A~~~g~~~iv~~Ll~ 334 (373)
T 2fo1_E 257 LVEKGAKVDYDGAARKDSEKYKGRTALHY--AAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQ 334 (373)
T ss_dssp HHHHTCCSSCCSGGGTSSSSCCCCCTHHH--HHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHH
T ss_pred HHHCCCCcccccccccCcccccCCCHHHH--HHHhCCHHHHHHHHHhcCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHH
Confidence 4445666554 56678888754 66677778888888765 9999999999999999999999999999999
Q ss_pred cCCCCCCccCCCCchhhHHHhcChHHHHHHHHhcCCC
Q 016152 90 YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGL 126 (394)
Q Consensus 90 ~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~ 126 (394)
+|||+|.+|.+|+||||+|+..|+.+++++|++++++
T Consensus 335 ~gad~~~~d~~g~t~l~~A~~~g~~~iv~~Ll~~~a~ 371 (373)
T 2fo1_E 335 QGASVEAVDATDHTARQLAQANNHHNIVDIFDRCRPE 371 (373)
T ss_dssp TTCCSSCCCSSSCCHHHHHHHTTCHHHHHHHHTTC--
T ss_pred cCCCccCCCCCCCCHHHHHHHcCCHHHHHHHHhcCcc
Confidence 9999999999999999999999999999999998875
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.67 E-value=8.7e-17 Score=152.63 Aligned_cols=115 Identities=24% Similarity=0.288 Sum_probs=98.6
Q ss_pred CCCcc---hhhhhhccccCcceeeehhhcCC--HHHHHHHHHhcCCCCcc--------ccCCCCCHHHHHHhcCcHHHHH
Q 016152 19 ATSSA---DKQKEKARVSRTSLILWHAHQND--AAAVRKLLEEDQSLVHA--------RDYDNRTPLHVASLHGWIDVAK 85 (394)
Q Consensus 19 ~~~~~---~~~~~~~~~~~~~~~~~~a~~~~--~~~~~~~L~~~g~~vn~--------~d~~g~t~Lh~A~~~~~~~~~~ 85 (394)
++..+ ++++..|..|.|++++ |+..++ ..+++++|++.|+++|. .|..|+||||+||..|+.++|+
T Consensus 218 Ll~~~~~~~~~~~~d~~g~t~L~~-A~~~~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~d~~g~t~Lh~A~~~g~~~~v~ 296 (373)
T 2fo1_E 218 MLNSTKLKGDIEELDRNGMTALMI-VAHNEGRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVK 296 (373)
T ss_dssp HTTSHHHHHTTSCCCTTSCCHHHH-HHHSCSTTHHHHHHHHHHHTCCSSCCSGGGTSSSSCCCCCTHHHHHSSCCHHHHH
T ss_pred HHhcCccccChhhcCCCCCCHHHH-HHHhCCcchHHHHHHHHHCCCCcccccccccCcccccCCCHHHHHHHhCCHHHHH
Confidence 45555 7888899999998754 444443 89999999999999886 6779999999999999999999
Q ss_pred HHHHcC-CCCCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCC
Q 016152 86 CLIEYG-ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSH 134 (394)
Q Consensus 86 ~Ll~~g-a~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~ 134 (394)
+|+++| +++|.+|.+|+||||+|+..|+.+++++|+++|++++..+...
T Consensus 297 ~Ll~~~~~~~n~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gad~~~~d~~g 346 (373)
T 2fo1_E 297 YLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATD 346 (373)
T ss_dssp HHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSS
T ss_pred HHHHhcCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccCCCCCC
Confidence 999876 9999999999999999999999999999999999887655443
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.67 E-value=6.3e-17 Score=143.42 Aligned_cols=108 Identities=21% Similarity=0.155 Sum_probs=63.6
Q ss_pred cchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCC----CCCCc
Q 016152 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA----DVNAQ 97 (394)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga----~~~~~ 97 (394)
.+.+++..|..|.|++++ |+..+..+++++|++.|++++.+|..|+||||+|+..|+.+++++|+++|+ +++.+
T Consensus 35 ~~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~ 112 (241)
T 1k1a_A 35 GGRELDIYNNLRQTPLHL--AVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEAR 112 (241)
T ss_dssp TTCCSCCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCTTSCCTTCC
T ss_pred cCCCCCcccccCCCHHHH--HHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Confidence 455555556666655533 444455556666666666666666666666666666666666666666555 55666
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~ 131 (394)
|..|+||||+|+..++.+++++|++.|++++..+
T Consensus 113 ~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~ 146 (241)
T 1k1a_A 113 NYDGLTALHVAVNTECQETVQLLLERGADIDAVD 146 (241)
T ss_dssp CTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred CcCCCcHHHHHHHcCCHHHHHHHHHcCCCccccc
Confidence 6666666666666666666666666665555443
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.66 E-value=1e-16 Score=145.32 Aligned_cols=109 Identities=21% Similarity=0.186 Sum_probs=97.2
Q ss_pred CCCcchhhhhh-ccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 19 ATSSADKQKEK-ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 19 ~~~~~~~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
++..|++++.. +..|.|+++. |+..+..+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+
T Consensus 24 Ll~~g~~~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~ 101 (285)
T 1wdy_A 24 LLEGGANVNFQEEEGGWTPLHN--AVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNEC 101 (285)
T ss_dssp HHHTTCCTTCCCTTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCB
T ss_pred HHHcCCCcccccCCCCCcHHHH--HHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcc
Confidence 45567888877 5566676643 66677789999999999999999999999999999999999999999999999999
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcCCCCCC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYG 129 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~ 129 (394)
|..|+||||+|+..|+.+++++|++.|++++.
T Consensus 102 ~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~ 133 (285)
T 1wdy_A 102 DFYGFTAFMEAAVYGKVKALKFLYKRGANVNL 133 (285)
T ss_dssp CTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTC
T ss_pred CcccCCHHHHHHHhCCHHHHHHHHHhCCCccc
Confidence 99999999999999999999999999987754
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.5e-16 Score=148.52 Aligned_cols=99 Identities=20% Similarity=0.150 Sum_probs=87.0
Q ss_pred eeeehhhcC-CHHHHHHHHHhcCCCCcccc--CCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcCh
Q 016152 37 LILWHAHQN-DAAAVRKLLEEDQSLVHARD--YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKK 113 (394)
Q Consensus 37 ~~~~~a~~~-~~~~~~~~L~~~g~~vn~~d--~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~ 113 (394)
++++ |+.. +..+++++|++.|+++|..| ..|+||||+||..|+.++|++|+++|+|+|.+|..|+||||+|+..|+
T Consensus 202 ~L~~-Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~ 280 (368)
T 3jue_A 202 LLFR-ASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGH 280 (368)
T ss_dssp HHHH-HTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTC
T ss_pred HHHH-HHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCc
Confidence 3344 5444 67778888889999999998 899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCC
Q 016152 114 FNMMELLNAHGGLSYGQNGSHFE 136 (394)
Q Consensus 114 ~~~~~~L~~~ga~~~~~~~s~~~ 136 (394)
.+++++|+++|++++..+....+
T Consensus 281 ~~~v~~LL~~Gad~~~~d~~G~T 303 (368)
T 3jue_A 281 TGLACLFLKRGADLGARDSEGRD 303 (368)
T ss_dssp HHHHHHHHHTTCCTTCCCTTSCC
T ss_pred HHHHHHHHHCcCCCCCcCCCCCC
Confidence 99999999999998766544433
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=4e-16 Score=137.84 Aligned_cols=111 Identities=21% Similarity=0.164 Sum_probs=92.7
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCcccc-CCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
++..|++++..+..|.|+++. |+..+..+++++|++.|++++..+ ..|+||||+|+..|+.+++++|+++|++++.+
T Consensus 28 Ll~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~ 105 (240)
T 3eu9_A 28 LVEAGYDVRQPDKENVTLLHW--AAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLI 105 (240)
T ss_dssp HHHTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHHHHTCHHHHHHHHHTTCCTTCC
T ss_pred HHHcCCCcCCCCCCCCCHHHH--HHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHHHcCCHHHHHHHHHcCCCCccc
Confidence 456788888888888887754 666777888888889998887655 45899999999999999999999999999999
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~ 131 (394)
|..|.||||+|+..++.+++++|++.|++++..+
T Consensus 106 ~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~ 139 (240)
T 3eu9_A 106 DGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMD 139 (240)
T ss_dssp CTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred CCCCCCHHHHHHHcCHHHHHHHHHhcCCCccccC
Confidence 9999999999999999999999999888766444
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* | Back alignment and structure |
|---|
Probab=99.62 E-value=5.3e-16 Score=152.84 Aligned_cols=98 Identities=17% Similarity=0.084 Sum_probs=86.3
Q ss_pred ehhhcCCHHHHHHHHHhcCCCCccc------cCCCCCHHHHHHh---cCcHHHHHHHHHcCCCCCCccCCCCchhhHHHh
Q 016152 40 WHAHQNDAAAVRKLLEEDQSLVHAR------DYDNRTPLHVASL---HGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG 110 (394)
Q Consensus 40 ~~a~~~~~~~~~~~L~~~g~~vn~~------d~~g~t~Lh~A~~---~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~ 110 (394)
+.|+..+..++++.|++.|+++|.. |..|+||||+||. .|+.++|++||++|||+|.+|.+|+||||+|+.
T Consensus 137 ~~A~~~g~~~~v~~ll~~g~~~n~~~~~~~~~~~g~t~Lh~A~~~a~~g~~~~v~~Ll~~ga~vn~~d~~g~TpLh~A~~ 216 (497)
T 3lvq_E 137 WTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAAL 216 (497)
T ss_dssp HHHHHHTCHHHHHHHHHTTCCSSSCBCCSSSCCSCBCHHHHHHHTCCTTTHHHHHHHHHHSCCTTCCCSSSCCHHHHHTT
T ss_pred HHHHhccCHHHHHHHHhhcccccCCCCCcccccccchHHHHHHHhcccccHHHHHHHHHcCCCCCccCCCCCcHHHHHHH
Confidence 3354555566666777899999988 8899999999966 999999999999999999999999999999999
Q ss_pred cChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 111 AKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 111 ~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
.|+.+++++|+++|++++..+....+|
T Consensus 217 ~g~~~~v~~Ll~~ga~~~~~d~~g~tp 243 (497)
T 3lvq_E 217 YNQPDCLKLLLKGRALVGTVNEAGETA 243 (497)
T ss_dssp TTCHHHHHHHHHTCCCCSCCCTTCCCH
T ss_pred cCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 999999999999999999887766655
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.61 E-value=1e-15 Score=139.12 Aligned_cols=97 Identities=15% Similarity=0.031 Sum_probs=82.2
Q ss_pred ehhhcCCHHHHHHHHHhcCCCC------ccccCCCCCHHHHHHhc---CcHHHHHHHHHcCCCCCCccCCCCchhhHHHh
Q 016152 40 WHAHQNDAAAVRKLLEEDQSLV------HARDYDNRTPLHVASLH---GWIDVAKCLIEYGADVNAQDRWKNTPLADAEG 110 (394)
Q Consensus 40 ~~a~~~~~~~~~~~L~~~g~~v------n~~d~~g~t~Lh~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~ 110 (394)
.|+..++. ..+..+++.|+++ +..|..|+||||+||.. |+.+++++|+++|||+|.+|..|+||||+|+.
T Consensus 136 ~a~~~~d~-~~~~~ll~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A~~ 214 (278)
T 1dcq_A 136 EAVKTRDI-FGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCL 214 (278)
T ss_dssp HHHHTTCH-HHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHH
T ss_pred hHhhhccc-HHHHHHHHhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHHHH
Confidence 34445554 4555566889984 45588999999999999 89999999999999999999999999999999
Q ss_pred cChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 111 AKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 111 ~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
.|+.+++++|+++|++++..+....+|
T Consensus 215 ~g~~~~v~~Ll~~gad~~~~d~~g~tp 241 (278)
T 1dcq_A 215 TDNAECLKLLLRGKASIEIANESGETP 241 (278)
T ss_dssp TTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred cCCHHHHHHHHHcCCCCCCccCCCCCH
Confidence 999999999999999988776555444
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.8e-16 Score=137.94 Aligned_cols=107 Identities=22% Similarity=0.184 Sum_probs=58.7
Q ss_pred CcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCc-HHHHHHHHHcCCCCCCccC
Q 016152 21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW-IDVAKCLIEYGADVNAQDR 99 (394)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~-~~~~~~Ll~~ga~~~~~~~ 99 (394)
..|++++..+..|.|+++. |+..+..+++++|++.|++++.+|..|.||||+|+..++ .+++++|++.|++++..+.
T Consensus 97 ~~g~~~~~~~~~g~t~l~~--A~~~~~~~~~~~Ll~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~~L~~~~~~~~~~~~ 174 (240)
T 3eu9_A 97 KYGADPSLIDGEGCSCIHL--AAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDK 174 (240)
T ss_dssp HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCSSTTHHHHHHTTCCTTCCCT
T ss_pred HcCCCCcccCCCCCCHHHH--HHHcCHHHHHHHHHhcCCCccccCCCCCcHHHHHHHhCChHHHHHHHHhcCCCcchhhc
Confidence 3455555555555555432 444444555555555555555555555555555554444 4555555555555555554
Q ss_pred -CCCchhhHHHhcChHHHHHHHHhcCCCCCC
Q 016152 100 -WKNTPLADAEGAKKFNMMELLNAHGGLSYG 129 (394)
Q Consensus 100 -~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~ 129 (394)
.|.||||+|+..++.+++++|+++|++++.
T Consensus 175 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~ 205 (240)
T 3eu9_A 175 YHKNTALHWAVLAGNTTVISLLLEAGANVDA 205 (240)
T ss_dssp TTCCCHHHHHHHHTCHHHHHHHHHHTCCTTC
T ss_pred cCCCcHHHHHHHcCCHHHHHHHHHcCCCCCC
Confidence 555666666666666666666665555443
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.3e-15 Score=140.00 Aligned_cols=98 Identities=15% Similarity=0.034 Sum_probs=83.9
Q ss_pred eeehhhcCCHHHHHHHHHhcCCCCcc------ccCCCCCHHHHHHhc---CcHHHHHHHHHcCCCCCCccCCCCchhhHH
Q 016152 38 ILWHAHQNDAAAVRKLLEEDQSLVHA------RDYDNRTPLHVASLH---GWIDVAKCLIEYGADVNAQDRWKNTPLADA 108 (394)
Q Consensus 38 ~~~~a~~~~~~~~~~~L~~~g~~vn~------~d~~g~t~Lh~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A 108 (394)
+++|+..++... ++.|++.|+++|. .|..|+||||+||.. |+.+++++|+++|+|+|.+|.+|+||||+|
T Consensus 155 L~~A~~~g~~~~-v~~ll~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh~A 233 (301)
T 2b0o_E 155 LWTAICNRDLLS-VLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYA 233 (301)
T ss_dssp HHHHHHTTCHHH-HHHHHHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHHHH
T ss_pred HhhhhhccCHHH-HHHHHhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Confidence 455555555554 5555599999998 689999999999997 899999999999999999999999999999
Q ss_pred HhcChHHHHHHHHhcCCCCCCCCCCCCC
Q 016152 109 EGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (394)
Q Consensus 109 ~~~~~~~~~~~L~~~ga~~~~~~~s~~~ 136 (394)
+..|+.+++++|+++|++++..+....+
T Consensus 234 ~~~g~~~~v~~Ll~~gad~~~~d~~G~T 261 (301)
T 2b0o_E 234 ALYNQPDCLKLLLKGRALVGTVNEAGET 261 (301)
T ss_dssp HHTTCHHHHHHHHHTTCCCSCCCTTSCC
T ss_pred HHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 9999999999999999998766554443
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.60 E-value=2e-15 Score=113.27 Aligned_cols=69 Identities=36% Similarity=0.511 Sum_probs=62.7
Q ss_pred CCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCC
Q 016152 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135 (394)
Q Consensus 67 ~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~ 135 (394)
+|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..++.+++++|++.|++++..+....
T Consensus 1 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 69 (93)
T 1n0q_A 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGR 69 (93)
T ss_dssp --CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred CCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCC
Confidence 589999999999999999999999999999999999999999999999999999999998876654443
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.59 E-value=5.5e-16 Score=144.43 Aligned_cols=88 Identities=17% Similarity=0.087 Sum_probs=76.3
Q ss_pred hhcCCHHHHHHHHHhcCCCCcc-ccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcCh---HHHH
Q 016152 42 AHQNDAAAVRKLLEEDQSLVHA-RDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKK---FNMM 117 (394)
Q Consensus 42 a~~~~~~~~~~~L~~~g~~vn~-~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~---~~~~ 117 (394)
++.+...+++++|++.|+++|. +|.+|+||||+||..|+.++|++||++|||+|.+|.+|+||||+|+..|+ .+++
T Consensus 104 a~~~~~~~~~~~l~~~g~dvn~~~d~~g~TpLh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~ 183 (327)
T 1sw6_A 104 SFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTF 183 (327)
T ss_dssp CHHHHHHHHHHHCTTSCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCH
T ss_pred HHHhhHHHHHHHHHhcCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHH
Confidence 3444556788888888999999 89999999999999999999999999999999999999999999999998 6777
Q ss_pred HHHHhcC-CCCCC
Q 016152 118 ELLNAHG-GLSYG 129 (394)
Q Consensus 118 ~~L~~~g-a~~~~ 129 (394)
+.|++.+ ++++.
T Consensus 184 ~~ll~~~~~~~~~ 196 (327)
T 1sw6_A 184 EALLDYLYPCLIL 196 (327)
T ss_dssp HHHHHHHGGGGGE
T ss_pred HHHHHhhhccccC
Confidence 7777766 44443
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.4e-15 Score=117.45 Aligned_cols=87 Identities=31% Similarity=0.324 Sum_probs=77.7
Q ss_pred CCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCC
Q 016152 17 GGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96 (394)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~ 96 (394)
+.++..|++++..|..|.|+++. |+..+..+++++|++.|++++.+|..|+||||+|+..|+.+++++|+++|||+|.
T Consensus 26 ~~Ll~~g~~~~~~d~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~~~~~~~~~~Ll~~ga~~n~ 103 (115)
T 2l6b_A 26 KKLLSKGADVNARSKDGNTPLHL--AAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNA 103 (115)
T ss_dssp HHHTTTTCCSSCCCSSSCCTTHH--HHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTSSSHHH
T ss_pred HHHHHcCCCCCCcCCCCCCHHHH--HHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCc
Confidence 34677899999999999998854 7777888999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCchh
Q 016152 97 QDRWKNTPL 105 (394)
Q Consensus 97 ~~~~g~t~l 105 (394)
++..|.||-
T Consensus 104 ~~~~~~~~~ 112 (115)
T 2l6b_A 104 RSWGSSHHH 112 (115)
T ss_dssp HSCCCC---
T ss_pred CCccccccc
Confidence 999999984
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.47 E-value=4.5e-14 Score=109.44 Aligned_cols=74 Identities=27% Similarity=0.231 Sum_probs=64.7
Q ss_pred CccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCC
Q 016152 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSH 134 (394)
Q Consensus 61 vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~ 134 (394)
.+..|.+|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..+...
T Consensus 17 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g 90 (110)
T 2zgd_A 17 GSHMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFG 90 (110)
T ss_dssp -----CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred ccccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCC
Confidence 45678899999999999999999999999999999999999999999999999999999999999887655433
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.42 E-value=4.1e-15 Score=140.69 Aligned_cols=90 Identities=17% Similarity=0.112 Sum_probs=75.4
Q ss_pred cccCcceeeehhhcCCHHHHHHHHHhcCCC-----CccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCC--ccCCCCc
Q 016152 31 RVSRTSLILWHAHQNDAAAVRKLLEEDQSL-----VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA--QDRWKNT 103 (394)
Q Consensus 31 ~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~-----vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~--~~~~g~t 103 (394)
..+.|+++ .|+.+++.+++++|++.|++ ++..+ +||||+||.+|+.++|++|+++|++++. .|..|+|
T Consensus 126 ~~~~tpL~--~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~---~TpLh~Aa~~G~~eiv~~Ll~~ga~~~~~~~d~~g~T 200 (376)
T 2aja_A 126 AENYQAFR--LAAENGHLHVLNRLCELAPTEIMAMIQAEN---YHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYY 200 (376)
T ss_dssp HHHHHHHH--HHHHTTCHHHHHHHHHSCTTTHHHHHSHHH---HHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHHH
T ss_pred cCCCCHHH--HHHHcCCHHHHHHHHhCCCCccccccCCCC---CCHHHHHHHCCCHHHHHHHHHcCCccchhccCCCCCC
Confidence 34556553 37777888999999999975 33333 9999999999999999999999999988 8999999
Q ss_pred hhhHHH-hcChHHHHHHHHhcCC
Q 016152 104 PLADAE-GAKKFNMMELLNAHGG 125 (394)
Q Consensus 104 ~l~~A~-~~~~~~~~~~L~~~ga 125 (394)
|||+|+ ..|+.++|++|++.|+
T Consensus 201 pL~~Aa~~~G~~eiv~~Ll~~ga 223 (376)
T 2aja_A 201 AFRWAAVGRGHHNVINFLLDCPV 223 (376)
T ss_dssp HHHHHHSTTCCHHHHHHHTTSHH
T ss_pred HHHHHHHHCCCHHHHHHHHhCCC
Confidence 999999 9999999999998664
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=5.6e-13 Score=119.85 Aligned_cols=141 Identities=13% Similarity=0.058 Sum_probs=108.4
Q ss_pred CccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEEEEec
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
.|++...++.|+.+.||++...+..+++|.......... ..+.+|+.+++.+. +..+.++++++.+.+..|+|||+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~---~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCH---HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 466677788888899999988888999998764221111 34778899998885 67788999999888899999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------
Q 016152 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP----------------------------------------- 275 (394)
Q Consensus 237 ~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~----------------------------------------- 275 (394)
++|.+|.+.+. +......++.++.++|..||+..
T Consensus 92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 99999887531 22234567889999999999810
Q ss_pred ----------------CCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 276 ----------------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 276 ----------------~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
..++|+|++|.|||+ +....+.|+||+.+..
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~--~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFV--KDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEE--ETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEE--ECCcEEEEEEchhccc
Confidence 238999999999999 5544567999998754
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.30 E-value=1.1e-13 Score=130.93 Aligned_cols=97 Identities=13% Similarity=0.035 Sum_probs=74.2
Q ss_pred hccccCcceeeehhhcCCHHHHHHHHHhcCCCC---ccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCC---CCccCCCC
Q 016152 29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLV---HARDYDNRTPLHVASLHGWIDVAKCLIEYGADV---NAQDRWKN 102 (394)
Q Consensus 29 ~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~v---n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~---~~~~~~g~ 102 (394)
.+.++.|+++. |++.+..+++++|++.|+.. +..+..|.||||+||.+|+.++|++|+++|+|+ +..+.+ +
T Consensus 88 ~g~~~~T~Lh~--Aa~~G~~e~v~~Ll~~ga~~~~~~~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~ 164 (376)
T 2aja_A 88 KGIKSEVICFV--AAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-Y 164 (376)
T ss_dssp HTCCHHHHHHH--HHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-H
T ss_pred cCCCcCCHHHH--HHHcCCHHHHHHHHHcCCcHHHHHHhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-C
Confidence 34445566643 66677788888898998822 234456889999999999999999999999863 333344 9
Q ss_pred chhhHHHhcChHHHHHHHHhcCCCCC
Q 016152 103 TPLADAEGAKKFNMMELLNAHGGLSY 128 (394)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~~~ga~~~ 128 (394)
||||+|+..|+.+++++|+++|+++.
T Consensus 165 TpLh~Aa~~G~~eiv~~Ll~~ga~~~ 190 (376)
T 2aja_A 165 HAFRLAAENGHLHVLNRLCELAPTEA 190 (376)
T ss_dssp HHHHHHHHTTCHHHHHHHHHSCGGGH
T ss_pred CHHHHHHHCCCHHHHHHHHHcCCccc
Confidence 99999999999999999999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.26 E-value=2.7e-11 Score=114.04 Aligned_cols=142 Identities=18% Similarity=0.215 Sum_probs=104.6
Q ss_pred cceeecCCceEEEEEEECCccEEEEEec--cCCCCcHHHHHHHHHHHHHHHhCC--CCceeeEEeEEEeC---CeeEEEE
Q 016152 162 SAIIGKGSFGEILKAYWRGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLGAVTER---KPLMLIT 234 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~~g~~~avK~l~--~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~---~~~~lv~ 234 (394)
.+.++.|.++.||+....+..+++|... .... ......+.+|+.+++.+. +..+++++.++.+. +..|+||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4568899999999998888889999664 2211 111246778999999887 45578888888766 4579999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE---------------------------------------- 274 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---------------------------------------- 274 (394)
||++|..+.+. ....++..+...++.++++.|..||+.
T Consensus 121 e~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99999877531 123467888889999999999999972
Q ss_pred ----------------CCCeEecCCCCCCEEEeeCCCC--cEEEeecCCcccc
Q 016152 275 ----------------PNVIIHRDLKPRNVLLVNSSAD--HLKVGDFGLSKLI 309 (394)
Q Consensus 275 ----------------~~~ivH~Dikp~Nilv~~~~~~--~~kl~DFg~a~~~ 309 (394)
...++|+|++|.|||+ +.++ .+.|+||+.+..-
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~--~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMF--HPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEE--CSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEE--eCCCCcEEEEECccccccC
Confidence 1349999999999999 4443 3689999988753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=2.8e-10 Score=101.73 Aligned_cols=134 Identities=19% Similarity=0.144 Sum_probs=93.8
Q ss_pred ccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCc--eeeEEeEEEeCCeeEEEEe
Q 016152 159 FSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN--IVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~~~~~~~~~lv~e 235 (394)
+.+..+.+.|..+.||++... |..+++|...... ...+..|+.+++.+.+.+ +.+++++...++..++|||
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 333333345666899998764 5779999865431 134667888888876434 5678888888888999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP---------------------------------------- 275 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---------------------------------------- 275 (394)
|++|.+|. .. ..+ ...++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 96 EVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp CCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred ecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 99998884 21 122 2245667777777777642
Q ss_pred ----------------CCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 276 ----------------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 276 ----------------~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
..++|+|++|.|||+ +.++.+.|+||+.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~--~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMV--ENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEE--ETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEE--ECCcEEEEEcchhccc
Confidence 129999999999999 5555567999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1.3e-10 Score=106.79 Aligned_cols=188 Identities=21% Similarity=0.224 Sum_probs=119.1
Q ss_pred ceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCc--eeeEEeEEEeCC---eeEEEEec
Q 016152 163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPN--IVQFLGAVTERK---PLMLITEY 236 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~--Iv~~~~~~~~~~---~~~lv~e~ 236 (394)
+.++.|....||+.. ..+++|+... ......+.+|..+++.+. +.. +.+++....... ..|+|||+
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 458899999998763 6799997532 133467888999998873 332 445555443333 34889999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------
Q 016152 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP----------------------------------------- 275 (394)
Q Consensus 237 ~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~----------------------------------------- 275 (394)
++|.+|.+... ..++..+...++.|++..|..||+..
T Consensus 98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99988875432 24677777888888888888888511
Q ss_pred ---------------CCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCC--cc---------Cccc
Q 016152 276 ---------------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE--TG---------SYRY 329 (394)
Q Consensus 276 ---------------~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~--~g---------t~~y 329 (394)
..++|+|++|.||++..+....+.|+||+.+..-..... -....... .+ ..+.
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HHHHHhhccccCHHHHHHHHHHcCC
Confidence 237999999999999322145688999998865321110 00000000 00 0001
Q ss_pred cC-ccccCCCCCCCcchHHHHHHHHHHHHcCCCCC
Q 016152 330 MA-PEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL 363 (394)
Q Consensus 330 ~a-PE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf 363 (394)
.. |+.... .....+.|+++.++|.+.+|..||
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 111110 112368999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=5.4e-07 Score=82.57 Aligned_cols=136 Identities=19% Similarity=0.150 Sum_probs=90.6
Q ss_pred cceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCC---ceeeEEeEEE-eCCeeEEEEecc
Q 016152 162 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP---NIVQFLGAVT-ERKPLMLITEYL 237 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~---~Iv~~~~~~~-~~~~~~lv~e~~ 237 (394)
...++.|....||+. |..+++|+.. .......+..|..+++.+.+. .|.+++.+.. ..+..++|||++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 345788888899987 7889999742 123346788999999998742 3567776664 445678999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-------------------------------------------
Q 016152 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------------------------------------------- 274 (394)
Q Consensus 238 ~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~------------------------------------------- 274 (394)
+|.+|.+..- ..++..+...++.++.+.|..||+.
T Consensus 96 ~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 96 QGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9988765321 1233334444444444444444431
Q ss_pred ---------------CCCeEecCCCCCCEEEeeCC---CCc-EEEeecCCcccc
Q 016152 275 ---------------PNVIIHRDLKPRNVLLVNSS---ADH-LKVGDFGLSKLI 309 (394)
Q Consensus 275 ---------------~~~ivH~Dikp~Nilv~~~~---~~~-~kl~DFg~a~~~ 309 (394)
...++|+|++|.|||+ +. .+. +.|+||+.+..-
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~--~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLT--NLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEE--CTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEE--ecCCCCCceEEEEehhhcCCC
Confidence 1237999999999999 54 344 579999988654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=1.7e-06 Score=77.54 Aligned_cols=132 Identities=20% Similarity=0.237 Sum_probs=91.3
Q ss_pred eecCCce-EEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEEEEeccCCC
Q 016152 165 IGKGSFG-EILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLRGG 240 (394)
Q Consensus 165 iG~G~~g-~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 240 (394)
+..|..+ .||+.... +..+++|.-.. .....+..|..+++.+. +--|.+++.++.+.+..++|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 4445444 68877653 56799997532 22356778999888775 334778888888889999999999998
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------------
Q 016152 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP--------------------------------------------- 275 (394)
Q Consensus 241 sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--------------------------------------------- 275 (394)
++.+..... ......+..++...|..||+..
T Consensus 106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 887765432 1223344555666666666410
Q ss_pred -----------CCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 276 -----------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 276 -----------~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
..++|+|+.+.|||+ +..+.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~--~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIF--DEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEE--ETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEE--ECCeEEEEEECccccc
Confidence 117999999999999 5555667999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=4e-06 Score=79.65 Aligned_cols=77 Identities=19% Similarity=0.277 Sum_probs=48.0
Q ss_pred cceeecCCceEEEEEEE--CCccEEEEEeccCCC-CcH---HHHHHHHHHHHHHHhCCC--C-ceeeEEeEEEeCCeeEE
Q 016152 162 SAIIGKGSFGEILKAYW--RGTPVAIKRILPSLS-DDR---LVIQDFRHEVNLLVKLRH--P-NIVQFLGAVTERKPLML 232 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~-~~~---~~~~~~~~E~~~l~~l~h--~-~Iv~~~~~~~~~~~~~l 232 (394)
.+.||.|..+.||++.. .+..++||....... ... ....++..|..+++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 34689999999999954 467899997654221 000 012345678888877642 3 34566643 3455689
Q ss_pred EEeccCCC
Q 016152 233 ITEYLRGG 240 (394)
Q Consensus 233 v~e~~~~~ 240 (394)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.16 E-value=2.2e-05 Score=72.52 Aligned_cols=72 Identities=17% Similarity=0.215 Sum_probs=40.3
Q ss_pred eeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-----CCCceeeEE-e--EEEeCCeeEEEEe
Q 016152 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-----RHPNIVQFL-G--AVTERKPLMLITE 235 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~Iv~~~-~--~~~~~~~~~lv~e 235 (394)
.|+.|..+.||+....+..+++|..... . ..+..|..+++.+ ..|.++... + +....+..+++|+
T Consensus 39 ~l~gG~~n~~~~v~~~~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp ECC----CEEEEEEETTEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eccccccCcEEEEEeCCCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4566778899998877767999987541 2 2222344444433 234443311 1 1234667899999
Q ss_pred ccCCCCH
Q 016152 236 YLRGGDL 242 (394)
Q Consensus 236 ~~~~~sL 242 (394)
|++|.++
T Consensus 112 ~i~G~~~ 118 (346)
T 2q83_A 112 WIEGRPF 118 (346)
T ss_dssp CCCCBCC
T ss_pred eecCccC
Confidence 9998643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=4e-06 Score=78.32 Aligned_cols=78 Identities=9% Similarity=0.035 Sum_probs=51.6
Q ss_pred ccee-ecCCceEEEEEEEC--------CccEEEEEeccCC---CCcHHHHHHHHHHHHHHHhCC-C--CceeeEEeEEEe
Q 016152 162 SAII-GKGSFGEILKAYWR--------GTPVAIKRILPSL---SDDRLVIQDFRHEVNLLVKLR-H--PNIVQFLGAVTE 226 (394)
Q Consensus 162 ~~~i-G~G~~g~V~~a~~~--------g~~~avK~l~~~~---~~~~~~~~~~~~E~~~l~~l~-h--~~Iv~~~~~~~~ 226 (394)
.+.| +.|....+|+.... +..+++|...... ... ...+..|+.+++.+. + -.+.+++.+..+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3456 78888999988765 6789999754322 000 133566777777764 2 356778877665
Q ss_pred C---CeeEEEEeccCCCCH
Q 016152 227 R---KPLMLITEYLRGGDL 242 (394)
Q Consensus 227 ~---~~~~lv~e~~~~~sL 242 (394)
. +..++|||+++|.++
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 5 356899999988654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.94 E-value=4.8e-05 Score=72.70 Aligned_cols=78 Identities=13% Similarity=0.126 Sum_probs=45.1
Q ss_pred CCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCC---CCCCcchHHHHHHH
Q 016152 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR---KYDKKVDVFSFAMI 352 (394)
Q Consensus 276 ~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGv~ 352 (394)
+.++|+|++|.|||+ +.++ ++|+||+.+..-...-.... ... .-...|.+|+..... .-....++.++...
T Consensus 232 ~~liHGDl~~~Nil~--~~~~-~~lID~e~a~~G~p~~Dla~-~l~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (420)
T 2pyw_A 232 QALIHGDLHTGSVMV--TQDS-TQVIDPEFSFYGPMGFDIGA-YLG--NLILAFFAQDGHATQENDRKEYKQWILRTIEQ 305 (420)
T ss_dssp CEEECSCCSGGGEEE--CSSC-EEECCCTTCEEECHHHHHHH-HHH--HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEE--eCCC-CEEEeCcccccCchHHHHHH-HHH--HHHHHHHhcccccccccchHHHHHHHHHHHHH
Confidence 349999999999999 5544 99999998875432111000 000 011335566554311 11223555677777
Q ss_pred HHHHHcC
Q 016152 353 LYEMLEG 359 (394)
Q Consensus 353 l~el~~g 359 (394)
+|+.+++
T Consensus 306 ~~~~y~~ 312 (420)
T 2pyw_A 306 TWNLFNK 312 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7777654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.83 E-value=9.2e-05 Score=67.64 Aligned_cols=75 Identities=21% Similarity=0.118 Sum_probs=59.0
Q ss_pred cceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC---CCceeeEEeEEEeCCeeEEEEeccC
Q 016152 162 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQFLGAVTERKPLMLITEYLR 238 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~~~~lv~e~~~ 238 (394)
...|+.|....+|+....+..+++|..... ....+..|...++.+. ...+++++.+....+..++|||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 346889999999999887888999976432 1356778888888774 3568888888887888999999999
Q ss_pred CCCH
Q 016152 239 GGDL 242 (394)
Q Consensus 239 ~~sL 242 (394)
|..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.0006 Score=61.82 Aligned_cols=71 Identities=8% Similarity=0.071 Sum_probs=42.8
Q ss_pred cceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCce-eeEEeEEEeCCeeEEEEecc-CC
Q 016152 162 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI-VQFLGAVTERKPLMLITEYL-RG 239 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~~~~~~~~~~~~~lv~e~~-~~ 239 (394)
.+.|+.|....+|+. ..+++|+........ ....+|+.+++.+...++ .+++.+ +.+.-++++||+ +|
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 567889999999998 679999765421111 112346666665542222 455543 333457899999 66
Q ss_pred CCH
Q 016152 240 GDL 242 (394)
Q Consensus 240 ~sL 242 (394)
.+|
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.0003 Score=64.80 Aligned_cols=31 Identities=35% Similarity=0.484 Sum_probs=25.9
Q ss_pred CeEecCCCCCCEEEeeCCC----CcEEEeecCCcccc
Q 016152 277 VIIHRDLKPRNVLLVNSSA----DHLKVGDFGLSKLI 309 (394)
Q Consensus 277 ~ivH~Dikp~Nilv~~~~~----~~~kl~DFg~a~~~ 309 (394)
.++|+|+.+.|||+ +.+ +.+.|+||+.+..-
T Consensus 184 ~lvHgD~~~~Nil~--~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 184 VFVHRDFHAQNLLW--LPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EEECSCCSGGGEEE--CTTSCGGGGEEECCCTTCEEE
T ss_pred eeEeCCcCcccEEe--ccCcCCCCCeEEEeCCCcCcC
Confidence 49999999999999 442 57899999988754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0025 Score=57.30 Aligned_cols=75 Identities=20% Similarity=0.158 Sum_probs=51.4
Q ss_pred cccceeecCCceEEEEEEE-CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC---CceeeEEeEEEeCCeeEEEEe
Q 016152 160 SSSAIIGKGSFGEILKAYW-RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH---PNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 160 ~~~~~iG~G~~g~V~~a~~-~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h---~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.....+|.|..+.||+... +|+.+++|+......... ..+..|+..|+.+.- --+++++.+ + .-++|||
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~---~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e 90 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALD---GLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAME 90 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCT---THHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEE
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchh---hHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEE
Confidence 3456789999999999987 488999997654332221 346778888887742 234555553 2 2378999
Q ss_pred ccCCCC
Q 016152 236 YLRGGD 241 (394)
Q Consensus 236 ~~~~~s 241 (394)
+++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0087 Score=54.48 Aligned_cols=140 Identities=19% Similarity=0.123 Sum_probs=74.4
Q ss_pred cceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCC--ceeeEEeE------EEeCCeeEEE
Q 016152 162 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP--NIVQFLGA------VTERKPLMLI 233 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~--~Iv~~~~~------~~~~~~~~lv 233 (394)
.+.|+.|....+|+....+..+++|........ ..+..|..+++.+... .+.+++.. ....+..+++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~-----~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eeccCCCcccceEEEEeCCccEEEEEeCCCCCH-----HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 345777888899998877668999987552111 2334566665554311 13333321 1234567899
Q ss_pred EeccCCCCHH-----------HH---HHhc--C---C----CCHHHHHHHH---------------HHHHHHHHHHHc--
Q 016152 234 TEYLRGGDLH-----------KY---LKEK--G---A----LSPSTAVNFA---------------LDIARGMAYLHN-- 273 (394)
Q Consensus 234 ~e~~~~~sL~-----------~~---~~~~--~---~----~~~~~~~~~~---------------~ql~~~l~~lH~-- 273 (394)
++|++|..+. .. ++.. + + .........+ ..+...++.+..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 9999885431 11 1110 0 0 1111111100 013334444442
Q ss_pred ---CCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 274 ---EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 274 ---~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
....++|+|+.+.|||+ +.++.+.|+||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~--~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFF--LGDELSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEE--ETTEEEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEE--eCCceEEEecchhccC
Confidence 11249999999999999 5444457999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0036 Score=57.23 Aligned_cols=73 Identities=7% Similarity=0.023 Sum_probs=44.2
Q ss_pred eeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC--CceeeEEeE-----EEeCCeeEEEEe
Q 016152 164 IIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGA-----VTERKPLMLITE 235 (394)
Q Consensus 164 ~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~~~~~-----~~~~~~~~lv~e 235 (394)
.++ |....||+.... |..+++|....... .. ..+..|..+++.+.. -.+++++.. ....+..+++|+
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCC-CH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 455 777889987654 56899998753322 22 344556666666531 124444432 223456688999
Q ss_pred ccCCCC
Q 016152 236 YLRGGD 241 (394)
Q Consensus 236 ~~~~~s 241 (394)
+++|..
T Consensus 108 ~i~G~~ 113 (328)
T 1zyl_A 108 SVGGRQ 113 (328)
T ss_dssp CCCCEE
T ss_pred ecCCCC
Confidence 998743
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0032 Score=60.61 Aligned_cols=73 Identities=21% Similarity=0.149 Sum_probs=45.7
Q ss_pred cceeecCCceEEEEEEECC--ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCce-eeEEeEEEeCCeeEEEEeccC
Q 016152 162 SAIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI-VQFLGAVTERKPLMLITEYLR 238 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~~g--~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~~~~~~~~~~~~~lv~e~~~ 238 (394)
.+.|+.|-...+|+....+ ..+++|+........ -+...|..+++.+...++ .++++.+. + .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~----idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI----INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC----SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh----cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 3467788889999998876 788999764322111 112468888888764444 56777663 2 35999998
Q ss_pred CCCH
Q 016152 239 GGDL 242 (394)
Q Consensus 239 ~~sL 242 (394)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0016 Score=61.13 Aligned_cols=139 Identities=19% Similarity=0.234 Sum_probs=76.7
Q ss_pred ceeecCCceEEEEEEEC---------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEE
Q 016152 163 AIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~---------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~l 232 (394)
+.+..|-...+|+.... +..+++|+.-. .... ...+.+|..+++.+. +.-..++++.+.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQG---VDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 35666777888988763 36788887522 1111 244557888887774 2223566665543 38
Q ss_pred EEeccCCCCHH--------------HHHHh---c-----CCCC--HHHHHHHHHHHHH-------------------HHH
Q 016152 233 ITEYLRGGDLH--------------KYLKE---K-----GALS--PSTAVNFALDIAR-------------------GMA 269 (394)
Q Consensus 233 v~e~~~~~sL~--------------~~~~~---~-----~~~~--~~~~~~~~~ql~~-------------------~l~ 269 (394)
||||++|.+|. +.+.+ - .... ..++.++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999885432 11111 0 1111 3445555544322 122
Q ss_pred H----HHcC--CCCeEecCCCCCCEEEeeC--CCCcEEEeecCCcccc
Q 016152 270 Y----LHNE--PNVIIHRDLKPRNVLLVNS--SADHLKVGDFGLSKLI 309 (394)
Q Consensus 270 ~----lH~~--~~~ivH~Dikp~Nilv~~~--~~~~~kl~DFg~a~~~ 309 (394)
. |... ...++|+|+.+.|||+..+ ..+.+.|+||..+..-
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 2 3221 1249999999999999432 1368999999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0022 Score=61.29 Aligned_cols=71 Identities=11% Similarity=0.119 Sum_probs=45.9
Q ss_pred cceeecCCceEEEEEEEC---------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCc-eeeEEeEEEeCCeeE
Q 016152 162 SAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERKPLM 231 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~~---------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~~~~ 231 (394)
.+.|+.|-...+|++... +..+++|+.... .. ...+..|..+++.+...+ .+++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 346778888999998864 467899977332 11 123446888887775333 3567765542 3
Q ss_pred EEEeccCCCC
Q 016152 232 LITEYLRGGD 241 (394)
Q Consensus 232 lv~e~~~~~s 241 (394)
+|+||++|.+
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 8999998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.012 Score=54.16 Aligned_cols=31 Identities=26% Similarity=0.455 Sum_probs=26.3
Q ss_pred CeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 277 ~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
.++|+|+.+.||++ +.++.+.|+||+.+..-
T Consensus 207 ~~~HgD~~~~N~l~--~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLV--GNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEE--CGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEE--eCCCeEEEEECCCCeeC
Confidence 49999999999999 55567999999887654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0019 Score=60.26 Aligned_cols=71 Identities=15% Similarity=0.146 Sum_probs=40.5
Q ss_pred ceeecCCceEEEEEEECC----------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCc-eeeEEeEEEeCCeeE
Q 016152 163 AIIGKGSFGEILKAYWRG----------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERKPLM 231 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~g----------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~~~~ 231 (394)
..++.|....+|+....+ ..+++|+....... ......|..+++.+...+ +.++++.+ . -+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 456778888999988754 67888875432110 012345777777664223 44666544 2 27
Q ss_pred EEEeccCCCC
Q 016152 232 LITEYLRGGD 241 (394)
Q Consensus 232 lv~e~~~~~s 241 (394)
+||||++|.+
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.09 E-value=0.1 Score=44.40 Aligned_cols=102 Identities=12% Similarity=0.109 Sum_probs=64.9
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH-HcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccccc
Q 016152 240 GDLHKYLKE-KGALSPSTAVNFALDIARGMAYL-HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317 (394)
Q Consensus 240 ~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~l-H~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~ 317 (394)
.||.+++.. +.++++++++.++.|.+..|.-+ +++. + ..+=+.|..|++ ..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l--~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRV--WRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEE--ETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEE--ecCCceeccc-cccc----------
Confidence 379999986 56899999999999999998776 2221 1 122334678888 7777776553 1110
Q ss_pred ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCC
Q 016152 318 YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPL 363 (394)
Q Consensus 318 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf 363 (394)
.....+.+||... ...+.+.=|||||+++|..+- |-++=
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~ 137 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN 137 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence 1122466888763 445678899999999999886 55443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.09 E-value=0.081 Score=50.17 Aligned_cols=71 Identities=11% Similarity=0.058 Sum_probs=43.5
Q ss_pred ceeecCCceEEEEEEEC---------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEE
Q 016152 163 AIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~---------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~l 232 (394)
+.+..|-...+|+.... +..+++++........ -+..+|..+++.+. +.-..++++.+. -++
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~----idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF----YDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC----CCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh----cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 45667777889998876 5789999754321111 12245777776664 222445665332 278
Q ss_pred EEeccCCCC
Q 016152 233 ITEYLRGGD 241 (394)
Q Consensus 233 v~e~~~~~s 241 (394)
||||++|..
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 999999855
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=82.46 E-value=0.66 Score=43.49 Aligned_cols=32 Identities=31% Similarity=0.426 Sum_probs=26.1
Q ss_pred eEecCCCCCCEEEee----CCCCcEEEeecCCcccc
Q 016152 278 IIHRDLKPRNVLLVN----SSADHLKVGDFGLSKLI 309 (394)
Q Consensus 278 ivH~Dikp~Nilv~~----~~~~~~kl~DFg~a~~~ 309 (394)
++|+|+.+.|||+.. +....+.++||..|..-
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 679999999999943 34567999999998754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 394 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-65 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-57 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-56 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-54 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-49 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-49 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-47 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-45 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-20 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 1e-16 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 8e-12 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-10 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 1e-09 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-09 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 1e-07 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 9e-07 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 6e-13 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 7e-12 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 4e-08 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 1e-05 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 2e-05 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 9e-13 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 4e-08 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 7e-05 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 7e-12 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 9e-08 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 7e-05 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 5e-11 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 1e-08 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 2e-06 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 3e-05 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 3e-10 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 4e-08 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 8e-05 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 0.001 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 4e-10 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 1e-09 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 3e-09 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 1e-06 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 8e-04 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 8e-10 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 3e-08 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 2e-04 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 5e-04 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 6e-09 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 4e-08 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 3e-07 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 9e-06 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 2e-08 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 5e-05 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 2e-04 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 9e-04 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 1e-07 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 1e-06 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 7e-05 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 7e-07 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 9e-07 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 1e-05 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 9e-06 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 2e-05 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 2e-05 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 2e-05 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 0.002 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 1e-04 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 0.004 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 3e-04 | |
| d1bi7b_ | 125 | d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma | 0.002 | |
| d1ycsb1 | 130 | d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (524), Expect = 9e-65
Identities = 73/248 (29%), Positives = 121/248 (48%), Gaps = 15/248 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
DWEI ++ IG GSFG + K W G VA+K + + + +Q F++EV +
Sbjct: 2 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQ-QLQAFKNEVGV 57
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 267
L K RH NI+ F+G T L ++T++ G L+ +L + ++ A A+G
Sbjct: 58 LRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
M YLH + IIHRDLK N+ L +K+GDFGL+ + + ++ +GS
Sbjct: 117 MDYLHAKS--IIHRDLKSNNIFL--HEDLTVKIGDFGLATVKSRWSGS--HQFEQLSGSI 170
Query: 328 RYMAPEVFKHRK---YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384
+MAPEV + + Y + DV++F ++LYE++ G+ P +N + ++
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
Query: 385 AKGFTPEL 392
Sbjct: 231 LSKVRSNC 238
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (519), Expect = 1e-63
Identities = 78/250 (31%), Positives = 112/250 (44%), Gaps = 18/250 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
++ DP +L FS IG GSFG + A VAIK++ S QD EV
Sbjct: 9 FKDDPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
L KLRHPN +Q+ G L+ EY G K L +G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+AYLH+ +IHRD+K N+LL S +K+GDFG + ++ G+
Sbjct: 128 LAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMA--------PANSFVGTP 175
Query: 328 RYMAPEVF---KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384
+MAPEV +YD KVDV+S + E+ E +PPL N A ++A+ P +
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ 235
Query: 385 AKGFTPELRE 394
+ ++ R
Sbjct: 236 SGHWSEYFRN 245
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 6e-63
Identities = 78/249 (31%), Positives = 119/249 (47%), Gaps = 23/249 (9%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
W ++ EL IGKG FG+++ +RG VA+K I + Q F E +++
Sbjct: 2 WALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVM 54
Query: 210 VKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIAR 266
+LRH N+VQ LG + E K L ++TEY+ G L YL+ +G L + F+LD+
Sbjct: 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
M YL +HRDL RNVL+ S + KV DFGL+K
Sbjct: 115 AMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS-------STQDTGKLP 163
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRA 385
++ APE + +K+ K DV+SF ++L+E+ G P + V +G++
Sbjct: 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-P 222
Query: 386 KGFTPELRE 394
G P + E
Sbjct: 223 DGCPPAVYE 231
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 4e-62
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 13/215 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF + +G G+ G + K + G +A K I + + E+ +L + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHECNSP 64
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
IV F GA + + E++ GG L + LK+ G + ++ + +G+ YL +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK- 123
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
+ I+HRD+KP N+L+ + +K+ DFG+S + G+ YM+PE
Sbjct: 124 HKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLIDS------MANSFVGTRSYMSPERL 175
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
+ Y + D++S + L EM G P+ + E
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 5e-62
Identities = 69/247 (27%), Positives = 114/247 (46%), Gaps = 18/247 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
W ++ DF +GKG FG + A + +A+K + + + V R EV
Sbjct: 3 WALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 58
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
+ LRHPNI++ G + + LI EY G +++ L++ + ++A
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 118
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
++Y H+ +IHRD+KP N+LL SA LK+ DFG S + G+
Sbjct: 119 LSYCHS--KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAPSSRRTTL------CGTL 168
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKG 387
Y+ PE+ + R +D+KVD++S ++ YE L G+PP E K ++ F
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF--PDF 226
Query: 388 FTPELRE 394
T R+
Sbjct: 227 VTEGARD 233
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-61
Identities = 73/238 (30%), Positives = 115/238 (48%), Gaps = 16/238 (6%)
Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG+GSF + K T VA + Q F+ E +L L+HPNIV+F
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 222 GA----VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
+ V +K ++L+TE + G L YLK + ++ I +G+ +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 134
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
IIHRDLK N+ + + +K+GD GL+ L + + V G+ +MAPE+++
Sbjct: 135 IIHRDLKCDNIFITGPT-GSVKIGDLGLATLKRASFAKAV------IGTPEFMAPEMYE- 186
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLAN-YEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
KYD+ VDV++F M + EM E P + + + V G +P K PE++E
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-60
Identities = 71/250 (28%), Positives = 119/250 (47%), Gaps = 19/250 (7%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
+WE+ L +G G FGE+ Y+ T VA+K + + F E N
Sbjct: 7 EWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEAN 60
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
L+ +L+H +V+ VT+ +P+ +ITEY+ G L +LK L+ + ++ A IA
Sbjct: 61 LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
GMA++ IHRDL+ N+L+ ++ K+ DFGL++LI ++ G
Sbjct: 120 EGMAFIEERN--YIHRDLRAANILVSDT--LSCKIADFGLARLI---EDNEYTAREGAKF 172
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFR 384
++ APE + + K DV+SF ++L E++ G P E + + G+R R
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-VR 231
Query: 385 AKGFTPELRE 394
EL +
Sbjct: 232 PDNCPEELYQ 241
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 6e-60
Identities = 71/248 (28%), Positives = 115/248 (46%), Gaps = 19/248 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
D+ IG GS+G K + G + K + + Q EVNLL +L+HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKHP 63
Query: 216 NIVQFLGAVTER--KPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMA 269
NIV++ + +R L ++ EY GGDL + KE+ L + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 270 YLH---NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
H + + ++HRDLKP NV L ++K+GDFGL++++ +HD G+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARIL----NHDTSFAKAFVGT 177
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK 386
YM+PE Y++K D++S +LYE+ PP + E A + EG +
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237
Query: 387 GFTPELRE 394
++ EL E
Sbjct: 238 -YSDELNE 244
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-59
Identities = 69/246 (28%), Positives = 119/246 (48%), Gaps = 17/246 (6%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
IDP +L F +G G FG + WR VAIK I + + +F E +++
Sbjct: 1 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMI----KEGSMSEDEFIEEAKVMM 54
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMA 269
L H +VQ G T+++P+ +ITEY+ G L YL + + + D+ M
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 329
YL ++ +HRDL RN L+ + +KV DFGLS+ + + G R+
Sbjct: 115 YLESKQ--FLHRDLAARNCLV--NDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRW 167
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388
PEV + K+ K D+++F ++++E+ G+ P + E A+++A+G R +R
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLA 226
Query: 389 TPELRE 394
+ ++
Sbjct: 227 SEKVYT 232
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-59
Identities = 69/253 (27%), Positives = 116/253 (45%), Gaps = 21/253 (8%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
+++P + + +G G+FG++ KA + A K I ++ +D+ E+++
Sbjct: 7 DLNPED-FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDI 62
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 267
L HPNIV+ L A L ++ E+ GG + + + + L+ S
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+ YLH+ N IIHRDLK N+L + +K+ DFG+S +N+ + + G+
Sbjct: 123 LNYLHD--NKIIHRDLKAGNILF--TLDGDIKLADFGVSA----KNTRTIQRRDSFIGTP 174
Query: 328 RYMAPEVF-----KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
+MAPEV K R YD K DV+S + L EM E EPP P +A+ P
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT 234
Query: 383 FRA-KGFTPELRE 394
++ ++
Sbjct: 235 LAQPSRWSSNFKD 247
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-58
Identities = 65/235 (27%), Positives = 114/235 (48%), Gaps = 13/235 (5%)
Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G G+FG + K Y++ VA+K + +D L + E N++ +L +P IV+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-KDELLAEANVMQQLDNPYIVRM 73
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
+G + E + ML+ E G L+KYL++ + + ++ GM YL +H
Sbjct: 74 IG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVH 130
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
RDL RNVLL + + K+ DFGLSK ++ ++ + G ++ APE + K+
Sbjct: 131 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHG-KWPVKWYAPECINYYKF 187
Query: 341 DKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
K DV+SF ++++E G+ P + E + +G R G E+ +
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP-AGCPREMYD 241
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 191 bits (486), Expect = 3e-58
Identities = 63/262 (24%), Positives = 118/262 (45%), Gaps = 19/262 (7%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD 195
+ P P+ K D +D + +G G+FG + + R G A K ++ D
Sbjct: 11 QYYPQPVEIKHDHVLD----HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 66
Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSP 254
+ + R E+ + LRHP +V A + +++I E++ GG+L + + E +S
Sbjct: 67 K---ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 123
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
AV + + +G+ ++H N +H DLKP N++ ++ LK+ DFGL+ + + S
Sbjct: 124 DEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181
Query: 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 374
V TG+ + APEV + + D++S ++ Y +L G P E +
Sbjct: 182 VKVT-----TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN 236
Query: 375 VAEGHRPFFRA--KGFTPELRE 394
V + G + + ++
Sbjct: 237 VKSCDWNMDDSAFSGISEDGKD 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-57
Identities = 79/246 (32%), Positives = 123/246 (50%), Gaps = 17/246 (6%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
IDPSEL F IG G FG + YW VAIK I + + +DF E +++
Sbjct: 2 IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMM 55
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGAL-SPSTAVNFALDIARGMA 269
KL HP +VQ G E+ P+ L+ E++ G L YL+ + L + T + LD+ GMA
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRY 329
YL +IHRDL RN L+ +KV DFG+++ + TG ++
Sbjct: 116 YLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKW 168
Query: 330 MAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388
+PEVF +Y K DV+SF ++++E+ EG+ P N E + ++ G R + +
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLA 227
Query: 389 TPELRE 394
+ + +
Sbjct: 228 STHVYQ 233
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 188 bits (479), Expect = 3e-57
Identities = 56/267 (20%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 133 SHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILP 190
+ P+PV + D + +G G+FG + + + G K I
Sbjct: 13 KKYVPQPVEVKQGSVYD--------YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 64
Query: 191 SLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG 250
D+ ++E++++ +L HP ++ A ++ ++LI E+L GG+L + +
Sbjct: 65 PYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 121
Query: 251 -ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
+S + +N+ G+ ++H + I+H D+KP N++ A +K+ DFGL+ +
Sbjct: 122 YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179
Query: 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPY 369
V T + + APE+ D+++ ++ Y +L G P A +
Sbjct: 180 NPDEIVKVT-----TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234
Query: 370 EAAKYVAEGHRPFFRA--KGFTPELRE 394
E + V F +PE ++
Sbjct: 235 ETLQNVKRCDWEFDEDAFSSVSPEAKD 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 5e-57
Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 12/241 (4%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
D+ +G+G++GE+ A R VA+K + + D ++ + E+ + L H
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHE 63
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
N+V+F G E L EY GG+L ++ + A F + G+ YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-- 121
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
I HRD+KP N+LL D+LK+ DFGL+ + + N + + G+ Y+APE+
Sbjct: 122 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERL--LNKMCGTLPYVAPELL 177
Query: 336 KHRKYD-KKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393
K R++ + VDV+S ++L ML GE P + + E K
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 394 E 394
Sbjct: 238 A 238
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 7e-57
Identities = 59/239 (24%), Positives = 112/239 (46%), Gaps = 10/239 (4%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF I+G+GSF ++ A AIK + + E +++ +L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
V+ + + L Y + G+L KY+++ G+ + + +I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-- 126
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
IIHRDLKP N+LL + H+++ DFG +K++ ++ + G+ +Y++PE+
Sbjct: 127 KGIIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ--ARANSFVGTAQYVSPELL 182
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
+ K D+++ I+Y+++ G PP Y + + + F + F P+ R+
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF--PEKFFPKARD 239
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-56
Identities = 69/236 (29%), Positives = 114/236 (48%), Gaps = 15/236 (6%)
Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
+G G+FG + + +R VAIK + ++ E ++ +L +P IV+
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYIVRL 74
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+G V + + LML+ E GG LHK+L ++ + S ++ GM YL + +
Sbjct: 75 IG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FV 131
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK 339
HRDL RNVLLVN + K+ DFGLSK + +S+ + G ++ APE RK
Sbjct: 132 HRDLAARNVLLVNR--HYAKISDFGLSKALGADDSYYTARSAG-KWPLKWYAPECINFRK 188
Query: 340 YDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
+ + DV+S+ + ++E L G+ P + E ++ +G R PEL
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP-PECPPELYA 243
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-56
Identities = 65/245 (26%), Positives = 114/245 (46%), Gaps = 16/245 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
DP + ++ IG+G+ G + A G VAI+++ + + +E+ ++
Sbjct: 17 DPKK-KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMR 72
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+ ++PNIV +L + L ++ EYL GG L + E + + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEF 131
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH+ +IHRD+K N+LL +K+ DFG I + + K + G+ +M
Sbjct: 132 LHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWM 183
Query: 331 APEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFT 389
APEV + Y KVD++S ++ EM+EGEPP N P A +A P + + +
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 390 PELRE 394
R+
Sbjct: 244 AIFRD 248
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (469), Expect = 4e-56
Identities = 65/236 (27%), Positives = 109/236 (46%), Gaps = 14/236 (5%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++G G+F E++ A + VAIK I + + +E+ +L K++HPNIV
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHPNIVALD 73
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
L LI + + GG+L + EKG + A + + YLH+ I+HR
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD--LGIVHR 131
Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY 340
DLKP N+L + D + + DFGLSK+ + ++ G+ Y+APEV + Y
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-----VLSTACGTPGYVAPEVLAQKPY 186
Query: 341 DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELRE 394
K VD +S +I Y +L G PP + + + + + F + ++
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-56
Identities = 70/253 (27%), Positives = 119/253 (47%), Gaps = 20/253 (7%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFR 203
D+EI ++ IG+G FG++ + + VAIK SD V + F
Sbjct: 1 DYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFL 56
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY-LKEKGALSPSTAVNFAL 262
E + + HP+IV+ +G +TE P+ +I E G+L + K +L ++ + +A
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
++ +AYL ++ +HRD+ RNVL+ SS D +K+GDFGLS+ + YK +
Sbjct: 116 QLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGDFGLSRYM---EDSTYYKASK 168
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRP 381
++MAPE R++ DV+ F + ++E+L G P + + + G R
Sbjct: 169 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228
Query: 382 FFRAKGFTPELRE 394
P L
Sbjct: 229 PMP-PNCPPTLYS 240
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-55
Identities = 71/286 (24%), Positives = 115/286 (40%), Gaps = 42/286 (14%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRILPSLS 193
WE L+F ++G G+FG+++ A G VA+K +
Sbjct: 23 FREYEYDLKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD 80
Query: 194 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK--- 249
+ E+ ++ +L H NIV LGA T P+ LI EY GDL YL+ K
Sbjct: 81 SSER--EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 138
Query: 250 --------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL 289
L+ + FA +A+GM +L + +HRDL RNVL
Sbjct: 139 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVL 196
Query: 290 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSF 349
+ + +K+ DFGL++ I +++ V ++MAPE Y K DV+S+
Sbjct: 197 V--THGKVVKICDFGLARDIMSDSNYVV--RGNARLPVKWMAPESLFEGIYTIKSDVWSY 252
Query: 350 AMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
++L+E+ G P + + + T E+
Sbjct: 253 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYI 298
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (462), Expect = 2e-55
Identities = 71/241 (29%), Positives = 121/241 (50%), Gaps = 16/241 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-----PVAIKRILPSLSDDRLVIQDFR 203
EID S + +IG G FGE+ + + VAIK + ++ + +DF
Sbjct: 20 AKEIDISCVKIEQ--VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFL 75
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFAL 262
E +++ + HPN++ G VT+ P+M+ITE++ G L +L++ G + V
Sbjct: 76 SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 135
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMT 321
IA GM YL + +HRDL RN+L+ +S KV DFGLS+ ++ S Y
Sbjct: 136 GIAAGMKYLADMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 322 GETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHR 380
G R+ APE ++RK+ DV+S+ ++++E++ GE P + + + + +R
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251
Query: 381 P 381
Sbjct: 252 L 252
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (461), Expect = 3e-55
Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 19/260 (7%)
Query: 140 VPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL 197
+ P PN WE++ +++ +G G +GE+ + W+ VA+K + +D +
Sbjct: 2 MDPSSPNYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTM 55
Query: 198 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL--KEKGALSPS 255
+++F E ++ +++HPN+VQ LG T P +ITE++ G+L YL + +S
Sbjct: 56 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV 115
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
+ A I+ M YL + IHRDL RN L+ +KV DFGLS+L+
Sbjct: 116 VLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHLVKVADFGLSRLM---TGD 168
Query: 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKY 374
G ++ APE + K+ K DV++F ++L+E+ G P + + +
Sbjct: 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 228
Query: 375 VAEGHRPFFRAKGFTPELRE 394
+ + +R +G ++ E
Sbjct: 229 LEKDYRMERP-EGCPEKVYE 247
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 3e-55
Identities = 79/261 (30%), Positives = 117/261 (44%), Gaps = 20/261 (7%)
Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDR 196
KP L K WEI L +G+G FGE+ W GT VAIK + P
Sbjct: 1 KPQTQGLA-KDAWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP- 56
Query: 197 LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSP 254
+ F E ++ KLRH +VQ V+ +P+ ++TEY+ G L +LK + L
Sbjct: 57 ---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRL 112
Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
V+ A IA GMAY+ +HRDL+ N+L+ KV DFGL++LI
Sbjct: 113 PQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADFGLARLI---ED 165
Query: 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAK 373
++ G ++ APE + ++ K DV+SF ++L E+ +G P E
Sbjct: 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 225
Query: 374 YVAEGHRPFFRAKGFTPELRE 394
V G+R L +
Sbjct: 226 QVERGYRMPCP-PECPESLHD 245
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-54
Identities = 65/235 (27%), Positives = 97/235 (41%), Gaps = 23/235 (9%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224
IGKG FGE+ + WRG VA+K E+ V LRH NI+ F+ A
Sbjct: 11 IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF----REAEIYQTVMLRHENILGFIAAD 66
Query: 225 TER----KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------ 274
+ L L+++Y G L YL ++ + AL A G+A+LH E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I HRDLK +N+L+ + D GL+ G+ RYMAPEV
Sbjct: 126 KPAIAHRDLKSKNILV--KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 335 F------KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF 383
KH + K+ D+++ ++ +E+ +E Y+ Y P
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-54
Identities = 66/244 (27%), Positives = 108/244 (44%), Gaps = 13/244 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 212
D +G GSFG + + W + VA+K + P + + DF EVN + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY-LKEKGALSPSTAVNFALDIARGMAYL 271
H N+++ G V P+ ++TE G L K +G T +A+ +A GM YL
Sbjct: 69 DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
++ IHRDL RN+LL ++ D +K+GDFGL + + + H V + + A
Sbjct: 128 ESKR--FIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYV-MQEHRKVPFAWCA 182
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390
PE K R + D + F + L+EM G+ P + + + R +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242
Query: 391 ELRE 394
++
Sbjct: 243 DIYN 246
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 3e-54
Identities = 46/235 (19%), Positives = 98/235 (41%), Gaps = 16/235 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
+G+G FG + + K + +D L + E+++L RH NI+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL----VKKEISILNIARHRNILHLHE 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ + L++I E++ G D+ + + L+ V++ + + +LH+ I H
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHF 126
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYD 341
D++P N++ + +K+ +FG ++ +K ++ + Y APEV +H
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA-----PEYYAPEVHQHDVVS 181
Query: 342 KKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPELRE 394
D++S ++Y +L G P + + + F K + E +
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-54
Identities = 81/240 (33%), Positives = 126/240 (52%), Gaps = 17/240 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFR 203
EI PS + +IG G FGE+ K + + PVAIK + ++ + DF
Sbjct: 2 TEIHPSC--VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFL 57
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFAL 262
E ++ + H NI++ G +++ KP+M+ITEY+ G L K+L+EK G S V
Sbjct: 58 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 117
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
IA GM YL N +HRDL RN+L+ +S KV DFGLS++++ + Y +G
Sbjct: 118 GIAAGMKYLANMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRVLE-DDPEATYTTSG 172
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRP 381
R+ APE +RK+ DV+SF ++++E++ GE P +E K + +G R
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 5e-54
Identities = 67/270 (24%), Positives = 123/270 (45%), Gaps = 16/270 (5%)
Query: 134 HFEPKPVPPPLPNKC-DWEIDPSELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKR 187
H + + P L I PS L + +IG+G FG + + A+K
Sbjct: 3 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYL 246
+ + F E ++ HPN++ LG + +++ Y++ GDL ++
Sbjct: 63 LNRITDIGE--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120
Query: 247 K-EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
+ E + + F L +A+GM +L ++ +HRDL RN +L +KV DFGL
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML--DEKFTVKVADFGL 176
Query: 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLA 364
++ + + V+ TG ++MA E + +K+ K DV+SF ++L+E++ G PP
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236
Query: 365 NYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
+ ++ Y+ +G R + + L E
Sbjct: 237 DVNTFDITVYLLQGRRL-LQPEYCPDPLYE 265
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 178 bits (451), Expect = 7e-54
Identities = 69/251 (27%), Positives = 111/251 (44%), Gaps = 15/251 (5%)
Query: 154 PSEL--DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
PS L + I+G G E+ A VA+K + L+ D FR E
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61
Query: 210 VKLRHPNIVQFLGAVTERKP----LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIA 265
L HP IV P ++ EY+ G L + +G ++P A+ D
Sbjct: 62 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
+ + + H IIHRD+KP N+++ S+ + +KV DFG+++ I + + V + G
Sbjct: 122 QALNFSHQNG--IIHRDVKPANIMI--SATNAVKVMDFGIARAIA-DSGNSVTQTAAVIG 176
Query: 326 SYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR--PFF 383
+ +Y++PE + D + DV+S +LYE+L GEPP P A P
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 236
Query: 384 RAKGFTPELRE 394
R +G + +L
Sbjct: 237 RHEGLSADLDA 247
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 6e-53
Identities = 76/281 (27%), Positives = 122/281 (43%), Gaps = 37/281 (13%)
Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLS 193
P LP WE + L F +G G+FG++++A VA+K + PS
Sbjct: 9 PTQLPYDHKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 194 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-- 250
+ E+ +L L H NIV LGA T P ++ITEY GDL +L+ K
Sbjct: 67 LTE--REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124
Query: 251 ----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294
AL ++F+ +A+GMA+L ++ IHRDL RN+LL +
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG- 181
Query: 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILY 354
K+ DFGL++ IK +++ V ++MAPE + Y + DV+S+ + L+
Sbjct: 182 -RITKICDFGLARDIKNDSNYVVKGNAR--LPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 355 EML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
E+ G P + + + E+ +
Sbjct: 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD 279
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-52
Identities = 67/240 (27%), Positives = 114/240 (47%), Gaps = 13/240 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRH 214
DF ++GKGSFG++ A ++ T AIK + + ++ E +L + H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
P + ++ L + EYL GGDL +++ S A +A +I G+ +LH+
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS- 121
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I++RDLK N+L H+K+ DFG+ K +N K G+ Y+APE+
Sbjct: 122 -KGIVYRDLKLDNIL--LDKDGHIKIADFGMCK----ENMLGDAKTNTFCGTPDYIAPEI 174
Query: 335 FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
+KY+ VD +SF ++LYEML G+ P + E + + + + E ++
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY--PRWLEKEAKD 232
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-51
Identities = 61/244 (25%), Positives = 110/244 (45%), Gaps = 16/244 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
+F ++G G+FG + K W PVAIK + + S ++ E ++
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMAS 67
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
+ +P++ + LG ++ G L + K + +N+ + IA+GM YL
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 331
+ ++HRDL RNVL+ + H+K+ DFGL+KL+ + Y G ++MA
Sbjct: 128 EDRR--LVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWMA 181
Query: 332 PEVFKHRKYDKKVDVFSFAMILYEML-EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390
E HR Y + DV+S+ + ++E++ G P E + + +G R T
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP-PICTI 240
Query: 391 ELRE 394
++
Sbjct: 241 DVYM 244
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (437), Expect = 1e-51
Identities = 72/278 (25%), Positives = 120/278 (43%), Gaps = 43/278 (15%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQD 201
E + +++ IG+G+FG + +A T VA+K + S D + D
Sbjct: 7 SLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQAD 62
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------- 250
F+ E L+ + +PNIV+ LG KP+ L+ EY+ GDL+++L+
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 251 -------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
LS + + A +A GMAYL +HRDL RN L+
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLV--GENMV 178
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
+K+ DFGLS+ I + + + R+M PE + +Y + DV+++ ++L+E+
Sbjct: 179 VKIADFGLSRNIYSADYYKA--DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 358 E-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
G P E YV +G+ + EL
Sbjct: 237 SYGLQPYYGMAHEEVIYYVRDGNILACP-ENCPLELYN 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 168 bits (426), Expect = 4e-50
Identities = 62/254 (24%), Positives = 111/254 (43%), Gaps = 26/254 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI------LPSLSDDRLVIQDFRHEVNLL 209
++ I+G+G + + + A+K I S + + + + EV++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 210 VKLR-HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
K+ HPNI+Q L+ + ++ G+L YL EK LS + +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYR 328
LH I+HRDLKP N+LL ++K+ DFG S + K+ G+
Sbjct: 124 CALHK--LNIVHRDLKPENILL--DDDMNIKLTDFGFSCQLDPGE-----KLREVCGTPS 174
Query: 329 YMAPEVF------KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
Y+APE+ H Y K+VD++S +I+Y +L G PP + + + + G+ F
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 383 FR--AKGFTPELRE 394
++ +++
Sbjct: 235 GSPEWDDYSDTVKD 248
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 8e-50
Identities = 82/278 (29%), Positives = 127/278 (45%), Gaps = 38/278 (13%)
Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT---------PVAIKRILPSLSD 194
LP WE+ L +G+G+FG+++ A G VA+K + ++
Sbjct: 2 LPEDPRWELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 59
Query: 195 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--- 250
+ D E+ ++ + +H NI+ LGA T+ PL +I EY G+L +YL+ +
Sbjct: 60 KD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 117
Query: 251 -------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
LS V+ A +ARGM YL ++ IHRDL RNVL+ + +
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLV--TEDNV 173
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
+K+ DFGL++ I + K T ++MAPE R Y + DV+SF ++L+E+
Sbjct: 174 MKIADFGLARDI--HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231
Query: 358 -EGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
G P E K + EGHR T EL
Sbjct: 232 TLGGSPYPGVPVEELFKLLKEGHRMDK-PSNCTNELYM 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-49
Identities = 80/266 (30%), Positives = 122/266 (45%), Gaps = 36/266 (13%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEV 206
+D +++ F +IG+G+FG++LKA + AIKR+ S D +DF E+
Sbjct: 6 VLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGEL 61
Query: 207 NLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---------------- 249
+L KL HPNI+ LGA R L L EY G+L +L++
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
LS ++FA D+ARGM YL + IHRDL RN+L+ K+ DFGLS+
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GENYVAKIADFGLSRGQ 177
Query: 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEP 368
K T R+MA E + Y DV+S+ ++L+E++ G P
Sbjct: 178 -----EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232
Query: 369 YEAAKYVAEGHRPFFRAKGFTPELRE 394
E + + +G+R E+ +
Sbjct: 233 AELYEKLPQGYRLEK-PLNCDDEVYD 257
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (424), Expect = 2e-49
Identities = 63/239 (26%), Positives = 112/239 (46%), Gaps = 15/239 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF +G GSFG + R G A+K + + ++ E +L + HP
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
I++ G + + + +I +Y+ GG+L L++ A +A ++ + YLH++
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
II+RDLKP N+LL H+K+ DFG +K + G+ Y+APEV
Sbjct: 125 --IIYRDLKPENILL--DKNGHIKITDFGFAKYVP-------DVTYTLCGTPDYIAPEVV 173
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
+ Y+K +D +SF +++YEML G P + + + + F F ++++
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVKD 230
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-49
Identities = 65/247 (26%), Positives = 108/247 (43%), Gaps = 31/247 (12%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
++G G G++L+ + + A+K + R EV L + + P+IV+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRI 70
Query: 221 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 274
+ RK L+++ E L GG+L ++++G A + A I + YLH+
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 129
Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
I HRD+KP N+L + + LK+ DFG +K NS T Y+APE
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPE 183
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHR------PFFRAKG 387
V KYDK D++S +I+Y +L G PP + + + R P
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 388 FTPELRE 394
+ E++
Sbjct: 244 VSEEVKM 250
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 5e-49
Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 14/225 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSL---SDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
+G G F + K + G A K I S + +D EV++L +++HPN++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
+ ++LI E + GG+L +L EK +L+ A F I G+ YLH+ I
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS--LQIA 135
Query: 280 HRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH 337
H DLKP N++L+ N +K+ DFGL+ I N + G+ ++APE+ +
Sbjct: 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-----EFKNIFGTPEFVAPEIVNY 190
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
+ D++S +I Y +L G P E V+ + F
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-48
Identities = 69/264 (26%), Positives = 121/264 (45%), Gaps = 29/264 (10%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQD 201
+WE+ ++ S +G+GSFG + + + T VAIK + + S +
Sbjct: 14 EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IE 69
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------A 251
F +E +++ + ++V+ LG V++ +P ++I E + GDL YL+
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 252 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
S S + A +IA GMAYL+ +HRDL RN ++ + +K+GDFG+++ I
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV--AEDFTVKIGDFGMTRDIYE 185
Query: 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EPPLANYEPYE 370
+ + K R+M+PE K + DV+SF ++L+E+ E P +
Sbjct: 186 TDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
Query: 371 AAKYVAEGHRPFFRAKGFTPELRE 394
++V EG L E
Sbjct: 244 VLRFVMEGGLLDKP-DNCPDMLFE 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (410), Expect = 5e-47
Identities = 68/244 (27%), Positives = 106/244 (43%), Gaps = 17/244 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN---LLVKL 212
DFS IIG+G FGE+ G A+K + + +E L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
P IV A L I + + GGDLH +L + G S + +A +I G+ ++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAP 332
N +++RDLKP N+LL H+++ D GL+ + H G++ YMAP
Sbjct: 125 N--RFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPHASV------GTHGYMAP 174
Query: 333 EVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAK-YVAEGHRPFFRAKGFTP 390
EV + YD D FS +L+++L G P ++ + + F+P
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234
Query: 391 ELRE 394
ELR
Sbjct: 235 ELRS 238
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-46
Identities = 59/239 (24%), Positives = 106/239 (44%), Gaps = 12/239 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
DF ++GKG+FG+++ + G A+K + + + + E +L RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+ A L + EY GG+L +L + + A + +I + YLH+
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
+++RD+K N++L H+K+ DFGL K + M G+ Y+APEV
Sbjct: 126 --VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLAPEVL 177
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
+ Y + VD + +++YEM+ G P N + + + F + +PE +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPEAKS 234
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-45
Identities = 63/224 (28%), Positives = 97/224 (43%), Gaps = 13/224 (5%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
+G+G F + KA + VAIK+I + + E+ LL +L HPNI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
L A + + L+ +++ L+PS + L +G+ YLH + I+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--HWIL 122
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV-FKHR 338
HRDLKP N+LL LK+ DFGL+K T + + Y APE+ F R
Sbjct: 123 HRDLKPNNLLL--DENGVLKLADFGLAKSF----GSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 339 KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
Y VD+++ IL E+L P L + + E
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 220
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-45
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 18/220 (8%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQD---FRHEVNLLVKLR--HPN 216
++G G FG + PVAIK + D + + EV LL K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 217 IVQFLGAVTERKPLMLITEYLRGG-DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+++ L +LI E DL ++ E+GAL A +F + + + HN
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
++HRD+K N+L+ + + LK+ DFG L+K T G+ Y PE
Sbjct: 131 --VLHRDIKDENILI-DLNRGELKLIDFGSGALLKDTV------YTDFDGTRVYSPPEWI 181
Query: 336 KHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKY 374
++ +Y + V+S ++LY+M+ G+ P + E +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 221
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (391), Expect = 2e-44
Identities = 60/239 (25%), Positives = 110/239 (46%), Gaps = 15/239 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
F +G GSFG ++ + G A+K + I+ +E +L + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
+V+ + + L ++ EY+ GG++ +L+ G S A +A I YLH+
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-- 159
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
+I+RDLKP N+L+ +++V DFG +K + G+ +APE+
Sbjct: 160 LDLIYRDLKPENLLIDQQ--GYIQVTDFGFAK-------RVKGRTWTLCGTPEALAPEII 210
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
+ Y+K VD ++ +++YEM G PP +P + + + G F F+ +L++
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--SHFSSDLKD 267
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 1e-43
Identities = 67/240 (27%), Positives = 118/240 (49%), Gaps = 18/240 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
+++ P +++ + IG+G++G + AY VAIK+I S + + Q E+
Sbjct: 4 FDVGP---RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIK 58
Query: 208 LLVKLRHPNIVQFLGAV----TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
+L++ RH NI+ + E+ + + +L G DL+K LK + LS F
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQ 117
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
I RG+ Y+H+ ++HRDLKP N+LL ++ LK+ DFGL+++ + H + +T
Sbjct: 118 ILRGLKYIHSAN--VLHRDLKPSNLLL--NTTCDLKICDFGLARVADPDHDHTGF-LTEY 172
Query: 324 TGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
+ Y APE+ + + Y K +D++S IL EML P + ++
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-43
Identities = 72/278 (25%), Positives = 121/278 (43%), Gaps = 37/278 (13%)
Query: 144 LP-NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRILPSLSDD 195
LP + WE L +G+G+FG++++A G VA+K + +
Sbjct: 1 LPYDASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 58
Query: 196 RLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTE-RKPLMLITEYLRGGDLHKYLKEKG--- 250
+ E+ +L+ H N+V LGA T+ PLM+I E+ + G+L YL+ K
Sbjct: 59 E--HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 116
Query: 251 -------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
L+ + ++ +A+GM +L + IHRDL RN+LL S +
Sbjct: 117 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNV 172
Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357
+K+ DFGL++ I D + ++MAPE R Y + DV+SF ++L+E+
Sbjct: 173 VKICDFGLARDI--YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230
Query: 358 EG-EPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394
P + E + TPE+ +
Sbjct: 231 SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (382), Expect = 1e-43
Identities = 47/243 (19%), Positives = 81/243 (33%), Gaps = 20/243 (8%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG GSFG+I G VAIK + E + ++ + +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGVGIPTIR 69
Query: 223 AV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
E +++ E L + S T + A + + Y+H+ IHR
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS--KNFIHR 127
Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVFKH 337
D+KP N L+ + + DFGL+K + +H + TG+ RY +
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 338 RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR------AKGFTPE 391
+ ++ D+ S +L G P + + KG+ E
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE 247
Query: 392 LRE 394
Sbjct: 248 FAT 250
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-43
Identities = 51/229 (22%), Positives = 91/229 (39%), Gaps = 16/229 (6%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G+FGE+ KA R G VA+K++L + I E+ +L L+H N+V +
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-ALREIKILQLLKHENVVNLIE 76
Query: 223 AVTERKP--------LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
+ + L+ ++ + S + G+ Y+H
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 136
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
I+HRD+K NVL+ LK+ DFGL++ + + + T + Y PE+
Sbjct: 137 K--ILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 335 F-KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
R Y +D++ I+ EM P + +++
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-42
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 25/228 (10%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
P E+ ++ + +IG GSFG + +A G VAIK++L + E+ ++ K
Sbjct: 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRK 69
Query: 212 LRHPNIVQFLGAVTERKP------LMLITEYLRGG---DLHKYLKEKGALSPSTAVNFAL 262
L H NIV+ L L+ +Y+ Y + K L +
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
+ R +AY+H+ I HRD+KP+N+LL + LK+ DFG +K + ++
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQL----VRGEPNVSY 182
Query: 323 ETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYE 370
Y +F Y +DV+S +L E+L G+P +
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 147 bits (371), Expect = 3e-42
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 11/220 (5%)
Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
IG+G++G + KA G A+K+I D+ + E+++L +L+H NIV+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHSNIVKLYDV 68
Query: 224 VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 283
+ +K L+L+ E+L +G L TA +F L + G+AY H+ ++HRDL
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDL 126
Query: 284 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF-KHRKYDK 342
KP+N+L+ + LK+ DFGL++ V K T E + Y AP+V +KY
Sbjct: 127 KPQNLLI--NREGELKIADFGLARAF----GIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 343 KVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
+D++S I EM+ G P + +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP 220
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (362), Expect = 1e-40
Identities = 51/245 (20%), Positives = 88/245 (35%), Gaps = 22/245 (8%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+GSFG I + VAIK P SD R E L + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVY 67
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
+ ++ L G L L G S T A + + +H +++R
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE--KSLVYR 125
Query: 282 DLKPRNVLL---VNSSADHLKVGDFGLSKLIKVQNSHDV---YKMTGETGSYRYMAPEVF 335
D+KP N L+ + +A+ + V DFG+ K + + + +G+ RYM+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGE---PPLANYEPYEAAKYVAEGHRPFFR---AKGFT 389
R+ ++ D+ + + L G L + + + E + GF
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 245
Query: 390 PELRE 394
E +
Sbjct: 246 EEFYK 250
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-40
Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 13/229 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
+F IG+G++G + KA + G VA+K+I + V E++LL +L HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHP 61
Query: 216 NIVQFLGAVTERKPLMLITEYL-RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
NIV+ L + L L+ E+L + + ++ + +G+A+ H+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEV 334
+ ++HRDLKP+N+L+ ++ +K+ DFGL++ V T E + Y APE+
Sbjct: 121 -HRVLHRDLKPQNLLI--NTEGAIKLADFGLARAF----GVPVRTYTHEVVTLWYRAPEI 173
Query: 335 FKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
KY VD++S I EM+ + +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 222
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 4e-39
Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 22/244 (9%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
K WE+ + +G G++G + A G VAIK++ + +
Sbjct: 10 TKTAWEVRA---VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA-KRAY 65
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL----RGGDLHKYLKEKGALSPSTAVN 259
E+ LL +RH N++ L T + L T++ G L + L
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 125
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
+ +G+ Y+H IIHRDLKP N+ + + LK+ DFGL++ +
Sbjct: 126 LVYQMLKGLRYIHA--AGIIHRDLKPGNLAV--NEDCELKILDFGLARQAD-------SE 174
Query: 320 MTGETGSYRYMAPEV-FKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378
MTG + Y APEV +Y + VD++S I+ EM+ G+ + + K + +
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234
Query: 379 HRPF 382
Sbjct: 235 TGTP 238
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 8e-39
Identities = 54/231 (23%), Positives = 100/231 (43%), Gaps = 20/231 (8%)
Query: 165 IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFR--HEVNLLVKLRHPNIVQ 219
IG+G++G++ KA G VA+KR+ ++ + + R + L HPN+V+
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 220 FLGAVTERKP-----LMLITEYLRGGDL-HKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
T + L L+ E++ + + + T + + RG+ +LH+
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 333
++HRDLKP+N+L+ +S+ +K+ DFGL+++ +T + Y APE
Sbjct: 135 HR--VVHRDLKPQNILV--TSSGQIKLADFGLARIY-----SFQMALTSVVVTLWYRAPE 185
Query: 334 VFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR 384
V Y VD++S I EM +P + + +
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 8e-38
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
IG+G++G + KA R VA+KR+ DD V E+ LL +L+H NIV+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
+ K L L+ E+ + G L P +F + +G+ + H+ ++HRD
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRD 126
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRK-YD 341
LKP+N+L+ + LK+ +FGL++ V + E + Y P+V K Y
Sbjct: 127 LKPQNLLI--NRNGELKLANFGLARAF----GIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 342 KKVDVFSFAMILYEMLEGEPPL 363
+D++S I E+ PL
Sbjct: 181 TSIDMWSAGCIFAELANAGRPL 202
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-37
Identities = 57/248 (22%), Positives = 104/248 (41%), Gaps = 18/248 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAY-----WRGTPVAIKRILPS-LSDDRLVIQDFRHEVNLLVK 211
+F ++G G++G++ G A+K + + + + R E +L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 212 LRH-PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
+R P +V A L LI +Y+ GG+L +L ++ + + +I + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330
LH II+RD+K N+LL S H+ + DFGLSK + Y G YM
Sbjct: 145 LHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAYDFCGT---IEYM 197
Query: 331 APEVF--KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFF--RAK 386
AP++ +DK VD +S +++YE+L G P + ++ +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 387 GFTPELRE 394
+ ++
Sbjct: 258 EMSALAKD 265
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (339), Expect = 5e-37
Identities = 46/226 (20%), Positives = 98/226 (43%), Gaps = 29/226 (12%)
Query: 150 WEIDPSELDFSSS------AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQD 201
W+ + +++ + +G+G + E+ +A V +K + P +
Sbjct: 22 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KK 75
Query: 202 FRHEVNLLVKLR-HPNIVQFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAV 258
+ E+ +L LR PNI+ V + + L+ E++ D + + L+
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIR 132
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
+ +I + + Y H+ I+HRD+KP NV++ + L++ D+GL++ H
Sbjct: 133 FYMYEILKALDYCHS--MGIMHRDVKPHNVMI-DHEHRKLRLIDWGLAEFY-----HPGQ 184
Query: 319 KMTGETGSYRYMAPEVF-KHRKYDKKVDVFSFAMILYEMLEGEPPL 363
+ S + PE+ ++ YD +D++S +L M+ + P
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-33
Identities = 55/227 (24%), Positives = 89/227 (39%), Gaps = 21/227 (9%)
Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
IG G+ G + AY VAIK++ + + E+ L+ + H NI+ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHKNIISLL 82
Query: 222 GAVT------ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
T E + + L+ E + E + G+ +LH+
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAG 139
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVF 335
IHRDLKP N+++ S LK+ DFGL++ + MT + Y APEV
Sbjct: 140 I--IHRDLKPSNIVV--KSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVI 190
Query: 336 KHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF 382
Y + VD++S I+ EM+ + + + V E
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-33
Identities = 54/244 (22%), Positives = 96/244 (39%), Gaps = 22/244 (9%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
NK WE+ + + + +G G++G + A+ G VA+K++ +
Sbjct: 10 NKTIWEVPE---RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTY 65
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM-----LITEYLRGGDLHKYLKEKGALSPSTAV 258
E+ LL ++H N++ L T + L + +L G D + + L+
Sbjct: 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQ 124
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
I RG+ Y+H+ IIHRDLKP N+ + LK+ DFGL+ D
Sbjct: 125 FLIYQILRGLKYIHS--ADIIHRDLKPSNLA--VNEDCELKILDFGLA------RHTDDE 174
Query: 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEG 378
+ + Y++ VD++S I+ E+L G + + K +
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 379 HRPF 382
Sbjct: 235 VGTP 238
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (273), Expect = 1e-27
Identities = 40/216 (18%), Positives = 79/216 (36%), Gaps = 26/216 (12%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN------ 216
+G G F + A T VA+K + D++ + E+ LL ++ +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 217 -----IVQFLGAVTERKP-----LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
I++ L + P +M+ E + + +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
G+ Y+H IIH D+KP NVL+ + ++ L + Y + +
Sbjct: 137 GLDYMHRRCG-IIHTDIKPENVLM-EIVDSPENLIQIKIADLGNACWYDEHYTNS--IQT 192
Query: 327 YRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPP 362
Y +PEV + D++S A +++E++ G+
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.4 bits (208), Expect = 7e-20
Identities = 31/211 (14%), Positives = 69/211 (32%), Gaps = 42/211 (19%)
Query: 164 IIGKGSFGEILKAY-WRGTPVAIKRILPSLSDDR---------------LVIQDFRHEVN 207
++G+G + Y + +K + + L I+ R+E
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
L KL+ + + ++ E + +L++ I
Sbjct: 67 ALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEVLDMILEE 115
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSY 327
+A ++ I+H DL NVL+ S + + + DF S + + ++ +
Sbjct: 116 VAKFYH--RGIVHGDLSQYNVLV---SEEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 328 RYMAPEVFKHRKYDKKVDVFSFAMILYEMLE 358
+ R Y + D+ S + +L+
Sbjct: 171 YF-------SRTYRTEKDINS---AIDRILQ 191
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.5 bits (192), Expect = 1e-16
Identities = 36/180 (20%), Positives = 69/180 (38%), Gaps = 3/180 (1%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
+ V+ LL+ S + + TPLH+A+ G +VAK L++ A VNA+ +
Sbjct: 8 SFMGHLPIVKNLLQRGAS-PNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDD 66
Query: 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSS 161
TPL A NM++LL + + P + + + +
Sbjct: 67 QTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQA 126
Query: 162 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
+ K F + A G + +L + ++ +++ V + +IV+ L
Sbjct: 127 --CMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLL 184
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.8 bits (154), Expect = 8e-12
Identities = 23/82 (28%), Positives = 38/82 (46%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A + K L + Q+ V+A+ +PLH A+ G D+ L++ GA N
Sbjct: 301 LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVS 360
Query: 99 RWKNTPLADAEGAKKFNMMELL 120
TPLA A+ ++ ++L
Sbjct: 361 SDGTTPLAIAKRLGYISVTDVL 382
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.6 bits (143), Expect = 2e-10
Identities = 19/55 (34%), Positives = 27/55 (49%)
Query: 70 TPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
TPLHVAS G + + K L++ GA N + TPL A A + + L +
Sbjct: 2 TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNK 56
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (136), Expect = 1e-09
Identities = 26/99 (26%), Positives = 42/99 (42%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A + V +LL E + +A + TPLHVA H +D+ K L+ G ++
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPA 195
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137
TPL A + + L +GG + ++ P
Sbjct: 196 WNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTP 234
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (134), Expect = 2e-09
Identities = 34/200 (17%), Positives = 73/200 (36%), Gaps = 2/200 (1%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A + + V + L + +A TPLH+A+ G ++ L+ A+ N +
Sbjct: 202 LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGN 261
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELD 158
+ TPL + ++L HG + + P V +
Sbjct: 262 KSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVAS--HYGNIKLVKFLLQH 319
Query: 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
+ K + + +A +G + +L + + V D + + +L + ++
Sbjct: 320 QADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVT 379
Query: 219 QFLGAVTERKPLMLITEYLR 238
L VT+ +L+++ R
Sbjct: 380 DVLKVVTDETSFVLVSDKHR 399
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (120), Expect = 1e-07
Identities = 25/86 (29%), Positives = 38/86 (44%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
A + L E ++ TPLHVA+ +G + VA+ L+E A NA +
Sbjct: 104 HIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGK 163
Query: 100 WKNTPLADAEGAKKFNMMELLNAHGG 125
TPL A ++++LL GG
Sbjct: 164 NGLTPLHVAVHHNNLDIVKLLLPRGG 189
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (114), Expect = 9e-07
Identities = 26/99 (26%), Positives = 42/99 (42%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A + V K L ++++ V+A+ D++TPLH A+ G ++ K L+E A+ N
Sbjct: 37 LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 96
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137
+TPL A + L F P
Sbjct: 97 TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTP 135
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.5 bits (161), Expect = 6e-13
Identities = 18/71 (25%), Positives = 32/71 (45%), Gaps = 1/71 (1%)
Query: 28 EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
+ +T LIL V++LLE++ ++ D D +T L +A +A+ L
Sbjct: 214 VRGERGKTPLILAVEK-KHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELL 272
Query: 88 IEYGADVNAQD 98
+ GA + D
Sbjct: 273 CKRGASTDCGD 283
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.4 bits (153), Expect = 7e-12
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 1/86 (1%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQD 98
+ +D A+ LL + + V+ R +TPL +A + + + L+E ++N D
Sbjct: 191 LSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTD 250
Query: 99 RWKNTPLADAEGAKKFNMMELLNAHG 124
T L A K + ELL G
Sbjct: 251 SDGKTALLLAVELKLKKIAELLCKRG 276
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (123), Expect = 4e-08
Identities = 24/96 (25%), Positives = 40/96 (41%), Gaps = 5/96 (5%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVA----SLHGWIDVAKCLIE 89
T+L+ A + ++ LL+E + V+A D R L A + L++
Sbjct: 149 ATALM-DAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLD 207
Query: 90 YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
+GADVN + TPL A K +++ L
Sbjct: 208 HGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEH 243
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (104), Expect = 1e-05
Identities = 24/95 (25%), Positives = 41/95 (43%)
Query: 30 ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE 89
A V L++ D V++LLE ++ + TPLH A D+ + L+
Sbjct: 1 AAVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLR 60
Query: 90 YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+GAD + + TP A A +++L + G
Sbjct: 61 HGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKG 95
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 2e-05
Identities = 18/64 (28%), Positives = 26/64 (40%), Gaps = 1/64 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLI-EYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
T L A+ G ++V K L+ E GADVNA D L A + + +E
Sbjct: 141 QERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEA 200
Query: 120 LNAH 123
+
Sbjct: 201 ITHL 204
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 65.9 bits (159), Expect = 9e-13
Identities = 23/82 (28%), Positives = 42/82 (51%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
+ A ++ V+ L+ E S +D D +TP+ +A+ G I+V LI+ GA V A D
Sbjct: 193 YAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDA 252
Query: 100 WKNTPLADAEGAKKFNMMELLN 121
+T A+ N++++ +
Sbjct: 253 TDHTARQLAQANNHHNIVDIFD 274
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 51.7 bits (122), Expect = 4e-08
Identities = 23/78 (29%), Positives = 35/78 (44%), Gaps = 9/78 (11%)
Query: 36 SLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL-------- 87
S I H + A+ + + +S+ NRT LH + + + ++ L
Sbjct: 2 SPIKLHTEAAGSYAITEPITR-ESVNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEAKEC 60
Query: 88 IEYGADVNAQDRWKNTPL 105
I GADVNA D +NTPL
Sbjct: 61 IAAGADVNAMDCDENTPL 78
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 42.0 bits (97), Expect = 7e-05
Identities = 9/52 (17%), Positives = 17/52 (32%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY 90
+ A Q V L + + V A D + T +A + ++
Sbjct: 225 IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDRC 276
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 63.1 bits (152), Expect = 7e-12
Identities = 16/85 (18%), Positives = 37/85 (43%), Gaps = 2/85 (2%)
Query: 28 EKARVSRTSLILWHAHQNDAAAVRKLLEED--QSLVHARDYDNRTPLHVASLHGWIDVAK 85
+ + S + + + L + ++++A+D + T L++A+ G I +
Sbjct: 217 QSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARLGNISIVD 276
Query: 86 CLIEYGADVNAQDRWKNTPLADAEG 110
L++YGAD ++ P+ G
Sbjct: 277 ALLDYGADPFIANKSGLRPVDFGAG 301
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 50.8 bits (120), Expect = 9e-08
Identities = 11/44 (25%), Positives = 21/44 (47%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
D TPLH + +++ K L+++G++ D + L A
Sbjct: 104 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKA 147
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 42.0 bits (97), Expect = 7e-05
Identities = 12/98 (12%), Positives = 33/98 (33%), Gaps = 3/98 (3%)
Query: 30 ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI- 88
S + A + ++++ + + + + + + + + L
Sbjct: 185 IITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDL 244
Query: 89 --EYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
+NAQD +T L A ++++ L +G
Sbjct: 245 KWIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYG 282
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 60.9 bits (146), Expect = 5e-11
Identities = 22/71 (30%), Positives = 34/71 (47%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A V KLL + + V+ +DYD TPLH A+ G + + L+E D+ A +
Sbjct: 203 LHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVN 262
Query: 99 RWKNTPLADAE 109
+ T A+
Sbjct: 263 KVGQTAFDVAD 273
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 53.2 bits (126), Expect = 1e-08
Identities = 20/121 (16%), Positives = 38/121 (31%), Gaps = 8/121 (6%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHAR--------DYDNRTPLHVASLHGWIDVAKCLIEY 90
+ A Q +++ + + L +D+ A G + L+E
Sbjct: 3 MADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDTEEVLRLLER 62
Query: 91 GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDW 150
GAD+N + T L A +M++ L +G + + P
Sbjct: 63 GADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIA 122
Query: 151 E 151
E
Sbjct: 123 E 123
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 47.0 bits (110), Expect = 2e-06
Identities = 22/85 (25%), Positives = 31/85 (36%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
+ R+ L T LHVA+ G+ +V K LI+ DVN +D
Sbjct: 171 KEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDY 230
Query: 100 WKNTPLADAEGAKKFNMMELLNAHG 124
TPL A K +L +
Sbjct: 231 DGWTPLHAAAHWGKEEACRILVENL 255
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 43.2 bits (100), Expect = 3e-05
Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 1/107 (0%)
Query: 25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVA 84
++K K + ++ L D V +LLE ++ + D T LH A + +D+
Sbjct: 31 RKKTKVKFDDGAVFLAACSSGDTEEVLRLLERGAD-INYANVDGLTALHQACIDDNVDMV 89
Query: 85 KCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131
K L+E GA++N D PL A ++ E L + G N
Sbjct: 90 KFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVN 136
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 58.8 bits (141), Expect = 3e-10
Identities = 14/101 (13%), Positives = 27/101 (26%), Gaps = 5/101 (4%)
Query: 28 EKARVSRTSLIL--WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAK 85
+K S + + + LL D+ V +N +A+ +G + V
Sbjct: 85 KKGIKSEVICFVAAITGCSSALDTLCLLLTSDEI-VKVIQAENYQAFRLAAENGHLHVLN 143
Query: 86 CLIEYGADVNAQDR--WKNTPLADAEGAKKFNMMELLNAHG 124
L E A +++ L
Sbjct: 144 RLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELA 184
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 52.2 bits (124), Expect = 4e-08
Identities = 10/80 (12%), Positives = 21/80 (26%), Gaps = 3/80 (3%)
Query: 48 AAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKC---LIEYGADVNAQDRWKNTP 104
A + ++ S H + + VA++ G L+ V
Sbjct: 70 AHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQA 129
Query: 105 LADAEGAKKFNMMELLNAHG 124
A +++ L
Sbjct: 130 FRLAAENGHLHVLNRLCELA 149
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 41.8 bits (97), Expect = 8e-05
Identities = 12/86 (13%), Positives = 21/86 (24%), Gaps = 5/86 (5%)
Query: 15 CKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLE----EDQSLVHARDYDNRT 70
G K + ++ + +R LL + + D
Sbjct: 260 NPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANE 319
Query: 71 PLHVASLHGWIDVAKCLIEYGADVNA 96
L +A G L+ V A
Sbjct: 320 LLRLALRLGNQGACALLLSIP-SVLA 344
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 38.3 bits (88), Expect = 0.001
Identities = 15/87 (17%), Positives = 26/87 (29%), Gaps = 4/87 (4%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHA-RDYDNRTPLHVASLHGWIDVAKCLIEYGADVN---AQ 97
A + +L E + + A +N +A+ +G + V L E Q
Sbjct: 134 AENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQ 193
Query: 98 DRWKNTPLADAEGAKKFNMMELLNAHG 124
A G N++ L
Sbjct: 194 AENYYAFRWAAVGRGHHNVINFLLDCP 220
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.3 bits (137), Expect = 4e-10
Identities = 22/85 (25%), Positives = 40/85 (47%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L A + K L + V+A + + TPLH A+ ++A L+E GA+ +A+D
Sbjct: 74 LHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKD 133
Query: 99 RWKNTPLADAEGAKKFNMMELLNAH 123
++ T + A M+ +L +
Sbjct: 134 HYEATAMHRAAAKGNLKMIHILLYY 158
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.7 bits (133), Expect = 1e-09
Identities = 18/72 (25%), Positives = 36/72 (50%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
+ A + +L ++ + +D + TPLH+A ++ AK L+ GA + ++
Sbjct: 140 MHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIEN 199
Query: 99 RWKNTPLADAEG 110
+ + TPL A+G
Sbjct: 200 KEEKTPLQVAKG 211
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (130), Expect = 3e-09
Identities = 25/121 (20%), Positives = 42/121 (34%), Gaps = 33/121 (27%)
Query: 37 LILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG----------------- 79
++ A+ +++ + D+SL D D+RT LH A G
Sbjct: 6 MVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVND 65
Query: 80 ----------------WIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
++ K L+ GA VNA ++ TPL A + + +L
Sbjct: 66 KDDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEG 125
Query: 124 G 124
G
Sbjct: 126 G 126
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (110), Expect = 1e-06
Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 2/91 (2%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
T L + A +N LLE + A+D+ T +H A+ G + + L+ Y A
Sbjct: 104 CTPLH-YAASKNRHEIAVMLLEGGAN-PDAKDHYEATAMHRAAAKGNLKMIHILLYYKAS 161
Query: 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
N QD NTPL A ++ +LL + G
Sbjct: 162 TNIQDTEGNTPLHLACDEERVEEAKLLVSQG 192
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 8e-04
Identities = 13/51 (25%), Positives = 23/51 (45%), Gaps = 1/51 (1%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE 89
L A + KLL + ++ + + +TPL VA G + K ++E
Sbjct: 173 LHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAK-GGLGLILKRMVE 222
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (134), Expect = 8e-10
Identities = 22/70 (31%), Positives = 41/70 (58%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
L HA +N++ ++ +LL + + V+A+ Y + LH AS G + + + L+ GAD + ++
Sbjct: 148 LIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKN 207
Query: 99 RWKNTPLADA 108
+TPL A
Sbjct: 208 CHNDTPLMVA 217
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.8 bits (122), Expect = 3e-08
Identities = 13/55 (23%), Positives = 25/55 (45%), Gaps = 4/55 (7%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEY----GADVNAQDRWKNTPLADAEGAKKFNMM 117
D TPLH+A + G + L+ G +++ + + TPL A +++
Sbjct: 2 DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVV 56
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (93), Expect = 2e-04
Identities = 11/47 (23%), Positives = 18/47 (38%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAK 85
L A + + L + ++ N TPL VA ID+ +
Sbjct: 181 LHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILR 227
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 5e-04
Identities = 38/226 (16%), Positives = 72/226 (31%), Gaps = 21/226 (9%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSL---VHARDYDNRTPLHVASLHGWIDVAKCLIEY 90
T L Q + AV +L+ Q + + +TPLH+A + V + L+
Sbjct: 4 DTPLH-IAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTA 62
Query: 91 GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDW 150
GA A DR T A + + L + + +
Sbjct: 63 GASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTEC 122
Query: 151 EIDPSELDF---SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVN 207
+ L A+ K ++ A + ++ +L ++ + ++
Sbjct: 123 QETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALH 182
Query: 208 LLVKLRHPNIVQFL---GAVTERK------PLML-----ITEYLRG 239
+V+ L GA + K PLM+ + + LRG
Sbjct: 183 SASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILRG 228
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 53.9 bits (128), Expect = 6e-09
Identities = 27/85 (31%), Positives = 34/85 (40%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
DA VR L + L RTPLH+A V + L++ GAD A+
Sbjct: 164 VAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMY 223
Query: 100 WKNTPLADAEGAKKFNMMELLNAHG 124
TPL A + LL AHG
Sbjct: 224 GGRTPLGSALLRPNPILARLLRAHG 248
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 51.6 bits (122), Expect = 4e-08
Identities = 12/47 (25%), Positives = 19/47 (40%), Gaps = 3/47 (6%)
Query: 65 DYDNRTPLHVASLHGWIDVAKCLIEYGAD---VNAQDRWKNTPLADA 108
D T LH+A +H L+ + A ++ Q+ T L A
Sbjct: 6 TEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLA 52
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 48.9 bits (115), Expect = 3e-07
Identities = 17/57 (29%), Positives = 24/57 (42%), Gaps = 2/57 (3%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
A+ + LL+ AR Y RTPL A L +A+ L +GA +D
Sbjct: 200 VEAQAASVLELLLKAGAD-PTARMYGGRTPLGSALLRPNPILARLLRAHGAP-EPED 254
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 44.3 bits (103), Expect = 9e-06
Identities = 18/94 (19%), Positives = 32/94 (34%), Gaps = 3/94 (3%)
Query: 34 RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
T+L + LL + ++ +T LH+A++ G + L G
Sbjct: 10 DTALH-LAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAG 68
Query: 92 ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
A V +R +T L A + +L
Sbjct: 69 AGVLVAERGGHTALHLACRVRAHTCACVLLQPRP 102
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 51.7 bits (122), Expect = 2e-08
Identities = 14/58 (24%), Positives = 27/58 (46%)
Query: 64 RDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLN 121
+D + TPL +A+ G + +K L++ A+ D P A +++ LL+
Sbjct: 152 QDDKDETPLFLAAREGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLLD 209
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.7 bits (96), Expect = 5e-05
Identities = 12/49 (24%), Positives = 22/49 (44%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
L+ A + + K L ++ + D+ +R P VAS D+ + L
Sbjct: 160 LFLAAREGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLL 208
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.8 bits (91), Expect = 2e-04
Identities = 18/85 (21%), Positives = 34/85 (40%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
A + + + L + ++A D +T LH A+ + L+ + A+ +AQD
Sbjct: 95 ILAARLAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDD 154
Query: 100 WKNTPLADAEGAKKFNMMELLNAHG 124
TPL A + + L +
Sbjct: 155 KDETPLFLAAREGSYEASKALLDNF 179
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 38.2 bits (87), Expect = 9e-04
Identities = 18/51 (35%), Positives = 25/51 (49%)
Query: 50 VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100
+ LL + L D T LH+A+ D AK L++ GAD N+QD
Sbjct: 5 ISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRLLDAGADANSQDNT 55
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.9 bits (117), Expect = 1e-07
Identities = 17/88 (19%), Positives = 30/88 (34%), Gaps = 4/88 (4%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEY----GADVNAQDRWKNTPLADAEGAKKFNMMELLNA 122
D + LH+A +H + +I A +N Q+ + TPL A + + E L
Sbjct: 1 DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLG 60
Query: 123 HGGLSYGQNGSHFEPKPVPPPLPNKCDW 150
G ++ P +
Sbjct: 61 AGCDPELRDFRGNTPLHLACEQGCLASV 88
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.8 bits (109), Expect = 1e-06
Identities = 17/85 (20%), Positives = 28/85 (32%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
+ V L+ + + RT LH+A D+ L++ GADVN
Sbjct: 117 LASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTY 176
Query: 100 WKNTPLADAEGAKKFNMMELLNAHG 124
+P G + + L
Sbjct: 177 QGYSPYQLTWGRPSTRIQQQLGQLT 201
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 7e-05
Identities = 3/32 (9%), Positives = 10/32 (31%)
Query: 62 HARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+ Y +P + + + L + +
Sbjct: 172 NRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 203
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 47.5 bits (111), Expect = 7e-07
Identities = 34/224 (15%), Positives = 73/224 (32%), Gaps = 18/224 (8%)
Query: 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
+N+ V++LL SL+ +D D R PLH + ++ L+ +VN D
Sbjct: 8 CMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLDDYPD 67
Query: 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSE-LDFS 160
++ A +E++ + + + + V + S+ L +
Sbjct: 68 DSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIEN 127
Query: 161 SSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHE--VNLLVKLRHPNI 217
+++ K F +I L + + +L L + QD + + + H +
Sbjct: 128 GASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDA 187
Query: 218 VQFL----GAVTERK------PLMLITEYLRGGDLHKYLKEKGA 251
L GA + + + K+
Sbjct: 188 AVLLVEKYGAEYDLVDNKGAKAEDVALNE----QVKKFFLNNVV 227
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 47.1 bits (110), Expect = 9e-07
Identities = 9/82 (10%), Positives = 23/82 (28%), Gaps = 1/82 (1%)
Query: 70 TPLHVASLHGWIDVAKCLIE-YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSY 128
PLH A + + L+ + + +D+ PL + + + L +
Sbjct: 2 YPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVN 61
Query: 129 GQNGSHFEPKPVPPPLPNKCDW 150
+ + +
Sbjct: 62 LDDYPDDSGWTPFHIACSVGNL 83
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 44.0 bits (102), Expect = 1e-05
Identities = 9/54 (16%), Positives = 14/54 (25%), Gaps = 3/54 (5%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
+ A L+E+ + D VA V K + D
Sbjct: 178 HALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALNE---QVKKFFLNNVVD 228
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (100), Expect = 9e-06
Identities = 8/33 (24%), Positives = 16/33 (48%)
Query: 70 TPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN 102
L A+ G ++ L++ +VNAQ+ +
Sbjct: 3 NELASAAARGDLEQLTSLLQNNVNVNAQNGFGR 35
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 2e-05
Identities = 12/52 (23%), Positives = 21/52 (40%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
A + V L++ S V R++ T +A L+G +V + G
Sbjct: 105 LAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANG 156
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.5 bits (98), Expect = 2e-05
Identities = 12/49 (24%), Positives = 25/49 (51%)
Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
L A +++ V +LL + + VH + +T ++ +G D+A+ L
Sbjct: 104 LHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.5 bits (98), Expect = 2e-05
Identities = 16/155 (10%), Positives = 41/155 (26%), Gaps = 3/155 (1%)
Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGL 126
D L A+ G D + L+ GA + A+ LL A
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGHFSTTEVLLRAGVSR 60
Query: 127 SYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIK 186
+ D ++ ++ + A ++
Sbjct: 61 DARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLK---MTALHWATEHNHQEVVE 117
Query: 187 RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
++ +D + + ++ + + ++ + L
Sbjct: 118 LLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 36.4 bits (82), Expect = 0.002
Identities = 19/59 (32%), Positives = 32/59 (54%)
Query: 62 HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
+A+D T LH A+ H +V + LI+YGADV+ Q ++ T + ++ E+L
Sbjct: 94 NAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 1e-04
Identities = 12/50 (24%), Positives = 17/50 (34%)
Query: 40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE 89
H + +S +H RD TPL +A G D+ L
Sbjct: 105 IHLAVQEGHTAVVSFLAAESDLHRRDARGLTPLELALQRGAQDLVDILQG 154
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.6 bits (80), Expect = 0.004
Identities = 16/63 (25%), Positives = 28/63 (44%), Gaps = 1/63 (1%)
Query: 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
V+ D P+H+A G V L +D++ +D TPL A +++++L
Sbjct: 94 VNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDARGLTPLELALQRGAQDLVDIL 152
Query: 121 NAH 123
H
Sbjct: 153 QGH 155
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 38.8 bits (89), Expect = 3e-04
Identities = 6/38 (15%), Positives = 12/38 (31%), Gaps = 1/38 (2%)
Query: 62 HARDYDNRTPLHVASLHGWIDVAKCLIEYGAD-VNAQD 98
+ TPL +A + L + + N+
Sbjct: 108 EIANESGETPLDIAKRLKHEHCEELLTQALSGRFNSHV 145
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.7 bits (80), Expect = 0.002
Identities = 9/31 (29%), Positives = 17/31 (54%)
Query: 70 TPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100
L A+ G ++ + L+E GA+ NA + +
Sbjct: 5 DWLATAAARGRVEEVRALLEAGANPNAPNSY 35
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.0 bits (79), Expect = 0.004
Identities = 7/31 (22%), Positives = 13/31 (41%)
Query: 70 TPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100
L +SL G D+ + +I D + +
Sbjct: 3 ALLLDSSLEGEFDLVQRIIYEVDDPSLPNDE 33
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 394 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.84 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.83 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.81 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.81 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.78 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.77 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.75 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.74 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.72 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.72 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.71 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.7 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.7 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.68 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.67 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.66 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.65 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.64 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.64 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.64 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.64 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.64 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.63 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.62 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.62 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.61 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.61 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.6 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.58 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.58 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.56 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.55 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.51 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.51 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.51 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.5 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.42 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.4 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.61 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.85 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.59 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.58 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.94 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-53 Score=381.23 Aligned_cols=225 Identities=31% Similarity=0.511 Sum_probs=198.4
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++++.||+|+||.||+|.++ ++.||+|++.+.........+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 8999999999999999999985 77899998864322222234668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+++|+|.+++.+.+.+++..+..++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+|.......
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill--~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL--GSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCCSCSCCCCCC--
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeecccccee--cCCCCEeecccceeeecCCCc--
Confidence 9999999999998889999999999999999999999988 9999999999999 888899999999998665332
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccccC
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~~ 394 (394)
.....||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..++.+.|.++.++. + +.+|+++++
T Consensus 161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-p-~~~s~~~~~ 233 (263)
T d2j4za1 161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-P-DFVTEGARD 233 (263)
T ss_dssp ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC-C-TTSCHHHHH
T ss_pred ----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-C-ccCCHHHHH
Confidence 234679999999999999999999999999999999999999999999999999998876543 3 347777653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=375.44 Aligned_cols=225 Identities=28% Similarity=0.506 Sum_probs=197.1
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|.+. |+.||||.+....... .+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 7999999999999999999874 8899999986554333 3668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
||+||+|.+++.+ +.+++.+++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+|..+.....
T Consensus 98 y~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl--~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEE--CCCCcEeeccchhheeeccccc-
Confidence 9999999998765 46999999999999999999999988 9999999999999 7888999999999987654322
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCCccccC
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGFTPELRE 394 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~~~~~~~ 394 (394)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+....+..+..|.+.. +.+|+++++
T Consensus 172 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 172 ---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (293)
T ss_dssp ---CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHH
T ss_pred ---cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHH
Confidence 2345679999999999999999999999999999999999999999999888888777665655543 457777653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=380.22 Aligned_cols=229 Identities=26% Similarity=0.486 Sum_probs=197.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++++.||+|+||.||+|.+. |+.||||++.+.........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 7999999999999999999985 78899999864322222234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|++||+|.+++...+.+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+|+.+......
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll--~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTTCEECC-----
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCcccccc--CCCceEEecccccceecccCCcc
Confidence 9999999999999999999999999999999999999988 9999999999999 88899999999999876533221
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccccC
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~~ 394 (394)
......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..++.++|.++..+ ++ +.+|++++|
T Consensus 165 --~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s~~~~~ 239 (288)
T d1uu3a_ 165 --ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD-FP-EKFFPKARD 239 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC-CC-TTCCHHHHH
T ss_pred --cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC-CC-ccCCHHHHH
Confidence 1234567999999999999999999999999999999999999999999999999999987644 34 347877653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-51 Score=377.89 Aligned_cols=225 Identities=33% Similarity=0.479 Sum_probs=203.5
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|+.++.||+|+||.||+|.+. ++.||||.+...........+.+.+|+.++++++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 5899999999999999999874 77899999877666666667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
||.+|+|..++..++++++.+++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+|.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl--~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEE--ETTTEEEECCCTTCBSSSS----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEE--CCCCCEEEeecccccccCC----
Confidence 9999999888888888999999999999999999999988 9999999999999 7888999999999986542
Q ss_pred ccccccCCccCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
.....||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+....+..+..|.+....+|+++
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~ 243 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHH
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 234679999999999864 4689999999999999999999999999999999999999999988888889887
Q ss_pred cC
Q 016152 393 RE 394 (394)
Q Consensus 393 ~~ 394 (394)
++
T Consensus 244 ~~ 245 (309)
T d1u5ra_ 244 RN 245 (309)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=372.36 Aligned_cols=229 Identities=29% Similarity=0.508 Sum_probs=188.6
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe--CCeeEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLI 233 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~lv 233 (394)
+|++.+.||+|+||.||+|.++ |+.||||.+...... ....+.+.+|+.++++++||||+++++++.+ +..+|+|
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 7999999999999999999875 788999998765443 4445778999999999999999999998865 4568999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCC---CCeEecCCCCCCEEEeeCCCCcEEEeecCCc
Q 016152 234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEP---NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a 306 (394)
||||++|+|.+++.+ ++.+++.+++.++.|++.||.|||+++ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll--~~~~~vkl~DFG~a 161 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFGLA 161 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE--CTTSCEEECCHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc--CCCCcEEEeeccce
Confidence 999999999999864 467999999999999999999999864 349999999999999 88899999999999
Q ss_pred cccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAK 386 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~ 386 (394)
..+..... ......||+.|+|||++.+..|+.++|||||||++|||+||++||.+.+..++...|..+.++.++.
T Consensus 162 ~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~- 236 (269)
T d2java1 162 RILNHDTS----FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY- 236 (269)
T ss_dssp HHC---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT-
T ss_pred eecccCCC----ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc-
Confidence 87654322 2345789999999999999999999999999999999999999999999999999999998887764
Q ss_pred CCCccccC
Q 016152 387 GFTPELRE 394 (394)
Q Consensus 387 ~~~~~~~~ 394 (394)
.+|+++++
T Consensus 237 ~~s~~l~~ 244 (269)
T d2java1 237 RYSDELNE 244 (269)
T ss_dssp TSCHHHHH
T ss_pred ccCHHHHH
Confidence 58888753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=380.68 Aligned_cols=228 Identities=26% Similarity=0.456 Sum_probs=200.9
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++++.||+|+||.||+|..+ |+.||||++.+.........+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 47999999999999999999974 8899999986542222223466789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl--~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCSCCTTC
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEe--cCCCCEEEeecccccccccCCc
Confidence 99999999999999999999999999999999999999998 9999999999999 8889999999999986653322
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccccC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~~ 394 (394)
.....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..++.+.+..+..+ ++ +.+|++++|
T Consensus 161 ----~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~-~p-~~~s~~~~d 234 (337)
T d1o6la_ 161 ----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-FP-RTLSPEAKS 234 (337)
T ss_dssp ----CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CC-TTSCHHHHH
T ss_pred ----ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC-CC-ccCCHHHHH
Confidence 234578999999999999999999999999999999999999999999999999999987654 34 347877653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=373.15 Aligned_cols=226 Identities=29% Similarity=0.478 Sum_probs=197.1
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|++++.||+|+||.||+|.+. ++.||||++...... ..+.+.+|+.++++++|||||++++++.+++.+++|||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 5899999999999999999975 778999998654332 23668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||++|+|.+++.+ .+.+++.++..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+|........
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll--~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILF--TLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeE--CCCCCEEEEechhhhccCCCcc
Confidence 9999999999765 457999999999999999999999988 9999999999999 8888999999999976543321
Q ss_pred cccccccCCccCccccCccccC-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCC
Q 016152 315 HDVYKMTGETGSYRYMAPEVFK-----HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA-KGF 388 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~-~~~ 388 (394)
......||+.|+|||++. +..|+.++|||||||++|||++|++||.+.+..++...|.++.+|.+.. ..+
T Consensus 166 ----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (288)
T d2jfla1 166 ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 241 (288)
T ss_dssp ----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGS
T ss_pred ----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccC
Confidence 234578999999999984 4568999999999999999999999999999999999999988877654 467
Q ss_pred CccccC
Q 016152 389 TPELRE 394 (394)
Q Consensus 389 ~~~~~~ 394 (394)
|++++|
T Consensus 242 s~~~~~ 247 (288)
T d2jfla1 242 SSNFKD 247 (288)
T ss_dssp CHHHHH
T ss_pred CHHHHH
Confidence 777653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=371.97 Aligned_cols=229 Identities=29% Similarity=0.449 Sum_probs=189.4
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++++.||+|+||.||+|.++ |+.||||.+...... ...+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 37999999999999999999975 789999998654322 23356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++|+|.+++.+++.+++.+++.++.||++||+|||++| |+||||||+|||+ +.++.+||+|||+|+.+.....
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl--~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEECEETTE
T ss_pred eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEE--CCCCCEEEccchhheeeccCCc
Confidence 99999999999988888999999999999999999999988 9999999999999 8888999999999987754332
Q ss_pred cccccccCCccCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPFFRAKGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~Pf~~~~~~-~~~~~i~~g~~p~~~~~~~~~~~ 392 (394)
. ......+||+.|||||++.+..+ +.++|||||||++|||++|++||...+.. .....+........+.+.+|+++
T Consensus 159 ~--~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 159 E--RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236 (271)
T ss_dssp E--CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred c--ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHH
Confidence 1 12345789999999999988776 57899999999999999999999765433 34444444444444445567665
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 237 ~ 237 (271)
T d1nvra_ 237 L 237 (271)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.7e-51 Score=375.82 Aligned_cols=224 Identities=28% Similarity=0.522 Sum_probs=198.7
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
.+|++++.||+|+||.||+|.++ |+.||||++.+.........+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 37999999999999999999975 8899999986432222223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||++||+|..++.....+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl--~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILL--DKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CTTSCEEECCCSSCEECSSC--
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeE--cCCCCEEEecCccceEeccc--
Confidence 99999999999999999999999999999999999999988 9999999999999 88899999999999876532
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|.++..+.. ..+|++++
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~ 229 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVK 229 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC--TTSCHHHH
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC--CCCCHHHH
Confidence 2346899999999999999999999999999999999999999999999999999998865443 24677765
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=363.73 Aligned_cols=227 Identities=31% Similarity=0.516 Sum_probs=192.0
Q ss_pred ccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe----CCeeEE
Q 016152 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RKPLML 232 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~~~l 232 (394)
|+..+.||+|+||.||+|.+. +..||+|.+...... ....+.+.+|+.++++++||||+++++++.+ ...+++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 466778999999999999985 668999988665433 3445778999999999999999999999865 346899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~ 312 (394)
||||+++|+|.+++.+.+.+++.+++.++.||++||+|||+++.+|+||||||+|||+. +.++.+||+|||+|+.....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~-~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT-GPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES-STTSCEEECCTTGGGGCCTT
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee-CCCCCEEEeecCcceeccCC
Confidence 99999999999999998899999999999999999999999766699999999999992 24678999999999754322
Q ss_pred cccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCCcc
Q 016152 313 NSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY-EPYEAAKYVAEGHRPFFRAKGFTPE 391 (394)
Q Consensus 313 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~-~~~~~~~~i~~g~~p~~~~~~~~~~ 391 (394)
.....+||+.|||||++.+ .++.++|||||||++|||++|++||.+. +..++.+.+..+.+|....+.++++
T Consensus 169 ------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (270)
T d1t4ha_ 169 ------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241 (270)
T ss_dssp ------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred ------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence 1235679999999999865 5999999999999999999999999765 5667778888887776666667887
Q ss_pred ccC
Q 016152 392 LRE 394 (394)
Q Consensus 392 ~~~ 394 (394)
+++
T Consensus 242 ~~~ 244 (270)
T d1t4ha_ 242 VKE 244 (270)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-51 Score=373.81 Aligned_cols=228 Identities=28% Similarity=0.473 Sum_probs=183.3
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
.|++.+.||+|+||.||+|.++ |+.||||++.+..... ....+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5999999999999999999985 7889999987654332 23567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-CCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+||+|.+++.+++.+++.++..++.||+.||+|||+++ |+||||||+|||+.. +.++.+||+|||++.......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~- 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS- 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence 9999999999999889999999999999999999999988 999999999999953 356789999999998665332
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFR--AKGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~--~~~~~~~~ 392 (394)
.....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++...|.++..+... .+.+|+++
T Consensus 165 ----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 165 ----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred ----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 234567999999999999999999999999999999999999999999999999999987655432 24577776
Q ss_pred cC
Q 016152 393 RE 394 (394)
Q Consensus 393 ~~ 394 (394)
+|
T Consensus 241 ~~ 242 (307)
T d1a06a_ 241 KD 242 (307)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=376.41 Aligned_cols=201 Identities=27% Similarity=0.479 Sum_probs=179.2
Q ss_pred CCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 155 ~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
...+|++.+.||+|+||.||+|.+. |+.||+|.+...... ...+.+.+|+.+++.++|||||+++++|.+++.+++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3458999999999999999999975 788999998654332 334678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
||||++||+|.+++.+++.+++..++.++.|++.||.|||++ | |+||||||+|||+ +.++.+||+|||+|..+..
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl--~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEE--CTTCCEEECCCCCCHHHHH
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeE--CCCCCEEEeeCCCccccCC
Confidence 999999999999999888999999999999999999999975 7 9999999999999 8889999999999987653
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
.. ..+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+
T Consensus 158 ~~------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 158 SM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HT------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred Cc------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 32 235689999999999999999999999999999999999999997654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-50 Score=368.78 Aligned_cols=239 Identities=29% Similarity=0.548 Sum_probs=204.5
Q ss_pred CCCCCCCCCcccCCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCcee
Q 016152 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218 (394)
Q Consensus 141 ~~~~~~~~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 218 (394)
.|+.|....|+|+.. +|++.+.||+|+||.||+|.+. ++.||||.+...... .+.+.+|+.++++++|||||
T Consensus 3 ~p~~p~~~~wei~~~--~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv 76 (287)
T d1opja_ 3 DPSSPNYDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLV 76 (287)
T ss_dssp CTTSTTCCTTBCCGG--GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCcccEecHH--HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEe
Confidence 345566778988754 6888999999999999999985 778999988654332 35688999999999999999
Q ss_pred eEEeEEEeCCeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC
Q 016152 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296 (394)
Q Consensus 219 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~ 296 (394)
++++++.+++.+++||||+++|+|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+|||+ +.++
T Consensus 77 ~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl--~~~~ 152 (287)
T d1opja_ 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENH 152 (287)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGG
T ss_pred cCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEE--CCCC
Confidence 9999999999999999999999999999764 46899999999999999999999988 9999999999999 8888
Q ss_pred cEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHH
Q 016152 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EPPLANYEPYEAAKYV 375 (394)
Q Consensus 297 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g-~~Pf~~~~~~~~~~~i 375 (394)
.+||+|||+|+....... .......||+.|+|||++.+..|+.++|||||||++|||++| .+||...+..++.+.+
T Consensus 153 ~~Kl~DFG~a~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i 229 (287)
T d1opja_ 153 LVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229 (287)
T ss_dssp CEEECCCCCTTTCCSSSS---EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred cEEEccccceeecCCCCc---eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH
Confidence 999999999987654322 122345689999999999999999999999999999999995 5566777888888888
Q ss_pred HcCCCCCCCCCCCCcccc
Q 016152 376 AEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 376 ~~g~~p~~~~~~~~~~~~ 393 (394)
..+.+|.++. .+|++++
T Consensus 230 ~~~~~~~~~~-~~~~~l~ 246 (287)
T d1opja_ 230 EKDYRMERPE-GCPEKVY 246 (287)
T ss_dssp HTTCCCCCCT-TCCHHHH
T ss_pred hcCCCCCCCc-cchHHHH
Confidence 8888887774 4787765
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=363.20 Aligned_cols=234 Identities=32% Similarity=0.556 Sum_probs=187.5
Q ss_pred CcccCCCCcCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 149 ~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
+|+++.. +|++.+.||+|+||.||+|.+++ .||||++....... ...+.+.+|+.++++++|||||++++++. ++
T Consensus 2 dwei~~~--~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 2 DWEIPDG--QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 76 (276)
T ss_dssp CCBCCTT--CCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred Ccccccc--cEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-cc
Confidence 6777654 68889999999999999998765 59999986554333 34578999999999999999999999765 45
Q ss_pred eeEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 229 PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
.+++||||+++|+|.+++... +.+++.++..++.|+++||+|||+++ ||||||||+|||+ +.++.+||+|||+|+
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl--~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFL--HEDLTVKIGDFGLAT 152 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--ETTSSEEECCCCCSC
T ss_pred EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEE--cCCCCEEEcccccee
Confidence 689999999999999999764 56999999999999999999999988 9999999999999 788899999999998
Q ss_pred ccccccccccccccCCccCccccCccccCC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCCCC-
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKH---RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY-EAAKYVAEGHRPF- 382 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~-~~~~~i~~g~~p~- 382 (394)
....... ........||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.+.. ++...+.++..+.
T Consensus 153 ~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 153 VKSRWSG--SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230 (276)
T ss_dssp C--------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC
T ss_pred eccccCC--cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc
Confidence 7653322 112345679999999999864 35899999999999999999999999887655 4455666665443
Q ss_pred CC--CCCCCcccc
Q 016152 383 FR--AKGFTPELR 393 (394)
Q Consensus 383 ~~--~~~~~~~~~ 393 (394)
+. ...+|++++
T Consensus 231 ~~~~~~~~~~~l~ 243 (276)
T d1uwha_ 231 LSKVRSNCPKAMK 243 (276)
T ss_dssp GGGSCTTCCHHHH
T ss_pred chhccccchHHHH
Confidence 22 245677665
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.7e-50 Score=373.45 Aligned_cols=226 Identities=23% Similarity=0.460 Sum_probs=197.1
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|.+. |+.||||++.... ....+.+.+|+.++++++|||||++++++.+++.+|+|||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 7999999999999999999975 8899999986532 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+||+|.+++.+ .+.+++.++..++.||+.||.|||++| |+||||||+|||+..+.++.+||+|||++..+....
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 9999999999854 567999999999999999999999988 999999999999965567899999999998765432
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~~ 392 (394)
......||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++.+.|..+....... ..+|+++
T Consensus 181 ----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 181 ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp ----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred ----ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 2334679999999999999999999999999999999999999999999999999998765443322 4567766
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 257 ~ 257 (350)
T d1koaa2 257 K 257 (350)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-49 Score=372.87 Aligned_cols=227 Identities=22% Similarity=0.443 Sum_probs=197.5
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++.+.||+|+||.||+|.+. |+.||||++.... ......+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 6999999999999999999974 8899999886543 2334667899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+||+|.+++...+ ++++.+++.++.||+.||.|||++| |+||||||+|||+.....+.+||+|||+|..+....
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 999999998876544 6999999999999999999999988 999999999999944467899999999998775432
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~~ 392 (394)
......||+.|+|||++.+..|+.++|||||||++|||+||++||.+.+..++...|.++..+.... ..+|+++
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 184 ----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp ----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred ----ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 2334679999999999999999999999999999999999999999999999999999876543332 4577776
Q ss_pred cC
Q 016152 393 RE 394 (394)
Q Consensus 393 ~~ 394 (394)
+|
T Consensus 260 ~~ 261 (352)
T d1koba_ 260 KD 261 (352)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=363.21 Aligned_cols=227 Identities=27% Similarity=0.461 Sum_probs=197.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCc---HHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD---RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
+|++++.||+|+||.||+|.++ |+.||||++.+..... ....+.+.+|+.++++++|||||++++++.+.+.+|+
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 6999999999999999999975 7899999986543221 1234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCC----cEEEeecCCccc
Q 016152 233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSKL 308 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~----~~kl~DFg~a~~ 308 (394)
|||||++|+|.+++..++.+++..++.++.|++.||+|||+++ |+||||||+|||+ +..+ .+||+|||++..
T Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill--~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SCSSSSSCCEEECCCTTCEE
T ss_pred EEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEE--ecCCCcccceEecchhhhhh
Confidence 9999999999999998889999999999999999999999988 9999999999999 4433 599999999987
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--C
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--K 386 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~ 386 (394)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...|.++..+.... +
T Consensus 167 ~~~~~-----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 167 IDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp CTTSC-----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred cCCCc-----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 65432 2345679999999999999999999999999999999999999999999999999999876654332 4
Q ss_pred CCCcccc
Q 016152 387 GFTPELR 393 (394)
Q Consensus 387 ~~~~~~~ 393 (394)
.+|++++
T Consensus 242 ~~s~~~~ 248 (293)
T d1jksa_ 242 NTSALAK 248 (293)
T ss_dssp TSCHHHH
T ss_pred CCCHHHH
Confidence 5666654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=361.56 Aligned_cols=224 Identities=29% Similarity=0.511 Sum_probs=190.3
Q ss_pred ceeecCCceEEEEEEEC----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEeccC
Q 016152 163 AIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~ 238 (394)
+.||+|+||.||+|.++ ++.||||.+.....+ ....+.+.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 47999999999999864 356999998654433 3445789999999999999999999998864 56789999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccc
Q 016152 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318 (394)
Q Consensus 239 ~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~ 318 (394)
+|+|.+++.+...+++.++..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.+...... ..
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill--~~~~~~kl~DFGla~~~~~~~~~-~~ 165 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL--VTQHYAKISDFGLSKALRADENY-YK 165 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCCTTCEECCTTCSE-EE
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcc--cccCcccccchhhhhhccccccc-cc
Confidence 9999999999889999999999999999999999988 9999999999999 77889999999999876543221 11
Q ss_pred cccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCccccC
Q 016152 319 KMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELRE 394 (394)
Q Consensus 319 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~~ 394 (394)
......||+.|+|||.+.+..++.++|||||||++|||+| |++||.+.+..++...|.+|.+|.++. .+|+++++
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~-~~~~~~~~ 241 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA-GCPREMYD 241 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT-TCCHHHHH
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCc-ccCHHHHH
Confidence 2334578999999999999999999999999999999998 999999999999999999999998875 47887753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.9e-50 Score=373.98 Aligned_cols=223 Identities=27% Similarity=0.481 Sum_probs=198.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++++.||+|+||.||+|.++ |+.||||++.+.........+.+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 7999999999999999999975 88999998854322222224668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
|+.+|+|.+++.+.+.+++.+++.++.||+.||.|||+++ ||||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl--~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECSSC---
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHccc--CCCCCEEeeeceeeeecccc---
Confidence 9999999999999889999999999999999999999988 9999999999999 88899999999999876532
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.....||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..++..+|..+.++.. ..+|++++
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~ 266 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--SHFSSDLK 266 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTCCHHHH
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC--ccCCHHHH
Confidence 2346799999999999999999999999999999999999999999999999999998765443 34777765
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=360.76 Aligned_cols=227 Identities=29% Similarity=0.535 Sum_probs=195.0
Q ss_pred Cccccce-eecCCceEEEEEEEC----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEE
Q 016152 158 DFSSSAI-IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 158 ~~~~~~~-iG~G~~g~V~~a~~~----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 232 (394)
+|.+.+. ||+|+||.||+|.++ +..||||.+.... .....+.+.+|+.++++++|||||++++++.+ +.+|+
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 5666664 999999999999764 3469999986432 34456789999999999999999999998865 56899
Q ss_pred EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 233 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 233 v~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
||||+++|+|.+++.. ++.+++.++..++.|+++||+|||+++ |+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill--~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLL--VNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--EETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheee--ccCCceeeccchhhhcccc
Confidence 9999999999999865 457999999999999999999999988 9999999999999 7788999999999987754
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCc
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTP 390 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~ 390 (394)
.... ........||+.|+|||++.++.++.++|||||||++|||+| |++||.+.+..++...|.+|.+|.++. .+|+
T Consensus 162 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~-~~~~ 239 (285)
T d1u59a_ 162 DDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP-ECPP 239 (285)
T ss_dssp CSCE-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT-TCCH
T ss_pred cccc-cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC-cCCH
Confidence 3321 112345678999999999998999999999999999999998 999999999999999999999998874 4788
Q ss_pred ccc
Q 016152 391 ELR 393 (394)
Q Consensus 391 ~~~ 393 (394)
+++
T Consensus 240 ~l~ 242 (285)
T d1u59a_ 240 ELY 242 (285)
T ss_dssp HHH
T ss_pred HHH
Confidence 775
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.9e-49 Score=358.67 Aligned_cols=231 Identities=28% Similarity=0.480 Sum_probs=192.6
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC----eeE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PLM 231 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----~~~ 231 (394)
+|++.+.||+|+||.||+|.+. |+.||||++.+....+......+.+|+.+++.++||||+++++++...+ .+|
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 6999999999999999999974 8899999998777766777788999999999999999999999987654 379
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
+||||++|++|.+++...+.+++.+++.++.||+.||+|||++| |+||||||+|||+ +.++.++|+|||.+.....
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll--~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI--SATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTSCEEECCCTTCEECC-
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCccccc--Cccccceeehhhhhhhhcc
Confidence 99999999999999999899999999999999999999999988 9999999999999 7888999999999876543
Q ss_pred ccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCC
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPF--FRAKGFT 389 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~--~~~~~~~ 389 (394)
.... .......+||+.|+|||++.+..+++++|||||||++|||+||++||.+.+..++..++.++.+.. ...+.+|
T Consensus 164 ~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 164 SGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred cccc-ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 3221 123445689999999999999999999999999999999999999999999988887777554432 2335677
Q ss_pred cccc
Q 016152 390 PELR 393 (394)
Q Consensus 390 ~~~~ 393 (394)
++++
T Consensus 243 ~~l~ 246 (277)
T d1o6ya_ 243 ADLD 246 (277)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=357.99 Aligned_cols=232 Identities=30% Similarity=0.518 Sum_probs=198.8
Q ss_pred CCCcccCCCCcCccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 016152 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (394)
Q Consensus 147 ~~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 225 (394)
..+|+|+. .+|++.+.||+|+||.||+|.++ +..||||.+...... .+.+.+|+.++++++|||||++++++.
T Consensus 5 ~~~wei~~--~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 5 EDEWEVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp TCTTBCCG--GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCeecCH--HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 45788865 37899999999999999999987 467999998654332 256899999999999999999999775
Q ss_pred eCCeeEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 226 ERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 226 ~~~~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
++.+++||||+++|+|.+++... ..+++.+++.++.||++||.|||+++ |+||||||+|||+ +.++.+||+||
T Consensus 79 -~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll--~~~~~~Kl~DF 153 (272)
T d1qpca_ 79 -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILV--SDTLSCKIADF 153 (272)
T ss_dssp -SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCC
T ss_pred -cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheee--ecccceeeccc
Confidence 45679999999999999977543 36999999999999999999999988 9999999999999 88899999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~ 382 (394)
|+|+.+..... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..++.+.+..+.+|.
T Consensus 154 Gla~~~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~ 230 (272)
T d1qpca_ 154 GLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230 (272)
T ss_dssp TTCEECSSSCE---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cceEEccCCcc---ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99987754321 12345678999999999998899999999999999999999 677788888999999999998888
Q ss_pred CCCCCCCcccc
Q 016152 383 FRAKGFTPELR 393 (394)
Q Consensus 383 ~~~~~~~~~~~ 393 (394)
.+. .+|++++
T Consensus 231 ~p~-~~~~~l~ 240 (272)
T d1qpca_ 231 RPD-NCPEELY 240 (272)
T ss_dssp CCT-TCCHHHH
T ss_pred Ccc-cChHHHH
Confidence 774 5787765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=365.45 Aligned_cols=226 Identities=29% Similarity=0.484 Sum_probs=194.6
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHH-hCCCCceeeEEeEEEeCCeeEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV-KLRHPNIVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~-~l~h~~Iv~~~~~~~~~~~~~lv~ 234 (394)
+|++++.||+|+||.||+|.+. ++.||||++.+.........+.+..|..++. .++||||+++++++.+++.+|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 7899999999999999999984 7889999986432111112245556666654 689999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 235 e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+++|+|.+++...+.+++.+++.++.||+.||+|||+++ |+||||||+|||+ +..+.+||+|||+++.......
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~--~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILL--DKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCTTC
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceee--cCCCceeccccchhhhcccccc
Confidence 99999999999999999999999999999999999999998 9999999999999 8889999999999986553322
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++.++|..+.++ ++ +.+|++++
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~p-~~~s~~~~ 231 (320)
T d1xjda_ 159 ----KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF-YP-RWLEKEAK 231 (320)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CC-TTSCHHHH
T ss_pred ----cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CC-ccCCHHHH
Confidence 234568999999999999999999999999999999999999999999999999999887543 33 34777765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-49 Score=360.78 Aligned_cols=230 Identities=30% Similarity=0.519 Sum_probs=186.0
Q ss_pred cCccccceeecCCceEEEEEEEC--Cc---cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GT---PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~---~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 231 (394)
.+|++.+.||+|+||.||+|.++ ++ .+|||.+.... .....+.+.+|+.++++++|||||++++++.+++.++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 36888999999999999999874 22 47888765432 3445578999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 232 LITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
+|||||++|+|.+++... +.+++.++..++.||++||.|||+++ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl--~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCC-------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEE--CCCCcEEECCcccceEcc
Confidence 999999999999988864 56999999999999999999999988 9999999999999 888999999999998776
Q ss_pred ccccccc-ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 016152 311 VQNSHDV-YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (394)
Q Consensus 311 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~ 388 (394)
....... .......||+.|||||.+.++.++.++|||||||++|||+| |++||.+.+..++...|.++.++..+. .+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~ 258 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM-DC 258 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT-TC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc-cc
Confidence 4432221 12233568999999999999999999999999999999998 999999999999999999998877664 47
Q ss_pred Ccccc
Q 016152 389 TPELR 393 (394)
Q Consensus 389 ~~~~~ 393 (394)
|++++
T Consensus 259 ~~~l~ 263 (299)
T d1jpaa_ 259 PSALH 263 (299)
T ss_dssp CHHHH
T ss_pred hHHHH
Confidence 77765
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=354.30 Aligned_cols=224 Identities=32% Similarity=0.596 Sum_probs=186.7
Q ss_pred CccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
+|++.+.||+|+||.||+|.+. ++.||||.+...... .+++.+|+.++++++||||+++++++.+++.+++||||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 6888999999999999999985 667999988654332 25788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 237 ~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
+++|+|.+++... ..+++..+..++.|+++||.|||+++ |+||||||+|||+ +.++.+||+|||+++........
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill--~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEE--CGGGCEEECSCC-----------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheee--cCCCCeEecccchheeccCCCce
Confidence 9999999998764 56899999999999999999999988 9999999999999 88889999999999876543221
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
......||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..++.+.|..+.++..+. .+|++++
T Consensus 158 ---~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~-~~~~~l~ 232 (263)
T d1sm2a_ 158 ---SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR-LASTHVY 232 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCT-TSCHHHH
T ss_pred ---eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCcc-ccCHHHH
Confidence 2234578999999999999999999999999999999999 688888889999999999998887774 4677664
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.6e-48 Score=350.50 Aligned_cols=229 Identities=26% Similarity=0.459 Sum_probs=197.8
Q ss_pred cCccccceeecCCceEEEEEEE--CCccEEEEEeccCCCCc------HHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeC
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDD------RLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER 227 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~--~g~~~avK~l~~~~~~~------~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~ 227 (394)
.+|++.+.||+|+||.||+|.+ .|+.+|||++.+..... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 3799999999999999999997 47899999987654322 223456789999999997 99999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
+.+|+||||+++|+|.++++.++.+++.+++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill--~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILL--DDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEE--cCCCCeEEccchhee
Confidence 999999999999999999999999999999999999999999999988 9999999999999 889999999999998
Q ss_pred ccccccccccccccCCccCccccCccccC------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFK------HRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
.+.... ......||+.|+|||.+. ...++.++||||+||++|||++|++||.+.+..+..+.|..+...
T Consensus 159 ~~~~~~-----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~ 233 (277)
T d1phka_ 159 QLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233 (277)
T ss_dssp ECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EccCCC-----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC
Confidence 765432 223467999999999984 345789999999999999999999999999999999999877543
Q ss_pred --CCCCCCCCccccC
Q 016152 382 --FFRAKGFTPELRE 394 (394)
Q Consensus 382 --~~~~~~~~~~~~~ 394 (394)
......+|++++|
T Consensus 234 ~~~~~~~~~s~~~~~ 248 (277)
T d1phka_ 234 FGSPEWDDYSDTVKD 248 (277)
T ss_dssp CCTTTGGGSCHHHHH
T ss_pred CCCcccccCCHHHHH
Confidence 2233467887764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=346.90 Aligned_cols=224 Identities=29% Similarity=0.548 Sum_probs=198.2
Q ss_pred CccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
+|++.+.||+|+||.||+|.++ ++.||||.+.+.... .+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 7889999999999999999986 558999998764433 25788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 237 ~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
+++|+|.+++.. ...+++..+..++.|+++||.|||++| |+||||||+|||+ +.++.+||+|||+++.+......
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill--~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLV--NDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEE--CTTCCEEECCCSSCCBCSSSSCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEE--cCCCcEEECcchhheeccCCCce
Confidence 999999999765 457999999999999999999999988 9999999999999 88899999999999876543221
Q ss_pred ccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..++..+|.++.++..+ +.+|++++
T Consensus 157 ---~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p-~~~~~~l~ 231 (258)
T d1k2pa_ 157 ---SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP-HLASEKVY 231 (258)
T ss_dssp ---CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC-TTCCHHHH
T ss_pred ---eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc-ccccHHHH
Confidence 2334679999999999999999999999999999999998 89999999999999999999888777 45777765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-49 Score=364.24 Aligned_cols=235 Identities=30% Similarity=0.475 Sum_probs=191.5
Q ss_pred CcccCCCCcCccccceeecCCceEEEEEEECC-------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeE
Q 016152 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220 (394)
Q Consensus 149 ~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g-------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~ 220 (394)
.|+++. .+|++++.||+|+||.||+|.+.+ ..||+|.+..... ......+.+|+.+++++ +|||||++
T Consensus 31 kwei~~--~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l 106 (325)
T d1rjba_ 31 KWEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNL 106 (325)
T ss_dssp GGBCCG--GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCH--HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence 466654 378899999999999999998743 2589998764432 22346788999999988 89999999
Q ss_pred EeEEEeCCeeEEEEeccCCCCHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 016152 221 LGAVTERKPLMLITEYLRGGDLHKYLKEK-----------------------GALSPSTAVNFALDIARGMAYLHNEPNV 277 (394)
Q Consensus 221 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-----------------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ 277 (394)
++++.+.+.+++|||||++|+|.++++.+ +.+++..++.++.|+++||.|||+++
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-- 184 (325)
T d1rjba_ 107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-- 184 (325)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 99999999999999999999999999754 24899999999999999999999988
Q ss_pred eEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHH
Q 016152 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEML 357 (394)
Q Consensus 278 ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~ 357 (394)
||||||||+|||+ +.++.+||+|||+|+........ .......||+.|||||++.++.++.++|||||||++|||+
T Consensus 185 IiHRDlKp~Nill--~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~eml 260 (325)
T d1rjba_ 185 CVHRDLAARNVLV--THGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260 (325)
T ss_dssp EEETTCSGGGEEE--ETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred eeeccCchhcccc--ccCCeEEEeeccccccccCCCce--eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHH
Confidence 9999999999999 88899999999999876544321 1223456899999999999999999999999999999999
Q ss_pred c-CCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCCccccC
Q 016152 358 E-GEPPLANYEPYEA-AKYVAEGHRPFFRAKGFTPELRE 394 (394)
Q Consensus 358 ~-g~~Pf~~~~~~~~-~~~i~~g~~p~~~~~~~~~~~~~ 394 (394)
| |++||.+.+..+. .+.+..+.+|..+ ..+|+++++
T Consensus 261 t~g~~Pf~~~~~~~~~~~~~~~~~~~~~p-~~~~~~l~~ 298 (325)
T d1rjba_ 261 SLGVNPYPGIPVDANFYKLIQNGFKMDQP-FYATEEIYI 298 (325)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHTTCCCCCC-TTCCHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHhcCCCCCCC-CcCCHHHHH
Confidence 8 9999988765444 4555667666665 347877753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=360.67 Aligned_cols=225 Identities=20% Similarity=0.344 Sum_probs=195.5
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++++.||+|+||.||+|.+. ++.||||.+.... .....+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 6999999999999999999975 7789999986542 223557899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||+||+|.+++...+ .+++.++..++.||+.||+|||++| |+||||||+|||+..+....+||+|||++.......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 999999999998665 7999999999999999999999988 999999999999955566689999999998764332
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCCccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA--KGFTPEL 392 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~--~~~~~~~ 392 (394)
......+|+.|+|||.+.+..|+.++|||||||++|+|++|++||...+..++...|.++....... +.+|+++
T Consensus 159 ----~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 159 ----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp ----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred ----cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 1234578999999999999999999999999999999999999999999999999999876543322 3567666
Q ss_pred c
Q 016152 393 R 393 (394)
Q Consensus 393 ~ 393 (394)
+
T Consensus 235 ~ 235 (321)
T d1tkia_ 235 M 235 (321)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=349.62 Aligned_cols=228 Identities=34% Similarity=0.572 Sum_probs=188.0
Q ss_pred CccccceeecCCceEEEEEEECC------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 231 (394)
.|+..++||+|+||.||+|.+++ ..||||.+.... .......+.+|+.++++++|||||++++++.+.+.++
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 57889999999999999998753 369999885433 3344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 232 LITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
+||||+.+++|.+++... +.+++.++..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl--~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCCCC-----
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEE--CCCCeEEEcccchhhccc
Confidence 999999999999988754 57999999999999999999999988 9999999999999 888999999999998765
Q ss_pred cccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGFT 389 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~ 389 (394)
..... ........||+.|+|||++.++.++.++|||||||++|||++ |.+||...+..++.+.+..|.+|..+. .+|
T Consensus 162 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~ 239 (283)
T d1mqba_ 162 DDPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM-DCP 239 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT-TCB
T ss_pred CCCcc-ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCch-hhH
Confidence 43221 112344568999999999999999999999999999999999 577778888999999999998887774 467
Q ss_pred cccc
Q 016152 390 PELR 393 (394)
Q Consensus 390 ~~~~ 393 (394)
++++
T Consensus 240 ~~l~ 243 (283)
T d1mqba_ 240 SAIY 243 (283)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7664
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-48 Score=364.95 Aligned_cols=226 Identities=30% Similarity=0.472 Sum_probs=185.6
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCC---cHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD---DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~---~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 231 (394)
.+|++.+.||+|+||.||+|.+. |+.||||++.+.... ..........|+.+++.++||||+++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 47999999999999999999985 789999998543211 1112223344577788889999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
+||||++||+|.+++.+++.+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+|..+..
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl--~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEE--cCCCcEEEeeeceeeecCC
Confidence 99999999999999999899999999999999999999999988 9999999999999 8889999999999987653
Q ss_pred ccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCCCCCCCCCC
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPY---EAAKYVAEGHRPFFRAKG 387 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~---~~~~~i~~g~~p~~~~~~ 387 (394)
.. .....||+.|+|||++.. ..|+.++|||||||++|||+||++||...+.. ++.+.+... ++.++ +.
T Consensus 160 ~~------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~-~~ 231 (364)
T d1omwa3 160 KK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVELP-DS 231 (364)
T ss_dssp SC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC-CCCCC-SS
T ss_pred Cc------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-CCCCC-CC
Confidence 32 234679999999999974 56899999999999999999999999875433 333333332 33333 35
Q ss_pred CCccccC
Q 016152 388 FTPELRE 394 (394)
Q Consensus 388 ~~~~~~~ 394 (394)
+|++++|
T Consensus 232 ~s~~~~~ 238 (364)
T d1omwa3 232 FSPELRS 238 (364)
T ss_dssp SCHHHHH
T ss_pred CCHHHHH
Confidence 7887753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-48 Score=348.58 Aligned_cols=232 Identities=29% Similarity=0.544 Sum_probs=187.5
Q ss_pred CcccCCCCcCccccceeecCCceEEEEEEEC-----CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeE
Q 016152 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223 (394)
Q Consensus 149 ~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~-----g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 223 (394)
+|+|+.. +|++.+.||+|+||.||+|.+. +..+|||.+... ......+.+.+|+.++++++||||++++++
T Consensus 1 ~~ei~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 76 (273)
T d1mp8a_ 1 DYEIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGV 76 (273)
T ss_dssp CCBCCGG--GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCcCHH--HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4777643 7899999999999999999874 235778876432 334456789999999999999999999998
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEee
Q 016152 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302 (394)
Q Consensus 224 ~~~~~~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~D 302 (394)
+. ++.+++||||+++|+|.+++.. .+.+++..++.++.||++||+|||+++ |+||||||+||++ +.++.+||+|
T Consensus 77 ~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll--~~~~~~Kl~D 151 (273)
T d1mp8a_ 77 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGD 151 (273)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECC
T ss_pred Ee-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheee--cCCCcEEEcc
Confidence 85 5678999999999999998765 457999999999999999999999988 9999999999999 7778999999
Q ss_pred cCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCC
Q 016152 303 FGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRP 381 (394)
Q Consensus 303 Fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p 381 (394)
||+++.+..... .......||+.|+|||.+.+..++.++|||||||++|||++ |.+||...+..++.++|..|.++
T Consensus 152 fG~a~~~~~~~~---~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~ 228 (273)
T d1mp8a_ 152 FGLSRYMEDSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228 (273)
T ss_dssp ----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred chhheeccCCcc---eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999987653322 12334568999999999999999999999999999999998 99999999999999999999888
Q ss_pred CCCCCCCCcccc
Q 016152 382 FFRAKGFTPELR 393 (394)
Q Consensus 382 ~~~~~~~~~~~~ 393 (394)
.++. .+|++++
T Consensus 229 ~~~~-~~~~~~~ 239 (273)
T d1mp8a_ 229 PMPP-NCPPTLY 239 (273)
T ss_dssp CCCT-TCCHHHH
T ss_pred CCCC-CCCHHHH
Confidence 7764 5788775
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=347.72 Aligned_cols=227 Identities=33% Similarity=0.610 Sum_probs=191.5
Q ss_pred CcccCCCCcCccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe-C
Q 016152 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-R 227 (394)
Q Consensus 149 ~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~ 227 (394)
.|+++.. +|++.+.||+|+||.||+|.++|+.||||.+.... ..+.+.+|+.++++++||||+++++++.+ .
T Consensus 1 ~w~i~~~--~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 1 GWALNMK--ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CCBCCGG--GEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CCccCHH--HeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 3666655 67889999999999999999999999999985432 22668899999999999999999998855 4
Q ss_pred CeeEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCC
Q 016152 228 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~ 305 (394)
+.+++||||+++|+|.+++.+++ .+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~--~~~~~~kl~dfg~ 149 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFGL 149 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTSCEEECCCCC
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhhee--cCCCCEeeccccc
Confidence 66899999999999999997543 5899999999999999999999988 9999999999999 8889999999999
Q ss_pred ccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCC
Q 016152 306 SKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFR 384 (394)
Q Consensus 306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~ 384 (394)
+...... .....+|+.|+|||++.+..+++++||||||+++|||+| |++||...+..++...|.++.+|.++
T Consensus 150 s~~~~~~-------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~ 222 (262)
T d1byga_ 150 TKEASST-------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 222 (262)
T ss_dssp -------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC
T ss_pred ceecCCC-------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9865432 223467899999999998999999999999999999998 89999999999999999999999988
Q ss_pred CCCCCccccC
Q 016152 385 AKGFTPELRE 394 (394)
Q Consensus 385 ~~~~~~~~~~ 394 (394)
. .+|+++++
T Consensus 223 ~-~~~~~~~~ 231 (262)
T d1byga_ 223 D-GCPPAVYE 231 (262)
T ss_dssp T-TCCHHHHH
T ss_pred c-cCCHHHHH
Confidence 5 47887753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=347.21 Aligned_cols=233 Identities=32% Similarity=0.529 Sum_probs=192.8
Q ss_pred CCCcccCCCCcCccccceeecCCceEEEEEEECC-ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 016152 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (394)
Q Consensus 147 ~~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g-~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 225 (394)
+.+|+|+.. +|++.+.||+|+||.||+|.+++ ..||||.+...... .+.+.+|+.++++++|||||++++++.
T Consensus 9 ~~~~~i~~~--~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~ 82 (285)
T d1fmka3 9 KDAWEIPRE--SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS 82 (285)
T ss_dssp TTCSBCCGG--GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CcceEcCHH--HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEe
Confidence 567888754 79999999999999999999864 57999998654332 267899999999999999999999885
Q ss_pred eCCeeEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 226 ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 226 ~~~~~~lv~e~~~~~sL~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
++.+++||||+++|+|..++.. .+.+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++++||+||
T Consensus 83 -~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll--~~~~~~kl~Df 157 (285)
T d1fmka3 83 -EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADF 157 (285)
T ss_dssp -SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECCC
T ss_pred -cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEE--CCCCcEEEccc
Confidence 4568999999999999988754 457999999999999999999999988 9999999999999 78889999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCC
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPF 382 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~ 382 (394)
|+++.+..... .......||+.|+|||++..+.++.++|||||||++|||++ |++||...+..++...+.++.++.
T Consensus 158 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~ 234 (285)
T d1fmka3 158 GLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 234 (285)
T ss_dssp CTTC-----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred chhhhccCCCc---eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99987653321 12334678999999999999999999999999999999999 567778888889999999988877
Q ss_pred CCCCCCCccccC
Q 016152 383 FRAKGFTPELRE 394 (394)
Q Consensus 383 ~~~~~~~~~~~~ 394 (394)
.+. .+|+++++
T Consensus 235 ~~~-~~~~~l~~ 245 (285)
T d1fmka3 235 CPP-ECPESLHD 245 (285)
T ss_dssp CCT-TSCHHHHH
T ss_pred CCc-ccCHHHHH
Confidence 664 47887753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-46 Score=346.49 Aligned_cols=229 Identities=30% Similarity=0.482 Sum_probs=197.1
Q ss_pred CcCccccceeecCCceEEEEEEECC-------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~g-------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 228 (394)
..+|++.+.||+|+||.||+|.+.+ +.||||.+.... .....+++.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 3479999999999999999998754 579999875433 3444578999999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 016152 229 PLMLITEYLRGGDLHKYLKEKG------------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK 284 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~------------------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dik 284 (394)
.++++||++++|+|.+++.... .+++.+++.++.|++.||+|||+++ |||||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlK 167 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLA 167 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEc
Confidence 9999999999999999996532 3889999999999999999999988 9999999
Q ss_pred CCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcC-CCCC
Q 016152 285 PRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EPPL 363 (394)
Q Consensus 285 p~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g-~~Pf 363 (394)
|+|||+ +.++.+||+|||+|+........ .......+|+.|+|||.+.+..|+.++|||||||++|||++| .+||
T Consensus 168 p~NILl--d~~~~~Kl~DFGls~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 168 TRNCLV--GENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp GGGEEE--CGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ccceEE--CCCCcEEEccchhheeccCCccc--cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999 88889999999999866543321 123456789999999999999999999999999999999998 5789
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 364 ANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 364 ~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.+.+..++...+.++.+|..+. .+|++++
T Consensus 244 ~~~~~~e~~~~v~~~~~~~~p~-~~~~~~~ 272 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGNILACPE-NCPLELY 272 (301)
T ss_dssp TTSCHHHHHHHHHTTCCCCCCT-TCCHHHH
T ss_pred CCCCHHHHHHHHHcCCCCCCCc-cchHHHH
Confidence 9999999999999999988774 4787764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=344.66 Aligned_cols=230 Identities=29% Similarity=0.531 Sum_probs=183.6
Q ss_pred cCccccceeecCCceEEEEEEECC-----ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~g-----~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 231 (394)
.+|++.+.||+|+||.||+|.+.+ ..||||.+.+.........+.+.+|+.++++++||||+++++++.+ +.++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 479999999999999999998642 2689998876655555666789999999999999999999999965 5679
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccc
Q 016152 232 LITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~ 310 (394)
+||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll--~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLL--ATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--EETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhcc--ccccceeeccchhhhhcc
Confidence 99999999999988765 456999999999999999999999988 9999999999999 677899999999999775
Q ss_pred cccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHc-CCCCCCCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAE-GHRPFFRAKGF 388 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~-g~~p~~~~~~~ 388 (394)
..... ........+|+.|+|||.+.+..++.++|||||||++|||+| |++||.+.+..++...|.+ +.+|..+ +.+
T Consensus 163 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~ 240 (273)
T d1u46a_ 163 QNDDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP-EDC 240 (273)
T ss_dssp C-CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC-TTC
T ss_pred cCCCc-ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCc-ccc
Confidence 44322 122334567889999999999999999999999999999998 8999999999999988875 4455444 567
Q ss_pred Ccccc
Q 016152 389 TPELR 393 (394)
Q Consensus 389 ~~~~~ 393 (394)
|++++
T Consensus 241 ~~~l~ 245 (273)
T d1u46a_ 241 PQDIY 245 (273)
T ss_dssp CHHHH
T ss_pred cHHHH
Confidence 88775
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=348.87 Aligned_cols=227 Identities=29% Similarity=0.566 Sum_probs=188.5
Q ss_pred cCccccceeecCCceEEEEEEEC--Cc----cEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCee
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL 230 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~----~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 230 (394)
.+|++++.||+|+||.||+|.+. |+ .||+|.+..... ....+.+.+|+.++++++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 47999999999999999999874 33 588887754322 22346789999999999999999999998764 56
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 231 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 231 ~lv~e~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
++++|++.+++|.+++..+ ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll--~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV--KTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--EETTEEEECCCSHHHHT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhccee--CCCCCeEeeccccceec
Confidence 7889999999999888764 57999999999999999999999988 9999999999999 77889999999999876
Q ss_pred ccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GEPPLANYEPYEAAKYVAEGHRPFFRAKGF 388 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~ 388 (394)
...... .......||+.|+|||++.++.|+.++|||||||++|||+| |.+||.+.+..++...+.+|.+|..+. .+
T Consensus 162 ~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~-~~ 238 (317)
T d1xkka_ 162 GAEEKE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP-IC 238 (317)
T ss_dssp TTTCC----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCT-TB
T ss_pred cccccc--ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc-cc
Confidence 543321 12334568999999999999999999999999999999998 899999999999999999999887764 47
Q ss_pred Ccccc
Q 016152 389 TPELR 393 (394)
Q Consensus 389 ~~~~~ 393 (394)
|++++
T Consensus 239 ~~~~~ 243 (317)
T d1xkka_ 239 TIDVY 243 (317)
T ss_dssp CHHHH
T ss_pred CHHHH
Confidence 77765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=342.47 Aligned_cols=236 Identities=34% Similarity=0.559 Sum_probs=197.4
Q ss_pred CCCcccCCCCcCccccceeecCCceEEEEEEECC---------ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCc
Q 016152 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPN 216 (394)
Q Consensus 147 ~~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~g---------~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 216 (394)
-+.|+|+.. +|++.+.||+|+||.||+|...+ ..||||.+.+.. ......++.+|...+.++ +|||
T Consensus 5 ~~~~~i~~~--~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 5 DPRWELPRD--RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp CTTTBCCGG--GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCcCcccHH--HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCe
Confidence 345776544 88999999999999999998632 368999886543 234456788888888887 7999
Q ss_pred eeeEEeEEEeCCeeEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEe
Q 016152 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIH 280 (394)
Q Consensus 217 Iv~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH 280 (394)
||++++++.+++.+++||||+++|+|.+++..+ ..+++.+++.++.|++.||+|||+++ |||
T Consensus 81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivH 158 (299)
T d1fgka_ 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIH 158 (299)
T ss_dssp BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEe
Confidence 999999999999999999999999999999754 34899999999999999999999988 999
Q ss_pred cCCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-C
Q 016152 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-G 359 (394)
Q Consensus 281 ~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g 359 (394)
|||||+|||+ +.++.+||+|||++.......... ......+|+.|+|||.+.++.|++++|||||||++|||++ |
T Consensus 159 rDiKp~NiLl--~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g 234 (299)
T d1fgka_ 159 RDLAARNVLV--TEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234 (299)
T ss_dssp SCCSGGGEEE--CTTCCEEECSTTCCCCGGGCCTTC--CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred eeecccceee--cCCCCeEeccchhhcccccccccc--ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCC
Confidence 9999999999 888999999999998776443221 2345678999999999999999999999999999999998 8
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 360 EPPLANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 360 ~~Pf~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
.+||.+.+..++.+.+..|.+|.++. .+|++++
T Consensus 235 ~~p~~~~~~~~~~~~i~~~~~~~~p~-~~~~~l~ 267 (299)
T d1fgka_ 235 GSPYPGVPVEELFKLLKEGHRMDKPS-NCTNELY 267 (299)
T ss_dssp CCSSTTCCHHHHHHHHHTTCCCCCCS-SCCHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCc-cchHHHH
Confidence 99999999999999999999998875 4787775
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=342.88 Aligned_cols=209 Identities=30% Similarity=0.435 Sum_probs=177.0
Q ss_pred ccceeecCCceEEEEEEEC--CccEEEEEeccCCCCc--HHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 161 SSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD--RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 161 ~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
.+++||+|+||.||+|.++ |+.||||++....... ....+.+.+|+.++++++|||||++++++.+++.+++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3568999999999999874 7889999886543221 11234678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccc
Q 016152 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316 (394)
Q Consensus 237 ~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~ 316 (394)
+.++++..+...+..+++.++..++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli--~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLL--DENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECCCGGGSTTTSCCC--
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEe--cCCCccccccCccccccCCCcc--
Confidence 998877777766778999999999999999999999988 9999999999999 8889999999999986654322
Q ss_pred cccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 317 VYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 317 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
.....+||+.|+|||++.. ..|+.++|||||||++|||++|++||.+.+..+.+.+|.+
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~ 215 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 215 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHH
Confidence 2345679999999999865 4679999999999999999999999999999888888764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=348.49 Aligned_cols=200 Identities=31% Similarity=0.539 Sum_probs=169.1
Q ss_pred Ccccc-ceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHh-CCCCceeeEEeEEEe----CCe
Q 016152 158 DFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTE----RKP 229 (394)
Q Consensus 158 ~~~~~-~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~----~~~ 229 (394)
+|.+. +.||+|+||.||+|.+. ++.||||++... ..+.+|+.++.+ .+||||++++++|.+ ...
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 78876 46999999999999974 789999988532 456679988655 589999999999875 456
Q ss_pred eEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCc
Q 016152 230 LMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLS 306 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a 306 (394)
+|+|||||+||+|.+++.++ ..+++.+++.++.||+.||+|||++| |+||||||+|||+... ..+.+||+|||+|
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccccccccccee
Confidence 89999999999999999875 36999999999999999999999988 9999999999999432 3567999999999
Q ss_pred cccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAA 372 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~ 372 (394)
+...... ......||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+..+..
T Consensus 162 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~ 222 (335)
T d2ozaa1 162 KETTSHN-----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 222 (335)
T ss_dssp EECCCCC-----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---
T ss_pred eeccCCC-----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH
Confidence 8765433 234567999999999999999999999999999999999999999776544443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=337.11 Aligned_cols=235 Identities=29% Similarity=0.459 Sum_probs=202.3
Q ss_pred CCcccCCCCcCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeE
Q 016152 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220 (394)
Q Consensus 148 ~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 220 (394)
..|+|+.. +|++.+.||+|+||.||+|.+. ++.||||.+.... .......+.+|+.++++++||||+++
T Consensus 13 ~~~ei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~ 88 (308)
T d1p4oa_ 13 DEWEVARE--KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRL 88 (308)
T ss_dssp CTTBCCGG--GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred cceeecHH--HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeee
Confidence 36888754 7889999999999999999874 4679999886432 34445678999999999999999999
Q ss_pred EeEEEeCCeeEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEE
Q 016152 221 LGAVTERKPLMLITEYLRGGDLHKYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 290 (394)
Q Consensus 221 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv 290 (394)
++++..++..++||||+++|+|.+++... ..++...+..++.|+++||.|||+++ |+||||||+|||+
T Consensus 89 ~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV 166 (308)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEE
T ss_pred eeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceee
Confidence 99999999999999999999999998642 24688999999999999999999988 9999999999999
Q ss_pred eeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcC-CCCCCCCCHH
Q 016152 291 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EPPLANYEPY 369 (394)
Q Consensus 291 ~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g-~~Pf~~~~~~ 369 (394)
+.++++||+|||+++.+..... ........||+.|+|||.+.+..++.++||||||+++|||+|| .+||.+.+..
T Consensus 167 --d~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~ 242 (308)
T d1p4oa_ 167 --AEDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242 (308)
T ss_dssp --CTTCCEEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred --cCCceEEEeecccceeccCCcc--eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH
Confidence 8889999999999987654432 1223445789999999999999999999999999999999997 6999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCcccc
Q 016152 370 EAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 370 ~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
++...|.++.+|..+. .+|++++
T Consensus 243 ~~~~~i~~~~~~~~p~-~~~~~l~ 265 (308)
T d1p4oa_ 243 QVLRFVMEGGLLDKPD-NCPDMLF 265 (308)
T ss_dssp HHHHHHHTTCCCCCCT-TCCHHHH
T ss_pred HHHHHHHhCCCCCCcc-cchHHHH
Confidence 9999999999888774 4777664
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=341.04 Aligned_cols=225 Identities=35% Similarity=0.515 Sum_probs=190.0
Q ss_pred cCccccceeecCCceEEEEEEEC--Cc--cEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEeCCeeE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM 231 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~--~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~ 231 (394)
.+|++.+.||+|+||.||+|.++ |. .||||.+..... ....+.+.+|+.+++++ +||||+++++++.+.+.++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 37888999999999999999875 33 467777643322 22346789999999998 6999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCC
Q 016152 232 LITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 295 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~ 295 (394)
+||||+++|+|.+++..+ ..+++.++..++.||+.||.|||+++ |+||||||+|||+ +.+
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~--~~~ 163 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GEN 163 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEE--cCC
Confidence 999999999999999753 56899999999999999999999988 9999999999999 888
Q ss_pred CcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcC-CCCCCCCCHHHHHHH
Q 016152 296 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EPPLANYEPYEAAKY 374 (394)
Q Consensus 296 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g-~~Pf~~~~~~~~~~~ 374 (394)
+.+||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..++.+.
T Consensus 164 ~~~kl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~ 238 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238 (309)
T ss_dssp GCEEECCTTCEESSCEECC-----C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CceEEcccccccccccccc-----ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 8999999999976543321 2345689999999999999999999999999999999995 578999999999999
Q ss_pred HHcCCCCCCCCCCCCcccc
Q 016152 375 VAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 375 i~~g~~p~~~~~~~~~~~~ 393 (394)
|.+|.+|..+. .+|++++
T Consensus 239 i~~~~~~~~~~-~~~~~~~ 256 (309)
T d1fvra_ 239 LPQGYRLEKPL-NCDDEVY 256 (309)
T ss_dssp GGGTCCCCCCT-TBCHHHH
T ss_pred HHhcCCCCCCc-cCCHHHH
Confidence 99999988874 4787775
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=338.93 Aligned_cols=234 Identities=30% Similarity=0.508 Sum_probs=182.9
Q ss_pred CcccCCCCcCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceeeE
Q 016152 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220 (394)
Q Consensus 149 ~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~ 220 (394)
.|+++. .+|++.+.||+|+||.||+|.+. ++.||||.+.... .....+.+.+|..++.++ +|+||+.+
T Consensus 7 ~wei~~--~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 7 KWEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHBCCG--GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccH--HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 466553 47999999999999999999864 2469999875433 233346677777777766 68999999
Q ss_pred EeEEEeC-CeeEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 016152 221 LGAVTER-KPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 283 (394)
Q Consensus 221 ~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Di 283 (394)
++++... ..+++|||||++|+|.+++..+ ..+++.++..++.|+++||.|||+++ |+||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDl 160 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 160 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcC
Confidence 9987654 5689999999999999999753 24889999999999999999999988 999999
Q ss_pred CCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcC-CCC
Q 016152 284 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEG-EPP 362 (394)
Q Consensus 284 kp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g-~~P 362 (394)
||+|||+ +.++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||+|| .+|
T Consensus 161 Kp~NILl--~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p 236 (299)
T d1ywna1 161 AARNILL--SEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236 (299)
T ss_dssp CGGGEEE--CGGGCEEECC------CCSCTT--SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CccceeE--CCCCcEEEccCcchhhcccccc--ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCC
Confidence 9999999 8888999999999986653322 1123456799999999999999999999999999999999985 678
Q ss_pred CCCCC-HHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 363 LANYE-PYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 363 f~~~~-~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
|.+.+ ..+....+.+|.+|..+. .+|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 267 (299)
T d1ywna1 237 YPGVKIDEEFCRRLKEGTRMRAPD-YTTPEMY 267 (299)
T ss_dssp STTCCCSHHHHHHHHHTCCCCCCT-TCCHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCc-cCCHHHH
Confidence 97765 445567778888888774 4777765
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-46 Score=335.27 Aligned_cols=220 Identities=28% Similarity=0.462 Sum_probs=179.9
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcH---HHHHHHHHHHHHHHhCC--CCceeeEEeEEEeCC
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLR--HPNIVQFLGAVTERK 228 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~~ 228 (394)
..+|++++.||+|+||.||+|.+. |+.||||.+.+...... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 347999999999999999999985 78999999865432211 11133567999999986 899999999999999
Q ss_pred eeEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeC-CCCcEEEeecCCc
Q 016152 229 PLMLITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLS 306 (394)
Q Consensus 229 ~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~-~~~~~kl~DFg~a 306 (394)
.+++|||++.+ +++.+++..++.+++.+++.++.||+.||+|||+++ |+||||||+|||+ + ..+.+||+|||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll--~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILI--DLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--ETTTTEEEECCCTTC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEE--ecCCCeEEECccccc
Confidence 99999999976 688899988889999999999999999999999988 9999999999999 5 3468999999999
Q ss_pred cccccccccccccccCCccCccccCccccCCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKY-DKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAEGHRPFFRA 385 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~g~~p~~~~ 385 (394)
...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+ .+.++... ++
T Consensus 159 ~~~~~~------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~-~~- 224 (273)
T d1xwsa_ 159 ALLKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF-FR- 224 (273)
T ss_dssp EECCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCC-CS-
T ss_pred eecccc------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccC-CC-
Confidence 765432 2345689999999999987665 678999999999999999999997632 34444332 22
Q ss_pred CCCCcccc
Q 016152 386 KGFTPELR 393 (394)
Q Consensus 386 ~~~~~~~~ 393 (394)
..+|++++
T Consensus 225 ~~~s~~~~ 232 (273)
T d1xwsa_ 225 QRVSSECQ 232 (273)
T ss_dssp SCCCHHHH
T ss_pred CCCCHHHH
Confidence 34677665
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=335.93 Aligned_cols=235 Identities=32% Similarity=0.501 Sum_probs=196.8
Q ss_pred CCcccCCCCcCccccceeecCCceEEEEEEEC-------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCceee
Q 016152 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQ 219 (394)
Q Consensus 148 ~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~-------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~ 219 (394)
..|+++.. +|++++.||+|+||.||+|.+. ++.||||.+.... .......+.+|+.+++.+ +|||||+
T Consensus 16 ~~~~~~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~ 91 (311)
T d1t46a_ 16 HKWEFPRN--RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVN 91 (311)
T ss_dssp GGGBCCGG--GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccCCHH--HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEE
Confidence 36777654 7888999999999999999863 3479999986543 234456788999999998 6999999
Q ss_pred EEeEEEeCCeeEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCeEec
Q 016152 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281 (394)
Q Consensus 220 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~------------------~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~ 281 (394)
+++++.+...+++|||||++|+|.+++.+.. .+++..+..++.||++||+|||+++ ++||
T Consensus 92 ~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHr 169 (311)
T d1t46a_ 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHR 169 (311)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred EEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 9999999999999999999999999997543 5899999999999999999999988 9999
Q ss_pred CCCCCCEEEeeCCCCcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHc-CC
Q 016152 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLE-GE 360 (394)
Q Consensus 282 Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~ 360 (394)
||||+||++ +..+.+||+|||+++....... ........||+.|+|||.+.+..++.++|||||||++|||+| |.
T Consensus 170 DLKp~NIl~--~~~~~~ki~DfG~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~ 245 (311)
T d1t46a_ 170 DLAARNILL--THGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245 (311)
T ss_dssp CCSGGGEEE--ETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ccccccccc--cccCcccccccchheeccCCCc--ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCC
Confidence 999999999 7888999999999987654332 123345679999999999999999999999999999999998 78
Q ss_pred CCCCCCCHHHH-HHHHHcCCCCCCCCCCCCcccc
Q 016152 361 PPLANYEPYEA-AKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 361 ~Pf~~~~~~~~-~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
+||...+..+. .+.+.++.+|..+. .+|++++
T Consensus 246 p~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~l~ 278 (311)
T d1t46a_ 246 SPYPGMPVDSKFYKMIKEGFRMLSPE-HAPAEMY 278 (311)
T ss_dssp CSSTTCCSSHHHHHHHHHTCCCCCCT-TSCHHHH
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCCcc-cccHHHH
Confidence 88877766544 45666788777664 4677765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=333.24 Aligned_cols=225 Identities=25% Similarity=0.489 Sum_probs=185.7
Q ss_pred cceeecCCceEEEEEEECC-----ccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe-CCeeEEEEe
Q 016152 162 SAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKPLMLITE 235 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~~g-----~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~lv~e 235 (394)
.++||+|+||.||+|.+.. ..||||.+.. .......+++.+|+.++++++||||+++++++.. +...++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECC--CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc--ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 5789999999999998742 2589998853 2345556889999999999999999999998765 568999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccc
Q 016152 236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314 (394)
Q Consensus 236 ~~~~~sL~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~ 314 (394)
||++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl--~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTCCEEECSSGGGCCTTTTTC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeE--CCCCCEEEecccchhhcccccc
Confidence 99999999998854 45788899999999999999999988 9999999999999 8889999999999987765543
Q ss_pred cccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCCcccc
Q 016152 315 HDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVAEGHRPFFRAKGFTPELR 393 (394)
Q Consensus 315 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf-~~~~~~~~~~~i~~g~~p~~~~~~~~~~~~ 393 (394)
..........||+.|+|||.+....++.++||||||+++|||+||..|| ...+..++...+..|.+|..+. .+|++++
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~-~~~~~l~ 264 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE-YCPDPLY 264 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCT-TCCHHHH
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcc-cCcHHHH
Confidence 3333344567899999999999999999999999999999999965555 5566778888899999988774 4677765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=330.24 Aligned_cols=209 Identities=29% Similarity=0.511 Sum_probs=176.3
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++++.||+|+||.||+|.+. |+.||||++...... ....+.+.+|+.++++++||||+++++++.+...+++|||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 7999999999999999999985 889999998654322 2224678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccc
Q 016152 236 YLRGGDLHKYLK-E-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313 (394)
Q Consensus 236 ~~~~~sL~~~~~-~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~ 313 (394)
|+.+ ++.+++. . .+.+++..++.++.|++.||+|||++| ||||||||+|||+ +.++.+||+|||+|.......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~--~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheee--cccCcceeccCCcceeccCCc
Confidence 9976 5554543 2 456999999999999999999999988 9999999999999 888899999999998665332
Q ss_pred ccccccccCCccCccccCccccCCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 314 SHDVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 314 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
. ......||+.|+|||.+.... ++.++|+|||||++|+|++|+.||.+.+..+....+.
T Consensus 157 ~----~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~ 216 (298)
T d1gz8a_ 157 R----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216 (298)
T ss_dssp B----CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred c----cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHH
Confidence 2 234567999999999987665 5799999999999999999999999988877776654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3e-44 Score=327.88 Aligned_cols=210 Identities=30% Similarity=0.500 Sum_probs=179.5
Q ss_pred CccccceeecCCceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEec
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 236 (394)
+|++.+.||+|+||.||+|.++ |+.||||++...... ....+.+.+|+.++++++||||+++++++.+++..+++||+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 7999999999999999999875 789999998654332 22236788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccccccccccc
Q 016152 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316 (394)
Q Consensus 237 ~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~~ 316 (394)
+.++.+..+...++.+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll--~~~~~~kl~DfG~a~~~~~~~~-- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLI--NREGELKIADFGLARAFGIPVR-- 155 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeE--cCCCCEEecccccceecccCcc--
Confidence 988777777666788999999999999999999999988 9999999999999 8889999999999987654322
Q ss_pred cccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 317 VYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 317 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
......+++.|+|||.+.+. .++.++|||||||++|||++|++||.+.+..+...++.
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~ 214 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 23345689999999998754 56999999999999999999999999998888777764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-44 Score=329.29 Aligned_cols=212 Identities=27% Similarity=0.474 Sum_probs=174.4
Q ss_pred CcCccccceeecCCceEEEEEEEC---CccEEEEEeccCCCCcHHHHHHHHHHHHHHHh---CCCCceeeEEeEEEe---
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK---LRHPNIVQFLGAVTE--- 226 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~---g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~---l~h~~Iv~~~~~~~~--- 226 (394)
..+|++++.||+|+||.||+|.+. ++.||||.+......... ...+.+|+.+++. .+||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-HHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 458999999999999999999874 456899998654322111 1234456666655 489999999998853
Q ss_pred --CCeeEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 227 --RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 227 --~~~~~lv~e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
...++++||++.++++...... ...+++..++.++.|++.||+|||+++ |+||||||+|||+ +..+.+||+||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi--~~~~~~kl~df 160 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILV--TSSGQIKLADF 160 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECSC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEE--cCCCCeeecch
Confidence 3468999999988766554443 456999999999999999999999988 9999999999999 88899999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
|++....... ......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....|.+
T Consensus 161 g~~~~~~~~~-----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 229 (305)
T d1blxa_ 161 GLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229 (305)
T ss_dssp CSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred hhhhhhcccc-----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9987654332 23467899999999999999999999999999999999999999999998888877753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.9e-43 Score=322.08 Aligned_cols=212 Identities=22% Similarity=0.296 Sum_probs=176.7
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC-CceeeEEeEEEeCCeeEEE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKPLMLI 233 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~~~~~~lv 233 (394)
.+|++.+.||+|+||.||+|.+. |+.||||++...... ..+.+|++.++.++| +|++.+++++......++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 37999999999999999999975 788999987554332 345678889999875 8999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee---CCCCcEEEeecCCcccc
Q 016152 234 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSKLI 309 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~---~~~~~~kl~DFg~a~~~ 309 (394)
||++ +++|.+++...+ .++..++..++.|++.||+|||++| |+||||||+|||+.. ...+.+||+|||+|+.+
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9998 679999987654 6999999999999999999999988 999999999999943 13568999999999887
Q ss_pred cccccccc---ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHH
Q 016152 310 KVQNSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANY---EPYEAAKYVA 376 (394)
Q Consensus 310 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~---~~~~~~~~i~ 376 (394)
........ .......||+.|||||++.+..+++++|||||||++|||++|+.||.+. +..+..+++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~ 229 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence 64432211 1234567999999999999999999999999999999999999999754 3444455544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=326.33 Aligned_cols=216 Identities=23% Similarity=0.398 Sum_probs=177.5
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe--------
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-------- 226 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-------- 226 (394)
.+|++++.||+|+||.||+|.+. |+.||||++....... .....+.+|+.+++.++||||+++++.+..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 38999999999999999999974 7899999886554332 223567889999999999999999998755
Q ss_pred CCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCc
Q 016152 227 RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306 (394)
Q Consensus 227 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a 306 (394)
...+++|||++.++.+..+......+++..++.++.|++.||.|||++| |+||||||+|||+ +.++.+||+|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl--~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLI--TRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheee--cCCCcEEeeeccee
Confidence 3458999999988766655555678999999999999999999999988 9999999999999 88899999999999
Q ss_pred cccccccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 307 KLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
..+..............+||+.|+|||++.+. .+++++|||||||++|||++|++||.+.+..+....+.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 87654433222234456799999999998765 689999999999999999999999999888887777653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=332.25 Aligned_cols=228 Identities=25% Similarity=0.420 Sum_probs=185.6
Q ss_pred cCccccceeecCCceEEEEEEE-----CCccEEEEEeccCCCC-cHHHHHHHHHHHHHHHhCCC-CceeeEEeEEEeCCe
Q 016152 157 LDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKP 229 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~-----~g~~~avK~l~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~~~~ 229 (394)
.+|++++.||+|+||.||+|.. +|+.||||.+.+.... .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 3799999999999999999986 3678999988653211 11123557789999999976 899999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccc
Q 016152 230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309 (394)
Q Consensus 230 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~ 309 (394)
++++|||+.+|+|.+++...+.+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++..+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill--~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceee--cCCCCEEEeeccchhhh
Confidence 9999999999999999999989999999999999999999999988 9999999999999 88899999999999876
Q ss_pred ccccccccccccCCccCccccCccccCCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHcCCCCCC
Q 016152 310 KVQNSHDVYKMTGETGSYRYMAPEVFKHR--KYDKKVDVFSFAMILYEMLEGEPPLANYEPYE----AAKYVAEGHRPFF 383 (394)
Q Consensus 310 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~----~~~~i~~g~~p~~ 383 (394)
...... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+ +.+....+.+ .+
T Consensus 180 ~~~~~~---~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~-~~ 255 (322)
T d1vzoa_ 180 VADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-PY 255 (322)
T ss_dssp CGGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC-CC
T ss_pred cccccc---cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC-CC
Confidence 543321 23456799999999999754 46889999999999999999999997765333 3333334433 33
Q ss_pred CCCCCCcccc
Q 016152 384 RAKGFTPELR 393 (394)
Q Consensus 384 ~~~~~~~~~~ 393 (394)
+ +.+|++++
T Consensus 256 ~-~~~s~~~~ 264 (322)
T d1vzoa_ 256 P-QEMSALAK 264 (322)
T ss_dssp C-TTSCHHHH
T ss_pred c-ccCCHHHH
Confidence 3 24777765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=322.45 Aligned_cols=200 Identities=30% Similarity=0.459 Sum_probs=163.0
Q ss_pred CccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC----eeEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PLMLI 233 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----~~~lv 233 (394)
+|...+.||+|+||.||+|.++|+.||||.+.... ........|+..+..++||||+++++++.+.+ .+|+|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 57788899999999999999999999999885321 11122234555556789999999999987654 58999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC------CCCeEecCCCCCCEEEeeCCCCcEEEeecCCcc
Q 016152 234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307 (394)
Q Consensus 234 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~------~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~ 307 (394)
|||+++|+|.+++++. .+++.++..++.|++.||.|+|+. .++|+||||||+|||+ +.++.+||+|||++.
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl--~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE--CTTSCEEECCCTTCE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE--cCCCCeEEEecCccc
Confidence 9999999999999865 589999999999999999999973 1239999999999999 888999999999999
Q ss_pred ccccccccccccccCCccCccccCccccCCC------CCCCcchHHHHHHHHHHHHcCCCCCC
Q 016152 308 LIKVQNSHDVYKMTGETGSYRYMAPEVFKHR------KYDKKVDVFSFAMILYEMLEGEPPLA 364 (394)
Q Consensus 308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGv~l~el~~g~~Pf~ 364 (394)
.................||+.|+|||++.+. .++.++|||||||++|||+||.+||.
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 8765543333334557899999999998754 25778999999999999999988774
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=322.02 Aligned_cols=211 Identities=31% Similarity=0.515 Sum_probs=174.5
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC----eeE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PLM 231 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----~~~ 231 (394)
+|++++.||+|+||.||+|.+. |+.||||++.+.. .....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 6999999999999999999875 8899999986433 3445577889999999999999999999987653 234
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~ 311 (394)
++++++.+|+|.+++..+ .+++..++.++.|++.||+|||++| ||||||||+|||+ +..+.+||+|||++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl--~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL--NTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEE--CCCCCEEEcccCceeeccC
Confidence 555667789999999754 6999999999999999999999988 9999999999999 8889999999999987654
Q ss_pred ccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 312 QNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 312 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
..... ......+||+.|+|||++.. ..++.++||||+||++|||++|++||...+..+....+.
T Consensus 162 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~ 226 (345)
T d1pmea_ 162 DHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226 (345)
T ss_dssp GGCBC-CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCccc-eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHh
Confidence 43222 22455779999999999854 567899999999999999999999999888766665543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=323.93 Aligned_cols=205 Identities=29% Similarity=0.406 Sum_probs=171.0
Q ss_pred CcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeC------
Q 016152 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------ 227 (394)
Q Consensus 156 ~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------ 227 (394)
..+|+.+++||+|+||.||+|.+. |+.||||++...... ..+|+.++++++||||++++++|...
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 447999999999999999999984 788999998654322 23699999999999999999998543
Q ss_pred CeeEEEEeccCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCC-CcEEEeec
Q 016152 228 KPLMLITEYLRGGDLHKY---LKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDF 303 (394)
Q Consensus 228 ~~~~lv~e~~~~~sL~~~---~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~-~~~kl~DF 303 (394)
..+++||||+.++.+..+ ......+++.+++.++.||+.||+|||++| |+||||||+|||+ +.+ ..+||+||
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl--~~~~~~~kl~DF 167 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLL--DPDTAVLKLCDF 167 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CTTTCCEEECCC
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEE--ecCCCceeEecc
Confidence 347999999976533332 234567999999999999999999999988 9999999999999 655 48999999
Q ss_pred CCccccccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
|++....... ......||+.|+|||.+.+ ..++.++|||||||++|||++|++||...+..+.+..|.
T Consensus 168 G~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~ 236 (350)
T d1q5ka_ 168 GSAKQLVRGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236 (350)
T ss_dssp TTCEECCTTS-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred cchhhccCCc-----ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHH
Confidence 9998765332 2345689999999998765 578999999999999999999999999988877776664
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-42 Score=313.58 Aligned_cols=206 Identities=23% Similarity=0.288 Sum_probs=168.2
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCc-eeeEEeEEEeCCeeEEEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERKPLMLIT 234 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~~~~lv~ 234 (394)
+|++.+.||+|+||.||+|.+. |+.||||++...... ..+..|+.+++.++|++ |+.+..++.+.+..++||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 6999999999999999999975 789999987654433 34678999999998766 555566678888899999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEee-CCCCcEEEeecCCccccccc
Q 016152 235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQ 312 (394)
Q Consensus 235 e~~~~~sL~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~-~~~~~~kl~DFg~a~~~~~~ 312 (394)
||+ +++|.+.+.. .+.+++.++..++.|++.||+|||++| |+||||||+|||+.. +.+..+||+|||+|+.+...
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 999 5577766654 567999999999999999999999988 999999999999832 34567999999999987654
Q ss_pred ccccc---ccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 016152 313 NSHDV---YKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEA 371 (394)
Q Consensus 313 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~ 371 (394)
..... .......||+.|+|||++.+..+++++|||||||++|||++|+.||...+..+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~ 221 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH
Confidence 32211 123456799999999999999999999999999999999999999987654433
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-42 Score=319.53 Aligned_cols=206 Identities=29% Similarity=0.511 Sum_probs=172.5
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCC------
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------ 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------ 228 (394)
.+|++++.||+|+||.||+|.+. |+.||||++..... .....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 47999999999999999999975 88999999865443 3445577889999999999999999999997655
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.+++||||+ +.+|..+++ ++.+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~--~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAV--NEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhc--ccccccccccccceec
Confidence 479999999 667877765 457999999999999999999999988 9999999999999 8899999999999976
Q ss_pred cccccccccccccCCccCccccCccccCC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKH-RKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
.... .....||+.|+|||.+.+ ..++.++||||+||++|+|++|++||.+.+..+....+.
T Consensus 171 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~ 232 (346)
T d1cm8a_ 171 ADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232 (346)
T ss_dssp CCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCc-------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHH
Confidence 5422 245679999999999876 456899999999999999999999999988777766554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=309.14 Aligned_cols=210 Identities=27% Similarity=0.463 Sum_probs=181.8
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEeCCeeEEEEe
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE 235 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e 235 (394)
+|++++.||+|+||.||+|.+. ++.||||++...... ......+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 7999999999999999999984 778999998655433 3345778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCcccccccccc
Q 016152 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315 (394)
Q Consensus 236 ~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~~~~~~~~ 315 (394)
++.+++|..++...+.+++..++.++.|++.||+|||+++ |+||||||+|||+ +..+.+||+|||.+........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli--~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLI--NRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSCCS-
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCccccc--ccCCceeeeecchhhcccCCCc-
Confidence 9999999999888889999999999999999999999988 9999999999999 7888999999999987654322
Q ss_pred ccccccCCccCccccCccccCCCC-CCCcchHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHH
Q 016152 316 DVYKMTGETGSYRYMAPEVFKHRK-YDKKVDVFSFAMILYEMLEGEPPL-ANYEPYEAAKYVA 376 (394)
Q Consensus 316 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~Pf-~~~~~~~~~~~i~ 376 (394)
......+++.|+|||.+.... ++.++|||||||++|||++|+.|| .+.+..+....+.
T Consensus 157 ---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~ 216 (292)
T d1unla_ 157 ---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred ---cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHH
Confidence 223456788999999987665 689999999999999999999885 5556666666654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-41 Score=314.01 Aligned_cols=207 Identities=27% Similarity=0.368 Sum_probs=168.8
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEEe------CC
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------RK 228 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~------~~ 228 (394)
.+|+++++||+|+||+||+|.+. |+.||||++...... .....++.+|+.++++++||||++++++|.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 37999999999999999999985 889999998765543 4445678899999999999999999999864 36
Q ss_pred eeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 229 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
.+|+||||+.+ ++.+.+ ...+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+|++|||++..
T Consensus 96 ~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~--~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCCCC---
T ss_pred eeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCcccccc--ccccceeeechhhhhc
Confidence 78999999976 555544 346899999999999999999999998 9999999999999 8888999999999876
Q ss_pred cccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 016152 309 IKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVA 376 (394)
Q Consensus 309 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~ 376 (394)
..... ......+|+.|+|||++.+..+++++||||+||++|+|++|++||.+.+......++.
T Consensus 169 ~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~ 231 (355)
T d2b1pa1 169 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccc-----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 55332 2344679999999999999999999999999999999999999999988777776665
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-41 Score=314.24 Aligned_cols=214 Identities=28% Similarity=0.492 Sum_probs=178.0
Q ss_pred CCcccCCCCcCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 016152 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT 225 (394)
Q Consensus 148 ~~~~i~~~~~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 225 (394)
+.|+++ .+|++++.||+|+||.||+|.+. |+.||||++.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~---~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 12 TIWEVP---ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp SEEEEE---TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred ccccCC---CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 346653 26999999999999999999874 889999998765433 344567889999999999999999999986
Q ss_pred eC-----CeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEE
Q 016152 226 ER-----KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300 (394)
Q Consensus 226 ~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl 300 (394)
.. ...+++|+++.+|+|.+++.. +.+++.+++.++.||+.||+|||++| |+||||||+|||+ +.++.+|+
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi--~~~~~~kl 162 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAV--NEDCELKI 162 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEE
T ss_pred eccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccc--cccccccc
Confidence 43 334667777889999999854 46999999999999999999999988 9999999999999 88899999
Q ss_pred eecCCccccccccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Q 016152 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYEPYEAAKYVAE 377 (394)
Q Consensus 301 ~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~~~~~~~~i~~ 377 (394)
+|||++...... ..+..||+.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+.......|.+
T Consensus 163 ~dfg~a~~~~~~-------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~ 233 (348)
T d2gfsa1 163 LDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233 (348)
T ss_dssp CCC----CCTGG-------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccchhcccCcc-------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999998765422 3456799999999987765 468999999999999999999999999988888777753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-40 Score=308.88 Aligned_cols=193 Identities=23% Similarity=0.437 Sum_probs=166.0
Q ss_pred cCccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeC--CeeE
Q 016152 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER--KPLM 231 (394)
Q Consensus 157 ~~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~--~~~~ 231 (394)
.+|++++.||+|+||.||+|.+. |+.||||++.... .+++.+|+.+++.++ ||||+++++++... ..++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 36999999999999999999975 8899999985432 256788999999995 99999999998743 5689
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCC-CCcEEEeecCCccccc
Q 016152 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIK 310 (394)
Q Consensus 232 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~-~~~~kl~DFg~a~~~~ 310 (394)
+||||+.+++|..+. +.+++.+++.++.||+.||.|||++| |+||||||+|||+ +. ++.+||+|||+|....
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi--~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTTTEEEECCGGGCEECC
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEE--cCCCCeeeecccccceecc
Confidence 999999999997753 46999999999999999999999998 9999999999999 54 4469999999998765
Q ss_pred cccccccccccCCccCccccCccccCCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 311 VQNSHDVYKMTGETGSYRYMAPEVFKHR-KYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 311 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus 182 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 182 PGQ-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp TTC-----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CCC-----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 432 23456799999999998765 57999999999999999999999997654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-34 Score=269.72 Aligned_cols=197 Identities=22% Similarity=0.351 Sum_probs=155.0
Q ss_pred CccccceeecCCceEEEEEEEC--CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-----------CCceeeEEeEE
Q 016152 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----------HPNIVQFLGAV 224 (394)
Q Consensus 158 ~~~~~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~Iv~~~~~~ 224 (394)
+|++++.||+|+||.||+|... |+.||||++.+. ....+.+.+|+.+++.++ |+||+++++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 6999999999999999999874 889999998543 233456678888887764 57899999887
Q ss_pred Ee--CCeeEEEEeccCCCC-HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeEecCCCCCCEEEeeCCC---
Q 016152 225 TE--RKPLMLITEYLRGGD-LHKYLK--EKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSA--- 295 (394)
Q Consensus 225 ~~--~~~~~lv~e~~~~~s-L~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~ivH~Dikp~Nilv~~~~~--- 295 (394)
.. ....+++++++..+. ...... ....+++..+..++.|++.||.|||+ .| |+||||||+|||+..+..
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence 54 345667777665443 333332 34578999999999999999999997 77 999999999999943222
Q ss_pred -CcEEEeecCCccccccccccccccccCCccCccccCccccCCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 016152 296 -DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRKYDKKVDVFSFAMILYEMLEGEPPLANYE 367 (394)
Q Consensus 296 -~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~Pf~~~~ 367 (394)
..++++|||.+...... .....||+.|+|||++....++.++|+||+||++++|++|++||...+
T Consensus 168 ~~~~kl~dfg~s~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cceeeEeecccccccccc-------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 14999999998755422 234679999999999999999999999999999999999999997543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=3.4e-25 Score=188.58 Aligned_cols=165 Identities=18% Similarity=0.195 Sum_probs=120.1
Q ss_pred cccceeecCCceEEEEEEE-CCccEEEEEeccCCCC---------------cHHHHHHHHHHHHHHHhCCCCceeeEEeE
Q 016152 160 SSSAIIGKGSFGEILKAYW-RGTPVAIKRILPSLSD---------------DRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223 (394)
Q Consensus 160 ~~~~~iG~G~~g~V~~a~~-~g~~~avK~l~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 223 (394)
.+++.||+|+||.||+|.. +|+.||||++...... ..........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 5678999999999999986 5889999986532111 01122344578889999999999988865
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCEEEeeCCCCcEEEeec
Q 016152 224 VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303 (394)
Q Consensus 224 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~ivH~Dikp~Nilv~~~~~~~~kl~DF 303 (394)
. ..+++|||+++..+.+ ++...+..++.|++.+|.|||++| |+||||||+|||+ ++ +.++|+||
T Consensus 83 ~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv--~~-~~~~liDF 146 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLV--SE-EGIWIIDF 146 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEE--ET-TEEEECCC
T ss_pred c----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheee--eC-CCEEEEEC
Confidence 3 2379999998865432 455667889999999999999988 9999999999999 44 35999999
Q ss_pred CCccccccccccccccccCCccCccccCc------cccCCCCCCCcchHHHHHHHH
Q 016152 304 GLSKLIKVQNSHDVYKMTGETGSYRYMAP------EVFKHRKYDKKVDVFSFAMIL 353 (394)
Q Consensus 304 g~a~~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwslGv~l 353 (394)
|+|.....+... .|+.. +. ..+.|+.++|+||+.--+
T Consensus 147 G~a~~~~~~~~~------------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR------------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH------------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH------------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 999765422211 11111 11 136678899999976544
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.84 E-value=1.2e-21 Score=152.72 Aligned_cols=98 Identities=24% Similarity=0.230 Sum_probs=90.3
Q ss_pred hhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHH
Q 016152 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLN 121 (394)
Q Consensus 42 a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~ 121 (394)
|++.+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+
T Consensus 9 A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~~v~~Ll 88 (118)
T d1myoa_ 9 ALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLL 88 (118)
T ss_dssp HHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCHHHHHHH
T ss_pred HHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchhhhhhhh
Confidence 56666778888888999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCCCC
Q 016152 122 AHGGLSYGQNGSHFEPKP 139 (394)
Q Consensus 122 ~~ga~~~~~~~s~~~p~~ 139 (394)
++|++++..+....+|..
T Consensus 89 ~~Gad~~~~d~~G~t~l~ 106 (118)
T d1myoa_ 89 SKGADKTVKGPDGLTALE 106 (118)
T ss_dssp TTCCCSSSSSSSTCCCCC
T ss_pred cccccceeeCCCCCCHHH
Confidence 999999888777666643
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=4.8e-21 Score=152.00 Aligned_cols=94 Identities=21% Similarity=0.267 Sum_probs=84.5
Q ss_pred eeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHH
Q 016152 37 LILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNM 116 (394)
Q Consensus 37 ~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~ 116 (394)
+++. |+..+..+++++|++.|+|+|.+|.+|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.++
T Consensus 4 lL~~-A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~ 82 (130)
T d1ycsb1 4 LLLD-SSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQV 82 (130)
T ss_dssp HHHH-HHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHH
T ss_pred HHHH-HHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHH
Confidence 3444 444455677888889999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCC
Q 016152 117 MELLNAHGGLSYGQN 131 (394)
Q Consensus 117 ~~~L~~~ga~~~~~~ 131 (394)
+++|+++|++++..+
T Consensus 83 v~~Ll~~ga~v~~~~ 97 (130)
T d1ycsb1 83 CKFLVESGAAVFAMT 97 (130)
T ss_dssp HHHHHHTTCCTTCCC
T ss_pred HHHHHHcCCCccccc
Confidence 999999999987554
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.81 E-value=1.5e-20 Score=153.35 Aligned_cols=96 Identities=20% Similarity=0.172 Sum_probs=86.0
Q ss_pred ccccCcceeeehhhc--CCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhH
Q 016152 30 ARVSRTSLILWHAHQ--NDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLAD 107 (394)
Q Consensus 30 ~~~~~~~~~~~~a~~--~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~ 107 (394)
+..|.|++++ |+.. .+..+++++|+++|+++|.+|.+|+||||+||..|+.+++++|+++|||++.+|.+|+||||+
T Consensus 42 ~~~g~t~Lh~-A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~ 120 (154)
T d1dcqa1 42 HEPDETALHL-AVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDI 120 (154)
T ss_dssp SSTTCBHHHH-HHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred CCCCCchHHH-HHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccccccccccccccccccCccccccCCCCCCHHHH
Confidence 5567777754 4432 356789999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhcChHHHHHHHHhcCCC
Q 016152 108 AEGAKKFNMMELLNAHGGL 126 (394)
Q Consensus 108 A~~~~~~~~~~~L~~~ga~ 126 (394)
|+..|+.+++++|++.++.
T Consensus 121 A~~~~~~~i~~~L~~~~~~ 139 (154)
T d1dcqa1 121 AKRLKHEHCEELLTQALSG 139 (154)
T ss_dssp HHHTTCHHHHHHHHHHHTT
T ss_pred HHHcCCHHHHHHHHHhCCC
Confidence 9999999999999998764
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=1.9e-20 Score=147.46 Aligned_cols=105 Identities=20% Similarity=0.240 Sum_probs=94.1
Q ss_pred CCCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCC-CHHHHHHhcCcHHHHHHHHHcCCC
Q 016152 15 CKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNR-TPLHVASLHGWIDVAKCLIEYGAD 93 (394)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~-t~Lh~A~~~~~~~~~~~Ll~~ga~ 93 (394)
+.+.++..|+++|..+.+|.|+++ +|.. ++.+++++|++.|+++|.+|..|. ||||+||..|+.+++++|+++|+|
T Consensus 18 ~v~~Ll~~gad~n~~~~~g~t~l~--~a~~-g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~~~~v~~Ll~~ga~ 94 (125)
T d1bi7b_ 18 EVRALLEAGANPNAPNSYGRRPIQ--VMMM-GSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGAR 94 (125)
T ss_dssp HHHHHHTTTCCTTCCCSSSCCTTT--SSCT-TCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCC
T ss_pred HHHHHHHcCCcccccccccccccc--cccc-ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 344567889999999999999763 4554 567899999999999999998875 699999999999999999999999
Q ss_pred CCCccCCCCchhhHHHhcChHHHHHHHHh
Q 016152 94 VNAQDRWKNTPLADAEGAKKFNMMELLNA 122 (394)
Q Consensus 94 ~~~~~~~g~t~l~~A~~~~~~~~~~~L~~ 122 (394)
+|.+|.+|+||||+|+..|+.+++++|++
T Consensus 95 ~~~~d~~G~T~l~~A~~~g~~~~v~~Lls 123 (125)
T d1bi7b_ 95 LDVRDAWGRLPVDLAEELGHRDVARYLRA 123 (125)
T ss_dssp SSCCCTTCCCHHHHHHHHTCHHHHHHHSS
T ss_pred cccccCCCCCHHHHHHHcCCHHHHHHHHh
Confidence 99999999999999999999999999975
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=6.1e-20 Score=145.52 Aligned_cols=108 Identities=23% Similarity=0.118 Sum_probs=94.4
Q ss_pred CCCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCC
Q 016152 15 CKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94 (394)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~ 94 (394)
+.+-.+..|+|+|.+|++|.|++++ |+..+..+++++|++.|+++|.+|.+|+||||+||.+|+.++|++|+++|||+
T Consensus 16 ~v~~Ll~~g~d~n~~d~~g~t~Lh~--A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~v 93 (130)
T d1ycsb1 16 LVQRIIYEVDDPSLPNDEGITALHN--AVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAV 93 (130)
T ss_dssp HHHHHTSTTSSCCCCCTTSCCHHHH--HHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCT
T ss_pred HHHHHHHcCCCcccccccccccccc--ccccccccccccccccccccccccccCcccccccchhhHHHHHHHHHHcCCCc
Confidence 3445678899999999999998855 67777888999999999999999999999999999999999999999999999
Q ss_pred CCccC-CCCchhhHH--HhcChHHHHHHHHhcC
Q 016152 95 NAQDR-WKNTPLADA--EGAKKFNMMELLNAHG 124 (394)
Q Consensus 95 ~~~~~-~g~t~l~~A--~~~~~~~~~~~L~~~g 124 (394)
|..+. .++||++.| ...|+.+++++|+..+
T Consensus 94 ~~~~~~~~~~~~~~~~a~~~g~~eiv~~L~~~~ 126 (130)
T d1ycsb1 94 FAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQ 126 (130)
T ss_dssp TCCCSSSCCCHHHHCCSSSTTCCCHHHHHHHHH
T ss_pred ccccCCCCCCHHHHHHHHHcChHHHHHHHHhHH
Confidence 98875 588887655 5678899999998643
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.77 E-value=1.4e-20 Score=146.63 Aligned_cols=91 Identities=20% Similarity=0.205 Sum_probs=83.3
Q ss_pred CCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 18 GATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
-++..|++++.++..|.|++++ |+..+..+++++|++.|+++|.+|.+|+||||+|+.+|+.+++++|+++|||+|.+
T Consensus 20 ~Ll~~g~d~n~~~~~g~t~lh~--A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~~v~~Ll~~Gad~~~~ 97 (118)
T d1myoa_ 20 DYVAKGEDVNRTLEGGRKPLHY--AADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVK 97 (118)
T ss_dssp HHHTTTCCCCCCSSSSCCTTHH--HHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCHHHHHHHTTCCCSSSS
T ss_pred HHHHhhhccccccccccccccc--cccccccccccccccccceeeecccccccchhhhhhcCchhhhhhhhcccccceee
Confidence 3667899999999999999854 66667788899999999999999999999999999999999999999999999999
Q ss_pred cCCCCchhhHHHh
Q 016152 98 DRWKNTPLADAEG 110 (394)
Q Consensus 98 ~~~g~t~l~~A~~ 110 (394)
|.+|+||||+|..
T Consensus 98 d~~G~t~l~~a~~ 110 (118)
T d1myoa_ 98 GPDGLTALEATDN 110 (118)
T ss_dssp SSSTCCCCCTCSS
T ss_pred CCCCCCHHHHHhH
Confidence 9999999999843
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=6.8e-19 Score=152.82 Aligned_cols=117 Identities=24% Similarity=0.256 Sum_probs=105.9
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
.+..|++++..|.+|.|++++ |+..+..+++++|++.|++++.+|..|.||||+|+..++.+++++|++.|+++|.+|
T Consensus 89 Ll~~~~d~~~~d~~g~tpL~~--A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d 166 (223)
T d1uoha_ 89 LLGKGAQVNAVNQNGCTPLHY--AASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQD 166 (223)
T ss_dssp HHHTTCCTTCCCTTCCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCC
T ss_pred HhccCceeEeeCCCCCchhhH--HHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhhhhcCCcchhhhhccccceeeecc
Confidence 456788999999999998754 666677889999999999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
.+|+||||+|+..|+.+++++|++.|++++..+....+|
T Consensus 167 ~~g~TpL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g~tp 205 (223)
T d1uoha_ 167 TEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEEKTP 205 (223)
T ss_dssp TTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCH
T ss_pred CCCCceeccccccCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 999999999999999999999999999988766655544
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.74 E-value=1.7e-18 Score=152.96 Aligned_cols=106 Identities=25% Similarity=0.213 Sum_probs=96.5
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCcc-ccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHA-RDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~-~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
....+.+++.++.+|.|+++. |+..+..+++++|++.+++.+. ++..|.||||+||..|+.+++++|+++|||+|.+
T Consensus 144 ~~~~~~~in~~d~~g~TpLh~--A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~TpL~~A~~~~~~~~v~~Ll~~gadin~~ 221 (255)
T d1oy3d_ 144 DEDWRLQLEAENYDGHTPLHV--AVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTAR 221 (255)
T ss_dssp CCCGGGGTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred hhhcCcccccccccCcccccc--cccccccccccchhcccccccccccccccccccccccccHHHHHHHHHHCCCCCCCC
Confidence 455788889999999998744 7777788999999999999876 4678999999999999999999999999999999
Q ss_pred cCCCCchhhHHHhcChHHHHHHHHhcCCC
Q 016152 98 DRWKNTPLADAEGAKKFNMMELLNAHGGL 126 (394)
Q Consensus 98 ~~~g~t~l~~A~~~~~~~~~~~L~~~ga~ 126 (394)
|++|.||||+|+..++.+++++|+++||+
T Consensus 222 d~~g~t~L~~A~~~~~~~i~~~Ll~~Ga~ 250 (255)
T d1oy3d_ 222 MYGGRTPLGSALLRPNPILARLLRAHGAP 250 (255)
T ss_dssp CTTSCCHHHHHHTSSCHHHHHHHHHTTCC
T ss_pred CCCCCCHHHHHHHCCCHHHHHHHHHcCCC
Confidence 99999999999999999999999999995
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=5.5e-18 Score=151.95 Aligned_cols=110 Identities=23% Similarity=0.243 Sum_probs=100.1
Q ss_pred cchhhhhhccccCcceee--ehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHH-cCCCCCCcc
Q 016152 22 SADKQKEKARVSRTSLIL--WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQD 98 (394)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~--~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~~~~ 98 (394)
.|++++..+..+.++..+ +++..++...++++|++.|+++|.+|..|.||||+|+..|+.+++++||+ .|+|+|.+|
T Consensus 171 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Li~~ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d 250 (285)
T d1wdya_ 171 MGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTD 250 (285)
T ss_dssp SCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCC
T ss_pred cCCCcccccCCCCcccccccccccchHHHHHHHHHHHCCCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCC
Confidence 578899999888877654 34677788899999999999999999999999999999999999999998 599999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhcCCCCCCCC
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~ 131 (394)
.+|.||||+|+..|+.+++++|+++||+++..+
T Consensus 251 ~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d 283 (285)
T d1wdya_ 251 SDGKTALLLAVELKLKKIAELLCKRGASTDCGD 283 (285)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSS
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccc
Confidence 999999999999999999999999999987654
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.4e-18 Score=136.62 Aligned_cols=97 Identities=21% Similarity=0.168 Sum_probs=83.5
Q ss_pred eeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCC-chhhHHHhcChHHH
Q 016152 38 ILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN-TPLADAEGAKKFNM 116 (394)
Q Consensus 38 ~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~-t~l~~A~~~~~~~~ 116 (394)
+++||. .++.+++++|++.|+|+|.+|.+|+||||+| ..|+.+++++|+++|+++|.+|..+. ||||+|+..|+.++
T Consensus 7 L~~Aa~-~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a-~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~~~~ 84 (125)
T d1bi7b_ 7 LATAAA-RGRVEEVRALLEAGANPNAPNSYGRRPIQVM-MMGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDT 84 (125)
T ss_dssp HHHHHH-HTCHHHHHHHHTTTCCTTCCCSSSCCTTTSS-CTTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHH
T ss_pred HHHHHH-CCCHHHHHHHHHcCCcccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc
Confidence 344444 5557788888899999999999999999977 47999999999999999999999887 69999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCCC
Q 016152 117 MELLNAHGGLSYGQNGSHFE 136 (394)
Q Consensus 117 ~~~L~~~ga~~~~~~~s~~~ 136 (394)
+++|+++|++++..+....+
T Consensus 85 v~~Ll~~ga~~~~~d~~G~T 104 (125)
T d1bi7b_ 85 LVVLHRAGARLDVRDAWGRL 104 (125)
T ss_dssp HHHHHHHTCCSSCCCTTCCC
T ss_pred cccccccccccccccCCCCC
Confidence 99999999998766554443
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=5.3e-18 Score=145.08 Aligned_cols=100 Identities=19% Similarity=0.232 Sum_probs=89.8
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
+...+++++..+..|.|+++. ++..+...++++|+..+.++|.+|..|.||||+||.+|+.++|++||++|||+|.+|
T Consensus 109 L~~~~~~~~~~~~~~~t~l~~--~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~n~~d 186 (209)
T d1ot8a_ 109 LITADADINAADNSGKTALHW--AAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITD 186 (209)
T ss_dssp HHHTTCCTTCBCTTSCBHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred hhhhcccccccCCCCCCcchh--hcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCCCCCCCcC
Confidence 344677788888999887644 556667778888889999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHH
Q 016152 99 RWKNTPLADAEGAKKFNMMELL 120 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L 120 (394)
..|+||||+|+..|+.++|++|
T Consensus 187 ~~g~Tpl~~A~~~~~~~iv~lL 208 (209)
T d1ot8a_ 187 HMDRLPRDVASERLHHDIVRLL 208 (209)
T ss_dssp TTSCCHHHHHHHTTCHHHHHHH
T ss_pred CCCCCHHHHHHHcCCHHHHhhc
Confidence 9999999999999999999987
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=6.3e-18 Score=138.08 Aligned_cols=112 Identities=21% Similarity=0.249 Sum_probs=83.0
Q ss_pred cchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCC
Q 016152 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (394)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (394)
.+++++..|..|.|+++ +|+.++. ++++.|++.++++|..+..|.+||++|+..++.+++++++++|+++|.+|.+|
T Consensus 25 ~~~~~n~~d~~g~t~L~--~A~~~~~-~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~ 101 (156)
T d1bd8a_ 25 ELVHPDALNRFGKTALQ--VMMFGST-AIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTG 101 (156)
T ss_dssp TCCCTTCCCTTSCCHHH--HSCTTCH-HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTS
T ss_pred CCCCCCccCCCCCcccc--ccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccCCC
Confidence 46777888888887763 3555554 55566667788888888888888888888888888888888888888888888
Q ss_pred CchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
+||||+|+..|+.+++++|+ .|++++..+....+|
T Consensus 102 ~t~L~~A~~~~~~~i~~~L~-~~~~~~~~d~~G~Tp 136 (156)
T d1bd8a_ 102 ALPIHLAVQEGHTAVVSFLA-AESDLHRRDARGLTP 136 (156)
T ss_dssp CCHHHHHHHHTCHHHHHHHH-TTSCTTCCCTTSCCH
T ss_pred Ceeecccccccccccccccc-ccccccccCCCCCCH
Confidence 88888888888888888776 567766655554444
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=6.2e-18 Score=146.65 Aligned_cols=101 Identities=19% Similarity=0.220 Sum_probs=92.0
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
++..|++++.++.++.|+++. |+..+...+.++|.+.|.++|.+|.+|+||||+|+..|+.++|++|+++|||++.+|
T Consensus 122 Ll~~g~d~~~~~~~~~t~L~~--a~~~~~~~~~~~L~~~~~~i~~~d~~g~TpL~~Aa~~g~~~~v~~LL~~Gad~~~~d 199 (223)
T d1uoha_ 122 LLEGGANPDAKDHYEATAMHR--AAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIEN 199 (223)
T ss_dssp HHHTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCC
T ss_pred HHHCCCCCCCcCCCCCccchh--hhhcCCcchhhhhccccceeeeccCCCCceeccccccCcHHHHHHHHHCCCCCCCCC
Confidence 356889999999999998744 666777888999999999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHh
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNA 122 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~ 122 (394)
.+|+||||+|+ .|+.+++++|++
T Consensus 200 ~~g~tpl~~A~-~~~~~i~~~Ll~ 222 (223)
T d1uoha_ 200 KEEKTPLQVAK-GGLGLILKRMVE 222 (223)
T ss_dssp TTSCCHHHHCC-TTHHHHHHHHHC
T ss_pred CCCCCHHHHHH-CCCHHHHhcccC
Confidence 99999999985 699999999985
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=2.7e-17 Score=155.00 Aligned_cols=102 Identities=25% Similarity=0.273 Sum_probs=91.2
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
++..|++++..+..+.|+++. ++..+...+++++++.|+++|.+|.+|.||||+||.+|+.++|++|+++|||+|.+|
T Consensus 283 Ll~~g~~~~~~~~~~~t~L~~--~~~~~~~~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~~~iv~~Ll~~GAd~n~~d 360 (408)
T d1n11a_ 283 LIKHGVMVDATTRMGYTPLHV--ASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVS 360 (408)
T ss_dssp HHHHTCCTTCCCSSCCCHHHH--HHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCC
T ss_pred HHHCCCccccccccccccchh--hcccCcceeeeeeccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Confidence 445688888888888888754 666666778888899999999999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHh
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNA 122 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~ 122 (394)
++|+||||+|+..|+.++|++|..
T Consensus 361 ~~G~t~L~~A~~~~~~~iv~~L~~ 384 (408)
T d1n11a_ 361 SDGTTPLAIAKRLGYISVTDVLKV 384 (408)
T ss_dssp SSSCCHHHHHHHTTCHHHHHHHHH
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHH
Confidence 999999999999999999987754
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.67 E-value=6e-17 Score=146.95 Aligned_cols=116 Identities=18% Similarity=0.039 Sum_probs=91.8
Q ss_pred Ccchhhhhh-ccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcH-------HHHHHH-----
Q 016152 21 SSADKQKEK-ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWI-------DVAKCL----- 87 (394)
Q Consensus 21 ~~~~~~~~~-~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~-------~~~~~L----- 87 (394)
..+.++|.. |.+|+|++|+ |+..++.+++++|++.|+|++.+|..|+||||.||..++. +++++|
T Consensus 94 ~~~~dvn~~~D~~G~T~LH~--Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~ 171 (301)
T d1sw6a_ 94 NTQLNLNIPVDEHGNTPLHW--LTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLI 171 (301)
T ss_dssp TSCCCSCSCCSTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGG
T ss_pred ccCCCcCcCcCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhh
Confidence 356677755 8889998754 6666677899999999999999999999999999986642 333322
Q ss_pred -------------------------------------HHcCC-------------------------------------C
Q 016152 88 -------------------------------------IEYGA-------------------------------------D 93 (394)
Q Consensus 88 -------------------------------------l~~ga-------------------------------------~ 93 (394)
+..+. .
T Consensus 172 ~~d~~g~t~lh~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (301)
T d1sw6a_ 172 LEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANM 251 (301)
T ss_dssp EECTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHT
T ss_pred hcccccCCHHHHHHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcC
Confidence 22221 1
Q ss_pred CCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCC
Q 016152 94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK 138 (394)
Q Consensus 94 ~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~ 138 (394)
+|.+|.+|+||||+|+..|+.++|++|+++|++++..+....+|.
T Consensus 252 in~~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl 296 (301)
T d1sw6a_ 252 LNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPV 296 (301)
T ss_dssp TTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGG
T ss_pred ccCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHH
Confidence 789999999999999999999999999999999988877666553
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.66 E-value=3.9e-17 Score=144.09 Aligned_cols=96 Identities=20% Similarity=0.099 Sum_probs=87.0
Q ss_pred hccccCcceeeehhhcCCHHHHHHHHHhcCCC---CccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchh
Q 016152 29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSL---VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105 (394)
Q Consensus 29 ~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~---vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l 105 (394)
.+++|.|++|+ |++.+..+++++|++.|++ +|.+|..|.||||+||..|+.+++++|+++|||++.+|.+|+|||
T Consensus 5 i~~~G~t~Lh~--A~~~~~~~~v~~Ll~~~a~~~~i~~~~~~g~TpL~~A~~~g~~~iv~~Ll~~ga~i~~~d~~g~tpL 82 (255)
T d1oy3d_ 5 VTEDGDTALHL--AVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTAL 82 (255)
T ss_dssp CCTTCCCHHHH--HHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHH
T ss_pred CCcCCCCHHHH--HHHcCCHHHHHHHHHcCCCcccccCcCCCCCCccchHHhhcccccccccccccccccccccccchhh
Confidence 45789998755 7777788899999999987 678889999999999999999999999999999999999999999
Q ss_pred hHHHhcChHHHHHHHHhcCCC
Q 016152 106 ADAEGAKKFNMMELLNAHGGL 126 (394)
Q Consensus 106 ~~A~~~~~~~~~~~L~~~ga~ 126 (394)
|+|+..++.+++++|++.+..
T Consensus 83 ~~A~~~~~~~~~~~Ll~~~~~ 103 (255)
T d1oy3d_ 83 HLACRVRAHTCACVLLQPRPS 103 (255)
T ss_dssp HHHTTTTCHHHHHHHSSSCCS
T ss_pred hhhhccCchHHHHHHHhhccc
Confidence 999999999999999887654
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.65 E-value=1.7e-16 Score=128.96 Aligned_cols=97 Identities=15% Similarity=0.092 Sum_probs=81.3
Q ss_pred ehhhcCCHHHHHHHHHhcCCCCccc------cCCCCCHHHHHHhc---CcHHHHHHHHHcCCCCCCccCCCCchhhHHHh
Q 016152 40 WHAHQNDAAAVRKLLEEDQSLVHAR------DYDNRTPLHVASLH---GWIDVAKCLIEYGADVNAQDRWKNTPLADAEG 110 (394)
Q Consensus 40 ~~a~~~~~~~~~~~L~~~g~~vn~~------d~~g~t~Lh~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~ 110 (394)
.|+..++...+.+++ ..|+|++.. +..|+||||+|+.. ++.++|++|+++|+|+|.+|.+|+||||+|+.
T Consensus 12 ~Av~~~dl~~l~~~~-~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~~ 90 (154)
T d1dcqa1 12 EAVKTRDIFGLLQAY-ADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCL 90 (154)
T ss_dssp HHHHTTCHHHHHHHH-HTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHH
T ss_pred HHHHhCCHHHHHHHH-HcCCCcCCCCCcccCCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccccc
Confidence 345566666665555 678887654 67899999999974 67899999999999999999999999999999
Q ss_pred cChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 111 AKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 111 ~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
.|+.+++++|+++|++++..+....+|
T Consensus 91 ~~~~~~v~~Ll~~gad~~~~d~~g~tp 117 (154)
T d1dcqa1 91 TDNAECLKLLLRGKASIEIANESGETP 117 (154)
T ss_dssp TTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred cccccccccccccCccccccCCCCCCH
Confidence 999999999999999988776655544
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=3.1e-16 Score=127.83 Aligned_cols=102 Identities=20% Similarity=0.211 Sum_probs=92.2
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCcc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 98 (394)
.+..+.+++..+..+.++++. ++..+...+.+++++.|+++|.+|.+|+||||+||..|+.+++++|+ .|+|++.+|
T Consensus 54 Ll~~~~~~~~~~~~~~~~l~~--~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~~i~~~L~-~~~~~~~~d 130 (156)
T d1bd8a_ 54 LLKQGASPNVQDTSGTSPVHD--AARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AESDLHRRD 130 (156)
T ss_dssp HHHTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHH-TTSCTTCCC
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccCCCCeeecccccccccccccccc-ccccccccC
Confidence 566788899988888887754 77777788999999999999999999999999999999999999887 789999999
Q ss_pred CCCCchhhHHHhcChHHHHHHHHhc
Q 016152 99 RWKNTPLADAEGAKKFNMMELLNAH 123 (394)
Q Consensus 99 ~~g~t~l~~A~~~~~~~~~~~L~~~ 123 (394)
.+|+||||+|+..|+.+++++|+++
T Consensus 131 ~~G~TpL~~A~~~g~~~iv~~Ll~h 155 (156)
T d1bd8a_ 131 ARGLTPLELALQRGAQDLVDILQGH 155 (156)
T ss_dssp TTSCCHHHHHHHSCCHHHHHHHHTT
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHhh
Confidence 9999999999999999999999875
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.64 E-value=5.6e-17 Score=144.62 Aligned_cols=111 Identities=23% Similarity=0.239 Sum_probs=90.2
Q ss_pred CCCCCCCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHH--------HhcCCCCccccCCCCCHHHHHHhcCcHH
Q 016152 11 STTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLL--------EEDQSLVHARDYDNRTPLHVASLHGWID 82 (394)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L--------~~~g~~vn~~d~~g~t~Lh~A~~~~~~~ 82 (394)
.+..+.+.+...+.+... .++|+|++|+ |+.++..+++++| ++.|+|||.+|.+|+||||+|+.+|+.+
T Consensus 12 ~~~~~~~~l~~~~~n~~~-~~~g~T~Lh~--A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh~A~~~g~~~ 88 (277)
T d2fo1e1 12 GSYAITEPITRESVNIID-PRHNRTVLHW--IASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRR 88 (277)
T ss_dssp SSSCCCSCCSTTTTTTCC-CSSCCCHHHH--HHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHH
T ss_pred CCHHHHHHHHhcCCCcCC-CCCCccHHHH--HHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeecccccccccc
Confidence 445667777766655422 2468887754 5555555555443 6789999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHHhcC
Q 016152 83 VAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124 (394)
Q Consensus 83 ~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~g 124 (394)
+|++|+++|||+|.+|.+|.|||++|...++.++++++...+
T Consensus 89 iv~~Ll~~Gad~n~~~~~g~t~l~~a~~~~~~~~~~~l~~~~ 130 (277)
T d2fo1e1 89 LVAYLMKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNST 130 (277)
T ss_dssp HHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHTTSH
T ss_pred ccccccccccccccccccccccccchhhhcchhhhhhhhhcc
Confidence 999999999999999999999999999999999999887654
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.64 E-value=1.8e-16 Score=142.51 Aligned_cols=122 Identities=23% Similarity=0.110 Sum_probs=101.9
Q ss_pred CCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCcc--------------------------------
Q 016152 16 KGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHA-------------------------------- 63 (394)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~-------------------------------- 63 (394)
.+-+++.|+++|..|.+|.|++++ |+.+++.+++++|++.|++.+.
T Consensus 56 v~~Ll~~Gadvn~~d~~G~T~L~~--A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~~~~~~~~~l~~~~~~~~ 133 (291)
T d1s70b_ 56 VLRLLERGADINYANVDGLTALHQ--ACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVG 133 (291)
T ss_dssp HHHHHHHCCCTTCBCTTCCBHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTT
T ss_pred HHHHHHCCCCCCccCCCCCcHHHH--HHhcCCceeeeeecccccccccccccccccccccccccccchhhcccccCcccc
Confidence 344677899999999999998754 6667778888888888765332
Q ss_pred -------------------------------------------------------------ccCCCCCHHHHHHhcCcHH
Q 016152 64 -------------------------------------------------------------RDYDNRTPLHVASLHGWID 82 (394)
Q Consensus 64 -------------------------------------------------------------~d~~g~t~Lh~A~~~~~~~ 82 (394)
.+..|.||||+|+..|+.+
T Consensus 134 ~~~~~~~~~~~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~t~L~~a~~~~~~~ 213 (291)
T d1s70b_ 134 AVNSEGDTPLDIAEEEAMEELLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTE 213 (291)
T ss_dssp CCCTTSCCHHHHCCSHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCCCTTTCCCHHHHHHHHTCHH
T ss_pred cccccCccccccccccccchhccccccccccccccccccccccccccchhhhcccccccccccCCCCChhhHHHHcCChh
Confidence 2355778888899999999
Q ss_pred HHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 016152 83 VAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKP 139 (394)
Q Consensus 83 ~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~~ 139 (394)
++++|+++|+|+|.+|.+|+||||+|+..|+.++|++|+++|++++..+....+|..
T Consensus 214 ~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~TaL~ 270 (291)
T d1s70b_ 214 VLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFD 270 (291)
T ss_dssp HHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTTT
T ss_pred hhcccccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHH
Confidence 999999999999999999999999999999999999999999999877765555543
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.64 E-value=5e-17 Score=140.95 Aligned_cols=100 Identities=22% Similarity=0.140 Sum_probs=61.6
Q ss_pred cchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcC-CCCccccCCCCCHHHHHHhcCcHHHHHHHHH-cCCCCCCccC
Q 016152 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQ-SLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQDR 99 (394)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g-~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~~~~~ 99 (394)
.|.+.+..|.+|.|++++ |+..+..+++++|++.| .++|.+|.+|+||||+|+..|+.++|++||+ .|||+|.+|.
T Consensus 127 ~~~~~~~~~~~g~t~l~~--a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~gad~~~~d~ 204 (229)
T d1ixva_ 127 NGASVRIKDKFNQIPLHR--AASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDN 204 (229)
T ss_dssp TTCCSCCCCTTSCCHHHH--HHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCCCT
T ss_pred hcccccccCCCCCCccch--hhhcccccccccccccccccccccccccCCchhhhcccccHHHHHHHHHhcCCCCCCcCC
Confidence 445555556666665532 33333445555555554 4666677777777777777777777777665 4677777777
Q ss_pred CCCchhhHHHhcChHHHHHHHHhcCCC
Q 016152 100 WKNTPLADAEGAKKFNMMELLNAHGGL 126 (394)
Q Consensus 100 ~g~t~l~~A~~~~~~~~~~~L~~~ga~ 126 (394)
+|+||||+|+. .+++++|++.|++
T Consensus 205 ~g~t~l~~A~~---~~~~~~Ll~~g~d 228 (229)
T d1ixva_ 205 KGAKAEDVALN---EQVKKFFLNNVVD 228 (229)
T ss_dssp TSCCTGGGCSC---HHHHHHHHHHCCC
T ss_pred CCCCHHHHHhh---HHHHHHHHHcCCC
Confidence 77777776653 3566777766664
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.64 E-value=1.6e-16 Score=128.93 Aligned_cols=76 Identities=29% Similarity=0.389 Sum_probs=67.0
Q ss_pred CCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHH
Q 016152 45 NDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120 (394)
Q Consensus 45 ~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L 120 (394)
....+++++|...|++++.+|.+|+||||+||..|+.+++++|+++|+|+|.+|++|+||||+|+..|+.+++++|
T Consensus 77 ~~~~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~Tpl~~A~~~g~~eiv~lL 152 (153)
T d1awcb_ 77 EGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152 (153)
T ss_dssp HTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred cccceeeecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCCHHHHHHHcCCHHHHHhC
Confidence 3355677777788888899999999999999999999999999999999999999999999999999999999877
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.63 E-value=6.3e-18 Score=156.55 Aligned_cols=107 Identities=14% Similarity=0.084 Sum_probs=86.6
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHH---HHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCC
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAV---RKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN 95 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~---~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~ 95 (394)
....+.+++.++..|.|++++ |+.+++.++ +++|++.|+++|.+|.+|+||||+||.+||.++|++|+++|++++
T Consensus 76 ~~~~~~~~~~~~~~~~t~L~~--Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~ 153 (346)
T d2ajaa1 76 AKQLWSDAHKKGIKSEVICFV--AAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEI 153 (346)
T ss_dssp CTTHHHHHHHHTCCHHHHHHH--HHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTH
T ss_pred hhhhhhHHHhccCCCCcHHHH--HHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCcc
Confidence 344566778888888888754 444444444 445889999999999999999999999999999999999999999
Q ss_pred Ccc--CCCCchhhHHHhcChHHHHHHHHhcCCCC
Q 016152 96 AQD--RWKNTPLADAEGAKKFNMMELLNAHGGLS 127 (394)
Q Consensus 96 ~~~--~~g~t~l~~A~~~~~~~~~~~L~~~ga~~ 127 (394)
..+ .+|+||||+|+..|+.++|++|++.|+..
T Consensus 154 ~~~~~~~g~t~L~~Aa~~g~~~iv~~Ll~~~~~~ 187 (346)
T d2ajaa1 154 MAMIQAENYHAFRLAAENGHLHVLNRLCELAPTE 187 (346)
T ss_dssp HHHHSHHHHHHHHHHHHTTCHHHHHHHHHSCGGG
T ss_pred ccccccCCCChhHHHHHHhhHHHHHHHHHcCCcc
Confidence 887 46999999999999999999999988754
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.62 E-value=2.4e-16 Score=134.57 Aligned_cols=115 Identities=20% Similarity=0.124 Sum_probs=100.0
Q ss_pred CCCcchhhhh-hccccCcceeeehhhcCCHHHHHHHHHhcCCCCccc---------------------------------
Q 016152 19 ATSSADKQKE-KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHAR--------------------------------- 64 (394)
Q Consensus 19 ~~~~~~~~~~-~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~--------------------------------- 64 (394)
++.+|+|+|. .|.+|.|++++ |+..++.+++++|++.|+++|.+
T Consensus 8 Ll~~g~din~~~d~~G~t~L~~--A~~~g~~e~v~~Ll~~g~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (209)
T d1ot8a_ 8 LLAQGAELNATMDKTGETSLHL--AARFARADAAKRLLDAGADANSQDNTGRTPLHAAVAADAMGVFQILLRNRATNLNA 85 (209)
T ss_dssp HHHHHHHHHHHHHHHCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTCTTCCTTC
T ss_pred HHHCCCCcCcCcCCCCCCHHHH--HHHcCCHHHHHHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 4668999997 58899998855 77778888999999988876554
Q ss_pred ----------------------------------cCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHh
Q 016152 65 ----------------------------------DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG 110 (394)
Q Consensus 65 ----------------------------------d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~ 110 (394)
+..|+||||+|+.++..++++.|++.++++|.+|..|.||||+|+.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~ 165 (209)
T d1ot8a_ 86 RMHDGTTPLILAARLAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAR 165 (209)
T ss_dssp CCTTCCCHHHHHHHTTCTTHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHH
T ss_pred ccccccccccccccccchhhhhhhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhcc
Confidence 6678999999999999999999999999999999999999999999
Q ss_pred cChHHHHHHHHhcCCCCCCCCCCCC
Q 016152 111 AKKFNMMELLNAHGGLSYGQNGSHF 135 (394)
Q Consensus 111 ~~~~~~~~~L~~~ga~~~~~~~s~~ 135 (394)
.|+.+++++|+++|++++..+....
T Consensus 166 ~g~~~~v~~Ll~~gad~n~~d~~g~ 190 (209)
T d1ot8a_ 166 EGSYEASKALLDNFANREITDHMDR 190 (209)
T ss_dssp TTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred ccHHHHHHHHHHCCCCCCCcCCCCC
Confidence 9999999999999999876554443
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=2.1e-16 Score=148.85 Aligned_cols=94 Identities=29% Similarity=0.277 Sum_probs=84.3
Q ss_pred cceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChH
Q 016152 35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF 114 (394)
Q Consensus 35 ~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~ 114 (394)
|||++ |+..+..+++++|++.|+++|.+|..|+||||+||..|+.++|++||++|||+|.+|.+|+||||+|+..|+.
T Consensus 2 TpL~~--Aa~~g~~~~v~~Ll~~g~~in~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gadi~~~~~~g~t~L~~A~~~g~~ 79 (408)
T d1n11a_ 2 TPLHV--ASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHT 79 (408)
T ss_dssp CHHHH--HHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHHHHTCH
T ss_pred ChHHH--HHHCcCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCH
Confidence 55544 5556677888888899999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCC
Q 016152 115 NMMELLNAHGGLSYGQ 130 (394)
Q Consensus 115 ~~~~~L~~~ga~~~~~ 130 (394)
+++++|+..+.+....
T Consensus 80 ~~~~~Ll~~~~~~~~~ 95 (408)
T d1n11a_ 80 NMVKLLLENNANPNLA 95 (408)
T ss_dssp HHHHHHHHHTCCTTCC
T ss_pred HHHHHHHHhhhccccc
Confidence 9999999888765443
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.61 E-value=9.7e-16 Score=136.39 Aligned_cols=99 Identities=27% Similarity=0.392 Sum_probs=86.4
Q ss_pred chhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCC
Q 016152 23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN 102 (394)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 102 (394)
....+..+..|.|+++ +++..++...+..++...+.+++.+|..|+||||+||..|+.++|++|+++|||+|.+|.+|+
T Consensus 177 ~~~~~~~~~~g~t~L~-~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~tpL~~A~~~g~~~iv~~Ll~~gadin~~d~~G~ 255 (277)
T d2fo1e1 177 AARKDSEKYKGRTALH-YAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDH 255 (277)
T ss_dssp GGGTSSSSCCCCCTHH-HHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSC
T ss_pred cccccccccCCCCccc-cccccccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCcCCCCC
Confidence 3445556677777764 456666666666778889999999999999999999999999999999999999999999999
Q ss_pred chhhHHHhcChHHHHHHHHh
Q 016152 103 TPLADAEGAKKFNMMELLNA 122 (394)
Q Consensus 103 t~l~~A~~~~~~~~~~~L~~ 122 (394)
||||+|+..|+.++|++|.+
T Consensus 256 T~L~~A~~~~~~~iv~lL~~ 275 (277)
T d2fo1e1 256 TARQLAQANNHHNIVDIFDR 275 (277)
T ss_dssp CHHHHHHHTTCHHHHHHHHT
T ss_pred CHHHHHHHcCCHHHHHHHHH
Confidence 99999999999999999985
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=1.1e-15 Score=130.72 Aligned_cols=71 Identities=27% Similarity=0.261 Sum_probs=46.7
Q ss_pred CCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 016152 69 RTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKP 139 (394)
Q Consensus 69 ~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p~~ 139 (394)
.+|||.|+..+..++++.++++|.+++.+|.+|.||||+|+..|+.+++++|++.|++++..+....+|..
T Consensus 145 ~~~l~~a~~~~~~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~TpL~ 215 (228)
T d1k1aa_ 145 RSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLM 215 (228)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTT
T ss_pred hhHHHHHHHhhhhhhhhhhhhhccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHH
Confidence 33344444444444444444444444444557889999999999999999999999988877666665543
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=5.5e-16 Score=133.80 Aligned_cols=122 Identities=23% Similarity=0.240 Sum_probs=94.2
Q ss_pred CCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHH-----------
Q 016152 17 GGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAK----------- 85 (394)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~----------- 85 (394)
......++++|.+|.+|+||+++ |+..+..+++++|++.|++++.+|..|+||||+|+..++.++++
T Consensus 23 ~~~~~~~~~in~~d~~g~TpLh~--A~~~~~~~iv~~L~~~g~d~~~~d~~g~t~l~~~~~~~~~~~~~~l~~~~~~~~~ 100 (221)
T d1iknd_ 23 RQVKGDLAFLNFQNNLQQTPLHL--AVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHL 100 (221)
T ss_dssp C-----CCCCCCCCTTCCCHHHH--HHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSS
T ss_pred HHHHhCCCCcccCCCCCCccccc--cccccccccccccccccccccccccccccccccccccccccccchhhhhcccccc
Confidence 34556788999999999999864 66666788999999999999998888888888888666555554
Q ss_pred ----------------------------HHHHcCCCCCCcc-CCCCchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCC
Q 016152 86 ----------------------------CLIEYGADVNAQD-RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFE 136 (394)
Q Consensus 86 ----------------------------~Ll~~ga~~~~~~-~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~ 136 (394)
+|+..|++++.++ .+|.||||+|+..|+.+++++|+++|++++..+....+
T Consensus 101 ~~~~~~~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~t 180 (221)
T d1iknd_ 101 HSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYS 180 (221)
T ss_dssp SCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCC
T ss_pred cccccccccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCC
Confidence 4456666666655 57999999999999999999999999999888777666
Q ss_pred CCCC
Q 016152 137 PKPV 140 (394)
Q Consensus 137 p~~~ 140 (394)
|...
T Consensus 181 pl~~ 184 (221)
T d1iknd_ 181 PYQL 184 (221)
T ss_dssp GGGG
T ss_pred HHHH
Confidence 6543
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=8.5e-16 Score=124.88 Aligned_cols=120 Identities=20% Similarity=0.184 Sum_probs=96.2
Q ss_pred CCCCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCC
Q 016152 15 CKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94 (394)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~ 94 (394)
+.+-++.+|++++.+|.+|.|+++ +|+.+ ..+++++|++.|++++.++..|.|+|+.++..++.+.++.|++.+.++
T Consensus 16 ~v~~Ll~~g~d~n~~d~~g~TpL~--~A~~~-~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 92 (156)
T d1ihba_ 16 QLTSLLQNNVNVNAQNGFGRTALQ--VMKLG-NPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADV 92 (156)
T ss_dssp HHHHHTTSCCCTTCCCTTSCCHHH--HCCSS-CHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCT
T ss_pred HHHHHHHCCCCcCccCCccccccc--ccccc-cccccccccccccccccccccCcccccccccccccccccccccccccc
Confidence 344577899999999999999874 46655 467888999999999988888888888888888888888888888888
Q ss_pred CCccCCCCchhhHHHhcChHHHHHHHHhcCC-CCCCCCCCCCCC
Q 016152 95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGG-LSYGQNGSHFEP 137 (394)
Q Consensus 95 ~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga-~~~~~~~s~~~p 137 (394)
+..|..|.+||++|+..++.+++++|+++++ +.+..+....+|
T Consensus 93 ~~~~~~~~~~l~~a~~~~~~~~~~~Ll~~~~~~~~~~d~~g~Tp 136 (156)
T d1ihba_ 93 NIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTA 136 (156)
T ss_dssp TCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCH
T ss_pred cccccccccccccccccccccccccccccccccccccCCCCCCH
Confidence 8888888888888888888888888887776 455444444443
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.58 E-value=1.5e-17 Score=154.07 Aligned_cols=110 Identities=17% Similarity=0.026 Sum_probs=93.2
Q ss_pred CCCCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccC--CCCCHHHHHHhcCcHHHHHHHHHcCCCC
Q 016152 17 GGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDY--DNRTPLHVASLHGWIDVAKCLIEYGADV 94 (394)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~--~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~ 94 (394)
+.+++.|+++|.+|.+|.|++++ |+++++.+++++|++.|++++..+. +|+||||+||.+||.++|++|++.|++.
T Consensus 110 ~~L~~~~~~in~~~~~g~taL~~--Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L~~Aa~~g~~~iv~~Ll~~~~~~ 187 (346)
T d2ajaa1 110 CLLLTSDEIVKVIQAENYQAFRL--AAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTE 187 (346)
T ss_dssp TTC--CCSSCC--CHHHHHHHHH--HHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHHHHHHTTCHHHHHHHHHSCGGG
T ss_pred HHHHhCCCcccccCCCCCCHHHH--HHHCCCHHHHHHHHHcCCCccccccccCCCChhHHHHHHhhHHHHHHHHHcCCcc
Confidence 45788999999999999999865 7888889999999999999998764 6999999999999999999999999875
Q ss_pred ---CCccCCCCchhhHHHhcChHHHHHHHHhcCCCCC
Q 016152 95 ---NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSY 128 (394)
Q Consensus 95 ---~~~~~~g~t~l~~A~~~~~~~~~~~L~~~ga~~~ 128 (394)
+..+.++.||++.|+.+|+.+++++|++.|+++.
T Consensus 188 ~~~~~~~~~~~t~l~~A~~~g~~~iv~~Ll~~ga~~~ 224 (346)
T d2ajaa1 188 ATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLA 224 (346)
T ss_dssp HHHHHHHHHHHHHHHHHSTTCCHHHHHHHTTSHHHHH
T ss_pred cccccccCCCcchhhHHhhcCHHHHHHHHHhCCCCcc
Confidence 4455677888899999999999999999988653
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=4e-15 Score=120.80 Aligned_cols=93 Identities=20% Similarity=0.141 Sum_probs=68.4
Q ss_pred hhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHHH
Q 016152 42 AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLN 121 (394)
Q Consensus 42 a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~ 121 (394)
|+..+..+++++|++.|+|+|.+|.+|+||||+|+ .|+.+++++|+++|++++.++..|.||++.++..++.++++.|+
T Consensus 8 Aa~~g~~~~v~~Ll~~g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~ 86 (156)
T d1ihba_ 8 AAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLL 86 (156)
T ss_dssp HHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHH
T ss_pred HHHcCCHHHHHHHHHCCCCcCccCCcccccccccc-cccccccccccccccccccccccCcccccccccccccccccccc
Confidence 44444556666677778888888888888888765 67788888888888888888888888888888888888888887
Q ss_pred hcCCCCCCCCCCCC
Q 016152 122 AHGGLSYGQNGSHF 135 (394)
Q Consensus 122 ~~ga~~~~~~~s~~ 135 (394)
..+...+..+....
T Consensus 87 ~~~~~~~~~~~~~~ 100 (156)
T d1ihba_ 87 EFQADVNIEDNEGN 100 (156)
T ss_dssp HTTCCTTCCCTTSC
T ss_pred cccccccccccccc
Confidence 77776665544433
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=8e-15 Score=126.35 Aligned_cols=85 Identities=24% Similarity=0.179 Sum_probs=75.6
Q ss_pred hhcCCHHHHHHHHHhcCCCCcccc-CCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHHHHHHH
Q 016152 42 AHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120 (394)
Q Consensus 42 a~~~~~~~~~~~L~~~g~~vn~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L 120 (394)
|+..+..+++++|...|++++..+ .+|+||||+|+..|+.+++++|+++|||+|.+|.+|+||||+|+..++.+++++|
T Consensus 118 a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl~~A~~~~~~~~~~~l 197 (221)
T d1iknd_ 118 ASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQL 197 (221)
T ss_dssp HHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGCTTSSCHHHHHHH
T ss_pred HhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCHHHHHHHCCCHHHHHHH
Confidence 445555667777888888888765 5799999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCC
Q 016152 121 NAHGGL 126 (394)
Q Consensus 121 ~~~ga~ 126 (394)
.+.+.+
T Consensus 198 ~~~~~~ 203 (221)
T d1iknd_ 198 GQLTLE 203 (221)
T ss_dssp HTTSCG
T ss_pred HHcCCc
Confidence 988765
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.51 E-value=6.4e-15 Score=132.18 Aligned_cols=93 Identities=25% Similarity=0.288 Sum_probs=82.6
Q ss_pred ceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHhcChHH
Q 016152 36 SLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFN 115 (394)
Q Consensus 36 ~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~ 115 (394)
+.+++||..|+ .+++++|++.|+|+|.+|.+|+||||+|+..|+.++|++|+++|++++..+..+.|||+.|+..++.+
T Consensus 42 t~l~~A~~~G~-~~~v~~Ll~~Gadvn~~d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~~~~~ 120 (291)
T d1s70b_ 42 AVFLAACSSGD-TEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLD 120 (291)
T ss_dssp HHHHHHHHHTC-HHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHH
T ss_pred hHHHHHHHcCC-HHHHHHHHHCCCCCCccCCCCCcHHHHHHhcCCceeeeeecccccccccccccccccccccccccccc
Confidence 44455666555 66667777999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCC
Q 016152 116 MMELLNAHGGLSYG 129 (394)
Q Consensus 116 ~~~~L~~~ga~~~~ 129 (394)
+++.|+++|+....
T Consensus 121 ~~~~l~~~~~~~~~ 134 (291)
T d1s70b_ 121 IAEYLISQGAHVGA 134 (291)
T ss_dssp HHHHHHHTTCCTTC
T ss_pred hhhcccccCccccc
Confidence 99999999886543
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.51 E-value=2.4e-14 Score=123.61 Aligned_cols=108 Identities=25% Similarity=0.175 Sum_probs=91.9
Q ss_pred hccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcC-CCCCCccCCCCchhhH
Q 016152 29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG-ADVNAQDRWKNTPLAD 107 (394)
Q Consensus 29 ~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~g-a~~~~~~~~g~t~l~~ 107 (394)
.+..+.+++. .++..+..++.++|+..|.+.+.+|..|+||||+|+..|+.+++++|++.| .++|.+|.+|+||||+
T Consensus 101 ~~~~~~~~l~--~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~ 178 (229)
T d1ixva_ 101 ITNQGVTCLH--LAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFH 178 (229)
T ss_dssp CCTTSCCHHH--HHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHH
T ss_pred cccccccccc--cccccchhhhhhhhhhhcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCchhh
Confidence 3344444443 356667788999999999999999999999999999999999999999987 7899999999999999
Q ss_pred HHhcChHHHHHHHHh-cCCCCCCCCCCCCCCC
Q 016152 108 AEGAKKFNMMELLNA-HGGLSYGQNGSHFEPK 138 (394)
Q Consensus 108 A~~~~~~~~~~~L~~-~ga~~~~~~~s~~~p~ 138 (394)
|+..|+.+++++|++ .|++++..+....+|.
T Consensus 179 A~~~~~~~~v~~Ll~~~gad~~~~d~~g~t~l 210 (229)
T d1ixva_ 179 ALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAE 210 (229)
T ss_dssp HHHTTCHHHHHHHHHHHCCCSCCCCTTSCCTG
T ss_pred hcccccHHHHHHHHHhcCCCCCCcCCCCCCHH
Confidence 999999999999996 6999987776655544
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=3.7e-15 Score=127.25 Aligned_cols=86 Identities=27% Similarity=0.443 Sum_probs=76.9
Q ss_pred cccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHHh
Q 016152 31 RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG 110 (394)
Q Consensus 31 ~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~~ 110 (394)
..+.+++ +.|+..+...+.+.+++.|.+++.+|..|.||||+||..|+.+++++|+++|||+|.+|.+|+||||+|+.
T Consensus 142 ~~~~~~l--~~a~~~~~~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~TpL~~A~~ 219 (228)
T d1k1aa_ 142 KSGRSPL--IHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARS 219 (228)
T ss_dssp TTCCCHH--HHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTTCSS
T ss_pred cchhhHH--HHHHHhhhhhhhhhhhhhccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHh
Confidence 3444554 33666777888888889999999999999999999999999999999999999999999999999999999
Q ss_pred cChHHHHH
Q 016152 111 AKKFNMME 118 (394)
Q Consensus 111 ~~~~~~~~ 118 (394)
.|+.++||
T Consensus 220 ~~~~divk 227 (228)
T d1k1aa_ 220 RRVIDILR 227 (228)
T ss_dssp HHHHHHHT
T ss_pred CCCccccC
Confidence 99999885
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.50 E-value=1.1e-14 Score=117.64 Aligned_cols=113 Identities=27% Similarity=0.261 Sum_probs=75.3
Q ss_pred cchhhhhhccccCcceeeehhhcCCHHHHHHHHHhcCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCC
Q 016152 22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101 (394)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g 101 (394)
+|++++ .|..|.|++++ |+..+..++++.+.......+..+..+.++++.++...+.+++++|+.+|++++.+|.+|
T Consensus 24 ~ga~~~-~~~~g~t~L~~--a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g 100 (153)
T d1awcb_ 24 NGAPFT-TDWLGTSPLHL--AAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLK 100 (153)
T ss_dssp HTCCCC-CCTTCCCHHHH--HHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTS
T ss_pred cCCCcc-cccCCCccccc--cccccccccccccccccccccccccccccccccccccccceeeecccccCCccccccccC
Confidence 344333 34444444322 333333344444444444444444444455555555577778889999999999999999
Q ss_pred CchhhHHHhcChHHHHHHHHhcCCCCCCCCCCCCCC
Q 016152 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137 (394)
Q Consensus 102 ~t~l~~A~~~~~~~~~~~L~~~ga~~~~~~~s~~~p 137 (394)
+||||+|+..|+.+++++|++.|++++..+....+|
T Consensus 101 ~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~Tp 136 (153)
T d1awcb_ 101 MTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTA 136 (153)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred chHHHhhhhcchhheeeeccccccCCcccCCCCCCH
Confidence 999999999999999999999999988666554443
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.42 E-value=3.9e-14 Score=128.02 Aligned_cols=49 Identities=27% Similarity=0.398 Sum_probs=47.6
Q ss_pred CccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCccCCCCchhhHHH
Q 016152 61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAE 109 (394)
Q Consensus 61 vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t~l~~A~ 109 (394)
+|.+|.+|+||||+||++|+.++|++|+++|||+|.+|+.|+|||++|+
T Consensus 252 in~~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl~~A~ 300 (301)
T d1sw6a_ 252 LNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300 (301)
T ss_dssp TTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTC
T ss_pred ccCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHcC
Confidence 6889999999999999999999999999999999999999999999996
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=5.3e-14 Score=125.40 Aligned_cols=79 Identities=22% Similarity=0.239 Sum_probs=68.0
Q ss_pred CCCcchhhhhhccccCcceeeehhhcCCHHHHHHHHHh-cCCCCccccCCCCCHHHHHHhcCcHHHHHHHHHcCCCCCCc
Q 016152 19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE-DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97 (394)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~L~~-~g~~vn~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 97 (394)
+++.|++++.++..|.|+++. |+..+..+++++|++ .|+++|.+|.+|.||||+|+.+|+.++|++||++|||+|++
T Consensus 205 Li~~ga~~n~~~~~g~t~L~~--a~~~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~ 282 (285)
T d1wdya_ 205 LLDHGADVNVRGERGKTPLIL--AVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG 282 (285)
T ss_dssp HHHTTCCSSCCCTTSCCHHHH--HHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCS
T ss_pred HHHCCCCCCccCCCCCCccch--hhhcCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcc
Confidence 456788999999999998643 555555677777765 69999999999999999999999999999999999999999
Q ss_pred cC
Q 016152 98 DR 99 (394)
Q Consensus 98 ~~ 99 (394)
|.
T Consensus 283 d~ 284 (285)
T d1wdya_ 283 DL 284 (285)
T ss_dssp SC
T ss_pred cC
Confidence 83
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.61 E-value=9.4e-08 Score=83.22 Aligned_cols=140 Identities=14% Similarity=0.067 Sum_probs=89.1
Q ss_pred ccccceeecCCceEEEEEEECCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEEEEecc
Q 016152 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYL 237 (394)
Q Consensus 159 ~~~~~~iG~G~~g~V~~a~~~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~ 237 (394)
|++.+..+.++.+.||+....+..+++|.......... ..+.+|...++.+. +--+.+++.+..+++..++||+++
T Consensus 16 ~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~---~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l 92 (263)
T d1j7la_ 16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp SEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccch---hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence 33333333444568999887888899998754432221 23556777776664 334677888888888999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-------------------------------------------
Q 016152 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------------------------------------------- 274 (394)
Q Consensus 238 ~~~sL~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~------------------------------------------- 274 (394)
+|.++.+..... .....++.++.+.+..||+.
T Consensus 93 ~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T d1j7la_ 93 DGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp SSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred cccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence 998775543211 11222333444444444421
Q ss_pred --------------CCCeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 275 --------------PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 275 --------------~~~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
...++|+|+.|.|||+ ++++.+-|+||+.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~--~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFV--KDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHSCCCCCEEEECSCCCTTSEEE--ETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCcCCcEEEEeeccCcceee--cCCceEEEeechhccc
Confidence 1127999999999999 5555556999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=1.2e-05 Score=69.09 Aligned_cols=71 Identities=20% Similarity=0.153 Sum_probs=47.9
Q ss_pred ecCC-ceEEEEEEEC-CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC--CCceeeEEeEEEeCCeeEEEEeccCCCC
Q 016152 166 GKGS-FGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRGGD 241 (394)
Q Consensus 166 G~G~-~g~V~~a~~~-g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~~~~~lv~e~~~~~s 241 (394)
..|. .+.||+.... +..+++|.-..... ..+..|...++.+. .-.+.+++.+..+++..++||++++|.+
T Consensus 19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred CCcccCCeEEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3444 3678988775 45688897654332 23456677666553 2336778888888888999999998855
Q ss_pred H
Q 016152 242 L 242 (394)
Q Consensus 242 L 242 (394)
+
T Consensus 93 ~ 93 (255)
T d1nd4a_ 93 L 93 (255)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.85 E-value=2e-05 Score=72.36 Aligned_cols=78 Identities=19% Similarity=0.253 Sum_probs=47.0
Q ss_pred cceeecCCceEEEEEEEC--CccEEEEEeccCC----CCcHHHHHHHHHHHHHHHhCC-C--CceeeEEeEEEeCCeeEE
Q 016152 162 SAIIGKGSFGEILKAYWR--GTPVAIKRILPSL----SDDRLVIQDFRHEVNLLVKLR-H--PNIVQFLGAVTERKPLML 232 (394)
Q Consensus 162 ~~~iG~G~~g~V~~a~~~--g~~~avK~l~~~~----~~~~~~~~~~~~E~~~l~~l~-h--~~Iv~~~~~~~~~~~~~l 232 (394)
.+.||.|....||+.... ++.++||.-.+.. ..-.....+...|..+++.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 346899999999998753 5678999643311 000111233455777776653 2 346666654 4455688
Q ss_pred EEeccCCCC
Q 016152 233 ITEYLRGGD 241 (394)
Q Consensus 233 v~e~~~~~s 241 (394)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.59 E-value=0.0032 Score=55.50 Aligned_cols=69 Identities=7% Similarity=0.026 Sum_probs=42.1
Q ss_pred CCceEEEEEEE-CCccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCc--eeeEE-----eEEEeCCeeEEEEeccCC
Q 016152 168 GSFGEILKAYW-RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN--IVQFL-----GAVTERKPLMLITEYLRG 239 (394)
Q Consensus 168 G~~g~V~~a~~-~g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~-----~~~~~~~~~~lv~e~~~~ 239 (394)
+....||++.. +|..+++|+..+..... ..+..|...+..+.... ++..+ ..+...+..+.+++++.|
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 33468999876 58889999876543322 44566777776654211 11111 123455667889999876
Q ss_pred C
Q 016152 240 G 240 (394)
Q Consensus 240 ~ 240 (394)
.
T Consensus 109 ~ 109 (325)
T d1zyla1 109 R 109 (325)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.58 E-value=0.0049 Score=55.84 Aligned_cols=71 Identities=13% Similarity=0.150 Sum_probs=45.4
Q ss_pred ceeecCCceEEEEEEEC---------CccEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEeCCeeEE
Q 016152 163 AIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML 232 (394)
Q Consensus 163 ~~iG~G~~g~V~~a~~~---------g~~~avK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~l 232 (394)
+.|+.|-.-.+|++... ...+++++.- . .... ....+|..+++.+. +.-..++++++.+ ++
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 46778888899998754 2346666543 2 2222 23456888888775 3334577776643 68
Q ss_pred EEeccCCCCH
Q 016152 233 ITEYLRGGDL 242 (394)
Q Consensus 233 v~e~~~~~sL 242 (394)
|+||++|.+|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.94 E-value=0.028 Score=48.73 Aligned_cols=30 Identities=27% Similarity=0.259 Sum_probs=25.3
Q ss_pred CeEecCCCCCCEEEeeCCCCcEEEeecCCccc
Q 016152 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308 (394)
Q Consensus 277 ~ivH~Dikp~Nilv~~~~~~~~kl~DFg~a~~ 308 (394)
++||+|+.+.||++ +.+...-|+||+.+..
T Consensus 184 giIHgDl~~dNvl~--~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFF--LGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEE--ETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhc--ccccceeEeccccccc
Confidence 39999999999999 6665568999998864
|